PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chiou, YY; Hu, JC; Sancar, A; Selby, CP				Chiou, Yi-Ying; Hu, Jinchuan; Sancar, Aziz; Selby, Christopher P.			RNA polymerase II is released from the DNA template during transcription-coupled repair in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; GENOME-WIDE; PYRIMIDINE DIMERS; ESCHERICHIA-COLI; ACTIVE GENES; COCKAYNES-SYNDROME; THYMINE DIMER; MFD PROTEIN; DAMAGE; ELONGATION	In mammalian cells, bulky DNA adducts located in the template but not the coding strand of genes block elongation by RNA polymerase II (RNAPII). The blocked RNAPII targets these transcription-blocking adducts to undergo more rapid excision repair than adducts located elsewhere in the genome. In excision repair, coupled incisions are made in the damaged DNA strand on both sides of the adduct. The fate of RNAPII in the course of this transcription-coupled repair (TCR) pathway is unclear. To address the fate of RNAPII, we used methods that control transcription to initiate a discrete "wave" of elongation complexes. Analyzing genome-wide transcription and repair by next-generation sequencing, we identified locations of elongation complexes and transcription-repair coupling events in genes throughout the genome. Using UV-exposed human skin fibroblasts, we found that, at the dose used, a single wave of elongation complexes was blocked within the first 25 kb of genes. TCR occurred where the elongation complexes were blocked, and repair was associated with the dissociation of these complexes. These results indicate that individual elongation complexes do not engage in multiple rounds of TCR with successive lesions. Our results are consistent with a model in which RNAPII is dissociated after the dual incision of the transcription-blocking lesion, perhaps by Cockayne syndrome group B translocase, or during the synthesis of a repair patch.	[Chiou, Yi-Ying; Hu, Jinchuan; Sancar, Aziz; Selby, Christopher P.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chiou, Yi-Ying] Natl Chung Hsing Univ, Inst Biochem, Taichung 402, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Chung Hsing University	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	邱, 奕穎/E-8593-2018	邱, 奕穎/0000-0002-8742-8848; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [GM118102, ES027255]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Andrade-Lima LC, 2015, NUCLEIC ACIDS RES, V43, P2744, DOI 10.1093/nar/gkv148; DONAHUE BA, 1994, P NATL ACAD SCI USA, V91, P8502, DOI 10.1073/pnas.91.18.8502; Fan J, 2016, NATURE, V536, P234, DOI 10.1038/nature19080; Fuchs G, 2015, NAT PROTOC, V10, P605, DOI 10.1038/nprot.2015.035; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; Hara R, 1999, J BIOL CHEM, V274, P24779, DOI 10.1074/jbc.274.35.24779; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Laine JP, 2006, EMBO J, V25, P387, DOI 10.1038/sj.emboj.7600933; MacKinnon-Roy C, 2011, MUTAT RES-FUND MOL M, V706, P53, DOI 10.1016/j.mrfmmm.2010.10.010; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Nojima T, 2016, NAT PROTOC, V11, P413, DOI 10.1038/nprot.2016.012; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1990, J BIOL CHEM, V265, P21330; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Smerdon MJ, 1999, PROG NUCLEIC ACID RE, V62, P227; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Verhage RA, 1997, MOL GEN GENET, V254, P284, DOI 10.1007/s004380050417; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Xu J, 2017, NATURE, V551, P653, DOI 10.1038/nature24658	40	34	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2476	2486		10.1074/jbc.RA117.000971	http://dx.doi.org/10.1074/jbc.RA117.000971			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29282293	Green Published, hybrid			2022-12-28	WOS:000425308300020
J	Cui, CH; Chen, XN; Liu, Y; Cao, BJ; Xing, Y; Liu, CJ; Yang, F; Li, YA; Yang, TX; Hua, LY; Tian, M; Wei, YY; Gong, Y; Jiang, JH				Cui, Chunhong; Chen, Xiaoning; Liu, Ying; Cao, Benjin; Xing, Yang; Liu, Chanjuan; Yang, Fan; Li, Yinan; Yang, Tianxiao; Hua, Lingyang; Tian, Mi; Wei, Yuanyan; Gong, Ye; Jiang, Jianhai			1,4-Galactosyltransferase V activates Notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; endothelial cell; glycosyltransferase; cancer stem cells; differentiation; 4GalTV; Notch1; glioma stem-like cell; transdifferentiation	HUMAN BETA-1,4-GALACTOSYLTRANSFERASE-V GENE; POLY-N-ACETYLLACTOSAMINE; GROWTH-FACTOR; MALIGNANT GLIOMA; OVER-EXPRESSION; CANCER-CELLS; TUMOR-GROWTH; COLON-CANCER; GLYCOSYLATION; ANGIOGENESIS	Malignant glioblastoma multiforme is one of the most aggressive human cancers, with very low survival rates. Recent studies have reported that glioma stem-like cells transdifferentiate into endothelial cells, indicating a new mechanism for tumor angiogenesis and potentially providing new therapeutic options for glioblastoma treatment. Glioma malignancy is strongly associated with altered expression of N-linked oligosaccharide structures on the cell surface. We have previously reported that 1,4-galactosyltransferase V (1,4GalTV), which galactosylates the GlcNAc1-6Man arm of the branched N-glycans, is highly expressed in glioma and promotes glioma cell growth in vitro and in vivo. However, the mechanism by which 1,4GalTV stimulates glioma growth is unknown. Here we demonstrate that short hairpin RNA-mediated 1,4GalTV knockdown inhibits the tumorigenesis of glioma stem-like cells and reduces their transdifferentiation into endothelial cells. We also found that 1,4GalTV overexpression increased glioma stem-like cell transdifferentiation into endothelial cells and that this effect required 1,4GalTV galactosylation activity. Moreover, 1,4GalTV promoted 1,4-galactosylation of Notch1 and increased Notch1 protein levels. Of note, ectopic expression of activated Notch1 rescued the inhibitory effect of 1,4GalTV depletion on glioma stem-like cell transdifferentiation. In summary, our findings indicate that 1,4GalTV stimulates transdifferentiation of glioma stem-like cells into endothelial cells by activating Notch1 signaling. These detailed insights shed important light on the mechanisms regulating glioma angiogenesis.	[Cui, Chunhong; Chen, Xiaoning; Liu, Ying; Cao, Benjin; Xing, Yang; Liu, Chanjuan; Yang, Fan; Li, Yinan; Yang, Tianxiao; Wei, Yuanyan; Jiang, Jianhai] Fudan Univ, Key Lab Glycoconjugates Res, Dept Biochem & Mol Biol, Minist Publ Hlth,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Hua, Lingyang; Gong, Ye] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China; [Tian, Mi; Gong, Ye] Fudan Univ, Huashan Hosp, Dept Crit Care Med, Shanghai 200040, Peoples R China	Fudan University; Fudan University; Fudan University	Wei, YY; Jiang, JH (corresponding author), Fudan Univ, Key Lab Glycoconjugates Res, Dept Biochem & Mol Biol, Minist Publ Hlth,Shanghai Med Coll, Shanghai 200032, Peoples R China.; Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200040, Peoples R China.; Gong, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Crit Care Med, Shanghai 200040, Peoples R China.	yywei@fudan.edu.cn; drgongye_hs@126.com; jianhaijiang@fudan.edu.cn		Cui, Chunhong/0000-0002-7705-204X	Program for National Natural Scientific Foundation of China [31370807, 81472724, 81773164, 31770856]; National Key R&D Program of China [2016YFA0501303]	Program for National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by the Program for National Natural Scientific Foundation of China (31370807, 81472724, 81773164, and 31770856) and the National Key R&D Program of China (2016YFA0501303). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Banerjee A, 2011, J BIOL CHEM, V286, P29127, DOI 10.1074/jbc.M110.169771; BANERJEE DK, 1993, INDIAN J BIOCHEM BIO, V30, P389; Batista F, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098103; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; CAVENEE WK, 1992, CANCER, V70, P1788, DOI 10.1002/1097-0142(19920915)70:4+<1788::AID-CNCR2820701621>3.0.CO;2-L; Couldrey C, 2000, BREAST CANCER RES, V2, P321, DOI 10.1186/bcr75; Dawson G, 2004, J NEUROCHEM, V89, P1436, DOI 10.1111/j.1471-4159.2004.02435.x; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang J, 2006, J CELL PHYSIOL, V209, P261, DOI 10.1002/jcp.20749; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Funasaka T, 2014, GLYCOBIOLOGY, V24, P886, DOI 10.1093/glycob/cwu086; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Guo HB, 2014, J BIOL CHEM, V289, P31534, DOI 10.1074/jbc.M114.602680; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Hakomori S, 1996, CANCER RES, V56, P5309; Harvey BM, 2016, J BIOL CHEM, V291, P16348, DOI 10.1074/jbc.M116.732537; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Jackson MW, 2002, CANCER RES, V62, P854; Jafar-Nejad H, 2010, GLYCOBIOLOGY, V20, P931, DOI 10.1093/glycob/cwq053; Jiang JH, 2007, MOL CELL BIOL, V27, P8770, DOI 10.1128/MCB.02302-06; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kolmakova A, 2009, GLYCOCONJUGATE J, V26, P547, DOI 10.1007/s10719-008-9206-9; Lo NW, 1998, GLYCOBIOLOGY, V8, P517, DOI 10.1093/glycob/8.5.517; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nakajima K, 2014, NEOPLASIA, V16, P939, DOI 10.1016/j.neo.2014.09.005; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Platonova N, 2015, GENE CHROMOSOME CANC, V54, P516, DOI 10.1002/gcc.22264; Rebbaa A, 1997, J BIOL CHEM, V272, P9275; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sato T, 2004, J BIOL CHEM, V279, P39574, DOI 10.1074/jbc.M405805200; Sato T, 2001, BIOCHIMIE, V83, P719, DOI 10.1016/S0300-9084(01)01304-9; Sato T, 2007, J BIOL CHEM, V282, P27702, DOI 10.1074/jbc.M611862200; Schuster-Gossler K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-6; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang JG, 2017, NAT PROTOC, V12, P279, DOI 10.1038/nprot.2016.160; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei YY, 2008, CANCER LETT, V267, P96, DOI 10.1016/j.canlet.2008.03.019; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Xing Y, 2016, ONCOTARGET, V7, P36395, DOI 10.18632/oncotarget.8954; Xu S, 2002, J EXP CLIN CANC RES, V21, P409; Xu SL, 2001, J CANCER RES CLIN, V127, P502, DOI 10.1007/s004320100246; Yamamoto H, 2000, CANCER RES, V60, P134	60	9	9	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2219	2230		10.1074/jbc.RA117.000682	http://dx.doi.org/10.1074/jbc.RA117.000682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269413	Green Published, hybrid			2022-12-28	WOS:000424948000032
J	Wu, JY; Xiang, SY; Zhang, M; Fang, B; Huang, H; Kwon, OK; Zhao, YM; Yang, Z; Bai, WL; Bepler, G; Zhang, XM				Wu, Jheng-Yu; Xiang, Shengyan; Zhang, Mu; Fang, Bin; Huang, He; Kwon, Oh Kwang; Zhao, Yingming; Yang, Zhe; Bai, Wenlong; Bepler, Gerold; Zhang, Xiaohong Mary			Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; histone acetylase; histone deacetylase (HDAC); histone deacetylase 6 (HDAC6); mitogen-activated protein kinase (MAPK); extracellular signal-regulated kinase1; 2 (ERK1; 2); acetylation	PROTEIN-KINASES; CANCER-CELLS; GROWTH; ACETYLATION; INHIBITION; RAS; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; APOPTOSIS	Histone deacetylase 6 (HDAC6), a class IIb HDAC, plays an important role in many biological and pathological processes. Previously, we found that ERK1, a downstream kinase in the mitogen-activated protein kinase signaling pathway, phosphorylates HDAC6, thereby increasing HDAC6-mediated deacetylation of -tubulin. However, whether HDAC6 reciprocally modulates ERK1 activity is unknown. Here, we report that both ERK1 and -2 are acetylated and that HDAC6 promotes ERK1 activity via deacetylation. Briefly, we found that both ERK1 and -2 physically interact with HDAC6. Endogenous ERK1/2 acetylation levels increased upon treatment with a pan-HDAC inhibitor, an HDAC6-specific inhibitor, or depletion of HDAC6, suggesting that HDAC6 deacetylates ERK1/2. We also noted that the acetyltransferases CREB-binding protein and p300 both can acetylate ERK1/2. Acetylated ERK1 exhibits reduced enzymatic activity toward the transcription factor ELK1, a well-known ERK1 substrate. Furthermore, mass spectrometry analysis indicated Lys-72 as an acetylation site in the ERK1 N terminus, adjacent to Lys-71, which binds to ATP, suggesting that acetylation status of Lys-72 may affect ERK1 ATP binding. Interestingly, an acetylation-mimicking ERK1 mutant (K72Q) exhibited less phosphorylation than the WT enzyme and a deacetylation-mimicking mutant (K72R). Of note, the K72Q mutant displayed decreased enzymatic activity in an in vitro kinase assay and in a cellular luciferase assay compared with the WT and K72R mutant. Taken together, our findings suggest that HDAC6 stimulates ERK1 activity. Along with our previous report that ERK1 promotes HDAC6 activity, we propose that HDAC6 and ERK1 may form a positive feed-forward loop, which might play a role in cancer.	[Wu, Jheng-Yu; Zhang, Mu; Bepler, Gerold; Zhang, Xiaohong Mary] Karmanos Canc Inst, Dept Oncol, Mol Therapeut Program, Detroit, MI 48201 USA; [Wu, Jheng-Yu; Xiang, Shengyan; Bai, Wenlong] Univ S Florida, Morsani Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA; [Fang, Bin] H Lee Moffitt Canc Ctr & Res Inst, Prote Core, Tampa, FL 33612 USA; [Huang, He; Kwon, Oh Kwang; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yang, Zhe] Wayne State Univ, Sch Med, Dept Microbiol Immunol & Biochem, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; University of Chicago; Wayne State University	Zhang, XM (corresponding author), Karmanos Canc Inst, 4100 John R St, Detroit, MI 48201 USA.	zhangx@karmanos.org	Bai, Wenlong/A-8977-2013; XIANG, SHENGYAN/C-3176-2013	Bai, Wenlong/0000-0002-9536-0556; XIANG, SHENGYAN/0000-0002-6940-3559	Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida; National Institutes of Health [R01CA164147]; Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE [R01CA164147, P30CA022453] Funding Source: NIH RePORTER	Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karmanos Cancer Institute start-up funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01CA164147 and by Karmanos Cancer Institute start-up funds (to X. M. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by the Department of Pathology and Cell Biology, Morsani College of Medicine, University of South Florida.	Ahn MY, 2015, ONCOL REP, V33, P1899, DOI 10.3892/or.2015.3776; Bahr JC, 2016, ONCOTARGET, V7, P69804, DOI 10.18632/oncotarget.12001; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Carson R, 2015, CLIN CANCER RES, V21, P3230, DOI 10.1158/1078-0432.CCR-14-2701; Chuang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073401, 10.1371/journal.pone.0083116]; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inks ES, 2012, ACS CHEM BIOL, V7, P330, DOI 10.1021/cb200134p; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim IA, 2009, RADIOTHER ONCOL, V92, P125, DOI 10.1016/j.radonc.2009.03.008; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Patki M, 2013, J BIOL CHEM, V288, P11047, DOI 10.1074/jbc.M112.438473; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pillai VB, 2011, MOL CELL BIOL, V31, P2349, DOI 10.1128/MCB.01205-10; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Robinson MJ, 1996, BIOCHEMISTRY-US, V35, P5641, DOI 10.1021/bi952723e; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Seto E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018713; Tien SC, 2014, ONCOGENE, V33, P2938, DOI 10.1038/onc.2013.241; Vougiouklakis T, 2015, ONCOTARGET, V6, P43162, DOI 10.18632/oncotarget.6351; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Williams KA, 2013, J BIOL CHEM, V288, P33156, DOI 10.1074/jbc.M113.472506; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu CR, 2007, CLIN CANCER RES, V13, P1140, DOI 10.1158/1078-0432.CCR-06-1751; Zhang LS, 2015, ONCOTARGET, V6, P9073, DOI 10.18632/oncotarget.3268; Zhang M, 2014, MOL CELL, V55, P31, DOI 10.1016/j.molcel.2014.04.028; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	46	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1976	1993		10.1074/jbc.M117.795955	http://dx.doi.org/10.1074/jbc.M117.795955			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259132	hybrid, Green Published			2022-12-28	WOS:000424948000012
J	Zhao, JB; Tian, Z; Kadomatsu, T; Xie, PY; Miyata, K; Sugizaki, T; Endo, M; Zhu, SS; Fan, HQ; Horiguchi, H; Morinaga, J; Terada, K; Yoshizawa, T; Yamagata, K; Oike, Y				Zhao, Jiabin; Tian, Zhe; Kadomatsu, Tsuyoshi; Xie, Peiyu; Miyata, Keishi; Sugizaki, Taichi; Endo, Motoyoshi; Zhu, Shunshun; Fan, Haoqiu; Horiguchi, Haruki; Morinaga, Jun; Terada, Kazutoyo; Yoshizawa, Tatsuya; Yamagata, Kazuya; Oike, Yuichi			Age-dependent increase in angiopoietin-like protein 2 accelerates skeletal muscle loss in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; catalase; exercise; inflammation; muscle atrophy; reactive oxygen species (ROS); senescence; ANGPTL2; sarcopenia; satellite cell	OXIDATIVE STRESS; SATELLITE CELLS; ANTIOXIDANT ENZYMES; ENDOTHELIAL-CELLS; STEM-CELLS; INFLAMMATION; SARCOPENIA; EXERCISE; ANGPTL2; ALPHA	Skeletal muscle atrophy, or sarcopenia, is commonly observed in older individuals and in those with chronic disease and is associated with decreased quality of life. There is recent medical and broad concern that sarcopenia is rapidly increasing worldwide as populations age. At present, strength training is the only effective intervention for preventing sarcopenia development, but it is not known how this exercise regimen counteracts this condition. Here, we report that expression of the inflammatory mediator angiopoietin-like protein 2 (ANGPTL2) increases in skeletal muscle of aging mice. Moreover, in addition to exhibiting increased inflammation and accumulation of reactive oxygen species (ROS), denervated atrophic skeletal muscles in a mouse model of denervation-induced muscle atrophy had increased ANGPTL2 expression. Interestingly, mice with a skeletal myocyte-specific Angptl2 knockout had attenuated inflammation and ROS accumulation in denervated skeletal muscle, accompanied by increased satellite cell activity and inhibition of muscular atrophy compared with mice harboring wildtype Angptl2. Moreover, consistent with these phenotypes, wildtype mice undergoing exercise training displayed decreased ANGPTL2 expression in skeletal muscle. In conclusion, ANGPTL2 up-regulation in skeletal myocytes accelerates muscle atrophy, and exercise-induced attenuation of ANGPTL2 expression in those tissues may partially explain how exercise training prevents sarcopenia.	[Zhao, Jiabin; Tian, Zhe; Kadomatsu, Tsuyoshi; Xie, Peiyu; Miyata, Keishi; Sugizaki, Taichi; Endo, Motoyoshi; Zhu, Shunshun; Fan, Haoqiu; Horiguchi, Haruki; Morinaga, Jun; Terada, Kazutoyo; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Miyata, Keishi] Kumamoto Univ, Grad Sch Med Sci, Dept Immunol Allergy & Vasc Biol, Kumamoto 8608556, Japan; [Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Grad Sch Med Sci, Dept Med Biochem, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Tian, Z; Oike, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	zhetian0118@gmail.com; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022; Endo, Motoyoshi/T-5840-2019	Miyata, Keishi/0000-0003-0336-1859; Yoshizawa, Tatsuya/0000-0002-5728-1996	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [17H05652]; Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST) [13417915]; CREST Programme of the Japan Agency for Medical Research and Development (AMED) [17gm0610007h0005]; Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED; Grants-in-Aid for Scientific Research [16H05328] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST); CREST Programme of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan Grant 17H05652 (to Y. O.), Core Research for Evolutional Science and Technology (CREST) Programme of the Japan Science and Technology Agency (JST) Grant 13417915 (to Y. O.), the CREST Programme of the Japan Agency for Medical Research and Development (AMED) Grant 17gm0610007h0005 (to Y. O.), and by the Project for Elucidating and Controlling Mechanisms of Aging and Longevity from AMED. The authors declare that they have no conflicts of interest with the contents of this article.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Farhat N, 2008, CAN J PHYSIOL PHARM, V86, P761, DOI 10.1139/Y08-082; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRONTERA WR, 1988, J APPL PHYSIOL, V64, P1038, DOI 10.1152/jappl.1988.64.3.1038; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Hawke TJ, 2005, EXERC SPORT SCI REV, V33, P63, DOI 10.1097/00003677-200504000-00002; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Jackson MJ, 2016, MOL ASPECTS MED, V50, P33, DOI 10.1016/j.mam.2016.05.002; Jang YC, 2011, COLD SH Q B, V76, P101, DOI 10.1101/sqb.2011.76.010652; Jansen S, 2009, REPRODUCTION, V138, P493, DOI 10.1530/REP-09-0038; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jo E, 2012, AGING CLIN EXP RES, V24, P412, DOI 10.3275/8464; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Montero-Fernandez N, 2013, EUR J PHYS REHAB MED, V49, P131; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Nakamura YK, 2009, NUTRITION, V25, P800, DOI 10.1016/j.nut.2009.01.003; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Poli G, 2000, IUBMB LIFE, V50, P315, DOI 10.1080/15216540051081092; Radak Z, 2002, PFLUG ARCH EUR J PHY, V445, P273, DOI 10.1007/s00424-002-0918-6; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; Seene T, 2012, ARCH GERONTOL GERIAT, V54, P374, DOI 10.1016/j.archger.2011.05.002; Shimamoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112900; Snijders T, 2017, CURR OPIN CLIN NUTR, V20, P186, DOI 10.1097/MCO.0000000000000360; Sullivan-Gunn MJ, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-104; Sung JY, 2000, IMMUNOPHARMACOLOGY, V47, P35, DOI 10.1016/S0162-3109(99)00185-X; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tian Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13016; Tian Z, 2013, J MOL CELL CARDIOL, V57, P1, DOI 10.1016/j.yjmcc.2013.01.004; Toyama T, 2004, BIOCHEM BIOPH RES CO, V324, P697, DOI 10.1016/j.bbrc.2004.09.110; Wang P, 2002, WORLD J GASTROENTERO, V8, P531, DOI 10.3748/wjg.v8.i3.531; Woods JA, 2012, AGING DIS, V3, P130; Zuo L, 2000, AM J PHYSIOL-CELL PH, V279, pC1058, DOI 10.1152/ajpcell.2000.279.4.C1058	44	17	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1596	1609		10.1074/jbc.M117.814996	http://dx.doi.org/10.1074/jbc.M117.814996			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29191837	hybrid, Green Published			2022-12-28	WOS:000424201700013
J	McFall, T; McKnight, B; Rosati, R; Kim, S; Huang, YF; Viola-Villegas, N; Ratnam, M				McFall, Thomas; McKnight, Brooke; Rosati, Rayna; Kim, Seongho; Huang, Yanfang; Viola-Villegas, Nerissa; Ratnam, Manohar			Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; estrogen; estrogen receptor; microRNA (miRNA); progesterone; tumor metastasis; luminal breast cancer; progesterone receptor	POSTMENOPAUSAL WOMEN; CELL AGGRESSIVENESS; MENSTRUAL-CYCLE; B-RECEPTORS; GROWTH; PROGESTINS; ISOFORMS; EXPRESSION; MDA-MB-231; MIGRATION	Distal metastasis of luminal breast cancer is frequent and incurable, yet the metastasis mechanisms are poorly understood. Estrogen, even at postmenopausal concentrations, suppresses invasiveness of luminal breast cancer cells through the estrogen receptor (ER). Invasive tumors overexpress the short progesterone receptor A (PR-A) isoform. Even at postmenopausal concentrations, progesterone activates PR-A, inducing invasiveness by counteracting estrogen's effects, particularly when cells are hypersensitized to progesterone by PR-A overexpression. To interrogate the role of this cross-talk in metastasis, we investigated selective cross-talk mechanisms of PR-A with ER. We developed a quantitative PCR-based lymph node infiltration assay to address the slowness of metastasis of tumor xenografts. We found that 15 microRNAs (miRNAs) are regulated by progesterone via PR-A, but not the longer PR-B isoform, with increased progesterone sensitivity when PR-A was overexpressed. Two of these miRNAs whose induction (miR-92a-3p) or repression (miR-26b-5p) by estrogen was suppressed by progesterone plus PR-A were critical for the PR-A-ER cross-talk causing a gene-regulatory pattern of invasiveness and metastasis and complete rescue of invasiveness in vitro. Constitutive expression of miR-92a-3p or inhibition of miR-26b-5p profoundly suppressed metastasis. Finally, in primary breast tumors, PR-A expression was correlated negatively with miR-92a-3p expression and positively with miR-26b-5p expression. Therefore, hormonal cross-talk of PR-A with ER is probably a fundamental mechanism that enables metastasis of luminal breast cancer. Moreover, miRNA biomarkers of hyperactive PR-A may help predict metastatic potential of luminal breast tumors. Further, miR-92a-3p and miR-26b-5p may reveal target pathways for selective intervention to suppress hormone-regulated metastasis, both pre- and postmenopause.	Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; Wayne State Univ, Dept Oncol, Detroit, MI 48201 USA	Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Ratnam, M (corresponding author), 4100 John R,HWCRC 840-1, Detroit, MI 48201 USA.	ratnamm@karmanos.org		Viola, Nerissa/0000-0003-4253-5639	National Institutes of Health R01 Grant [CA 140690]; NCI T-32 Fellowship [CA009531]; NATIONAL CANCER INSTITUTE [R01CA140690, T32CA009370, P30CA022453, T32CA009531] Funding Source: NIH RePORTER	National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI T-32 Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 Grant CA 140690 (to M. R.) and NCI T-32 Fellowship CA009531 (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	American Cancer Society, 2008, CANC FACTS FIG 2015; BAKKER GH, 1990, J STEROID BIOCHEM, V37, P789, DOI 10.1016/0960-0760(90)90421-G; Barnett JB, 2004, J CLIN ENDOCR METAB, V89, P776, DOI 10.1210/jc.2003-030506; Cardoso F, 2012, ANN ONCOL, V23, P11, DOI 10.1093/annonc/mds232; Chlebowski RT, 2013, JNCI-J NATL CANCER I, V105, P526, DOI 10.1093/jnci/djt043; Dai D, 2002, CANCER RES, V62, P881; Di Leva G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003311; Dunnwald LK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1639; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Gilam A, 2017, ONCOTARGET, V8, P25963, DOI 10.18632/oncotarget.15657; Gomez-Fernandez C, 2008, AM J CLIN PATHOL, V130, P879, DOI 10.1309/AJCPD1AO3YSYQYNW; Guttilla IK, 2012, TRENDS ENDOCRIN MET, V23, P73, DOI 10.1016/j.tem.2011.12.001; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Ibrahim YH, 2008, MOL CANCER RES, V6, P1491, DOI 10.1158/1541-7786.MCR-07-2173; JOHANSSON ED, 1969, ACTA ENDOCRINOL-COP, V61, P592, DOI 10.1530/acta.0.0610592; Kariagina A, 2013, HORM CANCER-US, V4, P371, DOI 10.1007/s12672-013-0158-6; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; LaCroix AZ, 2011, JAMA-J AM MED ASSOC, V305, P1305, DOI 10.1001/jama.2011.382; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang YY, 2010, MENOPAUSE, V17, P1040, DOI 10.1097/gme.0b013e3181d3dd0c; Lin VCL, 2001, CLIN CANCER RES, V7, P2880; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; MCDONNELL DP, 1994, J BIOL CHEM, V269, P11945; McFall T, 2015, ONCOTARGET, V6, P33146, DOI 10.18632/oncotarget.5082; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Missmer SA, 2004, JNCI-J NATL CANCER I, V96, P1856, DOI 10.1093/jnci/djh336; Miyamoto K, 2016, BRIT J CANCER, V115, P354, DOI 10.1038/bjc.2016.179; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; NEWTON CJ, 1986, J STEROID BIOCHEM, V24, P1033, DOI 10.1016/0022-4731(86)90356-0; Nilsson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036051; Oetken K., 2013, EFFECTS DIFFERENT ES; Ogba N, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0489-4; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Preusse M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151771; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Ries LAG, 2007, SEER CANC STAT REV 1; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Shatnawi A, 2007, MOL ENDOCRINOL, V21, P635, DOI 10.1210/me.2006-0274; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; Tan S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3644; Wickramasinghe NS, 2009, NUCLEIC ACIDS RES, V37, P2584, DOI 10.1093/nar/gkp117; Yamashita H., 2011, BREAST CANC CARCINOG, P331; Zhang XHF, 2013, CLIN CANCER RES, V19, P6389, DOI 10.1158/1078-0432.CCR-13-0838; Zhu AS, 2016, J CELL BIOCHEM, V117, P1370, DOI 10.1002/jcb.25428	49	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1163	1177		10.1074/jbc.M117.812438	http://dx.doi.org/10.1074/jbc.M117.812438			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29162724	hybrid, Green Published			2022-12-28	WOS:000423515000006
J	Monti, JLE; Montes, MR; Rossi, RC				Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.			Steady-state analysis of enzymes with non-Michaelis-Menten kinetics: The transport mechanism of Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme kinetics; enzyme mechanism; membrane transport; Na; K plus -ATPase; ATPase activity; Rb plus occlusion; kinetic mechanisms; non-Michaelis-Menten kinetics; steady-state kinetics	SODIUM-POTASSIUM PUMP; CRYSTAL-STRUCTURE; NA+,K+-ATPASE REACTIONS; HYDROLYSIS KINETICS; CATALYZED REACTIONS; K+-ATPASE; RED-CELLS; BINDING; NA; EXCHANGE	Procedures to define kinetic mechanisms from catalytic activity measurements that obey the Michaelis-Menten equation are well established. In contrast, analytical tools for enzymes displaying non-Michaelis-Menten kinetics are underdeveloped, and transient-state measurements, when feasible, are therefore preferred in kinetic studies. Of note, transient-state determinations evaluate only partial reactions, and these might not participate in the reaction cycle. Here, we provide a general procedure to characterize kinetic mechanisms from steady-state determinations. We described non-Michaelis-Menten kinetics with equations containing parameters equivalent to k(cat) and K-m and modeled the underlying mechanism by an approach similar to that used under Michaelis-Menten kinetics. The procedure enabled us to evaluate whether Na+/K+-ATPase uses the same sites to alternatively transport Na+ and K+. This ping-pong mechanism is supported by transient-state studies but contradicted to date by steady-state analyses claiming that the release of one cationic species as product requires the binding of the other (ternary-complex mechanism). To derive robust conclusions about the Na+/K+-ATPase transport mechanism, we did not rely on ATPase activity measurements alone. During the catalytic cycle, the transported cations become transitorily occluded (i.e. trapped within the enzyme). We employed radioactive isotopes to quantify occluded cations under steady-state conditions. We replaced K+ with Rb+ because K-42(+) has a short half-life, and previous studies showed that K+- and Rb+-occluded reaction intermediates are similar. We derived conclusions regarding the rate of Rb+ deocclusion that were verified by direct measurements. Our results validated the ping-pong mechanism and proved that Rb+ deocclusion is accelerated when Na+ binds to an allosteric, nonspecific site, leading to a 2-fold increase in ATPase activity.	[Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1053 Buenos Aires, DF, Argentina; [Monti, Jose L. E.; Montes, Monica R.; Rossi, Rolando C.] Univ Buenos Aires, CONICET, Inst Quim & Fis Quim Biol IQUIFI, RA-1053 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Monti, JLE (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1053 Buenos Aires, DF, Argentina.; Monti, JLE (corresponding author), Univ Buenos Aires, CONICET, Inst Quim & Fis Quim Biol IQUIFI, RA-1053 Buenos Aires, DF, Argentina.	litomonti@gmail.com		Monti, Jose Luis Eugenio/0000-0002-9508-7414	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-2014 1053]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 11220150100250CO]; Universidad de Buenos Aires Ciencia y Tecnica, Argentina [2014-2017 20020130100302BA]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires Ciencia y Tecnica, Argentina	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 2012-2014 1053, Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant PIP 11220150100250CO, and Universidad de Buenos Aires Ciencia y Tecnica Grant 2014-2017 20020130100302BA, Argentina. The authors declare that they have no conflicts of interest with the contents of this article.	ANTIA IJ, 1992, BRIT J CLIN PHARMACO, V34, P535, DOI 10.1111/j.1365-2125.1992.tb05659.x; Banerjee U, 2012, PROG NEURO-PSYCHOPH, V37, P56, DOI 10.1016/j.pnpbp.2011.12.006; BLOSTEIN R, 1985, J BIOL CHEM, V260, P829; BLOSTEIN R, 1983, J BIOL CHEM, V258, P7948; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; CHA S, 1968, J BIOL CHEM, V243, P820; CHIPPERFIELD AR, 1976, J PHYSIOL-LONDON, V260, P371, DOI 10.1113/jphysiol.1976.sp011520; Clarke RJ, 2003, ANN NY ACAD SCI, V986, P159, DOI 10.1111/j.1749-6632.2003.tb07154.x; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; Cornish-Bowden A., 2014, PERSPECT SCI, V1, P74, DOI DOI 10.1016/J.PISC.2014.02.006; Fedosova NU, 2003, BIOCHEMISTRY-US, V42, P3536, DOI 10.1021/bi0268302; FORBUSH B, 1987, J BIOL CHEM, V262, P11104; FORBUSH B, 1984, P NATL ACAD SCI-BIOL, V81, P5310, DOI 10.1073/pnas.81.17.5310; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; Garcia A, 2013, BIOPHYS J, V105, P2695, DOI 10.1016/j.bpj.2013.11.004; Garrahan P. J., 1976, CURRENT TOPICS MEMBR, VVol. 8, P29; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P159, DOI 10.1113/jphysiol.1967.sp008294; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P175, DOI 10.1113/jphysiol.1967.sp008295; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Glynn IM, 2002, ANNU REV PHYSIOL, V64, P1, DOI 10.1146/annurev.physiol.64.081501.130716; GLYNN IM, 1976, J PHYSIOL-LONDON, V256, P465, DOI 10.1113/jphysiol.1976.sp011333; HARA Y, 1986, J BIOCHEM, V99, P531, DOI 10.1093/oxfordjournals.jbchem.a135509; HARA Y, 1986, J BIOL CHEM, V261, P2655; HILL CM, 1977, MOL CELL BIOCHEM, V15, P173, DOI 10.1007/BF01734107; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; KARLISH SJD, 1974, ANN NY ACAD SCI, V242, P461, DOI 10.1111/j.1749-6632.1974.tb19110.x; Kaufman SB, 2006, J BIOL CHEM, V281, P15721, DOI 10.1074/jbc.M600953200; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Klodos I, 2002, KIDNEY INT, V62, P2097, DOI 10.1046/j.1523-1755.2002.00654.x; LEE KH, 1980, NATURE, V285, P338, DOI 10.1038/285338a0; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; Monti JLE, 2013, BBA-BIOMEMBRANES, V1828, P1374, DOI 10.1016/j.bbamem.2013.01.010; Nomenclature Committee of the International Union of Biochemistry (NC-IUB), 1983, ARCH BIOCHEM BIOPHYS, V224, P732, DOI [10.1016/0003-9861(83)90262-X, DOI 10.1016/0003-9861(83)90262-X6870287]; Nyblom M, 2013, SCIENCE, V342, P123, DOI 10.1126/science.1243352; PLESNER IW, 1985, BIOCHIM BIOPHYS ACTA, V818, P235, DOI 10.1016/0005-2736(85)90564-4; PLESNER L, 1988, BIOCHIM BIOPHYS ACTA, V937, P51, DOI 10.1016/0005-2736(88)90226-X; PLESNER L, 1985, BIOCHIM BIOPHYS ACTA, V818, P222, DOI 10.1016/0005-2736(85)90563-2; PLESNER L, 1988, BIOCHIM BIOPHYS ACTA, V937, P63, DOI 10.1016/0005-2736(88)90227-1; Plesner L, 1988, Prog Clin Biol Res, V268A, P335; POLVANI C, 1988, J BIOL CHEM, V263, P16757; ROBINSON JD, 1974, FEBS LETT, V38, P325, DOI 10.1016/0014-5793(74)80083-9; ROBINSON JD, 1973, ARCH BIOCHEM BIOPHYS, V156, P232, DOI 10.1016/0003-9861(73)90361-5; ROBINSON JD, 1974, ANN NY ACAD SCI, V242, P185, DOI 10.1111/j.1749-6632.1974.tb19090.x; ROSSI RC, 1989, BIOCHIM BIOPHYS ACTA, V981, P85, DOI 10.1016/0005-2736(89)90085-0; Rossi RC, 1999, ANAL BIOCHEM, V270, P276, DOI 10.1006/abio.1999.4094; SACHS JR, 1977, J PHYSIOL-LONDON, V273, P489, DOI 10.1113/jphysiol.1977.sp012106; SACHS JR, 1980, J PHYSIOL-LONDON, V302, P219; SACHS JR, 1986, J PHYSIOL-LONDON, V381, P149, DOI 10.1113/jphysiol.1986.sp016319; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; SCHULZ AR, 1994, ENZYME KINETICS DIAS; Segel IH., 1993, ENZYME KINETICS BEHA; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; WONG JTF, 1962, CAN J BIOCHEM PHYS, V40, P763	57	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1373	1385		10.1074/jbc.M117.799536	http://dx.doi.org/10.1074/jbc.M117.799536			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191836	Green Published, hybrid			2022-12-28	WOS:000423515000023
J	Morales, TGP; Ratia, K; Wang, DS; Gogos, A; Driver, TG; Federle, MJ				Morales, Tiara G. Perez; Ratia, Kiira; Wang, Duo-Sheng; Gogos, Artemis; Driver, Tom G.; Federle, Michael J.			A novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; O PEPO; PEPTIDE; EXPRESSION; VIRULENCE; RGG; PROTEIN; GROWTH; GENE; ROPB	Bacteria produce chemical signals (pheromones) to coordinate behaviors across a population in a process termed quorum sensing (QS). QS systems comprising peptide pheromones and their corresponding Rgg receptors are widespread among Firmicutes and may be useful targets for manipulating microbial behaviors, like suppressing virulence. The Rgg2/3 QS circuit of the human pathogen Streptococcus pyogenes controls genes affecting resistance to host lysozyme in response to short hydrophobic pheromones (SHPs). Considering that artificial activation of a QS pathway may be as useful in the objective of manipulating bacteria as inhibiting it, we sought to identify small-molecule inducers of the Rgg2/3 QS system. We report the identification of a small molecule, P516-0475, that specifically induced expression of Rgg2/3-regulated genes in the presence of SHP pheromones at concentrations lower than typically required for QS induction. In searching for the mode of action of P516-0475, we discovered that an S. pyogenes mutant deficient in pepO, a neprilysin-like metalloendopeptidase that degrades SHP pheromones, was unresponsive to the compound. P516-0475 directly inhibited recombinant PepO in vitro as an uncompetitive inhibitor. We conclude that this compound induces QS by stabilizing SHP pheromones in culture. Our study indicates the usefulness of cell-based screens that modulate pathway activities to identify unanticipated therapeutic targets contributing to QS signaling.	[Morales, Tiara G. Perez; Federle, Michael J.] Univ Illinois, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA; [Ratia, Kiira] Univ Illinois, UIC High Throughput Screening Core Facil, Chicago, IL 60607 USA; [Wang, Duo-Sheng; Driver, Tom G.] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gogos, Artemis; Federle, Michael J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA; [Driver, Tom G.] Huaqiao Univ, Inst Next Generat Matter Transformat, Coll Chem Engn, Xiamen 361021, Fujian, Peoples R China	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Huaqiao University	Federle, MJ (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, 900 S Ashland Ave M-C870 3152 MBRB, Chicago, IL 60607 USA.	mfederle@uic.edu	Wang, Duo-Sheng/O-9846-2018	Wang, Duo-Sheng/0000-0002-3519-2386; Gogos, Artemis/0000-0002-0555-3814	National Institutes of Health [AI091779, AI125452]; Burroughs Wellcome Fund PATH award; Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125452, R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund PATH award(Burroughs Wellcome Fund); Chicago Biomedical Consortium; Chicago Community Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI091779 and AI125452, the Burroughs Wellcome Fund PATH award, and the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2014, J BIOL CHEM, V289, P15833, DOI 10.1074/jbc.M113.530212; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Aggarwal C, 2015, MBIO, V6, DOI 10.1128/mBio.00393-15; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Bayes-Genis A, 2016, J AM COLL CARDIOL, V68, P639, DOI 10.1016/j.jacc.2016.04.060; Bland ND, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-16; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Chang JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168461; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chen YQ, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.492; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dandekar AA, 2012, SCIENCE, V338, P264, DOI 10.1126/science.1227289; Do H, 2017, P NATL ACAD SCI USA, V114, pE8498, DOI 10.1073/pnas.1705972114; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Gryllos I, 2008, P NATL ACAD SCI USA, V105, P16755, DOI 10.1073/pnas.0803815105; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Makthal N, 2016, MOL MICROBIOL, V99, P1119, DOI 10.1111/mmi.13294; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Neely MN, 2003, J BACTERIOL, V185, P5166, DOI 10.1128/JB.185.17.5166-5174.2003; Parashar V, 2015, P NATL ACAD SCI USA, V112, P5177, DOI 10.1073/pnas.1500357112; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; SULAVIK MC, 1992, J BACTERIOL, V174, P3577, DOI 10.1128/JB.174.11.3577-3586.1992; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Velarde JJ, 2014, J BIOL CHEM, V289, P36315, DOI 10.1074/jbc.M114.605394; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438	37	5	5	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					931	940		10.1074/jbc.M117.810994	http://dx.doi.org/10.1074/jbc.M117.810994			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203527	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000422864500014
J	Yang, TH; Fang, LL; Sanders, S; Jayanthi, S; Rajan, G; Podicheti, R; Thallapuranam, SK; Mockaitis, K; Medina-Bolivar, F				Yang, Tianhong; Fang, Lingling; Sanders, Sheri; Jayanthi, Srinivas; Rajan, Gayathri; Podicheti, Ram; Thallapuranam, Suresh Kumar; Mockaitis, Keithanne; Medina-Bolivar, Fabricio			Stilbenoid prenyltransferases define key steps in the diversification of peanut phytoalexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIS-HYPOGAEA SEEDS; RNA-SEQ; ASPERGILLUS-FLAVUS; IN-VIVO; MOLECULAR CHARACTERIZATION; ACCURATE ALGORITHM; SOPHORA-FLAVESCENS; NMR-SPECTRA; RESVERATROL; ALIGNMENT	Defense responses of peanut (Arachis hypogaea) to biotic and abiotic stresses include the synthesis of prenylated stilbenoids. Members of this compound class show several protective activities in human disease studies, and the list of potential therapeutic targets continues to expand. Despite their medical and biological importance, the biosynthetic pathways of prenylated stilbenoids remain to be elucidated, and the genes encoding stilbenoid-specific prenyltransferases have yet to be identified in any plant species. In this study, we combined targeted transcriptomic and metabolomic analyses to discover prenyltransferase genes in elicitor-treated peanut hairy root cultures. Transcripts encoding five enzymes were identified, and two of these were functionally characterized in a transient expression system consisting of Agrobacterium-infiltrated leaves of Nicotiana benthamiana. We observed that one of these prenyltransferases, AhR4DT-1, catalyzes a key reaction in the biosynthesis of prenylated stilbenoids, in which resveratrol is prenylated at its C-4 position to form arachidin-2, whereas another, AhR3'DT-1, added the prenyl group to C-3' of resveratrol. Each of these prenyltransferases was highly specific for stilbenoid substrates, and we confirmed their subcellular location in the plastid by fluorescence microscopy. Structural analysis of the prenylated stilbenoids suggested that these two prenyltransferase activities represent the first committed steps in the biosynthesis of a large number of prenylated stilbenoids and their derivatives in peanut. In summary, we have identified five candidate prenyltransferases in peanut and confirmed that two of them are stilbenoid-specific, advancing our understanding of this specialized enzyme family and shedding critical light onto the biosynthesis of bioactive stilbenoids.	[Yang, Tianhong; Fang, Lingling; Medina-Bolivar, Fabricio] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR 72401 USA; [Yang, Tianhong] Arkansas State Univ, Mol Biosci Grad Program, Jonesboro, AR 72401 USA; [Medina-Bolivar, Fabricio] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Sanders, Sheri; Mockaitis, Keithanne] Indiana Univ, Pervas Technol Inst, Bloomington, IN 47408 USA; [Rajan, Gayathri; Podicheti, Ram] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Mockaitis, Keithanne] Indiana Univ, Dept Biol, Bloomington, IN 47408 USA; [Jayanthi, Srinivas; Thallapuranam, Suresh Kumar] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 47408 USA	Arkansas State University; Arkansas State University; Arkansas State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Arkansas System; University of Arkansas Fayetteville	Medina-Bolivar, F (corresponding author), Arkansas Biosci Inst, POB 639, State Univ, AR 72467 USA.	fmedinabolivar@astate.edu	Jayanthi, Srinivas/AAD-2808-2019	Podicheti, Ram/0000-0003-3449-5155; Jayanthi, Srinivas/0000-0001-7357-760X	National Science Foundation-EPSCoR [EPS 0701890]; National Science Foundation [DBI-1458641, ABI-1062432]	National Science Foundation-EPSCoR(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	The Center for Plant-Powered Production-P3 was funded by National Science Foundation-EPSCoR Grant EPS 0701890. The Indiana University, National Center for Genome Analysis Support was funded by the National Science Foundation Grants DBI-1458641 and ABI-1062432 (to Indiana University, National Center for Genome Analysis Support). Facility support was also received from the Arkansas Science and Technology Authority and the Arkansas Biosciences Institute.	AGUAMAH GE, 1981, PHYTOCHEMISTRY, V20, P1381, DOI 10.1016/0031-9422(81)80044-1; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Akashi T, 2009, PLANT PHYSIOL, V149, P683, DOI 10.1104/pp.108.123679; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Araya-Cloutier C, 2017, FOOD CHEM, V226, P193, DOI 10.1016/j.foodchem.2017.01.026; Ball JM, 2015, ADV VIROL, V2015, DOI 10.1155/2015/293524; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Castillo AM, 2011, J MAGN RESON, V209, P123, DOI 10.1016/j.jmr.2010.12.008; Chang JC, 2006, J AGR FOOD CHEM, V54, P10281, DOI 10.1021/jf0620766; Chen RD, 2013, ADV SYNTH CATAL, V355, P1817, DOI 10.1002/adsc.201300196; Condori Jose, 2011, BMC Res Notes, V4, P392, DOI 10.1186/1756-0500-4-392; Condori J, 2010, PLANT PHYSIOL BIOCH, V48, P310, DOI 10.1016/j.plaphy.2010.01.008; COOKSEY CJ, 1988, PHYTOCHEMISTRY, V27, P1015, DOI 10.1016/0031-9422(88)80263-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Gambini J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/837042; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Huang CP, 2010, J AGR FOOD CHEM, V58, P12123, DOI 10.1021/jf102993j; Huang H, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001911; INGHAM JL, 1976, PHYTOCHEMISTRY, V15, P1791, DOI 10.1016/S0031-9422(00)97494-6; Karamat F, 2014, PLANT J, V77, P627, DOI 10.1111/tpj.12409; KEEN NT, 1976, PHYTOCHEMISTRY, V15, P1794, DOI 10.1016/S0031-9422(00)97495-8; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JH, 2014, CHEMBIOCHEM, V15, P1672, DOI 10.1002/cbic.201402160; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Medina-Bolivar Fabricio, 2004, Methods Mol Biol, V267, P351; Medrano Giuliana, 2009, V483, P51, DOI 10.1007/978-1-59745-407-0_4; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Puksasook T, 2017, J NAT MED-TOKYO, V71, P665, DOI 10.1007/s11418-017-1097-2; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shen GA, 2012, PLANT PHYSIOL, V159, P70, DOI 10.1104/pp.112.195271; Sobolev VS, 2006, PHYTOCHEM ANALYSIS, V17, P312, DOI 10.1002/pca.920; Sobolev VS, 2016, J AGR FOOD CHEM, V64, P579, DOI 10.1021/acs.jafc.5b04753; Sobolev VS, 2013, J AGR FOOD CHEM, V61, P1850, DOI 10.1021/jf3054752; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Sobolev VS, 2010, J AGR FOOD CHEM, V58, P875, DOI 10.1021/jf903410e; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; Wang HM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0513-6; Wang RS, 2014, J BIOL CHEM, V289, P35815, DOI 10.1074/jbc.M114.608265; WOTTON HR, 1985, J GEN MICROBIOL, V131, P487; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu ZY, 2011, J AGR FOOD CHEM, V59, P5993, DOI 10.1021/jf200776w; Yang TH, 2016, PLANT PHYSIOL, V171, P2483, DOI 10.1104/pp.16.00610; Yang T, 2015, J AGR FOOD CHEM, V63, P3942, DOI 10.1021/jf5050266; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023	63	24	24	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					28	46		10.1074/jbc.RA117.000564	http://dx.doi.org/10.1074/jbc.RA117.000564			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158266	Green Published, hybrid			2022-12-28	WOS:000419453200003
J	Conway, LC; Cardarelli, RA; Moore, YE; Jones, K; McWilliams, LJ; Baker, DJ; Burnham, MP; Burli, RW; Wang, Q; Brandon, NJ; Moss, SJ; Deeb, TZ				Conway, Leslie C.; Cardarelli, Ross A.; Moore, Yvonne E.; Jones, Karen; McWilliams, Lisa J.; Baker, David J.; Burnham, Matthew P.; Burli, Roland W.; Wang, Qi; Brandon, Nicholas J.; Moss, Stephen J.; Deeb, Tarek Z.			N-Ethylmaleimide increases KCC2 cotransporter activity by modulating transporter phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; epilepsy; GABA receptor; membrane protein; phosphorylation; KCC2; N-ethylmaleimide	K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NEUROPATHIC PAIN; NA+-K+-2CL(-) COTRANSPORT; PROTEIN PHOSPHATASE; NITRATE TRANSPORTER; HUMAN-ERYTHROCYTES; KCL COTRANSPORT; ACTIVATION; CELL	K+/Cl- cotransporter 2 (KCC2) is selectively expressed in the adult nervous system and allows neurons to maintain low intracellular Cl- levels. Thus, KCC2 activity is an essential prerequisite for fast hyperpolarizing synaptic inhibition mediated by type A -aminobutyric acid (GABA(A)) receptors, which are Cl--permeable, ligand-gated ion channels. Consistent with this, deficits in the activity of KCC2 lead to epilepsy and are also implicated in neurodevelopmental disorders, neuropathic pain, and schizophrenia. Accordingly, there is significant interest in developing activators of KCC2 as therapeutic agents. To provide insights into the cellular processes that determine KCC2 activity, we have investigated the mechanism by which N-ethylmaleimide (NEM) enhances transporter activity using a combination of biochemical and electrophysiological approaches. Our results revealed that, within 15 min, NEM increased cell surface levels of KCC2 and modulated the phosphorylation of key regulatory residues within the large cytoplasmic domain of KCC2 in neurons. More specifically, NEM increased the phosphorylation of serine 940 (Ser-940), whereas it decreased phosphorylation of threonine 1007 (Thr-1007). NEM also reduced with no lysine (WNK) kinase phosphorylation of Ste20-related proline/alanine-rich kinase (SPAK), a kinase that directly phosphorylates KCC2 at residue Thr-1007. Mutational analysis revealed that Thr-1007 dephosphorylation mediated the effects of NEM on KCC2 activity. Collectively, our results suggest that compounds that either increase the surface stability of KCC2 or reduce Thr-1007 phosphorylation may be of use as enhancers of KCC2 activity.	[Conway, Leslie C.; Cardarelli, Ross A.; Wang, Qi; Brandon, Nicholas J.; Moss, Stephen J.; Deeb, Tarek Z.] AstraZeneca Tufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Moore, Yvonne E.; Moss, Stephen J.; Deeb, Tarek Z.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Moore, Yvonne E.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Jones, Karen; Burnham, Matthew P.] AstraZeneca, IMED Biotech Unit, Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [McWilliams, Lisa J.; Baker, David J.] AstraZeneca, IMED Biotech Unit, Discovery Sci, Cambridge CB4 0WG, England; [Burli, Roland W.] AstraZeneca, IMED Biotech Unit, Neurosci, Cambridge CB21 6GH, England; [Wang, Qi; Brandon, Nicholas J.] AstraZeneca, Neurosci, IMED Biotech Unit, Boston, MA 02451 USA	Tufts University; University of London; University College London; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu		Burnham, Matthew/0000-0001-9136-937X; Brandon, Nicholas/0000-0002-3917-0096	AstraZeneca; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS080064] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funding from AstraZeneca. K. J., L. J. M., D. J. B., M. P. B., R. W. B., Q. W., and N. J. B. are full-time employees and shareholders of AstraZeneca. S. J. M. serves as a consultant for SAGE Therapeutics and AstraZeneca, relationships that are regulated by Tufts University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Bize I, 2000, J MEMBRANE BIOL, V177, P159, DOI 10.1007/s002320001109; Brown FC, 2015, BLOOD, V126, P2863, DOI 10.1182/blood-2014-10-609362; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Doyon N, 2013, EXPERT REV NEUROTHER, V13, P469, DOI [10.1586/ern.13.40, 10.1586/ERN.13.40]; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAJI DM, 1991, AM J PHYSIOL, V260, pC176, DOI 10.1152/ajpcell.1991.260.1.C176; LAUF PK, 1980, BIOCHEM BIOPH RES CO, V92, P1422, DOI 10.1016/0006-291X(80)90445-3; LAUF PK, 1985, J MEMBRANE BIOL, V88, P1, DOI 10.1007/BF01871208; Lavertu G, 2014, BRAIN, V137, P724, DOI 10.1093/brain/awt334; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Miles R., 2012, JASPERS BASIC MECH E; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saitsu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30072; Shen MR, 2001, P NATL ACAD SCI USA, V98, P14714, DOI 10.1073/pnas.251388798; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STEIN WD, 1986, AM J PHYSIOL, V250, pC523, DOI 10.1152/ajpcell.1986.250.4.C523; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Sun J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00386; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Titz S, 2015, NEUROPHARMACOLOGY, V95, P321, DOI 10.1016/j.neuropharm.2015.03.026; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; Zhang Z, 2013, MOL PHARMACOL, V84, P511, DOI 10.1124/mol.113.086496; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	53	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21253	21263		10.1074/jbc.M117.817841	http://dx.doi.org/10.1074/jbc.M117.817841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29092909	Green Published, hybrid			2022-12-28	WOS:000419013000004
J	Gonsberg, A; Jung, S; Ulbrich, S; Origi, A; Ziska, A; Baier, M; Koch, HG; Zimmermann, R; Winklhofer, KF; Tatzelt, J				Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Origi, Andrea; Ziska, Anke; Baier, Michael; Koch, Hans-Georg; Zimmermann, Richard; Winklhofer, Konstanze F.; Tatzelt, Joerg			The Sec61/SecY complex is inherently deficient in translocating intrinsically disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); intrinsically disordered protein; prion; protein secretion; protein translocation; SecY; Sec61; ER import	SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; PRION PROTEIN; QUALITY-CONTROL; NASCENT POLYPEPTIDE; SECRETORY PROTEINS; ESCHERICHIA-COLI; PROTEASOMAL DEGRADATION; MISLOCALIZED PROTEINS; RIBOSOME	About one-quarter to nearly one-third of the proteins synthesized in the cytosol of eukaryotic cells are integrated into the plasma membrane or are secreted. Translocation of secretory proteins into the lumen of the endoplasmic reticulum or the periplasm of bacteria is mediated by a highly conserved heterotrimeric membrane protein complex denoted Sec61 in eukaryotes and SecYEG in bacteria. To evaluate a possible modulation of the translocation efficiency by secondary structures of the nascent peptide chain, we performed a comparative analysis in bacteria, yeast, and mammalian cells. Strikingly, neither the bacterial SecY nor the eukaryotic Sec61 translocon was able to efficiently transport proteins entirely composed of intrinsically disordered domains (IDDs) or -strands. However, translocation could be restored by -helical domains in a position- and organism-dependent manner. In bacteria, we found that the -helical domains have to precede the IDD or -strands, whereas in mammalian cells, C-terminally located -helical domains are sufficient to promote translocation. Our study reveals an evolutionarily conserved deficiency of the Sec61/SecY complex to translocate IDDs and -strands in the absence of -helical domains. Moreover, our results may suggest that adaptive pathways co-evolved with the expansion of IDDs in the proteome of eukaryotic cells to increase the transport capacity of the Sec61 translocon.	[Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, D-44801 Bochum, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany; [Origi, Andrea; Koch, Hans-Georg] Albert Ludwigs Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Ziska, Anke; Zimmermann, Richard] Saarland Univ, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Res Grp Proteinopathies Neurodegenerat Dis, D-13353 Berlin, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Freiburg; Universitatsklinikum des Saarlandes; Robert Koch Institute	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	Joerg.Tatzelt@rub.de		Tatzelt, Jorg/0000-0001-5017-5528; Winklhofer, Konstanze/0000-0002-7256-8231; Jung, Sebastian/0000-0002-0365-5710	International Max Planck Research School in Chemical and Molecular Biology; Deutsche Forschungsgemeinschaft [TA 167/6, GRK 1326, ZI 234/13-1, Ko2184/8-1, RTG 2202]	International Max Planck Research School in Chemical and Molecular Biology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a short-term fellowship of the International Max Planck Research School in Chemical and Molecular Biology (to A. G.) and Deutsche Forschungsgemeinschaft Grants TA 167/6 (to J. T.), GRK 1326 (to A. Z.), ZI 234/13-1 (to R. Z.), and Ko2184/8-1 and RTG 2202 (to H. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Conti BJ, 2014, NAT STRUCT MOL BIOL, V21, P228, DOI 10.1038/nsmb.2779; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Dirndorfer D, 2013, J BIOL CHEM, V288, P13961, DOI 10.1074/jbc.M112.430264; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eberl H, 2002, BIOPHYS CHEM, V96, P293, DOI 10.1016/S0301-4622(02)00015-7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fujita H, 2011, J CELL SCI, V124, P4184, DOI 10.1242/jcs.086850; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Li AM, 2004, J BIOL CHEM, V279, P29469, DOI 10.1074/jbc.M402517200; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; Liang FC, 2012, J BIOL CHEM, V287, P12703, DOI 10.1074/jbc.M111.240903; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nouwen N, 2009, J MOL BIOL, V386, P1000, DOI 10.1016/j.jmb.2009.01.031; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Patterson MA, 2015, J BIOL CHEM, V290, P28944, DOI 10.1074/jbc.M115.672261; Pfeiffer NV, 2013, EMBO J, V32, P1036, DOI 10.1038/emboj.2013.46; Quan Shu, 2013, Methods Mol Biol, V966, P359, DOI 10.1007/978-1-62703-245-2_22; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	82	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21383	21396		10.1074/jbc.M117.788067	http://dx.doi.org/10.1074/jbc.M117.788067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29084847	Green Published, hybrid			2022-12-28	WOS:000419013000015
J	Kanemitsu, T; Tsurudome, Y; Kusunose, N; Oda, M; Matsunaga, N; Koyanagi, S; Ohdo, S				Kanemitsu, Takumi; Tsurudome, Yuya; Kusunose, Naoki; Oda, Masayuki; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro			Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; circadian rhythm; nucleoside; nucleotide metabolism; peroxisome proliferator-activated receptor (PPAR); uric acid; xanthine oxidase	PROLIFERATOR-ACTIVATED-RECEPTOR; POLYUNSATURATED FATTY-ACIDS; ALPHA ACTIVITY; INTESTINAL EXPRESSION; OXIDATIVE STRESS; CLOCK; LIVER; METABOLISM; PROTEIN; GENE	Xanthine oxidase (XOD), also known as xanthine dehydrogenase, is a rate-limiting enzyme in purine nucleotide degradation, which produces uric acid. Uric acid concentrations in the blood and liver exhibit circadian oscillations in both humans and rodents; however, the underlying mechanisms remain unclear. Here, we demonstrate that XOD expression and enzymatic activity exhibit circadian oscillations in the mouse liver. We found that the orphan nuclear receptor peroxisome proliferator-activated receptor- (PPAR) transcriptionally activated the mouse XOD gene and that bile acids suppressed XOD transactivation. The synthesis of bile acids is known to be under the control of the circadian clock, and we observed that the time-dependent accumulation of bile acids in hepatic cells interfered with the recruitment of the co-transcriptional activator p300 to PPAR, thereby repressing XOD expression. This time-dependent suppression of PPAR-mediated transactivation by bile acids caused an oscillation in the hepatic expression of XOD, which, in turn, led to circadian alterations in uric acid production. Finally, we also demonstrated that the anti-hyperuricemic effect of the XOD inhibitor febuxostat was enhanced by administering it at the time of day before hepatic XOD activity increased. These results suggest an underlying mechanism for the circadian alterations in uric acid production and also underscore the importance of selecting an appropriate time of day for administering XOD inhibitors.	[Kanemitsu, Takumi; Tsurudome, Yuya; Kusunose, Naoki; Oda, Masayuki; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Fukuoka 8128582, Japan; [Matsunaga, Naoya; Koyanagi, Satoru] Kyushu Univ, Dept Glocal Healthcare Sci, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; Tsurudome, Yuya/0000-0002-6454-9778; matsunaga2, naoya2/0000-0001-6226-8473	Japan Society for the Promotion of Science (JSPS) [16H02636, 17H06262]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by KAKENHI Grant-in-aid for Scientific Research 16H02636 and 17H06262 from the Japan Society for the Promotion of Science (JSPS) (to S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abhishek A, 2017, CLIN MED, V17, P54, DOI 10.7861/clinmedicine.17-1-54; Barsotti C, 2002, J BIOL CHEM, V277, P9865, DOI 10.1074/jbc.M111418200; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Committee on Biochemical Constituents and Their Analytical Regents, 1993, JPN J CLIN CHEM, V22, P300; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fustin JM, 2012, CELL REP, V1, P341, DOI 10.1016/j.celrep.2012.03.001; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gliozzi M, 2016, INT J CARDIOL, V213, P23, DOI 10.1016/j.ijcard.2015.08.087; Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; Han S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8231; Harris CM, 1997, J BIOL CHEM, V272, P28335, DOI 10.1074/jbc.272.45.28335; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; Lu YF, 2013, CHRONOBIOL INT, V30, P1135, DOI 10.3109/07420528.2013.805762; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; MINEMATSU S, 1995, EXP ANIM TOKYO, V44, P223, DOI 10.1538/expanim.44.223; Mochizuki K, 2002, GENE, V291, P271, DOI 10.1016/S0378-1119(02)00625-X; Moriwaki Y, 1996, HISTOCHEM CELL BIOL, V105, P71, DOI 10.1007/BF01450880; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Okamura A, 2014, J BIOL CHEM, V289, P25296, DOI 10.1074/jbc.M114.577023; ONEILL RD, 1990, BRAIN RES, V507, P267, DOI 10.1016/0006-8993(90)90281-F; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pandey A., 2012, NATL J PHYSL PHARM P, V2, P23; Ripperger JA, 2000, GENE DEV, V14, P679; ROSEMEYER H, 1983, EUR J BIOCHEM, V134, P513, DOI 10.1111/j.1432-1033.1983.tb07596.x; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; SHINOSAKI T, 1992, JPN J PHARMACOL, V58, P443, DOI 10.1254/jjp.58.443; Singh R, 2005, BIOMED PHARMACOTHER, V59, pS229, DOI 10.1016/S0753-3322(05)80037-X; Tapia E, 2013, AM J PHYSIOL-RENAL, V304, pF727, DOI 10.1152/ajprenal.00485.2012; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wada E, 2015, MOL PHARMACOL, V87, P314, DOI 10.1124/mol.114.094979; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Xu XX, 2016, PHARM BIOL, V54, P3151, DOI 10.1080/13880209.2016.1195847; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	48	24	26	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21397	21406		10.1074/jbc.M117.791285	http://dx.doi.org/10.1074/jbc.M117.791285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101234	hybrid, Green Published			2022-12-28	WOS:000419013000016
J	Taylor, AA				Taylor, Alexandra A.			A guy with a machine: Using NMR to study biological macromolecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						nuclear magnetic resonance (NMR); blood; hemoglobin; cell compartmentalization; protein structure						alexandraataylor@gmail.com						MOON RB, 1973, J BIOL CHEM, V248, P7276	1	0	0	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21381	21382		10.1074/jbc.CL117.001138	http://dx.doi.org/10.1074/jbc.CL117.001138			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29288240	Green Published, hybrid			2022-12-28	WOS:000419013000014
J	Yang, XN; Niu, YY; Liu, Y; Yang, Y; Wang, J; Cheng, XY; Liang, H; Wang, HS; Hu, YM; Lu, XY; Zhu, MX; Xu, TL; Tian, Y; Yu, Y				Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Cheng, Xiao-Yang; Liang, Hong; Wang, Heng-Shan; Hu, You-Min; Lu, Xiang-Yang; Zhu, Michael X.; Xu, Tian-Le; Tian, Yun; Yu, Ye			The nonproton ligand of acid-sensing ion channel 3 activates mollusk-specific FaNaC channels via a mechanism independent of the native FMRFamide peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); ion channel; ligand-binding protein; neuropeptide; small molecule; 2-guanidine-4-methylquinazoline (GMQ); FMRFamide (Phe-Met-Arg-Phe-NH2) peptides; FMRFamide peptide-gated sodium channel (FaNaC); acid-sensing ion channels (ASIC)	GATED NA+ CHANNEL; SODIUM-CHANNEL; MODULATION; AMILORIDE; CONTRIBUTES; EXPRESSION; CLONING; NEURONS; DOMAIN; ASIC3	The degenerin/epithelial sodium channel (DEG/ENaC) superfamily of ion channels contains subfamilies with diverse functions that are fundamental to many physiological and pathological processes, ranging from synaptic transmission to epileptogenesis. The absence in mammals of some DEG/ENaCs subfamily orthologues such as FMRFamide peptide-activated sodium channels (FaNaCs), which have been identified only in mollusks, indicates that the various subfamilies diverged early in evolution. We recently reported that the nonproton agonist 2-guanidine-4-methylquinazoline (GMQ) activates acid-sensing ion channels (ASICs), a DEG/ENaC subfamily mainly in mammals, in the absence of acidosis. Here, we show that GMQ also could directly activate the mollusk-specific FaNaCs. Differences in ion selectivity and unitary conductance and effects of substitutions at key residues revealed that GMQ and FMRFamide activate FaNaCs via distinct mechanisms. The presence of two activation mechanisms in the FaNaC subfamily diverging early in the evolution of DEG/ENaCs suggested that dual gating is an ancient feature in this superfamily. Notably, the GMQ-gating mode is still preserved in the mammalian ASIC subfamily, whereas FMRFamide-mediated channel gating was lost during evolution. This implied that GMQ activation may be essential for the functions of mammalian DEG/ENaCs. Our findings provide new insights into the evolution of DEG/ENaCs and may facilitate the discovery and characterization of their endogenous agonists.	[Yang, Xiao-Na; Niu, You-Ya; Lu, Xiang-Yang; Zhu, Michael X.; Tian, Yun; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China; [Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China; [Yang, Xiao-Na; Niu, You-Ya; Liu, Yan; Yang, Yang; Wang, Jin; Hu, You-Min; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China; [Niu, You-Ya] Hunan Univ Med, Dept Cell Biol & Genet, Huaihua 418000, Peoples R China; [Cheng, Xiao-Yang; Xu, Tian-Le] Shanghai Jiao Tong Univ, Dept Anat Histol & Embryol, Discipline Neurosci, Sch Med, Shanghai 200025, Peoples R China; [Liang, Hong; Wang, Heng-Shan] Guangxi Normal Univ, Sch Chem & Pharm, State Key Lab Chem & Mol Engn Med Resources, Guilin 541004, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Hunan Agricultural University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Guangxi Normal University; University of Texas System; University of Texas Health Science Center Houston	Tian, Y; Yu, Y (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200025, Peoples R China.; Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Shanghai 200025, Peoples R China.	tianyun@hunau.edu.cn; yuye@shsmu.edu.cn	Cheng, Xiaoyang/M-1257-2017; Pan, Ying-Ming/AAC-6424-2019; Cheng, Xiaoyang/N-9970-2019	Cheng, Xiaoyang/0000-0003-1446-2815; Cheng, Xiaoyang/0000-0003-1446-2815; Yu, Ye/0000-0002-4054-8543	National Program on Key Basic Research Project of China [2014CB910300/02]; National Natural Science Foundation of China [31570832, 21431001, 31170787, 81760626, 31400707]; Guangxi Foundation for Distinguished Experts; National Excellent Young Scientist Foundation of China [31222018]; Innovation Program of Shanghai Municipal Education Commission [14YZ034]; Research Foundation of Education Bureau of Hunan Province, China [17A153]	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Foundation for Distinguished Experts; National Excellent Young Scientist Foundation of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Research Foundation of Education Bureau of Hunan Province, China	This study was supported by National Program on Key Basic Research Project of China Grant 2014CB910300/02, National Natural Science Foundation of China Grants 31570832, 21431001, 31170787, 81760626, and 31400707, Guangxi Foundation for Distinguished Experts (2017), National Excellent Young Scientist Foundation of China Grant 31222018, Innovation Program of Shanghai Municipal Education Commission Grant 14YZ034, and Research Foundation of Education Bureau of Hunan Province, China Grant 17A153. The authors declare that they have no conflicts of interest with the contents of this article.	Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Arias RL, 2008, NEUROBIOL DIS, V31, P334, DOI 10.1016/j.nbd.2008.05.008; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Cabo R, 2015, HISTOCHEM CELL BIOL, V143, P267, DOI 10.1007/s00418-014-1278-y; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Cottrell GA, 2005, PFLUG ARCH EUR J PHY, V450, P168, DOI 10.1007/s00424-005-1385-7; Delaunay A, 2012, P NATL ACAD SCI USA, V109, P13124, DOI 10.1073/pnas.1120350109; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Furukawa Y, 2006, PFLUG ARCH EUR J PHY, V451, P646, DOI 10.1007/s00424-005-1498-z; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Green KA, 2002, PFLUG ARCH EUR J PHY, V443, P813, DOI 10.1007/s00424-001-0750-4; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kellenberger S, 2015, PHARMACOL REV, V67, P1, DOI 10.1124/pr.114.009225; Kreple CJ, 2014, NAT NEUROSCI, V17, P1083, DOI 10.1038/nn.3750; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li WG, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-88; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Marra S, 2016, EMBO J, V35, P414, DOI 10.15252/embj.201592335; McClenaghan C, 2016, J GEN PHYSIOL, V147, P497, DOI 10.1085/jgp.201611601; Niu YY, 2016, J BIOL CHEM, V291, P7571, DOI 10.1074/jbc.M115.710251; Omerbasic D, 2015, NEUROPHARMACOLOGY, V94, P80, DOI 10.1016/j.neuropharm.2014.12.007; Perry SJ, 2001, J NEUROSCI, V21, P5559, DOI 10.1523/JNEUROSCI.21-15-05559.2001; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smith RN, 2014, CHANNELS, V8, P49, DOI 10.4161/chan.26978; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM, V286, P24996, DOI 10.1074/jbc.M111.239558; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zhainazarov AB, 1998, J PHYSIOL-LONDON, V513, P19, DOI 10.1111/j.1469-7793.1998.019by.x; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	56	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21662	21675		10.1074/jbc.M117.814707	http://dx.doi.org/10.1074/jbc.M117.814707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123030	hybrid, Green Published			2022-12-28	WOS:000419013000040
J	Bengoechea, JA				Bengoechea, Jose A.			Vibrio cholerae amino acids go on the defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RESISTANCE	Gram-negative bacteria remodel their surfaces to interact with the environment, particularly to protect pathogens from immune surveillance and host defenses. The enzyme AlmG is known to be involved in remodeling the Vibrio cholerae surface, but its specific role was not clear. Anew study characterizes AlmG at the molecular level, showing it defies phylogenetic expectations to add amino acids to lipopolysaccharide (LPS). This LPS modification plays a pivotal role in V. cholerae resistance to antimicrobial peptides, weapons of the innate immune system against infections.	[Bengoechea, Jose A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Bengoechea, JA (corresponding author), Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland.	j.bengoechea@qub.ac.uk		Bengoechea, Jose/0000-0002-9677-8751	Biotechnology and Biomedical Sciences Research Council (BBSRC) [BB/P006078/1, BB/P020194/1, BB/N00700X/1]; Medical Research Council (MRC) [MR/R005893/1]; BBSRC [BB/N00700X/1, BB/P006078/1, BB/P020194/1] Funding Source: UKRI; MRC [MR/R005893/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P006078/1, BB/N00700X/1, BB/P020194/1] Funding Source: researchfish; Medical Research Council [MR/R005893/1] Funding Source: researchfish	Biotechnology and Biomedical Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Research in my laboratory is supported by the Biotechnology and Biomedical Sciences Research Council (BBSRC, Grants BB/P006078/1, BB/P020194/1, and BB/N00700X/1) and the Medical Research Council (MRC, Grant MR/R005893/1).	Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; Henderson JC, 2017, J BIOL CHEM, V292, P21205, DOI 10.1074/jbc.RA117.000131; Henderson JC, 2014, ACS CHEM BIOL, V9, P2382, DOI 10.1021/cb500438x; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Llobet E, 2015, P NATL ACAD SCI USA, V112, pE6369, DOI 10.1073/pnas.1508820112; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414	9	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21216	21217		10.1074/jbc.H117.000868	http://dx.doi.org/10.1074/jbc.H117.000868			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29273584	hybrid, Green Published			2022-12-28	WOS:000418453400035
J	Dannhauser, PN; Camus, SM; Sakamoto, K; Sadacca, LA; Torres, JA; Camus, MD; Briant, K; Vassilopoulos, S; Rothnie, A; Smith, CJ; Brodsky, FM				Dannhauser, Philip N.; Camus, Stephane M.; Sakamoto, Kazuho; Sadacca, L. Amanda; Torres, Jorge A.; Camus, Marine D.; Briant, Kit; Vassilopoulos, Stephane; Rothnie, Alice; Smith, Corinne J.; Brodsky, Frances M.			CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORM; COATED VESICLES; INSULIN-RESISTANCE; LIGHT-CHAINS; PROTEIN; AUXILIN; GLUT4; DISSOCIATION; ENDOCYTOSIS; MECHANISMS	Clathrins are cytoplasmic proteins that play essential roles in endocytosis and other membrane traffic pathways. Upon recruitment to intracellular membranes, the canonical clathrin triskelion assembles into a polyhedral protein coat that facilitates vesicle formation and captures cargo molecules for transport. The triskelion is formed by trimerization of three clathrin heavy-chain subunits. Most vertebrates have two isoforms of clathrin heavy chains, CHC17 and CHC22, generating two clathrins with distinct cellular functions. CHC17 forms vesicles at the plasma membrane for receptor-mediated endocytosis and at the trans-Golgi network for organelle biogenesis. CHC22 plays a key role in intracellular targeting of the insulin-regulated glucose transporter 4 (GLUT4), accumulates at the site of GLUT4 sequestration during insulin resistance, and has also been implicated in neuronal development. Here, we demonstrate that CHC22 and CHC17 share morphological features, in that CHC22 forms a triskelion and latticed vesicle coats. However, cellular CHC22-coated vesicles were distinct from those formed by CHC17. The CHC22 coat was more stable to pH change and was not removed by the enzyme complex that disassembles the CHC17 coat. Moreover, the two clathrins were differentially recruited to membranes by adaptors, and CHC22 did not support vesicle formation or transferrin endocytosis at the plasma membrane in the presence or absence of CHC17. Our findings provide biochemical evidence for separate regulation and distinct functional niches for CHC17 and CHC22 in human cells. Furthermore, the greater stability of the CHC22 coat relative to the CHC17 coat may be relevant to its excessive accumulation with GLUT4 during insulin resistance.	[Dannhauser, Philip N.; Camus, Stephane M.; Sadacca, L. Amanda; Camus, Marine D.; Briant, Kit; Brodsky, Frances M.] UCL, Div Biosci, London WC1E 6BT, England; [Dannhauser, Philip N.] Hannover Med Sch, Ctr Anat, Inst Cell Biol Electron Microscopy, D-30625 Hannover, Germany; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sakamoto, Kazuho] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Fukushima 9601295, Japan; [Vassilopoulos, Stephane] Inst Myol, F-75013 Paris, France; [Rothnie, Alice] Aston Univ, Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Smith, Corinne J.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Shizuoka, Sch Pharmaceut Sci, Dept Bioinformat Pharmacol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan	University of London; University College London; Hannover Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fukushima Medical University; UDICE-French Research Universities; Sorbonne Universite; Aston University; University of Warwick; University of Shizuoka	Brodsky, FM (corresponding author), UCL, Div Biosci, Gower St, London WC1E 6BT, England.	f.brodsky@ucl.ac.uk	Dannhauser, Philip/A-5675-2018; vassilopoulos, stéphane/F-6041-2014; vassilopoulos, stephane/AAF-3865-2021; Smith, Corinne/A-3170-2009; Rothnie, Alice/F-1358-2011	Dannhauser, Philip/0000-0002-6749-7678; vassilopoulos, stephane/0000-0003-0172-330X; Smith, Corinne/0000-0003-3364-7946; Rothnie, Alice/0000-0002-4259-7015; Briant, Kit/0000-0002-1368-6262; Camus, Stephane/0000-0002-4326-1724; Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health [R56-DK083589, P30-DK063720, R01-DK095663]; Wellcome Trust [107858/Z/15/Z]; American Heart Association; Japan Society for the Promotion of Science KAKENHI [25460338]; Royal Society; Medical Research Council [G0601125]; University College London Excellence Fellowship; BBSRC [BB/N008391/1, BB/K003461/1, BB/L018888/1] Funding Source: UKRI; MRC [G0601125] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N008391/1, BB/L018888/1, BB/K003461/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095663, R56DK083589, P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); American Heart Association(American Heart Association); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London Excellence Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R56-DK083589, P30-DK063720 (a Pilot and Feasibility Study from the UCSF DERC), and R01-DK095663, Wellcome Trust Investigator Award 107858/Z/15/Z (to F.M.B.), a grant from the American Heart Association (to S.M.C.), Japan Society for the Promotion of Science KAKENHI Grant 25460338 (to K.S.), an International Exchange Award by the Royal Society (to C.J.S. and F.M.B.), Medical Research Council Grant G0601125 (to C.J.S. and A.R.), and a University College London Excellence Fellowship (to P.N.D.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Dannhauser PN, 2015, TRAFFIC, V16, P519, DOI 10.1111/tra.12263; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Hood FE, 2009, J CELL SCI, V122, P2185, DOI 10.1242/jcs.046177; Hoshino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077787; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liu SH, 2001, EMBO J, V20, P272, DOI 10.1093/emboj/20.1.272; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nahorski MS, 2015, BRAIN, V138, P2147, DOI 10.1093/brain/awv149; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Rapoport I, 2008, MOL BIOL CELL, V19, P405, DOI 10.1091/mbc.E07-09-0870; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; UNANUE ER, 1981, CELL, V26, P439, DOI 10.1016/0092-8674(81)90213-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; UNGEWICKELL E, 1989, ANAL BIOCHEM, V179, P352, DOI 10.1016/0003-2697(89)90143-7; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wakeham DE, 2005, P NATL ACAD SCI USA, V102, P7209, DOI 10.1073/pnas.0502058102; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wilbur JD, 2010, DEV CELL, V18, P841, DOI 10.1016/j.devcel.2010.04.007; WOODWARD MP, 1978, P NATL ACAD SCI USA, V75, P4394, DOI 10.1073/pnas.75.9.4394; Young A, 2013, TRAFFIC, V14, P987, DOI 10.1111/tra.12085	37	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20834	20844		10.1074/jbc.M117.816256	http://dx.doi.org/10.1074/jbc.M117.816256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29097553	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000418453400003
J	Dimitrov, V; Bouttier, M; Boukhaled, G; Salehi-Tabar, R; Avramescu, RG; Memari, B; Hasaj, B; Lukacs, GL; Krawczyk, CM; White, JH				Dimitrov, Vassil; Bouttier, Manuella; Boukhaled, Giselle; Salehi-Tabar, Reyhaneh; Avramescu, Radu G.; Memari, Babak; Hasaj, Benedeta; Lukacs, Gergely L.; Krawczyk, Connie M.; White, John H.			Hormonal vitamin D up-regulates tissue-specific PD-L1 and PD-L2 surface glycoprotein expression in humans but not mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; immunology; inflammation; steroid hormone receptor; vitamin D; anti-tumor immunity; checkpoint inhibitors; inflammatory T cell responses; vitamin D signaling	INFLAMMATORY-BOWEL-DISEASE; SQUAMOUS-CELL CARCINOMA; T-CELLS; D-RECEPTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; DENDRITIC CELLS; CROHNS-DISEASE; CANCER	PD-L1 (programmed death ligand 1) and PD-L2 are cell-surface glycoproteins that interact with programmed death 1 (PD-1) on T cells to attenuate inflammation. PD-1 signaling has attracted intense interest for its role in a pathophysiological context: suppression of anti-tumor immunity. Similarly, vitamin D signaling has been increasingly investigated for its non-classical actions in stimulation of innate immunity and suppression of inflammatory responses. Here, we show that hormonal 1,25-dihydroxyvitamin D (1,25D) is a direct transcriptional inducer of the human genes encoding PD-L1 and PD-L2 through the vitamin D receptor, a ligand-regulated transcription factor. 1,25D stimulated transcription of the gene encoding PD-L1 in epithelial and myeloid cells, whereas the gene encoding the more tissue-restricted PD-L2 was regulated only in myeloid cells. We identified and characterized vitamin D response elements (VDREs) located in both genes and showed that 1,25D treatment induces cell-surface expression of PD-L1 in epithelial and myeloid cells. In co-culture experiments with primary human T cells, epithelial cells pretreated with 1,25D suppressed activation of CD4(+) and CD8(+) cells and inhibited inflammatory cytokine production in a manner that was abrogated by anti-PD-L1 blocking antibody. Consistent with previous observations of species-specific regulation of immunity by vitamin D, the VDREs are present in primate genes, but neither the VDREs nor the regulation by 1,25D is present in mice. These findings reinforce the physiological role of 1,25D in controlling inflammatory immune responses but may represent a double-edged sword, as they suggest that elevated vitamin D signaling in humans could suppress anti-tumor immunity.	[Dimitrov, Vassil; Bouttier, Manuella; Boukhaled, Giselle; Avramescu, Radu G.; Memari, Babak; Lukacs, Gergely L.; Krawczyk, Connie M.; White, John H.] McGill Univ, Dept Physiol, McIntyre Bldg,Rm 705B,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada; [Salehi-Tabar, Reyhaneh; Lukacs, Gergely L.; White, John H.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Hasaj, Benedeta; Krawczyk, Connie M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Krawczyk, CM (corresponding author), McGill Univ, Dept Physiol, McIntyre Bldg,Rm 705B,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.; White, JH (corresponding author), McGill Univ, Dept Physiol, McIntyre Bldg,Rm 1112,3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	connie.krawczyk@mcgill.ca; john.white@mcgill.ca	white, john h/N-9782-2013; Memari, Babak/W-2693-2018; Salehi Tabar, Reyhaneh/K-3633-2012	white, john h/0000-0002-4785-2687; Memari, Babak/0000-0002-4754-6217; Salehi Tabar, Reyhaneh/0000-0002-9111-6513; Boukhaled, Giselle/0000-0002-6567-6234; Lukacs, Gergely/0000-0003-0900-0675	Canadian Institutes of Health Research [MOP 106439]; Genome Quebec; Fonds de Recherche en Sante Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Quebec; Fonds de Recherche en Sante Quebec	This work was supported by grants from the Canadian Institutes of Health Research (MOP 106439) and Genome Quebec (to J. H. W.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a postdoctoral fellowship from the Fonds de Recherche en Sante Quebec.	Aguiar PN, 2016, IMMUNOTHERAPY-UK, V8, P1011, DOI 10.2217/imt-2016-0032; Akutsu N, 2001, MOL ENDOCRINOL, V15, P1127, DOI 10.1210/me.15.7.1127; An BS, 2010, MOL CELL BIOL, V30, P4890, DOI 10.1128/MCB.00180-10; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Bell RB, 2015, J ORAL MAXIL SURG, V73, pS107, DOI 10.1016/j.joms.2015.05.026; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YJ, 2011, CYTOKINE, V56, P231, DOI 10.1016/j.cyto.2011.06.004; Chiang KC, 2013, ANTI-CANCER AGENT ME, V13, P126, DOI 10.2174/187152013804487443; Cho YA, 2011, ORAL ONCOL, V47, P1148, DOI 10.1016/j.oraloncology.2011.08.007; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dimitrov V, 2016, J STEROID BIOCHEM, V164, P246, DOI 10.1016/j.jsbmb.2015.09.016; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fukaya T, 2010, BLOOD, V116, P2266, DOI 10.1182/blood-2009-10-250472; Gandini S, 2016, CRIT REV ONCOL HEMAT, V100, P88, DOI 10.1016/j.critrevonc.2016.02.001; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Gombart AF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-321; Gupta N, 2014, EUR J IMMUNOL, V44, P1363, DOI 10.1002/eji.201343701; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Heikkinen S, 2011, NUCLEIC ACIDS RES, V39, P9181, DOI 10.1093/nar/gkr654; Hirano F, 2005, CANCER RES, V65, P1089; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Jorgensen SP, 2010, ALIMENT PHARM THER, V32, P377, DOI 10.1111/j.1365-2036.2010.04355.x; Kabbani TCA, 2016, AM J GASTROENTEROL, V111, P712, DOI 10.1038/ajg.2016.53; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; Mayne ST, 2012, ANNU REV NUTR, V32, P369, DOI 10.1146/annurev-nutr-071811-150659; Moreno BH, 2015, BRIT J CANCER, V112, P1421, DOI 10.1038/bjc.2015.124; Mueller AC, 2015, MOL CELL BIOL, V35, P498, DOI 10.1128/MCB.01079-14; Okiyama N, 2014, J AUTOIMMUN, V53, P1, DOI 10.1016/j.jaut.2014.06.005; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Raftery T, 2015, UNITED EUR GASTROENT, V3, P294, DOI 10.1177/2050640615572176; Rahman S, 2017, NUCLEIC ACIDS RES, V45, P3017, DOI 10.1093/nar/gkw1220; Sadeghian M, 2016, NUTRITION, V32, P505, DOI 10.1016/j.nut.2015.11.008; Salehi-Tabar R, 2012, P NATL ACAD SCI USA, V109, P18827, DOI 10.1073/pnas.1210037109; Samson CM, 2012, J PEDIATR GASTR NUTR, V55, P679, DOI 10.1097/MPG.0b013e318262de16; Scandiuzzi L, 2014, CELL REP, V6, P625, DOI 10.1016/j.celrep.2014.01.020; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Verway M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003407; Wang TT, 2010, J BIOL CHEM, V285, P2237, DOI 10.1074/jbc.C109.071225; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; White JH, 2012, REV ENDOCR METAB DIS, V13, P21, DOI 10.1007/s11154-011-9195-z; Yang YF, 2016, ONCOTARGET, V7, P74350, DOI 10.18632/oncotarget.11291; Zhang TF, 2016, ONCOTARGET, V7, P73068, DOI 10.18632/oncotarget.12230	52	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20657	20668		10.1074/jbc.M117.793885	http://dx.doi.org/10.1074/jbc.M117.793885			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29061851	Green Published, hybrid			2022-12-28	WOS:000418267000027
J	Casasanta, MA; Yoo, CC; Smith, HB; Duncan, AJ; Cochrane, K; Varano, AC; Allen-Vercoe, E; Slade, DJ				Casasanta, Michael A.; Yoo, Christopher C.; Smith, Hans B.; Duncan, Alison J.; Cochrane, Kyla; Varano, Ann C.; Allen-Vercoe, Emma; Slade, Daniel J.			A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chemical biology; colorectal cancer; host-pathogen interaction; phospholipase A; protein secretion; Fusobacterium; autotransporter	INFECTIVE ENDOCARDITIS; BRAIN ABSCESSES; FAD-I; PROTEIN; INHIBITION; VIRULENCE; BINDING; MODEL; FAP2; A(2)	Fusobacterium nucleatum is an oral pathogen that is linked to multiple human infections and colorectal cancer. Strikingly, F. nucleatum achieves virulence in the absence of large, multiprotein secretion systems (Types I, II, III, IV, and VI), which are widely used by Gram-negative bacteria for pathogenesis. By contrast, F. nucleatum strains contain genomic expansions of Type V secreted effectors (autotransporters) that are critical for host cell adherence, invasion, and biofilm formation. Here, we present the first characterization of an F. nucleatum Type Vd phospholipase class A1 autotransporter (strain ATCC 25586, gene FN1704) that we hereby rename Fusobacterium phospholipase autotransporter (FplA). Biochemical analysis of multiple Fusobacterium strains revealed that FplA is expressed as a full-length 85-kDa outer membrane-embedded protein or as a truncated phospholipase domain that remains associated with the outer membrane. Whereas the role of Type Vd secretion in bacteria remains unidentified, we show that FplA binds with high affinity to host phosphoinositide-signaling lipids, revealing a potential role for this enzyme in establishing an F. nucleatum intracellular niche. To further analyze the role of FplA, we developed an fplA gene knock-out strain, which will guide future in vivo studies to determine its potential role in F. nucleatum pathogenesis. In summary, using recombinant FplA constructs, we have identified a biochemical toolbox that includes lipid substrates for enzymatic assays, potent inhibitors, and chemical probes to detect, track, and characterize the role of Type Vd secreted phospholipases in Gram-negative bacteria.	[Casasanta, Michael A.; Yoo, Christopher C.; Smith, Hans B.; Duncan, Alison J.; Slade, Daniel J.] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Cochrane, Kyla] British Columbia Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Cochrane, Kyla] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada; [Cochrane, Kyla] Simon Fraser Univ, Dept Biochem & Mol Biol, Burnaby, BC V5A 1S6, Canada; [Varano, Ann C.] Virginia Tech Caril Res Inst, Roanoke, VA 24016 USA; [Allen-Vercoe, Emma] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	Virginia Polytechnic Institute & State University; British Columbia Cancer Agency; University of British Columbia; Simon Fraser University; University of Guelph	Slade, DJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	dslade@vt.edu	Slade, Daniel/E-1329-2015	Slade, Daniel/0000-0001-5634-7220; Casasanta, Michael/0000-0001-6614-9623; Yoo, Christopher/0000-0003-0274-7960	Virginia Tech new faculty start-up funds; Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech); Canadian Cancer Society Research Institute	Virginia Tech new faculty start-up funds; Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported in part by Virginia Tech new faculty start-up funds and a seed grant from the Institute for Critical Technology and Applied Science (ICTAS, Virginia Tech) (to D. J. S.). This work was also supported in part through an Innovation grant from the Canadian Cancer Society Research Institute (to E. A. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006; ACKERMANN EJ, 1995, J BIOL CHEM, V270, P445, DOI 10.1074/jbc.270.1.445; Adibekian A., 2013, PROBE REPORTS NIH MO; Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264; Ahmed Z, 2015, WORLD J GASTROENTERO, V21, P3731, DOI 10.3748/wjg.v21.i12.3731; Albenne C, 2017, MOL MICROBIOL, V106, P505, DOI 10.1111/mmi.13832; Allewelt M, 2000, INFECT IMMUN, V68, P3998, DOI 10.1128/IAI.68.7.3998-4004.2000; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BANNAM TL, 1993, PLASMID, V29, P233, DOI 10.1006/plas.1993.1025; BENNETT CF, 1987, MOL PHARMACOL, V32, P587; Bhattacharyya S, 2016, INFECT IMMUN, V84, P1446, DOI 10.1128/IAI.01311-15; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Birmingham CL, 2007, AUTOPHAGY, V3, P442, DOI 10.4161/auto.4450; Brook I, 2008, ARCH CARDIOVASC DIS, V101, P665, DOI 10.1016/j.acvd.2008.08.008; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Coppenhagen-Glazer S, 2015, INFECT IMMUN, V83, P1104, DOI 10.1128/IAI.02838-14; Madeira PVD, 2016, J MOL BIOL, V428, P1790, DOI 10.1016/j.jmb.2016.03.012; Dahya V, 2015, AM J MED SCI, V349, P284, DOI 10.1097/MAJ.0000000000000388; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Desvaux M, 2005, BBA-BIOMEMBRANES, V1713, P92, DOI 10.1016/j.bbamem.2005.05.002; Dorrell N, 1999, GASTROENTEROLOGY, V117, P1098, DOI 10.1016/S0016-5085(99)70394-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fan EG, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0009-2015; Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3; Flores-Diaz M, 2016, MICROBIOL MOL BIOL R, V80, P597, DOI 10.1128/MMBR.00082-15; Gauthier S, 2011, J MATERN-FETAL NEO M, V24, P1329, DOI 10.3109/14767058.2010.550977; Gedik AH, 2014, PEDIATR PULM, V49, pE63, DOI 10.1002/ppul.22834; Gupta S, 2010, J BIOL CHEM, V285, P36523, DOI 10.1074/jbc.M110.133140; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Haake SK, 2006, PLASMID, V55, P27, DOI 10.1016/j.plasmid.2005.06.002; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Heckmann JG, 2003, CAN J NEUROL SCI, V30, P266, DOI 10.1017/S0317167100002717; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Howell HA, 2013, MBIO, V4, DOI 10.1128/mBio.00032-13; Huang Z., 1994, MEDIAT INFLAMM, V3, P307; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kapatral V, 2002, J BACTERIOL, V184, P2005, DOI 10.1128/JB.184.7.2005-2018.2002; Kaplan CW, 2010, INFECT IMMUN, V78, P4773, DOI 10.1128/IAI.00567-10; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lio YC, 1996, BBA-LIPID LIPID MET, V1302, P55, DOI 10.1016/0005-2760(96)00002-1; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Machado GBS, 2010, SHOCK, V33, P315, DOI 10.1097/SHK.0b013e3181b2b0f4; McGuire AM, 2014, MBIO, V5, DOI 10.1128/mBio.01864-14; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Perez Y., 2013, PROTOCOL EXCHANGE, DOI [10.1038/protex.2013.094, DOI 10.1038/PROTEX.2013.094]; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Randazzo A, 1998, J NAT PROD, V61, P571, DOI 10.1021/np9704922; Rashidi A, 2012, INDIAN J GASTROENTER, V31, P198, DOI 10.1007/s12664-012-0233-x; Rossiter AE, 2011, J BACTERIOL, V193, P4250, DOI 10.1128/JB.00192-11; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Salacha R, 2010, ENVIRON MICROBIOL, V12, P1498, DOI 10.1111/j.1462-2920.2010.02174.x; SCHEVITZ RW, 1995, NAT STRUCT BIOL, V2, P458, DOI 10.1038/nsb0695-458; Segall Y, 2003, TOXICOL SCI, V76, P131, DOI 10.1093/toxsci/kfg216; SHAMMAS NW, 1993, CLIN CARDIOL, V16, P72, DOI 10.1002/clc.4960160116; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tannaes T, 2005, FEMS IMMUNOL MED MIC, V44, P17, DOI 10.1016/j.femsim.2004.10.003; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Wilson MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117732; Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200	73	12	13	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20240	20254		10.1074/jbc.M117.819144	http://dx.doi.org/10.1074/jbc.M117.819144			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021252	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000417696400028
J	Kim, JK; Jang, HA; Kim, MS; Cho, JH; Lee, J; Di Lorenzo, F; Sturiale, L; Silipo, A; Molinaro, A; Lee, BL				Kim, Jiyeun Kate; Jang, Ho Am; Kim, Min Seon; Cho, Jae Hyun; Lee, Junbeom; Di Lorenzo, Flaviana; Sturiale, Luisa; Silipo, Alba; Molinaro, Antonio; Lee, Bok Luel			The lipopolysaccharide core oligosaccharide of Burkholderia plays a critical role in maintaining a proper gut symbiosis with the bean bug Riptortus pedestris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; insect; lipopolysaccharide (LPS); oligosaccharide; symbiosis	ESCHERICHIA-COLI; INNATE IMMUNITY; BACTERIAL LIPOPOLYSACCHARIDES; ANTIMICROBIAL PEPTIDES; INSECT GUT; O-ANTIGEN; BIOSYNTHESIS; ASSOCIATION; STINKBUG; COLONIZATION	Lipopolysaccharide, the outer cell-wall component of Gram-negative bacteria, has been shown to be important for symbiotic associations. We recently reported that the lipopolysaccharide O-antigen of Burkholderia enhances the initial colonization of the midgut of the bean bug, Riptortus pedestris. However, the midgut-colonizing Burkholderia symbionts lack the O-antigen but display the core oligosaccharide on the cell surface. In this study, we investigated the role of the core oligosaccharide, which directly interacts with the host midgut, in the Riptortus-Burkholderia symbiosis. To this end, we generated the core oligosaccharide mutant strains, wabS, wabO, waaF, and waaC, and determined the chemical structures of their oligosaccharides, which exhibited different compositions. The symbiotic properties of these mutant strains were compared with those of the wild-type and O-antigen-deficient wbiG strains. Upon introduction into Riptortus via the oral route, the core oligosaccharide mutant strains exhibited different rates of colonization of the insect midgut. The symbiont titers in fifth-instar insects revealed significantly reduced population sizes of the inner core oligosaccharide mutant strains waaF and waaC. These two strains also negatively affected host growth rate and fitness. Furthermore, R. pedestris individuals colonized with the waaF and waaC strains were vulnerable to septic bacterial challenge, similar to insects without a Burkholderia symbiont. Taken together, these results suggest that the core oligosaccharide from Burkholderia symbionts plays a critical role in maintaining a proper symbiont population and in supporting the beneficial effects of the symbiont on its host in the Riptortus-Burkholderia symbiosis.	[Kim, Jiyeun Kate] Kosin Univ, Dept Microbiol, Coll Med, Busan 49267, South Korea; [Jang, Ho Am; Kim, Min Seon; Cho, Jae Hyun; Lee, Junbeom; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Global Res Lab, Busan 46241, South Korea; [Di Lorenzo, Flaviana; Silipo, Alba; Molinaro, Antonio] Univ Napoli Federico II, Complesso Univ Monte S Angelo, Dipartimento Sci Chim, Via Cintia 4, I-80126 Naples, Italy; [Sturiale, Luisa] CNR, IPCB, Via P Gaifami 18, I-95126 Catania, Italy	Pusan National University; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR)	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Global Res Lab, Busan 46241, South Korea.	brlee@pusan.ac.kr	Silipo, Alba/L-5929-2014	Di Lorenzo, Flaviana/0000-0003-4821-0114	Ministry of Agriculture, Food and Rural Affairs [916009-02-1-SB020]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [NRF-2017R1A2B1002706]	Ministry of Agriculture, Food and Rural Affairs; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning	This work was supported by Ministry of Agriculture, Food and Rural Affairs Grant 916009-02-1-SB020 and Basic Science Research Program through the National Research Foundation of Korea funded by Ministry of Science, ICT, and Future Planning Grant NRF-2017R1A2B1002706. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; De Soyza A, 2008, INNATE IMMUN-LONDON, V14, P127, DOI 10.1177/1753425908093984; Di Lorenzo F, 2013, CHEMBIOCHEM, V14, P1105, DOI 10.1002/cbic.201300062; Dohi H, 2008, CHEM-EUR J, V14, P9530, DOI 10.1002/chem.200801279; Durka M, 2011, CHEM-EUR J, V17, P11305, DOI 10.1002/chem.201100396; Hassan AA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01027; Kikuchi Y, 2005, APPL ENVIRON MICROB, V71, P4035, DOI 10.1128/AEM.71.7.4035-4043.2005; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2014, MOL ECOL, V23, P1445, DOI 10.1111/mec.12479; Kikuchi Y, 2013, APPL ENVIRON MICROB, V79, P2088, DOI 10.1128/AEM.03299-12; Kikuchi Y, 2011, APPL ENVIRON MICROB, V77, P4075, DOI 10.1128/AEM.00358-11; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kim Jiyeun Kate, 2016, Developmental & Comparative Immunology, V64, P75, DOI 10.1016/j.dci.2016.01.005; Kim JK, 2016, DEV COMP IMMUNOL, V60, P202, DOI 10.1016/j.dci.2016.02.009; Kim JK, 2015, J BIOL CHEM, V290, P21042, DOI 10.1074/jbc.M115.651158; Kim JK, 2015, DEV COMP IMMUNOL, V53, P265, DOI 10.1016/j.dci.2015.07.006; Kim JK, 2015, ARCH INSECT BIOCHEM, V88, P4, DOI 10.1002/arch.21218; Kim JK, 2014, ISME J, V8, P552, DOI 10.1038/ismej.2013.168; Kim JK, 2013, APPL ENVIRON MICROB, V79, P4879, DOI 10.1128/AEM.01269-13; Kim JK, 2013, P NATL ACAD SCI USA, V110, pE2381, DOI 10.1073/pnas.1303228110; Lee DJ, 2017, DEV COMP IMMUNOL, V67, P427, DOI 10.1016/j.dci.2016.08.009; Lee JB, 2015, FEBS LETT, V589, P2784, DOI 10.1016/j.febslet.2015.08.022; LEONTEIN K, 1978, CARBOHYD RES, V62, P359, DOI 10.1016/S0008-6215(00)80882-4; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Molinaro A, 2015, CHEM-EUR J, V21, P500, DOI 10.1002/chem.201403923; Moreau F, 2008, BIOORG MED CHEM LETT, V18, P4022, DOI 10.1016/j.bmcl.2008.05.117; Ohbayashi T, 2015, P NATL ACAD SCI USA, V112, pE5179, DOI 10.1073/pnas.1511454112; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Post DMB, 2012, J BIOL CHEM, V287, P8515, DOI 10.1074/jbc.M111.324012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAFER A, 1994, J BACTERIOL, V176, P7309; Shibata TF, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00441-13; Silipo A, 2004, EUR J ORG CHEM, V2004, P2263, DOI 10.1002/ejoc.200400048; Silipo A, 2006, EUR J ORG CHEM, V2006, P4874, DOI 10.1002/ejoc.200600520; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Sturiale L, 2011, J MASS SPECTROM, V46, P1135, DOI 10.1002/jms.2000; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	46	18	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19226	19237		10.1074/jbc.M117.813832	http://dx.doi.org/10.1074/jbc.M117.813832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972189	hybrid, Green Published			2022-12-28	WOS:000416226700007
J	Tunduguru, R; Zhang, J; Aslamy, A; Salunkhe, VA; Brozinick, JT; Elmendorf, JS; Thurmond, DC				Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Brozinick, Joseph T.; Elmendorf, Jeffrey S.; Thurmond, Debbie C.			The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)-mediated glucose uptake into skeletal muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; glucose transporter type 4 (GLUT4); insulin resistance; serine; threonine protein kinase PAK 1 (PAK1); skeletal muscle; insulin signaling	GLUT4 TRANSLOCATION; N-WASP; ARP2/3 COMPLEX; INSULIN SENSITIVITY; PHOSPHATIDYLINOSITOL 3-KINASE; SYNTAXIN 4; TRANSPORT; KINASE; PAK1; ACTIVATION	Defects in translocation of the glucose transporter GLUT4 are associated with peripheral insulin resistance, preclinical diabetes, and progression to type 2 diabetes. GLUT4 recruitment to the plasma membrane of skeletal muscle cells requires F-actin remodeling. Insulin signaling in muscle requires p21-activated kinase-1 (PAK1), whose downstream signaling triggers actin remodeling, which promotes GLUT4 vesicle translocation and glucose uptake into skeletal muscle cells. Actin remodeling is a cyclic process, and although PAK1 is known to initiate changes to the cortical actin-binding protein cofilin to stimulate the depolymerizing arm of the cycle, how PAK1 might trigger the polymerizing arm of the cycle remains unresolved. Toward this, we investigated whether PAK1 contributes to the mechanisms involving the actin-binding and -polymerizing proteins neural Wiskott-Aldrich syndrome protein (N-WASP), cortactin, and ARP2/3 subunits. We found that the actin-polymerizing ARP2/3 subunit p41ARC is a PAK1 substrate in skeletal muscle cells. Moreover, co-immunoprecipitation experiments revealed that insulin stimulates p41ARC phosphorylation and increases its association with N-WASP coordinately with the associations of N-WASP with cortactin and actin. Importantly, all of these associations were ablated by the PAK inhibitor IPA3, suggesting that PAK1 activation lies upstream of these actin-polymerizing complexes. Using the N-WASP inhibitor wiskostatin, we further demonstrated that N-WASP is required for localized F-actin polymerization, GLUT4 vesicle translocation, and glucose uptake. These results expand the model of insulin-stimulated glucose uptake in skeletal muscle cells by implicating p41ARC as a new component of the insulin-signaling cascade and connecting PAK1 signaling to N-WASP-cortactin-mediated actin polymerization and GLUT4 vesicle translocation.	[Tunduguru, Ragadeepthi; Elmendorf, Jeffrey S.; Thurmond, Debbie C.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Aslamy, Arianne; Elmendorf, Jeffrey S.; Thurmond, Debbie C.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Thurmond, Debbie C.] City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Tunduguru, Ragadeepthi; Zhang, Jing; Aslamy, Arianne; Salunkhe, Vishal A.; Thurmond, Debbie C.] City Hope Natl Med Ctr, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Brozinick, Joseph T.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; City of Hope; City of Hope; Beckman Research Institute of City of Hope; Eli Lilly	Thurmond, DC (corresponding author), City Hope Natl Med Ctr, Diabet & Metab Res Inst, Dept Mol & Cellular Endocrinol, 1500 E Duarte Rd, Duarte, CA 91010 USA.; Thurmond, DC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dthurmond@coh.org	Tunduguru, Ragadeepthi/AAU-6056-2020; Zhang, Jing/E-4844-2013	Zhang, Jing/0000-0003-0391-7298; Tunduguru, Ragadeepthi/0000-0001-7075-5511	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512, R01DK067912, R01DK102233] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Susan Gunst and Dr. Simon Atkinson (Indiana University) for the N-WASP plasmid and sage advice and feedback on this project emanating from the doctoral dissertation of R. T. We also thank Lixuan Tackett, Erika Olson, and Rajakrishnan Veluthakal for technical assistance. The research reported in this publication also includes work performed in the Light Microscopy Core, supported by the NCI, National Institutes of Health under Award P30CA33572.	Abella JVG, 2016, NAT CELL BIOL, V18, P76, DOI 10.1038/ncb3286; Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Cheatham B, 1996, P NATL ACAD SCI USA, V93, P15169, DOI 10.1073/pnas.93.26.15169; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; De Meyts P., 2016, ENDOTEXT; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; FERRANNINI E, 1985, J CLIN INVEST, V76, P357, DOI 10.1172/JCI111969; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grassart A, 2010, TRAFFIC, V11, P1079, DOI 10.1111/j.1600-0854.2010.01075.x; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Guerriero CJ, 2007, AM J PHYSIOL-CELL PH, V292, pC1562, DOI 10.1152/ajpcell.00426.2006; Habegger KM, 2012, DIABETOLOGIA, V55, P457, DOI 10.1007/s00125-011-2334-y; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Ho H, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12058; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; KANAI F, 1993, J BIOL CHEM, V268, P14523; Khayat ZA, 2000, J CELL SCI, V113, P279; Kim YB, 2015, J BIOL CHEM, V290, P21076, DOI 10.1074/jbc.M115.675124; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Langlais P, 2012, J BIOL CHEM, V287, P39245, DOI 10.1074/jbc.M112.394148; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lim CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6951; Lopez JP, 2010, AM J PHYSIOL-ENDOC M, V299, pE772, DOI 10.1152/ajpendo.00199.2010; McCarthy AM, 2006, AM J PHYSIOL-CELL PH, V291, pC860, DOI 10.1152/ajpcell.00107.2006; Nazari H, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1262, DOI 10.1134/S0006297911110083; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Peterson JR, 2004, NAT STRUCT MOL BIOL, V11, P747, DOI 10.1038/nsmb796; Ramalingam L, 2014, DIABETOLOGIA, V57, P1476, DOI 10.1007/s00125-014-3227-7; Ramalingam L, 2013, CELL MOL LIFE SCI, V70, P2815, DOI 10.1007/s00018-012-1176-1; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Tunduguru R, 2014, BIOCHEM PHARMACOL, V92, P380, DOI 10.1016/j.bcp.2014.08.033; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Volchuk A, 1996, MOL BIOL CELL, V7, P1075, DOI 10.1091/mbc.7.7.1075; Vu V, 2013, J MOL ENDOCRINOL, V51, P155, DOI 10.1530/JME-13-0059; WALKER PS, 1990, J BIOL CHEM, V265, P1516; Wang RA, 2006, ONCOGENE, V25, P2931, DOI 10.1038/sj.onc.1209309; Wang ZX, 2011, J BIOL CHEM, V286, P41359, DOI 10.1074/jbc.M111.291500; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004	55	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19034	19043		10.1074/jbc.M117.801340	http://dx.doi.org/10.1074/jbc.M117.801340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972183	Green Published, hybrid			2022-12-28	WOS:000415848000026
J	Verhamme, IM				Verhamme, Ingrid M.			A novel antithrombin domain dictates the journey's end of a proteinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEASE; COMPLEX; ACTIVATION; INHIBITOR; MECHANISM; HEPARIN; SERPINS; SITE	Antithrombin (AT) is an anticoagulant serpin that irreversibly inactivates the clotting proteinases factor Xa and thrombin by forming covalent complexes with them. Mutations in its critical domains, such as those that impair the conformational rearrangement required for proteinase inactivation, increase the risk of venous thrombosis. Aguila et al. characterize for the first time the destabilizing effects of mutations in the region of AT that makes contact with the proteinase in the final acyl-enzyme complex. Their work adds new insight into the unique structural intricacies of the inhibitory mechanism.	[Verhamme, Ingrid M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, C3321A Med Ctr North, Nashville, TN 37232 USA	Vanderbilt University	Verhamme, IM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, C3321A Med Ctr North, Nashville, TN 37232 USA.	Ingrid.verhamme@vanderbilt.edu			National Institutes of Health [HL130018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL130018. The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Aguila S, 2017, J BIOL CHEM, V292, P16513, DOI 10.1074/jbc.M117.787325; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Maddur AA, 2013, J BIOL CHEM, V288, P32020, DOI 10.1074/jbc.M113.510990; Olson ST, 2011, PROG MOL BIOL TRANSL, V99, P185, DOI 10.1016/S1877-1173(11)99005-X; Stratikos E, 1997, P NATL ACAD SCI USA, V94, P453, DOI 10.1073/pnas.94.2.453; Swanson R, 2007, J BIOL CHEM, V282, P2305, DOI 10.1074/jbc.M609546200; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363	10	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16521	16522		10.1074/jbc.H117.787325	http://dx.doi.org/10.1074/jbc.H117.787325			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28986431	Green Published, hybrid			2022-12-28	WOS:000412414800011
J	Dolai, S; Liang, T; Orabi, AI; Xie, L; Holmyard, D; Javed, TA; Fernandez, NA; Xie, HL; Cattral, MS; Thurmond, DC; Thorn, P; Gaisano, HY				Dolai, Subhankar; Liang, Tao; Orabi, Abrahim I.; Xie, Li; Holmyard, Douglas; Javed, Tanveer A.; Fernandez, Nestor A.; Xie, Huanli; Cattral, Mark S.; Thurmond, Debbie C.; Thorn, Peter; Gaisano, Herbert Y.			Depletion of the membrane-fusion regulator Munc18c attenuates caerulein hyperstimulation-induced pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ACINAR-CELLS; BASOLATERAL EXOCYTOSIS; ALCOHOLIC PANCREATITIS; SEC1/MUNC18 PROTEINS; APICAL EXOCYTOSIS; ER STRESS; SNARE; AUTOPHAGY; SECRETION	Epithelial pancreatic acinar cells perform crucial functions in food digestion, and acinar cell homeostasis required for secretion of digestive enzymes relies on SNARE-mediated exocytosis. The ubiquitously expressed Sec1/Munc18 protein mammalian uncoordinated-18c (Munc18c) regulates membrane fusion by activating syntaxin-4 (STX-4) to bind cognate SNARE proteins to form a SNARE complex that mediates exocytosis in many cell types. However, in the acinar cell, Munc18c's functions in exocytosis and homeostasis remain inconclusive. Here, we found that pancreatic acini from Munc18c-depleted mice (Munc18c(+/-)) and human pancreas (lenti-Munc18c-shRNA-treated) exhibit normal apical exocytosis of zymogen granules (ZGs) in response to physiologic stimulation with the intestinal hormone cholecystokinin (CCK-8). However, when stimulated with supraphysiologic CCK-8 levels to mimic pancreatitis, Munc18c-depleted (Munc18c(+/-)) mouse acini exhibited a reduction in pathological basolateral exocytosis of ZGs resulting from a decrease in fusogenic STX-4 SNARE complexes. This reduced basolateral exocytosis in part explained the less severe pancreatitis observed in Munc18c(+/-) mice after hyperstimulation with the CCK-8 analog caerulein. Likely as a result of this secretory blockade, Munc18c-depleted acini unexpectedly activated a component of the endoplasmic reticulum (ER) stress response that contributed to autophagy induction, resulting in downstream accumulation of autophagic vacuoles and autolysosomes. We conclude that Munc18c's role in mediating ectopic basolateral membrane fusion of ZGs contributes to the initiation of CCK-induced pancreatic injury, and that blockade of this secretory process could increase autophagy induction.	[Dolai, Subhankar; Liang, Tao; Xie, Li; Fernandez, Nestor A.; Xie, Huanli; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Dolai, Subhankar; Liang, Tao; Xie, Li; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Orabi, Abrahim I.; Javed, Tanveer A.] UPMC, Childrens Hosp Pittsburgh, Div Pediat Gastroenterol, Pittsburgh, PA 15224 USA; [Holmyard, Douglas] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Cattral, Mark S.] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON M5G 2N2, Canada; [Thurmond, Debbie C.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA; [Thorn, Peter] Univ Sydney, Sch Biomed Sci, Sydney, NSW 2050, Australia	University of Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; City of Hope; Beckman Research Institute of City of Hope; University of Sydney	Dolai, S; Gaisano, HY (corresponding author), Rm 7368,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	subhankar.dolai@gmail.com; herbert.gaisano@utoronto.ca	Thorn, peter/F-7030-2010	Thorn, peter/0000-0002-3228-770X	3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation; Ontario Research Fund [19442]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102233, R01DK067912] Funding Source: NIH RePORTER	3D (Diet, Digestive Tract and Disease) Centre - Canadian Foundation for Innovation; Ontario Research Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Dr. Junichi Sadoshima (Rutgers New Jersey Medical School, Newark, New Jersey) for sending us the LC3B GFP adenovirus. We thank the patients, surgeons, pathologists, and staff of the University Health Network Program in Biospecimen Sciences who provided the normal pancreatic tissue in this project. Some of the equipment used in this study was supported by the 3D (Diet, Digestive Tract and Disease) Centre funded by the Canadian Foundation for Innovation and Ontario Research Fund Project Number 19442.	[Anonymous], 2012, PHYSL GASTROINTESTIN; Antonucci L, 2015, P NATL ACAD SCI USA, V112, pE6166, DOI 10.1073/pnas.1519384112; Archbold JK, 2014, CURR OPIN STRUC BIOL, V29, P44, DOI 10.1016/j.sbi.2014.09.003; Behrendorff N, 2011, J BIOL CHEM, V286, P29627, DOI 10.1074/jbc.M111.265199; Cosen-Binker LI, 2008, J CLIN INVEST, V118, P2535, DOI 10.1172/JCI34672; Cosen-Binker LI, 2007, GASTROENTEROLOGY, V132, P1527, DOI 10.1053/j.gastro.2007.01.042; Dolai S., 2012, REGULATION PHYSL PAT; Dolai S, 2012, GASTROENTEROLOGY, V143, P832, DOI 10.1053/j.gastro.2012.06.011; Dolai S, 2011, J BIOL CHEM, V286, P13638, DOI 10.1074/jbc.M110.201889; Fernandez NA, 2011, AM J PHYSIOL-CELL PH, V300, pC1513, DOI 10.1152/ajpcell.00433.2010; FERNANDEZDELCASTILLO C, 1994, SURGERY, V116, P497; Frossard JL, 2000, LANCET, V356, P766, DOI 10.1016/S0140-6736(05)73665-5; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Gaisano HY, 2001, J CLIN INVEST, V108, P1597; Gorelick FS, 2017, CELL MOL GASTROENTER, V4, P250, DOI 10.1016/j.jcmgh.2017.05.007; Gukovskaya AS, 2017, GASTROENTEROLOGY, V153, P1212, DOI 10.1053/j.gastro.2017.08.071; Hartwig W, 1999, GASTROENTEROLOGY, V117, P717, DOI 10.1016/S0016-5085(99)70466-X; Hess DA, 2016, MOL CELL BIOL, V36, P2931, DOI 10.1128/MCB.00366-16; Hetz C., 2018, MOL CELL; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kauppi M, 2002, J BIOL CHEM, V277, P43973, DOI 10.1074/jbc.M208315200; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kidd JF, 2002, J BIOL CHEM, V277, P6504, DOI 10.1074/jbc.M106802200; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubisch CH, 2007, AM J PHYSIOL-GASTR L, V292, pG1804, DOI 10.1152/ajpgi.00078.2007; Kubisch Constanze H, 2008, Expert Rev Gastroenterol Hepatol, V2, P249, DOI 10.1586/17474124.2.2.249; Lam PPL, 2007, TRAFFIC, V8, P605, DOI 10.1111/j.1600-0854.2007.00557.x; Liang T, 2017, J BIOL CHEM, V292, P5957, DOI 10.1074/jbc.M117.777433; Marciniak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078706; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Mukherjee R, 2016, GUT, V65, P1333, DOI 10.1136/gutjnl-2014-308553; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Pickett JA, 2005, J BIOL CHEM, V280, P1506, DOI 10.1074/jbc.M411967200; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; SALUJA A, 1985, AM J PHYSIOL, V249, pG702, DOI 10.1152/ajpgi.1985.249.6.G702; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Song S., 2017, J CELL PHYSL; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Talukdar R, 2016, GASTROENTEROLOGY, V151, P747, DOI 10.1053/j.gastro.2016.06.042; Tartakoff A M, 1974, Methods Enzymol, V31, P41; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang YR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1122, DOI 10.1152/ajpendo.00381.2006; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004	59	7	7	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2510	2522		10.1074/jbc.RA117.000792	http://dx.doi.org/10.1074/jbc.RA117.000792			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29284677	Green Published, hybrid			2022-12-28	WOS:000425308300023
J	Gau, D; Lewis, T; McDermott, L; Wipf, P; Koes, D; Roy, P				Gau, David; Lewis, Taber; McDermott, Lee; Wipf, Peter; Koes, David; Roy, Partha			Structure-based virtual screening identifies a small-molecule inhibitor of the profilin 1-actin interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ANGIOGENESIS; ACTIN; PHOSPHORYLATION; CYTOKINESIS; EFFICIENT; ACCURACY; INSIGHTS; DOCKING	Profilin 1 (Pfn1) is an important regulator of the actin cytoskeleton and plays a vital role in many actin-based cellular processes. Therefore, identification of a small-molecule intervention strategy targeted against the Pfn1-actin interaction could have broad utility in cytoskeletal research and further our understanding of the role of Pfn1 in actin-mediated biological processes. Based on an already resolved Pfn1-actin complex crystal structure, we performed structure-based virtual screening of small-molecule libraries to seek inhibitors of the Pfn1-actin interaction. We identified compounds that match the pharmacophore of the key actin residues of Pfn1-actin interaction and therefore have the potential to act as competitive inhibitors of this interaction. Subsequent biochemical assays identified two candidate compounds with nearly identical structures that can mitigate the effect of Pfn1 on actin polymerization in vitro. As a further proof-of-concept test for cellular effects of these compounds, we performed proximity ligation assays in endothelial cells (ECs) to demonstrate compound-induced inhibition of Pfn1-actin interaction. Consistent with the important role of Pfn1 in regulating actin polymerization and various fundamental actin-based cellular activities (migration and proliferation), treatment of these compounds reduced the overall level of cellular filamentous (F) actin, slowed EC migration and proliferation, and inhibited the angiogenic ability of ECs both in vitro and ex vivo. In summary, this study provides the first proof of principle of small-molecule-mediated interference with the Pfn1-actin interaction. Our findings may have potential general utility for perturbing actin-mediated cellular activities and biological processes.	[Gau, David; Wipf, Peter; Roy, Partha] Univ Pittsburgh, Dept Bioengn, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA; [Lewis, Taber; Wipf, Peter] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15219 USA; [McDermott, Lee; Koes, David] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roy, P (corresponding author), Univ Pittsburgh, Dept Bioengn, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.	Partha.Roy@pitt.edu	Gau, David M/G-8375-2011; Wipf, Peter/AAG-1771-2021; Koes, David Ryan/M-4523-2018	Gau, David M/0000-0002-3079-3692; Wipf, Peter/0000-0001-7693-5863; Koes, David Ryan/0000-0002-6892-6614; Roy, Partha/0000-0002-4946-8531	National Institutes of Health [2R01CA108607, R01GM108340, 2T32HL076124]; University of Pittsburgh Clinical and Translational Institute - National Institutes of Health [UL1TR001857]; National Science Foundation [2012139050]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001857] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Clinical and Translational Institute - National Institutes of Health; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 2R01CA108607 (to P. R.) and R01GM108340 (to D. K.) and a pilot grant (to D. K. and P. R.) from the University of Pittsburgh Clinical and Translational Institute (supported by the National Institutes of Health Grant UL1TR001857). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Predoctoral Fellowship 2012139050 and National Institutes of Health Cardiovascular Bioengineering Predoctoral Training Grant 2T32HL076124.	Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chan DSH, 2010, ANGEW CHEM INT EDIT, V49, P2860, DOI 10.1002/anie.200907360; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI 10.4161/cam.21832; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Ezezika OC, 2009, J BIOL CHEM, V284, P2088, DOI 10.1074/jbc.M807073200; Fan Y, 2014, NAT CELL BIOL, V16, P445, DOI 10.1038/ncb2954; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; FINKEL T, 1994, P NATL ACAD SCI USA, V91, P1510, DOI 10.1073/pnas.91.4.1510; Gau D, 2017, ANGIOGENESIS, V20, P663, DOI 10.1007/s10456-017-9560-y; Gauvin TJ, 2009, BIOCHEMISTRY-US, V48, P9327, DOI 10.1021/bi901354z; Goveia J, 2014, EMBO MOL MED, V6, P1105, DOI 10.15252/emmm.201404156; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Koes DR, 2013, J CHEM INF MODEL, V53, P1893, DOI 10.1021/ci300604z; Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW387, DOI 10.1093/nar/gks336; Koes DR, 2011, J CHEM INF MODEL, V51, P1307, DOI 10.1021/ci200097m; Kullmann JA, 2012, EMBO REP, V13, P75, DOI 10.1038/embor.2011.211; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; Lawrence HR, 2009, BIOORG MED CHEM LETT, V19, P3756, DOI 10.1016/j.bmcl.2009.04.124; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Moldovan NI, 1997, CURR BIOL, V7, P24, DOI 10.1016/S0960-9822(06)00024-8; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Mukherjee P, 2010, J CHEM INF MODEL, V50, P906, DOI 10.1021/ci1000373; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Schweinhuber SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117244; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	33	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2606	2616		10.1074/jbc.M117.809137	http://dx.doi.org/10.1074/jbc.M117.809137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29282288	hybrid, Green Published			2022-12-28	WOS:000425308300031
J	Li, H; Wang, Z; Li, YH; Fang, RP; Wang, HW; Shi, H; Zhang, XD; Zhang, WY; Ye, LH				Li, Hang; Wang, Zhen; Li, Yinghui; Fang, Runping; Wang, Huawei; Shi, Hui; Zhang, Xiaodong; Zhang, Weiying; Ye, Lihong			Hepatitis B X-interacting protein promotes the formation of the insulin gene-transcribing protein complex Pdx-1/Neurod1 in animal pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell; glucose; insulin; pancreas; transcription co-activator; transcription regulation; HBXIP; Neurod1; PDX-1	BREAST-CANCER CELLS; ISLET AMYLOID POLYPEPTIDE; CRE RECOMBINASE; TRANSCRIPTIONAL ACTIVATION; DIABETES-MELLITUS; INS-1 CELLS; HBXIP; PDX-1; EXPRESSION; SECRETION	The activation of insulin gene transcription depends on multiple nuclear proteins, including the transcription factors PDX-1 and NEUROD1, which form a transcriptional complex. We recently reported that hepatitis B X-interacting protein (HBXIP, also termed LAMTOR5) can modulate glucose metabolism reprogramming in cancer cells. However, the physiological role of HBXIP in the modulation of glucose metabolism in normal tissues is poorly understood. Here, we report that Hbxip is an essential regulator of the effect of the Pdx-1/Neurod1 complex on insulin gene transcription in murine pancreatic -cells in vitro and in vivo. We found that pancreatic -cell-specific Hbxip-knockout mice displayed higher fasting blood glucose levels and impaired glucose tolerance. Furthermore, Hbxip was involved in the regulation of insulin in the pancreas islets and increased insulin gene expression in rat pancreatic -cells. Mechanistically, Hbxip stimulated insulin enhancer activity by interacting with Pdx-1 and recruiting Neurod1 to Pdx-1. Functionally, we provide evidence that Hbxip is required for Pdx-1/Neurod1-mediated insulin expression in rat pancreatic -cells. Collectively, these results indicate that Hbxip is involved in the transcription of insulin by increasing the levels of the Pdx-1/Neurod1 complex in animal pancreatic -cells. Our finding provides the insight into the mechanism by which Hbxip stimulates the transcription of the insulin gene.	[Li, Hang; Wang, Zhen; Li, Yinghui; Fang, Runping; Wang, Huawei; Shi, Hui; Zhang, Weiying; Ye, Lihong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China; [Zhang, Xiaodong] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, WY; Ye, LH (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Dept Biochem, Tianjin 300071, Peoples R China.	zhwybao@nankai.edu.cn; yelihong@nankai.edu.cn	Fang, Runping/AAF-6835-2020		National Basic Research Program of China [2015CB553905]; National Natural Scientific Foundation of China [81372186, 31670771]; Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases [2016YFC1303401]	National Basic Research Program of China(National Basic Research Program of China); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases	This work was supported by National Basic Research Program of China Grant 973 Program No. 2015CB553905, National Natural Scientific Foundation of China Grants 81372186 and 31670771, and the Fundamental Research Funds for the Central Universities, Project of Prevention and Control of Key Chronic Non-Infectious Diseases Grant 2016YFC1303401. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad A, 2016, J CLIN RES PEDIATR E, V8, P270, DOI 10.4274/jcrpe.2819; Alcarraz-Vizan G, 2017, CELL MOL LIFE SCI, V74, P2827, DOI 10.1007/s00018-017-2505-1; Arcidiacono B, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00237; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bordone Laura, 2015, PLoS Biol, V13, pe1002346, DOI 10.1371/journal.pbio.1002346; BRUN T, 1993, J BIOL CHEM, V268, P18905; Chen F, 2016, DIABETOLOGIA, V59, P316, DOI 10.1007/s00125-015-3805-3; Chen H, 2012, J MOL CELL BIOL, V4, P256, DOI 10.1093/jmcb/mjs032; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Fan BS, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00079; Foti D, 2005, NAT MED, V11, P765, DOI 10.1038/nm1254; Furukawa N, 1999, ENDOCR J, V46, P43, DOI 10.1507/endocrj.46.43; Guo QS, 2012, EXP DIABETES RES, DOI 10.1155/2012/672013; Hambrock A, 2007, J BIOL CHEM, V282, P3347, DOI 10.1074/jbc.M608216200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jin J, 2013, BIOCHEM BIOPH RES CO, V430, P1228, DOI 10.1016/j.bbrc.2012.12.071; Josefsen K, 1996, J ENDOCRINOL, V149, P145, DOI 10.1677/joe.0.1490145; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Li CR, 2012, J MOL CELL BIOL, V4, P38, DOI 10.1093/jmcb/mjr040; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li H, 2015, J BIOL CHEM, V290, P22649, DOI 10.1074/jbc.M115.658468; Li HY, 2014, EMBO REP, V15, P714, DOI 10.1002/embr.201338181; Li YH, 2016, CANCER RES, V76, P293, DOI 10.1158/0008-5472.CAN-14-3607; Liu FB, 2015, ONCOTARGET, V6, P27199, DOI 10.18632/oncotarget.4508; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Liu XD, 2014, MOL CELL BIOCHEM, V394, P59, DOI 10.1007/s11010-014-2081-8; Marchetti L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36029; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Meinke G, 2016, CHEM REV, V116, P12785, DOI 10.1021/acs.chemrev.6b00077; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Merino B, 2015, SCI REP-UK, V5, DOI 10.1038/srep11622; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nomoto H, 2015, ENDOCRINOLOGY, V156, P3570, DOI 10.1210/en.2014-1906; Ohneda K, 2000, MOL CELL BIOL, V20, P900, DOI 10.1128/MCB.20.3.900-911.2000; Ozcan L, 2013, CELL METAB, V18, P803, DOI 10.1016/j.cmet.2013.10.011; Peng Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029437; Pomplun D, 2007, HORM METAB RES, V39, P336, DOI 10.1055/s-2007-976538; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Shao SY, 2010, J CELL BIOCHEM, V111, P634, DOI 10.1002/jcb.22750; Shi H, 2016, CANCER LETT, V382, P147, DOI 10.1016/j.canlet.2016.08.025; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Sun Y, 2008, ENDOCRINOLOGY, V149, P662, DOI 10.1210/en.2007-1275; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Xu FQ, 2014, INT J ONCOL, V45, P255, DOI 10.3892/ijo.2014.2411; Zhang YY, 2013, J BIOL CHEM, V288, P18961, DOI 10.1074/jbc.M113.458638; Zhao Y, 2016, CANCER RES, V76, P4696, DOI 10.1158/0008-5472.CAN-15-1734	56	6	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2053	2065		10.1074/jbc.M117.809582	http://dx.doi.org/10.1074/jbc.M117.809582			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259128	Green Published, hybrid			2022-12-28	WOS:000424948000018
J	Choi, JY; Surovtseva, YV; Sickle, SM; Kumpf, J; Bunz, UHF; Ben Mamoun, C; Voelker, DR				Choi, Jae-Yeon; Surovtseva, Yulia V.; Van Sickle, Sam M.; Kumpf, Jan; Bunz, Uwe H. F.; Ben Mamoun, Choukri; Voelker, Dennis R.			A novel fluorescence assay for measuring phosphatidylserine decarboxylase catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phospholipid; phosphatidylserine decarboxylase; membrane biogenesis; inhibitor; fluorescence; inhibitor screening	SACCHAROMYCES-CEREVISIAE; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; TOXOPLASMA-GONDII; MEMBRANE-LIPIDS; MITOCHONDRIA; YEAST; GENE; COMPLEMENTATION; IDENTIFICATION	Phosphatidylserine decarboxylases (PSDs) are central enzymes in phospholipid metabolism that produce phosphatidylethanolamine (PE) in bacteria, protists, plants, and animals. We developed a fluorescence-based assay for selectively monitoring production of PE in reactions using a maltose-binding protein fusion with Plasmodium knowlesi PSD (MBP-His(6)-34PkPSD) as the enzyme. The PE detection by fluorescence ((ex) = 403 nm, (em) = 508 nm) occurred after the lipid reacted with a water-soluble distyrylbenzene-bis-aldehyde (DSB-3), and provided strong discrimination against the phosphatidylserine substrate. The reaction conditions were optimized for enzyme, substrate, product, and DSB-3 concentrations with the purified enzyme and also tested with crude extracts and membrane fractions from bacteria and yeast. The assay is readily amenable to application in 96- and 384-well microtiter plates and should prove useful for high-throughput screening for inhibitors of PSD enzymes across diverse phyla.	[Choi, Jae-Yeon; Van Sickle, Sam M.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Basic Sci Sect, Denver, CO 80206 USA; [Surovtseva, Yulia V.] Yale Ctr Mol Discovery, West Haven, CT 06516 USA; [Ben Mamoun, Choukri] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Kumpf, Jan; Bunz, Uwe H. F.] Ruprecht Karls Univ Heidelberg, Inst Organ Chem, Neuenheimer Feld 270, D-69120 Heidelberg, Germany	National Jewish Health; Yale University; Ruprecht Karls University Heidelberg	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	voelkerd@njhealth.org			National Institutes of Health [GM104485, AI097218]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM104485 (to D.R.V.) and AI097218 (to C.B.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobenchik AM, 2013, P NATL ACAD SCI USA, V110, P18262, DOI 10.1073/pnas.1313965110; BOGGS KP, 1995, J BIOL CHEM, V270, P7757, DOI 10.1074/jbc.270.13.7757; BORCH RF, 1971, J AM CHEM SOC, V93, P2897, DOI 10.1021/ja00741a013; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; Choi JY, 2015, J BIOL CHEM, V290, P10972, DOI 10.1074/jbc.M115.642413; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Choi JY, 2005, ANAL BIOCHEM, V347, P165, DOI 10.1016/j.ab.2005.03.017; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; DENNIS EA, 1972, J LIPID RES, V13, P263; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gonzalez-Bulnes P, 2011, J BIOL CHEM, V286, P28940, DOI 10.1074/jbc.M111.268946; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; HAWROT E, 1975, P NATL ACAD SCI USA, V72, P1112, DOI 10.1073/pnas.72.3.1112; HAWROT E, 1978, J BIOL CHEM, V253, P8213; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; KANFER J, 1964, J BIOL CHEM, V239, P1720; KUGE O, 1991, J BIOL CHEM, V266, P6370; Kumpf J, 2015, ANALYST, V140, P3136, DOI [10.1039/C5AN00155B, 10.1039/c5an00155b]; Kumpf J, 2012, CHEM-EUR J, V18, P8921, DOI 10.1002/chem.201200930; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Schumacher MM, 2002, J BIOL CHEM, V277, P51033, DOI 10.1074/jbc.M205301200; Smithson DC, 2010, ASSAY DRUG DEV TECHN, V8, P175, DOI 10.1089/adt.2009.0249; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANGOLDE LM, 1974, BIOCHIM BIOPHYS ACTA, V360, P179, DOI 10.1016/0005-2760(74)90168-4; VOELKER DR, 1991, J BIOL CHEM, V266, P12185; VOELKER DR, 1989, P NATL ACAD SCI USA, V86, P9921, DOI 10.1073/pnas.86.24.9921; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	37	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1493	1503		10.1074/jbc.RA117.000525	http://dx.doi.org/10.1074/jbc.RA117.000525			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247006	hybrid, Green Published			2022-12-28	WOS:000424201700001
J	de Taeye, SW; de la Pena, AT; Vecchione, A; Scutigliani, E; Sliepen, K; Burger, JA; van der Woude, P; Schorcht, A; Schermer, EE; van Gils, MJ; LaBranche, CC; Montefiori, DC; Wilson, IA; Moore, JP; Ward, AB; Sanders, RW				de Taeye, Steven W.; de la Pena, Alba Torrents; Vecchione, Andrea; Scutigliani, Enzo; Sliepen, Kwinten; Burger, Judith A.; van der Woude, Patricia; Schorcht, Anna; Schermer, Edith E.; van Gils, Marit J.; LaBranche, Celia C.; Montefiori, David C.; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Sanders, Rogier W.			Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); vaccine development; HIV envelope glycoprotein trimer; protein design; glycoprotein structure; structure-function; V3 domain	BROADLY NEUTRALIZING ANTIBODIES; CRYO-EM STRUCTURE; AFFINITY MATURATION; DEPENDENT EPITOPE; CRYSTAL-STRUCTURE; IMMUNOGEN DESIGN; GLYCOPROTEIN; ENV; IMMUNIZATION; TARGET	To provide protective immunity against circulating primary HIV-1 strains, a vaccine most likely has to induce broadly neutralizing antibodies to the HIV-1 envelope glycoprotein (Env) spike. Recombinant Env trimers such as the prototype BG505 SOSIP.664 that closely mimic the native Env spike can induce autologous neutralizing antibodies (NAbs) against relatively resistant (tier 2) primary viruses. Ideally, Env immunogens should present broadly neutralizing antibody epitopes but limit the presentation of immunodominant non-NAb epitopes that might induce off-target and potentially interfering responses. The V3 loop in gp120 is such a non-NAb epitope that can effectively elicit non-NAbs when animals are immunized with SOSIP.664 trimers. V3 immunogenicity can be diminished, but not abolished, by reducing the conformational flexibility of trimers via targeted sequence changes, including an A316W substitution in V3, that create the SOSIP.v4.1 and SOSIP.v5.2 variants. Here, we further modified these trimer designs by introducing leucine residues at V3 positions 306 and 308 to create hydrophobic interactions with the tryptophan residue at position 316 and with other topologically proximal sites in the V1V2 domain. Together, these modifications further stabilized the resulting SOSIP.v5.2 S306L/R308L trimers in the prefusion state in which V3 is sequestered. When we tested these trimers as immunogens in rabbits, the induction of V3 non-NAbs was significantly reduced compared with the SOSIP.v5.2 trimers and even more so compared with the SOSIP.664 prototype, without affecting the autologous NAb response. Hence, these additional trimer sequence modifications may be beneficial for immunization strategies that seek to minimize off-target non-NAb responses.	[de Taeye, Steven W.; de la Pena, Alba Torrents; Vecchione, Andrea; Scutigliani, Enzo; Sliepen, Kwinten; Burger, Judith A.; van der Woude, Patricia; Schorcht, Anna; Schermer, Edith E.; van Gils, Marit J.; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, IAVI Neutralizing Antibody Ctr, Scripps CHAVI ID, La Jolla, CA 92037 USA; [Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Collaborat AIDS Vaccine Discovery, La Jolla, CA 92037 USA; [Moore, John P.; Sanders, Rogier W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [de Taeye, Steven W.] Sanquin Res, Dept Immunohematol Expt & Immunopathol, NL-1066 CX Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Duke University; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Cornell University	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.; Sanders, RW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.	r.w.sanders@amc.uva.nl	Ward, Andrew B/F-9203-2014; van Gils, Marit J./H-4791-2019; Ward, Andrew/ABD-7728-2021	Ward, Andrew B/0000-0001-7153-3769; van Gils, Marit J./0000-0003-3422-8161; Ward, Andrew/0000-0001-7153-3769; Schorcht, Anna/0000-0003-1548-790X; Scutigliani, Enzo/0000-0003-2504-2058	National Institutes of Health HIVRAD Grant [P01 AI110657]; NIAID [HHSN27201100016C]; Bill AMP; Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery [OPP1132237, OPP1084519, OPP1115782]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI110657] Funding Source: NIH RePORTER	National Institutes of Health HIVRAD Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill AMP; Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health HIVRAD Grant P01 AI110657 and NIAID Contract HHSN27201100016C and by the Bill & Melinda Gates Foundation through the Collaboration for AIDS Vaccine Discovery Grants OPP1132237, OPP1084519, and OPP1115782. S. W. d. T., A. T. d. l. P., I. A. W., J. P. M., A. B. W., and R. W. S. are listed as inventors on patents and patent applications concerning stabilized native-like HIV-1 Env trimers. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Behrens AJ, 2016, CELL REP, V14, P2695, DOI 10.1016/j.celrep.2016.02.058; Berro R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000548; Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10., 10.1111/imr.12509]; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Chaudhury S, 2014, J IMMUNOL, V193, P2073, DOI 10.4049/jimmunol.1401054; Cheng C, 2016, J VIROL, V90, P2740, DOI 10.1128/JVI.02380-15; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; Davis KL, 2009, VIROLOGY, V387, P414, DOI 10.1016/j.virol.2009.02.022; de la Pena AT, 2017, CELL REP, V20, P1805, DOI 10.1016/j.celrep.2017.07.077; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Derking R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004767; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Garces F, 2015, IMMUNITY, V43, P1053, DOI 10.1016/j.immuni.2015.11.007; Garrity RR, 1997, J IMMUNOL, V159, P279; Guenaga J, 2016, J VIROL, V90, P2806, DOI 10.1128/JVI.02652-15; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; HALL BF, 1991, IMMUNOPARASITOL TOD, pA22; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; He LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12041; Ingale J, 2016, CELL REP, V15, P1986, DOI 10.1016/j.celrep.2016.04.078; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Leaman DP, 2015, J VIROL, V89, P6725, DOI 10.1128/JVI.03738-14; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; MARRACK P, 1994, CELL, V76, P323, DOI 10.1016/0092-8674(94)90339-5; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Moore PL, 2017, IMMUNOL REV, V275, P217, DOI 10.1111/imr.12501; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Novotny LA, 2003, J IMMUNOL, V171, P1978, DOI 10.4049/jimmunol.171.4.1978; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2008, VIROLOGY, V381, P251, DOI 10.1016/j.virol.2008.08.032; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Pauthner M, 2017, IMMUNITY, V46, P1073, DOI 10.1016/j.immuni.2017.05.007; Peet NM, 1998, VIROLOGY, V251, P59, DOI 10.1006/viro.1998.9392; Plotkin S, 2014, P NATL ACAD SCI USA, V111, P12283, DOI 10.1073/pnas.1400472111; Poignard P, 2003, J VIROL, V77, P353, DOI 10.1128/JVI.77.1.353-365.2003; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Ringe RP, 2017, J VIROL, V91, DOI 10.1128/JVI.00677-17; Ringe RP, 2015, J VIROL, V89, P12189, DOI 10.1128/JVI.01768-15; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schiffner T, 2016, J VIROL, V90, P813, DOI 10.1128/JVI.01942-15; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Sliepen K, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0210-4; Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stanfield Robyn L., 2005, Human Antibodies, V14, P73; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Stieh DJ, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0207-z; Sullivan JT, 2017, J VIROL, V91, DOI 10.1128/JVI.00862-17; Tomaras GD, 2009, CURR OPIN HIV AIDS, V4, P373, DOI 10.1097/COH.0b013e32832f00c0; van Gils MJ, 2014, TRENDS MICROBIOL, V22, P550, DOI 10.1016/j.tim.2014.08.006; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150; Zolla-Pazner S, 2004, AIDS RES HUM RETROV, V20, P1254, DOI 10.1089/aid.2004.20.1254; Zolla-Pazner S, 2016, J VIROL, V90, P636, DOI 10.1128/JVI.01645-15	93	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1688	1701		10.1074/jbc.RA117.000709	http://dx.doi.org/10.1074/jbc.RA117.000709			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222332	hybrid, Green Published			2022-12-28	WOS:000424201700020
J	Perez-Peinado, C; Dias, SA; Domingues, MM; Benfield, AH; Freire, JM; Radis-Baptista, G; Gaspar, D; Castanho, MARB; Craik, DJ; Henriques, ST; Veiga, AS; Andreu, D				Perez-Peinado, Clara; Dias, Susana Almeida; Domingues, Marco M.; Benfield, Aurelie H.; Freire, Joao Miguel; Radis-Baptista, Gandhi; Gaspar, Diana; Castanho, Miguel A. R. B.; Craik, David J.; Henriques, Sonia Troeira; Veiga, Ana Salome; Andreu, David			Mechanisms of bacterial membrane permeabilization by crotalicidin (Ctn) and its fragment Ctn(15-34), antimicrobial peptides from rattlesnake venom	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); atomic force microscopy (AFM); surface plasmon resonance (SPR); confocal microscopy; Gram-negative bacteria; bacterial membrane disruption; bactericidal mechanism; time-resolved flow cytometry	CYCLOTIDE KALATA B1; CELL-PENETRATING PEPTIDES; ESCHERICHIA-COLI; ACTIVE PEPTIDES; CATHELICIDIN; IDENTIFICATION; BINDING; PRP(106-126); DESIGN; FAMILY	Crotalicidin (Ctn), a cathelicidin-related peptide from the venom of a South American rattlesnake, possesses potent antimicrobial, antitumor, and antifungal properties. Previously, we have shown that its C-terminal fragment, Ctn(15-34), retains the antimicrobial and antitumor activities but is less toxic to healthy cells and has improved serum stability. Here, we investigated the mechanisms of action of Ctn and Ctn(15-34) against Gram-negative bacteria. Both peptides were bactericidal, killing approximate to 90% of Escherichia coli and Pseudomonas aeruginosa cells within 90-120 and 5-30 min, respectively. Studies of potential at the bacterial cell membrane suggested that both peptides accumulate at and neutralize negative charges on the bacterial surface. Flow cytometry experiments confirmed that both peptides permeabilize the bacterial cell membrane but suggested slightly different mechanisms of action. Ctn(15-34) permeabilized the membrane immediately upon addition to the cells, whereas Ctn had a lag phase before inducing membrane damage and exhibited more complex cell-killing activity, probably because of two different modes of membrane permeabilization. Using surface plasmon resonance and leakage assays with model vesicles, we confirmed that Ctn(15-34) binds to and disrupts lipid membranes and also observed that Ctn(15-34) has a preference for vesicles that mimic bacterial or tumor cell membranes. Atomic force microscopy visualized the effect of these peptides on bacterial cells, and confocal microscopy confirmed their localization on the bacterial surface. Our studies shed light onto the antimicrobial mechanisms of Ctn and Ctn(15-34), suggesting Ctn(15-34) as a promising lead for development as an antibacterial/antitumor agent.	[Perez-Peinado, Clara; Radis-Baptista, Gandhi; Andreu, David] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona 08003, Spain; [Dias, Susana Almeida; Domingues, Marco M.; Freire, Joao Miguel; Gaspar, Diana; Castanho, Miguel A. R. B.; Veiga, Ana Salome] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Benfield, Aurelie H.; Craik, David J.; Henriques, Sonia Troeira] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Freire, Joao Miguel] Inst Pasteur, Dept Virol, F-75724 Paris, France; [Radis-Baptista, Gandhi] Univ Fed Ceara, Inst Marine Sci, Lab Biochem & Biotechnol, BR-60165081 Fortaleza, Ceara, Brazil	Pompeu Fabra University; Universidade de Lisboa; University of Queensland; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade Federal do Ceara	Andreu, D (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona Biomed Res Pk, Barcelona 08003, Spain.; Veiga, AS (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal.; Henriques, ST (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	s.henriques@imb.uq.edu.au; aveiga@medicina.ulisboa.pt; david.andreu@upf.edu	RADIS-BAPTISTA, GANDHI/J-4991-2019; Craik, David/B-1695-2010; RADIS-BAPTISTA, GANDHI/H-9574-2016; Domingues, Marco/AAA-9690-2021; Troeira Henriques, Sonia/J-3500-2016	RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Craik, David/0000-0003-0007-6796; RADIS-BAPTISTA, GANDHI/0000-0001-9210-092X; Troeira Henriques, Sonia/0000-0001-9564-9651; Veiga, Ana Salome/0000-0002-9892-2243; Dias, Susana/0000-0001-8910-5404; Benfield, Aurelie/0000-0002-3068-906X	Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2011-24899, AGL2014-52395-C2]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PTDC/QEQ-MED/4412/2014]; EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant [644167]	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant	This work was supported by Spanish Ministry of Economy and Competitiveness (MINECO) Grants SAF2011-24899 and AGL2014-52395-C2, by Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) Grants PTDC/QEQ-MED/4412/2014, and by EU Marie Sklodowska-Curie Research and Innovation Staff Exchange (RISE) program Grant 644167, 2015-2019. The authors declare that they have no conflicts of interest with the contents of this article.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Barry A.L., 1999, M26A NCCLS, V19; Blower RJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003862; Falcao CB, 2015, J MED CHEM, V58, P8553, DOI 10.1021/acs.jmedchem.5b01142; Cavalcante CSP, 2017, J ANTIBIOT, V70, P231, DOI 10.1038/ja.2016.135; Chen L, 2017, INT J BIOCHEM CELL B, V83, P71, DOI 10.1016/j.biocel.2016.12.011; Coutinho A, 2003, BIOPHYS J, V84, P3061, DOI 10.1016/S0006-3495(03)70032-0; Daleke DL, 2008, CURR OPIN HEMATOL, V15, P191, DOI 10.1097/MOH.0b013e3282f97af7; Dias SA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00775; Domingues MM, 2008, J PEPT SCI, V14, P394, DOI 10.1002/psc.1007; Du HJ, 2015, BBA-BIOMEMBRANES, V1848, P2394, DOI 10.1016/j.bbamem.2015.07.006; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Falcao CB, 2014, AMINO ACIDS, V46, P2561, DOI 10.1007/s00726-014-1801-4; Faust JE, 2017, BIOPHYS J, V112, P1663, DOI 10.1016/j.bpj.2017.03.003; Freire JM, 2014, FEBS J, V281, P191, DOI 10.1111/febs.12587; Freire JM, 2015, BBA-BIOMEMBRANES, V1848, P554, DOI 10.1016/j.bbamem.2014.11.001; Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hao QR, 2013, J PEPT SCI, V19, P173, DOI 10.1002/psc.2488; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2009, BIOCHEMISTRY-US, V48, P4198, DOI 10.1021/bi900009d; Hogberg LD, 2010, TRENDS PHARMACOL SCI, V31, P509, DOI 10.1016/j.tips.2010.08.002; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Jin L, 2016, J MED CHEM, V59, P1791, DOI 10.1021/acs.jmedchem.5b01264; Kaplan CW, 2011, ANTIMICROB AGENTS CH, V55, P3446, DOI 10.1128/AAC.00342-11; Kim D, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00530-17, 10.1128/AAC.00530-17]; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Li JG, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00073; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Marin-Medina N, 2016, APPL MICROBIOL BIOT, V100, P10251, DOI 10.1007/s00253-016-7975-9; Michael CA, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00145; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mu LX, 2017, AMINO ACIDS, V49, P1571, DOI 10.1007/s00726-017-2449-7; Rios AC, 2016, MICROBIOL RES, V191, P51, DOI 10.1016/j.micres.2016.04.008; Roversi D, 2014, ACS CHEM BIOL, V9, P2003, DOI 10.1021/cb500426r; Samuel R, 2016, BBA-BIOMEMBRANES, V1858, P1974, DOI 10.1016/j.bbamem.2016.05.015; Sani MA, 2016, ACCOUNTS CHEM RES, V49, P1130, DOI 10.1021/acs.accounts.6b00074; Shephard J, 2008, APPL ENVIRON MICROB, V74, P6980, DOI 10.1128/AEM.01117-08; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Termen S, 2003, CELL MOL LIFE SCI, V60, P536, DOI 10.1007/s000180300045; Thabit AK, 2015, EXPERT OPIN PHARMACO, V16, P159, DOI 10.1517/14656566.2015.993381; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Uzzell T, 2003, PEPTIDES, V24, P1655, DOI 10.1016/j.peptides.2003.08.024; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wei L, 2015, J BIOL CHEM, V290, P16633, DOI 10.1074/jbc.M115.642645; Wong JH, 2013, CURR PROTEIN PEPT SC, V14, P504, DOI 10.2174/13892037113149990067; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Y, 2010, PEPTIDES, V31, P1488, DOI 10.1016/j.peptides.2010.05.005; Zhao H, 2008, PEPTIDES, V29, P1685, DOI 10.1016/j.peptides.2008.06.008; Zhou HM, 2011, PEPTIDES, V32, P1131, DOI 10.1016/j.peptides.2011.04.002	61	53	54	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1536	1549		10.1074/jbc.RA117.000125	http://dx.doi.org/10.1074/jbc.RA117.000125			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29255091	Green Published, hybrid			2022-12-28	WOS:000424201700006
J	Schwander, T; McLean, R; Zarzycki, J; Erb, TJ				Schwander, Thomas; McLean, Richard; Zarzycki, Jan; Erb, Tobias J.			Structural basis for substrate specificity of methylsuccinyl-CoA dehydrogenase, an unusual member of the acyl-CoA dehydrogenase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme purification; enzyme structure; enzyme mutation; enzyme kinetics; enzyme catalysis; X-ray crystallography; bioengineering; flavin adenine dinucleotide (FAD); acyl-CoA dehydrogenase; ethylmalonyl-CoA pathway; glutaryl-CoA dehydrogenase; isobutyryl-CoA dehydrogenase; mesaconyl-CoA	RAT-LIVER MITOCHONDRIA; MEDIUM-CHAIN; COENZYME-A; CRYSTAL-STRUCTURES; GLUTARYL-COA; DECARBOXYLATION; MECHANISM; ELECTRON; IDENTIFICATION; PURIFICATION	(2S)-methylsuccinyl-CoA dehydrogenase (MCD) belongs to the family of FAD-dependent acyl-CoA dehydrogenase (ACD) and is a key enzyme of the ethylmalonyl-CoA pathway for acetate assimilation. It catalyzes the oxidation of (2S)-methylsuccinyl-CoA to ,-unsaturated mesaconyl-CoA and shows only about 0.5% activity with succinyl-CoA. Here we report the crystal structure of MCD at a resolution of 1.37 . The enzyme forms a homodimer of two 60-kDa subunits. Compared with other ACDs, MCD contains an approximate to 170-residue-long N-terminal extension that structurally mimics a dimer-dimer interface of these enzymes that are canonically organized as tetramers. MCD catalyzes the unprecedented oxidation of an -methyl branched dicarboxylic acid CoA thioester. Substrate specificity is achieved by a cluster of three arginines that accommodates the terminal carboxyl group and a dedicated cavity that facilitates binding of the C2 methyl branch. MCD apparently evolved toward preventing the nonspecific oxidation of succinyl-CoA, which is a close structural homolog of (2S)-methylsuccinyl-CoA and an essential intermediate in central carbon metabolism. For different metabolic engineering and biotechnological applications, however, an enzyme that can oxidize succinyl-CoA to fumaryl-CoA is sought after. Based on the MCD structure, we were able to shift substrate specificity of MCD toward succinyl-CoA through active-site mutagenesis.	[Schwander, Thomas; McLean, Richard; Zarzycki, Jan; Erb, Tobias J.] Max Planck Inst Terr Microbiol Marburg, Dept Biochem & Synthet Metab, Karl von Frisch Str 10, D-35043 Marburg, Germany; [Erb, Tobias J.] LOEWE Ctr Synthet Microbiol SYNMIKRO, D-35043 Marburg, Germany		Erb, TJ (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	toerb@mpi-marburg.mpg.de	; Erb, Tobias/J-5214-2013	Schwander, Thomas/0000-0001-9201-3017; Zarzycki, Jan/0000-0002-6307-6497; McLean, Richard/0000-0002-3237-3288; Erb, Tobias/0000-0003-3685-0894	European Research Council [ERC 637675]; IMPRS-Mic Fellowship; Max Planck Society	European Research Council(European Research Council (ERC)European Commission); IMPRS-Mic Fellowship; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported in part by European Research Council Grant ERC 637675 "SYBORG," an IMPRS-Mic Fellowship, and the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battaile KP, 2004, J BIOL CHEM, V279, P16526, DOI 10.1074/jbc.M400034200; Battaile KP, 2002, J BIOL CHEM, V277, P12200, DOI 10.1074/jbc.M111296200; BESRAT A, 1969, J BIOL CHEM, V244, P1461; Bhattacharyya S, 2007, J PHYS CHEM A, V111, P5729, DOI 10.1021/jp07l526+; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; Dwyer TM, 2001, J BIOL CHEM, V276, P133, DOI 10.1074/jbc.M007672200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Fu ZJ, 2004, BIOCHEMISTRY-US, V43, P9674, DOI 10.1021/bi049290c; GHISLA S, 1984, BIOCHEMISTRY-US, V23, P3154, DOI 10.1021/bi00309a008; IKEDA Y, 1983, J BIOL CHEM, V258, P1066; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; IZAI K, 1992, J BIOL CHEM, V267, P1027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiefer P, 2013, BIOINFORMATICS, V29, P963, DOI 10.1093/bioinformatics/btt080; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; KIM JJP, 1993, P NATL ACAD SCI USA, V90, P7523, DOI 10.1073/pnas.90.16.7523; Kuchler B, 1999, BIOCHEM J, V337, P225, DOI 10.1042/0264-6021:3370225; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Luo M, 2016, J BIOL CHEM, V291, P24065, DOI 10.1074/jbc.M116.756965; Mackenzie J, 2006, J BIOL CHEM, V281, P31012, DOI 10.1074/jbc.M603405200; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Nakajima Y, 2002, J BIOCHEM, V131, P365, DOI 10.1093/oxfordjournals.jbchem.a003111; Nguyen TV, 2002, MOL GENET METAB, V77, P68, DOI 10.1016/S1096-7192(02)00152-X; Peter DM, 2016, MOLECULES, V21, DOI 10.3390/molecules21040517; POHL B, 1986, EUR J BIOCHEM, V160, P109, DOI 10.1111/j.1432-1033.1986.tb09946.x; Rosenthal RG, 2014, NAT CHEM BIOL, V10, P50, DOI [10.1038/NCHEMBIO.1385, 10.1038/nchembio.1385]; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Tiffany KA, 1997, BIOCHEMISTRY-US, V36, P8455, DOI 10.1021/bi970422u; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wischgoll S, 2010, BIOCHEMISTRY-US, V49, P5350, DOI 10.1021/bi100317m	34	7	8	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1702	1712		10.1074/jbc.RA117.000764	http://dx.doi.org/10.1074/jbc.RA117.000764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29275330	hybrid, Green Published			2022-12-28	WOS:000424201700021
J	Forghany, Z; Robertson, F; Lundby, A; Olsen, JV; Baker, DA				Forghany, Zary; Robertson, Francesca; Lundby, Alicia; Olsen, Jesper V.; Baker, David A.			Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; AP1 transcription factor (AP-1); gene regulation; Notch pathway; signaling	ETS TRANSCRIPTION FACTORS; DELTA-LIKE 4; SIGNALING PATHWAY; GAMMA-SECRETASE; TEL ETV6; ANGIOGENESIS; DEGRADATION; MECHANISMS; BINDING; REGION	Notch signaling is a ubiquitous signal transduction pathway found in most if not all metazoan cell types characterized to date. It is indispensable for cell differentiation as well as tissue growth, tissue remodeling, and apoptosis. Although the canonical Notch signaling pathway is well characterized, accumulating evidence points to the existence of multiple, less well-defined layers of regulation. In this study, we investigated the function of the intracellular domain (ICD) of the Notch ligand Delta-like 4 (DLL4). We provide evidence that the DLL4 ICD is required for normal DLL4 subcellular localization. We further show that it is cleaved and interacts with the JUN proto-oncogene, which forms part of the activator protein 1 (AP-1) transcription factor complex. Mechanistically, the DLL4 ICD inhibited JUN binding to DNA and thereby controlled the expression of JUN target genes, including DLL4. Our work further demonstrated that JUN strongly stimulates endothelial cell tube formation and that DLL4 constrains this process. These results raise the possibility that Notch/DLL4 signaling is bidirectional and suggest that the DLL4 ICD could represent a point of cross-talk between Notch and receptor tyrosine kinase (RTK) signaling.	[Forghany, Zary; Robertson, Francesca; Baker, David A.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Lundby, Alicia; Olsen, Jesper V.] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark; [Lundby, Alicia] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Robertson, Francesca] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen; University of Copenhagen; University of Oxford	Baker, DA (corresponding author), Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands.	d.baker@lumc.nl	Olsen, Jesper/ABH-4638-2020	Olsen, Jesper/0000-0002-4747-4938	Dutch Cancer Society [30861]; Novo Nordisk Foundation Center for Protein Research [PI Jesper Velgaard Olsen] Funding Source: researchfish	Dutch Cancer Society(KWF Kankerbestrijding); Novo Nordisk Foundation Center for Protein Research	This work was supported by Dutch Cancer Society Grant 30861 (to D. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Ayllon V, 2015, LEUKEMIA, V29, P1741, DOI 10.1038/leu.2015.74; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Braune EB, 2016, DISCOV MED, V21, P189; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2708, DOI 10.1021/bi9923555; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Craig MP, 2016, ANGIOGENESIS, V19, P275, DOI 10.1007/s10456-016-9511-z; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; del Alamo D, 2011, CURR BIOL, V21, pR40, DOI 10.1016/j.cub.2010.10.034; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Duryagina R, 2013, STEM CELLS DEV, V22, P2736, DOI 10.1089/scd.2012.0638; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fiuza UM, 2007, J ENDOCRINOL, V194, P459, DOI 10.1677/JOE-07-0242; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Heuss SF, 2008, P NATL ACAD SCI USA, V105, P11212, DOI 10.1073/pnas.0800695105; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Josten F, 2004, DEV BIOL, V267, P181, DOI 10.1016/j.ydbio.2003.11.016; Jung J, 2011, MOL CELLS, V32, P161, DOI 10.1007/s10059-011-1046-y; Kanno T, 2012, ONCOGENE, V31, P3098, DOI 10.1038/onc.2011.475; Kim MY, 2011, EXP CELL RES, V317, P2438, DOI 10.1016/j.yexcr.2011.07.014; Kitagawa M, 2016, J BIOCHEM, V159, P287, DOI 10.1093/jb/mvv123; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Licht AH, 2006, J CELL BIOL, V175, P981, DOI 10.1083/jcb.200605149; Liebler SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053074; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Lundby A, 2014, NAT METHODS, V11, P868, DOI [10.1038/nmeth.2997, 10.1038/NMETH.2997]; Lundby A, 2011, METHODS MOL BIOL, V753, P143, DOI 10.1007/978-1-61779-148-2_10; Meester JAN, 2015, AM J HUM GENET, V97, P475, DOI 10.1016/j.ajhg.2015.07.015; Metrich M, 2015, CARDIOVASC RES, V108, P74, DOI 10.1093/cvr/cvv209; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Palmer WH, 2015, TRENDS CELL BIOL, V25, P697, DOI 10.1016/j.tcb.2015.07.010; Pintar A, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-19; Plotnik JP, 2014, NUCLEIC ACIDS RES, V42, P11928, DOI 10.1093/nar/gku929; Randi AM, 2009, BIOCHEM SOC T, V37, P1248, DOI 10.1042/BST0371248; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; Shah AV, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16002; Sharghi-Namini S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04031; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheldon H, 2010, BLOOD, V116, P2385, DOI 10.1182/blood-2009-08-239228; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Six EM, 2004, J BIOL CHEM, V279, P55818, DOI 10.1074/jbc.M408022200; Sun X, 1996, DEVELOPMENT, V122, P2465; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059	72	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1229	1242		10.1074/jbc.M117.819045	http://dx.doi.org/10.1074/jbc.M117.819045			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29196606	Green Published, hybrid			2022-12-28	WOS:000423515000011
J	Goh, CW; Lee, IC; Sundaram, JR; George, SE; Yusoff, P; Brush, MH; Sze, NSK; Shenolikar, S				Goh, Catherine Wenhui; Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; George, Simi Elizabeth; Yusoff, Permeen; Brush, Matthew Hayden; Sze, Newman Siu Kwan; Shenolikar, Shirish			Chronic oxidative stress promotes GADD34-mediated phosphorylation of the TAR DNA-binding protein TDP-43, a modification linked to neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; INITIATION-FACTOR 2; ENDOPLASMIC-RETICULUM; GROWTH ARREST; EIF2-ALPHA DEPHOSPHORYLATION; MAMMALIAN-CELLS; GADD34; RNA; TRANSLATION	Oxidative and endoplasmic reticulum (ER) stresses are hallmarks of the pathophysiology of ALS and other neurodegenerative diseases. In these stresses, different kinases phosphorylate eukaryotic initiation factor eIF2 alpha, enabling the translation of stress response genes; among these is GADD34, the protein product of which recruits the alpha-isoform of protein phosphatase 1 catalytic subunit (PP1 alpha) and eIF2 alpha to assemble a phosphatase complex catalyzing eIF2 alpha dephosphorylation and resumption of protein synthesis. Aberrations in this pathway underlie the aforementioned disorders. Previous observations indicating that GADD34 is induced by arsenite, a thiol-directed oxidative stressor, in the absence of eIF2 alpha phosphorylation suggest other roles for GADD34. Here, we report that arsenite-induced oxidative stress differs from thapsigargin-or tunicamycin-induced ER stress in promoting GADD34 transcription and the preferential translation of itsmRNAin the absence of eIF2 alpha phosphorylation. Arsenite also stabilized GADD34 protein, slowing its degradation. In response to oxidative stress, but not ER stress, GADD34 recruited TDP-43, and enhanced cytoplasmic distribution and cysteine modifications of TDP-43 promoted its binding to GADD34. Arsenite also recruited a TDP-43 kinase, casein kinase-1 epsilon (CK1 epsilon), to GADD34. Concomitant with TDP-43 aggregation and proteolysis after prolonged arsenite exposure, GADD34-boundCK1 epsilon catalyzed TDP-43 phosphorylations at serines 409/410, which were diminished or absent in GADD34(-/-) cells. Our findings highlight that the phosphatase regulator, GADD34, also functions as a kinase scaffold in response to chronic oxidative stress and recruits CK1 epsilon and oxidized TDP-43 to facilitate its phosphorylation, as seen in TDP-43 proteinopathies.	[Goh, Catherine Wenhui; Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Med Sch, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Lee, Irene Chengjie; Sundaram, Jeyapriya Rajameenakshi; George, Simi Elizabeth; Yusoff, Permeen; Shenolikar, Shirish] Duke NUS Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Brush, Matthew Hayden] Oregon Hlth & Sci Univ, Ontol Dev Grp, Portland, OR 97239 USA; [Sze, Newman Siu Kwan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Shenolikar, Shirish] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Shenolikar, Shirish] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Oregon Health & Science University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Duke University; Duke University	Shenolikar, S (corresponding author), Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.; Shenolikar, S (corresponding author), Duke NUS Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, 8 Coll Rd, Singapore 169857, Singapore.; Shenolikar, S (corresponding author), Duke NUS Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	Shirish.Shenolikar@Duke-NUS.edu.sg	LEE, IRENE CHENG JIE/AAV-2915-2020; Sze, Siu Kwan/AAO-3342-2020	LEE, IRENE CHENG JIE/0000-0001-6862-6438; Sze, Siu Kwan/0000-0002-5652-1687	Duke-NUS graduate fellowship; Duke-NUS start-up funds by the Singapore Ministry of Health; A-Star/BMRC Translational and Clinical Research Partnership Award [ACP0113683]; National Medical Research Council Translational Clinical Research Flagship Award [NMRC/TCR/013-NNI/2014]	Duke-NUS graduate fellowship; Duke-NUS start-up funds by the Singapore Ministry of Health; A-Star/BMRC Translational and Clinical Research Partnership Award; National Medical Research Council Translational Clinical Research Flagship Award	This work was supported by a Duke-NUS graduate fellowship (to C. W. G.) and Duke-NUS start-up funds provided by the Singapore Ministry of Health (to S. S.). Additional support was provided by A-Star/BMRC Translational and Clinical Research Partnership Award ACP0113683 and National Medical Research Council Translational Clinical Research Flagship Award NMRC/TCR/013-NNI/2014 (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brush MH, 2008, MOL CELL BIOL, V28, P6989, DOI 10.1128/MCB.00724-08; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Carlomagno Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090452; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chen RM, 2015, ELIFE, V4, DOI 10.7554/eLife.04871; Choksi DK, 2014, HUM MOL GENET, V23, P1025, DOI 10.1093/hmg/ddt498; Choy MS, 2015, CELL REP, V11, P1885, DOI 10.1016/j.celrep.2015.05.043; Cohen TJ, 2012, EMBO J, V31, P1241, DOI 10.1038/emboj.2011.471; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001; De Conti L, 2015, NUCLEIC ACIDS RES, V43, P8990, DOI 10.1093/nar/gkv814; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hasegawa T, 1999, BBA-GEN SUBJECTS, V1428, P161, DOI 10.1016/S0304-4165(99)00060-4; Hasegawa T, 2000, BIOCHEM BIOPH RES CO, V267, P593, DOI 10.1006/bbrc.1999.1991; Hasegawa T, 2000, BIOCHEM J, V352, P795, DOI 10.1042/0264-6021:3520795; Hung WJ, 2003, MOL CELL BIOL, V23, P3477, DOI 10.1128/MCB.23.10.3477-3486.2003; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Lee IC, 2018, CELL DEATH DIFFER, V25, P255, DOI 10.1038/cdd.2017.152; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Patterson AD, 2006, MOL CELL BIOL, V26, P1644, DOI 10.1128/MCB.26.5.1644-1653.2006; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Reid DW, 2016, MOL CELL BIOL, V36, P1868, DOI 10.1128/MCB.00190-16; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Shelkovnikova TA, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.199; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Somalinga BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035818; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Watanabe R, 2007, INT J MOL MED, V19, P475; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Zhang HM, 2010, MOL CELL PROTEOMICS, V9, P635, DOI 10.1074/mcp.M900314-MCP200; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	64	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					163	176		10.1074/jbc.M117.814111	http://dx.doi.org/10.1074/jbc.M117.814111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109149	Green Published, hybrid			2022-12-28	WOS:000419453200015
J	Cook, JD; Ng, SY; Lloyd, M; Eddington, S; Sun, H; Nathans, J; Bok, D; Radu, RA; Travis, GH				Cook, Jeremy D.; Ng, Sze Yin; Lloyd, Marcia; Eddington, Shannan; Sun, Hui; Nathans, Jeremy; Bok, Dean; Radu, Roxana A.; Travis, Gabriel H.			Peropsin modulates transit of vitamin A from retina to retinal pigment epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); gene knock-out; membrane; photoreceptor; retina; retinal metabolism; retinoid-binding protein; retinol; vitamin A	BINDING-PROTEIN; VISUAL CYCLE; KNOCKOUT MICE; MULLER CELLS; LIGHT; ACYLTRANSFERASE; RHODOPSIN; RPE65; PHOTORECEPTORS; CHROMOPHORE	Peropsin is a non-visual opsin in both vertebrate and invertebrate species. In mammals, peropsin is present in the apical microvilli of retinal pigment epithelial (RPE) cells. These structures interdigitate with the outer segments of rod and cone photoreceptor cells. RPE cells play critical roles in the maintenance of photoreceptors, including the recycling of visual chromophore for the opsin visual pigments. Here, we sought to identify the function of peropsin in the mouse eye. To this end, we generated mice with a null mutation in the peropsin gene (Rrh). These mice exhibited normal retinal histology, normal morphology of outer segments and RPE cells, and no evidence of photoreceptor degeneration. Biochemically, Rrh(-/-) mice had approximate to 2-fold higher vitamin A (all-trans-retinol (all-trans-ROL)) in the neural retina following a photobleach and 5-fold lower retinyl esters in the RPE. This phenotype was similar to those reported in mice that lack interphotoreceptor retinoid-binding protein (IRBP) or cellular retinol-binding protein, suggesting that peropsin plays a role in the movement of all-trans-ROL from photoreceptors to the RPE. We compared the phenotypes in mice lacking both peropsin and IRBP with those of mice lacking peropsin or IRBP alone and found that the retinoid phenotype was similarly severe in each of these knock-out mice. We conclude that peropsin controls all-trans-ROL movement from the retina to the RPE or may regulate all-trans-ROL storage within the RPE. We propose that peropsin affects light-dependent regulation of all-trans-ROL uptake from photoreceptors into RPE cells through an as yet undefined mechanism.	[Cook, Jeremy D.; Ng, Sze Yin; Lloyd, Marcia; Eddington, Shannan; Sun, Hui; Bok, Dean; Radu, Roxana A.; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Sun, Hui] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet Neurosci & Ophthalmol, Baltimore, MD 21205 USA; [Nathans, Jeremy] Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Bok, Dean] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA 90024 USA; [Bok, Dean] Univ Calif Los Angeles, Ophthalmol & Neurobiol, Los Angeles, CA 90024 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Ophthalmol & Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Travis, GH (corresponding author), Univ Calif Los Angeles, Sch Med, Stein Eye Inst, 100 Stein Plaza Driveway, Los Angeles, CA 90095 USA.	travis@jsei.ucla.edu	Radu, Roxana A./K-8924-2019; Travis, Gabriel Harvey/AIF-1062-2022	Travis, Gabriel Harvey/0000-0003-4020-9493; Nathans, Jeremy/0000-0001-8106-5460; Radu, Roxana/0000-0002-5064-6403	NEI, National Institutes of Health [R01-EY011713, R01-EY024379, R01-EY025002, P30-EY000331]; Howard Hughes Medical Institute; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331, R01EY025002, R01EY011713, R01EY024379] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health Grants R01-EY011713 and R01-EY024379 (to G. H. T.) and R01-EY025002 (to R. A. R.); the Howard Hughes Medical Institute (to J. N.); NEI, National Institutes of Health Core Grant P30-EY000331; and a Research to Prevent Blindness unrestricted grant (to the Jules Stein Eye Institute). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; DAS SR, 1992, BIOCHEM J, V285, P907, DOI 10.1042/bj2850907; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; FRANKE RR, 1992, J BIOL CHEM, V267, P14767; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Hao WS, 2000, METHOD ENZYMOL, V316, P413; Huang J, 2009, MOL VIS, V15, P223; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kang SW, 2015, GEN COMP ENDOCR, V211, P106, DOI 10.1016/j.ygcen.2014.11.020; Kaschula CH, 2006, EXP EYE RES, V82, P111, DOI 10.1016/j.exer.2005.05.010; KATZ ML, 1987, BIOCHIM BIOPHYS ACTA, V924, P432, DOI 10.1016/0304-4165(87)90157-7; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kaylor JJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00018-4; Kaylor JJ, 2014, P NATL ACAD SCI USA, V111, P7302, DOI 10.1073/pnas.1319142111; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LIOU GI, 1982, VISION RES, V22, P1457, DOI 10.1016/0042-6989(82)90210-3; Liou GI, 1998, J NEUROSCI, V18, P4511; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MACDONALD PN, 1988, BIOCHEM BIOPH RES CO, V156, P157, DOI 10.1016/S0006-291X(88)80818-0; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Nagata T, 2010, J COMP PHYSIOL A, V196, P51, DOI 10.1007/s00359-009-0493-9; Nieto PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026417; OZAKI K, 1983, BIOPHYS J, V44, P127, DOI 10.1016/S0006-3495(83)84285-4; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; PEPE IM, 1992, J PHOTOCH PHOTOBIO B, V13, P5, DOI 10.1016/1011-1344(92)80035-T; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; Toh PPC, 2016, EXP DERMATOL, V25, P1002, DOI 10.1111/exd.13226; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Van Gelder RN, 2016, ANNU REV VIS SCI, V2, P153, DOI 10.1146/annurev-vision-111815-114558; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wright CB, 2015, PROG MOL BIOL TRANSL, V134, P433, DOI 10.1016/bs.pmbts.2015.06.009; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392	49	10	10	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21407	21416		10.1074/jbc.M117.812701	http://dx.doi.org/10.1074/jbc.M117.812701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109151	Green Published, hybrid			2022-12-28	WOS:000419013000017
J	McMichael, TM; Zhang, LZ; Chemudupati, M; Hach, JC; Kenney, AD; Hang, HC; Yount, JS				McMichael, Temet M.; Zhang, Lizhi; Chemudupati, Mahesh; Hach, Jocelyn C.; Kenney, Adam D.; Hang, Howard C.; Yount, Jacob S.			The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; innate immunity; interferon; post-translational modification (PTM); protein palmitoylation; DHHC; IFITM; IFITM3; ZDHHC; palmitoyltransferase	WEST NILE VIRUS; S-PALMITOYLATION; FATTY-ACYLATION; SEVERE INFLUENZA; INFECTION; LOCALIZATION; RESISTANCE; STABILITY; RESTRICTS; CELLS	Interferon-induced transmembrane protein 3 (IFITM3) is a cellular endosome- and lysosome-localized protein that restricts numerous virus infections. IFITM3 is activated by palmitoylation, a lipid posttranslational modification. Palmitoylation of proteins is primarily mediated by zinc finger DHHC domain-containing palmitoyltransferases (ZDHHCs), but which members of this enzyme family can modify IFITM3 is not known. Here, we screened a library of human cell lines individually lacking ZDHHCs 1-24 and found that IFITM3 palmitoylation and its inhibition of influenza virus infection remained strong in the absence of any single ZDHHC, suggesting functional redundancy of these enzymes in the IFITM3-mediated antiviral response. In an overexpression screen with 23 mammalian ZDHHCs, we unexpectedly observed that more than half of the ZDHHCs were capable of increasing IFITM3 palmitoylation with ZDHHCs 3, 7, 15, and 20 having the greatest effect. Among these four enzymes, ZDHHC20 uniquely increased IFITM3 antiviral activity when both proteins were overexpressed. ZDHHC20 colocalized extensively with IFITM3 at lysosomes unlike ZDHHCs 3, 7, and 15, which showed a defined perinuclear localization pattern, suggesting that the location at which IFITM3 is palmitoylated may influence its activity. Unlike knock-out of individual ZDHHCs, siRNA-mediated knockdown of both ZDHHC3 and ZDHHC7 in ZDHHC20 knock-out cells decreased endogenous IFITM3 palmitoylation. Overall, our results demonstrate that multiple ZDHHCs can palmitoylate IFITM3 to ensure a robust antiviral response and that ZDHHC20 may serve as a particularly useful tool for understanding and enhancing IFITM3 activity.	[McMichael, Temet M.; Zhang, Lizhi; Chemudupati, Mahesh; Hach, Jocelyn C.; Kenney, Adam D.; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,Biomed Res Tower 790, Columbus, OH 43210 USA; [Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	University System of Ohio; Ohio State University; Rockefeller University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,Biomed Res Tower 790, Columbus, OH 43210 USA.	yount.37@osu.edu		Yount, Jacob/0000-0002-6128-4575; Chemudupati, Mahesh/0000-0002-6430-2484	National Institutes of Health [AI130110, GM087544]; Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute; Ohio State University Systems and Integrative Biology Training Program - National Institutes of Health [GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute; Ohio State University Systems and Integrative Biology Training Program - National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant AI130110 (to J. S. Y.) and GM087544 (to H. C. H.), a Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute (to T. M. M.), and The Ohio State University Systems and Integrative Biology Training Program funded by National Institutes of Health Grant GM068412 (to A. D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Charron G, 2011, MOL BIOSYST, V7, P67, DOI 10.1039/c0mb00183j; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0091-3; Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771; Dallavilla T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004774; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Kaur I, 2016, J NEUROSCI, V36, P7562, DOI 10.1523/JNEUROSCI.4859-14.2016; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16; Runkle KB, 2016, MOL CELL, V62, P385, DOI 10.1016/j.molcel.2016.04.003; Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsukamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075831; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Yount Jacob S, 2011, Curr Protoc Chem Biol, V3, P65; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YH, 2015, AIDS, V29, P889, DOI 10.1097/QAD.0000000000000632	57	46	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21517	21526		10.1074/jbc.M117.800482	http://dx.doi.org/10.1074/jbc.M117.800482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29079573	hybrid, Green Published			2022-12-28	WOS:000419013000026
J	Oh, JH; Chen, SJ; Varshavsky, A				Oh, Jang-Hyun; Chen, Shun-Jia; Varshavsky, Alexander			A reference-based protein degradation assay without global translation inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aptamer; protein degradation; Saccharomyces cerevisiae; ubiquitin; yeast; assay; chase; degradation; reference; GID; Mdh2; Gid4; tetracycline	END RULE PATHWAY; N-TERMINAL ACETYLATION; E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; QUALITY-CONTROL; IN-VIVO; COTRANSLATIONAL UBIQUITINATION; SUBSTRATE RECOGNITION; CELLULAR-PROTEINS; GID COMPLEX	Although it is widely appreciated that the use of global translation inhibitors, such as cycloheximide, in protein degradation assays may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust alternatives. We describe here the promoter reference technique (PRT), an assay for protein degradation with two advantageous features: a reference protein and a gene-specific inhibition of translation. In PRT assays, one measures, during a chase, the ratio of a test protein to a long-lived reference protein, a dihydrofolate reductase (DHFR). The test protein and DHFR are coexpressed, in the yeast Saccharomyces cerevisiae, on a low-copy plasmid from two identical P-TDH3 promoters containing additional, previously developed DNA elements. Once transcribed, these elements form 5-RNA aptamers that bind to the added tetracycline, which represses translation of aptamer-containing mRNAs. The selectivity of repression avoids a global inhibition of translation. This selectivity is particularly important if a component of a relevant proteolytic pathway (e.g. a specific ubiquitin ligase) is itself short-lived. We applied PRT to the Pro/N-end rule pathway, whose substrates include the short-lived Mdh2 malate dehydrogenase. Mdh2 is targeted for degradation by the Gid4 subunit of the GID ubiquitin ligase. Gid4 is also a metabolically unstable protein. Through analyses of short-lived Mdh2 as a target of short-lived Gid4, we illustrate the advantages of PRT over degradation assays that lack a reference and/or involve cycloheximide. In sum, PRT avoids the use of global translation inhibitors during a chase and also provides a built-in reference protein.	[Oh, Jang-Hyun; Chen, Shun-Jia; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Chen, Shun-Jia/0000-0002-5489-4930; Varshavsky, Alexander/0000-0002-4011-258X	National Institutes of Health [1R01GM031530, 1R01DK039520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 1R01GM031530 and 1R01DK039520 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Arnold L, 2015, MOL BIOL CELL, V26, P843, DOI 10.1091/mbc.E14-09-1342; Ausubel FM, 2010, CURRENT PROTOCOLS MO; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V88, P1090, DOI 10.1073/pnas.88.4.1090; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Buchler NE, 2005, P NATL ACAD SCI USA, V102, P9559, DOI 10.1073/pnas.0409553102; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cambridge SB, 2011, J PROTEOME RES, V10, P5275, DOI 10.1021/pr101183k; Cha-Molstad H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00085-7; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Cohen I, 2014, JOVE-J VIS EXP, DOI 10.3791/52021; Cui Y, 2011, EMBO J, V30, P2675, DOI 10.1038/emboj.2011.155; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dissmeyer N, 2018, NEW PHYTOL, V218, P929, DOI 10.1111/nph.14619; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Fan KT, 2016, J PROTEOME RES, V15, P851, DOI 10.1021/acs.jproteome.5b00772; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Gandin V, 2014, TRANSLATION, V2, DOI 10.4161/trla.28109; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Green DR, 2011, MEANS END APOPTOSIS; Ha SW, 2016, J BIOL CHEM, V291, P9827, DOI 10.1074/jbc.M116.716175; Holm L, 2013, AM J PHYSIOL-ENDOC M, V304, pE895, DOI 10.1152/ajpendo.00579.2012; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim I, 2013, MOL CELL PROTEOMICS, V12, P3370, DOI 10.1074/mcp.O113.031708; Kim MK, 2016, P NATL ACAD SCI USA, V113, P12438, DOI 10.1073/pnas.1612620113; Kotter P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp578; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Li XS, 2010, MOL CELL BIOL, V30, P1673, DOI 10.1128/MCB.00540-09; Lu D, 2014, J CELL BIOL, V207, P23, DOI 10.1083/jcb.201402041; Lucas X, 2017, CURR OPIN STRUC BIOL, V44, P101, DOI 10.1016/j.sbi.2016.12.015; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015; Menssen R, 2012, J BIOL CHEM, V287, P25602, DOI 10.1074/jbc.M112.363762; Meszaros B, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aak9982; Nie MH, 2015, J BIOL CHEM, V290, P22678, DOI 10.1074/jbc.M115.673038; Oh JH, 2017, P NATL ACAD SCI USA, V114, pE4370, DOI 10.1073/pnas.1705898114; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067952; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Shi Q, 2015, DEV CELL, V35, P483, DOI 10.1016/j.devcel.2015.10.014; Stein BJ, 2016, STRUCTURE, V24, P232, DOI 10.1016/j.str.2015.12.008; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Terweij M, 2013, G3-GENES GENOM GENET, V3, P1261, DOI 10.1534/g3.113.006213; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Vittal V, 2015, J BIOL CHEM, V290, P21244, DOI 10.1074/jbc.R115.675165; Wadas B, 2016, J BIOL CHEM, V291, P20976, DOI 10.1074/jbc.M116.747956; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	84	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21457	21465		10.1074/jbc.M117.814236	http://dx.doi.org/10.1074/jbc.M117.814236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29122887	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000419013000021
J	Suh, JH; Lai, L; Nam, D; Kim, J; Jo, J; Taffet, GE; Kim, E; Kaelber, JT; Lee, HK; Entman, ML; Cooke, JP; Reineke, EL				Suh, Ji Ho; Lai, Li; Nam, Deokhwa; Kim, Jong; Jo, Juyeon; Taffet, George E.; Kim, Eunah; Kaelber, Jason T.; Lee, Hyun-Kyoung; Entman, Mark L.; Cooke, John P.; Reineke, Erin L.			Steroid receptor coactivator-2 (SRC-2) coordinates cardiomyocyte paracrine signaling to promote pressure overload-induced angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; cardiac hypertrophy; cardiomyocyte; gene expression; hypoxia; transcription coactivator; transcription regulation	TRANSCRIPTION FACTOR GATA4; CARDIAC-HYPERTROPHY; HEART-FAILURE; REGULATOR; GROWTH; INHIBITION; ACTIVATION; TRANSITION; VENTRICLE; PROTEIN	Pressure overload-induced cardiac stress induces left ventricular hypertrophy driven by increased cardiomyocyte mass. The increased energetic demand and cardiomyocyte size during hypertrophy necessitate increased fuel and oxygen delivery and stimulate angiogenesis in the left ventricular wall. We have previously shown that the transcriptional regulator steroid receptor coactivator-2 (SRC-2) controls activation of several key cardiac transcription factors and that SRC-2 loss results in extensive cardiac transcriptional remodeling. Pressure overload in mice lacking SRC-2 induces an abrogated hypertrophic response and decreases sustained cardiac function, but the cardiomyocyte-specific effects of SRC-2 in these changes are unknown. Here, we report that cardiomyocyte-specific loss of SRC-2 (SRC-2 CKO) results in a blunted hypertrophy accompanied by a rapid, progressive decrease in cardiac function. We found that SRC-2 CKO mice exhibit markedly decreased left ventricular vasculature in response to transverse aortic constriction, corresponding to decreased expression of the angiogenic factor VEGF. Of note, SRC-2 knockdown in cardiomyocytes decreased VEGF expression and secretion to levels sufficient to blunt in vitro tube formation and proliferation of endothelial cells. During pressure overload, both hypertrophic and hypoxic signals can stimulate angiogenesis, both of which stimulated SRC-2 expression in vitro. Furthermore, SRC-2 coactivated the transcription factors GATA-binding protein 4 (GATA-4) and hypoxia-inducible factor (HIF)-1 and -2 in response to angiotensin II and hypoxia, respectively, which drive VEGF expression. These results suggest that SRC-2 coordinates cardiomyocyte secretion of VEGF downstream of the two major angiogenic stimuli occurring during pressure overload bridging both hypertrophic and hypoxia-stimulated paracrine signaling.	[Suh, Ji Ho; Nam, Deokhwa; Kim, Eunah; Reineke, Erin L.] Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Lai, Li; Cooke, John P.] Houston Methodist Res Inst, Dept Cardiovasc Sci, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA; [Kim, Jong] Univ Houston, Houston, TX 77004 USA; [Jo, Juyeon; Lee, Hyun-Kyoung] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat & Neurosci, Houston, TX 77030 USA; [Jo, Juyeon; Lee, Hyun-Kyoung] Texas Childrens Hosp, Neurol Res Inst, Houston, TX 77030 USA; [Taffet, George E.; Entman, Mark L.] Baylor Coll Med, Dept Med, Div Cardiovasc Sci, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; [Kaelber, Jason T.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Reineke, EL (corresponding author), Houston Methodist Res Inst, Ctr Bioenerget, 6670 Bertner Ave,R11-213, Houston, TX 77030 USA.	elreineke@houstonmethodist.org		Lai, Li/0000-0002-5731-2705; Lee, Hyun Kyoung/0000-0001-5793-4398; Kaelber, Jason/0000-0001-9426-1030	National Institutes of Health [R00-HL118159, R01-HL089792]; Souki Mitochondrial Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL118159, R01HL089792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Souki Mitochondrial Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R00-HL118159 (to E. L. R.), R01-HL089792 (to M. L. E.), and the Souki Mitochondrial Project Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Bajgelman MC, 2015, VIROLOGY, V476, P106, DOI 10.1016/j.virol.2014.12.009; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Biscetti F, 2008, DIABETES, V57, P1394, DOI 10.2337/db07-0765; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Demidenko ZN, 2011, CELL CYCLE, V10, P1557, DOI 10.4161/cc.10.10.15789; el Azzouzi H, 2015, TRENDS ENDOCRIN MET, V26, P502, DOI 10.1016/j.tem.2015.06.008; Guo J, 2015, EUR HEART J, V36, P2530, DOI 10.1093/eurheartj/ehv294; Haghikia A, 2014, CARDIOVASC RES, V102, P281, DOI 10.1093/cvr/cvu034; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Katanasaka Y, 2016, INT HEART J, V57, P672, DOI 10.1536/ihj.16-404; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li YH, 2003, ULTRASOUND MED BIOL, V29, P1281, DOI 10.1016/S0301-5629(03)00986-4; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Park AM, 2010, HYPERTENSION, V56, P1145, DOI 10.1161/HYPERTENSIONAHA.110.160515; Reineke EL, 2014, J BIOL CHEM, V289, P17721, DOI 10.1074/jbc.M113.539908; Reineke EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053395; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shang YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001527; Taffet GE, 1996, AM J PHYSIOL-HEART C, V270, pH2204; Walsh K, 2007, J CLIN INVEST, V117, P3176, DOI 10.1172/JCI34126	25	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21643	21652		10.1074/jbc.M117.804740	http://dx.doi.org/10.1074/jbc.M117.804740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127200	hybrid, Green Published			2022-12-28	WOS:000419013000038
J	Zhao, WK; Huang, YK; Zhang, JZ; Liu, MJ; Ji, HJ; Wang, CC; Cao, N; Li, CJ; Xia, Y; Jiang, Q; Qin, JZ				Zhao, Wukui; Huang, Yikai; Zhang, Jingzi; Liu, Mengjie; Ji, Haijing; Wang, Congcong; Cao, Ning; Li, Chaojun; Xia, Yin; Jiang, Qing; Qin, Jinzhong			Polycomb group RING finger proteins 3/5 activate transcription via an interaction with the pluripotency factor Tex10 in embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; embryonic stem cell; pluripotency; polycomb; transcriptional coactivator; Pcgf3; Pcgf5; Tex10; transcriptional activation	GENE-EXPRESSION; COMPLEX; PRC1; DIFFERENTIATION; HEMATOPOIESIS; METHYLATION; RECRUITMENT; MECHANISMS; REPRESSION; ENHANCER	Polycomb group (PcG) proteins are epigenetic transcriptional repressors that orchestrate numerous developmental processes and have been implicated in the maintenance of embryonic stem (ES) cell state. More recent evidence suggests that a subset of PcG proteins engages in transcriptional activation in some cellular contexts, but how this property is exerted remains largely unknown. Here, we generated ES cells with single or combined disruption of polycomb group RING finger protein 3 (Pcgf3) and Pcgf5 with the CRISPR-Cas9 technique. We report that although these mutant cells maintained their self-renewal and colony-forming capacity, they displayed severe defects in mesoderm differentiation in vitro and in vivo. Using RNA-seq to analyze transcriptional profiles of ES cells with single or combined Pcgf3/5 deficiencies, we found that in contrast to the canonical role of the related polycomb repressive complex 1 (PRC1) in gene repression, Pcgf3/5 mainly function as transcriptional activators driving expression of many genes involved in mesoderm differentiation. Proteomic approaches and promoter occupancy analyses helped to establish an extended Pcgf3/5 interactome and identified several novel Pcgf3/5 interactors. These included testis-expressed 10 (Tex10), which may directly contribute to transcriptional activation via the transcriptional co-activator p300. Furthermore, Pcgf3/5 deletion in ES cells substantially reduced the occupancy of Tex10 and p300 at target genes. Finally, we demonstrated that Pcgf3/5 are essential for regulating global levels of the histone modifier H2AK119ub1 in ES cells. Our findings establish Pcgf3/5 as transcriptional activators that interact with Tex10 and p300 in ES cells and point to redundant activity of Pcgf3/5 in pluripotency maintenance.	[Zhao, Wukui; Huang, Yikai; Zhang, Jingzi; Liu, Mengjie; Wang, Congcong; Cao, Ning; Li, Chaojun; Qin, Jinzhong] Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China; [Ji, Haijing] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210014, Jiangsu, Peoples R China; [Xia, Yin] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Jiang, Qing] Med Sch Nanjing Univ, Nanjing Drum Tower Hosp, Dept Sports Med & Adult Reconstruct Surg, Nanjing 21008, Jiangsu, Peoples R China	Nanjing University; Nanjing Agricultural University; Chinese University of Hong Kong	Qin, JZ (corresponding author), Nanjing Univ, Nanjing Biomed Res Inst, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	qinjz@nicemice.cn	zhao, wukui/AAI-9846-2020; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532; Li, Chaojun/0000-0001-9474-7321	National Natural Science Foundation of China [31471387, 31671532]; Shuangchuang Program of Jiangsu Province; Nanjing University Innovation and Creative Program for Ph.D. Candidates [2016027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shuangchuang Program of Jiangsu Province; Nanjing University Innovation and Creative Program for Ph.D. Candidates	This work was supported by National Natural Science Foundation of China Grants 31471387 and 31671532 and the 2015 Shuangchuang Program of Jiangsu Province (to J. Q.). This project was supported by Nanjing University Innovation and Creative Program for Ph.D. Candidates Grant 2016027 (to W. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Almeida M, 2017, SCIENCE, V356, P1081, DOI 10.1126/science.aal2512; Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Aranda S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500737; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Castle CD, 2012, MOL BIOL CELL, V23, P716, DOI 10.1091/mbc.E11-06-0530; Creppe C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004851; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Endoh M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002774; Eskeland R, 2010, COLD SH Q B, V75, P71, DOI 10.1101/sqb.2010.75.053; Evans M, 2011, NAT REV MOL CELL BIO, V12, P680, DOI 10.1038/nrm3190; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fanis P, 2012, MOL CELL PROTEOMICS, V11, P1263, DOI 10.1074/mcp.M112.017194; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gil J, 2014, TRENDS CELL BIOL, V24, P632, DOI 10.1016/j.tcb.2014.06.005; Gunning PW, 2001, J CELL SCI, V114, P513; Harrison SM, 2000, DEV BIOL, V227, P358, DOI 10.1006/dbio.2000.9878; Illingworth RS, 2015, GENE DEV, V29, P1897, DOI 10.1101/gad.268151.115; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo T, 2016, TRENDS BIOCHEM SCI, V41, P9, DOI 10.1016/j.tibs.2015.11.005; Kondo T, 2014, DEV CELL, V28, P94, DOI 10.1016/j.devcel.2013.11.021; Lee HG, 2015, GENOME RES, V25, P1170, DOI 10.1101/gr.188920.114; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Liu H, 2013, MOL CELLS, V36, P112, DOI 10.1007/s10059-013-0012-2; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Morey L, 2015, CELL STEM CELL, V17, P300, DOI 10.1016/j.stem.2015.08.009; Morey L, 2015, MOL CELL BIOL, V35, P2716, DOI 10.1128/MCB.00266-15; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Si S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154561; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smagulova FO, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-67; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Yan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep46276; Yang YS, 2015, GENE EXPR PATTERNS, V19, P45, DOI 10.1016/j.gep.2015.07.002; Zhao WK, 2017, J BIOL CHEM, V292, P2773, DOI 10.1074/jbc.M116.763961	50	30	30	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21527	21537		10.1074/jbc.M117.804054	http://dx.doi.org/10.1074/jbc.M117.804054			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29054931	Green Published, hybrid			2022-12-28	WOS:000419013000027
J	Al-Hashimi, AA; Lebeau, P; Majeed, F; Polena, E; Lhotak, S; Collins, CAF; Pinthus, JH; Gonzalez-Gronow, M; Hoogenes, J; Pizzo, SV; Crowther, M; Kapoor, A; Rak, J; Gyulay, G; D'Angelo, S; Marchio, S; Pasqualini, R; Arap, W; Shayegan, B; Austin, RC				Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Gonzalez-Gronow, Mario; Hoogenes, Jen; Pizzo, Salvatore V.; Crowther, Mark; Kapoor, Anil; Rak, Janusz; Gyulay, Gabriel; D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata; Arap, Wadih; Shayegan, Bobby; Austin, Richard C.			Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED PROTEIN 78; FACTOR PROCOAGULANT ACTIVITY; PROSTATE-CANCER; ENDOPLASMIC-RETICULUM; EXPRESSION; STRESS; CARCINOMA; RECEPTOR; BINDING; ANGIOGENESIS	Tumor cells display on their surface several molecular chaperones that normally reside in the endoplasmic reticulum. Because this display is unique to cancer cells, these chaperones are attractive targets for drug development. Previous epitope-mapping of autoantibodies (AutoAbs) from prostate cancer patients identified the 78-kDa glucose-regulated protein (GRP78) as one such target. Although we previously showed that anti-GRP78 AutoAbs increase tissue factor (TF) procoagulant activity on the surface of tumor cells, the direct effect of TF activation on tumor growth was not examined. In this study, we explore the interplay between the AutoAbs against cell surface-associated GRP78, TF expression/activity, and prostate cancer progression. First, we show that tumor GRP78 expression correlates with disease stage and that anti-GRP78 AutoAb levels parallel prostate-specific antigen concentrations in patient-derived serum samples. Second, we demonstrate that these anti-GRP78 AutoAbs target cell-surface GRP78, activating the unfolded protein response and inducing tumor cell proliferation through a TF-dependent mechanism, a specific effect reversed by neutralization or immunodepletion of the AutoAb pool. Finally, these AutoAbs enhance tumor growth in mice bearing human prostate cancer xenografts, and heparin derivatives specifically abrogate this effect by blocking AutoAb binding to cell-surface GRP78 and decreasing TF expression/activity. Together, these results establish a molecular mechanism in which AutoAbs against cell-surface GRP78 drive TF-mediated tumor progression in an experimental model of prostate cancer. Heparin derivatives counteract this mechanism and, as such, represent potentially appealing compounds to be evaluated in well-designed translational clinical trials.	[Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Hoogenes, Jen; Crowther, Mark; Kapoor, Anil; Gyulay, Gabriel; Shayegan, Bobby; Austin, Richard C.] McMaster Univ, Dept Med, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Lebeau, Paul; Majeed, Fadwa; Polena, Enio; Lhotak, Sarka; Collins, Celeste A. F.; Pinthus, Jehonathan H.; Hoogenes, Jen; Crowther, Mark; Kapoor, Anil; Gyulay, Gabriel; Shayegan, Bobby; Austin, Richard C.] St Josephs Healthcare Hamilton, Hamilton, ON L8N 4A6, Canada; [Al-Hashimi, Ali A.; Pinthus, Jehonathan H.; Hoogenes, Jen; Kapoor, Anil; Shayegan, Bobby] McMaster Univ, Dept Surg, Hamilton, ON L8N 4A6, Canada; [Gonzalez-Gronow, Mario; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Rak, Janusz] McGill Univ, Fac Med, Div Expt Med, Dept Pediat, Montreal, PQ H3A 0G4, Canada; [D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata; Arap, Wadih] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87106 USA; [D'Angelo, Sara; Marchio, Serena; Pasqualini, Renata] Univ New Mexico, Sch Med, Div Mol Med, Dept Internal Med, Albuquerque, NM 87131 USA; [Arap, Wadih] Univ New Mexico, Sch Med, Div Hematol Oncol, Dept Internal Med, Albuquerque, NM 87131 USA; [Marchio, Serena] Univ Turin, Dept Oncol, I-10124 Turin, Italy; [Marchio, Serena] IRCCS, FPO, Candiolo Canc Inst, I-10060 Candiolo, Italy	McMaster University; McMaster University; McMaster University; Duke University; McGill University; University of New Mexico; University of New Mexico; University of New Mexico; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Austin, RC (corresponding author), 50 Charlton Ave E,Rm T-3313, Hamilton, ON L8N 4A6, Canada.	austinr@taari.ca	Hoogenes, Jen/M-9034-2017; Pinthus, Jehonathan/AAQ-1667-2021; Kapoor, Anil/AAQ-7184-2021; MARCHIO', Serena/G-9054-2017	Hoogenes, Jen/0000-0002-4905-7986; Kapoor, Anil/0000-0001-9180-8029; MARCHIO', Serena/0000-0001-8214-0776	Ontario Institute for Cancer Research	Ontario Institute for Cancer Research	Biological Materials were provided by the Ontario Tumor Bank, which is funded by the Ontario Institute for Cancer Research. We thank Life Science Editors for editing assistance.	Abdulkadir SA, 2000, HUM PATHOL, V31, P443, DOI 10.1053/hp.2000.6547; Al-Hashimi AA, 2010, J BIOL CHEM, V285, P28912, DOI 10.1074/jbc.M110.119107; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Caldwell JA, 2010, LAB INVEST, V90, P953, DOI 10.1038/labinvest.2010.59; Chinni SR, 1997, CLIN CANCER RES, V3, P1557; Cohen M, 2011, CANCER LETT, V309, P104, DOI 10.1016/j.canlet.2011.05.022; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; de Ridder GG, 2011, MELANOMA RES, V21, P35, DOI 10.1097/CMR.0b013e3283426805; Delie F, 2012, J ONCOL, V2012, DOI 10.1155/2012/468615; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; Dobroff AS, 2016, P NATL ACAD SCI USA, V113, P12780, DOI 10.1073/pnas.1615288113; Epstein JI, 2017, AM J SURG PATHOL, V41, pE1, DOI 10.1097/PAS.0000000000000820; Fang CH, 1996, THROMB HAEMOSTASIS, V76, P361; Ferrara F., 2016, P NATL ACAD SCI USA, DOI [10.1073/pnas.16154001135, DOI 10.1073/PNAS.16154001135]; Gifford JB, 2016, MOL CANCER THER, V15, P1043, DOI 10.1158/1535-7163.MCT-15-0774; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Gopal U, 2016, J BIOL CHEM, V291, P10904, DOI 10.1074/jbc.M115.708131; HANSEN LK, 1995, BBA-PROTEIN STRUCT M, V1252, P135, DOI 10.1016/0167-4838(95)00113-9; Hoffman RM, 1995, CANCER EPIDEM BIOMAR, V25, P259; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Khorana AA, 2009, ANN ONCOL, V20, P1619, DOI 10.1093/annonc/mdp068; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Miao YR, 2013, CLIN CANCER RES, V19, P2107, DOI 10.1158/1078-0432.CCR-12-2991; Milsom C, 2007, PATHOPHYSIOL HAEMO T, V36, P160, DOI 10.1159/000175154; Mintz PJ, 2003, NAT BIOTECHNOL, V21, P57, DOI 10.1038/nbt774; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Misra UK, 2002, J BIOL CHEM, V277, P42082, DOI 10.1074/jbc.M206174200; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2015, J BIOL CHEM, V290, P9571, DOI 10.1074/jbc.M114.617837; Mousa SA, 2006, THROMB HAEMOSTASIS, V96, P816, DOI 10.1160/TH06-05-0289; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Papalas JA, 2010, MODERN PATHOL, V23, P134, DOI 10.1038/modpathol.2009.152; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Quinones QJ, 2008, HISTOL HISTOPATHOL, V23, P1409, DOI 10.14670/HH-23.1409; Raiter A, 2014, INT J BIOL MARKER, V29, pE431, DOI 10.5301/jbm.5000086; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; Rasche L, 2015, HAEMATOLOGICA, V100, P377, DOI 10.3324/haematol.2014.117945; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao Q, 2012, INT J ONCOL, V41, P1061, DOI 10.3892/ijo.2012.1515; Staquicini DI, 2018, PHARMACOGENOMICS J, V18, P436, DOI 10.1038/tpj.2017.46; Teeter AE, 2013, UROLOGY, V82, P53, DOI 10.1016/j.urology.2012.10.090; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Hemelrijck M, 2010, LANCET ONCOL, V11, P450, DOI 10.1016/S1470-2045(10)70038-3; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060	49	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21180	21192		10.1074/jbc.M117.799908	http://dx.doi.org/10.1074/jbc.M117.799908			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29066620	Green Published, hybrid			2022-12-28	WOS:000418453400032
J	Covarrubias, S; Robinson, EK; Shapleigh, B; Vollmers, A; Katzman, S; Hanley, N; Fong, N; McManus, MT; Carpenter, S				Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Katzman, Sol; Hanley, Nicole; Fong, Nicholas; McManus, Michael T.; Carpenter, Susan			CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-kappa B reporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE-EXPRESSION; ACTIVATION; TRANSCRIPTION; INFLAMMATION; REPRESSION; CANCER; ASSAY	The innate immune system protects against infections by initiating an inducible inflammatory response. NF-kappa B is one of the critical transcription factors controlling this complex response, but some aspects of its regulation remain unclear. For example, although long non-coding RNAs (lncRNAs) have been shown to critically regulate gene expression, only a fraction of these have been functionally characterized, and the extent to which lncRNAs control NF-kappa B expression is unknown. Here, we describe the generation of a GFP-based NF-kappa B reporter system in immortalized murine bone marrow-derived macrophages (iBMDM). Activation of this reporter, using Toll-like receptor ligands, resulted in GFP expression, which could be monitored by flow cytometry. We also established a CRISPR/Cas9 gene deletion system in this NF-kappa B reporter line, enabling us to screen for genes that regulate NF-kappa B signaling. Our deletion-based approach identified two long intergenic non-coding (linc) RNAs, lincRNA-Cox2 and lincRNA-AK170409, that control NF-kappa B signaling. We demonstrate a potential novel role for lincRNA-Cox2 in promoting I kappa B alpha degradation in the cytoplasm. For lincRNA-AK170409, we provide evidence that this nuclearly-localized lincRNA regulates a number of inflammation-related genes. In conclusion, we have established an NF-kappa B-GFP iBMDM reporter cell line and a line that stably expresses Cas9. Our approach enabled the identification of lincRNA-Cox2 and lincRNA-AK170409 as NF-kappa B regulators, and this tool will be useful for identifying additional genes involved in regulating this transcription factor critical for immune function.	[Covarrubias, Sergio; Robinson, Elektra K.; Shapleigh, Barbara; Vollmers, Apple; Hanley, Nicole; Fong, Nicholas; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Katzman, Sol] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [McManus, Michael T.] Univ Calif Santa Cruz, Diabet Ctr, Dept Microbiol & Immunol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Carpenter, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sucarpen@ucsc.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Vollmers, Apple/0000-0003-2787-0797; Covarrubias, Sergio/0000-0002-7197-9952	National Institutes of Health [R03AI131019]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI131019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R03AI131019 (to S. Carpenter).	Beamer CA, 2013, SEMIN IMMUNOPATHOL, V35, P693, DOI 10.1007/s00281-013-0391-7; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Burger-Kentischer A, 2010, J IMMUNOL METHODS, V358, P93, DOI 10.1016/j.jim.2010.03.020; Carpenter S, 2016, VIRUS RES, V212, P137, DOI 10.1016/j.virusres.2015.08.019; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Chen PH, 2012, ONCOGENE, V31, P2555, DOI 10.1038/onc.2011.438; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hangauer MJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003569; Hellweg CE, 2003, J BIOMOL SCREEN, V8, P511, DOI 10.1177/1087057103257204; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Price JV, 2014, IMMUNITY, V41, P685, DOI 10.1016/j.immuni.2014.10.015; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Sakai J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01600-y; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Vogel CFA, 2014, J BIOL CHEM, V289, P1866, DOI 10.1074/jbc.M113.505578; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120396	29	43	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20911	20920		10.1074/jbc.M117.799155	http://dx.doi.org/10.1074/jbc.M117.799155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29051223	Green Published, hybrid			2022-12-28	WOS:000418453400009
J	Idica, A; Sevrioukov, EA; Zisoulis, DG; Hamdorf, M; Daugaard, I; Kadandale, P; Pedersen, IM				Idica, Adam; Sevrioukov, Evgueni A.; Zisoulis, Dimitrios G.; Hamdorf, Matthias; Daugaard, Iben; Kadandale, Pavan; Pedersen, Irene M.			MicroRNA miR-128 represses LINE-1 (L1) retrotransposition by down-regulating the nuclear import factor TNPO1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						genomic instability; inhibitor; microRNA (miRNA); microRNA mechanism; nuclear transport; LINE-1 (L1); miR-128; nuclear import; mobile elements; miR; restriction; TNPO1; retrotransposition	ANTISENSE PROMOTER; KARYOPHERIN-BETA; GENOME EVOLUTION; SOMATIC-CELLS; PROTEIN; RNA; TRANSPORTIN; MECHANISM; ELEMENTS; PATHWAY	Repetitive elements, including LINE-1 (L1), comprise approximately half of the human genome. These elements can potentially destabilize the genome by initiating their own replication and reintegration into new sites (retrotransposition). In somatic cells, transcription of L1 elements is repressed by distinct molecular mechanisms, including DNA methylation and histone modifications, to repress transcription. Under conditions of hypomethylation (e.g. in tumor cells), a window of opportunity for L1 derepression arises, and additional restriction mechanisms become crucial. We recently demonstrated that the microRNA miR-128 represses L1 activity by directly binding to L1 ORF2 RNA. In this study, we tested whether miR-128 can also control L1 activity by repressing cellular proteins important for L1 retrotransposition. We found that miR-128 targets the 3 UTR of nuclear import factor transportin 1 (TNPO1) mRNA. Manipulation of miR-128 and TNPO1 levels demonstrated that induction or depletion of TNPO1 affects L1 retrotransposition and nuclear import of an L1-ribonucleoprotein complex (using L1-encoded ORF1p as a proxy for L1-ribonucleoprotein complexes). Moreover, TNPO1 overexpression partially reversed the repressive effect of miR-128 on L1 retrotransposition. Our study represents the first description of a protein factor involved in nuclear import of the L1 element and demonstrates that miR-128 controls L1 activity in somatic cells through two independent mechanisms: direct binding to L1 RNA and regulation of a cellular factor necessary for L1 nuclear import and retrotransposition.	[Idica, Adam; Sevrioukov, Evgueni A.; Zisoulis, Dimitrios G.; Hamdorf, Matthias; Daugaard, Iben; Kadandale, Pavan; Pedersen, Irene M.] Univ Calif Irvine, Dept Mol Biol & Biochem, Francisco J Ayala Sch Biol Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Pedersen, IM (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3244 McGaugh Hall,503 Phys Sci Rd, Irvine, CA 92697 USA.	imp@uci.edu	Daugaard, Iben/J-5699-2017	Daugaard, Iben/0000-0002-1766-0705	University of California Cancer Research Coordinating Committee [55205]; American Cancer Society Institutional Research Grant [98-279-08]; University of California Irvine Institute for Memory Impairments and Neurological Disorders grant; California Institute of Regenerative Medicine Grant [TG2-01152]	University of California Cancer Research Coordinating Committee(University of California System); American Cancer Society Institutional Research Grant(American Cancer Society); University of California Irvine Institute for Memory Impairments and Neurological Disorders grant; California Institute of Regenerative Medicine Grant	This work was supported by University of California Cancer Research Coordinating Committee 55205 (to I. M. P.), American Cancer Society Institutional Research Grant 98-279-08 (to I. M. P.), a University of California Irvine Institute for Memory Impairments and Neurological Disorders grant (to I. M. P.), and California Institute of Regenerative Medicine Grant TG2-01152 (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; Erwin JA, 2014, NAT REV NEUROSCI, V15, P497, DOI 10.1038/nrn3730; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fridell RA, 1997, J CELL SCI, V110, P1325; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2013, NUCLEIC ACIDS RES, V41, P7401, DOI 10.1093/nar/gkt512; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Hamdorf M, 2015, NAT STRUCT MOL BIOL, V22, P824, DOI 10.1038/nsmb.3090; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Heras SR, 2013, NAT STRUCT MOL BIOL, V20, P1173, DOI 10.1038/nsmb.2658; Hogan DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100951; Hunter SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003353; Jin M, 2014, CANCER RES, V74, P4183, DOI 10.1158/0008-5472.CAN-14-0404; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kent OA, 2013, ONCOGENE, V32, P2576, DOI 10.1038/onc.2012.266; Kimura M, 2013, MOL CELL PROTEOMICS, V12, P145, DOI 10.1074/mcp.M112.019414; KLECKNER N, 1990, ANNU REV CELL BIOL, V6, P297, DOI 10.1146/annurev.cb.06.110190.001501; Koito Atsushi, 2011, Mob Genet Elements, V1, P197; Kolosha VO, 1997, P NATL ACAD SCI USA, V94, P10155, DOI 10.1073/pnas.94.19.10155; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; Macia A, 2017, GENOME RES, V27, P335, DOI 10.1101/gr.206805.116; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Masri S, 2010, BREAST CANCER RES TR, V124, P89, DOI 10.1007/s10549-009-0716-3; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Nakielny S, 1996, EXP CELL RES, V229, P261, DOI 10.1006/excr.1996.0369; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi X, 2007, MOL CELL BIOL, V27, P1264, DOI 10.1128/MCB.01888-06; Shi Z, 2012, PLOS ONE, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE.0032709; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tsutsumi Y, 2000, JPN J CLIN ONCOL, V30, P289, DOI 10.1093/jjco/30.7.289; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wissing S, 2012, HUM MOL GENET, V21, P208, DOI 10.1093/hmg/ddr455; Xie Y, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-10; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Zhang Y, 2009, J MOL MED, V87, P43, DOI 10.1007/s00109-008-0403-6	80	14	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20494	20508		10.1074/jbc.M117.807677	http://dx.doi.org/10.1074/jbc.M117.807677			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28974576	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000418267000013
J	Li, Y; Roberts, J; AkhavanAghdam, Z; Hao, N				Li, Yang; Roberts, Julie; AkhavanAghdam, Zohreh; Hao, Nan			Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell fate decision; single-cell analysis; yeast mating response; mitogen-activated protein kinase (MAPK); differentiation; pheromone; cell signaling; imaging	SACCHAROMYCES-CEREVISIAE; SIGNALING DYNAMICS; GENE-EXPRESSION; SPECIFICITY; GROWTH; DIFFERENTIATION; FEEDBACK; PATHWAY; PHOSPHORYLATION; PROLIFERATION	In the yeast Saccharomyces cerevisiae, the exposure to mating pheromone activates a prototypic mitogen-activated protein kinase (MAPK) cascade and triggers a dose-dependent differentiation response. Whereas a high pheromone dose induces growth arrest and formation of a shmoo-like morphology in yeast cells, lower pheromone doses elicit elongated cell growth. Previous population-level analysis has revealed that the MAPK Fus3 plays an important role in mediating this differentiation switch. To further investigate how Fus3 controls the fate decision process at the single-cell level, we developed a specific translocation-based reporter for monitoring Fus3 activity in individual live cells. Using this reporter, we observed strikingly different dynamic patterns of Fus3 activation in single cells differentiated into distinct fates. Cells committed to growth arrest and shmoo formation exhibited sustained Fus3 activation. In contrast, most cells undergoing elongated growth showed either a delayed gradual increase or pulsatile dynamics of Fus3 activity. Furthermore, we found that chemically perturbing Fus3 dynamics with a specific inhibitor could effectively redirect the mating differentiation, confirming the causative role of Fus3 dynamics in driving cell fate decisions. MAPKs mediate proliferation and differentiation signals in mammals and are therapeutic targets in many cancers. Our results highlight the importance of MAPK dynamics in regulating single-cell responses and open up the possibility that MAPK signaling dynamics could be a pharmacological target in therapeutic interventions.	[Li, Yang; Roberts, Julie; AkhavanAghdam, Zohreh; Hao, Nan] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hao, N (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	nhao@ucsd.edu	Hao, Nan/O-3462-2016	Hao, Nan/0000-0003-2857-4789; AkhavanAghdam, Zohreh/0000-0003-3307-7541; Paxman, Julie/0000-0001-7259-247X; Li, Yang/0000-0001-5714-0416	National Institutes of Health [R01 GM111458]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111458, T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM111458. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AkhavanAghdam Z, 2016, ELIFE, V5, DOI 10.7554/eLife.18458; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Conlon P, 2016, P NATL ACAD SCI USA, V113, pE5896, DOI 10.1073/pnas.1610081113; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; Dixit G, 2014, MOL CELL, V55, P85, DOI 10.1016/j.molcel.2014.05.019; Doncic A, 2015, CELL, V160, P1182, DOI 10.1016/j.cell.2015.02.032; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Durandau E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0163-z; Erdman S, 2001, GENETICS, V159, P919; Hansen AS, 2015, NAT PROTOC, V10, P1181, DOI 10.1038/nprot.2015.079; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Houser JR, 2012, YEAST, V29, P519, DOI 10.1002/yea.2932; Kim J, 2012, GENE DEV, V26, P1110, DOI 10.1101/gad.187260.112; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Patterson JC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001275; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Shao B, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005671; Shimada Y, 2000, NAT CELL BIOL, V2, P117, DOI 10.1038/35000073; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Ydenberg CA, 2009, J CELL BIOL, V184, P409, DOI 10.1083/jcb.200809066; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	36	13	14	1	98	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20354	20361		10.1074/jbc.AC117.000548	http://dx.doi.org/10.1074/jbc.AC117.000548			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29123025	hybrid, Green Published			2022-12-28	WOS:000418267000001
J	Wang, YM; Shao, Q; Hall, CK				Wang, Yiming; Shao, Qing; Hall, Carol K.			N-terminal prion protein peptides (PrP(120-144)) form parallel in-register beta-sheets via multiple nucleation-dependent pathways (vol 291, 22093, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wang, Yiming/K-9382-2019	Wang, Yiming/0000-0003-3657-6100; Hall, Carol/0000-0002-7425-587X				Wang YM, 2016, J BIOL CHEM, V291, P22093, DOI 10.1074/jbc.M116.744573	1	1	1	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20655	20655		10.1074/jbc.AAC117.000823	http://dx.doi.org/10.1074/jbc.AAC117.000823			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29247131	hybrid, Green Published			2022-12-28	WOS:000418267000025
J	Agrawal, S; Jaswal, K; Shiver, AL; Balecha, H; Patra, T; Chaba, R				Agrawal, Shashank; Jaswal, Kanchan; Shiver, Anthony L.; Balecha, Himanshi; Patra, Tapas; Chaba, Rachna			A genome-wide screen in Escherichia coli reveals that ubiquinone is a key antioxidant for metabolism of long-chain fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial genetics; electron transport; fatty acid metabolism; oxidative stress; quinone; respiratory chain; long chain fatty acids; non-fermentable carbon sources; ubiI; ubiK	COENZYME-Q BIOSYNTHESIS; OXIDATIVE STRESS; NADH DEHYDROGENASE; ISOCITRATE LYASE; GENETIC-ANALYSIS; MEMBRANE; GROWTH; REDUCTION; MUTANTS; OPERON	Long-chain fatty acids (LCFAs) are used as a rich source of metabolic energy by several bacteria including important pathogens. Because LCFAs also induce oxidative stress, which may be detrimental to bacterial growth, it is imperative to understand the strategies employed by bacteria to counteract such stresses. Here, we performed a genetic screen in Escherichia coli on the LCFA, oleate, and compared our results with published genome-wide screens of multiple non-fermentable carbon sources. This large-scale analysis revealed that among components of the aerobic electron transport chain (ETC), only genes involved in the biosynthesis of ubiquinone, an electron carrier in the ETC, are highly required for growth in LCFAs when compared with other carbon sources. Using genetic and biochemical approaches, we show that this increased requirement of ubiquinone is to mitigate elevated levels of reactive oxygen species generated by LCFA degradation. Intriguingly, we find that unlike other ETC components whose requirement for growth is inversely correlated with the energy yield of non-fermentable carbon sources, the requirement of ubiquinone correlates with oxidative stress. Our results therefore suggest that a mechanism in addition to the known electron carrier function of ubiquinone is required to explain its antioxidant role in LCFA metabolism. Importantly, among the various oxidative stress combat players in E. coli, ubiquinone acts as the cell's first line of defense against LCFA-induced oxidative stress. Taken together, our results emphasize that ubiquinone is a key antioxidant during LCFA metabolism and therefore provides a rationale for investigating its role in LCFA-utilizing pathogenic bacteria.	[Agrawal, Shashank; Jaswal, Kanchan; Balecha, Himanshi; Patra, Tapas; Chaba, Rachna] Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar 140306, Punjab, India; [Shiver, Anthony L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Stanford University	Chaba, R (corresponding author), Indian Inst Sci Educ & Res IISER Mohali, Dept Biol Sci, Sas Nagar 140306, Punjab, India.	rachnachaba@iisermohali.ac.in	Patra, Tapas/W-3194-2019; Patra, Tapas/AAE-8231-2021	Patra, Tapas/0000-0002-3388-1719; Chaba, Rachna/0000-0002-9156-4543	Indian Institute of Science Education and Research Mohali (IISER-Mohali); Council of Scientific and Industrial Research, Government of India [37(1623)/14/EMR-II]; IISER-Mohali; Department of Science and Technology (DST)-Inspire fellowship; DST-Inspire	Indian Institute of Science Education and Research Mohali (IISER-Mohali); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); IISER-Mohali; Department of Science and Technology (DST)-Inspire fellowship(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); DST-Inspire(Department of Science & Technology (India))	This work was supported in part by start-up funds from Indian Institute of Science Education and Research Mohali (IISER-Mohali) (to R. C.) and Council of Scientific and Industrial Research project number 37(1623)/14/EMR-II, Government of India (to R. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from IISER-Mohali for doctoral work.; Recipient of a Department of Science and Technology (DST)-Inspire fellowship for doctoral work.; Supported by a fellowship from DST-Inspire for undergraduate studies.	Al-Attar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27631; Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; AU DCT, 1987, J BACTERIOL, V169, P3237, DOI 10.1128/jb.169.7.3237-3242.1987; Aussel L, 2014, BBA-BIOENERGETICS, V1837, P1004, DOI 10.1016/j.bbabio.2014.01.015; Aussel L, 2014, J BACTERIOL, V196, P70, DOI 10.1128/JB.01065-13; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BERGER EA, 1973, P NATL ACAD SCI USA, V70, P1514, DOI 10.1073/pnas.70.5.1514; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Booth I. R., 2005, ECOSAL ESCHERICHIA C; Campbell JW, 2003, MOL MICROBIOL, V47, P793, DOI 10.1046/j.1365-2958.2003.03341.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Carrica MC, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-95; Chehade MH, 2013, J BIOL CHEM, V288, P20085, DOI 10.1074/jbc.M113.480368; CLARK D, 1981, J BACTERIOL, V148, P521, DOI 10.1128/JB.148.2.521-526.1981; Clark D. P., 2005, ECOSAL ESCHERICHIA C; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; COX GB, 1970, BIOCHEM J, V117, P551, DOI 10.1042/bj1170551; Cronan J. E., 2006, ECOSAL ESCHERICHIA C; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; Doi H, 2014, APPL MICROBIOL BIOT, V98, P629, DOI 10.1007/s00253-013-5327-6; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Falk-Krzesinski HJ, 1998, J BACTERIOL, V180, P1174, DOI 10.1128/JB.180.5.1174-1184.1998; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; Feng YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046275; Friedrich T., 2007, ECOSAL ESCHERICHIA C; GIBERT I, 1988, J BACTERIOL, V170, P1346, DOI 10.1128/jb.170.3.1346-1349.1988; Goswami M, 2006, ANTIMICROB AGENTS CH, V50, P949, DOI 10.1128/AAC.50.3.949-954.2006; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Kotnik D., 2013, RES PRECISION INSTRU, V2, P6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kwon O, 2005, CURR MICROBIOL, V50, P180, DOI 10.1007/s00284-004-4417-1; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Lepore BW, 2011, P NATL ACAD SCI USA, V108, P10121, DOI 10.1073/pnas.1018532108; Loiseau L, 2017, J BIOL CHEM, V292, P11937, DOI 10.1074/jbc.M117.789164; Marathe SA, 2013, J ANTIMICROB CHEMOTH, V68, P139, DOI 10.1093/jac/dks375; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Pelosi L, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00091-16; Perez-Pantoja D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003764; PETITKOSKAS E, 1976, MOL GEN GENET, V143, P203, DOI 10.1007/BF00266923; Pipe LZ, 2008, MOL BIOSYST, V4, P192, DOI 10.1039/b708241j; Pradenas GA, 2012, MICROBIOL-SGM, V158, P1279, DOI 10.1099/mic.0.056903-0; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Sharma P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075412; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Shiver AL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006124; Soballe B, 1997, FEBS LETT, V414, P373, DOI 10.1016/S0014-5793(97)01041-7; Soballe B, 2000, MICROBIOL-SGM, V146, P787, DOI 10.1099/00221287-146-4-787; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STROOBAN.P, 1972, J BACTERIOL, V109, P134, DOI 10.1128/JB.109.1.134-139.1972; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran QH, 1997, EUR J BIOCHEM, V244, P155, DOI 10.1111/j.1432-1033.1997.00155.x; Unden G., 2004, ECOSAL ESCHERICHIA C; Unden G., 2008, ECOSAL ESCHERICHIA C; Wang KC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01614; WU GH, 1993, J GEN MICROBIOL, V139, P1795, DOI 10.1099/00221287-139-8-1795; Zhang HT, 2003, FEMS MICROBIOL LETT, V223, P67, DOI 10.1016/S0378-1097(03)00343-4; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhu JF, 2011, METAB ENG, V13, P704, DOI 10.1016/j.ymben.2011.09.006	66	23	23	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20086	20099		10.1074/jbc.M117.806240	http://dx.doi.org/10.1074/jbc.M117.806240			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042439	hybrid, Green Published			2022-12-28	WOS:000417696400016
J	Grumati, P; Dikic, I				Grumati, Paolo; Dikic, Ivan			Ubiquitin signaling and autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BECLIN 1; SELECTIVE AUTOPHAGY; POSTTRANSLATIONAL MODIFICATION; SALMONELLA-TYPHIMURIUM; ENDOPLASMIC-RETICULUM; LYSOSOMAL BIOGENESIS; PROTEIN AGGREGATION; REGULATES AUTOPHAGY; INHIBITS AUTOPHAGY; INDUCED MITOPHAGY	Ubiquitination is a widespread post-translational modification that controls multiple steps in autophagy, a major lyso-some-mediated intracellular degradation pathway. A variety of ubiquitin chains are attached as selective labels on protein aggregates and dysfunctional organelles, thus promoting their autophagy-dependent degradation. Moreover, ubiquitin modification of autophagy regulatory components is essential to positively or negatively regulate autophagy flux in both non-selective and selective pathways. We review the current findings that elucidate the components, timing, and kinetics of the multivalent role of ubiquitin signals in control of amplitude and selectivity of autophagy pathways as well as their impact on the development of human diseases.	[Grumati, Paolo; Dikic, Ivan] Goethe Univ Frankfurt, Med Fac, Univ Hosp, Inst Biochem 2, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Riedberg Campus, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt	Dikic, I (corresponding author), Frankfurt Med Sch, Inst Biochem, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ivan.dikic@biochem2.de	Dikic, Ivan/O-4650-2015; Grumati, Paolo/AAA-5787-2019	Dikic, Ivan/0000-0001-8156-9511; Grumati, Paolo/0000-0002-9942-9389	Deutsche Forschungsgemeinschaft [SFB 1177]; European Research Council (ERC) Grant Ub-BAC; Cluster of Excellence "Macromolecular Complexes" Grant [EXC 115]; LOEWE Grant Ub-Net; LOEWE Centre for Gene and Cell Therapy Frankfurt (CGT); COFUND, Goethe International Postdoc Programme (GO-IN) Grant [291776]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) Grant Ub-BAC(European Research Council (ERC)); Cluster of Excellence "Macromolecular Complexes" Grant; LOEWE Grant Ub-Net; LOEWE Centre for Gene and Cell Therapy Frankfurt (CGT); COFUND, Goethe International Postdoc Programme (GO-IN) Grant	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 1177, European Research Council (ERC) Grant Ub-BAC, Cluster of Excellence "Macromolecular Complexes" Grant (EXC 115), LOEWE Grant Ub-Net, LOEWE Centre for Gene and Cell Therapy Frankfurt (CGT) (to I.D.), and COFUND, Goethe International Postdoc Programme (GO-IN) Grant 291776 (to P. G.). This is the third article in the Thematic Minireview series "Autophagy." The authors declare that they have no conflicts of interest with the contents of this article.	Abrahamsen H, 2012, FEBS LETT, V586, P1584, DOI 10.1016/j.febslet.2012.04.046; Antonioli M, 2017, TRENDS BIOCHEM SCI, V42, P28, DOI 10.1016/j.tibs.2016.09.008; Antonioli M, 2014, DEV CELL, V31, P734, DOI 10.1016/j.devcel.2014.11.013; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Botti-Millet J, 2016, AM J PHYSIOL-CELL PH, V311, pC351, DOI 10.1152/ajpcell.00129.2016; Chen D, 2010, J BIOL CHEM, V285, P38214, DOI 10.1074/jbc.M110.101469; Cho SJ, 2015, AUTOPHAGY, V11, P100, DOI 10.4161/15548627.2014.984283; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Feng HZ, 2014, J CLIN INVEST, V124, P3741, DOI 10.1172/JCI73093; Fiskin E, 2016, MOL CELL, V62, P967, DOI 10.1016/j.molcel.2016.04.015; Fujita N, 2013, J CELL BIOL, V203, P115, DOI 10.1083/jcb.201304188; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Heath RJ, 2016, CELL REP, V17, P2183, DOI 10.1016/j.celrep.2016.11.005; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Herhaus L, 2015, EMBO REP, V16, P1071, DOI 10.15252/embr.201540891; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hu JG, 2017, AUTOPHAGY, V13, P333, DOI 10.1080/15548627.2016.1256520; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Hung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3111; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kalveram B, 2008, J CELL SCI, V121, P4079, DOI 10.1242/jcs.035006; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khaminets A, 2016, TRENDS CELL BIOL, V26, P6, DOI 10.1016/j.tcb.2015.08.010; Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498; Kim J, 2013, AUTOPHAGY, V9, P1110, DOI 10.4161/auto.24877; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li J, 2015, AUTOPHAGY, V11, P1216, DOI 10.1080/15548627.2015.1017180; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Linares JF, 2013, MOL CELL, V51, P283, DOI 10.1016/j.molcel.2013.06.020; Liu CC, 2016, MOL CELL, V61, P84, DOI 10.1016/j.molcel.2015.11.001; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Nakashima H, 2015, J BIOL CHEM, V290, P1485, DOI 10.1074/jbc.M114.593871; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nazio F, 2016, J CELL BIOL, V215, P841, DOI 10.1083/jcb.201605089; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Noad J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.63; Noda T, 2012, INT J CELL BIOL, V2012; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Papadopoulos C, 2017, EMBO J, V36, P135, DOI 10.15252/embj.201695148; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Polajnar M, 2017, EMBO REP, V18, P1572, DOI 10.15252/embr.201643851; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reidick C, 2015, CANCERS, V7, P1, DOI 10.3390/cancers7010001; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Riley BE, 2010, J CELL BIOL, V191, P537, DOI 10.1083/jcb.201005012; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sha YB, 2017, EMBO J, V36, P2544, DOI 10.15252/embj.201796699; Shi CS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000751; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Stolz A, 2014, MOL CELL, V56, P341, DOI 10.1016/j.molcel.2014.10.022; Strappazzon F, 2015, CELL DEATH DIFFER, V22, P517, DOI 10.1038/cdd.2014.190; Van Humbeeck C, 2011, J NEUROSCI, V31, P10249, DOI 10.1523/JNEUROSCI.1917-11.2011; van Wijk SJL, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.66; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Xia PY, 2013, EMBO J, V32, P2685, DOI 10.1038/emboj.2013.189; Xie YC, 2015, AUTOPHAGY, V11, P28, DOI 10.4161/15548627.2014.984267; Xu CF, 2011, FASEB J, V25, P2700, DOI 10.1096/fj.10-167676; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yuan HX, 2013, AUTOPHAGY, V9, P1983, DOI 10.4161/auto.26058; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	100	164	168	13	85	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5404	5413		10.1074/jbc.TM117.000117	http://dx.doi.org/10.1074/jbc.TM117.000117			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29187595	hybrid, Green Published			2022-12-28	WOS:000430044100005
J	Townsend, PD; Dixon, CH; Slootweg, EJ; Sukarta, OCA; Yang, AWH; Hughes, TR; Sharples, GJ; Palsson, LO; Takken, FLW; Goverse, A; Cann, MJ				Townsend, Philip D.; Dixon, Christopher H.; Slootweg, Erik J.; Sukarta, Octavina C. A.; Yang, Ally W. H.; Hughes, Timothy R.; Sharples, Gary J.; Palsson, Lars-Olof; Takken, Frank L. W.; Goverse, Aska; Cann, Martin J.			The intracellular immune receptor Rx1 regulates the DNA-binding activity of a Golden2-like transcription factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SEQUENCE SPECIFICITY; N-MEDIATED RESISTANCE; TOBACCO MOSAIC-VIRUS; CELL-DEATH; PLANT TRANSFORMATION; NUCLEAR ACCUMULATION; FACTORS COORDINATE; DEFENSE RESPONSES; INNATE IMMUNITY; RNA-POLYMERASE	Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable the immune system to recognize and respond to pathogen attack. An early consequence of immune activation is transcriptional reprogramming, and some NLRs have been shown to act in the nucleus and interact with transcription factors. The Rx1 NLR protein of potato is further able to bind and distort double-stranded DNA. However, Rx1 host targets that support a role for Rx1 in transcriptional reprogramming at DNA are unknown. Here, we report a functional interaction between Rx1 and NbGlk1, a Golden2-like transcription factor. Rx1 binds to NbGlk1 in vitro and in planta. NbGlk1 binds to known Golden2-like consensus DNA sequences. Rx1 reduces the binding affinity of NbGlk1 for DNA in vitro. NbGlk1 activates cellular responses to potato virus X, whereas Rx1 associates with NbGlk1 and prevents its assembly on DNA in planta unless activated by PVX. This study provides new mechanistic insight into how an NLR can coordinate an immune signaling response at DNA following pathogen perceptions.	[Townsend, Philip D.; Dixon, Christopher H.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England; [Townsend, Philip D.; Dixon, Christopher H.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, South Rd, Durham DH1 3LE, England; [Palsson, Lars-Olof] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England; [Slootweg, Erik J.; Sukarta, Octavina C. A.; Goverse, Aska] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 PB Wageningen, Netherlands; [Yang, Ally W. H.; Hughes, Timothy R.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	Durham University; Durham University; Durham University; Wageningen University & Research; University of Toronto; University of Amsterdam	Cann, MJ (corresponding author), Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England.	rn.j.cann@durham.ac.uk	Sharples, Gary/B-8638-2016; Townsend, Phiip/J-3761-2018; Pålsson, Lars-Olof A/F-3877-2012; Takken, Frank/C-8051-2012	Sharples, Gary/0000-0003-2495-0062; Townsend, Phiip/0000-0001-9235-3492; Pålsson, Lars-Olof A/0000-0003-3592-8506; Takken, Frank/0000-0003-2655-3108; Slootweg, Erik J./0000-0001-9935-7728	Biotechnology and Biological Sciences Research Council [BB/M007405/1]; Dutch Technology Foundation STW and Earth and Life Sciences ALW; ALW-VICI [865.14.003]; CIHR [FDN-148403]; Biotechnology and Biological Sciences Research Council [1220464] Funding Source: researchfish; BBSRC [BB/M007405/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Dutch Technology Foundation STW and Earth and Life Sciences ALW; ALW-VICI; CIHR(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/M007405/1 (to M.J.C., G.J.S., and L.O.P.), the Dutch Technology Foundation STW and Earth and Life Sciences ALW (to E.J.S., O.C.A.S., and A.G.), and ALW-VICI Project No. 865.14.003 (to F.L.W.T.) (Netherlands Organization for Scientific Research), and FDN-148403 from CIHR (to T.R.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chang C, 2013, PLANT CELL, V25, P1158, DOI 10.1105/tpc.113.109942; Chen M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01509; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Fenyk S, 2016, J BIOL CHEM, V291, P1137, DOI 10.1074/jbc.M115.698589; Fenyk S, 2015, J BIOL CHEM, V290, P24945, DOI 10.1074/jbc.M115.672121; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Finzi L, 2010, J BIOL CHEM, V285, P18973, DOI 10.1074/jbc.R109.062612; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; FRIED MG, 1984, J MOL BIOL, V172, P241, DOI 10.1016/S0022-2836(84)80025-X; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garner CM, 2016, SEMIN CELL DEV BIOL, V56, P150, DOI 10.1016/j.semcdb.2016.05.002; Han XY, 2016, BIOCHEM BIOPH RES CO, V477, P626, DOI 10.1016/j.bbrc.2016.06.110; Hosoda K, 2002, PLANT CELL, V14, P2015, DOI 10.1105/tpc.002733; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; Kolomeisky AB, 2011, PHYS CHEM CHEM PHYS, V13, P2088, DOI 10.1039/c0cp01966f; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Murmu J, 2014, MOL PLANT PATHOL, V15, P174, DOI 10.1111/mpp.12077; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Roberts M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003465; Rossini L, 2001, PLANT CELL, V13, P1231, DOI 10.1105/tpc.13.5.1231; Savitch LV, 2007, BIOCHEM BIOPH RES CO, V359, P234, DOI 10.1016/j.bbrc.2007.05.084; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tang GQ, 2011, J BIOL CHEM, V286, P38805, DOI 10.1074/jbc.M111.261966; Townsend PD, 2015, J BIOL CHEM, V290, P22225, DOI 10.1074/jbc.M115.669267; Tranier S, 2000, J BIOL CHEM, V275, P28075; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	58	29	31	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3218	3233		10.1074/jbc.RA117.000485	http://dx.doi.org/10.1074/jbc.RA117.000485			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29217772	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000426562800015
J	Sharma, P; Kranz, DM				Sharma, Preeti; Kranz, David M.			Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						directed evolution; major histocompatibility complex (MHC); protein engineering; protein-protein interaction; T-cell receptor (TCR); deep sequencing; single-codon libraries; yeast display	YEAST SURFACE-DISPLAY; PEPTIDE-MHC COMPLEXES; DIRECTED EVOLUTION; IN-VITRO; PHAGE DISPLAY; STAPHYLOCOCCAL-ENTEROTOXIN; THERMAL-STABILITY; RIBOSOME DISPLAY; PROTEIN FUNCTION; ALLOSTERIC SITE	Most affinity-maturation campaigns for antibodies and T-cell receptors (TCRs) operate on the residues at the binding site, located within the loops known as complementarity-determining regions (CDRs). Accordingly, mutations in contact residues, or so-called second shell residues, that increase affinity are typically identified by directed evolution involving combinatorial libraries. To determine the impact of residues located at a distance from the binding site, here we used single-codon libraries of both CDR and non-CDR residues to generate a deep mutational scan of a human TCR against the cancer antigen MART-1HLA-A2. Non-CDR residues included those at the interface of the TCR variable domains (V and V) and surface-exposed framework residues. Mutational analyses showed that both V/V interface and CDR residues were important in maintaining binding to MART-1HLA-A2, probably due to either structural requirements for proper V/V association or direct contact with the ligand. More surprisingly, many V/V interface substitutions yielded improved binding to MART-1HLA-A2. To further explore this finding, we constructed interface libraries and selected them for improved stability or affinity. Among the variants identified, one conservative substitution (F45Y) was most prevalent. Further analysis of F45Y showed that it enhanced thermostability and increased affinity by 60-fold. Thus, introducing a single hydroxyl group at the V/V interface, at a significant distance from the TCRpeptideMHC-binding site, remarkably affected ligand binding. The variant retained a high degree of specificity for MART-1HLA-A2, indicating that our approach provides a general strategy for engineering improvements in either soluble or cell-based TCRs for therapeutic purposes.	[Sharma, Preeti; Kranz, David M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@illinois.edu	Sharma, Preeti/P-1044-2019	Sharma, Preeti/0000-0002-8210-9004	National Institutes of Health [CA178844, CA187592]; NATIONAL CANCER INSTITUTE [R21CA187592, R01CA178844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA178844 and CA187592 (to D. M. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bonsor DA, 2011, BIOCHEMISTRY-US, V50, P2394, DOI 10.1021/bi102019c; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bowerman NA, 2009, J BIOL CHEM, V284, P32551, DOI 10.1074/jbc.M109.040501; Buonpane RA, 2005, J MOL BIOL, V353, P308, DOI 10.1016/j.jmb.2005.08.041; Buonpane RA, 2007, NAT MED, V13, P725, DOI 10.1038/nm1584; Carter P, 1995, J Hematother, V4, P463, DOI 10.1089/scd.1.1995.4.463; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Eisen HN, 2001, ANNU REV IMMUNOL, V19, P1, DOI 10.1146/annurev.immunol.19.1.1; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Haliloglu T, 2015, CURR OPIN STRUC BIOL, V35, P17, DOI 10.1016/j.sbi.2015.07.007; Hanes J, 1998, P NATL ACAD SCI USA, V95, P14130, DOI 10.1073/pnas.95.24.14130; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Harris DT, 2016, J BIOL CHEM, V291, P24566, DOI 10.1074/jbc.M116.748681; Harris DT, 2016, STRUCTURE, V24, P1142, DOI 10.1016/j.str.2016.04.011; He YN, 2015, J BIOL CHEM, V290, P19796, DOI 10.1074/jbc.M115.663799; Hellman LM, 2016, J IMMUNOL METHODS, V432, P95, DOI 10.1016/j.jim.2016.02.016; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Jones LL, 2008, BIOCHEMISTRY-US, V47, P12398, DOI 10.1021/bi801349g; Jones LL, 2008, J IMMUNOL, V181, P6255, DOI 10.4049/jimmunol.181.9.6255; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kieke MC, 1997, PROTEIN ENG, V10, P1303, DOI 10.1093/protein/10.11.1303; Kieke MC, 2001, J MOL BIOL, V307, P1305, DOI 10.1006/jmbi.2001.4560; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Moza B, 2006, P NATL ACAD SCI USA, V103, P9867, DOI 10.1073/pnas.0600220103; Natarajan A, 2016, CELL REP, V14, P2833, DOI 10.1016/j.celrep.2016.02.081; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Posnett D. N., 1996, IMMUNOLOGIST, V4, P5; Procko E, 2013, J MOL BIOL, V425, P3563, DOI 10.1016/j.jmb.2013.06.035; Richman SA, 2009, MOL IMMUNOL, V46, P902, DOI 10.1016/j.molimm.2008.09.021; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Sadowsky JD, 2011, P NATL ACAD SCI USA, V108, P6056, DOI 10.1073/pnas.1102376108; Schmitt TM, 2015, CLIN CANCER RES, V21, P5191, DOI 10.1158/1078-0432.CCR-15-0860; Sharma P, 2013, PROTEIN ENG DES SEL, V26, P781, DOI 10.1093/protein/gzt054; Shultzaberger RK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001042; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Smith CA, 2008, J MOL BIOL, V380, P742, DOI 10.1016/j.jmb.2008.05.023; Smith SN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6223; Smith SN, 2013, J MOL BIOL, V425, P4496, DOI 10.1016/j.jmb.2013.08.007; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Stone JD, 2011, J IMMUNOL, V187, P6281, DOI 10.4049/jimmunol.1101734; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Traxlmayr MW, 2017, METHODS MOL BIOL, V1575, P45, DOI 10.1007/978-1-4939-6857-2_4; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Wang N., CLIN VACCINE IMMUNOL, V17, P1781; Weber KS, 2005, P NATL ACAD SCI USA, V102, P19033, DOI 10.1073/pnas.0507554102; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yang XB, 2015, P NATL ACAD SCI USA, V112, P8166, DOI 10.1073/pnas.1510127112	76	18	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1820	1834		10.1074/jbc.M117.814152	http://dx.doi.org/10.1074/jbc.M117.814152			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29229779	Green Published, hybrid			2022-12-28	WOS:000424201700031
J	Volonte, D; Vyas, AR; Chen, C; Dacic, S; Stabile, LP; Kurland, BF; Abberbock, SR; Burns, TF; Herman, JG; Di, YP; Galbiati, F				Volonte, Daniela; Vyas, Avani R.; Chen, Chen; Dacic, Sanja; Stabile, Laura P.; Kurland, Brenda F.; Abberbock, Shira R.; Burns, Timothy F.; Herman, James G.; Di, Yuanpu Peter; Galbiati, Ferruccio			Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolae; caveolin; cellular senescence; oncogene; Ras protein; senescence	INDUCED PREMATURE SENESCENCE; LUNG-CANCER; K-RAS; SCAFFOLDING DOMAIN; MOUSE LUNG; TUMORIGENESIS; INHIBITION; MICE; ACTIVATION; EXPRESSION	Oncogene-induced senescence (OIS) is considered a powerful tumor suppressor mechanism. Caveolin-1 acts as a scaffolding protein to functionally regulate signaling molecules. We demonstrate that a lack of caveolin-1 expression inhibits oncogenic K-Ras (K-Ras(G12V))-induced premature senescence in mouse embryonic fibroblasts and normal human bronchial epithelial cells. Oncogenic K-Ras induces senescence by limiting the detoxification function of MTH1. We found that K-Ras(G12V) promotes the interaction of caveolin-1 with MTH1, which results in inhibition of MTH1 activity. Lung cancer cells expressing oncogenic K-Ras have bypassed the senescence barrier. Interestingly, overexpression of caveolin-1 restores cellular senescence in both A549 and H460 lung cancer cells and inhibits their transformed phenotype. In support of these findings, our in vivo data demonstrate that overexpression of oncogenic K-Ras (K-Ras(G12D)) induces cellular senescence in the lung of wildtype but not caveolin-1-null mice. A lack of K-Ras(G12D)-induced premature senescence in caveolin-1-null mice results in the formation of more abundant lung tumors. Consistent with these data, caveolin-1-null mice overexpressing K-Ras(G12D) display accelerated mortality. Finally, our animal data were supported by human sample analysis in which we show that caveolin-1 expression is dramatically down-regulated in lung adenocarcinomas from lung cancer patients, both at the mRNA and protein levels, and that low caveolin-1 expression is associated with poor survival. Together, our data suggest that lung cancer cells escape oncogene-induced premature senescence through down-regulation of caveolin-1 expression to progress from premalignant lesions to cancer.	[Volonte, Daniela; Vyas, Avani R.; Stabile, Laura P.; Galbiati, Ferruccio] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Chen, Chen; Di, Yuanpu Peter] Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Dacic, Sanja] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Kurland, Brenda F.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Stabile, Laura P.; Kurland, Brenda F.; Abberbock, Shira R.; Burns, Timothy F.; Herman, James G.] Univ Pittsburgh, Lung Canc Program, Hillman Canc Ctr, Inst Canc, Pittsburgh, PA 15232 USA; [Vyas, Avani R.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Galbiati, F (corresponding author), 200 Lothrop St, Pittsburgh, PA 15261 USA.	feg5@pitt.edu	Di, Yuanpu Peter/H-4191-2016; Kurland, Brenda F/AAM-9239-2020; Stabile, Laura/AAE-9235-2020; Vyas, Avani/J-1842-2019; Galbiati, Ferruccio/AAF-3527-2020	Di, Yuanpu Peter/0000-0003-2028-2087; Kurland, Brenda F/0000-0002-5669-0595; 	NCI, National Institutes of Health (NIH) [R01-CA205165, P50-CA090440, P30-CA047904]; NHLBI, NIH [R01-HL124747, R01-HL091938]; NATIONAL CANCER INSTITUTE [P50CA090440, R01CA205165, P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091938, R01HL124747] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NCI, National Institutes of Health (NIH), Grants R01-CA205165 (to F. G.), P50-CA090440, and P30-CA047904 and NHLBI, NIH, Grants R01-HL124747 (to F. G.) and R01-HL091938 (to Y. P. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek KH, 2013, J CLIN INVEST, V123, P4375, DOI 10.1172/JCI67465; Bartholomew JN, 2009, CANCER RES, V69, P2878, DOI 10.1158/0008-5472.CAN-08-2857; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Capozza F, 2003, AM J PATHOL, V162, P2029, DOI 10.1016/S0002-9440(10)64335-0; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Feldman R, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.28_suppl.134; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; FOLEY JF, 1991, EXP LUNG RES, V17, P157, DOI 10.3109/01902149109064408; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jagannadham MV, 2002, BIOCHEM BIOPH RES CO, V298, P203, DOI 10.1016/S0006-291X(02)02426-9; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Matveev S, 2001, ADV DRUG DELIVER REV, V49, P237, DOI 10.1016/S0169-409X(01)00138-7; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; OHSHIMA M, 1985, CANCER RES, V45, P2785; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Rai P, 2011, ONCOGENE, V30, P1489, DOI 10.1038/onc.2010.520; Rai Priyamvada, 2012, Small GTPases, V3, P120, DOI 10.4161/sgtp.19556; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; REHM S, 1991, EXP LUNG RES, V17, P181, DOI 10.3109/01902149109064410; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; SCHNITZER JE, 1995, J BIOL CHEM, V270, P14399, DOI 10.1074/jbc.270.24.14399; Segal SS, 1999, AM J PHYSIOL-HEART C, V277, pH1167; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMART EJ, 1995, J CELL BIOL, V131, P929, DOI 10.1083/jcb.131.4.929; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Stabile LP, 2011, CLIN CANCER RES, V17, P154, DOI 10.1158/1078-0432.CCR-10-0992; VANZANDWIJK N, 1995, LUNG CANCER-J IASLC, V12, pS27, DOI 10.1016/0169-5002(95)00418-Z; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268; Volonte D, 2013, MOL BIOL CELL, V24, P1852, DOI 10.1091/mbc.E12-09-0666; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; Volonte D, 2009, EMBO REP, V10, P1334, DOI 10.1038/embor.2009.215; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Williams TM, 2004, J BIOL CHEM, V279, P24745, DOI 10.1074/jbc.M402064200; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222	59	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1794	1809		10.1074/jbc.M117.815902	http://dx.doi.org/10.1074/jbc.M117.815902			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247004	Green Published, hybrid			2022-12-28	WOS:000424201700029
J	Bernard, K; Logsdon, NJ; Benavides, GA; Sanders, Y; Zhang, JH; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Benavides, Gloria A.; Sanders, Yan; Zhang, Jianhua; Darley-Usmar, Victor M.; Thannickal, Victor J.			Glutaminolysis is required for transforming growth factor-beta 1-induced myofibroblast differentiation and activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondrial metabolism; myofibroblast; glutamine; transforming growth factor beta (TGF-B); differentiation	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TGF-BETA; PROTEIN-KINASE; TISSUE-REPAIR; CELLS; METABOLISM; STABILIZATION; PROLIFERATION; HIF1-ALPHA; EXPRESSION	Myofibroblasts participate in physiological wound healing and pathological fibrosis. Myofibroblast differentiation is characterized by the expression of -smooth muscle actin and extracellular matrix proteins and is dependent on metabolic reprogramming. In this study, we explored the role of glutaminolysis and metabolites of TCA in supporting myofibroblast differentiation. Glutaminolysis converts Gln into -ketoglutarate (-KG), a critical intermediate in the TCA cycle. Increases in the steady-state concentrations of TCA cycle metabolites including -KG, succinate, fumarate, malate, and citrate were observed in TGF-1-differentiated myofibroblasts. The concentration of glutamate was also increased in TGF-1-differentiated myofibroblasts compared with controls, whereas glutamine levels were decreased, suggesting enhanced glutaminolysis. This was associated with TGF-1-induced expression of the glutaminase (GLS) isoform, GLS1, which converts Gln into glutamate, at both the mRNA and protein levels. The stimulation of GLS1 expression by TGF-1 was dependent on both SMAD3 and p38 mitogen-activated protein kinase activation. Depletion of extracellular Gln prevented TGF-1-induced myofibroblast differentiation. The removal of extracellular Gln postmyofibroblast differentiation decreased the expression of the profibrotic markers fibronectin and hypoxia-inducible factor-1 and reversed TGF-1-induced metabolic reprogramming. Silencing of GLS1 expression, in the presence of Gln, abrogated TGF-1-induced expression of profibrotic markers. Treatment of GLS1-deficient myofibroblasts with exogenous glutamate or -KG restored TGF-1-induced expression of profibrotic markers in GLS1-deficient myofibroblasts. Together, these data demonstrate that glutaminolysis is a critical component of myofibroblast metabolic reprogramming that regulates myofibroblast differentiation.	[Bernard, Karen; Logsdon, Naomi J.; Sanders, Yan; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Benavides, Gloria A.; Zhang, Jianhua; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL 35294 USA; [Thannickal, Victor J.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St S,BMRII 464, Birmingham, AL 35294 USA.	karenbernard@uabmc.edu	Sanders, Yan/AAJ-3413-2020	Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health [P01 HL114470, R01 AG046210, P30 DK079337]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210, P30AG050886] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Roger Davis (University of Massachusetts) and Dr. A. Brent Carter (University of Alabama at Birmingham) for providing us with the p38 MAPK mutant used in this study. We thank Dr. Stephen Barnes and Taylor F. Berryhill (Targeted Metabolomics and Proteomics Laboratory, University of Alabama at Birmingham). The University of Alabama at Birmingham O'Brien Acute Kidney Injury Center for the operation of the Targeted Metabolomics and Proteomics Laboratory, the University of Alabama at Birmingham Lung Health Center, and the University of Alabama at Birmingham Center for Free Radical Biology are supported by National Institutes of Health Grants P01 HL114470, R01 AG046210, and P30 DK079337.	Altman BJ, 2016, NAT REV CANCER, V16, P749, DOI 10.1038/nrc.2016.114; Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; BALDWIN JE, 1981, NATURE, V291, P381, DOI 10.1038/291381a0; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Briere JJ, 2005, HUM MOL GENET, V14, P3263, DOI 10.1093/hmg/ddi359; Burr SP, 2016, CELL METAB, V24, P740, DOI 10.1016/j.cmet.2016.09.015; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Glick GD, 2014, J PHARMACOL EXP THER, V351, P298, DOI 10.1124/jpet.114.218099; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kappler M, 2017, CLIN ORAL INVEST, V21, P211, DOI 10.1007/s00784-016-1780-9; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Portais JC, 1996, BIOCHIMIE, V78, P155, DOI 10.1016/0300-9084(96)89500-9; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; SHAPIRO RA, 1991, J BIOL CHEM, V266, P18792; Shi JD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09020-8; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith MR, 2016, REDOX BIOL, V8, P136, DOI 10.1016/j.redox.2016.01.002; Stegen S, 2016, CELL METAB, V23, P265, DOI 10.1016/j.cmet.2016.01.002; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Yu DC, 2015, ONCOTARGET, V6, P7619, DOI 10.18632/oncotarget.3196; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	52	79	84	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1218	1228		10.1074/jbc.RA117.000444	http://dx.doi.org/10.1074/jbc.RA117.000444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222329	hybrid, Green Published			2022-12-28	WOS:000423515000010
J	Sullivan, EM; Pennington, ER; Sparagna, GC; Torres, MJ; Neufer, PD; Harris, M; Washington, J; Anderson, EJ; Zeczycki, TN; Brown, DA; Shaikh, SR				Sullivan, E. Madison; Pennington, Edward Ross; Sparagna, Genevieve C.; Torres, Maria J.; Neufer, P. Darrell; Harris, Mitchel; Washington, James; Anderson, Ethan J.; Zeczycki, Tonya N.; Brown, David A.; Shaikh, Saame Raza			Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; lipid vesicle; mass spectrometry (MS); membrane; mitochondria; phospholipid; polyunsaturated fatty acid (PUFA)	CYTOCHROME-C-OXIDASE; POLYUNSATURATED FATTY-ACIDS; CORONARY-HEART-DISEASE; INDUCED-OBESE MICE; BARTH-SYNDROME; RESPIRATORY-CHAIN; COMPLEX-I; ATP SYNTHASE; TETRALINOLEOYL-CARDIOLIPIN; CARDIOVASCULAR-DISEASES	Cardiac mitochondrial phospholipid acyl chains regulate respiratory enzymatic activity. In several diseases, the rodent cardiac phospholipidome is extensively rearranged; however, whether specific acyl chains impair respiratory enzyme function is unknown. One unique remodeling event in the myocardium of obese and diabetic rodents is an increase in docosahexaenoic acid (DHA) levels. Here, we first confirmed that cardiac DHA levels are elevated in diabetic humans relative to controls. We then used dietary supplementation of a Western diet with DHA as a tool to promote cardiac acyl chain remodeling and to study its influence on respiratory enzyme function. DHA extensively remodeled the acyl chains of cardiolipin (CL), monolyso-CL, phosphatidylcholine, and phosphatidylethanolamine. Moreover, DHA lowered enzyme activities of respiratory complexes I, IV, V, and I + III. Mechanistically, the reduction in enzymatic activities was not driven by a dramatic reduction in the abundance of supercomplexes. Instead, replacement of tetralinoleoyl-CL with tetradocosahexaenoyl-CL in biomimetic membranes prevented formation of phospholipid domains that regulate enzyme activity. Tetradocosahexaenoyl-CL inhibited domain organization due to favorable Gibbs free energy of phospholipid mixing. Furthermore, in vitro substitution of tetralinoleoyl-CL with tetradocosahexaenoyl-CL blocked complex IV binding. Finally, reintroduction of linoleic acid, via fusion of phospholipid vesicles to mitochondria isolated from DHA-fed mice, rescued the major losses in the mitochondrial phospholipidome and complexes I, IV, and V activities. Altogether, our results show that replacing linoleic acid with DHA lowers select cardiac enzyme activities by potentially targeting domain organization and phospholipid-protein binding, which has implications for the ongoing debate about	[Sullivan, E. Madison; Pennington, Edward Ross; Harris, Mitchel; Washington, James; Zeczycki, Tonya N.; Shaikh, Saame Raza] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA; [Sullivan, E. Madison; Pennington, Edward Ross; Torres, Maria J.; Neufer, P. Darrell; Washington, James; Zeczycki, Tonya N.; Shaikh, Saame Raza] East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA; [Neufer, P. Darrell] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27834 USA; [Pennington, Edward Ross; Shaikh, Saame Raza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Pennington, Edward Ross; Shaikh, Saame Raza] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Sparagna, Genevieve C.] Univ Colorado, Dept Med, Div Cardiol, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Anderson, Ethan J.] Univ Iowa, Coll Pharm, Fraternal Order Eagles Diabet Res Ctr, Dept Pharmaceut Sci & Expt Therapeut, Iowa City, IA 52242 USA; [Brown, David A.] Virginia Tech, Corp Res Ctr, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24060 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Iowa; Virginia Polytechnic Institute & State University	Shaikh, SR (corresponding author), East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27834 USA.; Shaikh, SR (corresponding author), East Carolina Univ, Brody Sch Med, East Carolina Diabet & Obes Inst, Greenville, NC 27834 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA.; Shaikh, SR (corresponding author), Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA.	shaikhsa@email.unc.edu		Torres, Maria J./0000-0002-7551-8053; Zeczycki, Tonya/0000-0002-5216-1960	National Institutes of Health [R01HL123647, R01AT008375, P30DK056350, R01HL122863, R01DK110656]; National Center for Complementary & Integrative Health [R01AT008375] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123647, R01HL122863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350, R01DK110656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG057006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01HL123647 (to S. R. S. and D. A. B.), R01AT008375 (to S. R. S.), P30DK056350 (to S. R. S.), R01HL122863 (E. J. A.), and R01DK110656 (to P. D. N). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMOVITCH DA, 1990, BIOCHIM BIOPHYS ACTA, V1020, P34, DOI 10.1016/0005-2728(90)90090-Q; Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alexander DD, 2017, MAYO CLIN PROC, V92, P15, DOI 10.1016/j.mayocp.2016.10.018; Anderson EJ, 2014, ANTIOXID REDOX SIGN, V21, P1156, DOI 10.1089/ars.2014.5888; Anderson EJ, 2012, BIOCHEM J, V441, P359, DOI 10.1042/BJ20110626; Aoun M, 2012, BRIT J NUTR, V107, P647, DOI 10.1017/S000711451100331X; Arnarez C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01263; Arnarez C, 2013, J AM CHEM SOC, V135, P3112, DOI 10.1021/ja310577u; Beales PA, 2011, LANGMUIR, V27, P6107, DOI 10.1021/la104924c; Brown DA, 2017, NAT REV CARDIOL, V14, P238, DOI 10.1038/nrcardio.2016.203; Chowdhury R, 2014, ANN INTERN MED, V160, P398, DOI 10.7326/M13-1788; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Endo J, 2016, J CARDIOL, V67, P22, DOI 10.1016/j.jjcc.2015.08.002; Epand RF, 2007, J MOL BIOL, V365, P968, DOI 10.1016/j.jmb.2006.10.028; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; FRANTZ ID, 1989, ARTERIOSCLEROSIS, V9, P129, DOI 10.1161/01.ATV.9.1.129; FRY M, 1981, J BIOL CHEM, V256, P1874; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gomez LA, 2009, ARCH BIOCHEM BIOPHYS, V490, P30, DOI 10.1016/j.abb.2009.08.002; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Harris WS, 2017, ATHEROSCLEROSIS, V262, P51, DOI 10.1016/j.atherosclerosis.2017.05.007; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; He Q, 2014, CHEM PHYS LIPIDS, V179, P75, DOI 10.1016/j.chemphyslip.2013.10.007; Hodnik Vesna, 2013, Methods Mol Biol, V974, P23, DOI 10.1007/978-1-62703-275-9_2; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Hu XY, 2017, COMPR PHYSIOL, V7, P693, DOI 10.1002/cphy.c160021; Iverson SL, 2004, ARCH BIOCHEM BIOPHYS, V423, P37, DOI 10.1016/j.abb.2003.12.002; Jeckel KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051994; KATAN MB, 1995, AM J CLIN NUTR, V61, p1368S, DOI 10.1093/ajcn/61.6.1368S; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Kosaraju R, 2017, J IMMUNOL, V198, P4738, DOI 10.4049/jimmunol.1601031; Lee HJ, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-2; LeMieux MJ, 2015, J NUTR, V145, P411, DOI 10.3945/jn.114.202952; Lenaz G, 2010, BBA-BIOENERGETICS, V1797, P633, DOI 10.1016/j.bbabio.2010.01.025; Li J, 2010, CELL METAB, V12, P154, DOI 10.1016/j.cmet.2010.07.003; Liu GY, 2017, J BIOL CHEM, V292, P10672, DOI 10.1074/jbc.M117.783068; Liu XF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-109; Lombardo YB, 2007, LIPIDS, V42, P427, DOI 10.1007/s11745-007-3039-3; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Madingou N, 2016, PROSTAG LEUKOTR ESS, V111, P11, DOI 10.1016/j.plefa.2016.06.001; Maniti O, 2009, BIOPHYS J, V96, P2428, DOI 10.1016/j.bpj.2008.12.3911; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Nettleton JA, 2005, J AM DIET ASSOC, V105, P428, DOI 10.1016/j.jada.2004.11.029; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Paradies G, 1997, BBA-BIOENERGETICS, V1319, P5, DOI 10.1016/S0005-2728(97)00012-1; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Pennington ER, 2017, BBA-BIOMEMBRANES, V1859, P257, DOI 10.1016/j.bbamem.2016.11.012; Petrosillo G, 2005, BBA-BIOENERGETICS, V1710, P78, DOI 10.1016/j.bbabio.2005.10.003; Pinel A, 2016, J LIPID RES, V57, P1382, DOI 10.1194/jlr.M065458; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; RAMSDEN CE, 2013, BMJ-BRIT MED J, V346, pe8707, DOI DOI 10.1136/BMJ.E8707; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Rangel-Huerta O. D., 2017, CLIN NUTR, V2017, pS0261; ROBINSON NC, 1982, BIOCHEMISTRY-US, V21, P184, DOI 10.1021/bi00530a031; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Rockett BD, 2012, J LIPID RES, V53, P674, DOI 10.1194/jlr.M021782; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rosca MG, 2013, HEART FAIL REV, V18, P607, DOI 10.1007/s10741-012-9340-0; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schmid EM, 2015, METHOD CELL BIOL, V128, P319, DOI 10.1016/bs.mcb.2015.02.004; Sedlak E, 2006, BIOCHEMISTRY-US, V45, P746, DOI 10.1021/bi050870z; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shaikh SR, 2009, BBA-BIOMEMBRANES, V1788, P2421, DOI 10.1016/j.bbamem.2009.08.019; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; Shindou H, 2017, J BIOL CHEM, V292, P12054, DOI [10.1074/jbc.M117.790568, 10.1074/jbc.m117.790568]; Sparagna GC, 2005, J LIPID RES, V46, P1196, DOI 10.1194/jlr.M500031-JLR200; Sparagna GC, 2007, J LIPID RES, V48, P1559, DOI 10.1194/jlr.M600551-JLR200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Sullivan EM, 2017, J NUTR BIOCHEM, V45, P94, DOI 10.1016/j.jnutbio.2017.04.004; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; WHEELDON LW, 1965, J LIPID RES, V6, P481; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	86	32	37	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					466	483		10.1074/jbc.M117.812834	http://dx.doi.org/10.1074/jbc.M117.812834			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162722	Green Published, hybrid			2022-12-28	WOS:000419915400005
J	Gasparotto, J; Girardi, CS; Somensi, N; Ribeiro, CT; Moreira, JCF; Michels, M; Sonai, B; Rocha, M; Steckert, AV; Barichello, T; Quevedo, J; Dal-Pizzol, F; Gelain, DP				Gasparotto, Juciano; Girardi, Carolina S.; Somensi, Nauana; Ribeiro, Camila T.; Moreira, Jose C. F.; Michels, Monique; Sonai, Beatriz; Rocha, Mariane; Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao; Dal-Pizzol, Felipe; Gelain, Daniel P.			Receptor for advanced glycation end products mediates sepsis-triggered amyloid-beta accumulation, Tau phosphorylation, and cognitive impairment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; CECAL LIGATION; ANIMAL-MODEL; MOUSE MODEL; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS; RAGE; BRAIN; PROTEIN	Patients recovering from sepsis have higher rates of CNS morbidities associated with long-lasting impairment of cognitive functions, including neurodegenerative diseases. However, the molecular etiology of these sepsis-induced impairments is unclear. Here, we investigated the role of the receptor for advanced glycation end products (RAGE) in neuroinflammation, neurodegeneration-associated changes, and cognitive dysfunction arising after sepsis recovery. Adult Wistar rats underwent cecal ligation and perforation (CLP), and serum and brain (hippocampus and prefrontal cortex) samples were obtained at days 1, 15, and 30 after the CLP. We examined these samples for systemic and brain inflammation; amyloid-beta peptide (A beta) and Ser-202-phosphorylated Tau (p-Tau(Ser-202)) levels; and RAGE, RAGE ligands, and RAGE intracellular signaling. Serum markers associated with the acute proinflammatory phase of sepsis (TNF alpha, IL-1 beta, and IL-6) rapidly increased and then progressively decreased during the 30-day period post-CLP, concomitant with a progressive increase in RAGE ligands (S100B, N epsilon-[carboxymethyl]lysine, HSP70, and HMGB1). In the brain, levels of RAGE and Toll-like receptor 4, glial fibrillary acidic protein and neuronal nitric-oxide synthase, and A beta and p-Tau(Ser-202) also increased during that time. Of note, intracerebral injection of RAGE antibody into the hippocampus at days 15, 17, and 19 post-CLP reduced A beta and p-Tau(Ser-202) accumulation, Akt/mechanistic target of rapamycin signaling, levels of ionized calcium-binding adapter molecule 1 and glial fibrillary acidic protein, and behavioral deficits associated with cognitive decline. These results indicate that brain RAGE is an essential factor in the pathogenesis of neurological disorders following acute systemic inflammation.	[Gasparotto, Juciano; Girardi, Carolina S.; Somensi, Nauana; Ribeiro, Camila T.; Moreira, Jose C. F.; Gelain, Daniel P.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Ctr Estudos Estresse Oxidat, BR-90035003 Porto Alegre, RS, Brazil; [Michels, Monique; Sonai, Beatriz; Rocha, Mariane; Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense Criciuma, Inst Nacl Ciencia & Tecnol Translac Med, Lab Fisiopatol Expt, BR-88806000 Criciuma, SC, Brazil; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Extremo Sul Catarinense Criciuma, Unidade Acad Ciencias Saude, Programa Posgrad Ciencias Saude, Lab Neurociencias, BR-88806000 Criciuma, SC, Brazil; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, Translat Psychiat Program, Houston, TX 77030 USA; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Psychiat & Behav Sci, Ctr Excellence Mood Disorders, Houston, TX 77030 USA; [Steckert, Amanda V.; Barichello, Tatiana; Quevedo, Joao] Univ Texas Grad Sch Biomed Sci Houston, Neurosci Grad Program, Houston, TX 77030 USA	Universidade Federal do Rio Grande do Sul; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Gelain, DP (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Rua Ramiro Barcelos,2600 Anexo, BR-90035003 Porto Alegre, RS, Brazil.	daniel.gelain@ufrgs.br	moreira, jose claudio/AAO-6400-2021; Gelain, Daniel Pens/I-5144-2013; Barichello, Tatiana/E-2725-2013; de Quevedo, João Luciano/E-5491-2013; MICHELS, MONIQUE/U-3967-2019; Gasparotto, Juciano/K-3239-2013; Girardi, Carolina/M-8804-2019	Gelain, Daniel Pens/0000-0001-5254-0509; de Quevedo, João Luciano/0000-0003-3114-6611; MICHELS, MONIQUE/0000-0001-8440-1976; Gasparotto, Juciano/0000-0003-2545-7288; Saibro Girardi, Carolina/0000-0002-1685-011X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul; Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina; Propesq/UFRGS; Fundacao CAPES, Instituto Cerebro e Mente; UNESC	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina; Propesq/UFRGS; Fundacao CAPES, Instituto Cerebro e Mente(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); UNESC	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to D. P. G., J. C. F. M., J. Q., and F. D.-P.), Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (to D. P. G. and J. C. F. M.), Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (to J. Q. and F. D.-P.), Propesq/UFRGS (to D. P. G. and J. C. F. M.), Fundacao CAPES, Instituto Cerebro e Mente (to J. Q.) and UNESC (to T. B., J. Q., and F. D.-P.). The authors declare that they have no conflicts of interest with the contents of this article.	Annane D, 2015, LANCET RESP MED, V3, P61, DOI 10.1016/S2213-2600(14)70246-2; Asati V, 2016, EUR J MED CHEM, V109, P314, DOI 10.1016/j.ejmech.2016.01.012; Barichello T, 2007, BRAZ J MED BIOL RES, V40, P831, DOI 10.1590/S0100-879X2007000600013; Barichello T, 2006, CRIT CARE MED, V34, P886, DOI 10.1097/01.CCM.0000201880.50116.12; Barichello T, 2005, CRIT CARE MED, V33, P1671, DOI 10.1097/01.CCM.0000170192.54682.C1; Barichello T, 2005, CRIT CARE MED, V33, P221, DOI 10.1097/01.CCM.0000150741.12906.BD; Barichello T, 2007, CRIT CARE MED, V35, P2186, DOI 10.1097/01.CCM.0000281452.60683.96; Batkulwar KB, 2015, PROTEOMICS, V15, P245, DOI 10.1002/pmic.201400169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candela P, 2010, J ALZHEIMERS DIS, V22, P849, DOI 10.3233/JAD-2010-100462; Capetillo-Zarate E, 2011, AM J PATHOL, V179, P2551, DOI 10.1016/j.ajpath.2011.07.045; Chavan SS, 2012, MOL MED, V18, P930, DOI 10.2119/molmed.2012.00195; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Creagh-Brown BC, 2010, INTENS CARE MED, V36, P1644, DOI 10.1007/s00134-010-1952-z; Cunningham C, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0117-2; Dal-Pizzol F, 2006, AM J RESP CRIT CARE, V173, P84, DOI 10.1164/rccm.200507-1118OC; Dal-Pizzol F, 2013, MOL NEUROBIOL, V48, P62, DOI 10.1007/s12035-013-8433-7; Dal-Pizzol F, 2012, MOL MED, V18, P1357, DOI 10.2119/molmed.2012.00317; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Dent Paul, 2014, Cancer Biol Ther, V15, P245, DOI 10.4161/cbt.27541; DUMOULIN GC, 1985, BRAIN RES, V340, P261, DOI 10.1016/0006-8993(85)90922-9; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Galasko D, 2014, NEUROLOGY, V82, P1536, DOI 10.1212/WNL.0000000000000364; Gendron TF, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-13; Goedert M, 1998, BIOCHEM SOC T, V26, P463, DOI 10.1042/bst0260463; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Guillot F, 2016, J ALZHEIMERS DIS, V51, P1157, DOI 10.3233/JAD-150926; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hong Y, 2016, NEUROCHEM RES, V41, P1192, DOI 10.1007/s11064-015-1814-8; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamat PK, 2014, MOL NEUROBIOL, V50, P852, DOI 10.1007/s12035-014-8699-4; Kuhla A, 2013, BRIT J SURG, V100, P1229, DOI 10.1002/bjs.9188; Lee JY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0310-z; Li XH, 2012, NEUROBIOL AGING, V33, P1400, DOI 10.1016/j.neurobiolaging.2011.02.003; Lukic IK, 2008, ANN NY ACAD SCI, V1126, P76, DOI 10.1196/annals.1433.059; Lutterloh EC, 2007, CRIT CARE, V11, DOI 10.1186/cc6184; Lutterloh EC, 2007, EXPERT OPIN PHARMACO, V8, P1193, DOI 10.1517/14656566.8.9.1193; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Michels Monique, 2015, Intensive Care Med Exp, V3, P30, DOI 10.1186/s40635-015-0066-x; Michels M, 2015, BRAIN BEHAV IMMUN, V43, P54, DOI 10.1016/j.bbi.2014.07.002; Multhaup G, 2015, J BIOL CHEM, V290, P23515, DOI 10.1074/jbc.R115.677211; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; [National Research Council (U.S.) Institute for Laboratory Animal Research (U.S.) & National Academies Press (U.S.).], 2011, COMM UPD GUID CAR US; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Opp MR, 2015, BRAIN BEHAV IMMUN, V50, P259, DOI 10.1016/j.bbi.2015.07.023; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Paxinos G., 2005, RAT BRAIN STEREOTAXI, P181; Ritter C, 2004, CRIT CARE MED, V32, P342, DOI 10.1097/01.CCM.0000109454.13145.CA; Ritter C, 2003, INTENS CARE MED, V29, P1782, DOI 10.1007/s00134-003-1789-9; Roesler R, 1999, NEUROBIOL LEARN MEM, V72, P252, DOI 10.1006/nlme.1999.3910; Sabbagh MN, 2011, ALZ DIS ASSOC DIS, V25, P206, DOI 10.1097/WAD.0b013e318204b550; Schwalm MT, 2014, MOL NEUROBIOL, V49, P380, DOI 10.1007/s12035-013-8526-3; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Semmler A, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-38; Sharshar T, 2003, LANCET, V362, P1799, DOI 10.1016/S0140-6736(03)14899-4; Shi S, 2016, J ALZHEIMERS DIS, V50, P859, DOI 10.3233/JAD-150963; Simic G, 2002, LANCET NEUROL, V1, P276, DOI 10.1016/S1474-4422(02)00130-8; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Tobon-Velasco JC, 2014, CNS NEUROL DISORD-DR, V13, P1615, DOI 10.2174/1871527313666140806144831; van Zoelen MAD, 2008, CRIT CARE, V12, DOI 10.1186/cc6187; van Zoelen MAD, 2009, J INFECT DIS, V200, P765, DOI 10.1086/604730; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Widmann CN, 2014, LANCET NEUROL, V13, P630, DOI 10.1016/S1474-4422(14)70017-1; Wilson JX, 2003, CAN J NEUROL SCI, V30, P98, DOI 10.1017/S031716710005335X; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Xia P, 2016, EUR J PHARMACOL, V779, P102, DOI 10.1016/j.ejphar.2016.03.017; Yarlagadda Atmaram, 2009, Psychiatry (Edgmont), V6, P18; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658; Yu Y, 2015, CELL MOL NEUROBIOL, V35, P71, DOI 10.1007/s10571-014-0101-6; Zilka N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-47; Zuo L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/604658	82	67	71	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					226	244		10.1074/jbc.M117.786756	http://dx.doi.org/10.1074/jbc.M117.786756			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29127203	Green Published, hybrid			2022-12-28	WOS:000419453200020
J	Hanke-Gogokhia, C; Wu, ZJ; Sharif, A; Yazigi, H; Frederick, JM; Baehr, W				Hanke-Gogokhia, Christin; Wu, Zhijian; Sharif, Ali; Yazigi, Hussein; Frederick, Jeanne M.; Baehr, Wolfgang			The guanine nucleotide exchange factor Arf-like protein 13b is essential for assembly of the mouse photoreceptor transition zone and outer segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Joubert syndrome; photoreceptor; cilia; retinal degeneration; guanine nucleotide exchange factor (GEF); small GTPase; ARL13b; ARL3-GTP; ciliogenesis; transition zone; photoreceptor outer segment	INTRAFLAGELLAR TRANSPORT; JOUBERT-SYNDROME; RETINITIS-PIGMENTOSA; MEMBRANE-PROTEIN; SMALL GTPASES; PRIMARY CILIA; GENE-THERAPY; GTP-BINDING; ARL13B; CELLS	Arf-like protein 13b (ARL13b) is a small GTPase that functions as a guanosine nucleotide exchange factor (GEF) for ARL3-GDP. ARL13b is located exclusively in photoreceptor outer segments (OS) presumably anchored to discs by palmitoylation, whereas ARL3 is an inner segment cytoplasmic protein. Hypomorphic mutations affecting the ARL13b G-domain inactivate GEF activity and lead to Joubert syndrome (JS) in humans. However, the molecular mechanisms in ARL13b mutation-induced Joubert syndrome, particularly the function of primary cilia, are still incompletely understood. Because Arl13b germline knockouts in mouse are lethal, we generated retina-specific deletions of ARL13b in which ARL3-GTP formation is impaired. In mouse (ret)Arl13b(-/-) central retina at postnatal day 6 (P6) and older, outer segments were absent, thereby preventing trafficking of outer segment proteins to their destination. Ultrastructure of postnatal day 10 (P10) central (ret)Arl13b(-/-) photoreceptors revealed docking of basal bodies to cell membranes, but mature transition zones and disc structures were absent. Deletion of ARL13b in adult mice via tamoxifen-induced Cre/loxP recombination indicated that axonemes gradually shorten and outer segments progressively degenerate. IFT88, essential for anterograde intraflagellar transport (IFT), was significantly reduced at (tam)Arl13b(-/-) basal bodies, suggesting impairment of intraflagellar transport. AAV2/8 vector-mediated ARL13b expression in the (ret)Arl13b(-/-) retina rescued ciliogenesis.	[Hanke-Gogokhia, Christin; Sharif, Ali; Yazigi, Hussein; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, John A Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Wu, Zhijian] NEI, NIH, Bethesda, MD 20892 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, John A Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	wbaehr@hsc.utah.edu	wu, zhi/GXH-3041-2022		National Institutes of Health [EY08123, EY019298]; NEI, National Institutes of Health [EY014800-039003]; Research to Prevent Blindness (RPB) (New York); NATIONAL EYE INSTITUTE [T32EY024234, P30EY014800, R01EY008123, ZIAEY000443, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB) (New York)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY08123 and EY019298 (to W. B.), NEI, National Institutes of Health, Core Grant EY014800-039003, and Research to Prevent Blindness (RPB) (New York) unrestricted grants to the University of Utah Department of Ophthalmology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Barabas P, 2011, INVEST OPHTH VIS SCI, V52, P6766, DOI 10.1167/iovs.10-7147; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chuang Jen-Zen, 2015, Cilia, V4, P4, DOI 10.1186/s13630-015-0013-1; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim YK, 2013, ACTA HISTOCHEM, V115, P789, DOI 10.1016/j.acthis.2013.03.005; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Li YY, 2016, J AM SOC NEPHROL, V27, P3628, DOI 10.1681/ASN.2015091004; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Mariani LE, 2016, MOL BIOL CELL, V27, P3780, DOI 10.1091/mbc.E16-03-0189; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Ronquillo CC, 2016, FASEB J, V30, P3400, DOI 10.1096/fj.201600511R; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Song P, 2016, INVEST OPHTH VIS SCI, V57, P4517, DOI 10.1167/iovs.16-19898; Strom SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150944; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wright ZC, 2016, HUM MOL GENET, V25, P2031, DOI 10.1093/hmg/ddw077; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24534; Zhang Q, 2013, EXP CELL RES, V319, P2316, DOI 10.1016/j.yexcr.2013.03.024	61	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21442	21456		10.1074/jbc.RA117.000141	http://dx.doi.org/10.1074/jbc.RA117.000141			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089384	hybrid, Green Published			2022-12-28	WOS:000419013000020
J	Plitzko, B; Kaweesa, EN; Loesgen, S				Plitzko, Birte; Kaweesa, Elizabeth N.; Loesgen, Sandra			The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMET ASSAY; DNA-DAMAGE; DEATH; GENE; CYTOTOXICITY; DOXORUBICIN; INHIBITION; ORGANELLES; MUTATIONS; DISTINCT	Mensacarcin is a highly oxygenated polyketide that was first isolated from soil-dwelling Streptomyces bacteria. It exhibits potent cytostatic properties (mean of 50% growth inhibition = 0.2 mu M) in almost all cell lines of the National Cancer Institute (NCI)-60 cell line screen and relatively selective cytotoxicity against melanoma cells. Moreover, its low COMPARE correlations with known standard antitumor agents indicate a unique mechanism of action. Effective therapies for managing melanoma are limited, so we sought to investigate mensacarcin's unique cytostatic and cytotoxic effects and its mode of action. By assessing morphological and biochemical features, we demonstrated that mensacarcin activates caspase-3/7-dependent apoptotic pathways and induces cell death in melanoma cells. Upon mensacarcin exposure, SK-Mel-28 and SK-Mel-5 melanoma cells, which have the BRAFV600E mutation associated with drug resistance, showed characteristic chromatin condensation as well as distinct poly(ADP-ribose) polymerase-1 cleavage. Flow cytometry identified a large population of apoptotic melanoma cells, and single-cell electrophoresis indicated that mensacarcin causes genetic instability, a hallmark of early apoptosis. To visualize mensacarcin's subcellular localization, we synthesized a fluorescent mensacarcin probe that retained activity. The natural product probe was localized to mitochondria within 20 min of treatment. Live-cell bioenergetic flux analysis confirmed that mensacarcin disturbs energy production and mitochondrial function rapidly. The subcellular localization of the fluorescently labeled mensacarcin together with its unusual metabolic effects in melanoma cells provide evidence that mensacarcin targets mitochondria. Mensacarcin's unique mode of action suggests that it may be a useful probe for examining energy metabolism, particularly in BRAF-mutant melanoma, and represent a promising lead for the development of new anticancer drugs.	[Plitzko, Birte; Kaweesa, Elizabeth N.; Loesgen, Sandra] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA	Oregon State University	Loesgen, S (corresponding author), Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA.	sandra.loesgen@oregonstate.edu			Oregon State University	Oregon State University	This work was primarily supported by Oregon State University startup funds. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2017, CANC FACTS FIG 2017, P24; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Curtius T., 1894, J PRAKT CHEM, V50, P275, DOI [10.1002/prac.18940500125, DOI 10.1002/PRAC.18940500125]; D'Souza GGM, 2011, BBA-BIOENERGETICS, V1807, P689, DOI 10.1016/j.bbabio.2010.08.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Giordano S, 2012, BIOENERGETIC RESPONS, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Huang SN, 2003, J PHARMACOL EXP THER, V306, P681, DOI 10.1124/jpet.103.051581; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lupertz R, 2010, TOXICOLOGY, V271, P115, DOI 10.1016/j.tox.2010.03.012; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Maier S, 2015, CHEMBIOCHEM, V16, P1175, DOI 10.1002/cbic.201500048; Maier S, 2014, CHEMBIOCHEM, V15, P749, DOI 10.1002/cbic.201300704; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATSU J, 1963, J ANTIBIOT, V16, P203; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; PAULL KD, 1992, CANCER RES, V52, P3892; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Piehler J, 1997, ANAL BIOCHEM, V249, P94, DOI 10.1006/abio.1997.2160; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rundell MS, 2003, ENVIRON MOL MUTAGEN, V42, P61, DOI 10.1002/em.10175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Serrill JD, 2015, BIOCHEM PHARMACOL, V93, P251, DOI 10.1016/j.bcp.2014.11.015; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith P. A. S., 2004, ORG REACTIONS, V3, P337; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Tietze LF, 2005, EUR J ORG CHEM, V2005, P2459, DOI 10.1002/ejoc.200400826; Tietze LF, 2004, CHEM-EUR J, V10, P5233, DOI 10.1002/chem.200400342; Tietze LF, 2005, EUR J ORG CHEM, V2005, P1752, DOI 10.1002/ejoc.200400786; Tietze LF, 2007, EUR J ORG CHEM, V2007, P4563, DOI 10.1002/ejoc.200700418; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Van Noorden CJF, 2001, ACTA HISTOCHEM, V103, P241, DOI 10.1078/0065-1281-00601; VonSteyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267, DOI 10.1177/44.3.8648087; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan XH, 2012, CHEMBIOCHEM, V13, P224, DOI 10.1002/cbic.201100574; Zhao JY, 2013, INT J MOL SCI, V14, P16851, DOI 10.3390/ijms140816851; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	54	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21102	21116		10.1074/jbc.M116.774836	http://dx.doi.org/10.1074/jbc.M116.774836			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074620	hybrid, Green Published			2022-12-28	WOS:000418453400025
J	Vyklicka, L; Boukalova, S; Macikova, L; Chvojka, S; Vlachova, V				Vyklicka, Lenka; Boukalova, Stepana; Macikova, Lucie; Chvojka, Stepan; Vlachova, Viktorie			The human transient receptor potential vanilloid 3 channel is sensitized via the ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLMSTED SYNDROME; CATION CHANNEL; TRPV3 CHANNEL; PROTEIN; SKIN; MUTATIONS; HEAT	The transient receptor potential vanilloid 3 (TRPV3) channel is a Ca2+-permeable thermosensitive ion channel widely expressed in keratinocytes, where together with epidermal growth factor receptor (EGFR) forms a signaling complex regulating epidermal homeostasis. Proper signaling through this complex is achieved and maintained via several pathways in whichTRPV3activation is absolutely required. Results of recent studies have suggested that low-level constitutive activity of TRPV3 induces EGFR-dependent signaling that, in turn, amplifies TRPV3 via activation of the mitogen-activated protein kinase ERK in a positive feedback loop. Here, we explored the molecular mechanism that increases TRPV3 activity through EGFR activation. We used mutagenesis and whole-cell patch clamp experiments on TRPV3 channels endogenously expressed in an immortalized human keratinocyte cell line (HaCaT) and in transiently transfected HEK293T cells and found that the sensitizing effect of EGFR on TRPV3 is mediated by ERK. We observed that ERK-mediated phosphorylation of TRPV3 alters its responsiveness to repeated chemical stimuli. Among several putative ERK phosphorylation sites, we identified threonine 264 in the N-terminal ankyrin repeat domain as the most critical site for the ERK-dependent modulation of TRPV3 channel activity. Of note, Thr264 is in close vicinity to a structurally and functionally important TRPV3 region comprising an atypical finger 3 and oxygen-dependent hydroxylation site. In summary, our findings indicate that Thr264 in TRPV3 is a key ERK phosphorylation site mediating EGFR-induced sensitization of the channel to stimulate signaling pathways involved in regulating skin homeostasis.	[Vyklicka, Lenka; Boukalova, Stepana; Macikova, Lucie; Chvojka, Stepan; Vlachova, Viktorie] Czech Acad Sci, Inst Physiol, Dept Cellular Neurophysiol, Prague 14220 4, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Vyklicka, L (corresponding author), Czech Acad Sci, Inst Physiol, Dept Cellular Neurophysiol, Prague 14220 4, Czech Republic.; Vlachova, V (corresponding author), Inst Physiol CAS, Dept Cellular Neurophysiol, Videnska 1083, Prague 14220 4, Czech Republic.	lenka.vyklicka@fgu.cas.cz; viktorie.vlachova@fgu.cas.cz	Boukalova, Stepana/H-2610-2014; Boukalova, Stepana/AAM-3541-2020; Marsakova, Lenka/F-8637-2014; Vlachova, Viktorie/Q-2040-2019; Vlachova, Viktorie/A-4380-2012; Macikova, Lucie/O-1048-2017	Boukalova, Stepana/0000-0002-6478-4604; Boukalova, Stepana/0000-0002-6478-4604; Vlachova, Viktorie/0000-0002-8621-0935; Vlachova, Viktorie/0000-0002-8621-0935; Macikova, Lucie/0000-0003-2249-442X	Czech Science Foundation [15-15839S]; Grant Agency of Charles University [GA UK 74417]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University	This work was supported by Czech Science Foundation Grant 15-15839S and the Grant Agency of Charles University Grant GA UK 74417. The authors declare that they have no conflicts of interest with the contents of this article.	Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Benedikt J, 2007, J NEUROCHEM, V100, P211, DOI 10.1111/j.1471-4159.2006.04192.x; Billen B, 2015, J BIOL CHEM, V290, P12964, DOI 10.1074/jbc.M114.628925; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2017, P NATL ACAD SCI USA, V114, P1589, DOI 10.1073/pnas.1615304114; Liu BY, 2011, J GEN PHYSIOL, V138, P509, DOI 10.1085/jgp.201110689; Luo JL, 2014, CURR TOP MEMBR, V74, P325, DOI [10.1016/B978-0-12-800181-3.00012-9, 10.1016/B978-0-12-80018-3.00012-9]; Martin SW, 2006, CELL CALCIUM, V39, P275, DOI 10.1016/j.ceca.2005.11.002; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi DJ, 2013, PROTEIN CELL, V4, P942, DOI 10.1007/s13238-013-3091-0; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang P, 2014, HANDB EXP PHARMACOL, V222, P273, DOI 10.1007/978-3-642-54215-2_11	30	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21083	21091		10.1074/jbc.M117.801167	http://dx.doi.org/10.1074/jbc.M117.801167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084846	hybrid, Green Published			2022-12-28	WOS:000418453400023
J	Esteso, G; Guerra, S; Vales-Gomez, M; Reyburn, HT				Esteso, Gloria; Guerra, Susana; Vales-Gomez, Mar; Reyburn, Hugh T.			Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; double-stranded RNA (dsRNA); natural killer cells (NK cells); pattern recognition receptor (PRR); virus; NKG2D; NKG2D ligands; dsRNA; self; non-self-discrimination; virus infection	NATURAL CYTOTOXICITY RECEPTORS; PARAMYXOVIRUS V-PROTEINS; RIG-I; HUMAN CYTOMEGALOVIRUS; HUMAN FIBROBLASTS; HELICASE LGP2; CELLS; VIRULENCE; PATHWAYS; TARGETS	Self/non-self-discrimination by the innate immune system relies on germline-encoded, non-rearranging receptors expressed by innate immune cells recognizing conserved pathogen-associated molecular patterns. The natural killer group 2D (NKG2D) receptor is a potent immune-activating receptor that binds human genome-encoded ligands, whose expression is negligible in normal tissues, but increased in stress and disease conditions for reasons that are incompletely understood. Here it is not clear how the immune system reconciles receptor binding of self-proteins with self/non-self-discrimination to avoid autoreactivity. We now report that increased expression of NKG2D ligands after virus infection depends on interferon response factors activated by the detection of viral double-stranded RNA by pattern-recognition receptors (RIG-I/MDA-5) and that NKG2D ligand up-regulation can be blocked by the expression of viral dsRNA-binding proteins. Thus, innate immunity-mediated recognition of viral nucleic acids triggers the infected cell to release interferon for NK cell recruitment and to express NKG2D ligands to become more visible to the immune system. Finally, the observation that NKG2D-ligand induction is a consequence of signaling by pattern-recognition receptors that have been selected over evolutionary time to be highly pathogen-specific explains how the risks of autoreactivity in this system are minimized.	[Esteso, Gloria; Vales-Gomez, Mar; Reyburn, Hugh T.] CSIC, Dept Immunol & Oncol, CNB, Madrid 28049, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid 28029, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid	Reyburn, HT (corresponding author), CSIC, Dept Immunol & Oncol, CNB, Madrid 28049, Spain.	htreyburn@cnb.csic.es	Valés-Gómez, Mar/F-5351-2012; Vales-Gomez, Mar/ABG-7808-2020	Valés-Gómez, Mar/0000-0001-7424-3206; Vales-Gomez, Mar/0000-0001-7424-3206; Esteso Tornero, Gloria/0000-0001-6162-013X	Fondo de Investigacion Sanitaria (FIS) [PI11/00298, PS09/00181]; Ministerio de Economia y Competividad (MINECO) [SAF2012-32293, SAF2014-54623, SAF2014-58752-R, SAF2015-69169-R]; Comunidad de Madrid [S2010/BMD-2326]	Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); Ministerio de Economia y Competividad (MINECO); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Fondo de Investigacion Sanitaria (FIS) Grants PI11/00298 and PS09/00181, Ministerio de Economia y Competividad (MINECO) Grants SAF2012-32293, SAF2014-54623, SAF2014-58752-R, and SAF2015-69169-R, and Comunidad de Madrid Grant S2010/BMD-2326. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bahar MW, 2011, J STRUCT BIOL, V175, P127, DOI 10.1016/j.jsb.2011.03.010; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; Cham CM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/780436; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Esteso G, 2014, J IMMUNOL, V193, P1344, DOI 10.4049/jimmunol.1303441; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Fernandez-Messina L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00299; Gowen BG, 2015, ELIFE, V4, DOI 10.7554/eLife.08474; Greene TT, 2016, ELIFE, V5, DOI 10.7554/eLife.14749; Guerra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028677; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Lam AR, 2014, CANCER RES, V74, P2193, DOI 10.1158/0008-5472.CAN-13-1703; Liu RK, 2016, J VIROL, V90, P7864, DOI 10.1128/JVI.00869-16; Lopez-Pelaez M, 2014, P NATL ACAD SCI USA, V111, P17432, DOI 10.1073/pnas.1418399111; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McSharry BP, 2001, J GEN VIROL, V82, P855, DOI 10.1099/0022-1317-82-4-855; Nachmani D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5186; Nanbakhsh A, 2014, BLOOD, V123, P3585, DOI 10.1182/blood-2013-11-536219; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Ribaudo Randall, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1011s04; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Uccellini L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-170; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Vales-Gomez M, 2006, CELL MICROBIOL, V8, P581, DOI 10.1111/j.1462-5822.2005.00645.x; Van Belle TL, 2009, MOL IMMUNOL, V47, P8, DOI 10.1016/j.molimm.2009.02.023; Wen F, 2011, AUTOIMMUNITY, V44, P82, DOI 10.3109/08916934.2010.491842	47	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20472	20480		10.1074/jbc.M117.818393	http://dx.doi.org/10.1074/jbc.M117.818393			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28986447	hybrid, Green Published			2022-12-28	WOS:000418267000011
J	Lee, YK; Lim, JJ; Jeoun, UW; Min, S; Lee, EB; Kwon, SM; Lee, C; Yoon, G				Lee, Young-Kyoung; Lim, Jin J.; Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Kwon, So Mee; Lee, Changhan; Yoon, Gyesoon			Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; hepatocellular carcinoma; mitochondrial metabolism; mitochondrial respiratory chain complex; ribosome	HUMAN BREAST-CANCER; TUMOR MICROENVIRONMENT; LARGE SUBUNIT; EXPRESSION; GENE; DNA; DYSFUNCTION; METABOLISM; RIBOSOME; DEHYDROGENASE	Impaired mitochondrial oxidative phosphorylation (OXPHOS) capacity, accompanied by enhanced glycolysis, is a key metabolic feature of cancer cells, but its underlying mechanism remains unclear. Previously, we reported that human hepatoma cells that harbor OXPHOS defects exhibit high tumor cell invasiveness via elevated claudin-1 (CLN1). In the present study, we show that OXPHOS-defective hepatoma cells (SNU354 and SNU423 cell lines) exhibit reduced expression of mitochondrial ribosomal protein L13 (MRPL13), a mitochondrial ribosome (mitoribosome) subunit, suggesting a ribosomal defect. Specific inhibition of mitoribosomal translation by doxycycline, chloramphenicol, or siRNA-mediated MRPL13 knockdown decreased mitochondrial protein expression, reduced oxygen consumption rate, and increased CLN1-mediated tumor cell invasiveness in SNU387 cells, which have active mitochondria. Interestingly, we also found that exogenous lactate treatment suppressed MRPL13 expression and oxygen consumption rate and induced CLN1 expression. A bioinformatic analysis of the open RNA-Seq database from The Cancer Genome Atlas (TCGA) liver hepatocellular carcinoma (LIHC) cohort revealed a significant negative correlation between MRPL13 and CLN1 expression. Moreover, in patients with low MRPL13 expression, two oxidative metabolic indicators, pyruvate dehydrogenase B expression and the ratio of lactate dehydrogenase type B to type A, significantly and negatively correlated with CLN1 expression, indicating that the combination of elevated glycolysis and deficient MRPL13 activity was closely linked to CLN1-mediated tumor activity in LIHC. These results suggest that OXPHOS defects may be initiated and propagated by lactate-mediated mitoribosomal deficiencies and that these deficiencies are critically involved in LIHC development.	[Lee, Young-Kyoung; Lim, Jin J.; Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Kwon, So Mee; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea; [Jeoun, Un-woo; Min, Seongki; Lee, Eun-beom; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon 16499, South Korea; [Lee, Changhan] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA	Ajou University; Ajou University; University of Southern California	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 16499, South Korea.	ypeace@ajou.ac.kr		LIM, Jin J./0000-0003-0616-5183	National Research Foundation of Korea from the Korean Ministry of Science, ICT and Future Planning [2015R1A2A1A10055038]; NATIONAL INSTITUTE ON AGING [R01AG052558] Funding Source: NIH RePORTER	National Research Foundation of Korea from the Korean Ministry of Science, ICT and Future Planning; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Research Foundation of Korea Grant 2015R1A2A1A10055038 from the Korean Ministry of Science, ICT and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chandra D, 2011, BBA-BIOENERGETICS, V1807, P620, DOI 10.1016/j.bbabio.2010.10.023; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; D'Andrea A, 2016, ONCOTARGET, V7, P72415, DOI 10.18632/oncotarget.11719; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Gopisetty G, 2016, GENE, V589, P27, DOI 10.1016/j.gene.2016.05.008; Greber BJ, 2016, ANNU REV BIOCHEM, V85, P103, DOI 10.1146/annurev-biochem-060815-014343; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; GROHMANN L, 1994, CURR GENET, V26, P8, DOI 10.1007/BF00326298; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594; Lee C, 2016, FREE RADICAL BIO MED, V100, P182, DOI 10.1016/j.freeradbiomed.2016.05.015; Lee J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000380; Lee YK, 2015, HEPATOLOGY, V62, P1174, DOI 10.1002/hep.27976; Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4; Li XN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863564; Ma JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064912; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Nishikawa M, 2001, CANCER RES, V61, P1843; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; PIETROMONACO SF, 1991, BIOCHIMIE, V73, P827, DOI 10.1016/0300-9084(91)90062-6; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Rudrabhatla SR, 2006, J INVEST DERMATOL, V126, P1378, DOI 10.1038/sj.jid.5700255; Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Tang XH, 2012, CANCER RES, V72, P491, DOI 10.1158/0008-5472.CAN-11-2076; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Wazir U, 2012, ANTICANCER RES, V32, P671; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	41	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20208	20217		10.1074/jbc.M117.809012	http://dx.doi.org/10.1074/jbc.M117.809012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28978646	Green Published, hybrid			2022-12-28	WOS:000417696400025
J	Cesa, LC; Shao, H; Srinivasan, SR; Tse, E; Jain, C; Zuiderweg, ERP; Southworth, DR; Mapp, AK; Gestwicki, JE				Cesa, Laura C.; Shao, Hao; Srinivasan, Sharan R.; Tse, Eric; Jain, Chetali; Zuiderweg, Erik R. P.; Southworth, Daniel R.; Mapp, Anna K.; Gestwicki, Jason E.			X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; ONCOGENE ADDICTION; SUBSTRATE-BINDING; CO-CHAPERONES; HSP90; CANCER; REVEALS; DEGRADATION; DNAK; COMPLEX	Heat shock protein 70 (Hsp70) and Hsp90 are molecular chaperones that play essential roles in tumor growth by stabilizing pro-survival client proteins. However, although the development of Hsp90 inhibitors has benefited from the identification of clients, such as Raf-1 proto-oncogene, Ser/Thr kinase (RAF1), that are particularly dependent on this chaperone, no equivalent clients for Hsp70 have been reported. Using chemical probes and MDA-MB-231 breast cancer cells, we found here that the inhibitors of apoptosis proteins, including c-IAP1 and X-linked inhibitor of apoptosis protein (XIAP), are obligate Hsp70 clients that are rapidly (within similar to 3-12 h) lost after inhibition of Hsp70 but not of Hsp90. Mutagenesis and pulldown experiments revealed multiple Hsp70-binding sites on XIAP, suggesting that it is a direct, physical Hsp70 client. Interestingly, this interaction was unusually tight (similar to 260 nM) for an Hsp70-client interaction and involved non-canonical regions of the chaperone. Finally, we also found that Hsp70 inhibitor treatments caused loss of c-IAP1 and XIAP in multiple cancer cell lines and in tumor xenografts, but not in healthy cells. These results are expected to significantly accelerate Hsp70 drug discovery by providing XIAP as a pharmacodynamic biomarker. More broadly, our findings further suggest that Hsp70 and Hsp90 have partially non-overlapping sets of obligate protein clients in cancer cells.	[Cesa, Laura C.; Srinivasan, Sharan R.; Southworth, Daniel R.; Mapp, Anna K.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Jain, Chetali; Mapp, Anna K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Tse, Eric; Zuiderweg, Erik R. P.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Tse, Eric; Southworth, Daniel R.; Mapp, Anna K.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Shao, Hao; Gestwicki, Jason E.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Gestwicki, JE (corresponding author), Univ Calif San Francisco, Sander Ctr, Rm 311,675 Nelson Rising Lane, San Francisco, CA 94158 USA.	Jason.gestwicki@ucsf.edu	, Dr Anna Mapp/GPX-8261-2022	Tse, Eric/0000-0002-2082-9006; Srinivasan, Sharan/0000-0003-2729-6625; Cesa, Laura/0000-0002-8367-3790; , Chetali/0000-0002-8778-4199	National Institutes of Health [NS059690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant NS059690 (to J. E. G. and E. R. P. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Arnaud LT, 2009, J NEUROCHEM, V110, P328, DOI 10.1111/j.1471-4159.2009.06142.x; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Brodsky JL, 2006, CURR TOP MED CHEM, V6, P1215, DOI 10.2174/156802606777811997; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chang L, 2010, J BIOL CHEM, V285, P21282, DOI 10.1074/jbc.M110.124149; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Colvin TA, 2014, CANCER RES, V74, P4731, DOI 10.1158/0008-5472.CAN-14-0747; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Garrido C, 2003, CELL CYCLE, V2, P579, DOI 10.4161/cc.2.6.521; Hinds MG, 1999, NAT STRUCT BIOL, V6, P648; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kaiser M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.28; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Kellner R, 2014, P NATL ACAD SCI USA, V111, P13355, DOI 10.1073/pnas.1407086111; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Leu JIJ, 2014, ACS CHEM BIOL, V9, P2508, DOI 10.1021/cb500236y; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Li XK, 2015, MOL CANCER THER, V14, P642, DOI 10.1158/1535-7163.MCT-14-0650; Li XK, 2013, ACS MED CHEM LETT, V4, P1042, DOI 10.1021/ml400204n; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mashaghi A, 2016, NATURE, V539, P448, DOI 10.1038/nature20137; Matts RL, 2011, BIOORGAN MED CHEM, V19, P684, DOI 10.1016/j.bmc.2010.10.029; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; Nagel R, 2016, EMBO REP, V17, P1516, DOI 10.15252/embr.201643030; Pellecchia M, 2000, NAT STRUCT BIOL, V7, P298; Powers MV, 2009, CELL CYCLE, V8, P518, DOI 10.4161/cc.8.4.7583; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Rauch JN, 2016, J BIOL CHEM, V291, P19848, DOI 10.1074/jbc.M116.742502; Rauch JN, 2014, J BIOL CHEM, V289, P1402, DOI 10.1074/jbc.M113.521997; Rousaki A, 2011, J MOL BIOL, V411, P614, DOI 10.1016/j.jmb.2011.06.003; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Sekhar A, 2015, P NATL ACAD SCI USA, V112, P10395, DOI 10.1073/pnas.1508504112; Sherman MY, 2015, ONCOGENE, V34, P4153, DOI 10.1038/onc.2014.349; Srinivasan SR, 2018, MOL CANCER RES, V16, P58, DOI 10.1158/1541-7786.MCR-17-0408; Srinivasan SR, 2012, MOL BIOSYST, V8, P2323, DOI 10.1039/c2mb25145k; Sun HY, 2008, J MED CHEM, V51, P7169, DOI 10.1021/jm8006849; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tillotson B, 2010, J BIOL CHEM, V285, P39835, DOI 10.1074/jbc.M110.141580; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vasko RC, 2010, ACS MED CHEM LETT, V1, P4, DOI 10.1021/ml900003t; Wang AM, 2013, NAT CHEM BIOL, V9, P112, DOI [10.1038/NCHEMBIO.1140, 10.1038/nchembio.1140]; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Young ZT, 2016, CELL CHEM BIOL, V23, P992, DOI 10.1016/j.chembiol.2016.04.014	59	31	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2370	2380		10.1074/jbc.RA117.000634	http://dx.doi.org/10.1074/jbc.RA117.000634			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29255093	Green Published, hybrid			2022-12-28	WOS:000425308300011
J	Hashiramoto, A; Konishi, Y; Murayama, K; Kawasaki, H; Yoshida, K; Tsumiyama, K; Tanaka, K; Mizuhara, M; Shiotsuki, T; Kitamura, H; Komai, K; Kimura, T; Yagita, H; Shiozawa, K; Shiozawa, S				Hashiramoto, Akira; Konishi, Yoshitake; Murayama, Koichi; Kawasaki, Hiroki; Yoshida, Kohsuke; Tsumiyama, Ken; Tanaka, Kimie; Mizuhara, Masaru; Shiotsuki, Toshio; Kitamura, Hitomi; Komai, Koichiro; Kimura, Tomoatsu; Yagita, Hideo; Shiozawa, Kazuko; Shiozawa, Shunichi			A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; arthritis; caspase; death domain; lymphocyte	TNF-LIKE LIGAND; DOMAIN-CONTAINING RECEPTOR; GENOME-WIDE ASSOCIATION; CYTOKINE 1A TL1A; DECOY RECEPTOR-3; FAS GENE; SUSCEPTIBILITY LOCI; CIRCULATING LEVELS; CROHNS-DISEASE; DR3	Rheumatoid arthritis (RA) is a chronic polyarthritis of unknown etiology. To unravel the molecular mechanisms in RA, we performed targeted DNA sequencing analysis of patients with RA. This analysis identified a variant of the death receptor 3 (DR3) gene, a member of the family of apoptosis-inducing Fas genes, which contains four single-nucleotide polymorphisms (SNPs) and a 14-nucleotide deletion within exon 5 and intron 5. We found that the deletion causes the binding of splicing regulatory proteins to DR3 pre-mRNA intron 5, resulting in a portion of intron 5 becoming part of the coding sequence, thereby generating a premature stop codon. We also found that this truncated DR3 protein product lacks the death domain and forms a heterotrimer complex with wildtype DR3 that dominant-negatively inhibits ligand-induced apoptosis in lymphocytes. Myelocytes from transgenic mice expressing the human DR3 variant produced soluble truncated DR3, forming a complex with TNF-like ligand 1A (TL1A), which inhibited apoptosis induction. In summary, our results reveal that a DR3 splice variant that interferes with ligand-induced T cell responses and apoptosis may contribute to RA pathogenesis.	[Hashiramoto, Akira; Konishi, Yoshitake; Murayama, Koichi; Kawasaki, Hiroki; Yoshida, Kohsuke; Tanaka, Kimie; Mizuhara, Masaru; Shiotsuki, Toshio; Kitamura, Hitomi; Komai, Koichiro] Kobe Univ, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Tsumiyama, Ken; Shiozawa, Shunichi] Kyushu Univ, Beppu Hosp, Rheumat Dis Unit, Dept Med, 4546 Tsurumihara, Beppu, Oita 8740838, Japan; [Kimura, Tomoatsu] Toyama Univ, Dept Orthoped Surg, Fac Med, 3190 Gofuku, Toyama 9300194, Japan; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138431, Japan; [Shiozawa, Kazuko] Hyogo Prefectural Kakogawa Med Ctr, Dept Rheumatol, Kakogawa, Hyogo 6758555, Japan	Kobe University; Kyushu University; University of Toyama; Juntendo University	Shiozawa, S (corresponding author), Kyushu Univ, Beppu Hosp, Rheumat Dis Unit, Dept Med, 4546 Tsurumihara, Beppu, Oita 8740838, Japan.	shiozawa@port.kobe-u.ac.jp	Komai, Koichiro/L-1633-2019; Shiozawa, Shunichi/W-2992-2019	Komai, Koichiro/0000-0003-0015-5283; 				Aiba Y, 2014, LIVER INT, V34, P679, DOI 10.1111/liv.12296; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bamias G, 2013, CLIN IMMUNOL, V147, P144, DOI 10.1016/j.clim.2013.03.002; Bamias G, 2003, J IMMUNOL, V171, P4868, DOI 10.4049/jimmunol.171.9.4868; Bamias G, 2008, CLIN IMMUNOL, V129, P249, DOI 10.1016/j.clim.2008.07.014; Bamias G, 2006, P NATL ACAD SCI USA, V103, P8441, DOI 10.1073/pnas.0510903103; Bamias G, 2011, EXP DERMATOL, V20, P725, DOI 10.1111/j.1600-0625.2011.01304.x; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Borysenko CW, 2005, BIOCHEM BIOPH RES CO, V328, P794, DOI 10.1016/j.bbrc.2005.01.017; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cassatella MA, 2007, J IMMUNOL, V178, P7325, DOI 10.4049/jimmunol.178.11.7325; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Fang L, 2008, J EXP MED, V205, P1037, DOI 10.1084/jem.20072528; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fukao T, 2010, MOL GENET METAB, V100, P339, DOI 10.1016/j.ymgme.2010.03.012; Genetta T, 2001, J BIOL CHEM, V276, P25589, DOI 10.1074/jbc.M011637200; Hayashi S, 2007, ARTHRITIS RHEUM, V56, P1067, DOI 10.1002/art.22494; Jin S, 2013, MUCOSAL IMMUNOL, V6, P886, DOI 10.1038/mi.2012.124; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kakuta Y, 2009, HUM MOL GENET, V18, P1089, DOI 10.1093/hmg/ddp005; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; Konsta M, 2013, RHEUMATOLOGY, V52, P448, DOI 10.1093/rheumatology/kes316; Li L, 2014, ARCH DERMATOL RES, V306, P927, DOI 10.1007/s00403-014-1497-z; Liu JH, 2002, BLOOD, V100, P1449, DOI 10.1182/blood.V100.4.1449.h81602001449_1449_1453; Lu ZX, 2007, HUM MUTAT, V28, P978, DOI 10.1002/humu.20547; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Meusch U, 2015, ARTHRITIS RHEUMATOL, V67, P1760, DOI 10.1002/art.39138; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Osawa K, 2004, GENES IMMUN, V5, P439, DOI 10.1038/sj.gene.6364097; Otsuki T, 2000, IMMUNOL LETT, V72, P137, DOI 10.1016/S0165-2478(00)00177-2; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Peng R, 2002, RNA, V8, P1334, DOI 10.1017/S1355838202022070; Pobezinskaya YL, 2011, J IMMUNOL, V186, P5212, DOI 10.4049/jimmunol.1002374; Prehn JL, 2007, J IMMUNOL, V178, P4033, DOI 10.4049/jimmunol.178.7.4033; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Schreiber TH, 2010, J CLIN INVEST, V120, P3629, DOI 10.1172/JCI42933; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Siakavellas SI, 2015, SEMIN ARTHRITIS RHEU, V45, P1, DOI 10.1016/j.semarthrit.2015.02.007; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; Sun X, 2013, SCAND J RHEUMATOL, V42, P97, DOI 10.3109/03009742.2012.727026; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Takami N, 2006, ARTHRITIS RHEUM-US, V54, P779, DOI 10.1002/art.21637; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; van Doorn R, 2002, CANCER RES, V62, P5389; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Xiu ZJ, 2015, CYTOKINE, V72, P185, DOI 10.1016/j.cyto.2014.12.026; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Zhang J, 2009, J IMMUNOL, V183, P5350, DOI 10.4049/jimmunol.0802645; Zinovieva E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000528	62	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1933	1943		10.1074/jbc.M117.798884	http://dx.doi.org/10.1074/jbc.M117.798884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29180447	hybrid, Green Published			2022-12-28	WOS:000424948000009
J	Kracher, D; Andlar, M; Furtmuller, PG; Ludwig, R				Kracher, Daniel; Andlar, Martina; Furtmueller, Paul G.; Ludwig, Roland			Active-site copper reduction promotes substrate binding of fungal lytic polysaccharide monooxygenase and reduces stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloenzyme; protein stability; carbohydrate-binding protein; plant cell wall; polysaccharide; Active-site copper; lytic polysaccharide monooxygenase	CELLOBIOSE DEHYDROGENASE; OXIDATIVE CLEAVAGE; FUNCTIONAL-CHARACTERIZATION; CELLULOSE DEGRADATION; NEUROSPORA-CRASSA; ACTIVATION; HYDROLYSIS; DISCOVERY; INSIGHT; PROTEIN	Lytic polysaccharide monooxygenases (LPMOs) are a class of copper-containing enzymes that oxidatively degrade insoluble plant polysaccharides and soluble oligosaccharides. Upon reductive activation, they cleave the substrate and promote biomass degradation by hydrolytic enzymes. In this study, we employed LPMO9C from Neurospora crassa, which is active toward cellulose and soluble -glucans, to study the enzyme-substrate interaction and thermal stability. Binding studies showed that the reduction of the mononuclear active-site copper by ascorbic acid increased the affinity and the maximum binding capacity of LPMO for cellulose. The reduced redox state of the active-site copper and not the subsequent formation of the activated oxygen species increased the affinity toward cellulose. The lower affinity of oxidized LPMO could support its desorption after catalysis and allow hydrolases to access the cleavage site. It also suggests that the copper reduction is not necessarily performed in the substrate-bound state of LPMO. Differential scanning fluorimetry showed a stabilizing effect of the substrates cellulose and xyloglucan on the apparent transition midpoint temperature of the reduced, catalytically active enzyme. Oxidative auto-inactivation and destabilization were observed in the absence of a suitable substrate. Our data reveal the determinants of LPMO stability under turnover and non-turnover conditions and indicate that the reduction of the active-site copper initiates substrate binding.	[Kracher, Daniel; Andlar, Martina; Ludwig, Roland] BOKU Univ Nat Resources & Life Sci, Biocatalysis & Biosensing Res Grp, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria; [Furtmueller, Paul G.] BOKU Univ Nat Resources & Life Sci, Div Biochem, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Kracher, D; Ludwig, R (corresponding author), BOKU Univ Nat Resources & Life Sci, Biocatalysis & Biosensing Res Grp, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria.	daniel.kracher@boku.ac.at; roland.ludwig@boku.ac.at	Kracher, Daniel/H-6667-2019; Furtmüller, Paul G./Y-5819-2018	Kracher, Daniel/0000-0002-3856-3170; Furtmüller, Paul G./0000-0002-1199-2469; Ludwig, Roland/0000-0002-5058-5874; Andlar, Martina/0000-0002-8745-7921	Austrian Science Fund (FWF) [I2385 N28]; Project BioToP [W1224]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Project BioToP	This work was supported in part by Austrian Science Fund (FWF) Project I2385 N28 and Project BioToP, Grant W1224. The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; BEERS RF, 1952, J BIOL CHEM, V195, P133; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Danneels B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178446; Eibinger M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01028-y; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2017, CARBOHYD RES, V448, P187, DOI 10.1016/j.carres.2017.03.010; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Gregory RC, 2016, DALTON T, V45, P16904, DOI 10.1039/c6dt02793h; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuusk S, 2018, J BIOL CHEM, V293, P523, DOI 10.1074/jbc.M117.817593; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; O'Dell WB, 2017, ANGEW CHEM INT EDIT, V56, P767, DOI 10.1002/anie.201610502; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sabel CE, 2010, ANAL BIOCHEM, V397, P218, DOI 10.1016/j.ab.2009.10.037; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Sygmund C, 2012, APPL ENVIRON MICROB, V78, P6161, DOI 10.1128/AEM.01503-12; Tanghe M, 2017, PROTEIN ENG DES SEL, V30, P401, DOI 10.1093/protein/gzx014; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep18561; Zhang YHP, 2005, BIOMACROMOLECULES, V6, P1510, DOI 10.1021/bm049235j	41	54	57	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1676	1687		10.1074/jbc.RA117.000109	http://dx.doi.org/10.1074/jbc.RA117.000109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259126	Green Published, hybrid			2022-12-28	WOS:000424201700019
J	Derler, I; Butorac, C; Krizova, A; Stadlbauer, M; Muik, M; Fahrner, M; Frischauf, I; Romanin, C				Derler, Isabella; Butorac, Carmen; Krizova, Adela; Stadlbauer, Michael; Muik, Martin; Fahrner, Marc; Frischauf, Irene; Romanin, Christoph			Authentic CRAC channel activity requires STIM1 and the conserved portion of the Orai N terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium release-activated calcium channel protein 1 (ORAI1); electrophysiology; signal transduction; stromal interaction molecule 1 (STIM1); calcium-dependent inactivation; sodium permeation	INTERACTION MOLECULE-1 STIM1; ACTIVATED CALCIUM CURRENT; STORE-OPERATED CHANNELS; CA2+ CHANNELS; TRANSMEMBRANE SEGMENT; ION SELECTIVITY; I-CRAC; INACTIVATION; MUTATIONS; PERMEATION	Calcium (Ca2+) is an essential second messenger required for diverse signaling processes in immune cells. Ca2+ release-activated Ca2+ (CRAC) channels represent one main Ca2+ entry pathway into the cell. They are fully reconstituted via two proteins, the stromal interaction molecule 1 (STIM1), a Ca2+ sensor in the endoplasmic reticulum, and the Ca2+ ion channel Orai in the plasma membrane. After Ca2+ store depletion, STIM1 and Orai couple to each other, allowing Ca2+ influx. CRAC-/STIM1-mediated Orai channel currents display characteristic hallmarks such as high Ca2+ selectivity, an increase in current density when switching from a Ca2+-containing solution to a divalent-free Na+ one, and fast Ca2+-dependent inactivation. Here, we discovered several constitutively active Orai1 and Orai3 mutants, containing substitutions in the TM3 and/or TM4 regions, all of which displayed a loss of the typical CRAC channel hallmarks. Restoring authentic CRAC channel activity required both the presence of STIM1 and the conserved Orai N-terminal portion. Similarly, these structural requisites were found in store-operated Orai channels. Key molecular determinants within the Orai N terminus that together with STIM1 maintained the typical CRAC channel hallmarks were distinct from those that controlled store-dependent Orai activation. In conclusion, the conserved portion of the Orai N terminus is essential for STIM1, as it fine-tunes the open Orai channel gating, thereby establishing authentic CRAC channel activity.	[Derler, Isabella; Butorac, Carmen; Krizova, Adela; Stadlbauer, Michael; Muik, Martin; Fahrner, Marc; Frischauf, Irene; Romanin, Christoph] Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria	Johannes Kepler University Linz	Derler, I; Romanin, C (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	Isabella.derler@jku.at; christoph.romanin@jku.at	Hoeglinger, Carmen/AAF-9364-2021; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Frischauf, Irene/0000-0003-0661-2932; Fahrner, Marc/0000-0002-2689-0158; Hoglinger, Carmen/0000-0002-2754-592X; Tiffner, Adela/0000-0002-7529-4504	Austrian Science Fund (FWF) [P25210, P27641, P28123, P28498, P26067, P27263, W1250]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by the Austrian Science Fund (FWF) projects P25210 and P27641 (to I. D.), P28123 (to M. F.), P28498 (to M. M.), and P26067, P27263, and W1250 (to C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bohm J, 2017, HUM MUTAT, V38, P426, DOI 10.1002/humu.23172; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Calloway N, 2009, MOL BIOL CELL, V20, P389, DOI 10.1091/mbc.E07-11-1132; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Dynes JL, 2016, P NATL ACAD SCI USA, V113, P440, DOI 10.1073/pnas.1523410113; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Fahrner M, 2018, J BIOL CHEM, V293, P1271, DOI 10.1074/jbc.M117.812693; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Gudlur A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6164; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2013, CURR TOP MEMBR, V71, P237, DOI 10.1016/B978-0-12-407870-3.00010-X; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Mullins FM, 2016, J GEN PHYSIOL, V147, P153, DOI 10.1085/jgp.201511438; Mullins FM, 2016, J GEN PHYSIOL, V147, P137, DOI 10.1085/jgp.201511437; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; Palty R, 2016, J BIOL CHEM, V291, P334, DOI 10.1074/jbc.M115.685289; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3033, DOI 10.1113/jphysiol.2008.156885; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Su ZC, 2004, BIOPHYS J, V86, P805, DOI 10.1016/S0006-3495(04)74156-9; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yen M, 2016, BIOPHYS J, V111, P1897, DOI 10.1016/j.bpj.2016.09.020; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	64	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1259	1270		10.1074/jbc.M117.812206	http://dx.doi.org/10.1074/jbc.M117.812206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29237734	hybrid, Green Published			2022-12-28	WOS:000423515000013
J	Zhou, L; Todorovic, V; Kakavas, S; Sielaff, B; Medina, L; Wang, LY; Sadhukhan, R; Stockmann, H; Richardson, PL; DiGiammarino, E; Sun, CH; Scott, V				Zhou, Li; Todorovic, Viktor; Kakavas, Steve; Sielaff, Bernhard; Medina, Limary; Wang, Leyu; Sadhukhan, Ramkrishna; Stockmann, Henning; Richardson, Paul L.; DiGiammarino, Enrico; Sun, Chaohong; Scott, Victoria			Quantitative ligand and receptor binding studies reveal the mechanism of interleukin-36 (IL-36) pathway activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; kinetics; protein-protein interaction; signaling; surface plasmon resonance (SPR); IL-1Rrp2; IL-36R	PSORIASIS; SKIN; INFLAMMATION; IL-36-GAMMA; AGONIST; IL-1F9	IL-36 cytokines signal through the IL-36 receptor (IL-36R) and a shared subunit, IL-1RAcP (IL-1 receptor accessory protein). The activation mechanism for the IL-36 pathway is proposed to be similar to that of IL-1 in that an IL-36R agonist (IL-36, IL-36, or IL-36) forms a binary complex with IL-36R, which then recruits IL-1RAcP. Recent studies have shown that IL-36R interacts with IL-1RAcP even in the absence of an agonist. To elucidate the IL-36 activation mechanism, we considered all possible binding events for IL-36 ligands/receptors and examined these events in direct binding assays. Our results indicated that the agonists bind the IL-36R extracellular domain with micromolar affinity but do not detectably bind IL-1RAcP. Using surface plasmon resonance (SPR), we found that IL-1RAcP also does not bind IL-36R when no agonist is present. In the presence of IL-36, however, IL-1RAcP bound IL-36R strongly. These results suggested that the main pathway to the IL-36R<bold>IL</bold>-36<bold>IL</bold>-1RAcP ternary complex is through the IL-36R<bold>IL</bold>-36 binary complex, which recruits IL-1RAcP. We could not measure the binding affinity of IL-36R to IL-1RAcP directly, so we engineered a fragment crystallizable-linked construct to induce IL-36R<bold>IL</bold>-1RAcP heterodimerization and predicted the binding affinity during a complete thermodynamic cycle to be 74 m. The SPR analysis also indicated that the IL-36R antagonist IL-36Ra binds IL-36R with higher affinity and a much slower off rate than the IL-36R agonists, shedding light on IL-36 pathway inhibition. Our results reveal the landscape of IL-36 ligand and receptor interactions, improving our understanding of IL-36 pathway activation and inhibition.	[Zhou, Li; Sielaff, Bernhard; Medina, Limary; Wang, Leyu; Sadhukhan, Ramkrishna] AbbVie Biores Ctr, Worcester, MA 01605 USA; [Todorovic, Viktor; Kakavas, Steve; Stockmann, Henning; Richardson, Paul L.; DiGiammarino, Enrico; Sun, Chaohong; Scott, Victoria] AbbVie Inc, Abbott Pk, IL 60064 USA	AbbVie; AbbVie	Zhou, L (corresponding author), AbbVie, 100 Res Dr, Worcester, MA 01605 USA.	li.zhou@abbvie.com	Zhou, Li/S-5449-2019; Stockmann, Henning/A-1891-2012	Zhou, Li/0000-0002-9683-3562; Todorovic, Viktor/0000-0002-1428-6973; Stockmann, Henning/0000-0002-2409-5476	AbbVie Inc.; AbbVie	AbbVie Inc.(AbbVie); AbbVie(AbbVie)	This work was supported by AbbVie Inc. All authors are employees of AbbVie. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Dietrich D, 2014, NAT REV RHEUMATOL, V10, P639, DOI 10.1038/nrrheum.2014.156; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; JOBLING SA, 1988, J BIOL CHEM, V263, P16372; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Sims JE, 2010, NAT IMMUNOL, V11, P883, DOI 10.1038/ni1010-883; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Stockmann H, 2017, J AM CHEM SOC, V139, P16822, DOI 10.1021/jacs.7b09359; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Wu YH, 2011, NATURE, V475, P510, DOI 10.1038/nature10183; Yi GH, 2016, J BIOL CHEM, V291, P16597, DOI 10.1074/jbc.M116.723064	20	23	25	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					403	411		10.1074/jbc.M117.805739	http://dx.doi.org/10.1074/jbc.M117.805739			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29180446	Green Published, hybrid			2022-12-28	WOS:000419915400001
J	Bansal, M; Moharir, SC; Sailasree, SP; Sirohi, K; Sudhakar, C; Sarathi, DP; Lakshmi, BJ; Buono, M; Kumar, S; Swarup, G				Bansal, Megha; Moharir, Shivranjani C.; Sailasree, S. Purnima; Sirohi, Kapil; Sudhakar, Cherukuri; Sarathi, D. Partha; Lakshmi, B. Jyothi; Buono, Mario; Kumar, Satish; Swarup, Ghanshyam			Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; GLAUCOMA-ASSOCIATED MUTANT; RETINAL GANGLION-CELLS; SELECTIVE AUTOPHAGY; MYOSIN-VI; DAMAGED MITOCHONDRIA; TRANSFERRIN RECEPTOR; MAMMALIAN AUTOPHAGY; LC3 LIPIDATION; ATG PROTEINS	Autophagy is a quality-control mechanism that helps to maintain cellular homeostasis by removing damaged proteins and organelles through lysosomal degradation. During autophagy, signaling events lead to the formation of a cup-shaped structure called the phagophore that matures into the autophagosome. Recruitment of the autophagy-associated Atg12-5-16L1 complex to Wipi2-positive phagophores is crucial for producing microtubule-associated protein 1 light chain 3-II (LC3-II), which is required for autophagosome formation. Here, we explored the role of the autophagy receptor optineurin (Optn) in autophagosome formation. Fibroblasts from Optn knock-out mouse showed reduced LC3-II formation and a lower number of autophagosomes and autolysosomes during both basal and starvation- induced autophagy. However, the number of Wipi2-positive phagophores was not decreased in Optn-deficient cells. We also found that the number of Atg12/16L1-positive puncta and recruitment of the Atg12-5-16L1 complex to Wipi2-positive puncta are reduced in Optn-deficient cells. Of note, Optn was recruited to Atg12-5-16L1-positive puncta, and interacted with Atg5 and also with Atg12-5 conjugate. A disease-associated Optn mutant, E478G, defective in ubiquitin binding, was also defective in autophagosome formation and recruitment to the Atg12-5-16L1-positive puncta. Moreover, we noted that Optn phosphorylation at Ser-177 was required for autophagosome formation but not for Optn recruitment to the phagophore. These results suggest that Optn potentiates LC3-II production and maturation of the phagophore into the autophagosome, by facilitating the recruitment of the Atg12-5-16L1 complex to Wipi2-positive phagophores.	[Bansal, Megha; Moharir, Shivranjani C.; Sailasree, S. Purnima; Sirohi, Kapil; Sudhakar, Cherukuri; Sarathi, D. Partha; Lakshmi, B. Jyothi; Kumar, Satish; Swarup, Ghanshyam] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Buono, Mario] Univ Oxford, MRC Mol Hematol Unit, Oxford OX3 9DS, England; [Sirohi, Kapil] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Oxford; National Jewish Health	Swarup, G (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India.	gshyam@ccmb.res.in	Sirohi, Kapil/N-6676-2019; Sirohi, Kapil/GVT-2867-2022	Sirohi, Kapil/0000-0001-5039-2848; Sirohi, Kapil/0000-0001-5039-2848; Moharir, Shivranjani/0000-0001-8713-4543; Swarup, Ghanshyam/0000-0002-8098-0509	Council of Scientific and Industrial Research, Government of India [BSC-0115, BSC-0208]; Dept. of Science and Technology, Government of India [SR/S2/JCB-41/2010]; Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Dept. of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, Government of India Grants BSC-0115 and BSC-0208 (to G. S.). G. S. is grateful to the Dept. of Science and Technology, Government of India for J C Bose National Fellowship Grant SR/S2/JCB-41/2010. M. Bansal and S. C. M are recipients of a Research Fellowship from the Council of Scientific and Industrial Research, New Delhi, India. The authors declare that they have no conflict of interest with the content of this article.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bansal M, 2015, IUBMB LIFE, V67, P120, DOI 10.1002/iub.1355; Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chalasani ML, 2009, OPHTHALMIC RES, V42, P176, DOI 10.1159/000232400; Chalasani MLS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095758; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Fracchiolla D, 2016, ELIFE, V5, DOI 10.7554/eLife.18544; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Ito H, 2011, ACTA NEUROPATHOL, V122, P223, DOI 10.1007/s00401-011-0842-y; Kachaner D, 2012, CELL CYCLE, V11, P2808, DOI 10.4161/cc.20946; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Minegishi Y, 2016, PROG RETIN EYE RES, V55, P149, DOI 10.1016/j.preteyeres.2016.08.002; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moore AS, 2016, P NATL ACAD SCI USA, V113, pE3349, DOI 10.1073/pnas.1523810113; Moreau K, 2011, CELL, V146, P303, DOI 10.1016/j.cell.2011.06.023; Nagabhushana A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017477; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Nakamura S, 2017, J CELL SCI, V130, P1209, DOI 10.1242/jcs.196352; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2013, EMBO REP, V14, P206, DOI 10.1038/embor.2012.208; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011547; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Richter B, 2016, P NATL ACAD SCI USA, V113, P4039, DOI 10.1073/pnas.1523926113; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Shen WC, 2015, AUTOPHAGY, V11, P685, DOI 10.4161/auto.36098; Shen XA, 2011, J BIOL CHEM, V286, P3618, DOI 10.1074/jbc.M110.175810; Shim MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33830; Sirohi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138289; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sundaramoorthy V, 2015, HUM MOL GENET, V24, P3830, DOI 10.1093/hmg/ddv126; Tooze Sharon A, 2015, Methods Mol Biol, V1270, P155, DOI 10.1007/978-1-4939-2309-0_12; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; von Muhlinen N, 2010, AUTOPHAGY, V6, P288, DOI 10.4161/auto.6.2.11118; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	61	45	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					132	147		10.1074/jbc.M117.801944	http://dx.doi.org/10.1074/jbc.M117.801944			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133525	hybrid, Green Published			2022-12-28	WOS:000419453200013
J	Glidden, MD; Aldabbagh, K; Phillips, NB; Carr, K; Chen, YS; Whittaker, J; Phillips, M; Wickramasinghe, NP; Rege, N; Swain, M; Peng, Y; Yang, YW; Lawrence, MC; Yee, VC; Ismail-Beigi, F; Weiss, MA				Glidden, Michael D.; Aldabbagh, Khadijah; Phillips, Nelson B.; Carr, Kelley; Chen, Yen-Shan; Whittaker, Jonathan; Phillips, Manijeh; Wickramasinghe, Nalinda P.; Rege, Nischay; Swain, Mamuni; Peng, Yi; Yang, Yanwu; Lawrence, Michael C.; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.			An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RECEPTOR-BINDING; IGF-I; SECRETORY EXPRESSION; MINI-PROINSULIN; LIGAND-BINDING; CROSS-LINKING; STABILITY; DESIGN; FIBRILLATION	Thermal degradation of insulin complicates its delivery and use. Previous efforts to engineer ultra-stable analogs were confounded by prolonged cellular signaling in vivo, of unclear safety and complicating mealtime therapy. We therefore sought an ultra-stable analog whose potency and duration of action on intravenous bolus injection in diabetic rats are indistinguishable from wild-type (WT) insulin. Here, we describe the structure, function, and stability of such an analog, a 57-residue single-chain insulin (SCI) with multiple acidic substitutions. Cell-based studies revealed native-like signaling properties with negligible mitogenic activity. Its crystal structure, determined as a novel zinc-free hexamer at 2.8 angstrom, revealed a native insulin fold with incomplete or absent electron density in the C domain; complementary NMR studies are described in the accompanying article. The stability of the analog (Delta G(U) 5.0(+/-0.1) kcal/mol at 25 degrees C) was greater than that of WT insulin (3.3(+/-0.1) kcal/mol). On gentle agitation, the SCI retained full activity for >140 days at 45 degrees C and >48 h at 75 degrees C. These findings indicate that marked resistance to thermal inactivation in vitro is compatible with native duration of activity in vivo. Further, whereas WT insulin forms large and heterogeneous aggregates above the standard 0.6 mM pharmaceutical strength, perturbing the pharmacokinetic properties of concentrated formulations, dynamic light scattering, and size-exclusion chromatography revealed only limited SCI self-assembly and aggregation in the concentration range 1-7 mM. Such a combination of favorable biophysical and biological properties suggests that SCIs could provide a global therapeutic platform without a cold chain.	[Glidden, Michael D.; Aldabbagh, Khadijah; Phillips, Nelson B.; Carr, Kelley; Chen, Yen-Shan; Whittaker, Jonathan; Phillips, Manijeh; Wickramasinghe, Nalinda P.; Rege, Nischay; Swain, Mamuni; Yang, Yanwu; Yee, Vivien C.; Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Glidden, Michael D.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Peng, Yi] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Wickramasinghe, Nalinda P/F-9465-2010; Lawrence, Michael C/A-5357-2009	Lawrence, Michael/0000-0003-1999-0801; Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health [R01 DK040949, R01 DK069764]; Australian National Health and Medical Research Council [APP1058233]; Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme; Sanofi (Germany); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK040949, F30DK112644, F30DK104618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); Sanofi (Germany)(Sanofi-Aventis); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work, a contribution of the Cleveland Center for Membrane and Structural Biology and CWRU Institute for the Science of Origins, was supported in part by National Institutes of Health Grants R01 DK040949 and R01 DK069764 (to M.A.W.), Australian National Health and Medical Research Council Project Grant APP1058233 (to M.C.L.), Victorian State Government Operational Infrastructure Support, and funding from the Australian NHMRC Independent Research Institutes Infrastructure Support Scheme, both to his institution. M.A.W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N.B.P. and F.I.-B. are consultants to Thermalin Diabetes, LLC. Part of M.C.L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Barlocco Daniela, 2003, Curr Opin Investig Drugs, V4, P1240; BENTLEY GA, 1992, J MOL BIOL, V228, P1163, DOI 10.1016/0022-2836(92)90323-C; Bode BW, 2011, ENDOCR PRACT, V17, P271, DOI 10.4158/EP10260.RA; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Brange J., 1997, PROTEIN DELIVERY PHY, P343; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chan SJ, 2000, AM ZOOL, V40, P213; CHU YC, 1992, J PROTEIN CHEM, V11, P571, DOI 10.1007/BF01025035; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; Cyranoski D, 2009, NATURE, V458, P561, DOI 10.1038/458561b; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eby EL, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2014-000074; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frikke-Schmidt H, 2015, DIABETES, V64, P1057, DOI 10.2337/db14-0914; Gallagher EJ, 2013, DIABETES, V62, P3553, DOI 10.2337/db13-0249; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Ginter E, 2013, ADV EXP MED BIOL, V771, P42; Glidden MD, 2018, J BIOL CHEM, V293, P69, DOI 10.1074/jbc.M117.808667; Goldin A. A., 2002, SOFTWARE PARTICLE SI; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; HUANG XF, 1994, J BIOL CHEM, V269, P20838; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; JOHNSON IS, 1983, SCIENCE, V219, P632, DOI 10.1126/science.6337396; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kjeldsen T, 2000, APPL MICROBIOL BIOT, V54, P277, DOI 10.1007/s002530000402; Kjeldsen T, 1999, BIOTECHNOL APPL BIOC, V29, P79; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; Knudsen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051972; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Landreh M, 2012, FEBS J, V279, P4589, DOI 10.1111/febs.12045; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Listov-Saabye N, 2009, J APPL TOXICOL, V29, P470, DOI 10.1002/jat.1428; Mansur M, 2005, BIOTECHNOL LETT, V27, P339, DOI 10.1007/s10529-005-1007-7; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Niu CH, 1998, J PHARM SCI, V87, P1331, DOI 10.1021/js9800782; OHARA T, 1989, J BIOL CHEM, V264, P20625; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pace C.N., 2000, PROTEINS, V41, P1; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Phillips Nelson B, 2012, J Diabetes Sci Technol, V6, P277; Phillips NB, 2010, J BIOL CHEM, V285, P11755, DOI 10.1074/jbc.C110.105825; Poon K, 2010, DRUG HEALTHC PATIENT, V2, P213, DOI 10.2147/DHPS.S7301; Poon R.Y.C., 2015, CELL CYCLE CONTROL, DOI [10.1016/B978-0-12-801238-3.98748-8, DOI 10.1016/B978-0-12-801238-3.98748-8]; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Reutrakul Sirimon, 2012, J Diabetes Sci Technol, V6, P412; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sciacca Laura, 2012, Front Endocrinol (Lausanne), V3, P21, DOI 10.3389/fendo.2012.00021; Segal AR, 2016, ENDOCRIN METAB CLIN, V45, P845, DOI 10.1016/j.ecl.2016.06.009; Setter SM, 2000, ANN PHARMACOTHER, V34, P1423; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Stammberger I, 2006, INT J TOXICOL, V25, P25, DOI 10.1080/10915810500488379; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; STEINER DF, 1967, SCIENCE, V157, P697, DOI 10.1126/science.157.3789.697; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sunga AJ, 2008, FEMS YEAST RES, V8, P870, DOI 10.1111/j.1567-1364.2008.00410.x; Svendsen AM, 2014, BIOCHEM J, V457, P69, DOI 10.1042/BJ20130490; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; Waugh D. F., 1957, J CELL COMP PHYSL, V49, P20; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Zaykov AN, 2016, NAT REV DRUG DISCOV, V15, P425, DOI 10.1038/nrd.2015.36; Zaykov AN, 2014, ACS CHEM BIOL, V9, P683, DOI 10.1021/cb400792s; Zhou C, 2016, J PHARM SCI-US, V105, P551, DOI 10.1016/j.xphs.2015.10.023	103	19	21	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					47	68		10.1074/jbc.M117.808626	http://dx.doi.org/10.1074/jbc.M117.808626			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29114035	Green Published, hybrid			2022-12-28	WOS:000419453200004
J	Edwards, RL; Luis, PB; Varuzza, PV; Joseph, AI; Presley, SH; Chaturvedi, R; Schneider, C				Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Chaturvedi, Rupesh; Schneider, Claus			The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoxidation; cysteine; electrophile; glutathione; protein adduction; polyphenol; flavonoid; quinone; NF-B; redox regulation	NF-KAPPA-B; DEGRADATION-PRODUCTS; ENDOTHELIAL-CELLS; CLINICAL-TRIALS; KINASE-ACTIVITY; CANCER; INFLAMMATION; MECHANISMS; DERIVATIVES; ACTIVATION	The spice turmeric, with its active polyphenol curcumin, has been used as anti-inflammatory remedy in traditional Asian medicine for centuries. Many cellular targets of curcumin have been identified, but how such a wide range of targets can be affected by a single compound is unclear. Here, we identified curcumin as a pro-drug that requires oxidative activation into reactive metabolites to exert anti-inflammatory activities. Synthetic curcumin analogs that undergo oxidative transformation potently inhibited the pro-inflammatory transcription factor nuclear factor B (NF-B), whereas stable, non-oxidizable analogs were less active, with a correlation coefficient (R-2) of IC(50)versus log of autoxidation rate of 0.75. Inhibition of glutathione biosynthesis, which protects cells from reactive metabolites, increased the potency of curcumin and decreased the amount of curcumin-glutathione adducts in cells. Oxidative metabolites of curcumin adducted to and inhibited the inhibitor of NF-B kinase subunit (IKK), an activating kinase upstream of NF-B. An unstable, alkynyl-tagged curcumin analog yielded abundant adducts with cellular protein that were decreased by pretreatment with curcumin or an unstable analog but not by a stable analog. Bioactivation of curcumin occurred readily in vitro, which may explain the wide range of cellular targets, but if bioactivation is insufficient in vivo, it may also help explain the inconclusive results in human studies with curcumin so far. We conclude that the paradigm of metabolic bioactivation uncovered here should be considered for the evaluation and design of clinical trials of curcumin and other polyphenols of medicinal interest.	[Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Chaturvedi, Rupesh] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Vanderbilt University; Vanderbilt University; Jawaharlal Nehru University, New Delhi	Schneider, C (corresponding author), 23rd Ave S & Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu			National Institutes of Health from the National Center for Complementary and Integrative Health (NCCIH) [R01AT006896]; Office of Dietary Supplements (ODS); Vanderbilt Institute in Chemical Biology; National Cancer Institute SPORE in GI Cancer Grant [5P50CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute in Chemical Biology; National Cancer Institute SPORE in GI Cancer Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01AT006896 from the National Center for Complementary and Integrative Health (NCCIH) and the Office of Dietary Supplements (ODS) and in part by pilot awards from the Vanderbilt Institute in Chemical Biology and National Cancer Institute SPORE in GI Cancer Grant 5P50CA095103 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Amin HP, 2015, MOL NUTR FOOD RES, V59, P1095, DOI 10.1002/mnfr.201400803; Angelo LS, 2013, BIOORGAN MED CHEM, V21, P932, DOI 10.1016/j.bmc.2012.12.008; Awasthi S, 2000, CHEM-BIOL INTERACT, V128, P19, DOI 10.1016/S0009-2797(00)00185-X; Byun MS, 2006, EXP MOL MED, V38, P546, DOI 10.1038/emm.2006.64; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Daily JW, 2016, J MED FOOD, V19, P717, DOI 10.1089/jmf.2016.3705; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dietz BM, 2011, CHEM-BIOL INTERACT, V192, P72, DOI 10.1016/j.cbi.2010.10.007; Dinkova-Kostova AT, 1998, J MED CHEM, V41, P5287, DOI 10.1021/jm980424s; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Edwards M, 2015, J AGR FOOD CHEM, V63, P2423, DOI 10.1021/jf5041993; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Gafner S, 2004, PHYTOCHEMISTRY, V65, P2849, DOI 10.1016/j.phytochem.2004.08.008; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Gonzalez-Sarrias A, 2016, MOL NUTR FOOD RES, V60, P701, DOI 10.1002/mnfr.201500780; Gordon ON, 2015, CHEM RES TOXICOL, V28, P989, DOI 10.1021/acs.chemrestox.5b00009; Gordon ON, 2015, J BIOL CHEM, V290, P4817, DOI 10.1074/jbc.M114.618785; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Gordon ON, 2012, TRENDS MOL MED, V18, P361, DOI 10.1016/j.molmed.2012.04.011; Griesser M, 2011, J BIOL CHEM, V286, P1114, DOI 10.1074/jbc.M110.178806; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heger M, 2014, PHARMACOL REV, V66, P222, DOI 10.1124/pr.110.004044; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jobin C, 1999, J IMMUNOL, V163, P3474; Ketron AC, 2013, BIOCHEMISTRY-US, V52, P221, DOI 10.1021/bi3014455; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Ligeret H, 2004, FREE RADICAL BIO MED, V36, P919, DOI 10.1016/j.freeradbiomed.2003.12.018; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Luis PB, 2017, BIOCHEM PHARMACOL, V132, P143, DOI 10.1016/j.bcp.2017.03.002; Luo Z, 2014, BIOCONJUGATE CHEM, V25, P32, DOI 10.1021/bc4002008; Mahran RI, 2017, AAPS J, V19, P54, DOI 10.1208/s12248-016-0003-2; Masuda T, 1999, J AGR FOOD CHEM, V47, P71, DOI 10.1021/jf9805348; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Nunez-Sanchez MA, 2015, MOL NUTR FOOD RES, V59, P1274, DOI 10.1002/mnfr.201400866; Nurfina AN, 1997, EUR J MED CHEM, V32, P321, DOI 10.1016/S0223-5234(97)89084-8; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Portes E, 2007, TETRAHEDRON, V63, P9092, DOI 10.1016/j.tet.2007.06.085; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rietjens IMCM, 2011, CHEM-BIOL INTERACT, V192, P87, DOI 10.1016/j.cbi.2010.09.016; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanidad KZ, 2016, J AGR FOOD CHEM, V64, P9189, DOI 10.1021/acs.jafc.6b04343; Schneider C, 2015, J AGR FOOD CHEM, V63, P7606, DOI 10.1021/acs.jafc.5b00244; SCHNEIDER S, 1992, J LABELLED COMPD RAD, V31, P489, DOI 10.1002/jlcr.2580310609; Shen L, 2012, TRENDS MOL MED, V18, P138, DOI 10.1016/j.molmed.2012.01.004; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wang JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22146; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]; Wright MH, 2016, NAT PROD REP, V33, P681, DOI 10.1039/c6np00001k; Zhu JL, 2017, FOOD FUNCT, V8, P907, DOI 10.1039/c6fo01770c	65	108	114	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21243	21252		10.1074/jbc.RA117.000123	http://dx.doi.org/10.1074/jbc.RA117.000123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29097552	Green Published, hybrid			2022-12-28	WOS:000419013000003
J	Smeazzetto, S; Armanious, GP; Moncelli, MR; Bak, JJ; Lemieux, MJ; Young, HS; Tadini-Buoninsegni, F				Smeazzetto, Serena; Armanious, Gareth P.; Moncelli, Maria Rosa; Bak, Jessi J.; Lemieux, M. Joanne; Young, Howard S.; Tadini-Buoninsegni, Francesco			Conformational memory in the association of the transmembrane protein phospholamban with the sarcoplasmic reticulum calcium pump SERCA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; calcium ATPase; cardiac muscle; membrane transport; sarcoplasmic reticulum (SR); calcium translocation; phospholamban; sarcolipin; solid supported membrane	CHARGE TRANSLOCATION; CRYSTAL-STRUCTURES; LIPID-BILAYERS; ATPASE SERCA; SARCOLIPIN; CA2+-ATPASE; PHOSPHORYLATION; INHIBITION; MEMBRANES; DYNAMICS	The sarcoplasmic reticulum Ca2+-ATPase SERCA promotes muscle relaxation by pumping calcium ions from the cytoplasm into the sarcoplasmic reticulum. SERCA activity is regulated by a variety of small transmembrane peptides, most notably by phospholamban in cardiac muscle and sarcolipin in skeletal muscle. However, how phospholamban and sarcolipin regulate SERCA is not fully understood. In the present study, we evaluated the effects of phospholamban and sarcolipin on calcium translocation and ATP hydrolysis by SERCA under conditions that mimic environments in sarcoplasmic reticulum membranes. For pre-steady-state current measurements, proteoliposomes containing SERCA and phospholamban or sarcolipin were adsorbed to a solid-supported membrane and activated by substrate concentration jumps. We observed that phospholamban altered ATP-dependent calcium translocation by SERCA within the first transport cycle, whereas sarcolipin did not. Using pre-steady-state charge (calcium) translocation and steady-state ATPase activity under substrate conditions (various calcium and/or ATP concentrations) promoting particular conformational states of SERCA, we found that the effect of phospholamban on SERCA depends on substrate preincubation conditions. Our results also indicated that phospholamban can establish an inhibitory interaction with multiple SERCA conformational states with distinct effects on SERCA's kinetic properties. Moreover, we noted multiple modes of interaction between SERCA and phospholamban and observed that once a particular mode of association is engaged it persists throughout the SERCA transport cycle and multiple turnover events. These observations are consistent with conformational memory in the interaction between SERCA and phospholamban, thus providing insights into the physiological role of phospholamban and its regulatory effect on SERCA transport activity.	[Smeazzetto, Serena; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco] Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy; [Armanious, Gareth P.; Bak, Jessi J.; Lemieux, M. Joanne; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Florence; University of Alberta	Tadini-Buoninsegni, F (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy.; Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca; francesco.tadini@unifi.it	Tadini-Buoninsegni, Francesco/CAJ-5745-2022	TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554; Young, Howard/0000-0002-5990-8422	Ente Cassa di Risparmio di Firenze; Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE); Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program; International Research Training Group in Membrane Biology	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program; International Research Training Group in Membrane Biology	This work was supported by Ente Cassa di Risparmio di Firenze and Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE) 2007-2013 (to S. S., M. R. M., and F. T.-B.), the Heart and Stroke Foundation of Canada (to H. S. Y.), and the Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program and the International Research Training Group in Membrane Biology (to G. P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; BILEZIKJIAN LM, 1981, CIRC RES, V49, P1356, DOI 10.1161/01.RES.49.6.1356; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Buoninsegni FT, 2004, BIOPHYS J, V86, P3671, DOI 10.1529/biophysj.103.036608; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chu GX, 1998, J BIOL CHEM, V273, P33674, DOI 10.1074/jbc.273.50.33674; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Ferrandi M, 2013, BRIT J PHARMACOL, V169, P1849, DOI 10.1111/bph.12278; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gorski PA, 2015, J BIOL CHEM, V290, P6777, DOI 10.1074/jbc.M114.585604; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Ji Y, 1999, AM J PHYSIOL-HEART C, V276, pH89, DOI 10.1152/ajpheart.1999.276.1.H89; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Li J, 2012, J MOL BIOL, V418, P379, DOI 10.1016/j.jmb.2012.02.011; Loukianov E, 1998, CIRC RES, V83, P889; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pintschovius J, 1999, BIOPHYS J, V76, P814, DOI 10.1016/S0006-3495(99)77245-0; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Schorner M, 2015, J PHYS CHEM B, V119, P13964, DOI 10.1021/acs.jpcb.5b07494; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Smeazzetto S, 2016, PHYS CHEM CHEM PHYS, V18, P1629, DOI 10.1039/c5cp05893g; Smeazzetto S, 2011, PHYS CHEM CHEM PHYS, V13, P12935, DOI 10.1039/c1cp20460b; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Tada M, 1976, Recent Adv Stud Cardiac Struct Metab, V9, P225; Tadini-Buoninsegni F, 2008, MOL PHARMACOL, V73, P1134, DOI 10.1124/mol.107.043745; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Tadini-Buoninsegni F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14282; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	54	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21330	21339		10.1074/jbc.M117.794453	http://dx.doi.org/10.1074/jbc.M117.794453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29081402	Green Published, hybrid			2022-12-28	WOS:000419013000010
J	Tian, H; Tackmann, NR; Jin, AW; Zheng, JN; Zhang, YP				Tian, Hui; Tackmann, Nicole R.; Jin, Aiwen; Zheng, Junnian; Zhang, Yanping			Inactivation of the MDM2 RING domain enhances p53 transcriptional activity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MDM2; MDMX; Mouse; p53; Ubiquitin E3	UBIQUITIN LIGASE ACTIVITY; ACTIVITY IN-VIVO; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; DNA-DAMAGE; ACETYLATION; DEGRADATION; ACTIVATION; PATHWAY; PROTEIN	The MDM2 RING domain harbors E3 ubiquitin ligase activity critical for regulating the degradation of tumor suppressor p53, which controls many cellular pathways. The MDM2 RING domain also is required for an interaction with MDMX. Mice containing a substitution in the MDM2 RING domain, MDM2(C462A), disrupting MDM2 E3 function and the MDMX interaction, die during early embryogenesis that can be rescued by p53 deletion. To investigate whether MDM2(C462A), which retains p53 binding, has p53-suppressing activity, we generated Mdm2(C462A/C462A);p53(ER/-) mice, in which we replaced the endogenous p53 alleles with an inducible p53(ER/-) allele, and compared survival with that of similarly generated Mdm2(-/-);p53(ER/-) mice. Adult Mdm2-null mice died approximate to 7 days after tamoxifen-induced p53 activation, indicating that in the absence of MDM2, MDMX cannot suppress p53. Surprisingly, Mdm2(C462A/C462A);p53(ER/-) mice died approximate to 5 days after tamoxifen injection, suggesting that p53 activity is higher in the presence of MDM2(C462A) than in the absence of MDM2. Indeed, in MDM2(C462A)-expressing mouse tissues and embryonic fibroblasts, p53 exhibited higher transcriptional activity than in those expressing no MDM2 or no MDM2 and MDMX. This observation indicated that MDM2(C462A) not only is unable to suppress p53 but may have gained the ability to enhance p53 activity. We also found that p53 acetylation, a measure of p53 transcriptional activity, was higher in the presence of MDM2(C462A) than in the absence of MDM2. These results reveal an unexpected role of MDM2(C462A) in enhancing p53 activity and suggest the possibility that compounds targeting MDM2 RING domain function could produce even more robust p53 activation.	[Tian, Hui; Tackmann, Nicole R.; Jin, Aiwen; Zhang, Yanping] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA; [Tackmann, Nicole R.] Univ North Carolina Chapel Hill, Sch Med, Curriculum Genet & Mol Biol, 450 West Dr, Chapel Hill, NC 27514 USA; [Tian, Hui; Zheng, Junnian; Zhang, Yanping] Xuzhou Med Univ, Inst Canc, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Xuzhou 221002, Jiangsu, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xuzhou Medical University	Zhang, YP (corresponding author), Univ North Carolina Chapel Hill, Dept Radiat Oncol, 450 West Dr, Chapel Hill, NC 27514 USA.; Zhang, YP (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27514 USA.	ypzhang@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021		National Institutes of Health [CA127770, CA100302, CA167637]; Natural Science Foundation of China [81272207]; NIGMS, National Institutes of Health [5T32 GM007092]; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA212407, R01CA100302, R01CA167637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA127770, CA100302, and CA167637; Natural Science Foundation of China Grant 81272207 (to Y. Z.); and NIGMS, National Institutes of Health Grant 5T32 GM007092 (to N. R. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Clegg HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038212; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farhang Ghahremani M, 2013, CELL DEATH DIFFER, V20, P888, DOI 10.1038/cdd.2013.12; Garcia D, 2011, GENE DEV, V25, P1746, DOI 10.1101/gad.16722111; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Leslie PL, 2015, J BIOL CHEM, V290, P12941, DOI 10.1074/jbc.M115.644435; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; LUNA RMD, 1995, NATURE, V378, P203; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Sabbatini P, 2002, DNA CELL BIOL, V21, P519, DOI 10.1089/104454902320219077; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tollini LA, 2014, CANCER CELL, V26, P235, DOI 10.1016/j.ccr.2014.06.006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wang XJ, 2011, CELL CYCLE, V10, P4225, DOI 10.4161/cc.10.24.18662; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Wang XJ, 2004, FEBS LETT, V561, P195, DOI 10.1016/S0014-5793(04)00168-1	42	6	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21614	21622		10.1074/jbc.RA117.000122	http://dx.doi.org/10.1074/jbc.RA117.000122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123033	Green Published, hybrid			2022-12-28	WOS:000419013000035
J	Zhang, LP; Turner, B; Ribbeck, K; Ten Hagen, KG				Zhang, Liping; Turner, Bradley; Ribbeck, Katharina; Ten Hagen, Kelly G.			Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; glycosylation; interleukin 6 (IL-6); mucin; mucus; JAK; STAT; Tango1; niche; peritrophic membrane; progenitor cell; mucous membrane; O-glycosylation; Upd3	INTESTINAL STEM-CELLS; N-ACETYLGALACTOSAMINYLTRANSFERASE FAMILY; COLITIS-ASSOCIATED CANCER; ADULT DROSOPHILA MIDGUT; PORCINE GASTRIC MUCIN; O-GLYCOSYLATION; EXPRESSION ANALYSIS; PERITROPHIC MATRIX; COLORECTAL-CANCER; UDP-GALNAC	The mucous barrier of our digestive tract is the first line of defense against pathogens and damage. Disruptions in this barrier are associated with diseases such as Crohn's disease, colitis, and colon cancer, but mechanistic insights into these processes and diseases are limited. We have previously shown that loss of a conserved O-glycosyltransferase (PGANT4) in Drosophila results in aberrant secretion of components of the peritrophic/mucous membrane in the larval digestive tract. Here, we show that loss of PGANT4 disrupts the mucosal barrier, resulting in epithelial expression of the IL-6-like cytokine Upd3, leading to activation of JAK/STAT signaling, differentiation of cells that form the progenitor cell niche, and abnormal proliferation of progenitor cells. This niche disruption could be recapitulated by overexpressing upd3 and rescued by deleting upd3, highlighting a crucial role for this cytokine. Moreover, niche integrity and cell proliferation in pgant4-deficient animals could be rescued by overexpression of the conserved cargo receptor Tango1 and partially rescued by supplementation with exogenous mucins or treatment with antibiotics. Our findings help elucidate the paracrine signaling events activated by a compromised mucosal barrier and provide a novel in vivo screening platform for mucin mimetics and other strategies to treat diseases of the oral mucosa and digestive tract.	[Zhang, Liping; Ten Hagen, Kelly G.] NIDCR, Dev Glycobiol Sect, NIH, Bethesda, MD 20892 USA; [Turner, Bradley; Ribbeck, Katharina] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Massachusetts Institute of Technology (MIT)	Ten Hagen, KG (corresponding author), Bldg 30,Rm 426,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	Kelly.Tenhagen@nih.gov			Intramural Research Program of NIDCR, National Institutes of Health [Z01-DE-000713]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000713] Funding Source: NIH RePORTER	Intramural Research Program of NIDCR, National Institutes of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of NIDCR, National Institutes of Health, Grant Z01-DE-000713 (to K. G. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arike L, 2016, J MOL BIOL, V428, P3221, DOI 10.1016/j.jmb.2016.02.010; Arndt S, 2007, ONCOL REP, V18, P885; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Celli J, 2005, BIOMACROMOLECULES, V6, P1329, DOI 10.1021/bm0493990; Chaudhury NMA, 2015, J DENT RES, V94, P1660, DOI 10.1177/0022034515609070; Chaudhury NMA, 2016, MOL CELL PROTEOMICS, V15, P1048, DOI 10.1074/mcp.M115.052993; Corfield AP, 2015, BBA-GEN SUBJECTS, V1850, P236, DOI 10.1016/j.bbagen.2014.05.003; Dutzan N, 2017, IMMUNITY, V46, P133, DOI 10.1016/j.immuni.2016.12.010; Fox DT, 2009, CELL STEM CELL, V5, P290, DOI 10.1016/j.stem.2009.06.003; Gao N, 2016, AM J PHYSIOL-GASTR L, V311, pG74, DOI 10.1152/ajpgi.00060.2016; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo Z, 2013, J CELL BIOL, V201, P945, DOI 10.1083/jcb.201302049; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harvey NM, 2011, BIOMACROMOLECULES, V12, P1041, DOI 10.1021/bm101369d; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Jiang HQ, 2011, EXP CELL RES, V317, P2780, DOI 10.1016/j.yexcr.2011.07.020; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kobayashi S, 2003, BIOCHEM BIOPH RES CO, V308, P306, DOI 10.1016/S0006-291X(03)01362-7; Kramer JR, 2015, P NATL ACAD SCI USA, V112, P12574, DOI 10.1073/pnas.1516127112; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Lohmann N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai9044; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Schwartz DM, 2016, NAT REV RHEUMATOL, V12, P25, DOI 10.1038/nrrheum.2015.167; Slattery ML, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.21841; Syed ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003041; TABAK LA, 1995, ANNU REV PHYSIOL, V57, P547, DOI 10.1146/annurev.ph.57.030195.002555; Takashima S, 2012, STEM CELL REV REP, V8, P597, DOI 10.1007/s12015-012-9351-1; Ten Hagen KG, 2003, J BIOL CHEM, V278, P35039, DOI 10.1074/jbc.M303836200; Tian AG, 2015, J CELL BIOL, V208, P807, DOI 10.1083/jcb.201409025; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wang SW, 2014, INT J ONCOL, V44, P1032, DOI 10.3892/ijo.2014.2259; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zeng XK, 2015, CELL REP, V10, P1226, DOI 10.1016/j.celrep.2015.01.051; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111; Zhou F, 2013, DEV BIOL, V373, P383, DOI 10.1016/j.ydbio.2012.10.023; Zhou J, 2015, DEV BIOL, V399, P189, DOI 10.1016/j.ydbio.2014.12.017	56	16	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21231	21242		10.1074/jbc.M117.809848	http://dx.doi.org/10.1074/jbc.M117.809848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127201	Green Published, hybrid			2022-12-28	WOS:000419013000002
J	Lee, JH; Wendorff, TJ; Berger, JM				Lee, Joyce H.; Wendorff, Timothy J.; Berger, James M.			Resveratrol: A novel type of topoisomerase II inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENT; DNA TOPOISOMERASE; DIETARY-SUPPLEMENTS; CATALYTIC INHIBITOR; ATPASE DOMAIN; STEADY-STATE; MECHANISM; GYRASE; BINDING; DOXORUBICIN	Resveratrol, a polyphenol found in various plant sources, has gained attention as a possible agent responsible for the purported health benefits of certain foods, such as red wine. Despite annual multi-million dollar market sales as a nutriceutical, there is little consensus about the physiological roles of resveratrol. One suggested molecular target of resveratrol is eukaryotic topoisomerase II (topo II), an enzyme essential for chromosome segregation and DNA supercoiling homeostasis. Interestingly, resveratrol is chemically similar to ICRF-187, a clinically approved chemotherapeutic that stabilizes an ATP-dependent dimerization interface in topo II to block enzyme activity. Based on this similarity, we hypothesized that resveratrol may antagonize topo II by a similar mechanism. Using a variety of biochemical assays, we find that resveratrol indeed acts through the ICRF-187 binding locus, but that it inhibits topo II by preventing ATPase domain dimerization rather than stabilizing it. This work presents the first comprehensive analysis of the biochemical effects of both ICRF-187 and resveratrol on the human isoforms of topo II, and reveals a new mode for the allosteric regulation of topo II through modulation of ATPase status. Natural polyphenols related to resveratrol that have been shown to impact topo II function may operate in a similar manner.	[Lee, Joyce H.; Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St,WBSB 713, Baltimore, MD 21205 USA; [Wendorff, Timothy J.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA	Johns Hopkins University; University of California System; University of California Berkeley	Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St,WBSB 713, Baltimore, MD 21205 USA.	jmberger@jhmi.edu		Wendorff, Timothy/0000-0002-3729-4706	National Institutes of Health [T32-GM007445, R01-CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32-GM007445 (to J. H. L.) and R01-CA077373 (to J. M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; ALVARADO F, 1967, BIOCHIM BIOPHYS ACTA, V135, P483, DOI 10.1016/0005-2736(67)90038-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BODLEY A, 1989, CANCER RES, V49, P5969; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Christenson J, 2016, METAB SYNDR RELAT D, V14, P323, DOI 10.1089/met.2016.0035; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; CREIGHTON AM, 1969, NATURE, V222, P384, DOI 10.1038/222384a0; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Cuya SM, 2017, CANCER CHEMOTH PHARM, V80, P1, DOI 10.1007/s00280-017-3334-5; Cuzzola VF, 2011, CNS NEUROL DISORD-DR, V10, P849, DOI 10.2174/187152711798072310; Demoulin B, 2015, TOXICOL IN VITRO, V29, P1156, DOI 10.1016/j.tiv.2015.04.015; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gahche Jamie, 2011, NCHS Data Brief, P1; Gu J, 2016, INT IMMUNOPHARMACOL, V32, P1, DOI 10.1016/j.intimp.2016.01.002; Halsted CH, 2003, AM J CLIN NUTR, V77, p1001S, DOI 10.1093/ajcn/77.4.1001S; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; Hasinoff BB, 1997, BIOCHEM PHARMACOL, V53, P1843, DOI 10.1016/S0006-2952(97)00013-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Huang KC, 2001, J BIOL CHEM, V276, P44488, DOI 10.1074/jbc.M104383200; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Jo JY, 2006, J AGR FOOD CHEM, V54, P2083, DOI 10.1021/jf052700z; Jo JY, 2005, J AGR FOOD CHEM, V53, P2489, DOI 10.1021/jf048524w; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Leone S, 2012, INT J CANCER, V131, pE173, DOI 10.1002/ijc.27358; Leone S, 2010, CANCER LETT, V295, P167, DOI 10.1016/j.canlet.2010.02.022; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mennen LI, 2005, AM J CLIN NUTR, V81, p326S, DOI 10.1093/ajcn/81.1.326S; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Novelle MG, 2015, AGEING RES REV, V21, P1, DOI 10.1016/j.arr.2015.01.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Renodon-Corniere A, 2003, BIOCHEMISTRY-US, V42, P9749, DOI 10.1021/bi034557d; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehested M, 1998, CANCER RES, V58, P1460; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; SPEYER JL, 1988, NEW ENGL J MED, V319, P745, DOI 10.1056/NEJM198809223191203; SPEYER JL, 1992, J CLIN ONCOL, V10, P117, DOI 10.1200/JCO.1992.10.1.117; Starr RR, 2015, AM J PUBLIC HEALTH, V105, P478, DOI 10.2105/AJPH.2014.302348; Sun AY, 2010, MOL NEUROBIOL, V41, P375, DOI 10.1007/s12035-010-8111-y; Swain SM, 2004, J CANCER RES CLIN, V130, P1, DOI 10.1007/s00432-003-0498-7; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P200, DOI 10.1016/S0753-3322(02)00178-6; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; WASSERMAN RA, 1994, J BIOL CHEM, V269, P20943; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117	72	31	33	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21011	21022		10.1074/jbc.M117.810580	http://dx.doi.org/10.1074/jbc.M117.810580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074616	hybrid, Green Published			2022-12-28	WOS:000418453400017
J	Meliambro, K; Wong, JS; Ray, J; Calizo, RC; Towne, S; Cole, B; El Salem, F; Gordon, RE; Kaufman, L; He, JC; Azeloglu, EU; Campbell, KN				Meliambro, Kristin; Wong, Jenny S.; Ray, Justina; Calizo, Rhodora C.; Towne, Sara; Cole, Beatriz; El Salem, Fadi; Gordon, Ronald E.; Kaufman, Lewis; He, John C.; Azeloglu, Evren U.; Campbell, Kirk N.			The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-CONTROL; WW DOMAIN; PROTEIN; NEPHRIN; EXPRESSION; APOPTOSIS; CANCER; MORPHOLOGY; FAILURE; DISEASE	Kidney podocytes represent a key constituent of the glomerular filtration barrier. Identifying the molecular mechanisms of podocyte injury and survival is important for better understanding and management of kidney diseases. KIBRA (kidney brain protein), an upstream regulator of the Hippo signaling pathway encoded by the Wwc1 gene, shares the pro-injury properties of its putative binding partner dendrin and antagonizes the pro-survival signaling of the downstream Hippo pathway effector YAP (Yes-associated protein) in Drosophila and MCF10A cells. We recently identified YAP as an essential component of the glomerular filtration barrier that promotes podocyte survival by inhibiting dendrin pro-apoptotic function. Despite these recent advances, the signaling pathways that mediate podocyte injury remain poorly understood. Here we tested the hypothesis that, similar to its role in other model systems, KIBRA promotes podocyte injury. We found increased expression of KIBRA and phosphorylated YAP protein in glomeruli of patients with biopsy-proven focal segmental glomerulosclerosis (FSGS). KIBRA/WWc1 overexpression in murine podocytes promoted LATS kinase phosphorylation, leading to subsequent YAP Ser-127 phosphorylation, YAP cytoplasmic sequestration, and reduction in YAP target gene expression. Functionally, KIBRA overexpression induced significant morphological changes in podocytes, including disruption of the actin cytoskeletal architecture and reduction of focal adhesion size and number, all of which were rescued by subsequent YAP overexpression. Conversely, constitutive KIBRA knockout mice displayed reduced phosphorylated YAP and increased YAP expression at baseline. These mice were protected from acute podocyte foot process effacement following protamine sulfate perfusion. KIBRA knockdown podocytes were also protected against protamine-induced injury. These findings suggest an important role for KIBRA in the pathogenesis of podocyte injury and the progression of proteinuric kidney disease.	[Meliambro, Kristin; Wong, Jenny S.; Ray, Justina; Cole, Beatriz; Kaufman, Lewis; He, John C.; Campbell, Kirk N.] Icahn Sch Med Mt Sinai, Div Nephrol, Box 1243,One Gustave L Levy Pl, New York, NY 10029 USA; [Calizo, Rhodora C.; Towne, Sara; He, John C.; Azeloglu, Evren U.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [El Salem, Fadi; Gordon, Ronald E.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Campbell, KN (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Box 1243,One Gustave L Levy Pl, New York, NY 10029 USA.	kirk.campbell@mssm.edu	Salem, Fadi/AAP-9399-2020	Salem, Fadi/0000-0002-2603-2778; Azeloglu, Evren/0000-0001-6137-109X	National Institutes of Health [R01 DK103022]; American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant R01 DK103022 (to K. N. C.) and an American Society of Nephrology Nephcure Kidney International-ASN Foundation for Kidney Research Career Development Award (to E. U. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Azeloglu EU, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004621; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Diepenbruck M, 2014, J CELL SCI, V127, P1523, DOI 10.1242/jcs.139865; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Griffin SV, 2006, J BIOL CHEM, V281, P28048, DOI 10.1074/jbc.M513336200; Griffin SV, 2004, AM J PATHOL, V165, P1175, DOI 10.1016/S0002-9440(10)63378-0; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanwar YS, 2015, AM J PHYSIOL-RENAL, V308, pF420, DOI 10.1152/ajprenal.00640.2014; Katschnig AM, 2017, ONCOGENE, V36, P5995, DOI 10.1038/onc.2017.202; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; KURIHARA H, 1992, AM J PATHOL, V141, P805; Leeuwis JW, 2010, ADV DRUG DELIVER REV, V62, P1325, DOI 10.1016/j.addr.2010.08.012; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Mohammadhoseiniakbari H, 2009, MED SCI MONITOR, V15, pPH109; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Polito MG, 2010, NEPHROL DIAL TRANSPL, V25, P490, DOI 10.1093/ndt/gfp355; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Schiwek D, 2004, KIDNEY INT, V66, P91, DOI 10.1111/j.1523-1755.2004.00711.x; Schwartzman M, 2016, J AM SOC NEPHROL, V27, P216, DOI 10.1681/ASN.2014090916; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Szeto SG, 2016, J AM SOC NEPHROL, V27, P3117, DOI 10.1681/ASN.2015050499; Wada T, 2005, KIDNEY INT, V68, P1618, DOI 10.1111/j.1523-1755.2005.00574.x; Wagrowska-Danilewicz M, 2007, NEFROLOGIA, V27, P710; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Weins A, 2015, AM J PATHOL, V185, P2143, DOI 10.1016/j.ajpath.2015.04.011; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	48	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21137	21148		10.1074/jbc.M117.819029	http://dx.doi.org/10.1074/jbc.M117.819029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	28982981	hybrid, Green Published			2022-12-28	WOS:000418453400028
J	Poljak, K; Breitling, J; Gauss, R; Rugarabamu, G; Pellanda, M; Aebi, M				Poljak, Kristina; Breitling, Joerg; Gauss, Robert; Rugarabamu, George; Pellanda, Mauro; Aebi, Markus			Analysis of substrate specificity of Trypanosoma brucei oligosaccharyltransferases (OSTs) by functional expression of domain-swapped chimeras in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N-linked glycosylation; oligosaccharide; oligosaccharyltransferase; Trypanosoma brucei; yeast; glycosylation occupancy analysis; lipid-linked oligosaccharide specificity	LIPID-LINKED OLIGOSACCHARIDE; N-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; TRANSFERASE-ACTIVITY; LEISHMANIA-MAJOR; SWATH-MS; IN-VIVO; SUBUNIT	N-Linked protein glycosylation is an essential and highly conserved post-translational modification in eukaryotes. The transfer of a glycan from a lipid-linked oligosaccharide (LLO) donor to the asparagine residue of a nascent polypeptide chain is catalyzed by an oligosaccharyltransferase (OST) in the lumen of the endoplasmic reticulum (ER). Trypanosoma brucei encodes three paralogue single-protein OSTs called TbSTT3A, TbSTT3B, and TbSTT3C that can functionally complement the Saccharomyces cerevisiae OST, making it an ideal experimental system to study the fundamental properties of OST activity. We characterized the LLO and polypeptide specificity of all three TbOST isoforms and their chimeric forms in the heterologous expression host S. cerevisiae where we were able to apply yeast genetic tools and newly developed glycoproteomics methods. We demonstrated that TbSTT3A accepted LLO substrates ranging from Man(5)GlcNAc(2) to Man(7)GlcNAc(2). In contrast, TbSTT3B required more complex precursors ranging from Man(6)GlcNAc(2) to Glc(3)Man(9)GlcNAc(2) structures, and TbSTT3C did not display any LLO preference. Sequence differences between the isoforms cluster in three distinct regions. We have swapped the individual regions between different OST proteins and identified region 2 to influence the specificity toward the LLO and region 1 to influence polypeptide substrate specificity. These results provide a basis to further investigate the molecular mechanisms and contribution of single amino acids in OST interaction with its substrates.	[Poljak, Kristina; Breitling, Joerg; Gauss, Robert; Rugarabamu, George; Pellanda, Mauro; Aebi, Markus] ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland; [Poljak, Kristina] Life Sci Zurich Grad Program Mol Life Sci, Zurich, Switzerland; [Gauss, Robert] Freies Gymnasium Zurich, Arbenzstr 19, CH-8008 Zurich, Switzerland; [Rugarabamu, George] Policy Cures Res, Paramount House,55 Brisbane St, Sydney, NSW 2010, Australia; [Pellanda, Mauro] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Aebi, M (corresponding author), ETH, Inst Microbiol, Vladimir Prelog Weg 4, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch		Poljak, Kristina/0000-0002-0199-3812	Swiss National Science Foundation [310030B_144083, 310030_162636]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	This work was supported by Swiss National Science Foundation Grants 310030B_144083 and 310030_162636 (to M. A.) and ETH Zurich. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1991, Methods Enzymol, V194, P1; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Castillo-Acosta VM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005851; Castillo-Acosta VM, 2013, MOL MICROBIOL, V90, P665, DOI 10.1111/mmi.12359; Castro O, 2006, P NATL ACAD SCI USA, V103, P14756, DOI 10.1073/pnas.0607086103; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DELACANAL L, 1987, J BIOL CHEM, V262, P11128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; HEESEN ST, 1992, EMBO J, V11, P2071, DOI 10.1002/j.1460-2075.1992.tb05265.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Jakob CA, 1998, GLYCOBIOLOGY, V8, P155, DOI 10.1093/glycob/8.2.155; Jinnelov A, 2017, J BIOL CHEM, V292, P20328, DOI 10.1074/jbc.M117.810945; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; PARODI AJ, 1981, P NATL ACAD SCI-BIOL, V78, P6201, DOI 10.1073/pnas.78.10.6201; PATHAK R, 1995, BIOCHEMISTRY-US, V34, P4179, DOI 10.1021/bi00013a005; Poljak K., 2017, MOL CELL PROTEOMICS; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Roboti P, 2012, J CELL SCI, V125, P220, DOI 10.1242/jcs.094599; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu Y, 2015, PROTEOMICS, V15, P2177, DOI 10.1002/pmic.201400465; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zacchi LF, 2016, MOL CELL PROTEOMICS, V15, P2435, DOI 10.1074/mcp.M115.056366; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	47	5	5	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20342	20352		10.1074/jbc.M117.811133	http://dx.doi.org/10.1074/jbc.M117.811133			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042445	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000417696400036
J	Adachi, A; Koizumi, M; Ohsumi, Y				Adachi, Atsuhiro; Koizumi, Michiko; Ohsumi, Yoshinori			Autophagy induction under carbon starvation conditions is negatively regulated by carbon catabolite repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; autophagy; energy metabolism; glucose; yeast	DEPENDENT PROTEIN-KINASE; VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; SELECTIVE AUTOPHAGY; TRANSCRIPTIONAL REGULATION; NITROGEN STARVATION; SIGNALING PATHWAYS; INHIBITS AUTOPHAGY; BUDDING YEAST; RECEPTOR	Autophagy is a conserved process in which cytoplasmic components are sequestered for degradation in the vacuole/lysosomes in eukaryotic cells. Autophagy is induced under a variety of starvation conditions, such as the depletion of nitrogen, carbon, phosphorus, zinc, and others. However, apart from nitrogen starvation, it remains unclear how these stimuli induce autophagy. In yeast, for example, it remains contentious whether autophagy is induced under carbon starvation conditions, with reports variously suggesting both induction and lack of induction upon depletion of carbon. We therefore undertook an analysis to account for these inconsistencies, concluding that autophagy is induced in response to abrupt carbon starvation when cells are grown with glycerol but not glucose as the carbon source. We found that autophagy under these conditions is mediated by nonselective degradation that is highly dependent on the autophagosome-associated scaffold proteins Atg11 and Atg17. We also found that the extent of carbon starvation-induced autophagy is positively correlated with cells' oxygen consumption rate, drawing a link between autophagy induction and respiratory metabolism. Further biochemical analyses indicated that maintenance of intracellular ATP levels is also required for carbon starvation-induced autophagy and that autophagy plays an important role in cell viability during prolonged carbon starvation. Our findings suggest that carbon starvation-induced autophagy is negatively regulated by carbon catabolite repression.	[Adachi, Atsuhiro; Koizumi, Michiko; Ohsumi, Yoshinori] Tokyo Inst Technol, Ctr Cell Biol, Inst Innovat Res, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Ohsumi, Y (corresponding author), Tokyo Inst Technol, Ctr Cell Biol, Inst Innovat Res, Midori Ku, 4259-S2-12 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009	Ohsumi, Yoshinori/0000-0003-2384-2166	Ministry of Education, Culture, Sports, Science and Technology of Japan [23000015, 16H06375]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research 23000015 (to Y. O.) and 16H06375 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	An ZY, 2014, AUTOPHAGY, V10, P1702, DOI 10.4161/auto.32122; Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bartholomew CR, 2012, P NATL ACAD SCI USA, V109, P11206, DOI 10.1073/pnas.1200313109; Bernard A, 2015, CURR BIOL, V25, P546, DOI 10.1016/j.cub.2014.12.049; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Deminoff SJ, 2006, GENETICS, V173, P1909, DOI 10.1534/genetics.106.059238; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fendt SM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-12; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Hagman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068734; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jin MY, 2014, CURR BIOL, V24, P1314, DOI 10.1016/j.cub.2014.04.048; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kawamata T, 2005, BIOCHEM BIOPH RES CO, V338, P1884, DOI 10.1016/j.bbrc.2005.10.163; Kawamata T, 2017, J BIOL CHEM, V292, P8520, DOI 10.1074/jbc.M116.762948; Kayikci O, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov068; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Kira S, 2014, AUTOPHAGY, V10, P1565, DOI 10.4161/auto.29397; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Mao K, 2013, P NATL ACAD SCI USA, V110, pE2875, DOI 10.1073/pnas.1300064110; Matsui A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003245; Meijer MMC, 1998, J BIOL CHEM, V273, P24102, DOI 10.1074/jbc.273.37.24102; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pilatus U, 2001, MAGNET RESON MED, V45, P749, DOI 10.1002/mrm.1102; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Seo AY, 2017, ELIFE, V6, DOI 10.7554/eLife.21690; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Stephan JS, 2010, AUTOPHAGY, V6, P294, DOI 10.4161/auto.6.2.11129; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Sutter BM, 2013, CELL, V154, P403, DOI 10.1016/j.cell.2013.06.041; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Yamamoto H, 2015, J BIOL CHEM, V290, P29506, DOI 10.1074/jbc.M115.684233; Yi C, 2017, DEV CELL, V41, P59, DOI 10.1016/j.devcel.2017.03.007; Yokota H, 2017, BIOCHEM BIOPH RES CO, V483, P522, DOI 10.1016/j.bbrc.2016.12.112; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	69	31	31	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19905	19918		10.1074/jbc.M117.817510	http://dx.doi.org/10.1074/jbc.M117.817510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29042435	hybrid, Green Published			2022-12-28	WOS:000416911300032
J	Heron, PW; Sygusch, J				Heron, Paul W.; Sygusch, Jurgen			Isomer activation controls stereospecificity of class I fructose-1,6-bisphosphate aldolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme catalysis; enzyme mechanism; glycolysis; stereoselectivity	TRIOSE PHOSPHATE ISOMERASE; SCHIFF-BASE FORMATION; FRUCTOSE-BISPHOSPHATE ALDOLASE; DIHYDROXYACETONE PHOSPHATE; MUSCLE ALDOLASE; GLYCERALDEHYDE 3-PHOSPHATE; SUBSTRATE-SPECIFICITY; PROTON-TRANSFER; ACTIVE-SITE; STEREOCHEMISTRY	Fructose-1,6-bisphosphate (FBP) aldolase, a glycolytic enzyme, catalyzes the reversible and stereospecific aldol addition of dihydroxyacetone phosphate (DHAP) and d-glyceraldehyde 3-phosphate (d-G3P) by an unresolved mechanism. To afford insight into the molecular determinants of FBP aldolase stereospecificity during aldol addition, a key ternary complex formed by DHAP and d-G3P, comprising 2% of the equilibrium population at physiological pH, was cryotrapped in the active site of Toxoplasma gondii aldolase crystals to high resolution. The growth of T. gondii aldolase crystals in acidic conditions enabled trapping of the ternary complex as a dominant population. The obligate 3(S)-4(R) stereochemistry at the nascent C3-C4 bond of FBP requires a si-face attack by the covalent DHAP nucleophile on the d-G3P aldehyde si-face in the active site. The cis-isomer of the d-G3P aldehyde, representing the dominant population trapped in the ternary complex, would lead to re-face attack on the aldehyde and yield tagatose 1,6-bisphosphate, a competitive inhibitor of the enzyme. We propose that unhindered rotational isomerization by the d-G3P aldehyde moiety in the ternary complex generates the active trans-isomer competent for carbonyl bond activation by active-site residues, thereby enabling si-face attack by the DHAP enamine. C-C bond formation by the cis-isomer is suppressed by hydrogen bonding of the cis-aldehyde carbonyl with the DHAP enamine phosphate dianion through a tetrahedrally coordinated water molecule. The active site geometry further suppresses C-C bond formation with the l-G3P enantiomer of d-G3P. Understanding C-C formation is of fundamental importance in biological reactions and has considerable relevance to biosynthetic reactions in organic chemistry.	[Heron, Paul W.; Sygusch, Jurgen] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Sygusch, J (corresponding author), Stn Ctr Ville, CP 6128, Montreal, PQ H3C 3J7, Canada.	jurgen.sygusch@umontreal.ca		Sygusch, Jurgen/0000-0002-6629-2128	DOE Office of Science by Brookhaven National Laboratory [DE-AC02-98CH10886]	DOE Office of Science by Brookhaven National Laboratory(United States Department of Energy (DOE))	We are grateful to Dr. David Sibley and Bang Shen (University of Washington, St. Louis) for providing T. gondii aldolase expression vector. This research used resources of beamlines X25 and X29A of the National Synchrotron Light Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract DE-AC02-98CH10886.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BEDNARSKI MD, 1989, J AM CHEM SOC, V111, P627, DOI 10.1021/ja00184a034; BISSETT DL, 1980, J BIOL CHEM, V255, P8745; Boucher LE, 2014, ACTA CRYSTALLOGR F, V70, P1186, DOI 10.1107/S2053230X14017087; BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONNETT RJ, 1985, J BIOL CHEM, V260, P3314; CORDES EH, 1962, J AM CHEM SOC, V84, P832, DOI 10.1021/ja00864a031; DeLano WL, 2014, PYMOL MOL GRAPH SYST; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; DUAN XF, 1992, J AM CHEM SOC, V114, P5849, DOI 10.1021/ja00040a055; DUBOIS JE, 1972, TETRAHEDRON, V28, P1653, DOI 10.1016/0040-4020(72)88047-5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espelt L, 2005, CHEM-EUR J, V11, P1392, DOI 10.1002/chem.200400648; Fleming I., 2011, MOL ORBITALS ORGANIC; Gefflaut T, 1995, PROG BIOPHYS MOL BIO, V63, P301, DOI 10.1016/0079-6107(95)00008-9; Gorbitz C. H., 1992, J CHEM SOC P2, V1, P131; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; GRAZI E, 1974, BIOCHEM BIOPH RES CO, V56, P106, DOI 10.1016/S0006-291X(74)80321-9; GRAZI E, 1973, BIOCHEMISTRY-US, V12, P2583, DOI 10.1021/bi00738a006; HARTMAN FC, 1965, BIOCHEMISTRY-US, V4, P1068, DOI 10.1021/bi00882a014; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOBES RD, 1969, J BIOL CHEM, V244, P1919; KUO DJ, 1985, BIOCHEMISTRY-US, V24, P3947, DOI 10.1021/bi00336a022; LAI CY, 1968, BIOCHEM BIOPH RES CO, V30, P665, DOI 10.1016/0006-291X(68)90564-0; Light SH, 2014, ACTA CRYSTALLOGR D, V70, P544, DOI 10.1107/S1399004713030666; LowKam C, 2010, J BIOL CHEM, V285, P21143, DOI 10.1074/jbc.M109.080358; Maurady A, 2002, J BIOL CHEM, V277, P9474, DOI 10.1074/jbc.M107600200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; MELOCHE HP, 1973, J BIOL CHEM, V248, P6333; Azofra LM, 2015, CHEMPHYSCHEM, V16, P2226, DOI 10.1002/cphc.201500139; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PECZON BD, 1972, BIOCHEMISTRY-US, V11, P2209, DOI 10.1021/bi00762a001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RACKER E, 1947, J BIOL CHEM, V167, P843; REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285; RICHARDS OC, 1961, J BIOL CHEM, V236, P3185; ROSE IA, 1977, J BIOL CHEM, V252, P479; ROSE IA, 1969, J BIOL CHEM, V244, P126; ROSE IA, 1985, BIOCHEMISTRY-US, V24, P3952, DOI 10.1021/bi00336a023; ROSE IA, 1987, J BIOL CHEM, V262, P692; ROSE IA, 1969, J BIOL CHEM, V244, P6548; SAYER JM, 1974, J AM CHEM SOC, V96, P7998, DOI 10.1021/ja00833a027; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; St-Jean M, 2009, BIOCHEMISTRY-US, V48, P4528, DOI 10.1021/bi8021558; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P597, DOI 10.1107/S0907444907009791; TRENTHAM DR, 1969, BIOCHEM J, V114, P19, DOI 10.1042/bj1140019; TUNG TC, 1954, BIOCHIM BIOPHYS ACTA, V14, P488, DOI 10.1016/0006-3002(54)90228-0; VEECH RL, 1969, BIOCHEM J, V115, P837, DOI 10.1042/bj1150837; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; ZIMMERMAN HE, 1957, J AM CHEM SOC, V79, P1920, DOI 10.1021/ja01565a041	67	4	4	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19849	19860		10.1074/jbc.M117.811034	http://dx.doi.org/10.1074/jbc.M117.811034			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972169	Green Published, hybrid			2022-12-28	WOS:000416911300028
J	Richard, AJ; Hang, H; Stephens, JM				Richard, Allison J.; Hang, Hardy; Stephens, Jacqueline M.			Pyruvate dehydrogenase complex (PDC) subunits moonlight as interaction partners of phosphorylated STAT5 in adipocytes and adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); adipocyte; growth hormone; pyruvate dehydrogenase complex (PDC); signal transducers and activators of transcription 1 (STAT1)	ELECTRON-TRANSPORT CHAIN; HISTONE ACETYLATION; MITOCHONDRIAL STAT3; SIGNAL TRANSDUCER; TRANSCRIPTION; METABOLISM; EXPRESSION; ACTIVATOR; PROTEIN; TRANSLOCATION	STAT5 proteins play a role in adipocyte development and function, but their specific functions are largely unknown. To this end, we used an unbiased MS-based approach to identify novel STAT5-interacting proteins. We observed that STAT5A bound the E1 and E2 subunits of the pyruvate dehydrogenase complex (PDC). Whereas STAT5A typically localizes to the cytosol or nucleus, PDC normally resides within the mitochondrial matrix where it converts pyruvate to acetyl-CoA. We employed affinity purification and immunoblotting to validate the interaction between STAT5A and PDC subunits in murine and human cultured adipocytes, as well as in adipose tissue. We found that multiple PDC subunits interact with hormone-activated STAT5A in a dose- and time-dependent manner that coincides with tyrosine phosphorylation of STAT5. Using subcellular fractionation and immunofluorescence microscopy, we observed that PDC-E2 is present within the adipocyte nucleus where it associates with STAT5A. Because STAT5A is a transcription factor, we used chromatin immunoprecipitation (ChIP) to assess PDC's ability to interact with STAT5 DNA-binding sites. These analyses revealed that PDC-E2 is bound to a STAT5-binding site in the promoter of the STAT5 target gene cytokine-inducible SH2-containing protein (cish). We have demonstrated a compelling interaction between STAT5A and PDC subunits in adipocytes under physiological conditions. There is previous evidence that PDC localizes to cancer cell nuclei where it plays a role in histone acetylation. On the basis of our ChIP data and these previous findings, we hypothesize that PDC may modulate STAT5's ability to regulate gene expression by controlling histone or STAT5 acetylation.	[Richard, Allison J.; Hang, Hardy; Stephens, Jacqueline M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Stephens, Jacqueline M.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University	Stephens, JM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA.	jsteph1@lsu.edu	Stephens, Jacqueline M/R-5217-2018	Hang, Hardy/0000-0003-0794-3514	COBRE from the National Institutes of Health [NIH8 1P30GM118430-01]; NORC center from the National Institutes of Health [NIH 1P30-DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052968, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118430] Funding Source: NIH RePORTER	COBRE from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NORC center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anik Boudreau for technical support and manuscript editing. We are also grateful to Drs. Randy Mynatt, David Burk, and Rob Noland for sharing resources and equipment and for providing technical advice that helped us assess the association of PDC with STAT5A in vitro and in vivo. This project used Genomics and Cell Biology and Bioimaging core facilities that are supported in part by COBRE (NIH8 1P30GM118430-01) and NORC (NIH 1P30-DK072476) center grants from the National Institutes of Health.	Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Carrer A, 2017, J BIOL CHEM, V292, P3312, DOI 10.1074/jbc.M116.750620; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; Chueh FY, 2010, BIOCHEM BIOPH RES CO, V402, P778, DOI 10.1016/j.bbrc.2010.10.112; Davey HW, 1999, MOL CELL ENDOCRINOL, V158, P111, DOI 10.1016/S0303-7207(99)00175-6; Fuller S, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/862575; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hiromasa Y, 2004, J BIOL CHEM, V279, P6921, DOI 10.1074/jbc.M308172200; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Khan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055426; Kheterpal I, 2010, PHYTOTHER RES, V24, P1278, DOI 10.1002/ptr.3093; Ling C, 2001, ENDOCRINOLOGY, V142, P4880, DOI 10.1210/en.142.11.4880; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Monaghan RM, 2015, TRENDS BIOCHEM SCI, V40, P728, DOI 10.1016/j.tibs.2015.10.003; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Richard AJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/549750; Richard AJ, 2012, BBA-MOL BASIS DIS, V1822, P557, DOI 10.1016/j.bbadis.2011.12.005; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Stewart WC, 2011, OBESITY, V19, P1731, DOI 10.1038/oby.2011.66; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Szczepanek K, 2012, MITOCHONDRION, V12, P180, DOI 10.1016/j.mito.2011.08.011; Szczepanek K, 2011, J BIOL CHEM, V286, P29610, DOI 10.1074/jbc.M111.226209; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; White UA, 2016, AM J PHYSIOL-ENDOC M, V310, pE129, DOI 10.1152/ajpendo.00068.2015; Xu YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep39517; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	31	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19733	19742		10.1074/jbc.M117.811794	http://dx.doi.org/10.1074/jbc.M117.811794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982698	Green Published, hybrid			2022-12-28	WOS:000416911300018
J	Kanai, SM; Edwards, AJ; Rurik, JG; Osei-Owusu, P; Blumer, KJ				Kanai, Stanley M.; Edwards, Alethia J.; Rurik, Joel G.; Osei-Owusu, Patrick; Blumer, Kendall J.			Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of G(q/11) signaling and vascular contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; G protein; proteasome; regulator of G protein signaling (RGS); ubiquitylation; ubiquitination; ubiquitin; vascular biology; vascular smooth muscle cells	BLOOD MONONUCLEAR-CELLS; SMOOTH-MUSCLE-CELLS; END RULE PATHWAY; ANGIOTENSIN-II; MESSENGER-RNA; UP-REGULATION; RGS PROTEINS; HYPERTENSIVE PATIENTS; PRESSURE; IDENTIFICATION	Regulator of G protein signaling 2 (RGS2) controls signaling by receptors coupled to the G(q/11) class heterotrimeric G proteins. RGS2 deficiency causes several phenotypes in mice and occurs in several diseases, including hypertension in which a proteolytically unstable RGS2 mutant has been reported. However, the mechanisms and functions of RGS2 proteolysis remain poorly understood. Here we addressed these questions by identifying degradation signals in RGS2, and studying dynamic regulation of G(q/11)-evoked Ca2+ signaling and vascular contraction. We identified a novel bipartite degradation signal in the N-terminal domain of RGS2. Mutations disrupting this signal blunted proteolytic degradation downstream of E3 ubiquitin ligase binding to RGS2. Analysis of RGS2 mutants proteolyzed at various rates and the effects of proteasome inhibition indicated that proteolytic degradation controls agonist efficacy by setting RGS2 protein expression levels, and affecting the rate at which cells regain agonist responsiveness as synthesis of RGS2 stops. Analyzing contraction of mesenteric resistance arteries supported the biological relevance of this mechanism. Because RGS2 mRNA expression often is strikingly and transiently up-regulated and then down-regulated upon cell stimulation, our findings indicate that proteolytic degradation tightly couples RGS2 transcription, protein levels, and function. Together these mechanisms provide tight temporal control of G(q/11)-coupled receptor signaling in the cardiovascular, immune, and nervous systems.	[Kanai, Stanley M.; Rurik, Joel G.; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Edwards, Alethia J.; Osei-Owusu, Patrick] Drexel Univ, Dept Physiol & Pharmacol, Coll Med, Philadelphia, PA 19102 USA	Washington University (WUSTL); Drexel University	Blumer, KJ (corresponding author), Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu	Rurik, Joel/ABD-6427-2021; Osei-Owusu, Patrick/AAH-9063-2019	Kanai, Stanley/0000-0001-9074-0624; Dixon, Alethia/0000-0002-4374-0688; Rurik, Joel/0000-0002-7156-4626	National Institutes of Health [GM044592, HL075632]; American Heart Association [16SDG27260276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health Grants GM044592 and HL075632 (to K.J.B.) and American Heart Association Grant 16SDG27260276 (to P. O.-O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de Queiroz DB, 2015, BRIT J PHARMACOL, V172, P4699, DOI 10.1111/bph.13244; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grant SL, 2000, MOL PHARMACOL, V57, P460, DOI 10.1124/mol.57.3.460; Gu S, 2008, MOL PHARMACOL, V73, P1, DOI 10.1124/mol.107.036285; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Gurley SB, 2010, J AM SOC NEPHROL, V21, P1847, DOI 10.1681/ASN.2009121306; Hahntow IN, 2009, AM J HYPERTENS, V22, P80, DOI 10.1038/ajh.2008.310; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 2001, J BIOL CHEM, V276, P14195, DOI 10.1074/jbc.M009942200; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; Heximer SP, 1997, DNA CELL BIOL, V16, P589, DOI 10.1089/dna.1997.16.589; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Ingi T, 1998, J NEUROSCI, V18, P7178; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kach J, 2012, AM J PHYSIOL-HEART C, V303, pH19, DOI 10.1152/ajpheart.00764.2011; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Ko JK, 2001, BIOCHEM BIOPH RES CO, V287, P1025, DOI 10.1006/bbrc.2001.5692; Lu C, 2010, EUR J PHARMACOL, V634, P107, DOI 10.1016/j.ejphar.2010.02.006; Lutz S, 2005, J BIOL CHEM, V280, P11134, DOI 10.1074/jbc.M411322200; Neubig RR, 2015, PROG MOL BIOL TRANSL, V133, P13, DOI 10.1016/bs.pmbts.2015.04.010; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Noe L, 2010, J THROMB HAEMOST, V8, P1594, DOI 10.1111/j.1538-7836.2010.03885.x; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Osei-Owusu P, 2007, J BIOL CHEM, V282, P31656, DOI 10.1074/jbc.M706360200; Osei-Owusu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132594; Osei-Owusu P, 2014, AM J PHYSIOL-HEART C, V306, pH654, DOI 10.1152/ajpheart.00601.2013; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Park-Windhol C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040048; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Raveh A, 2014, MOL PHARMACOL, V86, P406, DOI 10.1124/mol.114.092403; Riddle EL, 2006, HYPERTENSION, V47, P415, DOI 10.1161/01.HYP.0000200714.81990.61; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2006, J BIOL CHEM, V281, P32684, DOI 10.1074/jbc.M604416200; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Sastre E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126017; Semplicini A, 2006, J HYPERTENS, V24, P1115, DOI 10.1097/01.hjh.0000226202.80689.8f; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; SIDEROVSKI DP, 1994, DNA CELL BIOL, V13, P125, DOI 10.1089/dna.1994.13.125; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Sjogren B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123581; Sjogren B, 2012, MOL PHARMACOL, V82, P500, DOI 10.1124/mol.112.079293; Sjogren B, 2016, J PHARMACOL EXP THER, V357, P311, DOI 10.1124/jpet.115.231571; Sun XG, 2005, MOL PHARMACOL, V67, P631, DOI 10.1124/mol.104.007724; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; Xie ZW, 2011, J BIOL CHEM, V286, P44646, DOI 10.1074/jbc.M111.265462; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang J, 2005, J HYPERTENS, V23, P1497, DOI 10.1097/01.hjh.0000174606.41651.ae; Zhang W, 2006, J BIOL CHEM, V281, P5811, DOI 10.1074/jbc.M507871200; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	60	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19266	19278		10.1074/jbc.M117.797134	http://dx.doi.org/10.1074/jbc.M117.797134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974581	Green Published, hybrid			2022-12-28	WOS:000416226700010
J	Lamontagne, J; Al-Mass, A; Nolan, CJ; Corkey, BE; Madiraju, SRM; Joly, E; Prentki, M				Lamontagne, Julien; Al-Mass, Anfal; Nolan, Christopher J.; Corkey, Barbara E.; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc			Identification of the signals for glucose-induced insulin secretion in INS1 (832/13) -cells using metformin-induced metabolic deceleration as a model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); glucose metabolism; insulin secretion; metformin; mitochondrial metabolism; metabolic coupling factors; metabolic deceleration	PANCREATIC BETA-CELLS; ACTIVATED PROTEIN-KINASE; CHRONIC EXPOSURE; MOUSE ISLETS; MALONYL-COA; CHAIN; FUEL; MITOCHONDRIA; PATHWAYS; POTENTIATION	Metabolic deceleration in pancreatic -cells is associated with inhibition of glucose-induced insulin secretion (GIIS), but only in the presence of intermediate/submaximal glucose concentrations. Here, we used acute metformin treatment as a tool to induce metabolic deceleration in INS1 (832/13) -cells, with the goal of identifying key pathways and metabolites involved in GIIS. Metabolites and pathways previously implicated as signals for GIIS were measured in the cells at 2-25 mm glucose, with or without 5 mm metformin. We defined three criteria to identify candidate signals: 1) glucose-responsiveness, 2) sensitivity to metformin-induced inhibition of the glucose effect at intermediate glucose concentrations, and 3) alleviation of metformin inhibition by elevated glucose concentrations. Despite the lack of recovery from metformin-induced impairment of mitochondrial energy metabolism (glucose oxidation, O-2 consumption, and ATP production), insulin secretion was almost completely restored at elevated glucose concentrations. Meeting the criteria for candidates involved in promoting GIIS were the following metabolic indicators and metabolites: cytosolic NAD(+)/NADH ratio (inferred from the dihydroxyacetone phosphate:glycerol-3-phosphate ratio), mitochondrial membrane potential, ADP, Ca2+, 1-monoacylglycerol, diacylglycerol, malonyl-CoA, and HMG-CoA. On the contrary, most of the purine and nicotinamide nucleotides, acetoacetyl-CoA, H2O2, reduced glutathione, and 2-monoacylglycerol were not glucose-responsive. Overall these results underscore the significance of mitochondrial energy metabolism-independent signals in GIIS regulation; in particular, the candidate lipid signaling molecules 1-monoacylglycerol, diacylglycerol, and malonyl-CoA; the predominance of K-ATP/Ca2+ signaling control by low ADPMg(2+) rather than by high ATP levels; and a role for a more oxidized state (NAD(+)/NADH) in the cytosol during GIIS that favors high glycolysis rates.	[Lamontagne, Julien; Al-Mass, Anfal; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc] CRCHUM, Mol Nutr Unit, Montreal, PQ H2X 0A9, Canada; [Lamontagne, Julien; Al-Mass, Anfal; Madiraju, S. R. Murthy; Joly, Erik; Prentki, Marc] CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Rm R08-412, Montreal, PQ H2X 0A9, Canada; [Prentki, Marc] Univ Montreal, Dept Nutr, Montreal, PQ H3T 1J4, Canada; [Prentki, Marc] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Al-Mass, Anfal] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Nolan, Christopher J.] Australian Natl Univ, Canberra Hosp, Dept Endocrinol, Canberra, ACT 2605, Australia; [Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT 2605, Australia; [Corkey, Barbara E.] Boston Univ, Dept Med, Obes Res Ctr, Sch Med, Boston, MA 02118 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University; Australian National University; Canberra Hospital; Australian National University; Boston University	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, 900 St Denis,Rm R08-412, Montreal, PQ H2X 0A9, Canada.	marc.prentki@umontreal.ca	Nolan, Christopher J/B-2026-2008	Nolan, Christopher J/0000-0002-6964-3819	Canadian Institutes of Health Research; Kuwait University	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kuwait University	This work was supported by grants from Canadian Institutes of Health Research (to M. P. and S. R. M. M.) and a scholarship from Kuwait University (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Andrikopoulos S, 2010, MOL CELL ENDOCRINOL, V316, P140, DOI 10.1016/j.mce.2009.09.031; Attane C, 2016, DIABETOLOGIA, V59, P2654, DOI 10.1007/s00125-016-4105-2; BRADLEY DC, 1989, ANAL BIOCHEM, V180, P11, DOI 10.1016/0003-2697(89)90081-X; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Corkey BE, 2012, TRENDS ENDOCRIN MET, V23, P594, DOI 10.1016/j.tem.2012.07.006; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; El-Azzouny M, 2014, J BIOL CHEM, V289, P13575, DOI 10.1074/jbc.M113.531970; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Farfari S, 2000, DIABETES, V49, P718, DOI 10.2337/diabetes.49.5.718; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Ferdaoussi M, 2017, TRENDS CELL BIOL, V27, P163, DOI 10.1016/j.tcb.2016.10.003; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Fu A, 2015, DIABETOLOGIA, V58, P1513, DOI 10.1007/s00125-015-3579-7; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Hinke SA, 2007, BRIT J PHARMACOL, V150, P1031, DOI 10.1038/sj.bjp.0707189; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kefas BA, 2004, BIOCHEM PHARMACOL, V68, P409, DOI 10.1016/j.bcp.2004.04.003; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Masini M, 2014, DIABETES RES CLIN PR, V104, P163, DOI 10.1016/j.diabres.2013.12.031; MATSCHINSKY FM, 1986, J BIOL CHEM, V261, P14057; Mugabo Y, 2017, J BIOL CHEM, V292, P7407, DOI 10.1074/jbc.M116.763060; Mugabo Y, 2016, P NATL ACAD SCI USA, V113, pE430, DOI 10.1073/pnas.1514375113; Mulder H, 2016, DIABETOLOGIA, V59, P2510, DOI 10.1007/s00125-016-4111-4; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2016, PHYSIOL REV, V96, P1385, DOI 10.1152/physrev.00009.2016; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Panten U, 2013, METABOLISM, V62, P1375, DOI 10.1016/j.metabol.2013.05.006; Pearson GL, 2016, MOL METAB, V5, P404, DOI 10.1016/j.molmet.2016.04.003; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; PRENTKI M, 1992, J BIOL CHEM, V267, P5802; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Prentki M, 2012, MOL CELL ENDOCRINOL, V353, P88, DOI 10.1016/j.mce.2011.11.004; Roduit R, 2004, DIABETES, V53, P1007, DOI 10.2337/diabetes.53.4.1007; Rutter GA, 2015, BIOCHEM J, V466, P203, DOI 10.1042/BJ20141384; Salani B, 2014, ENDOCR-RELAT CANCER, V21, pR461, DOI 10.1530/ERC-14-0284; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Sheu L, 2003, J BIOL CHEM, V278, P27556, DOI 10.1074/jbc.M303203200; Spegel P, 2015, ENDOCRINOLOGY, V156, P1995, DOI 10.1210/en.2014-1391; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Swisa A, 2015, J BIOL CHEM, V290, P20934, DOI 10.1074/jbc.M115.639237; Templeman NM, 2017, J ENDOCRINOL, V232, pR173, DOI [10.1530/JOE-16-0449, 10.1530/joe-16-0449]; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; Zhao S, 2015, MOL METAB, V4, P940, DOI 10.1016/j.molmet.2015.09.012; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003	59	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19458	19468		10.1074/jbc.M117.808105	http://dx.doi.org/10.1074/jbc.M117.808105			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972173	Green Published, hybrid			2022-12-28	WOS:000416226700025
J	Khoa, LTP; Dou, YL				Le Tran Phuc Khoa; Dou, Yali			Phosphoproteomics links glycogen synthase kinase-3 to RNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PHOSPHORYLATION; SPECIFICITY	Protein kinases play essential biological roles by phosphorylating a diverse range of signaling molecules, but deciphering their direct physiological targets remains a challenge. A new study by Shinde et al. uses phosphoproteomics to identify glycogen synthase kinase-3 (GSK-3) substrates in mouse embryonic stem cells (mESCs), providing a broad profile of GSK-3 activity and defining a new role for this central kinase in regulating RNA splicing.	[Le Tran Phuc Khoa; Dou, Yali] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Dou, YL (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	yalid@med.umich.edu	Le, Khoa/AAL-2599-2020	Tran Phuc Le, Khoa/0000-0002-6076-3857	NIGMS, National Institutes of Health [GM082856]; NINDS, National Institutes of Health [NS100156]; NCI, National Institutes of Health [CA187004]; AACR Stand Up to Cancer; NATIONAL CANCER INSTITUTE [R01CA187004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100156] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR Stand Up to Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIGMS, National Institutes of Health GM082856, NINDS, National Institutes of Health (NS100156) and NCI, National Institutes of Health (CA187004) as well as AACR Stand Up to Cancer (to Y. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrell WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050422; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Heyd F, 2010, MOL CELL, V40, P126, DOI 10.1016/j.molcel.2010.09.013; Martinez NM, 2015, GENE DEV, V29, P2054, DOI 10.1101/gad.267245.115; Shinde MY, 2017, J BIOL CHEM, V292, P18240, DOI 10.1074/jbc.M117.813527; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang Q, 2017, CELL STEM CELL, V20, P70, DOI 10.1016/j.stem.2016.10.002; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 3	2017	292	44					18256	18257		10.1074/jbc.H117.813527	http://dx.doi.org/10.1074/jbc.H117.813527			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL7VE	29101250	Green Published, hybrid			2022-12-28	WOS:000414458200022
J	Taylor, AA				Taylor, Alexandra A.			Sensitive sequencing: Instrumentation led to biological revolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTEIN SEQUENATOR		[Taylor, Alexandra A.] Johns Hopkins Univ, Sci & Med writing, Baltimore, MD 21218 USA	Johns Hopkins University	Taylor, AA (corresponding author), Johns Hopkins Univ, Sci & Med writing, Baltimore, MD 21218 USA.	alexandraataylor@gmail.com						HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HUNKAPILLER MW, 1980, SCIENCE, V207, P523, DOI 10.1126/science.7352258	2	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17977	17978		10.1074/jbc.CL117.000137	http://dx.doi.org/10.1074/jbc.CL117.000137			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	29079643	hybrid, Green Published			2022-12-28	WOS:000414013000033
J	Fan, FX; Li, X; Pang, B; Zhang, C; Li, Z; Zhang, LJ; Li, J; Zhang, JY; Yan, MY; Liang, WL; Kan, B				Fan, Fenxia; Li, Xu; Pang, Bo; Zhang, Cheng; Li, Zhe; Zhang, Lijuan; Li, Jie; Zhang, Jingyun; Yan, Meiying; Liang, Weili; Kan, Biao			The outer-membrane protein TolC of Vibrio cholerae serves as a second cell-surface receptor for the VP3 phage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; GRAM-NEGATIVE BACTERIA; TRANSMEMBRANE CHANNELS; BORDETELLA-PERTUSSIS; ADENYLATE-CYCLASE; MULTIDRUG EFFLUX; YERSINIA-PESTIS; TERMINAL DOMAIN; HOST-RANGE; IDENTIFICATION	Receptor recognition is a key step in the initiation of phage infection. Previously, we found that VP3, the T7 family phage of the Vibrio cholerae serogroup O1 biotype El Tor, can adsorb the core oligosaccharide (OS) of lipopolysaccharides of V. cholerae. However, some wildtype strains of V. cholerae possessing the intact OS gene cluster still have VP3 binding but are resistant to VP3 infection. Moreover, an OS gene-deletion mutant still exhibits weak VP3 binding, suggesting multiple factors are possibly involved in VP3 binding to V. cholerae. Here, we report that the outer-membrane protein TolC of V. cholerae is involved in the host adsorption of VP3. We observed that TolC directly interacts with the VP3 tail fiber protein gp44 and its C-terminal domains, and we also found that three amino acid residues in the outside loops of TolC, at positions 78, 290, and 291, are critical for binding to gp44. Among the VP3-resistant wildtype V. cholerae strains, frequent amino acid residue mutations were observed in the loops around the sites 78, 290, and 291, which were predicted to be exposed to the cell surface. These findings reveal a co-receptor-binding mechanism for VP3 infection of V. cholerae and that both outer-membrane TolC and OS are necessary for successful VP3 infection of V. cholerae. We conclude that mutations on the outside loops of the receptor may confer V. cholerae strains with VP3 phage resistance, enabling these strains to survive in environments containing VP3 or related phages.	[Fan, Fenxia; Li, Xu; Pang, Bo; Li, Zhe; Zhang, Lijuan; Li, Jie; Zhang, Jingyun; Yan, Meiying; Liang, Weili; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Liang, Weili; Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Cheng] Natl Inst Biol Sci, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; National Institute of Biological Sciences, Beijing	Kan, B (corresponding author), 155 Changbai Rd, Beijing 102206, Peoples R China.	kanbiao@icdc.cn	Zhang, JY/ABI-2768-2020	Zhang, JY/0000-0002-8577-7956	National Science Foundation of China [81501724]; National Basic Research Priorities Program [2015CB554201]; State Key Laboratory of Infections Disease Prevention and Control [2014SKLID101]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Priorities Program(National Basic Research Program of China); State Key Laboratory of Infections Disease Prevention and Control	This work was supported by National Science Foundation of China Youth Fund 81501724, National Basic Research Priorities Program Grant 2015CB554201, and Science Priority Grant 2014SKLID101 from the State Key Laboratory of Infections Disease Prevention and Control. The authors declare that they have no conflicts of interest with the contents of this article.	ALHENDY A, 1992, INFECT IMMUN, V60, P870, DOI 10.1128/IAI.60.3.870-875.1992; ALHENDY A, 1991, MICROB PATHOGENESIS, V10, P47, DOI 10.1016/0882-4010(91)90065-I; Aono R, 1998, J BACTERIOL, V180, P938, DOI 10.1128/JB.180.4.938-944.1998; Berrier C, 2000, FEBS LETT, V476, P129, DOI 10.1016/S0014-5793(00)01705-1; Boardman BK, 2004, J BACTERIOL, V186, P8137, DOI 10.1128/JB.186.23.8137-8143.2004; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Cescau S, 2007, J BACTERIOL, V189, P1496, DOI 10.1128/JB.01480-06; Chiang SL, 2000, INFECT IMMUN, V68, P6391, DOI 10.1128/IAI.68.11.6391-6397.2000; DATTA DB, 1977, J BACTERIOL, V131, P821, DOI 10.1128/JB.131.3.821-829.1977; DAVIES JK, 1975, J BACTERIOL, V123, P102, DOI 10.1128/JB.123.1.102-117.1975; DEZWAIG RN, 1967, J BACTERIOL, V94, P1112, DOI 10.1128/JB.94.4.1112-1123.1967; Didelot X, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005072; Disease Control Bureau of the Ministry of Health of China, 2013, 2013 MANUAL OF CHOLE; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Eckert B, 2007, J MOL BIOL, V373, P452, DOI 10.1016/j.jmb.2007.07.060; Fan FX, 2014, INFECT IMMUN, V82, P1676, DOI 10.1128/IAI.01377-13; FEELEY JC, 1965, J BACTERIOL, V89, P665, DOI 10.1128/JB.89.3.665-670.1965; FEUCHT A, 1990, J BIOL CHEM, V265, P18561; FRALICK JA, 1994, J BACTERIOL, V176, P6404, DOI 10.1128/jb.176.20.6404-6406.1994; Frost JA, 1999, EPIDEMIOL INFECT, V123, P47, DOI 10.1017/S095026889900254X; Gao S, 1984, FU HUO LUAN ZI LIAO, P237; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; GEHRING K, 1987, J BACTERIOL, V169, P2103, DOI 10.1128/jb.169.5.2103-2106.1987; German GJ, 2001, J MOL BIOL, V308, P579, DOI 10.1006/jmbi.2001.4578; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; HELLER KJ, 1992, ARCH MICROBIOL, V158, P235, DOI 10.1007/BF00245239; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Judson N, 2000, NAT BIOTECHNOL, V18, P740, DOI 10.1038/77305; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kiljunen S, 2011, J BACTERIOL, V193, P4963, DOI 10.1128/JB.00339-11; KILLMANN H, 1995, J BACTERIOL, V177, P694, DOI 10.1128/jb.177.3.694-698.1995; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; KRUGER DH, 1981, MICROBIOL REV, V45, P9; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; LADANT D, 1988, J BIOL CHEM, V263, P2612; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; Li W, 2013, ARCH VIROL, V158, P1865, DOI 10.1007/s00705-013-1676-9; LINDBERG AA, 1973, ANNU REV MICROBIOL, V27, P205, DOI 10.1146/annurev.mi.27.100173.001225; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller J. H, 1972, EXPT MOL GENETICS; MOFFATT BA, 1988, J BACTERIOL, V170, P2095, DOI 10.1128/jb.170.5.2095-2105.1988; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; MORONA R, 1984, J BACTERIOL, V159, P570, DOI 10.1128/JB.159.2.570-578.1984; MORONA R, 1985, J BACTERIOL, V164, P539, DOI 10.1128/JB.164.2.539-543.1985; NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Parent KN, 2014, MOL MICROBIOL, V92, P47, DOI 10.1111/mmi.12536; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Porcek NB, 2015, J MOL BIOL, V427, P1964, DOI 10.1016/j.jmb.2015.03.012; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; ROESSNER CA, 1986, J BIOL CHEM, V261, P386; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Shin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043392; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Thanassi DG, 2000, CURR OPIN CELL BIOL, V12, P420, DOI 10.1016/S0955-0674(00)00111-3; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Traurig M, 1999, FEMS MICROBIOL LETT, V181, P101, DOI 10.1111/j.1574-6968.1999.tb08831.x; Tsou AM, 2011, MICROBIOL-SGM, V157, P1620, DOI 10.1099/mic.0.046235-0; Vakharia H, 1996, MOL MICROBIOL, V19, P881, DOI 10.1046/j.1365-2958.1996.430957.x; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu DL, 2014, J VIROL, V88, P7109, DOI 10.1128/JVI.03186-13; Xu JL, 2013, J BACTERIOL, V195, P798, DOI 10.1128/JB.01770-12; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; YU F, 1982, J BACTERIOL, V151, P718, DOI 10.1128/JB.151.2.718-722.1982; Zhang JY, 2009, J BACTERIOL, V191, P2622, DOI 10.1128/JB.01370-08; Zhao XN, 2013, J VIROL, V87, P12260, DOI 10.1128/JVI.01948-13	78	13	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4000	4013		10.1074/jbc.M117.805689	http://dx.doi.org/10.1074/jbc.M117.805689			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29259138	Green Published, hybrid			2022-12-28	WOS:000427587500013
J	Shang, YL; Yan, J; Tang, WH; Liu, C; Xiao, S; Guo, YS; Yuan, L; Chen, L; Jiang, H; Guo, XJ; Qiao, J; Li, W				Shang, Yongliang; Yan, Jie; Tang, Wenhao; Liu, Chao; Xiao, Sai; Guo, Yueshuai; Yuan, Li; Chen, Liang; Jiang, Hui; Guo, Xuejiang; Qiao, Jie; Li, Wei			Mechanistic insights into acephalic spermatozoa syndrome-associated mutations in the human SUN5 gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAD; MORPHOGENESIS; DNAJB13; MEMBER; TAIL	Acephalic spermatozoa syndrome has been reported for many decades; it is characterized by very few intact spermatozoa and tailless sperm heads in the semen and causes severe male infertility. The only gene in which mutations have been found to be associated with this syndrome encodes Sad1 and UNC84 domain-containing 5 (SUN5), a testis-specific nuclear envelope protein. The functional role of SUN5 has been well-studied in mouse models, but the molecular basis for the pathogenic effects of mutations in the human SUN5 gene remains elusive. Here, we report a new SUN5 mutation (c.475C -> T; p.Arg159*), and explore the pathogenic effects of all known SUN5 mutations on acephalic spermatozoa syndrome. Using an artificial splicing system, we found that the intronic mutation affects the splicing of SUN5 mRNA, yielding a premature stop codon that results in a truncated SUN5 protein. We also found that SUN5 interacts with the coupling apparatus protein DnaJ heat shock protein family (Hsp40) member B13 (DNAJB13) during spermatogenesis, and the substitutions in the SUN5 SUN domain impair its interaction with DNAJB13. Furthermore, we observed that many SUN5 mutations affect the secondary structure of the protein and influence its folding and cellular localization. In summary, our findings indicate an interaction of SUN5 with DNAJB13 during spermatogenesis, provide mechanistic insights into the functional role of this interaction in sperm head-tail integration, and elucidate the molecular etiology of acephalic spermatozoa syndrome-associated SUN5 mutations.	[Shang, Yongliang; Liu, Chao; Xiao, Sai; Li, Wei] Chinese Acad Sci, State Key Lab Stem Cell & Reprod Biol, Inst Zool, Beijing 100101, Peoples R China; [Shang, Yongliang; Liu, Chao; Xiao, Sai; Li, Wei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yan, Jie; Tang, Wenhao; Qiao, Jie] Peking Univ, Hosp 3, Beijing Key Lab Reprod Endocrinol & Assisted Repr, Ctr Reprod Med,Dept Obstet & Gynecol, Beijing 100191, Peoples R China; [Guo, Yueshuai; Guo, Xuejiang] Nanjing Med Univ, State Key Lab Reprod Med, Collaborat Innovat Ctr Genet & Dev, Dept Histol & Embryol, Nanjing 210029, Jiangsu, Peoples R China; [Yuan, Li] Univ Chinese Acad Sci, Savaid Sch Med, Beijing 100049, Peoples R China; [Chen, Liang] Peking Univ, Hosp 1, Med Ctr Reprod & Genet, Beijing 100034, Peoples R China; [Jiang, Hui] Peking Univ, Hosp 3, Dept Urol, Beijing 100191, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Nanjing Medical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Peking University	Qiao, J (corresponding author), Peking Univ, Hosp 3, 49 North Garden Rd, Beijing, Peoples R China.; Li, W (corresponding author), Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.	jie.qiao@263.net; leways@ioz.ac.cn	; Guo, Xuejiang/J-9600-2014	Guo, Yueshuai/0000-0002-2719-1244; Guo, Xuejiang/0000-0002-0475-5705	National Key Research and Development Program of China [2016YFA0500901]; National Nature Science Foundation of China [31471277, 91649202]; National Key Research and Development Program [2017YFC1002002]	National Key Research and Development Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program	This work was supported by Grant 2016YFA0500901 from the National Key Research and Development Program of China, Grants 31471277 and 91649202 from the National Nature Science Foundation of China (to W. L.), and Grant 2017YFC1002002 from the National Key Research and Development Program (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	BACCETTI B, 1984, J REPROD FERTIL, V70, P395; CHEMES HE, 1987, FERTIL STERIL, V47, P310; Chemes HE, 2012, ASIAN J ANDROL, V14, P14, DOI 10.1038/aja.2011.168; El Khouri E, 2016, AM J HUM GENET, V99, P489, DOI 10.1016/j.ajhg.2016.06.022; Elkhatib RA, 2017, HUM MOL GENET, V26, P3167, DOI 10.1093/hmg/ddx200; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Guo HP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01551; Guo XJ, 2010, J ANDROL, V31, P419, DOI 10.2164/jandrol.109.007534; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Liu C, 2016, AUTOPHAGY, V12, P814, DOI 10.1080/15548627.2016.1159377; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Oji A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31666; PEROTTI ME, 1981, J REPROD FERTIL, V63, P543; PEROTTI ME, 1981, CELL BIOL INT REP, V5, P113, DOI 10.1016/0309-1651(81)90018-7; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shang YL, 2017, ELIFE, V6, DOI [10.7554/eLife.28199.001, 10.7554/eLife.28199]; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Tokuhiro K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000712; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yang HM, 2005, DNA SEQUENCE, V16, P166, DOI 10.1080/10425170500129736; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112; Zhu FX, 2016, AM J HUM GENET, V99, P942, DOI 10.1016/j.ajhg.2016.08.004	26	27	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2395	2407		10.1074/jbc.RA117.000861	http://dx.doi.org/10.1074/jbc.RA117.000861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29298896	Green Published, hybrid			2022-12-28	WOS:000425308300014
J	Tian, W; de la Vega, MR; Schmidlin, CJ; Ooi, A; Zhang, DD				Tian, Wang; de la Vega, Montserrat Rojo; Schmidlin, Cody J.; Ooi, Aikseng; Zhang, Donna D.			Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein degradation; protein domain; protein motif; protein stability; nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); KEAP1; NRF1	TRANSCRIPTION FACTOR NRF1; N-TERMINAL DOMAIN; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE; STRESS; FAMILY; DEGRADATION; ACTIVATION; INDUCTION; MECHANISM	Nuclear factor erythroid-2-related factor 1 (NRF1) and NRF2 are essential for maintaining redox homeostasis and coordinating cellular stress responses. They are highly homologous transcription factors that regulate the expression of genes bearing antioxidant-response elements (AREs). Genetic ablation of NRF1 or NRF2 results in vastly different phenotypic outcomes, implying that they play different roles and may be differentially regulated. Kelch-like ECH-associated protein 1 (KEAP1) is the main negative regulator of NRF2 and mediates ubiquitylation and degradation of NRF2 through its NRF2-ECH homology-like domain 2 (Neh2). Here, we report that KEAP1 binds to the Neh2-like (Neh2L) domain of NRF1 and stabilizes it. Consistently, NRF1 is more stable in KEAP1(+/+) than in KEAP1(-/-) isogenic cell lines, whereas NRF2 is dramatically stabilized in KEAP1(-/-) cells. Replacing NRF1's Neh2L domain with NRF2's Neh2 domain renders NRF1 sensitive to KEAP1-mediated degradation, indicating that the amino acids between the DLG and ETGE motifs, not just the motifs themselves, are essential for KEAP1-mediated degradation. Systematic site-directed mutagenesis identified the core amino acid residues required for KEAP1-mediated degradation and further indicated that the DLG and ETGE motifs with correct spacing are insufficient as a KEAP1 degron. Our results offer critical insights into our understanding of the differential regulation of NRF1 and NRF2 by KEAP1 and their different physiological roles.	[Tian, Wang; de la Vega, Montserrat Rojo; Schmidlin, Cody J.; Ooi, Aikseng; Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of Arizona	Zhang, DD (corresponding author), Coll Pharm, Dept Pharmacol & Toxicol, 1703 E Mabel St,Rm 408, Tucson, AZ 85721 USA.	dzhang@pharmacy.arizona.edu			National Institutes of Health [R01 CA154377, R01 DK109555, R01 ES026845]; NATIONAL CANCER INSTITUTE [P30CA023074, R01CA154377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026845, P30ES006694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health Grants R01 CA154377, R01 DK109555, and R01 ES026845 (to D. D. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Baird L, 2013, P NATL ACAD SCI USA, V110, P15259, DOI 10.1073/pnas.1305687110; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Bugno M, 2015, BBA-GENE REGUL MECH, V1849, P1260, DOI 10.1016/j.bbagrm.2015.08.001; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; Chan JY, 1998, EMBO J, V17, P1779, DOI 10.1093/emboj/17.6.1779; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Chen JY, 2015, FEBS LETT, V589, P2347, DOI 10.1016/j.febslet.2015.07.030; Chepelev NL, 2013, REDOX BIOL, V1, P183, DOI 10.1016/j.redox.2013.01.005; Chepelev NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029167; de la Vega Montserrat Rojo, 2016, Current Opinion in Toxicology, V1, P62, DOI 10.1016/j.cotox.2016.10.005; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Fukagai K, 2016, BIOCHEM BIOPH RES CO, V478, P363, DOI 10.1016/j.bbrc.2016.07.045; Fuse Y, 2017, MOLECULES, V22, DOI 10.3390/molecules22030436; Gacesa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27740; Gameiro I, 2017, SCI REP-UK, V7, DOI 10.1038/srep45701; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hirotsu Y, 2014, GENES CELLS, V19, P650, DOI 10.1111/gtc.12165; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kim HM, 2016, GENE, V584, P17, DOI 10.1016/j.gene.2016.03.002; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Lee CS, 2013, FEBS J, V280, P3609, DOI 10.1111/febs.12350; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Lisek K, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2016.1217967; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; MIGNOTTE V, 1989, P NATL ACAD SCI USA, V86, P6548, DOI 10.1073/pnas.86.17.6548; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Mulvaney KM, 2016, J BIOL CHEM, V291, P23719, DOI 10.1074/jbc.M116.729418; Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Radhakrishnan SK, 2014, ELIFE, V3, DOI [10.7554/elife.01856, 10.7554/eLife.01856]; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sha Z, 2014, CURR BIOL, V24, P1573, DOI 10.1016/j.cub.2014.06.004; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Tao SS, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00660-16; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tsuchiya Y, 2011, MOL CELL BIOL, V31, P4500, DOI 10.1128/MCB.05663-11; Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14; Uruno A, 2013, MOL CELL BIOL, V33, P2996, DOI 10.1128/MCB.00225-13; Vegran F, 2009, BRIT J CANCER, V101, P1357, DOI 10.1038/sj.bjc.6605310; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wang WP, 2006, J BIOL CHEM, V281, P19676, DOI 10.1074/jbc.M602802200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang YG, 2006, BIOCHEM J, V399, P373, DOI 10.1042/BJ20060725; Zhang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12983; Zhang YG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109159, 10.1371/journal.pone.0105725, 10.1371/journal.pone.0093458, 10.1371/journal.pone.0088491]; Zhang YG, 2010, BIOCHEM J, V430, P497, DOI 10.1042/BJ20100471; Zhang YH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01943	71	38	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2029	2040		10.1074/jbc.RA117.000428	http://dx.doi.org/10.1074/jbc.RA117.000428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29255090	hybrid, Green Published			2022-12-28	WOS:000424948000016
J	Wallroth, A; Haucke, V				Wallroth, Alexander; Haucke, Volker			Phosphoinositide conversion in endocytosis and the endolysosomal system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						phosphatidylinositol; phosphatidylinositol kinase (PI Kinase); phosphatidylinositol phosphatase; phosphatidylinositol signaling; autophagy; endocytosis; endosome; lysosome; mTOR complex (mTORC)	AUTOPHAGOSOME-LYSOSOME FUSION; MEMBRANE CONTACT SITES; LIPID KINASE; MEDIATED ENDOCYTOSIS; CELL REGULATION; RAG GTPASES; V-ATPASE; CLATHRIN; MTORC1; COMPLEX	Phosphoinositides (PIs) are phospholipids that perform crucial cell functions, ranging from cell migration and signaling to membrane trafficking, by serving as signposts of compartmental membrane identity. Although phosphatidylinositol 4,5-bisphosphate, 3-phosphate, and 3,5-bisphosphate are commonly considered as hallmarks of the plasma membrane, endosomes, and lysosomes, these compartments contain other functionally important PIs. Here, we review the roles of PIs in different compartments of the endolysosomal system in mammalian cells and discuss the mechanisms that spatiotemporally control PI conversion in endocytosis and endolysosomal membrane dynamics during endosome maturation and sorting. As defective PI conversion underlies human genetic diseases, including inherited myopathies, neurological disorders, and cancer, PI-converting enzymes represent potential targets for drug-based therapies.	[Wallroth, Alexander; Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany; [Haucke, Volker] Free Univ Berlin, Fac Biol Chem & Pharm, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin	Haucke, V (corresponding author), Leibniz Inst Mol Pharmakol FMP, Robert Rossle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de			Deutsche Forschungsgemeinschaft [SFB 740/TP C08, TRR 186/TP A08]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 740/TP C08 and TRR 186/TP A08. The authors declare that they have no conflicts of interest with the contents of this article.	Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Antonescu CN, 2011, MOL BIOL CELL, V22, P2588, DOI 10.1091/mbc.E11-04-0362; Bakula D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15637; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Baskin JM, 2016, NAT CELL BIOL, V18, P132, DOI 10.1038/ncb3271; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bendris N, 2017, TRENDS CELL BIOL, V27, P189, DOI 10.1016/j.tcb.2016.11.001; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Bridges D, 2012, MOL BIOL CELL, V23, P2955, DOI 10.1091/mbc.E11-12-1034; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Cao C, 2007, TRAFFIC, V8, P1052, DOI 10.1111/j.1600-0854.2007.00586.x; Daste F, 2017, J CELL BIOL, V216, P3745, DOI 10.1083/jcb.201704061; Daumke O, 2014, CELL, V156, P882, DOI 10.1016/j.cell.2014.02.017; De Leo MG, 2016, NAT CELL BIOL, V18, P839, DOI 10.1038/ncb3386; Devereaux K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076405; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; Erdmann KS, 2007, DEV CELL, V13, P377, DOI 10.1016/j.devcel.2007.08.004; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Franco I, 2014, DEV CELL, V28, P647, DOI 10.1016/j.devcel.2014.01.022; Fujimoto LM, 2000, TRAFFIC, V1, P161, DOI 10.1034/j.1600-0854.2000.010208.x; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Guardia CM, 2016, CELL REP, V17, P1950, DOI 10.1016/j.celrep.2016.10.062; Hao F, 2016, FEBS LETT, V590, P161, DOI 10.1002/1873-3468.12048; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hasegawa J, 2016, EMBO J, V35, P1853, DOI 10.15252/embj.201593148; Henmi Y, 2016, MOL BIOL CELL, V27, P990, DOI 10.1091/mbc.E15-08-0564; Hoglinger D, 2014, BBA-MOL CELL BIOL L, V1841, P1085, DOI 10.1016/j.bbalip.2014.03.012; Hong Z, 2017, J CELL BIOL, V216, P4217, DOI 10.1083/jcb.201611073; Idevall-Hagren O, 2015, BBA-MOL CELL BIOL L, V1851, P736, DOI 10.1016/j.bbalip.2014.12.008; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jean S, 2012, MOL BIOL CELL, V23, P2723, DOI 10.1091/mbc.E12-05-0375; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2014, MOL BIOL CELL, V25, P1171, DOI 10.1091/mbc.E14-01-0021; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Liu Y, 2013, BIOCHEM J, V455, P195, DOI 10.1042/BJ20130644; Lo WT, 2017, DEV CELL, V43, P522, DOI 10.1016/j.devcel.2017.10.019; Marat AL, 2017, SCIENCE, V356, P968, DOI 10.1126/science.aaf8310; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; Marwaha R, 2017, J CELL BIOL, V216, P1051, DOI 10.1083/jcb.201607085; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Nakatsu F, 2010, J CELL BIOL, V190, P307, DOI 10.1083/jcb.201005018; Nandez R, 2014, ELIFE, V3, DOI 10.7554/eLife.02975; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; O'Farrell F, 2013, FEBS J, V280, P6322, DOI 10.1111/febs.12486; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pu J, 2017, J CELL BIOL, V216, P4183, DOI 10.1083/jcb.201703094; Raiborg C, 2016, BIOCHEM SOC T, V44, P425, DOI 10.1042/BST20150190; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Sabha N, 2016, J CLIN INVEST, V126, P3613, DOI 10.1172/JCI86841; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schoneberg J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15873; Schoneberg J, 2017, NAT REV MOL CELL BIO, V18, P5, DOI 10.1038/nrm.2016.121; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Sridhar S, 2013, EMBO J, V32, P324, DOI 10.1038/emboj.2012.341; Staiano L, 2015, BBA-MOL CELL BIOL L, V1851, P867, DOI 10.1016/j.bbalip.2014.12.001; Stanley RE, 2014, TRENDS CELL BIOL, V24, P73, DOI 10.1016/j.tcb.2013.07.008; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Wan W, 2017, MOL CELL, V68, P323, DOI 10.1016/j.molcel.2017.09.020; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou J, 2012, P NATL ACAD SCI USA, V109, P9539, DOI 10.1073/pnas.1207021109	98	94	97	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1526	1535		10.1074/jbc.R117.000629	http://dx.doi.org/10.1074/jbc.R117.000629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29282290	hybrid, Green Published			2022-12-28	WOS:000424201700005
J	Miyazaki, R; Myougo, N; Mori, H; Akiyama, Y				Miyazaki, Ryoji; Myougo, Naomi; Mori, Hiroyuki; Akiyama, Yoshinori			A photo-cross-linking approach to monitor folding and assembly of newly synthesized proteins in a living cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); protein assembly; protein dynamic; protein synthesis; protein-protein interaction; amber suppression; p-benzoyl-L-phenylalanine (pBPA); unnatural amino acid	BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; AMINO-ACID; IN-VIVO; ALKALINE-PHOSPHATASE; LIPOPOLYSACCHARIDE INSERTION; STRUCTURAL BASIS; GENETIC-CODE; SECY; TRANSLOCATION	Many proteins form multimeric complexes that play crucial roles in various cellular processes. Studying how proteins are correctly folded and assembled into such complexes in a living cell is important for understanding the physiological roles and the qualitative and quantitative regulation of the complex. However, few methods are suitable for analyzing these rapidly occurring processes. Site-directed in vivo photo-cross-linking is an elegant technique that enables analysis of protein-protein interactions in living cells with high spatial resolution. However, the conventional site-directed in vivo photo-cross-linking method is unsuitable for analyzing dynamic processes. Here, by combining an improved site-directed in vivo photo-cross-linking technique with a pulse-chase approach, we developed a new method that can analyze the folding and assembly of a newly synthesized protein with high spatiotemporal resolution. We demonstrate that this method, named the pulse-chase and in vivo photo-cross-linking experiment (PiXie), enables the kinetic analysis of the formation of an Escherichia coli periplasmic (soluble) protein complex (PhoA). We also used our new technique to investigate assembly/folding processes of two membrane complexes (SecD-SecF in the inner membrane and LptD-LptE in the outer membrane), which provided new insights into the biogenesis of these complexes. Our PiXie method permits analysis of the dynamic behavior of various proteins and enables examination of protein-protein interactions at the level of individual amino acid residues. We anticipate that our new technique will have valuable utility for studies of protein dynamics in many organisms.	[Miyazaki, Ryoji; Myougo, Naomi; Mori, Hiroyuki; Akiyama, Yoshinori] Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Akiyama, Y (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Sakyo Ku, Kyoto 6068507, Japan.	yakiyama@infront.kyoto-u.ac.jp		Miyazaki, Ryoji/0000-0003-1626-2569; Mori, Hiroyuki/0000-0002-0429-1269	JSPS KAKENHI [15J05262, 15H04350, 17K07334]; MEXT KAKENHI [24117003, 15H01532, 17H05666, 17H05879]; Grants-in-Aid for Scientific Research [17K07334] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Hizukuri for helpful comments, and M. Sano and Y. Fujimoto (Machida) for technical support, S. Urin for helpful advices about UV irradiators and National BioResource Project (NBRP)-E. coli at National Institute of Genetics, Japan for strains. This study was supported by JSPS KAKENHI Grants 15J05262 (to R. M.), 15H04350 (to Y. A.), and 17K07334 (to H. M.) and MEXT KAKENHI Grants 24117003 (to H. M.), 15H01532 (to Y. A.), 17H05666 (to H. M.), and 17H05879 (to H. M.).	Akiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08928; AKIYAMA Y, 1989, J BIOL CHEM, V264, P437; AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BlondeletRouault MH, 1997, GENE, V190, P315, DOI 10.1016/S0378-1119(97)00014-0; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Dong HH, 2014, NATURE, V511, P52, DOI 10.1038/nature13464; Freinkman E, 2011, P NATL ACAD SCI USA, V108, P2486, DOI 10.1073/pnas.1015617108; Furukawa A, 2017, CELL REP, V19, P895, DOI 10.1016/j.celrep.2017.04.030; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Ieva R, 2011, P NATL ACAD SCI USA, V108, pE383, DOI 10.1073/pnas.1103827108; Ishii E, 2015, P NATL ACAD SCI USA, V112, pE5513, DOI 10.1073/pnas.1513001112; Jubb HC, 2017, PROG BIOPHYS MOL BIO, V128, P3, DOI 10.1016/j.pbiomolbio.2016.10.002; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Lee HS, 2009, BIOORG MED CHEM LETT, V19, P5222, DOI 10.1016/j.bmcl.2009.07.011; Lee J, 2016, P NATL ACAD SCI USA, V113, P8717, DOI 10.1073/pnas.1604100113; MANOIL C, 1985, P NATL ACAD SCI USA, V82, P8129, DOI 10.1073/pnas.82.23.8129; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Miyazaki R, 2016, SCI REP-UK, V6, DOI 10.1038/srep24147; Mori H, 2002, J BIOL CHEM, V277, P48550, DOI 10.1074/jbc.M204436200; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Narita S, 2013, P NATL ACAD SCI USA, V110, pE3612, DOI 10.1073/pnas.1312012110; Nichols BP, 1998, J BACTERIOL, V180, P6408; Okuda S, 2012, SCIENCE, V338, P1214, DOI 10.1126/science.1228984; Qiao S, 2014, NATURE, V511, P108, DOI 10.1038/nature13484; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Tanaka Keiji, 2013, Keio Journal of Medicine, V62, P1, DOI 10.2302/kjm.2012-0006-RE; TANI K, 1989, J BIOL CHEM, V264, P18582; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Yamamoto K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21909; Yang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12299; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	42	13	14	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					677	686		10.1074/jbc.M117.817270	http://dx.doi.org/10.1074/jbc.M117.817270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158258	Green Published, hybrid			2022-12-28	WOS:000419915400022
J	Paasch, F; den Brave, F; Psakhye, I; Pfander, B; Jentsch, S				Paasch, Florian; den Brave, Fabian; Psakhye, Ivan; Pfander, Boris; Jentsch, Stefan			Failed mitochondrial import and impaired proteostasis trigger SUMOylation of mitochondrial proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70-kilodalton heat shock protein (HSP70); mitochondria; proteasome; proteostasis; small ubiquitin-like modifier (SUMO); mitochondrial proteins; protein quality control; SUMOylation	UBIQUITIN-PROTEASOME SYSTEM; ALPHA-SYNUCLEIN AGGREGATION; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; QUALITY-CONTROL; SUMO MODIFICATION; STRESS-RESPONSE; ALCOHOL-DEHYDROGENASE; MISFOLDED PROTEINS; PRECURSOR PROTEIN	Modification by the ubiquitin-like protein SUMO affects hundreds of cellular substrate proteins and regulates a wide variety of physiological processes. While the SUMO system appears to predominantly target nuclear proteins and, to a lesser extent, cytosolic proteins, hardly anything is known about the SUMOylation of proteins targeted to membrane-enclosed organelles. Here, we identify a large set of structurally and functionally unrelated mitochondrial proteins as substrates of the SUMO pathway in yeast. We show that SUMO modification of mitochondrial proteins does not rely on mitochondrial targeting and, in fact, is strongly enhanced upon import failure, consistent with the modification occurring in the cytosol. Moreover, SUMOylated forms of mitochondrial proteins particularly accumulate in HSP70- and proteasome-deficient cells, suggesting that SUMOylation participates in cellular protein quality control. We therefore propose that SUMO serves as a mark for nonfunctional mitochondrial proteins, which only sporadically arise in unstressed cells but strongly accumulate upon defective mitochondrial import and impaired proteostasis. Overall, our findings provide support for a role of SUMO in the cytosolic response to aberrant proteins.	[Paasch, Florian; den Brave, Fabian; Psakhye, Ivan; Jentsch, Stefan] Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany; [Pfander, Boris] Max Planck Inst Biochem, Res Grp DNA Replicat & Genome Integr, Klopferspitz 18, D-82152 Martinsried, Germany; [Psakhye, Ivan] FIRC Inst Mol Oncol, IFOM, Via Adamello 16, I-20139 Milan, Italy	Max Planck Society; Max Planck Society; IFOM - FIRC Institute of Molecular Oncology	den Brave, F (corresponding author), Max Planck Inst Biochem, Dept Mol Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.; Pfander, B (corresponding author), Max Planck Inst Biochem, Res Grp DNA Replicat & Genome Integr, Klopferspitz 18, D-82152 Martinsried, Germany.	denbrave@biochem.mpg.de; bpfander@biochem.mpg.de		Psakhye, Ivan/0000-0003-3877-133X; den Brave, Fabian/0000-0001-6955-4616; Pfander, Boris/0000-0003-2180-5054	Max Planck Society; Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich; Louis-Jeantet Foundation; European Research Council (ERC); EU Marie Curie Training Network	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich; Louis-Jeantet Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission); EU Marie Curie Training Network(European Commission)	Research in the S.J. lab is supported by Max Planck Society, Deutsche Forschungsgemeinschaft, Center for Integrated Protein Science Munich, Louis-Jeantet Foundation, and a European Research Council (ERC) Advanced Grant. Research in the B.P. lab is supported by Max Planck Society and Deutsche Forschungsgemeinschaft. This work was also supported by a stipend from EU Marie Curie Training Network (to I. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Abeywardana T, 2015, BIOCHEMISTRY-US, V54, P959, DOI 10.1021/bi501512m; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bragoszewski P, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170007; Bragoszewski P, 2013, MOL CELL BIOL, V33, P2136, DOI 10.1128/MCB.01579-12; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Castoralova M, 2012, BBA-MOL CELL RES, V1823, P911, DOI 10.1016/j.bbamcr.2012.01.010; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cullin C, 1996, YEAST, V12, P1511, DOI 10.1002/(SICI)1097-0061(199612)12:15<1511::AID-YEA41>3.0.CO;2-B; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Escobar-Henriques M, 2014, EMBO REP, V15, P231, DOI 10.1002/embr.201338225; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Guo LL, 2014, MOL CELL, V55, P15, DOI 10.1016/j.molcel.2014.04.030; Habelhah H, 2004, J BIOL CHEM, V279, P53782, DOI 10.1074/jbc.M410315200; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Itakura E, 2016, MOL CELL, V63, P21, DOI 10.1016/j.molcel.2016.05.020; Janer A, 2010, HUM MOL GENET, V19, P181, DOI 10.1093/hmg/ddp478; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kitakawa M, 1997, EUR J BIOCHEM, V245, P449, DOI 10.1111/j.1432-1033.1997.t01-2-00449.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krumova P, 2013, CELL MOL LIFE SCI, V70, P2123, DOI 10.1007/s00018-012-1158-3; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Liebelt F, 2016, AM J PHYSIOL-CELL PH, V311, pC284, DOI 10.1152/ajpcell.00091.2016; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066; Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2; Mihara K, 1996, EXPERIENTIA, V52, P1063, DOI 10.1007/BF01952103; Mori M, 1998, BBA-MOL CELL RES, V1403, P12, DOI 10.1016/S0167-4889(98)00021-4; Mukherjee S, 2009, J BIOL CHEM, V284, P21296, DOI 10.1074/jbc.M109.011494; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pang SS, 1999, BIOCHEMISTRY-US, V38, P5222, DOI 10.1021/bi983013m; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pearce DA, 1997, J BIOL CHEM, V272, P31829, DOI 10.1074/jbc.272.50.31829; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Psakhye I, 2016, METHODS MOL BIOL, V1475, P219, DOI 10.1007/978-1-4939-6358-4_16; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Radke S, 2008, J BIOL CHEM, V283, P12681, DOI 10.1074/jbc.C800036200; RASSOW J, 1990, FEBS LETT, V275, P190, DOI 10.1016/0014-5793(90)81469-5; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; SHEFFIELD WP, 1990, J BIOL CHEM, V265, P11069; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; SUGAR J, 1970, ARCH INT PHYS BIOCH, V78, P1009; Takahashi Y, 1999, BIOCHEM BIOPH RES CO, V259, P582, DOI 10.1006/bbrc.1999.0821; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2001, GENE, V275, P223, DOI 10.1016/S0378-1119(01)00662-X; Takahashi Y, 2000, J BIOCHEM-TOKYO, V128, P723, DOI 10.1093/oxfordjournals.jbchem.a022807; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; TERADA K, 1995, MOL CELL BIOL, V15, P3708; Wang XW, 2015, NATURE, V524, P481, DOI 10.1038/nature14859; Wang Z, 2009, MOL CELL BIOL, V29, P1694, DOI 10.1128/MCB.01470-08; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wrobel L, 2015, NATURE, V524, P485, DOI 10.1038/nature14951; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	81	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					599	609		10.1074/jbc.M117.817833	http://dx.doi.org/10.1074/jbc.M117.817833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183993	Green Published, hybrid			2022-12-28	WOS:000419915400016
J	Fujita-Yamaguchi, Y; Bagramyan, K; Yamaguchi, Y; Ikeda, A; Dohmae, N; Hong, TB; Kalkum, M				Fujita-Yamaguchi, Yoko; Bagramyan, Karine; Yamaguchi, Yoshiki; Ikeda, Akemi; Dohmae, Naoshi; Hong, Teresa B.; Kalkum, Markus			Mass spectrometric revival of an l-rhamnose- and d-galactose-specific lectin from a lost strain of Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; lectin; mass spectrometry (MS); microarray; nuclear magnetic resonance (NMR); protein sequence; recombinant protein expression; glycan; rhamnose binding; Streptomyces	BINDING LECTINS; EXPRESSION; REVEALS; EGGS	Blood type B-specific Streptomyces sp. 27S5 hemagglutinin (SHA) was discovered and characterized in the 1970s. Although strain 27S5 has been lost, the purified SHA protein survived intact under frozen conditions and retained its activity. Using modern techniques, here we further characterized SHA. Fourier-transform ion cyclotron resonance MS analysis determined the average molecular mass of SHA as 13,314.67 Da. MS of digested SHA peptides, Streptomyces genomic database matching, and N-terminal sequencing solved the 131-residue amino acid sequence of SHA. We found that SHA is homologous to N-terminally truncated hypothetical proteins encoded by the genomes of Streptomyces lavendulae, Streptomyces sp. Mg1, and others. The gene of the closest homologue in S. lavendulae, a putative polysaccharide deacetylase (PDSL), encodes 68 additional N-terminal amino acids, and its C terminus perfectly matched the SHA sequence, except for a single Ala-to-Glu amino acid difference. We expressed recombinant SHA(PDSL-A108E) (rSHA) as an enzymatically cleavable fusion protein in Escherichia coli, and glycan microarray analyses indicated that refolded rSHA exhibits the blood type B- and l-rhamnose-specific characteristics of authentic SHA, confirming that rSHA is essentially identical with SHA produced by Streptomyces sp. 27S5. We noted that SHA comprises three similar domains, representing 70% of the protein, and that these SHA domains partially overlap with annotated clostridial hydrophobic with conserved W domains. Furthermore, examination of GFP-tagged SHA revealed binding to microbial surfaces. rSHA may be useful both for studying the role of SHA/clostridial hydrophobic with conserved W domains in carbohydrate binding and for developing novel diagnostics and therapeutics for l-rhamnose-containing microorganisms.	[Fujita-Yamaguchi, Yoko] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Fujita-Yamaguchi, Yoko] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Bagramyan, Karine; Hong, Teresa B.; Kalkum, Markus] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Immunol, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Yamaguchi, Yoshiki; Ikeda, Akemi] RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama 3510198, Japan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; RIKEN; RIKEN	Fujita-Yamaguchi, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 East Duarte Rd, Duarte, CA 91010 USA.; Kalkum, M (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Immunol, 1500 East Duarte Rd, Duarte, CA 91010 USA.	yyamaguchi@coh.org; mkalkum@coh.org	Dohmae, Naoshi/C-2040-2011; Yamaguchi, Yoshiki/N-5246-2015	Dohmae, Naoshi/0000-0002-5242-9410; Yamaguchi, Yoshiki/0000-0003-0100-5439; Kalkum, Markus/0000-0002-9506-671X	NCI, National Institutes of Health [P30 CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Paul Straight of Texas A&M University for the kind gift of Streptomyces sp. Mg1. We also thank Dr. Alexander Pozhitkov for helping with microarray reader setup and Dr. Sarah T. Wilkinson for editing the manuscript. Y. F.-Y. thanks the late Drs. Kunio Oishi, Koichi Suzuki, and Kazutomo Imahori for the excellent mentoring and valuable comments she received while conducting the initial phase of this research at the University of Tokyo Graduate School. City of Hope facilities, including the Integrative Genomics Core used in this study, were supported, in part, by the NCI, National Institutes of Health under Grant P30 CA33572.	Carpentier G., 2010, IMAGEJ NEWS, V10; Cheng HN, 2012, POLYM REV, V52, P81, DOI 10.1080/15583724.2012.668154; Fujimoto Z, 2013, J BIOL CHEM, V288, P12376, DOI 10.1074/jbc.M113.460097; FUJITA Y, 1975, BIOCHEMISTRY-US, V14, P4465, DOI 10.1021/bi00691a019; FUJITA Y, 1972, J GEN APPL MICROBIOL, V18, P73, DOI 10.2323/jgam.18.73; FUJITA Y, 1973, BIOCHEM BIOPH RES CO, V53, P495, DOI 10.1016/0006-291X(73)90689-X; Fujita Y., 1976, THESIS; FUJITAYAMAGUCHI Y, 1982, BIOCHIM BIOPHYS ACTA, V701, P86, DOI 10.1016/0167-4838(82)90315-6; Guerrero F, 2015, PROTEIN EXPRES PURIF, V116, P42, DOI 10.1016/j.pep.2015.08.019; Harrison J, 2014, MICROB BIOTECHNOL, V7, P373, DOI 10.1111/1751-7915.12143; Hoefler BC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00535-13; Hosono M, 1999, BBA-GEN SUBJECTS, V1472, P668, DOI 10.1016/S0304-4165(99)00185-3; Negre-Salvayre A, 2009, ANTIOXID REDOX SIGN, V11, P3071, DOI [10.1089/ars.2009.2484, 10.1089/ARS.2009.2484]; Ng SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115296; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; OSMAN ME, 1993, J AGR FOOD CHEM, V41, P71, DOI 10.1021/jf00025a016; OZEKI Y, 1995, EXP CELL RES, V216, P318, DOI 10.1006/excr.1995.1040; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Sullivan L, 2007, ENZYME MICROB TECH, V42, P29, DOI 10.1016/j.enzmictec.2007.07.022; Tateno H, 2002, BIOSCI BIOTECH BIOCH, V66, P604, DOI 10.1271/bbb.66.604; Tateno H, 2002, BIOSCI BIOTECH BIOCH, V66, P1356, DOI 10.1271/bbb.66.1356; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; Tateno H, 2010, BIOSCI BIOTECH BIOCH, V74, P1141, DOI 10.1271/bbb.100086; Terada T, 2007, BBA-GEN SUBJECTS, V1770, P617, DOI 10.1016/j.bbagen.2006.11.003; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Yasuda E, 2011, APPL ENVIRON MICROB, V77, P4539, DOI 10.1128/AEM.00240-11; Zhang QB, 2009, J PROTEOME RES, V8, P754, DOI 10.1021/pr800858h	28	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					368	378		10.1074/jbc.M117.812719	http://dx.doi.org/10.1074/jbc.M117.812719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29101228	Green Published, hybrid			2022-12-28	WOS:000419453200031
J	Yan, XF; Xin, LY; Yen, JT; Zeng, YK; Jin, SY; Cheang, QW; Fong, RACY; Chiam, KH; Liang, ZX; Gao, YG				Yan, Xin-Fu; Xin, Lingyi; Yen, Jackie Tan; Zeng, Yukai; Jin, Shengyang; Cheang, Qing Wei; Fong, Rachel Andrea Chea Yuen; Chiam, Keng-Hwee; Liang, Zhao-Xun; Gao, Yong-Gui			Structural analyses unravel the molecular mechanism of cyclic di-GMP regulation of bacterial chemotaxis via a PilZ adaptor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; DOMAIN PROTEINS; CRYSTAL-STRUCTURE; BINDING; METHYLTRANSFERASE; REVEALS; RECEPTOR; DIVERSE; DIGUANYLATE; INTERACTS	The bacterial second messenger cyclic di-GMP (c-di-GMP) has emerged as a prominent mediator of bacterial physiology, motility, and pathogenicity. c-di-GMP often regulates the function of its protein targets through a unique mechanism that involves a discrete PilZ adaptor protein. However, the molecular mechanism for PilZ protein-mediated protein regulation is unclear. Here, we present the structure of the PilZ adaptor protein MapZ cocrystallized in complex with c-di-GMP and its protein target CheR1, a chemotaxis-regulating methyltransferase in Pseudomonas aeruginosa. This cocrystal structure, together with the structure of free CheR1, revealed that the binding of c-di-GMP induces dramatic structural changes inMapZthat are crucial for CheR1 binding. Importantly, we found that restructuring and repositioning of two C-terminal helices enable MapZ to disrupt the CheR1 active site by dislodging a structural domain. The crystallographic observations are reinforced by protein-protein binding and single cell-based flagellar motor switching analyses. Our studies further suggest that the regulation of chemotaxis by c-di-GMP through MapZ orthologs/ homologs is widespread in proteobacteria and that the use of allosterically regulated C-terminal motifs could be a common mechanism for PilZ adaptor proteins. Together, the findings provide detailed structural insights into how c-di-GMP controls the activity of an enzyme target indirectly through a PilZ adaptor protein.	[Yan, Xin-Fu; Xin, Lingyi; Yen, Jackie Tan; Jin, Shengyang; Cheang, Qing Wei; Fong, Rachel Andrea Chea Yuen; Liang, Zhao-Xun; Gao, Yong-Gui] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Yan, Xin-Fu; Yen, Jackie Tan; Jin, Shengyang; Gao, Yong-Gui] Nanyang Technol Univ, NTU Inst Struct Biol, 59 Nanyang Dr, Singapore 639798, Singapore; [Zeng, Yukai; Chiam, Keng-Hwee] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01, S-138671 Singapore, Singapore; [Gao, Yong-Gui] ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liang, ZX; Gao, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Gao, YG (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, 59 Nanyang Dr, Singapore 639798, Singapore.; Gao, YG (corresponding author), ASTAR, Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	zxliang@ntu.edu.sg; ygao@ntu.edu.sg	Gao, Yonggui/A-9473-2015; Gao, Yong Gui/A-2187-2011; Liang, Zhao-Xun/A-2191-2011	Gao, Yonggui/0000-0001-7298-0835; Zeng, Yukai/0000-0003-1337-5912; Yan, Xin-Fu/0000-0001-6248-2349; Liang, Zhao-Xun/0000-0002-3128-1330	Ministry of Education of Singapore Tier I Grants [RG40/17, RG43/15]	Ministry of Education of Singapore Tier I Grants(Ministry of Education, Singapore)	This work was supported by Ministry of Education of Singapore Tier I Grants RG40/17 (to Z.-X. L.) and RG43/15 (to Y.-G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alicia TGG, 2016, LAB CHIP, V16, P368, DOI 10.1039/c5lc01137j; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Batra M, 2016, J STRUCT BIOL, V196, P364, DOI 10.1016/j.jsb.2016.08.005; Boriack-Sjodin PA, 2016, BIOCHEMISTRY-US, V55, P1557, DOI 10.1021/acs.biochem.5b01129; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Fujiwara T, 2013, BIOCHEM BIOPH RES CO, V431, P802, DOI 10.1016/j.bbrc.2012.12.103; Garcia-Fontana C, 2013, J BIOL CHEM, V288, P18987, DOI 10.1074/jbc.M113.472605; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ko J, 2010, J MOL BIOL, V398, P97, DOI 10.1016/j.jmb.2010.03.007; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liang ZX, 2015, NAT PROD REP, V32, P663, DOI 10.1039/c4np00086b; Long ZC, 2014, ANALYST, V139, P5254, DOI 10.1039/c4an00877d; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Qian C, 2013, APPL ENVIRON MICROB, V79, P4734, DOI 10.1128/AEM.01027-13; Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Schumacher MA, 2016, P NATL ACAD SCI USA, V113, P10067, DOI 10.1073/pnas.1607503113; Shin JS, 2011, PROTEIN SCI, V20, P270, DOI 10.1002/pro.557; Venkataramani P, 2017, METHODS MOL BIOL, V1657, P11, DOI 10.1007/978-1-4939-7240-1_2; Wang CJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002449; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Xu LH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7584; Xu LH, 2016, J BIOL CHEM, V291, P16112, DOI 10.1074/jbc.M116.730887	40	15	15	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					100	111		10.1074/jbc.M117.815704	http://dx.doi.org/10.1074/jbc.M117.815704			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29146598	hybrid, Green Published			2022-12-28	WOS:000419453200007
J	Erdogan, H; Vandemeulebroucke, A; Nauser, T; Bounds, PL; Koppenol, WH				Erdogan, Huriye; Vandemeulebroucke, An; Nauser, Thomas; Bounds, Patricia L.; Koppenol, Willem H.			Jumpstarting the cytochrome P450 catalytic cycle with a hydrated electron	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; electron transfer; isotope effect; kinetics; oxidation-reduction (redox)	PSEUDOMONAS-PUTIDA CYTOCHROME-P-450; COMPOUND-I FORMATION; KINETIC CHARACTERIZATION; HYDROGEN-PEROXIDE; P450CAM; HYDROXYLATION; CAMPHOR; ACTIVATION; REDUCTION; SUBSTRATE	Cytochrome P450cam (CYP101Fe(3+)) regioselectively hydroxylates camphor. Possible hydroxylating intermediates in the catalytic cycle of this well-characterized enzyme have been proposed on the basis of experiments carried out at very low temperatures and shunt reactions, but their presence has not yet been validated at temperatures above 0 degrees C during a normal catalytic cycle. Here, we demonstrate that it is possible to mimic the natural catalytic cycle of CYP101Fe(3+) by using pulse radiolysis to rapidly supply the second electron of the catalytic cycle to camphor-bound CYP101[FeO2](2+). Judging by the appearance of an absorbance maximum at 440 nm, we conclude that CYP101[FeOOH](2+) (compound 0) accumulates within 5 s and decays rapidly to CYP101Fe(3+), with a k(440 nm) of 9.6 x 10(4) s(-1). All processes are complete within 40 s at 4 degrees C. Importantly, no transient absorbance bands could be assigned to CYP101[FeO(2+)por(center dot+)] (compound 1) or CYP101[FeO2+] (compound 2). However, indirect evidence for the involvement of compound 1 was obtained from the kinetics of formation and decay of a tyrosyl radical. 5-Hydroxycamphor was formed quantitatively, and the catalytic activity of the enzyme was not impaired by exposure to radiation during the pulse radiolysis experiment. The rapid decay of compound 0 enabled calculation of the limits for the Gibbs activation energies for the conversions of compound 0 compound 1 compound 2 CYP101Fe(3+), yielding a G(double dagger) of 45, 39, and 39 kJ/mol, respectively. At 37 degrees C, the steps from compound 0 to the iron(III) state would take only 4 s. Our kinetics studies at 4 degrees C complement the canonical mechanism by adding the dimension of time.	[Erdogan, Huriye; Nauser, Thomas; Bounds, Patricia L.; Koppenol, Willem H.] Swiss Fed Inst Technol, Inst Inorgan, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Vandemeulebroucke, An] Swiss Fed Inst Technol, Inst Organ Chem, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland; [Erdogan, Huriye] Ilko Argem Biyoteknol Merkezi, Teknopk Istanbul,Sanayi Mah,Teknopk Bulvari, TR-34906 Pendik Istanbul, Turkey; [Vandemeulebroucke, An] F Hoffmann La Roche Ltd, Roche Pharma Res & Early Dev, Chem Biol, Grenzacherstr 124,065-210, CH-4070 Basel, Switzerland; [Bounds, Patricia L.] Fdn Res Informat Technol Soc, Zeughausstr 43, CH-8004 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Roche Holding	Koppenol, WH (corresponding author), Swiss Fed Inst Technol, Inst Inorgan, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.	koppenol@inorg.chem.ethz.ch	Erdogan, Huriye/AAV-7170-2020; Dagdas, Huriye Erdogan/AAH-6098-2019; Koppenol, Willem Hendrik/H-2991-2013	Erdogan, Huriye/0000-0003-0057-5579; Koppenol, Willem Hendrik/0000-0002-1620-6594	ETH Zurich [ETH-3810-3]	ETH Zurich(ETH Zurich)	This work was supported by the ETH Zurich, Grant ETH-3810-3. The authors declare that they have no conflicts of interest with the contents of this article.	ATKINS WM, 1988, BIOCHEMISTRY-US, V27, P1610, DOI 10.1021/bi00405a033; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BRAAMS R, 1966, RADIAT RES, V27, P319, DOI 10.2307/3571952; Collins D. P., 2010, HDB PORPHYRIN SCI, P299; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Davydov R, 2013, BIOCHEMISTRY-US, V52, P667, DOI 10.1021/bi301527c; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; de Visser SP, 2004, J AM CHEM SOC, V126, P8362, DOI 10.1021/ja048528h; DEBEY P, 1979, BIOCHEM BIOPH RES CO, V86, P953, DOI 10.1016/0006-291X(79)90210-9; Denisov I. G., 2015, CYTOCHROME P450 STRU, P69, DOI [10.1007/978-3-319-12108-6_3, DOI 10.1007/978-3-319-12108-6_3]; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Franke A, 2015, CHEM-EUR J, V21, P15201, DOI 10.1002/chem.201501886; GEORGE P, 1952, NATURE, V169, P612, DOI 10.1038/169612a0; GETOFF N, 1992, Amino Acids (Vienna), V2, P195, DOI 10.1007/BF00805942; GRIFFIN BW, 1972, BIOCHEMISTRY-US, V11, P4740, DOI 10.1021/bi00775a017; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Gunsalus I C, 1978, Methods Enzymol, V52, P166; Harada K, 2008, J AM CHEM SOC, V130, P432, DOI 10.1021/ja077902l; HASINOFF BB, 1985, BIOCHIM BIOPHYS ACTA, V829, P1, DOI 10.1016/0167-4838(85)90060-3; Hsieh CH, 2017, BIOCHEMISTRY-US, V56, P3347, DOI 10.1021/acs.biochem.7b00338; Kawakami N, 2015, J PORPHYR PHTHALOCYA, V19, P329, DOI 10.1142/S1088424615500145; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; KOBAYASHI K, 1987, J BIOL CHEM, V262, P5445; Koppenol WH, 2007, J AM CHEM SOC, V129, P9686, DOI 10.1021/ja071546p; Kuznetsov VY, 2006, BIOCHEMISTRY-US, V45, P11934, DOI 10.1021/bi0611154; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Mahmoudi L, 2016, BIOCHEMISTRY-US, V55, P2849, DOI 10.1021/acs.biochem.6b00019; Masoudian S, 2011, INDIAN J CHEM A, V50, P1002; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; PETERSON JA, 1972, ARCH BIOCHEM BIOPHYS, V149, P197, DOI 10.1016/0003-9861(72)90315-3; Plata RE, 2015, J AM CHEM SOC, V137, P3811, DOI 10.1021/ja5111392; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; Prasad B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061897; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; SCHULER RH, 1980, J PHYS CHEM-US, V84, P2088, DOI 10.1021/j100453a020; Schunemann V, 2000, FEBS LETT, V479, P149, DOI 10.1016/S0014-5793(00)01886-X; Shaik S, 2010, CHEM REV, V110, P949, DOI 10.1021/cr900121s; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Spolitak T, 2006, J INORG BIOCHEM, V100, P2034, DOI 10.1016/j.jinorgbio.2006.09.026; Vandemeulebroucke A, 2015, BIOCHEMISTRY-US, V54, P6692, DOI 10.1021/acs.biochem.5b00939; Yuan XT, 2009, BIOCHEMISTRY-US, V48, P9140, DOI 10.1021/bi901258m	43	8	8	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21481	21489		10.1074/jbc.M117.813683	http://dx.doi.org/10.1074/jbc.M117.813683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109145	Green Published, hybrid			2022-12-28	WOS:000419013000023
J	Castro-Fernandez, V; Herrera-Morande, A; Zamora, R; Merino, F; Gonzalez-Ordenes, F; Padilla-Salinas, F; Pereira, HM; Brandao-Neto, J; Garratt, RC; Guixe, V				Castro-Fernandez, Victor; Herrera-Morande, Alejandra; Zamora, Ricardo; Merino, Felipe; Gonzalez-Ordenes, Felipe; Padilla-Salinas, Felipe; Pereira, Humberto M.; Brandao-Neto, Jose; Garratt, Richard C.; Guixe, Victoria			Reconstructed ancestral enzymes reveal that negative selection drove the evolution of substrate specificity in ADP-dependent kinases (vol 292, pg 15598, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Zamora, Ricardo A/O-8717-2018	Zamora, Ricardo A/0000-0002-7707-7482				Castro-Fernandez V, 2017, J BIOL CHEM, V292, P15598, DOI 10.1074/jbc.M117.790865	1	3	3	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21218	21218		10.1074/jbc.AAC117.001147	http://dx.doi.org/10.1074/jbc.AAC117.001147			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29273585	Green Published, hybrid			2022-12-28	WOS:000418453400036
J	Dumas, S; Ntambi, JM				Dumas, Sabrina; Ntambi, James M.			Co-conspirators in a new mechanism for the degradation of 9-desaturase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							PROTECTS MICE; DEPENDENT DEGRADATION	9-Desaturases are central enzymes in unsaturated fatty acid synthesis regulated at the transcriptional and mRNA levels and by proteasomal degradation. A new study by Murakami et al. uncovers a novel regulatory pathway in which an N-terminal di-proline motif in the Drosophila 9-desaturase mediates protein degradation by a calcium-dependent cysteine protease in response to unsaturated fatty acids. This study provides new details of desaturase regulation with therapeutic implications for the treatment of metabolic syndrome.	[Dumas, Sabrina; Ntambi, James M.] Univ Wisconsin Madison, Dept Nutr Sci, Madison, WI 53706 USA; [Ntambi, James M.] Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ntambi, JM (corresponding author), Univ Wisconsin Madison, Dept Nutr Sci, Madison, WI 53706 USA.; Ntambi, JM (corresponding author), Univ Wisconsin Madison, Dept Biochem, Madison, WI 53706 USA.	james.ntambi@wisc.edu			National Institutes of Health [R01 DK062388]; American Diabetes Association [DA 7-13-BS-540 118]; U.S. Department of Agriculture Hatch grants [W2005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); U.S. Department of Agriculture Hatch grants; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Critical reading and helpful comments on the manuscript by the members of the Ntambi laboratory are greatly appreciated. The stearoyl-CoA desaturase work in the Ntambi laboratory has been supported by National Institutes of Health Grant R01 DK062388, American Diabetes Association Grant DA 7-13-BS-540 118, and U.S. Department of Agriculture Hatch W2005 grants (to J.M.N.).	Gonzalez CI, 1996, J BIOL CHEM, V271, P25801, DOI 10.1074/jbc.271.42.25801; Kato H, 2006, J CELL SCI, V119, P2342, DOI 10.1242/jcs.02951; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Murakami A, 2017, J BIOL CHEM, V292, P19976, DOI 10.1074/jbc.M117.801936; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Saez ME, 2006, DRUG DISCOV TODAY, V11, P917, DOI 10.1016/j.drudis.2006.08.009; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Shen LR, 2010, J LIPID RES, V51, P2985, DOI 10.1194/jlr.M008524; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12	10	1	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19987	19988		10.1074/jbc.H117.801936	http://dx.doi.org/10.1074/jbc.H117.801936			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29222194	Green Published, hybrid			2022-12-28	WOS:000417696400005
J	Marmont, LS; Whitfield, GB; Rich, JD; Yip, P; Giesbrecht, LB; Stremick, CA; Whitney, JC; Parsek, MR; Harrison, JJ; Howell, PL				Marmont, Lindsey S.; Whitfield, Gregory B.; Rich, Jacquelyn D.; Yip, Patrick; Giesbrecht, Laura B.; Stremick, Carol A.; Whitney, John C.; Parsek, Matthew R.; Harrison, Joe J.; Howell, P. Lynne			PelA and PelB proteins form a modification and secretion complex essential for Pel polysaccharide-dependent biofilm formation in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofilm; polysaccharide; protein-protein interaction; Pseudomonas aeruginosa (P; aeruginosa); X-ray crystallography	GRAM-NEGATIVE BACTERIA; STRUCTURAL BASIS; OUTER-MEMBRANE; ALGINATE; EXOPOLYSACCHARIDE; COMPONENT; SYSTEM; MATRIX; PA14; PSL	The pellicle (PEL) polysaccharide is synthesized by the opportunistic pathogen Pseudomonas aeruginosa and is an important biofilm constituent critical for bacterial virulence and persistence. PEL is a cationic polymer that promotes cell-cell interactions within the biofilm matrix through electrostatic interactions with extracellular DNA. Translocation of PEL across the outer membrane is proposed to occur via PelB, a membrane-embedded porin with a large periplasmic domain predicted to contain 19 tetratricopeptide repeats (TPRs). TPR-containing domains are typically involved in protein-protein interactions, and we therefore sought to determine whether PelB serves as a periplasmic scaffold that recruits other components of the PEL secretion apparatus. In this study, we show that the TPR domain of PelB interacts with PelA, an enzyme with PEL deacetylase and hydrolase activities. Structure determination of PelB TPRs 8-11 enabled us to design systematic deletions of individual TPRs and revealed that repeats 9-14, which are required for the cellular localization of PelA with PelB are also essential for PEL-dependent biofilm formation. Copurification experiments indicated that the interaction between PelA and PelB is direct and that the deacetylase activity of PelA increases and its hydrolase activity decreases when these proteins interact. Combined, our results indicate that the TPR-containing domain of PelB localizes PelA to the PEL secretion apparatus within the periplasm and that this may allow for efficient deacetylation of PEL before its export from the cell.	[Marmont, Lindsey S.; Whitfield, Gregory B.; Yip, Patrick; Giesbrecht, Laura B.; Whitney, John C.; Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada; [Marmont, Lindsey S.; Whitfield, Gregory B.; Whitney, John C.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rich, Jacquelyn D.; Stremick, Carol A.; Harrison, Joe J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Calgary; University of Washington; University of Washington Seattle	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Med, Toronto, ON M5G 0A4, Canada.; Howell, PL (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	howell@sickkids.ca	Harrison, Joe/AAV-6071-2021	Harrison, Joe/0000-0003-0368-9539	Canadian Institutes of Health Research [43998]; National Institute of Health [2R01AI077628]; Natural Sciences and Engineering Research Council (NSERC); NSERC Canada graduate scholarship; Ontario Graduate Scholarship Program; Cystic Fibrosis Canada; Canada Research Chair; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077628] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada graduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); Cystic Fibrosis Canada; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Canadian Institutes of Health Research Grant 43998 (to P. L. H.), National Institute of Health Grant 2R01AI077628 (to M. R. P.), and a Natural Sciences and Engineering Research Council (NSERC) Grant (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an NSERC Canada graduate scholarship and the Ontario Graduate Scholarship Program.; Supported by an NSERC Canada graduate scholarship and a graduate scholarship from Cystic Fibrosis Canada.; Recipient of a Canada Research Chair.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Almblad H, 2015, J BACTERIOL, V197, P2190, DOI 10.1128/JB.00193-15; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Baker P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501632; BERRY A, 1989, J BACTERIOL, V171, P2312, DOI 10.1128/jb.171.5.2312-2317.1989; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Green MR, 2012, MOL CLONING LAB MANU, V1; Hmelo LR, 2015, NAT PROTOC, V10, P1820, DOI 10.1038/nprot.2015.115; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Job V, 2010, J BIOL CHEM, V285, P23222, DOI 10.1074/jbc.M110.111278; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khakimova M, 2013, J BACTERIOL, V195, P2011, DOI 10.1128/JB.02061-12; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Marmont LS, 2017, P NATL ACAD SCI USA, V114, P2892, DOI 10.1073/pnas.1613606114; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Moradali MF, 2015, MBIO, V6, DOI 10.1128/mBio.00453-15; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rehman ZU, 2013, APPL ENVIRON MICROB, V79, P3264, DOI 10.1128/AEM.00460-13; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Wang Y, 2016, J BIOL CHEM, V291, P10046, DOI 10.1074/jbc.M115.711762; Whitney JC, 2011, P NATL ACAD SCI USA, V108, P13083, DOI 10.1073/pnas.1104984108; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	46	24	27	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19411	19422		10.1074/jbc.M117.812842	http://dx.doi.org/10.1074/jbc.M117.812842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972168	hybrid, Green Published			2022-12-28	WOS:000416226700022
J	Meng, H; Bartholomew, B				Meng, Huan; Bartholomew, Blaine			Emerging roles of transcriptional enhancers in chromatin looping and promoter-proximal pausing of RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						chromatin; chromatin modification; chromatin regulation; gene transcription; nuclear organization; transcription enhancer	LOCUS-CONTROL REGION; BETA-GLOBIN LOCUS; GENE-EXPRESSION; SUPER-ENHANCERS; U1 SNRNP; IN-VIVO; INTERGENIC TRANSCRIPTION; ANDROGEN RECEPTOR; ACTIVE CHROMATIN; CELL IDENTITY	Initiation and regulation of transcription by RNA polymerase II (RNAPII) in eukaryotes rely on the transcriptional regulatory elements. Promoters and enhancers share similar architectures and functions, and the prevailing view is that they can initiate bidirectional transcription. We summarize functional roles of enhancer transcription and possible mechanisms in enhancer-promoter communication. We discuss the potential roles of enhancer RNAs (eRNAs) in early elongation and highlight that transcriptional enhancers might modulate the release of paused RNAPII via 3D chromatin looping. Emerging evidence suggests that transcriptional enhancers regulate the promoter-proximal pausing of RNAPII, a key rate-limiting step required for productive elongation.	[Meng, Huan; Bartholomew, Blaine] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Bartholomew, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.; Meng, H (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	huan.meng@bcm.edu; bbartholomew@mdanderson.org	Meng, Huan/AAT-4986-2021; Meng, Huan/ABC-8895-2021	Meng, Huan/0000-0001-6698-7918; 	National Institutes of Health R01 Grant [048413]	National Institutes of Health R01 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health R01 Grant 048413 (to B. B.). This is the second article in the Thematic Minireview series "Chromatin and Transcription." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Akbari OS, 2008, DEVELOPMENT, V135, P123, DOI 10.1242/dev.010744; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Andersson R, 2015, MOL CELL, V60, P346, DOI 10.1016/j.molcel.2015.10.015; Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Arner E, 2015, SCIENCE, V347, P1010, DOI 10.1126/science.1259418; Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Baptista T, 2018, MOL CELL, V70, P1163, DOI 10.1016/j.molcel.2018.06.007; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jonkers I, 2015, NAT REV MOL CELL BIO, V16, P167, DOI 10.1038/nrm3953; Joshi O, 2015, CELL STEM CELL, V17, P748, DOI 10.1016/j.stem.2015.11.010; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kaplan CD, 2016, NAT GENET, V48, P975, DOI 10.1038/ng.3649; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Masternak K, 2003, NAT IMMUNOL, V4, P132, DOI 10.1038/ni883; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mohibullah N, 2008, GENE DEV, V22, P2994, DOI 10.1101/gad.1724408; MOREAU P, 1981, NUCLEIC ACIDS RES, V9, P6047, DOI 10.1093/nar/9.22.6047; Mousavi K, 2013, MOL CELL, V51, P606, DOI 10.1016/j.molcel.2013.07.022; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Paralkar VR, 2016, MOL CELL, V62, P104, DOI 10.1016/j.molcel.2016.02.029; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Routledge SJE, 2002, J MOL BIOL, V323, P601, DOI 10.1016/S0022-2836(02)01011-2; Roux BT, 2017, METHODS MOL BIOL, V1468, P11, DOI 10.1007/978-1-4939-4035-6_2; Schaukowitch K, 2014, MOL CELL, V56, P29, DOI 10.1016/j.molcel.2014.08.023; Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; SERFLING E, 1985, EMBO J, V4, P3851, DOI 10.1002/j.1460-2075.1985.tb04157.x; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Vucicevic D, 2015, CELL CYCLE, V14, P253, DOI 10.4161/15384101.2014.977641; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Warfield L, 2017, MOL CELL, V68, P118, DOI 10.1016/j.molcel.2017.08.014; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xiang JF, 2014, CELL RES, V24, P513, DOI 10.1038/cr.2014.35; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	91	24	24	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13786	13794		10.1074/jbc.R117.813485	http://dx.doi.org/10.1074/jbc.R117.813485			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29187597	hybrid, Green Published			2022-12-28	WOS:000444070700004
J	Thorburn, A				Thorburn, Andrew			Autophagy and disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ADVANCED SOLID TUMORS; PHASE-I TRIAL; CELL-DEATH; MITOCHONDRIAL APOPTOSIS; GLUCOSE-HOMEOSTASIS; RECENT INSIGHTS; DISTINCT ROLES; HYDROXYCHLOROQUINE; INHIBITION; PROTEIN	As outlined in the accompanying Minireviews, autophagy is a complicated and highly regulated process that delivers cellular material to lysosomes for degrading, recycling, and generating molecules that fuel cellular metabolism. Autophagy is important for normal cellular and organismal physiology, and both increased and decreased autophagy has been associated with disease. Importantly, these connections are already being exploited to treat patients with dozens of clinical trials that aim to manipulate autophagy to treat (or prevent) disease. This Minireview discusses some of the important issues and problems to be solved if these efforts are to be successful.	[Thorburn, Andrew] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Thorburn, A (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	andrew.thorburn@ucdenver.edu			National Institutes of Health from NCI [CA150925, CA190170, CA197887]; NATIONAL CANCER INSTITUTE [R21CA197887, R01CA190170, R01CA150925] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA150925, CA190170, and CA197887 from NCI. This is the fifth article in the Thematic Minireview series "Autophagy." The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amaravadi R, 2016, GENE DEV, V30, P1913, DOI 10.1101/gad.287524.116; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Chen S, 2016, GENE DEV, V30, P856, DOI 10.1101/gad.276428.115; Cuervo AM, 2014, CELL RES, V24, P92, DOI 10.1038/cr.2013.153; DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472; Delorme-Axford E, 2018, J BIOL CHEM, V293, P5396, DOI 10.1074/jbc.R117.804641; Deretic V, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018481; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fitzwalter BE, 2015, FEBS J, V282, P4279, DOI 10.1111/febs.13515; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Katheder NS, 2017, NATURE, V541, P417, DOI 10.1038/nature20815; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraya AA, 2015, AUTOPHAGY, V11, P60, DOI 10.4161/15548627.2014.984273; Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652; Ladoire S, 2012, AUTOPHAGY, V8, P1175, DOI 10.4161/auto.20353; Lee IH, 2012, SCIENCE, V336, P225, DOI 10.1126/science.1218395; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2015, J CLIN INVEST, V125, P14, DOI 10.1172/JCI73938; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Levy JMM, 2017, ELIFE, V6, DOI 10.7554/eLife.19671; Levy JMM, 2014, CANCER DISCOV, V4, P773, DOI 10.1158/2159-8290.CD-14-0049; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Lock R, 2014, CANCER DISCOV, V4, P466, DOI 10.1158/2159-8290.CD-13-0841; Mahalingam D, 2014, AUTOPHAGY, V10, P1403, DOI 10.4161/auto.29231; Marino G, 2014, AUTOPHAGY, V10, P1879, DOI 10.4161/auto.36413; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Maskey D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3130; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Rosenfeldt MT, 2012, AUTOPHAGY, V8, P963, DOI 10.4161/auto.20186; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Rubinsztein DC, 2015, J EXP MED, V212, P979, DOI 10.1084/jem.20150956; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Thorburn A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001967; Thorburn J, 2009, CELL DEATH DIFFER, V16, P175, DOI 10.1038/cdd.2008.143; Thorburn J, 2014, CELL REP, V7, P45, DOI 10.1016/j.celrep.2014.02.036; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Towers CG, 2016, EBIOMEDICINE, V14, P15, DOI 10.1016/j.ebiom.2016.10.034; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	72	52	58	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5425	5430		10.1074/jbc.R117.810739	http://dx.doi.org/10.1074/jbc.R117.810739			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29191833	Green Published, hybrid			2022-12-28	WOS:000430044100007
J	Tanaka, T; Zhou, Y; Ozawa, T; Okizono, R; Banba, A; Yamamura, T; Oga, E; Muraguchi, A; Sakurai, H				Tanaka, Tomohiro; Zhou, Yue; Ozawa, Tatsuhiko; Okizono, Ryuya; Banba, Ayako; Yamamura, Tomohiro; Oga, Eiji; Muraguchi, Atsushi; Sakurai, Hiroaki			Ligand-activated epidermal growth factor receptor (EGFR) signaling governs endocytic trafficking of unliganded receptor monomers by non-canonical phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; DOWN-REGULATION; FACTOR-ALPHA; CANCER; STRESS; DOMAIN; INTERNALIZATION; UBIQUITINATION; SUPPRESSION; MECHANISM	The canonical description of transmembrane receptor function is initial binding of ligand, followed by initiation of intracellular signaling and then internalization en route to degradation or recycling to the cell surface. It is known that low concentrations of extracellular ligand lead to a higher proportion of receptor that is recycled and that non-canonical mechanisms of receptor activation, including phosphorylation by the kinase p38, can induce internalization and recycling. However, no connections have been made between these pathways; i.e. it has yet to be established what happens to unbound receptors following stimulation with ligand. Here we demonstrate that a minimal level of activation of epidermal growth factor receptor (EGFR) tyrosine kinase by low levels of ligand is sufficient to fully activate downstream mitogen-activated protein kinase (MAPK) pathways, with most of the remaining unbound EGFR molecules being efficiently phosphorylated at intracellular serine/threonine residues by activated mitogen-activated protein kinase. This non-canonical, p38-mediated phosphorylation of the C-tail of EGFR, near Ser-1015, induces the clathrin-mediated endocytosis of the unliganded EGFR monomers, which occurs slightly later than the canonical endocytosis of ligand-bound EGFR dimers via tyrosine autophosphorylation. EGFR endocytosed via the non-canonical pathway is largely recycled back to the plasma membrane as functional receptors, whereas p38-independent populations are mainly sorted for lysosomal degradation. Moreover, ligand concentrations balance these endocytic trafficking pathways. These results demonstrate that ligand-activated EGFR signaling controls unliganded receptors through feedback phosphorylation, identifying a dual-mode regulation of the endocytic trafficking dynamics of EGFR.	[Tanaka, Tomohiro; Zhou, Yue; Okizono, Ryuya; Banba, Ayako; Yamamura, Tomohiro; Oga, Eiji; Muraguchi, Atsushi; Sakurai, Hiroaki] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, 2630 Sugitani, Toyama 9300194, Japan; [Ozawa, Tatsuhiko; Muraguchi, Atsushi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Immunol, Toyama 9300194, Japan; [Zhou, Yue] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, MOE Key Lab Standardizat Chinese Med, Shanghai 201203, Peoples R China; [Zhou, Yue] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai Key Lab Compound Chinese Med, Shanghai 201203, Peoples R China	University of Toyama; University of Toyama; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Sakurai, H (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Canc Cell Biol, 2630 Sugitani, Toyama 9300194, Japan.	hsakurai@pha.u-toyama.ac.jp	Sakurai, Hiroaki/AAE-4294-2019	Ozawa, Tatsuhiko/0000-0002-3112-452X; Zhou, Yue/0000-0002-1335-5703; Sakurai, Hiroaki/0000-0003-0657-9570	JSPS KAKENHI [JP16H04694]; JSPS; Japan Agency for Medical Research and Development	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by JSPS KAKENHI Grant JP16H04694, JSPS Core-to-Core Program, B. Asia-Africa Science Platforms, and the Platform Project for Supporting Drug Discovery and Life Science Research from the Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; COUNTAWAY JL, 1992, J BIOL CHEM, V267, P1129; Francavilla C, 2016, NAT STRUCT MOL BIOL, V23, P608, DOI 10.1038/nsmb.3218; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goh LK, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017459; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Henriksen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058148; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Ozawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052383; Parachoniak CA, 2012, TRENDS CELL BIOL, V22, P231, DOI 10.1016/j.tcb.2012.02.002; Refaat A, 2015, BIOCHEM BIOPH RES CO, V458, P856, DOI 10.1016/j.bbrc.2015.02.044; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; Sato K, 2013, CANCER SCI, V104, P1315, DOI 10.1111/cas.12225; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Sun QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012819; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; THEROUX SJ, 1992, J BIOL CHEM, V267, P16620; Tomas A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8324; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Uyemura T, 2005, BIOPHYS J, V88, P3720, DOI 10.1529/biophysj.104.053330; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; WILEY HS, 1991, J BIOL CHEM, V266, P11083; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhou Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8679; Zhou Y, 2014, FEBS LETT, V588, P131, DOI 10.1016/j.febslet.2013.11.020; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	44	27	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2288	2301		10.1074/jbc.M117.811299	http://dx.doi.org/10.1074/jbc.M117.811299			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29255092	Green Published, hybrid			2022-12-28	WOS:000425308300005
J	Zou, L; Linck, V; Zhai, YJ; Galarza-Paez, L; Li, LD; Yue, Q; Al-Khalili, O; Bao, HF; Ma, HP; Thai, TL; Jiao, JD; Eaton, DC				Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Jiao, Jundong; Eaton, Douglas C.			Knockout of mitochondrial voltage-dependent anion channel type 3 increases reactive oxygen species (ROS) levels and alters renal sodium transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); hypertension; mitochondria; reactive oxygen species (ROS); voltage-dependent anion channel (VDAC); VDAC3-knockout mice; dietary salt	INTERMEMBRANE SPACE; ENAC ACTIVITY; HYPERTENSION; RELEASE; MECHANISMS; SUBUNIT; MUSCLES; DAMAGE; CELLS; VDAC3	It has been suggested that voltage-dependent anion channels (VDACs) control the release of superoxide from mitochondria. We have previously shown that reactive oxygen species (ROS) such as superoxide (O2.) and hydrogen peroxide (H2O2) stimulate epithelial sodium channels (ENaCs) in sodium-transporting epithelial tissue, including cortical collecting duct (CCD) principal cells. Therefore, we hypothesized that VDACs could regulate ENaC by modulating cytosolic ROS levels. Herein, we find that VDAC3-knockout(KO) mice can maintain normal salt and water balance on low-salt and high-salt diets. However, on a high-salt diet for 2 weeks, VDAC3-KO mice had significantly higher systolic blood pressure than wildtype mice. Consistent with this observation, after a high-salt diet for 2 weeks, ENaC activity in VDAC3-KO mice was significantly higher than wildtype mice. EM analysis disclosed a significant morphological change of mitochondria in the CCD cells of VDAC3-KO mice compared with wildtype mice, which may have been caused by mitochondrial superoxide overload. Of note, compared with wildtype animals, ROS levels in VDAC3-KO animals fed a normal or high-salt diet were consistently and significantly increased in renal tubules. Both the ROS scavenger 1-oxyl-2,2,6,6-tetramethyl-4-hydroxypiperidine (TEMPOL) and the mitochondrial ROS scavenger (2-(2,2,6,6-tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl)triphenylphosphonium chloride (mito-TEMPO) could reverse the effect of high-salt on ENaC activity and systolic blood pressure in the VDAC3-KO mice. Mito-TEMPO partially correct the morphological changes in VDAC3-KO mice. Our results suggest that knocking out mitochondrial VDAC3 increases ROS, alters renal sodium transport, and leads to hypertension.	[Zou, Li; Jiao, Jundong] Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China; [Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Zou, Li; Linck, Valerie; Zhai, Yu-Jia; Galarza-Paez, Laura; Li, Linda; Yue, Qiang; Al-Khalili, Otor; Bao, Hui-Fang; Ma, He-Ping; Thai, Tiffany L.; Eaton, Douglas C.] Emory Univ, Sch Med, Ctr Cell & Mol Signaling, Atlanta, GA 30322 USA; [Jiao, Jundong] Harbin Med Univ, Inst Nephrol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Emory University; Emory University; Harbin Medical University	Jiao, JD (corresponding author), Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Heilongjiang, Peoples R China.; Eaton, DC (corresponding author), Whitehead Biomed Res Bldg,615 Michael St, Atlanta, GA 30322 USA.	jiaojundong@163.com; deaton@emory.edu		Linck, Valerie/0000-0001-8029-3461	National Institutes of Health [R37DK037963, R01-DK100582]; Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC); Emory College of Arts and Sciences; Emory University School of Medicine; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000454, S10 RR025679]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR002378] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK037963, R25DK101390, R01DK100582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC); Emory College of Arts and Sciences; Emory University School of Medicine; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R37DK037963 (to D. C. E.) and R01-DK100582 (to H.-P. M.), in part by the Robert P. Apkarian Integrated Electron Microscopy Core (RPAIEMC), which is subsidized by the Emory College of Arts and Sciences and the Emory University School of Medicine and is one of the Emory Integrated Core Facilities, and National Center for Advancing Translational Sciences, National Institutes of Health Grants UL1TR000454 and S10 RR025679. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Amodeo GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103879; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Anflous-Pharayra K, 2011, BBA-BIOENERGETICS, V1807, P150, DOI 10.1016/j.bbabio.2010.09.007; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; Downs CA, 2015, AM J PHYSIOL-LUNG C, V308, pL943, DOI 10.1152/ajplung.00213.2014; Downs CA, 2013, AM J PHYSIOL-LUNG C, V305, pL595, DOI 10.1152/ajplung.00212.2013; Downs CA, 2013, J BIOL CHEM, V288, P8136, DOI 10.1074/jbc.M112.389536; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Helms MN, 2008, J BIOL CHEM, V283, P22875, DOI 10.1074/jbc.M801363200; Herrmann JM, 2010, ANTIOXID REDOX SIGN, V13, P1341, DOI 10.1089/ars.2009.3063; Imaizumi Y, 2016, J CLIN HYPERTENS, V18, P315, DOI 10.1111/jch.12668; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Ling BN, 1997, J BIOL CHEM, V272, P594; Loperena R, 2017, MED CLIN N AM, V101, P169, DOI 10.1016/j.mcna.2016.08.004; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Mironova Elena, 2013, Methods Mol Biol, V998, P341, DOI 10.1007/978-1-62703-351-0_27; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Nistala R, 2008, ANTIOXID REDOX SIGN, V10, P2047, DOI 10.1089/ars.2008.2034; Owusu-Ansah E., 2008, RES SQ; Pagano A, 2004, AM J PHYSIOL-LUNG C, V286, pL275, DOI 10.1152/ajplung.00181.2003; Reina S, 2016, ONCOTARGET, V7, P2249, DOI 10.18632/oncotarget.6850; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Thai TL, 2015, J BIOL CHEM, V290, P28805, DOI 10.1074/jbc.M115.668293; Uetake Y, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0002-9; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	35	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1666	1675		10.1074/jbc.M117.798645	http://dx.doi.org/10.1074/jbc.M117.798645			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29180450	Green Published, hybrid			2022-12-28	WOS:000424201700018
J	Kim, J; Fukuto, HS; Brown, DA; Bliska, JB; London, E				Kim, JiHyun; Fukuto, Hana S.; Brown, Deborah A.; Bliska, James B.; London, Erwin			Effects of host cell sterol composition upon internalization of Yersinia pseudotuberculosis and clustered beta 1 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial adhesion; cholesterol; endocytosis; integrin; sterol; YadA; adhesins; bacterial internalization; invasin; sterol substitution	LIPID RAFTS; EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; CAMPYLOBACTER-JEJUNI; INVASIN EXPRESSION; PERFRINGOLYSIN-O; MAMMALIAN-CELLS; DOMAINS RAFTS; III SECRETION; CHOLESTEROL	Yersinia pseudotuberculosis is a foodborne pathogenic bacterium that causes acute gastrointestinal illness, but its mechanisms of infection are incompletely described. We examined how host cell sterol composition affected Y. pseudotuberculosis uptake. To do this, we depleted or substituted cholesterol in human MDA-MB-231 epithelial cells with various alternative sterols. Decreasing host cell cholesterol significantly reduced pathogen internalization. When host cell cholesterol was substituted with various sterols, only desmosterol and 7-dehydrocholesterol supported internalization. This specificity was not due to sterol dependence of bacterial attachment to host cells, which was similar with all sterols studied. Because a key step in Y. pseudotuberculosis internalization is interaction of the bacterial adhesins invasin and YadA with host cell 1 integrin, we compared the sterol dependence of wildtype Y. pseudotuberculosis internalization with that of inv, yadA, and invyadA mutant strains. YadA deletion decreased bacterial adherence to host cells, whereas invasin deletion had no effect. Nevertheless, host cell sterol substitution had a similar effect on internalization of these bacterial deletion strains as on the wildtype bacteria. The invyadA double mutant adhered least to cells and so was not significantly internalized. The sterol structure dependence of Y. pseudotuberculosis internalization differed from that of endocytosis, as monitored using antibody-clustered 1 integrin and previous studies on other proteins, which had a more permissive sterol dependence. This study suggests that agents could be designed to interfere with internalization of Yersinia without disturbing endocytosis.	[Kim, JiHyun; Brown, Deborah A.; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Fukuto, Hana S.; Bliska, James B.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Fukuto, Hana S.; Bliska, James B.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	erwin.london@stonybrook.edu		Bliska, James/0000-0002-6047-8837	National Institutes of Health [GM 122493, AI099222]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122493] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM 122493 (to E. L.) and AI099222 (to J. B. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amphlett A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv202; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x; BLISKA JB, 1993, INFECT IMMUN, V61, P3914, DOI 10.1128/IAI.61.9.3914-3921.1993; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Campbell SM, 2001, J CLIN VIROL, V22, P217, DOI 10.1016/S1386-6532(01)00193-7; Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342; Chakravarti B, 2012, ADV EXP MED BIOL, V740, P103, DOI 10.1007/978-94-007-2888-2_5; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Clemente R, 2009, J VIROL, V83, P2655, DOI 10.1128/JVI.02206-08; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; COVER TL, 1989, NEW ENGL J MED, V321, P16, DOI 10.1056/NEJM198907063210104; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; Davis W, 2011, BBA-MOL CELL BIOL L, V1811, P1152, DOI 10.1016/j.bbalip.2011.07.010; Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Durand EA, 2010, CELL MICROBIOL, V12, P1064, DOI 10.1111/j.1462-5822.2010.01451.x; Eberhart GP, 1998, J CLIN ENDOCR METAB, V83, P836, DOI 10.1210/jc.83.3.836; Eitel J, 2002, INFECT IMMUN, V70, P4880, DOI 10.1128/IAI.70.9.4880-4891.2002; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Gimpl G, 1997, BIOCHEMISTRY-US, V36, P10959, DOI 10.1021/bi963138w; Grabenstein JP, 2004, INFECT IMMUN, V72, P4973, DOI 10.1128/IAI.72.9.4973-4984.2004; Grassl GA, 2003, INT J MED MICROBIOL, V293, P41, DOI 10.1078/1438-4221-00243; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hudson KJ, 2005, CELL MICROBIOL, V7, P1474, DOI 10.1111/j.1462-5822.2005.00571.x; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Isberg RR, 2000, MICROBES INFECT, V2, P793, DOI 10.1016/S1286-4579(00)90364-2; Jafurulla M, 2014, BBA-BIOMEMBRANES, V1838, P158, DOI 10.1016/j.bbamem.2013.08.015; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KAPPERUD G, 1987, INFECT IMMUN, V55, P2247, DOI 10.1128/IAI.55.9.2247-2254.1987; Kim J, 2017, J CELL SCI, V130, P2682, DOI 10.1242/jcs.201731; KONKEL ME, 1992, MICROB PATHOGENESIS, V13, P357, DOI 10.1016/0882-4010(92)90079-4; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lauer S, 2000, EMBO J, V19, P3556, DOI 10.1093/emboj/19.14.3556; Lin QQ, 2013, BIOPHYS J, V105, P2733, DOI 10.1016/j.bpj.2013.11.002; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; Mikula KM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00169; Nagel G, 2001, MOL MICROBIOL, V41, P1249, DOI 10.1046/j.1365-2958.2001.02522.x; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Palmer LE, 1998, MOL MICROBIOL, V27, P953, DOI 10.1046/j.1365-2958.1998.00740.x; Pankov R, 2005, ARCH BIOCHEM BIOPHYS, V442, P160, DOI 10.1016/j.abb.2005.08.003; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Revell PA, 2000, MOL MICROBIOL, V35, P677, DOI 10.1046/j.1365-2958.2000.01740.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Romanenko VG, 2009, AM J PHYSIOL-CELL PH, V296, pC878, DOI 10.1152/ajpcell.00438.2008; Ryndak MB, 2005, INFECT IMMUN, V73, P2433, DOI 10.1128/IAI.73.4.2433-2443.2005; Sato Y, 2006, J MICROBIOL, V44, P98; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; SIMONET M, 1992, INFECT IMMUN, V60, P4414, DOI 10.1128/IAI.60.10.4414-4417.1992; Vainio S, 2006, J BIOL CHEM, V281, P348, DOI 10.1074/jbc.M509530200; VANNHIEU GT, 1993, EMBO J, V12, P1887, DOI 10.1002/j.1460-2075.1993.tb05837.x; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Vieira FS, 2010, BIOL CELL, V102, P391, DOI 10.1042/BC20090138; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Zaas DW, 2005, BBA-MOL CELL RES, V1746, P305, DOI 10.1016/j.bbamcr.2005.10.003; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127; Zerenturk EJ, 2013, PROG LIPID RES, V52, P666, DOI 10.1016/j.plipres.2013.09.002; Zhang Y, 2011, INFECT IMMUN, V79, P4322, DOI 10.1128/IAI.05396-11; Zwerger M, 2010, MOL BIOL CELL, V21, P354, DOI 10.1091/mbc.E09-08-0739	69	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1466	1479		10.1074/jbc.M117.811224	http://dx.doi.org/10.1074/jbc.M117.811224			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29197826	Green Published, hybrid			2022-12-28	WOS:000423515000030
J	Huang, T; Mathieu, M; Lee, S; Wang, XH; Kee, YS; Bevers, JJ; Ciferri, C; Estavez, A; Wong, MD; Chiang, NY; Nakamura, G; Brezski, RJ				Huang, Tao; Mathieu, Mary; Lee, Sophia; Wang, Xinhua; Kee, Yee Seir; Bevers, Jack J., III; Ciferri, Claudio; Estavez, Alberto; Wong, Manda; Chiang, Nancy Y.; Nakamura, Gerald; Brezski, Randall J.			Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTICALLY-INACTIVATED IGGS; TUMOR-NECROSIS-FACTOR; IN-VITRO; THERAPEUTIC ANTIBODIES; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; EFFECTOR FUNCTION; GLOBULIN FACTORS; HOST IMMUNITY; RECEPTOR 1	Anti-hinge antibodies (AHAs) are an autoantibody subclass that, following proteolytic cleavage, recognize cryptic epitopes exposed in the hinge regions of immunoglobulins (Igs) and do not bind to the intact Ig counterpart. AHAs have been postulated to exacerbate chronic inflammatory disorders such as inflammatory bowel disease and rheumatoid arthritis. On the other hand, AHAs may protect against invasive microbial pathogens and cancer. However, despite more than 50 years of study, the origin and specific B cell compartments that express AHAs remain elusive. Recent research on serum AHAs suggests that they arise during an active immune response, in contrast to previous proposals that they derive from the preexisting immune repertoire in the absence of antigenic stimuli. We report here the isolation and characterization of AHAs from memory B cells, although anti-hinge-reactive B cells were also detected in the naive B cell compartment. IgG AHAs cloned from a single human donor exhibited restricted specificity for proteasecleaved F(ab')2 fragments and did not bind the intact IgG counterpart. The cloned IgG-specific AHA-variable regions were mutated from germ line-derived sequences and displayed a high sequence variability, confirming that these AHAs underwent class-switch recombination and somatic hypermutation. Consistent with previous studies of serum AHAs, several of these clones recognized a linear, peptide-like epitope, but one clone was unique in recognizing a conformational epitope. All cloned AHAs could restore immune effector functions to proteolytically generated F(ab') 2 fragments. Our results confirm that a diverse set of epitope-specific AHAs can be isolated from a single human donor.	[Huang, Tao; Mathieu, Mary; Lee, Sophia; Wang, Xinhua; Kee, Yee Seir; Bevers, Jack J., III; Chiang, Nancy Y.; Nakamura, Gerald; Brezski, Randall J.] Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA; [Ciferri, Claudio; Estavez, Alberto; Wong, Manda] Genentech Inc, Struct Biol Dept, CryoEM Unit, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Brezski, RJ (corresponding author), Genentech Inc, Antibody Engn Dept, San Francisco, CA 94080 USA.	brezski.randall@gene.com	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Wong, Manda/0000-0001-5830-1517	Genentech	Genentech(Roche HoldingGenentech)	This work was supported by Genentech. All authors are present or former paid employees of Genentech.	Biancheri P, 2015, GASTROENTEROLOGY, V149, P1564, DOI 10.1053/j.gastro.2015.07.002; Brezski RJ, 2008, ADV EXP MED BIOL, V640, P12, DOI 10.1007/978-0-387-09789-3_2; Brezski RJ, 2008, J IMMUNOL, V181, P3183, DOI 10.4049/jimmunol.181.5.3183; Brezski RJ, 2014, MABS-AUSTIN, V6, P1265, DOI 10.4161/mabs.29825; Brezski RJ, 2011, MABS-AUSTIN, V3, P558, DOI 10.4161/mabs.3.6.18119; Brezski RJ, 2011, THESCIENTIFICWORLDJO, V11, P1153, DOI 10.1100/tsw.2011.107; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Cordy JC, 2015, CLIN EXP IMMUNOL, V182, P139, DOI 10.1111/cei.12680; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Falkenburg WJJ, 2017, J IMMUNOL, V198, P82, DOI 10.4049/jimmunol.1601096; Fan XJ, 2015, MOL CANCER THER, V14, P681, DOI 10.1158/1535-7163.MCT-14-0715; Franz B, 2011, BLOOD, V118, P348, DOI 10.1182/blood-2011-03-341917; Gearing AJH, 2002, IMMUNOL LETT, V81, P41, DOI 10.1016/S0165-2478(01)00333-9; Holland MC, 2013, J CLIN IMMUNOL, V33, P1192, DOI 10.1007/s10875-013-9915-0; Jordan RE, 2016, IMMUNOL LETT, V172, P29, DOI 10.1016/j.imlet.2016.02.009; Kim HS, 2016, MABS-AUSTIN, V8, P1536, DOI 10.1080/19420862.2016.1219006; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Lin ZH, 2014, NAT PROTOC, V9, P1563, DOI 10.1038/nprot.2014.104; Malia TJ, 2014, PROTEINS, V82, P1656, DOI 10.1002/prot.24545; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; OSTERLAND CK, 1963, VOX SANG, V8, P133; Rispens T, 2012, J IMMUNOL METHODS, V375, P93, DOI 10.1016/j.jim.2011.09.011; Ryan MH, 2008, MOL IMMUNOL, V45, P1837, DOI 10.1016/j.molimm.2007.10.043; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TERNESS P, 1995, J IMMUNOL, V154, P6446; Trouw LA, 2017, NAT REV RHEUMATOL, V13, P331, DOI 10.1038/nrrheum.2017.15; van de Stadt LA, 2014, ARTHRITIS RHEUMATOL, V66, P1133, DOI 10.1002/art.38335; van Schie KA, 2015, MABS-AUSTIN, V7, P662, DOI 10.1080/19420862.2015.1048411; Vincents B, 2004, BIOCHEMISTRY-US, V43, P15540, DOI 10.1021/bi048284d; WALLER M, 1966, J IMMUNOL, V97, P438; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; YANO S, 1995, EUR J IMMUNOL, V25, P3128, DOI 10.1002/eji.1830251121; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]	35	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					906	919		10.1074/jbc.RA117.000165	http://dx.doi.org/10.1074/jbc.RA117.000165			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191832	Green Published, hybrid			2022-12-28	WOS:000422864500012
J	Wang, H; Chen, XJ; Wang, DH; Yao, C; Wang, Q; Xie, JY; Shi, XL; Xiang, Y; Liu, WL; Zhang, LQ				Wang, Hua; Chen, Xiangjun; Wang, Dianhong; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Xiang, Ye; Liu, Wanli; Zhang, Linqi			Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto-and heterologous viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPREHENSIVE ANALYSIS; CRYSTAL-STRUCTURE; VACCINE; TARGET; RECOGNITION; TRIMERS; DESIGN; AIDS; GLYCOSYLATION; IMMUNIZATION	Recent discoveries of broadly neutralizing antibodies (bnAbs) in HIV-1-infected individuals have led to the identification of several major "vulnerable sites" on the HIV-1 envelope (Env) glycoprotein. These sites have provided precise targets for HIV-1 vaccine development, but identifying and utilizing many of these targets remain technically challenging. Using a yeast surface display-based approach, we sought to identify epitope-focused antigenic domains (EADs) containing one of the "vulnerable sites," the CD4-binding site (CD4bs), through screening and selection of a combinatorial antigen library of the HIV-1 envelope glycoprotein with the CD4bs bnAb VRC01. We isolated multiple EADs and found that their trimeric forms have biochemical and structural features that preferentially bind and activate B cells that express VRC01 in vitro. More importantly, these EADs could induce detectable levels of neutralizing antibodies against genetically related autologous and heterologous subtype B viruses in guinea pigs. Our results demonstrate that an epitope-focused approach involving a screen of a combinatorial antigen library is feasible. The EADs identified here represent a promising collection of possible targets in the rational design of HIV-1 vaccines and lay the foundation for harnessing the specific antigenicity of CD4bs for protective immunogenicity in vivo.	[Wang, Hua; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Wang, Hua; Yao, Chen; Wang, Qian; Xie, Jiayu; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Chen, Xiangjun; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Collaborat Innovat Ctr Diag & Treatment Infect Di, MOE Key Lab Prot Sci,Inst Immunol, Beijing 100084, Peoples R China; [Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing 100084, Peoples R China; [Wang, Dianhong; Xiang, Ye] Tsinghua Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing 100084, Peoples R China; [Yao, Chen] NIAMS, Lymphocyte Cell Biol Sect, NIH, Bethesda, MD 20892 USA	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; Tsinghua University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med A209, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; liu, wanli/H-5690-2011	liu, wanli/0000-0003-2624-6802; Yao, Chen/0000-0001-6852-5661; Xiang, Ye/0000-0003-0230-9522; Liu, Wanli/0000-0003-0395-2800	National Institutes of Health from NIAID [HHSN27201100016C]	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Drs. K. Dane Wittrup and Annie Gai at Massachusetts Institute of Technology for providing the yeast surface display vector pCTCON2; Drs. John Mascola at Vaccine Research Center, National Institutes of Health, and Michel Nussenzweig at Rockefeller University for providing HIV-1 bnAbs; Drs. Peter Kwong and Tongqing Zhou at National Institutes of Health for providing RSC3 and RSC3 Delta 371I proteins; Drs. David Montefiori and Hongmei Gao at Duke University Medical Center for tier phenotying of the CNE pseudovirues; Dr. Xinquan Wang and student Dr. Xi Liu at Tsinghua University for providing the Sf9 cell line, pFastBac (TM) dual vector, and technical suggestions; Dr. Susan K. Pierce at National Institutes of Health for providing the Human Ramos B cell line; Dr. Chenqi Xu at Chinese Academy of Science for providing the Gcamp5 gene; Dr. Yi Shi at Chinese Academy of Science for providing the NL4-3 SOSIP. 664 gp140 trimer protein, and Kelly Arledge previously of our laboratory for providing valuable suggestions and input. National Institutes of Health Contract HHSN27201100016C from NIAID was awarded to Duke University Medical Center.	Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9552; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Crooks ET, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004932; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Feng Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005767; Georgiev IS, 2015, J VIROL, V89, P5318, DOI 10.1128/JVI.03451-14; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Haynes BF, 2015, JAMA-J AM MED ASSOC, V313, P2419, DOI 10.1001/jama.2015.2427; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Jiang XQ, 2016, J VIROL, V90, P11007, DOI 10.1128/JVI.01409-16; Jin S, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0243-3; Joyce MG, 2013, J VIROL, V87, P2294, DOI 10.1128/JVI.02717-12; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu WL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002820; Liu WL, 2010, IMMUNITY, V32, P778, DOI 10.1016/j.immuni.2010.06.006; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; McCoy LE, 2016, CELL REP, V16, P2327, DOI 10.1016/j.celrep.2016.07.074; Overbaugh J, 2001, SCIENCE, V292, P1106, DOI 10.1126/science.1059128; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Ross AL, 2010, LANCET INFECT DIS, V10, P305, DOI 10.1016/S1473-3099(10)70069-4; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Sharma SK, 2015, CELL REP, V11, P539, DOI 10.1016/j.celrep.2015.03.047; Sok D, 2016, SCIENCE, V353, P1557, DOI 10.1126/science.aah3945; Steichen JM, 2016, IMMUNITY, V45, P483, DOI 10.1016/j.immuni.2016.08.016; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yang Z, 2015, INTERNATIONAL CONFERENCE ON AUTOMATION, MECHANICAL AND ELECTRICAL ENGINEERING (AMEE 2015), P1; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep25856; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zuo T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9855; Zuo T, 2011, J BIOL CHEM, V286, P33511, DOI 10.1074/jbc.M111.270553	57	10	11	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					830	846		10.1074/jbc.M117.816447	http://dx.doi.org/10.1074/jbc.M117.816447			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187598	Green Published, hybrid			2022-12-28	WOS:000422864500007
J	Zhang, WC; Du, LJ; Zheng, XJ; Chen, XQ; Shi, CJ; Chen, BY; Sun, XN; Li, C; Zhang, YY; Liu, Y; Xiao, H; Leng, QB; Jiang, XQ; Zhang, ZY; Sun, SY; Duan, SZ				Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Chen, Xiao-Qing; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Xiao, Hui; Leng, Qibin; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong			Elevated sodium chloride drives type I interferon signaling in macrophages and increases antiviral resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC T(H)17 CELLS; REGULATORY T-CELLS; VACCINE ADJUVANT; VIRUS-INFECTION; ACTIVATION; INDUCTION; PATHWAY; HOMEOSTASIS; DISEASE; KINASE	Type I IFN production and signaling in macrophages play critical roles in innate immune responses. High salt (i.e. high concentrations of NaCl) has been proposed to be an important environmental factor that influences immune responses in multiple ways. However, it remains unknown whether high salt regulates type I IFN production and signaling in macrophages. Here, we demonstrated that high salt promoted IFN beta production and its signaling in both human and mouse macrophages, and consequentially primed macrophages for strengthened immune sensing and signaling when challenged with viruses or viral nucleic acid analogues. Using both pharmacological inhibitors and RNA interference we showed that these effects of high salt on IFN beta signaling were mediated by the p38 MAPK/ATF2/AP1 signaling pathway. Consistently, high salt increased resistance to vesicle stomatitis virus (VSV) infection in vitro. In vivo data indicated that a high-salt diet protected mice from lethal VSV infection. Taken together, these results identify high salt as a crucial regulator of type I IFN production and signaling, shedding important new light on the regulation of innate immune responses.	[Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Sch Stomatol, Ninth Peoples Hosp, Sch Med, Shanghai 200011, Peoples R China; [Zhang, Wu-Chang; Du, Lin-Juan; Zheng, Xiao-Jun; Shi, Chaoji; Chen, Bo-Yan; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao; Liu, Yan; Jiang, Xinquan; Zhang, Zhiyuan; Sun, Shuyang; Duan, Sheng-Zhong] Shanghai Jiao Tong Univ, Sch Med, Natl Clin Res Ctr Stomatol, Shanghai Res Inst Stomatol, Shanghai 200011, Peoples R China; [Du, Lin-Juan; Zheng, Xiao-Jun; Sun, Xue-Nan; Li, Chao; Zhang, Yu-Yao] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Chen, Xiao-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xiao, Hui; Leng, Qibin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Shanghai 200031, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Sun, SY (corresponding author), Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Sch Med, Dept Oral & Maxillofacial Head Neck Oncol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Duan, SZ (corresponding author), Shanghai Jiao Tong Univ, Ninth Peoples Hosp, Sch Med, Lab Oral Microbiota & System Dis, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.	shuyangs@shsmu.edu.cn; duansz@shsmu.edu.cn	Du, Linjuan/GZL-3707-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022	Zhang, Wu-Chang/0000-0002-8494-306X; Zheng, Xiaojun/0000-0002-2105-170X	National Natural Science Foundation of China [81725003, 31671181, 31371153, 91339110]; Shanghai Summit & Plateau Discipline Developing Projects	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Summit & Plateau Discipline Developing Projects	This work was supported by the National Natural Science Foundation of China Grants 81725003, 31671181, 31371153, and 91339110 and the Shanghai Summit & Plateau Discipline Developing Projects. The authors declare that they have no conflicts of interest with the contents of this article.	Alfieri RR, 2007, PFLUG ARCH EUR J PHY, V454, P173, DOI 10.1007/s00424-006-0195-x; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Hernandez AL, 2015, J CLIN INVEST, V125, P4212, DOI 10.1172/JCI81151; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hornung V, 2014, IMMUNITY, V41, P868, DOI 10.1016/j.immuni.2014.10.005; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Karupiah G, 1996, J VIROL, V70, P8301, DOI 10.1128/JVI.70.12.8301-8309.1996; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Lehmann MH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0252-1; Liu SY, 2011, CURR OPIN IMMUNOL, V23, P57, DOI 10.1016/j.coi.2010.11.003; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Luo M., 2017, CELL RES; Martinez-Gil L, 2013, J VIROL, V87, P1290, DOI 10.1128/JVI.02338-12; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Safa K, 2015, J AM SOC NEPHROL, V26, P2341, DOI 10.1681/ASN.2014090914; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wiig H, 2013, J CLIN INVEST, V123, P2803, DOI 10.1172/JCI60113; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28065; Yang JH, 2015, J VIROL, V89, P10860, DOI 10.1128/JVI.01627-15; Zhang WC, 2015, CELL RES, V25, P893, DOI 10.1038/cr.2015.87; Zhao Y, 2016, CELL METAB, V23, P699, DOI 10.1016/j.cmet.2016.02.019; Zust R, 2014, J VIROL, V88, P7276, DOI 10.1128/JVI.03827-13	33	22	22	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1030	1039		10.1074/jbc.M117.805093	http://dx.doi.org/10.1074/jbc.M117.805093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203528	Green Published, hybrid			2022-12-28	WOS:000422864500023
J	Castaneda, CA; Wolfson, NA; Leng, KR; Kuo, YM; Andrews, AJ; Fierke, CA				Castaneda, Carol Ann; Wolfson, Noah A.; Leng, Katherine R.; Kuo, Yin-Ming; Andrews, Andrew J.; Fierke, Carol A.			HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme turnover; histone; histone acetylation; histone deacetylase (HDAC); nucleosome; peptides; protein complex; non-natural amino acid incorporation	NUCLEOSOME CORE PARTICLE; DEACETYLASE 8; CRYSTAL-STRUCTURE; RECOMBINANT HISTONES; LYSINE ACETYLATION; PROTEIN; ASSAY; SPECIFICITY; INHIBITORS; COMPLEXES	Histone deacetylases (HDACs) catalyze deacetylation of acetyl-lysine residues within proteins. To date, HDAC substrate specificity and selectivity have been largely estimated using peptide substrates. However, it is unclear whether peptide substrates accurately reflect the substrate selectivity of HDAC8 toward full-length proteins. Here, we compare HDAC8 substrate selectivity in the context of peptides, full-length proteins, and protein-nucleic acid complexes. We demonstrate that HDAC8 catalyzes deacetylation of tetrameric histone (H3/H4) substrates with catalytic efficiencies that are 40-300-fold higher than those for corresponding peptide substrates. Thus, we conclude that additional contacts with protein substrates enhance catalytic efficiency. However, the catalytic efficiency decreases for larger multiprotein complexes. These differences in HDAC8 substrate selectivity for peptides and full-length proteins suggest that HDAC8 substrate preference is based on a combination of short- and long-range interactions. In summary, this work presents detailed kinetics for HDAC8-catalyzed deacetylation of singly-acetylated, full-length protein substrates, revealing that HDAC8 substrate selectivity is determined by multiple factors. These insights provide a foundation for understanding recognition of full-length proteins by HDACs.	[Castaneda, Carol Ann; Fierke, Carol A.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Wolfson, Noah A.; Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Leng, Katherine R.; Fierke, Carol A.] Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA; [Kuo, Yin-Ming; Andrews, Andrew J.] Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fox Chase Cancer Center	Fierke, CA (corresponding author), Univ Michigan, Dept Chem, 930 N Univ Ave, Ann Arbor, MI 48109 USA.; Andrews, AJ (corresponding author), Fox Chase Canc Ctr, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Andrew.Andrews@fccc.edu; fierke@umich.edu		Fierke, Carol/0000-0002-1481-0579	National Science Foundation; National Institutes of Health [5-R01-GM-040602]; University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health [5T32GM008597]; Rackham Graduate School; Cellular Biotechnology Training Program [T32-GM008353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM040602, T32GM008597] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health; Rackham Graduate School; Cellular Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Science Foundation predoctoral fellowship (to N. A. W.), National Institutes of Health Grant 5-R01-GM-040602 (to C. A. F.), University of Michigan Chemistry-Biology Interface (CBI) Training Program, National Institutes of Health Grant 5T32GM008597 (to C. A. C.), Rackham Graduate School (to C. A. C.), and the Cellular Biotechnology Training Program T32-GM008353 (to N. A. W. and K. R. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam N, 2016, STRUCTURE, V24, P458, DOI 10.1016/j.str.2016.02.002; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cole KE, 2011, J AM CHEM SOC, V133, P12474, DOI 10.1021/ja205972n; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; Decroos C, 2015, BIOCHEMISTRY-US, V54, P2126, DOI 10.1021/acs.biochem.5b00010; Dose A, 2016, ANGEW CHEM INT EDIT, V55, P1192, DOI 10.1002/anie.201508174; Dowling DP, 2010, BIOCHEMISTRY-US, V49, P5048, DOI 10.1021/bi1005046; Dowling DP, 2008, BIOCHEMISTRY-US, V47, P13554, DOI 10.1021/bi801610c; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Fenichel MP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv165; Gantt ML, 2016, BIOCHEMISTRY-US, V55, P820, DOI 10.1021/acs.biochem.5b01327; Gantt SL, 2006, BIOCHEMISTRY-US, V45, P6170, DOI 10.1021/bi060212u; Gantt SL, 2010, J BIOL CHEM, V285, P6036, DOI 10.1074/jbc.M109.033399; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gober IN, 2016, J AM CHEM SOC, V138, P9452, DOI 10.1021/jacs.6b02836; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; Gurard-Levin ZA, 2010, ACS CHEM BIOL, V5, P863, DOI 10.1021/cb100088g; Gurard-Levin ZA, 2009, CHEMBIOCHEM, V10, P2159, DOI 10.1002/cbic.200900417; Hedstrom L, 2010, ENCY LIFE SCI; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Huang XY, 2011, ANAL BIOCHEM, V414, P278, DOI 10.1016/j.ab.2011.04.001; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kaiser FJ, 2014, HUM MOL GENET, V23, P2888, DOI 10.1093/hmg/ddu002; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kuo YM, 2015, BIOCHEM J, V472, P239, DOI 10.1042/BJ20150654; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Lee H, 2004, MOL CELL BIOL, V24, P765, DOI 10.1128/MCB.24.2.765-773.2004; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marek M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003645; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Poole RM, 2014, DRUGS, V74, P1543, DOI 10.1007/s40265-014-0275-8; Riester D, 2007, BIOCHEM BIOPH RES CO, V357, P439, DOI 10.1016/j.bbrc.2007.03.158; Saha A, 2013, BIOORGAN MED CHEM, V21, P4201, DOI 10.1016/j.bmc.2013.05.002; Shahian T, 2012, METHODS MOL BIOL, V833, P337, DOI 10.1007/978-1-61779-477-3_20; Smith BC, 2007, J BIOL CHEM, V282, P37256, DOI 10.1074/jbc.M707878200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Toro TB, 2015, PROTEIN SCI, V24, P2020, DOI 10.1002/pro.2813; Van den Wyngaert I, 2000, FEBS LETT, V478, P77, DOI 10.1016/S0014-5793(00)01813-5; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Waltregny D, 2004, AM J PATHOL, V165, P553, DOI 10.1016/S0002-9440(10)63320-2; Wegener D, 2003, ANAL BIOCHEM, V321, P202, DOI 10.1016/S0003-2697(03)00426-3; Wegener D, 2003, CHEM BIOL, V10, P61, DOI 10.1016/S1074-5521(02)00305-8; Whitehead L, 2011, BIOORGAN MED CHEM, V19, P4626, DOI 10.1016/j.bmc.2011.06.030; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2014, ANAL BIOCHEM, V456, P61, DOI 10.1016/j.ab.2014.03.012; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan J, 2009, CELL CYCLE, V8, P1747, DOI 10.4161/cc.8.11.8620; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	66	20	20	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21568	21577		10.1074/jbc.M117.811026	http://dx.doi.org/10.1074/jbc.M117.811026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109148	hybrid, Green Published			2022-12-28	WOS:000419013000031
J	Chen, XY; Zhou, L; Peng, NF; Yu, HS; Li, MQ; Cao, ZY; Lin, Y; Wang, XY; Li, Q; Wang, J; She, YL; Zhu, CL; Lu, MJ; Zhu, Y; Liu, S				Chen, Xueyuan; Zhou, Li; Peng, Nanfang; Yu, Haisheng; Li, Mengqi; Cao, Zhongying; Lin, Yong; Wang, Xueyu; Li, Qian; Wang, Jun; She, Yinglong; Zhu, Chengliang; Lu, Mengji; Zhu, Ying; Liu, Shi			MicroRNA-302a suppresses influenza A virus-stimulated interferon regulatory factor-5 expression and cytokine storm induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; cytokine storm; influenza virus; interferon regulatory factor (IRF); microRNA (miRNA); signaling	TRANSCRIPTION FACTOR; SIGNALING PATHWAY; GENE INDUCTION; I INTERFERON; CELLS; REPLICATION; IRF5; INFLAMMATION; INFECTION; RESPONSES	During influenza A virus (IAV) infection, cytokine storms play a vital and critical role in clinical outcomes. We have previously reported that microRNA (miR)-302c regulates IAV-induced IFN expression by targeting the 3-UTR of nuclear factor B (NF-B)-inducing kinase. In the current study, we found that miR-302a, another member of the miR-302 cluster, controls the IAV-induced cytokine storm. According to results from cell-based and knockout mouse models, IAV induces a cytokine storm via interferon regulatory factor-5 (IRF-5). We also found that IAV infection up-regulates IRF-5 expression and that IRF-5 in turn promotes IAV replication. Furthermore, we observed that IRF-5 is a direct target of miR-302a, which down-regulated IRF-5 expression by binding its 3-UTR. Moreover, IAV increased IRF-5 expression by down-regulating miR-302a expression. Interestingly, miR-302a inhibited IAV replication. In IAV-infected patients, miR-302a expression was down-regulated, whereas IRF-5 expression was up-regulated. Taken together, our work uncovers and defines a signaling pathway implicated in an IAV-induced cytokine storm.	[Chen, Xueyuan; Peng, Nanfang; Yu, Haisheng; Li, Mengqi; Cao, Zhongying; She, Yinglong; Zhu, Ying; Liu, Shi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Zhou, Li] Wuhan Univ, Sch Med, Ctr Expt Anim, Anim Biosafety Level Lab 3, Wuhan 430072, Hubei, Peoples R China; [Lin, Yong; Wang, Xueyu; Li, Qian; Lu, Mengji] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, D-45122 Essen, Germany; [Zhu, Chengliang] Wuhan Univ, Renmin Hosp, Dept Clin Lab, Wuhan 430060, Hubei, Peoples R China; [Wang, Jun] Jiangnan Univ, Peoples Hosp Wuxi 5, Ctr Clin Lab, Wuxi 214005, Jiangsu, Peoples R China	Wuhan University; Wuhan University; University of Duisburg Essen; Wuhan University; Jiangnan University	Liu, S (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liushi_liushi@whu.edu.cn	Lu, Mengji/ABF-9410-2020; Li, Hongpu/B-7707-2014	Li, Hongpu/0000-0003-2323-6107	National Natural Science Foundation of China [31500149, 31570870, 81301428]; Fundamental Research Funds for the Central Universities [2042017kf0221, 2042015kf0188]; National Basic Research Program of China (973 Program) [2014CB542603]; Deutsche Forschungsgemeinschaft [TRR60, RTG1949]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China Grants 31500149 (to S. L.), 31570870 (to Y. Z.), and 81301428 (to L. Z.); Fundamental Research Funds for the Central Universities Grants 2042017kf0221 (to S. L.) and 2042015kf0188 (to L. Z.); National Basic Research Program of China (973 Program) Grant 2014CB542603 (to S. L.); and Deutsche Forschungsgemeinschaft Grants TRR60 and RTG1949 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Banerjee I, 2014, SCIENCE, V346, P473, DOI 10.1126/science.1257037; Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bi XH, 2011, J INTERF CYTOK RES, V31, P373, DOI 10.1089/jir.2010.0084; Cai N, 2013, RNA, V19, P85, DOI 10.1261/rna.035295.112; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen L, 2015, CANCER RES, V75, P3832, DOI 10.1158/0008-5472.CAN-14-3690; Clark IA, 2007, IMMUNOL CELL BIOL, V85, P271, DOI 10.1038/sj.icb.7100062; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Gui SL, 2015, FEBS LETT, V589, P4112, DOI 10.1016/j.febslet.2015.11.011; Harrison C, 2010, NAT REV DRUG DISCOV, V9, P360, DOI 10.1038/nrd3162; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Iwasaki A, 2011, CELL, V146, P861, DOI 10.1016/j.cell.2011.08.027; Jing MZ, 2016, VACCINE, V34, P516, DOI 10.1016/j.vaccine.2015.11.069; Kedzierski L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004134; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Liu S, 2015, J HEPATOL, V62, P1015, DOI 10.1016/j.jhep.2014.11.035; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Morens DM, 2012, NATURE, V486, P335, DOI 10.1038/nature11170; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Peng L, 2016, EBIOMEDICINE, V14, P83, DOI 10.1016/j.ebiom.2016.10.041; Peng NF, 2016, J IMMUNOL, V196, P2753, DOI 10.4049/jimmunol.1501481; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Ren JY, 2014, P NATL ACAD SCI USA, V111, P17438, DOI 10.1073/pnas.1418516111; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Si LL, 2016, SCIENCE, V354, P1170, DOI 10.1126/science.aah5869; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Teijaro JR, 2014, P NATL ACAD SCI USA, V111, P3799, DOI 10.1073/pnas.1400593111; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Xie JJ, 2014, BBA-MOL BASIS DIS, V1842, P2479, DOI 10.1016/j.bbadis.2014.04.017; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhang HP, 2017, INFLAMMATION, V40, P1450, DOI 10.1007/s10753-017-0588-3; Zhu SL, 2016, BIOCHEM BIOPH RES CO, V471, P95, DOI 10.1016/j.bbrc.2016.01.173	41	40	42	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21291	21303		10.1074/jbc.M117.805937	http://dx.doi.org/10.1074/jbc.M117.805937			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29046356	Green Published, hybrid			2022-12-28	WOS:000419013000007
J	Bae, N; Gao, M; Li, X; Premkumar, T; Sbardella, G; Chen, JJ; Bedford, MT				Bae, Narkhyun; Gao, Min; Li, Xu; Premkumar, Tolkappiyan; Sbardella, Gianluca; Chen, Junjie; Bedford, Mark T.			A transcriptional coregulator, SPIN.DOC, attenuates the coactivator activity of Spindlin1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUDOR-LIKE DOMAINS; HISTONE MODIFICATIONS; CELL-CYCLE; METHYLATION; PROTEIN; OVEREXPRESSION; RECOGNITION; LANGUAGE; NETWORK; COMPLEX	Spindlin1 (SPIN1) is a transcriptional coactivator with critical functions in embryonic development and emerging roles in cancer. SPIN1 harbors three Tudor domains, two of which engage the tail of histone H3 by reading the H3-Lys-4 trimethylation and H3-Arg-8 asymmetric dimethylation marks. To gain mechanistic insight into how SPIN1 functions as a transcriptional coactivator, here we purified its interacting proteins. We identified an uncharacterized protein (C11orf84), which we renamed SPIN1 docking protein (SPIN.DOC), that directly binds SPIN1 and strongly disrupts its histone methylation reading ability, causing it to disassociate from chromatin. The Spindlin family of coactivators has five related members (SPIN1, 2A, 2B, 3, and 4), and we found that all of them bind SPIN.DOC. It has been reported previously that SPIN1 regulates gene expression in the Wnt signaling pathway by directly interacting with transcription factor 4 (TCF4). Weobserved here that SPIN.DOC associates with TCF4 in a SPIN1-dependent manner and dampens SPIN1 coactivator activity in TOPflash reporter assays. Furthermore, knockdown and overexpression experiments indicated that SPIN.DOC represses the expression of a number of SPIN1-regulated genes, including those encoding ribosomal RNA and the cytokine IL1B. In conclusion, we have identified SPIN.DOC as a transcriptional repressor that binds SPIN1 and masks its ability to engage the H3-Lys-4 trimethylation activation mark.	[Bae, Narkhyun; Premkumar, Tolkappiyan; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Gao, Min; Li, Xu; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Sbardella, Gianluca] Univ Salerno, Epigenet Med Chem Lab, Dipartimento Farm, Via Giovanni Paolo 2 132, I-84084 Fisciano, SA, Italy	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Salerno	Bedford, MT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Sbardella, Gianluca/E-2823-2010	Sbardella, Gianluca/0000-0003-0748-1145; Premkumar, Tolkappiyan/0000-0003-2540-5533; bedford, mark/0000-0002-8899-1050; /0000-0002-5592-9349	Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale [PRIN 20152TE5PK]; Universita di Salerno (Italy); European Cooperation in Science and Technology (COST Action) [CM1406]; National Institutes of Health [CA216911, DK062248]; CPRIT [RP130432]	Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center; Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale; Universita di Salerno (Italy); European Cooperation in Science and Technology (COST Action)(European Cooperation in Science and Technology (COST)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT	Supported by the Odyssey Fellowship Program at The University of Texas MD Anderson Cancer Center.; Supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Progetti di Ricerca di Interesse Nazionale (PRIN 20152TE5PK), Universita di Salerno (Italy), and European Cooperation in Science and Technology (COST Action CM1406).; Supported by National Institutes of Health Grant CA216911.; Supported by National Institutes of Health Grant DK062248 and CPRIT Grant RP130432 for the protein array analysis.	Bae N, 2017, NAT CHEM BIOL, V13, P750, DOI 10.1038/nchembio.2377; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Chen SD, 2015, MOL CELL, V60, P319, DOI 10.1016/j.molcel.2015.08.019; Chew TG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069764; Drane P, 2017, NATURE, V543, P211, DOI 10.1038/nature21358; Franz H, 2015, ONCOTARGET, V6, P4773, DOI 10.18632/oncotarget.3000; Gao YH, 2005, BIOCHEM BIOPH RES CO, V335, P343, DOI 10.1016/j.bbrc.2005.07.087; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Li X, 2017, CELL REP, V20, P737, DOI 10.1016/j.celrep.2017.06.077; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Oh B, 1997, DEVELOPMENT, V124, P493; Shanle EK, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0117-5; Staub E, 2002, GENOME BIOL, V3; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su XN, 2014, GENE DEV, V28, P622, DOI 10.1101/gad.233239.113; Su ZL, 2016, ACS CHEM BIOL, V11, P564, DOI 10.1021/acschembio.5b00864; Wagner T, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw089; Wang JX, 2012, MOL CANCER RES, V10, P326, DOI 10.1158/1541-7786.MCR-11-0440; Wang WX, 2011, EMBO REP, V12, P1160, DOI 10.1038/embor.2011.184; Wang Y, 2010, J BIOL CHEM, V285, P10890, DOI 10.1074/jbc.M109.058347; Yang N, 2012, P NATL ACAD SCI USA, V109, P17954, DOI 10.1073/pnas.1208517109; Yuan HF, 2008, GENE, V410, P67, DOI 10.1016/j.gene.2007.11.019; Yue Wen, 2004, Ai Zheng, V23, P141; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42; Zhan YN, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0026-4; Zhang AL, 2017, J BIOL CHEM, V292, P6461, DOI 10.1074/jbc.M117.777474; Zhang P, 2008, J CELL PHYSIOL, V217, P400, DOI 10.1002/jcp.21515; Zhao Q, 2007, J BIOL CHEM, V282, P647, DOI 10.1074/jbc.M604029200	30	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20808	20817		10.1074/jbc.M117.814913	http://dx.doi.org/10.1074/jbc.M117.814913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29061846	hybrid, Green Published			2022-12-28	WOS:000418453400001
J	Kolodecik, TR; Reed, AM; Date, K; Shugrue, CA; Patel, V; Chung, SL; Desir, GV; Gorelick, FS				Kolodecik, Thomas R.; Reed, Anamika M.; Date, Kimie; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.			The serum protein renalase reduces injury in experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; ACINAR-CELLS; CA2+; INHIBITION; EXPRESSION; OXIDASE; GROWTH; AKI	Acute pancreatitis is a disease associated with inflammation and tissue damage. One protein that protects against acute injury, including ischemic injury to both the kidney and heart, is renalase, which is secreted into the blood by the kidney and other tissues. However, whether renalase reduces acute injury associated with pancreatitis is unknown. Here, we used both in vitro and in vivo murine models of acute pancreatitis to study renalase's effects on this condition. In isolated pancreatic lobules, pretreatment with recombinanthumanrenalase(rRNLS) blockedzymogen activation causedbycerulein, carbachol, andabileacid. Renalase also blocked cerulein-induced cell injury and histological changes. In the in vivo cerulein model of pancreatitis, genetic deletion of renalase resulted in more severe disease, and administering rRNLS to cerulein-exposed WT mice after pancreatitis onset was protective. Because pathological increases in acinar cell cytosolic calcium levels are central to the initiation of acute pancreatitis, we also investigated whether rRNLS could function through its binding protein, plasma membrane calcium ATPase 4b (PMCA4b), which excretes calcium from cells. We found that PMCA4b is expressed in both murine and human acinar cells and that a PMCA4b-selective inhibitor worsens pancreatitis-induced injury and blocks the protective effects of rRNLS. These findings suggest that renalase is a protective plasmaprotein that reduces acinar cell injury through a plasma membrane calcium ATPase. Because exogenous rRNLS reduces the severity of acute pancreatitis, it has potential as a therapeutic agent.	[Kolodecik, Thomas R.; Reed, Anamika M.; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.] Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06510 USA; [Kolodecik, Thomas R.; Reed, Anamika M.; Shugrue, Christine A.; Patel, Vikhil; Chung, Shang-Lin; Desir, Gary V.; Gorelick, Fred S.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Date, Kimie] Ochanomizu Univ, Tokyo 1128610, Japan	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Ochanomizu University	Gorelick, FS (corresponding author), VA CT Healthcare Syst, Dept Internal Med & Cell Biol, 950 Campbell Ave, West Haven, CT 06516 USA.; Gorelick, FS (corresponding author), Yale Univ, Sch Med, 950 Campbell Ave, West Haven, CT 06516 USA.	fred.gorelick@yale.edu	Asanuma, Kimie/AAW-2543-2020; Chung, Shang-Lin/GYR-1637-2022	Asanuma, Kimie/0000-0003-4311-0544; 	National Institutes of Health [P30DK079310, P30DK034989]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086402, P30DK034989, RC1DK086465, P30DK079310, R01DK081037, T32DK007356] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Guy E. Groblewski from the University of Wisconsin for providing the human cDNA used for PCR analysis of PMCA isoforms. We also acknowledge the Yale George M. O'Brien Kidney Center at Yale (supported by National Institutes of Health Grant P30DK079310) and the Yale Silvio O. Conte Digestive Diseases Research Core Center (supported by National Institutes of Health Grant P30DK034989) for technical support.	Alexander RT, 2015, AM J PHYSIOL-RENAL, V309, pF604, DOI 10.1152/ajprenal.00651.2014; Baggaley E, 2007, J BIOL CHEM, V282, P37678, DOI 10.1074/jbc.M703416200; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bruce JIE, 2007, AM J PHYSIOL-CELL PH, V293, pC938, DOI 10.1152/ajpcell.00582.2006; Duan WJ, 2013, PROTEIN CELL, V4, P286, DOI 10.1007/s13238-013-2116-z; Gerasimenko JV, 2014, J PHYSIOL-LONDON, V592, P269, DOI 10.1113/jphysiol.2013.261784; Guo XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22996; Hollander L, 2016, CANCER RES, V76, P3884, DOI 10.1158/0008-5472.CAN-15-1524; Kim HJ, 2012, J CELL BIOL, V199, P1145, DOI 10.1083/jcb.201204067; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Li XG, 2015, KIDNEY BLOOD PRESS R, V40, P215, DOI 10.1159/000368497; Mankad P, 2012, J BIOL CHEM, V287, P1823, DOI 10.1074/jbc.M111.326272; Patel R, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108712; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Reed AM, 2011, J BIOL CHEM, V286, P1919, DOI 10.1074/jbc.M110.158329; Roy N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110843; Samad A, 2014, J BIOL CHEM, V289, P23582, DOI 10.1074/jbc.M114.589440; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Strehler EE, 2015, BIOCHEM BIOPH RES CO, V460, P26, DOI 10.1016/j.bbrc.2015.01.121; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122932; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wang Y, 2017, J CELL MOL MED, V21, P1260, DOI 10.1111/jcmm.13062; Wildi S, 2007, GUT, V56, P685, DOI 10.1136/gut.2006.105833; Wu YL, 2011, KIDNEY INT, V79, P853, DOI 10.1038/ki.2010.488; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Yang YM, 2014, J BIOL CHEM, V289, P24971, DOI 10.1074/jbc.M114.577221	27	16	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21047	21059		10.1074/jbc.M117.789776	http://dx.doi.org/10.1074/jbc.M117.789776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29042438	Green Published, hybrid			2022-12-28	WOS:000418453400020
J	Yano, H; Provasi, D; Cai, NS; Filizola, M; Ferre, S; Javitch, JA				Yano, Hideaki; Provasi, Davide; Cai, Ning Sheng; Filizola, Marta; Ferre, Sergi; Javitch, Jonathan A.			Development of novel biosensors to study receptor-mediated activation of the G-protein subunits G(s) and G(olf)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); dopamine receptor; G protein; G-protein-coupled receptor (GPCR); pharmacology	BETA(2) ADRENERGIC-RECEPTOR; ADENYLYL-CYCLASE; NUCLEOTIDE EXCHANGE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; LIVING CELLS; DOPAMINE; STRIATUM; COMPLEX	G(s) (G(s)) and G(olf) (G(olf)) are highly homologous G-protein subunits that activate adenylate cyclase, thereby serving as crucial mediators of intracellular signaling. Because of their dramatically different brain expression patterns, we studied similarities and differences between their activation processes with the aim of comparing their receptor coupling mechanisms. We engineered novel luciferase- and Venus-fused G constructs that can be used in bioluminescence resonance energy transfer assays. In conjunction with molecular simulations, these novel biosensors were used to determine receptor activation-induced changes in conformation. Relative movements in G(s) were consistent with the crystal structure of (2) adrenergic receptor in complex with G(s). Conformational changes in G(olf) activation are shown to be similar to those in G(s). Overall the current study reveals general similarities between G(s) and G(olf) activation at the molecular level and provides a novel set of tools to search for G(s)- and G(olf)-specific receptor pharmacology. In view of the wide functional and pharmacological roles of G(s)- and G(olf)-coupled dopamine D-1 receptor and adenosine A(2A) receptor in the brain and other organs, elucidating their differential structure-function relationships with G(s) and G(olf) might provide new approaches for the treatment of a variety of neuropsychiatric disorders. In particular, these novel biosensors can be used to reveal potentially therapeutic dopamine D-1 receptor and adenosine A(2A) receptor ligands with functionally selective properties between G(s) and G(olf) signaling.	[Yano, Hideaki; Cai, Ning Sheng; Ferre, Sergi] NIDA, Baltimore, MD 21224 USA; [Provasi, Davide; Filizola, Marta] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute	Yano, H (corresponding author), NIDA, Baltimore, MD 21224 USA.; Javitch, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA.; Javitch, JA (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA.; Javitch, JA (corresponding author), New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA.	yanoh@nih.gov; jaj2@columbia.edu	; Ferre, Sergi/K-6115-2014	Provasi, Davide/0000-0002-2868-303X; Yano, Hideaki/0000-0001-9242-3884; Ferre, Sergi/0000-0002-1747-1779; Javitch, Jonathan/0000-0001-7395-2967	National Institute on Drug Abuse; Japan Society for the Promotion of Science; National Institutes of Health [DA022413, MH54137, DA026434]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, K02DA026434, ZIADA000493] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Intramural funds of the National Institute on Drug Abuse (to S.F.), a fellowship from the Japan Society for the Promotion of Science (to H.Y.), and National Institutes of Health Grants DA022413 and MH54137 (to J.A.J.) and DA026434 (to M.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Corradi JP, 2005, MOL PSYCHIATR, V10, P1017, DOI 10.1038/sj.mp.4001713; Corvol JC, 2001, J NEUROCHEM, V76, P1585, DOI 10.1046/j.1471-4159.2001.00201.x; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Frederick AL, 2015, MOL PSYCHIATR, V20, P1373, DOI 10.1038/mp.2014.166; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Gabay M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002223; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Herve D, 2001, J NEUROSCI, V21, P4390, DOI 10.1523/JNEUROSCI.21-12-04390.2001; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; Herve D, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00048; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kumar KR, 2014, JAMA NEUROL, V71, P490, DOI 10.1001/jamaneurol.2013.4677; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu HY, 2001, J NEUROCHEM, V78, P325, DOI 10.1046/j.1471-4159.2001.00422.x; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Marchi M, 1999, J CHEM PHYS, V110, P3697, DOI 10.1063/1.478259; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwindinger WF, 2003, J BIOL CHEM, V278, P6575, DOI 10.1074/jbc.M211132200; Schwindinger WF, 2010, J BIOL CHEM, V285, P29787, DOI 10.1074/jbc.M110.142620; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Urizar E, 2011, NAT CHEM BIOL, V7, P624, DOI [10.1038/NCHEMBIO.623, 10.1038/nchembio.623]; Vemula SR, 2013, HUM MOL GENET, V22, P2510, DOI 10.1093/hmg/ddt102; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Xie KQ, 2015, ELIFE, V4, DOI 10.7554/eLife.10451; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zhuang XX, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0001.2000	41	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19989	19998		10.1074/jbc.M117.800698	http://dx.doi.org/10.1074/jbc.M117.800698			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042444	hybrid, Green Published			2022-12-28	WOS:000417696400006
J	Hashimoto, S; Ishii, A; Kamano, N; Watamura, N; Saito, T; Ohshima, T; Yokosuka, M; Saido, TC				Hashimoto, Shoko; Ishii, Ayano; Kamano, Naoko; Watamura, Naoto; Saito, Takashi; Ohshima, Toshio; Yokosuka, Makoto; Saido, Takaomi C.			Endoplasmic reticulum stress responses in mouse models of Alzheimer's disease: Overexpression paradigm versus knockin paradigm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED-PROTEIN RESPONSE; AMYLOID PRECURSOR PROTEIN; INDUCED ER STRESS; CELL-DEATH; PRESENILIN-1 MUTATIONS; CALCIUM HOMEOSTASIS; CORTICAL-NEURONS; GAMMA-SECRETASE; PC12 CELLS; BETA	Endoplasmic reticulum (ER) stress is believed to play an important role in the etiology of Alzheimer's disease (AD). The accumulation of misfolded proteins and perturbation of intracellular calcium homeostasis are thought to underlie the induction of ER stress, resulting in neuronal dysfunction and cell death. Several reports have shown an increased ER stress response in amyloid precursor protein (APP) and presenilinl (PS1) double-transgenic (Tg) AD mouse models. However, whether the ER stress observed in these mouse models is actually caused by AD pathology remains unclear. APP and PS1 contain one and nine transmembrane domains, respectively, for which it has been postulated that overexpressed membrane proteins can become wedged in a misfolded configuration in ER membranes, thereby inducing nonspecific ER stress. Here, we used an App-knockin (KI) AD mouse model that accumulates amyloid-beta (A beta) peptide without overexpressing APP to investigate whether the ER stress response is heightened because of A beta pathology. Thorough examinations indicated that no ER stress responses arose in App-KI or single APP-Tg mice. These results suggest that PS1 overexpression or mutation induced a nonspecific ER stress response that was independent of A beta pathology in the double-Tg mice. Moreover, we observed no ER stress in a mouse model of tauopathy (P301S-Tau-Tg mice) at various ages, suggesting that ER stress is also not essential in tau pathology induced neurodegeneration. We conclude that the role of ER stress in AD pathogenesis needs to be carefully addressed in future studies.	[Hashimoto, Shoko; Ishii, Ayano; Kamano, Naoko; Watamura, Naoto; Saito, Takashi; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Ishii, Ayano; Yokosuka, Makoto] Nippon Vet & Life Sci Univ, Lab Comparat Med, 1-7-1 Kyonancho, Musashino, Tokyo 1808602, Japan; [Watamura, Naoto; Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Lab Mol Brain Sci, Tokyo 1628480, Japan; [Saito, Takashi] Nagoya Univ, Environm Med Res Inst, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan	RIKEN; Nippon Veterinary & Life Science University; Waseda University; Nagoya University	Hashimoto, S; Saido, TC (corresponding author), RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	Shoko-Hashimoto@brain.riken.jp; saido@brain.riken.jp	Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Saido, Takaomi C/0000-0003-1970-6903; Watamura, Naoto/0000-0001-7971-7378; Ishii, Ayano/0000-0002-7732-0681	Ministry of Education, Culture, Sports, Science and Technology (MEXT); RIKEN Special Postdoctoral Research Program; MEXT; RIKEN Brain Science Institute; Japan Agency for Medical Research and Development; Grants-in-Aid for Scientific Research [15K19036] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Special Postdoctoral Research Program; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Brain Science Institute; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for young scientists (B) (a Ministry of Education, Culture, Sports, Science and Technology (MEXT) grant) (to S.H.), research grants from the RIKEN Special Postdoctoral Research Program (to S.H.), a grant-in-aid for scientific research (B) (a MEXT grant) (to T.S.), Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (to T.C.S.), and a research grant from RIKEN Brain Science Institute. S.H., T.S., and T.C.S. serve as a member, advisor and chief executive officer, respectively, for RIKEN RIO Co. Ltd., which sublicenses animal models to for-profit organizations, the profits from which are used for the identification of disease biomarkers.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barbero-Camps E, 2014, AM J PATHOL, V184, P2066, DOI 10.1016/j.ajpath.2014.03.014; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Costa RO, 2013, MOL CELL NEUROSCI, V52, P1, DOI 10.1016/j.mcn.2012.09.005; Endres Kristina, 2013, Am J Neurodegener Dis, V2, P247; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guo Q, 1996, NEUROREPORT, V8, P379, DOI 10.1097/00001756-199612200-00074; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Honarnejad K, 2012, INT J BIOCHEM CELL B, V44, P1983, DOI 10.1016/j.biocel.2012.07.019; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Cornejo VH, 2013, SEMIN IMMUNOPATHOL, V35, P277, DOI 10.1007/s00281-013-0373-9; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kang EB, 2013, APOPTOSIS, V18, P1332, DOI 10.1007/s10495-013-0884-9; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Lee JH, 2010, EXP MOL MED, V42, P386, DOI 10.3858/emm.2010.42.5.040; Nijholt DAT, 2011, CELL DEATH DIFFER, V18, P1071, DOI 10.1038/cdd.2010.176; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Reinhardt S, 2014, FASEB J, V28, P978, DOI 10.1096/fj.13-234864; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato N, 2000, NAT CELL BIOL, V2, P863, DOI 10.1038/35046500; Soejima N, 2013, CURR ALZHEIMER RES, V10, P11; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Terro F, 2002, J NEUROSCI RES, V69, P530, DOI 10.1002/jnr.10312; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010	41	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3118	3125		10.1074/jbc.M117.811315	http://dx.doi.org/10.1074/jbc.M117.811315			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29298895	hybrid, Green Published			2022-12-28	WOS:000426562800007
J	Xu, L; Mowrey, DD; Chirasani, VR; Wang, Y; Pasek, DA; Dokholyan, NV; Meissner, G				Xu, Le; Mowrey, David D.; Chirasani, Venkat R.; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard			G4941K substitution in the pore-lining S6 helix of the skeletal muscle ryanodine receptor increases RyR1 sensitivity to cytosolic and luminal Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; molecular dynamics; mutagenesis; ryanodine receptor; sarcoplasmic reticulum (SR); skeletal muscle	CALCIUM-RELEASE CHANNEL; AMINO-ACID-RESIDUES; SARCOPLASMIC-RETICULUM; ELECTROSTATICS; ACTIVATION; MUTATIONS; COMPLEX	The ryanodine receptor ion channel RyR1 is present in skeletal muscle and has a large cytoplasmic N-terminal domain and smaller C-terminal pore-forming domain comprising six transmembrane helices, a pore helix, and a selectivity filter. The RyR1 S6 pore-lining helix has two conserved glycines, Gly-4934 and Gly-4941, that facilitate RyR1 channel gating by providing S6 flexibility and minimizing amino acid clashes. Here, we report that substitution of Gly-4941 with Asp or Lys results in functional channels as indicated by caffeine-induced Ca2+ release response in HEK293 cells, whereas a low response of the corresponding Gly-4934 variants suggested loss of function. Following purification, the RyR1 mutants G4934D, G4934K, and G4941D did not noticeably conduct Ca2+ in single-channel measurements. Gly-4941 replacement with Lys resulted in channels having reduced K+ conductance and reduced selectivity for Ca2+ compared with wildtype. RyR1-G4941K did not fully close at nanomolar cytosolic Ca2+ concentrations and nearly fully opened at 2 m cytosolic or sarcoplasmic reticulum luminal Ca2+, and Ca2+- and voltage-dependent regulation of RyR1-G4941K mutant channels was demonstrated. Computational methods and single-channel recordings indicated that the open G4941K variant results in the formation of a salt bridge to Asp-4938. In contrast, wildtype RyR1 was closed and not activated by luminal Ca2+ at low cytosolic Ca2+ levels. A model suggested that luminal Ca2+ activates RyR1 by accessing a recently identified cytosolic Ca2+-binding site in the open channel as the Ca2+ ions pass through the pore.	[Xu, Le; Mowrey, David D.; Chirasani, Venkat R.; Wang, Ying; Pasek, Daniel A.; Dokholyan, Nikolay V.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dokholyan, NV; Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	dokh@unc.edu; meissner@med.unc.edu	Xu, Le/HDN-9623-2022; Chirasani, Venkata Reddy/AFN-6812-2022; Chirasani, Venkata Reddy/ABB-4967-2021; Dokholyan, Nikolay/D-8081-2018	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Dokholyan, Nikolay/0000-0002-8225-4025	National Institutes of Health [AR018687]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant AR018687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Euden J, 2013, J BIOL CHEM, V288, P16671, DOI 10.1074/jbc.M113.465310; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gaburjakova J, 2006, J MEMBRANE BIOL, V212, P17, DOI 10.1007/s00232-006-7018-z; Gaburjakova J, 2016, BIOELECTROCHEMISTRY, V109, P49, DOI 10.1016/j.bioelechem.2016.01.002; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gao L, 1997, FEBS LETT, V412, P223, DOI 10.1016/S0014-5793(97)00781-3; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hamilton SL, 2009, J BIOL CHEM, V284, P4047, DOI 10.1074/jbc.R800054200; HerrmannFrank A, 1996, PFLUG ARCH EUR J PHY, V432, P155, DOI 10.1007/s004240050117; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Klauda JB, 2012, J PHYS CHEM B, V116, P9424, DOI 10.1021/jp304056p; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; LEE HB, 1994, J BIOL CHEM, V269, P13305; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marcoline FV, 2015, STRUCTURE, V23, P1526, DOI 10.1016/j.str.2015.05.014; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mei YW, 2015, J BIOL CHEM, V290, P17535, DOI 10.1074/jbc.M115.659672; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Mowrey DD, 2017, J BIOL CHEM, V292, P12947, DOI 10.1074/jbc.M116.760199; Murayama T, 2011, J BIOL CHEM, V286, P35571, DOI 10.1074/jbc.M111.255240; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; SITSAPESAN R, 1995, J MEMBRANE BIOL, V146, P133, DOI 10.1007/BF00238004; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Sun B, 2016, J BIOL CHEM, V291, P26024, DOI 10.1074/jbc.M116.758821; Sutko JL, 1997, PHARMACOL REV, V49, P53; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829; Uehara A, 2017, J GEN PHYSIOL, V149, P199, DOI 10.1085/jgp.201611624; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 2008, J BIOL CHEM, V283, P6321, DOI 10.1074/jbc.M707353200; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yin S, 2007, STRUCTURE, V15, P1567, DOI 10.1016/j.str.2007.09.024; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	54	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2015	2028		10.1074/jbc.M117.803247	http://dx.doi.org/10.1074/jbc.M117.803247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29255089	Green Published, hybrid			2022-12-28	WOS:000424948000015
J	Gates-Tanzer, LT; Shisler, JL				Gates-Tanzer, Lauren T.; Shisler, Joanna L.			Cellular FLIP long isoform (cFLIP(L))-IKK interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFN expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cFLIP(L); IRF7; IKK; IFN; TLR9	TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTORS; I INTERFERON; C-FLIP; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; UBIQUITINATION; INDUCTION; CELLS; GENE	Interferon (IFN) is important for antiviral and anticancer defenses. However, overproduction is associated with autoimmune disorders. Thus, the cell must precisely up- and down-regulate IFN to achieve immune system homeostasis. The cellular FLICE-like inhibitory protein (cFLIP) is reported to inhibit IFN production. However, the mechanism for this antagonism remained unknown. The goal here was to identify this mechanism. Here we examined the signal transduction events that occur during TLR9-induced IRF7 activation. The cFLIP long isoform (cFLIP(L)) inhibited the expression of IRF7-controlled natural or synthetic genes in several cell lines, including those with abundant IRF7 protein levels (e.g. dendritic cells). cFLIP(L) inhibited IRF7 phosphorylation; however, cFLIP(L)-IRF7 interactions were not detectable, implying that cFLIP(L) acted upstream of IRF7 dimerization. Interestingly, cFLIP(L) co-immunoprecipitated with IKK, and these interactions correlated with a loss of IKK-IRF7 interactions. Thus, cFLIP appears to bind to IKK to prevent IKK from phosphorylating and activating IRF7. To the best of our knowledge, this is the first report of a cellular protein that uses this approach to inhibit IRF7 activation. Perhaps this cFLIP property could be engineered to minimize the deleterious effects of IFN expression that occur during certain autoimmune disorders.	[Gates-Tanzer, Lauren T.; Shisler, Joanna L.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Shisler, JL (corresponding author), Dept Microbiol, B103 Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA.	jshisler@illinois.edu			University of Illinois; National Institutes of Health	University of Illinois; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the University of Illinois and the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Balzarolo M, 2012, EUR J IMMUNOL, V42, P3019, DOI 10.1002/eji.201242385; Baratchian M, 2016, J BIOL CHEM, V291, P7608, DOI 10.1074/jbc.M116.718122; Buskiewicz IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096156; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Chen RF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-340; Cheng XG, 2014, J BIOL CHEM, V289, P9146, DOI 10.1074/jbc.M113.534321; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Cortez-Gonzalez X, 2006, DNA CELL BIOL, V25, P253, DOI 10.1089/dna.2006.25.253; Crow MK, 2014, J IMMUNOL, V192, P5459, DOI 10.4049/jimmunol.1002795; Day TW, 2009, ANTICANCER RES, V29, P3883; Ferrao R, 2014, MOL CELL, V55, P891, DOI 10.1016/j.molcel.2014.08.006; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Gates LT, 2016, J IMMUNOL, V197, P923, DOI 10.4049/jimmunol.1502611; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Gordy C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107724; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Hirai M, 2011, BLOOD, V117, P500, DOI 10.1182/blood-2010-05-284737; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2010, J IMMUNOL, V184, P3341, DOI 10.4049/jimmunol.0901648; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Julian MW, 2012, J IMMUNOL, V189, P433, DOI 10.4049/jimmunol.1101375; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kemper C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00306; Kerkmann M, 2003, J IMMUNOL, V170, P4465, DOI 10.4049/jimmunol.170.9.4465; Kitagawa Y, 2013, J VIROL, V87, P7966, DOI 10.1128/JVI.03525-12; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kui L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7462945; Li W, 2013, VIROLOGY, V439, P152, DOI 10.1016/j.virol.2013.02.015; Liang QM, 2011, J IMMUNOL, V186, P1001, DOI 10.4049/jimmunol.1002240; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long LY, 2014, IMMUNITY, V40, P515, DOI 10.1016/j.immuni.2014.01.015; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Naiki Y, 2015, INNATE IMMUN-LONDON, V21, P770, DOI 10.1177/1753425915596844; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Pelka K, 2013, EUR J IMMUNOL, V43, P1693, DOI 10.1002/eji.201343739; Pradhan Vandana D, 2012, Indian J Hum Genet, V18, P155, DOI 10.4103/0971-6866.100750; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Randall CMH, 2014, P NATL ACAD SCI USA, V111, pE265, DOI 10.1073/pnas.1314569111; Reder AT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00281; Safa A. R., 2012, Experimental Oncology, V34, P176; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Song YJ, 2008, P NATL ACAD SCI USA, V105, P18448, DOI 10.1073/pnas.0809933105; Sun L, 2014, EUR J IMMUNOL, V44, P2153, DOI 10.1002/eji.201344310; Sweeney SE, 2011, CELL IMMUNOL, V271, P342, DOI 10.1016/j.cellimm.2011.07.014; Teofilovic NK, 2017, BIOORG MED CHEM LETT, V27, P1530, DOI 10.1016/j.bmcl.2017.02.048; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Wang J, 2013, J IMMUNOL, V191, P3393, DOI 10.4049/jimmunol.1300740; Wang P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004726; Wang Y., 2015, GETMOBILE MOBILE COM, V19, P10, DOI DOI 10.1016/j.febslet.2015.04.019; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Yang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005500; Yang SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26605; Yu YX, 2010, IMMUNITY, V33, P863, DOI 10.1016/j.immuni.2010.11.027; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhou QJ, 2015, J BIOL CHEM, V290, P14729, DOI 10.1074/jbc.M114.633065; Zouali M., 2005, MOL AUTOIMMUNITY COM, P329	79	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1745	1755		10.1074/jbc.RA117.000541	http://dx.doi.org/10.1074/jbc.RA117.000541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222334	Green Published, hybrid			2022-12-28	WOS:000424201700025
J	Tuerde, D; Kimura, T; Miyasaka, T; Furusawa, K; Shimozawa, A; Hasegawa, M; Ando, K; Hisanaga, S				Tuerde, Dilina; Kimura, Taeko; Miyasaka, Tomohiro; Furusawa, Kotaro; Shimozawa, Aki; Hasegawa, Masato; Ando, Kanae; Hisanaga, Shin-ichi			Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; Alzheimer disease; brain; development; phosphorylation; Tau protein (Tau); AT8; Phos-tag; hypothyroidism; isoform	ALZHEIMERS-DISEASE; THYROID-HORMONE; FETAL-TAU; EXON 10; EXPRESSION; CEREBELLUM; NEURODEGENERATION; PLASTICITY; DISORDERS; SEQUENCES	Tau is a microtubule (MT)-associated protein that regulates MT dynamics in the axons of neurons. Tau binds to MTs via its C-terminal MT-binding repeats. There are two types of tau, those with three (3R) or four (4R) MT-binding repeats; 4R tau has a stronger MT-stabilizing activity than 3R tau. The MT-stabilizing activity of tau is regulated by phosphorylation. Interestingly, both the isoform and phosphorylation change at the time of neuronal circuit formation during postnatal development; highly phosphorylated 3R tau is replaced with 4R tau, which is less phosphorylated. However, it is not known how the transition of the isoforms and phosphorylation are regulated. Here, we addressed this question using developing mouse brains. Detailed analysis of developing brains revealed that the switch from 3R to 4R tau occurred during postnatal day 9 (P9) to P18 under the same time course as the conversion of phosphorylation from high to low. However, hypothyroidism, which is known to delay brain development, delayed the timing of tau dephosphorylation but not the exchange of isoforms, indicating that isoform switching and phosphorylation are not necessarily linked. Furthermore, we confirmed this finding by using mouse brains that expressed a single isoform of human tau. Human tau, either 3R or 4R, reduced phosphorylation levels during development even though the isoform did not change. We also found that 3R tau and 4R tau were phosphorylated differently in vivo even at the same developmental days. These results show for the first time that the phosphorylation and isoform alteration of tau are regulated differently during mouse development.	[Tuerde, Dilina; Kimura, Taeko; Furusawa, Kotaro; Ando, Kanae; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Miyasaka, Tomohiro] Doshisha Univ, Fac Life & Med Sci, Neuropathol, Kyotanabe, Kyoto 6100394, Japan; [Shimozawa, Aki; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan University; Doshisha University; Tokyo Metropolitan Institute of Medical Science	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Lab Mol Neurosci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		Miyasaka, Tomohiro/0000-0003-4867-7910; Hisanaga, Shin-ichi/0000-0002-7572-472X	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-aid Project Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control) of Japan (to T. M., M. H., K. A., and S. H.) and by a MEXT grant-in-aid (to S. H. and T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson GW, 2008, CEREBELLUM, V7, P60, DOI 10.1007/s12311-008-0021-4; ANIELLO F, 1991, P NATL ACAD SCI USA, V88, P4035, DOI 10.1073/pnas.88.9.4035; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BRION JP, 1993, J NEUROCHEM, V61, P2071, DOI 10.1111/j.1471-4159.1993.tb07444.x; Bullmann T, 2010, J COMP NEUROL, V518, P2538, DOI 10.1002/cne.22351; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Jovanov-Milosevic N, 2012, INT J BIOCHEM CELL B, V44, P1290, DOI 10.1016/j.biocel.2012.05.001; KENESSEY A, 1993, BRAIN RES, V629, P40, DOI 10.1016/0006-8993(93)90478-6; Kimura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33479; Kimura T, 2016, AM J PATHOL, V186, P398, DOI 10.1016/j.ajpath.2015.10.009; Kimura T, 2013, J BIOL CHEM, V288, P7968, DOI 10.1074/jbc.M112.433326; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Koibuchi N, 2003, CEREBELLUM, V2, P279, DOI 10.1080/14734220310011920; KOSIK KS, 1989, NEURON, V2, P1389, DOI 10.1016/0896-6273(89)90077-9; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Lu M, 2001, MOL BIOL CELL, V12, P171, DOI 10.1091/mbc.12.1.171; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Nikolakaki E, 2001, J BIOL CHEM, V276, P40175, DOI 10.1074/jbc.M104755200; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Oyanagi K, 2015, J NEUROSCI RES, V93, P592, DOI 10.1002/jnr.23519; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Qian W, 2014, NEUROSCI BULL, V30, P367, DOI 10.1007/s12264-013-1411-2; Quignodon L, 2007, J MOL ENDOCRINOL, V39, P17, DOI 10.1677/JME-06-0054; Sawano E, 2013, J NEUROSCI RES, V91, P382, DOI 10.1002/jnr.23161; Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Singh TJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P43, DOI 10.1006/abbi.1996.0140; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Sugiyama S, 2009, DEV GROWTH DIFFER, V51, P369, DOI 10.1111/j.1440-169X.2009.01093.x; Takahashi M, 2008, J NEUROCHEM, V104, P640, DOI 10.1111/j.1471-4159.2007.05049.x; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7; Wada Y, 1998, J BIOCHEM-TOKYO, V124, P738, DOI 10.1093/oxfordjournals.jbchem.a022174; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Yin XM, 2012, J BIOL CHEM, V287, P30497, DOI 10.1074/jbc.M112.355412; Yoshioka N, 2011, J NEUROSCI RES, V89, P381, DOI 10.1002/jnr.22552; Yu Y, 2009, J NEUROCHEM, V108, P1480, DOI 10.1111/j.1471-4159.2009.05882.x	53	29	29	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1781	1793		10.1074/jbc.M117.798918	http://dx.doi.org/10.1074/jbc.M117.798918			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29196605	Green Published, hybrid			2022-12-28	WOS:000424201700028
J	Yue, YY; Jiang, MY; He, LQQ; Zhang, ZJJ; Zhang, QX; Gu, C; Liu, MJ; Li, N; Zhao, QS				Yue, Yunyun; Jiang, Mingyang; He, Luqingqing; Zhang, Zhaojunjie; Zhang, Qinxin; Gu, Chun; Liu, Meijing; Li, Nan; Zhao, Qingshun			The transcription factor Foxc1a in zebrafish directly regulates expression of nkx2.5, encoding a transcriptional regulator of cardiac progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiogenesis; Foxc1a; nkx2; 5; zebrafish	2ND HEART FIELD; AXENFELD-RIEGER-SYNDROME; CARDIOVASCULAR DEVELOPMENT; VENTRICULAR IDENTITY; BREAST-CANCER; GENE; MUTATIONS; DISEASE; CARDIOMYOGENESIS; SYSTEM	Cardiogenesis is a tightly controlled biological process required for formation of a functional heart. The transcription factor Foxc1 not only plays a crucial role in outflow tract development in mice, but is also involved in cardiac structure formation and normal function in humans. However, the molecular mechanisms by which Foxc1 controls cardiac development remain poorly understood. Previously, we reported that zebrafish embryos deficient in foxc1a, an ortholog of mammalian Foxc1, display pericardial edemas and die 9-10 days postfertilization. To further investigate Foxc1a's role in zebrafish cardiogenesis and identify its downstream target genes during early heart development, we comprehensively analyzed the cardiovascular phenotype of foxc1a-null zebrafish embryos. Our results confirmed that foxc1a-null mutants exhibit disrupted cardiac morphology, structure, and function. Performing transcriptome analysis on the foxc1a mutants, we found that the expression of the cardiac progenitor marker gene nkx2.5 was significantly decreased, but the expression of germ layer-patterning genes was unaffected. Dual-fluorescence in situ hybridization assays revealed that foxc1a and nkx2.5 are co-expressed in the anterior lateral plate mesoderm at the somite stage. Chromatin immunoprecipitation and promoter truncation assays disclosed that Foxc1a regulates nkx2.5 expression via direct binding to two noncanonical binding sites in the proximal nkx2.5 promoter. Moreover, functional rescue experiments revealed that developmental stage-specific nkx2.5 overexpression partially rescues the cardiac defects of the foxc1a-null embryos. Taken together, our results indicate that during zebrafish cardiogenesis, Foxc1a is active directly upstream of nkx2.5.	[Yue, Yunyun; Jiang, Mingyang; He, Luqingqing; Zhang, Zhaojunjie; Zhang, Qinxin; Gu, Chun; Liu, Meijing; Li, Nan; Zhao, Qingshun] Nanjing Univ, Key Lab Model Anim Dis Study, Minist Educ, Model Anim Res Ctr, 12 Xuefu Rd,Pukou Hightech Dev Zone, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Zhao, QS (corresponding author), Nanjing Univ, Key Lab Model Anim Dis Study, Minist Educ, Model Anim Res Ctr, 12 Xuefu Rd,Pukou Hightech Dev Zone, Nanjing 210061, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			National Natural Science Foundation of China [31471355, 31671518]; Graduate Student Research and Innovation Program of Jiangsu Province [KYZZ15_0041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Research and Innovation Program of Jiangsu Province	This work was supported by the National Natural Science Foundation of China Grants 31471355 and 31671518 and Graduate Student Research and Innovation Program of Jiangsu Province Grant KYZZ15_0041. The authors declare that they have no conflicts of interest with the contents of this article.	Berry FB, 2006, HUM MOL GENET, V15, P905, DOI 10.1093/hmg/ddl008; Berry FB, 2002, J BIOL CHEM, V277, P10292, DOI 10.1074/jbc.M110266200; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Chang SW, 2013, HUM MUTAT, V34, P1226, DOI 10.1002/humu.22366; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Du J, 2012, BREAST CANCER RES TR, V131, P65, DOI 10.1007/s10549-011-1396-3; Du RF, 2016, OPHTHALMIC GENET, V37, P111, DOI 10.3109/13816810.2014.924016; George V, 2015, DEV BIOL, V400, P10, DOI 10.1016/j.ydbio.2014.12.019; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Gripp KW, 2013, AM J MED GENET A, V161A, P114, DOI 10.1002/ajmg.a.35697; Guner-Ataman B, 2013, DEVELOPMENT, V140, P1353, DOI 10.1242/dev.088351; Han BC, 2015, CELL REP, V13, P1046, DOI 10.1016/j.celrep.2015.09.063; Hannenhalli S, 2006, CIRCULATION, V114, P1269, DOI 10.1161/CIRCULATIONAHA.106.632430; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; Honkanen RA, 2003, AM J OPHTHALMOL, V135, P368, DOI 10.1016/S0002-9394(02)02061-5; Jain R, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6071; Jay P. Y., 2003, NOVART FDN SYMP, V250, P238; Jay P. Y., 2003, NOVART FDN SYMP, V250, P276; Jay Patrick Y, 2003, Novartis Found Symp, V250, P227; KAUFMANN E, 1995, J MOL BIOL, V248, P239, DOI 10.1006/jmbi.1995.0218; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Lambers E, 2016, DEV DYNAM, V245, P751, DOI [10.1002/dvdy.24397, 10.1002/DVDY.24397]; Lambers E, 2016, STEM CELLS, V34, P1487, DOI 10.1002/stem.2301; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Li J, 2015, CELL RES, V25, P634, DOI 10.1038/cr.2015.43; Li JY, 2015, J BIOL CHEM, V290, P10216, DOI 10.1074/jbc.M114.612572; Li JB, 2016, ZEBRAFISH, V13, P9, DOI 10.1089/zeb.2015.1117; Li JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092728; Liang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030865; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Nakashima Y, 2014, CIRC RES, V114, P1103, DOI 10.1161/CIRCRESAHA.114.303219; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seo S, 2006, DEV BIOL, V296, P421, DOI 10.1016/j.ydbio.2006.06.012; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Targoff KL, 2013, DEVELOPMENT, V140, P4203, DOI 10.1242/dev.095562; Tong YF, 2016, GENE, V588, P86, DOI 10.1016/j.gene.2016.04.061; Veldman MB, 2012, CIRC RES, V110, P220, DOI 10.1161/CIRCRESAHA.111.251298; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Yeo HC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31068; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094; Zhu H, 2016, LIFE SCI, V144, P194, DOI 10.1016/j.lfs.2015.12.001	48	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					638	650		10.1074/jbc.RA117.000414	http://dx.doi.org/10.1074/jbc.RA117.000414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162723	Green Published, hybrid			2022-12-28	WOS:000419915400019
J	Noborn, F; Toledo, AG; Nasir, W; Nilsson, J; Dierker, T; Kjellen, L; Larson, G				Noborn, Fredrik; Toledo, Alejandro Gomez; Nasir, Waqas; Nilsson, Jonas; Dierker, Tabea; Kjellen, Lena; Larson, Goran			Expanding the chondroitin glycoproteome of Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); chondroitin; glycosaminoglycan; mass spectrometry (MS); proteoglycan; proteoglycan structure	SULFATE PROTEOGLYCANS; EXTRACELLULAR-MATRIX; CORE PROTEIN; IDENTIFICATION; BIOSYNTHESIS; HEPARAN; MS/MS; GLYCOSAMINOGLYCANS; GLYCOPEPTIDES; MORPHOGENESIS	Chondroitin sulfate proteoglycans (CSPGs) are important structural components of connective tissues in essentially all metazoan organisms. In vertebrates, CSPGs are involved also in more specialized processes such as neurogenesis and growth factor signaling. In invertebrates, however, knowledge of CSPGs core proteins and proteoglycan-related functions is relatively limited, even for Caenorhabditis elegans. This nematode produces large amounts of non-sulfated chondroitin in addition to low-sulfated chondroitin sulfate chains. So far, only nine core proteins (CPGs) have been identified, some of which have been shown to be involved in extracellular matrix formation. We recently introduced a protocol to characterize proteoglycan core proteins by identifying CS-glycopeptides with a combination of biochemical enrichment, enzymatic digestion, and nano-scale liquid chromatography MS/MS analysis. Here, we have used this protocol to map the chondroitin glycoproteome in C. elegans, resulting in the identification of 15 novel CPG proteins in addition to the nine previously established. Three of the newly identified CPGs displayed homology to vertebrate proteins. Bioinformatics analysis of the primary protein sequences revealed that the CPG proteins altogether contained 19 unique functional domains, including Kunitz and endostatin domains, suggesting direct involvement in protease inhibition and axonal migration, respectively. The analysis of the core protein domain organization revealed that all chondroitin attachment sites are located in unstructured regions. Our results suggest that CPGs display a much greater functional and structural heterogeneity than previously appreciated and indicate that specialized proteoglycan-mediated functions evolved early in metazoan evolution.	[Noborn, Fredrik; Toledo, Alejandro Gomez; Nasir, Waqas; Nilsson, Jonas; Larson, Goran] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, SE-41345 Gothenburg, Sweden; [Dierker, Tabea; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	University of Gothenburg; Uppsala University	Larson, G (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Bruna Straket 16, SE-41345 Gothenburg, Sweden.	goran.larson@clinchem.gu.se	Larson, Göran/AAF-3404-2019	Nilsson, Jonas/0000-0001-5263-2454; Larson, Goran/0000-0002-2616-0366	Swedish Research Council [8266]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grant 8266 (to G. L.) and by governmental grants to the Sahlgrenska University Hospital (to G. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Bartolomucci A, 2011, ENDOCR REV, V32, P755, DOI 10.1210/er.2010-0027; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dierker T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34662; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Halim A, 2014, J PROTEOME RES, V13, P6024, DOI 10.1021/pr500898r; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Izumikawa T, 2016, J BIOL CHEM, V291, P23294, DOI 10.1074/jbc.M116.757328; Kelley M, 2015, ELIFE, V4, DOI 10.7554/eLife.06565; King SL, 2017, BLOOD ADV, V1, P429, DOI 10.1182/bloodadvances.2016002121; KJELLEN L, 1989, BIOCHEM J, V263, P105, DOI 10.1042/bj2630105; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Nasir W, 2016, J PROTEOME RES, V15, P2826, DOI 10.1021/acs.jproteome.6b00417; Noborn F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34537; Noborn F, 2015, MOL CELL PROTEOMICS, V14, P41, DOI 10.1074/mcp.M114.043703; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Pedersen ME, 2013, SCIENCE, V341, P1404, DOI 10.1126/science.1242528; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Siebert JR, 2011, J NEUROCHEM, V119, P176, DOI 10.1111/j.1471-4159.2011.07370.x; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Yu J, 2016, CHEM-EUR J, V22, P1114, DOI 10.1002/chem.201503659	38	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					379	389		10.1074/jbc.M117.807800	http://dx.doi.org/10.1074/jbc.M117.807800			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29138239	hybrid, Green Published			2022-12-28	WOS:000419453200032
J	Rodarte, EM; Ramos, MA; Davalos, AJ; Moreira, DC; Moreno, DS; Cardenas, EI; Rodarte, AI; Petrova, Y; Molina, S; Rendon, LE; Sanchez, E; Breaux, K; Tortoriello, A; Manllo, J; Gonzalez, EA; Tuvim, MJ; Dickey, BF; Burns, AR; Heidelberger, R; Adachi, R				Rodarte, Elsa M.; Ramos, Marco A.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Petrova, Youlia; Molina, Sofia; Rendon, Luis E.; Sanchez, Elizabeth; Breaux, Keegan; Tortoriello, Alejandro; Manllo, John; Gonzalez, Erika A.; Tuvim, Michael J.; Dickey, Burton F.; Burns, Alan R.; Heidelberger, Ruth; Adachi, Roberto			Munc13 proteins control regulated exocytosis in mast cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; exocytosis; immunoglobulin E (IgE); mast cell; SNARE proteins; Munc13; anaphylaxis	READILY RELEASABLE POOL; CAPACITANCE MEASUREMENTS; FUSION-COMPETENCE; IL-6 PRODUCTION; TNF-ALPHA; GRANULES; DEGRANULATION; SECRETION; TRYPTASE; GENE	Mast cells (MCs) are involved in host defenses against pathogens and inflammation. Stimulated MCs release substances stored in their granules via regulated exocytosis. In other cell types, Munc13 (mammalian homolog of Caenorhabditis elegans uncoordinated gene 13) proteins play essential roles in regulated exocytosis. Here, we found that MCs express Munc13-2 and -4, and we studied their roles using global and conditional knock-out (KO) mice. In a model of systemic anaphylaxis, we found no difference between WT and Munc13-2 KO mice, but global and MC-specific Munc13-4 KO mice developed less hypothermia. This protection correlated with lower plasma histamine levels and with histological evidence of defective MC degranulation but not with changes in MC development, distribution, numbers, or morphology. In vitro assays revealed that the defective response in Munc13-4-deficient MCs was limited to regulated exocytosis, leaving other MC secretory effector responses intact. Single cell capacitance measurements in MCs from mouse mutants differing in Munc13-4 expression levels in their MCs revealed that as levels of Munc13-4 decrease, the rate of exocytosis declines first, and then the total amount of exocytosis decreases. A requirement for Munc13-2 in MC exocytosis was revealed only in the absence of Munc13-4. Electrophysiology and EM studies uncovered that the number of multigranular compound events (i.e. granule-to-granule homotypic fusion) was severely reduced in the absence of Munc13-4. We conclude that although Munc13-2 plays a minor role, Munc13-4 is essential for regulated exocytosis in MCs, and that this MC effector response is required for a full anaphylactic response.	[Rodarte, Elsa M.; Ramos, Marco A.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Petrova, Youlia; Molina, Sofia; Rendon, Luis E.; Sanchez, Elizabeth; Breaux, Keegan; Tortoriello, Alejandro; Manllo, John; Gonzalez, Erika A.; Tuvim, Michael J.; Dickey, Burton F.; Adachi, Roberto] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA; [Rodarte, Elsa M.; Davalos, Alfredo J.; Moreira, Daniel C.; Moreno, David S.; Cardenas, Eduardo I.; Rodarte, Alejandro I.; Molina, Sofia; Tortoriello, Alejandro; Gonzalez, Erika A.] Tecnol Monterrey, Escuela Med & Ciencias Salud Monterrey, Nuevo Leon 64710, Mexico; [Burns, Alan R.] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Heidelberger, Ruth] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; UTMD Anderson Cancer Center; Tecnologico de Monterrey; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston	Adachi, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	radachi@mdanderson.org		Cardenas, Eduardo/0000-0001-5973-5675; Adachi, Roberto/0000-0002-0146-0768; Rodarte, Elsa M./0000-0001-7138-0790; Moreno McNeill, David/0000-0003-0049-1770; Tuvim, Michael/0000-0001-8126-7716; Heidelberger, Ruth/0000-0002-8033-2050	National Institutes of Health [AI093533, HL129795, CA016672, EY007551, EY018239]; Cancer Prevention Research Institute of Texas [RP110166]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018239, P30EY007551] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097000, R01HL129795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grants AI093533, HL129795, CA016672, EY007551, and EY018239 and the Cancer Prevention Research Institute of Texas Grant RP110166. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi R, 2012, J BIOL CHEM, V287, P20047, DOI 10.1074/jbc.M112.360388; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Beil WJ, 1996, INT ARCH ALLERGY IMM, V109, P383, DOI 10.1159/000237267; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; Betz A, 1997, J BIOL CHEM, V272, P2520; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; BROCK TA, 1988, AM J PHYSIOL, V255, pC667, DOI 10.1152/ajpcell.1988.255.5.C667; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Bulfone-Paus S, 2017, TRENDS IMMUNOL, V38, P657, DOI 10.1016/j.it.2017.01.008; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cairns JA, 1996, J IMMUNOL, V156, P275; Camacho M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15293; Chen ZX, 2013, J NEUROSCI, V33, P8336, DOI 10.1523/JNEUROSCI.5128-12.2013; Dernick G, 2007, FRONT NEUROENG, V1, P315; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Dudenhoffer-Pfeifer M, 2013, TRAFFIC, V14, P798, DOI 10.1111/tra.12074; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; FAWCETT DW, 1954, J EXP MED, V100, P217, DOI 10.1084/jem.100.2.217; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; FINKELSTEIN A, 1986, ANNU REV PHYSIOL, V48, P163, DOI 10.1146/annurev.ph.48.030186.001115; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Gupta AA, 1996, J IMMUNOL, V157, P2123; Hamilton MJ, 2011, P NATL ACAD SCI USA, V108, P290, DOI 10.1073/pnas.1005758108; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Higashio H, 2008, J IMMUNOL, V180, P4774, DOI 10.4049/jimmunol.180.7.4774; Higashio H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22539; Hogan AD, 1997, METHODS, V13, P43, DOI 10.1006/meth.1997.0494; Jahn R, 2004, ANN NY ACAD SCI, V1014, P170, DOI 10.1196/annals.1294.018; Kaeser PS, 2017, CURR OPIN NEUROBIOL, V43, P63, DOI 10.1016/j.conb.2016.12.012; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; Kulka M, 2008, IMMUNOLOGY, V123, P398, DOI 10.1111/j.1365-2567.2007.02705.x; Lai Y, 2017, NEURON, V95, P591, DOI 10.1016/j.neuron.2017.07.004; LEALBERUMEN I, 1994, J IMMUNOL, V152, P5468; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13696; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Makabe-Kobayashi Y, 2002, J ALLERGY CLIN IMMUN, V110, P298, DOI 10.1067/mai.2002.125977; Marshall JS, 1996, J CLIN INVEST, V97, P1122, DOI 10.1172/JCI118506; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Melicoff E, 2009, J BIOL CHEM, V284, P19445, DOI 10.1074/jbc.M109.002550; Michelassi F, 2017, NEURON, V95, P577, DOI 10.1016/j.neuron.2017.07.015; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; Olszewski MB, 2007, J IMMUNOL, V178, P5701, DOI 10.4049/jimmunol.178.9.5701; Olszewski MB, 2006, EUR J IMMUNOL, V36, P997, DOI 10.1002/eji.200535323; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; ROYET JP, 1991, PROG NEUROBIOL, V37, P433, DOI 10.1016/0301-0082(91)90009-P; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Singh RK, 2013, FEBS J, V280, P892, DOI 10.1111/febs.12081; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Thakurdas SM, 2007, J BIOL CHEM, V282, P20809, DOI 10.1074/jbc.M611842200; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woo SS, 2017, MOL BIOL CELL, V28, P792, DOI 10.1091/mbc.E16-08-0617; Xu JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22567; Yang XY, 2015, NAT STRUCT MOL BIOL, V22, P547, DOI 10.1038/nsmb.3038; Yu YY, 2016, EUR J PHARMACOL, V780, P115, DOI 10.1016/j.ejphar.2016.03.038	83	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					345	358		10.1074/jbc.M117.816884	http://dx.doi.org/10.1074/jbc.M117.816884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29141910	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000419453200029
J	Shanker, S; Schaefer, GK; Barnhart, BK; Wallace-Kneale, VL; Chang, D; Coyle, TJ; Metzler, DA; Huang, J; Lawton, JA				Shanker, Sreejesh; Schaefer, Grace K.; Barnhart, Benjamin K.; Wallace-Kneale, Vicki L.; Chang, Dorsin; Coyle, Thomas J.; Metzler, David A.; Huang, Jeffrey; Lawton, Jeffrey A.			The virulence-associated protein HsvA from the fire blight pathogen Erwinia amylovora is a polyamine amidinotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; polyamine; protein structure; virulence factor; X-ray crystallography; amidinotransferase; fire blight	L-ARGININEGLYCINE AMIDINOTRANSFERASE; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; HOG KIDNEY; BIOSYNTHESIS; TRANSAMIDINASE; PURIFICATION; IDENTIFICATION; PHASEOLOTOXIN; HOMOARGININE	Studies of virulence determinants in the bacterial phytopathogen Erwinia amylovora, the cause of devastating fire blight disease in apple and pear, have shown that HsvA, a putative amidinotransferase enzyme located in the Hrp pathogenicity island, is required for systemic infection in apple. However, the mechanism by which HsvA contributes to virulence is unclear. To investigate the role of HsvA in virulence, we carried out a series of biochemical and structural studies to characterize the amidinotransferase activity of HsvA. We found that HsvA displays a preference for linear aliphatic polyamines as the amidino acceptor substrate, especially for spermidine and putrescine (K-m values of 33 m and 3.9 mm, respectively). The three-dimensional structure, determined at 2.30 resolution using X-ray crystallography, revealed that the overall architecture of HsvA is similar to that of the human arginine-glycine amidinotransferase in the creatine biosynthesis pathway. The active site is located in the core of the protein at the base of a long, narrow substrate access channel. Specific amino acids near the entrance of the channel may serve as major determinants of the substrate specificity, including a glutamate residue at the rim of the channel entrance that appears to be positioned to interact with the distal primary amine in the putrescine substrate as well as the internal and distal amines in the spermidine substrate. These results suggest potential in vivo functions for HsvA as a virulence factor in fire blight and may also provide a basis for strategies to control fire blight by inhibiting HsvA activity.	[Shanker, Sreejesh] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Schaefer, Grace K.; Barnhart, Benjamin K.; Wallace-Kneale, Vicki L.; Chang, Dorsin; Coyle, Thomas J.; Metzler, David A.; Huang, Jeffrey; Lawton, Jeffrey A.] Eastern Univ, Dept Chem, 1300 Eagle Rd, St Davids, PA 19087 USA	Baylor College of Medicine	Lawton, JA (corresponding author), Eastern Univ, Dept Chem, 1300 Eagle Rd, St Davids, PA 19087 USA.	jlawton@eastern.edu			Cottrell College Science Award from the Research Corporation for Science Advancement [7714]; HBE Foundation; VWR Charitable Foundation; Eastern University Office of the Provost; Eastern University Department of Chemistry	Cottrell College Science Award from the Research Corporation for Science Advancement; HBE Foundation; VWR Charitable Foundation; Eastern University Office of the Provost; Eastern University Department of Chemistry	This work was supported in part by Cottrell College Science Award 7714 from the Research Corporation for Science Advancement (to J. A. L.) and funding from the HBE Foundation, the VWR Charitable Foundation, the Eastern University Office of the Provost, and the Eastern University Department of Chemistry. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baron-Sola A, 2013, MICROBIOLOGYOPEN, V2, P447, DOI 10.1002/mbo3.78; Bartolomeo Maria Paola, 2006, J Biomol Tech, V17, P131; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; CONCONI F, 1965, J BIOL CHEM, V240, P2461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FEISTNER GJ, 1993, ORG MASS SPECTROM, V28, P163, DOI 10.1002/oms.1210280307; FEISTNER GJ, 1994, BIOL MASS SPECTROM, V23, P793, DOI 10.1002/bms.1200231212; Fritsche E, 1997, EUR J BIOCHEM, V247, P483, DOI 10.1111/j.1432-1033.1997.00483.x; Fritsche E, 1998, BIOCHEMISTRY-US, V37, P17664, DOI 10.1021/bi981949p; GRAZI E, 1968, J BIOL CHEM, V243, P538; Hernandez-Guzman G, 2001, MOL PLANT MICROBE IN, V14, P545, DOI 10.1094/MPMI.2001.14.4.545; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Humm A, 1997, BIOL CHEM, V378, P193; Jelsbak L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036149; Jimenez-Bremont JF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00095; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jung YG, 2003, FEMS MICROBIOL LETT, V219, P285, DOI 10.1016/S0378-1097(03)00019-3; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Lee GT, 2002, PHYTOCHEMISTRY, V61, P781, DOI 10.1016/S0031-9422(02)00401-6; Li M, 2016, FEBS OPEN BIO, V6, P603, DOI 10.1002/2211-5463.12071; Malnoy M, 2012, ANNU REV PHYTOPATHOL, V50, P475, DOI 10.1146/annurev-phyto-081211-172931; MARKISCH U, 1990, J BASIC MICROB, V30, P425, DOI 10.1002/jobm.3620300611; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Molnar-Perl I, 2011, J CHROMATOGR B, V879, P1241, DOI 10.1016/j.jchromb.2011.01.027; Muenchhoff J, 2012, FEBS J, V279, P805, DOI 10.1111/j.1742-4658.2012.08472.x; Muenchhoff J, 2010, FEBS J, V277, P3844, DOI 10.1111/j.1742-4658.2010.07788.x; National Agricultural Statistics Service, 2016, NONC FRUITS NUTS 201; Norelli JL, 2003, PLANT DIS, V87, P756, DOI 10.1094/PDIS.2003.87.7.756; Ogasawara Y, 2016, BIOORG MED CHEM LETT, V26, P3662, DOI 10.1016/j.bmcl.2016.05.090; Oh CS, 2005, MOL PLANT PATHOL, V6, P125, DOI 10.1111/j.1364-3703.2005.00269.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rambaut A., 2014, FIGTREE PHYLOGENETIC; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; SRIVENUGOPAL KS, 1980, BIOCHEM J, V189, P553, DOI 10.1042/bj1890553; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Walker J B, 1979, Adv Enzymol Relat Areas Mol Biol, V50, P177; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wortham BW, 2010, ENVIRON MICROBIOL, V12, P2034, DOI 10.1111/j.1462-2920.2010.02219.x; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106	45	4	4	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21366	21380		10.1074/jbc.M117.815951	http://dx.doi.org/10.1074/jbc.M117.815951			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123034	Green Published, hybrid			2022-12-28	WOS:000419013000013
J	Chemin, J; Taiakina, V; Monteil, A; Piazza, M; Guan, W; Stephens, RF; Kitmitto, A; Pang, ZPP; Dolphin, AC; Perez-Reyes, E; Dieckmann, T; Guillemette, JG; Spafford, JD				Chemin, Jean; Taiakina, Valentina; Monteil, Arnaud; Piazza, Michael; Guan, Wendy; Stephens, Robert F.; Kitmitto, Ashraf; Pang, Zhiping P.; Dolphin, Annette C.; Perez-Reyes, Edward; Dieckmann, Thorsten; Guillemette, Joseph Guy; Spafford, J. David			Calmodulin regulates Ca(v)3 T-type channels at their gating brake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; circular dichroism (CD); cryo-electron microscopy; gating; isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); patch clamp; short hairpin RNA (shRNA)	VOLTAGE-GATED CALCIUM; CHILDHOOD ABSENCE EPILEPSY; PROTEIN SECONDARY STRUCTURE; PLASMA-MEMBRANE EXPRESSION; I-II LOOP; CA2+ CHANNEL; DEPENDENT INACTIVATION; SODIUM-CHANNEL; CA2+-DEPENDENT INACTIVATION; FUNCTIONAL-CHARACTERIZATION	Calcium (Ca(v)1 and Ca(v)2) and sodium channels possess homologous CaM-binding motifs, known as IQ motifs in their C termini, which associate with calmodulin (CaM), a universal calcium sensor. Ca(v)3 T-type channels, which serve as pacemakers of the mammalian brain and heart, lack a C-terminal IQ motif. We illustrate that T-type channels associate with CaM using co-immunoprecipitation experiments and single particle cryo-electron microscopy. We demonstrate that protostome invertebrate (LCa(v)3) and human Ca(v)3.1, Ca(v)3.2, and Ca(v)3.3 T-type channels specifically associate with CaM at helix 2 of the gating brake in the I-II linker of the channels. Isothermal titration calorimetry results revealed that the gating brake and CaM bind each other with high-nanomolar affinity. We show that the gating brake assumes a helical conformation upon binding CaM, with associated conformational changes to both CaM lobes as indicated by amide chemical shifts of the amino acids of CaM in H-1-N-15 HSQC NMR spectra. Intact Ca2+-binding sites on CaM and an intact gating brake sequence (first 39 amino acids of the I-II linker) were required in Ca(v)3.2 channels to prevent the runaway gating phenotype, a hyperpolarizing shift in voltage sensitivities and faster gating kinetics. We conclude that the presence of high-nanomolar affinity binding sites for CaM at its universal gating brake and its unique form of regulation via the tuning of the voltage range of activity could influence the participation of Ca(v)3 T-type channels in heart and brain rhythms. Our findings may have implications for arrhythmia disorders arising from mutations in the gating brake or CaM.	[Chemin, Jean; Monteil, Arnaud] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct, F-34094 Montpellier, France; [Taiakina, Valentina; Piazza, Michael; Dieckmann, Thorsten; Guillemette, Joseph Guy] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada; [Guan, Wendy; Stephens, Robert F.; Spafford, J. David] Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada; [Kitmitto, Ashraf] Univ Manchester, Fac Biol Med & Hlth, Div Cardiovasc Sci, Manchester M13 9NT, Lancs, England; [Pang, Zhiping P.] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, New Brunswick, NJ 08901 USA; [Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Waterloo; University of Waterloo; University of Manchester; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of London; University College London; University of Virginia	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Pang, Zhiping/AAF-5757-2020; Monteil, Arnaud/G-3113-2012; Dolphin, Annette/F-7416-2010	Monteil, Arnaud/0000-0003-1632-7318; Dolphin, Annette/0000-0003-4626-4856; Perez-Reyes, Edward/0000-0001-6237-3863; Pang, Zhiping/0000-0002-6183-1233; chemin, jean/0000-0002-6089-5964; Kitmitto, Ashraf/0000-0001-8971-017X	Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; British Heart Foundation; LabEx "Ion Channel Science and Therapeutics"; National Institutes of Health [NS067456]; NSERC Canada Graduate Scholarship; University of Waterloo;  [ANR-10-BLAN-1601]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067456] Funding Source: NIH RePORTER; Medical Research Council [G0901758, G0801756] Funding Source: researchfish; MRC [G0801756, G0901758] Funding Source: UKRI	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); British Heart Foundation(British Heart Foundation); LabEx "Ion Channel Science and Therapeutics"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Waterloo; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Heart and Stroke Foundation of Canada grant-in-aid (to J.D.S.), Natural Sciences and Engineering Research Council of Canada Discovery grants (to J.D.S., T.D., and J.G.G.), British Heart Foundation (to A. K.), LabEx "Ion Channel Science and Therapeutics" and ANR-10-BLAN-1601 (to J.C. and A.M.), National Institutes of Health Grant NS067456 (to E.P.-R.), an NSERC Canada Graduate Scholarship (to V.T.), and research incentive funds from University of Waterloo. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Bae J, 2010, MOL CELLS, V30, P185, DOI 10.1007/s10059-010-0106-z; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Ben-Johny M, 2015, CURR MOL PHARMACOL, V8, P188, DOI 10.2174/1874467208666150507110359; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; BREHM P, 1978, J PHYSIOL-LONDON, V274, P639, DOI 10.1113/jphysiol.1978.sp012171; BREHM P, 1978, J PHYSIOL-LONDON, V283, P557, DOI 10.1113/jphysiol.1978.sp012519; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; Broecker J, 2011, ANAL BIOCHEM, V418, P307, DOI 10.1016/j.ab.2011.07.027; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Carbone E, 2014, PFLUG ARCH EUR J PHY, V466, P677, DOI 10.1007/s00424-014-1489-z; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; CHEN RF, 1968, ANAL BIOCHEM, V25, P412, DOI 10.1016/0003-2697(68)90116-4; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Cheong E, 2013, PHYSIOL REV, V93, P961, DOI 10.1152/physrev.00010.2012; Cribbs LL, 2010, CHANNELS, V4, P447, DOI 10.4161/chan.4.6.12870; Dawson TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092941; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Findeisen F, 2010, CHANNELS, V4, P459, DOI 10.4161/chan.4.6.12867; Freiburger LA, 2009, CHEMBIOCHEM, V10, P2871, DOI 10.1002/cbic.200900614; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; Gray LS, 2013, EXPERT REV ANTICANC, V13, P589, DOI [10.1586/ERA.13.34, 10.1586/era.13.34]; Halling D Brent, 2006, Sci STKE, V2006, per1; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jeziorski MC, 1998, J BIOL CHEM, V273, P22792, DOI 10.1074/jbc.273.35.22792; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; KINCAID RL, 1982, J BIOL CHEM, V257, P638; KINK JA, 1990, CELL, V62, P165, DOI 10.1016/0092-8674(90)90250-I; Kovalevskaya NV, 2013, PFLUG ARCH EUR J PHY, V465, P1507, DOI 10.1007/s00424-013-1278-0; Kuo IYT, 2014, PFLUG ARCH EUR J PHY, V466, P767, DOI 10.1007/s00424-013-1430-x; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee N, 2017, MOL PHARMACOL, V92, P347, DOI 10.1124/mol.117.108530; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Liang J, 2007, ANN HUM GENET, V71, P325, DOI 10.1111/j.1469-1809.2006.00332.x; Liebeskind BJ, 2011, P NATL ACAD SCI USA, V108, P9154, DOI 10.1073/pnas.1106363108; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Mesirca P, 2014, PFLUG ARCH EUR J PHY, V466, P791, DOI 10.1007/s00424-014-1482-6; Pang ZP, 2010, J BIOL CHEM, V285, P33930, DOI 10.1074/jbc.M110.150151; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 2014, PFLUG ARCH EUR J PHY, V466, P627, DOI 10.1007/s00424-013-1419-5; Perez-Reyes E, 2010, CHANNELS, V4, P453, DOI 10.4161/chan.4.6.12889; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Piazza M, 2014, BIOCHEMISTRY-US, V53, P1241, DOI 10.1021/bi401466s; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Sarhan MF, 2009, J BIOL CHEM, V284, P33265, DOI 10.1074/jbc.M109.052910; Schauer-Vukasinovic V, 2002, ANAL BIOANAL CHEM, V373, P501, DOI 10.1007/s00216-002-1351-6; Senatore A, 2014, PFLUG ARCH EUR J PHY, V466, P645, DOI 10.1007/s00424-014-1449-7; Senatore A, 2014, J BIOL CHEM, V289, P11952, DOI 10.1074/jbc.M114.551473; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Smith CL, 2017, J GEN PHYSIOL, V149, P483, DOI 10.1085/jgp.201611683; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Spafford J. D., 2011, JOVE-J VIS EXP, V47, P2314; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Splawski I, 2006, J BIOL CHEM, V281, P22085, DOI 10.1074/jbc.M603316200; Stephens RF, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00153; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Taiakina V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061765; Tan BZ, 2011, J BIOL CHEM, V286, P42725, DOI 10.1074/jbc.M111.265207; Tan GMY, 2012, J BIOL CHEM, V287, P832, DOI 10.1074/jbc.M111.268722; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Walsh CP, 2009, J BIOL CHEM, V284, P22310, DOI 10.1074/jbc.M109.017152; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Whitmore L., 2004, NUCLEIC ACIDS RES, V89, pW668; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang PS, 2014, NAT CHEM BIOL, V10, P231, DOI [10.1038/NCHEMBIO.1436, 10.1038/nchembio.1436]; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	91	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20010	20031		10.1074/jbc.M117.807925	http://dx.doi.org/10.1074/jbc.M117.807925			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972185	Green Published, hybrid			2022-12-28	WOS:000417696400008
J	Juanes, ME; Elvira, G; Garcia-Grande, A; Calero, M; Gasset, M				Juanes, Maria E.; Elvira, Gema; Garcia-Grande, Aranzazu; Calero, Miguel; Gasset, Maria			RETRACTION: Biosynthesis of prion protein nucleocytoplasmic isoforms by alternative initiation of translation. (Retraction of Vol 284, Pg 2787, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Gasset, Maria/K-4339-2012	Gasset, Maria/0000-0001-6436-4055				Juanes ME, 2009, J BIOL CHEM, V284, P2787, DOI 10.1074/jbc.M804051200	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20044	20044		10.1074/jbc.W117.000658	http://dx.doi.org/10.1074/jbc.W117.000658			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29222195	Green Published, hybrid			2022-12-28	WOS:000417696400010
J	Umezawa, Y; Akiyama, H; Okada, K; Ishida, S; Nogami, A; Oshikawa, G; Kurosu, T; Miura, O				Umezawa, Yoshihiro; Akiyama, Hiroki; Okada, Keigo; Ishida, Shinya; Nogami, Ayako; Oshikawa, Gaku; Kurosu, Tetsuya; Miura, Osamu			Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C-X-C chemokine receptor type 4 (CXCR-4); cell migration; chemokine; myeloid cell; platelet endothelial cell adhesion molecule (PECAM-1); Ras-related protein 1 (Rap1); receptor internalization; signal transduction; tyrosine-protein kinase (tyrosine kinase); SDF-1	INTERNAL TANDEM DUPLICATION; TYROSINE PHOSPHORYLATION; INTEGRIN ACTIVATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; MAMMALIAN TARGET; DRUG-RESISTANCE; LEUKEMIA-CELLS; MIGRATION; CXCR4	Platelet endothelial cell adhesion molecule 1 (PECAM-1) is a cell adhesion protein involved in the regulation of cell adhesion and migration. Interestingly, several PECAM-1-deficient hematopoietic cells exhibit impaired chemotactic responses to stromal cell-derived factor 1 (SDF-1), a chemokine essential for B lymphopoiesis and bone marrow myelopoiesis. However, whether PECAM-1 is involved in SDF-1-regulated chemotaxis is unknown. We report here that SDF-1 induces tyrosine phosphorylation of PECAM-1 at its immunoreceptor tyrosine-based inhibition motifs in several hematopoietic cell lines via the Src family kinase Lyn, Bruton's tyrosine kinase, and JAK2 and that inhibition of these kinases reduced chemotaxis. Overexpression and knockdown of PECAM-1 enhanced and down-regulated, respectively, SDF-1-induced G(i)-dependent activation of the PI3K/Akt/mTORC1 pathway and small GTPase Rap1 in hematopoietic 32Dcl3 cells, and these changes in activation correlated with chemotaxis. Furthermore, pharmacological or genetic inhibition of the PI3K/Akt/mTORC1 pathway or Rap1, respectively, revealed that these pathways are independently activated and required for SDF-1-induced chemotaxis. When coexpressed in 293T cells, PECAM-1 physically associated with the SDF-1 receptor CXCR4. Moreover, PECAM-1 overexpression and knockdown reduced and enhanced SDF-1-induced endocytosis of CXCR4, respectively. Furthermore, when expressed in 32Dcl3 cells, an endocytosis-defective CXCR4 mutant, CXCR4-S324A/S325A, could activate the PI3K/Akt/mTORC1 pathway as well as Rap1 and induce chemotaxis in a manner similar to PECAM-1 overexpression. These findings suggest that PECAM-1 enhances SDF-1-induced chemotaxis by augmenting and prolonging activation of the PI3K/Akt/mTORC1 pathway and Rap1 and that PECAM-1, at least partly, exerts its activity by inhibiting SDF-1-induced internalization of CXCR4.	[Umezawa, Yoshihiro; Akiyama, Hiroki; Okada, Keigo; Ishida, Shinya; Nogami, Ayako; Oshikawa, Gaku; Kurosu, Tetsuya; Miura, Osamu] Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU)	Miura, O (corresponding author), Tokyo Med & Dent Univ, Dept Hematol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	miura.hema@tmd.ac.jp		Miura, Osamu/0000-0002-0981-3054; Umezawa, Yoshihiro/0000-0003-1027-1552	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09467, 24591384, 26461416]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan Grants 15K09467, 24591384, and 26461416. The authors declare that they have no conflicts of interest with the contents of this article.	Arai A, 2005, CELL SIGNAL, V17, P497, DOI 10.1016/j.cellsig.2004.09.007; Arai A, 2001, J BIOL CHEM, V276, P10453, DOI 10.1074/jbc.M004627200; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Melo RDC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085926; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; dela Paz NG, 2014, J BIOL CHEM, V289, P7413, DOI 10.1074/jbc.M113.542514; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Dillenburg-Pilla P, 2015, FASEB J, V29, P1056, DOI 10.1096/fj.14-260083; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Gallay N, 2007, CANCER RES, V67, P8624, DOI 10.1158/0008-5472.CAN-07-0402; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hunter ZR, 2014, BLOOD, V123, P1637, DOI 10.1182/blood-2013-09-525808; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson DE, 1997, J BIOL CHEM, V272, P24868, DOI 10.1074/jbc.272.40.24868; Jin A, 2006, ONCOGENE, V25, P4332, DOI 10.1038/sj.onc.1209459; KOMATSU N, 1991, CANCER RES, V51, P341; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; MIURA O, 1991, MOL CELL BIOL, V11, P4895, DOI 10.1128/MCB.11.10.4895; MIURA O, 1993, MOL CELL BIOL, V13, P1788, DOI 10.1128/MCB.13.3.1788; Montresor A, 2013, J CELL BIOL, V203, P1003, DOI 10.1083/jcb.201303067; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Nagasawa T, 2015, FRONT IMMUNOL, V6, DOI [10.3389/fimmu.2015.00301, 10.3389/fimmu.2014.00445]; Nakata Y, 2006, BLOOD, V107, P4234, DOI 10.1182/blood-2005-08-3343; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Nosaka Y, 2001, BIOCHEM BIOPH RES CO, V285, P675, DOI 10.1006/bbrc.2001.5222; Onish C, 2014, J BIOL CHEM, V289, P31053, DOI 10.1074/jbc.M114.568287; Oshikawa G, 2011, J BIOL CHEM, V286, P30263, DOI 10.1074/jbc.M111.232348; Pawig L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00429; Pellegatta F, 1998, J BIOL CHEM, V273, P27768, DOI 10.1074/jbc.273.43.27768; Pozzobon T, 2016, IMMUNOL LETT, V177, P6, DOI 10.1016/j.imlet.2016.06.006; Privratsky JR, 2014, CELL TISSUE RES, V355, P607, DOI 10.1007/s00441-013-1779-3; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Roccaro AM, 2014, BLOOD, V123, P4120, DOI 10.1182/blood-2014-03-564583; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Schmid MC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060226, 10.1371/journal.pone.0061623]; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Tonino SH, 2008, BLOOD, V112, P840, DOI 10.1182/blood-2008-03-144576; Tourdot BE, 2013, BIOCHEMISTRY-US, V52, P2597, DOI 10.1021/bi301461t; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wheadon H, 2003, BIOCHEM J, V376, P147, DOI 10.1042/BJ20031160; Wu N, 2013, INT J ONCOL, V42, P419, DOI 10.3892/ijo.2012.1729; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	55	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19639	19655		10.1074/jbc.M117.779603	http://dx.doi.org/10.1074/jbc.M117.779603			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974577	Green Published, hybrid			2022-12-28	WOS:000416911300012
J	Emptage, RP; Schoenberger, MJ; Ferguson, KM; Marmorstein, R				Emptage, Ryan P.; Schoenberger, Megan J.; Ferguson, Kathryn M.; Marmorstein, Ronen			Intramolecular autoinhibition of checkpoint kinase 1 is mediated by conserved basic motifs of the C-terminal kinase-associated 1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; checkpoint control; crystal structure; DNA damage response; enzyme inactivation; enzyme mechanism; protein domain; serine; threonine protein kinase; structural biology	DNA-DAMAGE; CHK1; PHOSPHORYLATION; POLARITY; PATHWAY	Precise control of the cell cycle allows for timely repair of genetic material prior to replication. One factor intimately involved in this process is checkpoint kinase 1 (Chk1), a DNA damage repair inducing Ser/Thr protein kinase that contains an N-terminal kinase domain and a C-terminal regulatory region consisting of a approximate to 100-residue linker followed by a putative kinase-associated 1 (KA1) domain. We report the crystal structure of the human Chk1 KA1 domain, demonstrating striking structural homology with other sequentially diverse KA1 domains. Separately purified Chk1 kinase and KA1 domains are intimately associated in solution, which results in inhibition of Chk1 kinase activity. Using truncation mutants and site-directed mutagenesis, we define the inhibitory face of the KA1 domain as a series of basic residues residing on two conserved regions of the primary structure. These findings point to KA1-mediated intramolecular autoinhibition as a key regulatory mechanism of human Chk1, and provide new therapeutic possibilities with which to attack this validated oncology target with small molecules.	[Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Schoenberger, Megan J.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Ferguson, Kathryn M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Ferguson, Kathryn M.] Yale Univ, Sch Med, Canc Biol Inst, New Haven, CT 06520 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Yale University; Yale University	Emptage, RP; Marmorstein, R (corresponding author), 421 Curie Blvd, Philadelphia, PA 19104 USA.	emptage@upenn.edu; marmor@upenn.edu			National Institutes of Health Postdoctoral Fellowship [F32-GM115098]; National Institutes of Health [P01-CA114046]; NATIONAL CANCER INSTITUTE [P01CA114046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM115098] Funding Source: NIH RePORTER	National Institutes of Health Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Postdoctoral Fellowship F32-GM115098 (to R. P. E.) and National Institutes of Health Grant P01-CA114046 (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Caparelli ML, 2013, CELL CYCLE, V12, P916, DOI 10.4161/cc.23881; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Copeland Robert A, 2005, Methods Biochem Anal, V46, P1; Emptage RP, 2017, BIOCHEM J, V474, P385, DOI 10.1042/BCJ20160792; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garrett MD, 2011, TRENDS PHARMACOL SCI, V32, P308, DOI 10.1016/j.tips.2011.02.014; Gong EY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10856; Han XZ, 2016, J BIOL CHEM, V291, P12951, DOI 10.1074/jbc.M115.713248; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kosoy A, 2008, MOL BIOL CELL, V19, P4546, DOI 10.1091/mbc.E08-04-0444; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee J, 2001, MOL BIOL CELL, V12, P551, DOI 10.1091/mbc.12.3.551; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Marx A, 2006, J BIOL CHEM, V281, P27586, DOI 10.1074/jbc.M604865200; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Okita N, 2012, FEBS LETT, V586, P3974, DOI 10.1016/j.febslet.2012.09.048; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palermo C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001427; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez-Barrena MJ, 2007, MOL CELL, V26, P427, DOI 10.1016/j.molcel.2007.04.013; Scorah J, 2008, J BIOL CHEM, V283, P17250, DOI 10.1074/jbc.M800369200; Smits VAJ, 2015, FEBS J, V282, P3681, DOI 10.1111/febs.13387; Tapia-Alveal C, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-8; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wu JX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9953; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Yang ZQ, 2012, MOL CELL, V47, P469, DOI 10.1016/j.molcel.2012.06.037; Zhang Y, 2016, ONCOTARGET, V7, P34688, DOI 10.18632/oncotarget.9156; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226	41	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19024	19033		10.1074/jbc.M117.811265	http://dx.doi.org/10.1074/jbc.M117.811265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972186	Green Published, hybrid			2022-12-28	WOS:000415848000025
J	Frazier, AE; Thorburn, DR; Compton, AG				Frazier, Ann E.; Thorburn, David R.; Compton, Alison G.			Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						genetic disease; genomics; mitochondria; mitochondrial disease; respiratory chain; OXPHOS	RECURRENT DE-NOVO; OXIDATIVE-PHOSPHORYLATION; ACYLGLYCEROL KINASE; MEMBRANE-PROTEIN; SENGERS SYNDROME; DNA MUTATIONS; NARP MUTATION; COMPLEX; DEFICIENCY; SUBUNIT	Inherited disorders of oxidative phosphorylation cause the clinically and genetically heterogeneous diseases known as mitochondrial energy generation disorders, or mitochondrial diseases. Over the last three decades, mutations causing these disorders have been identified in almost 290 genes, but many patients still remain without a molecular diagnosis. Moreover, while our knowledge of the genetic causes is continually expanding, our understanding into how these defects lead to cellular dysfunction and organ pathology is still incomplete. Here, we review recent developments in disease gene discovery, functional characterization, and shared pathogenic parameters influencing disease pathology that offer promising avenues toward the development of effective therapies.	[Frazier, Ann E.; Thorburn, David R.; Compton, Alison G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Frazier, Ann E.; Thorburn, David R.; Compton, Alison G.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Compton, AG (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Brain & Mitochondrial Res, Melbourne, Vic 3052, Australia.	alison.compton@mcri.edu.au		thorburn, david/0000-0002-7725-9470; Compton, Alison/0000-0002-2725-7055; Frazier, Ann/0000-0002-6491-3437	Australian National Health and Medical Research Council [GNT1022896, GNT1068409, GNT1107094]; Victorian Government's Operational Infrastructure Support Program	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by the Australian National Health and Medical Research Council (GNT1022896, GNT1068409, GNT1107094) and the Victorian Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Alston CL, 2017, J PATHOL, V241, P236, DOI 10.1002/path.4809; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Besse A, 2015, CELL METAB, V21, P417, DOI 10.1016/j.cmet.2015.02.008; Bohovych I, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00109; Boycott KM, 2017, AM J HUM GENET, V100, P695, DOI 10.1016/j.ajhg.2017.04.003; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cohen B. H., 2014, GENE REV; Cooper HM, 2017, HUM MOL GENET, V26, P1432, DOI 10.1093/hmg/ddx042; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Desai R, 2017, BRAIN, V140, P1595, DOI 10.1093/brain/awx094; Deutschmann AJ, 2014, HUM MOL GENET, V23, P3618, DOI 10.1093/hmg/ddu072; DiMauro S, 2013, NEUROLOGY, V81, P281, DOI 10.1212/WNL.0b013e31829bfe89; Diodato Daria, 2014, Int J Cell Biol, V2014, P787956, DOI 10.1155/2014/787956; Donti TR, 2014, DIS MODEL MECH, V7, P271, DOI 10.1242/dmm.013466; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; ENDO H, 1989, AM J HUM GENET, V44, P358; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Friederich MW, 2017, HUM MOL GENET, V26, P702, DOI 10.1093/hmg/ddw431; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Gowda GAN, 2016, ANAL CHEM, V88, P4817, DOI 10.1021/acs.analchem.6b00442; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Haack TB, 2014, BRAIN, V137, DOI 10.1093/brain/awu128; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Harel T, 2016, AM J HUM GENET, V99, P831, DOI 10.1016/j.ajhg.2016.08.007; Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kang YL, 2017, MOL CELL, V67, P457, DOI 10.1016/j.molcel.2017.06.014; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679; Koopman WJH, 2016, EMBO MOL MED, V8, P311, DOI 10.15252/emmm.201506131; Koopman WJH, 2012, NEW ENGL J MED, V366, P1132, DOI 10.1056/NEJMra1012478; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Lake NJ, 2017, AM J HUM GENET, V101, P239, DOI 10.1016/j.ajhg.2017.07.005; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Lebon S, 2003, J MED GENET, V40, P896, DOI 10.1136/jmg.40.12.896; LIU TC, 1993, P NATL ACAD SCI USA, V90, P5186, DOI 10.1073/pnas.90.11.5186; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Mattiazzi M, 2004, HUM MOL GENET, V13, P869, DOI 10.1093/hmg/ddh103; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013; MORAES CT, 1993, NAT GENET, V4, P284, DOI 10.1038/ng0793-284; Musante L, 2017, HUM MUTAT, V38, P621, DOI 10.1002/humu.23205; Nesbitt V, 2013, J NEUROL NEUROSUR PS, V84, P936, DOI 10.1136/jnnp-2012-303528; Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Pfeffer G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004426.pub3; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Richter-Dennerlein R, 2014, CELL METAB, V20, P158, DOI 10.1016/j.cmet.2014.04.016; Rorbach J, 2016, P NATL ACAD SCI USA, V113, P12198, DOI 10.1073/pnas.1609338113; Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Sasarman F, 2015, HUM MOL GENET, V24, P2841, DOI 10.1093/hmg/ddv044; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Sperl W, 2015, J INHERIT METAB DIS, V38, P391, DOI 10.1007/s10545-014-9787-3; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Strauss M, 2008, EMBO J, V27, P1154, DOI 10.1038/emboj.2008.35; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Theisen BE, 2017, AM J MED GENET A, V173, P2505, DOI 10.1002/ajmg.a.38339; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Touw CML, 2014, BBA-MOL BASIS DIS, V1842, P2021, DOI 10.1016/j.bbadis.2014.05.032; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Valsecchi F, 2012, BBA-BIOENERGETICS, V1817, P1925, DOI 10.1016/j.bbabio.2012.03.006; Vukotic M, 2017, MOL CELL, V67, P471, DOI 10.1016/j.molcel.2017.06.013; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wollweber F, 2017, BBA-MOL CELL RES, V1864, P1481, DOI 10.1016/j.bbamcr.2017.05.004; Wortmann SB, 2015, J INHERIT METAB DIS, V38, P437, DOI 10.1007/s10545-015-9823-y; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069282	100	112	113	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5386	5395		10.1074/jbc.R117.809194	http://dx.doi.org/10.1074/jbc.R117.809194			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	29233888	hybrid, Green Published			2022-12-28	WOS:000464517500012
J	Nagarajan, D; Nagarajan, T; Roy, N; Kulkarni, O; Ravichandran, S; Mishra, M; Chakravortty, D; Chandra, N				Nagarajan, Deepesh; Nagarajan, Tushar; Roy, Natasha; Kulkarni, Omkar; Ravichandran, Sathyabaarathi; Mishra, Madhulika; Chakravortty, Dipshikha; Chandra, Nagasuma			Computational antimicrobial peptide design and evaluation against multidrug-resistant clinical isolates of bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; INDUCED NEPHROTOXICITY; AMPHIPATHIC PEPTIDES; RATIONAL DESIGN; MODEL; HOST; GENERATION; TRYPTOPHAN; MECHANISM; COMPLEX	There is a pressing need for new therapeutics to combat multidrug- and carbapenem-resistant bacterial pathogens. This challenge prompted us to use a long short-term memory (LSTM) language model to understand the underlying grammar, i.e. the arrangement and frequencies of amino acid residues, in known antimicrobial peptide sequences. According to the output of our LSTM network, we synthesized 10 peptides and tested them against known bacterial pathogens. All of these peptides displayed broad-spectrum antimicrobial activity, validating our LSTM-based peptide design approach. Our two most effective antimicrobial peptides displayed activity against multidrug- resistant clinical isolates of Escherichia coli, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and coagulase-negative staphylococci strains. High activity against extended-spectrum beta-lactamase, methicillin-resistant S. aureus, and carbapenem-resistant strains was also observed. Our peptides selectively interacted with and disrupted bacterial cell membranes and caused secondary gene-regulatory effects. Initial structural characterization revealed that our most effective peptide appeared to be well folded. We conclude that our LSTM-based peptide design approach appears to have correctly deciphered the underlying grammar of antimicrobial peptide sequences, as demonstrated by the experimentally observed efficacy of our designed peptides.	[Nagarajan, Deepesh; Kulkarni, Omkar; Ravichandran, Sathyabaarathi; Mishra, Madhulika; Chandra, Nagasuma] Indian Inst Sci IISc, Dept Biochem, Bangalore 560012, Karnataka, India; [Nagarajan, Tushar] Indian Inst Sci IISc, Dept Computat & Data Sci, Bangalore 560012, Karnataka, India; [Roy, Natasha] Indian Inst Sci IISc, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Chakravortty, Dipshikha] Indian Inst Sci IISc, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Chakravortty, Dipshikha; Chandra, Nagasuma] Indian Inst Sci IISc, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Chandra, N (corresponding author), Indian Inst Sci IISc, Dept Biochem, Bangalore 560012, Karnataka, India.; Chandra, N (corresponding author), Indian Inst Sci IISc, Ctr Biosyst Sci & Engn, Bangalore 560012, Karnataka, India.	nchandra@iisc.ac.in	Mishra, Madhulika/AAL-2287-2020; Ravichandran, Sathyabaarathi/AAD-8564-2022; Chakravortty, Dipshikha/AAI-4448-2020	Mishra, Madhulika/0000-0001-7133-4743; Kulkarni, Omkar/0000-0001-6997-9999; Nagarajan, Deepesh/0000-0001-8468-9834; Chandra, Nagasuma/0000-0002-9939-8439; Chakravortty, Dipshikha/0000-0002-7838-5145; Roy, Natasha/0000-0003-4536-3895; Ravichandran, Sathyabaarathi/0000-0003-2488-8617	Department of Biotechnology (DBT), India	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology (DBT), India. The authors declare that they have no conflicts of interest with the contents of this article.	BAUMANN G, 1974, Journal of Supramolecular Structure, V2, P538, DOI 10.1002/jss.400020504; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BLONDELLE SE, 1992, BIOCHEMISTRY-US, V31, P12688, DOI 10.1021/bi00165a020; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Chen YY, 2016, INT J FOOD MICROBIOL, V222, P16, DOI 10.1016/j.ijfoodmicro.2016.01.017; Chong ZS, 2015, MOL MICROBIOL, V98, P1133, DOI 10.1111/mmi.13202; CULLEN J, 1971, BIOCHEM J, V125, P733, DOI 10.1042/bj1250733; Dai CS, 2014, ANTIMICROB AGENTS CH, V58, P4075, DOI 10.1128/AAC.00070-14; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Deslouches B, 2013, ANTIMICROB AGENTS CH, V57, P2511, DOI 10.1128/AAC.02218-12; Fjell CD, 2011, CHEM BIOL DRUG DES, V77, P48, DOI 10.1111/j.1747-0285.2010.01044.x; Fox JL, 2013, NAT BIOTECHNOL, V31, P379, DOI 10.1038/nbt.2572; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Gusman H, 2001, INFECT IMMUN, V69, P1402, DOI 10.1128/IAI.69.3.1402-1408.2001; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KATSU T, 1988, BIOCHIM BIOPHYS ACTA, V939, P57, DOI 10.1016/0005-2736(88)90047-8; Keirstead ND, 2014, TOXICOL SCI, V137, P278, DOI 10.1093/toxsci/kft247; Kozlowska J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004104; Lam SJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.162, 10.1038/nmicrobiol.2016.162]; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; LAOIDE BM, 1990, EMBO J, V9, P999, DOI 10.1002/j.1460-2075.1990.tb08202.x; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Loffhagen N, 2007, ENG LIFE SCI, V7, P67, DOI 10.1002/elsc.200620168; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Maccari G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003212; Mangan MW, 2006, MOL MICROBIOL, V59, P1831, DOI 10.1111/j.1365-2958.2006.05062.x; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; MILLER MJ, 1983, J BIOL CHEM, V258, P9159; MOSS RA, 1992, LANGMUIR, V8, P1731, DOI 10.1021/la00043a008; Namjoshi S, 2010, BIOPOLYMERS, V94, P673, DOI 10.1002/bip.21476; Nell MJ, 2006, PEPTIDES, V27, P649, DOI 10.1016/j.peptides.2005.09.016; O'Neill J, 2014, ANTIMICROBIAL RESIST; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Piotto SP, 2012, INT J ANTIMICROB AG, V39, P346, DOI 10.1016/j.ijantimicag.2011.12.003; Sader HS, 2004, ANTIMICROB AGENTS CH, V48, P3112, DOI 10.1128/AAC.48.8.3112-3118.2004; Saravolatz LD, 2012, ANTIMICROB AGENTS CH, V56, P4478, DOI 10.1128/AAC.00194-12; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sass P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-186; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stonehouse E, 2008, J BACTERIOL, V190, P4736, DOI 10.1128/JB.00089-08; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; Thomas S., 2009, NUCLEIC ACIDS RES, V38, pD770; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; YONEZAWA A, 1992, BIOCHEMISTRY-US, V31, P2998, DOI 10.1021/bi00126a022	58	52	53	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3492	3509		10.1074/jbc.M117.805499	http://dx.doi.org/10.1074/jbc.M117.805499			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29259134	Green Published, hybrid			2022-12-28	WOS:000427030200004
J	Banerjee, G; Ghosh, I; Kim, CJ; Debus, RJ; Brudvig, GW				Banerjee, Gourab; Ghosh, Ipsita; Kim, Christopher J.; Debus, Richard J.; Brudvig, Gary W.			Substitution of the D1-Asn(87) site in photosystem II of cyanobacteria mimics the chloride-binding characteristics of spinach photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; FTIR DIFFERENCE SPECTROSCOPY; PHOTOSYNTHETIC WATER OXIDATION; S-STATE CYCLE; TRANSFORM INFRARED-SPECTROSCOPY; ELECTRON-PARAMAGNETIC-RES; D1 POLYPEPTIDE; MN4CAO5 CLUSTER; UNDERGOES OXIDATION; OXIDIZING COMPLEX	Photoinduced water oxidation at the O-2-evolving complex (OEC) of photosystem II (PSII) is a complex process involving a tetramanganese-calcium cluster that is surrounded by a hydrogen-bonded network of water molecules, chloride ions, and amino acid residues. Although the structure of the OEC has remained conserved over eons of evolution, significant differences in the chloride-binding characteristics exist between cyanobacteria and higher plants. An analysis of amino acid residues in and around the OEC has identified residue 87 in the D1 subunit as the only significant difference between PSII in cyanobacteria and higher plants. We substituted the D1-Asn(87) residue in the cyanobacterium Synechocystis sp. PCC 6803 (wildtype) with alanine, present in higher plants, or with aspartic acid. We studied PSII core complexes purified from D1-N87A and D1-N87D variant strains to probe the function of the D1-Asn87 residue in the water-oxidation mechanism. EPR spectra of the S-2 state and flash-induced FTIR spectra of both D1-N87A and D1-N87D PSII core complexes exhibited characteristics similar to those of wildtype Synechocystis PSII core complexes. However, flash-induced O-2-evolution studies revealed a decreased cycling efficiency of the D1-N87D variant, whereas the cycling efficiency of the D1-N87A PSII variant was similar to that of wildtype PSII. Steady-state O-2-evolution activity assays revealed that substitution of the D1 residue at position 87 with alanine perturbs the chloride-binding site in the proton-exit channel. These findings provide new insight into the role of the D1-Asn87 site in the water-oxidation mechanism and explain the difference in the chloride-binding properties of cyanobacterial and higher-plant PSII.	[Banerjee, Gourab; Ghosh, Ipsita; Brudvig, Gary W.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Kim, Christopher J.; Debus, Richard J.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	Yale University; University of California System; University of California Riverside	Brudvig, GW (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.; Debus, RJ (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	richard.debus@ucr.edu; gary.brudvig@yale.edu			Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences;  [DE-FG02-05ER15646];  [DE-SC0005291]	Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences(United States Department of Energy (DOE)); ; 	This work was supported by grants from the Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences. Oxygen-release and EPR studies were supported by Grant DE-FG02-05ER15646 (to G.W.B.). Mutant construction, whole cell fluorescence measurements, and FTIR studies were supported by Grant DE-SC0005291 (to R.J.D.). The authors declare that they have no conflicts of interest with the contents of this article.	BECK WF, 1985, BIOCHEMISTRY-US, V24, P3035, DOI 10.1021/bi00333a035; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boussac A, 2012, BBA-BIOENERGETICS, V1817, P802, DOI 10.1016/j.bbabio.2012.02.031; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cooper IB, 2008, BIOPHYS J, V95, P5843, DOI 10.1529/biophysj.108.136879; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; Debus RJ, 2014, BIOCHEMISTRY-US, V53, P2941, DOI 10.1021/bi500309f; Debus RJ, 2005, BIOCHEMISTRY-US, V44, P1367, DOI 10.1021/bi047558u; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Freier E, 2011, P NATL ACAD SCI USA, V108, P11435, DOI 10.1073/pnas.1104735108; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Haddy A, 2004, BIOPHYS J, V87, P2885, DOI 10.1529/biophysj.104.040238; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hou LH, 2011, BIOCHEMISTRY-US, V50, P9248, DOI 10.1021/bi200943q; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; Kandori H, 2000, J AM CHEM SOC, V122, P11745, DOI 10.1021/ja0032069; Kandori H, 2000, BBA-BIOENERGETICS, V1460, P177, DOI 10.1016/S0005-2728(00)00138-9; Kimura Y, 2005, J BIOL CHEM, V280, P37895, DOI 10.1074/jbc.M505887200; Kimura Y, 2003, BIOCHEMISTRY-US, V42, P13170, DOI 10.1021/bi035420q; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kuhne H, 1999, BIOCHEMISTRY-US, V38, P6604, DOI 10.1021/bi990341t; LINDBERG K, 1993, PHOTOSYNTH RES, V38, P401, DOI 10.1007/BF00046767; Lindberg K, 1996, BIOCHEMISTRY-US, V35, P14259, DOI 10.1021/bi961244s; Linke K, 2014, BBA-BIOENERGETICS, V1837, P14, DOI 10.1016/j.bbabio.2013.08.003; Marechal A, 2011, P NATL ACAD SCI USA, V108, P8634, DOI 10.1073/pnas.1019419108; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Noguchi T, 2000, BIOCHEMISTRY-US, V39, P10943, DOI 10.1021/bi001040i; Noguchi T, 1999, BIOCHEMISTRY-US, V38, P10187, DOI 10.1021/bi990631+; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P15706, DOI 10.1021/bi020603i; Noguchi T., 1999, FOURIER TRANSFORM SP, P460; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Noguchi T, 2007, PHOTOSYNTH RES, V91, P59, DOI 10.1007/s11120-007-9137-5; Noguchi T, 2013, BIOMED SPECTROSC IMA, V2, P115, DOI 10.3233/BSI-130040; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V851, P193, DOI 10.1016/0005-2728(86)90125-8; Pokhrel R, 2015, BIOCHEMISTRY-US, V54, P1663, DOI 10.1021/bi501468h; Pokhrel R, 2014, PHYS CHEM CHEM PHYS, V16, P11812, DOI 10.1039/c4cp00493k; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Retegan M, 2016, CHEM SCI, V7, P6463, DOI 10.1039/c6sc02340a; SANDUSKY PO, 1984, BIOCHIM BIOPHYS ACTA, V766, P603, DOI 10.1016/0005-2728(84)90121-X; SANDUSKY PO, 1986, BIOCHIM BIOPHYS ACTA, V849, P85, DOI 10.1016/0005-2728(86)90099-X; Service RJ, 2014, BIOCHEMISTRY-US, V53, P1001, DOI 10.1021/bi401450y; Service RJ, 2013, BIOCHEMISTRY-US, V52, P8452, DOI 10.1021/bi401339f; Service RJ, 2011, BIOCHEMISTRY-US, V50, P63, DOI 10.1021/bi1015937; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; Shimada Y, 2009, BIOCHEMISTRY-US, V48, P6095, DOI 10.1021/bi900317a; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Strickler MA, 2007, BIOCHEMISTRY-US, V46, P3151, DOI 10.1021/bi062195e; Strickler MA, 2006, BIOCHEMISTRY-US, V45, P8801, DOI 10.1021/bi060583a; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suzuki H, 2008, BIOCHEMISTRY-US, V47, P11024, DOI 10.1021/bi801580e; vanVliet P, 1996, BIOCHEMISTRY-US, V35, P1829, DOI 10.1021/bi9514471; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vinyard DJ, 2017, J PHYS CHEM B, V121, P1020, DOI 10.1021/acs.jpcb.7b00110; Vinyard DJ, 2015, BIOCHEMISTRY-US, V54, P622, DOI 10.1021/bi5014134; Vinyard DJ, 2013, BBA-BIOENERGETICS, V1827, P861, DOI 10.1016/j.bbabio.2013.04.008; Vogt L, 2015, CURR OPIN CHEM BIOL, V25, P152, DOI 10.1016/j.cbpa.2014.12.040; Yamanari T, 2004, BIOCHEMISTRY-US, V43, P7479, DOI 10.1021/bi0362323	62	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2487	2497		10.1074/jbc.M117.813170	http://dx.doi.org/10.1074/jbc.M117.813170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29263091	Green Published, hybrid			2022-12-28	WOS:000425308300021
J	Zukowski, A; Al-Afaleq, NO; Duncan, ED; Yao, TT; Johnson, AM				Zukowski, Alexis; Al-Afaleq, Nouf Omar; Duncan, Emily D.; Yao, Tingting; Johnson, Aaron M.			Recruitment and allosteric stimulation of a histone-deubiquitinating enzyme during heterochromatin assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SILENT CHROMATIN; SACCHAROMYCES-CEREVISIAE; H2B UBIQUITYLATION; STRUCTURAL BASIS; TELOMERIC HETEROCHROMATIN; NUCLEOSOME CORE; GENE-EXPRESSION; BUDDING YEAST; CELL-GROWTH; PROTEIN	Heterochromatin formation in budding yeast is regulated by the silent information regulator (SIR) complex. The SIR complex comprises the NAD-dependent deacetylase Sir2, the scaffolding protein Sir4, and the nucleosome-binding protein Sir3. Transcriptionally active regions present a challenge to SIR complex-mediated de novo heterochromatic silencing due to the presence of antagonistic histone post-translational modifications, including acetylation and methylation. Methylation of histone H3K4 and H3K79 is dependent on monoubiquitination of histone H2B (H2B-Ub). The SIR complex cannot erase H2B-Ub or histone methylation on its own. The deubiquitinase (DUB) Ubp10 is thought to promote heterochromatic silencing by maintaining low H2B-Ub at sub-telomeres. Here, we biochemically characterized the interactions between Ubp10 and the SIR complex machinery. Wedemonstrate that a direct interaction between Ubp10 and the Sir2/4 sub-complex facilitates Ubp10 recruitment to chromatin via a co-assembly mechanism. Using hydrolyzable H2B-Ub analogs, we show that Ubp10 activity is lower on nucleosomes compared with H2B-Ub in solution. We find that Sir2/4 stimulates Ubp10 DUB activity on nucleosomes, likely through a combination of targeting and allosteric regulation. This coupling mechanism between the silencing machinery and its DUB partner allows erasure of active PTMs and the de novo transition of a transcriptionally active DNA region to a silent chromatin state.	[Zukowski, Alexis; Duncan, Emily D.; Johnson, Aaron M.] Univ Colorado, Dept Biochem & Mol Genet, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Zukowski, Alexis; Duncan, Emily D.; Johnson, Aaron M.] Univ Colorado, Program Mol Biol, Denver Anschutz Med Campus, Aurora, CO 80045 USA; [Al-Afaleq, Nouf Omar; Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Al-Afaleq, Nouf Omar] King Saud Univ, Riyadh 11451, Saudi Arabia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; King Saud University	Johnson, AM (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, 12801 E 17th Ave, Aurora, CO 80045 USA.	aaron.m.johnson@ucdenver.edu	alafaleq, nouf/GQA-4274-2022	Zukowski, Alexis/0000-0002-1212-2254; AlAfaleq, Nouf/0000-0003-1868-4706; Duncan, Emily/0000-0003-2062-2942	National Institutes of Health [T32GM008730, R01GM098401, R35GM119575]; Saudi Arabia Ministry of Higher Education; King Saud University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098401, R35GM119575, T32GM008730] Funding Source: NIH RePORTER; Direct For Biological Sciences [1158323] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saudi Arabia Ministry of Higher Education; King Saud University(King Saud University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Institutes of Health Grants T32GM008730 (to A.Z.), R01GM098401 (to T.Y.), and R35GM119575 (to A.M.J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a scholarship from the Saudi Arabia Ministry of Higher Education and King Saud University.	Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Behrouzi R, 2016, ELIFE, V5, DOI 10.7554/eLife.17556; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ehrentraut S, 2011, GENE DEV, V25, P1835, DOI 10.1101/gad.17175111; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Huang OW, 2013, CURR OPIN STRUC BIOL, V23, P806, DOI 10.1016/j.sbi.2013.07.012; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Johnson A, 2013, J BIOL CHEM, V288, P28771, DOI 10.1074/jbc.M113.460071; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Kahana A, 1999, MOL CELL BIOL, V19, P6608; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kueng S, 2013, ANNU REV GENET, V47, P275, DOI 10.1146/annurev-genet-021313-173730; Lan XJ, 2016, CELL REP, V17, P2382, DOI 10.1016/j.celrep.2016.10.076; Larin ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005425; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Long L, 2014, METHODS, V70, P134, DOI 10.1016/j.ymeth.2014.07.006; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Oppikofer M, 2013, GENE, V527, P10, DOI 10.1016/j.gene.2013.05.088; Oppikofer M, 2011, EMBO J, V30, P2610, DOI 10.1038/emboj.2011.170; Orlandi I, 2004, J BIOL CHEM, V279, P6414, DOI 10.1074/jbc.M306464200; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Reed BJ, 2015, J BIOL CHEM, V290, P20601, DOI 10.1074/jbc.M115.650952; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Singer MS, 1998, GENETICS, V150, P613; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Trujillo KM, 2012, MOL CELL, V48, P734, DOI 10.1016/j.molcel.2012.09.019; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang F, 2013, P NATL ACAD SCI USA, V110, P8495, DOI 10.1073/pnas.1300126110; Wolberger C, 2014, PROTEIN SCI, V23, P344, DOI 10.1002/pro.2415; Wu MY, 2017, NUCLEIC ACIDS RES, V45, P8225, DOI 10.1093/nar/gkx422	56	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2498	2509		10.1074/jbc.RA117.000498	http://dx.doi.org/10.1074/jbc.RA117.000498			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29288197	Green Published, hybrid			2022-12-28	WOS:000425308300022
J	To, JY; Smrcka, AV				To, Jesi Y.; Smrcka, Alan V.			Activated heterotrimeric G protein (i) subunits inhibit Rap-dependent cell adhesion and promote cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell signaling; G protein; G protein-coupled receptor (GPCR); adhesion; integrin; chemokines	RHO; CHEMOTAXIS; MOTILITY; RADIL	Our recent work uncovered novel roles for activated G(i) signaling in the regulation of neutrophil polarity and adhesion. G(i)GTP-mediated enhancement of neutrophil polarization was dependent on inhibition of cAMP/PKA signaling, whereas reversal of G-stimulated adhesion was cAMP/PKA independent. To uncover the mechanism for G(i) regulation of adhesion, we analyzed the effects of constitutively active G(i1)(Q204L) expression on adhesion driven by constitutively active Rap1a(G12V) or its downstream effector Radil in neutrophil-like HL-60 cells, or in HT-1080 fibrosarcoma cells. In HT-1080 cells, Rap1a(G12V) or Radil cause an increase in cell spreading and adhesion to fibronectin, which are both reversed by G(i1)(Q204L) but not WT G(i1). In contrast, G(i1)(Q204L) did not reverse Rap1-GTP-interacting adaptor molecule (RIAM)-dependent increases in cell adhesion. This indicates that adhesion regulation by G(i)-GTP occurs downstream of Rap1a and Radil, but is upstream of components such as integrins and talin that are regulated by both Radil and RIAM. HL-60 neutrophil-like cells expressing Rap1a(G12V) or Radil have an elongated phenotype because of enhanced uropod adhesion as they attempt to migrate on fibronectin. This elongated phenotype driven by Rap1a(G12V) or Radil is reversed by G(i1)(Q204L), but not by WT G(i1) expression, suggesting that G(i)-GTP also regulates adhesion in immune cells at the level of, or downstream of, Radil. These data identify a novel role of G(i)-GTP in regulation of cell adhesion and migration. Cell migration involves cycles of adhesion and de-adhesion, and we propose that the dynamic spatiotemporal balance between G-promoted adhesion and G(i)-GTP reversal of adhesion is important for this process.	[To, Jesi Y.; Smrcka, Alan V.] Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14623 USA; [Smrcka, Alan V.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Rochester; University of Michigan System; University of Michigan	Smrcka, AV (corresponding author), Univ Rochester, Sch Med, Dept Physiol & Pharmacol, Rochester, NY 14623 USA.	avsmrcka@umich.edu			National Institutes of Health [R01GM081772]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by National Institutes of Health Grant R01GM081772 (to A. V. S.). The authors declare that they have no conflicts of interest regarding the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Ahmed SM, 2010, J BIOL CHEM, V285, P6538, DOI 10.1074/jbc.M109.069948; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lagarrigue F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9492; Liu LH, 2012, MOL BIOL CELL, V23, P4751, DOI 10.1091/mbc.E12-05-0408; Mochizuki N, 1999, NATURE, V400, P891, DOI 10.1038/23738; Neptune ER, 1999, J BIOL CHEM, V274, P2824, DOI 10.1074/jbc.274.5.2824; Post A, 2015, MOL CELL BIOL, V35, P2495, DOI 10.1128/MCB.01453-14; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Surve CR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad8163; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435	22	8	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1570	1578		10.1074/jbc.RA117.000964	http://dx.doi.org/10.1074/jbc.RA117.000964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259127	Green Published, hybrid			2022-12-28	WOS:000424201700010
J	Sawaya, AP; Pastar, I; Stojadinovic, O; Lazovic, S; Davis, SC; Gil, J; Kirsner, RS; Tomic-Canic, M				Sawaya, Andrew P.; Pastar, Irena; Stojadinovic, Olivera; Lazovic, Sonja; Davis, Stephen C.; Gil, Joel; Kirsner, Robert S.; Tomic-Canic, Marjana			Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucocorticoid receptor; long noncoding RNA (long ncRNA; lncRNA); Myc (c-Myc); skin; wound healing; diabetic foot ulcers; statin; Gas5	COA REDUCTASE INHIBITORS; DIABETIC FOOT ULCERS; FARNESYL PYROPHOSPHATE; VENOUS ULCERS; GROWTH-FACTORS; STEM-CELLS; HUMAN SKIN; EXPRESSION; STATINS; EPITHELIALIZATION	Diabetic foot ulcers (DFUs), a life-threatening complication of diabetes mellitus, have limited treatment options, often resulting in amputations. HMG-CoA reductase inhibitors such as statins are cholesterol-reducing agents that may provide a new therapeutic option. Statins target the cholesterol pathway and block the synthesis of the wound-healing inhibitors farnesyl pyrophosphate (FPP) and cortisol, ligands for the glucocorticoid receptor (GR). Here we demonstrate that the naturally occurring statin mevastatin reverses FPP's effects and promotes healing by using in vitro wound healing assays, human ex vivo and porcine in vivo wound models, and DFU tissue. Moreover, we measured cortisol levels by ELISA and found that mevastatin inhibited cortisol synthesis in keratinocytes and biopsies from patients with DFU. Of note, topical mevastatin stimulated epithelialization and angiogenesis in vivo. Mevastatin also reversed FPP-mediated induction of the GR target, the transcription factor c-Myc (a biomarker of non-healing wounds), in porcine and human wound models. Importantly, mevastatin reversed c-Myc overexpression in DFUs. It induced expression of the long noncoding RNA Gas5 that blocks c-Myc expression, which was confirmed by overexpression studies. We conclude that topical mevastatin accelerates wound closure by promoting epithelialization via multiple mechanisms: modulation of GR ligands and induction of the long noncoding RNA Gas5, leading to c-Myc inhibition. In light of these findings, we propose that repurposing statin drugs for topical treatment of DFUs may offer another option for managing this serious condition.	[Sawaya, Andrew P.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Mol & Cellular Pharmacol Program, Miami, FL 33136 USA; [Sawaya, Andrew P.; Pastar, Irena; Stojadinovic, Olivera; Lazovic, Sonja; Davis, Stephen C.; Gil, Joel; Kirsner, Robert S.; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Stojadinovic, Olivera] Univ Kragujevac, Fac Med Sci, Immunol Infect & Inflammat Grad Program, Kragujevac 34000, Serbia; [Kirsner, Robert S.; Tomic-Canic, Marjana] Univ Miami Hlth Syst, Univ Miami Hosp, Wound Healing Clin Res Program, Miami, FL 33136 USA	University of Miami; University of Miami; University of Kragujevac; University of Miami	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program,RMSB, 1600 NW 10th Ave,Rm 2023A, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [AR060562, NR015649, NR013881]; University of Miami SAC Award [SAC 2013-19]; New York University [PCT/U52010/062361]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR013881, R01NR015649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami SAC Award; New York University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by National Institutes of Health Grants AR060562, NR015649, and NR013881 (to M. T. C.) and University of Miami SAC Award SAC 2013-19. M. T. C. is listed as the inventor of Patent PCT/U52010/062361, "Composition and Methods for Promoting Epithelialization and Wound Closure," issued to New York University based on the data presented, in part, in this study and stands to potentially gain royalties from future commercialization.	Apostolopoulou M, 2015, EUR J CLIN INVEST, V45, P745, DOI 10.1111/eci.12461; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Asai J, 2012, AM J PATHOL, V181, P2217, DOI 10.1016/j.ajpath.2012.08.023; Banach M, 2015, EXPERT OPIN DRUG SAF, V14, P935, DOI 10.1517/14740338.2015.1039980; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barrientos S, 2014, WOUND REPAIR REGEN, V22, P569, DOI 10.1111/wrr.12205; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bitto A, 2008, PHARMACOL RES, V57, P159, DOI 10.1016/j.phrs.2008.01.005; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Brem H, 2009, J INVEST DERMATOL, V129, P2275, DOI 10.1038/jid.2009.26; Corrao G, 2014, DIABETES CARE, V37, P2225, DOI 10.2337/dc13-2215; Das S, 2007, MOL ENDOCRINOL, V21, P2672, DOI 10.1210/me.2007-0080; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Evangelista MTP, 2014, BRIT J DERMATOL, V170, P1151, DOI 10.1111/bjd.12883; Fox JD, 2016, WOUND REPAIR REGEN, V24, P454, DOI 10.1111/wrr.12400; Gould L, 2015, J AM GERIATR SOC, V63, P427, DOI 10.1111/jgs.13332; Haag WG, 2011, WOUND REPAIR REGEN, V19, P442, DOI 10.1111/j.1524-475X.2011.00693.x; Herskovitz I, 2017, J INVEST DERMATOL, V137, P2646, DOI 10.1016/j.jid.2017.07.837; Hu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107016; Johansen OE, 2009, J DIABETES, V1, P182, DOI 10.1111/j.1753-0407.2009.00031.x; Jozic I, 2017, J INVEST DERMATOL, V137, P1144, DOI 10.1016/j.jid.2016.11.036; Jozic I, 2014, J INVEST DERMATOL, V134, P2869, DOI 10.1038/jid.2014.363; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Laing T, 2010, J SURG RES, V161, P336, DOI 10.1016/j.jss.2009.01.024; Liang L, 2016, WOUND REPAIR REGEN, V24, P943, DOI 10.1111/wrr.12470; Lindley LE, 2016, PLAST RECONSTR SURG, V138, p18S, DOI 10.1097/PRS.0000000000002682; Liu Y, 2010, COMPARATIVE MED, V60, P142; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Mehta VB, 2008, GROWTH FACTORS, V26, P301, DOI 10.1080/08977190802393596; MENON GK, 1985, J LIPID RES, V26, P418; Olivera S, 2013, METHODS MOL BIOL, V1037, P255, DOI 10.1007/978-1-62703-505-7_14; Pastar I, 2016, J CELL PHYSIOL, V231, P2452, DOI 10.1002/jcp.25357; Pastar I, 2014, ADV WOUND CARE, V3, P445, DOI 10.1089/wound.2013.0473; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O., 2010, EXPET REV DERMATOL, V5, P689, DOI [10.1586/edm.10.60, DOI 10.1586/EDM.10.60, 10.1586/edm.10.60.]; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Stojadinovic O, 2014, WOUND REPAIR REGEN, V22, P220, DOI 10.1111/wrr.12142; Stojadinovic O, 2013, EXP DERMATOL, V22, P216, DOI 10.1111/exd.12104; Stojadinovic O, 2008, J CELL MOL MED, V12, P2675, DOI 10.1111/j.1582-4934.2008.00321.x; Stone RC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf8611; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Takwi AAL, 2012, EMBO MOL MED, V4, P896, DOI 10.1002/emmm.201101045; Vukelic S, 2011, J BIOL CHEM, V286, P10265, DOI 10.1074/jbc.M110.188268; Vukelic S, 2010, J BIOL CHEM, V285, P1980, DOI 10.1074/jbc.M109.016741; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200	54	35	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1439	1449		10.1074/jbc.M117.811240	http://dx.doi.org/10.1074/jbc.M117.811240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158265	hybrid, Green Published			2022-12-28	WOS:000423515000028
J	Chakraborty, A; Dorsett, KA; Trummell, HQ; Yang, ES; Oliver, PG; Bonner, JA; Buchsbaum, DJ; Bellis, SL				Chakraborty, Asmi; Dorsett, Kaitlyn A.; Trummell, Hoa Q.; Yang, Eddy S.; Oliver, Patsy G.; Bonner, James A.; Buchsbaum, Donald J.; Bellis, Susan L.			ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; COLON-CANCER CELLS; DEATH RECEPTOR; LINE SUIT-2; IN-VITRO; KAPPA-B; SIALYLATION; EXPRESSION; METABOLISM; APOPTOSIS	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis. Gemcitabine, as a single agent or in combination therapy, remains the frontline chemotherapy despite its limited efficacy due to de novo or acquired chemoresistance. There is an acute need to decipher mechanisms underlying chemoresistance and identify new targets to improve patient outcomes. Here, we report a novel role for the ST6Gal-I sialyltransferase in gemcitabine resistance. Utilizing MiaPaCa-2 and BxPC-3 PDAC cells, we found that knockdown (KD) of ST6Gal-I expression, as well as removal of surface alpha 2-6 sialic acids by neuraminidase, enhances gemcitabine-mediated cell death assessed via clonogenic assays and cleaved caspase 3 expression. Additionally, KD of ST6Gal-I potentiates gemcitabine-induced DNA damage as measured by comet assays and quantification of gamma H2AX foci. ST6Gal-I KD also alters mRNA expression of key gemcitabine metabolic genes, RRM1, RRM2, hENT1, and DCK, leading to an increased gemcitabine sensitivity ratio, an indicator of gemcitabine toxicity. Gemcitabine-resistant MiaPaCa-2 cells display higher ST6Gal-I levels than treatment-naive cells along with a reduced gemcitabine sensitivity ratio, suggesting that chronic chemotherapy selects for clonal variants with more abundant ST6Gal-I. Finally, we examined Suit2 PDAC cells and Suit2 derivatives with enhanced metastatic potential. Intriguingly, three metastatic and chemoresistant subclones, S2-CP9, S2-LM7AA, and S2-013, exhibit up-regulated ST6Gal-I relative to parental Suit2 cells. ST6Gal-I KD in S2-013 cells increases gemcitabine-mediated DNA damage, indicating that suppressing ST6Gal-I activity sensitizes inherently resistant cells to gemcitabine. Together, these findings place ST6Gal-I as a critical player in imparting gemcitabine resistance and as a potential target to restore PDAC chemoresponse.	[Chakraborty, Asmi; Dorsett, Kaitlyn A.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA; [Trummell, Hoa Q.; Yang, Eddy S.; Oliver, Patsy G.; Bonner, James A.; Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu	chakraborty, asmi/AAX-5384-2021	chakraborty, asmi/0000-0002-6528-8602; Buchsbaum, Donald/0000-0003-2797-5847	National Institutes of Health [P30AR048311, P30AI027767]; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge assistance from the University of Alabama at Birmingham Flow Cytometry Core Facility (National Institutes of Health Grants P30AR048311 and P30AI027767).	Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bhutia YD, 2011, CANCER RES, V71, P1825, DOI 10.1158/0008-5472.CAN-10-2736; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1016/j.ejphar.2014.07.041, 10.1010/j.ejphar.2014.07.041]; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Feng FY, 2007, ONCOGENE, V26, P3431, DOI 10.1038/sj.onc.1210129; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Holdbrooks A. T., 2017, J BIOL CHEM; Hong XH, 2016, NUCLEIC ACIDS RES, V44, P8855, DOI 10.1093/nar/gkw748; Horiuchi T, 2016, J SURG RES, V206, P1, DOI 10.1016/j.jss.2016.06.047; Hou S, 2016, FASEB J, V30, P4120, DOI 10.1096/fj.201600665R; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Hung SW, 2015, CANCER LETT, V359, P233, DOI 10.1016/j.canlet.2015.01.017; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; Joseph R, 2014, J ONCOL PHARM PRACT, V20, P393, DOI 10.1177/1078155213506477; Kirby MK, 2016, MOL ONCOL, V10, P1169, DOI 10.1016/j.molonc.2016.05.004; Kitamura N, 2001, CLIN EXP METASTAS, V18, P561, DOI 10.1023/A:1011900818419; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Le N, 2016, DIGEST LIVER DIS, V48, P223, DOI 10.1016/j.dld.2015.11.001; Lee M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-47; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Pan X, 2008, CLIN CANCER RES, V14, P8143, DOI 10.1158/1078-0432.CCR-08-1539; Pappas S, 2015, SURGERY, V158, P888; Park JJ, 2012, BIOCHEM PHARMACOL, V83, P849, DOI 10.1016/j.bcp.2012.01.007; Parsels LA, 2009, MOL CANCER THER, V8, P45, DOI 10.1158/1535-7163.MCT-08-0662; Pignochino Y, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-631; Rauchwerger DR, 2000, CANCER RES, V60, P6075; Recchi MA, 1998, CANCER RES, V58, P4066; Saif M, 2012, THER ADV MED ONCOL, V4, P341, DOI 10.1177/1758834012453755; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simon PO, 2009, INT J CANCER, V125, P942, DOI 10.1002/ijc.24424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; UCHIDA Y, 1979, J BIOCHEM-TOKYO, V86, P1573, DOI 10.1093/oxfordjournals.jbchem.a132675; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Waters JA, 2015, SURGERY, V158, P881, DOI 10.1016/j.surg.2015.04.043; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zinzi L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00163	53	45	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					984	994		10.1074/jbc.M117.808584	http://dx.doi.org/10.1074/jbc.M117.808584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191829	hybrid, Green Published			2022-12-28	WOS:000422864500019
J	Lee, S; Rivera, OC; Kelleher, SL				Lee, Sooyeon; Rivera, Olivia C.; Kelleher, Shannon L.			Zinc transporter 2 interacts with vacuolar ATPase and is required for polarization, vesicle acidification, and secretion in mammary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell polarity; mammary gland; secretion; vacuolar ATPase; vesicles; zinc; acidification; lactation; zinc transporter	H+-ATPASE; PLASMA-MEMBRANE; PROTON PUMPS; GLAND DEVELOPMENT; BREAST-MILK; PTEN; POLARITY; ACTIVATION; PROLACTIN; PROTEIN	An important feature of the mammary gland is its ability to undergo profound morphological, physiological, and intracellular changes to establish and maintain secretory function. During this process, key polarity proteins and receptors are recruited to the surface of mammary epithelial cells (MECs), and the vesicle transport system develops and matures. However, the intracellular mechanisms responsible for the development of secretory function in these cells are unclear. The vesicular zinc (Zn2+) transporter ZnT2 is critical for appropriate mammary gland architecture, and ZnT2 deletion is associated with cytoplasmic Zn2+ accumulation, loss of secretory function and lactation failure. The underlying mechanisms are important to understand as numerous mutations and non-synonymous genetic variation in ZnT2 have been detected in women that result in severe Zn2+ deficiency in exclusively breastfed infants. Here we found that ZnT2 deletion in lactating mice and cultured MECs resulted in Zn2+-mediated degradation of phosphatase and tensin homolog (PTEN), which impaired intercellular junction formation, prolactin receptor trafficking, and alveolar lumen development. Moreover, ZnT2 directly interacted with vacuolar H+-ATPase (V-ATPase), and ZnT2 deletion impaired vesicle biogenesis, acidification, trafficking, and secretion. In summary, our findings indicate that ZnT2 and V-ATPase interact and that this interaction critically mediates polarity establishment, alveolar development, and secretory function in the lactating mammary gland. Our observations implicate disruption in ZnT2 function as a modifier of secretory capacity and lactation performance.	[Lee, Sooyeon; Rivera, Olivia C.; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Lee, Sooyeon] Stanford Univ, Sch Med, Dept Med, Div Endocrinol, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University	Kelleher, SL (corresponding author), Univ Massachusetts, 883 Broadway, Lowell, MA 01854 USA.	shannon_kelleher@uml.edu		Rivera, Olivia/0000-0001-6953-253X; Lee, Sooyeon/0000-0002-1076-3314	Penn State Hershey Department of Surgery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002016, UL1TR002014] Funding Source: NIH RePORTER	Penn State Hershey Department of Surgery; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by intramural funds from the Penn State Hershey Department of Surgery (to S. L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AINSCOUGH EW, 1980, AM J CLIN NUTR, V33, P1314, DOI 10.1093/ajcn/33.6.1314; Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Berglund FM, 2013, ONCOGENE, V32, P4417, DOI 10.1038/onc.2012.459; BLAKEBOROUGH P, 1983, BIOCHEM J, V209, P505, DOI 10.1042/bj2090505; Bostanci Z, 2015, REPROD TOXICOL, V54, P84, DOI 10.1016/j.reprotox.2014.07.076; Bray K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3487; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Chakraborti S, 2010, LANGMUIR, V26, P3506, DOI 10.1021/la903118c; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chandler P, 2016, MOL CANCER, V15, DOI 10.1186/s12943-015-0486-y; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Collaco AM, 2013, AM J PHYSIOL-CELL PH, V305, pC981, DOI 10.1152/ajpcell.00067.2013; Pozzi CMC, 2015, FOOD CHEM, V166, P492, DOI 10.1016/j.foodchem.2014.06.040; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; Crivellato E, 2010, ANAT REC, V293, P1115, DOI 10.1002/ar.21146; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Druso JE, 2016, J BIOL CHEM, V291, P8886, DOI 10.1074/jbc.M115.694349; Dupont J, 2002, J CLIN INVEST, V110, P815, DOI [10.1172/JCI200213829, 10.1172/JCI0213829]; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Fukao Y, 2011, PLANT SIGNAL BEHAV, V6, P1253, DOI 10.4161/psb.6.9.16529; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; HARTMANN PE, 1978, J PHYSIOL-LONDON, V275, P1, DOI 10.1113/jphysiol.1978.sp012173; HARZER G, 1982, AM J CLIN NUTR, V35, P981, DOI 10.1093/ajcn/35.5.981; Hennigar SR, 2015, J NUTR, V145, P1999, DOI 10.3945/jn.115.214122; Hennigar SR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08033; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jager Richard, 2008, BMC Res Notes, V1, P29, DOI 10.1186/1756-0500-1-29; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2003, J NUTR, V133, P3378, DOI 10.1093/jn/133.11.3378; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Langlois MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015742; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lavialle F, 2000, BBA-BIOMEMBRANES, V1464, P83, DOI 10.1016/S0005-2736(99)00251-5; Lavoie N, 2011, J NEUROSCI, V31, P18251, DOI 10.1523/JNEUROSCI.4164-11.2011; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu FM, 2015, STEM CELL RES, V15, P376, DOI 10.1016/j.scr.2015.08.001; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; Melnik VI, 2001, NEUROCHEM RES, V26, P549, DOI 10.1023/A:1010973214930; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Moore H.-P. H., 2002, Archives of Physiology and Biochemistry, V110, P16, DOI 10.1076/apab.110.1.16.903; MORTON JA, 1994, PEDIATRICS, V93, P802; Nagaoka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065127; Nagaoka K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1678; Naik HB, 2009, AM J PHYSIOL-CELL PH, V297, pC979, DOI 10.1152/ajpcell.00577.2008; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Noatynska A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130083; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Pamarthy S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.347; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peixoto EBMI, 2006, CELL BIOL INT, V30, P101, DOI 10.1016/j.cellbi.2005.08.004; Piela Z, 1998, CUTIS, V61, P197; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Roignot J., 2013, COLD SPRING HARBOR P, V5; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Semba RD, 1999, CLIN DIAGN LAB IMMUN, V6, P671, DOI 10.1128/CDLI.6.5.671-674.1999; Seo YA, 2014, J BIOL CHEM, V289, P23653, DOI 10.1074/jbc.M113.531145; Shinde SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10689; Shore AN, 2016, DEV BIOL, V409, P202, DOI 10.1016/j.ydbio.2015.10.023; SINGH H, 1989, J DAIRY RES, V56, P249, DOI 10.1017/S0022029900026467; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Stiernet P, 2006, J BIOL CHEM, V281, P22142, DOI 10.1074/jbc.M513224200; Tanguy E, 2016, J NEUROCHEM, V137, P904, DOI 10.1111/jnc.13577; Tarasenko AS, 2010, J MOL NEUROSCI, V41, P358, DOI 10.1007/s12031-010-9351-z; Triplett AA, 2005, GENESIS, V43, P1, DOI 10.1002/gene.20149; Truchet S, 2009, ANIMAL, V3, P1733, DOI 10.1017/S1751731109990589; Wagner Kay-Uwe, 1997, Genes and Function, V1, P233; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091160; Watkin H, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-6; Whyte J, 2010, J CELL SCI, V123, P3316, DOI 10.1242/jcs.065243; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xie YQ, 2016, ONCOL LETT, V12, P375, DOI 10.3892/ol.2016.4636; Xu R, 2010, CELL CYCLE, V9, P4315, DOI 10.4161/cc.9.21.13578; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]; Zhou J, 2009, NAT CELL BIOL, V11, P1177, DOI 10.1038/ncb1009-1177; Zimmermann B, 2003, J EXP BIOL, V206, P1867, DOI 10.1242/jeb.00376	101	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21598	21613		10.1074/jbc.M117.794461	http://dx.doi.org/10.1074/jbc.M117.794461			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29114036	Green Published, hybrid			2022-12-28	WOS:000419013000034
J	Serrano, BP; Szydlo, HS; Alfandari, D; Hardy, JA				Serrano, Banyuhay P.; Szydlo, Hannah S.; Alfandari, Dominique; Hardy, Jeanne A.			Active site-adjacent phosphorylation at Tyr-397 by c-Abl kinase inactivates caspase-9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABL tyrosine kinase; apoptosis; caspase; protease; protein phosphorylation; phosphocapture; phosphoenrichment; substrate-binding groove	DEATH PROTEASE CASPASE-9; TYROSINE KINASE; BCR-ABL; FAMILY KINASES; CYTOCHROME-C; CANCER-CELLS; ACTIVATION; APOPTOSIS; CLEAVAGE; STRESS	Caspase-9 (casp-9) is an initiator caspase and plays a central role in activating apoptotic cell death. Control of all caspases is tightly regulated by a series of phosphorylation events enacted by several different kinases. Caspase-9 is the most heavily phosphorylated of all caspases, with phosphorylation of at least 11 distinct residues in all three caspase-9 domains by nine kinases. Caspase-9 phosphorylation by the non-receptor tyrosine kinase c-Abl at Tyr-153 reportedly leads to caspase-9 activation. All other phosphorylation events on caspases have been shown to block proteolytic function by a number of mechanisms, so we sought to unravel the molecular mechanism of the putative caspase-9 activation by phosphorylation. Surprisingly, we observed no evidence for Tyr-153 phosphorylation of caspase-9 in vitro or in cells, suggesting that Tyr-153 is not phosphorylated by c-Abl. Instead, we identified a new site for c-Abl-mediated phosphorylation, Tyr-397. This residue is adjacent to the caspase-9 active site but, as a member of the second shell, not a residue that directly contacts substrate. Our results further indicate that Tyr-397 is the dominant site of c-Abl phosphorylation both in vitro and upon c-Abl activation in cells. Of note, phosphorylation at this site inhibits caspase-9 activity, and the bulk of the added phosphate moiety appeared to directly block substrate binding. c-Abl plays both proapoptotic and prosurvival roles, and our findings suggest that c-Abl's effects on caspase-9 activity promote the prosurvival mode.	[Serrano, Banyuhay P.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, 104 LGRT,710 North Pleasant St, Amherst, MA 01003 USA; [Szydlo, Hannah S.; Alfandari, Dominique] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Hardy, JA (corresponding author), Univ Massachusetts, Dept Chem, 104 LGRT,710 North Pleasant St, Amherst, MA 01003 USA.	hardy@chem.umass.edu		Hardy, Jeanne/0000-0002-3406-7997	National Institutes of Health [GM080532, RO1DE016289]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080532, T32GM008515] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD021485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM080532 (to J. A. H.) and RO1DE016289 and R24OD021485 (to D. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Checinska A, 2009, J PROTEOMICS, V72, P575, DOI 10.1016/j.jprot.2008.11.016; CHENG HC, 1993, MOL CELL BIOCHEM, V128, P103, DOI 10.1007/BF01076761; Cheng TC, 2016, ELIFE, V5, DOI 10.7554/eLife.17755; Dagbay K, 2014, METHOD ENZYMOL, V544, P215, DOI 10.1016/B978-0-12-417158-9.00009-1; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Duncan JS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001682; Eron SJ, 2017, STRUCTURE, V25, P27, DOI 10.1016/j.str.2016.11.001; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Franklin RA, 2000, LEUKEMIA, V14, P2019, DOI 10.1038/sj.leu.2401967; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang WJ, 2013, GENE DEV, V27, P2039, DOI 10.1101/gad.224428.113; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kurokawa M, 2009, CELL, V138, P838, DOI 10.1016/j.cell.2009.08.021; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Machuy N, 2004, CELL DEATH DIFFER, V11, P290, DOI 10.1038/sj.cdd.4401336; Manning Brendan D, 2002, Sci STKE, V2002, ppe49, DOI 10.1126/stke.2002.162.pe49; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; McDonnell MA, 2008, J BIOL CHEM, V283, P20149, DOI 10.1074/jbc.M802846200; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Powley IR, 2016, ONCOGENE, V35, P5629, DOI 10.1038/onc.2016.99; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Seaman JE, 2016, CELL DEATH DIFFER, V23, P1717, DOI 10.1038/cdd.2016.62; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Serrano B. P., 2017, CELL DEATH IN PRESS; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Skotte NH, 2017, CELL DEATH DIFFER, V24, P433, DOI 10.1038/cdd.2016.139; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tsang JLY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153946; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Velazquez-Delgado EM, 2012, STRUCTURE, V20, P742, DOI 10.1016/j.str.2012.02.003; Voss J, 2000, ONCOGENE, V19, P1684, DOI 10.1038/sj.onc.1203467; Wang JYJ, 2014, MOL CELL BIOL, V34, P1188, DOI 10.1128/MCB.01454-13; Witkowski WA, 2009, PROTEIN SCI, V18, P1459, DOI 10.1002/pro.151; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wu CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13565; Wu JZJ, 1998, BIOORG MED CHEM LETT, V8, P2279, DOI 10.1016/S0960-894X(98)00413-2; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zamaraev AV, 2017, TRENDS CELL BIOL, V27, P322, DOI 10.1016/j.tcb.2017.01.003; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	60	6	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21352	21365		10.1074/jbc.M117.811976	http://dx.doi.org/10.1074/jbc.M117.811976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29066624	Green Published, hybrid			2022-12-28	WOS:000419013000012
J	Gill, K; Macdonald-Obermann, JL; Pike, LJ				Gill, Kamaldeep; Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); growth factor receptor-bound protein 2 (GRB2); receptor tyrosine kinase; signal transduction; Gab1; Shc	SITE-SPECIFIC PHOSPHORYLATION; AUTOPHOSPHORYLATION SITES; EGF RECEPTOR; SH2 DOMAINS; GRB2; KINASES; IDENTIFICATION; ACTIVATION; CELLS; REQUIREMENT	The EGF receptor is a classic receptor tyrosine kinase. It contains nine tyrosines in its C-terminal tail, many of which are phosphorylated and bind proteins containing SH2 or phosphotyrosine-binding (PTB) domains. To determine how many and which tyrosines are required to enable EGF receptor-mediated signaling, we generated a series of EGF receptors that contained only one tyrosine in their C-terminal tail. Assays of the signaling capabilities of these single-Tyr EGF receptors indicated that they can activate a range of downstream signaling pathways, including MAP kinase and Akt. The ability of the single-Tyr receptors to signal correlated with their ability to bind Gab1 (Grb2-associated binding protein 1). However, Tyr-992 appeared to be almost uniquely required to observe activation of phospholipase C. These results demonstrate that multiply phosphorylated receptors are not required to support most EGF-stimulated signaling but identify Tyr-992 and its binding partners as a unique node within the network. We also studied the binding of the isolated SH2 domain of Grb2 (growth factor receptor-bound protein 2) and the isolated PTB domain of Shc (SHC adaptor protein) to the EGF receptor. Although these adapter proteins bound readily to wild-type EGF receptor, they bound poorly to the single-Tyr EGF receptors, even those that bound full-length Grb2 and Shc well. This suggests that in addition to pTyr-directed associations, secondary interactions between the tail and regions of the adapter proteins outside of the SH2/PTB domains are important for stabilizing the binding of Grb2 and Shc to the single-Tyr EGF receptors.	[Gill, Kamaldeep; Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	pike@wustl.edu			National Institutes of Health [R01 GM099695, R01 GM108785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695, R01GM108785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM099695 and R01 GM108785 (to L. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Chen ZM, 2012, J VIROL, V86, P1421, DOI 10.1128/JVI.05993-11; Curran TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6924; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Huang J, 2007, CANCER RES, V67, P5906, DOI 10.1158/0008-5472.CAN-07-0691; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Kim KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11107; Kim Y, 2012, BIOCHEMISTRY-US, V51, P5212, DOI 10.1021/bi300476v; Koland JG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003435; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PIKE LJ, 1982, P NATL ACAD SCI-BIOL, V79, P1443, DOI 10.1073/pnas.79.5.1443; PIKE LJ, 1987, METHOD ENZYMOL, V146, P353; POWIS G, 1994, CANCER RES, V54, P2419; Reddy RJ, 2016, P NATL ACAD SCI USA, V113, P3114, DOI 10.1073/pnas.1521288113; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; SORKIN A, 1992, J BIOL CHEM, V267, P8672; Sturla LM, 2005, J BIOL CHEM, V280, P14597, DOI 10.1074/jbc.M413287200; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	49	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20744	20755		10.1074/jbc.M117.802553	http://dx.doi.org/10.1074/jbc.M117.802553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074618	hybrid, Green Published			2022-12-28	WOS:000418267000034
J	Krout, D; Schaar, A; Sun, YY; Sukumaran, P; Roemmich, JN; Singh, BB; Claycombe-Larson, KJ				Krout, Danielle; Schaar, Anne; Sun, Yuyang; Sukumaran, Pramod; Roemmich, James N.; Singh, Brij B.; Claycombe-Larson, Kate J.			The TRPC1 Ca2+-permeable channel inhibits exercise-induced protection against high-fat diet-induced obesity and type II diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; exercise; obesity; transient receptor potential channels (TRP channels); SOCE; TRPC1	PRENATAL LOW-PROTEIN; RECEPTOR POTENTIAL CHANNELS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; MITOCHONDRIAL RESPIRATION; METABOLIC SYNDROME; CA2+; CELLS; EXPRESSION; ACIDS	The transient receptor potential canonical channel-1 (TRPC1) is a Ca2+-permeable channel found in key metabolic organs and tissues, including the hypothalamus, adipose tissue, and skeletal muscle. Loss of TRPC1 may alter the regulation of cellular energy metabolism resulting in insulin resistance thereby leading to diabetes. Exercise reduces insulin resistance, but it is not known whether TRPC1 is involved in exercise-induced insulin sensitivity. The role of TRPC1 in adiposity and obesity-associated metabolic diseases has not yet been determined. Our results show that TRPC1 functions as a major Ca2+ entry channel in adipocytes. We have also shown that fat mass and fasting glucose concentrations were lower in TRPC1 KO mice that were fed a high-fat (HF) (45% fat) diet and exercised as compared with WT mice fed a HF diet and exercised. Adipocyte numbers were decreased in both subcutaneous and visceral adipose tissue of TRPC1 KO mice fed a HF diet and exercised. Finally, autophagy markers were decreased and apoptosis markers increased in TRPC1 KO mice fed a HF diet and exercised. Overall, these findings suggest that TRPC1 plays an important role in the regulation of adiposity via autophagy and apoptosis and that TRPC1 inhibits the positive effect of exercise on type II diabetes risk under a HF diet-induced obesity environment.	[Krout, Danielle; Roemmich, James N.; Claycombe-Larson, Kate J.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA; [Schaar, Anne; Sun, Yuyang; Sukumaran, Pramod; Singh, Brij B.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58203 USA	United States Department of Agriculture (USDA); University of North Dakota Grand Forks	Singh, BB (corresponding author), 1301 North Columbia Rd,Ste W221,POB 9037, Grand Forks, ND 58201 USA.; Claycombe-Larson, KJ (corresponding author), 2420 2nd Ave North, Grand Forks, ND 58203 USA.	brij.singh@med.und.edu; kate.larson@ars.usda.gov		Singh, Brij/0000-0003-0535-5997; SCHAAR, ANNE/0000-0002-5315-333X; Roemmich, James/0000-0002-6270-9678	National Institutes of Health [R01DE017102, R01DE022765, R21DE024300, P20GM113123]; U.S. Department of Agriculture, Agricultural Research Service Project [3062-51000-052-00D]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024300, R01DE022765, R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture, Agricultural Research Service Project; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DE017102, R01DE022765, R21DE024300, and P20GM113123 (to B. B. S.) and by the U.S. Department of Agriculture, Agricultural Research Service Project 3062-51000-052-00D (to K. J. C.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the United States government.	ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bollimuntha S, 2006, BRAIN RES, V1099, P141, DOI 10.1016/j.brainres.2006.04.104; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Claycombe KJ, 2016, J NUTR BIOCHEM, V31, P113, DOI 10.1016/j.jnutbio.2016.01.008; Claycombe KJ, 2015, J NUTR BIOCHEM, V26, P729, DOI 10.1016/j.jnutbio.2015.01.008; Claycombe KJ, 2015, J NUTR BIOCHEM, V26, P184, DOI 10.1016/j.jnutbio.2014.10.003; Claycombe KJ, 2013, J NUTR, V143, P1533, DOI 10.3945/jn.113.178038; CRAIG BW, 1981, J APPL PHYSIOL, V51, P1500, DOI 10.1152/jappl.1981.51.6.1500; Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008; Graham S, 2012, EXP BIOL MED, V237, P111, DOI 10.1258/ebm.2011.011208; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Ouguerram K, 2006, BRIT J NUTR, V96, P100, DOI 10.1079/BJN20061806; Pan Z, 2001, J BIOL CHEM, V276, P32257, DOI 10.1074/jbc.M100178200; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rao JN, 2006, AM J PHYSIOL-GASTR L, V290, pG782, DOI 10.1152/ajpgi.00441.2005; Sabourin J, 2015, J BIOL CHEM, V290, P30530, DOI 10.1074/jbc.M115.682583; Saltevo J, 2011, EUR J ENDOCRINOL, V165, P429, DOI 10.1530/EJE-11-0066; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; SORVA A, 1990, GERONTOLOGY, V36, P212, DOI 10.1159/000213202; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Sukumaran P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.7; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Witczak CA, 2006, J APPL PHYSIOL, V101, P752, DOI 10.1152/japplphysiol.00235.2006; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	44	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20799	20807		10.1074/jbc.M117.809954	http://dx.doi.org/10.1074/jbc.M117.809954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074621	Green Published, hybrid			2022-12-28	WOS:000418267000038
J	Lanchec, E; Desilets, A; Beliveau, F; Flamier, A; Mahmoud, S; Bernier, G; Gris, D; Leduc, R; Lavoie, C				Lanchec, Erwan; Desilets, Antoine; Beliveau, Francois; Flamier, Anthony; Mahmoud, Shaimaa; Bernier, Gilbert; Gris, Denis; Leduc, Richard; Lavoie, Christine			The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to -amyloid peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (A); brain; enzyme processing; extracellular matrix protein; serine protease; matriptase; ST14	HEPATOCYTE GROWTH-FACTOR; MAPPING BRAIN MATURATION; ALZHEIMERS-DISEASE; CELL-SURFACE; STEM-CELLS; IN-VITRO; BETA; APP; SECRETASE; CANCER	Recent studies have reported that many proteases, besides the canonical -, -, and -secretases, cleave the amyloid precursor protein (APP) and modulate -amyloid (A) peptide production. Moreover, specific APP isoforms contain Kunitz protease-inhibitory domains, which regulate the proteolytic activity of serine proteases. This prompted us to investigate the role of matriptase, a member of the type II transmembrane serine protease family, in APP processing. Using quantitative RT-PCR, we detected matriptase mRNA in several regions of the human brain with an enrichment in neurons. RNA sequencing data of human dorsolateral prefrontal cortex revealed relatively high levels of matriptase RNA in young individuals, whereas lower levels were detected in older individuals. We further demonstrate that matriptase and APP directly interact with each other and that matriptase cleaves APP at a specific arginine residue (Arg-102) both in vitro and in cells. Site-directed (Arg-to-Ala) mutagenesis of this cleavage site abolished matriptase-mediated APP processing. Moreover, we observed that a soluble, shed matriptase form cleaves endogenous APP in SH-SY5Y cells and that this cleavage significantly reduces APP processing to A40. In summary, this study identifies matriptase as an APP-cleaving enzyme, an activity that could have important consequences for the abundance of A and in Alzheimer's disease pathology.	[Lanchec, Erwan; Desilets, Antoine; Beliveau, Francois; Leduc, Richard; Lavoie, Christine] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol Physiol, Sherbrooke, PQ J1H 5N4, Canada; [Flamier, Anthony; Bernier, Gilbert] Hop Maison Neuve Rosemont, Stem Cell & Dev Biol Lab, 5415 Blvd Assompt, Montreal, PQ H1T 2M4, Canada; [Mahmoud, Shaimaa; Gris, Denis] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pediat, Sherbrooke, PQ J1H 5N4, Canada; [Bernier, Gilbert] Univ Montreal, Dept Neurosci, Montreal, PQ H3C 3J7, Canada	University of Sherbrooke; Universite de Montreal; University of Sherbrooke; Universite de Montreal	Leduc, R; Lavoie, C (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol Physiol, Sherbrooke, PQ J1H 5N4, Canada.	Richard.Leduc@USherbrooke.ca; Christine.L.Lavoie@USherbrooke.ca	Gris, Denis/AGA-1192-2022; Gris, Denis/ABE-5229-2021	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434; Beliveau, Francois/0000-0001-6324-2363; Desilets, Antoine/0000-0001-5081-5564; Leduc, Richard/0000-0001-6854-8003	Pfizer-Fonds de Recherche du Quebec-Sante Innovation Funds for Alzheimer Disease and Related Disorders	Pfizer-Fonds de Recherche du Quebec-Sante Innovation Funds for Alzheimer Disease and Related Disorders	This work was supported by Pfizer-Fonds de Recherche du Quebec-Sante Innovation Funds for Alzheimer Disease and Related Disorders. The authors declare that they have no conflicts of interest with the contents of this article.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; ARAI H, 1991, ANN NEUROL, V30, P686, DOI 10.1002/ana.410300509; Barao S, 2016, TRENDS NEUROSCI, V39, P158, DOI 10.1016/j.tins.2016.01.003; Beckmann AM, 2016, BIOL CHEM, V397, P777, DOI 10.1515/hsz-2015-0263; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chiang PK, 2008, CURR MOL MED, V8, P580, DOI 10.2174/156652408785747951; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; Fang JD, 2011, J BIOL CHEM, V286, P5667, DOI 10.1074/jbc.M110.153866; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; JOHNSON SA, 1990, SCIENCE, V248, P854, DOI 10.1126/science.2111579; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2012, EUR J CELL BIOL, V91, P234, DOI 10.1016/j.ejcb.2011.01.017; Kawaguchi M, 2014, CANCERS, V6, P1890, DOI 10.3390/cancers6041890; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; KITAGUCHI N, 1988, NATURE, V331, P530, DOI 10.1038/331530a0; Koivuniemi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056117; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; Ledesma MD, 2000, EMBO REP, V1, P530; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Ludewig S, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00161; Miyata S, 2007, HUM CELL, V20, P100, DOI 10.1111/j.1749-0774.2007.00035.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Nicolas M, 2014, DEVELOPMENT, V141, P2543, DOI 10.1242/dev.108712; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Preece P, 2004, MOL BRAIN RES, V122, P1, DOI 10.1016/j.molbrainres.2003.08.022; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SCHMAIER AH, 1993, J CLIN INVEST, V92, P2540, DOI 10.1172/JCI116863; SHI YE, 1993, CANCER RES, V53, P1409; SMALL DH, 1994, J NEUROSCI, V14, P2117; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762	63	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20669	20682		10.1074/jbc.M117.792911	http://dx.doi.org/10.1074/jbc.M117.792911			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29054928	Green Published, hybrid			2022-12-28	WOS:000418267000028
J	Stepanova, V; Dergilev, KV; Holman, KR; Parfyonova, YV; Tsokolaeva, ZI; Teter, M; Atochina-Vasserman, EN; Volgina, A; Zaitsev, SV; Lewis, SP; Zabozlaev, FG; Obraztsova, K; Krymskaya, VP; Cines, DB				Stepanova, Victoria; Dergilev, Konstantin V.; Holman, Kelci R.; Parfyonova, Yelena V.; Tsokolaeva, Zoya I.; Teter, Mimi; Atochina-Vasserman, Elena N.; Volgina, Alla; Zaitsev, Sergei V.; Lewis, Shane P.; Zabozlaev, Fedor G.; Obraztsova, Kseniya; Krymskaya, Vera P.; Cines, Douglas B.			Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lung; mammalian target of rapamycin (mTOR); mTOR complex (mTORC); plasminogen; TOR complex (TORC); tuberous sclerosis complex (TSC); tumor cell biology; urokinase receptor	PULMONARY LYMPHANGIOLEIOMYOMATOSIS LAM; FIBROBLAST-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; SERUM RESPONSE FACTOR; MATRIX METALLOPROTEINASES; MAMMALIAN TARGET; EXTRACELLULAR-MATRIX; TRANSCRIPTION FACTOR; MUTATIONAL ANALYSIS; INSULIN-RESISTANCE	Lymphangioleiomyomatosis (LAM) is a fatal lung disease associated with germline or somatic inactivating mutations in tuberous sclerosis complex genes (TSC1 or TSC2). LAM is characterized by neoplastic growth of smooth muscle--actin-positive cells that destroy lung parenchyma and by the formation of benign renal neoplasms called angiolipomas. The mammalian target of rapamycin complex 1 (mTORC1) inhibitor rapamycin slows progression of these diseases but is not curative and associated with notable toxicity at clinically effective doses, highlighting the need for better understanding LAM's molecular etiology. We report here that LAM lesions and angiomyolipomas overexpress urokinase-type plasminogen activator (uPA). Tsc1(-/-) and Tsc2(-/-) mouse embryonic fibroblasts expressed higher uPA levels than their WT counterparts, resulting from the TSC inactivation. Inhibition of uPA expression in Tsc2-null cells reduced the growth and invasiveness and increased susceptibility to apoptosis. However, rapamycin further increased uPA expression in TSC2-null tumor cells and immortalized TSC2-null angiomyolipoma cells, but not in cells with intact TSC. Induction of glucocorticoid receptor signaling or forkhead box (FOXO) 1/3 inhibition abolished the rapamycin-induced uPA expression in TSC-compromised cells. Moreover, rapamycin-enhanced migration of TSC2-null cells was inhibited by the uPA inhibitor UK122, dexamethasone, and a FOXO inhibitor. uPA-knock-out mice developed fewer and smaller TSC2-null lung tumors, and introduction of uPA shRNA in tumor cells or amiloride-induced uPA inhibition reduced tumorigenesis in vivo. These findings suggest that interference with the uPA-dependent pathway, when used along with rapamycin, might attenuate LAM progression and potentially other TSC-related disorders.	[Stepanova, Victoria; Zaitsev, Sergei V.; Cines, Douglas B.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA; [Atochina-Vasserman, Elena N.; Volgina, Alla; Obraztsova, Kseniya; Krymskaya, Vera P.] Univ Penn, Perelman Sch Med, Penn Ctr Pulm Biol, Pulm Allergy & Crit Care Div,Dept Med, Philadelphia, PA 19104 USA; [Dergilev, Konstantin V.; Parfyonova, Yelena V.; Tsokolaeva, Zoya I.] Natl Med Res Ctr Cardiol, Angiogenesis Lab, Inst Expt Cardiol, Moscow 121552, Russia; [Holman, Kelci R.; Teter, Mimi; Lewis, Shane P.] Drexel Univ, Coll Arts & Sci, Philadelphia, PA 19104 USA; [Zabozlaev, Fedor G.] Fed Med & Biol Agcy Russia, Dept Pathol, Fed Res Clin Ctr, Moscow 115682, Russia	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Medical Research Center of Cardiology; Drexel University; University of Pennsylvania	Stepanova, V (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, 512 Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	vstepano@pennmedicine.upenn.edu	Parfyonova, Yelena V/B-9307-2014; Atochina-Vasserman, Elena/AAN-2286-2020; Дергилев, Константин/J-9423-2015	Parfyonova, Yelena V/0000-0002-0969-5780; Дергилев, Константин/0000-0003-2712-4997; Atochina-Vasserman, Elena N/0000-0001-7950-7004; Cines, Douglas/0000-0001-5986-504X	National Institutes of Health Grants from NHLBI [RO1 HL116916, RO1 HL114085, R01 HL131626]; Department of the Army Congressionally Directed Medical Research Programs [TS150032 W21XWH-16-1-0187]; University of Pennsylvania Perelman School of Medicine Orphan Disease Center [MDBR-17-118-LAM]; Russian Science Foundation [17-15-01368]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131626, R01HL116916, R01HL114085] Funding Source: NIH RePORTER	National Institutes of Health Grants from NHLBI; Department of the Army Congressionally Directed Medical Research Programs; University of Pennsylvania Perelman School of Medicine Orphan Disease Center; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants from NHLBI RO1 HL116916 (to D. B. C.) and RO1 HL114085 and R01 HL131626 (to V. P. K.), Department of the Army Congressionally Directed Medical Research Programs Grant TS150032 W21XWH-16-1-0187 (to V. S.), University of Pennsylvania Perelman School of Medicine Orphan Disease Center Grant MDBR-17-118-LAM) (to V. S.), and Russian Science Foundation Grant 17-15-01368 (to K. V. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfano D, 2006, J BIOL CHEM, V281, P17758, DOI 10.1074/jbc.M601812200; Alphonso A, 2009, NEOPLASIA, V11, P1264, DOI 10.1593/neo.91302; Asuthkar S, 2013, MOL BIOL CELL, V24, P2620, DOI 10.1091/mbc.E12-04-0306; Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bittmann I, 2003, HUM PATHOL, V34, P95, DOI 10.1053/hupa.2003.50; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Burgos SA, 2013, HORM METAB RES, V45, P183, DOI 10.1055/s-0032-1323742; Cai XO, 2010, AM J RESP CRIT CARE, V182, P1410, DOI 10.1164/rccm.201003-0489OC; Cao Y, 2006, J BIOL CHEM, V281, P40242, DOI 10.1074/jbc.M608116200; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriero MV, 2009, FRONT BIOSCI-LANDMRK, V14, P3782, DOI [10.2735/3488, 10.2741/3488]; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cavallaro U, 1998, FASEB J, V12, P1027, DOI 10.1096/fasebj.12.11.1027; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chiang SPH, 2016, AM J PHYSIOL-CELL PH, V311, pC1, DOI 10.1152/ajpcell.00238.2015; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dabora SL, 2001, AM J HUM GENET, V68, P64, DOI 10.1086/316951; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Eijkelenboom A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.74; El-Chemaly S, 2015, EXPERT REV RESP MED, V9, P195, DOI 10.1586/17476348.2015.1024663; Etique N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152163; Evans SE, 2004, CHEST, V125, P1063, DOI 10.1378/chest.125.3.1063; FAZIOLI F, 1994, TRENDS PHARMACOL SCI, V15, P25, DOI 10.1016/0165-6147(94)90130-9; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; FUKUDA Y, 1990, HUM PATHOL, V21, P1252, DOI 10.1016/S0046-8177(06)80039-0; Goncharova E, 2004, J CELL BIOL, V167, P1171, DOI 10.1083/jcb.200405130; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P561, DOI 10.1165/rcmb.2005-0300OC; Goncharova EA, 2006, AM J RESP CELL MOL, V34, P473, DOI 10.1165/rcmb.2005-0374OC; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003840; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Gonias SL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00154; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; GYETKO MR, 1994, J CLIN INVEST, V93, P1380, DOI 10.1172/JCI117114; Habib SL, 2011, ONCOTARGET, V2, P958; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hayashi T, 1997, HUM PATHOL, V28, P1071, DOI 10.1016/S0046-8177(97)90061-7; Heinemann V, 2013, BRIT J CANCER, V108, P766, DOI 10.1038/bjc.2013.62; Henske EP, 2012, J CLIN INVEST, V122, P3807, DOI 10.1172/JCI58709; Hodges LC, 2002, MOL CELL ENDOCRINOL, V196, P11, DOI 10.1016/S0303-7207(02)00230-7; HOWE SR, 1995, ENDOCRINOLOGY, V136, P4996, DOI 10.1210/en.136.11.4996; HOWE SR, 1995, AM J PATHOL, V146, P1568; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ilagan E, 2016, TRENDS CANCER, V2, P241, DOI 10.1016/j.trecan.2016.03.008; Inoue Y, 2002, AM J RESP CRIT CARE, V166, P765, DOI 10.1164/rccm.2010014; Jankun J, 1999, Cancer Biochem Biophys, V17, P109; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Juvet SC, 2007, AM J RESP CELL MOL, V36, P398, DOI 10.1165/rcmb.2006-0372TR; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Kobayashi T, 1999, CANCER RES, V59, P1206; Koolwijk P, 1996, J CELL BIOL, V132, P1177, DOI 10.1083/jcb.132.6.1177; KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153; Krymskaya VP, 2017, ANNU REV MED, V68, P69, DOI 10.1146/annurev-med-050715-104245; Krymskaya VP, 2003, CELL SIGNAL, V15, P729, DOI 10.1016/S0898-6568(03)00040-8; Krymskaya VP, 2003, AM J RESP CELL MOL, V28, P546, DOI 10.1165/rcmb.F267; Kwaan HC, 2013, SEMIN THROMB HEMOST, V39, P382, DOI 10.1055/s-0033-1338127; Kwiatkowski DJ, 2010, LYMPHAT RES BIOL, V8, P51, DOI 10.1089/lrb.2009.0013; Lee PS, 2010, AM J RESP CELL MOL, V42, P227, DOI 10.1165/rcmb.2009-0050OC; Li CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104809; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Liu RH, 2012, FUTURE ONCOL, V8, P463, DOI [10.2217/FON.12.26, 10.2217/fon.12.26]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loo SY, 2012, CURR PHARM DESIGN, V18, P1372; Ma Z, 2001, J CELL SCI, V114, P3387; Makowski GS, 1998, INFLAMMATION, V22, P287, DOI 10.1023/A:1022300216202; Matthews H, 2011, INT J CANCER, V129, P2051, DOI 10.1002/ijc.26156; MATTHEWS TJ, 1993, J CLIN PATHOL, V46, P479, DOI 10.1136/jcp.46.5.479; Mazzieri R, 2005, THROMB HAEMOSTASIS, V93, P641, DOI 10.1160/TH05-01-0021; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2016, AM J RESP CRIT CARE, V194, P748, DOI 10.1164/rccm.201607-1384ST; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Menshikov M, 2006, J VASC RES, V43, P482, DOI 10.1159/000095248; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; Mori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088891; MURPHY G, 1994, ANN NY ACAD SCI, V732, P31, DOI 10.1111/j.1749-6632.1994.tb24722.x; Nassar T, 2011, AM J RESP CELL MOL, V45, P1015, DOI 10.1165/rcmb.2010-0302OC; Nozaki S, 1998, ORAL ONCOL, V34, P58, DOI 10.1016/S1368-8375(97)00028-6; O'Halloran TV, 2013, THERANOSTICS, V3, P496, DOI 10.7150/thno.4953; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pandey A, 2016, CURR DIABETES REV, V12, P223, DOI 10.2174/1573399811666150804104858; PELTZ SW, 1982, BIOCHEMISTRY-US, V21, P2798, DOI 10.1021/bi00540a035; Pew T, 2008, ENDOCRINOLOGY, V149, P2637, DOI 10.1210/en.2007-1096; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; Sancak O, 2005, EUR J HUM GENET, V13, P731, DOI 10.1038/sj.ejhg.5201402; Sebaaly J, 2016, J ALLER CL IMM-PRACT, V4, P352, DOI 10.1016/j.jaip.2015.11.007; Shetty S, 2002, AM J PHYSIOL-LUNG C, V283, pL319, DOI 10.1152/ajplung.00395.2001; Shi YJ, 2005, MOL CANCER THER, V4, P1533, DOI 10.1158/1535-7163.MCT-05-0068; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Stepanova V, 2016, J BIOL CHEM, V291, P15029, DOI 10.1074/jbc.M115.678490; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Storz P, 2009, MOL CELL BIOL, V29, P4906, DOI 10.1128/MCB.00077-09; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Sun Y, 2014, AM J RESP CELL MOL, V51, P738, DOI 10.1165/rcmb.2014-0033OC; Tarui T, 2006, THROMB HAEMOSTASIS, V95, P524, DOI 10.1160/TH05-06-0457; Tay Y, 2014, CELL REP, V8, P714, DOI 10.1016/j.celrep.2014.06.064; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tian BQ, 2017, ONCOTARGET, V8, P42300, DOI 10.18632/oncotarget.15857; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; VASSALLI JD, 1987, FEBS LETT, V214, P187, DOI 10.1016/0014-5793(87)80039-X; Yao JH, 2014, AM J RESP CRIT CARE, V190, P1273, DOI 10.1164/rccm.201405-0918OC; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003; Zaki Khawaja S, 2016, World J Transplant, V6, P249, DOI 10.5500/wjt.v6.i1.249; Zhang GQ, 2009, J BIOL CHEM, V284, P29050, DOI 10.1074/jbc.M109.010249; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhe XN, 2005, AM J RESP CELL MOL, V32, P28, DOI 10.1165/rcmb.2004-0289OC; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	121	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20528	20543		10.1074/jbc.M117.799593	http://dx.doi.org/10.1074/jbc.M117.799593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28972182	Green Published, hybrid			2022-12-28	WOS:000418267000015
J	Weissgerber, TL; Savic, M; Winham, SJ; Stanisavljevic, D; Garovic, VD; Milic, NM				Weissgerber, Tracey L.; Savic, Marko; Winham, Stacey J.; Stanisavljevic, Dejana; Garovic, Vesna D.; Milic, Natasa M.			Data visualization, bar naked: A free tool for creating interactive graphics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bar graphs; data visualization; interactive graphics; open science; transparency	CLUSTERED DATA; TRANSPARENCY; CHARTS; KEY	Although bar graphs are designed for categorical data, they are routinely used to present continuous data in studies that have small sample sizes. This presentation is problematic, as many data distributions can lead to the same bar graph, and the actual data may suggest different conclusions from the summary statistics. To address this problem, many journals have implemented new policies that require authors to show the data distribution. This paper introduces a free, web-based tool for creating an interactive alternative to the bar graph (http://statistika.mfub.bg.ac.rs/interactive-dotplot/). This tool allows authors with no programming expertise to create customized interactive graphics, including univariate scatterplots, box plots, and violin plots, for comparing values of a continuous variable across different study groups. Individual data points may be overlaid on the graphs. Additional features facilitate visualization of subgroups or clusters of non-independent data. A second tool enables authors to create interactive graphics from data obtained with repeated independent experiments (http://statistika.mfub.bg.ac.rs/interactive-repeated-experiments-dotplot/). These tools are designed to encourage exploration and critical evaluation of the data behind the summary statistics and may be valuable for promoting transparency, reproducibility, and open science in basic biomedical research.	[Weissgerber, Tracey L.; Garovic, Vesna D.; Milic, Natasa M.] Mayo Clin, Div Nephrol & Hypertens, 200 First St SW,RO HA-06-675-11, Rochester, MN 55905 USA; [Winham, Stacey J.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Savic, Marko; Stanisavljevic, Dejana; Milic, Natasa M.] Univ Belgrade, Dept Med Stat & Informat, Fac Med, Belgrade 11000, Serbia	Mayo Clinic; Mayo Clinic; University of Belgrade	Weissgerber, TL (corresponding author), Mayo Clin, Div Nephrol & Hypertens, 200 First St SW,RO HA-06-675-11, Rochester, MN 55905 USA.	weissgerber.tracey@mayo.edu	Weissgerber, Tracey L/D-2324-2014	Weissgerber, Tracey L/0000-0002-7490-2600	CTSA Grant from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	CTSA Grant from the National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by CTSA Grant UL1 TR000135 from the National Center for Advancing Translational Sciences, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2017, NATURE, V546, P8; [Anonymous], 2016, NAT MED, V22, P1, DOI 10.1038/nm.4033; [Anonymous], 2014, NAT METHODS, V11, P113, DOI 10.1038/nmeth.2837; [Anonymous], 2015, INT J PRIMATOLOGY; [Anonymous], 2016, J NEUROSCIENCE RES; [Anonymous], 2015, J BIOL CHEM; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Ellis DA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01782; Fosang AJ, 2015, J BIOL CHEM, V290, P29692, DOI 10.1074/jbc.E115.000002; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; George CH, 2017, BRIT J PHARMACOL, V174, P2801, DOI 10.1111/bph.13925; Halsey LG, 2015, NAT METHODS, V12, P179, DOI 10.1038/nmeth.3288; Hayes B, 2012, AM SCI, V100, P106, DOI 10.1511/2012.95.106; Holman C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002331; Jambor H., 2016, BARBARPLOTS; Kidney International, 2017, GUID FOR AUTH; Koyama T, BEWARE OF DYNAMITE; Krumholz HM, 2015, CIRC-CARDIOVASC QUAL, V8, P533, DOI 10.1161/CIRCOUTCOMES.115.002415; Lazic SE, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-5; NIH, 2015, CONS SEX BIOL VAR NI; Pallmann P, 2016, ARCH TOXICOL, V90, P1631, DOI 10.1007/s00204-015-1608-4; PLOS Biology, 2016, PLOS BIOL; Rousselet G., 2016, BASIC STAT SIMPLE ST; Saxon E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0169-6; Teare MD, 2016, ELIFE, V5, DOI 10.7554/eLife.21070; Vaux DL, 2012, NATURE, V492, P180, DOI 10.1038/492180a; Wadman M, 2013, NATURE, V500, P14, DOI 10.1038/500014a; Weissgerber TL, 2016, J NEUROSCI RES, V94, P859, DOI 10.1002/jnr.23785; Weissgerber TL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002484; Weissgerber TL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002430; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128	32	56	56	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20592	20598		10.1074/jbc.RA117.000147	http://dx.doi.org/10.1074/jbc.RA117.000147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28974579	hybrid, Green Published			2022-12-28	WOS:000418267000020
J	Khuong, MT; Fei, J; Cruz-Becerra, G; Kadonaga, JT				Khuong, Mai T.; Fei, Jia; Cruz-Becerra, Grisel; Kadonaga, James T.			A simple and versatile system for the ATP-dependent assembly of chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin structure; histone; histone chaperone; nucleosome	CHROMOSOMAL-PROTEINS HMG-14; HMGN PROTEINS; NUCLEOSOME MOBILITY; REMODELING FACTOR; HISTONE VARIANTS; CORE HISTONES; DROSOPHILA; ACF; RECONSTITUTION; TRANSCRIPTION	Chromatin is the natural form of DNA in the eukaryotic nucleus and is the substrate for diverse biological phenomena. The functional analysis of these processes ideally would be carried out with nucleosomal templates that are assembled with customized core histones, DNA sequences, and chromosomal proteins. Here we report a simple, reliable, and versatile method for the ATP-dependent assembly of evenly spaced nucleosome arrays. This minimal chromatin assembly system comprises the Drosophila nucleoplasmin-like protein (dNLP) histone chaperone, the imitation switch (ISWI) ATP-driven motor protein, core histones, template DNA, and ATP. The dNLP and ISWI components were synthesized in bacteria, and each protein could be purified in a single step by affinity chromatography. We show that the dNLP-ISWI system can be used with different DNA sequences, linear or circular DNA, bulk genomic DNA, recombinant or native Drosophila core histones, native human histones, the linker histone H1, the non-histone chromosomal protein HMGN2, and the core histone variants H3.3 and H2A.V. The dNLP-ISWI system should be accessible to a wide range of researchers and enable the assembly of customized chromatin with specifically desired DNA sequences, core histones, and other chromosomal proteins.	[Khuong, Mai T.; Fei, Jia; Cruz-Becerra, Grisel; Kadonaga, James T.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kadonaga, JT (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.	jkadonaga@ucsd.edu		Cruz Becerra, Grisel/0000-0001-6297-4132	National Institutes of Health [R35 GM 118060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R35 GM 118060 (to J. T. K.). The authors declare potential competing financial interests with the contents of this article. The chromatin assembly system described in this article could potentially be sold commercially as a research reagent. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBRIGHT LM, 1988, J BACTERIOL, V170, P1279, DOI 10.1128/jb.170.3.1279-1289.1988; ALBRIGHT SC, 1980, J BIOL CHEM, V255, P3673; ALFONSO PJ, 1994, J MOL BIOL, V236, P189, DOI 10.1006/jmbi.1994.1128; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Bulger M., 1994, METH MOL G, V5, P241; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Craig N., 2014, MOL BIOL PRINCIPLES; Crevel G, 1997, J STRUCT BIOL, V118, P9, DOI 10.1006/jsbi.1996.3836; Croston G.E., 1991, Protein Expression and Purification, V2, P162, DOI 10.1016/1046-5928(91)90066-R; David Y, 2017, J AM CHEM SOC, V139, P9090, DOI 10.1021/jacs.7b03430; ELFRING LK, 1994, MOL CELL BIOL, V14, P2225, DOI 10.1128/MCB.14.4.2225; Fyodorov D. V., 2002, CURR PROTOC MOL BIOL, V21, P7; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1996, MOL CELL BIOL, V16, P3112; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Ito T, 1996, J BIOL CHEM, V271, P25041, DOI 10.1074/jbc.271.40.25041; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kalashnikova AA, 2016, BBA-GENE REGUL MECH, V1859, P455, DOI 10.1016/j.bbagrm.2015.10.004; KAWASAKI K, 1994, J BIOL CHEM, V269, P10169; Khuong MT, 2015, COLD SH Q B, V80, P65, DOI 10.1101/sqb.2015.80.027300; KUEHL L, 1984, J CELL BIOL, V99, P648, DOI 10.1083/jcb.99.2.648; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Loyola A, 2003, METHODS, V31, P96, DOI 10.1016/S1046-2023(03)00093-8; Luger K, 1999, METH MOL B, V119, P1; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Namboodiri VMH, 2003, STRUCTURE, V11, P175, DOI 10.1016/S0969-2126(03)00007-8; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Rattner BP, 2009, MOL CELL, V34, P620, DOI 10.1016/j.molcel.2009.04.014; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; SANDEEN G, 1980, NUCLEIC ACIDS RES, V8, P3757, DOI 10.1093/nar/8.17.3757; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; STEIN A, 1989, METHOD ENZYMOL, V170, P585; VANDAAL A, 1988, NUCLEIC ACIDS RES, V16, P7487, DOI 10.1093/nar/16.15.7487; VARSHAVSKY AJ, 1976, NUCLEIC ACIDS RES, V3, P477, DOI 10.1093/nar/3.2.477; Weber CM, 2014, GENE DEV, V28, P672, DOI 10.1101/gad.238873.114; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zhu N, 2010, BBA-GENE REGUL MECH, V1799, P74, DOI 10.1016/j.bbagrm.2009.11.006	51	12	12	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19478	19490		10.1074/jbc.M117.815365	http://dx.doi.org/10.1074/jbc.M117.815365			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982979	Green Published, hybrid			2022-12-28	WOS:000416226700027
J	Seth, B; Yadav, A; Agarwal, S; Tiwari, SK; Chaturvedi, RK				Seth, Brashket; Yadav, Anuradha; Agarwal, Swati; Tiwari, Shashi Kant; Chaturvedi, Rajnish Kumar			Inhibition of the transforming growth factor-/SMAD cascade mitigates the anti-neurogenic effects of the carbamate pesticide carbofuran	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural stem cell (NSC); neurite outgrowth; neurodegeneration; neurogenesis; neuroprotection; stem cells; toxicity; toxicology; neurotoxicity; pesticide	STEM-CELL PROLIFERATION; TGF-BETA; HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; BISPHENOL-A; CEREBROSPINAL-FLUID; COGNITIVE DEFICITS; ADULT NEUROGENESIS; INTERFERON-GAMMA; MEMORY DEFICITS	The widely used carbamate pesticide carbofuran causes neurophysiological and neurobehavioral deficits in rodents and humans and therefore poses serious health hazards around the world. Previously, we reported that gestational carbofuran exposure has detrimental effects on hippocampal neurogenesis, the generation of new neurons from neural stem cells (NSC), in offspring. However, the underlying cellular and molecular mechanisms for carbofuran-impaired neurogenesis remain unknown. Herein, we observed that chronic carbofuran exposure from gestational day 7 to postnatal day 21 altered expression of genes and transcription factors and levels of proteins involved in neurogenesis and the TGF- pathway (i.e. TGF-; SMAD-2, -3, and -7; and SMURF-2) in the rat hippocampus. We found that carbofuran increases TGF- signaling (i.e. increased phosphorylated SMAD-2/3 and reduced SMAD-7 expression) in the hippocampus, which reduced NSC proliferation because of increased p21 levels and reduced cyclin D1 levels. Moreover, the carbofuran-altered TGF- signaling impaired neuronal differentiation (BrdU/DCX+ and BrdU/NeuN(+) cells) and increased apoptosis and neurodegeneration in the hippocampus. Blockade of the TGF- pathway with the specific inhibitor SB431542 and via SMAD-3 siRNA prevented carbofuran-mediated inhibition of neurogenesis in both hippocampal NSC cultures and the hippocampus, suggesting the specific involvement of this pathway. Of note, both in vitro and in vivo studies indicated that TGF- pathway attenuation reverses carbofuran's inhibitory effects on neurogenesis and associated learning and memory deficits. These results suggest that carbofuran inhibits NSC proliferation and neuronal differentiation by altering TGF- signaling. Therefore, we conclude that TGF- may represent a potential therapeutic target against carbofuran-mediated neurotoxicity and neurogenesis disruption.	[Seth, Brashket; Yadav, Anuradha; Agarwal, Swati; Tiwari, Shashi Kant; Chaturvedi, Rajnish Kumar] CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan 31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Seth, Brashket; Yadav, Anuradha; Chaturvedi, Rajnish Kumar] CSIR IITR, Acad Sci & Innovat Res AcSIR, Lucknow Campus, Lucknow 226001, Uttar Pradesh, India; [Agarwal, Swati] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Tiwari, Shashi Kant] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Johns Hopkins University; University of California System; University of California San Diego	Chaturvedi, RK (corresponding author), CSIR IITR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Vishvigyan Bhavan 31,Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	itrcrajnish@gmail.com	Chaturvedi, Rajnish/AAZ-9955-2020; Tiwari, Shashi Kant/R-8533-2018	Tiwari, Shashi Kant/0000-0002-6121-6249; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636	Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR [EMR/2016/001933]; Department of Biotechnology, New Delhi [BT/PR15819/MED/31/322/2015]; Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from UGC, New Delhi	Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR; Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Senior Research Fellowship from CSIR, New Delhi; Senior Research Fellowship from UGC, New Delhi	This work was supported by the Lady Tata Memorial-UK Young Scientist Grant; Science and Engineering Research Board (SERB), New Delhi, EMR Grant EMR/2016/001933; and Department of Biotechnology, New Delhi, Research Grant BT/PR15819/MED/31/322/2015 (to R. K. C.). This is CSIR-IITR manuscript communication 3483. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Senior Research Fellowship from CSIR, New Delhi.; Recipient of a Senior Research Fellowship from UGC, New Delhi.	Abrous DN, 2002, J NEUROSCI, V22, P3656; Agarwal S, 2016, J BIOL CHEM, V291, P15923, DOI 10.1074/jbc.M115.709493; Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Angbohang A, 2016, STEM CELLS DEV, V25, P1, DOI 10.1089/scd.2015.0262; Apelt J, 2001, BRAIN RES, V894, P21, DOI 10.1016/S0006-8993(00)03176-0; Baligar PN, 2002, IND HEALTH, V40, P345, DOI 10.2486/indhealth.40.345; Betancourt AM, 2006, TOXICOL SCI, V92, P500, DOI 10.1093/toxsci/kfl004; Bizet AA, 2012, J CELL BIOCHEM, V113, P238, DOI 10.1002/jcb.23349; Boschen KE, 2016, NEUROSCIENCE, V324, P355, DOI 10.1016/j.neuroscience.2016.03.033; Broadwater MA, 2014, DEV NEUROSCI-BASEL, V36, P297, DOI 10.1159/000362874; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chauhan LKS, 2000, MUTAT RES-GEN TOX EN, V465, P123, DOI 10.1016/S1383-5718(99)00219-3; Chen NN, 2012, J ALZHEIMERS DIS, V30, P585, DOI 10.3233/JAD-2012-111946; D'Amico LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066487; Daynac M, 2014, STEM CELLS, V32, P3257, DOI 10.1002/stem.1815; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dutto I, 2015, ARCH TOXICOL, V89, P155, DOI 10.1007/s00204-014-1430-4; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032; Gammon DW, 2012, PEST MANAG SCI, V68, P362, DOI 10.1002/ps.2270; Goad RT, 2004, TOXICOL MECH METHOD, V14, P233, DOI 10.1080/15376520490434476; GOULD E, 1992, J NEUROSCI, V12, P3642; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Gupta RC, 2007, TOXICOL APPL PHARM, V219, P97, DOI 10.1016/j.taap.2006.10.028; GUPTA RC, 1994, J TOXICOL ENV HEALTH, V43, P383, DOI 10.1080/15287399409531931; Hagedorn L, 2000, DEV BIOL, V228, P57, DOI 10.1006/dbio.2000.9936; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hicks SD, 2011, EXP NEUROL, V229, P372, DOI 10.1016/j.expneurol.2011.03.003; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Kamboj A, 2007, NEUROCHEM RES, V32, P507, DOI 10.1007/s11064-006-9264-y; Kandasamy M, 2010, J NEUROPATH EXP NEUR, V69, P717, DOI 10.1097/NEN.0b013e3181e4f733; Karnboj A, 2006, MOL CELL BIOCHEM, V286, P107, DOI 10.1007/s11010-005-9100-8; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Klincumhom N, 2014, NEUROSCI LETT, V578, P1, DOI 10.1016/j.neulet.2014.06.001; Ko TC, 1998, ONCOGENE, V16, P3445, DOI 10.1038/sj.onc.1201902; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Li H, 2009, J APPL TOXICOL, V29, P149, DOI 10.1002/jat.1392; LINK J, 1994, ANN NEUROL, V36, P379, DOI 10.1002/ana.410360309; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; MACHEMER LH, 1994, TOXICOLOGY, V91, P29, DOI 10.1016/0300-483X(94)90237-2; Madhu V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1035374; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P1198, DOI 10.1002/hipo.22159; Milatovic D, 2005, TOXICOLOGY, V208, P13, DOI 10.1016/j.tox.2004.11.004; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; MOGI M, 1995, NEUROSCI LETT, V193, P129, DOI 10.1016/0304-3940(95)11686-Q; Moser VC, 2010, TOXICOL SCI, V114, P113, DOI 10.1093/toxsci/kfp286; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Okado N, 2001, BRAIN DEV-JPN, V23, pS11, DOI 10.1016/S0387-7604(01)00371-0; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Palazuelos J, 2014, J NEUROSCI, V34, P7917, DOI 10.1523/JNEUROSCI.0363-14.2014; PANT N, 1995, HUM EXP TOXICOL, V14, P889, DOI 10.1177/096032719501401106; Pant N, 1997, HUM EXP TOXICOL, V16, P267, DOI 10.1177/096032719701600506; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Pineda JR, 2013, M S-MED SCI, V29, P572, DOI 10.1051/medsci/2013296006; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schmuck G, 2004, ARCH TOXICOL, V78, P330, DOI 10.1007/s00204-004-0546-3; Siegenthaler JA, 2005, J NEUROSCI, V25, P8627, DOI 10.1523/JNEUROSCI.1876-05.2005; Spampanato J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041029; Stipursky J, 2007, GLIA, V55, P1023, DOI 10.1002/glia.20522; Stipursky J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00393; Strain JJ, 2015, AM J CLIN NUTR, V101, P530, DOI 10.3945/ajcn.114.100503; Sudai E, 2011, ADDICT BIOL, V16, P251, DOI 10.1111/j.1369-1600.2010.00241.x; Sun J, 2014, BIOCHEM BIOPH RES CO, V443, P1066, DOI 10.1016/j.bbrc.2013.12.097; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tanaka T, 2003, CELL STRUCT FUNCT, V28, P165; Tiwari SK, 2016, MOL NEUROBIOL, V53, P3010, DOI 10.1007/s12035-015-9197-z; Tiwari SK, 2015, J BIOL CHEM, V290, P28540, DOI 10.1074/jbc.M115.652586; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tyler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073720; Ueda K, 2013, EUR J PHARMACOL, V699, P188, DOI 10.1016/j.ejphar.2012.11.054; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0; Walter J, 2011, NEUROBIOL AGING, V32, P1906, DOI 10.1016/j.neurobiolaging.2009.11.011; Wang FW, 2011, STEM CELL RES, V7, P41, DOI 10.1016/j.scr.2011.03.004; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; WyssCoray T, 1997, J NEUROIMMUNOL, V77, P45, DOI 10.1016/S0165-5728(97)00049-0; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851; Zetterberg H, 2004, NEUROSCI LETT, V367, P194, DOI 10.1016/j.neulet.2004.06.001; Zhang Shuchen, 2014, World J Stem Cells, V6, P305, DOI 10.4252/wjsc.v6.i3.305; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	94	23	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19423	19440		10.1074/jbc.M117.798074	http://dx.doi.org/10.1074/jbc.M117.798074			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982980	Green Published, hybrid			2022-12-28	WOS:000416226700023
J	Ding, D; Bergmaier, P; Sachs, P; Klangwart, M; Ruckert, T; Bartels, N; Demmers, J; Dekker, M; Poot, RA; Mermoud, JE				Ding, Dong; Bergmaier, Philipp; Sachs, Parysatis; Klangwart, Marius; Rueckert, Tamina; Bartels, Nora; Demmers, Jeroen; Dekker, Mike; Poot, Raymond A.; Mermoud, Jacqueline E.			The CUE1 domain of the SNF2-like chromatin remodeler SMARCAD1 mediates its association with KRAB-associated protein 1 (KAP1) and KAP1 target genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; UBIQUITIN-BINDING; SELF-RENEWAL; MICE LACKING; RNAI SCREEN; PLURIPOTENCY; TRANSCRIPTION; COMPLEX; GENOME; REPLICATION	Chromatin in embryonic stem cells (ESCs) differs markedly from that in somatic cells, with ESCs exhibiting a more open chromatin configuration. Accordingly, ATP-dependent chromatin remodeling complexes are important regulators of ESC homeostasis. Depletion of the remodeler SMARCAD1, an ATPase of the SNF2 family, has been shown to affect stem cell state, but the mechanistic explanation for this effect is unknown. Here, we set out to gain further insights into the function of SMARCAD1 in mouse ESCs. We identified KRAB-associated protein 1 (KAP1) as the stoichiometric binding partner of SMARCAD1 in ESCs. We found that this interaction occurs on chromatin and that SMARCAD1 binds to different classes of KAP1 target genes, including zinc finger protein (ZFP) and imprinted genes. We also found that the RING B-box coiled-coil (RBCC) domain in KAP1 and the proximal coupling of ubiquitin conjugation to ER degradation (CUE) domain in SMARCAD1 mediate their direct interaction. Of note, retention of SMARCAD1 in the nucleus depended on KAP1 in both mouse ESCs and human somatic cells. Mutations in the CUE1 domain of SMARCAD1 perturbed the binding to KAP1 in vitro and in vivo. Accordingly, an intact CUE1 domain was required for tethering this remodeler to the nucleus. Moreover, mutation of the CUE1 domain compromised SMARCAD1 binding to KAP1 target genes. Taken together, our results reveal a mechanism that localizes SMARCAD1 to genomic sites through the interaction of SMARCAD1's CUE1 motif with KAP1.	[Ding, Dong; Bergmaier, Philipp; Sachs, Parysatis; Klangwart, Marius; Rueckert, Tamina; Bartels, Nora; Mermoud, Jacqueline E.] Philipps Univ Marburg, Inst Mol Biol & Tumour Res, D-35043 Marburg, Germany; [Demmers, Jeroen] Erasmus MC, Ctr Prote, NL-3015 CN Rotterdam, Netherlands; [Dekker, Mike; Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 CN Rotterdam, Netherlands	Philipps University Marburg; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mermoud, JE (corresponding author), Philipps Univ Marburg, Inst Mol Biol & Tumour Res, D-35043 Marburg, Germany.	mermoud@imt.uni-marburg.de	Demmers, Jeroen AA/F-4046-2016	Demmers, Jeroen AA/0000-0002-8757-9611; Mermoud, Jacqueline/0000-0002-7718-646X	Deutsche Forschungsgemeinschaft [TRR81]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (TRR81 to J. M., P. S., and P. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adkins NL, 2017, J BIOL CHEM, V292, P5271, DOI 10.1074/jbc.M117.776369; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Byeon B, 2013, J BIOL CHEM, V288, P23182, DOI 10.1074/jbc.M113.471979; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cheng B, 2014, MOL CELL BIOL, V34, P2075, DOI 10.1128/MCB.01729-13; Cheng Chun-Ting, 2014, World J Biol Chem, V5, P308, DOI 10.4331/wjbc.v5.i3.308; Densham RM, 2017, NUCLEUS-PHILA, V8, P116, DOI 10.1080/19491034.2016.1267092; Densham RM, 2016, NAT STRUCT MOL BIOL, V23, P647, DOI 10.1038/nsmb.3236; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doiguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20179; Durand-Dubief M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002974; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hong F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000607; Hota SK, 2016, DEVELOPMENT, V143, P2882, DOI 10.1242/dev.128892; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Lee J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14527; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Marcon E, 2015, NAT METHODS, V12, P725, DOI [10.1038/NMETH.3472, 10.1038/nmeth.3472]; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Rother MB, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0285; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Steglich B., 2015, PLOS GENET, P11; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Strogantsev R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0672-7; Sun R, 2014, J VIROL, V88, P7331, DOI 10.1128/JVI.00596-14; Taneja N, 2017, MOL CELL, V66, P50, DOI 10.1016/j.molcel.2017.02.006; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Xiao S, 2017, CELL REP, V18, P3117, DOI 10.1016/j.celrep.2017.02.070; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046	59	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2711	2724		10.1074/jbc.RA117.000959	http://dx.doi.org/10.1074/jbc.RA117.000959			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29284678	hybrid, Green Published			2022-12-28	WOS:000426051900008
J	Sun, XJ; Gupta, K; Wu, BG; Zhang, DY; Yuan, B; Zhang, XW; Chiang, HC; Zhang, C; Curiel, TJ; Bendeck, MP; Hursting, S; Hu, YF; Li, R				Sun, Xiujie; Gupta, Kshama; Wu, Bogang; Zhang, Deyi; Yuan, Bin; Zhang, Xiaowen; Chiang, Huai-Chin; Zhang, Chi; Curiel, Tyler J.; Bendeck, Michelle P.; Hursting, Stephen; Hu, Yanfen; Li, Rong			Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MESENCHYMAL TRANSITION; TYROSINE KINASES; CLAUDIN-LOW; BASAL-LIKE; OBESITY; INFLAMMATION; PROGRESSION; EXPRESSION; TISSUE	Discoidin domain receptor 1 (DDR1) is a collagen receptor that mediates cell communication with the extracellular matrix (ECM). Aberrant expression and activity of DDR1 in tumor cells are known to promote tumor growth. Although elevated DDR1 levels in the stroma of breast tumors are associated with poor patient outcome, a causal role for tumor-extrinsic DDR1 in cancer promotion remains unclear. Here we report that murine mammary tumor cells transplanted to syngeneic recipient mice in which Ddr1 has been knocked out (KO) grow less robustly than in WT mice. We also found that the tumor-associated stroma in Ddr1-KO mice exhibits reduced collagen deposition compared with the WT controls, supporting a role for stromal DDR1 in ECM remodeling of the tumor microenvironment. Furthermore, the stromal-vascular fraction (SVF) of Ddr1 knockout adipose tissue, which contains committed adipose stem/progenitor cells and preadipocytes, was impaired in its ability to stimulate tumor cell migration and invasion. Cytokine array-based screening identified interleukin 6 (IL-6) as a cytokine secreted by the SVF in a DDR1-dependent manner. SVF-produced IL-6 is important for SVF-stimulated tumor cell invasion in vitro, and, using antibody-based neutralization, we show that tumor promotion by IL-6 in vivo requires DDR1. In conclusion, our work demonstrates a previously unrecognized function of DDR1 in promoting tumor growth.	[Sun, Xiujie; Gupta, Kshama; Wu, Bogang; Zhang, Deyi; Yuan, Bin; Zhang, Xiaowen; Chiang, Huai-Chin; Zhang, Chi; Curiel, Tyler J.; Hu, Yanfen; Li, Rong] Univ Texas Hlth San Antonio, Dept Med, Dept Mol Med, San Antonio, TX 78229 USA; [Bendeck, Michelle P.] Univ Toronto, Ted Rogers Ctr Heart Res, Toronto, ON M5G 1M1, Canada; [Hursting, Stephen] Univ N Carolina, Nutr Res Inst, Dept Nutr, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas Health San Antonio; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill	Hu, YF; Li, R (corresponding author), Univ Texas Hlth San Antonio, Dept Mol Med, STRF, 8403 Floyd Curl Dr,Rm 219, San Antonio, TX 78229 USA.	huy3@uthscsa.edu; lir3@uthscsa.edu	Yuan, Bin/AAT-1286-2021; Wu, Bogang/O-2441-2018; Gupta, Kshama/GRS-8778-2022; Sun, Xiujie/L-1244-2017	Wu, Bogang/0000-0003-1654-198X; Sun, Xiujie/0000-0003-3814-7406	NCI, National Institutes of Health [CA206529, CA161349, CA212674]; Department of Defense [WSlXWH-14-1-0129, W81XWH-17-1-0007]; Tom C. and H. Frost Endowment; Cancer Prevention and Research Institute of Texas [RP170126]; National Institutes of Health Postdoctoral Training Grant [T32CA148724]; Owens Foundation; Skinner Endowment; University of Texas Health San Antonio Cancer Center [CA054174]; NATIONAL CANCER INSTITUTE [R01CA206529, R01CA161349, P30CA054174, T32CA148724, R01CA212674] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Tom C. and H. Frost Endowment; Cancer Prevention and Research Institute of Texas; National Institutes of Health Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Owens Foundation; Skinner Endowment; University of Texas Health San Antonio Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grants CA206529 and CA161349, Department of Defense Grant WSlXWH-14-1-0129), and the Tom C. and H. Frost Endowment (to R. L.); NCI, National Institutes of Health Grant CA212674, Department of Defense Grant W81XWH-17-1-0007, and Cancer Prevention and Research Institute of Texas Grant RP170126 (to Y.-F. H.); National Institutes of Health Postdoctoral Training Grant T32CA148724 (to H.-C. C.); and the Owens Foundation and the Skinner Endowment (to T. J. C.). This work was also supported by University of Texas Health San Antonio Cancer Center Grant CA054174. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Ara T, 2009, CANCER RES, V69, P329, DOI 10.1158/0008-5472.CAN-08-0613; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Bulun SE, 2009, ANN NY ACAD SCI, V1155, P121, DOI 10.1111/j.1749-6632.2009.03705.x; Bussard KM, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0740-2; Chan DSM, 2014, ANN ONCOL, V25, P1901, DOI 10.1093/annonc/mdu042; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Dorison A, 2017, NEPHRON, V137, P212, DOI 10.1159/000479119; Dunlap SM, 2012, CANCER PREV RES, V5, P930, DOI 10.1158/1940-6207.CAPR-12-0034; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Ford NA, 2015, CANCER PREV RES, V8, P796, DOI 10.1158/1940-6207.CAPR-15-0018; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gao H, 2016, CELL, V166, P47, DOI 10.1016/j.cell.2016.06.009; Ghosh S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2794; Gilbert CA, 2013, ANNU REV MED, V64, P45, DOI 10.1146/annurev-med-121211-091527; Gimble JM, 2013, ORGANOGENESIS, V9, P3, DOI 10.4161/org.24279; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Moley KH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8842; Nair SJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10913; Nieman KM, 2013, BBA-MOL CELL BIOL L, V1831, P1533, DOI 10.1016/j.bbalip.2013.02.010; Niu MM, 2016, MOL PHARMACEUT, V13, P1833, DOI 10.1021/acs.molpharmaceut.5b00987; O'Flanagan CH, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0027-5; Olson OC, 2017, SCIENCE, V358, P1130, DOI 10.1126/science.aao5801; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Picon-Ruiz M, 2016, CANCER RES, V76, P491, DOI 10.1158/0008-5472.CAN-15-0927; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; SEHGAL PB, 1990, P SOC EXP BIOL MED, V195, P183; Stewart TJ, 2007, J IMMUNOL, V179, P2851, DOI 10.4049/jimmunol.179.5.2851; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; TAMM I, 1989, J EXP MED, V170, P1649, DOI 10.1084/jem.170.5.1649; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Wang YY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.87489; Zahid H, 2016, CURR OPIN PHARMACOL, V31, P90, DOI 10.1016/j.coph.2016.11.003; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11674	49	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2841	2849		10.1074/jbc.RA117.000672	http://dx.doi.org/10.1074/jbc.RA117.000672			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29298894	Green Published, hybrid			2022-12-28	WOS:000426051900019
J	Castelblanco, M; Lugrin, J; Ehirchiou, D; Nasi, S; Ishii, I; So, A; Martinon, F; Busso, N				Castelblanco, Mariela; Lugrin, Jerome; Ehirchiou, Driss; Nasi, Sonia; Ishii, Isao; So, Alexander; Martinon, Fabio; Busso, Nathalie			Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-LYASE; MONOSODIUM URATE CRYSTALS; ACID PHENETHYL ESTER; INDUCED CELL-DEATH; NRF2 ACTIVATION; INJURY; GOUT; MACROPHAGES; INDUCTION; MECHANISM	A variety of stimuli, including monosodium urate (MSU) crystals, activate the NLRP3 inflammasome, and this activation involves several molecular mechanisms including xanthine oxidase (XO) up-regulation and mitochondrial dysfunction. Upon oligomerization of apoptosis-associated speck-like protein containing a CARD(ASC), caspase-1 becomes active and cleaves the proinflammatory cytokine IL-1 beta into its active secreted form. Hydrogen sulfide (H2S), a gasotransmitter mainly produced by cystathionine gamma-lyase (CSE) in macrophages, could modulate inflammation. Here, we sought to investigate the effects of exogenous and endogenous H2S on NLRP3 inflammasome activation in vitro and in vivo. Primed bone marrow-derived macrophages (BMDM) isolated from wildtype (wt) or CSE-deficient mice and human macrophages (THP1 cells and primary macrophages), were stimulated with MSU crystals in the presence or absence of a H2S donor, sodium thiosulfate (STS) or GYY4137 (GYY). In murine and human macrophages in vitro, both STS and GYY inhibited MSU crystal-induced IL-1 beta secretionin a dose-dependent manner. Moreover, the H2S donors inhibited MSU crystal-induced XO/caspase-1 activities, mitochondrial reactive oxygen species (ROS) generation, and ASC oligomerization. Accordingly, IL-1 beta secretion and XO/caspase-1 activities were higher in CSE-deficient BMDMs than in wt BMDMs. For in vivo studies, we experimentally induced peritonitis by intraperitoneal injection of MSU crystals into mice. GYY pretreatment ameliorated inflammation, evidenced by decreased IL-6/monocyte chemoattractant protein-1 (MCP-1) released into peritoneal lavages. Taken together, our results suggest that both exogenous (via H2S donors) and endogenous (via CSE) H2S production may represent approaches for managing, for example, acute gout or other inflammation conditions	[Castelblanco, Mariela; Nasi, Sonia; So, Alexander; Busso, Nathalie] Univ Lausanne, Serv Rheumatol, DAL, Lausanne Univ Hosp CHUV, CH-1551066 Epalinges, Switzerland; [Lugrin, Jerome; Ehirchiou, Driss; Martinon, Fabio] Univ Lausanne, Dept Biochem, CH-1551066 Epalinges, Switzerland; [Ishii, Isao] Showa Pharmaceut Univ, Tokyo 1948543, Japan	University of Lausanne; University of Lausanne; Showa Pharmaceutical University	Busso, N (corresponding author), Ctr Labs Epalinges, Lab Rheumatol, CLE D04-404 Chemin Boveresses, CH-1551066 Epalinges, Switzerland.	Nathalie.Busso@chuv.ch	Martinon, Fabio/A-5575-2009; Lugrin, Jérôme/N-8772-2019	Martinon, Fabio/0000-0002-6969-822X; Lugrin, Jérôme/0000-0002-1178-2752; Ishii, Isao/0000-0002-5367-205X; Nasi, Sonia/0000-0002-6625-8309	Swiss National Science Foundation [FN 310030_173134]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant FN 310030_173134. The authors declare that they have no conflicts of interest with the contents of this article.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bian JS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6549625; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Gong ZZ, 2015, MOL NUTR FOOD RES, V59, P2132, DOI 10.1002/mnfr.201500316; Greaney AJ, 2016, J LEUKOCYTE BIOL, V99, P189, DOI 10.1189/jlb.3A0415-155RR; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Hourihan JM, 2013, ANTIOXID REDOX SIGN, V19, P465, DOI 10.1089/ars.2012.4944; Huang CWH, 2016, PHARMACOL RES, V113, P533, DOI 10.1016/j.phrs.2016.09.032; Imhoff BR, 2010, CELL BIOL TOXICOL, V26, P541, DOI 10.1007/s10565-010-9162-6; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Jamilloux Y, 2016, METHODS MOL BIOL, V1417, P207, DOI 10.1007/978-1-4939-3566-6_14; Jhang JJ, 2015, CELL MOL IMMUNOL, V12, P424, DOI 10.1038/cmi.2014.65; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Joosten LAB, 2011, JOINT BONE SPINE, V78, P107, DOI 10.1016/j.jbspin.2010.11.004; Khanna PP, 2014, SEMIN ARTHRITIS RHEU, V44, P31, DOI 10.1016/j.semarthrit.2014.02.003; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Kuo CF, 2015, NAT REV RHEUMATOL, V11, P649, DOI 10.1038/nrrheum.2015.91; Lamkanfi M, 2011, IMMUNOL REV, V243, P163, DOI 10.1111/j.1600-065X.2011.01042.x; Lee HE, 2016, SCI REP-UK, V6, DOI 10.1038/srep38622; Predmore BL, 2012, ANTIOXID REDOX SIGN, V17, P119, DOI 10.1089/ars.2012.4612; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Lohninger L, 2015, BIOCHIMIE, V112, P187, DOI 10.1016/j.biochi.2015.03.009; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Marino A, 2016, BRIT J PHARMACOL, V173, P3222, DOI 10.1111/bph.13583; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Marutani E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002125; McNally JS, 2005, ARTERIOSCL THROM VAS, V25, P1623, DOI 10.1161/01.ATV.0000170827.16296.6e; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pR922, DOI 10.1152/ajpregu.1987.253.6.R922; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Orlowski GM, 2017, J LEUKOCYTE BIOL, V102, P7, DOI 10.1189/jlb.3HI0316-152R; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Rios ECS, 2015, INT J MOL MED, V35, P1741, DOI 10.3892/ijmm.2015.2176; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shi Y, 2015, MED SCI MONITOR, V21, P2774, DOI 10.12659/MSM.895272; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Sorbara MT, 2011, CELL RES, V21, P558, DOI 10.1038/cr.2011.20; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Toldo S, 2014, CIRC-CARDIOVASC GENE, V7, P311, DOI 10.1161/CIRCGENETICS.113.000381; Tozser J., 2016, MEDIAT INFLAMM, V2016, P1; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wallace JL, 2012, ANTIOXID REDOX SIGN, V17, P58, DOI 10.1089/ars.2011.4351; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Xie LP, 2016, DIABETES, V65, P3171, DOI 10.2337/db16-0020; Xie ZZ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6043038; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114; Zheng SC, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0070-7; Zheng YY, 2015, ACTA PHARM SIN B, V5, P367, DOI 10.1016/j.apsb.2015.06.004	63	68	72	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2546	2557		10.1074/jbc.M117.806869	http://dx.doi.org/10.1074/jbc.M117.806869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29279328	Green Published, hybrid			2022-12-28	WOS:000425308300026
J	Davidson, R; Baas, BJ; Akiva, E; Holliday, GL; Polacco, BJ; LeVieux, JA; Pullara, CR; Zhang, YJ; Whitman, CP; Babbitt, PC				Davidson, Rebecca; Baas, Bert-Jan; Akiva, Eyal; Holliday, Gemma L.; Polacco, Benjamin J.; LeVieux, Jake A.; Pullara, Collin R.; Zhang, Yan Jessie; Whitman, Christian P.; Babbitt, Patricia C.			A global view of structure-function relationships in the tautomerase superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-INHIBITORY FACTOR; TRANS-3-CHLOROACRYLIC ACID DEHALOGENASE; MALONATE SEMIALDEHYDE DECARBOXYLASE; SITE ARGININE RESIDUES; 4-OXALOCROTONATE TAUTOMERASE; CRYSTAL-STRUCTURE; FACTOR MIF; DIVERGENT EVOLUTION; ANGSTROM RESOLUTION; ENZYMATIC-ACTIVITY	The tautomerase superfamily (TSF) consists of more than 11,000 nonredundant sequences present throughout the biosphere. Characterized members have attracted much attention because of the unusual and key catalytic role of an N-terminal proline. These few characterized members catalyze a diverse range of chemical reactions, but the full scale of their chemical capabilities and biological functions remains unknown. To gain new insight into TSF structure-function relationships, we performed a global analysis of similarities across the entire superfamily and computed a sequence similarity network to guide classification into distinct subgroups. Our results indicate that TSF members are found in all domains of life, with most being present in bacteria. The eukaryotic members of the cis-3-chloroacrylic acid dehalogenase subgroup are limited to fungal species, whereas the macrophage migration inhibitory factor subgroup has wide eukaryotic representation (including mammals). Unexpectedly, we found that 346 TSF sequences lack Pro-1, of which 85% are present in the malonate semialdehyde decarboxylase subgroup. The computed network also enabled the identification of similarity paths, namely sequences that link functionally diverse subgroups and exhibit transitional structural features that may help explain reaction divergence. A structure-guided comparison of these linker proteins identified conserved transitions between them, and kinetic analysis paralleled these observations. Phylogenetic reconstruction of the linker set was consistent with these findings. Our results also suggest that contemporary TSF members may have evolved from a short 4-oxalocrotonate tautomerase-like ancestor followed by gene dupli-cation and fusion. Our new linker-guided strategy can be used to enrich the discovery of sequence/structure/function transitions in other enzyme superfamilies.	[Davidson, Rebecca; Akiva, Eyal; Holliday, Gemma L.; Polacco, Benjamin J.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Babbitt, Patricia C.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Baas, Bert-Jan; Pullara, Collin R.; Whitman, Christian P.] Univ Texas Austin, Div Chem Biol & Med Chem, Coll Pharm, Austin, TX 78712 USA; [LeVieux, Jake A.; Zhang, Yan Jessie] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Zhang, Yan Jessie] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Whitman, CP (corresponding author), Univ Texas Austin, Div Chem Biol & Med Chem, Austin, TX 78712 USA.; Babbitt, PC (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	whitman@austin.utexas.edu; babbitt@cgl.ucsf.edu		Holliday, Gemma/0000-0002-6731-6398; Zhang, Yan/0000-0002-9360-5388; Babbitt, Patricia/0000-0003-0375-9015; Polacco, Benjamin/0000-0003-1570-9234	College of Natural Sciences at the University of Texas at Austin; Office of the Executive Vice President and Provost at the University of Texas at Austin; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health; Howard Hughes Medical Institute; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; National Institute of General Medical Sciences; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547, R01GM060595] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021832] Funding Source: NIH RePORTER	College of Natural Sciences at the University of Texas at Austin; Office of the Executive Vice President and Provost at the University of Texas at Austin; Institute for Cellular and Molecular Biology at the University of Texas at Austin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Instrumentation and technical assistance were provided by the Macromolecular Crystallography Facility, with financial support from the College of Natural Sciences, the Office of the Executive Vice President and Provost, and the Institute for Cellular and Molecular Biology at the University of Texas at Austin. The X-ray diffraction data were collected at the Advanced Light Sources (ALS) (Berkeley, CA). The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract DE-AC02-05CH11231. We are indebted to Marieke Baas for carefully proofreading and formatting the manuscript and to Kathy Clement for help with generating graphics files for SSNs.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Almonacid DE, 2011, CURR OPIN CHEM BIOL, V15, P435, DOI 10.1016/j.cbpa.2011.03.008; Almrud JJ, 2010, BIOORG CHEM, V38, P252, DOI 10.1016/j.bioorg.2010.07.002; Almrud JJ, 2005, BIOCHEMISTRY-US, V44, P14818, DOI 10.1021/bi051383m; Almrud JJ, 2002, BIOCHEMISTRY-US, V41, P12010, DOI 10.1021/bi020271h; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Azurmendi HF, 2004, BIOCHEMISTRY-US, V43, P4082, DOI 10.1021/bi030241u; Barber AE, 2012, BIOINFORMATICS, V28, P2845, DOI 10.1093/bioinformatics/bts532; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bloom J, 2016, EXPERT OPIN THER TAR, V20, P1463, DOI 10.1080/14728222.2016.1251582; Brown SD, 2012, J BIOL CHEM, V287, P35, DOI 10.1074/jbc.R111.283408; Burks EA, 2010, BIOCHEMISTRY-US, V49, P5016, DOI 10.1021/bi100502z; Chauhan N, 2015, ACTA TROP, V142, P71, DOI 10.1016/j.actatropica.2014.10.009; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Czerwinski RM, 2001, BIOCHEMISTRY-US, V40, P1984, DOI 10.1021/bi0024714; Czerwinski RM, 1999, BIOCHEMISTRY-US, V38, P12358, DOI 10.1021/bi9911177; de Jong RM, 2007, J BIOL CHEM, V282, P2440, DOI 10.1074/jbc.M608134200; de Jong RM, 2004, J BIOL CHEM, V279, P11546, DOI 10.1074/jbc.M311966200; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flaster H, 2007, MOL ENDOCRINOL, V21, P1267, DOI 10.1210/me.2007-0065; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Harris TK, 1999, BIOCHEMISTRY-US, V38, P12343, DOI 10.1021/bi991116e; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huddleston JP, 2014, ARCH BIOCHEM BIOPHYS, V564, P189, DOI 10.1016/j.abb.2014.08.019; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; LeVieux JA, 2017, ARCH BIOCHEM BIOPHYS, V636, P50, DOI 10.1016/j.abb.2017.10.018; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Murzin AG, 1996, CURR OPIN STRUC BIOL, V6, P386, DOI 10.1016/S0959-440X(96)80059-5; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Panstruga R, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0337-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poelarends GJ, 2008, CELL MOL LIFE SCI, V65, P3606, DOI 10.1007/s00018-008-8285-x; Poelarends GJ, 2008, BIOCHEMISTRY-US, V47, P8139, DOI 10.1021/bi8007388; Poelarends GJ, 2007, BIOCHEMISTRY-US, V46, P9596, DOI 10.1021/bi7007189; Poelarends GJ, 2006, BIOCHEMISTRY-US, V45, P7700, DOI 10.1021/bi0600603; Poelarends GJ, 2004, J AM CHEM SOC, V126, P15658, DOI 10.1021/ja044304n; Poelarends GJ, 2004, BIOCHEMISTRY-US, V43, P7187, DOI 10.1021/bi049823h; Poelarends GJ, 2004, BIOCHEMISTRY-US, V43, P759, DOI 10.1021/bi0355948; Poelarends GJ, 2003, J BIOL CHEM, V278, P48674, DOI 10.1074/jbc.M306706200; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sparkes A, 2017, IMMUNOBIOLOGY, V222, P473, DOI 10.1016/j.imbio.2016.10.006; Stamps SL, 2000, BIOCHEMISTRY-US, V39, P9671, DOI 10.1021/bi000373c; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P814, DOI 10.1021/bi9510789; Stivers JT, 1996, BIOCHEMISTRY-US, V35, P803, DOI 10.1021/bi951077g; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sugimoto H, 1996, FEBS LETT, V389, P145, DOI 10.1016/0014-5793(96)00553-4; Taylor AB, 1999, BIOCHEMISTRY-US, V38, P7444, DOI 10.1021/bi9904048; Taylor AB, 1998, BIOCHEMISTRY-US, V37, P14692, DOI 10.1021/bi981607j; Uberto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074477; van der Meer JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10911; Wang SC, 2003, BIOCHEMISTRY-US, V42, P8762, DOI 10.1021/bi034598+; WHITMAN CP, 1992, J AM CHEM SOC, V114, P10104, DOI 10.1021/ja00052a002; Whitman CP, 2002, ARCH BIOCHEM BIOPHYS, V402, P1, DOI 10.1016/S0003-9861(02)00052-8; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yu DY, 2013, J IND MICROBIOL BIOT, V40, P159, DOI 10.1007/s10295-012-1207-9	72	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2342	2357		10.1074/jbc.M117.815340	http://dx.doi.org/10.1074/jbc.M117.815340			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29184004	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000425308300009
J	Thomas, SA; Nandan, D; Kass, J; Reiner, NE				Thomas, Sneha A.; Nandan, Devki; Kass, Jennifer; Reiner, Neil E.			Countervailing, time-dependent effects on host autophagy promotes intracellular survival of Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN AUTOPHAGY; MACROPHAGE; INFECTION; MECHANISMS; INDUCTION; DONOVANI; TRANSLATION; AMAZONENSIS; GENERATION; EXPRESSION	Autophagy is essential for cell survival under stress and has also been implicated in host defense. Here, we investigated the interactions between Leishmania donovani, the main etiological agent of visceral leishmaniasis, and the autophagic machinery of human macrophages. Our results revealed that during early infection-and via activation of the Akt pathway-Leishmania actively inhibits the induction of autophagy. However, by 24 h, Leishmania switched from being an inhibitor to an overall inducer of autophagy. These findings of a dynamic, biphasic response were based on the accumulation of lipidated light chain 3 (LC3), an autophagosome marker, by Western blotting and confocal fluorescence microscopy. We also present evidence that Leishmania induces delayed host cell autophagy via a mechanism independent of reduced activity of the mechanistic target of rapamycin (mTOR). Notably, Leishmania actively inhibited mTOR-regulated autophagy even at later stages of infection, whereas there was a clear induction of autophagy via some other mechanism. In this context, we examined host inositol monophosphatase (IMPase), reduced levels of which have been implicated in mTOR-independent autophagy, and we found that IMPase activity is significantly decreased in infected cells. These findings indicate that Leishmania uses an alternative pathway to mTOR to induce autophagy in host macrophages. Finally, RNAi-mediated down-regulation of host autophagy protein 5 (ATG5) or autophagy protein 9A (ATG9A) decreased parasite loads, demonstrating that autophagy is essential for Leishmania survival. We conclude that Leishmania uses an alternative pathway to induce host autophagy while simultaneously inhibiting mTOR-regulated autophagy to fine-tune the timing and magnitude of this process and to optimize parasite survival.	[Thomas, Sneha A.; Nandan, Devki; Kass, Jennifer; Reiner, Neil E.] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V6H 3Z6, Canada; [Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V6H 3Z6, Canada.; Reiner, NE (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	nreiner@mail.ubc.ca			Canadian Institutes for Health Research [MOP-125879]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Grant MOP-125879 from the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Cheekatla SS, 2012, MED MICROBIOL IMMUN, V201, P37, DOI 10.1007/s00430-011-0202-5; Crauwels P, 2015, AUTOPHAGY, V11, P285, DOI 10.1080/15548627.2014.998904; Cyrino LT, 2012, TISSUE CELL, V44, P401, DOI 10.1016/j.tice.2012.08.003; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Franco LH, 2017, J BIOL CHEM, V292, P13087, DOI 10.1074/jbc.M117.780981; Frank B, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0974-3; Gingras AC, 2001, GENE DEV, V15, P2852; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hung CM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008771; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Jain SK, 2012, JOVE-J VIS EXP, DOI 10.3791/4054; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Jiang PD, 2015, METHODS, V75, P13, DOI 10.1016/j.ymeth.2014.11.021; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kima PE, 2016, CELL IMMUNOL, V309, P19, DOI 10.1016/j.cellimm.2016.09.004; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Mitroulis I, 2009, PARASITOL INT, V58, P475, DOI 10.1016/j.parint.2009.07.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Motoi Y, 2014, ACS CHEM NEUROSCI, V5, P434, DOI 10.1021/cn500056q; Naderer T, 2008, CELL MICROBIOL, V10, P301, DOI 10.1111/j.1462-5822.2007.01096.x; Nalbandian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122888; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; OLIVIER M, 1992, J IMMUNOL, V148, P1188; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Paulus GLC, 2015, CURR OPIN GASTROEN, V31, P14, DOI 10.1097/MOG.0000000000000134; Pinheiro RO, 2009, MICROBES INFECT, V11, P181, DOI 10.1016/j.micinf.2008.11.006; Py BF, 2007, AUTOPHAGY, V3, P117, DOI 10.4161/auto.3618; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Romanov J, 2012, EMBO J, V31, P4304, DOI 10.1038/emboj.2012.278; Ruckdeschel K, 2002, ARCH IMMUNOL THER EX, V50, P131; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Schaible UE, 1999, J CELL SCI, V112, P681; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shadab Md, 2011, Mol Biol Int, V2011, P343961, DOI 10.4061/2011/343961; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Singh AK, 2016, AUTOPHAGY, V12, P1817, DOI 10.1080/15548627.2016.1203500; Singh AK, 2015, INFECT IMMUN, V83, P1853, DOI 10.1128/IAI.02833-14; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Winchell CG, 2014, INFECT IMMUN, V82, P2229, DOI 10.1128/IAI.01236-13; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865	70	28	29	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2617	2630		10.1074/jbc.M117.808675	http://dx.doi.org/10.1074/jbc.M117.808675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269416	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000425308300032
J	Larabee, JL; Hauck, GD; Ballard, JD				Larabee, Jason L.; Hauck, Garrett D.; Ballard, Jimmy D.			Cell-penetrating peptides derived from Clostridium difficile TcdB2 and a related large clostridial toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; biotechnology; cell-penetrating peptide (CPP); peptides; toxin	MAMMALIAN-CELLS; ANTHRAX TOXIN; LETHAL TOXIN; DELIVERY; CARGO; TRANSLOCATION; MAUROCALCINE; MEMBRANE; PROTEINS; EPITOPES	Clostridium difficile TcdB (2366 amino acid residues) is an intracellular bacterial toxin that binds to cells and enters the cytosol where it glucosylates small GTPases. In the current study, we examined a putative cell entry region of TcdB (amino acid residues 1753-1851) for short sequences that function as cell-penetrating peptides (CPPs). To screen for TcdB-derived CPPs, a panel of synthetic peptides was tested for the ability to enhance transferrin (Tf) association with cells. Four candidate CPPs were discovered, and further study on one peptide (PepB2) pinpointed an asparagine residue necessary for CPP activity. PepB2 mediated the cell entry of a wide variety of molecules including dextran, streptavidin, microspheres, and lentivirus particles. Of note, this uptake was dramatically reduced in the presence of the Na+/H+ exchange blocker and micropinocytosis inhibitor amiloride, suggesting that PepB2 invokes macropinocytosis. Moreover, we found that PepB2 had more efficient cell-penetrating activity than several other well-known CPPs (TAT, penetratin, Pep-1, and TP10). Finally, Tf assay-based screening of peptides derived from two other large clostridial toxins, TcdA and TcsL, uncovered two new TcdA-derived CPPs. In conclusion, we have identified six CPPs from large clostridial toxins and have demonstrated the ability of PepB2 to promote cell association and entry of several molecules through a putative fluid-phase macropinocytotic mechanism.	[Larabee, Jason L.; Hauck, Garrett D.; Ballard, Jimmy D.] Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Dept Microbiol & Immunol, Hlth Sci Ctr, BMSB 1053,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [R21AI121925, R01AI119048]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR13-070]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121925, R01AI119048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology (OCAST); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R21AI121925 and R01AI119048 (to J. D. B.) and by Grant HR13-070 from the Oklahoma Center for the Advancement of Science and Technology (OCAST) (to J. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Ballard JD, 1998, INFECT IMMUN, V66, P4696, DOI 10.1128/IAI.66.10.4696-4699.1998; Beilhartz GL, 2017, BIOCHEM PHARMACOL, V142, P13, DOI 10.1016/j.bcp.2017.04.009; Bolz DD, 2015, SHOCK, V43, P178, DOI 10.1097/SHK.0000000000000266; Carter GP, 2012, TRENDS MICROBIOL, V20, P21, DOI 10.1016/j.tim.2011.11.003; Chen S, 2016, TOXINS, V8, pE241; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Davies AH, 2011, BIOCHEM J, V436, P517, DOI 10.1042/BJ20110106; Deng X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142558; Dupont E, 2015, METHODS MOL BIOL, V1324, P29, DOI 10.1007/978-1-4939-2806-4_2; Falnes PO, 2000, CURR OPIN CELL BIOL, V12, P407, DOI 10.1016/S0955-0674(00)00109-5; Giacca Mauro, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P277, DOI 10.2174/1568008043339767; Gomarasca M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02545-16, 10.1128/aac.02545-16]; Guidotti G, 2017, TRENDS PHARMACOL SCI, V38, P406, DOI 10.1016/j.tips.2017.01.003; Hunt JJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00268-17; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Larabee JL, 2017, MBIO, V8, DOI 10.1128/mBio.00503-17; Larabee JL, 2015, J BIOL CHEM, V290, P6975, DOI 10.1074/jbc.M114.612184; Larabee JL, 2011, INFECT IMMUN, V79, P3302, DOI 10.1128/IAI.05070-11; Mishra A, 2011, P NATL ACAD SCI USA, V108, P16883, DOI 10.1073/pnas.1108795108; Orrell KE, 2017, CRIT REV BIOCHEM MOL, V52, P461, DOI 10.1080/10409238.2017.1325831; Poillot C, 2012, J BIOL CHEM, V287, P17331, DOI 10.1074/jbc.M112.360628; Poillot C, 2010, J BIOL CHEM, V285, P34168, DOI 10.1074/jbc.M110.104919; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; Pruitt RN, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00028; Qa'Dan M, 2001, INFECT IMMUN, V69, P5487, DOI 10.1128/IAI.69.9.5487-5493.2001; Rabideau AE, 2016, ACS CHEM BIOL, V11, P1490, DOI 10.1021/acschembio.6b00169; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Watson P, 2006, ADV DRUG DELIVER REV, V58, P1581, DOI 10.1016/j.addr.2006.09.016; Wilson BA, 2014, CURR TOP MED CHEM, V14, P2081, DOI 10.2174/1568026614666141022094517; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634	36	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1810	1819		10.1074/jbc.M117.815373	http://dx.doi.org/10.1074/jbc.M117.815373			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29247010	Green Published, hybrid			2022-12-28	WOS:000424201700030
J	Li, TS; Li, MJ; Hou, LL; Guo, YM; Wang, L; Sun, GQ; Chen, L				Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Sun, Guiqin; Chen, Li			Identification and characterization of a core fucosidase from the bacterium Elizabethkingia meningoseptica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; glycobiology; glycoprotein; mass spectrometry (MS); mutagenesis; oligosaccharide; chemical rescue; core-1; 3-fucose; core-1; 3 fucosylation; core fucosidase	ALPHA-L-FUCOSIDASE; GEOBACILLUS-STEAROTHERMOPHILUS T-6; ARCHAEON SULFOLOBUS-SOLFATARICUS; HYDROLASE FAMILY 29; GLYCOSIDE HYDROLASE; SUBSTRATE-SPECIFICITY; BACTEROIDES-THETAIOTAOMICRON; HEPATOCELLULAR-CARCINOMA; BIFIDOBACTERIUM-BIFIDUM; HORSERADISH-PEROXIDASE	All reported -l-fucosidases catalyze the removal of nonreducing terminal l-fucoses from oligosaccharides or their conjugates, while having no capacity to hydrolyze core fucoses in glycoproteins directly. Here, we identified an -fucosidase from the bacterium Elizabethkingia meningoseptica with catalytic activity against core -1,3-fucosylated substrates, and we named it core fucosidase I (cFase I). Using site-specific mutational analysis, we found that three acidic residues (Asp-242, Glu-302, and Glu-315) in the predicted active pocket are critical for cFase I activity, with Asp-242 and Glu-315 acting as a pair of classic nucleophile and acid/base residues and Glu-302 acting in an as yet undefined role. These findings suggest a catalytic mechanism for cFase I that is different from known -fucosidase catalytic models. In summary, cFase I exhibits glycosidase activity that removes core -1,3-fucoses from substrates, suggesting cFase I as a new tool for glycobiology, especially for studies of proteins with core fucosylation.	[Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Chen, Li] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Li, Tiansheng; Li, Mengjie; Hou, Linlin; Guo, Yameng; Wang, Lei; Chen, Li] Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Hlth, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Sun, Guiqin] Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou 310053, Zhejiang, Peoples R China	Fudan University; Fudan University; Zhejiang Chinese Medical University	Chen, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Educ, 130 Dongan Rd, Shanghai 200032, Peoples R China.; Chen, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Med Microbiol, Key Lab Med Mol Virol,Minist Hlth, 130 Dongan Rd, Shanghai 200032, Peoples R China.; Sun, GQ (corresponding author), Zhejiang Chinese Med Univ, Coll Med Technol, Hangzhou 310053, Zhejiang, Peoples R China.	sunguiqin2001@163.com; lichen_bk@fudan.edu.cn	li, mengjie/GRS-3931-2022	Chen, Li/0000-0002-7006-4443	National Science and Technology Major Project of the Ministry of Science and Technology of China [2014ZX09101046-004]; National Natural Science Foundation of China [31600644]	National Science and Technology Major Project of the Ministry of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China Grant 2014ZX09101046-004 and the National Natural Science Foundation of China Grant 31600644. The authors declare that they have no conflicts of interest with the contents of this article.	Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Barboza M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015248; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Berteau O, 2002, GLYCOBIOLOGY, V12, P273, DOI 10.1093/glycob/12.4.273; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; Bravman T, 2003, J BIOL CHEM, V278, P26742, DOI 10.1074/jbc.M304144200; Bridges CC, 2012, ARCH BIOCHEM BIOPHYS, V517, P20, DOI 10.1016/j.abb.2011.11.002; BUTTERS TD, 1991, BIOCHEM J, V279, P189, DOI 10.1042/bj2790189; Cao HN, 2014, J BIOL CHEM, V289, P25624, DOI 10.1074/jbc.M114.583286; Cobucci-Ponzano B, 2005, BIOCHEMISTRY-US, V44, P6331, DOI 10.1021/bi047495f; Cobucci-Ponzano B, 2003, BIOCHEMISTRY-US, V42, P9525, DOI 10.1021/bi035036t; Cobucci-Ponzano B, 2002, PROTEINS, V48, P98, DOI 10.1002/prot.10128; DAWSON G, 1977, ARCH BIOCHEM BIOPHYS, V184, P12, DOI 10.1016/0003-9861(77)90321-6; de Fraipont F, 2001, TRENDS MOL MED, V7, P401, DOI 10.1016/S1471-4914(01)02102-5; DICIOCCIO RA, 1982, J BIOL CHEM, V257, P714; Dupoiron S, 2015, J BIOL CHEM, V290, P6022, DOI 10.1074/jbc.M114.624593; Fan SQ, 2016, J BASIC MICROB, V56, P347, DOI 10.1002/jobm.201500582; FAZEL AR, 1989, AM J ANAT, V184, P76, DOI 10.1002/aja.1001840109; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; FUHR BJ, 1973, J AM CHEM SOC, V95, P6944, DOI 10.1021/ja00802a013; Garbe J, 2012, J INNATE IMMUN, V4, P121, DOI 10.1159/000334775; Guillotin L, 2014, BIOCHEMISTRY-US, V53, P1447, DOI 10.1021/bi400951q; Harmoko R, 2016, NEW PHYTOL, V212, P108, DOI 10.1111/nph.14031; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Jitonnom J, 2014, J PHYS CHEM B, V118, P4771, DOI 10.1021/jp500652x; JOHNSON SW, 1991, COMP BIOCHEM PHYS B, V99, P479, DOI 10.1016/0305-0491(91)90327-A; Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; Lannoo N, 2015, PLANT SCI, V239, P67, DOI 10.1016/j.plantsci.2015.06.023; Li YK, 2002, BIOCHEMISTRY-US, V41, P2751, DOI 10.1021/bi016049e; Liu SW, 2009, BIOCHEMISTRY-US, V48, P110, DOI 10.1021/bi801529t; Liu TW, 2009, P NATL ACAD SCI USA, V106, P14581, DOI 10.1073/pnas.0903286106; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; MacLeod AM, 1996, BIOCHEMISTRY-US, V35, P13165, DOI 10.1021/bi9610616; Marrero JA, 2004, GASTROENTEROLOGY, V127, pS113, DOI 10.1053/j.gastro.2004.09.024; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Newburg DS, 2004, GLYCOBIOLOGY, V14, P253, DOI 10.1093/glycob/cwh020; Palmberger D, 2014, BIOTECHNOL J, V9, P1206, DOI 10.1002/biot.201400061; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Phopin K, 2013, MOL REPROD DEV, V80, P273, DOI 10.1002/mrd.22164; Poltl G, 2007, GLYCOBIOLOGY, V17, P220, DOI [10.1093/glycob/cw1068, 10.1093/glycob/cwl068]; Rahman MZ, 2016, BIOSCI BIOTECH BIOCH, V80, P291, DOI 10.1080/09168451.2015.1079479; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rydberg EH, 2002, BIOCHEMISTRY-US, V41, P4492, DOI 10.1021/bi011821z; Sakurama H, 2012, BIOSCI BIOTECH BIOCH, V76, P1022, DOI 10.1271/bbb.111004; Sakurama H, 2012, J BIOL CHEM, V287, P16709, DOI 10.1074/jbc.M111.333781; SCANLIN TF, 1979, CLIN CHIM ACTA, V91, P197, DOI 10.1016/0009-8981(79)90457-1; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; Sela DA, 2012, APPL ENVIRON MICROB, V78, P795, DOI 10.1128/AEM.06762-11; Shaikh FA, 2013, BIOCHEMISTRY-US, V52, P5857, DOI 10.1021/bi400183q; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; Sjogren J, 2014, FUTURE MICROBIOL, V9, P1039, DOI [10.2217/FMB.14.71, 10.2217/fmb.14.71]; Staudacher E, 1998, GLYCOCONJUGATE J, V15, P355, DOI 10.1023/A:1006969701231; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Sun G., 2015, GENOME ANNOUNC, V3; Sun GQ, 2015, J BIOL CHEM, V290, P7452, DOI 10.1074/jbc.M114.605493; Tarling CA, 2003, J BIOL CHEM, V278, P47394, DOI 10.1074/jbc.M306610200; Tsai TI, 2017, ACS CHEM BIOL, V12, P63, DOI 10.1021/acschembio.6b00821; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Wang K, 2014, BRIT J CANCER, V110, P1811, DOI 10.1038/bjc.2014.102; WILLEMS PJ, 1988, AM J HUM GENET, V43, P756; Wilson IBH, 1998, GLYCOBIOLOGY, V8, P651, DOI 10.1093/glycob/8.7.651; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Wuhrer M, 2005, BBA-GEN SUBJECTS, V1723, P229, DOI 10.1016/j.bbagen.2005.02.013; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zeleny R, 2006, PHYTOCHEMISTRY, V67, P641, DOI 10.1016/j.phytochem.2006.01.021	71	11	12	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1243	1258		10.1074/jbc.M117.804252	http://dx.doi.org/10.1074/jbc.M117.804252			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29196602	Green Published, hybrid			2022-12-28	WOS:000423515000012
J	Yoo, L; Chung, KC				Yoo, Lang; Chung, Kwang Chul			The ubiquitin E3 ligase CHIP promotes proteasomal degradation of the serine/threonine protein kinase PINK1 during staurosporine-induced cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						70 kilodalton heat shock protein (Hsp70); cell death; E3 ubiquitin ligase; PTEN-induced putative kinase 1 (PINK1); ubiquitylation; ubiquitination; CHIP; Hsp70; staurosporine	QUALITY-CONTROL; MITOCHONDRIAL; IDENTIFICATION; CHAPERONES; MUTATIONS; STABILITY; APOPTOSIS; COMPLEX; PARKIN; MUTANT	Mutations in the gene for the serine/threonine protein kinase PTEN-induced putative kinase 1 (PINK1) are the second most frequent cause of autosomal recessive Parkinson's disease (PD). Via its kinase activity, PINK1 regulates neuronal cell survival and mitochondrial quality control. Numerous reports have revealed that PINK1 has diverse and physiologically significant functions, and therefore its activity should be tightly regulated. However, the molecular mechanisms regulating PINK1 stability and the modulator(s) involved have not been elucidated. In this study, we demonstrate that the ubiquitin E3 ligase carboxyl terminus of Hsp70-interacting protein (CHIP) promotes PINK1 ubiquitination and decreases its steady-state levels. Moreover, PINK1 levels were strongly reduced in HEK293 and SH-SY5Y cells exposed to the apoptosis-inducer staurosporine. Of note, we found that this reduction resulted from CHIP-mediated PINK1 ubiquitination. Accordingly, siRNA-mediated CHIP knockdown reduced susceptibility to staurosporine-induced cell death. Taken together, these findings suggest that CHIP plays a role in negative regulation of PINK1 stability and may suppress PINK1's cytoprotective effect during staurosporine-induced mammalian cell death. We propose that this PINK1 regulatory pathway might contribute to Parkinson's disease pathogenesis.	[Yoo, Lang; Chung, Kwang Chul] Yonsei Univ, Dept Syst Biol, Coll Life Sci & Biotechnol, Seoul 03722, South Korea	Yonsei University	Chung, KC (corresponding author), Yonsei Ro 50, Seoul 03722, South Korea.	kchung@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2014M3C7A1064545]; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C0936]; NRF [2015R1A2A2A01003080]; Yonsei University Future-leading Research Initiative [2015-22-0055]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; NRF; Yonsei University Future-leading Research Initiative	This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning Grant 2014M3C7A1064545 (to K. C. C.) and the Korea Healthcare Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare Grant HI17C0936 (to K. C. C.), Republic of Korea. This work was also supported in part by the NRF Grant 2015R1A2A2A01003080 (to K. C. C.) and by the Yonsei University Future-leading Research Initiative of 2015 Grant 2015-22-0055 (to K. C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Anand R, 2013, BBA-MOL CELL RES, V1833, P195, DOI 10.1016/j.bbamcr.2012.06.025; Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Berthier A, 2011, HUM PATHOL, V42, P75, DOI 10.1016/j.humpath.2010.05.016; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Durcan TM, 2015, GENE DEV, V29, P989, DOI 10.1101/gad.262758.115; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Lazarou M, 2012, DEV CELL, V22, P320, DOI 10.1016/j.devcel.2011.12.014; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Murata H, 2013, MOL BIOL CELL, V24, P2772, DOI 10.1091/mbc.E13-01-0016; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Paul I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918183; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sun C, 2014, J CANCER RES CLIN, V140, P189, DOI 10.1007/s00432-013-1571-5; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103	39	16	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1286	1297		10.1074/jbc.M117.803890	http://dx.doi.org/10.1074/jbc.M117.803890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242192	hybrid, Green Published			2022-12-28	WOS:000423515000015
J	Oide, M; Okajima, K; Nakagami, H; Kato, T; Sekiguchi, Y; Oroguchi, T; Hikima, T; Yamamoto, M; Nakasako, M				Oide, Mao; Okajima, Koji; Nakagami, Hirofumi; Kato, Takayuki; Sekiguchi, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi			Blue light-excited LOV1 and LOV2 domains cooperatively regulate the kinase activity of full-length phototropin2 from Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT PHOTORECEPTOR DOMAIN; INDUCED STRUCTURAL-CHANGES; CHLOROPLAST RELOCATION; CONFORMATIONAL-CHANGES; BINDING DOMAINS; ACTIVATION; RECEPTOR; PROTEIN; OXYGEN; NPL1	Phototropin2 (phot2) is a blue-light (BL) receptor that regulates BL-dependent activities for efficient photosynthesis in plants. phot2 comprises two BL-receiving light-oxygen-voltage-sensing domains (LOV1 and LOV2) and a kinase domain. BL-excited LOV2 is thought to be primarily responsible for the BL-dependent activation of the kinase. However, the molecular mechanisms by which small BL-induced conformational changes in the LOV2 domain are transmitted to the kinase remain unclear. Here, we used full-length wild-type and mutant phot2 proteins from Arabidopsis to study their molecular properties in the dark and under BL irradiation. Phosphorylation assays and absorption measurements indicated that the LOV1 domain assists the thermal relaxation of BL-excited LOV2 and vice versa. Using small-angle X-ray scattering and electron microscopy, we observed that phot2 forms a dimer and has a rod shape with a maximum length of 188 angstrom and a radius of gyration of 44 angstrom. Under BL, phot2 displayed large conformational changes that bent the rod shape. By superimposing the crystal structures of the LOV1 dimer, LOV2, and a homology model of the kinase to the observed changes, we inferred that the BL-dependent change consisted of positional shifts of both LOV2 and the kinase relative to LOV1. Furthermore, phot2 mutants lacking the photocycle in LOV1 or LOV2 still exhibited conformational changes under BL, suggesting that LOV1 and LOV2 cooperatively contribute to the conformational changes that activate the kinase. These results suggest that BL-activated LOV1 contributes to the kinase activity of phot2. We discuss the possible intramolecular interactions and signaling mechanisms in phot2.	[Oide, Mao; Okajima, Koji; Sekiguchi, Yuki; Oroguchi, Tomotaka; Nakasako, Masayoshi] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoko Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Oide, Mao; Okajima, Koji; Sekiguchi, Yuki; Oroguchi, Tomotaka; Hikima, Takaaki; Yamamoto, Masaki; Nakasako, Masayoshi] RIKEN SPring 8 Ctr, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan; [Nakagami, Hirofumi] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa 2300045, Japan; [Nakagami, Hirofumi] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany; [Kato, Takayuki] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan	Keio University; RIKEN; RIKEN; Max Planck Society; Osaka University	Okajima, K (corresponding author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoko Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	okajima@phys.keio.ac.jp	Yamamoto, Masaki/B-7844-2015; Nakagami, Hirofumi/A-4122-2011	Yamamoto, Masaki/0000-0002-1311-1768; Nakagami, Hirofumi/0000-0003-2569-7062	Japan Society for the Promotion of Science (JSPS) [jp16H02218, jp22244054, jp22018027, jp20050030, jp1920402, jp26800227, jp17H04854, jp16K14682, jp15K18559]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [jp15076210, jp15H01647, jp17H05891, jp25120725, jp23120525, jp26104535]; Grants-in-Aid for Scientific Research [17H04854] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants jp16H02218, jp22244054, jp22018027, jp20050030, jp1920402 (to M. N.), jp26800227, jp17H04854 (to T. O.), jp16K14682 (to T. K.), and jp15K18559 (to K. O.) and by Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants jp15076210, jp15H01647, jp17H05891, jp25120725, jp23120525 (to M. N.), and jp26104535 (to T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Aihara Y, 2008, PLANT J, V56, P364, DOI 10.1111/j.1365-313X.2008.03605.x; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; de Carbonnel M, 2010, PLANT PHYSIOL, V152, P1391, DOI 10.1104/pp.109.150441; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Fujita S, 2013, CURR BIOL, V23, P1969, DOI 10.1016/j.cub.2013.08.006; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Guinier A., 1955, SMALL ANGLE SCATTERI; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Inoue S, 2011, PLANT PHYSIOL, V156, P117, DOI 10.1104/pp.111.175943; Iwata T, 2003, BIOCHEMISTRY-US, V42, P8183, DOI 10.1021/bi0345135; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kashojiya S, 2016, FEBS LETT, V590, P139, DOI 10.1002/1873-3468.12028; Kashojiya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124284; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Li FW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00637; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Oide M, 2016, J BIOL CHEM, V291, P19975, DOI 10.1074/jbc.M116.735787; Okajima K, 2016, J PLANT RES, V129, P149, DOI 10.1007/s10265-016-0783-6; Okajima K, 2014, J BIOL CHEM, V289, P413, DOI 10.1074/jbc.M113.515403; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Suetsugu N, 2013, AM J BOT, V100, P60, DOI 10.3732/ajb.1200308; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Tseng TS, 2010, PLANT CELL, V22, P392, DOI 10.1105/tpc.109.066423	49	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					963	972		10.1074/jbc.RA117.000324	http://dx.doi.org/10.1074/jbc.RA117.000324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29196607	Green Published, hybrid			2022-12-28	WOS:000422864500017
J	Perez, JM; Chen, YH; Xiao, TS; Abbott, DW				Perez, Jessica M.; Chen, Yinghua; Xiao, Tsan S.; Abbott, Derek W.			Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPRESSION; RESPONSES; ALPHA; A20	Heightened and extended inflammation underlies the pathogenesis of many disorders, including inflammatory bowel disease, sepsis, and inflammatory arthritis. Ubiquitin networks help dictate the strength and duration of inflammatory signaling. In innate immunity, the itchy E3 ubiquitin protein ligase (ITCH)-A20 ubiquitin-editing complex inhibits receptor-interacting Ser/Thr kinase (RIPK) activation by removing Lys-63linked polyubiquitinated chains from key proteins in the nuclear factor kappa B (NF-kappa B) signaling pathway. The complex then attaches polyubiquitinated chains to these proteins to target them for lysosomal or proteasomal destruction. ITCHis phosphorylated and thereby inhibited by inhibitor of nuclear factor kappa B kinase subunit beta (IKK beta) to fine-tune the inflammatory response to the strength of the offending signal. However, the biochemical mechanism by which E3 ubiquitination is impaired by IKK-driven phosphorylation remains unclear. Here, we report that this phosphorylation impedes ITCH binding to its cognate E2 ubiquitin ligase, UbcH7. UsingCRISPR-Cas9geneticknockouttomimictheITCHUbcH7-inhibited state, we further show that genetic UbcH7 deficiency phenocopies ITCH phosphorylation in regulating RIPK2 ubiquitination. Weconclude that phosphorylation can disrupt the binding of an E3 ubiquitin ligase to an E2-conjugating enzyme, leading to prolonged inflammatory signaling. To our knowledge, this is the first report of E3 ubiquitin ligase phosphorylation inhibiting E3 ligase activity by impairing E2-E3 complex formation.	[Perez, Jessica M.; Xiao, Tsan S.; Abbott, Derek W.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Chen, Yinghua] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Abbott, DW (corresponding author), Room 6531,Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	dwa4@case.edu	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X	National Institutes of Health [R01GM086550, P01DK091222, F31GM108403A]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK091222, P30DK097948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM108403, R01GM086550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM086550 (to D.W.A.), P01DK091222 (to D.W.A.), and F31GM108403A (to J.M.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arend WP, 2001, SEMIN ARTHRITIS RHEU, V30, P1, DOI 10.1053/sarh.2001.23693; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Fraser JA, 2010, J BIOL CHEM, V285, P37762, DOI 10.1074/jbc.M110.143099; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Matesic LE, 2008, CURR TOP MICROBIOL, V321, P185; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Perez JM, 2015, CELL REP, V12, P537, DOI 10.1016/j.celrep.2015.06.050; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; SMITH MF, 1994, J IMMUNOL, V153, P3584; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tigno-Aranjuez JT, 2012, BBA-MOL CELL RES, V1823, P2022, DOI 10.1016/j.bbamcr.2012.03.017; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815	29	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1100	1105		10.1074/jbc.RA117.000408	http://dx.doi.org/10.1074/jbc.RA117.000408			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29212706	Green Published, hybrid			2022-12-28	WOS:000422864500028
J	Lv, B; Sun, HL; Huang, S; Feng, XD; Jiang, T; Li, C				Lv, Bo; Sun, Hanli; Huang, Shen; Feng, Xudong; Jiang, Tao; Li, Chun			Structure-guided engineering of the substrate specificity of a fungal -glucuronidase toward triterpenoid saponins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme mutation; glycoside hydrolase; protein engineering; substrate specificity; fungal -glucuronidase; triterpenoid saponins	GLYCYRRHETIC ACID MONOGLUCURONIDE; CODE SATURATION MUTAGENESIS; MAIZE BETA-GLUCOSIDASE; HUMAN INTESTINAL FLORA; CANCER DRUG TOXICITY; AGLYCONE SPECIFICITY; CRYSTAL-STRUCTURES; HYDROLASE; INSIGHTS; COMPLEX	Glycoside hydrolases (GHs) have attracted special attention in research aimed at modifying natural products by partial removal of sugar moieties to manipulate their solubility and efficacy. However, these modifications are challenging to control because the low substrate specificity of most GHs often generates undesired by-products. We previously identified a GH2-type fungal -glucuronidase from Aspergillus oryzae (PGUS) exhibiting promiscuous substrate specificity in hydrolysis of triterpenoid saponins. Here, we present the PGUS structure, representing the first structure of a fungal -glucuronidase, and that of an inactive PGUS mutant in complex with the native substrate glycyrrhetic acid 3-O-mono--glucuronide (GAMG). PGUS displayed a homotetramer structure with each monomer comprising three distinct domains: a sugar-binding, an immunoglobulin-like -sandwich, and a TIM barrel domain. Two catalytic residues, Glu(414) and Glu(505), acted as acid/base and nucleophile, respectively. Structural and mutational analyses indicated that the GAMG glycan moiety is recognized by polar interactions with nine residues (Asp(162), His(332), Asp(414), Tyr(469), Tyr(473), Asp(505), Arg(563), Asn(567), and Lys(569)) and that the aglycone moiety is recognized by aromatic stacking and by a interaction with the four aromatic residues Tyr(469), Phe(470), Trp(472), and Tyr(473). Finally, structure-guided mutagenesis to precisely manipulate PGUS substrate specificity in the biotransformation of glycyrrhizin into GAMG revealed that two amino acids, Ala(365) and Arg(563), are critical for substrate specificity. Moreover, we obtained several mutants with dramatically improved GAMG yield (>95%). Structural analysis suggested that modulating the interaction of -glucuronidase simultaneously toward glycan and aglycone moieties is critical for tuning its substrate specificity toward triterpenoid saponins.	[Lv, Bo; Huang, Shen; Feng, Xudong; Li, Chun] Beijing Inst Technol, Sch Chem & Chem Engn, Inst Biotransformat & Synthet Biosyst, Dept Biochem Engn, Beijing 100081, Peoples R China; [Sun, Hanli; Jiang, Tao] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS	Li, C (corresponding author), Beijing Inst Technol, Sch Chem & Chem Engn, Inst Biotransformat & Synthet Biosyst, Dept Biochem Engn, Beijing 100081, Peoples R China.	lichun@bit.edu.cn			National Natural Science Foundation of China [21606019, 21506011]; National Natural Science Fund for Distinguished Young Scholars of China [21425624]; Basic Research Foundation of Beijing Institute of Technology [20151642001]; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education [2015202]; Strategic Priority Research Program [XDB08010301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Basic Research Foundation of Beijing Institute of Technology; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education; Strategic Priority Research Program(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 21606019 and 21506011; National Natural Science Fund for Distinguished Young Scholars of China Grant 21425624; Basic Research Foundation of Beijing Institute of Technology Grant 20151642001; Foundation of Key Laboratory for Industrial Biocatalysis (Tsinghua University), Ministry of Education Grant 2015202; and The Strategic Priority Research Program Grant XDB08010301. The authors declare that they have no conflicts of interest with the contents of this article.	Akao T, 2000, BIOL PHARM BULL, V23, P1418, DOI 10.1248/bpb.23.1418; Akao T, 2001, BIOL PHARM BULL, V24, P1108, DOI 10.1248/bpb.24.1108; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito-Arias Marco, 2007, P1; Chouiter R, 2008, J MOL CATAL B-ENZYM, V50, P114, DOI 10.1016/j.molcatb.2007.09.015; Cicek M, 2000, J BIOL CHEM, V275, P20002, DOI 10.1074/jbc.M001609200; Czjzek M, 2001, BIOCHEM J, V354, P37, DOI 10.1042/0264-6021:3540037; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; Gleadow RM, 2014, ANNU REV PLANT BIOL, V65, P155, DOI 10.1146/annurev-arplant-050213-040027; Iglesias-Fernandez J, 2015, CHEM SCI, V6, P1167, DOI 10.1039/c4sc02240h; Ikram NKBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00129; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jain S, 1996, NAT STRUCT BIOL, V3, P375, DOI 10.1038/nsb0496-375; Jensen M, 2011, BIOORGAN MED CHEM, V19, P2407, DOI 10.1016/j.bmc.2011.02.016; Karmazyn M, 2011, DRUGS, V71, P1989, DOI 10.2165/11594300-000000000-00000; Koleva II, 2012, MOL NUTR FOOD RES, V56, P30, DOI 10.1002/mnfr.201100165; Krahulec J, 2007, APPL MICROBIOL BIOT, V74, P1016, DOI 10.1007/s00253-006-0745-3; Luan ZJ, 2015, CATAL SCI TECHNOL, V5, P2622, DOI 10.1039/c5cy00085h; Madeira JV, 2015, CRIT REV BIOTECHNOL, V35, P75, DOI 10.3109/07388551.2013.803020; Maeda Y, 2008, INTERNAL MED, V47, P1345, DOI 10.2169/internalmedicine.47.1080; Michikawa M, 2012, J BIOL CHEM, V287, P14069, DOI 10.1074/jbc.M112.346288; MIZUTANI K, 1994, BIOSCI BIOTECH BIOCH, V58, P554, DOI 10.1271/bbb.58.554; Naz H, 2013, REJUV RES, V16, P352, DOI 10.1089/rej.2013.1407; Nishizawa K, 2014, J VIROL, V88, P4083, DOI 10.1128/JVI.03775-13; Pentzold S, 2014, BIOL REV, V89, P531, DOI 10.1111/brv.12066; Poo H, 2002, BIOTECHNOL LETT, V24, P1185, DOI 10.1023/A:1016107230825; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Saino H, 2014, J BIOL CHEM, V289, P16826, DOI 10.1074/jbc.M114.553271; Sakurama H, 2014, APPL MICROBIOL BIOT, V98, P4021, DOI 10.1007/s00253-013-5325-8; Seki H, 2015, PLANT CELL PHYSIOL, V56, P1463, DOI 10.1093/pcp/pcv062; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Sun ZT, 2016, ACS CATAL, V6, P1590, DOI 10.1021/acscatal.5b02751; Sun ZT, 2016, ACS CATAL, V6, P1598, DOI 10.1021/acscatal.5b02752; Tankrathok A, 2013, ACTA CRYSTALLOGR D, V69, P2124, DOI 10.1107/S0907444913020568; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005; Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175; Xu LH, 2006, BIOTECHNIQUES, V41, P319, DOI 10.2144/000112219	40	18	22	4	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					433	443		10.1074/jbc.M117.801910	http://dx.doi.org/10.1074/jbc.M117.801910			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29146597	Green Published, hybrid			2022-12-28	WOS:000419915400003
J	Watts, JS; Morton, DG; Kemphues, KJ; Watts, JL				Watts, Jason S.; Morton, Diane G.; Kemphues, Kenneth J.; Watts, Jennifer L.			The biotin-ligating protein BPL-1 is critical for lipid biosynthesis and polarization of the Caenorhabditis elegans embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotin; Caenorhabditis elegans (C; elegans); cell polarity; development; embryo; polyunsaturated fatty acid (PUFA)	MULTIPLE CARBOXYLASE DEFICIENCY; HUMAN HOLOCARBOXYLASE SYNTHETASE; FATTY-ACID OXIDATION; C-ELEGANS; MALONYL-COA; INTERMEDIARY METABOLISM; GENE; BIOTINYLATION; TEMPERATURE; DESATURASE	Biotin is an essential cofactor for multiple metabolic reactions catalyzed by carboxylases. Biotin is covalently linked to apoproteins by holocarboxylase synthetase (HCS). Accordingly, some mutations in HCS cause holocarboxylase deficiency, a rare metabolic disorder that can be life-threatening if left untreated. However, the long-term effects of HCS deficiency are poorly understood. Here, we report our investigations of bpl-1, which encodes the Caenorhabditis elegans ortholog of HCS. We found that mutations in the biotin-binding region of bpl-1 are maternal-effect lethal and cause defects in embryonic polarity establishment, meiosis, and the integrity of the eggshell permeability barrier. We confirmed that BPL-1 biotinylates four carboxylase enzymes, and we demonstrate that BPL-1 is required for efficient de novo fatty acid biosynthesis. We also show that the lack of larval growth defects as well as nearly normal fatty acid composition in young adult worms is due to sufficient fatty acid precursors provided by dietary bacteria. However, BPL-1 disruption strongly decreased levels of polyunsaturated fatty acids in embryos produced by bpl-1 mutant hermaphrodites, revealing a critical role for BPL-1 in lipid biosynthesis during embryogenesis and demonstrating that dietary fatty acids and lipid precursors are not adequate to support early embryogenesis in the absence of BPL-1. Our findings highlight that studying BPL-1 function in C. elegans could help dissect the roles of this important metabolic enzyme under different environmental and dietary conditions.	[Watts, Jason S.; Watts, Jennifer L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Watts, Jason S.; Watts, Jennifer L.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Morton, Diane G.; Kemphues, Kenneth J.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Washington State University; Washington State University; Cornell University	Watts, JL (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@vetmed.wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639	National Science Foundation/Biological Infrastructure/Living Collections program [DBI-0742708]; National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079112, T32GM083864] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Science Foundation/Biological Infrastructure/Living Collections program; National Institutes of Health Office of Research Infrastructure Programs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Bacterial strains were provided by the Coli Genetic Stock Center, supported by National Science Foundation/Biological Infrastructure/Living Collections program Grant DBI-0742708. Nematode strains were provided by the Caenorhabditis Genetics Center, funded by National Institutes of Health Office of Research Infrastructure Programs Grant P40 OD010440. We thank Liam Coyne for assistance with early bpl-1 RNAi experiments.	Bao BL, 2011, BIOCHEM BIOPH RES CO, V412, P115, DOI 10.1016/j.bbrc.2011.07.055; Benenati G, 2009, MECH DEVELOP, V126, P382, DOI 10.1016/j.mod.2009.02.001; Boyd L, 1996, DEVELOPMENT, V122, P3075; Brennan LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075712; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; BURRI BJ, 1981, J CLIN INVEST, V68, P1491, DOI 10.1172/JCI110402; Chandler RJ, 2006, MOL GENET METAB, V89, P64, DOI 10.1016/j.ymgme.2006.06.001; Dancy BCR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141850; Deline ML, 2013, JOVE-J VIS EXP, DOI 10.3791/50879; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gurvitz A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007791; HARDER ME, 1972, P NATL ACAD SCI USA, V69, P3105, DOI 10.1073/pnas.69.11.3105; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; KEMPHUES KJ, 1988, GENETICS, V120, P977; Lin CCJ, 2017, NAT CELL BIOL, V19, P550, DOI 10.1038/ncb3515; MCGARRY JD, 1977, J CLIN INVEST, V60, P265, DOI 10.1172/JCI108764; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mock DM, 2009, J NUTR, V139, P154, DOI 10.3945/jn.108.095273; MOORE J H, 1979, Progress in Lipid Research, V17, P347, DOI 10.1016/0079-6832(79)90012-0; Narang MA, 2004, HUM MOL GENET, V13, P15, DOI 10.1093/hmg/ddh006; Olson SK, 2012, J CELL BIOL, V198, P731, DOI 10.1083/jcb.201206008; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; POSTBEITTENMILLER D, 1992, PLANT PHYSIOL, V100, P923, DOI 10.1104/pp.100.2.923; Rappleye CA, 2002, DEV CELL, V2, P195, DOI 10.1016/S1534-5807(02)00114-4; Rappleye Chad A, 2003, BMC Dev Biol, V3, P8, DOI 10.1186/1471-213X-3-8; Reche PA, 2000, PROTEIN SCI, V9, P1922, DOI 10.1110/ps.9.10.1922; Rios-Avila L, 2011, CLIN CHIM ACTA, V412, P735, DOI 10.1016/j.cca.2010.12.031; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rose Lesilee, 2014, WormBook, P1, DOI 10.1895/wormbook.1.30.2; Shi X, 2013, J LIPID RES, V54, P2504, DOI 10.1194/jlr.M039669; Sternicki LM, 2017, TRENDS BIOCHEM SCI, V42, P383, DOI 10.1016/j.tibs.2017.02.001; Stiernagle T., 2006, WORMBOOK, DOI [10.1895/wormbook.1.1010.1, DOI 10.1895/W0RMB00K.1.1010.1]; Suzuki Y, 2005, HUM MUTAT, V26, P285, DOI 10.1002/humu.20204; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; TAKAMURA Y, 1988, J GEN MICROBIOL, V134, P2249; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tang HY, 2017, CELL, V169, P457, DOI 10.1016/j.cell.2017.03.049; Trujillo-Gonzalez I, 2014, MOL GENET METAB, V111, P321, DOI 10.1016/j.ymgme.2013.10.016; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Verbrugghe KJC, 2011, JOVE-J VIS EXP, DOI 10.3791/2625; Watson E, 2016, ELIFE, V5, DOI 10.7554/eLife.17670; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; WOLF B, 1981, PEDIATRICS, V68, P113; Yang X, 2001, HUM GENET, V109, P526, DOI 10.1007/s004390100603; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Zempleni J, 2014, NUTR REV, V72, P369, DOI 10.1111/nure.12103; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zheng YX, 2011, J BIOL CHEM, V286, P24046, DOI 10.1074/jbc.M111.251496; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429	55	12	12	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					610	622		10.1074/jbc.M117.798553	http://dx.doi.org/10.1074/jbc.M117.798553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158261	Green Published, hybrid			2022-12-28	WOS:000419915400017
J	Medrano, JL; Naya, FJ				Medrano, Jose L.; Naya, Francisco J.			The transcription factor MEF2A fine-tunes gene expression in the atrial and ventricular chambers of the adult heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPATIOTEMPORAL REGULATION; MOLECULAR REGULATION; TARGET PROMOTERS; REGULATOR; DIFFERENTIATION; RECEPTORS; PROGRAMS; PITX2; CARDIOMYOCYTES; CARDIOGENESIS	The distinct morphological and functional properties of the cardiac chambers arise from an elaborate developmental program involving cell lineage determination, morphogenesis, and dynamic spatiotemporal gene expression patterns. Although a number of transcription factors have been identified for proper gene regulation in the chambers, the complete transcriptional network that controls these patterns remains poorly defined. Previous studies have implicated the MEF2C transcription factor in the regulation of chamber-restricted enhancers. To better understand the mechanisms of MEF2-mediated regional gene regulation in the heart, we took advantage of MEF2A knock-out (KO) mice, a model that displays a predominantly ventricular chamber phenotype. Transcriptomic analysis of atrial and ventricular tissue from adult MEF2A KO hearts revealed a striking difference in chamber gene expression, with a larger proportion of dysregulated genes in the atrial chambers. Canonical pathway analysis of genes preferentially dysregulated in the atria and ventricles revealed distinct MEF2A-dependent cellular processes in each cardiac chamber. In the atria, MEF2A regulated genes involved in fibrosis and adhesion, whereas in the ventricles, it controlled inflammation and endocytosis. Finally, analysis of transcription factor-binding site motifs of differentially dysregulated genes uncovered distinct MEF2A co-regulators for the atrial and ventricular gene sets, and a subset of these was found to cooperate with MEF2A. In conclusion, our results suggest a mechanism in which MEF2 transcriptional activity is differentially recruited to fine-tune gene expression levels in each cardiac chamber. This regulatory mechanism ensures optimal output of these gene products for proper physiological function of the atrial and ventricular chambers.	[Medrano, Jose L.; Naya, Francisco J.] Boston Univ, Program Cell & Mol Biol, Dept Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL73304]; Boston University Bioinformatics CTSI Grant [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Bioinformatics CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL73304 (to F. J. N.) and Boston University Bioinformatics CTSI Grant U54-TR001012. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth AS, 2005, PFLUG ARCH EUR J PHY, V450, P201, DOI 10.1007/s00424-005-1404-8; Bruneau BG, 2001, MOL CELL BIOL, V21, P1730, DOI 10.1128/MCB.21.5.1730-1736.2001; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen C, 2016, J MOL CELL CARDIOL, V93, P162, DOI 10.1016/j.yjmcc.2015.11.010; Christoffels VM, 2004, TRENDS CARDIOVAS MED, V14, P301, DOI 10.1016/j.tcm.2004.09.002; Desjardins CA, 2016, J CARDIOVASC DEV DIS, V3, DOI 10.3390/jcdd3030026; Desjardins CA, 2017, J BIOL CHEM, V292, P10613, DOI 10.1074/jbc.M117.776153; Dupays L, 2017, CELL MOL LIFE SCI, V74, P257, DOI 10.1007/s00018-016-2322-y; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Franchini KG, 2012, J MOL CELL CARDIOL, V52, P485, DOI 10.1016/j.yjmcc.2011.06.021; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Hasin T, 2011, BASIC RES CARDIOL, V106, P175, DOI 10.1007/s00395-010-0145-9; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Jankowski M, 2001, P NATL ACAD SCI USA, V98, P11765, DOI 10.1073/pnas.201394198; Li JY, 2015, CYTOKINE GROWTH F R, V26, P75, DOI 10.1016/j.cytogfr.2014.10.007; Lizotte E, 2009, CELL PHYSIOL BIOCHEM, V23, P75, DOI 10.1159/000204096; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Morin S, 2005, J BIOL CHEM, V280, P32272, DOI 10.1074/jbc.M507640200; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Ng SY, 2010, AM J PHYSIOL-CELL PH, V299, pC1234, DOI 10.1152/ajpcell.00402.2009; Niu Z, 2007, CURR OPIN CELL BIOL, V19, P618, DOI 10.1016/j.ceb.2007.09.013; Paige SL, 2015, CIRC RES, V116, P341, DOI 10.1161/CIRCRESAHA.116.302752; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rana MS, 2013, ACTA PHYSIOL, V207, P588, DOI 10.1111/apha.12061; Ross RS, 1996, DEVELOPMENT, V122, P1799; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Small EM, 2004, TRENDS CARDIOVAS MED, V14, P13, DOI 10.1016/j.tcm.2003.09.005; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Spater D, 2014, DEVELOPMENT, V141, P4418, DOI 10.1242/dev.091538; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tessari A, 2008, CIRC RES, V102, P813, DOI 10.1161/CIRCRESAHA.107.163188; Toro R, 2004, J BIOL CHEM, V279, P52087, DOI 10.1074/jbc.M404802200; van Rooij E, 2010, CIRC RES, V106, P155, DOI 10.1161/CIRCRESAHA.109.207084; Vedantham V, 2013, DEV BIOL, V373, P149, DOI 10.1016/j.ydbio.2012.10.017; Vincentz JW, 2008, DEV DYNAM, V237, P3809, DOI 10.1002/dvdy.21803; Vite A, 2014, CELL COMMUN ADHES, V21, P169, DOI 10.3109/15419061.2014.908853; Wang J, 2010, P NATL ACAD SCI USA, V107, P9753, DOI 10.1073/pnas.0912585107; Wu SP, 2013, DEV CELL, V25, P417, DOI 10.1016/j.devcel.2013.04.017; Xin M, 2007, P NATL ACAD SCI USA, V104, P7975, DOI 10.1073/pnas.0702447104; Yao HP, 2013, NAT REV CANCER, V13, P466, DOI 10.1038/nrc3545; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhao XS, 2002, PHYSIOL GENOMICS, V12, P53, DOI 10.1152/physiolgenomics.00086.2002	49	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20975	20988		10.1074/jbc.M117.806422	http://dx.doi.org/10.1074/jbc.M117.806422			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29054930	Green Published, hybrid			2022-12-28	WOS:000418453400014
J	Viborg, AH; Katayama, T; Arakawa, T; Abou Hachem, M; Lo Leggio, L; Kitaoka, M; Svensson, B; Fushinobu, S				Viborg, Alexander Holm; Katayama, Takane; Arakawa, Takatoshi; Abou Hachem, Maher; Lo Leggio, Leila; Kitaoka, Motomitsu; Svensson, Birte; Fushinobu, Shinya			Discovery of alpha-L-arabinopyranosidases from human gut microbiome expands the diversity within glycoside hydrolase family 42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MILK OLIGOSACCHARIDES; BIFIDOBACTERIUM-BREVE UCC2003; BETA-GALACTOSIDASE; L-ARABINOFURANOSIDASE; CRYSTAL-STRUCTURE; METABOLISM; SPECIFICITIES; SEQUENCE; REVEALS; BIOSYNTHESIS	Enzymes of the glycoside hydrolase family 42 (GH42) are widespread in bacteria of the human gut microbiome and play fundamental roles in the decomposition of both milk and plant oligosaccharides. All GH42 enzymes characterized so far have beta-galactosidase activity. Here, we report the existence of a GH42 subfamily that is exclusively specific for beta-L-arabinopyranoside and describe the first representative of this subfamily. We found that this enzyme (BlArap42B) from a probiotic Bifidobacterium species cannot hydrolyze beta-galactosides. However, BlArap42B effectively hydrolyzed paeonolide and ginsenoside Rb2, plant glycosides containing an aromatic aglycone conjugated to beta-L-arabinopyranosyl-(1,6)-beta-D-glucopyranoside. Paeonolide, a natural glycoside from the roots of the plant genus Paeonia, is not hydrolyzed by classicalGH42 beta-galactosidases. X-ray crystallography revealed a unique Trp345-X12-Trp358 sequence motif at the BlArap42B active site, as compared with a Phe-X12-His motif in classicalGH42 beta-galactosidases. This analysis also indicated that the C6 position of galactose is blocked by the aromatic side chains, hence allowing accommodation only of Arap lacking this carbon. Automated docking of paeonolide revealed that it can fit into the BlArap42B active site. The Glcp moiety of paeonolide stacks onto the aromatic ring of the Trp252 at subsite beta 1 and C4-OH is hydrogen bonded with Asp249. Moreover, the aglycone stacks against Phe421 from the neighboring monomer in the BlArap42B trimer, forming a proposed subsite beta 2. These results further support the notion that evolution of metabolic specialization can be tracked at the structural level in key enzymes facilitating degradation of specific glycans in an ecological niche.	[Viborg, Alexander Holm; Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; [Katayama, Takane] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan; [Katayama, Takane] Ishikawa Prefectural Univ, Fac Bioresources & Environm Sci, Nonoichi, Ishikawa 9218836, Japan; [Viborg, Alexander Holm; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, DK-2400 Lyngby, Denmark; [Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Kitaoka, Motomitsu] Natl Agr & Food Res Org, Food Res Inst, Tsukuba, Ibaraki 3058642, Japan; [Viborg, Alexander Holm] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 124, Canada	University of Tokyo; Kyoto University; Ishikawa Prefecture University; Technical University of Denmark; University of Copenhagen; National Agriculture & Food Research Organization - Japan; University of British Columbia	Fushinobu, S (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Lab Enzymol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Arakawa, Takatoshi/K-9739-2013; Kitaoka, Motomitsu/R-1536-2019; Abou Hachem, Maher/M-4772-2019; Viborg, Alexander/AAI-4943-2021; Fushinobu, Shinya/E-4987-2011	Arakawa, Takatoshi/0000-0001-6496-5440; Kitaoka, Motomitsu/0000-0002-0083-1838; Abou Hachem, Maher/0000-0001-8250-1842; Fushinobu, Shinya/0000-0003-1346-6435; Katayama, Takane/0000-0003-4009-7874; Svensson, Birte/0000-0002-2993-8196	Japan Society for the Promotion of Science (JSPS); JSPS [15H02443, 26660083]; Platform for Drug Discovery, Informatics, and Structural Life Science - MEXT; Technical University of Denmark	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science - MEXT; Technical University of Denmark	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellowship (to A. H. V.), and JSPS KAKENHI Grant Numbers 15H02443 and 26660083 (to S. F.), the Platform for Drug Discovery, Informatics, and Structural Life Science funded by MEXT, and a Technical University of Denmark Ph.D. fellowship (to A. H. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Barrangou R, 2009, J BACTERIOL, V191, P4144, DOI 10.1128/JB.00155-09; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ding LQ, 2017, NAT PROD RES, V31, P253, DOI 10.1080/14786419.2016.1230114; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P1615, DOI [10.1099/ijs.0.02143-0, 10.1099/00207713-52-5-1615]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraisse D, 2000, FITOTERAPIA, V71, P463, DOI 10.1016/S0367-326X(00)00145-3; Godoy AS, 2016, FEBS J, V283, P4097, DOI 10.1111/febs.13908; Han NS, 2012, BIOTECHNOL ADV, V30, P1268, DOI 10.1016/j.biotechadv.2011.11.003; Hidaka M, 2002, J MOL BIOL, V322, P79, DOI 10.1016/S0022-2836(02)00746-5; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; James K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38560; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lee DY, 2015, J MICROBIOL BIOTECHN, V25, P2011, DOI 10.4014/jmb.1505.05069; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Maksimainen M, 2012, FEBS J, V279, P1788, DOI 10.1111/j.1742-4658.2012.08555.x; Metwally AM, 2010, PHARMACOGN MAG, V6, P212, DOI 10.4103/0973-1296.66939; Motherway MO, 2011, MICROB BIOTECHNOL, V4, P403, DOI 10.1111/j.1751-7915.2010.00218.x; Ndeh D, 2017, NATURE, V544, P65, DOI 10.1038/nature21725; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2101, DOI 10.1271/bbb.70320; Nishimoto M, 2009, CARBOHYD RES, V344, P2573, DOI 10.1016/j.carres.2009.09.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OURA H, 1975, J BIOCHEM-TOKYO, V77, P1057, DOI 10.1093/oxfordjournals.jbchem.a130806; Peacock KS, 2013, J AGR FOOD CHEM, V61, P12612, DOI 10.1021/jf403789r; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ridley BL, 2001, PHYTOCHEMISTRY, V57, P929, DOI 10.1016/S0031-9422(01)00113-3; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shin HY, 2003, APPL ENVIRON MICROB, V69, P7116, DOI 10.1128/AEM.69.12.7116-7123.2003; Solomon HV, 2015, ACTA CRYSTALLOGR D, V71, P2433, DOI 10.1107/S1399004715018672; Tabachnikov O, 2013, FEBS J, V280, P950, DOI 10.1111/febs.12089; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turroni F, 2010, P NATL ACAD SCI USA, V107, P19514, DOI 10.1073/pnas.1011100107; Van Laere KMJ, 2000, APPL ENVIRON MICROB, V66, P1379, DOI 10.1128/AEM.66.4.1379-1384.2000; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Viborg AH, 2015, TRENDS GLYCOSCI GLYC, V27, pE9, DOI 10.4052/tigg.1436.4E; Viborg AH, 2014, MOL MICROBIOL, V94, P1024, DOI 10.1111/mmi.12815; Vincken JP, 2003, PLANT PHYSIOL, V132, P1781, DOI 10.1104/pp.103.022350; Yoshida E, 2012, GLYCOBIOLOGY, V22, P361, DOI 10.1093/glycob/cwr116	48	5	5	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21092	21101		10.1074/jbc.M117.792598	http://dx.doi.org/10.1074/jbc.M117.792598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29061847	Green Published, hybrid			2022-12-28	WOS:000418453400024
J	Chiang, CK; Tworak, A; Kevany, BM; Xu, B; Mayne, J; Ning, ZB; Figeys, D; Palczewski, K				Chiang, Cheng-Kang; Tworak, Aleksander; Kevany, Brian M.; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel; Palczewski, Krzysztof			Quantitative phosphoproteomics reveals involvement of multiple signaling pathways in early phagocytosis by the retinal pigmented epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eye; receptor recycling; retina; retinal degeneration; retinal metabolism	PHOTORECEPTOR OUTER SEGMENTS; FOCAL ADHESION KINASE; ARREST-SPECIFIC GENE; PHOSPHATIDYLINOSITOL 3-KINASE; ALPHA-V-BETA-5 INTEGRIN; PROMOTES PHAGOCYTOSIS; ROD; PHOSPHORYLATION; CELLS; ACTIVATION	One of the major biological functions of the retinal pigmented epithelium (RPE) is the clearance of shed photoreceptor outer segments (POS) through a multistep process resembling phagocytosis. RPE phagocytosis helps maintain the viability of photoreceptors that otherwise could succumb to the high metabolic flux and photo-oxidative stress associated with visual processing. The regulatory mechanisms underlying phagocytosis in the RPE are not fully understood, although dysfunction of this process contributes to the pathogenesis of multiple human retinal degenerative disorders, including age-related macular degeneration. Here, we present an integrated transcriptomic, proteomic, and phosphoproteomic analysis of phagocytosing RPE cells, utilizing three different experimental models: the human-derived RPE-like cell line ARPE-19, cultured murine primary RPE cells, and RPE samples from live mice. Our combined results indicated that early stages of phagocytosis in the RPE are mainly characterized by pronounced changes in the protein phosphorylation level. Global phosphoprotein enrichment analysis revealed involvement of PI3K/Akt, mechanistic target of rapamycin (mTOR), and MEK/ERK pathways in the regulation of RPE phagocytosis, confirmed by immunoblot analyses and in vitro phagocytosis assays. Most strikingly, phagocytosis of POS by cultured RPE cells was almost completely blocked by pharmacological inhibition of phosphorylation of Akt. Our findings, along with those of previous studies, indicate that these phosphorylation events allow the RPE to integrate multiple signals instigated by shed POS at different stages of the phagocytic process.	[Chiang, Cheng-Kang; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Chiang, Cheng-Kang; Xu, Bo; Mayne, Janice; Ning, Zhibin; Figeys, Daniel] Univ Ottawa, Dept Biochem Microbiol & Immunol, Fac Med, Ottawa, ON K1H 8M5, Canada; [Chiang, Cheng-Kang] Natl Dong Hwa Univ, Dept Chem, 1 Sec 2 Da Hsueh Rd, Hualien 97401, Taiwan; [Tworak, Aleksander; Kevany, Brian M.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA; [Figeys, Daniel] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	University of Ottawa; University of Ottawa; National Dong Hwa University; Case Western Reserve University; Case Western Reserve University; Canadian Institute for Advanced Research (CIFAR)	Figeys, D (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Fac Med, Ottawa, ON K1H 8M5, Canada.; Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA.; Palczewski, K (corresponding author), Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Sch Med, Cleveland, OH 44106 USA.; Figeys, D (corresponding author), Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada.	dfigeys@uottawa.ca; kxp65@case.edu	Chiang, Cheng-Kang/AAQ-7472-2021	Figeys, Daniel/0000-0002-5373-7546; Tworak, Aleksander/0000-0002-3256-8990	National Institutes of Health [EY009339, EY024864, EY011373]; National Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institute for Advanced Research (CIFAR); Canadian Institutes of Health Research (CIHR); Arnold and Mabel Beckman Foundation; Canadian Foundation for Innovation (CFI); Ontario Research Fund; la Fondation J.-Louis Levesque; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, R24EY024864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Arnold and Mabel Beckman Foundation; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund; la Fondation J.-Louis Levesque; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY009339 and EY024864 (to K. P.) and EY011373 (VSRC CORE grant); the National Sciences and Engineering Research Council (NSERC) of Canada (to D. F.); the Canadian Institute for Advanced Research (CIFAR) and the Canadian Institutes of Health Research (CIHR) (to D. F.); the Arnold and Mabel Beckman Foundation (to K. P.); and the Canadian Foundation for Innovation (CFI), the Ontario Research Fund, and la Fondation J.-Louis Levesque (to D. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Ainscough SL, 2009, EXP EYE RES, V89, P629, DOI 10.1016/j.exer.2009.06.005; Bennis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141597; Bulloj A, 2013, EXP EYE RES, V113, P9, DOI 10.1016/j.exer.2013.05.002; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Filippi S, 2016, CELL REP, V15, P2524, DOI 10.1016/j.celrep.2016.05.024; Finnemann SC, 1997, P NATL ACAD SCI USA, V94, P12932, DOI 10.1073/pnas.94.24.12932; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freeman SA, 2014, IMMUNOL REV, V262, P193, DOI 10.1111/imr.12212; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; Garg Tarun K, 2003, BMC Ophthalmol, V3, P5, DOI 10.1186/1471-2415-3-5; Glotin AL, 2006, INVEST OPHTH VIS SCI, V47, P4614, DOI 10.1167/iovs.06-0297; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Hall MO, 2002, EXP EYE RES, V75, P391, DOI 10.1006/exer.2002.2030; HETH CA, 1991, CURR EYE RES, V10, P1049, DOI 10.3109/02713689109020343; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Ishimoto Y, 2000, J BIOCHEM-TOKYO, V127, P411, DOI 10.1093/oxfordjournals.jbchem.a022622; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kyosseva SV, 2016, OPHTHALMOL EYE DIS, V8, P23, DOI 10.4137/OED.S32200; Lande-Diner L, 2013, P NATL ACAD SCI USA, V110, P16021, DOI 10.1073/pnas.1305980110; Law AL, 2009, MOL BIOL CELL, V20, P3896, DOI 10.1091/mbc.E08-12-1204; Lee H, 2011, INT J BIOL MACROMOL, V48, P194, DOI 10.1016/j.ijbiomac.2010.11.006; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makino-Okamura C, 2014, PIGM CELL MELANOMA R, V27, P1063, DOI [10.1111/pcmr.12284, 10.1111/pcmr.12287]; Mao YY, 2012, MOL BIOL CELL, V23, P1104, DOI 10.1091/mbc.E11-10-0840; May RC, 2001, J CELL SCI, V114, P1061; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; Olchawa MM, 2016, FREE RADICAL RES, V50, P887, DOI 10.1080/10715762.2016.1194519; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onishi Y, 2008, MOL CELL BIOL, V28, P3477, DOI 10.1128/MCB.02227-07; Palczewska G, 2016, J BIOL CHEM, V291, P26937, DOI 10.1074/jbc.M116.764563; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Rizzolo LJ, 2014, EXP EYE RES, V126, P16, DOI 10.1016/j.exer.2013.12.018; Ruggiero L, 2012, P NATL ACAD SCI USA, V109, P8145, DOI 10.1073/pnas.1121101109; Ryeom SW, 1996, J CELL SCI, V109, P387; Ryeom SW, 1996, J BIOL CHEM, V271, P20536, DOI 10.1074/jbc.271.34.20536; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasore T, 2014, ADV EXP MED BIOL, V801, P805, DOI 10.1007/978-1-4614-3209-8_101; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; TATE DJ, 1995, INVEST OPHTH VIS SCI, V36, P1271; Wang XM, 2016, EXP CELL RES, V344, P219, DOI 10.1016/j.yexcr.2016.04.017; Wrann CD, 2007, J IMMUNOL, V178, P5940, DOI 10.4049/jimmunol.178.9.5940; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Yu B, 2014, INVEST OPHTH VIS SCI, V55, P8638, DOI 10.1167/iovs.14-14758; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	64	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19826	19839		10.1074/jbc.M117.812677	http://dx.doi.org/10.1074/jbc.M117.812677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28978645	hybrid, Green Published			2022-12-28	WOS:000416911300026
J	Swasthi, HM; Mukhopadhyay, S				Swasthi, Hema M.; Mukhopadhyay, Samrat			Electrostatic lipid-protein interactions sequester the curli amyloid fold on the lipopolysaccharide membrane surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; atomic force microscopy (AFM); biofilm; fibril; fluorescence; lipopolysaccharide (LPS); protein aggregation; protein misfolding	ESCHERICHIA-COLI K-12; FIBRIL FORMATION; DISEASES; AGGREGATION; MECHANISM; OLIGOMERS; POLYMERIZATION; NUCLEATOR; BETA; CSGB	Curli is a functional amyloid protein in the extracellular matrix of enteric Gram-negative bacteria. Curli is assembled at the cell surface and consists of CsgA, the major subunit of curli, and a membrane-associated nucleator protein, CsgB. Oligomeric intermediates that accumulate during the lag phase of amyloidogenesis are generally toxic, but the underlying mechanism by which bacterial cells overcome this toxicity during curli assembly at the surface remains elusive. Here, we elucidated the mechanism of curli amyloidogenesis and provide molecular insights into the strategy by which bacteria can potentially bypass the detrimental consequences of toxic amyloid intermediates. Using a diverse range of biochemical and biophysical tools involving circular dichroism, fluorescence, Raman spectroscopy, and atomic force microscopy imaging, we characterized the molecular basis of the interaction of CsgB with a membrane-mimetic anionic surfactant as well as with lipopolysaccharide (LPS) constituting the outer leaflet of Gram-negative bacteria. Aggregation studies revealed that the electrostatic interaction of the positively charged C-terminal region of the protein with a negatively charged head group of surfactant/LPS promotes a protein-protein interaction that results in facile amyloid formation without a detectable lag phase. We also show that CsgB, in the presence of surfactant/LPS, accelerates the fibrillation rate of CsgA by circumventing the lag phase during nucleation. Our findings suggest that the electrostatic interactions between lipid and protein molecules play a pivotal role in efficiently sequestering the amyloid fold of curli on the membrane surface without significant accumulation of toxic oligomeric intermediates.	[Swasthi, Hema M.; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Ctr Prot Sci Design & Engn, Sect 81, Mohali, Punjab, India; [Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Biol Sci, Sect 81, Mohali, Punjab, India; [Swasthi, Hema M.; Mukhopadhyay, Samrat] Indian Inst Sci Educ & Res, Dept Chem Sci, Sect 81, Mohali, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali	Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Ctr Prot Sci Design & Engn, Sect 81, Mohali, Punjab, India.; Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Sect 81, Mohali, Punjab, India.; Mukhopadhyay, S (corresponding author), Indian Inst Sci Educ & Res, Dept Chem Sci, Sect 81, Mohali, Punjab, India.	mukhopadhyay@iisermohali.ac.in		Mukhopadhyay, Samrat/0000-0003-1242-9958	Indian Institute of Science Education and Research (IISER) Mohali; Ministry of Human Resource Development; Department of Science and Technology, Ministry of Science and Technology, Government of India	Indian Institute of Science Education and Research (IISER) Mohali; Ministry of Human Resource Development; Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Indian Institute of Science Education and Research (IISER) Mohali, the Ministry of Human Resource Development, and the Department of Science and Technology, Ministry of Science and Technology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen M, 2015, BBA-BIOMEMBRANES, V1848, P1897, DOI 10.1016/j.bbamem.2015.01.018; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Auer S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000222; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bhattacharya M, 2015, LANGMUIR, V31, P8911, DOI 10.1021/acs.langmuir.5b02074; Bhattacharya M, 2013, J PHYS CHEM LETT, V4, P480, DOI 10.1021/jz3019786; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chaudhary H, 2014, FEBS LETT, V588, P4457, DOI 10.1016/j.febslet.2014.10.016; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Collinson SK, 1999, J MOL BIOL, V290, P741, DOI 10.1006/jmbi.1999.2882; Dalal V, 2015, BIOCHEMISTRY-US, V54, P7505, DOI 10.1021/acs.biochem.5b01110; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Gershenson A, 2014, NAT CHEM BIOL, V10, P884, DOI 10.1038/nchembio.1670; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hammer ND, 2012, J MOL BIOL, V422, P376, DOI 10.1016/j.jmb.2012.05.043; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kumar S, 2010, CURR SCI INDIA, V98, P639; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li LY, 2014, TRENDS BIOCHEM SCI, V39, P130, DOI 10.1016/j.tibs.2014.01.002; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Narang D, 2016, J PHYS CHEM B, V120, P7815, DOI 10.1021/acs.jpcb.6b05619; Olsen A, 1998, INFECT IMMUN, V66, P944; Olsen A, 2002, J BIOL CHEM, V277, P34568, DOI 10.1074/jbc.M206353200; Otzen D, 2008, CELL MOL LIFE SCI, V65, P910, DOI 10.1007/s00018-007-7404-4; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Pain C, 2015, BIOCHIMIE, V111, P82, DOI 10.1016/j.biochi.2015.01.012; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Romling U, 1998, J BACTERIOL, V180, P722; Sciacca MFM, 2012, BIOPHYS J, V103, P702, DOI 10.1016/j.bpj.2012.06.045; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; Wang X, 2008, J BIOL CHEM, V283, P21530, DOI 10.1074/jbc.M800466200; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; Zhou YZ, 2012, METHODS MOL BIOL, V849, P303, DOI 10.1007/978-1-61779-551-0_21	52	18	19	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19861	19872		10.1074/jbc.M117.815522	http://dx.doi.org/10.1074/jbc.M117.815522			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021250	Green Published, hybrid			2022-12-28	WOS:000416911300029
J	Rush, JS; Edgar, RJ; Deng, P; Chen, J; Zhu, HN; van Sorge, NM; Morris, AJ; Korotkov, KV; Korotkova, N				Rush, Jeffrey S.; Edgar, Rebecca J.; Deng, Pan; Chen, Jing; Zhu, Haining; van Sorge, Nina M.; Morris, Andrew J.; Korotkov, Konstantin V.; Korotkova, Natalia			The molecular mechanism of N-acetylglucosamine side-chain attachment to the Lancefield group A carbohydrate in Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate biosynthesis; cell wall; glycosyltransferase; polysaccharide; Streptococcus pyogenes (S; pyogenes); lipid intermediate	RHAMNOSE-GLUCOSE POLYSACCHARIDE; TANDEM MASS-SPECTROMETRY; GROUP-B STREPTOCOCCI; CELL-WALL; ANOMERIC CONFIGURATION; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; BACILLUS-CEREUS; GENE-CLUSTER; WEB SERVER	In many Lactobacillales species (i.e. lactic acid bacteria), peptidoglycan is decorated by polyrhamnose polysaccharides that are critical for cell envelope integrity and cell shape and also represent key antigenic determinants. Despite the biological importance of these polysaccharides, their biosynthetic pathways have received limited attention. The important human pathogen, Streptococcus pyogenes, synthesizes a key antigenic surface polymer, the Lancefield group A carbohydrate (GAC). GAC is covalently attached to peptidoglycan and consists of a polyrhamnose polymer, with N-acetylglucosamine (GlcNAc) side chains, which is an essential virulence determinant. The molecular details of the mechanism of polyrhamnose modification with GlcNAc are currently unknown. In this report, using molecular genetics, analytical chemistry, and mass spectrometry analysis, we demonstrated that GAC biosynthesis requires two distinct undecaprenol-linked GlcNAc-lipid intermediates: GlcNAc-pyrophosphoryl-undecaprenol (GlcNAc-P-P-Und) produced by the GlcNAc-phosphate transferase GacO and GlcNAc-phosphate-undecaprenol (GlcNAc-P-Und) produced by the glycosyltransferase GacI. Further investigations revealed that the GAC polyrhamnose backbone is assembled on GlcNAc-P-P-Und. Our results also suggested that a GT-C glycosyltransferase, GacL, transfers GlcNAc from GlcNAc-P-Und to polyrhamnose. Moreover, GacJ, a small membrane-associated protein, formed a complex with GacI and significantly stimulated its catalytic activity. Of note, we observed that GacI homologs perform a similar function in Streptococcus agalactiae and Enterococcus faecalis. In conclusion, the elucidation of GAC biosynthesis in S. pyogenes reported here enhances our understanding of how other Gram-positive bacteria produce essential components of their cell wall.	[Rush, Jeffrey S.; Edgar, Rebecca J.; Chen, Jing; Zhu, Haining; Korotkov, Konstantin V.; Korotkova, Natalia] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Deng, Pan; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40536 USA; [Deng, Pan; Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Lexington, KY 40536 USA; [van Sorge, Nina M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	University of Kentucky; University of Kentucky; University of Kentucky; Utrecht University; Utrecht University Medical Center	Korotkova, N (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	nkorotkova@uky.edu	Zhu, Haining/A-6076-2008; Deng, Pan/AAS-2346-2020; van Sorge, Nina/E-3290-2017	Zhu, Haining/0000-0001-5498-6694; Deng, Pan/0000-0003-2974-7389; van Sorge, Nina/0000-0002-2695-5863; Korotkova, Natalia/0000-0002-8696-4892; Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health from the NIAID [R21AI113253]; Center of Biomedical Research Excellence (COBRE) pilot grant; National Institutes of Health from the NIGMS [P30GM110787]; Vidi Grant from the Netherlands Organization for Scientific Research (NWO) [91713303];  [R01GM102129];  [1S10OD021753]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527, R01GM102129, P30GM110787] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021753] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Biomedical Research Excellence (COBRE) pilot grant; National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vidi Grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R21AI113253 from the NIAID (to N. K.), R01GM102129 (to J. S. R.), and 1S10OD021753 (to A. J. M.) and by the Center of Biomedical Research Excellence (COBRE) pilot grant (to K. V. K., N. K., and J. S. R.) supported by National Institutes of Health Grant P30GM110787 from the NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Vidi Grant 91713303 from the Netherlands Organization for Scientific Research (NWO).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Ardiccioni C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10175; Berg KH, 2012, J BACTERIOL, V194, P627, DOI 10.1128/JB.06273-11; BEVENUE A, 1951, ARCH BIOCHEM BIOPHYS, V34, P225, DOI 10.1016/S0003-9861(51)80032-8; Bui NK, 2012, ANAL BIOCHEM, V421, P657, DOI 10.1016/j.ab.2011.11.026; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Chu M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005946; COLIGAN JE, 1978, IMMUNOCHEMISTRY, V15, P755, DOI 10.1016/0161-5890(78)90105-0; Dale JL, 2015, ANTIMICROB AGENTS CH, V59, P4094, DOI 10.1128/AAC.00344-15; DANILOV LL, 1989, CHEM PHYS LIPIDS, V51, P191, DOI 10.1016/0009-3084(89)90006-6; DITTMER JC, 1964, J LIPID RES, V5, P126; Edgar RJ, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00126; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gomez-Casati DF, 2013, PROTEIN PEPTIDE LETT, V20, P856; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hoff JS, 2011, INFECT IMMUN, V79, P2404, DOI 10.1128/IAI.01191-10; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kabanova A, 2010, VACCINE, V29, P104, DOI 10.1016/j.vaccine.2010.09.018; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lancefield RC, 1933, J EXP MED, V57, P571, DOI 10.1084/jem.57.4.571; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lood R, 2014, ANTIMICROB AGENTS CH, V58, P3073, DOI 10.1128/AAC.00115-14; Mann E, 2016, CAN J CHEM, V94, P883, DOI 10.1139/cjc-2015-0594; MCCARTY M, 1956, J EXP MED, V104, P629, DOI 10.1084/jem.104.5.629; MCCARTY M, 1952, J EXP MED, V96, P569, DOI 10.1084/jem.96.6.569; MEIERDIETER U, 1992, J BIOL CHEM, V267, P746; MICHON F, 1991, INFECT IMMUN, V59, P1690, DOI 10.1128/IAI.59.5.1690-1696.1991; Mistou MY, 2016, FEMS MICROBIOL REV, V40, P464, DOI 10.1093/femsre/fuw006; MURAZUMI N, 1979, J BIOL CHEM, V254, P1791; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; PRITCHARD DG, 1984, ARCH BIOCHEM BIOPHYS, V235, P385, DOI 10.1016/0003-9861(84)90211-X; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; REUSCH VM, 1977, J BACTERIOL, V129, P1407, DOI 10.1128/JB.129.3.1407-1414.1977; Ruiz N, 1998, MOL MICROBIOL, V27, P337, DOI 10.1046/j.1365-2958.1998.00681.x; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Rush JS, 1997, GLYCOBIOLOGY, V7, P315, DOI 10.1093/glycob/7.2.315; Sabharwal H, 2006, J INFECT DIS, V193, P129, DOI 10.1086/498618; Santander J, 2013, MICROBIOL-SGM, V159, P1471, DOI 10.1099/mic.0.066639-0; Schaefer K, 2017, NAT CHEM BIOL, V13, P396, DOI 10.1038/nchembio.2302; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shibata Y, 2002, INFECT IMMUN, V70, P2891, DOI 10.1128/IAI.70.6.2891-2898.2002; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soldo B, 2002, MICROBIOL-SGM, V148, P2079, DOI 10.1099/00221287-148-7-2079; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Tsukioka Y, 1997, J BACTERIOL, V179, P4411, DOI 10.1128/jb.179.13.4411-4414.1997; van der Beek SL, 2015, MOL MICROBIOL, V98, P946, DOI 10.1111/mmi.13169; van Sorge NM, 2014, CELL HOST MICROBE, V15, P729, DOI 10.1016/j.chom.2014.05.009; Wolucka BA, 1996, J AM SOC MASS SPECTR, V7, P541, DOI 10.1016/1044-0305(96)00020-7; Wolucka BA, 1998, ANAL BIOCHEM, V255, P244, DOI 10.1006/abio.1997.2421; YAMAMORI S, 1978, J BIOL CHEM, V253, P6516; Yamashita Y, 1999, J BACTERIOL, V181, P6556, DOI 10.1128/JB.181.20.6556-6559.1999; Yamashita Y, 1998, J BACTERIOL, V180, P5803, DOI 10.1128/JB.180.21.5803-5807.1998	63	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19441	19457		10.1074/jbc.M117.815910	http://dx.doi.org/10.1074/jbc.M117.815910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	29021255	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000416226700024
J	Solmonson, A; DeBerardinis, RJ				Solmonson, Ashley; DeBerardinis, Ralph J.			Lipoic acid metabolism and mitochondrial redox regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ALPHA-KETOGLUTARATE DEHYDROGENASE; LIPOATE-PROTEIN LIGASE; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; SUPEROXIDE/HYDROGEN PEROXIDE; POSTTRANSLATIONAL MODIFICATION; LIPOAMIDE DEHYDROGENASE; S-GLUTATHIONYLATION; MOLECULAR-CLONING; CARRIER PROTEIN	Lipoic acid is an essential cofactor for mitochondrial metabolism and is synthesized de novo using intermediates from mitochondrial fatty-acid synthesis type II, S-adenosylmethionine and iron-sulfur clusters. This cofactor is required for catalysis by multiple mitochondrial 2-ketoacid dehydrogenase complexes, including pyruvate dehydrogenase, -ketoglutarate dehydrogenase, and branched-chain ketoacid dehydrogenase. Lipoic acid also plays a critical role in stabilizing and regulating these multienzyme complexes. Many of these dehydrogenases are regulated by reactive oxygen species, mediated through the disulfide bond of the prosthetic lipoyl moiety. Collectively, its functions explain why lipoic acid is required for cell growth, mitochondrial activity, and coordination of fuel metabolism.	[Solmonson, Ashley; DeBerardinis, Ralph J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBerardinis, RJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Res Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ralph.deberardinis@utsouthwestern.edu		Solmonson, Ashley/0000-0001-8863-4558	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R35 CA220449] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA220449] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ambrus A, 2018, NEUROCHEM INT, V117, P5, DOI 10.1016/j.neuint.2017.05.018; Ambrus A, 2010, BBA-BIOENERGETICS, V1797, P57, DOI 10.1016/j.bbabio.2010.04.187; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Baker PR, 2014, BRAIN, V137, P366, DOI 10.1093/brain/awt328; Beer SM, 2004, J BIOL CHEM, V279, P47939, DOI 10.1074/jbc.M408011200; Bunik V, 1997, BIOL CHEM, V378, P1125, DOI 10.1515/bchm.1997.378.10.1125; BUNIK V, 1993, FEBS LETT, V336, P197, DOI 10.1016/0014-5793(93)80801-Z; BUNIK VI, 1993, FEBS LETT, V323, P166, DOI 10.1016/0014-5793(93)81472-C; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; Burr SP, 2016, CELL METAB, V24, P740, DOI 10.1016/j.cmet.2016.09.015; Chang CF, 2002, J BIOL CHEM, V277, P15865, DOI 10.1074/jbc.M110952200; Cronan JE., 2014, ECOSAL PLUS, V6, P1, DOI [10.1128/ecosalplus.ESP-0001-2012, DOI 10.1128/ECOSALPLUS.ESP-0001-2012]; Cronan JE, 2016, MICROBIOL MOL BIOL R, V80, P429, DOI 10.1128/MMBR.00073-15; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; Ewald R, 2014, PLANT PHYSIOL, V165, P978, DOI 10.1104/pp.114.238311; Faure M, 1999, EUR J BIOCHEM, V259, P104, DOI 10.1046/j.1432-1327.1999.00009.x; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Fujino T, 2001, J BIOL CHEM, V276, P35961, DOI 10.1074/jbc.M106651200; FUJIWARA K, 1994, J BIOL CHEM, V269, P16605; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; Fujiwara K, 2001, J BIOL CHEM, V276, P28819, DOI 10.1074/jbc.M101748200; FUKUSHIMA T, 1989, J BIOL CHEM, V264, P16483; Goncalves RLS, 2016, FREE RADICAL BIO MED, V91, P247, DOI 10.1016/j.freeradbiomed.2015.12.020; GOPALAKRISHNAN S, 1989, BIOCHEM BIOPH RES CO, V160, P715, DOI 10.1016/0006-291X(89)92492-3; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; Habarou F, 2017, AM J HUM GENET, V101, P283, DOI 10.1016/j.ajhg.2017.07.001; Heimer G, 2016, AM J HUM GENET, V99, P1229, DOI 10.1016/j.ajhg.2016.09.021; Hermes FA, 2013, YEAST, V30, P415, DOI 10.1002/yea.2979; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Jordan SW, 1997, METHOD ENZYMOL, V279, P176; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Jordan SW, 2003, J BACTERIOL, V185, P1582, DOI 10.1128/JB.185.5.1582-1589.2003; Kang SG, 2007, GENE, V393, P53, DOI 10.1016/j.gene.2007.01.011; Kato M, 2006, EMBO J, V25, P5983, DOI 10.1038/sj.emboj.7601444; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; Machius M, 2006, STRUCTURE, V14, P287, DOI 10.1016/j.str.2005.10.009; Mailloux RJ, 2016, REDOX BIOL, V8, P285, DOI 10.1016/j.redox.2016.02.002; Marvin ME, 2001, FEMS MICROBIOL LETT, V199, P131, DOI 10.1016/S0378-1097(01)00170-7; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Mayr JA, 2014, J INHERIT METAB DIS, V37, P553, DOI 10.1007/s10545-014-9705-8; McCarthy EL, 2017, SCIENCE, V358, P373, DOI 10.1126/science.aan4574; McLain AL, 2013, FREE RADICAL BIO MED, V61, P161, DOI 10.1016/j.freeradbiomed.2013.03.020; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; NAKANO K, 1994, EUR J BIOCHEM, V224, P179, DOI 10.1111/j.1432-1033.1994.tb20010.x; NEAGLE J, 1989, FEBS LETT, V253, P11, DOI 10.1016/0014-5793(89)80919-6; Nulton-Persson A., 2009, LIPOIC ACID OXIDATIV, DOI [10.1201/9781420045390.ch8, DOI 10.1201/9781420045390.CH8]; O'Brien M, 2017, FREE RADICAL BIO MED, V106, P302, DOI 10.1016/j.freeradbiomed.2017.02.046; PARRY RJ, 1978, J AM CHEM SOC, V100, P5243, DOI 10.1021/ja00484a073; PARRY RJ, 1977, J AM CHEM SOC, V99, P6464, DOI 10.1021/ja00461a061; PATTERSON EL, 1951, J AM CHEM SOC, V73, P5919, DOI 10.1021/ja01156a566; PORPACZY Z, 1987, J BIOL CHEM, V262, P9509; POWERSGREENWOOD SL, 1989, J BIOL CHEM, V264, P3655; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; RAHMATULLAH M, 1987, J BIOL CHEM, V262, P10265; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; Reed L. J., 1974, ACCOUNTS CHEM RES, V1974, P7, DOI 10.1021/ar50074a002; Reed L. J., 2006, ADV ENZYMOLOGY RELAT, P319; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1958, J BIOL CHEM, V232, P123; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93; Rowland EA, 2017, MBIO, V8, DOI 10.1128/mBio.01096-17; Saudubray J.-M., 2016, INBORN METABOLIC DIS, P169, DOI [10.1007/978-3-662-49771-5_14, DOI 10.1007/978-3-662-49771-5_14]; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Shaag A, 1999, AM J MED GENET, V82, P177, DOI 10.1002/(SICI)1096-8628(19990115)82:2<177::AID-AJMG15>3.3.CO;2-0; Smith S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047196; Soreze Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-192; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; SULO P, 1993, J BIOL CHEM, V268, P17634; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Vessey DA, 2003, J BIOCHEM MOL TOXIC, V17, P1, DOI 10.1002/jbt.10056; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; WHITE RH, 1980, BIOCHEMISTRY-US, V19, P15, DOI 10.1021/bi00542a003; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008; WILLIAMS CH, 1982, P NATL ACAD SCI-BIOL, V79, P2199, DOI 10.1073/pnas.79.7.2199; Wu HL, 2010, BBA-BIOENERGETICS, V1797, P1705, DOI 10.1016/j.bbabio.2010.06.003; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005	85	119	123	8	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7522	7530		10.1074/jbc.TM117.000259	http://dx.doi.org/10.1074/jbc.TM117.000259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29191830	Green Published, hybrid			2022-12-28	WOS:000437256500006
J	Sun, SS; Tan, PC; Huang, XH; Zhang, W; Kong, C; Ren, FF; Su, X				Sun, Shishuo; Tan, Pengcheng; Huang, Xiaoheng; Zhang, Wei; Kong, Chen; Ren, Fangfang; Su, Xiong			Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; PROTEIN-TYROSINE KINASES; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; HYPERTENSIVE-RATS; RESISTANCE; PHOSPHORYLATION; MICE; DEGRADATION; SENSITIVITY	Both the magnitude and duration of insulin signaling are important in executing its cellular functions. Insulin-induced degradation of insulin receptor substrate 1 (IRS1) represents a key negative feedback loop that restricts insulin signaling. Moreover, high concentrations of fatty acids (FAs) and glucose involved in the etiology of obesity-associated insulin resistance also contribute to the regulation of IRS1 degradation. The scavenger receptor CD36 binds many lipid ligands, and its contribution to insulin resistance has been extensively studied, but the exact regulation of insulin sensitivity by CD36 is highly controversial. Herein, we found that CD36 knockdown in C2C12 myotubes accelerated insulin-stimulated Akt activation, but the activated signaling was sustained for a much shorter period of time as compared with WT cells, leading to exacerbated insulin-induced insulin resistance. This was likely due to enhanced insulin-induced IRS1 degradation after CD36 knockdown. Overexpression of WTCD36, but not a ubiquitination-defective CD36 mutant, delayed IRS1 degradation. We also found that CD36 functioned through ubiquitination-dependent binding to IRS1 and inhibiting its interaction with cullin 7, a key component of the multisubunit cullin-RING E3 ubiquitin ligase complex. Moreover, dissociation of the Src family kinase Fyn from CD36 by free FAs or Fyn knockdown/inhibition accelerated insulin-induced IRS1 degradation, likely due to disrupted IRS1 interaction with CD36 and thus enhanced binding to cullin 7. In summary, we identified a CD36-dependent FA-sensing pathway that plays an important role in negative feedback regulation of insulin activation and may open up strategies for preventing or managing type 2 diabetes mellitus.	[Sun, Shishuo; Tan, Pengcheng; Huang, Xiaoheng; Ren, Fangfang; Su, Xiong] Soochow Univ, Med Coll, Dept Biochem & Mol Biol, Suzhou 215123, Peoples R China; [Zhang, Wei; Kong, Chen] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA	Soochow University - China; Washington University (WUSTL)	Su, X (corresponding author), Soochow Univ, Med Coll, 199 Renai Rd, Suzhou 215123, Peoples R China.	xsu@suda.edu.cn		Sun, Shishuo/0000-0001-8608-7204	National Natural Science Foundation of China [31371437, 31570806, 31620103906]; Natural Science Foundation of Jiangsu Province [BK20150006]; Priority Academic Programme Development of Jiangsu Higher Education Institutions; National Institutes of Health [DK097608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097608, P30DK056341] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Programme Development of Jiangsu Higher Education Institutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Grants 31371437, 31570806, and 31620103906; Natural Science Foundation of Jiangsu Province Grant BK20150006; a project funded by Priority Academic Programme Development of Jiangsu Higher Education Institutions; and National Institutes of Health Grant DK097608. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dong LY, 2017, ONCOTARGET, V8, P22550, DOI 10.18632/oncotarget.15123; Duan L, 2014, J BIOL CHEM, V289, P21694, DOI 10.1074/jbc.M114.550038; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; Garbacz WG, 2016, MOL CELL BIOL, V36, P2715, DOI 10.1128/MCB.00138-16; Gobrecht P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5561; Goel R, 2002, J BIOL CHEM, V277, P18640, DOI 10.1074/jbc.M108995200; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Gual P, 2003, J BIOL CHEM, V278, P26550, DOI 10.1074/jbc.M212273200; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hu XQ, 2016, J LIPID RES, V57, P663, DOI 10.1194/jlr.M066530; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Kaiser C, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-23; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lavin DP, 2016, DIABETOLOGIA, V59, P2280, DOI 10.1007/s00125-016-4072-7; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Lv ZM, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5671803; Mayer CM, 2010, ENDOCRINOLOGY, V151, P75, DOI 10.1210/en.2009-0838; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Newton JG, 2017, PEDIATR DEVEL PATHOL, V20, P224, DOI 10.1177/1093526616688753; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Porter HA, 2013, CANCER LETT, V338, P239, DOI 10.1016/j.canlet.2013.03.030; Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200; Sajan MP, 2010, AM J PHYSIOL-ENDOC M, V298, pE179, DOI 10.1152/ajpendo.00392.2009; Samovski D, 2015, DIABETES, V64, P353, DOI 10.2337/db14-0582; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith J, 2008, J BIOL CHEM, V283, P13578, DOI 10.1074/jbc.M800008200; Song JX, 2004, NAT IMMUNOL, V5, P150, DOI 10.1038/ni1030; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Sun XJ, 1996, J BIOL CHEM, V271, P10583, DOI 10.1074/jbc.271.18.10583; Sun YJ, 2010, DIABETES CARE, V33, P2065, DOI 10.2337/dc10-0460; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhou DQ, 2012, FASEB J, V26, P4733, DOI 10.1096/fj.12-206862	51	11	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2383	2394		10.1074/jbc.M117.811471	http://dx.doi.org/10.1074/jbc.M117.811471			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269414	hybrid, Green Published			2022-12-28	WOS:000425308300013
J	de Godoy, MA; Saraiva, LM; de Carvalho, LRP; Vasconcelos-dos-Santos, A; Beiral, HJV; Ramos, AB; Silva, LRD; Leal, RB; Monteiro, VHS; Braga, CV; de Araujo-Silva, CA; Sinis, LC; Bodart-Santos, V; Kasai-Brunswick, TH; Alcantara, CD; Lima, APCA; da Cunha-e Silva, NL; Galina, A; Vieyra, A; De Felice, FG; Mendez-Otero, R; Ferreira, ST				de Godoy, Mariana A.; Saraiva, Leonardo M.; de Carvalho, Luiza R. P.; Vasconcelos-dos-Santos, Andreia; Beiral, Hellen J. V.; Ramos, Alane Bernardo; de Paula Silva, Livian R.; Leal, Renata B.; Monteiro, Victor H. S.; Braga, Carolina V.; de Araujo-Silva, Carlla A.; Sinis, Leandro C.; Bodart-Santos, Victor; Kasai-Brunswick, Tais Hanae; Alcantara, Carolina de Lima; Lima, Ana Paula C. A.; da Cunha-e Silva, Narcisa L.; Galina, Antonio; Vieyra, Adalberto; De Felice, Fernanda G.; Mendez-Otero, Rosalia; Ferreira, Sergio T.			Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid- oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; catalase; cytokine action; endocytosis; extracellular vesicles; hippocampus; mesenchymal stem cells (MSCs); oxidative stress; synapse; amyloid-; oligomers	A-BETA OLIGOMERS; CENTRAL-NERVOUS-SYSTEM; RENAL TUBULAR CELLS; ALZHEIMERS-DISEASE; STROMAL CELLS; IN-VITRO; PRION PROTEIN; NEUROVASCULAR PLASTICITY; TAU-HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT	Alzheimer's disease (AD) is a disabling and highly prevalent neurodegenerative condition, for which there are no effective therapies. Soluble oligomers of the amyloid- peptide (AOs) are thought to be proximal neurotoxins involved in early neuronal oxidative stress and synapse damage, ultimately leading to neurodegeneration and memory impairment in AD. The aim of the current study was to evaluate the neuroprotective potential of mesenchymal stem cells (MSCs) against the deleterious impact of AOs on hippocampal neurons. To this end, we established transwell cocultures of rat hippocampal neurons and MSCs. We show that MSCs and MSC-derived extracellular vesicles protect neurons against AO-induced oxidative stress and synapse damage, revealed by loss of pre- and postsynaptic markers. Protection by MSCs entails three complementary mechanisms: 1) internalization and degradation of AOs; 2) release of extracellular vesicles containing active catalase; and 3) selective secretion of interleukin-6, interleukin-10, and vascular endothelial growth factor to the medium. Results support the notion that MSCs may represent a promising alternative for cell-based therapies in AD.	[de Godoy, Mariana A.; de Carvalho, Luiza R. P.; Vasconcelos-dos-Santos, Andreia; Beiral, Hellen J. V.; Ramos, Alane Bernardo; de Paula Silva, Livian R.; Leal, Renata B.; Monteiro, Victor H. S.; Braga, Carolina V.; de Araujo-Silva, Carlla A.; Sinis, Leandro C.; Kasai-Brunswick, Tais Hanae; Alcantara, Carolina de Lima; Lima, Ana Paula C. A.; da Cunha-e Silva, Narcisa L.; Vieyra, Adalberto; Mendez-Otero, Rosalia; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil; [Saraiva, Leonardo M.; Bodart-Santos, Victor; Galina, Antonio; De Felice, Fernanda G.; Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil; [Vieyra, Adalberto] Fed Univ Rio Janeiro, Natl Ctr Struct Biol & Bioimaging, CENABIO, BR-21944590 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Mendez-Otero, R; Ferreira, ST (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.	rmotero@biof.ufrj.br; ferreira@bioqmed.ufrj.br	de Godoy, Mariana Araya/S-3528-2019; Cunha-e-Silva, Narcisa L/Q-2902-2018; Ferreira, Sergio/AAZ-1576-2020; Lima, Ana Paula CA/G-4122-2012; Araujo-Silva, Carlla/M-6658-2018; Kasai-Brunswick, Tais Hanae/AAK-9905-2020; Mendez-Otero, Rosalia/AAL-7551-2020	Cunha-e-Silva, Narcisa L/0000-0003-4863-4945; Ferreira, Sergio/0000-0001-7160-9866; Araujo-Silva, Carlla/0000-0003-0733-9632; Mendez-Otero, Rosalia/0000-0002-1798-9930; Kasai-Brunswick, Tais Hanae/0000-0002-6361-5980	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); National Institute for Translational Neuroscience; Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute for Translational Neuroscience; Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), National Institute for Translational Neuroscience, and Departamento de Ciencia e Tecnologia do Ministerio da Saude (DECIT/MS) (to S. T. F., R. M. O., F. G. D. F., A. V., A. G., N. L. C. S., and A. P. C. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Asselineau D, 2015, J ALZHEIMERS DIS, V46, P837, DOI 10.3233/JAD-142832; Bissonnette CJ, 2011, STEM CELLS, V29, P802, DOI 10.1002/stem.626; Blazquez R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00556; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Chi Y, 2014, CELL TISSUE BANK, V15, P397, DOI 10.1007/s10561-013-9404-y; Choi M, 2014, MOL CELLS, V37, P133, DOI 10.14348/molcells.2014.2317; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Danielyan L, 2014, CELL TRANSPLANT, V23, pS123, DOI 10.3727/096368914X684970; De Felice FG, 2008, NEUROBIOL AGING, V29, P1334, DOI 10.1016/j.neurobiolaging.2007.02.029; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; De Felice FG, 2001, FASEB J, V15, P1297, DOI 10.1096/fj.00-0676fje; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; dos Santos AD, 2010, BRAIN RES, V1306, P149, DOI 10.1016/j.brainres.2009.09.094; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Farinazzo A, 2015, CYTOTHERAPY, V17, P571, DOI 10.1016/j.jcyt.2015.01.005; Ferreira ST, 2007, IUBMB LIFE, V59, P332, DOI 10.1080/15216540701283882; Ferreira ST, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00191; Ferreira ST, 2011, NEUROBIOL LEARN MEM, V96, P529, DOI 10.1016/j.nlm.2011.08.003; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Garcia KO, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00030; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haney MJ, 2015, J CONTROL RELEASE, V207, P18, DOI 10.1016/j.jconrel.2015.03.033; He J, 2012, NEPHROLOGY, V17, P493, DOI 10.1111/j.1440-1797.2012.01589.x; Heiskanen M, 2010, ATHEROSCLEROSIS, V208, P190, DOI 10.1016/j.atherosclerosis.2009.06.032; Imtiaz B, 2014, BIOCHEM PHARMACOL, V88, P661, DOI 10.1016/j.bcp.2014.01.003; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Katsuda T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01197; Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140; Kim JY, 2010, FEBS LETT, V584, P3601, DOI 10.1016/j.febslet.2010.07.028; Kowal EJK, 2017, METHODS MOL BIOL, V1660, P143, DOI 10.1007/978-1-4939-7253-1_12; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ledo JH, 2016, J NEUROSCI, V36, P12106, DOI 10.1523/JNEUROSCI.1269-16.2016; Lee HJ, 2012, NEUROBIOL AGING, V33, P588, DOI 10.1016/j.neurobiolaging.2010.03.024; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee JK, 2012, STEM CELLS, V30, P1544, DOI 10.1002/stem.1125; Lee JK, 2009, NEUROSCI LETT, V450, P136, DOI 10.1016/j.neulet.2008.11.059; Lindoso RS, 2016, PROTEOMICS, V16, P328, DOI 10.1002/pmic.201500341; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; MARGOLIASH E, 1962, J BIOL CHEM, V237, P2359; Montemurro T, 2016, EUR J CELL BIOL, V95, P228, DOI 10.1016/j.ejcb.2016.04.003; Moraes L, 2012, STEM CELL RES, V9, P143, DOI 10.1016/j.scr.2012.05.005; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Naaldijk Y, 2017, NEUROPATH APPL NEURO, V43, P299, DOI 10.1111/nan.12319; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; Noda Mariko, 2012, Int J Alzheimers Dis, V2012, P891087, DOI 10.1155/2012/891087; Plotnikov EY, 2010, EXP CELL RES, V316, P2447, DOI 10.1016/j.yexcr.2010.06.009; Ramos TL, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0124-8; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Salazar SV, 2017, BIOCHEM BIOPH RES CO, V483, P1143, DOI 10.1016/j.bbrc.2016.09.062; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Song MS, 2015, NEUROSCIENCE, V307, P37, DOI 10.1016/j.neuroscience.2015.08.011; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Valle-Prieto A, 2010, STEM CELLS DEV, V19, P1885, DOI 10.1089/scd.2010.0093; van de Haar HJ, 2016, RADIOLOGY, V281, P527, DOI 10.1148/radiol.2016152244; Vargas-Alarcon G, 2016, IMMUNOL LETT, V177, P47, DOI 10.1016/j.imlet.2016.07.011; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wu QY, 2007, NEUROSCI LETT, V417, P281, DOI 10.1016/j.neulet.2007.02.092; Xie ZH, 2016, CLIN EXP MED, V16, P89, DOI 10.1007/s10238-015-0375-0; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Yang H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt227; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479; Zhang GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092129; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhou Y, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt194	94	96	96	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1957	1975		10.1074/jbc.M117.807180	http://dx.doi.org/10.1074/jbc.M117.807180			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29284679	Green Published, hybrid			2022-12-28	WOS:000424948000011
J	Fraile, JM; Campos-Iglesias, D; Rodriguez, F; Astudillo, A; Vilarrasa-Blasi, R; Verdaguer-Dot, N; Prado, MA; Paulo, JA; Gygi, SP; Martin-Subero, JI; Freije, JMP; Lopez-Otin, C				Fraile, Julia M.; Campos-Iglesias, Diana; Rodriguez, Francisco; Astudillo, Aurora; Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Prado, Miguel A.; Paulo, Joao A.; Gygi, Steven P.; Martin-Subero, Jose I.; Freije, Jose M. P.; Lopez-Otin, Carlos			Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes preimplantation lethality in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); nucleolus; protease; protein synthesis; ribosome	RIBOSOME BIOGENESIS; NUCLEOLAR STRUCTURE; UBIQUITIN SYSTEM; POLYMERASE I; ENZYME USP36; CELL-GROWTH; EXPRESSION; GENE; IDENTIFICATION; PROTEASES	Deubiquitinases are proteases with a wide functional diversity that profoundly impact multiple biological processes. Among them, the ubiquitin-specific protease 36 (USP36) has been implicated in the regulation of nucleolar activity. However, its functional relevance in vivo has not yet been fully described. Here, we report the generation of an Usp36-deficient mouse model to examine the function of this enzyme. We show that Usp36 depletion is lethal in preimplantation mouse embryos, where it blocks the transition from morula to blastocyst during embryonic development. USP36 reduces the ubiquitination levels and increases the stability of the DEAH-box RNA helicase DHX33, which is critically involved in ribosomal RNA synthesis and mRNA translation. In agreement with this finding, O-propargyl-puromycin incorporation experiments, Northern blot, and electron microscopy analyses demonstrated the role of USP36 in ribosomal RNA and protein synthesis. Finally, we show that USP36 down-regulation alters cell proliferation in human cancer cells by inducing both apoptosis and cell cycle arrest, and that reducing DHX33 levels through short hairpin RNA interference has the same effect. Collectively, these results support that Usp36 is essential for cell and organism viability because of its role in ribosomal RNA processing and protein synthesis, which is mediated, at least in part, by regulating DHX33 stability.	[Fraile, Julia M.; Campos-Iglesias, Diana; Rodriguez, Francisco; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Astudillo, Aurora] Hosp Univ Cent Asturias, Serv Anat Patol, Oviedo 33006, Spain; [Vilarrasa-Blasi, Roser; Verdaguer-Dot, Nuria; Martin-Subero, Jose I.] Univ Barcelona, IDIBAPS, Dept Anat Patol Farmacol & Microbiol, E-08036 Barcelona, Spain; [Prado, Miguel A.; Paulo, Joao A.; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Freije, Jose M. P.; Lopez-Otin, Carlos] Ctr Invest Biomed Red Canc, Madrid, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Harvard University; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Freije, JMP (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.; Lopez-Otin, C (corresponding author), Univ Oviedo, Fac Med, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.	jmpf@uniovi.es; clo@uniovi.es	Prado, Miguel A/P-3922-2017; Freije, José M.P./A-6535-2008; Paulo, Joao/AAO-3981-2020; López-Otín, Carlos/AAB-2106-2020	Prado, Miguel A/0000-0002-4914-1619; Freije, José M.P./0000-0002-4688-8266; Paulo, Joao/0000-0002-4291-413X; López-Otín, Carlos/0000-0001-6964-1904; Campos-Iglesias, Diana/0000-0002-7679-229X; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Verdaguer, Nuria/0000-0002-6523-3038; Vilarrasa-Blasi, Roser/0000-0002-3384-0693	Fundacion Bancaria Caja de Ahorros de Asturias; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK098285] Funding Source: NIH RePORTER	Fundacion Bancaria Caja de Ahorros de Asturias; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. G. Bretones, C. Barcena, G. Velasco, R. Valdes-Mas, V. Quesada, Y. Espanol, D. Rodriguez, A. Salas and J. A. Vega, for helpful comments and assistance, and M. Serrano, B. Vogelstein, and J. Weber for providing reagents. We also thank the generous support by J. I. Cabrera. The Instituto Universitario de Oncologia is supported by Fundacion Bancaria Caja de Ahorros de Asturias.	Ashton-Beaucage D, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002539; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Brighenti E, 2015, ONCOTARGET, V6, P38617, DOI 10.18632/oncotarget.5775; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Chen H, 2008, BIOCHEM BIOPH RES CO, V365, P636, DOI 10.1016/j.bbrc.2007.11.019; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; Clague MJ, 2015, TRENDS CELL BIOL, V25, P417, DOI 10.1016/j.tcb.2015.03.002; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fraile JM, 2013, ONCOTARGET, V4, P1919, DOI 10.18632/oncotarget.1303; Hamdane N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004505; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kim MS, 2011, J CELL BIOCHEM, V112, P498, DOI 10.1002/jcb.22940; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Newton K, 2003, MOL CELL BIOL, V23, P8519, DOI 10.1128/MCB.23.23.8519-8527.2003; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Osorio FG, 2016, NAT MED, V22, P91, DOI 10.1038/nm.4013; Paulo JA, 2015, MOL BIOL CELL, V26, P4063, DOI 10.1091/mbc.E15-07-0499; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Reed BJ, 2015, J BIOL CHEM, V290, P20601, DOI 10.1074/jbc.M115.650952; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Romanova LG, 2006, BIOL REPROD, V75, P690, DOI 10.1095/biolreprod.106.054072; Ronau JA, 2016, CELL RES, V26, P441, DOI 10.1038/cr.2016.38; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Taillebourg E, 2012, AUTOPHAGY, V8, P767, DOI 10.4161/auto.19381; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang ZQ, 2016, GENE DEV, V30, P946, DOI 10.1101/gad.271841.115; Zhang YD, 2015, MOL CELL BIOL, V35, P2918, DOI 10.1128/MCB.00315-15; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	44	18	19	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2183	2194		10.1074/jbc.M117.788430	http://dx.doi.org/10.1074/jbc.M117.788430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29273634	Green Published, hybrid			2022-12-28	WOS:000424948000029
J	Woodcock, CSC; Huang, Y; Woodcock, SR; Salvatore, SR; Singh, B; Golin-Bisello, F; Davidson, NE; Neumann, CA; Freeman, BA; Wendell, SG				Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R.; Salvatore, Sonia R.; Singh, Bhupinder; Golin-Bisello, Franca; Davidson, Nancy E.; Neumann, Carola A.; Freeman, Bruce A.; Wendell, Stacy G.			Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer chemoprevention; drug action; NF-kappaB; proliferation; reactive nitrogen species (RNS); reactive oxygen species (ROS); signaling; tumor immunology; tumor necrosis factor (TNF)	NF-KAPPA-B; CONJUGATED LINOLEIC-ACID; TRITERPENOID CDDO-ME; CONSTITUTIVE ACTIVATION; COVALENT MODIFICATION; PPAR-GAMMA; DEGRADATION; GLUTATHIONE; RESISTANCE; EXPRESSION	Triple-negative breast cancer (TNBC) comprises approximate to 20% of all breast cancers and is the most aggressive mammary cancer subtype. Devoid of the estrogen and progesterone receptors, along with the receptor tyrosine kinase ERB2 (HER2), that define most mammary cancers, there are no targeted therapies for patients with TNBC. This, combined with a high metastatic rate and a lower 5-year survival rate than for other breast cancer phenotypes, means there is significant unmet need for new therapeutic strategies. Herein, the anti-neoplastic effects of the electrophilic fatty acid nitroalkene derivative, 10-nitro-octadec-9-enoic acid (nitro-oleic acid, NO2-OA), were investigated in multiple preclinical models of TNBC. NO2-OA reduced TNBC cell growth and viability in vitro, attenuated TNF-induced TNBC cell migration and invasion, and inhibited the tumor growth of MDA-MB-231 TNBC cell xenografts in the mammary fat pads of female nude mice. The up-regulation of these aggressive tumor cell growth, migration, and invasion phenotypes is mediated in part by the constitutive activation of pro-inflammatory nuclear factor B (NF-B) signaling in TNBC. NO2-OA inhibited TNF-induced NF-B transcriptional activity in human TNBC cells and suppressed downstream NF-B target gene expression, including the metastasis-related proteins intercellular adhesion molecule-1 and urokinase-type plasminogen activator. The mechanisms accounting for NF-B signaling inhibition by NO2-OA in TNBC cells were multifaceted, as NO2-OA (a) inhibited the inhibitor of NF-B subunit kinase phosphorylation and downstream inhibitor of NF-B degradation, (b) alkylated the NF-B RelA protein to prevent DNA binding, and (c) promoted RelA polyubiquitination and proteasomal degradation. Comparisons with non-tumorigenic human breast epithelial MCF-10A and MCF7 cells revealed that NO2-OA more selectively inhibited TNBC function. This was attributed to more facile mechanisms for maintaining redox homeostasis in normal breast epithelium, including a more favorable thiol/disulfide balance, greater extents of multidrug resistance protein-1 (MRP1) expression, and greater MRP1-mediated efflux of NO2-OA-glutathione conjugates. These observations reveal that electrophilic fatty acid nitroalkenes react with more alkylation-sensitive targets in TNBC cells to inhibit growth and viability.	[Woodcock, Chen-Shan Chen; Huang, Yi; Woodcock, Steven R.; Salvatore, Sonia R.; Singh, Bhupinder; Golin-Bisello, Franca; Neumann, Carola A.; Freeman, Bruce A.; Wendell, Stacy G.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Huang, Yi; Neumann, Carola A.] UPMC Hillman Canc Ctr, Womens Canc Res Ctr, Pittsburgh, PA 15232 USA; [Davidson, Nancy E.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Davidson, Nancy E.] Univ Washington, Dept Med, Seattle, WA 98109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Freeman, BA; Wendell, SG (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	freerad@pitt.edu; gstacy@pitt.edu	Gelhaus, Stacy/AAF-2570-2019; Woodcock, Steven/AAE-9199-2020; Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Singh, Bhupinder/0000-0002-4241-4610; Neumann, Carola/0000-0003-2801-9531; Salvatore, Sonia/0000-0002-9942-3905	United States Army Breast Cancer Research Breakthrough Awards [W81XWH-14-1-0237, W81XWH-14-1-0238]; National Institutes of Health [R01-HL058115, R01-HL64937, P30-DK072506, P01-HL103455, R21AI122071-01A1, 5P30-CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058115, P01HL103455, R01HL064937, R01HL132550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI122071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	United States Army Breast Cancer Research Breakthrough Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by United States Army Breast Cancer Research Breakthrough Awards W81XWH-14-1-0237 (to Y.H.) and W81XWH-14-1-0238 (to N. E. D.) and National Institutes of Health Grants R01-HL058115, R01-HL64937, P30-DK072506, and P01-HL103455 (to B. A. F.), R21AI122071-01A1 (to S. G. W.), and 5P30-CA047904 (to N. E. D.). B. A. F., S. G. W., S. R. W., and C. C. W. acknowledge interest in Complexa, Inc. No potential conflicts of interest were disclosed by other authors. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Alexander RL, 2006, BIOCHEMISTRY-US, V45, P7889, DOI 10.1021/bi0605639; Alli E, 2009, CANCER RES, V69, P3589, DOI 10.1158/0008-5472.CAN-08-4016; Ambrozova G, 2016, FREE RADICAL BIO MED, V90, P252, DOI 10.1016/j.freeradbiomed.2015.11.026; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bonacci G, 2012, J BIOL CHEM, V287, P44071, DOI 10.1074/jbc.M112.401356; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Codreanu SG, 2014, MOL CELL PROTEOMICS, V13, P849, DOI 10.1074/mcp.M113.032953; Cole MP, 2009, CIRC RES, V105, P965, DOI 10.1161/CIRCRESAHA.109.199075; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; Delmastro-Greenwood M, 2015, FREE RADICAL BIO MED, V89, P333, DOI 10.1016/j.freeradbiomed.2015.07.149; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Diers AR, 2010, BIOCHEM J, V430, P69, DOI 10.1042/BJ20091193; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Fazzari M, 2017, J LIPID RES, V58, P375, DOI 10.1194/jlr.M072058; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Heitz F, 2009, EUR J CANCER, V45, P2792, DOI 10.1016/j.ejca.2009.06.027; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hughan KS, 2017, HYPERTENSION, V70, P634, DOI 10.1161/HYPERTENSIONAHA.117.09016; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kalimutho M, 2015, TRENDS PHARMACOL SCI, V36, P822, DOI 10.1016/j.tips.2015.08.009; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kastrati I, 2016, J BIOL CHEM, V291, P3639, DOI 10.1074/jbc.M115.679704; Kelley EE, 2014, CARDIOVASC RES, V101, P352, DOI 10.1093/cvr/cvt341; Klinke A, 2014, AM J RESP CELL MOL, V51, P155, DOI 10.1165/rcmb.2013-0063OC; Koenitzer JR, 2016, REDOX BIOL, V8, P1, DOI 10.1016/j.redox.2015.11.002; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Levonen AL, 2014, FREE RADICAL BIO MED, V71, P196, DOI 10.1016/j.freeradbiomed.2014.03.025; Li HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10244; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Lin D, 2008, CHEM RES TOXICOL, V21, P2361, DOI 10.1021/tx800248x; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Moody WE, 2016, HYPERTENSION, V67, P368, DOI 10.1161/HYPERTENSIONAHA.115.06608; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Paranjpe A, 2013, CARCINOGENESIS, V34, P990, DOI 10.1093/carcin/bgt032; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Qiao YC, 2016, J BIOL CHEM, V291, P5068, DOI 10.1074/jbc.M115.702571; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rudnicki M, 2011, ARTERIOSCL THROM VAS, V31, P1360, DOI 10.1161/ATVBAHA.111.224626; Rudolph TK, 2016, CARDIOVASC RES, V109, P174, DOI 10.1093/cvr/cvv254; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Salvatore SR, 2013, J LIPID RES, V54, P1998, DOI 10.1194/jlr.M037804; Samudio I, 2005, J BIOL CHEM, V280, P36273, DOI 10.1074/jbc.M507518200; Schopfer FJ, 2011, CHEM REV, V111, P5997, DOI 10.1021/cr200131e; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Sibhatu MB, 2008, CARCINOGENESIS, V29, P807, DOI 10.1093/carcin/bgn013; SMITH C, 1992, BIOCHEM J, V286, P901, DOI 10.1042/bj2860901; Snyder NW, 2015, CHEM-BIOL INTERACT, V234, P144, DOI 10.1016/j.cbi.2014.10.029; So JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107616; Song NY, 2011, CHEM RES TOXICOL, V24, P1231, DOI 10.1021/tx200090n; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Switzer CH, 2012, CANCER RES, V72, P2394, DOI 10.1158/0008-5472.CAN-11-3115; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Verescakova H, 2017, FREE RADICAL BIO MED, V104, P10, DOI 10.1016/j.freeradbiomed.2017.01.003; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wang HP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/293474; Wang WD, 2016, AM J PHYSIOL-RENAL, V310, pF697, DOI 10.1152/ajprenal.00321.2015; Wang YY, 2014, MOL CANCER, V13, DOI [10.1186/1476-4598-13-30, 10.1186/s12934-014-0151-y]; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x; Zalba G, 2007, ARTERIOSCL THROM VAS, V27, P587, DOI 10.1161/01.ATV.0000256467.25384.c6	71	36	37	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1120	1137		10.1074/jbc.M117.814368	http://dx.doi.org/10.1074/jbc.M117.814368			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158255	hybrid, Green Published			2022-12-28	WOS:000423515000002
J	Langemeyer, L; Perz, A; Kummel, D; Ungermann, C				Langemeyer, Lars; Perz, Angela; Kuemmel, Daniel; Ungermann, Christian			A guanine nucleotide exchange factor (GEF) limits Rab GTPase-driven membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; guanine nucleotide exchange factor (GEF); lysosome; membrane fusion; Rab; GDI; Mon1-Ccz1; Ypt7; Rab7; GDI	GDP DISSOCIATION INHIBITOR; VACUOLE DOCKING; COMPLEX; DISPLACEMENT; HOPS; IDENTIFICATION; PRENYLATION; MECHANISM; PROTEINS; ACTIVATION	The identity of organelles in the endomembrane system of any eukaryotic cell critically depends on the correctly localized Rab GTPase, which binds effectors and thus promotes membrane remodeling or fusion. However, it is still unresolved which factors are required and therefore define the localization of the correct fusion machinery. Using SNARE-decorated proteoliposomes that cannot fuse on their own, we now demonstrate that full fusion activity can be achieved by just four soluble factors: a soluble SNARE (Vam7), a guanine nucleotide exchange factor (GEF, Mon1-Ccz1), a Rab-GDP dissociation inhibitor (GDI) complex (prenylated Ypt7-GDI), and a Rab effector complex (HOPS). Our findings reveal that the GEF Mon1-Ccz1 is necessary and sufficient for stabilizing prenylated Ypt7 on membranes. HOPS binding to Ypt7-GTP then drives SNARE-mediated fusion, which is fully GTP-dependent. We conclude that an entire fusion cascade can be controlled by a GEF.	[Langemeyer, Lars; Perz, Angela; Ungermann, Christian] Univ Osnabruck, Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany; [Kuemmel, Daniel] Univ Osnabruck, Struct Biochem, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany	University Osnabruck; University Osnabruck	Ungermann, C (corresponding author), Univ Osnabruck, Biochem Sect, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de			Department of Biology/Chemistry of the University of Osnabruck;  [SFB 944];  [P11];  [P18]	Department of Biology/Chemistry of the University of Osnabruck; ; ; 	This work was supported by SFB 944 Project P11 (to C.U.) and Project P18 (to D.K.) and an incentive award of the Department of Biology/Chemistry of the University of Osnabruck (to L.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Blumer J, 2013, J CELL BIOL, V200, P287, DOI 10.1083/jcb.201209113; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Cabrera M, 2014, J CELL SCI, V127, P1043, DOI 10.1242/jcs.140921; Calero M, 2002, FEBS LETT, V515, P89, DOI 10.1016/S0014-5793(02)02442-0; Chen CZ, 2004, GENETICS, V168, P1827, DOI 10.1534/genetics.104.032888; Cui Y, 2014, PLANT CELL, V26, P2080, DOI 10.1105/tpc.114.123141; Dennis MK, 2016, J CELL BIOL, V214, P293, DOI 10.1083/jcb.201605090; DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gerondopoulos A, 2012, CURR BIOL, V22, P2135, DOI 10.1016/j.cub.2012.09.020; Goody RS, 2017, BIOL CHEM, V398, P565, DOI 10.1515/hsz-2016-0274; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hegedus K, 2016, MOL BIOL CELL, V27, P3132, DOI 10.1091/mbc.E16-03-0205; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Kalinin A, 2001, PROTEIN EXPRES PURIF, V22, P84, DOI 10.1006/prep.2001.1423; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Lachmann Jens, 2011, Small GTPases, V2, P182; Langemeyer L, 2014, ELIFE, V3, DOI 10.7554/eLife.01623; Li Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep18101; Lurick A, 2017, MOL BIOL CELL, V28, P322, DOI 10.1091/mbc.E16-11-0764; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mizuno-Yamasaki E, 2010, DEV CELL, V18, P828, DOI 10.1016/j.devcel.2010.03.016; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Oesterlin LK, 2012, P NATL ACAD SCI USA, V109, P5621, DOI 10.1073/pnas.1121161109; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Orr A, 2015, MOL BIOL CELL, V26, P305, DOI 10.1091/mbc.E14-08-1298; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Pereira-Leal JB, 2001, FEBS LETT, V498, P197, DOI 10.1016/S0014-5793(01)02483-8; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Singh MK, 2014, CURR BIOL, V24, P1383, DOI 10.1016/j.cub.2014.05.005; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Suh HY, 2010, EMBO J, V29, P496, DOI 10.1038/emboj.2009.347; Thoma NH, 2001, J BIOL CHEM, V276, P48631, DOI 10.1074/jbc.M106470200; Thomas LL, 2016, J CELL BIOL, V215, P499, DOI 10.1083/jcb.201608123; Wu YW, 2007, P NATL ACAD SCI USA, V104, P12294, DOI 10.1073/pnas.0701817104; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107; Zick M., 2016, MOL BIOL CELL, V27, P1, DOI [10.1091/mbc.E15-06-0352, DOI 10.1091/MBC.E15-06-035226715420]; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zick M, 2012, MOL BIOL CELL, V23, P3429, DOI 10.1091/mbc.E12-04-0279; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	52	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					731	739		10.1074/jbc.M117.812941	http://dx.doi.org/10.1074/jbc.M117.812941			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184002	hybrid, Green Published			2022-12-28	WOS:000419915400026
J	Huang, HT; Bobst, CE; Iwig, JS; Chivers, PT; Kaltashov, IA; Maroney, MJ				Huang, Hsin-Ting; Bobst, Cedric E.; Iwig, Jeffrey S.; Chivers, Peter T.; Kaltashov, Igor A.; Maroney, Michael J.			Co(II) and Ni(II) binding of the Escherichia coli transcriptional repressor RcnR orders its N terminus, alters helix dynamics, and reduces DNA affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal homeostasis; metal ion-protein interaction; metalloprotein; transcription regulation; hydrogen exchange mass spectrometry	CONTROLLING ZINC HOMEOSTASIS; HYDROGENASE MATURATION; PROTEIN NIKA; NICKEL; REGULATOR; RECOGNITION; PATHWAY; HYPB; SLYD; CSOR	RcnR, a transcriptional regulator in Escherichia coli, derepresses the expression of the export proteins RcnAB upon binding Ni(II) or Co(II). Lack of structural information has precluded elucidation of the allosteric basis for the decreased DNA affinity in RcnR's metal-bound states. Here, using hydrogen-deuterium exchange coupled with MS (HDX-MS), we probed the RcnR structure in the presence of DNA, the cognate metal ions Ni(II) and Co(II), or the noncognate metal ion Zn(II). We found that cognate metal binding altered flexibility from the N terminus through helix 1 and modulated the RcnR-DNA interaction. Apo-RcnR and RcnR-DNA complexes and the Zn(II)-RcnR complex exhibited similar H-2 uptake kinetics, with fast-exchanging segments located in the N terminus, in helix 1 (residues 14-24), and at the C terminus. The largest difference in H-2 incorporation between apo- and Ni(II)- and Co(II)-bound RcnR was observed in helix 1, which contains the N terminus and His-3, and has been associated with cognate metal binding. H-2 uptake in helix 1 was suppressed in the Ni(II)- and Co(II)-bound RcnR complexes, in particular in the peptide corresponding to residues 14-24, containing Arg-14 and Lys-17. Substitution of these two residues drastically affected DNA-binding affinity, resulting in rcnA expression in the absence of metal. Our results suggest that cognate metal binding to RcnR orders its N terminus, decreases helix 1 flexibility, and induces conformational changes that restrict DNA interactions with the positively charged residues Arg-14 and Lys-17. These metal-induced alterations decrease RcnR-DNA binding affinity, leading to rcnAB expression.	[Huang, Hsin-Ting; Bobst, Cedric E.; Kaltashov, Igor A.; Maroney, Michael J.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Iwig, Jeffrey S.] Carmot Therapeut Inc, San Francisco, CA 94158 USA; [Chivers, Peter T.] Univ Durham, Dept Biosci, Durham DH1 3LE, England; [Chivers, Peter T.] Univ Durham, Dept Chem, Durham DH1 3LE, England	University of Massachusetts System; University of Massachusetts Amherst; Durham University; Durham University	Maroney, MJ (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.	mmaroney@chem.umass.edu		Chivers, Peter/0000-0002-8779-1452; Maroney, Michael/0000-0002-5598-3038	National Institutes of Health [R01-GM069696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM069696 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blaha D, 2011, BIOCHIMIE, V93, P434, DOI 10.1016/j.biochi.2010.10.016; Bleriot C, 2011, J BACTERIOL, V193, P3785, DOI 10.1128/JB.05032-11; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Carr CE, 2017, INORG CHEM, V56, P6459, DOI 10.1021/acs.inorgchem.7b00527; Chang FMJ, 2015, BIOCHEMISTRY-US, V54, P2463, DOI 10.1021/acs.biochem.5b00154; Chang FMJ, 2014, J BIOL CHEM, V289, P19204, DOI 10.1074/jbc.M114.556704; Choi SY, 2014, METALLOMICS, V6, P1198, DOI 10.1039/c4mt00064a; Chung KCC, 2011, J BIOL CHEM, V286, P43081, DOI 10.1074/jbc.M111.290726; Denby KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38879; DEPINA K, 1995, EUR J BIOCHEM, V227, P857; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Heddle J, 2003, J BIOL CHEM, V278, P50322, DOI 10.1074/jbc.M307941200; Higgins KA, 2013, BIOCHEMISTRY-US, V52, P84, DOI 10.1021/bi300886q; Higgins KA, 2012, BIOCHEMISTRY-US, V51, P7816, DOI 10.1021/bi300981m; Higgins KA, 2012, J AM CHEM SOC, V134, P7081, DOI 10.1021/ja300834b; Hube M, 2002, J BACTERIOL, V184, P3879, DOI 10.1128/JB.184.14.3879-3885.2002; Hud NV, 2003, BIOPOLYMERS, V69, P144, DOI 10.1002/bip.10364; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; Kaltashov IA, 2013, PROTEIN SCI, V22, P530, DOI 10.1002/pro.2238; Kaluarachchi H, 2011, BIOCHEMISTRY-US, V50, P10761, DOI 10.1021/bi201590d; Leach MR, 2005, BIOCHEMISTRY-US, V44, P12229, DOI 10.1021/bi050993j; Leitch S, 2007, J AM CHEM SOC, V129, P5085, DOI 10.1021/ja068505y; Lu XJ, 2000, J MOL BIOL, V300, P819, DOI 10.1006/jmbi.2000.3690; MAIER T, 1995, EUR J BIOCHEM, V230, P133, DOI 10.1111/j.1432-1033.1995.tb20543.x; Musiani F, 2015, METALLOMICS, V7, P1305, DOI 10.1039/c5mt00072f; Nevin P, 2015, FEBS J, V282, P2646, DOI 10.1111/febs.13304; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	35	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					324	332		10.1074/jbc.RA117.000398	http://dx.doi.org/10.1074/jbc.RA117.000398			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29150441	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000419453200027
J	Sala, MA; Chen, C; Zhang, Q; Do-Umehara, HC; Wu, WJ; Misharin, AV; Waypa, GB; Fang, DY; Budinger, GRS; Liu, SW; Chandel, NS; Schumacker, PT; Sznajder, JI; Liu, J				Sala, Marc A.; Chen, Cong; Zhang, Qiao; Do-Umehara, Hanh Chi; Wu, Wenjiao; Misharin, Alexander V.; Waypa, Gregory B.; Fang, Deyu; Budinger, G. R. Scott; Liu, Shuwen; Chandel, Navdeep S.; Schumacker, Paul T.; Sznajder, Jacob I.; Liu, Jing			JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; PROTEIN-KINASE; SIGNAL-TRANSDUCTION; ARTERY PRESSURE; FACTOR-I; JUN; ACTIVATION; EXPRESSION; MICE; UBIQUITINATION	The hypoxic response is a stress response triggered by low oxygen tension. Hypoxia-inducible factors (HIFs) play a prominent role in the pathobiology of hypoxia-associated conditions, including pulmonary hypertension (PH) and polycythemia. The c-Jun N-terminal protein kinase (JNK), a stress-activated protein kinase that consists of two ubiquitously expressed isoforms, JNK1 and JNK2, and a tissue-specific isoform, JNK3, has been shown to be activated by hypoxia. However, the physiological role of JNK1 and JNK2 in the hypoxic response remains elusive. Here, using genetic knockout cells and/or mice, we show that JNK2, but not JNK1, up-regulates the expression of HIF-1- and HIF-2 alpha and contributes to hypoxia-induced PH and polycythemia. Knockout or silencing of JNK2, but not JNK1, prevented the accumulation of HIF-1- in hypoxia-treated cells. Loss of JNK2 resulted in a decrease in HIF-1 and HIF-2 mRNAlevels under resting conditions and in response to hypoxia. Consequently, hypoxia-treated Jnk2 / mice had reduced erythropoiesis and were less prone to polycythemia because of decreased expression of the HIF target gene erythropoietin (Epo). Jnk2 / mice were also protected from hypoxia-induced PH, as indicated by lower right ventricular systolic pressure, a process that depends on HIF. Taken together, our results suggest that JNK2 is a positive regulator of HIFs and therefore may contribute to HIF-dependent pathologies.	[Sala, Marc A.; Chen, Cong; Zhang, Qiao; Do-Umehara, Hanh Chi; Wu, Wenjiao; Misharin, Alexander V.; Budinger, G. R. Scott; Chandel, Navdeep S.; Sznajder, Jacob I.; Liu, Jing] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA; [Waypa, Gregory B.; Schumacker, Paul T.] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Fang, Deyu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhang, Qiao; Wu, Wenjiao; Liu, Shuwen] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou 510515, Guangdong, Peoples R China	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Southern Medical University - China	Liu, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA.	jing@northwestern.edu	Misharin, Alexander/AAD-6456-2019	Liu, Shuwen/0000-0001-6346-5006; Schumacker, Paul T/0000-0001-9591-2034	National Institutes of Health [R01 HL114763-01A1]; American Lung Association Senior Research Training Grant [RT-416649]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076139, R01HL114763, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association Senior Research Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 HL114763-01A1 (to J. L.) and American Lung Association Senior Research Training Grant RT-416649 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; ANTHONISEN NR, 1983, ANN INTERN MED, V99, P519, DOI 10.7326/0003-4819-99-4-519; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BERAN M, 1971, SCAND J HAEMATOL, V8, P5; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Comerford KM, 2004, CANCER RES, V64, P9057, DOI 10.1158/0008-5472.CAN-04-1919; COOPER R, 1991, CHEST, V99, P112, DOI 10.1378/chest.99.1.112; Cote C, 2007, EUR RESPIR J, V29, P923, DOI 10.1183/09031936.00137106; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cuttica MJ, 2010, RESP MED, V104, P1877, DOI 10.1016/j.rmed.2010.05.009; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dumitriu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012088; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1998, ONCOGENE, V17, P1483, DOI 10.1038/sj.onc.1202184; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fuchs SY, 1996, ONCOGENE, V13, P1531; Girgis RE, 2007, CLIN CHEST MED, V28, P219, DOI 10.1016/j.ccm.2006.11.006; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Gozal E, 1999, J NEUROCHEM, V73, P665, DOI 10.1046/j.1471-4159.1999.0730665.x; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Incalzi RA, 1999, CIRCULATION, V99, P1600, DOI 10.1161/01.CIR.99.12.1600; Jin NJ, 2000, AM J RESP CELL MOL, V23, P593, DOI 10.1165/ajrcmb.23.5.3921; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KAMPF D, 1992, NEPHRON, V61, P393, DOI 10.1159/000186955; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; Leclerc Guy J, 2002, Cancer Cell Int, V2, P1, DOI 10.1186/1475-2867-2-1; Lee G, 2015, EUR J INTERN MED, V26, P297, DOI 10.1016/j.ejim.2015.03.007; Lee YJ, 1999, MOL CELL BIOCHEM, V202, P1, DOI 10.1023/A:1007059806016; LESLEY J, 1984, CELL IMMUNOL, V83, P14, DOI 10.1016/0008-8749(84)90220-X; Liu J, 2004, MOL CELL BIOL, V24, P10844, DOI 10.1128/MCB.24.24.10844-10856.2004; Luo FB, 2016, CELL PHYSIOL BIOCHEM, V39, P1051, DOI 10.1159/000447812; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McCloskey CA, 2004, SHOCK, V22, P380, DOI 10.1097/01.shk.0000140660.78744.bf; Mishra OP, 2004, NEUROSCIENCE, V123, P179, DOI 10.1016/j.neuroscience.2003.08.008; Nakamura A, 2000, RESPIRATION, V67, P502, DOI 10.1159/000067463; Nijboer CH, 2010, BRAIN BEHAV IMMUN, V24, P812, DOI 10.1016/j.bbi.2009.09.008; OU LC, 1980, J APPL PHYSIOL, V48, P857, DOI 10.1152/jappl.1980.48.5.857; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Park JY, 2016, BIOCHEM BIOPH RES CO, V469, P251, DOI 10.1016/j.bbrc.2015.11.111; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Tsuboi I, 2015, J CELL PHYSIOL, V230, P1534, DOI 10.1002/jcp.24899; Wang G L, 1996, Curr Opin Hematol, V3, P156; WANG GL, 1993, BLOOD, V82, P3610; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; WEITZENBLUM E, 1981, THORAX, V36, P752, DOI 10.1136/thx.36.10.752; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; YORK EL, 1980, AM REV RESPIR DIS, V121, P813; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang Q, 2015, NAT IMMUNOL, V16, P458, DOI 10.1038/ni.3130	71	12	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					271	284		10.1074/jbc.RA117.000440	http://dx.doi.org/10.1074/jbc.RA117.000440			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29118187	hybrid, Green Published			2022-12-28	WOS:000419453200023
J	Weng, ZF; Shang, Y; Yao, DQ; Zhu, JW; Zhang, RG				Weng, Zhuangfeng; Shang, Yuan; Yao, Deqiang; Zhu, Jinwei; Zhang, Rongguang			Structural analyses of key features in the KANK1 center dot KIF21A complex yield mechanistic insights into the cross-talk between microtubules and the cell cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL FIBROSIS; KINESIN KIF21A; KANK PROTEINS; ADHESION; MIGRATION; ENDS; MUTATIONS; DYNAMICS; ACTIN; STABILIZATION	The cross-talk between dynamic microtubules and the cell cortex plays important roles in cell division, polarity, and migration. A critical adaptor that links the plus ends of microtubules with the cell cortex is the KANK N-terminal motif and ankyrin repeat domains 1 (KANK1)/kinesin family member 21A (KIF21A) complex. Genetic defects in these two proteins are associated with various cancers and developmental diseases, such as congenital fibrosis of the extraocular muscles type 1. However, the molecular mechanism governing the KANK1/KIF21A interaction and the role of the conserved ankyrin (ANK) repeats in this interaction are still unclear. In this study, we present the crystal structure of the KANK1 center dot KIF21A complex at 2.1 angstrom resolution. The structure, together with biochemical studies, revealed that a five-helix-bundle-capping domain immediately preceding the ANK repeats of KANK1 forms a structural and functional supramodule with its ANK repeats in binding to an evolutionarily conserved peptide located in the middle of KIF21A. We also show that several missense mutations present in cancer patients are located at the interface of the KANK1 center dot KIF21A complex and destabilize its formation. In conclusion, our study elucidates the molecular basis underlying the KANK1/KIF21A interaction and also provides possible mechanistic explanations for the diseases caused by mutations in KANK1 and KIF21A.	[Weng, Zhuangfeng; Yao, Deqiang; Zhu, Jinwei; Zhang, Rongguang] Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, Natl Ctr Prot Sci Shanghai,Univ Chinese Acad Sci, 333 Haike Rd, Shanghai 201203, Peoples R China; [Weng, Zhuangfeng; Zhang, Rongguang] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Shang, Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Zhang, Rongguang] Chinese Acad Sci, Shanghai Res Ctr, Shanghai 200031, Peoples R China; [Shang, Yuan] Univ Arizona, Ctr Biomed Informat & Biostat, Tucson, AZ 85721 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Hong Kong University of Science & Technology; Chinese Academy of Sciences; University of Arizona	Zhu, JW; Zhang, RG (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, Natl Ctr Prot Sci Shanghai,Univ Chinese Acad Sci, 333 Haike Rd, Shanghai 201203, Peoples R China.; Zhang, RG (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.; Zhang, RG (corresponding author), Chinese Acad Sci, Shanghai Res Ctr, Shanghai 200031, Peoples R China.	jinwei.zhu@sibcb.ac.cn; rgzhang@sibcb.ac.cn	SHANG, Raymond Yuan/AAV-3446-2020	SHANG, Yuan/0000-0002-7093-4234	National Natural Science Foundation of China [31470733, U1532121]; Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant [14YF1406700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08030104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31470733 and U1532121, Shanghai Municipal Science and Technology Commission, China ("Yang-Fan program") Grant 14YF1406700 (to J. Z.), and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08030104 (to R. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2015, NAT REV MOL CELL BIO, V16, P711, DOI 10.1038/nrm4084; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Astro V, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3312; Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; de Curtis I, 2012, J CELL SCI, V125, P4435, DOI 10.1242/jcs.108266; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Drabek K, 2006, CURR BIOL, V16, P2259, DOI 10.1016/j.cub.2006.09.065; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Heidary Gena, 2008, Semin Ophthalmol, V23, P3, DOI 10.1080/08820530701745181; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kakinuma N, 2009, BIOCHEM BIOPH RES CO, V386, P639, DOI 10.1016/j.bbrc.2009.06.109; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Kumar P, 2012, TRENDS CELL BIOL, V22, P418, DOI 10.1016/j.tcb.2012.05.005; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; Luo M, 2016, EXP DERMATOL, V25, P321, DOI 10.1111/exd.12933; Mayor R, 2016, NAT REV MOL CELL BIO, V17, P97, DOI 10.1038/nrm.2015.14; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; Sveen A, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0434-0; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; Tuncay H, 2016, CELL MOL LIFE SCI, V73, P1195, DOI 10.1007/s00018-015-2116-7; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Willour VL, 2004, AM J HUM GENET, V75, P508, DOI 10.1086/423899; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Zhu JW, 2011, MOL CELL, V43, P418, DOI 10.1016/j.molcel.2011.07.011; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	51	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					215	225		10.1074/jbc.M117.816017	http://dx.doi.org/10.1074/jbc.M117.816017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158259	hybrid, Green Published			2022-12-28	WOS:000419453200019
J	Ghosh, T; Varshney, A; Kumar, P; Kaur, M; Kumar, V; Shekhar, R; Devi, R; Priyanka, P; Khan, MM; Saxena, S				Ghosh, Tanushree; Varshney, Akhil; Kumar, Praveen; Kaur, Manpreet; Kumar, Vipin; Shekhar, Ritu; Devi, Raksha; Priyanka, Priyanka; Khan, Md Muntaz; Saxena, Sandeep			MicroRNA-874-mediated inhibition of the major G(1)/S phase cyclin, CCNE1, is lost in osteosarcomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell biology; cell cycle; cell proliferation; cyclin; microRNA (miRNA); microRNA mechanism; non-coding RNA; cyclin E1; oncogenesis	CELL-CYCLE; MESSENGER-RNAS; MIR-16 FAMILY; IN-VITRO; CANCER; PROLIFERATION; E1; OVEREXPRESSION; CONTRIBUTES; EXPRESSION	The tumor microenvironment is characterized by nutrient-deprived conditions in which the cancer cells have to adapt for survival. Serum starvation resembles the growth factor deprivation characteristic of the poorly vascularized tumor microenvironment and has aided in the discovery of key growth regulatory genes and microRNAs (miRNAs) that have a role in the oncogenic transformation. We report here that miR-874 down-regulates the major G(1)/S phase cyclin, cyclin E1 (CCNE1), during serum starvation. Because the adaptation of cancer cells to the tumor microenvironment is vital for subsequent oncogenesis, we tested for miR-874 and CCNE1 interdependence in osteosarcoma cells. We observed that miR-874 inhibits CCNE1 expression in primary osteoblasts, but in aggressive osteosarcomas, miR-874 is down-regulated, leading to elevated CCNE1 expression and appearance of cancer-associated phenotypes. We established that loss of miR-874-mediated control of cyclin E1 is a general feature of osteosarcomas. The down-regulation of CCNE1 by miR-874 is independent of E2F transcription factors. Restoration of miR-874 expression impeded S phase progression, suppressing aggressive growth phenotypes, such as cell invasion, migration, and xenograft tumors, in nude mice. In summary, we report that miR-874 inhibits CCNE1 expression during growth factor deprivation and that miR-874 down-regulation in osteosarcomas leads to CCNE1 up-regulation and more aggressive growth phenotypes.	[Ghosh, Tanushree; Varshney, Akhil; Kumar, Praveen; Kaur, Manpreet; Kumar, Vipin; Shekhar, Ritu; Devi, Raksha; Priyanka, Priyanka; Khan, Md Muntaz; Saxena, Sandeep] Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in		Devi, Raksha/0000-0003-3179-2891; Priyanka, Fnu/0000-0001-7933-3809; Varshney, Akhil/0000-0003-0759-0982; Ghosh, Tanushree/0000-0002-0988-2367				Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; D'Abaco GM, 2002, J CELL SCI, V115, P4607, DOI 10.1242/jcs.00161; Ekholm SV, 2001, MOL CELL BIOL, V21, P3256, DOI 10.1128/MCB.21.9.3256-3265.2001; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; Golpour M, 2014, INT J MOL CELL MED, V3, P74; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Han JF, 2016, ONCOL REP, V36, P542, DOI 10.3892/or.2016.4810; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Iida H, 1997, BLOOD, V90, P3707, DOI 10.1182/blood.V90.9.3707; Zubillaga-Guerrero MI, 2015, INT J CLIN EXP MED, V8, P15999; Jiang BF, 2014, J GASTROENTEROL, V49, P1011, DOI 10.1007/s00535-013-0851-9; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Levin VA, 2010, J PROTEOME RES, V9, P179, DOI 10.1021/pr900392b; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lockwood WW, 2011, J MOL DIAGN, V13, P289, DOI 10.1016/j.jmoldx.2010.11.020; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; Minella AC, 2008, GENE DEV, V22, P1677, DOI 10.1101/gad.1650208; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Pautke C, 2004, ANTICANCER RES, V24, P3743; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Shtutman M, 2003, EXP CELL RES, V286, P22, DOI 10.1016/S0014-4827(03)00087-9; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Tashiro E, 2003, CANCER RES, V63, P424; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Wang J, 2014, TUMOR BIOL, V35, P4859, DOI 10.1007/s13277-014-1637-2; Wang L, 2014, FEBS LETT, V588, P4527, DOI 10.1016/j.febslet.2014.09.035; Wolowiec D, 1996, BRIT J HAEMATOL, V95, P518, DOI 10.1046/j.1365-2141.1996.d01-1930.x; Yang R, 2017, CELL PHYSIOL BIOCHEM, V42, P126, DOI 10.1159/000477121; Yasui W, 1996, VIRCHOWS ARCH, V429, P13; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang FY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0187-x; Zhang RP, 2017, ONCOTARGET, V8, P26079, DOI 10.18632/oncotarget.15317; Zhang X, 2014, BIOCHEM BIOPH RES CO, V443, P1078, DOI 10.1016/j.bbrc.2013.12.095; Zhang XY, 2015, ONCOTARGET, V6, P1605, DOI 10.18632/oncotarget.2748; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	48	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21264	21281		10.1074/jbc.M117.808287	http://dx.doi.org/10.1074/jbc.M117.808287			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109143	hybrid, Green Published			2022-12-28	WOS:000419013000005
J	Lee, SG; Jez, JM				Lee, Soon Goo; Jez, Joseph M.			Conformational changes in the di-domain structure of Arabidopsis phosphoethanolamine methyltransferase leads to active-site formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; enzyme kinetics; X-ray crystallography; protein structure; S-adenosylmethionine (SAM)	PHOSPHOMETHYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMODIUM-FALCIPARUM; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; CLONING; METABOLISM; PATHWAY; CHOLINE	Phosphocholine (pCho) is a precursor for phosphatidylcholine and osmoprotectants in plants. In plants, de novo synthesis of pCho relies on the phosphobase methylation pathway. Phosphoethanolamine methyltransferase (PMT) catalyzes the triple methylation of phosphoethanolamine (pEA) to pCho. The plant PMTs are di-domain methyltransferases that divide the methylation of pEA in one domain from subsequent methylations in the second domain. To understand the molecular basis of this architecture, we examined the biochemical properties of three Arabidopsis thaliana PMTs (AtPMT1-3) and determined the X-ray crystal structures of AtPMT1 and AtPMT2. Although each isoform synthesizes pCho from pEA, their physiological roles differ with AtPMT1 essential for normal growth and salt tolerance, whereas AtPMT2 and AtPMT3 overlap functionally. The structures of AtPMT1 and AtPMT2 reveal unique features in each methyltransferase domain, including active sites that use different chemical mechanisms for phosphobase methylation. These structures also show how rearrangements in both the active sites and the di-domain linker form catalytically competent active sites and provide insight on the evolution of the PMTs in plants, nematodes, and apicomplexans. Connecting conformational changes with catalysis in modular enzymes, like the PMT, provides new insights on interdomain communication in biosynthetic systems.	[Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Science Foundation [EPS 0236913, MCB 045531, DBI 0521587]; Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Contract No. DE-AC02-06CH11357. Lipid analysis was performed at the Kansas Lipidomics Research Center Analytical Laboratory, which is supported by National Science Foundation Grants EPS 0236913, MCB 045531, and DBI 0521587; Kansas Technology Enterprise Corp.; and K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health Grant P20RR16475, and Kansas State University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BeGora MD, 2010, J BIOL CHEM, V285, P29147, DOI 10.1074/jbc.M110.112151; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; Kanipes M. I., 1997, BIOCHIM BIOPHYS ACTA, V1348, P138; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Saen-oon S, 2014, J BIOL CHEM, V289, P33815, DOI 10.1074/jbc.M114.611319; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang YC, 2011, J AM CHEM SOC, V133, P20684, DOI 10.1021/ja2085993; Wu SW, 2007, MOL BIOTECHNOL, V36, P102, DOI 10.1007/s12033-007-0009-1; Ye CJ, 2005, DNA SEQUENCE, V16, P364, DOI 10.1080/10425170500187791; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094	52	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21690	21702		10.1074/jbc.RA117.000106	http://dx.doi.org/10.1074/jbc.RA117.000106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29084845	Green Published, hybrid			2022-12-28	WOS:000419013000042
J	Wang, L; Tong, X; Gu, F; Zhang, L; Chen, W; Cheng, XW; Xie, LW; Chang, YS; Zhang, HB				Wang, Lu; Tong, Xin; Gu, Fang; Zhang, Lei; Chen, Wei; Cheng, Xiaowen; Xie, Liwei; Chang, Yongsheng; Zhang, Huabing			The KLF14 transcription factor regulates hepatic gluconeogenesis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gluconeogenesis; Kruppel-like factor 14 (KLF14); PGC-1; type 2 diabetes; peroxisome proliferator-activated receptor coactivator 1 (PPARGC1); diabetes; hepatocyte; glucose metabolism	DEPENDENT DIABETES-MELLITUS; INSULIN-RESISTANCE; PGC-1-ALPHA; METABOLISM; GLUCOSE; IDENTIFICATION; ASSOCIATION; GENERATION; HEALTH; FAMILY	Kruppel-like factor 14 (KLF14) is a member of the Cys(2)/His(2) zinc-finger DNA-binding proteins. Despite strong evidence showing that a polymorphism in the Klf14 gene is closely linked to the development of type 2 diabetes, the physiological and metabolic functions of KLF14 still remain unclear. In the present study, we investigated the role of KLF14 in the regulation of hepatic gluconeogenesis. Adenoviruses expressing KLF14 (Ad-Klf14) or KLF14-specific shRNAs (Ad-shKlf14) were injected into normal C57BL/6J, db/db diabetic, or high-fat diet-induced obese (DIO) mice. Gene expression, hepatic glucose production, glucose tolerance, and insulin resistance were tested in C57BL/6J, db/db, and DIO mice and primary hepatocytes. Our results demonstrate that KLF14 expression is induced in the livers of normal C57BL/6J mice upon fasting and significantly up-regulated in the livers of db/db mice, suggesting a physiological link between KLF14 and gluconeogenesis. Adenovirus-mediated overexpression of KLF14 in primary hepatocytes increased both the mRNA and protein levels of peroxisome proliferator-activated receptor- coactivator 1 (Pgc-1, also known as Ppargc1a), thereby stimulating cellular glucose production. Conversely, knockdown of KLF14 expression led to a reduction in PGC-1, subsequently inhibiting glucose output in primary hepatocytes. Finally, forced expression of KLF14 in the livers of normal mice increased the plasma glucose levels and impaired glucose tolerance; in contrast, KLF14 knockdown in diabetic mouse livers improved glucose tolerance. Taken together, our data strongly indicate that KLF14 modulates hepatic gluconeogenesis.	[Wang, Lu; Tong, Xin; Gu, Fang; Zhang, Huabing] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China; [Zhang, Lei; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Lei; Chang, Yongsheng] Peking Union Med Coll, Beijing 100005, Peoples R China; [Chen, Wei] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei 230032, Anhui, Peoples R China; [Cheng, Xiaowen] Anhui Med Univ, Dept Clin Lab, Affiliated Hosp 1, Hefei 230032, Anhui, Peoples R China; [Xie, Liwei] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangzhou 510070, Guangdong, Peoples R China	Anhui Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Anhui Medical University; Anhui Medical University; Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Zhang, HB (corresponding author), Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Anhui, Peoples R China.; Chang, YS (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China.; Chang, YS (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Xie, LW (corresponding author), Guangdong Inst Microbiol, 100 Xianlie Middle Rd,Bldg 58, Guangzhou 500070, Guangdong, Peoples R China.	liweixie1984@gmail.com; changy@ibms.pumc.edu.cn; slzhang1977@163.com		zhang, huabing/0000-0001-8402-7830	National Natural Science Foundation of China [81670517, 31371191]; Natural Science Foundation of Anhui Province [1408085MH153, 1508085MH175]; Anhui Provincial Excellent Young Talent Support Program [gxyqAD2017024]; Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund) [2060204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Anhui Provincial Excellent Young Talent Support Program; Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund)	This work was supported by National Natural Science Foundation of China Grants 81670517 and 31371191, Natural Science Foundation of Anhui Province Grants 1408085MH153 and 1508085MH175, Anhui Provincial Excellent Young Talent Support Program Grant gxyqAD2017024, and the Open Project of State Key Laboratory of Medical Molecular Biology (Peking Union Medical College, National Laboratory Special Fund 2060204). The authors declare that they have no conflicts of interest with the contents of this article.	Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Canto C, 2010, CELL METAB, V11, P6, DOI 10.1016/j.cmet.2009.12.003; Civelek M, 2011, NAT GENET, V43, P506, DOI 10.1038/ng.842; Cui Y, 2016, DIABETOLOGIA, V59, P2229, DOI 10.1007/s00125-016-4043-z; de Assuncao TM, 2014, J BIOL CHEM, V289, P15798, DOI 10.1074/jbc.M113.544346; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; GERICH JE, 1991, DIABETOLOGIA, V34, P607, DOI 10.1007/BF00400282; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Guo YH, 2015, J CLIN INVEST, V125, P3819, DOI 10.1172/JCI79048; Hanson RL, 2013, DIABETES, V62, P2984, DOI 10.2337/db12-1767; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nielsen T, 2011, DIABETOLOGIA, V54, P1052, DOI 10.1007/s00125-011-2054-3; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Schmidt SF, 2011, GENE DEV, V25, P1453, DOI 10.1101/gad.2076411; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yang M, 2015, CELL SIGNAL, V27, P2201, DOI 10.1016/j.cellsig.2015.07.019; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089552; Zhang HB, 2013, J HEPATOL, V58, P763, DOI 10.1016/j.jhep.2012.11.024	33	15	16	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21631	21642		10.1074/jbc.RA117.000184	http://dx.doi.org/10.1074/jbc.RA117.000184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123026	Green Published, hybrid			2022-12-28	WOS:000419013000037
J	Li, MW; Sletten, AC; Lee, J; Pyles, KD; Matkovich, SJ; Ory, DS; Schaffer, JE				Li, Melissa W.; Sletten, Arthur C.; Lee, Jiyeon; Pyles, Kelly D.; Matkovich, Scot J.; Ory, Daniel S.; Schaffer, Jean E.			Nuclear export factor 3 regulates localization of small nucleolar RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; molecular cell biology; nuclear transport; RNA transport; small nucleolar RNA (snoRNA)	MESSENGER-RNA; METABOLIC STRESS; NONCODING RNAS; FACTOR FAMILY; BIOGENESIS; SNORNA; CELLS; U3; INVOLVEMENT; MECHANISMS	Small nucleolar RNAs (snoRNAs) guide chemical modifications of ribosomal and small nuclear RNAs, functions that are carried out in the nucleus. Although most snoRNAs reside in the nucleolus, a growing body of evidence indicates that snoRNAs are also present in the cytoplasm and that snoRNAs move between the nucleus and cytoplasm by a mechanism that is regulated by lipotoxic and oxidative stress. Here, in a genome-wide shRNA-based screen, we identified nuclear export factor 3 (NXF3) as a transporter that alters the nucleocytoplasmic distribution of box C/D snoRNAs from the ribosomal protein L13a (Rpl13a) locus. Using RNA-sequencing analysis, we show that NXF3 associates not only with Rpl13a snoRNAs, but also with a broad range of box C/D and box H/ACA snoRNAs. Under homeostatic conditions, gain- or loss-of-function of NXF3, but not related family member NXF1, decreases or increases cytosolic Rpl13a snoRNAs, respectively. Furthermore, treatment with the adenylyl cyclase activator forskolin diminishes cytosolic localization of the Rpl13a snoRNAs through a mechanism that is dependent on NXF3 but not NXF1. Our results provide evidence of a new role for NXF3 in regulating the distribution of snoRNAs between the nuclear and cytoplasmic compartments.	[Li, Melissa W.; Sletten, Arthur C.; Lee, Jiyeon; Pyles, Kelly D.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, Diabet Res Ctr, St Louis, MO 63110 USA; [Matkovich, Scot J.] Washington Univ, Sch Med, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, 660 South Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	jschaff@wustl.edu	Matkovich, Scot J/AFP-0908-2022; Matkovich, Scot J/B-9077-2009	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Lee, Jiyeon/0000-0002-8952-7938; Pyles, Kelly/0000-0001-9478-3365	NCI [P30 CA91842]; ICTS/CTSA from the NCRR [UL1 TR000448]; National Institutes of Health; National Institutes of Health Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, R01DK064989] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICTS/CTSA from the NCRR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Genome Technology Access Center at the Department of Genetics, Washington University School of Medicine, for help with RNA-sequencing. The Center is partially supported by NCI Cancer Center Support Grant P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant UL1 TR000448 from the NCRR, National Institutes of Health, and National Institutes of Health Roadmap for Medical Research.	BASERGA SJ, 1992, GENE DEV, V6, P1120, DOI 10.1101/gad.6.6.1120; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Caputa G, 2016, CELL DEATH DIFFER, V23, P347, DOI 10.1038/cdd.2015.105; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Dupuis-Sandoval F, 2015, WIRES RNA, V6, P381, DOI 10.1002/wrna.1284; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Fasold M, 2011, NUCLEIC ACIDS RES, V39, pW112, DOI 10.1093/nar/gkr357; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Freedman DA, 2004, CELL CYCLE, V3, P811; GALLI C, 1995, J NEUROSCI, V15, P1172; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Holden Paul, 2009, BMC Res Notes, V2, P243, DOI 10.1186/1756-0500-2-243; Holley CL, 2015, J BIOL CHEM, V290, P11741, DOI 10.1074/jbc.M115.637413; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Izaurralde E, 2001, CELL MOL LIFE SCI, V58, P1105, DOI 10.1007/PL00000924; Jenkinson EM, 2016, NAT GENET, V48, P1185, DOI 10.1038/ng.3661; Jun L, 2001, CURR BIOL, V11, P1381, DOI 10.1016/S0960-9822(01)00419-5; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Katahira J, 2008, NUCLEIC ACIDS RES, V36, P616, DOI 10.1093/nar/gkm556; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; Lee JY, 2016, J CLIN INVEST, V126, P4616, DOI 10.1172/JCI88069; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; MICHAUD N, 1992, J CELL BIOL, V116, P851, DOI 10.1083/jcb.116.4.851; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Sasaki M, 2005, GENOMICS, V85, P641, DOI 10.1016/j.ygeno.2005.01.003; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Shanker Savita, 2015, J Biomol Tech, V26, P4, DOI 10.7171/jbt.15-2601-001; Sienna N, 1996, EXP CELL RES, V227, P98, DOI 10.1006/excr.1996.0254; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang J, 2001, MOL CELL, V8, P397, DOI 10.1016/S1097-2765(01)00303-3; Yang K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13599; Yin YM, 2013, BIOCHEM J, V452, P67, DOI 10.1042/BJ20121006; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112	44	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20228	20239		10.1074/jbc.M117.818146	http://dx.doi.org/10.1074/jbc.M117.818146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021253	Green Published, hybrid			2022-12-28	WOS:000417696400027
J	Banerjee, T; Zheng, ZL; Abolafia, J; Harper, S; Oliver, D				Banerjee, Tithi; Zheng, Zeliang; Abolafia, Jane; Harper, Shelby; Oliver, Donald			The SecA protein deeply penetrates into the SecYEG channel during insertion, contacting most channel transmembrane helices and periplasmic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Sec system	ESCHERICHIA-COLI SECA; IN-VIVO; PREPROTEIN TRANSLOCATION; MEMBRANE; COMPLEX; ATPASE; PHOSPHOLIPIDS; COMPONENT; MECHANISM; TOPOLOGY	The bacterial Sec-dependent system is the major protein-biogenic pathway for protein secretion across the cytoplasmic membrane or insertion of integral membrane proteins into the phospholipid bilayer. The mechanism of SecA-driven protein transport across the SecYEG channel complex has remained controversial with conflicting claims from biochemical and structural studies regarding the depth and extent of SecA insertion into SecYEG during ongoing protein transport. Here we utilized site-specific in vivo photo-crosslinking to thoroughly map SecY regions that are in contact with SecA during its insertion cycle. An arabinose-inducible, rapidly folding OmpA-GFP chimera was utilized to jam the SecYEG channels with an arrested substrate protein to freeze them in their SecA-inserted state. Examination of 117 sites distributed throughout SecY indicated that SecA not only interacts extensively with the cytosolic regions of SecY as shown previously, but it also interacts with most of the transmembrane helices and periplasmic regions of SecY, with a clustering of interaction sights around the lateral gate and pore ring regions. Our observations support previous reports of SecA membrane insertion during in vitro protein transport as well as those documenting the membrane penetration properties of this protein. They suggest that one or more SecA regions transiently integrate into the heart of the SecY channel complex to span the membrane to promote the protein transport cycle. These findings indicate that high-resolution structural information about the membrane-inserted state of SecA is still lacking and will be critical for elucidating the bacterial protein transport mechanism.	[Banerjee, Tithi; Zheng, Zeliang; Abolafia, Jane; Harper, Shelby; Oliver, Donald] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA; [Harper, Shelby] Duke Univ, Sch Med, Durham, NC 27710 USA	Wesleyan University; Duke University	Oliver, D (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06459 USA.	doliver@wesleyan.edu	Banerjee, Tithi/ABB-7530-2021		National Institutes of Health [GM110552]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM110552 (to D. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AHN T, 1994, BIOCHEM BIOPH RES CO, V203, P326, DOI 10.1006/bbrc.1994.2185; Allen WJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15598; Banerjee T, 2017, MOL MICROBIOL, V103, P439, DOI 10.1111/mmi.13567; Bauer BW, 2014, CELL, V157, P1416, DOI 10.1016/j.cell.2014.03.063; Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; BREUKINK E, 1992, BIOCHEMISTRY-US, V31, P1119, DOI 10.1021/bi00119a021; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chen XC, 1996, J BIOL CHEM, V271, P29698, DOI 10.1074/jbc.271.47.29698; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1998, J BIOL CHEM, V273, P21675, DOI 10.1074/jbc.273.34.21675; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Flower AM, 2007, TRENDS MICROBIOL, V15, P203, DOI 10.1016/j.tim.2007.03.001; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Park E, 2012, J CELL BIOL, V198, P881, DOI 10.1083/jcb.201205140; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RHOADS DB, 1984, J BACTERIOL, V159, P63, DOI 10.1128/JB.159.1.63-70.1984; Sachelaru I, 2013, J BIOL CHEM, V288, P16295, DOI 10.1074/jbc.M112.446583; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tanaka Y, 2015, CELL REP, V13, P1561, DOI 10.1016/j.celrep.2015.10.025; Tian P, 2006, BIOPHYS J, V90, P2718, DOI 10.1529/biophysj.105.073304; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van Voorst F, 1998, BIOCHEMISTRY-US, V37, P12261, DOI 10.1021/bi9809021; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Zheng ZL, 2016, J BIOL CHEM, V291, P5997, DOI 10.1074/jbc.M115.694844; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	55	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19693	19707		10.1074/jbc.RA117.000130	http://dx.doi.org/10.1074/jbc.RA117.000130			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28986446	Green Published, hybrid			2022-12-28	WOS:000416911300015
J	Choi, BH; Pagano, M; Huang, CS; Dai, W				Choi, Byeong Hyeok; Pagano, Michele; Huang, Chuanshu; Dai, Wei			Cdh1, a substrate-recruiting component of anaphase-promoting complex/cyclosome (APC/C) ubiquitin E3 ligase, specifically interacts with phosphatase and tensin homolog (PTEN) and promotes its removal from chromatin (vol 289, pg 17951, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Choi, Byeong Hyeok/0000-0002-8866-1131				Choi BH, 2014, J BIOL CHEM, V289, P17951, DOI 10.1074/jbc.M114.559005	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19609	19609		10.1074/jbc.AAC117.000864	http://dx.doi.org/10.1074/jbc.AAC117.000864			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29196572	Green Published, hybrid			2022-12-28	WOS:000416911300009
J	Cornella, N; Tebaldi, T; Gasperini, L; Singh, J; Padgett, RA; Rossi, A; Macchi, P				Cornella, Nicola; Tebaldi, Toma; Gasperini, Lisa; Singh, Jarnail; Padgett, Richard A.; Rossi, Annalisa; Macchi, Paolo			The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; E2F transcription factor; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA; RNA metabolism; hnRNP-associated with lethal yellow homolog (RALY)	RNA-POLYMERASE-II; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; BREAST-CANCER CELLS; MESSENGER-RNA; BINDING PROTEINS; IN-VITRO; NONCODING RNA; GENE; DISEASE; FUS	The heterogeneous nuclear ribonucleoproteins (hnRNP) form a large family of RNA-binding proteins that exert numerous functions in RNA metabolism. RALY is a member of the hnRNP family that binds poly-U-rich elements within several RNAs and regulates the expression of specific transcripts. RALY is up-regulated in different types of cancer, and its down-regulation impairs cell cycle progression. However, the RALY's role in regulating RNA levels remains elusive. Here, we show that numerous genes coding for factors involved in transcription and cell cycle regulation exhibit an altered expression in RALY-down-regulated HeLa cells, consequently causing impairments in transcription, cell proliferation, and cell cycle progression. Interestingly, by comparing the list of RALY targets with the list of genes affected by RALY down-regulation, we found an enrichment of RALY mRNA targets in the down-regulated genes upon RALY silencing. The affected genes include the E2F transcription factor family. Given its role as proliferation-promoting transcription factor, we focused on E2F1. We demonstrate that E2F1 mRNA stability and E2F1 protein levels are reduced in cells lacking RALY expression. Finally, we also show that RALY interacts with transcriptionally active chromatin in both an RNA-dependent and -independent manner and that this association is abolished in the absence of active transcription. Taken together, our results highlight the importance of RALY as an indirect regulator of transcription and cell cycle progression through the regulation of specific mRNA targets, thus strengthening the possibility of a direct gene expression regulation exerted by RALY.	[Cornella, Nicola; Gasperini, Lisa; Rossi, Annalisa; Macchi, Paolo] Univ Trento, Ctr Integrat Biol, Lab Mol & Cellular Neurobiol, Via Sommar 9, I-38123 Trento, Italy; [Tebaldi, Toma] Univ Trento, Ctr Integrat Biol, Lab Translat Genom, Via Sommar 9, I-38123 Trento, Italy; [Padgett, Richard A.] Lerner Res Inst, Cleveland, OH 44195 USA; [Singh, Jarnail] Deciphera Pharmaceut, Lawrence, KS 66044 USA	University of Trento; University of Trento; Cleveland Clinic Foundation	Rossi, A; Macchi, P (corresponding author), Univ Trento, Ctr Integrat Biol, Lab Mol & Cellular Neurobiol, Via Sommar 9, I-38123 Trento, Italy.	annalisa.rossi-1@unitn.it; paolo.macchi@unitn.it	Tebaldi, Toma/AAX-6869-2020; Tebaldi, Toma/AAZ-5955-2020	Tebaldi, Toma/0000-0002-0625-1631; Tebaldi, Toma/0000-0002-0625-1631	University of Trento (Progetto Biotecnologie); Autonomous Province of Trento (MaDEleNA Project)	University of Trento (Progetto Biotecnologie); Autonomous Province of Trento (MaDEleNA Project)	This work was supported by the University of Trento (Progetto Biotecnologie) and the Autonomous Province of Trento (MaDEleNA Project) (to P. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Baldwin RM, 2012, CELL CYCLE, V11, P4597, DOI 10.4161/cc.22871; Bondy-Chorney E, 2017, INT J BIOCHEM CELL B, V91, P124, DOI 10.1016/j.biocel.2017.07.008; Brinegar AE, 2016, BRAIN RES, V1647, P1, DOI 10.1016/j.brainres.2016.02.050; Busch A, 2012, WIRES RNA, V3, P1, DOI 10.1002/wrna.100; CALVIO C, 1995, RNA, V1, P724; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen Y, 2016, NUCLEIC ACIDS RES, V44, P4381, DOI 10.1093/nar/gkw177; Cirillo D, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r13; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Daigle JG, 2013, HUM MOL GENET, V22, P1193, DOI 10.1093/hmg/dds526; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Dickhuth J, 2015, OR SURG OR MED OR PA, V120, P429, DOI 10.1016/j.oooo.2015.06.001; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dowling CM, 2014, BIOSCIENCE REP, V34, P415, DOI 10.1042/BSR20140031; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; Farra R, 2011, DIGEST LIVER DIS, V43, P1006, DOI 10.1016/j.dld.2011.07.007; Fasken MB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005044; Fredericks AM, 2015, BIOMOLECULES, V5, P893, DOI 10.3390/biom5020893; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Huang YS, 2004, CURR OPIN CELL BIOL, V16, P308, DOI 10.1016/j.ceb.2004.03.002; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jiang WP, 1998, BBA-GENE STRUCT EXPR, V1399, P229, DOI 10.1016/S0167-4781(98)00114-6; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; Kang MJ, 2014, CELL REP, V7, P1401, DOI 10.1016/j.celrep.2014.04.050; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Korotayev K, 2008, CELL DEATH DIFFER, V15, P1813, DOI 10.1038/cdd.2008.155; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Lemieux B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126654; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindqvist A, 2007, PLOS BIOL, V5, P1127, DOI 10.1371/journal.pbio.0050123; Lu XD, 2016, NUCLEIC ACIDS RES, V44, P6853, DOI 10.1093/nar/gkw571; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Massey AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134306; Masuda A, 2015, GENE DEV, V29, P1045, DOI 10.1101/gad.255737.114; McAfee JG, 1996, RNA, V2, P1139; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2013, J BIOL CHEM, V288, P24788, DOI 10.1074/jbc.M113.496679; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; NORTON PA, 1994, J CELL SCI, V107, P1; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pellicelli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165951; PETERSON MG, 1991, NATURE, V354, P369; Philips AV, 2000, CELL MOL LIFE SCI, V57, P235, DOI 10.1007/PL00000687; Pineda Gabriel, 2015, BMC Res Notes, V8, P616, DOI 10.1186/s13104-015-1569-y; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Rajagopalan LE, 1998, NUCLEIC ACIDS RES, V26, P3418, DOI 10.1093/nar/26.14.3418; Rhodes GH, 1997, J AUTOIMMUN, V10, P447, DOI 10.1006/jaut.1997.9996; Rossi A, 2017, NUCLEIC ACIDS RES, V45, P6775, DOI 10.1093/nar/gkx235; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Russo AJ, 2006, CANCER RES, V66, P7253, DOI 10.1158/0008-5472.CAN-05-3725; Safina A, 2013, CELL CYCLE, V12, P2423, DOI 10.4161/cc.25452; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sallam T, 2016, NATURE, V534, P124, DOI 10.1038/nature17674; Sama RR, 2014, ASN NEURO, V6; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swinburne IA, 2006, GENOME RES, V16, P912, DOI 10.1101/gr.5211806; TAKIMOTO M, 1993, J BIOL CHEM, V268, P18249; Tenzer S, 2013, J PROTEOME RES, V12, P2869, DOI 10.1021/pr400193j; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Vigo E, 1999, MOL CELL BIOL, V19, P6379; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wu MH, 2015, ONCOTARGET, V6, P11252, DOI 10.18632/oncotarget.3594; Yang LQ, 2014, P NATL ACAD SCI USA, V111, P17809, DOI 10.1073/pnas.1414004111; Yasuda K, 2013, J CELL BIOL, V203, P737, DOI 10.1083/jcb.201306058; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Yu Y, 2015, P NATL ACAD SCI USA, V112, P8608, DOI 10.1073/pnas.1506282112	82	15	15	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19674	19692		10.1074/jbc.M117.795591	http://dx.doi.org/10.1074/jbc.M117.795591			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972179	Green Published, hybrid			2022-12-28	WOS:000416911300014
J	Benkovic, SJ; Spiering, MM				Benkovic, Stephen J.; Spiering, Michelle M.			Understanding DNA replication by the bacteriophage T4 replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						bacteriophage; DNA-binding protein; DNA helicase; DNA polymerase; DNA primase; DNA replication	LAGGING-STRAND SYNTHESIS; POLYMERASE ACCESSORY PROTEINS; COORDINATED LEADING-STRAND; OKAZAKI FRAGMENT SYNTHESIS; SLIDING CLAMP INTERACTIONS; HELICASE LOADER PROTEIN; PRIMER SYNTHESIS; SINGLE-MOLECULE; HOLOENZYME COMPLEX; CRYSTAL-STRUCTURE	The T4 replisome has provided a unique opportunity to investigate the intricacies of DNA replication. We present a comprehensive review of this system focusing on the following: its 8-protein composition, their individual and synergistic activities, and assembly in vitro and in vivo into a replisome capable of coordinated leading/lagging strand DNA synthesis. We conclude with a brief comparison with other replisomes with emphasis on how coordinated DNA replication is achieved.	[Benkovic, Stephen J.; Spiering, Michelle M.] Penn State Univ, Dept Chem, Wartik Labs 414, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Labs 414, University Pk, PA 16802 USA.	sjb1@psu.edu	Spiering, Michelle M/B-8789-2016	Benkovic, Stephen/0000-0003-3680-3481	National Institutes of Health [GM013306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM013306 (to S. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Alley SC, 2000, BIOCHEMISTRY-US, V39, P3076, DOI 10.1021/bi992377r; Alley SC, 1999, BIOCHEMISTRY-US, V38, P7696, DOI 10.1021/bi9827971; Alley SC, 2001, J BIOL CHEM, V276, P39340, DOI 10.1074/jbc.M104956200; Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; Berdis AJ, 1996, BIOCHEMISTRY-US, V35, P9253, DOI 10.1021/bi952569w; Berdis AJ, 1996, P NATL ACAD SCI USA, V93, P12822, DOI 10.1073/pnas.93.23.12822; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; CAPSON TL, 1991, CELL, V65, P249, DOI 10.1016/0092-8674(91)90159-V; Carver TE, 1997, BIOCHEMISTRY-US, V36, P14409, DOI 10.1021/bi971423p; CHA TA, 1986, J BIOL CHEM, V261, P7001; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chen DQ, 2013, J BIOL CHEM, V288, P20807, DOI 10.1074/jbc.M113.485961; Delagoutte E, 2005, J MOL BIOL, V347, P257, DOI 10.1016/j.jmb.2005.01.036; Delagoutte E, 2001, BIOCHEMISTRY-US, V40, P4459, DOI 10.1021/bi001306l; Dohrmann PR, 2011, J MOL BIOL, V414, P15, DOI 10.1016/j.jmb.2011.09.039; DONG F, 1995, J BIOL CHEM, V270, P7462, DOI 10.1074/jbc.270.13.7462; Drake J. W, 1970, MOL BASIS MUTATION; Dudas KC, 2005, J BIOL CHEM, V280, P21561, DOI 10.1074/jbc.m502351200; FREY MW, 1993, P NATL ACAD SCI USA, V90, P2579, DOI 10.1073/pnas.90.7.2579; Geertsema HJ, 2014, P NATL ACAD SCI USA, V111, P4073, DOI 10.1073/pnas.1402010111; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; GOGOL EP, 1992, J MOL BIOL, V224, P395, DOI 10.1016/0022-2836(92)91003-8; GOPALAKRISHNAN V, 1994, J BIOL CHEM, V269, P21123; Graham JE, 2017, CELL, V169, P1201, DOI 10.1016/j.cell.2017.05.041; HACKER KJ, 1994, J BIOL CHEM, V269, P24221; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HUANG CC, 1981, J BIOL CHEM, V256, P4087; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; Ishmael FT, 2002, J BIOL CHEM, V277, P20555, DOI 10.1074/jbc.M111951200; Ishmael FT, 2001, J BIOL CHEM, V276, P25236, DOI 10.1074/jbc.M100783200; JARVIS TC, 1991, J BIOL CHEM, V266, P1830; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; Jing DH, 1999, J BIOL CHEM, V274, P27287, DOI 10.1074/jbc.274.38.27287; Johnson SK, 2000, BIOCHEMISTRY-US, V39, P736, DOI 10.1021/bi991554l; Kaboord BF, 1996, BIOCHEMISTRY-US, V35, P1084, DOI 10.1021/bi9520747; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; KABOORD BF, 1993, P NATL ACAD SCI USA, V90, P10881, DOI 10.1073/pnas.90.22.10881; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Kulczyk AW, 2016, ENZYMES, V39, P89, DOI 10.1016/bs.enz.2016.02.001; Kurth I, 2013, NATURE, V496, P119, DOI 10.1038/nature11988; Latham GJ, 1997, J BIOL CHEM, V272, P31685, DOI 10.1074/jbc.272.50.31685; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lefebvre SD, 1999, J BIOL CHEM, V274, P22830, DOI 10.1074/jbc.274.32.22830; Lewis JS, 2016, ENZYMES, V39, P31, DOI 10.1016/bs.enz.2016.04.001; LIU CC, 1981, J BIOL CHEM, V256, P2813; LIU CC, 1979, COLD SPRING HARB SYM, V43, P469, DOI 10.1101/SQB.1979.043.01.053; MACE DC, 1984, J MOL BIOL, V177, P295, DOI 10.1016/0022-2836(84)90458-3; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6174, DOI 10.1093/nar/gks253; Manosas M, 2012, NUCLEIC ACIDS RES, V40, P6187, DOI 10.1093/nar/gks254; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Moarefi I, 2000, J MOL BIOL, V296, P1215, DOI 10.1006/jmbi.1999.3511; MUNN MM, 1991, J BIOL CHEM, V266, P20034; Nelson SW, 2008, J BIOL CHEM, V283, P22838, DOI 10.1074/jbc.M802762200; Nelson SW, 2006, J BIOL CHEM, V281, P8697, DOI 10.1074/jbc.M512185200; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; NOSSAL NG, 1980, J BIOL CHEM, V255, P2176; NOSSAL NG, 1979, J BIOL CHEM, V254, P6032; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Pietroni P, 2001, J MOL BIOL, V309, P869, DOI 10.1006/jmbi.2001.4687; Pietroni P, 1997, J BIOL CHEM, V272, P31666, DOI 10.1074/jbc.272.50.31666; Raney KD, 1996, J BIOL CHEM, V271, P14074, DOI 10.1074/jbc.271.24.14074; REDDY MK, 1993, P NATL ACAD SCI USA, V90, P3211, DOI 10.1073/pnas.90.8.3211; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4725; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Schrock RD, 1996, J BIOL CHEM, V271, P16678, DOI 10.1074/jbc.271.28.16678; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Shamoo Y, 1999, CELL, V99, P155, DOI 10.1016/S0092-8674(00)81647-5; Smiley RD, 2006, BIOCHEMISTRY-US, V45, P7990, DOI 10.1021/bi0603322; Soumillion P, 1998, BIOCHEMISTRY-US, V37, P1819, DOI 10.1021/bi972526a; Spiering MM, 2017, P NATL ACAD SCI USA, V114, P5635, DOI 10.1073/pnas.1620459114; Stano NM, 2005, NATURE, V435, P370, DOI 10.1038/nature03615; Tanner NA, 2008, NAT STRUCT MOL BIOL, V15, P170, DOI 10.1038/nsmb.1381; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; Trakselis MA, 2003, J MOL BIOL, V326, P435, DOI 10.1016/S0022-2836(02)01330-X; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; Valentine AM, 2001, BIOCHEMISTRY-US, V40, P15074, DOI 10.1021/bi0108554; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WU CA, 1992, J BIOL CHEM, V267, P4030; Xi J, 2005, BIOCHEMISTRY-US, V44, P7747, DOI 10.1021/bi047296w; Xi J, 2005, BIOCHEMISTRY-US, V44, P2305, DOI 10.1021/bi0479508; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; YOUNG MC, 1994, J MOL BIOL, V235, P1447, DOI 10.1006/jmbi.1994.1100; Yuan Q, 2014, NUCLEIC ACIDS RES, V42, P1747, DOI 10.1093/nar/gkt1098; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045; Zhang D, 2016, ENZYMES, V39, P191, DOI 10.1016/bs.enz.2016.03.004; Zhang ZQ, 2005, P NATL ACAD SCI USA, V102, P3254, DOI 10.1073/pnas.0500327102; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	100	10	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18434	18442		10.1074/jbc.R117.811208	http://dx.doi.org/10.1074/jbc.R117.811208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972188	hybrid, Green Published			2022-12-28	WOS:000414958100005
J	Sutavani, RV; Phair, IR; Barker, R; McFarlane, A; Shpiro, N; Lang, S; Woodland, A; Arthur, JSC				Sutavani, Ruhcha V.; Phair, Iain R.; Barker, Rebecca; McFarlane, Alison; Shpiro, Natalia; Lang, Stuart; Woodland, Andrew; Arthur, J. Simon C.			Differential control of Toll-like receptor 4-induced interleukin-10 induction in macrophages and B cells reveals a role for p90 ribosomal S6 kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IL-10 PRODUCTION; DENDRITIC CELLS; B10 CELLS; INFLAMMATORY RESPONSE; PHOSPHORYLATION SITES; TRANSCRIPTION FACTOR; REGULATORY FUNCTION; TNF-ALPHA	Increasing evidence has linked dysregulated interleukin (IL)-10 production by IL-10(+ve) B cells to autoimmunity, highlighting the importance of improving the understanding of the regulation of IL-10 production in these cells. In both B cells and myeloid cells, IL-10 can be produced in response to Toll-like receptor (TLR) agonists. In macrophages, previous studies have established that mitogen-and stress-activated protein kinases (MSKs) regulate IL-10 production via the phosphorylation of cAMP response element-binding (CREB) protein on the IL-10 promoter. We found here that although MSKs are activated in peritoneal B cells in response to TLR4 agonists, neither MSKs nor CREB are required for IL-10 production in these cells. Using a combination of chemical inhibitors and knockout mice, we found that IL-10 induction in B cells was regulated by an ERK1/2- and p90 ribosomal S6 kinase-dependent mechanism, unlike in macrophages in which p90 ribosomal S6 kinase was not required. This observation highlights fundamental differences in the signaling controlling IL-10 production in B cells and macrophages, even though these two cell types respond to a common TLR stimulus.	[Sutavani, Ruhcha V.; Phair, Iain R.; Barker, Rebecca; McFarlane, Alison; Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bldg,Dow St, Dundee DD1 5EH, Scotland; [Shpiro, Natalia] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Lang, Stuart; Woodland, Andrew] Univ Dundee, Sch Life Sci, Div Biol Chem & Drug Discovery, Drug Discovery Unit, Dundee DD1 5EH, Scotland	University of Dundee; University of Dundee; University of Dundee	Arthur, JSC (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Wellcome Trust Bldg,Dow St, Dundee DD1 5EH, Scotland.	j.s.c.arthur@dundee.ac.uk		Phair, Iain/0000-0001-7814-0263; McFarlane, Alison/0000-0002-8847-2410; Arthur, Simon/0000-0002-8135-1958	Medical Research Council; Arthritis Research UK; MRC [MR/L000849/1, MR/L008785/1] Funding Source: UKRI; Medical Research Council [MR/L000849/1, MR/L008785/1, 1644173] Funding Source: researchfish; Versus Arthritis [20409] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This work was funded by the Medical Research Council and Arthritis Research UK. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Aronchik I, 2014, MOL CANCER RES, V12, P803, DOI 10.1158/1541-7786.MCR-13-0595; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Aziz M, 2017, J IMMUNOL, V199, P750, DOI 10.4049/jimmunol.1602056; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barr TA, 2007, EUR J IMMUNOL, V37, P3040, DOI 10.1002/eji.200636483; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Ehlting C, 2011, J BIOL CHEM, V286, P24113, DOI 10.1074/jbc.M111.235275; Elcombe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060086; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Foey AD, 1998, J IMMUNOL, V160, P920; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Gaestel M, 2013, BIOL CHEM, V394, P1301, DOI 10.1515/hsz-2013-0197; Gee K, 2006, J BIOL CHEM, V281, P31647, DOI 10.1074/jbc.M512109200; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Grammer AC, 1998, J IMMUNOL, V161, P1183; Jain R, 2015, J MED CHEM, V58, P6766, DOI 10.1021/acs.jmedchem.5b00450; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Koscso B, 2012, J IMMUNOL, V188, P445, DOI 10.4049/jimmunol.1101224; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Li BBX, 2009, CHEMBIOCHEM, V10, P2721, DOI 10.1002/cbic.200900552; Liu YW, 2006, CELL SIGNAL, V18, P1492, DOI 10.1016/j.cellsig.2005.12.001; Lucas M, 2005, J IMMUNOL, V175, P469, DOI 10.4049/jimmunol.175.1.469; Lykken JM, 2015, INT IMMUNOL, V27, P471, DOI 10.1093/intimm/dxv046; Ma W, 2001, J BIOL CHEM, V276, P13664, DOI 10.1074/jbc.M011157200; MacKenzie KF, 2014, CRIT REV IMMUNOL, V34, P315, DOI 10.1615/CritRevImmunol.2014010694; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Matsumoto M, 2011, IMMUNITY, V34, P703, DOI 10.1016/j.immuni.2011.03.016; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2017, J CLIN INVEST, V127, P772, DOI 10.1172/JCI85113; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; McGuire VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31159; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; Mion F, 2014, MOL IMMUNOL, V62, P266, DOI 10.1016/j.molimm.2014.05.018; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; OGARRA A, 1992, ANN NY ACAD SCI, V651, P182; Rangaswamy US, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003858; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmidt EGW, 2012, INFLAMM BOWEL DIS, V18, P284, DOI 10.1002/ibd.21769; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Tedder TF, 2015, J IMMUNOL, V194, P1395, DOI 10.4049/jimmunol.1401329; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Watanabe R, 2010, J IMMUNOL, V184, P4801, DOI 10.4049/jimmunol.0902385; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wingate AD, 2009, GENESIS, V47, P688, DOI 10.1002/dvg.20548; Zaru R, 2007, NAT IMMUNOL, V8, P1227, DOI 10.1038/ni1517; Ziegler S, 2014, EUR J IMMUNOL, V44, P1285, DOI 10.1002/eji.201343994	75	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2302	2317		10.1074/jbc.M117.805424	http://dx.doi.org/10.1074/jbc.M117.805424			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29229781	hybrid, Green Published			2022-12-28	WOS:000425308300006
J	Hu, Y; Semova, I; Sun, XW; Kang, H; Chahar, S; Hollenberg, AN; Masson, D; Hirschey, MD; Miao, J; Biddinger, SB				Hu, Yue; Semova, Ivana; Sun, Xiaowei; Kang, Hong; Chahar, Satyapal; Hollenberg, Anthony N.; Masson, David; Hirschey, Matthew D.; Miao, Ji; Biddinger, Sudha B.			Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dyslipidemia; fructose; glucose; lipogenesis; mammalian target of rapamycin (mTOR); metabolic syndrome	FATTY-ACID SYNTHESIS; HEPATIC STEATOSIS; CELL-GROWTH; NUCLEAR COREPRESSOR; INSULIN SENSITIVITY; METABOLIC SYNDROME; UNITED-STATES; UP-REGULATION; X-RECEPTOR; LIVER	Although calorically equivalent to glucose, fructose appears to be more lipogenic, promoting dyslipidemia, fatty liver disease, cardiovascular disease, and diabetes. To better understand how fructose induces lipogenesis, we compared the effects of fructose and glucose on mammalian target of rapamycin complex 1 (mTORC1), which appeared to have both positive and negative effects on lipogenic gene expression. We found that fructose acutely and transiently suppressed mTORC1 signaling in vitro and in vivo. The constitutive activation of mTORC1 reduced hepatic lipogenic gene expression and produced hypotriglyceridemia after 1 week of fructose feeding. In contrast, glucose did not suppress mTORC1, and the constitutive activation of mTORC1 failed to suppress plasma triglycerides after 1 week of glucose feeding. Thus, these data reveal fundamental differences in the signaling pathways used by fructose and glucose to regulate lipid metabolism.	[Hu, Yue; Semova, Ivana; Sun, Xiaowei; Kang, Hong; Chahar, Satyapal; Miao, Ji; Biddinger, Sudha B.] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Metab & Diabet, Boston, MA 02215 USA; [Hollenberg, Anthony N.] Harvard Med Sch, Boston, MA 02215 USA; [Masson, David] INSERM, Lipid Nutr Canc UMR 1231, F-21000 Dijon, France; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Duke University; Duke University	Miao, J; Biddinger, SB (corresponding author), Boston Childrens Hosp, 3 Blackfan Circle CLS16023-2, Boston, MA 02115 USA.	ji.miao@childrens.harvard.edu; sudha.biddinger@childrens.harvard.edu	Miao, Ji/F-9398-2015; Masson, David/R-6633-2019; Semova, Ivana/AAL-3392-2020; MASSON, David/AAC-8896-2022	Miao, Ji/0000-0003-0869-4492; MASSON, David/0000-0003-1692-0699	National Institutes of Health [DK094162, DK100539, DK056123]; China Scholarship Council; Boston Children's Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK100539, R01DK094162, R01DK056123, R56DK056123, K99DK100539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); Boston Children's Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK094162 (to S. B. B.), DK100539 (to J. M.), and DK056123 (to A. N. H.) as well as a fellowship from the China Scholarship Council (to Y. H.) and a career development award from Boston Children's Hospital (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astapova I, 2014, J CLIN INVEST, V124, P1976, DOI 10.1172/JCI73419; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Baena M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26149; Baena M, 2015, BBA-MOL CELL BIOL L, V1851, P107, DOI 10.1016/j.bbalip.2014.11.003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen Q, 2016, J BIOL CHEM, V291, P2371, DOI 10.1074/jbc.M115.677351; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Haas JT, 2012, CELL METAB, V15, P873, DOI 10.1016/j.cmet.2012.05.002; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ishibashi M, 2013, ARTERIOSCL THROM VAS, V33, P1171, DOI 10.1161/ATVBAHA.112.300812; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2012, P NATL ACAD SCI USA, V109, pE1619, DOI 10.1073/pnas.1204298109; Kim MS, 2016, J CLIN INVEST, V126, P4372, DOI 10.1172/JCI81993; Konishi M, 2011, CARDIOVASC RES, V89, P309, DOI 10.1093/cvr/cvq335; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee MN, 2009, MOL CELL BIOL, V29, P3991, DOI 10.1128/MCB.00165-09; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7498; Miyazaki M, 2004, J BIOL CHEM, V279, P25164, DOI 10.1074/jbc.M402781200; Mori T, 2011, J NUTR, V141, P2003, DOI 10.3945/jn.111.143602; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Sapp V, 2014, HEPATOLOGY, V60, P1581, DOI 10.1002/hep.27284; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Titchenell PM, 2016, CELL METAB, V23, P1154, DOI 10.1016/j.cmet.2016.04.022; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067; Wang H, 2015, ENDOCRINOLOGY, V156, P169, DOI 10.1210/en.2014-1454; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	58	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2006	2014		10.1074/jbc.M117.782557	http://dx.doi.org/10.1074/jbc.M117.782557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29222328	Green Published, hybrid			2022-12-28	WOS:000424948000014
J	Langenegger, N; Koua, D; Schurch, S; Heller, M; Nentwig, W; Kuhn-Nentwig, L				Langenegger, Nicolas; Koua, Dominique; Schurch, Stefan; Heller, Manfred; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia			Identification of a precursor processing protease from the spider Cupiennius salei essential for venom neurotoxin maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antimicrobial peptide (AMP); enzyme purification; neurotoxin; protein processing; serine protease; processing quadruplet motif (PQM); propeptide	MULTICOMPONENT VENOM; PEPTIDES; TRANSCRIPTOME; EXPRESSION; ALGORITHM; LATARCINS; CLONING; ARANEAE; CSTX-1; SITE	Spider venom neurotoxins and cytolytic peptides are expressed as elongated precursor peptides, which are post-translationally processed by proteases to yield the active mature peptides. The recognition motifs for these processing proteases, first published more than 10 years ago, include the processing quadruplet motif (PQM) and the inverted processing quadruplet motif (iPQM). However, the identification of the relevant proteases was still pending. Here we describe the purification of a neurotoxin precursor processing protease from the venom of the spider Cupiennius salei. The chymotrypsin-like serine protease is a 28-kDa heterodimer with optimum activity at venom's pH of 6.0. We designed multiple synthetic peptides mimicking the predicted cleavage sites of neurotoxin precursors. Using these peptides as substrates, we confirm the biochemical activity of the protease in propeptide removal from neurotoxin precursors by cleavage C-terminal of the PQM. Furthermore, the PQM protease also cleaves the iPQM relevant for heterodimerization of a subgroup of neurotoxins. An involvement in the maturing of cytolytic peptides is very likely, due to high similarity of present protease recognition motifs. Finally, bioinformatics analysis, identifying sequences of homolog proteins from 18 spiders of 9 families, demonstrate the wide distribution and importance of the isolated enzyme for spiders. In summary, we establish the first example of a PQM protease, essential for maturing of spider venom neurotoxins. In the future, the here described protease may be established as a powerful tool for production strategies of recombinant toxic peptides, adapted to the maturing of spider venom toxins.	[Langenegger, Nicolas; Koua, Dominique; Nentwig, Wolfgang; Kuhn-Nentwig, Lucia] Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland; [Koua, Dominique] Inst Natl Polytech Felix Houphouet Boigny, BP 1093 Yamoussoukro, Yamoussoukro, Cote Ivoire; [Schurch, Stefan] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland; [Heller, Manfred] Univ Bern, Dept Clin Res, Prote & Mass Spectrometry Core Facil, Freiburgstr 15, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern	Kuhn-Nentwig, L (corresponding author), Univ Bern, Inst Ecol & Evolut, Baltzerstr 6, CH-3012 Bern, Switzerland.	lucia.kuhn@iee.unibe.ch	Schürch, Stefan/ABE-4977-2022	Schürch, Stefan/0000-0001-5109-4623	Swiss National Science Foundation [31003A_162564]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A_162564 (to W. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Biner O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143963; Brugger V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14272; Catalan A, 2011, J BIOCHEM MOL TOXIC, V25, P393, DOI 10.1002/jbt.20399; Corzo G, 2002, J BIOL CHEM, V277, P23627, DOI 10.1074/jbc.M200511200; Dubovskii PV, 2015, CELL MOL LIFE SCI, V72, P4501, DOI 10.1007/s00018-015-2016-x; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; Haney RA, 2016, GENOME BIOL EVOL, V8, P228, DOI 10.1093/gbe/evv253; Hanquier J, 2003, APPL ENVIRON MICROB, V69, P1108, DOI 10.1128/AEM.69.2.1108-1113.2003; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kozlov SA, 2007, TOXICON, V49, P721, DOI 10.1016/j.toxicon.2006.11.007; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kuhn-Nentwig L, 2004, TOXICON, V43, P543, DOI 10.1016/j.toxicon.2004.02.009; Kuhn-Nentwig L, 2016, TOXINOLOGY, P47, DOI 10.1007/978-94-007-6389-0_12; Kuhn-Nentwig L, 2012, J BIOL CHEM, V287, P25640, DOI 10.1074/jbc.M112.339051; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; KUHNNENTWIG L, 1994, TOXICON, V32, P287, DOI 10.1016/0041-0101(94)90082-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Milne TJ, 2003, J BIOL CHEM, V278, P31105, DOI 10.1074/jbc.M304843200; Nentwig W., 2013, SPIDER ECOPHYSIOLOGY, P505; Oliva MLV, 2003, CURR MED CHEM, V10, P1085, DOI 10.2174/0929867033457548; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Planas E, 2015, TOXICON, V93, P11, DOI 10.1016/j.toxicon.2014.10.005; Polotow D, 2015, INVERTEBR SYST, V29, P124, DOI 10.1071/IS14041; Qian J, 2008, ACTA BIOCH BIOPH SIN, V40, P174, DOI 10.1111/j.1745-7270.2008.00385.x; Richardson M, 2006, COMP BIOCHEM PHYS C, V142, P173, DOI 10.1016/j.cbpc.2005.09.010; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; SANTOS AD, 1992, J BIOL CHEM, V267, P20701; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Trachsel C, 2012, FEBS J, V279, P2683, DOI 10.1111/j.1742-4658.2012.08650.x; Vassilevski AA, 2008, RECENT PATENTS INFLA, V2, P58, DOI 10.2174/187221308783399261; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wheeler WC, 2017, CLADISTICS, V33, P574, DOI 10.1111/cla.12182; Wullschleger B, 2004, P NATL ACAD SCI USA, V101, P11251, DOI 10.1073/pnas.0402226101; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001	43	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2079	2090		10.1074/jbc.M117.810911	http://dx.doi.org/10.1074/jbc.M117.810911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269415	Green Published, hybrid			2022-12-28	WOS:000424948000020
J	Lavrsen, K; Dabelsteen, S; Vakhrushev, SY; Levann, AMR; Haue, AD; Dylander, A; Mandel, U; Hansen, L; Frodin, M; Bennett, EP; Wandall, HH				Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Frodin, Morten; Bennett, Eric P.; Wandall, Hans H.			De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell adhesion; colon cancer; differentiation; glycobiology; GalNAc; GalNAc-Ts; genetic engineering; glycoproteomics; tissue model	ALPHA-D-GALACTOSAMINE; ACETYL-D-GALACTOSAMINE; TRANSFERASE GENE FAMILY; O-LINKED GLYCOSYLATION; BOVINE UDP-GALNAC; PANCREATIC-CANCER; COLORECTAL-CANCER; BREAST-CANCER; POOR-PROGNOSIS; CDNA CLONING	Aberrant expression of O-glycans is a hallmark of epithelial cancers. Mucin-type O-glycosylation is initiated by a large family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (GalNAc-Ts) that target different proteins and are differentially expressed in cells and organs. Here, we investigated the expression patterns of all of the GalNAc-Ts in colon cancer by analyzing transcriptomic data. We found that GalNAc-T6 was highly up-regulated in colon adenocarcinomas but absent in normal-appearing adjacent colon tissue. These results were verified by immunohistochemistry, suggesting that GalNAc-T6 plays a role in colon carcinogenesis. To investigate the function of GalNAc-T6 in colon cancer, we used precise gene targeting to produce isogenic colon cancer cell lines with a knockout/rescue system for GALNT6. GalNAc-T6 expression was associated with a cancer-like, dysplastic growth pattern, whereas GALNT6 knockout cells showed a more normal differentiation pattern, reduced proliferation, normalized cell-cell adhesion, and formation of crypts in tissue cultures. O-Glycoproteomic analysis of the engineered cell lines identified a small set of GalNAc-T6-specific targets, suggesting that this isoform has unique cellular functions. In support of this notion, the genetically and functionally closely related GalNAc-T3 homolog did not show compensatory functionality for effects observed for GalNAc-T6. Taken together, these data strongly suggest that aberrant GalNAc-T6 expression and site-specific glycosylation is involved in oncogenic transformation.	[Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Bennett, Eric P.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Lavrsen, Kirstine; Dabelsteen, Sally; Vakhrushev, Sergey Y.; Levann, Asha M. R.; Haue, Amalie Dahl; Dylander, August; Mandel, Ulla; Hansen, Lars; Bennett, Eric P.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Odontol, DK-2200 Copenhagen N, Denmark; [Frodin, Morten] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.; Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Fac Hlth Sci, Dept Odontol, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Vakhrushev, Sergey Y/A-7638-2014; Bennett, Eric/AAG-6120-2020	Vakhrushev, Sergey Y/0000-0002-0418-5765; Bennett, Eric/0000-0002-4976-0647; Haue, Amalie Dahl/0000-0001-7656-7976; Mandel, Ulla/0000-0001-7012-9836; Rudjord-Levann, Asha M./0000-0002-9966-0345; Wandall, Hans H./0000-0003-0240-9232; Frodin, Morten/0000-0003-3691-9820; Dabelsteen, Sally/0000-0002-4279-8060	Danish Research Councils Grant [1331-00133B]; Programme of Excellence Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO from the University of Copenhagen; Danish National Research Foundation [DNRF107]; Lundbeck Foundation	Danish Research Councils Grant; Programme of Excellence Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO from the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by Danish Research Councils Grant 1331-00133B (to K. L., S. D., and H. H. W.), Programme of Excellence 2016 Copenhagen as the Next Leader in Precise Genetic Engineering Grant CDO2016 from the University of Copenhagen (to K. L. and H. H. W.), Danish National Research Foundation Grant DNRF107, and The Lundbeck Foundation (to K. L. and H. H. W.). H. H. W. is a consultant and owns stock in GO therapeutics.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Adachi T, 1997, J IMMUNOL, V159, P2645; Andergassen U, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/792672; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Aruga J, 2003, MOL CELL NEUROSCI, V24, P117, DOI 10.1016/S1044-7431(03)00129-5; Ashley N, 2013, CANCER RES, V73, P5798, DOI 10.1158/0008-5472.CAN-13-0454; Baldus SE, 2000, CANCER-AM CANCER SOC, V88, P1536, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1536::AID-CNCR6>3.3.CO;2-N; Bennett EP, 1996, J BIOL CHEM, V271, P17006, DOI 10.1074/jbc.271.29.17006; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Bergmann H, 2012, IMMUNOL CELL BIOL, V90, P839, DOI 10.1038/icb.2012.51; Berois N, 2006, J HISTOCHEM CYTOCHEM, V54, P317, DOI 10.1369/jhc.5A6783.2005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Boskovski MT, 2013, NATURE, V504, P456, DOI 10.1038/nature12723; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5; CHING CK, 1993, GUT, V34, P1722, DOI 10.1136/gut.34.12.1722; Clausen H, 1996, GLYCOBIOLOGY, V6, P635, DOI 10.1093/glycob/6.6.635; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; Daniotti JL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00306; DAVID L, 1992, APMIS, V100, P162; Ding MX, 2012, ASIAN PAC J CANCER P, V13, P5653, DOI 10.7314/APJCP.2012.13.11.5653; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Ferreira JA, 2013, MOL ONCOL, V7, P719, DOI 10.1016/j.molonc.2013.03.001; Freire T, 2006, INT J CANCER, V119, P1383, DOI 10.1002/ijc.21959; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gornes J, 2009, J HISTOCHEM CYTOCHEM, V57, P79, DOI 10.1369/jhc.2008.952283; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Gu C, 2004, BRIT J CANCER, V90, P436, DOI 10.1038/sj.bjc.6601531; Hagen FK, 1997, J BIOL CHEM, V272, P13843, DOI 10.1074/jbc.272.21.13843; HAGEN FK, 1993, J BIOL CHEM, V268, P18960; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Harada Yoshikazu, 2015, Tumour Biol, V36, P10003, DOI 10.1007/s13277-015-4211-7; Herath NI, 2010, INT J CANCER, V126, P2003, DOI 10.1002/ijc.25147; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; HOMA FL, 1993, J BIOL CHEM, V268, P12609; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Inoue T, 2007, MODERN PATHOL, V20, P267, DOI 10.1038/modpathol.3800700; Ishikawa M, 2005, PATHOBIOLOGY, V72, P139, DOI 10.1159/000084117; Ishikawa M, 2004, J SURG ONCOL, V86, P28, DOI 10.1002/jso.20042; ITZKOWITZ S, 1991, GASTROENTEROLOGY, V100, P1691, DOI 10.1016/0016-5085(91)90671-7; Kariya Y, 2014, BIOCHEM J, V463, P93, DOI 10.1042/BJ20140060; Kim GE, 2002, GASTROENTEROLOGY, V123, P1052, DOI 10.1053/gast.2002.36018; Kitada S, 2013, BRIT J CANCER, V109, P472, DOI 10.1038/bjc.2013.331; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Lavrsen K, 2013, GLYCOCONJUGATE J, V30, P227, DOI 10.1007/s10719-012-9437-7; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Li Z, 2011, BRIT J CANCER, V104, P1882, DOI 10.1038/bjc.2011.166; Liesche F, 2016, MOL MED REP, V13, P4309, DOI 10.3892/mmr.2016.5044; LYUBSKY S, 1988, AM J CLIN PATHOL, V89, P160, DOI 10.1093/ajcp/89.2.160; Madsen CB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050139; Mandel U, 1999, GLYCOBIOLOGY, V9, P43, DOI 10.1093/glycob/9.1.43; Maresca M, 2013, GENOME RES, V23, P539, DOI 10.1101/gr.145441.112; Matsumoto Y, 2012, BIOCHEM BIOPH RES CO, V419, P7, DOI 10.1016/j.bbrc.2012.01.086; Maxson JE, 2014, J BIOL CHEM, V289, P5820, DOI 10.1074/jbc.M113.508440; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miyahara N, 2004, CLIN CANCER RES, V10, P2090, DOI 10.1158/1078-0432.CCR-1024-03; Mochizuki Y, 2013, THYROID, V23, P1553, DOI 10.1089/thy.2012.0613; Onitsuka K, 2003, CANCER SCI, V94, P32, DOI 10.1111/j.1349-7006.2003.tb01348.x; Ozaki H, 2012, CLIN EXP METASTAS, V29, P229, DOI 10.1007/s10585-011-9445-1; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Park JH, 2010, CANCER RES, V70, P2759, DOI 10.1158/0008-5472.CAN-09-3911; Patani Neill, 2008, Cancer Genomics & Proteomics, V5, P333; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Pedersen JW, 2014, INT J CANCER, V134, P2180, DOI 10.1002/ijc.28538; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Peng LB, 2014, J MOL HISTOL, V45, P555, DOI 10.1007/s10735-014-9577-0; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Pinto R, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx371; Potapenko IO, 2015, MOL ONCOL, V9, P861, DOI 10.1016/j.molonc.2014.12.013; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Shibao K, 2002, CANCER, V94, P1939, DOI 10.1002/cncr.10423; Steentoft Catharina, 2013, Methods Mol Biol, V1022, P387, DOI 10.1007/978-1-62703-465-4_29; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Sutherlin ME, 1997, CANCER RES, V57, P4744; Takeda K, 2011, ANTICANCER RES, V31, P263; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tarhan YE, 2016, NEOPLASIA, V18, P265, DOI 10.1016/j.neo.2016.03.005; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Ten Hagen BG, 1998, J BIOL CHEM, V273, P27749; Ten Hagen KG, 1999, J BIOL CHEM, V274, P27867; Ten Hagen KG, 2001, J BIOL CHEM, V276, P17395, DOI 10.1074/jbc.M009638200; TOM BH, 1976, IN VITRO CELL DEV B, V12, P180; Trecesson SD, 2011, J BIOL CHEM, V286, P12825, DOI 10.1074/jbc.M110.186437; Um JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6423; Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972; Vester-Christensen Malene Bech, 2013, Methods Mol Biol, V1022, P403, DOI 10.1007/978-1-62703-465-4_30; Walker F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022733; Wandall HH, 2007, ORAL ONCOL, V43, P301, DOI 10.1016/j.oraloncology.2006.03.005; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang ZQ, 2014, ONCOTARGET, V5, P544, DOI 10.18632/oncotarget.1652; White KE, 2000, GENE, V246, P347, DOI 10.1016/S0378-1119(00)00050-0; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; Wilson DG, 2011, J CELL BIOL, V193, P935, DOI 10.1083/jcb.201007162; Yamamoto S, 2004, PATHOBIOLOGY, V71, P12, DOI 10.1159/000072957; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Zhang L, 2014, J PATHOL, V234, P60, DOI 10.1002/path.4375; Zhang LP, 2014, P NATL ACAD SCI USA, V111, P7296, DOI 10.1073/pnas.1322264111	112	46	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1298	1314		10.1074/jbc.M117.812826	http://dx.doi.org/10.1074/jbc.M117.812826			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29187600	hybrid, Green Published			2022-12-28	WOS:000423515000016
J	Offenbacher, AR; Iavarone, AT; Klinman, JP				Offenbacher, Adam R.; Iavarone, Anthony T.; Klinman, Judith P.			Hydrogen-deuterium exchange reveals long-range dynamical allostery in soybean lipoxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme inhibitor; fatty acid; hydrogen exchange mass spectrometry; inhibition mechanism; SLO; allostery; hydrogen-deuterium exchange (HDX); lipoxygenase	MONOUNSATURATED FATTY-ACIDS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; CONFORMATIONAL DYNAMICS; SUBSTRATE-SPECIFICITY; HUMAN 15-LIPOXYGENASE; STRUCTURAL DYNAMICS; CALCIUM ACTIVATION; MEMBRANE-BINDING; PROTEIN MOTIONS	In lipoxygenases, the topologically conserved C-terminal domain catalyzes the oxidation of polyunsaturated fatty acids, generating an assortment of biologically relevant signaling mediators. Plant and animal lipoxygenases also contain a 100-150-amino acid N-terminal C2-like domain that has been implicated in interactions with isolated fatty acids and at the phospholipid bilayer. These interactions may lead to increased substrate availability and contribute to the regulation of active-site catalysis. Because of a lack of structural information, a molecular understanding of this lipid-protein interaction remains unresolved. Herein, we employed hydrogen-deuterium exchange MS (HDXMS) to spatially resolve changes in protein conformation upon interaction of soybean lipoxygenase with a fatty acid surrogate, oleyl sulfate (OS), previously shown to act at a site separate from the substrate-binding site. Specific, OS-induced conformational changes are detected both at the N-terminal domain and within the substrate portal nearly 30 angstrom away. Combining previously measured kinetic properties in the presence of OS with its impact on the K-d for linoleic acid substrate binding, we conclude that OS binding brings about an increase in rate constants for both the ingress and egress of substrate. We discuss the role of OS-induced changes in protein flexibility in the context of changes in the mechanism of substrate acquisition.	[Offenbacher, Adam R.; Iavarone, Anthony T.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Offenbacher, Adam R.] East Carolina Univ, Dept Chem, Greenville, NC 27858 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of North Carolina; East Carolina University	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu		Offenbacher, Adam/0000-0001-6990-7178	National Institutes of Health [GM113432, GM118117]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM113432, R35GM118117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grants GM113432 (to A. R. O.) and GM118117 (to J. P. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allard JB, 2005, CURR PROTEIN PEPT SC, V6, P125, DOI 10.2174/1389203053545417; Anand GS, 2002, J MOL BIOL, V323, P377, DOI 10.1016/S0022-2836(02)00919-1; Andreou A, 2009, PHYTOCHEMISTRY, V70, P1504, DOI 10.1016/j.phytochem.2009.05.008; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Burke JE, 2009, J AM CHEM SOC, V131, P8083, DOI 10.1021/ja900098y; CHATTOPADHYAY A, 1984, ANAL BIOCHEM, V139, P408, DOI 10.1016/0003-2697(84)90026-5; Clapp CH, 2001, J AM CHEM SOC, V123, P747, DOI 10.1021/ja0032071; Clapp CH, 2006, BIOCHEMISTRY-US, V45, P15884, DOI 10.1021/bi0619425; Deredge D, 2016, J BIOL CHEM, V291, P10078, DOI 10.1074/jbc.M115.708370; Di Venere A, 2003, J BIOL CHEM, V278, P18281, DOI 10.1074/jbc.M212122200; Droege KD, 2017, BIOCHEMISTRY-US, V56, P5065, DOI 10.1021/acs.biochem.7b00559; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gaffney BJ, 2012, BIOPHYS J, V103, P2134, DOI 10.1016/j.bpj.2012.10.002; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Hatcher E, 2004, J AM CHEM SOC, V126, P5763, DOI 10.1021/ja039606o; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hoofnagle AN, 2001, P NATL ACAD SCI USA, V98, P956, DOI 10.1073/pnas.98.3.956; Hu SS, 2014, J AM CHEM SOC, V136, P8157, DOI 10.1021/ja502726s; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Konermann L, 2014, ANALYST, V139, P6078, DOI 10.1039/c4an01307g; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lewis ER, 1999, J AM CHEM SOC, V121, P1395, DOI 10.1021/ja983083g; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; Liu YH, 2008, BIOCHEMISTRY-US, V47, P6342, DOI 10.1021/bi800463q; Liu YH, 2006, FEBS LETT, V580, P5137, DOI 10.1016/j.febslet.2006.08.042; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; Mogul R, 2000, BIOCHEMISTRY-US, V39, P4801, DOI 10.1021/bi992805t; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Offenbacher AR, 2017, ACS CENTRAL SCI, V3, P570, DOI 10.1021/acscentsci.7b00142; Offenbacher AR, 2016, TETRAHEDRON LETT, V57, P4537, DOI 10.1016/j.tetlet.2016.08.071; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Oyeyemi OA, 2010, P NATL ACAD SCI USA, V107, P10074, DOI 10.1073/pnas.1003678107; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; RESTREPO F, 1973, J FOOD SCI, V38, P779, DOI 10.1111/j.1365-2621.1973.tb02074.x; Ruddat VC, 2003, BIOCHEMISTRY-US, V42, P4172, DOI 10.1021/bi020698o; SCHOWEN KB, 1982, METHOD ENZYMOL, V87, P551; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; Sowole MA, 2014, ANAL CHEM, V86, P6715, DOI 10.1021/ac501849n; Tatulian SA, 1998, BIOCHEMISTRY-US, V37, P15481, DOI 10.1021/bi981062t; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; VANDERHEIJDT LM, 1995, EUR J BIOCHEM, V231, P186, DOI 10.1111/j.1432-1033.1995.tb20685.x; VANDERHEIJDT LM, 1992, EUR J BIOCHEM, V207, P793, DOI 10.1111/j.1432-1033.1992.tb17110.x; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Walther M, 2011, ARCH BIOCHEM BIOPHYS, V516, P1, DOI 10.1016/j.abb.2011.09.004; Wecksler AT, 2009, BIOCHEMISTRY-US, V48, P8721, DOI 10.1021/bi9009242; Wecksler AT, 2009, BIOORGAN MED CHEM, V17, P6534, DOI 10.1016/j.bmc.2009.08.005; Wennman A, 2016, J BIOL CHEM, V291, P8130, DOI 10.1074/jbc.M115.707380; Whitehouse M W, 2006, Inflammopharmacology, V14, P99, DOI 10.1007/s10787-006-1523-7; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006	64	16	16	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1138	1148		10.1074/jbc.M117.817197	http://dx.doi.org/10.1074/jbc.M117.817197			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191828	hybrid, Green Published			2022-12-28	WOS:000423515000003
J	O'Donnell, JP; Byrnes, LJ; Cooley, RB; Sondermann, H				O'Donnell, John P.; Byrnes, Laura J.; Cooley, Richard B.; Sondermann, Holger			A hereditary spastic paraplegia-associated atlastin variant exhibits defective allosteric coupling in the catalytic core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dynamin-related proteins; GTPase; membrane fusion; allosteric regulation; enzyme structure; axonopathy; hereditary spastic paraplegia	CRYSTAL-STRUCTURE; GTP HYDROLYSIS; STRUCTURAL INSIGHTS; HOMOTYPIC FUSION; MEMBRANE-FUSION; PROVIDE INSIGHT; G DOMAIN; DYNAMIN; DIMERIZATION; NETWORK	The dynamin-related GTPase atlastin (ATL) catalyzes membrane fusion of the endoplasmic reticulum and thus establishes a network of branched membrane tubules. When ATL function is compromised, the morphology of the endoplasmic reticulum deteriorates, and these defects can result in neurological disorders such as hereditary spastic paraplegia and hereditary sensory neuropathy. ATLs harness the energy of GTP hydrolysis to initiate a series of conformational changes that enable homodimerization and subsequent membrane fusion. Disease-associated amino acid substitutions cluster in regions adjacent to ATL's catalytic site, but the consequences for the GTPase's molecular mechanism are often poorly understood. Here, we elucidate structural and functional defects of an atypical hereditary spastic paraplegia mutant, ATL1-F151S, that is impaired in its nucleotide-hydrolysis cycle but can still adopt a high-affinity homodimer when bound to a transition-state analog. Crystal structures of mutant proteins yielded models of the monomeric pre- and post-hydrolysis states of ATL. Together, these findings define a mechanism for allosteric coupling in which Phe(151) is the central residue in a hydrophobic interaction network connecting the active site to an interdomain interface responsible for nucleotide loading.	[O'Donnell, John P.; Byrnes, Laura J.; Cooley, Richard B.; Sondermann, Holger] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Byrnes, Laura J.] Pfizer, Worldwide Med Chem, Eastern Point Rd, Groton, CT 06340 USA; [Cooley, Richard B.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Cornell University; Pfizer; Oregon State University	Sondermann, H (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	hs293@cornell.edu		O'Donnell, John/0000-0002-0571-3603; Cooley, Richard/0000-0003-3928-2757	National Science Foundation [DMR1332208]; National Institutes of Health [GM103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008267, P41GM103485, T32GM008500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077650] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	CHESS is supported by National Science Foundation Grant DMR1332208. The macromolecular diffraction at the CHESS facility is supported by National Institutes of Health Grant GM103485.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anand R, 2016, BIOCHEM BIOPH RES CO, V469, P76, DOI 10.1016/j.bbrc.2015.11.074; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Byrnes LJ, 2013, EMBO J, V32, P369, DOI 10.1038/emboj.2012.353; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Daumke O, 2016, BIOPOLYMERS, V105, P580, DOI 10.1002/bip.22855; De N, 2010, METHOD ENZYMOL, V471, P161, DOI 10.1016/S0076-6879(10)71010-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Faust JE, 2015, J BIOL CHEM, V290, P4772, DOI 10.1074/jbc.M114.601823; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Fischer D, 2014, BRAIN, V137, DOI 10.1093/brain/awu091; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Guelly C, 2011, AM J HUM GENET, V88, P99, DOI 10.1016/j.ajhg.2010.12.003; Haller O, 2010, J BIOL CHEM, V285, P28419, DOI 10.1074/jbc.R110.145839; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hu XY, 2015, PROTEIN CELL, V6, P307, DOI 10.1007/s13238-015-0139-3; Hubner CA, 2014, BRAIN, V137, P3109, DOI 10.1093/brain/awu287; Ivanova N, 2007, ARCH NEUROL-CHICAGO, V64, P706, DOI 10.1001/archneur.64.5.706; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khan TN, 2014, EUR J HUM GENET, V22, P1180, DOI 10.1038/ejhg.2014.5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunzelmann S, 2005, METHOD ENZYMOL, V404, P512, DOI 10.1016/S0076-6879(05)04045-0; Li J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43490; Liu TY, 2015, P NATL ACAD SCI USA, V112, pE1851, DOI 10.1073/pnas.1504368112; Liu TY, 2012, P NATL ACAD SCI USA, V109, pE2146, DOI 10.1073/pnas.1208385109; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; Moss TJ, 2011, P NATL ACAD SCI USA, V108, P11133, DOI 10.1073/pnas.1105056108; Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; O'Donnell JP, 2017, STRUCTURE, V25, P997, DOI 10.1016/j.str.2017.05.007; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pendin D, 2011, P NATL ACAD SCI USA, V108, P16283, DOI 10.1073/pnas.1106421108; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Saini SG, 2014, MOL BIOL CELL, V25, P3942, DOI 10.1091/mbc.E14-08-1284; Smith BN, 2009, CLIN GENET, V75, P485, DOI 10.1111/j.1399-0004.2009.01184.x; Ulengin I, 2015, MOL BIOL CELL, V26, P1616, DOI 10.1091/mbc.E14-10-1447; Vetter IR, 2014, RAS SUPERFAMILY SMAL, V1, P25; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang SY, 2013, J CELL BIOL, V203, P801, DOI 10.1083/jcb.201308001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winsor J, 2017, J CELL BIOL, V216, P1321, DOI 10.1083/jcb.201609071; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wu FY, 2015, PROTEIN CELL, V6, P139, DOI 10.1007/s13238-014-0118-0; Yan LM, 2015, J CELL BIOL, V210, P961, DOI 10.1083/jcb.201502078; Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758	62	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					687	700		10.1074/jbc.RA117.000380	http://dx.doi.org/10.1074/jbc.RA117.000380			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29180453	Green Published, hybrid			2022-12-28	WOS:000419915400023
J	Moon, SH; Liu, XP; Cedars, AM; Yang, K; Kiebish, MA; Joseph, SM; Kelley, J; Jenkins, CM; Gross, RW				Moon, Sung Ho; Liu, Xinping; Cedars, Ari M.; Yang, Kui; Kiebish, Michael A.; Joseph, Susan M.; Kelley, John; Jenkins, Christopher M.; Gross, Richard W.			Heart failure-induced activation of phospholipase iPLA(2)gamma generates hydroxyeicosatetraenoic acids opening the mitochondrial permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE EPOXIDE HYDROLASE; MYOCARDIAL ISCHEMIA-REPERFUSION; FAILING HUMAN HEARTS; CELL-DEATH; A(2)GAMMA IPLA(2)GAMMA; SARCOPLASMIC-RETICULUM; DILATED CARDIOMYOPATHY; INFARCT SIZE; NITRIC-OXIDE; CALCIUM	Congestive heart failure typically arises from cardiac myocyte necrosis/apoptosis, associated with the pathological opening of the mitochondrial permeability transition pore (mPTP). mPTP opening decreases the mitochondrial membrane potential leading to the activation of Ca2+-independent phospholipase A(2)gamma (iPLA(2)gamma) and the production of downstream toxic metabolites. However, the array of enzymatic mediators and the exact chemical mechanisms responsible for modulating myocardial mPTP opening remain unclear. Herein, we demonstrate that human heart failure activates specific myocardial mitochondrial phospholipases that increase Ca2+-dependent production of toxic hydroxyeicosatetraenoic acids (HETEs) and attenuate the activity of phospholipases that promote the synthesis of protective epoxyeicosatrienoic acids (EETs). Mechanistically, HETEs activated the Ca2+-induced opening of the mPTP in failing human myocardium, and the highly selective pharmacological blockade of either iPLA(2)gamma or lipoxygenases attenuated mPTP opening in failing hearts. In contrast, pharmacological inhibition of cytochrome P450 epoxygenases opened the myocardial mPTP in human heart mitochondria. Remarkably, the major mitochondrial phospholipase responsible for Ca2+-activated release of arachidonic acid (AA) in mitochondria from non-failing hearts was calcium-dependent phospholipase A(2)zeta (cPLA(2)zeta) identified by sequential column chromatographies and activity-based protein profiling. In contrast, iPLA(2)gamma predominated in failing human myocardium. Stable isotope kinetics revealed that in non-failing human hearts, cPLA(2)zeta metabolically channels arachidonic acid into EETs, whereas in failing hearts, increased iPLA(2)gamma activity channels AA into toxic HETEs. These results mechanistically identify the sequelae of pathological remodeling of human mitochondrial phospholipases in failing myocardium. This remodeling metabolically channels AA into toxic HETEs promoting mPTP opening, which induces necrosis/apoptosis leading to further progression of heart failure.	[Moon, Sung Ho; Liu, Xinping; Cedars, Ari M.; Yang, Kui; Kiebish, Michael A.; Kelley, John; Jenkins, Christopher M.; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Joseph, Susan M.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Ctr Cardiovasc Res, Dept Med, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Cedars, Ari M.] Baylor Heart & Vasc Hosp, Ctr Adult Congenital Heart Dis, 621 North Hall St,Ste 120, Dallas, TX 75226 USA; [Yang, Kui] US FDA, St Louis, MO 63110 USA; [Kiebish, Michael A.] BERG Hlth, 500 Old Connecticut Path, Framingham, MA 01701 USA; [Joseph, Susan M.] Baylor Heart & Vasc Hosp, Ctr Adv Heart & Lung Dis, 3410 Worth St,Suite 250, Dallas, TX 75246 USA; [Kelley, John] BJC HealthCare, 425 S Euclid Ave,Mailstop 90-09-340, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); US Food & Drug Administration (FDA)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	aricedars1@baylorhealth.edu; Michael.Kiebish@BergHealth.com; susanjoseph@baylorhealth.edu; John.Kelley@bjc.org; rgross@wustl.edu			National Institutes of Health [RO1HL133178, RO1HL118639]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639, R01HL133178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants RO1HL133178 and RO1HL118639. R. W. G. has financial relationships with LipoSpectrum and Platomics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Frias MA, 2007, CARDIOVASC RES, V73, P57, DOI 10.1016/j.cardiores.2006.09.016; Ghosh M, 2007, J BIOL CHEM, V282, P11676, DOI 10.1074/jbc.M608458200; Gross GJ, 2013, J MOL CELL CARDIOL, V59, P20, DOI 10.1016/j.yjmcc.2013.02.003; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; HAZEN SL, 1993, J CLIN INVEST, V91, P2513, DOI 10.1172/JCI116487; HAZEN SL, 1992, CIRC RES, V70, P486, DOI 10.1161/01.RES.70.3.486; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Holzem KM, 2016, FASEB J, V30, P2698, DOI 10.1096/fj.201500118R; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kayama Y, 2009, J EXP MED, V206, P1565, DOI 10.1084/jem.20082596; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Kwong JQ, 2015, CELL METAB, V21, P206, DOI 10.1016/j.cmet.2014.12.001; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; Liu XP, 2013, ANAL BIOCHEM, V442, P40, DOI 10.1016/j.ab.2013.06.014; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lopez-Crisosto C, 2017, NAT REV CARDIOL, V14, P342, DOI 10.1038/nrcardio.2017.23; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161629; Lv XJ, 2008, EUR J PHARMACOL, V596, P118, DOI 10.1016/j.ejphar.2008.08.008; Merabet N, 2012, J MOL CELL CARDIOL, V52, P660, DOI 10.1016/j.yjmcc.2011.11.015; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Moon SH, 2016, J BIOL CHEM, V291, P19687, DOI 10.1074/jbc.M116.740597; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Motoki A, 2008, AM J PHYSIOL-HEART C, V295, pH2128, DOI 10.1152/ajpheart.00428.2008; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Nazarewicz RR, 2007, ARCH BIOCHEM BIOPHYS, V468, P114, DOI 10.1016/j.abb.2007.09.018; Nithipatikom K, 2004, CIRC RES, V95, pE65, DOI 10.1161/01.RES.0000146277.62128.6f; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Rauckhorst AJ, 2015, FEBS LETT, V589, P2367, DOI 10.1016/j.febslet.2015.07.016; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; SCHWINGER RHG, 1995, CIRCULATION, V92, P3220, DOI 10.1161/01.CIR.92.11.3220; Shinmura K, 2005, AM J PHYSIOL-HEART C, V288, pH2093, DOI 10.1152/ajpheart.01003.2004; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Suzuki H, 2015, DIABETES, V64, P618, DOI 10.2337/db13-1896; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Thiemermann C, 2000, PHARMACOL THERAPEUT, V87, P61, DOI 10.1016/S0163-7258(00)00069-3; Wen YS, 2003, TRENDS CARDIOVAS MED, V13, P129, DOI 10.1016/S1050-1738(03)00027-6; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200	50	25	28	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					115	129		10.1074/jbc.RA117.000405	http://dx.doi.org/10.1074/jbc.RA117.000405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158256	hybrid, Green Published			2022-12-28	WOS:000419453200011
J	Nitani, A; Muta, H; Adachi, M; So, M; Sasahara, K; Sakurai, K; Chatani, E; Naoe, K; Ogi, H; Hall, D; Goto, Y				Nitani, Ayame; Muta, Hiroya; Adachi, Masayuki; So, Masatomo; Sasahara, Kenji; Sakurai, Kazumasa; Chatani, Eri; Naoe, Kazumitsu; Ogi, Hirotsugu; Hall, Damien; Goto, Yuji			Heparin-dependent aggregation of hen egg white lysozyme reveals two distinct mechanisms of amyloid fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; fluorescence; protein aggregation; protein crystallization; protein misfolding	PROTEIN AGGREGATION; CONFORMATIONAL STATES; CRYSTAL NUCLEATION; PHASE-DIAGRAM; NEUTRAL PH; SUPERSATURATION; FIBRILS; GLYCOSAMINOGLYCANS; CRYSTALLIZATION; SCRAPIE	Heparin, a biopolymer possessing high negative charge density, is known to accelerate amyloid fibrillation by various proteins. Using hen egg white lysozyme, we studied the effects of heparin on protein aggregation at low pH, raised temperature, and applied ultrasonic irradiation, conditions under which amyloid fibrillation was promoted. Heparin exhibited complex bimodal concentration-dependent effects, either accelerating or inhibiting fibrillation at pH 2.0 and 60 degrees C. At concentrations lower than 20 g/ml, heparin accelerated fibrillation through transient formation of hetero-oligomeric aggregates. Between 0.1 and 10 mg/ml, heparin rapidly induced amorphous heteroaggregation with little to no accompanying fibril formation. Above 10 mg/ml, heparin again induced fibrillation after a long lag time preceded by oligomeric aggregate formation. Compared with studies performed using monovalent and divalent anions, the results suggest two distinct mechanisms of heparin-induced fibrillation. At low heparin concentrations, initial hen egg white lysozyme cluster formation and subsequent fibrillation is promoted by counter ion binding and screening of repulsive charges. At high heparin concentrations, fibrillation is caused by a combination of salting out and macromolecular crowding effects probably independent of protein net charge. Both fibrillation mechanisms compete against amorphous aggregation, producing a complex heparin concentration-dependent phase diagram. Moreover, the results suggest an active role for amorphous oligomeric aggregates in triggering fibrillation, whereby breakdown of supersaturation takes place through heterogeneous nucleation of amyloid on amorphous aggregates.	[Nitani, Ayame; Muta, Hiroya; Adachi, Masayuki; So, Masatomo; Sasahara, Kenji; Hall, Damien; Goto, Yuji] Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan; [Sakurai, Kazumasa] Kindai Univ, Inst Adv Technol, 930 Nishimitani, Kinokawa, Wakayama 6496493, Japan; [Chatani, Eri] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Naoe, Kazumitsu] Nara Coll, Natl Inst Technol, Nara 6391080, Japan; [Ogi, Hirotsugu] Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hall, Damien] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	Osaka University; Kobe University; Australian National University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	gtyj8126@protein.osaka-u.ac.jp	Hall, Damien/AGY-5341-2022; Hall, Damien/D-9927-2012	Hall, Damien/0000-0003-1538-7618; Hall, Damien/0000-0003-1538-7618; Goto, Yuji/0000-0003-1221-1270; So, Masatomo/0000-0002-4815-4995; NAOE, Kazumitsu/0000-0002-3892-7018	Cooperative Research Program for the Institute for Protein, Osaka University [ICR-15-02, CR-16-02, VFCR-16-04]; JSPS [15H04362, 15K14458, 15K07038, 16H00836, 17K07363, 17H06352]; SENTAN from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17K07363, 17H06352] Funding Source: KAKEN	Cooperative Research Program for the Institute for Protein, Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENTAN from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was performed under the Cooperative Research Program for the Institute for Protein, Osaka University, ICR-15-02, CR-16-02, and VFCR-16-04 and was supported by JSPS KAKENHI Grants 15H04362, 15K14458, 15K07038, 16H00836, 17K07363, and 17H06352 and by the SENTAN from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bazar E, 2011, CHEMBIOCHEM, V12, P761, DOI 10.1002/cbic.201000486; Bazar E, 2010, CHEMBIOCHEM, V11, P1997, DOI 10.1002/cbic.201000207; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Coquerel G, 2014, CHEM SOC REV, V43, P2286, DOI 10.1039/c3cs60359h; Crespo R, 2010, J APPL CRYSTALLOGR, V43, P1419, DOI 10.1107/S0021889810040951; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; GOTO Y, 1991, J MOL BIOL, V218, P387, DOI 10.1016/0022-2836(91)90720-Q; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HAGIHARA Y, 1993, J MOL BIOL, V231, P180, DOI 10.1006/jmbi.1993.1272; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hall D, 2016, ANAL BIOCHEM, V498, P78, DOI 10.1016/j.ab.2015.11.021; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; Hall D, 2009, BIOPHYS CHEM, V145, P17, DOI 10.1016/j.bpc.2009.08.004; Harano K, 2012, NAT MATER, V11, P877, DOI [10.1038/NMAT3408, 10.1038/nmat3408]; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Levin A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6219; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Matsushita Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17647; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22015; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; So M, 2017, PROTEIN SCI, V26, P1024, DOI 10.1002/pro.3149; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; So M, 2015, LANGMUIR, V31, P9973, DOI 10.1021/acs.langmuir.5b02186; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Vekilov PG, 2012, NAT MATER, V11, P838, DOI 10.1038/nmat3441; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; WASHABAUGH MW, 1986, J BIOL CHEM, V261, P2477; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2015, BBA-PROTEINS PROTEOM, V1854, P209, DOI 10.1016/j.bbapap.2014.12.014; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yamazaki T, 2017, P NATL ACAD SCI USA, V114, P2154, DOI 10.1073/pnas.1606948114; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zhao Ran, 2016, Biophys Rev, V8, P445, DOI 10.1007/s12551-016-0233-7	53	23	23	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21219	21230		10.1074/jbc.M117.813097	http://dx.doi.org/10.1074/jbc.M117.813097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101231	Green Published, hybrid			2022-12-28	WOS:000419013000001
J	Bandyopadhyay, B; Goldenzweig, A; Unger, T; Adato, O; Fleishman, SJ; Unger, R; Horovitz, A				Bandyopadhyay, Boudhayan; Goldenzweig, Adi; Unger, Tamar; Adato, Orit; Fleishman, Sarel J.; Unger, Ron; Horovitz, Amnon			Local energetic frustration affects the dependence of green fluorescent protein folding on the chaperonin GroEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; chaperonin; GroEL; kinetics; protein design; protein folding	ESCHERICHIA-COLI PROTEINS; IN-VIVO; CRYSTAL-STRUCTURE; ALLOSTERY; COMPLEX	The GroE chaperonin system in Escherichia coli comprises GroEL and GroES and facilitates ATP-dependent protein folding in vivo and in vitro. Proteins with very similar sequences and structures can differ in their dependence on GroEL for efficient folding. One potential but unverified source for GroEL dependence is frustration, wherein not all interactions in the native state are optimized energetically, thereby potentiating slow folding and misfolding. Here, we chose enhanced green fluorescent protein as a model system and subjected it to random mutagenesis, followed by screening for variants whose in vivo folding displays increased or decreased GroEL dependence. We confirmed the altered GroEL dependence of these variants with in vitro folding assays. Strikingly, mutations at positions predicted to be highly frustrated were found to correlate with decreased GroEL dependence. Conversely, mutations at positions with low frustration were found to correlate with increased GroEL dependence. Further support for this finding was obtained by showing that folding of an enhanced green fluorescent protein variant designed computationally to have reduced frustration is indeed less GroEL-dependent. Our results indicate that changes in local frustration also affect partitioning in vivo between spontaneous and chaperonin-mediated folding. Hence, the design of minimally frustrated sequences can reduce chaperonin dependence and improve protein expression levels.	[Bandyopadhyay, Boudhayan; Horovitz, Amnon] Weizmann Inst Sci, Dept Biol Struct, IL-7610001 Rehovot, Israel; [Goldenzweig, Adi; Fleishman, Sarel J.] Weizmann Inst Sci, Dept Biomol Sci, IL-7610001 Rehovot, Israel; [Unger, Tamar] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Adato, Orit; Unger, Ron] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Bar Ilan University	Horovitz, A (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-7610001 Rehovot, Israel.; Unger, R (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	ron@biomodel.os.biu.ac.il; Amnon.Horovitz@weizmann.ac.il	Bandyopadhyay, Boudhayan/AAP-6630-2021	Bandyopadhyay, Boudhayan/0000-0002-3888-1988; Fleishman, Sarel/0000-0003-3177-7560	Minerva Foundation; Federal German Ministry for Education and Research; Israel Science Foundation [772/13]; European Research Council	Minerva Foundation; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Minerva Foundation with funding from the Federal German Ministry for Education and Research (to A. H.) and Grant 772/13 from the Israel Science Foundation (to R. U.). Research in the Fleishman laboratory was supported by a European Research Council's Starter's Grant and by a donation from Sam Switzer and family. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki K, 2000, J BIOL CHEM, V275, P13755, DOI 10.1074/jbc.275.18.13755; Azia A, 2012, FEBS J, V279, P543, DOI 10.1111/j.1742-4658.2011.08458.x; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chaudhuri TK, 2005, CELL STRESS CHAPERON, V10, P24, DOI 10.1379/CSC-64R1.1; Clark AC, 1996, BIOCHEMISTRY-US, V35, P5893, DOI 10.1021/bi953051v; Ferreiro DU, 2014, Q REV BIOPHYS, V47, P285, DOI 10.1017/S0033583514000092; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Parra RG, 2016, NUCLEIC ACIDS RES, V44, pW356, DOI 10.1093/nar/gkw304; GRAY TE, 1993, J MOL BIOL, V232, P1197, DOI 10.1006/jmbi.1993.1471; Gruber R, 2016, CHEM REV, V116, P6588, DOI 10.1021/acs.chemrev.5b00556; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; He LC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601625; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lorimer GH, 1996, FASEB J, V10, P5, DOI 10.1096/fasebj.10.1.8566548; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Noivirt-Brik O, 2007, BIOINFORMATICS, V23, P3276, DOI 10.1093/bioinformatics/btm513; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Sokolovski M, 2015, BIOPHYS J, V109, P1157, DOI 10.1016/j.bpj.2015.04.032; Stan G, 2005, PROTEIN SCI, V14, P193, DOI 10.1110/ps.04933205; Tartaglia GG, 2010, J MOL BIOL, V400, P579, DOI 10.1016/j.jmb.2010.03.066; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Unger T, 2010, J STRUCT BIOL, V172, P34, DOI 10.1016/j.jsb.2010.06.016; VIITANEN PV, 1992, PROTEIN SCI, V1, P363; Wu Y, 2003, J MOL BIOL, V330, P1131, DOI 10.1016/S0022-2836(03)00723-X; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944	31	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20583	20591		10.1074/jbc.M117.808576	http://dx.doi.org/10.1074/jbc.M117.808576			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29066625	Green Published, hybrid			2022-12-28	WOS:000418267000019
J	Ishikawa, T; Kimura, Y; Hirano, H; Higashi, S				Ishikawa, Tomohiro; Kimura, Yayoi; Hirano, Hisashi; Higashi, Shouichi			Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell-surface protein; matrix metalloproteinase (MMP); shedding; tumor metastasis	HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; SERINE-PROTEASE INHIBITOR; POLYCYSTIC KIDNEY-DISEASE; AMINO-ACID-RESIDUES; CHOLESTEROL SULFATE; MATRILYSIN MMP-7; MATRIPTASE; DOMAIN; IDENTIFICATION	Matrix metalloproteinase-7 (MMP-7) plays important roles in tumor progression and metastasis. Our previous studies have demonstrated that MMP-7 binds to colon cancer cells via cell surface-bound cholesterol sulfate and induces significant cell aggregation by cleaving cell-surface protein(s). These aggregated cells exhibit a dramatically enhanced metastatic potential. However, the molecular mechanism inducing this cell-cell adhesion through the proteolytic action of MMP-7 remained to be clarified. Here, we explored MMP-7 substrates on the cell surface; the proteins on the cell surface were first biotinylated, and a labeled protein fragment specifically released from the cells after MMP-7 treatment was analyzed using LC-MS/MS. We found that hepatocyte growth factor activator inhibitor type 1 (HAI-1), a membrane-bound Kunitz-type serine protease inhibitor, is an MMP-7 substrate. We also found that the cell-bound MMP-7 cleaves HAI-1 mainly between Gly(451) and Leu(452) and thereby releases the extracellular region as soluble HAI-1 (sHAI-1). We further demonstrated that this sHAI-1 can induce cancer cell aggregation and determined that the HAI-1 region corresponding to amino acids 141-249, which does not include the serine protease inhibitor domain, has the cell aggregation-inducing activity. Interestingly, a cell-surface cholesterol sulfate-independent proteolytic action of MMP-7 is critical for the sHAI-1-mediated induction of cell aggregation, whereas cholesterol sulfate is needed for the MMP-7-catalyzed generation of sHAI-1. Considering that MMP-7-induced cancer cell aggregation is an important mechanism in cancer metastasis, we propose that sHAI-1 is an essential component of MMP-7-induced stimulation of cancer metastasis and may therefore represent a suitable target for antimetastatic therapeutic strategies.	[Ishikawa, Tomohiro; Higashi, Shouichi] Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan; [Kimura, Yayoi; Hirano, Hisashi] Yokohama City Univ, Adv Med Res Ctr, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Yokohama City University	Higashi, S (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	shigashi@yokohama-cu.ac.jp			Yokohama City University, Japan [SG2802]; Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University, Japan; fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [16K12900]	Yokohama City University, Japan; Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University, Japan; fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports, Science and Technology of Japan; 	This work was supported in part by the grant for Research Development Fund (No. SG2802) of Yokohama City University, Japan (to S. H.), and an Extramural Collaborative Research Grant of the Cancer Research Institute, Kanazawa University, Japan (to S. H.), and Grants-in-Aid for Challenging Exploratory Research 16K12900 (to S. H.) and the fund for Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program in the Project for Developing Innovation Systems (to S. H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi Y, 1999, GUT, V45, P252, DOI 10.1136/gut.45.2.252; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Farahani E, 2014, CARCINOGENESIS, V35, P747, DOI 10.1093/carcin/bgu045; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Higashi S, 2008, J BIOL CHEM, V283, P35735, DOI 10.1074/jbc.M806285200; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Ishikawa T, 1996, CANCER LETT, V107, P5, DOI 10.1016/0304-3835(96)04336-4; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kioi M, 2003, ONCOGENE, V22, P8662, DOI 10.1038/sj.onc.1207181; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; MIYAZAKI K, 1990, CANCER RES, V50, P7758; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagashima Y, 1997, INT J CANCER, V72, P441, DOI 10.1002/(SICI)1097-0215(19970729)72:3<441::AID-IJC11>3.0.CO;2-F; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Takakura D, 2014, PROTEOMICS, V14, P196, DOI 10.1002/pmic.201300332; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yamamoto K, 2006, J BIOL CHEM, V281, P9170, DOI 10.1074/jbc.M510377200	31	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20769	20784		10.1074/jbc.M117.796789	http://dx.doi.org/10.1074/jbc.M117.796789			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29046355	Green Published, hybrid			2022-12-28	WOS:000418267000036
J	Varadarajan, R; Hammer, JA; Rusan, NM				Varadarajan, Ramya; Hammer, John A.; Rusan, Nasser M.			A centrosomal scaffold shows some self-control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MICROTUBULE NUCLEATION; TARGETING MOTIF; GOLGI-APPARATUS; AKAP450	The scaffolding protein AKAP350A is known to localize to the centrosome and the Golgi, but the molecular details of its function at the centrosome remain elusive. Using structure-function analyses, protein interaction assays, and super-resolution microscopy, Kolobova et al. now identify AKAP350A's specific location and protein partners at the centrosome. The authors further define an autoregulatory mechanism that likely controls AKAP350A's ability to nucleate microtubule growth.	[Varadarajan, Ramya; Hammer, John A.; Rusan, Nasser M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rusan, NM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	nasser@nih.gov	Rusan, Nasser/U-2513-2017		Division of Intramural Research, National Heart, Lung, and Blood Institute [1ZIAHL006126, 1ZIAHL000514]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000514, ZIAHL006121, ZIAHL006126] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute Grants 1ZIAHL006126 (to N. M. R.) and 1ZIAHL000514 (to J. A. H.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Carlson CR, 2001, J CELL SCI, V114, P3243; Gillingham AK, 2000, EMBO REP, V1, P524; Hurtado L, 2011, J CELL BIOL, V193, P917, DOI 10.1083/jcb.201011014; Kolobova E, 2017, J BIOL CHEM, V292, P20394, DOI 10.1074/jbc.M117.806018; Mennella V, 2014, TRENDS CELL BIOL, V24, P188, DOI 10.1016/j.tcb.2013.10.001; Pagan JK, 2015, NAT CELL BIOL, V17, P31, DOI 10.1038/ncb3076; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Shanks RA, 2002, J BIOL CHEM, V277, P40967, DOI 10.1074/jbc.M203307200; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112	9	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20410	20411		10.1074/jbc.H117.806018	http://dx.doi.org/10.1074/jbc.H117.806018			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29247130	Green Published, hybrid			2022-12-28	WOS:000418267000005
J	Hahn, C; Tyka, K; Saba, JD; Lenzen, S; Gurgul-Convey, E				Hahn, Claudine; Tyka, Karolina; Saba, Julie D.; Lenzen, Sigurd; Gurgul-Convey, Ewa			Overexpression of sphingosine-1-phosphate lyase protects insulin-secreting cells against cytokine toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; diabetes; inflammation; insulin secretion; pancreatic islet; sphingosine-1-phosphate (S1P); S1P-lyase; insulin-secreting cells	ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; SPHINGOSINE 1-PHOSPHATE; LEW.1AR1-IDDM RAT; SPHINGOLIPID METABOLISM; ISLET INFLAMMATION; MEDIATED MECHANISM; DIABETES-MELLITUS; INS-1 CELLS; S1P LYASE	Increasing evidence suggests a crucial role of inflammation in cytokine-mediated -cell dysfunction and death in type 1 diabetes mellitus, although the mechanisms are incompletely understood. Sphingosine 1-phosphate (S1P) is a multifunctional bioactive sphingolipid involved in the development of many autoimmune and inflammatory diseases. Here, we investigated the role of intracellular S1P in insulin-secreting INS1E cells by genetically manipulating the S1P-metabolizing enzyme S1P lyase (SPL). The expression of spl was down-regulated by cytokines in INS1E cells and rat islets. Overexpression of SPL protected against cytokine toxicity. Interestingly, the SPL overexpression did not suppress the cytokine-induced NFB-iNOS-NO pathway but attenuated calcium leakage from endoplasmic reticulum (ER) stores as manifested by lower cytosolic calcium levels, higher expression of the ER protein Sec61a, decreased dephosphorylation of Bcl-2-associated death promoter (Bad) protein, and weaker caspase-3 activation in cytokine-treated (IL-1, TNF, and IFN) cells. This coincided with reduced cytokine-mediated ER stress, indicated by measurements of CCAAT/enhancer-binding protein homologous protein (chop) and immunoglobulin heavy chain binding protein (bip) levels. Moreover, cytokine-treated SPL-overexpressing cells exhibited increased expression of prohibitin 2 (Phb2), involved in the regulation of mitochondrial assembly and respiration. SPL-overexpressing cells were partially protected against cytokine-mediated ATP reduction and inhibition of glucose-induced insulin secretion. siRNA-mediated spl suppression resulted in effects opposite to those observed for SPL overexpression. Knockdown of phb2 partially reversed beneficial effects of SPL overexpression. In conclusion, the relatively low endogenous Spl expression level in insulin-secreting cells contributes to their extraordinary vulnerability to proinflammatory cytokine toxicity and may therefore represent a promising target for -cell protection in type 1 diabetes mellitus.	[Hahn, Claudine; Tyka, Karolina; Lenzen, Sigurd; Gurgul-Convey, Ewa] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany; [Saba, Julie D.] Univ Calif San Francisco, Childrens Hosp, Oakland Res Inst, San Francisco, CA 94609 USA	Hannover Medical School; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco	Gurgul-Convey, E (corresponding author), Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany.	Gurgul-Convey.Ewa@mh-hannover.de		Gurgul-Convey, Ewa/0000-0002-9269-266X; Tyka, Karolina/0000-0002-4169-1675	Innovative Medicines Initiative Joint Undertaking [155005]; European Union; EFPIA companies; NATIONAL CANCER INSTITUTE [R01CA129438] Funding Source: NIH RePORTER	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement 155005 (IMIDIA), resources of which are composed of a financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Aoki M, 2016, MEDIAT INFLAMM, V2016, DOI [DOI 10.1155/2016/8606878, 10.1155/2016/8606878]; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Candido K, 2016, MINI-REV MED CHEM, V16, P547, DOI 10.2174/1389557515666150709122517; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chang I, 2004, J IMMUNOL, V172, P7008, DOI 10.4049/jimmunol.172.11.7008; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Coppieters KT, 2014, DIABETES, V63, P3581, DOI 10.2337/db14-0824; Degagne E, 2014, CLIN EXP GASTROENTER, V7, P205, DOI 10.2147/CEG.S43453; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Gurgul-Convey E, 2012, ENDOCRINOLOGY, V153, P2612, DOI 10.1210/en.2011-2027; Gurgul-Convey E, 2011, J MOL MED, V89, P785, DOI 10.1007/s00109-011-0747-1; Gurgul-Convey E, 2010, J BIOL CHEM, V285, P11121, DOI 10.1074/jbc.M109.054775; Hagen N, 2011, CELL DEATH DIFFER, V18, P1356, DOI 10.1038/cdd.2011.7; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanzelka K, 2012, BIOCHEM J, V445, P349, DOI 10.1042/BJ20111920; Harris CM, 2016, J PHARMACOL EXP THER, V359, P151, DOI 10.1124/jpet.116.235002; Hla T, 2001, SCIENCE, V294, P1875, DOI 10.1126/science.1065323; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huwiler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022436; Japtok L, 2015, FASEB J, V29, P3357, DOI 10.1096/fj.14-263194; Jessup Claire F., 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P262; Jorns A, 2014, J MOL MED, V92, P743, DOI 10.1007/s00109-014-1137-2; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Jorns A, 2010, ENDOCRINOLOGY, V151, P3555, DOI 10.1210/en.2010-0202; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Laychock SG, 2006, ENDOCRINOLOGY, V147, P4705, DOI 10.1210/en.2006-0456; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maki T, 2005, TRANSPLANTATION, V79, P1051, DOI 10.1097/01.TP.0000161220.87548.EE; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; Mastrandrea LD, 2010, J LIPID RES, V51, P2171, DOI 10.1194/jlr.M000802; Mastrandrea LD, 2005, DIABETES, V54, P1429, DOI 10.2337/diabetes.54.5.1429; Mitroi DN, 2016, SCI REP-UK, V6, DOI 10.1038/srep37064; Morgan NG, 2014, IUBMB LIFE, V66, P723, DOI 10.1002/iub.1330; Nagao K, 2013, BBA-MOL CELL BIOL L, V1831, P398, DOI 10.1016/j.bbalip.2012.11.002; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Rabinovitch A, 2003, REV ENDOCR METAB DIS, V4, P291, DOI 10.1023/A:1025160614313; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Saba JD, 2013, BBA-MOL CELL BIOL L, V1831, P167, DOI 10.1016/j.bbalip.2012.06.009; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Supale S, 2013, DIABETES, V62, P3488, DOI 10.2337/db13-0152; Taguchi Y, 2016, J BIOL CHEM, V291, P12029, DOI 10.1074/jbc.M116.728170; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van Vliet AR, 2017, MOL CELL, V65, P885, DOI 10.1016/j.molcel.2017.01.020; Veltman M, 2016, AM J PHYSIOL-LUNG C, V311, pL1000, DOI 10.1152/ajplung.00298.2016; Veret J, 2014, J CLIN MED, V3, P646, DOI 10.3390/jcm3020646; Wang F, 1997, BIOCHEM J, V324, P481, DOI 10.1042/bj3240481; Ximenes HM, 2007, LIFE SCI, V80, P2045, DOI 10.1016/j.lfs.2007.03.001; Zhu Q, 2009, FEBS LETT, V583, P2136, DOI 10.1016/j.febslet.2009.05.047; Zimmermann R, 2016, J CLIN IMMUNOL, V36, pS5, DOI 10.1007/s10875-016-0250-0	66	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20292	20304		10.1074/jbc.M117.814491	http://dx.doi.org/10.1074/jbc.M117.814491			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29070677	Green Published, hybrid			2022-12-28	WOS:000417696400032
J	Prinz, WA				Prinz, William A.			A cholesterol-sensing mechanism unfolds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SQUALENE MONOOXYGENASE; DEGRADATION	Squalene monooxygenase (SM), which synthesizes a cholesterol precursor, is degraded when cholesterol levels in the endoplasmic reticulum (ER) membrane are high, but the signal for degradation was not known. In this issue of JBC, Brown and co-workers identify an N-terminal domain in SM that interconverts in a cholesterol-sensitive manner between a membrane-binding amphipathic helix and a soluble degradation-prone segment, providing the first example of a cholesterol-degron collaboration.	[Prinz, William A.] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Prinz, WA (corresponding author), NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	wp53m@nih.gov			National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The author declares that he has no conflicts of interest with the contents of this article.	Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Brown M. S., 2017, ANNU REV BIOCHEM, DOI [10.1146/annurev-biochem-062917-011852, DOI 10.1146/ANNUREV-BIOCHEM-062917-0]; Chua NK, 2017, J BIOL CHEM, V292, P19959, DOI 10.1074/jbc.M117.794230; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Infante RE, 2017, ELIFE, V6, DOI 10.7554/eLife.25466; Johnson PR, 1998, CELL, V94, P217, DOI 10.1016/S0092-8674(00)81421-X; Lange Y, 1999, J LIPID RES, V40, P2264; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004	10	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19974	19975		10.1074/jbc.H117.794230	http://dx.doi.org/10.1074/jbc.H117.794230			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29222193	Green Published, hybrid			2022-12-28	WOS:000417696400003
J	Gomis-Ruth, FX				Gomis-Ruth, F. Xavier			Third time lucky? Getting a grip on matrix metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CANCER; STRATEGIES	Drug candidates against matrix metalloproteinases (MMPs) failed in the clinic in the past because their strong zinc-targeting warheads led to a lack of specificity. More recently, significant selectivity among MMPs was achieved by blocking the enzymes' specificity pockets, nearby exosites, and downstream domains. Scannevin and colleagues now elegantly twist the plot and achieve ultimate selectivity: They target MMP-9 by allosterically preventing activation of its zymogen.	[Gomis-Ruth, F. Xavier] CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, Barcelona Sci Pk,Baldiri Reixac 15-21, E-08028 Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Gomis-Ruth, FX (corresponding author), CSIC, Proteolysis Lab, Mol Biol Inst Barcelona, Barcelona Sci Pk,Baldiri Reixac 15-21, E-08028 Barcelona, Spain.	xgrcri@ibmb.csic.es		Gomis-Ruth, F. Xavier/0000-0002-6848-6874	Spanish and Catalan agencies [BFU2015-64487-R, MDM-2014-0435, 2017SGR3]	Spanish and Catalan agencies	This work was supported in part by grants from Spanish and Catalan agencies (BFU2015-64487-R; MDM-2014-0435, and 2017SGR3). The author declares that he has no conflicts of interest with the contents of this article.	Caton J, 2011, PHARMACOL RES, V63, P114, DOI 10.1016/j.phrs.2010.12.003; Dufour A, 2013, TRENDS PHARMACOL SCI, V34, P233, DOI 10.1016/j.tips.2013.02.004; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Scannevin RH, 2017, J BIOL CHEM, V292, P17963, DOI 10.1074/jbc.M117.806075; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Zucker S, 2000, ONCOGENE, V19, P6642, DOI 10.1038/sj.onc.1204097	10	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17975	17976		10.1074/jbc.H117.806075	http://dx.doi.org/10.1074/jbc.H117.806075			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	29079642	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000414013000032
J	Pandey, NK; Isas, JM; Rawat, A; Lee, RV; Langen, J; Pandey, P; Langen, R				Pandey, Nitin K.; Isas, J. Mario; Rawat, Anoop; Lee, Rachel V.; Langen, Jennifer; Pandey, Priyatama; Langen, Ralf			The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ISLET AMYLOID POLYPEPTIDE; NUCLEAR-MAGNETIC-RESONANCE; BOUND ALPHA-SYNUCLEIN; POLYGLUTAMINE AGGREGATION; MUTANT HUNTINGTIN; FLANKING SEQUENCES; LIPID-MEMBRANES; PROTEIN AGGREGATION; MAMMALIAN-CELLS	Aggregation of huntingtin protein arising from expanded polyglutamine (polyQ) sequences in the exon-1 region of mutant huntingtin plays a central role in the pathogenesis of Huntington's disease. The huntingtin aggregation pathways are of therapeutic and diagnostic interest, but obtaining critical information from the physiologically relevant htt exon-1 (Httex1) protein has been challenging. Using biophysical techniques and an expression and purification protocol that generates clean, monomeric Httex1, we identified and mapped three distinct aggregation pathways: 1) unseeded in solution; 2) seeded in solution; and 3) membrane-mediated. In solution, aggregation proceeded in a highly stepwise manner, in which the individual domains (N terminus containing 17 amino acids (N17), polyQ, and proline-rich domain (PRD)) become ordered at very different rates. The aggregation was initiated by an early oligomer requiring a pathogenic, expanded Gln length and N17 beta-helix formation. In the second phase, beta-sheet forms in the polyQ. The slowest step is the final structural maturation of the PRD. This stepwise mechanism could be bypassed by seeding, which potently accelerated aggregation and was a prerequisite for prion-like spreading in vivo. Remarkably, membranes could catalyze aggregation even more potently than seeds, in a process that caused significant membrane damage. The N17 governed membrane-mediated aggregation by anchoring Httex1 to the membrane, enhancing local concentration and promoting collision via two-dimensionaldiffusion. Considering its central roles in solution and in membrane-mediated aggregation, the N17 represents an attractive target for inhibiting multiple pathways. Our approach should help evaluate such inhibitors and identify diagnostic markers for the misfolded forms identified here.	[Langen, Ralf] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biochem & Mol Medicine, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Langen, R (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90033 USA.	langen@usc.edu	Rawat, Anoop/GPS-5531-2022; Rawat, Anoop/AAO-6795-2021; Pandey, Nitin K./AAP-1523-2021	Rawat, Anoop/0000-0002-5838-0275; Pandey, Nitin K./0000-0001-6124-4090; Langen, Jennifer/0000-0003-4427-1489	National Institutes of Health [NS084345, NS089932, GM115736]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084345, R01NS089932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS084345, NS089932, and GM115736. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Buning S, 2017, PHYS CHEM CHEM PHYS, V19, P10738, DOI 10.1039/c6cp08167c; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Burke KA, 2013, BBA-BIOMEMBRANES, V1828, P1953, DOI 10.1016/j.bbamem.2013.04.025; Chaibva M, 2014, BIOCHEMISTRY-US, V53, P2355, DOI 10.1021/bi401619q; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dikiy I, 2012, BBA-BIOMEMBRANES, V1818, P1013, DOI 10.1016/j.bbamem.2011.09.008; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Isas JM, 2017, BIOCHEMISTRY-US, V56, P3579, DOI 10.1021/acs.biochem.7b00138; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayaraman M, 2012, BIOCHEMISTRY-US, V51, P2706, DOI 10.1021/bi3000929; Jayaraman M, 2012, J MOL BIOL, V415, P881, DOI 10.1016/j.jmb.2011.12.010; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Jiang DL, 2012, LANGMUIR, V28, P12711, DOI 10.1021/la3021436; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6738, DOI 10.1021/bi500449a; Kokona B, 2014, BIOCHEMISTRY-US, V53, P6747, DOI 10.1021/bi501066q; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin DDO, 2015, TRENDS NEUROSCI, V38, P26, DOI 10.1016/j.tins.2014.09.003; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Michalek M, 2013, BIOCHEMISTRY-US, V52, P847, DOI 10.1021/bi301325q; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muller P, 2014, BIOINFORMATICS, V30, P2532, DOI 10.1093/bioinformatics/btu328; Okada AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31094; Perevozchikova T, 2014, BIOPHYS J, V107, P411, DOI 10.1016/j.bpj.2014.06.002; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Relini A, 2009, CHEM PHYS LIPIDS, V158, P1, DOI 10.1016/j.chemphyslip.2008.11.003; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sahoo B, 2016, METHODS MOL BIOL, V1345, P67, DOI 10.1007/978-1-4939-2978-8_5; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Shen K, 2016, ELIFE, V5, DOI 10.7554/eLife.18065; Singer D, 2010, J PEPT SCI, V16, P358, DOI 10.1002/psc.1252; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tan Z, 2015, MOL PSYCHIATR, V20, P1286, DOI 10.1038/mp.2015.81; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Valencia A, 2010, J NEUROSCI RES, V88, P179, DOI 10.1002/jnr.22184; Varkey J, 2017, J MAGN RESON, V280, P127, DOI 10.1016/j.jmr.2017.02.014; Vieweg S, 2016, J BIOL CHEM, V291, P12074, DOI 10.1074/jbc.M116.713982; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905; Zhang LL, 2017, J PHYS CHEM B, V121, P4713, DOI 10.1021/acs.jpcb.7b01476	67	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2597	2605		10.1074/jbc.M117.813667	http://dx.doi.org/10.1074/jbc.M117.813667			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29282287	hybrid, Green Published			2022-12-28	WOS:000425308300030
J	Xue, CL; Lam, KH; Zhang, HW; Sun, KL; Lee, SH; Chen, X; Au, SWN				Xue, Chaolun; Lam, Kwok Ho; Zhang, Huawei; Sun, Kailei; Lee, Sai Hang; Chen, Xin; Au, Shannon Wing Ngor			Crystal structure of the FliF-FliG complex from Helicobacter pylori yields insight into the assembly of the motor MS-C ring in the bacterial flagellum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; Helicobacter pylori; molecular motor; protein assembly; protein structure; flagellar motor; bacterial motility	SWITCH PROTEIN FLIG; SALMONELLA-TYPHIMURIUM; SYSTEM; CONSERVATION	The bacterial flagellar motor is a self-assembling supramolecular nanodevice. Its spontaneous biosynthesis is initiated by the insertion of the MS ring protein FliF into the inner membrane, followed by attachment of the switch protein FliG. Assembly of this multiprotein complex is tightly regulated to avoid nonspecific aggregation, but the molecular mechanisms governing flagellar assembly are unclear. Here, we present the crystal structure of the cytoplasmic domain of FliF complexed with the N-terminal domain of FliG (FliF(C)-FliG(N)) from the bacterium Helicobacter pylori. Within this complex, FliF(C) interacted with FliG(N) through extensive hydrophobic contacts similar to those observed in the FliF(C)-FliG(N) structure from the thermophile Thermotoga maritima, indicating conservation of the FliF(C)-FliG(N) interaction across bacterial species. Analysis of the crystal lattice revealed that the heterodimeric complex packs as a linear superhelix via stacking of the armadillo repeat-like motifs (ARM) of FliG(N). Notably, this linear helix was similar to that observed for the assembly of the FliG middle domain. We validated the in vivo relevance of the FliG(N) stacking by complementation studies in Escherichia coli. Furthermore, structural comparison with apo FliG from the thermophile Aquifex aeolicus indicated that FliF regulates the conformational transition of FliG and exposes the complementary ARM-like motifs of FliG(N), containing conserved hydrophobic residues. FliF apparently both provides a template for FliG polymerization and spatiotemporally controls subunit interactions within FliG. Our findings reveal that a small protein fold can serve as a versatile building block to assemble into a multiprotein machinery of distinct shapes for specific functions.	[Xue, Chaolun; Lam, Kwok Ho; Zhang, Huawei; Sun, Kailei; Lee, Sai Hang; Chen, Xin; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Lam, Kwok Ho] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA	Chinese University of Hong Kong; University of California System; University of California Irvine	Au, SWN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	shannon-au@cuhk.edu.hk	zhang, huawei/S-6761-2019	zhang, huawei/0000-0002-5625-5809	General Research Fund Project [460112]; NSFC-RGC Joint Research Scheme Project [N_CUHK454/13]; Research Grants Council, Hong Kong; Chinese University of Hong Kong	General Research Fund Project; NSFC-RGC Joint Research Scheme Project; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the General Research Fund Project Grant 460112 and NSFC-RGC Joint Research Scheme Project Grant N_CUHK454/13, Research Grants Council, Hong Kong, and the Direct Grant from The Chinese University of Hong Kong. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker M. A. B., 2016, NAT STRUCT MOL BIOL; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; Kim EA, 2017, J MOL BIOL, V429, P1305, DOI 10.1016/j.jmb.2017.02.014; Kubori T, 1997, J BACTERIOL, V179, P813, DOI 10.1128/jb.179.3.813-817.1997; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Levenson R, 2012, BIOCHEMISTRY-US, V51, P5052, DOI 10.1021/bi3004582; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Lynch MJ, 2017, STRUCTURE, V25, P317, DOI 10.1016/j.str.2016.12.006; Marykwas DL, 1996, J MOL BIOL, V256, P564, DOI 10.1006/jmbi.1996.0109; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	28	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2066	2078		10.1074/jbc.M117.797936	http://dx.doi.org/10.1074/jbc.M117.797936			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29229777	hybrid, Green Published			2022-12-28	WOS:000424948000019
J	Nicolussi, A; Dunn, JD; Mlynek, G; Bellei, M; Zamocky, M; Battistuzzi, G; Djinovic-Carugo, K; Furtmuller, PG; Soldati, T; Obinger, C				Nicolussi, Andrea; Dunn, Joe Dan; Mlynek, Georg; Bellei, Marzia; Zamocky, Marcel; Battistuzzi, Gianantonio; Djinovic-Carugo, Kristina; Furtmueller, Paul G.; Soldati, Thierry; Obinger, Christian			Secreted heme peroxidase from Dictyostelium discoideum: Insights into catalysis, structure, and biological role	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dictyostelium; post-translational modification (PTM); heme; peroxidase; heme peroxidase; oxidation-reduction (redox); X-ray crystallography; kinetics; antibacterial activity; halide oxidation; modified heme-modified heme; antibacterial activity; fruiting body	BACTERIAL PEROXIDASE; REDOX THERMODYNAMICS; COVALENT HEME; PROTEIN BONDS; COMPOUND-I; MYELOPEROXIDASE; MODEL; LACTOPEROXIDASE; THIOCYANATE; MECHANISMS	Oxidation of halides and thiocyanate by heme peroxidases to antimicrobial oxidants is an important cornerstone in the innate immune system of mammals. Interestingly, phylogenetic and physiological studies suggest that homologous peroxidases are already present in mycetozoan eukaryotes such as Dictyostelium discoideum. This social amoeba kills bacteria via phagocytosis for nutrient acquisition at its single-cell stage and for antibacterial defense at its multicellular stages. Here, we demonstrate that peroxidase A from D. discoideum (DdPoxA) is a stable, monomeric, glycosylated, and secreted heme peroxidase with homology to mammalian peroxidases. The first crystal structure (2.5 resolution) of a mycetozoan peroxidase of this superfamily shows the presence of a post-translationally-modified heme with one single covalent ester bond between the 1-methyl heme substituent and Glu-236. The metalloprotein follows the halogenation cycle, whereby compound I oxidizes iodide and thiocyanate at high rates (>10(8) m(-1) s(-1)) and bromide at very low rates. It is demonstrated that DdPoxA is up-regulated and likely secreted at late multicellular development stages of D. discoideum when migrating slugs differentiate into fruiting bodies that contain persistent spores on top of a cellular stalk. Expression of DdPoxA is shown to restrict bacterial contamination of fruiting bodies. Structure and function of DdPoxA are compared with evolutionary-related mammalian peroxidases in the context of non-specific immune defense.	[Nicolussi, Andrea; Zamocky, Marcel; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria; [Dunn, Joe Dan; Soldati, Thierry] Univ Geneva, Fac Sci, Dept Biochem, CH-1211 Geneva, Switzerland; [Mlynek, Georg; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Bellei, Marzia] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy; [Battistuzzi, Gianantonio] Univ Modena & Reggio Emilia, Dept Chem & Geol, Via Campi 103, I-41125 Modena, Italy; [Zamocky, Marcel] Slovak Acad Sci, Inst Mol Biol, Bratislava 84551, Slovakia; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Ljubljana 1000, Slovenia	University of Natural Resources & Life Sciences, Vienna; University of Geneva; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; Slovak Academy of Sciences; University of Ljubljana	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, A-1190 Vienna, Austria.	christian.obinger@boku.ac.at	Battistuzzi, Gianantonio/L-7183-2015; Djinovic-Carugo, Kristina/AAW-1167-2021; SOLDATI, Thierry/A-2902-2009; Obinger, Christian/AAV-3173-2021; SOLDATI, Thierry/U-6494-2019; Furtmüller, Paul G./Y-5819-2018; Zamocky, Marcel/AAC-2882-2019	Battistuzzi, Gianantonio/0000-0003-4716-5745; Djinovic-Carugo, Kristina/0000-0003-0252-2972; SOLDATI, Thierry/0000-0002-2056-7931; SOLDATI, Thierry/0000-0002-2056-7931; Furtmüller, Paul G./0000-0002-1199-2469; Zamocky, Marcel/0000-0002-2443-2823; Dunn, Joe Dan/0000-0002-5091-4527; Obinger, Christian/0000-0002-7133-3430	Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant [W1224]; Swiss National Science Foundation; Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise" [253275]	Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise"	This work was supported in part by Austrian Science Fund (FWF) Doctoral Program BioToP-Molecular Technology of Proteins Grant W1224 and multiple grants from the Swiss National Science Foundation (to the T. Soldati laboratory). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by Federal Ministry of Economy, Family and Youth through the initiative "Laura Bassi Centres of Expertise," funding the Center of Optimized Structural Studies, Grant 253275.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Annesley SJ, 2009, MOL CELL BIOCHEM, V329, P73, DOI 10.1007/s11010-009-0111-8; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Auer M, 2014, J BIOL CHEM, V289, P31480, DOI 10.1074/jbc.M114.595157; Auer M, 2013, J BIOL CHEM, V288, P27181, DOI 10.1074/jbc.M113.477067; Bafort F, 2014, ENZYME RES, V2014, DOI DOI 10.1155/2014/517164; Banerjee S, 2011, BIOTECHNOL J, V6, P231, DOI 10.1002/biot.201000375; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V500, P21, DOI 10.1016/j.abb.2010.03.002; Battistuzzi G, 2010, ARCH BIOCHEM BIOPHYS, V494, P72, DOI 10.1016/j.abb.2009.11.021; BETTS PM, 1979, CAN J MICROBIOL, V25, P1277, DOI 10.1139/m79-201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley CM, 2016, P NATL ACAD SCI USA, V113, pE5906, DOI 10.1073/pnas.1524532113; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Chandler JD, 2015, FREE RADICAL RES, V49, P695, DOI 10.3109/10715762.2014.1003372; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Cosson P, 2014, CELL MICROBIOL, V16, P816, DOI 10.1111/cmi.12291; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; Desjardins M, 2005, IMMUNOL REV, V207, P158, DOI 10.1111/j.0105-2896.2005.00319.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Furtmuller PG, 2000, BIOCHEMISTRY-US, V39, P15578, DOI 10.1021/bi0020271; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Hagedorn Monica, 2006, V346, P327; Hofbauer S, 2014, BIOTECHNOL J, V9, P461, DOI 10.1002/biot.201300210; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Leiba J, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12722; Li SI, 2011, TRENDS GENET, V27, P48, DOI 10.1016/j.tig.2010.11.003; Lin YW, 2015, BBA-PROTEINS PROTEOM, V1854, P844, DOI 10.1016/j.bbapap.2015.04.019; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Malik A, 2012, CRIT REV MICROBIOL, V38, P168, DOI 10.3109/1040841X.2011.645519; Monnat J, 1997, FEBS LETT, V418, P357, DOI 10.1016/S0014-5793(97)01415-4; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; Nicolussi A, 2017, BIOCHEMISTRY-US, V56, P4525, DOI 10.1021/acs.biochem.7b00632; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Paumann-Page M, 2017, J BIOL CHEM, V292, P4583, DOI 10.1074/jbc.M117.775213; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Romeralo M, 2012, PROTIST, V163, P327, DOI 10.1016/j.protis.2011.09.004; Sharma Sujata, 2013, Int J Biochem Mol Biol, V4, P108; Shetaya WH, 2012, GEOCHIM COSMOCHIM AC, V77, P457, DOI 10.1016/j.gca.2011.10.034; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Skaff O, 2009, BIOCHEM J, V422, P111, DOI 10.1042/BJ20090276; Stajdohar M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1706-9; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhang XZ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00269; Zhang XZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10938	68	6	6	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1330	1345		10.1074/jbc.RA117.000463	http://dx.doi.org/10.1074/jbc.RA117.000463			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242189	Green Published, hybrid			2022-12-28	WOS:000423515000019
J	Lee, NS; Chang, HR; Kim, S; Ji, JH; Lee, J; Lee, HJ; Seo, Y; Kang, M; Han, JS; Myung, K; Kim, Y; Kim, H				Lee, Nam Soo; Chang, Hae Ryung; Kim, Soomi; Ji, Jae-Hoon; Lee, Joorak; Lee, Hyun Ji; Seo, Yoojeong; Kang, Misun; Han, Joo Seok; Myung, Kyungjae; Kim, Yonghwan; Kim, Hongtae			Ring finger protein 126 (RNF126) suppresses ionizing radiation-induced p53-binding protein 1 (53BP1) focus formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; histone modification; signal transduction; ubiquitylation (ubiquitination)	DOUBLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; HOMOLOGOUS RECOMBINATION; BINDING DOMAINS; REPAIR PROTEINS; UBIQUITIN; ATM; BRCA1; RNF8; UBIQUITYLATION	Cells have evolved sophisticated mechanisms to maintain genomic integrity in response to DNA damage. Ionizing radiation (IR)-induced DNA damage results in the formation of IR-induced foci (iRIF) in the nucleus. The iRIF formation is part of the DNA damage response (DDR), which is an essential signaling cascade that must be strictly regulated because either the loss of or an augmented DDR leads to loss of genome integrity. Accordingly, negative regulation of the DDR is as critical as its activation. In this study, we have identified ring finger protein 126 (RNF126) as a negative regulator of the DDR from a screen of iRIF containing 53BP1. RNF126 overexpression abolishes not only the formation of 53BP1 iRIF but also of RNF168, FK2, RAP80, and BRCA1. However, the iRIF formation of H2AX, MDC1, and RNF8 is maintained, indicating that RNF126 acts between RNF8 and RNF168 during the DDR. In addition, RNF126 overexpression consistently results in the loss of RNF168-mediated H2A monoubiquitination at lysine 13/15 and inhibition of the non-homologous end joining capability. Taken together, our findings reveal that RNF126 is a novel factor involved in the negative regulation of DDR, which is important for sustaining genomic integrity.	[Lee, Nam Soo; Kim, Soomi; Lee, Joorak; Kim, Hongtae] Sungkyunkwan Univ, Dept Biol Sci, Suwon 16419, South Korea; [Chang, Hae Ryung; Lee, Hyun Ji; Seo, Yoojeong; Kim, Yonghwan] Sookmyung Womens Univ, Dept Biol Sci, Seoul 04310, South Korea; [Ji, Jae-Hoon] Ajou Univ, Sch Med, Genom Instabil Res Ctr, Suwon 16499, South Korea; [Kang, Misun; Han, Joo Seok; Myung, Kyungjae] Ulsan Natl Inst Sci & Technol, Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Kim, Hongtae] Sungkyunkwan Univ, Inst Basic Sci, Ctr Neurosci Imaging Res, Suwon 16419, South Korea	Sungkyunkwan University (SKKU); Sookmyung Women's University; Ajou University; Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST); Institute for Basic Science - Korea (IBS); Sungkyunkwan University (SKKU)	Kim, Y (corresponding author), 100 Cheongpa Ro,47 Gil, Seoul 04310, South Korea.; Kim, H (corresponding author), 300 Cheoncheon Dong, Suwon 16473, South Korea.	yhkim@sookmyung.ac.kr; khtcat@skku.edu		Kim, Soomi/0000-0003-2171-4398; Lee, Hyunji/0000-0001-8092-6273	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2015R1A2A2A01003975, NRF-2016R1A5A1011974]; Genome Technology to Business Translation Program [2014M3C9A2064688]; Korean government (MSIP) [2011-0030043]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Genome Technology to Business Translation Program; Korean government (MSIP)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (NRF-2015R1A2A2A01003975 and NRF-2016R1A5A1011974), the Genome Technology to Business Translation Program (2014M3C9A2064688), and the Korean government (MSIP) (2011-0030043). The authors declare that they have no conflicts of interest with the contents of this article.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bekker-Jensen S, 2010, DNA REPAIR, V9, P1219, DOI 10.1016/j.dnarep.2010.09.010; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ishida N, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00347-16; Jungmichel S, 2012, NUCLEIC ACIDS RES, V40, P3913, DOI 10.1093/nar/gkr1300; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Min S, 2014, CELL CYCLE, V13, P666, DOI 10.4161/cc.27548; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Moyal L, 2011, MOL CELL, V41, P529, DOI 10.1016/j.molcel.2011.02.015; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang Y, 2016, ONCOGENE, V35, P1363, DOI 10.1038/onc.2015.198	33	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					588	598		10.1074/jbc.M116.765602	http://dx.doi.org/10.1074/jbc.M116.765602			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29167269	Green Published, hybrid			2022-12-28	WOS:000419915400015
J	Kingsley, CN; Antanasijevic, A; Palka-Hamblin, H; Durst, M; Ramirez, B; Lavie, A; Caffrey, M				Kingsley, Carolyn N.; Antanasijevic, Aleksandar; Palka-Hamblin, Helena; Durst, Matthew; Ramirez, Benjamin; Lavie, Arnon; Caffrey, Michael			Probing the metastable state of influenza hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein structure; influenza virus; nuclear magnetic resonance (NMR); peptide conformation; virus; hemagglutinin	MEMBRANE-FUSION; ENTRY; PEPTIDES; TRIFLUOROETHANOL; MECHANISMS; INFECTION; SYSTEM	Viral entry into host cells is mediated by membrane proteins in a metastable state that transition to a more stable state upon a stimulus. For example, in the influenza envelope protein hemagglutinin (HA), the low pH in the endosome triggers a transition from the metastable prefusion conformation to the stable fusion conformation. To identify probes that interfere with HA function, here we screened a library of H7 HA peptides for inhibition of H7 HA-mediated entry. We discovered a peptide, PEP87 (WSYNAELLVAMENQHTI), that inhibited H7 and H5 HA-mediated entry. PEP87 corresponds to a highly conserved helical region of the HA2 subunit of HA that self-interacts in the neutral pH conformation. Mutagenesis experiments indicated that PEP87 binds to its native region in the HA trimer. We also found that PEP87 is unstructured in isolation but tends to form a helix as evidenced by CD and NMR studies. Fluorescence, chemical cross-linking, and saturation transfer difference NMR data suggested that PEP87 binds to the neutral pH conformation of HA and disrupts the HA structure without affecting its oligomerization state. Together, this work provides support for a model in which PEP87 disrupts HA function by displacing native interactions of the neutral pH conformation. Moreover, our observations indicate that the HA prefusion structure (and perhaps the metastable states of other viral entry proteins) is more dynamic with transient motions being larger than generally appreciated. These findings also suggest that the ensemble of prefusion structures presents many potential sites for targeting in therapeutic interventions.	[Kingsley, Carolyn N.; Antanasijevic, Aleksandar; Palka-Hamblin, Helena; Durst, Matthew; Ramirez, Benjamin; Lavie, Arnon; Caffrey, Michael] Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Caffrey, M (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	caffrey@uic.edu		Lavie, Arnon/0000-0001-5591-8722; Durst, Matthew/0000-0001-9513-2361; Kingsley, Carolyn/0000-0001-8564-7345	Chicago Biomedical Consortium; Chicago Community Trust	Chicago Biomedical Consortium; Chicago Community Trust	This work was supported by the Chicago Biomedical Consortium with support from Searle Funds at the Chicago Community Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Antanasijevic A, 2016, J BIOMOL NMR, V64, P255, DOI 10.1007/s10858-016-0025-1; Antanasijevic A, 2014, J BIOMOL NMR, V60, P37, DOI 10.1007/s10858-014-9848-9; Antanasijevic A, 2014, J BIOL CHEM, V289, P22237, DOI 10.1074/jbc.M114.572974; Antanasijevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076363; Basu A, 2014, J VIROL, V88, P1447, DOI 10.1128/JVI.01225-13; Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bosch BJ, 2004, P NATL ACAD SCI USA, V101, P8455, DOI 10.1073/pnas.0400576101; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; Celigoy J, 2011, J BIOL CHEM, V286, P23975, DOI 10.1074/jbc.M111.251025; Chen Q, 2016, ACS INFECT DIS, V2, P187, DOI 10.1021/acsinfecdis.5b00139; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guilhaudis L, 2002, EUR J BIOCHEM, V269, P4860, DOI 10.1046/j.1432-1033.2002.03187.x; Guo Y, 2009, J MOL BIOL, V394, P600, DOI 10.1016/j.jmb.2009.10.032; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Jiang SB, 2002, CURR PHARM DESIGN, V8, P563; Klein M, 2017, EXPERT OPIN DRUG DIS, V12, P1117, DOI 10.1080/17460441.2017.1372745; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lawless MK, 1996, BIOCHEMISTRY-US, V35, P13697, DOI 10.1021/bi9606962; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; McReynolds S, 2008, BIOCHEMISTRY-US, V47, P6802, DOI 10.1021/bi800622t; MERUTKA G, 1995, J BIOMOL NMR, V5, P14, DOI 10.1007/BF00227466; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Warschawski DE, 2011, BBA-BIOMEMBRANES, V1808, P1957, DOI 10.1016/j.bbamem.2011.03.016; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q	33	3	3	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21590	21597		10.1074/jbc.M117.815043	http://dx.doi.org/10.1074/jbc.M117.815043			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127198	Green Published, hybrid			2022-12-28	WOS:000419013000033
J	Fox-Loe, AM; Moonschi, FH; Richards, CI				Fox-Loe, Ashley M.; Moonschi, Faruk H.; Richards, Christopher I.			Organelle-specific single-molecule imaging of alpha 4 beta 2 nicotinic receptors reveals the effect of nicotine on receptor assembly and cell-surface trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTORS; UP-REGULATION; SUBUNIT STOICHIOMETRY; PULL-DOWN; BINDING; PHARMACOLOGY; CHAPERONE; SENSITIVITY; EXPRESSION; COMPLEXES	Nicotinic acetylcholine receptors (nAChRs) assemble in the endoplasmic reticulum (ER) and traffic to the cell surface as pentamers composed of alpha and beta subunits. Many nAChR sub-types can assemble with varying subunit ratios, giving rise to multiple stoichiometries exhibiting different subcellular localization and functional properties. In addition to the endogenous neurotransmitter acetylcholine, nicotine also binds and activates nAChRs and influences their trafficking and expression on the cell surface. Currently, no available technique can specifically elucidate the stoichiometry of nAChRs in the ER versus those in the plasma membrane. Here, we report a method involving single-molecule fluorescence measurements to determine the structural properties of these membrane proteins after isolation in nanoscale vesicles derived from specific organelles. These cell-derived nanovesicles allowed us to separate single membrane receptors while maintaining them in their physiological environment. Sorting the vesicles according to the organelle of origin enabled us to determine localized differences in receptor structural properties, structural influence on transport between organelles, and changes in receptor assembly within intracellular organelles. These organelle-specific nanovesicles revealed that one structural isoform of the alpha 4 beta 2 nAChR was preferentially trafficked to the cell surface. Moreover, nicotine altered nAChR assembly in the ER, resulting in increased production of the receptor isoform that traffics more efficiently to the cell surface. We conclude that the combined effects of the increased assembly of one nAChR stoichiometry and its preferential trafficking likely drive the up-regulation of nAChRs on the cell surface upon nicotine exposure.	[Fox-Loe, Ashley M.; Moonschi, Faruk H.; Richards, Christopher I.] Univ Kentucky, Dept Chem, 505 Rose St, Lexington, KY 40506 USA	University of Kentucky	Richards, CI (corresponding author), Univ Kentucky, Dept Chem, 505 Rose St, Lexington, KY 40506 USA.	chris.richards@uky.edu			National Institute on Drug Abuse, National Institutes of Health [DA016176, DA038817]; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA038817, T32DA016176, R21DA038817] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institute on Drug Abuse, National Institutes of Health Training Grants DA016176 (A. M. F.-L.) and DA038817. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Amici SA, 2012, J BIOL CHEM, V287, P23119, DOI 10.1074/jbc.M111.328294; ANAND R, 1991, J BIOL CHEM, V266, P11192; Araki Y, 2010, P NATL ACAD SCI USA, V107, P11080, DOI 10.1073/pnas.1006584107; Banerjee PR, 2016, ANGEW CHEM INT EDIT, V55, P12789, DOI 10.1002/anie.201606963; Bharill S, 2014, P NATL ACAD SCI USA, V111, P6491, DOI 10.1073/pnas.1400248111; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Durisic N, 2012, J NEUROSCI, V32, P12915, DOI 10.1523/JNEUROSCI.2050-12.2012; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Fasoli F, 2016, NEUROPHARMACOLOGY, V108, P324, DOI 10.1016/j.neuropharm.2016.04.048; Foo YH, 2012, BIOPHYS J, V102, P1174, DOI 10.1016/j.bpj.2012.01.040; Fox AM, 2015, J BIOL CHEM, V290, P24403, DOI 10.1074/jbc.M115.661827; Fox-Loe AM, 2016, NEUROMETHODS, V117, P119, DOI 10.1007/978-1-4939-3768-4_7; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Henderson BJ, 2015, NEUROPHARMACOLOGY, V96, P178, DOI 10.1016/j.neuropharm.2015.01.022; Henderson BJ, 2014, J GEN PHYSIOL, V143, P51, DOI 10.1085/jgp.201311102; Husbands AY, 2016, PLANT CELL, V28, P1783, DOI 10.1105/tpc.16.00289; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Khiroug SS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-141; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lee J, 2017, BIOCHEMISTRY-US, V56, P977, DOI 10.1021/acs.biochem.6b01252; Li XH, 2014, METHODS MOL BIOL, V1174, P85, DOI 10.1007/978-1-4939-0944-5_6; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Marks MJ, 2015, NEUROPHARMACOLOGY, V99, P142, DOI 10.1016/j.neuropharm.2015.07.019; Mazzo F, 2013, J NEUROSCI, V33, P12316, DOI 10.1523/JNEUROSCI.2393-13.2013; Moonschi FH, 2015, ANGEW CHEM INT EDIT, V54, P481, DOI 10.1002/anie.201408707; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Morales-Perez CL, 2016, STRUCTURE, V24, P797, DOI 10.1016/j.str.2016.03.004; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mukhin AG, 2008, J NUCL MED, V49, P1628, DOI 10.2967/jnumed.108.050716; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Ngolab J, 2015, J NEUROSCI, V35, P8570, DOI 10.1523/JNEUROSCI.4453-14.2015; Richards CI, 2012, NANO LETT, V12, P3690, DOI 10.1021/nl301480h; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Rodgers ML, 2015, RNA, V21, P1031, DOI 10.1261/rna.047845.114; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Srinivasan R, 2012, MOL PHARMACOL, V81, P759, DOI 10.1124/mol.112.077792; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; Zhang ZH, 2017, BIOCHEMISTRY-US, V56, P240, DOI 10.1021/acs.biochem.6b00853; Zwart R, 1998, MOL PHARMACOL, V54, P1124, DOI 10.1124/mol.54.6.1124	44	4	5	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21159	21169		10.1074/jbc.M117.801431	http://dx.doi.org/10.1074/jbc.M117.801431			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074617	hybrid, Green Published			2022-12-28	WOS:000418453400030
J	Perlenfein, TJ; Murphy, RM				Perlenfein, Tyler J.; Murphy, Regina M.			A mechanistic model to predict effects of cathepsin B and cystatin C on beta-amyloid aggregation and degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; THIOFLAVIN-T; FIBRIL FORMATION; STRUCTURAL BASIS; MEMORY DEFICITS; KINETIC-DATA; WILD-TYPE; BINDING; ANGIOPATHY	beta-Amyloid (A beta) aggregation is thought to initiate a cascade of neurodegenerative events in Alzheimer's disease (AD). Much effort is underway to develop strategies to reduceA beta-concentration or inhibit aggregation. Cathepsin B (CatB) proteolytically degrades A beta into non-aggregating fragments but is potently inhibited by cystatin C (CysC). It has been suggested that decreasing CysC would facilitate A beta clearance by relieving CatB inhibition. However, CysC binds A beta and inhibits A beta aggregation, suggesting that an intervention that increases CysC would prevent A beta aggregation. Both approaches have been tested in animal models, yielding contradictory results, possibly because of the opposing influences of CysC on A beta degradation versus aggregation. Here, we sought to develop a model that quantitatively predicts the effects of CysC and CatB on A beta aggregation. A beta aggregation kinetics in the absence of CatB or CysC was measured. The rate constant for A beta degradation by CatB and the equilibrium constant for binding of CysC to A beta were determined. We derived a mathematical model that combines material balances and kinetic rate equations. The model accurately predicted A beta aggregation kinetics at various CatB and CysC concentrations. We derived approximate expressions for the half-times of degradation and aggregation and show that their ratio can be used to estimate, at any given A beta, CatB, or CysC concentration, whether A beta aggregation or degradation will result. Our results may be useful for designing experiments and interpreting results from investigations of manipulation of CysC concentration as an AD therapy.	[Perlenfein, Tyler J.; Murphy, Regina M.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Murphy, RM (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	regina.murphy@wisc.edu			National Science Foundation [CBET-1262729, CBET-1703237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grants CBET-1262729 and CBET-1703237. The authors declare that they have no conflicts of interest with the contents of this article.	Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Asgeirsson B, 1998, BIOCHEM J, V329, P497, DOI 10.1042/bj3290497; Bernacki JP, 2009, BIOPHYS J, V96, P2871, DOI 10.1016/j.bpj.2008.12.3903; BJORK I, 1994, BIOCHEM J, V299, P219, DOI 10.1042/bj2990219; Bourhim M, 2007, J NEUROSCI METH, V160, P264, DOI 10.1016/j.jneumeth.2006.09.013; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Calero M, 2001, J NEUROCHEM, V77, P628, DOI 10.1046/j.1471-4159.2001.00256.x; CORIA F, 1987, AM J PATHOL, V129, P422; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Ekiel I, 1997, J MOL BIOL, V271, P266, DOI 10.1006/jmbi.1997.1150; Ekiel I, 1996, J BIOL CHEM, V271, P1314, DOI 10.1074/jbc.271.3.1314; Embury CM, 2017, J NEUROIMMUNE PHARM, V12, P340, DOI 10.1007/s11481-016-9721-6; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; Hall A, 1998, BIOCHEMISTRY-US, V37, P4071, DOI 10.1021/bi971197j; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hook VYH, 2008, J BIOL CHEM, V283, P7745, DOI 10.1074/jbc.M708362200; Hyytia H, 2010, J IMMUNOL METHODS, V355, P14, DOI 10.1016/j.jim.2010.02.014; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Juszczyk P, 2009, J MED CHEM, V52, P2420, DOI 10.1021/jm801115e; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Laurent-Matha V, 2012, FASEB J, V26, P5172, DOI 10.1096/fj.12-205229; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Lindberg DJ, 2017, BIOCHEMISTRY-US, V56, P2170, DOI 10.1021/acs.biochem.7b00035; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Liu L, 2006, BIOCHEMISTRY-US, V45, P15702, DOI 10.1021/bi0618520; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; MARUYAMA K, 1992, NEUROSCI LETT, V144, P38, DOI 10.1016/0304-3940(92)90710-O; Mathews PM, 2016, AGEING RES REV, V32, P38, DOI 10.1016/j.arr.2016.06.003; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McCarron MO, 2000, NEUROLOGY, V54, P242, DOI 10.1212/WNL.54.1.242; Merz GS, 1997, J CELL PHYSIOL, V173, P423; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Murphy R. M., 2013, TANDEM REPEATS GENES, P201; Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Nycander M, 1998, FEBS LETT, V422, P61, DOI 10.1016/S0014-5793(97)01604-9; Pate KM, 2017, ISR J CHEM, V57, P602, DOI 10.1002/ijch.201600078; Pellarin R, 2006, J MOL BIOL, V360, P882, DOI 10.1016/j.jmb.2006.05.033; Perlenfein TJ, 2017, J BIOL CHEM, V292, P11485, DOI 10.1074/jbc.M117.786558; Perlenfein TJ, 2016, PROTEIN EXPRES PURIF, V117, P35, DOI 10.1016/j.pep.2015.09.023; POLGAR L, 1987, J BIOL CHEM, V262, P14448; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sundelof J, 2010, J ALZHEIMERS DIS, V22, P1223, DOI 10.3233/JAD-2010-101023; Tiribuzi R, 2014, NEUROBIOL AGING, V35, P345, DOI 10.1016/j.neurobiolaging.2013.08.003; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; VINTERS HV, 1990, ANN NEUROL, V28, P34, DOI 10.1002/ana.410280108; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Wang R, 2017, IEEE PHOTONICS J, V9, DOI 10.1109/JPHOT.2017.2733044; Wang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161093; Werle B, 1997, BRIT J CANCER, V75, P1137, DOI 10.1038/bjc.1997.196; Xue C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160696; Yakovlev AA, 2013, NEUROCHEM J+, V7, P111, DOI 10.1134/S1819712413020098; Yang DT, 2013, BIOCHEMISTRY-US, V52, P2849, DOI 10.1021/bi4001613; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang T, 2017, J NEUROSCI, V37, P152, DOI 10.1523/JNEUROSCI.1698-16.2016; Zhong XT, 2013, RES J BIOTECHNOL, V8, P42	70	9	9	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21071	21082		10.1074/jbc.M117.811448	http://dx.doi.org/10.1074/jbc.M117.811448			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29046353	Green Published, hybrid			2022-12-28	WOS:000418453400022
J	Ayed, SH; Cloutier, AD; McLeod, LJ; Foo, ACY; Damry, AM; Goto, NK				Ayed, Saud H.; Cloutier, Adam D.; McLeod, Laura J.; Foo, Alexander C. Y.; Damry, Adam M.; Goto, Natalie K.			Dissecting the role of conformational change and membrane binding by the bacterial cell division regulator MinE in the stimulation of MinD ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; cell division; circular dichroism (CD); conformational change; enzyme kinetics; nuclear magnetic resonance (NMR); protein structure; protein-lipid interaction	PROTEIN SECONDARY STRUCTURE; TO-POLE OSCILLATION; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; IN-VITRO; TOPOLOGICAL SPECIFICITY; DYNAMIC LOCALIZATION; INHIBITOR MINC; CIRCULAR-DICHROISM; CORRECT PLACEMENT	The bacterial cell division regulators MinD and MinE together with the division inhibitor MinC localize to the membrane in concentrated zones undergoing coordinated pole-to-pole oscillation to help ensure that the cytokinetic division septum forms only at the mid-cell position. This dynamic localization is driven by MinD-catalyzed ATP hydrolysis, stimulated by interactions with MinE's anti-MinCD domain. This domain is buried in the 6--stranded MinE closed structure, but is liberated for interactions with MinD, giving rise to a 4--stranded open structure through an unknown mechanism. Here we show that MinE-membrane interactions induce a structural change into a state resembling the open conformation. However, MinE mutants lacking the MinE membrane-targeting sequence stimulated higher ATP hydrolysis rates than the full-length protein, indicating that binding to MinD is sufficient to trigger this conformational transition in MinE. In contrast, conformational change between the open and closed states did not affect stimulation of ATP hydrolysis rates in the absence of membrane binding, although the MinD-binding residue Ile-25 is critical for this conformational transition. We therefore propose an updated model where MinE is brought to the membrane through interactions with MinD. After stimulation of ATP hydrolysis, MinE remains bound to the membrane in a state that does not catalyze additional rounds of ATP hydrolysis. Although the molecular basis for this inhibited state is unknown, previous observations of higher-order MinE self-association may explain this inhibition. Overall, our findings have general implications for Min protein oscillation cycles, including those that regulate cell division in bacterial pathogens.	[Ayed, Saud H.; Cloutier, Adam D.; McLeod, Laura J.; Foo, Alexander C. Y.; Damry, Adam M.; Goto, Natalie K.] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Goto, NK (corresponding author), Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada.	ngoto@uottawa.ca	Goto, Natalie/AAO-7979-2020	Goto, Natalie/0000-0003-4877-4884; Foo, Alexander/0000-0002-4331-2085	NSERC Discovery grant; Dr. Yu Scholarship; Ontario Graduate Scholarship; NSERC postgraduate scholarship	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dr. Yu Scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by an NSERC Discovery grant (to N. K. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Dr. Yu Scholarship.; Supported by an Ontario Graduate Scholarship.; Supported by an NSERC postgraduate scholarship.	ADLER HI, 1967, P NATL ACAD SCI USA, V57, P321, DOI 10.1073/pnas.57.2.321; ANTHONY LSD, 1994, FEMS MICROBIOL LETT, V124, P157, DOI 10.1111/j.1574-6968.1994.tb07278.x; Bonny M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003347; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; DEBOER PAJ, 1988, J BACTERIOL, V170, P2106, DOI 10.1128/jb.170.5.2106-2112.1988; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eng NF, 2006, RES MICROBIOL, V157, P333, DOI 10.1016/j.resmic.2005.09.005; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Ghasriani H, 2010, P NATL ACAD SCI USA, V107, P18416, DOI 10.1073/pnas.1007141107; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Hsieh CW, 2010, MOL MICROBIOL, V75, P499, DOI 10.1111/j.1365-2958.2009.07006.x; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Hu ZL, 2001, MOL CELL, V7, P1337, DOI 10.1016/S1097-2765(01)00273-8; Huang KC, 2003, P NATL ACAD SCI USA, V100, P12724, DOI 10.1073/pnas.2135445100; Ivanov V, 2010, P NATL ACAD SCI USA, V107, P8071, DOI 10.1073/pnas.0911036107; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King GF, 2000, NAT STRUCT BIOL, V7, P1013, DOI 10.1038/80917; Lackner LL, 2003, J BACTERIOL, V185, P735, DOI 10.1128/JB.185.3.735-749.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laughlin RB, 2015, P NATL ACAD SCI USA, V112, P10371, DOI 10.1073/pnas.1422855112; Leger MM, 2015, P NATL ACAD SCI USA, V112, P10239, DOI 10.1073/pnas.1421392112; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Loose M, 2011, NAT STRUCT MOL BIOL, V18, P577, DOI 10.1038/nsmb.2037; Ma LY, 2003, J BACTERIOL, V185, P4948, DOI 10.1128/JB.185.16.4948-4955.2003; Meacci G, 2006, PHYS BIOL, V3, P255, DOI 10.1088/1478-3975/3/4/003; Mileykovskaya E, 2003, J BIOL CHEM, V278, P22193, DOI 10.1074/jbc.M302603200; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Park KT, 2017, P NATL ACAD SCI USA, V114, P7497, DOI 10.1073/pnas.1707385114; Park KT, 2012, MOL MICROBIOL, V85, P271, DOI 10.1111/j.1365-2958.2012.08110.x; Park KT, 2011, CELL, V146, P396, DOI 10.1016/j.cell.2011.06.042; Parti RP, 2011, MICROB PATHOGENESIS, V51, P378, DOI 10.1016/j.micpath.2011.07.003; Parti RP, 2011, MICROBES INFECT, V13, P545, DOI 10.1016/j.micinf.2011.01.018; Ramirez-Arcos S, 2002, MOL MICROBIOL, V46, P493, DOI 10.1046/j.1365-2958.2002.03168.x; Ramirez-Arcos S, 2001, MICROBIOL-SGM, V147, P225, DOI 10.1099/00221287-147-1-225; Ramos D, 2006, BIOCHEMISTRY-US, V45, P4593, DOI 10.1021/bi060022j; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Renner LD, 2012, J BIOL CHEM, V287, P38835, DOI 10.1074/jbc.M112.407817; Rowland SL, 2000, J BACTERIOL, V182, P613, DOI 10.1128/JB.182.3.613-619.2000; Sengupta S, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056003; Shih YL, 2013, ENVIRON MICROBIOL, V15, P3229, DOI 10.1111/1462-2920.12119; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; SUD IJ, 1975, J BACTERIOL, V124, P713, DOI 10.1128/JB.124.2.713-717.1975; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto J, 2004, J BACTERIOL, V186, P7175, DOI 10.1128/JB.186.21.7175-7185.2004; Szeto J, 2001, J BACTERIOL, V183, P6253, DOI 10.1128/JB.183.21.6253-6264.2001; Taghbalout A, 2006, J BACTERIOL, V188, P2993, DOI 10.1128/JB.188.8.2993-3001.2006; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Vecchiarelli AG, 2016, P NATL ACAD SCI USA, V113, pE1479, DOI 10.1073/pnas.1600644113; Vecchiarelli AG, 2014, MOL MICROBIOL, V93, P453, DOI 10.1111/mmi.12669; Walsh JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128148; WESTLINGHAGGSTROM B, 1977, J BACTERIOL, V129, P333; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9; Wu LJ, 2012, NAT REV MICROBIOL, V10, P8, DOI 10.1038/nrmicro2671; Wu W, 2011, MOL MICROBIOL, V79, P1515, DOI 10.1111/j.1365-2958.2010.07536.x; Zheng M, 2014, J BIOL CHEM, V289, P21252, DOI 10.1074/jbc.M114.571976; Zhou H, 2003, J BACTERIOL, V185, P4326, DOI 10.1128/JB.185.15.4326-4335.2003; Zieske K, 2014, ELIFE, V3, DOI 10.7554/eLife.03949; Zieske K, 2014, FEBS LETT, V588, P2545, DOI 10.1016/j.febslet.2014.06.026; Zieske K, 2013, ANGEW CHEM INT EDIT, V52, P459, DOI 10.1002/anie.201207078	69	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20732	20743		10.1074/jbc.M117.805945	http://dx.doi.org/10.1074/jbc.M117.805945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29066619	Green Published, hybrid			2022-12-28	WOS:000418267000033
J	Yee, D; Shah, KM; Coles, MC; Sharp, TV; Lagos, D				Yee, Daniel; Shah, Kunal M.; Coles, Mark C.; Sharp, Tyson V.; Lagos, Dimitris			MicroRNA-155 induction via TNF- and IFN- suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial cell; fibroblast; inflammation; interferon; microRNA (miRNA); PD-L1; immune checkpoint inhibitors; lymphatic endothelial cells; miR-155	ANTIVIRAL INNATE IMMUNITY; ENDOTHELIAL-CELLS; CANCER; MIR-155; B7-H1; DISRUPTION; REGULATORS; TOLERANCE; MPDL3280A	Programmed death ligand-1 (PD-L1) is a critical regulator of T cell function contributing to peripheral immune tolerance. Although it has been shown that posttranscriptional regulatory mechanisms control PD-L1 expression in cancer, it remains unknown whether such regulatory loops operate also in non-transformed cells. Here we studied PD-L1 expression in human dermal lymphatic endothelial cells (HDLECs), which play key roles in immunity and cancer. Treatment of HDLECs with the pro-inflammatory cytokines IFN- and TNF- synergistically up-regulated PD-L1 expression. IFN- and TNF- also affected expression of several microRNAs (miRNAs) that have the potential to suppress PD-L1 expression. The most highly up-regulated miRNA following IFN- and TNF- treatment in HDLECs was miR-155, which has a central role in the immune system and cancer. Induction of miR-155 was driven by TNF-, the effect of which was significantly enhanced by IFN-. The PD-L1 3-UTR contains two functional miR-155-binding sites. Endogenous miR-155 controlled the kinetics and maximal levels of PD-L1 induction upon IFN- and TNF- treatments. We obtained similar findings in dermal fibroblasts, demonstrating that the IFN-/TNF-/miR-155/PD-L1 pathway is not restricted to HDLECs. These results reveal miR-155 as a critical component of an inflammation-induced regulatory loop controlling PD-L1 expression in primary cells.	[Yee, Daniel; Coles, Mark C.; Lagos, Dimitris] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Yee, Daniel; Coles, Mark C.; Lagos, Dimitris] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Shah, Kunal M.; Sharp, Tyson V.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London EC1M 6BQ, England	University of York - UK; University of Hull; University of York - UK; University of London; Queen Mary University London	Lagos, D (corresponding author), Univ York, Hull York Med Sch, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	dimitris.lagos@york.ac.uk	Sharp, Tyson/AAD-6190-2020	Sharp, Tyson/0000-0003-1861-7984; Lagos, Dimitris/0000-0003-0637-281X	Medical Research Council New Investigator Research Grant [MR/L008505/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I007571/2]; BBSRC Doctoral Training Program in "Mechanistic Biology and its Strategic Application" Grant [BB/J01113/1]; Biotechnology and Biological Sciences Research Council [BB/I007571/2, BB/I007571/1, 1504182, BB/L027755/1, BB/L003945/1] Funding Source: researchfish; Cancer Research UK [12733] Funding Source: researchfish; Medical Research Council [1365502, MR/L008505/1] Funding Source: researchfish; BBSRC [BB/I007571/1, BB/I007571/2, BB/L003945/1, BB/L027755/1] Funding Source: UKRI; MRC [MR/L008505/1] Funding Source: UKRI	Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Doctoral Training Program in "Mechanistic Biology and its Strategic Application" Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by Medical Research Council New Investigator Research Grant MR/L008505/1 (to D. L.) and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/I007571/2 (to T. V. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the BBSRC Doctoral Training Program in "Mechanistic Biology and its Strategic Application" Grant BB/J01113/1.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Backes C, 2016, NUCLEIC ACIDS RES, V44, pW110, DOI 10.1093/nar/gkw345; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cortez MA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv303; Dorand RD, 2016, SCIENCE, V353, P399, DOI 10.1126/science.aae0477; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Gracias DT, 2013, NAT IMMUNOL, V14, P593, DOI 10.1038/ni.2576; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep12063; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mazanet MM, 2002, J IMMUNOL, V169, P3581, DOI 10.4049/jimmunol.169.7.3581; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rasmussen TK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0660-z; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rouhani SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7771; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tewalt EF, 2012, BLOOD, V120, P4772, DOI 10.1182/blood-2012-04-427013; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yee D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00104; Zhao L, 2016, ONCOTARGET, V7, P45370, DOI 10.18632/oncotarget.9659; Zhao XH, 2013, NANO, V8, DOI 10.1142/S1793292013500318	43	82	86	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20683	20693		10.1074/jbc.M117.809053	http://dx.doi.org/10.1074/jbc.M117.809053			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29066622	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000418267000029
J	Nielsen, BS; Alstrom, JS; Nicholson, BJ; Nielsen, MS; MacAulay, N				Nielsen, Brian Skriver; Alstrom, Jette Skov; Nicholson, Bruce J.; Nielsen, Morten Schak; MacAulay, Nanna			Permeant-specific gating of connexin 30 hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; connexin; connexon (hemichannel); fluorescence; gating; ion channel; permeability	GAP-JUNCTION CHANNELS; 1ST EXTRACELLULAR LOOP; PORE-LINING RESIDUES; SELECTIVE PERMEABILITY; XENOPUS OOCYTES; ATP RELEASE; INTERSUBUNIT INTERACTIONS; METABOLIC INHIBITION; CX26 HEMICHANNELS; MOLECULAR-BASIS	Gap junctions confer interconnectivity of the cytoplasm in neighboring cells via docking of two connexons expressed in each of the adjacent membranes. Undocked connexons, referred to as hemichannels, may open and connect the cytoplasm with the extracellular fluid. The hemichannel configuration of connexins (Cxs) displays isoform-specific permeability profiles that are not directly determined by the size and charge of the permeant. To further explore Ca2+-mediated gating and permeability features of connexin hemichannels, we heterologously expressed Cx30 hemichannels in Xenopus laevis oocytes. The sensitivity toward divalent cation-mediated gating differed between small atomic ions (current) and fluorescent dye permeants, indicating that these permeants are distinctly gated. Three aspartate residues in Cx30 (Asp-50, Asp-172, and Asp-179) have been implicated previously in the Ca2+ sensitivity of other hemichannel isoforms. Although the aspartate at position Asp-50 was indispensable for divalent cation-dependent gating of Cx30 hemichannels, substitutions of the two other residues had no significant effect on gating, illustrating differences in the gating mechanisms between connexin isoforms. Using the substituted cysteine accessibility method (SCAM), we evaluated the role of possible pore-lining residues in the permeation of ions and ethidium through Cx30 hemichannels. Of the cysteine-substituted residues, interaction of a proposed pore-lining cysteine at position 37 with the positively charged compound [2-(trimethylammonium)ethyl] methane thiosulfonate bromide (MTS-ET) increased Cx30-mediated currents with unperturbed ethidium permeability. In summary, our results demonstrate that the permeability of hemichannels is regulated in a permeant-specific manner and underscores that hemichannels are selective rather than non-discriminating and freely diffusable pores.	[Nielsen, Brian Skriver; Alstrom, Jette Skov; MacAulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Neurosci, DK-2200 Copenhagen N, Denmark; [Nielsen, Morten Schak] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Nicholson, Bruce J.] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Biochem, San Antonio, TX 78229 USA	University of Copenhagen; University of Copenhagen; University of Texas System; University of Texas Health San Antonio	MacAulay, N (corresponding author), Univ Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	MacAulay, Nanna/AER-7709-2022; Nielsen, Morten Schak/C-1494-2009	MacAulay, Nanna/0000-0002-7800-6600; Nielsen, Morten Schak/0000-0002-9718-5421; Nielsen, Brian Skriver/0000-0002-3018-3309	Faculty of Health and Medical Sciences (University of Copenhagen)	Faculty of Health and Medical Sciences (University of Copenhagen)	This work was predominantly supported by the Faculty of Health and Medical Sciences (University of Copenhagen). The authors declare that they have no conflicts of interest with the contents of this article.	Abbaci M, 2008, BIOTECHNIQUES, V45, P33, DOI 10.2144/000112810; Alstrom JS, 2015, J NEUROPHYSIOL, V114, P3014, DOI 10.1152/jn.00575.2015; Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; Bao L, 2004, AM J PHYSIOL-CELL PH, V287, pC1389, DOI 10.1152/ajpcell.00220.2004; Bennett BC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9770; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Bukauskas FF, 2002, J GEN PHYSIOL, V119, P171, DOI 10.1085/jgp.119.2.171; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Garre JM, 2010, P NATL ACAD SCI USA, V107, P22659, DOI 10.1073/pnas.1013793107; Goldberg GS, 1999, NAT CELL BIOL, V1, P457, DOI 10.1038/15693; Goldberg GS, 2004, BBA-BIOMEMBRANES, V1662, P96, DOI 10.1016/j.bbamem.2003.11.022; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Gomez-Hernandez JM, 2003, P NATL ACAD SCI USA, V100, P16030, DOI 10.1073/pnas.2530348100; Gonzalez D, 2006, FASEB J, V20, P2329, DOI 10.1096/fj.06-5828com; Hansen DB, 2014, J BIOL CHEM, V289, P26058, DOI 10.1074/jbc.M114.582155; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jan AY, 2004, J INVEST DERMATOL, V122, P1108, DOI 10.1111/j.0022-202X.2004.22518.x; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kanaporis G, 2011, AM J PHYSIOL-CELL PH, V300, pC600, DOI 10.1152/ajpcell.00316.2010; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; KWAK BR, 1995, EXP CELL RES, V220, P456, DOI 10.1006/excr.1995.1337; Lee JR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001276; Lee JR, 2009, J INVEST DERMATOL, V129, P870, DOI 10.1038/jid.2008.335; Lopez W, 2016, P NATL ACAD SCI USA, V113, pE7986, DOI 10.1073/pnas.1609378113; Lopez W, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.26789; Lopez W, 2013, J GEN PHYSIOL, V142, P23, DOI 10.1085/jgp.201210893; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nicholson BJ, 2000, BRAZ J MED BIOL RES, V33, P369, DOI 10.1590/S0100-879X2000000400002; Nielsen BS, 2017, NEUROCHEM RES, V42, P2537, DOI 10.1007/s11064-017-2243-7; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Niessen H, 2000, J CELL SCI, V113, P1365; Orellana JA, 2011, BIOCHEM BIOPH RES CO, V409, P603, DOI 10.1016/j.bbrc.2011.05.031; Oviedo-Orta E, 2004, BBA-BIOMEMBRANES, V1662, P102, DOI 10.1016/j.bbamem.2003.10.021; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; Toloue M. M., 2007, THESIS; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Vavrusova M, 2013, J AGR FOOD CHEM, V61, P5380, DOI 10.1021/jf400741e; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; WHITE TW, 1992, MOL BIOL CELL, V3, P711, DOI 10.1091/mbc.3.7.711; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yum SW, 2007, AM J PHYSIOL-CELL PH, V293, pC1032, DOI 10.1152/ajpcell.00011.2007; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	61	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19999	20009		10.1074/jbc.M117.805986	http://dx.doi.org/10.1074/jbc.M117.805986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28982982	hybrid, Green Published			2022-12-28	WOS:000417696400007
J	Gururaj, S; Evely, KM; Pryce, KD; Li, J; Qu, J; Bhattacharjee, A				Gururaj, Sushmitha; Evely, Katherine M.; Pryce, Kerri D.; Li, Jun; Qu, Jun; Bhattacharjee, Arin			Protein kinase A-induced internalization of Slack channels from the neuronal membrane occurs by adaptor protein-2/clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; clathrin; endocytosis; neuron; pain; potassium channel; trafficking	ACTIVATED POTASSIUM CHANNEL; ROOT GANGLION NEURONS; K-NA CHANNELS; SENSORY NEURONS; NEUROPATHIC PAIN; CAMP; RAT; HYPEREXCITABILITY; PHOSPHORYLATION; RECOGNITION	The sodium-activated potassium (K-Na) channel Kcnt1 (Slack) is abundantly expressed in nociceptor (pain-sensing) neurons of the dorsal root ganglion (DRG), where they transmit the large outward conductance I-KNa and arbitrate membrane excitability. Slack channel expression at the DRG membrane is necessary for their characteristic firing accommodation during maintained stimulation, and reduced membrane channel density causes hyperexcitability. We have previously shown that in a pro-inflammatory state, a decrease in membrane channel expression leading to reduced Slack-mediated I-KNa expression underlies DRG neuronal sensitization. An important component of the inflammatory milieu, PKA internalizes Slack channels from the DRG membrane, reduces I-KNa, and produces DRG neuronal hyperexcitability when activated in cultured primary DRG neurons. Here, we show that this PKA-induced retrograde trafficking of Slack channels also occurs in intact spinal cord slices and that it is carried out by adaptor protein-2 (AP-2) via clathrin-mediated endocytosis. We provide mass spectrometric and biochemical evidence of an association of native neuronal AP-2 adaptor proteins with Slack channels, facilitated by a dileucine motif housed in the cytoplasmic Slack C terminus that binds AP-2. By creating a competitive peptide blocker of AP-2-Slack binding, we demonstrated that this interaction is essential for clathrin recruitment to the DRG membrane, Slack channel endocytosis, and DRG neuronal hyperexcitability after PKA activation. Together, these findings uncover AP-2 and clathrin as players in Slack channel regulation. Given the significant role of Slack in nociceptive neuronal excitability, the AP-2 clathrin-mediated endocytosis trafficking mechanism may enable targeting of peripheral and possibly, central neuronal sensitization.	[Gururaj, Sushmitha; Pryce, Kerri D.; Bhattacharjee, Arin] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA; [Evely, Katherine M.; Bhattacharjee, Arin] SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA; [Li, Jun; Qu, Jun] New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bhattacharjee, A (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14214 USA.	ab68@buffalo.edu		Pryce, Kerri/0000-0001-6771-2000	National Institutes of Health [NS078184]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM095459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in whole by National Institutes of Health Grant NS078184. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar RC, 2001, J BIOL CHEM, V276, P13145, DOI 10.1074/jbc.M010591200; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; Bischoff U, 1998, J PHYSIOL-LONDON, V510, P743, DOI 10.1111/j.1469-7793.1998.743bj.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Brattacharjee A, 2005, J COMP NEUROL, V484, P80, DOI 10.1002/cne.20462; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Bucelli RC, 2008, J PHARMACOL EXP THER, V324, P1172, DOI 10.1124/jpet.107.132795; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ensenat-Waser R, 2002, IUBMB LIFE, V54, P33, DOI 10.1080/15216540213823; Gururaj S, 2016, NEUROPHARMACOLOGY, V103, P279, DOI 10.1016/j.neuropharm.2015.12.016; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kostich W, 2016, J PHARMACOL EXP THER, V358, P371, DOI 10.1124/jpet.116.235333; Lu RR, 2015, J NEUROSCI, V35, P1125, DOI 10.1523/JNEUROSCI.2423-14.2015; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Malmberg AB, 1997, J NEUROSCI, V17, P7462; Mason AK, 2008, J BIOL CHEM, V283, P5973, DOI 10.1074/jbc.M709756200; Moser B, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600332; Nuwer MO, 2010, J NEUROSCI, V30, P14165, DOI 10.1523/JNEUROSCI.3150-10.2010; Nuwer MO, 2009, NEUROPHARMACOLOGY, V57, P219, DOI 10.1016/j.neuropharm.2009.06.006; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Popova NV, 2013, ACTA NATURAE, V5, P62, DOI 10.32607/20758251-2013-5-3-62-73; RUEFF A, 1993, NEUROSCIENCE, V54, P527, DOI 10.1016/0306-4522(93)90272-H; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Tamsett TJ, 2009, J NEUROSCI, V29, P5127, DOI 10.1523/JNEUROSCI.0859-09.2009; Tomasello DL, 2015, J BIOL CHEM, V290, P18575, DOI 10.1074/jbc.M115.643536; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Ye B, 2006, PHYSIOL RES, V55, P617, DOI 10.33549/physiolres.930866; Zheng JH, 2007, J NEUROPHYSIOL, V97, P15, DOI 10.1152/jn.00559.2006	38	5	6	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19304	19314		10.1074/jbc.M117.804716	http://dx.doi.org/10.1074/jbc.M117.804716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982974	Green Published, hybrid			2022-12-28	WOS:000416226700013
J	Salsaa, M; Case, K; Greenberg, ML				Salsaa, Michael; Case, Kendall; Greenberg, Miriam L.			Orchestrating phospholipid biosynthesis: Phosphatidic acid conducts and Opi1p performs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; INOSITOL SYNTHESIS; METABOLISM; SYNTHASE; CELLS	Phosphatidic acid (PA) and the conserved integral ER membrane protein Scs2p regulate localization of the transcriptional repressor Opi1p, which controls expression of phospholipid biosynthesis genes, but the mechanisms conducting Opi1p localization are not fully understood. A new study suggests the existence of a distinct pool of PA in the ER that is required for regulation of Opi1p localization and thus phospholipid metabolism in yeast.	[Salsaa, Michael; Case, Kendall; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Salsaa, Michael/0000-0001-6247-6336	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125082] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM125082] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Draskovic P, 2008, CHEM BIOL, V15, P274, DOI 10.1016/j.chembiol.2008.01.011; Gaspar ML, 2017, J BIOL CHEM, V292, P18713, DOI 10.1074/jbc.M117.809970; Guan GM, 2003, ARCH BIOCHEM BIOPHYS, V417, P251, DOI 10.1016/S0003-9861(03)00388-6; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Luevano-Martinez LA, 2013, FUNGAL GENET BIOL, V60, P150, DOI 10.1016/j.fgb.2013.03.005; Qiu YX, 2016, J BIOL CHEM, V291, P26455, DOI 10.1074/jbc.M116.763839; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978; Yu WX, 2016, J BIOL CHEM, V291, P10437, DOI 10.1074/jbc.M116.714816; Zhong Q, 2003, J BIOL CHEM, V278, P33978, DOI 10.1074/jbc.M305242200	10	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18729	18730		10.1074/jbc.H117.809970	http://dx.doi.org/10.1074/jbc.H117.809970			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	29127205	hybrid, Green Published			2022-12-28	WOS:000414958100028
J	Melikyan, GB				Melikyan, Gregory B.			How entry inhibitors synergize to fight HIV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								HIV fusion with the cell membrane can be inhibited by blocking coreceptor binding or by preventing fusion-inducing conformational changes in the Env protein. Logically, inhibitors that act by these two mechanisms should act synergistically, but previous studies have reported conflicting results. A new study by Ahn and Root reconciles these discordant reports by demonstrating that synergy emerges when Env engages multiple coreceptors prior to inducing fusion and when high-affinity inhibitory peptides are used, a condition that may not be satisfied in vivo.	[Melikyan, Gregory B.] Emory Univ, Sch Med, Dept Pediat, Infect Dis, Atlanta, GA 30322 USA	Emory University	Melikyan, GB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Infect Dis, Atlanta, GA 30322 USA.	gmeliki@emory.edu			National Institutes of Health Grant [R01 GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Critical reading and helpful comments on the manuscript by the members of the Melikyan laboratory are greatly appreciated. The HIV fusion work in the Melikyan laboratory is supported by the National Institutes of Health Grant R01 GM054787.	Ahn KW, 2017, J BIOL CHEM, V292, P16498, DOI 10.1074/jbc.M117.791731; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Champagne K, 2009, J BIOL CHEM, V284, P3619, DOI 10.1074/jbc.M809269200; Kahle KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000674; Khasnis MD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006098; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Steger HK, 2006, J BIOL CHEM, V281, P25813, DOI 10.1074/jbc.M601457200; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10	9	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16511	16512		10.1074/jbc.H117.791731	http://dx.doi.org/10.1074/jbc.H117.791731			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28986430	hybrid, Green Published			2022-12-28	WOS:000412414800009
J	Krishnan, N; Konidaris, KF; Gasser, G; Tonks, NK				Krishnan, Navasona; Konidaris, Konstantis F.; Gasser, Gilles; Tonks, Nicholas K.			A potent, selective, and orally bioavailable inhibitor of the protein-tyrosine phosphatase PTP1B improves insulin and leptin signaling in animal models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug discovery; obesity; phosphorylation; signal transduction; type 2 diabetes; tyrosine-protein phosphatase (tyrosine phosphatase); drug discovery	MICROINJECTION; SENSITIVITY; DISEASE; OBESITY; DRUGS	The protein-tyrosine phosphatase PTP1B is a negative regulator of insulin and leptin signaling and a highly validated therapeutic target for diabetes and obesity. Conventional approaches to drug development have produced potent and specific PTP1B inhibitors, but these inhibitors lack oral bioavailability, which limits their potential for drug development. Here, we report that DPM-1001, an analog of the specific PTP1B inhibitor trodusquemine (MSI-1436), is a potent, specific, and orally bioavailable inhibitor of PTP1B. DPM-1001 also chelates copper, which enhanced its potency as a PTP1B inhibitor. DPM-1001 displayed anti-diabetic properties that were associated with enhanced signaling through insulin and leptin receptors in animal models of diet-induced obesity. Therefore, DPM-1001 represents a proof of concept for a new approach to therapeutic intervention in diabetes and obesity. Although the PTPs have been considered undruggable, the findings of this study suggest that allosteric PTP inhibitors may help reinvigorate drug development efforts that focus on this important family of signal-transducing enzymes.	[Krishnan, Navasona; Tonks, Nicholas K.] Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA; [Konidaris, Konstantis F.] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Gasser, Gilles] PSL Res Univ, ChimieParisTech, Lab Inorgan Chem Biol, F-75005 Paris, France	Cold Spring Harbor Laboratory; University of Zurich; UDICE-French Research Universities; PSL Research University Paris; Chimie ParisTech	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu	Konidaris, Konstantis/W-3256-2019	Konidaris, Konstantis/0000-0002-7366-5682	National Institutes of Health [CA53840, GM55989]; Cold Spring Harbor Laboratory Cancer Centre Support Grant from the National Institutes of Health [CA45508]; CSHL-Northwell Alliance; ANR [ANR-10-IDEX-0001-02 PSL]; NATIONAL CANCER INSTITUTE [R37CA053840, P30CA045508, R01CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Centre Support Grant from the National Institutes of Health; CSHL-Northwell Alliance; ANR(French National Research Agency (ANR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants CA53840 and GM55989 (to N.K.T.), Cold Spring Harbor Laboratory Cancer Centre Support Grant CA45508 from the National Institutes of Health, the CSHL-Northwell Alliance, and the "Investissements d'Avenir" Program launched by the French Government and implemented by the ANR with reference ANR-10-IDEX-0001-02 PSL (to G.G.). N.K. and N.K.T. serve on the Scientific Advisory Board of DepYmed Inc., a company that focuses on inhibitors of PTP1B in various disease indications. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chatterjee D, 2008, CHEM COMMUN, P2864, DOI 10.1039/b803261k; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; CICIRELLI MF, 1990, P NATL ACAD SCI USA, V87, P5514, DOI 10.1073/pnas.87.14.5514; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Cooper GJS, 2012, CURR MED CHEM, V19, P2828; Das A, 2015, MIDDLE EAST AFR J OP, V22, P133, DOI 10.4103/0974-9233.154385; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Feldhammer M, 2013, CRIT REV BIOCHEM MOL, V48, P430, DOI 10.3109/10409238.2013.819830; Fricker SP, 2007, DALTON T, P4903, DOI 10.1039/b705551j; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Haas KL, 2009, CHEM REV, V109, P4921, DOI 10.1021/cr900134a; Haque A, 2011, CELL, V147, P185, DOI 10.1016/j.cell.2011.08.036; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; HORLEIN D, 1982, BIOCHEMISTRY-US, V21, P5577; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Marin-Penalver JJ, 2016, WORLD J DIABETES, V7, P354, DOI 10.4239/wjd.v7.i17.354; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krishnamurthy D, 2008, J MED CHEM, V51, P4790, DOI 10.1021/jm800101w; Krishnan N, 2014, NAT CHEM BIOL, V10, P558, DOI [10.1038/NCHEMBIO.1528, 10.1038/nchembio.1528]; Levina A, 2011, DALTON T, V40, P11675, DOI 10.1039/c1dt10380f; Lu LP, 2014, ANTIOXID REDOX SIGN, V20, P2210, DOI 10.1089/ars.2013.5720; Maheswari N., 2017, CURR DRUG TARGETS, DOI [10. 2174/1389450118666170222143739 28228082, DOI 10.2174/138945011866617022214373928228082]; Martin KR, 2014, METHODS, V65, P219, DOI 10.1016/j.ymeth.2013.08.013; MCNEILL JH, 1992, J MED CHEM, V35, P1489, DOI 10.1021/jm00086a020; Meggers E, 2009, CHEM COMMUN, P1001, DOI 10.1039/b813568a; Mjos KD, 2014, CHEM REV, V114, P4540, DOI 10.1021/cr400460s; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Rubino JT, 2012, J INORG BIOCHEM, V107, P129, DOI 10.1016/j.jinorgbio.2011.11.024; Squitti R, 2017, J ALZHEIMERS DIS, V56, P1055, DOI 10.3233/JAD-161033; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Tanaka A, 2009, ENDOCR J, V56, P699, DOI 10.1507/endocrj.K09E-051; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; TONKS NK, 1990, MOL CELL BIOL, V10, P458, DOI 10.1128/MCB.10.2.458; Tsou RC, 2012, J OBES, V2012, DOI 10.1155/2012/926857; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X	38	57	62	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1517	1525		10.1074/jbc.C117.819110	http://dx.doi.org/10.1074/jbc.C117.819110			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29217773	Green Published, hybrid			2022-12-28	WOS:000424201700004
J	Schuhmacher, LN; Callejo, G; Srivats, S; Smith, ES				Schuhmacher, Laura-Nadine; Callejo, Gerard; Srivats, Shyam; Smith, Ewan St John			Naked mole-rat acid-sensing ion channel 3 forms nonfunctional homomers, but functional heteromers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); ion channel; neuron; neurophysiology; pain	SENSORY NEURONS; INFLAMMATORY PAIN; NONPROTON LIGAND; ASIC3; SUBUNITS; MOUSE; MICE; DESENSITIZATION; INSENSITIVITY; SENSITIZATION	Acid-sensing ion channels (ASICs) form both homotrimeric and heterotrimeric ion channels that are activated by extracellular protons and are involved in a wide range of physiological and pathophysiological processes, including pain and anxiety. ASIC proteins can form both homotrimeric and heterotrimeric ion channels. The ASIC3 subunit has been shown to be of particular importance in the peripheral nervous system with pharmacological and genetic manipulations demonstrating a role in pain. Naked mole-rats, despite having functional ASICs, are insensitive to acid as a noxious stimulus and show diminished avoidance of acidic fumes, ammonia, and carbon dioxide. Here we cloned naked mole-rat ASIC3 (nmrASIC3) and used a cell-surface biotinylation assay to demonstrate that it traffics to the plasma membrane, but using whole-cell patch clamp electrophysiology we observed that nmrASIC3 is insensitive to both protons and the non-proton ASIC3 agonist 2-guanidine-4-methylquinazoline. However, in line with previous reports of ASIC3 mRNA expression in dorsal root ganglia neurons, we found that the ASIC3 antagonist APETx2 reversibly inhibits ASIC-like currents in naked mole-rat dorsal root ganglia neurons. We further show that like the proton-insensitive ASIC2b and ASIC4, nmrASIC3 forms functional, proton-sensitive heteromers with other ASIC subunits. An amino acid alignment of ASIC3s between 9 relevant rodent species and human identified unique sequence differences that might underlie the proton insensitivity of nmrASIC3. However, introducing nmrASIC3 differences into rat ASIC3 (rASIC3) produced only minor differences in channel function, and replacing the nmrASIC3 sequence with that of rASIC3 did not produce a proton-sensitive ion channel. Our observation that nmrASIC3 forms nonfunctional homomers may reflect a further adaptation of the naked mole-rat to living in an environment with high-carbon dioxide levels.	[Schuhmacher, Laura-Nadine; Callejo, Gerard; Srivats, Shyam; Smith, Ewan St John] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Schuhmacher, Laura-Nadine] UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England	University of Cambridge; University of London; University College London	Smith, ES (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	es336@cam.ac.uk	Martín, Gerard Callejo/F-8757-2019; St. John Smith, Ewan/G-1776-2011	Martín, Gerard Callejo/0000-0003-4366-0482; St. John Smith, Ewan/0000-0002-2699-1979	Biotechnology and Biological Sciences Research Council [BB/J014540/1]; David James Pharmacology Award; Arthritis Research UK Grant [20930]; Cambridge International; European Trust; Royal Society [RG130110]; Biotechnology and Biological Sciences Research Council [1223845] Funding Source: researchfish; Versus Arthritis [20930] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); David James Pharmacology Award; Arthritis Research UK Grant(Versus Arthritis); Cambridge International; European Trust; Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	Supported by Biotechnology and Biological Sciences Research Council Doctoral Training Programme Grant BB/J014540/1 and a recipient of the David James Pharmacology Award.; Supported by Arthritis Research UK Grant 20930.; Supported by the Cambridge International and European Trust.; Supported by Royal Society Research Grant RG130110.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Alijevic O, 2012, J BIOL CHEM, V287, P36059, DOI 10.1074/jbc.M112.360487; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Callejo G, 2015, PAIN, V156, P483, DOI 10.1097/01.j.pain.0000460335.49525.17; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Garbarino VR, 2015, ARCH BIOCHEM BIOPHYS, V576, P8, DOI 10.1016/j.abb.2015.01.029; Grunder S, 2015, NEUROPHARMACOLOGY, V94, P9, DOI 10.1016/j.neuropharm.2014.12.016; Grunder S, 2000, NEUROREPORT, V11, P1607; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hiasa M, 2017, CANCER RES, V77, P1283, DOI 10.1158/0008-5472.CAN-15-3545; Ikeuchi M, 2008, PAIN, V137, P662, DOI 10.1016/j.pain.2008.01.020; Izumi M, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-77; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeggle P, 2015, BIOCHEM BIOPH RES CO, V464, P38, DOI 10.1016/j.bbrc.2015.05.091; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kapoor N, 2011, AM J PHYSIOL-CELL PH, V300, pC1246, DOI 10.1152/ajpcell.00199.2010; Kweon HJ, 2016, BMB REP, V49, P542, DOI 10.5483/BMBRep.2016.49.10.057; Kweon HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30684; LaVinka PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045060; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lee JYP, 2018, BRIT J PHARMACOL, V175, P2204, DOI 10.1111/bph.14089; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu Z, 2013, J CHEM, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0066666; Meng QY, 2009, NEUROSCIENCE, V159, P1126, DOI 10.1016/j.neuroscience.2009.01.069; Omerbasic D, 2016, CELL REP, V17, P748, DOI 10.1016/j.celrep.2016.09.035; Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Peng Z, 2015, CELL REP, V13, P387, DOI 10.1016/j.celrep.2015.09.002; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Reimers C, 2017, P NATL ACAD SCI USA, V114, pE3507, DOI 10.1073/pnas.1616232114; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schuhmacher LN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0279-2; Schuhmacher LN, 2015, MOL PHARMACOL, V87, P561, DOI 10.1124/mol.114.096909; Schumacher L, 2015, OPEN ACCESS ANIM PHY, V7, P137, DOI [DOI 10.2147/OAAP.S50376, 10.2147/OAAP.S50376, 10.2147/oaap.s50376]; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; Smith ESJ, 2009, J COMP PHYSIOL A, V195, P1089, DOI 10.1007/s00359-009-0482-z; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Wu WL, 2010, GENES BRAIN BEHAV, V9, P603, DOI 10.1111/j.1601-183X.2010.00591.x; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	55	13	13	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1756	1766		10.1074/jbc.M117.807859	http://dx.doi.org/10.1074/jbc.M117.807859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29237731	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000424201700026
J	Jules, J; Chen, W; Feng, X; Li, YP				Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping			C/EBP transcription factor is regulated by the RANK cytoplasmic (IVVY538)-I-535 motif and stimulates osteoclastogenesis more strongly than c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; c-Fos; CCAAT; enhancer-binding protein (C; EBP); differentiation; NFAT transcription factor; osteoclast; transcription factor	NF-KAPPA-B; TNF-INDUCED OSTEOCLASTOGENESIS; FACTOR RBP-J; BONE-RESORPTION; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; EXTRACELLULAR ACIDIFICATION; PROTON PUMP; ESSENTIAL COMPONENT; LINEAGE COMMITMENT	Binding of receptor activator of NF-B ligand (RANKL) to its receptor RANK on osteoclast (OC) precursors up-regulates c-Fos and CCAAT/enhancer-binding protein- (C/EBP), two critical OC transcription factors. However, the effects of c-Fos and C/EBP on osteoclastogenesis have not been compared. Herein, we demonstrate that overexpression of c-Fos or C/EBP in OC precursors up-regulates OC genes and initiates osteoclastogenesis independently of RANKL. However, although C/EBP up-regulated c-Fos, c-Fos failed to up-regulate C/EBP in OC precursors. Consistently, C/EBP overexpression more strongly promoted OC differentiation than did c-Fos overexpression. RANK has a cytoplasmic (IVVY538)-I-535 (IVVY) motif that is essential for osteoclastogenesis, and we found that mutation of the IVVY motif blocked OC differentiation by partly inhibiting expression of C/EBP but not expression of c-Fos. We therefore hypothesized that C/EBP overexpression might rescue osteoclastogenesis in cells expressing the mutated IVVY motif. However, overexpression of C/EBP or c-Fos failed to stimulate osteoclastogenesis in the mutant cells. Notably, the IVVY motif mutation abrogated OC gene expression compared with a vector control, suggesting that the IVVY motif might counteract OC inhibitors during osteoclastogenesis. Consistently, the IVVY motif mutant triggered up-regulation of recombinant recognition sequence-binding protein at the J site (RBP-J) protein, a potent OC inhibitor. Mechanistically, C/EBP or c-Fos overexpression in the mutant cells failed to control the up-regulated RBP-J expression, leading to suppression of OC genes. Accordingly, RBP-J silencing in the mutant cells rescued osteoclastogenesis with C/EBP or c-Fos overexpression with C/EBP exhibiting a stronger osteoclastogenic effect. Collectively, our findings indicate that C/EBP is a stronger inducer of OC differentiation than c-Fos, partly via C/EBP regulation by the RANK (IVVY538)-I-535 motif.	[Jules, Joel; Chen, Wei; Feng, Xu; Li, Yi-Ping] Univ Alabama Birmingham, Dept Pathol, SHEL 815,1825 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chen, W; Li, YP (corresponding author), Univ Alabama Birmingham, Dept Pathol, SHEL 815,1825 Univ Blvd, Birmingham, AL 35294 USA.	wechen@uabmc.edu; yipingli@uabmc.edu			National Institutes of Health [P30 AR046031, P30 NS0474666]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046031, R01AR047830, R01AR070135, R01AR044741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr. Jue Wangfor extensive reading and discussion of the manuscript. We appreciate the assistance of the Center for Metabolic Bone Disease at the University of Alabama at Birmingham (UAB) (supported by National Institutes of Health Grant P30 AR046031). We are also grateful for the assistance of the Small Animal Phenotyping Core, Metabolism Core, and Neuroscience Molecular Detection Core Laboratory at UAB (supported by National Institutes of Health GrantP30 NS0474666).	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Ashley JW, 2011, ASSAY DRUG DEV TECHN, V9, P40, DOI 10.1089/adt.2010.0307; Boggs K, 2009, CELL BIOL INT, V33, P318, DOI 10.1016/j.cellbi.2008.12.005; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen S, 2013, J BONE MINER RES, V28, P649, DOI 10.1002/jbmr.1770; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Chen W, 2014, P NATL ACAD SCI USA, V111, P8482, DOI 10.1073/pnas.1310617111; Chen W, 2013, P NATL ACAD SCI USA, V110, P7294, DOI 10.1073/pnas.1211383110; Das S, 2014, J MOL ENDOCRINOL, V53, P81, DOI 10.1530/JME-14-0077; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Jules J, 2016, J BIOL CHEM, V291, P16390, DOI 10.1074/jbc.M115.674598; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Li YP, 1996, BIOCHEM BIOPH RES CO, V218, P813, DOI 10.1006/bbrc.1996.0145; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; LI YP, 1995, J BONE MINER RES, V10, P1197; Ma J, 2013, MOL BIOL REP, V40, P2097, DOI 10.1007/s11033-012-2268-6; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rozenberg JM, 2014, ARTERIOSCL THROM VAS, V34, P2624, DOI 10.1161/ATVBAHA.114.304634; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Swarnkar G, 2015, P NATL ACAD SCI USA, V112, P154, DOI 10.1073/pnas.1415213112; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tian F, 2014, J BONE MINER RES, V29, P1564, DOI 10.1002/jbmr.2275; Wagner H, 2010, NAT REV RHEUMATOL, V6, P73, DOI 10.1038/nrrheum.2009.274; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Wu MR, 2017, P NATL ACAD SCI USA, V114, P10119, DOI 10.1073/pnas.1619294114; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Yang S, 2013, BONE RES, V1, P260, DOI 10.4248/BR201303005; Yang SY, 2007, GENE DEV, V21, P1803, DOI 10.1101/gad.1544107; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhao QX, 2007, FRONT BIOSCI-LANDMRK, V12, P2519, DOI 10.2741/2252	55	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1480	1492		10.1074/jbc.M116.736009	http://dx.doi.org/10.1074/jbc.M116.736009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29122885	Green Published, hybrid			2022-12-28	WOS:000423515000031
J	Wang, DS; Liu, CY; Wang, JQ; Jia, YY; Hu, X; Jiang, H; Shao, ZM; Zeng, YA				Wang, Daisong; Liu, Chunye; Wang, Jingqiang; Jia, Yingying; Hu, Xin; Jiang, Hai; Shao, Zhi-ming; Zeng, Yi Arial			Protein C receptor stimulates multiple signaling pathways in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cell signaling; mammary gland; signal transduction; stem cells; PROCR; breast cancer; TNBC; ERK; Akt; RhoA	HEMATOPOIETIC STEM-CELLS; ACTIVATED RECEPTOR-1; GROWTH-FACTOR; IDENTIFICATION; ANTICOAGULANT; EXPRESSION; MIGRATION; PROMOTE; EPCR	The protein C receptor (PROCR) has emerged as a stem cell marker in several normal tissues and has also been implicated in tumor progression. However, the functional role of PROCR and the signaling mechanisms downstream of PROCR remain poorly understood. Here, we dissected the PROCR signaling pathways in breast cancer cells. Combining protein array, knockdown, and overexpression methods, we found that PROCR concomitantly activates multiple pathways. We also noted that PROCR-dependent ERK and PI3k-Akt-mTOR signaling pathways proceed through Src kinase and transactivation of insulin-like growth factor 1 receptor (IGF-1R). These pathway activities led to the accumulation of c-Myc and cyclin D1. On the other hand, PROCR-dependent RhoA-ROCK-p38 signaling relied on coagulation factor II thrombin receptor (F2R). We confirmed these findings in primary cells isolated from triple-negative breast cancer-derived xenografts (PDX) that have high expression of PROCR. To the best our knowledge, this is the first comprehensive study of PROCR signaling in breast cancer cells, and its findings also shed light on the molecular mechanisms of PROCR in stem cells in normal tissue.	[Wang, Daisong; Liu, Chunye; Wang, Jingqiang; Jia, Yingying; Zeng, Yi Arial] Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Hu, Xin; Shao, Zhi-ming] Fudan Univ, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai Canc Ctr,Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China; [Jiang, Hai] Chinese Acad Sci, Shanghai Inst Biol Sci, Innovat Ctr Cell Signaling Network, Key Lab Syst Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zeng, YA (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Shao, ZM (corresponding author), Fudan Univ, Key Lab Breast Canc Shanghai, Dept Breast Surg, Shanghai Canc Ctr,Dept Oncol,Shanghai Med Coll, Shanghai 200032, Peoples R China.	zhimingshao@yahoo.com; yzeng@sibcb.ac.cn			National Natural Science Foundation of China [31530045, 31371500]; Ministry of Science and Technology of China [2014CB964800]; Chinese Academy of Sciences [XDB19000000, XDA12020349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 31530045 and 31371500 (to Y. A. Z.), Ministry of Science and Technology of China Grant 2014CB964800 (to Y. A. Z.), and Chinese Academy of Sciences Grants XDB19000000 and XDA12020349 (to Y. A. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton I, 2012, AM J RESP CRIT CARE, V186, P96, DOI 10.1164/rccm.201110-1826OC; Bae JS, 2007, BLOOD, V110, P3909, DOI 10.1182/blood-2007-06-096651; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Beaulieu LM, 2007, EXP CELL RES, V313, P677, DOI 10.1016/j.yexcr.2006.11.019; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Fares I, 2017, BLOOD, V129, P3344, DOI 10.1182/blood-2016-11-750729; Feistritzer C, 2006, J IMMUNOL, V176, P1019, DOI 10.4049/jimmunol.176.2.1019; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gramling MW, 2010, EXP CELL RES, V316, P314, DOI 10.1016/j.yexcr.2009.10.024; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Griffin JH, 2012, INT J HEMATOL, V95, P333, DOI 10.1007/s12185-012-1059-0; Hiscox S, 2008, EXPERT OPIN THER TAR, V12, P757, DOI [10.1517/14728222.12.6.757, 10.1517/14728222.12.6.757 ]; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Keshava S, 2013, CANCER RES, V73, P3963, DOI 10.1158/0008-5472.CAN-12-1690; Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Polyak Kornelia, 2012, Cancer Cell, V22, P562, DOI 10.1016/j.ccr.2012.06.021; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Sato K, 2003, GENES CELLS, V8, P995, DOI 10.1046/j.1356-9597.2003.00691.x; Schaffner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061071; Schuepbach RA, 2012, J THROMB HAEMOST, V10, P1675, DOI 10.1111/j.1538-7836.2012.04825.x; Taylor FB, 2000, BLOOD, V95, P1680, DOI 10.1182/blood.V95.5.1680.005k33_1680_1686; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Vetrano S, 2011, P NATL ACAD SCI USA, V108, P19830, DOI 10.1073/pnas.1107140108; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2011, J BIOL CHEM, V286, P6742, DOI 10.1074/jbc.M110.181388; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85; Yunokawa M, 2012, CANCER SCI, V103, P1665, DOI 10.1111/j.1349-7006.2012.02359.x; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	39	18	18	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1413	1424		10.1074/jbc.M117.814046	http://dx.doi.org/10.1074/jbc.M117.814046			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29217770	Green Published, hybrid			2022-12-28	WOS:000423515000026
J	Pathan-Chhatbar, S; Taft, MH; Reindl, T; Hundt, N; Latham, SL; Manstein, DJ				Pathan-Chhatbar, Salma; Taft, Manuel H.; Reindl, Theresia; Hundt, Nikolas; Latham, Sharissa L.; Manstein, Dietmar J.			Three mammalian tropomyosin isoforms have different regulatory effects on nonmuscle myosin-2B and filamentous beta-actin in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TROPOMYOSIN; CYTOPLASMIC MYOSINS; MOLECULAR MOTORS; SMOOTH-MUSCLE; N-TERMINUS; F-ACTIN; BINDING; COMPLEX; IIB; CYTOSKELETON	The metazoan actin cytoskeleton supports a wide range of contractile and transport processes. Recent studies have shown how the dynamic association with specific tropomyosin isoforms generates actin filament populations with distinct functional properties. However, critical details of the associated molecular interactions remain unclear. Here, we report the properties of actomyosin-tropomyosin complexes containing filamentous beta-actin, nonmuscle myosin-2B (NM-2B) constructs, and either tropomyosin isoform Tpm1.8cy (b.-.b.d), Tpm1.12br (b.-.b.c), or Tpm3.1cy(b.-.a.d). Our results show the extent to which the association of filamentous beta-actin with these different tropomyosin cofilaments affects the actin-mediated activation of NM-2B and the release of the ATP hydrolysis products ADP and phosphate from the active site. Phosphate release gates a transition from weak to strong F-actin-binding states. The release of ADP has the opposite effect. These changes in dominant rate-limiting steps have a direct effect on the duty ratio, the fraction of time that NM-2B spends in strongly F-actin-bound states during ATP turnover. The duty ratio is increased similar to 3-fold in the presence of Tpm1.12 and 5-fold for both Tpm1.8 and Tpm3.1. The presence of Tpm1.12 extends the time required per ATP hydrolysis cycle 3.7-fold, whereas it is shortened by 27 and 63% in the presence of Tpm1.8 and Tpm3.1, respectively. The resulting Tpm isoform-specific changes in the frequency, duration, and efficiency of actomyosin interactions establish a molecular basis for the ability of these complexes to support cellular processes with widely divergent demands in regard to force production, capacity to move processively, and speed of movement.	[Pathan-Chhatbar, Salma; Taft, Manuel H.; Reindl, Theresia; Hundt, Nikolas; Latham, Sharissa L.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Manstein, Dietmar J.] Hannover Med Sch, Div Struct Biochem, D-30625 Hannover, Germany; [Hundt, Nikolas] Univ Oxford, Phys & Theoret Chem Lab, Dept Chem, Oxford OX1 3TA, England	Hannover Medical School; Hannover Medical School; University of Oxford	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Taft, Manuel/O-1396-2019; Manstein, Dietmar J./AAG-2640-2019; Taft, Manuel H/T-2508-2017; Manstein, Dietmar J. J/M-1034-2013; Latham, Sharissa/B-2353-2016	Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147; Taft, Manuel H/0000-0001-5853-8629; Manstein, Dietmar J. J/0000-0003-0763-0147; Reindl, Theresia/0000-0001-9633-1899; Latham, Sharissa/0000-0003-1128-5315	Deutsche Forschungsgemeinschaft [MA1081/21-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA1081/21-1 (to D.J.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ampe C, 2017, HANDB EXP PHARMACOL, V235, P1, DOI 10.1007/164_2016_43; Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; Barua B, 2014, BIOCHEMISTRY-US, V53, P4015, DOI 10.1021/bi500162z; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CHO YJ, 1991, P NATL ACAD SCI USA, V88, P10153, DOI 10.1073/pnas.88.22.10153; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Clayton JE, 2015, CYTOSKELETON, V72, P131, DOI 10.1002/cm.21213; Coulton A, 2006, BIOCHEMISTRY-US, V45, P12853, DOI 10.1021/bi0613224; Currier MA, 2017, MOL CANCER THER, V16, P1555, DOI 10.1158/1535-7163.MCT-16-0873; Curthoys NM, 2014, MOL CELL NEUROSCI, V58, P11, DOI 10.1016/j.mcn.2013.10.011; Desai R, 2015, J BIOL CHEM, V290, P1915, DOI 10.1074/jbc.M114.609743; Diensthuber RP, 2011, FEBS LETT, V585, P767, DOI 10.1016/j.febslet.2011.01.042; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Erdmann T, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052403; Frye J, 2010, BIOCHEMISTRY-US, V49, P4908, DOI 10.1021/bi100349a; Gateva G, 2017, CURR BIOL, V27, P705, DOI 10.1016/j.cub.2017.01.018; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Geeves M, 2011, BIOPHYS J, V100, P2679, DOI 10.1016/j.bpj.2011.04.020; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Greenfield NJ, 2009, BIOCHEMISTRY-US, V48, P1272, DOI 10.1021/bi801861k; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; Heissler SM, 2012, CELL MOL LIFE SCI, V69, P299, DOI 10.1007/s00018-011-0749-8; Hodges AR, 2012, CURR BIOL, V22, P1410, DOI 10.1016/j.cub.2012.05.035; Hundt N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20554; ITOH K, 1995, J BIOL CHEM, V270, P14533, DOI 10.1074/jbc.270.24.14533; Kee AJ, 2016, TRAFFIC, V17, P80, DOI 10.1111/tra.12342; Kis-Bicskei N, 2013, CYTOSKELETON, V70, P755, DOI 10.1002/cm.21143; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kuhlbrandt W, 2014, SCIENCE, V343, P1443, DOI 10.1126/science.1251652; Lehman W, 2013, J MUSCLE RES CELL M, V34, P155, DOI 10.1007/s10974-013-9342-0; Ma Xuefei, 2014, Bioarchitecture, V4, P88, DOI 10.4161/bioa.29766; Manstein DJ, 2016, TRAFFIC, V17, P872, DOI 10.1111/tra.12399; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; MCLACHLAN AD, 1976, J MOL BIOL, V106, P1017, DOI 10.1016/0022-2836(76)90349-1; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Muller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070636; Munnich S, 2014, FEBS LETT, V588, P4754, DOI 10.1016/j.febslet.2014.11.007; Murakami K, 2008, P NATL ACAD SCI USA, V105, P7200, DOI 10.1073/pnas.0801950105; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nelson SR, 2011, METHODS MOL BIOL, V778, P111, DOI 10.1007/978-1-61779-261-8_8; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Preller M, 2013, STRUCTURE, V21, P1911, DOI 10.1016/j.str.2013.09.015; Radke MB, 2014, ELIFE, V3, DOI 10.7554/eLife.01603; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shutova MS, 2014, CURR BIOL, V24, P1958, DOI 10.1016/j.cub.2014.07.070; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Stam S, 2015, BIOPHYS J, V108, P1997, DOI 10.1016/j.bpj.2015.03.030; Taft MH, 2008, J BIOL CHEM, V283, P26902, DOI 10.1074/jbc.M802957200; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Walklate J, 2016, J EXP BIOL, V219, P168, DOI 10.1242/jeb.124594; Wang CLA, 2010, INT REV CEL MOL BIO, V281, P91, DOI 10.1016/S1937-6448(10)81003-2; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WEGNER A, 1980, FEBS LETT, V119, P245, DOI 10.1016/0014-5793(80)80263-8; WEIGT C, 1991, BIOCHEMISTRY-US, V30, P10700, DOI 10.1021/bi00108a014; Wolfenson H, 2016, NAT CELL BIOL, V18, P33, DOI 10.1038/ncb3277	70	25	25	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					863	875		10.1074/jbc.M117.806521	http://dx.doi.org/10.1074/jbc.M117.806521			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191834	Green Published, hybrid			2022-12-28	WOS:000422864500009
J	Schumacher, MM; Jun, DJ; Johnson, BM; DeBose-Boyd, RA				Schumacher, Marc M.; Jun, Dong-Jae; Johnson, Brittany M.; DeBose-Boyd, Russell A.			UbiA prenyltransferase domain-containing protein-1 modulates HMG-CoA reductase degradation to coordinate synthesis of sterol and nonsterol isoprenoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); endoplasmic reticulum-associated protein degradation (ERAD); Golgi; cholesterol metabolism; isoprenoid	COENZYME-A REDUCTASE; CRYSTALLINE CORNEAL-DYSTROPHY; ENDOPLASMIC-RETICULUM; ACCELERATED DEGRADATION; FEEDBACK-REGULATION; HUMAN FIBROBLASTS; MESSENGER-RNA; TARGET GENES; CHOLESTEROL; CELLS	UBIAD1 (UbiA prenyltransferase domain-containing protein-1) utilizes geranylgeranyl pyrophosphate (GGpp) to synthesize vitamin K-2. We previously reported that sterols stimulate binding of UBIAD1 to endoplasmic reticulum (ER)-localized 3-hydroxy-3-methylglutaryl (HMG) CoA reductase. UBIAD1 binding inhibits sterol-accelerated, ER-associated degradation (ERAD) of reductase, one of several mechanisms for feedback control of this rate-limiting enzyme in the branched pathway that produces cholesterol and nonsterol isoprenoids such as GGpp. Accumulation of GGpp in ER membranes triggers release of UBIAD1 from reductase, permitting its maximal ERAD and ER-to-Golgi transport of UBIAD1. Mutant UBIAD1 variants associated with Schnyder corneal dystrophy (SCD), a human disorder characterized by corneal accumulation of cholesterol, resist GGpp-induced release from reductase and remain sequestered in the ER to block reductase ERAD. Using lines of genetically manipulated cells, we now examine consequences of UBIAD1 deficiency and SCD-associated UBIAD1 on reductase ERAD and cholesterol synthesis. Our results indicated that reductase becomes destabilized in the absence of UBIAD1, resulting in reduced cholesterol synthesis and intracellular accumulation. In contrast, an SCD-associated UBIAD1 variant inhibited reductase ERAD, thereby stabilizing the enzyme and contributing to enhanced synthesis and intracellular accumulation of cholesterol. Finally, we present evidence that GGpp-regulated, ER-to-Golgi transport enables UBIAD1 to modulate reductase ERAD such that synthesis of nonsterol isoprenoids is maintained in sterol-replete cells. These findings further establish UBIAD1 as a central player in the reductase ERAD pathway and regulation of isoprenoid synthesis. They also indicate that UBIAD1-mediated inhibition of reductase ERAD underlies cholesterol accumulation associated with SCD.	[Schumacher, Marc M.; Jun, Dong-Jae; Johnson, Brittany M.; DeBose-Boyd, Russell A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeBose-Boyd, RA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu		Schumacher, Marc/0000-0002-5527-4215	National Institutes of Health [HL020948, GM112409]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL020948 and GM112409 (to R. D. B.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1980, J LIPID RES, V21, P505; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Elsabrouty R, 2013, MOL BIOL CELL, V24, P3300, DOI 10.1091/mbc.E13-03-0157; FAUST JR, 1979, ARCH BIOCHEM BIOPHYS, V192, P86, DOI 10.1016/0003-9861(79)90074-2; Fredericks WJ, 2013, INT J ONCOL, V43, P638, DOI 10.3892/ijo.2013.1985; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hwang S, 2017, J BIOL CHEM, V292, P9382, DOI 10.1074/jbc.M117.788562; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Liu SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147306; Morris LL, 2014, J BIOL CHEM, V289, P19053, DOI 10.1074/jbc.M114.576652; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2013, HUM MUTAT, V34, P317, DOI 10.1002/humu.22230; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; ROITELMAN J, 1992, J CELL BIOL, V117, P959, DOI 10.1083/jcb.117.5.959; Schumacher MM, 2016, J LIPID RES, V57, P1286, DOI 10.1194/jlr.M068759; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	33	16	16	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					312	323		10.1074/jbc.RA117.000423	http://dx.doi.org/10.1074/jbc.RA117.000423			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29167270	Green Published, hybrid			2022-12-28	WOS:000419453200026
J	Stober, VP; Johnson, CG; Majors, A; Lauer, ME; Cali, V; Midura, RJ; Wisniewski, HG; Aronica, MA; Garantziotis, S				Stober, Vandy P.; Johnson, Collin G.; Majors, Alana; Lauer, Mark E.; Cali, Valbona; Midura, Ronald J.; Wisniewski, Hans-Georg; Aronica, Mark A.; Garantziotis, Stavros			TNF-stimulated gene 6 promotes formation of hyaluronan-inter-alpha-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MURINE MODEL; SMOOTH-MUSCLE-CELLS; MORTALITY; PROTEIN; INFLAMMATION; HEALTH; LUNG; DEPOSITION; POLLUTION; ACTIVATION	Exposure to pollutants, such as ozone, exacerbates airway inflammation and hyperresponsiveness (AHR). TNF-stimulated gene 6 (TSG-6) is required to transfer inter-alpha-inhibitor heavy chains (HC) to hyaluronan (HA), facilitating HA receptor binding. TSG-6 is necessary for AHR in allergic asthma, because it facilitates the development of a pathological HA-HC matrix. However, the role of TSG-6 in acute airway inflammation is not well understood. Here, we hypothesized that TSG-6 is essential for the development ofHA-and ozone-induced AHR. TSG-6(-/-) and TSG-6(+/+) mice were exposed to ozone or short-fragment HA (sHA), and AHR was assayed via flexiVent. The AHR response to sHA was evaluated in the isolated tracheal ring assay in tracheal rings from TSG-6(-/-) or TSG-6(+/+), with or without the addition of exogenous TSG-6, and with or without inhibitors of Rho-associated, coiled-coil-containing protein kinase (ROCK), ERK, or PI3K. Smooth-muscle cells from mouse tracheas were assayed in vitro for signaling pathways. We found that TSG-6 deficiency protects against AHR after ozone (in vivo) or sHA (in vitro and in vivo) exposure. Moreover, TSG-6(-/-) tracheal ring non-responsiveness to sHA was reversed by exogenous TSG-6 addition. sHA rapidly activated RhoA, ERK, and Akt in airway smooth-muscle cells, but only in the presence of TSG-6. Inhibition of ROCK, ERK, or PI3K/Akt blocked sHA/TSG-6-mediated AHR. In conclusion, TSG-6 is necessary for AHR in response to ozone or sHA, in part because it facilitates rapid formation of HA-HC complexes. The sHA/TSG-6 effect is mediated by RhoA, ERK, and PI3K/Akt signaling.	[Stober, Vandy P.; Johnson, Collin G.; Garantziotis, Stavros] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Majors, Alana; Lauer, Mark E.; Cali, Valbona; Midura, Ronald J.; Aronica, Mark A.] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Wisniewski, Hans-Georg] Matrix Biol Inst, Edgewater, NJ 07020 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Cleveland Clinic Foundation	Garantziotis, S (corresponding author), NIEHS, NIH, MD CU-01,111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	garantziotis@niehs.nih.gov	Garantziotis, Stavros/A-6903-2009	Garantziotis, Stavros/0000-0003-4007-375X; Johnson, Collin/0000-0002-5078-9551	Division of Intramural Research, NIEHS, National Institutes of Health [P01HL107147, HL103453, HL081064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, U10HL109250, P01HL103453, P01HL081064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102605] Funding Source: NIH RePORTER	Division of Intramural Research, NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported partly through funds from the Division of Intramural Research, NIEHS, National Institutes of Health, by Grants P01HL107147 (to V.C. and R.M.) and HL103453 and HL081064 (to M.A.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair JE, 2009, J BIOL CHEM, V284, P16922, DOI 10.1074/jbc.M808560200; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020932; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Choi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081773; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Fann N, 2012, RISK ANAL, V32, P81, DOI 10.1111/j.1539-6924.2011.01630.x; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Foskett AM, 2014, AM J PHYSIOL-LUNG C, V306, pL120, DOI 10.1152/ajplung.00240.2013; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Garantziotis S, 2007, J IMMUNOL, V179, P4187, DOI 10.4049/jimmunol.179.6.4187; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gryparis A, 2004, AM J RESP CRIT CARE, V170, P1080, DOI 10.1164/rccm.200403-333OC; Hubbell BJ, 2005, ENVIRON HEALTH PERSP, V113, P73, DOI 10.1289/ehp.7186; Ito K, 2005, EPIDEMIOLOGY, V16, P446, DOI 10.1097/01.ede.0000165821.90114.7f; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jourdain M, 1997, AM J RESP CRIT CARE, V156, P1825, DOI 10.1164/ajrccm.156.6.9611100; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; KATSOUYANNI K, 1995, EUR RESPIR J, V8, P1030; Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507; Lauer ME, 2015, J BIOL CHEM, V290, P23124, DOI 10.1074/jbc.M115.663823; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lazrak A, 2015, AM J PHYSIOL-LUNG C, V308, pL891, DOI 10.1152/ajplung.00377.2014; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Levy JI, 2005, EPIDEMIOLOGY, V16, P458, DOI 10.1097/01.ede.0000165820.08301.b3; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Li ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027137; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; OBYRNE PM, 1984, AM REV RESPIR DIS, V130, P214; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Sakai H, 2010, PFLUG ARCH EUR J PHY, V460, P645, DOI 10.1007/s00424-010-0844-y; Song WF, 2015, AM J PHYSIOL-LUNG C, V309, pL205, DOI 10.1152/ajplung.00159.2015; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Xie J, 2015, STEM CELLS, V33, P468, DOI 10.1002/stem.1851; Zhao M, 2006, MOL PHARMACOL, V69, P66, DOI 10.1124/mol.105.016923; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200	49	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20845	20858		10.1074/jbc.M116.756627	http://dx.doi.org/10.1074/jbc.M116.756627			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29122888	Green Published, hybrid			2022-12-28	WOS:000418453400004
J	Zhou, XH; DeLucia, M; Hao, CL; Hrecka, K; Monnie, C; Skowronski, J; Ahn, J				Zhou, Xiaohong; DeLucia, Maria; Hao, Caili; Hrecka, Kasia; Monnie, Christina; Skowronski, Jacek; Ahn, Jinwoo			HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL NUCLEAR ANTIGEN; REPLICATION FORK; G(2) ARREST; ACCESSORY PROTEINS; IN-VIVO; DNA; ACTIVATION; COMPLEX; CYCLE	The viral protein R (Vpr) is an accessory virulence factor of HIV-1 that facilitates infection in immune cells. Cellular functions of Vpr are tied to its interaction with DCAF1, a substrate receptor component of the CRL4 E3 ubiquitin ligase. Recent proteomic approaches suggested that Vpr degrades helicase-like transcription factor (HLTF) DNA helicase in a proteasome-dependent manner by redirecting the CRL4-DCAF1 E3 ligase. However, the precise molecular mechanism of Vpr-dependent HLTF depletion is not known. Here, using in vitro reconstitution assays, we show that Vpr mediates polyubiquitination of HLTF, by directly loading it onto the C-terminal WD40 domain of DCAF1 in complex with the CRL4 E3 ubiquitin ligase. Mutational analyses suggest that Vpr interacts with DNA-binding residues in the N-terminal HIRAN domain of HLTF in a manner similar to the recruitment of another target, uracil DNA glycosylase (UNG2), to the CRL4-DCAF1 E3 by Vpr. Strikingly, Vpr also engages a second, adjacent region, which connects the HIRAN and ATPase/helicase domains. Thus, our findings reveal that Vpr utilizes common as well as distinctive interfaces to recruit multiple postreplication DNA repair proteins to the CRL4-DCAF1 E3 ligase for ubiquitin-dependent proteasomal degradation.	[Zhou, Xiaohong; DeLucia, Maria; Monnie, Christina; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15260 USA; [Zhou, Xiaohong; DeLucia, Maria; Monnie, Christina; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Hao, Caili; Hrecka, Kasia; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University	Ahn, J (corresponding author), Biomed Sci Tower 3,Rm 1055,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	jia12@pitt.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	National Institute of Health [P50GM082251, R01GM116642, R01AI100673, R01GM123973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123973, R01GM116642, P50GM082251] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants P50GM082251 (J. A. and J. S.), R01GM116642 (J. A.), R01AI100673 (J. S.), and R01GM123973 (J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Collins DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003851; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; DePaula-Silva AB, 2015, VIROLOGY, V477, P10, DOI 10.1016/j.virol.2014.12.040; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2016, P NATL ACAD SCI USA, V113, pE3921, DOI 10.1073/pnas.1605023113; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lahouassa H, 2016, P NATL ACAD SCI USA, V113, P5311, DOI 10.1073/pnas.1600485113; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poon B, 1997, J VIROL, V71, P3961, DOI 10.1128/JVI.71.5.3961-3971.1997; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vermeire J, 2016, CELL REP, V17, P413, DOI 10.1016/j.celrep.2016.09.023; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wu Y, 2016, NAT STRUCT MOL BIOL, V23, P933, DOI 10.1038/nsmb.3284; Zhou XH, 2016, J BIOL CHEM, V291, P16936, DOI 10.1074/jbc.M116.721183; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	44	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21117	21127		10.1074/jbc.M117.798801	http://dx.doi.org/10.1074/jbc.M117.798801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079575	Green Published, hybrid			2022-12-28	WOS:000418453400026
J	Sun, JF; Han, ZX; Qi, TM; Zhao, R; Liu, SW				Sun, Junfeng; Han, Zongxi; Qi, Tianming; Zhao, Ran; Liu, Shengwang			Chicken galectin-1B inhibits Newcastle disease virus adsorption and replication through binding to hemagglutinin-neuraminidase (HN) glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galectin; glycoprotein; viral replication; virus; virus entry; Chicken galectin-1B; HN glycoprotein; Newcastle disease virus; adsorption; replication	N-LINKED GLYCOSYLATION; WEST-NILE-VIRUS; DC-SIGN; OLIGOSACCHARIDE CHAINS; ENVELOPE GLYCOPROTEINS; MONOCLONAL-ANTIBODIES; FUSION ACTIVATION; INFLUENZA-VIRUSES; PROTEIN; INFECTION	Galectin-1 is an important immunoregulatory factor and can mediate the host-pathogen interaction via binding glycans on the surface of various viruses. We previously reported that avian respiratory viruses, including lentogenic Newcastle disease virus (NDV), can induce up-regulation of chicken galectin (CG)-1B in the primary target organ. In this study, we investigated whether CG-1B participated in the infectious process of NDV in chickens. We demonstrated that velogenic NDV induced up-regulation of CG-1B in target organs. We also found that CG-1B directly bound to NDV virions and inhibited their hemagglutination activity in vitro. We confirmed that CG-1B interacted with NDV hemagglutinin-neuraminidase (HN) glycoprotein, in which the specific G4 N-glycans significantly contributed to the interaction between CG-1B and HN glycoprotein. The presence of extracellular CG-1B, rather than the internalization process, inhibited adsorption of NDV. The interaction between intracellular CG-1B and NDV HN glycoproteins inhibited cell-surface expression of HN glycoprotein and reduced the titer of progeny virus in NDV-infected DF-1 cells. Significantly, the replication of parental and HN glycosylation mutant viruses in CG-1B knockdown and overexpression cells demonstrated that the replication of NDV was correlated with the expression of CG-1B in a specific glycan-dependent manner. Collectively, our results indicate that CG-1B has anti-NDV activity by binding to N-glycans on HN glycoprotein.	[Sun, Junfeng; Han, Zongxi; Qi, Tianming; Zhao, Ran; Liu, Shengwang] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin 150001, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Liu, SW (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin 150001, Heilongjiang, Peoples R China.	swliu@hvri.ac.cn			National Natural Science Foundation of China [31502088]; Special Fund for Agro-scientific Research in the Public Interest [201303033]; Natural Science Foundation of Heilongjiang Province [QC2015038]; China Agriculture Research System [CARS-40-K18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); China Agriculture Research System	This work was supported by the National Natural Science Foundation of China Grant 31502088, Special Fund for Agro-scientific Research in the Public Interest Grant 201303033, Natural Science Foundation of Heilongjiang Province Grant QC2015038, and the China Agriculture Research System Grant CARS-40-K18. The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar HC, 2006, J VIROL, V80, P4878, DOI 10.1128/JVI.80.10.4878-4889.2006; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Birnbaum ME, 2014, P NATL ACAD SCI USA, V111, P17576, DOI 10.1073/pnas.1420936111; Bose S, 2014, J VIROL, V88, P3925, DOI 10.1128/JVI.03741-13; Bose S, 2012, P NATL ACAD SCI USA, V109, pE2625, DOI 10.1073/pnas.1213813109; Bousse TL, 2004, J VIROL, V78, P13351, DOI 10.1128/JVI.78.23.13351-13355.2004; Brown CC, 2013, AVIAN DIS, V57, P36, DOI 10.1637/10299-070312-Reg.1; Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Chen MS, 2001, VIRUS RES, V79, P91, DOI 10.1016/S0168-1702(01)00322-7; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; El Najjar F, 2014, VIRUSES-BASEL, V6, P3019, DOI 10.3390/v6083019; Garner OB, 2015, J VIROL, V89, P2520, DOI 10.1128/JVI.02435-14; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; Ge JY, 2007, J VIROL, V81, P150, DOI 10.1128/JVI.01514-06; Hogenkamp A, 2008, VET MICROBIOL, V130, P37, DOI 10.1016/j.vetmic.2007.12.008; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IORIO RM, 1992, J GEN VIROL, V73, P1167, DOI 10.1099/0022-1317-73-5-1167; Iorio RM, 2001, J VIROL, V75, P1918, DOI 10.1128/JVI.75.4.1918-1927.2001; Irie T, 2002, J GEN VIROL, V83, P3045, DOI 10.1099/0022-1317-83-12-3045; Ji X, 2005, J GEN VIROL, V86, P2535, DOI 10.1099/vir.0.81199-0; Kaltner H, 2011, ANAT REC, V294, P427, DOI 10.1002/ar.21341; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lucendo MF, 2009, J MOL BIOL, V386, P366, DOI 10.1016/j.jmb.2008.09.054; MCGINNES LW, 1995, VIROLOGY, V212, P398, DOI 10.1006/viro.1995.1497; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295; Nason EL, 2001, J VIROL, V75, P6625, DOI 10.1128/JVI.75.14.6625-6634.2001; NG DTW, 1990, MOL CELL BIOL, V10, P1989, DOI 10.1128/MCB.10.5.1989; Ng WC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/732191; Panda A, 2004, J VIROL, V78, P4965, DOI 10.1128/JVI.78.10.4965-4975.2004; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rajasagi NK, 2012, J IMMUNOL, V188, P4631, DOI 10.4049/jimmunol.1103063; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seal BS, 2000, DEV COMP IMMUNOL, V24, P257, DOI 10.1016/S0145-305X(99)00077-4; SHAKINESHLEMAN SH, 1992, J BIOL CHEM, V267, P10690; Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Sun JF, 2014, PROTEOMICS, V14, P1403, DOI 10.1002/pmic.201300404; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Toledo KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112474; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; Wise MG, 2004, J CLIN MICROBIOL, V42, P329, DOI 10.1128/JCM.42.1.329-338.2004; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yuan P, 2011, P NATL ACAD SCI USA, V108, P14920, DOI 10.1073/pnas.1111691108; Zaitsev V, 2004, J VIROL, V78, P3733, DOI 10.1128/JVI.78.7.3733-3741.2004; Zhang XT, 2013, ARCH VIROL, V158, P2115, DOI 10.1007/s00705-013-1723-6	58	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20141	20161		10.1074/jbc.M116.772897	http://dx.doi.org/10.1074/jbc.M116.772897			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28978647	Green Published, hybrid			2022-12-28	WOS:000417696400020
J	Williamson, RL; Laulagnier, K; Miranda, AM; Fernandez, MA; Wolfe, MS; Sadoul, R; Di Paolo, G				Williamson, Rebecca L.; Laulagnier, Karine; Miranda, Andre M.; Fernandez, Marty A.; Wolfe, Michael S.; Sadoul, Remy; Di Paolo, Gilbert			Disruption of amyloid precursor protein ubiquitination selectively increases amyloid (A) 40 levels via presenilin 2-mediated cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid precursor protein (APP); amyloid- (A); endosome; intracellular processing; intracellular trafficking; lysosome; presenilin; ubiquitination	INTRACELLULAR A-BETA; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; SUBSTRATE-SPECIFICITY; MULTIVESICULAR BODIES; EFFICIENT INHIBITION; TERMINAL FRAGMENTS; APP; TRAFFICKING; A-BETA-42	Amyloid plaques, a neuropathological hallmark of Alzheimer's disease, are largely composed of amyloid (A) peptide, derived from cleavage of amyloid precursor protein (APP) by - and -secretases. The endosome is increasingly recognized as an important crossroad for APP and these secretases, with major implications for APP processing and amyloidogenesis. Among various post-translational modifications affecting APP accumulation, ubiquitination of cytodomain lysines may represent a key signal controlling APP endosomal sorting. Here, we show that substitution of APP C-terminal lysines with arginine disrupts APP ubiquitination and that an increase in the number of substituted lysines tends to increase APP metabolism. An APP mutant lacking all C-terminal lysines underwent the most pronounced increase in processing, leading to accumulation of both secreted and intracellular A40. Artificial APP ubiquitination with rapalog-mediated proximity inducers reduced A40 generation. A lack of APP C-terminal lysines caused APP redistribution from endosomal intraluminal vesicles (ILVs) to the endosomal limiting membrane, with a subsequent decrease in APP C-terminal fragment (CTF) content in secreted exosomes, but had minimal effects on APP lysosomal degradation. Both the increases in secreted and intracellular A40 were abolished by depletion of presenilin 2 (PSEN2), recently shown to be enriched on the endosomal limiting membrane compared with PSEN1. Our findings demonstrate that ubiquitin can act as a signal at five cytodomain-located lysines for endosomal sorting of APP. They further suggest that disruption of APP endosomal sorting reduces its sequestration in ILVs and results in PSEN2-mediated processing of a larger pool of APP-CTF on the endosomal membrane.	[Williamson, Rebecca L.; Miranda, Andre M.; Di Paolo, Gilbert] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Di Paolo, Gilbert] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Laulagnier, Karine; Sadoul, Remy] INSERM, Grenoble Inst Neurosci, F-38042 Grenoble, France; [Miranda, Andre M.] Univ Minho, Life & Hlth Sci Res Inst, Sch Med, P-4710057 Braga, Portugal; [Miranda, Andre M.] Life & Hlth Sci Res Inst, Res Grp 3Bs, Biodegradables & Biomimet Associate Lab, P-4710057 Braga, Portugal; [Fernandez, Marty A.; Wolfe, Michael S.] Harvard Univ, Ctr Neurol Dis, Boston, MA 02115 USA; [Wolfe, Michael S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA	Columbia University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidade do Minho; Harvard University; University of Kansas	Di Paolo, G (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, 630 West 168th St,P&S 12-510, New York, NY 10032 USA.	gd2175@cumc.columbia.edu		Fernandez, Marty/0000-0002-3211-2563; SADOUL, Remy/0000-0002-4763-0320; Miranda, Andre/0000-0002-0175-9938	National Institutes of Health [R01 NS056049, F30 AG047748, AG015379]; Fondation Plan Alzheimer; Inserm; Universite Grenoble Alpes; France Alzheimer Foundation; Fundacao para a Ciencia e Tecnologia [PD/BD/105915/2014]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG047748, P01AG015379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Plan Alzheimer; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Grenoble Alpes; France Alzheimer Foundation; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants R01 NS056049 (to G. D. P. and Ronald Liem), F30 AG047748 (to R. L. W.), and AG015379 (to M. S. W. and Dennis J. Selkoe). G. D. P. is a full time employee of Denali Therapeutics Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Fondation Plan Alzheimer.; Supported by Inserm, Universite Grenoble Alpes, France Alzheimer Foundation.; Supported by Fundacao para a Ciencia e Tecnologia Grant PD/BD/105915/2014.	Acx H, 2014, J BIOL CHEM, V289, P4346, DOI 10.1074/jbc.M113.530907; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Bate C, 2010, J ALZHEIMERS DIS, V21, P985, DOI 10.3233/JAD-2010-100528; Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Bhalla A, 2012, NEUROBIOL DIS, V47, P126, DOI 10.1016/j.nbd.2012.03.030; Bohdanowicz M, 2012, MOL BIOL CELL, V23, P176, DOI 10.1091/mbc.E11-06-0489; Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chivet M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00145; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Crabtree GR, 1996, TRENDS BIOCHEM SCI, V21, P418, DOI 10.1016/S0968-0004(96)20027-1; Das U, 2016, NAT NEUROSCI, V19, P55, DOI 10.1038/nn.4188; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; De Strooper B, 2015, ANNU REV PHARMACOL, V55, P419, DOI 10.1146/annurev-pharmtox-010814-124309; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Del Prete D, 2016, J BIOL CHEM, V291, P17209, DOI 10.1074/jbc.M116.733626; Edgar JR, 2015, J CELL SCI, V128, P2520, DOI 10.1242/jcs.170233; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Fernandez MA, 2014, J BIOL CHEM, V289, P31043, DOI 10.1074/jbc.M114.581165; Ford DL, 2007, BIOCHEMISTRY-US, V46, P8827, DOI 10.1021/bi700604q; Funmilayo E, 2016, J BIOL CHEM, V291, P15753, DOI 10.1074/jbc.M116.718023; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Gouras Gunnar K, 2013, Int J Cell Biol, V2013, P141083, DOI 10.1155/2013/141083; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kim J, 2007, J NEUROSCI, V27, P627, DOI 10.1523/JNEUROSCI.4849-06.2007; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Massey LK, 2004, J ALZHEIMERS DIS, V6, P79; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meckler X, 2016, J BIOL CHEM, V291, P12821, DOI 10.1074/jbc.M115.708297; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Muhammad A, 2008, P NATL ACAD SCI USA, V105, P7327, DOI 10.1073/pnas.0802545105; Murray MM, 2009, J AM CHEM SOC, V131, P6316, DOI 10.1021/ja8092604; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Rajendrana L, 2007, NEURODEGENER DIS, V4, P164, DOI 10.1159/000101841; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Toh WH, 2016, BIOCHEM J, V473, P1977, DOI 10.1042/BCJ20160147; Tosto G, 2015, ANN CLIN TRANSL NEUR, V2, P810, DOI 10.1002/acn3.223; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; Urwin H, 2009, BIOCHEM SOC T, V37, P208, DOI 10.1042/BST0370208; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vilette D, 2015, CELL MOL LIFE SCI, V72, P4409, DOI 10.1007/s00018-015-1945-8; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Watanabe T, 2012, J NEUROSCI, V32, P3352, DOI 10.1523/JNEUROSCI.5659-11.2012; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Wolfe MS, 2013, BBA-BIOMEMBRANES, V1828, P2886, DOI 10.1016/j.bbamem.2013.04.015; Wolfe MS, 2012, BIOL CHEM, V393, P899, DOI 10.1515/hsz-2012-0140; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Yan YL, 2007, J MOL BIOL, V369, P909, DOI 10.1016/j.jmb.2007.04.014; Yonemura Y, 2016, BIOCHEM BIOPH RES CO, V478, P1751, DOI 10.1016/j.bbrc.2016.09.018; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	82	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19873	19889		10.1074/jbc.M117.818138	http://dx.doi.org/10.1074/jbc.M117.818138			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021256	Green Published, hybrid			2022-12-28	WOS:000416911300030
J	Gumbart, JC				Gumbart, James C.			Producing membrane proteins one simulation at a time	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TRANSLOCON; DESIGN	Integral membrane proteins are studied with a number of structural and biophysical techniques, many requiring protein overexpression to reach sufficient quantities. However, achievement of the overexpression of membrane proteins is not necessarily straightforward, and the mechanisms and factors that influence expression are not clearly understood. A new study has now broken through this uncertainty by demonstrating the capability of coarse-grained simulations of membrane protein insertion to predict protein expression levels in Escherichia coli.	[Gumbart, James C.] Georgia Inst Technol, Dept Phys, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Gumbart, JC (corresponding author), 837 State St, Atlanta, GA 30332 USA.	gumbart@physics.gatech.edu			National Institutes of Health [R01-GM123169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM123169. The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Gumbart JC, 2016, BBA-BIOMEMBRANES, V1858, P1663, DOI 10.1016/j.bbamem.2016.02.017; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; Marshall SS, 2016, CELL REP, V16, P2169, DOI 10.1016/j.celrep.2016.07.042; Niesen MJM, 2017, J BIOL CHEM, V292, P19537, DOI 10.1074/jbc.M117.813469; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039	10	0	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19546	19547		10.1074/jbc.H117.813469	http://dx.doi.org/10.1074/jbc.H117.813469			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	29175817	Green Published, hybrid			2022-12-28	WOS:000416226700032
J	Resto, M; Kim, BH; Fernandez, AG; Abraham, BJ; Zhao, K; Lewis, BA				Resto, Melissa; Kim, Bong-Hyun; Fernandez, Alfonso G.; Abraham, Brian J.; Zhao, Keji; Lewis, Brian A.			O-GlcNAcase is an RNA polymerase II elongation factor coupled to pausing factors SPT5 and TIF1 beta (vol 291, pg 22703, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Resto M, 2016, J BIOL CHEM, V291, P22703, DOI 10.1074/jbc.M116.751420	1	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16524	16525		10.1074/jbc.A116.751420	http://dx.doi.org/10.1074/jbc.A116.751420			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28986433	Green Published, hybrid			2022-12-28	WOS:000412414800013
J	Tekirdag, K; Cuervo, AM				Tekirdag, Kumsal; Cuervo, Ana Maria			Chaperone-mediated autophagy and endosomal microautophagy: Jointed by a chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RAT-LIVER LYSOSOMES; CYTOSOLIC PROTEINS; SELECTIVE PATHWAY; INTRACELLULAR DEGRADATION; SACCHAROMYCES-CEREVISIAE; PEPTIDE SEQUENCES; OXIDATIVE STRESS; SERUM WITHDRAWAL; PICHIA-PASTORIS; MEMBRANE	A variety of mechanisms deliver cytosolic materials to the lysosomal compartment for degradation through autophagy. Here, we focus on two autophagic pathways, the chaperone-mediated autophagy and the endosomal microautophagy that rely on the cytosolic chaperone hsc70 for substrate targeting. Although hsc70 participates in the triage of proteins for degradation by different proteolytic systems, the common characteristic shared by these two forms of autophagy is that hsc70 binds directly to a specific five-amino acid motif in the cargo protein for its autophagic targeting. We summarize the current understanding of the molecular machineries behind each of these types of autophagy.	[Tekirdag, Kumsal; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Inst Aging Studies, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu		Tekirdag-Kosar, A.Kumsal/0000-0001-7986-0035; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health from NIA [AG021904, AG031782, AG038072, AG054108]; National Institutes of Health from NINDS [NS100717]; National Institutes of Health from NIDDK [DK098408]; Leducq Network Award [RA15CVD04]; Rainwaters Foundation; Glen Foundation; Backus Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, P30DK020541, R01DK098408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS100717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG021904, P01AG031782, P30AG038072, RF1AG054108, R01AG021904] Funding Source: NIH RePORTER	National Institutes of Health from NIA; National Institutes of Health from NINDS; National Institutes of Health from NIDDK; Leducq Network Award; Rainwaters Foundation; Glen Foundation; Backus Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants AG021904, AG031782, AG038072, and AG054108 from NIA, Grant NS100717 from NINDS, Grant DK098408 from NIDDK, Leducq Network Award RA15CVD04, the Rainwaters Foundation, Glen Foundation, and Backus Foundation, and the generous support of Robert and Renee Belfer. This is the fourth article in the Thematic Minireview series "Autophagy." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarraberes FA, 2001, J CELL SCI, V114, P2491; Agarraberes FA, 1997, J CELL BIOL, V137, P825, DOI 10.1083/jcb.137.4.825; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; Aniento F, 1996, FEBS LETT, V390, P47, DOI 10.1016/0014-5793(96)00625-4; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Arias E, 2017, METHOD ENZYMOL, V588, P283, DOI 10.1016/bs.mie.2016.10.009; Arias E, 2015, MOL CELL, V59, P270, DOI 10.1016/j.molcel.2015.05.030; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; BACKER JM, 1986, P NATL ACAD SCI USA, V83, P5830, DOI 10.1073/pnas.83.16.5830; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Berger J J, 1985, Prog Clin Biol Res, V180, P479; Bonhoure A, 2017, EUR J CELL BIOL, V96, P83, DOI 10.1016/j.ejcb.2016.12.002; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Cannizzo ES, 2012, CELL REP, V2, P136, DOI 10.1016/j.celrep.2012.06.005; Chava S, 2017, ONCOTARGET, V8, P40019, DOI 10.18632/oncotarget.16685; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; CHIANG HL, 1989, SCIENCE, V246, P382, DOI 10.1126/science.2799391; Cuervo AM, 1999, KIDNEY INT, V55, P529, DOI 10.1046/j.1523-1755.1999.00268.x; Cuervo AM, 2000, J BIOL CHEM, V275, P33329, DOI 10.1074/jbc.M005655200; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 1998, MOL BIOL CELL, V9, P1995, DOI 10.1091/mbc.9.8.1995; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 2000, J CELL SCI, V113, P4441; CUERVO AM, 1995, AM J PHYSIOL-CELL PH, V269, pC1200, DOI 10.1152/ajpcell.1995.269.5.C1200; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DETER RL, 1967, J CELL BIOL, V35, pC11, DOI 10.1083/jcb.35.2.C11; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; DICE JF, 1986, J BIOL CHEM, V261, P6853; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Finn PF, 2005, J BIOL CHEM, V280, P25864, DOI 10.1074/jbc.M502456200; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gomes LR, 2017, AUTOPHAGY, V13, P928, DOI 10.1080/15548627.2017.1293767; Gough NR, 1997, J CELL BIOL, V137, P1161, DOI 10.1083/jcb.137.5.1161; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kalachev AV, 2017, PROTOPLASMA, V254, P609, DOI 10.1007/s00709-016-0963-1; Kaushik S., 2018, NAT REV MOL IN PRESS; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kaushik S, 2006, EMBO J, V25, P3921, DOI 10.1038/sj.emboj.7601283; Kaushik S, 2015, NAT MED, V21, P1406, DOI 10.1038/nm.4001; Kaushik S, 2015, NAT CELL BIOL, V17, P759, DOI 10.1038/ncb3166; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Koga H, 2011, J NEUROSCI, V31, P18492, DOI 10.1523/JNEUROSCI.3219-11.2011; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Kvam E, 2004, J CELL SCI, V117, P4959, DOI 10.1242/jcs.01372; Leao-Helder AN, 2004, FEBS LETT, V577, P491, DOI 10.1016/j.febslet.2004.10.055; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Levine B, 2017, P NATL ACAD SCI USA, V114, P201, DOI 10.1073/pnas.1619876114; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; MARZELLA L, 1981, VIRCHOWS ARCH B, V36, P219, DOI 10.1007/BF02912068; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Morozova K, 2016, J BIOL CHEM, V291, P18096, DOI 10.1074/jbc.M116.736744; MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506; Mukherjee A, 2016, AUTOPHAGY, V12, P1984, DOI 10.1080/15548627.2016.1208887; Napolitano G, 2015, EMBO MOL MED, V7, P158, DOI 10.15252/emmm.201404223; Numrich J, 2015, J CELL SCI, V128, P2278, DOI 10.1242/jcs.164905; Oku M, 2017, J CELL BIOL, V216, P3263, DOI 10.1083/jcb.201611029; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Park C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7823; Qi L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046834, 10.1371/journal.pone.0029572]; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rodriguez-Muela N, 2013, AGING CELL, V12, P478, DOI 10.1111/acel.12072; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Rout AK, 2014, J BIOL CHEM, V289, P35111, DOI 10.1074/jbc.M114.609446; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Salvador N, 2000, J BIOL CHEM, V275, P27447; Sato M, 2016, GENES CELLS, V21, P861, DOI 10.1111/gtc.12390; Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Seo AY, 2017, ELIFE, V6, DOI 10.7554/eLife.21690; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sooparb S, 2004, KIDNEY INT, V65, P2135, DOI 10.1111/j.1523-1755.2004.00639.x; Suzuki J, 2017, BIOCHEM BIOPH RES CO, V482, P1334, DOI 10.1016/j.bbrc.2016.12.037; Tsuji T, 2017, ELIFE, V6, DOI 10.7554/eLife.25960; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; Uytterhoeven V, 2015, NEURON, V88, P735, DOI 10.1016/j.neuron.2015.10.012; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003; Vevea JD, 2015, DEV CELL, V35, P584, DOI 10.1016/j.devcel.2015.11.010; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wu JN, 2017, SIXTEENTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, P1; Xia HG, 2015, J CELL BIOL, V210, P705, DOI 10.1083/jcb.201503044; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yuan WP, 1997, J CELL SCI, V110, P1935; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang JZ, 2017, J BIOL CHEM, V292, P10328, DOI 10.1074/jbc.M116.764076; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	99	181	186	14	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 13	2018	293	15					5414	5424		10.1074/jbc.R117.818237	http://dx.doi.org/10.1074/jbc.R117.818237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GC8KX	29247007	hybrid, Green Published			2022-12-28	WOS:000430044100006
J	Alvarez, M; Nevot, M; Mendieta, J; Martinez, MA; Menendez-Arias, L				Alvarez, Mar; Nevot, Maria; Mendieta, Jesus; Martinez, Miguel A.; Menendez-Arias, Luis			Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL DRUG-RESISTANCE; THYMIDINE NUCLEOTIDE ANALOGS; DEPENDENT PRIMER UNBLOCKING; IN-VITRO; MOLECULAR-MECHANISMS; DIPEPTIDE INSERTION; CATALYTIC COMPLEX; THUMB SUBDOMAIN; AZT RESISTANCE	Nucleoside reverse transcriptase (RT) inhibitors (NRTIs) are the backbone of current antiretroviral treatments. However, the emergence of viral resistance against NRTIs is a major threat to their therapeutic effectiveness. In HIV-1, NRTI resistance-associated mutations either reduce RT-mediated incorporation of NRTI triphosphates (discrimination mechanism) or confer an ATP-mediated nucleotide excision activity that removes the inhibitor from the 3' terminus of DNA primers, enabling further primer elongation (excision mechanism). In HIV-2, resistance to zidovudine (3'-azido-3'-deoxythymidine (AZT)) and other NRTIs is conferred by mutations affecting nucleotide discrimination. Mutations of the excision pathway such as M41L, D67N, K70R, or S215Y (known as thymidine-analogue resistance mutations (TAMs)) are rare in the virus from HIV-2-infected individuals. Here, we demonstrate that mutant M41L/D67N/K70R/S215Y HIV-2 RT lacks ATP-dependent excision activity, and recombinant virus containing this RT remains susceptible to AZT inhibition. Mutant HIV-2 RTs were tested for their ability to unblock and extend DNA primers terminated with AZT and other NRTIs, when complexed with RNA or DNA templates. Our results show that Met(73) and, to a lesser extent, Ile(75) suppress excision activity when TAMs are present in the HIV-2 RT. Interestingly, recombinant HIV-2 carrying a mutant D67N/K70R/M73K RT showed 10-fold decreased AZT susceptibility and increased rescue efficiency on AZT- or tenofovir-terminated primers, as compared with the double-mutant D67N/K70R. Molecular dynamics simulations reveal that Met(73) influences beta 3-beta 4 hairpin loop conformation, whereas its substitution affects hydrogen bond interactions at position 70, required for NRTI excision. Our work highlights critical HIV-2 RT residues impeding the development of excision-mediated NRTI resistance.	[Alvarez, Mar; Mendieta, Jesus; Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain; [Mendieta, Jesus; Menendez-Arias, Luis] Univ Autonoma Madrid, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain; [Nevot, Maria; Martinez, Miguel A.] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Lab Retrovirol, Barcelona 08916, Spain; [Mendieta, Jesus] Univ Francisco de Vitoria, Dept Biotecnol, Madrid 28223, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universidad Francisco de Vitoria	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.csic.es	Nevot, Maria/AAC-7839-2022; Nevot, Maria/E-6187-2016; Menendez Arias, Luis/N-7447-2016; Martinez, Miguel Angel/K-6435-2014	Nevot, Maria/0000-0003-4947-4648; Nevot, Maria/0000-0003-4947-4648; Alvarez, Mar/0000-0002-6086-6557; Menendez Arias, Luis/0000-0002-1251-6640; Martinez, Miguel Angel/0000-0002-6681-4950; Mendieta, Jesus/0000-0001-9286-2166	Fundacion Ramon Areces	Fundacion Ramon Areces	An institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa is also acknowledged.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; Alvarez M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44834; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Betancor G, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-68; Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Boyer PL, 2006, PLOS PATHOG, V2, P101, DOI 10.1371/journal.ppat0020010; Boyer PL, 2012, J VIROL, V86, P5885, DOI 10.1128/JVI.06597-11; Brandin E, 2003, AIDS RES HUM RETROV, V19, P543, DOI 10.1089/088922203322230905; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; Colson P, 2005, J MED VIROL, V75, P381, DOI 10.1002/jmv.20296; Damond F, 2005, ANTIVIR THER, V10, P861; Damond F, 2004, ANTIVIR THER, V9, P635; Descamps D, 2004, J MED VIROL, V74, P197, DOI 10.1002/jmv.20174; Deuzing IP, 2015, J VIROL, V89, P833, DOI 10.1128/JVI.02259-14; Deval J, 2002, J BIOL CHEM, V277, P42097, DOI 10.1074/jbc.M206725200; Foley B., 2014, HIV SEQUENCE COMPEND; Fujita Y, 2013, VIROLOGY, V436, P100, DOI 10.1016/j.virol.2012.10.036; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P848, DOI 10.1086/597577; Gottlieb GS, 2008, AIDS, V22, P2069, DOI 10.1097/QAD.0b013e32830edd44; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Hachiya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016242; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kim B, 1996, J BIOL CHEM, V271, P4872, DOI 10.1074/jbc.271.9.4872; Kisic M, 2008, J MOL BIOL, V382, P327, DOI 10.1016/j.jmb.2008.07.030; Kisic M, 2011, J BIOL CHEM, V286, P20615, DOI 10.1074/jbc.M111.226100; LARDER BA, 1994, J GEN VIROL, V75, P951, DOI 10.1099/0022-1317-75-5-951; Lloyd SB, 2016, VIROLOGY, V492, P1, DOI 10.1016/j.virol.2016.02.008; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2004, J BIOL CHEM, V279, P24569, DOI 10.1074/jbc.M312658200; Matamoros T, 2009, J BIOL CHEM, V284, P32792, DOI 10.1074/jbc.M109.038885; Matsumi S, 2003, AIDS, V17, P1127, DOI 10.1097/00002030-200305230-00003; Mendieta J, 2008, PROTEINS, V71, P565, DOI 10.1002/prot.21711; Menendez-Arias L, 1998, BIOCHEMISTRY-US, V37, P16636, DOI 10.1021/bi981830g; Menendez-Arias L, 2008, VIRUS RES, V134, P124, DOI 10.1016/j.virusres.2007.12.015; Menendez-Arias L, 2008, TRENDS PHARMACOL SCI, V29, P42, DOI 10.1016/j.tips.2007.10.013; Menendez-Arias L, 2014, ANTIVIR RES, V102, P70, DOI 10.1016/j.antiviral.2013.12.001; Menendez-Arias L, 2013, ANTIVIR RES, V98, P93, DOI 10.1016/j.antiviral.2013.01.007; Meyer PR, 2002, ANTIMICROB AGENTS CH, V46, P1540, DOI 10.1128/AAC.46.5.1540-1545.2002; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Ntemgwa ML, 2009, ANTIMICROB AGENTS CH, V53, P3611, DOI 10.1128/AAC.00154-09; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; Reid P, 2005, VIROLOGY, V336, P251, DOI 10.1016/j.virol.2005.03.030; Ren J, 2002, P NATL ACAD SCI USA, V99, P14410, DOI 10.1073/pnas.222366699; Rodes B, 2000, J CLIN MICROBIOL, V38, P1370; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Sevilya Z, 2001, J MOL BIOL, V311, P957, DOI 10.1006/jmbi.2001.4904; SHIRASAKA T, 1995, P NATL ACAD SCI USA, V92, P2398, DOI 10.1073/pnas.92.6.2398; Smith RA, 2008, ANTIMICROB AGENTS CH, V52, P329, DOI 10.1128/AAC.01004-07; Smith RA, 2009, J INFECT DIS, V199, P1323, DOI 10.1086/597802; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Trevino A, 2011, J ANTIMICROB CHEMOTH, V66, P1484, DOI 10.1093/jac/dkr164; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; van der Ende ME, 2000, J ACQ IMMUN DEF SYND, V25, P11, DOI 10.1097/00126334-200009010-00002; White KL, 2004, ANTIMICROB AGENTS CH, V48, P992, DOI 10.1128/AAC.48.3.992-1003.2004; Yahi N, 1999, J CLIN MICROBIOL, V37, P4099, DOI 10.1128/JCM.37.12.4099-4106.1999	64	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2247	2259		10.1074/jbc.RA117.000177	http://dx.doi.org/10.1074/jbc.RA117.000177			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29275329	Green Published, hybrid			2022-12-28	WOS:000425308300002
J	Saldate, JJ; Shiau, J; Cazares, VA; Stuenkel, EL				Saldate, Johnny J.; Shiau, Jason; Cazares, Victor A.; Stuenkel, Edward L.			The ubiquitin-proteasome system functionally links neuronal Tomosyn-1 to dendritic morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LETHAL-GIANT-LARVAE; SYNAPTIC PLASTICITY; NEUROTRANSMITTER RELEASE; STRUCTURAL BASIS; YEAST HOMOLOGS; LIGASE HRD1; RAB GTPASE; PROTEIN; DEGRADATION; SNARE	Altering the expression of Tomosyn-1 (Tomo-1), a soluble, R-SNARE domain-containing protein, significantly affects behavior in mice, Drosophila, and Caenorhabditis elegans. Yet, the mechanisms that modulate Tomo-1 expression and its regulatory activity remain poorly defined. Here, we found that Tomo-1 expression levels influence postsynaptic spine density. Tomo-1 overexpression increased dendritic spine density, whereas Tomo-1 knockdown (KD) decreased spine density. These findings identified a novel action of Tomo-1 on dendritic spines, which is unique because it occurs independently of Tomo-1' s C-terminal R-SNARE domain. We also demonstrated that the ubiquitin-proteasome system (UPS), which is known to influence synaptic strength, dynamically regulates Tomo-1 protein levels. Immunoprecipitated and affinity-purified Tomo-1 from cultured rat hippocampal neurons was ubiquitinated, and the levels of ubiquitinated Tomo-1 dramatically increased upon pharmacological proteasome blockade. Moreover, Tomo-1 ubiquitination appeared to be mediated through an interaction with the E3 ubiquitin ligase HRD1, as immunoprecipitation of Tomo-1 from neurons co-precipitated HRD1, and this interaction increases upon proteasome inhibition. Further, in vitro reactions indicated direct, HRD1 concentration-dependent Tomo-1 ubiquitination. We also noted that the UPS regulates both Tomo-1 expression and functional output, as HRD1 KD in hippocampal neurons increased Tomo-1 protein level and dendritic spine density. Notably, the effect of HRD1 KD on spine density was mitigated by additional KD of Tomo-1, indicating a direct HRD1/Tomo-1 effector relationship. In summary, our results indicate that the UPS is likely to participate in tuning synaptic efficacy and spine dynamics by precise regulation of neuronal Tomo-1 levels.	[Saldate, Johnny J.; Stuenkel, Edward L.] Univ Michigan, Med Sch, Neurosci Grad Program, Ann Arbor, MI 48109 USA; [Shiau, Jason; Cazares, Victor A.; Stuenkel, Edward L.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stuenkel, EL (corresponding author), Univ Michigan, Med Sch, Neurosci Grad Program, Ann Arbor, MI 48109 USA.; Stuenkel, EL (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	esterm@umich.edu		Saldate, Johnny/0000-0003-4912-6299; Stuenkel, Edward/0000-0001-8225-5725; Cazares, Victor A/0000-0002-6625-7103	National Institutes of Health [R01 NS097498, F31 NS087883]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097498, F31NS087883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS097498 (to E. L. S.). Additional training support was provided by National Institutes of Health Grant F31 NS087883 (to J. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Barak B, 2013, NEUROMOL MED, V15, P351, DOI 10.1007/s12017-013-8223-4; Barak B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00149; Ben-Simon Y, 2015, CELL REP, V12, P396, DOI 10.1016/j.celrep.2015.06.037; Bhatnagar S, 2014, J BIOL CHEM, V289, P25276, DOI 10.1074/jbc.M114.575985; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bielopolski N, 2014, J BIOL CHEM, V289, P17087, DOI 10.1074/jbc.M113.515296; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bolte ER, 2003, MED HYPOTHESES, V60, P119, DOI 10.1016/S0306-9877(02)00345-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burdina AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026185; Cazares VA, 2016, J NEUROSCI, V36, P11208, DOI 10.1523/JNEUROSCI.1297-16.2016; Chen KY, 2011, P NATL ACAD SCI USA, V108, P18482, DOI 10.1073/pnas.1110184108; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Davis LK, 2009, J NEURODEV DISORD, V1, P292, DOI 10.1007/s11689-009-9013-z; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Geerts CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091697; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Guntupalli S, 2017, J BIOL CHEM, V292, P8186, DOI 10.1074/jbc.M116.774554; Hamilton A. M., 2013, NEURAL PLAST, V2013, P1; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hegde AN, 2017, NEUROBIOL LEARN MEM, V138, P98, DOI 10.1016/j.nlm.2016.09.003; Hegde AN, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00096; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; Huang J, 2015, NEURON, V86, P726, DOI 10.1016/j.neuron.2015.03.049; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Jiang XP, 2010, J NEUROSCI, V30, P1798, DOI 10.1523/JNEUROSCI.4965-09.2010; Kagami M, 1998, GENETICS, V149, P1717; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389; Kienle N, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-19; Kim H, 2016, J NEUROSCI, V36, P4888, DOI 10.1523/JNEUROSCI.4204-15.2016; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lin YC, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00263; Lussier MP, 2012, P NATL ACAD SCI USA, V109, P19426, DOI 10.1073/pnas.1217477109; Mabb AM, 2014, NEURON, V82, P1299, DOI 10.1016/j.neuron.2014.05.016; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Mao JH, 2017, HUM MOL GENET, V26, P1877, DOI 10.1093/hmg/ddx096; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Murakami T, 2007, NEUROSCIENCE, V146, P1, DOI 10.1016/j.neuroscience.2007.01.069; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nagano K, 2015, INT J BIOCHEM CELL B, V62, P62, DOI 10.1016/j.biocel.2015.02.013; Nalavadi VC, 2012, J NEUROSCI, V32, P2582, DOI 10.1523/JNEUROSCI.5057-11.2012; Omura T, 2008, J NEUROSCI RES, V86, P1577, DOI 10.1002/jnr.21616; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Rosenberg T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00086; Rossi G, 2011, MOL BIOL CELL, V22, P842, DOI 10.1091/mbc.E10-07-0570; Rossi G, 2015, J BIOL CHEM, V290, P612, DOI 10.1074/jbc.M114.595892; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schreiber J, 2015, J CELL BIOL, V211, P569, DOI 10.1083/jcb.201506048; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tsai NP, 2014, BBA-MOL CELL RES, V1843, P2838, DOI 10.1016/j.bbamcr.2014.08.006; Waites CL, 2013, EMBO J, V32, P954, DOI 10.1038/emboj.2013.27; Watson K, 2015, MOL BIOL CELL, V26, P3289, DOI 10.1091/mbc.E15-04-0228; Williams AL, 2011, J BIOL CHEM, V286, P14542, DOI 10.1074/jbc.M110.215624; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Ying HY, 2012, INT REV CEL MOL BIO, V294, P223, DOI 10.1016/B978-0-12-394305-7.00005-7; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; ZHANG Peng, 2015, ADV METEOROLOGICAL S, V5, P6; Zhang Q, 2013, CELL MOL LIFE SCI, V70, P153, DOI 10.1007/s00018-012-1103-5; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015	93	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2232	2246		10.1074/jbc.M117.815514	http://dx.doi.org/10.1074/jbc.M117.815514			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29269412	Green Published, hybrid			2022-12-28	WOS:000425308300001
J	Hasegawa, M; Fushimi, K; Miyake, K; Nakajima, T; Oikawa, Y; Enomoto, G; Sato, M; Ikeuchi, M; Narikawa, R				Hasegawa, Masumi; Fushimi, Keiji; Miyake, Keita; Nakajima, Takahiro; Oikawa, Yuki; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko; Narikawa, Rei			Molecular characterization of DXCF cyanobacteriochromes from the cyanobacterium Acaryochloris marina identifies a blue-light power sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; photobiology; photoreceptor; site-directed mutagenesis; spectroscopy; cyanobacteriochrome; phytochrome	PHOTOACTIVE GAF DOMAIN; REVERSIBLE PHOTOCONVERSION; NEGATIVE PHOTOTAXIS; SPECTRAL PROPERTIES; PHYTOCHROME-B; PHYCOVIOLOBILIN; PHOTORECEPTORS; PHYCOCYANOBILIN; PHOTOCYCLES; CHROMOPHORE	Cyanobacteriochromes (CBCRs) are linear tetrapyrrole-binding photoreceptors that sense a wide range of wavelengths from ultraviolet to far-red. The primary photoreaction in these reactions is a Z/E isomerization of the double bond between rings C and D. After this isomerization, various color-tuning events establish distinct spectral properties of the CBCRs. Among the various CBCRs, the DXCF CBCR lineage is widely distributed among cyanobacteria. Because the DXCF CBCRs from the cyanobacterium Acaryochloris marina vary widely in sequence, we focused on these CBCRs in this study. We identified seven DXCF CBCRs in A. marina and analyzed them after isolation from Escherichia coli that produces phycocyanobilin, a main chromophore for the CBCRs. We found that six of these CBCRs covalently bound a chromophore and exhibited variable properties, including blue/green, blue/teal, green/teal, and blue/orange reversible photoconversions. Notably, one CBCR, AM1_1870g4, displayed unidirectional photoconversion in response to blue-light illumination, with a rapid dark reversion that was temperature-dependent. Furthermore, the photoconversion took place without Z/E isomerization. This observation indicated that AM1_1870g4 likely functions as a blue-light power sensor, whereas typical CBCRs reversibly sense two light qualities. We also found that AM1_1870g4 possesses a GDCF motif in which the Asp residue is swapped with the next Gly residue within the DXCF motif. Site-directed mutagenesis revealed that this swap is essential for the light power-sensing function of AM1_1870g4. This is the first report of a blue-light power sensor from the CBCR superfamily and of photoperception without Z/E isomerization among the bilin-based photoreceptors.	[Hasegawa, Masumi; Fushimi, Keiji; Miyake, Keita; Oikawa, Yuki; Narikawa, Rei] Shizuoka Univ, Fac Sci, Dept Biol Sci, Suruga Ku, Shizuoka 4228529, Japan; [Narikawa, Rei] Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Suruga Ku, Shizuoka 4228529, Japan; [Nakajima, Takahiro; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Fushimi, Keiji; Nakajima, Takahiro; Enomoto, Gen; Sato, Moritoshi; Ikeuchi, Masahiko; Narikawa, Rei] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	Shizuoka University; Shizuoka University; University of Tokyo; Japan Science & Technology Agency (JST)	Narikawa, R (corresponding author), Shizuoka Univ, Fac Sci, Dept Biol Sci, Suruga Ku, Shizuoka 4228529, Japan.; Narikawa, R (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Biol Res Div, Suruga Ku, Shizuoka 4228529, Japan.; Narikawa, R (corresponding author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	narikawa.rei@shizuoka.ac.jp	Enomoto, Gen/ABE-4194-2021; Fushimi, Keiji/U-2974-2019; Narikawa, Rei/AAA-5829-2021; Sato, Moritoshi/O-2735-2018	Enomoto, Gen/0000-0002-9492-7557; Sato, Moritoshi/0000-0002-3095-5831; Hasegawa, Masumi/0000-0002-4227-8321	Japan Science and Technology Agency, CREST Grant [JPMJCR1653]; Japan Society for the Promotion of Science KAKENHI Grant [26702036]	Japan Science and Technology Agency, CREST Grant(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency, CREST Grant JPMJCR1653 (to R. N.), and Japan Society for the Promotion of Science KAKENHI Grant 26702036 (to R. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abatedaga I, 2017, PHOTOCHEM PHOTOBIOL, V93, P805, DOI 10.1111/php.12760; Anders K, 2015, CURR OPIN STRUC BIOL, V35, P7, DOI 10.1016/j.sbi.2015.07.005; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Bai YN, 2016, J PHOTOCH PHOTOBIO B, V161, P192, DOI 10.1016/j.jphotobiol.2016.05.014; Burgie ES, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14037-0; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Cho SM, 2015, J BIOL CHEM, V290, P28502, DOI 10.1074/jbc.M115.669150; Enomoto G, 2015, P NATL ACAD SCI USA, V112, P8082, DOI 10.1073/pnas.1504228112; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Fujii Y, 2017, P NATL ACAD SCI USA, V114, P9206, DOI 10.1073/pnas.1704462114; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P903, DOI 10.1111/php.12764; Fushimi K, 2017, PHOTOCHEM PHOTOBIOL, V93, P681, DOI 10.1111/php.12732; Fushimi K, 2016, BIOCHEMISTRY-US, V55, P6981, DOI 10.1021/acs.biochem.6b00940; Fushimi K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00588; GROMBEIN S, 1975, H-S Z PHYSIOL CHEM, V356, P1709, DOI 10.1515/bchm2.1975.356.2.1709; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legris M, 2016, SCIENCE, V354, P897, DOI 10.1126/science.aaf5656; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Loughlin PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27547; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Mukougawa K, 2006, FEBS LETT, V580, P1333, DOI 10.1016/j.febslet.2006.01.051; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Narikawa R, 2006, PHOTOCHEM PHOTOBIOL, V82, P1627, DOI 10.1562/2006-05-02-RA-888; Narikawa R, 2008, PHOTOCH PHOTOBIO SCI, V7, P1253, DOI 10.1039/b811214b; Narikawa R, 2015, BIOCHEM BIOPH RES CO, V461, P390, DOI 10.1016/j.bbrc.2015.04.045; Narikawa R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07950; Narikawa R, 2014, BIOCHEMISTRY-US, V53, P5051, DOI 10.1021/bi500376b; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Narikawa R, 2011, PLANT CELL PHYSIOL, V52, P2214, DOI 10.1093/pcp/pcr155; Njimona I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109794; Njimona I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025977; Oka Y, 2004, PLANT CELL, V16, P2104, DOI 10.1105/tpc.104.022350; Okajima K, 2005, J BIOCHEM, V137, P741, DOI 10.1093/jb/mvi089; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2017, PHOTOCHEM PHOTOBIOL, V93, P741, DOI 10.1111/php.12708; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P929, DOI 10.1039/c4pp00486h; Rockwell NC, 2014, BIOCHEMISTRY-US, V53, P3118, DOI 10.1021/bi500037a; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Singh NK, 2015, EXCLI J, V14, P268, DOI 10.17179/excli2014-723; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Watanabe M, 2013, PHOTOSYNTH RES, V116, P265, DOI 10.1007/s11120-013-9905-3; Wiltbank LB, 2016, MBIO, V7, DOI 10.1128/mBio.02130-15; Yoshihara S, 2006, BIOCHEMISTRY-US, V45, P3775, DOI 10.1021/bi051983l; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; ZHAO KH, 1995, BBA-BIOENERGETICS, V1228, P235, DOI 10.1016/0005-2728(94)00181-4	59	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1713	1727		10.1074/jbc.M117.816553	http://dx.doi.org/10.1074/jbc.M117.816553			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29229775	Green Published, hybrid			2022-12-28	WOS:000424201700022
J	Li, HH; Yang, K; Wang, WJ; Niu, YB; Li, J; Dong, YH; Liu, YF; Wang, CC; Wang, L; Liang, HH				Li, Huanhuan; Yang, Kai; Wang, Wenjia; Niu, Yingbo; Li, Jun; Dong, Yuhui; Liu, Yingfang; Wang, Chih-chen; Wang, Lei; Liang, Huanhuan			Crystal and solution structures of human protein-disulfide isomerase-like protein of the testis (PDILT) provide insight into its chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						conformational change; molecular chaperone; protein structure; small-angle X-ray scattering (SAXS); X-ray crystallography	X-RAY-SCATTERING; MHC CLASS-I; BIOLOGICAL MACROMOLECULES; ENDOPLASMIC-RETICULUM; FOLDING CATALYST; QUALITY-CONTROL; BINDING SITE; B' DOMAIN; RESOLUTION; SYSTEM	Protein-disulfide isomerase-like protein of the testis (PDILT), a member of the protein-disulfide isomerase family, is a chaperone essential for the folding of spermatogenesis-specific proteins in male postmeiotic germ cells. However, the structural mechanisms that regulate the chaperone function of PDILTs are unknown. Here, we report the structures of human PDILT (hPDILT) determined by X-ray crystallography to 2.4 resolution and small-angle X-ray scattering (SAXS). Distinct from previously reported U-like structures of related PDI family proteins, our structures revealed that hPDILT folds into a compact L-like structure in crystals and into an extended chain-like structure in solution. The hydrophobic regions and the hydrophobic pockets in hPDILT, which are important for substrate recognition, were clearly delineated in the crystal structure. Moreover, our results of the SAXS analysis and of structure-based substitutions and truncations indicated that the C-terminal tail in hPDILT is required for suppression of aggregation of denatured proteins, suggesting that the tail is crucial for the chaperone activity of PDILT. Taken together, our findings have identified the critical regions and conformational changes of PDILT that enable and control its activity. These results advance our understanding of the structural mechanisms involved in the chaperone activity of PDILT.	[Li, Huanhuan; Li, Jun; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Yang, Kai; Niu, Yingbo; Wang, Chih-chen; Wang, Lei] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Wenjia; Dong, Yuhui] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China; [Li, Huanhuan; Yang, Kai; Niu, Yingbo; Li, Jun; Wang, Chih-chen; Wang, Lei] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Yingfang] Sun Yat Sen Univ, Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Huanhuan] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sun Yat Sen University; Sun Yat Sen University	Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Wang, L (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Wang, L (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.; Liang, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China.	wanglei@moon.ibp.ac.cn; hhliang@moon.ibp.ac.cn	Yang, Kai S./AAC-9906-2021	Yang, Kai S./0000-0002-1890-4169; Wang, Lei/0000-0002-5071-5800; Dong, Yuhui/0000-0002-4422-4685	National Natural Science Foundation of China [31530015, 31571163, 31370775]; National Key R&D Program of China [2016YFA0500200, 2017YFA0504000]; Strategic Priority Research Program, CAS Grant [XDB08000000]; Frontier Sciences Project, CAS Grant [QYZDYSSW-SMC018]; Youth Innovation Promotion Association CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Strategic Priority Research Program, CAS Grant; Frontier Sciences Project, CAS Grant; Youth Innovation Promotion Association CAS	This work was supported by National Natural Science Foundation of China Grants 31530015, 31571163, and 31370775, National Key R&D Program of China Grants 2016YFA0500200 and 2017YFA0504000, the Strategic Priority Research Program, CAS Grant XDB08000000, Frontier Sciences Project, CAS Grant QYZDYSSW-SMC018, and Youth Innovation Promotion Association CAS (to L. W). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bastos-Aristizabal S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04464; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Diwaker D, 2015, VIRAL IMMUNOL, V28, P153, DOI 10.1089/vim.2014.0095; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P509, DOI 10.1021/bi00002a015; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Landegren N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20104; Lipton SA, 2007, INT REV NEUROBIOL, V82, P1, DOI 10.1016/S0074-7742(07)82001-0; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Smulders RHPH, 1996, J BIOL CHEM, V271, P29060, DOI 10.1074/jbc.271.46.29060; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tokuhiro K, 2012, P NATL ACAD SCI USA, V109, P3850, DOI 10.1073/pnas.1117963109; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; van Lith M, 2007, MOL BIOL CELL, V18, P2795, DOI 10.1091/mbc.E07-02-0147; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang C, 2013, ANTIOXID REDOX SIGN, V19, P44, DOI 10.1089/ars.2012.4630; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wang L, 2015, FREE RADICAL BIO MED, V83, P305, DOI 10.1016/j.freeradbiomed.2015.02.007; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Watanabe S, 2017, P NATL ACAD SCI USA, V114, pE3224, DOI 10.1073/pnas.1621426114	52	6	7	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1192	1202		10.1074/jbc.M117.797290	http://dx.doi.org/10.1074/jbc.M117.797290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29203529	Green Published, hybrid			2022-12-28	WOS:000423515000008
J	Morgan, GJ; Burkhardt, DH; Kelly, JW; Powers, ET				Morgan, Gareth J.; Burkhardt, David H.; Kelly, Jeffery W.; Powers, Evan T.			Translation efficiency is maintained at elevated temperature in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK RESPONSE; TRANSCRIPTION FACTOR SIGMA(32); SIGNAL RECOGNITION PARTICLE; RIBOSOME PROFILING REVEALS; CODON USAGE BIAS; GENE-EXPRESSION; MESSENGER-RNA; GENOME-WIDE; TRIGGER FACTOR; IN-VIVO	Cellular protein levels are dictated by the balance between gene transcription, mRNA translation, and protein degradation, among other factors. Translation requires the interplay of several RNA hybridization processes, which are expected to be temperature-sensitive. We used ribosome profiling to monitor translation in Escherichia coli at 30 degrees C and to investigate how this changes after 10-20 min of heat shock at 42 degrees C. Translation efficiencies are robustly maintained after thermal heat shock and after mimicking the heat-shock response transcriptional program at 30 degrees C by overexpressing the heat shock sigma factor encoded by the rpoH gene. We compared translation efficiency, the ratio of ribosome footprint reads to mRNA reads for each gene, to parameters derived from gene sequences. Genes with stable mRNA structures, non-optimal codon use, and those whose gene product is cotranslationally translocated into the inner membrane are generally less highly translated than other genes. Comparison with other published datasets suggests a role for translational elongation in coupling mRNA structures to translation initiation. Genome-wide calculations of the temperature dependence of mRNA structure predict that relatively few mRNAs show a melting transition between 30 and 42 degrees C, consistent with the observed lack of changes in translation efficiency. We developed a linear model with six parameters that can predict 38% of the variation in translation efficiency between genes, which may be useful in interpreting transcriptome data.	[Morgan, Gareth J.; Kelly, Jeffery W.; Powers, Evan T.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Morgan, Gareth J.; Kelly, Jeffery W.; Powers, Evan T.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Burkhardt, David H.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Burkhardt, David H.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Powers, ET (corresponding author), 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	epowers@scripps.edu			National Institutes of Health from NIGMS [GM101644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, R01GM101644] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM101644 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; ALLEN SP, 1992, J BACTERIOL, V174, P6938, DOI 10.1128/JB.174.21.6938-6947.1992; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Avcilar-Kucukgoze I, 2016, NUCLEIC ACIDS RES, V44, P8324, DOI 10.1093/nar/gkw697; Bartholomaus A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0069; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Borujeni AE, 2017, NUCLEIC ACIDS RES, V45, P5437, DOI 10.1093/nar/gkx061; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diaz-Mejia JJ, 2009, FEMS MICROBIOL REV, V33, P66, DOI 10.1111/j.1574-6976.2008.00141.x; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gorochowski TE, 2015, NUCLEIC ACIDS RES, V43, P3022, DOI 10.1093/nar/gkv199; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Guimaraes JC, 2014, NUCLEIC ACIDS RES, V42, P4791, DOI 10.1093/nar/gku126; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson O, 2010, P NATL ACAD SCI USA, V107, P21487, DOI 10.1073/pnas.1006821107; Li GW, 2015, CURR OPIN MICROBIOL, V24, P66, DOI 10.1016/j.mib.2015.01.001; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lim B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001735; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NATH K, 1970, J BIOL CHEM, V245, P2889; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; OHTAKA Y, 1963, SCIENCE, V142, P493, DOI 10.1126/science.142.3591.493; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Powers ET, 2012, CELL REP, V1, P265, DOI 10.1016/j.celrep.2012.02.011; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Quax TEF, 2013, CELL REP, V4, P938, DOI 10.1016/j.celrep.2013.07.049; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; RUUSALA T, 1984, EMBO J, V3, P2575, DOI 10.1002/j.1460-2075.1984.tb02176.x; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Schrader JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004463; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; THOMAS MS, 1987, J MOL BIOL, V196, P333, DOI 10.1016/0022-2836(87)90694-2; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; TU GF, 1995, J BIOL CHEM, V270, P9322, DOI 10.1074/jbc.270.16.9322; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WIKSTROM PM, 1992, J MOL BIOL, V224, P949, DOI 10.1016/0022-2836(92)90462-S; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Yura T, 2007, P NATL ACAD SCI USA, V104, P17638, DOI 10.1073/pnas.0708819104; Zhang X, 2014, ACS CHEM BIOL, V9, P1945, DOI 10.1021/cb5004477; Zhang YQ, 2017, GENOM PROTEOM BIOINF, V15, P324, DOI 10.1016/j.gpb.2017.04.005	77	20	20	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					777	793		10.1074/jbc.RA117.000284	http://dx.doi.org/10.1074/jbc.RA117.000284			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29183994	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000422864500003
J	Xiong, AL; Haithcock, J; Liu, YY; Eusner, L; McConnell, M; White, HD; Belknap, B; Forgacs, E				Xiong, Ailian; Haithcock, Jessica; Liu, Yingying; Eusner, Lauren; McConnell, Matthew; White, Howard D.; Belknap, Betty; Forgacs, Eva			The shaker-1 mouse myosin VIIa deafness mutation results in a severely reduced rate of the ATP hydrolysis step	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							USHER-SYNDROME; MUSCLE-CONTRACTION; CELLULAR FUNCTIONS; FLUORESCENT-PROBE; FERM DOMAIN; ACTOMYOSIN; COMPLEX; GENE; STEREOCILIA; CELLS	Mutations in the MYO7A gene, encoding the motor protein myosin VIIa, can cause Usher 1B, a deafness/blindness syndrome in humans, and the shaker-1 phenotype, characterized by deafness, head tossing, and circling behavior, in mice. Myosin VIIa is responsible for tension bearing and the transduction mechanism in the stereocilia and for melanosome transport in the retina, in line with the phenotypic outcomes observed in mice. However, the effect of the shaker-1 mutation, a R502P amino acid substitution, on the motor function is unclear. To explore this question, we determined the kinetic properties and the effect on the filopodial tip localization of the recombinant mouse myosin VIIa-5IQ-SAH R502P (myoVIIa-sh1) construct. Interestingly, although residue 502 is localized to a region thought to be involved in interacting with actin, the kinetic parameters for actin binding changed only slightly for the mutant construct. However, the rate constant for ATP hydrolysis (k(+H)+k(-H)) was reduced by similar to 200-fold from 12 s(-1) to 0.05 s(-1), making the hydrolysis step the rate-limiting step of the ATPase cycle in the presence and absence of actin. Given that wild-type mouse myosin VIIa is a slow, high-duty ratio, monomeric motor, this altered hydrolysis rate would reduce activity to extremely low levels. Indeed, the translocation to the filopodial tips was hampered by the diminished motor function of a dimeric construct of the shaker-1 mutant. We conclude that the diminished motor activity of this mutant is most likely responsible for impaired hearing in the shaker-1 mice.	[Xiong, Ailian; Haithcock, Jessica; Liu, Yingying; Eusner, Lauren; McConnell, Matthew; White, Howard D.; Belknap, Betty; Forgacs, Eva] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA	Eastern Virginia Medical School	Forgacs, E (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	forgace@evms.edu	LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022		NIDCD, National Institutes of Health [R03DC009335, 3RO3DC009335-02S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC009335] Funding Source: NIH RePORTER	NIDCD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIDCD, National Institutes of Health RO3 Grants R03DC009335 and 3RO3DC009335-02S1 (to E.F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Black DJ, 2000, BIOCHEMISTRY-US, V39, P13831, DOI 10.1021/bi001106+; Bloemink MJ, 2011, SEMIN CELL DEV BIOL, V22, P961, DOI 10.1016/j.semcdb.2011.09.015; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chavrier P, 2002, NAT CELL BIOL, V4, pE169, DOI 10.1038/ncb0702-e169; Cohen M, 2007, INT J AUDIOL, V46, P82, DOI 10.1080/14992020600975279; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Ebrahim S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10833; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Gibbs D, 2010, INVEST OPHTH VIS SCI, V51, P1130, DOI 10.1167/iovs.09-4032; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Grati M, 2011, P NATL ACAD SCI USA, V108, P11476, DOI 10.1073/pnas.1104161108; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Hartman MA, 2012, J CELL SCI, V125, P1627, DOI 10.1242/jcs.094300; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Heissler SM, 2016, TRAFFIC, V17, P839, DOI 10.1111/tra.12388; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lee SH, 1997, J BIOL CHEM, V272, P9252, DOI 10.1074/jbc.272.14.9252; Li JC, 2017, STRUCTURE, V25, P579, DOI 10.1016/j.str.2017.02.002; Li JC, 2016, TRAFFIC, V17, P822, DOI 10.1111/tra.12383; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu YY, 2015, BIOCHEMISTRY-US, V54, P1963, DOI 10.1021/bi5015166; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Maniak M, 2001, CURR BIOL, V11, pR315, DOI 10.1016/S0960-9822(01)00173-7; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Self T, 1998, DEVELOPMENT, V125, P557; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tamagawa Y, 2002, LARYNGOSCOPE, V112, P292, DOI 10.1097/00005537-200202000-00017; Tuxworth RI, 2001, CURR BIOL, V11, P318, DOI 10.1016/S0960-9822(01)00097-5; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Varkuti BH, 2012, NAT STRUCT MOL BIOL, V19, P299, DOI 10.1038/nsmb.2216; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; Walklate J, 2016, J EXP BIOL, V219, P168, DOI 10.1242/jeb.124594; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	50	3	3	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					819	829		10.1074/jbc.M117.810119	http://dx.doi.org/10.1074/jbc.M117.810119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29167268	hybrid, Green Published			2022-12-28	WOS:000422864500006
J	Ramos, CJ; Lin, CM; Liu, XW; Antonetti, DA				Ramos, Carla J.; Lin, Chengmao; Liu, Xuwen; Antonetti, David A.			The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras-related protein 1 (Rap1); small GTPase; tight junction; tumor necrosis factor (TNF); vascular endothelial growth factor (VEGF); EPAC; blood-retinal barrier	ENDOTHELIAL BARRIER FUNCTION; TIGHT JUNCTION TRAFFICKING; EXCHANGE FACTOR; OCCLUDIN PHOSPHORYLATION; CELL JUNCTIONS; CYCLIC-AMP; CAMP; RAP1; EPAC; PROTEIN	Increased retinal vascular permeability contributes to macular edema, a leading cause of vision loss in eye pathologies such as diabetic retinopathy, age-related macular degeneration, and central retinal vein occlusions. Pathological changes in vascular permeability are driven by growth factors such as VEGF and pro-inflammatory cytokines such as TNF-. Identifying the pro-barrier mechanisms that block vascular permeability and restore the blood-retinal barrier (BRB) may lead to new therapies. The cAMP-dependent guanine nucleotide exchange factor (EPAC) exchange-protein directly activated by cAMP promotes exchange of GTP in the small GTPase Rap1. Rap1 enhances barrier properties in human umbilical endothelial cells by promoting adherens junction assembly. We hypothesized that the EPAC-Rap1 signaling pathway may regulate the tight junction complex of the BRB and may restore barrier properties after cytokine-induced permeability. Here, we show that stimulating EPAC or Rap1 activation can prevent or reverse VEGF- or TNF--induced permeability in cell culture and in vivo. Moreover, EPAC activation inhibited VEGF receptor (VEGFR) signaling through the Ras/MEK/ERK pathway. We also found that Rap1B knockdown or an EPAC antagonist increases endothelial permeability and that VEGF has no additive effect, suggesting a common pathway. Furthermore, GTP-bound Rap1 promoted tight junction assembly, and loss of Rap1B led to loss of junctional border organization. Collectively, our results indicate that the EPAC-Rap1 pathway helps maintain basal barrier properties in the retinal vascular endothelium and activation of the EPAC-Rap1 pathway may therefore represent a potential therapeutic strategy to restore the BRB.	[Ramos, Carla J.; Lin, Chengmao; Liu, Xuwen; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan	Antonetti, DA (corresponding author), Kellogg Eye Ctr, 1000 Wall St, Ann Arbor, MI 48105 USA.	dantonet@med.umich.edu	LIU, XUWEN/AAR-9250-2020	Lin, Cheng-mao/0000-0003-2409-9423; Ramos, Carla Jhoana/0000-0001-5041-6758; antonetti, david/0000-0003-1130-6577	National Institutes of Health [EY012021, P30EY007003]; Research to Prevent Blindness; Kellogg Eye Center Core Center for Vision Research; Michigan Diabetes Research and Training Center [DK020572]; NATIONAL EYE INSTITUTE [P30EY007003, R01EY012021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Kellogg Eye Center Core Center for Vision Research; Michigan Diabetes Research and Training Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant EY012021 (to D. A. A.), grants from the Research to Prevent Blindness (to D. A. A.) and Kellogg Eye Center Core Center for Vision Research, National Institutes of Health Grant P30EY007003, and Michigan Diabetes Research and Training Center Grant DK020572. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson RH, 2008, AM J PHYSIOL-HEART C, V294, pH1188, DOI 10.1152/ajpheart.00937.2007; Adamson RH, 1998, AM J PHYSIOL-HEART C, V274, pH1885, DOI 10.1152/ajpheart.1998.274.6.H1885; Antonetti David A, 2003, Methods Mol Med, V89, P365; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 1997, BBA-REV CANCER, V1333, pM19, DOI 10.1016/S0304-419X(97)00015-2; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145689; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; D'Atri F, 2002, MOL MEMBR BIOL, V19, P103, DOI 10.1080/09687680210129236; de Kreuk BJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11394; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeMaio L, 2004, MICROVASC RES, V68, P295, DOI 10.1016/j.mvr.2004.06.007; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Citalan-Madrid AF, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.26938; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Harhaj NS, 2006, INVEST OPHTH VIS SCI, V47, P5106, DOI 10.1167/iovs.06-0322; He P, 2000, AM J PHYSIOL-HEART C, V278, pH1124, DOI 10.1152/ajpheart.2000.278.4.H1124; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liu J, 2015, SCI CHINA LIFE SCI, V58, P521, DOI 10.1007/s11427-015-4860-1; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Penzes P, 2011, MOL CELL NEUROSCI, V46, P368, DOI 10.1016/j.mcn.2010.11.008; Post A, 2013, P NATL ACAD SCI USA, V110, P11427, DOI 10.1073/pnas.1306595110; Ramos CJ, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1339768; Roberts OL, 2014, BIOCHEM SOC T, V42, P89, DOI 10.1042/BST20130253; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; ROUSSEAUMERCK MF, 1990, CYTOGENET CELL GENET, V53, P2, DOI 10.1159/000132883; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Sehrawat S, 2008, MOL BIOL CELL, V19, P1261, DOI 10.1091/mbc.E06-10-0972; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Sundstrom JM, 2009, J PROTEOME RES, V8, P808, DOI 10.1021/pr7007913; Tian YF, 2015, J BIOL CHEM, V290, P4097, DOI 10.1074/jbc.M114.620377; Titchenell PM, 2012, BIOCHEM J, V446, P455, DOI 10.1042/BJ20111961; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; van Dam Teunis J P, 2011, Small GTPases, V2, P4; VAN MEER G, 1986, EMBO J, V5, P1455, DOI 10.1002/j.1460-2075.1986.tb04382.x; Wang HB, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.56; Whitaker CM, 2010, NEUROSCIENCE, V165, P955, DOI 10.1016/j.neuroscience.2009.10.054; Wilson CW, 2014, CELL ADHES MIGR, V8, P76, DOI 10.4161/cam.28115; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Wittchen ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073070; Wittchen ES, 2011, INVEST OPHTH VIS SCI, V52, P7455, DOI 10.1167/iovs.11-7295; Yuan ZG, 2013, INT J MOL SCI, V14, P13377, DOI 10.3390/ijms140713377	62	34	35	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					717	730		10.1074/jbc.M117.815381	http://dx.doi.org/10.1074/jbc.M117.815381			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158262	Green Published, hybrid			2022-12-28	WOS:000419915400025
J	Kajimoto, T; Mohamed, NNI; Badawy, SMM; Matovelo, SA; Hirase, M; Nakamura, S; Yoshida, D; Okada, T; Ijuin, T; Nakamura, S				Kajimoto, Taketoshi; Mohamed, Nesma Nabil Ibrahim; Badawy, Shaymaa Mohamed Mohamed; Matovelo, Shubi Ambwene; Hirase, Mitsuhiro; Nakamura, Shunsuke; Yoshida, Daisuke; Okada, Taro; Ijuin, Takeshi; Nakamura, Shun-ichi			Involvement of G beta gamma subunits of G(i) protein coupled with S1P receptor on multivesicular endosomes in F-actin formation and cargo sorting into exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SPHINGOSINE 1-PHOSPHATE; BIOGENESIS; ACTIVATION; MEMBRANE; RAC; SPHINGOSINE-1-PHOSPHATE; CYTOSKELETON; MECHANISM; CERAMIDE	Exosomes play a critical role in cell-to-cell communication by delivering cargo molecules to recipient cells. However, the mechanism underlying the generation of the exosomal multivesicular endosome (MVE) is one of the mysteries in the field of endosome research. Although sphingolipid metabolites such as ceramide and sphingosine 1-phosphate (S1P) are known to play important roles in MVE formation and maturation, the detailed molecular mechanisms are still unclear. Here, we show that Rho family GTPases, including Cdc42 and Rac1, are constitutively activated on exosomal MVEs and are regulated by S1P signaling as measured by fluorescence resonance energy transfer (FRET)based conformational changes. Moreover, we detected S1P signaling- induced filamentous actin (F-actin) formation. A selective inhibitor of G beta gamma subunits, M119, strongly inhibited both F-actin formation on MVEs and cargo sorting into exosomal intralumenal vesicles of MVEs, both of which were fully rescued by the simultaneous expression of constitutively active Cdc42 and Rac1. Our results shed light on the mechanism underlying exosomal MVE maturation and inform the understanding of the physiological relevance of continuous activation of the S1P receptor and subsequent downstream G protein signaling to G beta gamma subunits/Rho family GTPases-regulated F-actin formation on MVEs for cargo sorting into exosomal intralumenal vesicles.	[Kajimoto, Taketoshi; Mohamed, Nesma Nabil Ibrahim; Badawy, Shaymaa Mohamed Mohamed; Matovelo, Shubi Ambwene; Hirase, Mitsuhiro; Nakamura, Shunsuke; Yoshida, Daisuke; Okada, Taro; Ijuin, Takeshi; Nakamura, Shun-ichi] Kobe Univ, Div Biochem, Dept Biochem & Mol Biol, Grad Sch Med, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan	Kobe University	Nakamura, S (corresponding author), Kobe Univ, Div Biochem, Dept Biochem & Mol Biol, Grad Sch Med, 7-5-1 Kusunoki, Kobe, Hyogo 6500017, Japan.	snakamur@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Technology Development Research Grant from the Nakatani Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology Development Research Grant from the Nakatani Foundation	This work was supported in part by a Grant-in-Aid for challenging Exploratory Research (to S.-i. N.), a Grant-in-Aid for Scientific Research (C) (to T. O.), a Grant-in-Aid for Scientific Research (C) (to T. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Technology Development Research Grant from the Nakatani Foundation (to T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ledezma-Sanchez BA, 2010, BIOCHEM BIOPH RES CO, V391, P1647, DOI 10.1016/j.bbrc.2009.12.108; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Naito Yuki, 2013, Methods Mol Biol, V942, P57, DOI 10.1007/978-1-62703-119-6_3; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Perry DK, 1998, BBA-MOL CELL BIOL L, V1436, P233, DOI 10.1016/S0005-2760(98)00145-3; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	31	36	36	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					245	253		10.1074/jbc.M117.808733	http://dx.doi.org/10.1074/jbc.M117.808733			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133526	hybrid, Green Published			2022-12-28	WOS:000419453200021
J	Woodcock, JM; Goodwin, KL; Sandow, JJ; Coolen, C; Perugini, MA; Webb, AI; Pitson, SM; Lopez, AF; Carver, JA				Woodcock, Joanna M.; Goodwin, Katy L.; Sandow, Jarrod J.; Coolen, Carl; Perugini, Matthew A.; Webb, Andrew I.; Pitson, Stuart M.; Lopez, Angel F.; Carver, John A.			Role of salt bridges in the dimer interface of 14-3-3 zeta in dimer dynamics, N-terminal alpha-helical order, and molecular chaperone activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; PHOSPHORYLATION; BINDING; DIMERIZATION; EXCHANGE	The 14-3-3 family of intracellular proteins are dimeric, multifunctional adaptor proteins that bind to and regulate the activities of many important signaling proteins. The subunits within 14-3-3 dimers are predicted to be stabilized by salt bridges that are largely conserved across the 14-3-3 protein family and allow the different isoforms to form heterodimers. Here, we have examined the contributions of conserved salt-bridging residues in stabilizing the dimeric state of 14-3-3 zeta. Using analytical ultracentrifugation, our results revealed that Asp21 and Glu89 both play key roles in dimer dynamics and contribute to dimer stability. Furthermore, hydrogen-deuterium exchange coupled with mass spectrometry showed that mutation of Asp21 promoted disorder in the N-terminal helices of 14-3-3 zeta, suggesting that this residue plays an important role in maintaining structure across the dimer interface. Intriguingly, a D21N 14-3-3 zeta mutant exhibited enhanced molecular chaperone ability that prevented amorphous protein aggregation, suggesting a potential role for N-terminal disorder in 14-3-3 zeta's poorly understood chaperone action. Taken together, these results imply that disorder in the N-terminal helices of 14-3-3 zeta is a consequence of the dimermonomer dynamics and may play a role in conferring chaperone function to 14-3-3 zeta protein.	[Woodcock, Joanna M.; Coolen, Carl; Pitson, Stuart M.; Lopez, Angel F.] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Woodcock, Joanna M.; Coolen, Carl; Pitson, Stuart M.; Lopez, Angel F.] SA Pathol, Adelaide, SA 5000, Australia; [Goodwin, Katy L.] Univ Adelaide, Sch Phys Sci, Adelaide, SA 5005, Australia; [Sandow, Jarrod J.; Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Parkville, Vic 3052, Australia; [Sandow, Jarrod J.; Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Perugini, Matthew A.] La Trobe Univ, LA Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Carver, John A.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	Centre for Cancer Biology; University of South Australia; SA Pathology; University of Adelaide; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; Australian National University	Woodcock, JM (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.; Woodcock, JM (corresponding author), SA Pathol, Adelaide, SA 5000, Australia.	Joanna.Woodcock@health.sa.gov.au	Pitson, Stuart/B-9342-2009; Carver, John Adrian/J-3825-2014	Pitson, Stuart/0000-0002-9527-2740; Carver, John Adrian/0000-0002-2441-8108; Perugini, Matthew/0000-0001-8052-5584; Woodcock, Joanna/0000-0001-5127-9687	Australian National Health and Medical Research Council [1068087]; National Health and Medical Research Council [1071897]; Fay Fuller Foundation; National Health and Medical Research Council Senior Research Fellowship [1042589]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Fay Fuller Foundation; National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian National Health and Medical Research Council Project Grant 1068087 (to J. A. C.), National Health and Medical Research Council Program Grant 1071897 (to A. F. L.), and the Fay Fuller Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council Senior Research Fellowship 1042589.	Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Goodwin K. L., 2015, THESIS; Haladova K, 2012, J STRUCT BIOL, V179, P10, DOI 10.1016/j.jsb.2012.04.016; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Laue TM, 1999, ANNU REV BIOPH BIOM, V28, P75, DOI 10.1146/annurev.biophys.28.1.75; LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Obsilova V, 2004, J BIOL CHEM, V279, P4531, DOI 10.1074/jbc.M306939200; Pascal BD, 2012, J AM SOC MASS SPECTR, V23, P1512, DOI 10.1007/s13361-012-0419-6; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Peverelli MG, 2016, J BIOL CHEM, V291, P9785, DOI 10.1074/jbc.M115.696591; Powell DW, 2003, MOL CELL BIOL, V23, P5376, DOI 10.1128/MCB.23.15.5376-5387.2003; Sheluho D, 2001, J BIOL CHEM, V276, P39945, DOI 10.1074/jbc.M107252200; Sluchanko NN, 2008, ARCH BIOCHEM BIOPHYS, V477, P305, DOI 10.1016/j.abb.2008.05.020; Sluchanko NN, 2017, FEBS J, V284, P1279, DOI 10.1111/febs.13986; Sluchanko NN, 2015, BBA-PROTEINS PROTEOM, V1854, P492, DOI 10.1016/j.bbapap.2015.02.017; Sluchanko NN, 2014, ARCH BIOCHEM BIOPHYS, V549, P32, DOI 10.1016/j.abb.2014.03.008; Sluchanko NN, 2012, FEBS LETT, V586, P4249, DOI 10.1016/j.febslet.2012.10.048; Sluchanko NN, 2012, BIOCHEMISTRY-US, V51, P6127, DOI 10.1021/bi300674e; Sluchanko NN, 2011, BIOCHEMISTRY-US, V50, P9797, DOI 10.1021/bi201374s; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Williams DM, 2011, BIOCHEM J, V437, P493, DOI 10.1042/BJ20102178; Woodcock JM, 2003, J BIOL CHEM, V278, P36323, DOI 10.1074/jbc.M304689200; Woodcock JM, 2015, ONCOTARGET, V6, P14522, DOI 10.18632/oncotarget.3995; Woodcock JM, 2010, CELL SIGNAL, V22, P1291, DOI 10.1016/j.cellsig.2010.04.004; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229	32	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					89	99		10.1074/jbc.M117.801019	http://dx.doi.org/10.1074/jbc.M117.801019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109150	Green Published, hybrid			2022-12-28	WOS:000419453200006
J	Barycki, JJ				Barycki, Joseph J.			Covering their bases: The phosphobase methylation pathway in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						Arabidopsis thaliana; methyltransferase; phosphocholine; X-ray crystallography; enzyme kinetics; phosphatidylcholine; plant biochemistry	PHOSPHOMETHYLETHANOLAMINE N-METHYLTRANSFERASE; PHOSPHOLIPID-METABOLISM; PHOSPHOCHOLINE BIOSYNTHESIS; PLASMODIUM-FALCIPARUM; ARABIDOPSIS; CHOLINE	Phosphoethanolamine methyltransferases add three methyl groups successively to their substrate to produce phosphocholine, an important precursor for phospholipid biosynthesis in diverse organisms. New work from Lee and Jez reveals critical domain movements that explain how multiple methylation reactions are uniquely coordinated by plant methyltransferases and provides insights into the evolution of this class of enzymes. As opposed to closely related family members, the intermediates in this pathway are likely shuttled between two tethered domains to ensure complete methylation.	[Barycki, Joseph J.] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Barycki, JJ (corresponding author), North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA.	jjbaryck@ncsu.edu			NCI, National Institutes of Health [R21 CA185993]; NATIONAL CANCER INSTITUTE [R21CA185993] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant R21 CA185993. The author declares that he has no conflicts of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BeGora MD, 2010, J BIOL CHEM, V285, P29147, DOI 10.1074/jbc.M110.112151; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; Lee SG, 2017, J BIOL CHEM, V292, P21690, DOI 10.1074/jbc.RA117.000106; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200	10	0	0	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21703	21704		10.1074/jbc.H117.000712	http://dx.doi.org/10.1074/jbc.H117.000712			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29288241	Green Published, hybrid			2022-12-28	WOS:000419013000043
J	Lloyd, KP; Ojelabi, OA; De Zutter, JK; Carruthers, A				Lloyd, Kenneth P.; Ojelabi, Ogooluwa A.; De Zutter, Julie K.; Carruthers, Anthony			Reconciling contradictory findings: Glucose transporter 1 (GLUT1) functions as an oligomer of allosteric, alternating access transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE GLUCOSE-TRANSPORTER; GLUT1-MEDIATED SUGAR-TRANSPORT; HOMOLOGY-SCANNING-MUTAGENESIS; CYTOCHALASIN-B; ESCHERICHIA-COLI; LIGAND-BINDING; SEQUENCE DETERMINANTS; FACILITATED DIFFUSION; CRYSTAL-STRUCTURE; ACCURATE DOCKING	Recent structural studies suggest that GLUT1 (glucose transporter 1)-mediated sugar transport is mediated by an alternating access transporter that successively presents exofacial (e2) and endofacial (e1) substrate-binding sites. Transport studies, however, indicate multiple, interacting (allosteric), and co-existent, exo-and endofacial GLUT1 ligand-binding sites. The present study asks whether these contradictory conclusions result from systematic analytical error or reveal a more fundamental relationship between transporter structure and function. Here, homology modeling supported the alternating access transporter model for sugar transport by confirming at least four GLUT1 conformations, the so-called outward, outward-occluded, inward-occluded, and inward GLUT1 conformations. Results from docking analysis suggested that outward and outward-occluded conformations present multiple beta-D-glucose and maltose interaction sites, whereas inward-occluded and inward conformations present only a single beta-D-glucose interaction site. Gln-282 contributed to sugar binding in all GLUT1 conformations via hydrogen bonding. Mutating Gln-282 to alanine (Q282A) doubled the Km(app) for 2-deoxy-D-glucose uptake and eliminated cis-allostery (stimulation of sugar uptake by sub-saturating extracellular maltose) but not trans-allostery (uptake stimulation by subsaturating cytochalasin B). cis-Allostery persisted, but trans-allostery was lost in an oligomerization-deficient GLUT1 variant in which we substituted membrane helix 9 with the equivalent GLUT3 sequence. Moreover, Q282A eliminated cis-allostery in the oligomerization variant. These findings reconcile contradictory conclusions from structural and transport studies by suggesting that GLUT1 is an oligomer of allosteric, alternating access transporters in which 1) cis-allostery is mediated by intrasubunit interactions and 2) trans-allostery requires intersubunit interactions.	[Lloyd, Kenneth P.; Ojelabi, Ogooluwa A.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Med Sch, Grad Sch Biomed Sci, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK36081, DK44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK044888, R01DK036081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK36081 and DK44888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BAKER GF, 1973, J PHYSIOL-LONDON, V231, P143, DOI 10.1113/jphysiol.1973.sp010225; BAKER GF, 1979, BIOCHIM BIOPHYS ACTA, V550, P474, DOI 10.1016/0005-2736(79)90150-0; BAKER PF, 1981, J PHYSIOL-LONDON, V316, P481, DOI 10.1113/jphysiol.1981.sp013802; BALDWIN SA, 1979, BIOCHIM BIOPHYS ACTA, V552, P183, DOI 10.1016/0005-2736(79)90257-8; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2005, BIOCHEMISTRY-US, V44, P2650, DOI 10.1021/bi048247m; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3898, DOI 10.1021/bi00230a014; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; CODERRE PE, 1995, BIOCHEMISTRY-US, V34, P9762, DOI 10.1021/bi00030a014; Cunningham P, 2014, J MEMBRANE BIOL, V247, P1161, DOI 10.1007/s00232-014-9711-7; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; HINKLE PC, 1979, FUNCTION MOL ASPECTS, P487; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JARVIS SM, 1986, BIOCHIM BIOPHYS ACTA, V855, P312, DOI 10.1016/0005-2736(86)90179-3; Lemieux MJ, 2003, PROTEIN SCI, V12, P2748, DOI 10.1110/ps.03276603; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NAFTALIN RJ, 1988, TRENDS BIOCHEM SCI, V13, P425; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Ojelabi OA, 2016, J BIOL CHEM, V291, P26762, DOI 10.1074/jbc.M116.759175; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Reddy, 2013, FEBS J, V280, P3975, DOI 10.1111/febs.12405; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; SOGIN DC, 1980, BIOCHEMISTRY-US, V19, P5417, DOI 10.1021/bi00564a041; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Yan N, 2017, J MOL BIOL, V429, P2710, DOI 10.1016/j.jmb.2017.07.009; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	52	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21035	21046		10.1074/jbc.M117.815589	http://dx.doi.org/10.1074/jbc.M117.815589			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29066623	Green Published, hybrid			2022-12-28	WOS:000418453400019
J	Ma, YB; Min, HK; Oh, U; Hawkridge, AM; Wang, W; Mohsin, AA; Chen, Q; Sanyal, A; Lesnefsky, EJ; Fang, XJ				Ma, Yibao; Min, Hae-Ki; Oh, Unsong; Hawkridge, Adam M.; Wang, Wei; Mohsin, Ahmed A.; Chen, Qun; Sanyal, Arun; Lesnefsky, Edward J.; Fang, Xianjun			The lignan manassantin is a potent and specific inhibitor of mitochondrial complex I and bioenergetic activity in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSPORT CHAIN; SAURURUS-CHINENSIS; HEXOKINASE II; GLYCOLYSIS; PHOSPHORYLATION; DEFICIENCY; ACTIVATION; GENERATION; SAUCERNEOL; EXPRESSION	Dineolignans manassantinAandBfrom the plant Saururus cernuus are used in traditional medicine to manage a wide range of ailments such as edema, jaundice, and gonorrhea. Cell-based studies have identified several molecular target candidates of manassantin including NF-kappa B, MAPK, STAT3, and hypoxia-inducible factor 1 alpha (HIF-1 alpha). It is unclear whether or how these structurally diverse proteins or pathways mediate any of the medical benefits of manassantin in vivo. Moreover, it has recently been reported that manassantin causes developmental arrestin zebrafish by inhibiting the mitochondrial complex I, but it is unknown whether manassantin inhibits mitochondrial respiration in intact mammalian cells and live animals. Here, we present direct evidence that manas-santin potently and specifically inhibits the mitochondrial complex I and bioenergetic activity in mammalian systems. Manassantin had no effect on complex II- or complex IV-mediated respiration. Of note, it decreased NADH-ubiquinone reductase activity but not the activity of NADH-ferricyanide reductase. Treatment with manassantin reduced cellular ATP levels and concomitantly stimulated AMP-activated protein kinase in vitro and in vivo. As an adaptive response to manassantin-induced bioenergetic deficiency, mammalian cells up-regulated aerobic glycolysis, a process mediated by AMP-activated protein kinase (AMPK) independently of HIF-1 alpha. Together these results demonstrate a biologically important activity of manassantin in the control of complex I-mediated respiration and its profound effects on oxygen utilization, energy homeostasis, and glucose metabolism in mammalian cells.	[Ma, Yibao; Wang, Wei; Lesnefsky, Edward J.; Fang, Xianjun] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Min, Hae-Ki; Mohsin, Ahmed A.; Chen, Qun; Sanyal, Arun; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23298 USA; [Oh, Unsong] Virginia Commonwealth Univ, Dept Neurol, Sch Med, Richmond, VA 23298 USA; [Hawkridge, Adam M.] Virginia Commonwealth Univ, Dept Pharmaceut, Sch Pharm, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center	Fang, XJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Sanger Hall 2-016,1101 East Marshall St, Richmond, VA 23298 USA.	xianjun.fang@vcuhealth.org	Ma, Yibao/H-3849-2016; Mohsin, Ahmed A/T-4012-2019; Chen, Qun/HGD-0868-2022; Mohsin, Ahmed A/AAC-7272-2021	Ma, Yibao/0000-0002-3270-8893; Mohsin, Ahmed A/0000-0001-7680-4636	Astar Biotech; Department of Veterans Affairs, Office of Research and Development, Medical Research Service [2IO1BX001355-01A2]; American Heart Association [15GRNT24480123]; NIA, National Institutes of Health [R21 AG054975]; Pauley Heart Center of Virginia Commonwealth University; National Institutes of Health [DK 105961, DK AA 20758, P30 CA16059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG054975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020758] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001355] Funding Source: NIH RePORTER	Astar Biotech; Department of Veterans Affairs, Office of Research and Development, Medical Research Service(US Department of Veterans Affairs); American Heart Association(American Heart Association); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pauley Heart Center of Virginia Commonwealth University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported in part by an Astar Biotech research award (to X. F.); Department of Veterans Affairs, Office of Research and Development, Medical Research Service Merit Review Award 2IO1BX001355-01A2 (to E. J. L.); American Heart Association Grant-in-aid 15GRNT24480123 (to Q. C.); NIA, National Institutes of Health Grant R21 AG054975 (to Q. C.); the Pauley Heart Center of Virginia Commonwealth University (to Q. C. and E. J. L.); National Institutes of Health Grants DK 105961 (to A. S.), DK AA 20758 (to A. S.), and Grant P30 CA16059 (to the Massey Cancer Center of Virginia Commonwealth University School of Medicine). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ball AL, 2016, TOXICOL SCI, V153, P341, DOI 10.1093/toxsci/kfw126; BEUTLER E, 1967, BLOOD-J HEMATOL, V30, P311, DOI 10.1182/blood.V30.3.311.311; BRASS EP, 1980, BIOCHEM J, V188, P451, DOI 10.1042/bj1880451; Chang JS, 2011, J PHARMACOL SCI, V115, P84, DOI 10.1254/jphs.10239SC; Chung BS, 1990, DICT KOREAN FOLK MED, P813; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; Ferrick D., 2008, DRUG INDUCED MITOCHO, P373; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hargrave B, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12710; Hodges TW, 2004, J NAT PROD, V67, P767, DOI 10.1021/np030514m; HOPPEL CL, 1987, J CLIN INVEST, V80, P71, DOI 10.1172/JCI113066; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Kim JY, 2009, J PHARMACOL SCI, V109, P583, DOI 10.1254/jphs.08299FP; Kim SJ, 2011, BIOL PHARM BULL, V34, P1769, DOI 10.1248/bpb.34.1769; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Komulainen T, 2015, TOXICOLOGY, V331, P47, DOI 10.1016/j.tox.2015.03.001; Kwon DY, 2015, J MED CHEM, V58, P7659, DOI 10.1021/acs.jmedchem.5b01220; Kwon OE, 2005, ARCH PHARM RES, V28, P55, DOI 10.1007/BF02975136; Lai K, 2013, ACS CHEM BIOL, V8, P257, DOI 10.1021/cb300495e; Lee JH, 2003, BIOCHEM PHARMACOL, V66, P1925, DOI 10.1016/S0006-2952(03)00553-7; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; Lee WS, 2004, BIOORG MED CHEM LETT, V14, P3109, DOI 10.1016/j.bmcl.2004.04.023; Lu Y, 2013, BIOL PHARM BULL, V36, P1370, DOI 10.1248/bpb.b13-00146; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma Y, 2016, ONCOGENE, V35, P6132, DOI 10.1038/onc.2016.150; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Mukherjee A, 2015, NEOPLASIA, V17, P723, DOI 10.1016/j.neo.2015.09.003; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Nicholls DG, 2010, J VIS EXP, P2511; Park HC, 2012, KOREAN J ANESTHESIOL, V62, P161, DOI 10.4097/kjae.2012.62.2.161; RAO KV, 1983, TETRAHEDRON LETT, V24, P4947, DOI 10.1016/S0040-4039(01)99818-1; Rho MC, 2003, PLANTA MED, V69, P1147, DOI 10.1055/s-2003-818007; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Seo CS, 2009, PHYTOTHER RES, V23, P1531, DOI 10.1002/ptr.2791; Shao HJ, 2016, ONCOTARGET, V7, P3832, DOI 10.18632/oncotarget.6757; Son KN, 2005, MOL CELLS, V20, P105; Song SY, 2005, INT J MOL MED, V16, P517; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Wallace MAG, 2016, J PROTEOME RES, V15, P2688, DOI 10.1021/acs.jproteome.6b00237; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	44	7	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20989	20997		10.1074/jbc.M117.812925	http://dx.doi.org/10.1074/jbc.M117.812925			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29046352	Green Published, hybrid			2022-12-28	WOS:000418453400015
J	Khandokar, YB; Srivastava, P; Cowieson, N; Sarker, S; Aragao, D; Das, S; Smith, KM; Raidal, SR; Forwood, JK				Khandokar, Yogesh B.; Srivastava, Parul; Cowieson, Nathan; Sarker, Subir; Aragao, David; Das, Shubagata; Smith, Kate M.; Raidal, Shane R.; Forwood, Jade K.			Structural insights into GDP-mediated regulation of a bacterial acyl-CoA thioesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); coenzyme A (CoA); enzyme kinetics; enzyme structure; hydrolase; Neisseria meningitidis; enzyme regulation; hotdog-fold; thioesterase	FUNCTIONAL-CHARACTERIZATION; PURIFICATION; SPECIFICITY; HYDROLASE; MECHANISM; REVEALS	Thioesterases catalyze the cleavage of thioester bonds within many activated fatty acids and acyl-CoA substrates. They are expressed ubiquitously in both prokaryotes and eukaryotes and are subdivided into 25 thioesterase families according to their catalytic active site, protein oligomerization, and substrate specificity. Although many of these enzyme families are well-characterized in terms of function and substrate specificity, regulation across most thioesterase families is poorly understood. Here, we characterized a TE6 thioesterase from the bacterium Neisseria meningitidis. Structural analysis with X-ray crystallographic diffraction data to 2.0- revealed that each protein subunit harbors a hot dog-fold and that the TE6 enzyme forms a hexamer with D3 symmetry. An assessment of thioesterase activity against a range of acyl-CoA substrates revealed the greatest activity against acetyl-CoA, and structure-guided mutagenesis of putative active site residues identified Asn(24) and Asp(39) as being essential for activity. Our structural analysis revealed that six GDP nucleotides bound the enzyme in close proximity to an intersubunit disulfide bond interactions that covalently link thioesterase domains in a double hot dog dimer. Structure-guided mutagenesis of residues within the GDP-binding pocket identified Arg(93) as playing a key role in the nucleotide interaction and revealed that GDP is required for activity. All mutations were confirmed to be specific and not to have resulted from structural perturbations by X-ray crystallography. This is the first report of a bacterial GDP-regulated thioesterase and of covalent linkage of thioesterase domains through a disulfide bond, revealing structural similarities with ADP regulation in the human ACOT12 thioesterase.	[Khandokar, Yogesh B.; Srivastava, Parul; Smith, Kate M.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Boorooma St, Wagga Wagga, NSW 2678, Australia; [Das, Shubagata; Raidal, Shane R.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW 2678, Australia; [Cowieson, Nathan] Diamond Light Source, Div Life Sci, Didcot OX11 0DE, Oxon, England; [Sarker, Subir] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic 3086, Australia; [Aragao, David] Australian Natl Synchrotron, Melbourne, Vic 3168, Australia	Charles Sturt University; Charles Sturt University; Diamond Light Source; La Trobe University	Forwood, JK (corresponding author), Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.	jforwood@csu.edu.au	Raidal, Shane/C-4632-2008; Aragao, David/A-1695-2012; Aragao, David/AAV-5514-2021; Sarker, Subir/U-8444-2019	Raidal, Shane/0000-0001-7917-8976; Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; Sarker, Subir/0000-0002-2685-8377; Das, Shubhagata/0000-0003-0795-2752; Smith, Kate/0000-0002-1183-8832; Forwood, Jade/0000-0003-3267-9997; KHANDOKAR, YOGESH/0000-0002-4630-8508				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cantu DC, 2014, CHEM-EUR J, V20, P9045, DOI 10.1002/chem.201304228; Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417; Cao J, 2009, BIOCHEMISTRY-US, V48, P1293, DOI 10.1021/bi801879z; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Rodriguez-Rodriguez MF, 2014, PHYTOCHEMISTRY, V107, P7, DOI 10.1016/j.phytochem.2014.08.014; Forwood JK, 2007, P NATL ACAD SCI USA, V104, P10382, DOI 10.1073/pnas.0700974104; Han SX, 2012, J LIPID RES, V53, P2620, DOI 10.1194/jlr.M029538; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Jeong JH, 2012, J BIOL CHEM, V287, P29648, DOI 10.1074/jbc.C112.384420; Khandokar YB, 2016, J BIOL CHEM, V291, P1866, DOI 10.1074/jbc.M115.677484; Khandokar YB, 2013, ACTA CRYSTALLOGR F, V69, P1303, DOI 10.1107/S1744309113028042; Kirkby B, 2010, PROG LIPID RES, V49, P366, DOI 10.1016/j.plipres.2010.04.001; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kotowska M, 2014, APPL MICROBIOL BIOT, V98, P7735, DOI 10.1007/s00253-014-5952-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; Labonte JW, 2013, CHEM REV, V113, P2182, DOI 10.1021/cr300169a; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Marfori M, 2011, J BIOL CHEM, V286, P35643, DOI 10.1074/jbc.M111.225953; Park H, 2014, PLANT BIOTECHNOL J, V12, P1035, DOI 10.1111/pbi.12209; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rabbani N, 2014, BIOCHEM SOC T, V42, P419, DOI 10.1042/BST20140008; Swarbrick CMD, 2014, J BIOL CHEM, V289, P24263, DOI 10.1074/jbc.M114.589408; Weeks AM, 2012, P NATL ACAD SCI USA, V109, P19667, DOI 10.1073/pnas.1212591109; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Wu R, 2014, BIOCHEMISTRY-US, V53, P4788, DOI 10.1021/bi500334v; Yamada J, 1996, ARCH BIOCHEM BIOPHYS, V326, P106, DOI 10.1006/abbi.1996.0053	32	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20461	20471		10.1074/jbc.M117.800227	http://dx.doi.org/10.1074/jbc.M117.800227			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28972175	Green Published, hybrid			2022-12-28	WOS:000418267000010
J	Ma, Q; Cao, Z; Yu, YN; Yan, LL; Zhang, WJ; Shi, Y; Zhou, NM; Huang, HS				Ma, Qiang; Cao, Zheng; Yu, Yena; Yan, Lili; Zhang, Wenjuan; Shi, Ying; Zhou, Naiming; Huang, Haishan			Bombyx neuropeptide G protein-coupled receptor A7 is the third cognate receptor for short neuropeptide F from silkworm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bombyx mori; G protein-coupled receptor (GPCR); neuropeptide; signaling; silkworm; short neuropeptide F	GLOSSINA-MORSITANS-MORSITANS; N-LINKED GLYCOSYLATION; DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; FUNCTIONAL-CHARACTERIZATION; NEUROHORMONE GPCRS; FEEDING-BEHAVIOR; GENE-EXPRESSION; INSECT CELLS; TSETSE-FLY	The short neuropeptide F (sNPF) neuropeptides, closely related to vertebrate neuropeptide Y (NPY), have been suggested to exert pleiotropic effects on many physiological processes in insects. In the silkworm (Bombyx mori) two orphan G protein-coupled receptors, Bombyx neuropeptide G protein-coupled receptor (BNGR) A10 and A11, have been identified as cognate receptors for sNPFs, but other sNPF receptors and their signaling mechanisms in B. mori remain unknown. Here, we cloned the full-length cDNA of the orphan receptor BNGR-A7 from the brain of B. mori larvae and identified it as a receptor for Bombyx sNPFs. Further characterization of signaling and internalization indicated that BNGR-A7, -A10, and -A11 are activated by direct interaction with synthetic Bombyx sNPF-1 and -3 peptides. This activation inhibited forskolin or adipokinetic hormone-induced adenylyl cyclase activity and intracellular Ca2+ mobilization via a G(i/o)-dependent pathway. Upon activation by sNPFs, BNGR-A7, -A10, and -A11 evoked ERK1/2 phosphorylation and underwent internalization. On the basis of these findings, we designated the receptors BNGR-A7, -A10, and -A11 as Bommo-sNPFR-1, -2, and -3, respectively. Moreover, the results obtained with quantitative RT-PCR analysis revealed that the three Bombyx sNPF receptor subtypes exhibit differential spatial and temporal expression patterns, suggesting possible roles of sNPF signaling in the regulation of a wide range of biological processes. Our findings provide the first in-depth information on sNPF signaling for further elucidation of the roles of the Bombyx sNPF/sNPFR system in the regulation of physiological activities.	[Ma, Qiang; Cao, Zheng; Yan, Lili; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Ma, Qiang; Yu, Yena; Zhang, Wenjuan; Huang, Haishan] Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University	Huang, HS (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China.; Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Zijingang Campus,866 Yuhang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhounaiming@zju.edu.cn; haishan_333@163.com	Zhou, Naiming/AHC-1121-2022		National Natural Science Foundation of China [31301881]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 31301881 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Ament SA, 2011, INSECT MOL BIOL, V20, P335, DOI 10.1111/j.1365-2583.2011.01068.x; Beck B, 2001, NEUROSCI BIOBEHAV R, V25, P143, DOI 10.1016/S0149-7634(01)00003-3; Blaukat A, 1999, BIOCHEMISTRY-US, V38, P1300, DOI 10.1021/bi981727r; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; Caers J, 2016, J INSECT PHYSIOL, V93-94, P105, DOI 10.1016/j.jinsphys.2016.09.013; Caers J, 2016, GEN COMP ENDOCR, V235, P142, DOI 10.1016/j.ygcen.2016.06.005; Can Ling, 2010, Acta Entomologica Sinica, V53, P9; Cerstiaens A, 1999, PEPTIDES, V20, P39, DOI 10.1016/S0196-9781(98)00152-1; Chen ME, 2006, ARCH INSECT BIOCHEM, V61, P195, DOI 10.1002/arch.20103; Chen WF, 2013, INSECT BIOCHEM MOLEC, V43, P809, DOI 10.1016/j.ibmb.2013.06.003; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; DAVIS D, 1995, MOL ENDOCRINOL, V9, P159, DOI 10.1210/me.9.2.159; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; Dillen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053604; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Garczynski SF, 2006, PEPTIDES, V27, P575, DOI 10.1016/j.peptides.2005.06.029; Garczynski SF, 2007, PEPTIDES, V28, P109, DOI 10.1016/j.peptides.2006.09.019; Grunewald S, 1996, BIOCHEMISTRY-US, V35, P15162, DOI 10.1021/bi960757w; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; He XB, 2015, BIOCHEM J, V466, P391, DOI 10.1042/BJ20141146; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Hong SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002857; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Kaneko Y, 2014, DEV BIOL, V393, P312, DOI 10.1016/j.ydbio.2014.07.014; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu HL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-57; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Michineau S, 2004, BIOL CHEM, V385, P49, DOI 10.1515/BC.2004.007; Nagata Shinji, 2012, Front Endocrinol (Lausanne), V3, P3, DOI 10.3389/fendo.2012.00003; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nassel DR, 2011, PEPTIDES, V32, P1335, DOI 10.1016/j.peptides.2011.03.013; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Olson JM, 2003, BIOCHEM PHARMACOL, V65, P1931, DOI 10.1016/S0006-2952(03)00200-4; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Reale V, 2004, EUR J NEUROSCI, V19, P570, DOI 10.1111/j.0953-816X.2003.03141.x; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shukla AK, 2006, BIOCHEM BIOPH RES CO, V349, P6, DOI 10.1016/j.bbrc.2006.07.210; Spittaels K, 1996, INSECT BIOCHEM MOLEC, V26, P375, DOI 10.1016/0965-1748(95)00104-2; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANKOPPEN CJ, 1990, J BIOL CHEM, V265, P20887; Vecsey CG, 2014, J NEUROPHYSIOL, V111, P1033, DOI 10.1152/jn.00712.2013; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Zimanyi IA, 1998, CURR PHARM DESIGN, V4, P349	54	15	15	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20599	20612		10.1074/jbc.M117.815191	http://dx.doi.org/10.1074/jbc.M117.815191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29084843	hybrid, Green Published			2022-12-28	WOS:000418267000021
J	Brannmark, C; Lovfors, W; Komai, AM; Axelsson, T; El Hachmane, MF; Musovic, S; Paul, A; Nyman, E; Olofsson, CS				Brannmark, Cecilia; Lovfors, William; Komai, Ali M.; Axelsson, Tom; El Hachmane, Mickael F.; Musovic, Saliha; Paul, Alexandra; Nyman, Elin; Olofsson, Charlotta S.			Mathematical modeling of white adipocyte exocytosis predicts adiponectin secretion and quantifies the rates of vesicle exo- and endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipokine; adiponectin; electrophysiology; endocytosis; exocytosis; mathematical modeling	ADRENAL CHROMAFFIN CELLS; PANCREATIC BETA-CELLS; 3T3-L1 ADIPOCYTES; INSULIN-RESISTANCE; CAMP CONCENTRATIONS; GLUCOSE-TRANSPORT; SYSTEMS-BIOLOGY; CA2+; ATP; CALCIUM	Adiponectin is a hormone secreted from white adipocytes and takes part in the regulation of several metabolic processes. Although the pathophysiological importance of adiponectin has been thoroughly investigated, the mechanisms controlling its release are only partly understood. We have recently shown that adiponectin is secreted via regulated exocytosis of adiponectin-containing vesicles, that adiponectin exocytosis is stimulated by cAMP-dependent mechanisms, and that Ca2+ and ATP augment the cAMP-triggered secretion. However, much remains to be discovered regarding the molecular and cellular regulation of adiponectin release. Here, we have used mathematical modeling to extract detailed information contained within our previously obtained high-resolution patch-clamp time-resolved capacitance recordings to produce the first model of adiponectin exocytosis/secretion that combines all mechanistic knowledge deduced from electrophysiological experimental series. This model demonstrates that our previous understanding of the role of intracellular ATP in the control of adiponectin exocytosis needs to be revised to include an additional ATP-dependent step. Validation of the model by introduction of data of secreted adiponectin yielded a very close resemblance between the simulations and experimental results. Moreover, we could show that Ca2+-dependent adiponectin endocytosis contributes to the measured capacitance signal, and we were able to predict the contribution of endocytosis to the measured exocytotic rate under different experimental conditions. In conclusion, using mathematical modeling of published and newly generated data, we have obtained estimates of adiponectin exo- and endocytosis rates, and we have predicted adiponectin secretion. We believe that our model should have multiple applications in the study of metabolic processes and hormonal control thereof.	[Brannmark, Cecilia; Komai, Ali M.; El Hachmane, Mickael F.; Musovic, Saliha; Olofsson, Charlotta S.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol Metab Physiol, Medicinaregatan 11, SE-40530 Gothenburg, Sweden; [Lovfors, William; Axelsson, Tom; Nyman, Elin] Linkoping Univ, Dept Biomed Engn, SE-58183 Linkoping, Sweden; [Lovfors, William] Linkoping Univ, Dept Math, SE-58183 Linkoping, Sweden; [Paul, Alexandra] Chalmers Univ Technol, Dept Biol & Biol Engn, Kemivagen 10, SE-41296 Gothenburg, Sweden; [Nyman, Elin] AstraZeneca R&D, Cardiovasc & Metab Dis iMed Biotech Unit, S-43183 Gothenburg, Sweden	University of Gothenburg; Linkoping University; Linkoping University; Chalmers University of Technology; AstraZeneca	Nyman, E (corresponding author), Dept Biomed Engn, SE-58183 Linkoping, Sweden.; Olofsson, CS (corresponding author), Gothenburg Univ, Dept Physiol Metab Physiol, Box 432, S-40530 Gothenburg, Sweden.	elin.nyman@liu.se; charlotta.olofsson@gu.se	Nyman, Elin/I-3363-2019; Paul, Alexandra/L-8289-2017	Nyman, Elin/0000-0002-4261-0291; Paul, Alexandra/0000-0002-8368-9880; Lovfors, William/0000-0002-9058-7049; Olofsson, Charlotta/0000-0001-8824-3151; Brannmark, Cecilia/0000-0003-4848-0480	Swedish Diabetes Foundation [DIA2015-062]; Goljes Memory Fund; Swedish Medical Research Council [2010-2656, 2013-7107]; AstraZeneca; European Union [607842]	Swedish Diabetes Foundation; Goljes Memory Fund; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); AstraZeneca(AstraZeneca); European Union(European Commission)	This work was supported by Swedish Diabetes Foundation Grant DIA2015-062, the Goljes Memory Fund, Swedish Medical Research Council Grants 2010-2656 and 2013-7107, and AstraZeneca. AstraZeneca provided support in the form of salary for author E. N.; Recipient of funding from the European Union Seventh Framework Programme FP7/2007-2013 under Grant Agreement 607842.	Amatore C, 2000, BIOCHIMIE, V82, P481, DOI 10.1016/S0300-9084(00)00213-3; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Bogan JS, 1999, J CELL BIOL, V146, P609, DOI 10.1083/jcb.146.3.609; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Brackmann C, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3505024; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Cedersund G, 2012, FEBS J, V279, P3513, DOI 10.1111/j.1742-4658.2012.08725.x; Cedersund G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000096; El Hachmane MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119530; Eliasson L, 1996, J PHYSIOL-LONDON, V493, P755, DOI 10.1113/jphysiol.1996.sp021420; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; Galvanovskis J, 2011, INTERFACE FOCUS, V1, P143, DOI 10.1098/rsfs.2010.0006; Goforth PB, 2002, J GEN PHYSIOL, V120, P307, DOI 10.1085/jgp.20028581; He ZX, 2008, TRAFFIC, V9, P910, DOI 10.1111/j.1600-0854.2008.00730.x; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hresko RC, 1998, J BIOL CHEM, V273, P20658, DOI 10.1074/jbc.273.32.20658; Iancu RV, 2008, AM J PHYSIOL-CELL PH, V295, pC414, DOI 10.1152/ajpcell.00038.2008; Jarukanont D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144045; KEIZER J, 1989, BIOPHYS J, V56, P229, DOI 10.1016/S0006-3495(89)82669-4; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; KLIP A, 1987, J BIOL CHEM, V262, P9141; Komai AM, 2016, DIABETES, V65, P3301, DOI 10.2337/db15-1597; Komai AM, 2014, J PHYSIOL-LONDON, V592, P5169, DOI 10.1113/jphysiol.2014.280388; Lee AK, 2001, J PHYSIOL-LONDON, V533, P389, DOI 10.1111/j.1469-7793.2001.0389a.x; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Nyman E, 2015, FEBS J, V282, P951, DOI 10.1111/febs.13194; Nyman E, 2014, J BIOL CHEM, V289, P33215, DOI 10.1074/jbc.M114.608927; Nyman E, 2011, J BIOL CHEM, V286, P26028, DOI 10.1074/jbc.M110.188987; Rajan MR, 2016, J BIOL CHEM, V291, P15806, DOI 10.1074/jbc.M116.715763; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Schmidt H, 2007, BIOINFORMATICS, V23, P646, DOI 10.1093/bioinformatics/btl668; SCHWABE U, 1973, N-S ARCH PHARMACOL, V276, P133, DOI 10.1007/BF00501186; Sips FLP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135665; Sun L, 2009, BIOPHYS J, V97, P1832, DOI 10.1016/j.bpj.2009.06.042; Sun T, 2010, J NEUROSCI, V30, P11838, DOI 10.1523/JNEUROSCI.1481-10.2010; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003; Zu LX, 2008, MOL PHARMACOL, V73, P215, DOI 10.1124/mol.107.039479	39	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20032	20043		10.1074/jbc.M117.801225	http://dx.doi.org/10.1074/jbc.M117.801225			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	28972187	hybrid, Green Published			2022-12-28	WOS:000417696400009
J	Matard-Mann, M; Bernard, T; Leroux, C; Barbeyron, T; Larocque, R; Prechoux, A; Jeudy, A; Jam, M; Collen, PN; Michel, G; Czjzek, M				Matard-Mann, Maria; Bernard, Thomas; Leroux, Cedric; Barbeyron, Tristan; Larocque, Robert; Prechoux, Aurelie; Jeudy, Alexandra; Jam, Murielle; Collen, Pi Nyvall; Michel, Gurvan; Czjzek, Mirjam			Structural insights into marine carbohydrate degradation by family GH16-carrageenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; enzyme kinetics; polysaccharide; processivity; site-directed mutagenesis; carbohydrate recognition; enzyme-substrate complex; kappa-carrageenan; sulfated polysaccharides	CELL-WALL POLYSACCHARIDE; KAPPA-CARRAGEENASE GENE; ACTIVE-SITE; HYDROLYSIS; PURIFICATION; RESIDUES; CELLOBIOHYDROLASE; NOMENCLATURE; RECOGNITION; FEATURES	Carrageenans are sulfated -1,3--1,4-galactans found in the cell wall of some red algae that are practically valuable for their gelation and biomimetic properties but also serve as a potential carbon source for marine bacteria. Carbohydrate degradation has been studied extensively for terrestrial plant/bacterial systems, but sulfation is not present in these cases, meaning the marine enzymes used to degrade carrageenans must possess unique features to recognize these modifications. To gain insights into these features, we have focused on -carrageenases from two distant bacterial phyla, which belong to glycoside hydrolase family 16 and cleave the -1,4 linkage of -carrageenan. We have solved the crystal structure of the catalytic module of ZgCgkA from Zobellia galactanivorans at 1.66 resolution and compared it with the only other structure available, that of PcCgkA from Pseudoalteromonas carrageenovora 9(T) (ATCC 43555(T)). We also describe the first substrate complex in the inactivated mutant form of PcCgkA at 1.7 resolution. The structural and biochemical comparison of these enzymes suggests key determinants that underlie the functional properties of this subfamily. In particular, we identified several arginine residues that interact with the polyanionic substrate, and confirmed the functional relevance of these amino acids using a targeted mutagenesis strategy. These results give new insight into the diversity of the -carrageenase subfamily. The phylogenetic analyses show the presence of several distinct clades of enzymes that relate to differences in modes of action or subtle differences within the same substrate specificity, matching the hybrid character of the -carrageenan polymer.	[Matard-Mann, Maria; Barbeyron, Tristan; Larocque, Robert; Prechoux, Aurelie; Jam, Murielle; Michel, Gurvan; Czjzek, Mirjam] UPMC Univ Paris 06, CNRS, UMR 8227, Sorbonne Univ,Integrat Biol Marine Models,Stn Bio, F-90074 Roscoff, Bretagne, France; [Bernard, Thomas] Univ Aix Marseille I & II, Architecture & Fonct Macromol Biol, Unite Mixed Rech 6098, CNRS, Case 932,163 Ave Luminy, F-13288 Marseille 9, France; [Leroux, Cedric; Jeudy, Alexandra] UPMC Univ Paris 06, Sorbonne Univ, CNRS, FR 2424,Stn Biol Roscoff, F-29682 Roscoff, Bretagne, France; [Matard-Mann, Maria; Collen, Pi Nyvall] Amadeite SAS, Pole Biotechnol Haut Bois, F-56580 Brehan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), UPMC Univ Paris 06, CNRS, UMR 8227, Sorbonne Univ,Integrat Biol Marine Models,Stn Bio, F-90074 Roscoff, Bretagne, France.	czjzek@sb-roscoff.fr		MICHEL, Gurvan/0000-0002-3009-6205; LEROUX, Cedric/0000-0001-9225-1234	ANRT; Olmix group Ph.D. Grant [CIFRE-684/2014]; French National Research Agency [ANR-10-BTBR-04]; "Region Bretagne"	ANRT(French National Research Agency (ANR)); Olmix group Ph.D. Grant; French National Research Agency(French National Research Agency (ANR)); "Region Bretagne"(Region Bretagne)	This work was supported by ANRT and Olmix group Ph.D. Grant CIFRE-684/2014 (to M. M.-M.). This work was also supported by the French National Research Agency with regard to the investment expenditure program IDE-ALG (Grant Agreement ANR-10-BTBR-04) and supported by the "Region Bretagne." The authors declare that they have no conflicts of interest with the contents of this article.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Agirre J, 2015, NAT STRUCT MOL BIOL, V22, P833, DOI 10.1038/nsmb.3115; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BARBEYRON T, 1994, GENE, V139, P105, DOI 10.1016/0378-1119(94)90531-2; Barbeyron T, 1998, MOL BIOL EVOL, V15, P528, DOI 10.1093/oxfordjournals.molbev.a025952; Barbeyron T, 2016, ENVIRON MICROBIOL, V18, P4610, DOI 10.1111/1462-2920.13584; Bjursell MK, 2006, J BIOL CHEM, V281, P36269, DOI 10.1074/jbc.M606509200; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falshaw R, 1996, CARBOHYD RES, V285, P81, DOI 10.1016/0008-6215(96)00031-6; Gilad R, 2003, J BACTERIOL, V185, P391, DOI 10.1128/JB.185.2.391-398.2003; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Guibet M, 2007, BIOCHEM J, V404, P105, DOI [10.1042//BJ20061359, 10.1042/BJ20061359]; Hall T., 2011, GERF B BIOSCI, V2, P60; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Huang WJ, 2001, BIOCHEMISTRY-US, V40, P2359, DOI 10.1021/bi0024254; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; KNUTSEN SH, 1994, BOT MAR, V37, P163, DOI 10.1515/botm.1994.37.2.163; KNUTSEN SH, 1987, BOT MAR, V30, P497, DOI 10.1515/botm.1987.30.6.497; Kobayashi T, 2012, BIOSCI BIOTECH BIOCH, V76, P506, DOI 10.1271/bbb.110809; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lemoine M, 2009, BIOCHEM J, V419, P545, DOI 10.1042/BJ20080619; Liu GL, 2011, PROCESS BIOCHEM, V46, P265, DOI 10.1016/j.procbio.2010.08.021; Liu ZM, 2013, APPL MICROBIOL BIOT, V97, P10057, DOI 10.1007/s00253-013-5215-0; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martin M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01487; Martin M, 2014, APPL MICROBIOL BIOT, V98, P2917, DOI 10.1007/s00253-014-5557-2; Michel G, 2003, J MOL BIOL, V334, P421, DOI 10.1016/j.jmb.2003.09.056; Michel G, 2001, STRUCTURE, V9, P513, DOI 10.1016/S0969-2126(01)00612-8; Michel G, 2013, WOODH PUB SER BIOMED, P429, DOI 10.1533/9781908818355.3.429; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; OSTLING S, 1946, ACTA PHYSIOL SCAND, V11, P289, DOI 10.1111/j.1748-1716.1946.tb00349.x; Planas N, 2000, BBA-PROTEIN STRUCT M, V1543, P361, DOI 10.1016/S0167-4838(00)00231-4; POTIN P, 1995, EUR J BIOCHEM, V228, P971, DOI 10.1111/j.1432-1033.1995.0971m.x; POTIN P, 1991, EUR J BIOCHEM, V201, P241, DOI 10.1111/j.1432-1033.1991.tb16280.x; Rebuffet E, 2010, BIOCHEMISTRY-US, V49, P7590, DOI 10.1021/bi1003475; RIORDAN JF, 1970, BIOCHEM BIOPH RES CO, V41, P122, DOI 10.1016/0006-291X(70)90477-8; RIORDAN JF, 1977, SCIENCE, V195, P884, DOI 10.1126/science.190679; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Senni K, 2011, MAR DRUGS, V9, P1664, DOI 10.3390/md9091664; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Usov A. I., 2011, POLYSACCHARIDES RED, P116; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang LN, 2015, J OCEAN U CHINA, V14, P759, DOI 10.1007/s11802-015-2713-y; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; WEIGL J, 1966, CAN J MICROBIOL, V12, P939, DOI 10.1139/m66-127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu XY, 2015, J OCEAN U CHINA, V14, P1082, DOI 10.1007/s11802-015-2652-7; YAPHE W, 1955, APPL MICROBIOL, V3, P380, DOI 10.1128/AEM.3.6.380-383.1955; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	61	24	24	2	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19919	19934		10.1074/jbc.M117.808279	http://dx.doi.org/10.1074/jbc.M117.808279			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29030427	Green Published, hybrid			2022-12-28	WOS:000416911300033
J	Geilfus, CM; Tenhaken, R; Carpentier, SC				Geilfus, Christoph-Martin; Tenhaken, Raimund; Carpentier, Sebastien Christian			Transient alkalinization of the leaf apoplast stiffens the cell wall during onset of chloride salinity in corn leaves	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						abscisic acid (ABA); chloride transport; extracellular matrix; proteomics; ribosome; sodium transport; tubulin	DOWN-REGULATION; ABSCISIC-ACID; CELLULOSE MICROFIBRILS; ARABIDOPSIS CONTAINS; SMALL GENOME; GUARD-CELLS; SALT STRESS; MAIZE; GROWTH; PH	During chloride salinity, the pH of the leaf apoplast (pH(apo)) transiently alkalizes. There is an ongoing debate about the physiological relevance of these stress-induced pH(apo) changes. Using proteomic analyses of expanding leaves of corn (Zea mays L.), we show that this transition in pH(apo) conveys functionality by (i) adjusting protein abundances and (ii) affecting the rheological properties of the cell wall. pH(apo) was monitored in planta via microscopy-based ratio imaging, and the leaf-proteomic response to the transient leaf apoplastic alkalinization was analyzed via ultra-high performance liquid chromatography-MS. This analysis identified 1459 proteins, of which 44 exhibited increased abundance specifically through the chloride-induced transient rise in pH(apo). These elevated protein abundances did not directly arise from high tissue concentrations of Cl- or Na+ but were due to changes in the pH(apo). Most of these proteins functioned in growth-relevant processes and in the synthesis of cell wall-building components such as arabinose. Measurements with a linear-variable differential transducer revealed that the transient alkalinization rigidified (i.e. stiffened) the cell wall during the onset of chloride salinity. A decrease in t-coumaric and t-ferulic acids indicates that the wall stiffening arises from cross-linkage to cell wall polymers. We conclude that the pH of the apoplast represents a dynamic factor that is mechanistically coupled to cellular responses to chloride stress. By hardening the wall, the increased pH abrogates wall loosening required for cell expansion and growth. We conclude that the transient alkalinization of the leaf apoplast is related to salinity-induced growth reduction.	[Geilfus, Christoph-Martin; Carpentier, Sebastien Christian] Katholieke Univ Leuven, SYBIOMA, Prote Core Facil, O&N II Herestr 49,Bus 901, B-3000 Leuven, Belgium; [Geilfus, Christoph-Martin] Humboldt Univ, Albrecht Daniel Thaer Inst Agr & Hort Sci, Albrecht Thaer Weg 1, D-14195 Berlin, Germany; [Tenhaken, Raimund] Salzburg Univ, Div Plant Physiol, Dept Cell Biol, Salzburg, Austria; [Carpentier, Sebastien Christian] Katholieke Univ Leuven, Dept Biosyst, Div Crop Biotech, Willem Croylaan 42,Box 2455, B-3001 Leuven, Belgium	KU Leuven; Humboldt University of Berlin; Salzburg University; KU Leuven	Geilfus, CM (corresponding author), Humboldt Univ, Div Controlled Environm Hort, Fac Life Sci, Albrecht Daniel Thaer Inst Agr & Hort Sci, Albrecht Thaer Weg 1, D-14195 Berlin, Germany.	geilfusc@hu-berlin.de	Tenhaken, Raimund/O-6556-2019; carpentier, sebastien C.M./D-9482-2018	Tenhaken, Raimund/0000-0002-6764-4826; carpentier, sebastien C.M./0000-0002-7389-6405	Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action [FA1306]	Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action	This work was supported by a Cooperation europeenne dans le domaine de la recherche scientifique et technique STSM scholarship COST Action FA1306 (to C.-M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Alberts B., 2008, MOL BIOL CEL, V5th ed.; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Bindschedler LV, 2007, PHYTOCHEMISTRY, V68, P2635, DOI 10.1016/j.phytochem.2007.08.029; Blancaflor EB, 1997, PLANT PHYSIOL, V113, P1447, DOI 10.1104/pp.113.4.1447; BLATT MR, 1992, J GEN PHYSIOL, V99, P615, DOI 10.1085/jgp.99.4.615; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Buts K, 2014, J PROTEOMICS, V105, P31, DOI 10.1016/j.jprot.2014.02.015; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Carpentier Sebastien Christian, 2008, V428, P327; Davies WJ, 2005, J PLANT GROWTH REGUL, V24, P285, DOI 10.1007/s00344-005-0103-1; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Felle HH, 2001, PLANT BIOLOGY, V3, P577, DOI 10.1055/s-2001-19372; Felle HH, 2008, J PLANT PHYSIOL, V165, P52, DOI 10.1016/j.jplph.2007.08.006; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Geilfus CM, 2015, NEW PHYTOL, V208, P803, DOI 10.1111/nph.13507; Geilfus CM, 2015, J BIOL CHEM, V290, P11235, DOI 10.1074/jbc.M114.619718; Geilfus CM, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-31; Geilfus CM, 2013, NEW PHYTOL, V197, P1117, DOI 10.1111/nph.12046; Geilfus CM, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00013; Geilfus CM, 2012, PLANT CELL ENVIRON, V35, P578, DOI 10.1111/j.1365-3040.2011.02437.x; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Jabeen R, 2006, J PLANT PHYSIOL, V163, P538, DOI 10.1016/j.jplph.2005.05.004; KAKES P, 1985, PLANTA, V166, P156, DOI 10.1007/BF00397342; Karkonen A, 2005, BIOCHEM J, V391, P409, DOI 10.1042/BJ20050800; Kleczkowski LA, 2010, CRIT REV PLANT SCI, V29, P191, DOI 10.1080/07352689.2010.483578; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; KUTSCHERA U, 1994, NEW PHYTOL, V126, P549, DOI 10.1111/j.1469-8137.1994.tb02951.x; KUTSCHERA U, 1986, PLANTA, V167, P527, DOI [10.1007/BF00391229, 10.1007/BF00392142]; Lager I, 2010, PLANT CELL ENVIRON, V33, P1513, DOI 10.1111/j.1365-3040.2010.02161.x; Maathuis FJM, 1999, CURR OPIN PLANT BIOL, V2, P236, DOI 10.1016/S1369-5266(99)80041-7; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Monshausen GB, 2007, P NATL ACAD SCI USA, V104, P20996, DOI 10.1073/pnas.0708586104; MUELLER SC, 1982, PLANTA, V154, P489, DOI 10.1007/BF00402993; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; NEUMANN PM, 1994, PLANT CELL ENVIRON, V17, P303, DOI 10.1111/j.1365-3040.1994.tb00296.x; Neves-Piestun BG, 2001, PLANT PHYSIOL, V125, P1419, DOI 10.1104/pp.125.3.1419; Omidbakhshfard MA, 2012, PLANT SIGNAL BEHAV, V7, P1095, DOI 10.4161/psb.21218; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Reboul R, 2011, J BIOL CHEM, V286, P39982, DOI 10.1074/jbc.M111.255695; Roach M, 2012, PLANT J, V70, P967, DOI 10.1111/j.1365-313X.2012.04929.x; Rosler J, 1997, PLANT PHYSIOL, V113, P175, DOI 10.1104/pp.113.1.175; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shoji T, 2006, PLANT CELL PHYSIOL, V47, P1158, DOI 10.1093/pcp/pcj090; SNUSTAD DP, 1992, PLANT CELL, V4, P549, DOI 10.1105/tpc.4.5.549; Sumer A, 2004, J APPL BOT FOOD QUAL, V78, P135; Vanhove AC, 2015, J PROTEOMICS, V119, P10, DOI 10.1016/j.jprot.2015.01.014; Waldron KW, 1996, PHYTOCHEM ANALYSIS, V7, P305, DOI 10.1002/(SICI)1099-1565(199611)7:6&lt;305::AID-PCA320&gt;3.0.CO;2-A; Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559; Wilkinson S, 2002, PLANT CELL ENVIRON, V25, P195, DOI 10.1046/j.0016-8025.2001.00824.x; Wilkinson S, 1999, PLANT GROWTH REGUL, V29, P87, DOI 10.1023/A:1006203715640; Yeats TH, 2016, PLANT PHYSIOL, V171, P110, DOI 10.1104/pp.16.00302	58	19	19	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18800	18813		10.1074/jbc.M117.799866	http://dx.doi.org/10.1074/jbc.M117.799866			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972176	Green Published, hybrid			2022-12-28	WOS:000415848000006
J	Christakos, S				Christakos, Sylvia			In search of regulatory circuits that control the biological activity of vitamin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							1-ALPHA-HYDROXYLASE GENE; 25-HYDROXYVITAMIN D-3; PARATHYROID-HORMONE; MULTIPLE-SCLEROSIS; METABOLISM; EXPRESSION; VARIANT	Although the cytochrome P450 CYP27B1 plays a critical role in vitamin D biology, the molecular mechanisms involved in regulation of CYP27B1 have remained undefined. A new study has identified a kidney-specific control module distal to the Cyp27b1 gene that mediates the basal activity and hormonal regulation of Cyp27b1. This work provides a novel mechanism indicating differential regulation of Cyp27b1 in renal and nonrenal cells and has implications for vitamin D biology in multiple sclerosis and perhaps other autoimmune diseases as well.	[Christakos, Sylvia] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Christakos, S (corresponding author), Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA.	christak@njms.rutgers.edu			National Institutes of Health [AG044552, AI121621, DK112365]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Recipient of National Institutes of Health Grants AG044552, AI121621, and DK112365.	Alcina A, 2013, J MED GENET, V50, P25, DOI 10.1136/jmedgenet-2012-101085; Brenza HL, 2000, ARCH BIOCHEM BIOPHYS, V381, P143, DOI 10.1006/abbi.2000.1970; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Jones G, 2014, J LIPID RES, V55, P13, DOI 10.1194/jlr.R031534; Karaky M, 2016, MULT SCLER J, V22, P999, DOI 10.1177/1352458515610208; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901	9	6	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17559	17560		10.1074/jbc.H117.806901	http://dx.doi.org/10.1074/jbc.H117.806901			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	29055009	Green Published, hybrid			2022-12-28	WOS:000414009300034
J	Edin, ML; Hamedani, BG; Gruzdev, A; Graves, JP; Lih, FB; Arbes, SJ; Singh, R; Leon, ACO; Bradbury, JA; DeGraff, LM; Hoopes, SL; Arand, M; Zeldin, DC				Edin, Matthew L.; Hamedani, Behin Gholipour; Gruzdev, Artiom; Graves, Joan P.; Lih, Fred B.; Arbes, Samuel J., III; Singh, Rohanit; Leon, Anette C. Orjuela; Bradbury, J. Alyce; DeGraff, Laura M.; Hoopes, Samantha L.; Arand, Michael; Zeldin, Darryl C.			Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and impairs cardiac recovery after ischemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPOXYEICOSATRIENOIC ACID METABOLISM; POLYUNSATURATED FATTY-ACIDS; ENDOTHELIAL-CELLS; CYTOCHROME-P450 ENZYMES; TARGETED DISRUPTION; REPERFUSION INJURY; CYP2J SUBFAMILY; MOUSE-LIVER; EICOSANOIDS; INHIBITION	Stimuli such as inflammation or hypoxia induce cytochrome P450 epoxygenase-mediated production of arachidonic acid-derived epoxyeicosatrienoic acids (EETs). EETs have cardioprotective, vasodilatory, angiogenic, anti-inflammatory, and analgesic effects, which are diminished by EET hydrolysis yielding biologically less active dihydroxyeicosatrienoic acids (DHETs). Previous in vitro assays have suggested that epoxide hydrolase 2 (EPHX2) is responsible for nearly all EET hydrolysis. EPHX1, which exhibits slow EET hydrolysis in vitro, is thought to contribute only marginally to EET hydrolysis. Using Ephx1(-/-), Ephx2(-/-), and Ephx1(-/-) Ephx2(-/-) mice, we show here that EPHX1 significantly contributes to EET hydrolysis in vivo. Disruption of Ephx1 and/or Ephx2 genes did not induce compensatory changes in expression of other Ephx genes or CYP2 family epoxygenases. Plasma levels of 8,9-, 11,12-, and 14,15-DHET were reduced by 38, 44, and 67% in Ephx2(-/-) mice compared with wildtype (WT) mice, respectively; however, plasma from Ephx1(-/-) Ephx2(-/-) mice exhibited significantly greater reduction (100, 99, and 96%) of those respective DHETs. Kinetic assays and FRET experiments indicated that EPHX1 is a slow EET scavenger, but hydrolyzes EETs in a coupled reaction with cytochrome P450 to limit basal EET levels. Moreover, we also found that EPHX1 activities are biologically relevant, as Ephx1(-/-) Ephx2(-/-) hearts had significantly better postischemic functional recovery (71%) than both WT (31%) and Ephx2(-/-) (51%) hearts. These findings indicate that Ephx1(-/-) Ephx2(-/-) mice are a valuable model for assessing EET-mediated effects, uncover a new paradigm for EET metabolism, and suggest that dual EPHX1 and EPHX2 inhibition may represent a therapeutic approach to manage human pathologies such as myocardial infarction.	[Edin, Matthew L.; Gruzdev, Artiom; Graves, Joan P.; Lih, Fred B.; Arbes, Samuel J., III; Singh, Rohanit; Bradbury, J. Alyce; DeGraff, Laura M.; Hoopes, Samantha L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Hamedani, Behin Gholipour; Leon, Anette C. Orjuela; Arand, Michael] Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Zurich	Zeldin, DC (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018; Edin, Matthew/AAI-1934-2019; Arand, Michael/J-3926-2014	Zeldin, Darryl C/0000-0002-2087-7307; Arand, Michael/0000-0003-2413-3177; Edin, Matthew/0000-0002-7042-500X	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [Z01 ES025034]; Swiss National Foundation [PDFMP3_127330]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES103005, ZIAES025034, Z01ES025034, ZICES102425] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES025034 to D.C.Z.) and by the Swiss National Foundation Grant PDFMP3_127330 (to M.A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abukhashim M, 2011, CELL BIOL TOXICOL, V27, P321, DOI 10.1007/s10565-011-9190-x; Carlson GP, 2010, J TOXICOL ENV HEAL A, V73, P1689, DOI 10.1080/15287394.2010.516240; Chaudhary KR, 2010, J CARDIOVASC PHARM, V55, P67, DOI 10.1097/FJC.0b013e3181c37d69; Chen D, 2012, J CLIN PHARMACOL, V52, P319, DOI 10.1177/0091270010397049; Dansette PM, 2012, CHEM RES TOXICOL, V25, P348, DOI 10.1021/tx2004085; Decker M, 2012, J LIPID RES, V53, P2038, DOI 10.1194/jlr.M024448; Decker M, 2009, ARCH TOXICOL, V83, P297, DOI 10.1007/s00204-009-0416-0; Ding YD, 2014, J PHARMACOL EXP THER, V350, P14, DOI 10.1124/jpet.114.214254; Edin ML, 2011, FASEB J, V25, P3436, DOI 10.1096/fj.11-188300; Fang X, 2000, J LIPID RES, V41, P66; Fang X, 2002, AM J PHYSIOL-HEART C, V283, pH2306, DOI 10.1152/ajpheart.00448.2002; Fang X, 2001, J BIOL CHEM, V276, P14867, DOI 10.1074/jbc.M011761200; Gautier JC, 1996, CHEM RES TOXICOL, V9, P418, DOI 10.1021/tx9500944; GILL SS, 1981, BIOCHEM PHARMACOL, V30, P2111, DOI 10.1016/0006-2952(81)90230-6; GILL SS, 1981, NATURE, V291, P167, DOI 10.1038/291167a0; GILL SS, 1980, BIOCHEM PHARMACOL, V29, P389, DOI 10.1016/0006-2952(80)90518-3; GLATT H, 1977, ARCH TOXICOL, V39, P87, DOI 10.1007/BF00343278; Graves JP, 2015, DRUG METAB DISPOS, V43, P1169, DOI 10.1124/dmd.115.064139; Graves JP, 2013, DRUG METAB DISPOS, V41, P763, DOI 10.1124/dmd.112.049429; GUENTHNER TM, 1981, J BIOL CHEM, V256, P3163; Hoopes SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175348; Hu J, 2014, J EXP MED, V211, P281, DOI 10.1084/jem.20131494; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jamieson KL, 2017, PHARMACOL THERAPEUT, V179, P47, DOI 10.1016/j.pharmthera.2017.05.005; KAMINSKY LS, 1981, J BIOL CHEM, V256, P6359; Kohn MC, 2001, CHEM-BIOL INTERACT, V135, P285, DOI 10.1016/S0009-2797(01)00176-4; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; Leon ACO, 2017, ARCH TOXICOL, V91, P3561, DOI 10.1007/s00204-017-2072-0; Marowsky A, 2009, NEUROSCIENCE, V163, P646, DOI 10.1016/j.neuroscience.2009.06.033; Marowsky A, 2017, ARCH TOXICOL, V91, P3571, DOI 10.1007/s00204-017-2060-4; Miyata M, 1999, J BIOL CHEM, V274, P23963, DOI 10.1074/jbc.274.34.23963; Morisseau C, 2014, J LIPID RES, V55, P1131, DOI 10.1194/jlr.M049718; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Newman JW, 2003, P NATL ACAD SCI USA, V100, P1558, DOI 10.1073/pnas.0437724100; Nithipatikom K, 2010, J CARDIOVASC PHARM T, V15, P112, DOI 10.1177/1074248409358408; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; OESCH F, 1987, ARCH TOXICOL, V60, P174, DOI 10.1007/BF00296975; Oni-Orisan A, 2014, J MOL CELL CARDIOL, V74, P199, DOI 10.1016/j.yjmcc.2014.05.016; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Taura K, 2002, ARCH BIOCHEM BIOPHYS, V402, P275, DOI 10.1016/S0003-9861(02)00079-6; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Vaclavikova R, 2015, GENE, V571, P1, DOI 10.1016/j.gene.2015.07.071; Weintraub NL, 1999, AM J PHYSIOL-HEART C, V277, pH2098, DOI 10.1152/ajpheart.1999.277.5.H2098; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001	50	38	39	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3281	3292		10.1074/jbc.RA117.000298	http://dx.doi.org/10.1074/jbc.RA117.000298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29298899	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000426562800021
J	Niu, WN; Wang, J; Qian, J; Wang, MY; Wu, P; Chen, F; Yan, SS				Niu, Weining; Wang, Jun; Qian, Jing; Wang, Mengying; Wu, Ping; Chen, Fei; Yan, Shasha			Allosteric control of human cystathionine beta-synthase activity by a redox active disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS HYDROGEN-SULFIDE; REACTION-MECHANISM; STRUCTURAL-BASIS; HEME; PROTEIN; H2S; BINDING; TISSUE; KINETICS; LIGANDS	Cystathionine beta-synthase (CBS) is the central enzyme in the trans-sulfuration pathway that converts homocysteine to cysteine. It is also one of the three major enzymes involved in the biogenesis of H2S. CBS is a complex protein with a modular three-domain architecture, the central domain of which contains a (CXXC275)-C-272 motif whose function has yet to be determined. In the present study, we demonstrated that the CXXC motif exists in oxidized and reduced states in the recombinant enzyme by mass spectroscopic analysis and a thiol labeling assay. The activity of reduced CBS is similar to 2-3-fold greater than that of the oxidized enzyme, and substitution of either cysteine in CXXC motif leads to a loss of redox sensitivity. The Cys(272-)Cys2(75) disulfide bond in CBS has a midpoint potential of -314 mV at pH 7.4. Additionally, the CXXC motif also exists in oxidized and reduced states in HEK293 cells under oxidative and reductive conditions, and stressing these cells with DTT results in more reduced enzyme and a concomitant increase in H2S production in live HEK293 cells as determined using a H2S fluorescent probe. By contrast, incubation of cells with aminooxy-acetic acid, an inhibitor of CBS and cystathionine gamma-lyase, eliminated the increase of H2S production after the cells were exposed to DTT. These findings indicate that CBS is post-translationally regulated by a redox-active disulfide bond in the CXXC motif. The results also demonstrate that CBS-derived H2S production is increased in cells under reductive stress conditions.	[Niu, Weining; Wang, Jun; Qian, Jing; Wang, Mengying; Wu, Ping; Chen, Fei; Yan, Shasha] Northwestern Polytech Univ, Sch Life Sci, 127 Youyi Rd W, Xian 710072, Peoples R China	Northwestern Polytechnical University	Niu, WN (corresponding author), Northwestern Polytech Univ, Sch Life Sci, 127 Youyi Rd W, Xian 710072, Peoples R China.	niuweining@nwpu.edu.cn	Wu, Ping/E-3749-2013	Wu, Ping/0000-0003-2664-8502	National Natural Science Foundation of China [31471086]; Key Science and Technology Program of Shaanxi Province, China [2017GY-143]; Fundamental Research Funds for the Central Universities of China [G2017KY0001]; Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University [Z2017233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Program of Shaanxi Province, China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University	This work was supported by Grant 31471086 from the National Natural Science Foundation of China, Grant 2017GY-143 from the Key Science and Technology Program of Shaanxi Province, China, Grant G2017KY0001 from the Fundamental Research Funds for the Central Universities of China, and Grant Z2017233 from the Seed Foundation of Innovation and Creation for Graduate Students in Northwestern Polytechnical University. The authors declare that they have no conflicts of interest with the contents of this article.	Asimakopoulou A, 2013, BRIT J PHARMACOL, V169, P922, DOI 10.1111/bph.12171; Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Barr Ian, 2015, Bio Protoc, V5; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Botello-Morte L, 2014, ANTIOXID REDOX SIGN, V20, P1396, DOI 10.1089/ars.2013.5376; Carballal S, 2016, J BIOL CHEM, V291, P8004, DOI 10.1074/jbc.M116.718734; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Celano L, 2009, ARCH BIOCHEM BIOPHYS, V491, P96, DOI 10.1016/j.abb.2009.08.022; CHAN KY, 1993, CEREAL CHEM, V70, P22; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chen YH, 2005, CHEST, V128, P3205, DOI 10.1378/chest.128.5.3205; Cook KM, 2013, ANTIOXID REDOX SIGN, V18, P1987, DOI 10.1089/ars.2012.4807; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Ereno-Orbea J, 2014, P NATL ACAD SCI USA, V111, pE3845, DOI 10.1073/pnas.1414545111; Ereno-Orbea J, 2013, P NATL ACAD SCI USA, V110, pE3790, DOI 10.1073/pnas.1313683110; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; Han Y, 2006, CELL MOL NEUROBIOL, V26, P101, DOI 10.1007/s10571-006-8848-z; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hisatomi O, 2014, J BIOL CHEM, V289, P17379, DOI 10.1074/jbc.M114.554618; Hyodo F, 2006, CANCER RES, V66, P9921, DOI 10.1158/0008-5472.CAN-06-0879; Jiang J, 2014, NANOSCALE, V6, P12104, DOI 10.1039/c4nr01263a; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KERY V, 1995, ARCH BIOCHEM BIOPHYS, V316, P24, DOI 10.1006/abbi.1995.1005; Kery V, 1998, ARCH BIOCHEM BIOPHYS, V355, P222, DOI 10.1006/abbi.1998.0723; Keshari KR, 2011, P NATL ACAD SCI USA, V108, P18606, DOI 10.1073/pnas.1106920108; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kraus JP, 1999, HUM MUTAT, V13, P362; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Li LZ, 2012, J BIOENERG BIOMEMBR, V44, P645, DOI 10.1007/s10863-012-9469-5; Lin VS, 2013, P NATL ACAD SCI USA, V110, P7131, DOI 10.1073/pnas.1302193110; Liu Haiguang, 2008, V443, P259; Majtan T, 2016, BIOCHIMIE, V126, P6, DOI 10.1016/j.biochi.2016.01.009; Majtan T, 2008, J BIOL CHEM, V283, P34588, DOI 10.1074/jbc.M805928200; McCorvie TJ, 2014, J BIOL CHEM, V289, P36018, DOI 10.1074/jbc.M114.610782; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Niu WN, 2015, ANTIOXID REDOX SIGN, V22, P350, DOI 10.1089/ars.2014.5891; Niu WN, 2017, MEDCHEMCOMM, V8, P198, DOI 10.1039/c6md00493h; OGASAWARA Y, 1994, BIOL PHARM BULL, V17, P1535; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Vicente JB, 2016, J BIOL CHEM, V291, P572, DOI 10.1074/jbc.M115.681221; Vicente JB, 2014, J BIOL CHEM, V289, P8579, DOI 10.1074/jbc.M113.507533; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	56	34	36	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2523	2533		10.1074/jbc.RA117.000103	http://dx.doi.org/10.1074/jbc.RA117.000103			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29298893	hybrid, Green Published			2022-12-28	WOS:000425308300024
J	Cornelius, F; Tsunekawa, N; Toyoshima, C				Cornelius, Flemming; Tsunekawa, Naoki; Toyoshima, Chikashi			Distinct pH dependencies of Na+/K+ selectivity at the two faces of Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; membrane transport; enzyme kinetics; enzyme mechanism; membrane protein; E1; E2 conformations; pH; pKa; protonation of binding sites	SODIUM-PUMP; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATASE; ACIDIC RESIDUES; ALPHA-SUBUNIT; POTASSIUM; NA+,K+-ATPASE; TRANSPORT; SITES; K+	The sodium pump (Na,K-ATPase) in animal cells is vital for actively maintaining ATP hydrolysis-powered Na+ and K+ electrochemical gradients across the cell membrane. These ion gradients drive co- and countertransport and are critical for establishing the membrane potential. It has been an enigma how Na,K-ATPase discriminates between Na+ and K+, despite the pumped ion on each side being at a lower concentration than the other ion. Recent crystal structures of analogs of the intermediate conformations E2Pi2K(+) and Na+-bound E1 approximate to PADP suggest that the dimensions of the respective binding sites in Na,K-ATPase are crucial in determining its selectivity. Here, we found that the selectivity at each membrane face is pH-dependent and that this dependence is unique for each face. Most notable was a strong increase in the specific affinity for K+ at the extracellular face (i.e. E2 conformation) as the pH is lowered from 7.5 to 5. We also observed a smaller increase in affinity for K+ on the cytoplasmic side (E1 conformation), which reduced the selectivity for Na+. Theoretical analysis of the pK(a) values of ion-coordinating acidic amino acid residues suggested that the face-specific pH dependences and Na+/K+ selectivities may arise from the protonation or ionization of key residues. The increase in K+ selectivity at low pH on the cytoplasmic face, for instance, appeared to be associated with Asp(808) protonation. We conclude that changes in the ionization state of coordinating residues in Na,K-ATPase could contribute to altering face-specific ion selectivity.	[Cornelius, Flemming] Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark; [Tsunekawa, Naoki; Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Aarhus University; University of Tokyo	Cornelius, F (corresponding author), Univ Aarhus, Dept Biomed, Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	fc@biomed.au.dk	Toyoshima, Chikashi/R-4153-2019; Cornelius, Flemming/C-1912-2019	Cornelius, Flemming/0000-0003-1566-0020; Toyoshima, Chikashi/0000-0001-9640-0778	Danish Medical Research Council; Danish Agency for Science, Technology, and Innovation; Novo Nordisk Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Agency for Science, Technology, and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Danish Medical Research Council, the Danish Agency for Science, Technology, and Innovation, and the Novo Nordisk Foundation. The authors declare that they have no conflicts of interests with the contents of this article.	BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BREITWIESER GE, 1987, AM J PHYSIOL, V253, pC547, DOI 10.1152/ajpcell.1987.253.4.C547; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cymes GD, 2016, P NATL ACAD SCI USA, V113, pE7106, DOI 10.1073/pnas.1608519113; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; GARAY RP, 1973, J PHYSIOL-LONDON, V231, P297, DOI 10.1113/jphysiol.1973.sp010234; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; GLYNN IM, 1962, J PHYSIOL-LONDON, V160, pP18; Han M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39829; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; Lervik A, 2012, PHYS CHEM CHEM PHYS, V14, P3543, DOI 10.1039/c2cp23002j; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahmmoud YA, 2002, BIOPHYS J, V82, P1907, DOI 10.1016/S0006-3495(02)75540-9; Milanick MA, 2002, J GEN PHYSIOL, V120, P497, DOI 10.1085/jgp.20028573; Musgaard M, 2011, BIOCHEMISTRY-US, V50, P11109, DOI 10.1021/bi201164b; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; OTTOLENGHI P, 1975, BIOCHEM J, V151, P61, DOI 10.1042/bj1510061; Peluffo RD, 2009, BIOCHEMISTRY-US, V48, P8105, DOI 10.1021/bi900687u; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; SACHS JR, 1986, J PHYSIOL-LONDON, V381, P149, DOI 10.1113/jphysiol.1986.sp016319; Salonikidis PS, 2000, BBA-BIOMEMBRANES, V1509, P496, DOI 10.1016/S0005-2736(00)00356-4; SEN AK, 1964, J BIOL CHEM, V239, P345; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SIMONS TJB, 1974, J PHYSIOL-LONDON, V237, P123, DOI 10.1113/jphysiol.1974.sp010474; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; SKOU JC, 1974, Q REV BIOPHYS, V7, P401, DOI 10.1017/S0033583500001475; SKOU JC, 1979, BIOCHIM BIOPHYS ACTA, V567, P421, DOI 10.1016/0005-2744(79)90128-1; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Sugita Y, 2005, J AM CHEM SOC, V127, P6150, DOI 10.1021/ja0427505; Terkildsen JR, 2007, AM J PHYSIOL-HEART C, V293, pH3036, DOI 10.1152/ajpheart.00771.2007; Therien AG, 1999, AM J PHYSIOL-CELL PH, V277, pC891, DOI 10.1152/ajpcell.1999.277.5.C891; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VILSEN B, 1993, BIOCHEMISTRY-US, V32, P13340, DOI 10.1021/bi00211a048; WHITTAM R, 1965, BIOCHEM J, V97, P214, DOI 10.1042/bj0970214; Yu HB, 2011, NAT STRUCT MOL BIOL, V18, P1159, DOI 10.1038/nsmb.2113	44	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2195	2205		10.1074/jbc.RA117.000700	http://dx.doi.org/10.1074/jbc.RA117.000700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29247005	Green Published, hybrid			2022-12-28	WOS:000424948000030
J	Holdbrooks, AT; Britain, CM; Bellis, SL				Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.			ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; -galactoside 2-6 sialyltransferase 1 (ST6Gal-I); cell signaling; glycosylation; tumor cell biology; tumor necrosis factor (TNF); TNFR1; death receptor	MESENCHYMAL TRANSITION; MEDIATED APOPTOSIS; CARCINOMA CELLS; EXPRESSION; ALPHA; ADHESION; ACTIVATION; INDUCTION; PHENOTYPE; LIFE	Activation of the tumor necrosis factor receptor 1 (TNFR1) death receptor by TNF induces either cell survival or cell death. However, the mechanisms mediating these distinct outcomes remain poorly understood. In this study, we report that the ST6Gal-I sialyltransferase, an enzyme up-regulated in numerous cancers, sialylates TNFR1 and thereby protects tumor cells from TNF-induced apoptosis. Using pancreatic and ovarian cancer cells with ST6Gal-I knockdown or overexpression, we determined that 2-6 sialylation of TNFR1 had no effect on early TNF-induced signaling events, including the rapid activation of NF-B, c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase (ERK), and Akt (occurring within 15 min). However, upon extended TNF treatment (6-24 h), cells with high ST6Gal-I levels exhibited resistance to TNF-induced apoptosis, as indicated by morphological evidence of cell death and decreased activation of caspases 8 and 3. Correspondingly, at these later time points, high ST6Gal-I expressers displayed sustained activation of the survival molecules Akt and NF-B. Additionally, extended TNF treatment resulted in the selective enrichment of clonal variants with high ST6Gal-I expression, further substantiating a role for ST6Gal-I in cell survival. Given that TNFR1 internalization is known to be essential for apoptosis induction, whereas survival signaling is initiated by TNFR1 at the plasma membrane, we examined TNFR1 localization. The 2-6 sialylation of TNFR1 was found to inhibit TNF-induced TNFR1 internalization. Thus, by restraining TNFR1 at the cell surface via sialylation, ST6Gal-I acts as a functional switch to divert signaling toward survival. These collective findings point to a novel glycosylation-dependent mechanism that regulates the cellular response to TNF and may promote cancer cell survival within TNF-rich tumor microenvironments.	[Holdbrooks, Andrew T.; Britain, Colleen M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 350 McCallum Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health [R01 GM111093, R21 CA192629]; cardiovascular pathophysiology training grant fellowship [T32 HL007918]; American Heart Association predoctoral fellowship; NATIONAL CANCER INSTITUTE [R21CA192629] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111093, T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); cardiovascular pathophysiology training grant fellowship; American Heart Association predoctoral fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM111093 and R21 CA192629 (to S. L. B.), a T32 HL007918 cardiovascular pathophysiology training grant fellowship (to A. T. H.), and an American Heart Association predoctoral fellowship (to A. T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.451; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; BRADLEY JR, 1995, AM J PATHOL, V146, P27; Britain CM, 2017, J BIOL CHEM, V292, P4663, DOI 10.1074/jbc.M116.763862; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; ChambautGuerin AM, 1997, NEUROREPORT, V8, P1451, DOI 10.1097/00001756-199704140-00025; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen XX, 2016, ONCOTARGET, V7, P51955, DOI 10.18632/oncotarget.10192; Chhibber-Goel J, 2016, J BIOL CHEM, V291, P5971, DOI 10.1074/jbc.M115.679076; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; Dall'Olio F, 2014, BBA-GEN SUBJECTS, V1840, P2752, DOI 10.1016/j.bbagen.2014.06.006; Fritsch J, 2014, MOL CELL BIOL, V34, P3214, DOI 10.1128/MCB.00048-14; Fukumori T, 2003, CANCER RES, V63, P8302; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Ham Boram, 2016, Trends Cancer Res, V11, P1; Harduin-Lepers Anne, 2012, Front Biosci (Elite Ed), V4, P499; Hsieh CC, 2017, ONCOTARGET, V8, P7691, DOI 10.18632/oncotarget.13845; Jones SJ, 1999, J IMMUNOL, V162, P1042; Lee M, 2010, ONCOL REP, V23, P757, DOI 10.3892/or_00000695; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu JS, 2015, MOLECULES, V20, P7509, DOI 10.3390/molecules20057509; Lu JS, 2014, J BIOL CHEM, V289, P34627, DOI 10.1074/jbc.M114.593392; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Puimege L, 2014, CYTOKINE GROWTH F R, V25, P285, DOI 10.1016/j.cytogfr.2014.03.004; Recchi MA, 1998, CANCER RES, V58, P4066; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Schultz MJ, 2016, CANCER RES, V76, P3978, DOI 10.1158/0008-5472.CAN-15-2834; Schultz MJ, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-25; Schultz MJ, 2012, CANCER METAST REV, V31, P501, DOI 10.1007/s10555-012-9359-7; Schutze S, 1999, J BIOL CHEM, V274, P10203, DOI 10.1074/jbc.274.15.10203; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056664; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	51	51	51	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1610	1622		10.1074/jbc.M117.801480	http://dx.doi.org/10.1074/jbc.M117.801480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29233887	Green Published, hybrid			2022-12-28	WOS:000424201700014
J	Liu, XM; Wang, YK; Liu, YH; Yu, XX; Wang, PC; Li, X; Du, ZQ; Yang, CX				Liu, Xiao-Man; Wang, Yan-Kui; Liu, Yun-Hua; Yu, Xiao-Xia; Wang, Pei-Chao; Li, Xuan; Du, Zhi-Qiang; Yang, Cai-Xia			Single-cell transcriptome sequencing reveals that cell division cycle 5-like protein is essential for porcine oocyte maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; embryo; gene expression; meiosis; oocyte; brilliant cresyl blue; CDC5L; pig; single cell RNA-seq	BRILLIANT CRESYL BLUE; IN-VITRO MATURATION; GENE-EXPRESSION PATTERN; DEVELOPMENTAL COMPETENCE; RNA-SEQ; EMBRYONIC-DEVELOPMENT; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; BOVINE OOCYTES; MOUSE OOCYTES; STEM-CELLS	The brilliant cresyl blue (BCB) test is used in both basic biological research and assisted reproduction to identify oocytes likely to be developmentally competent. However, the underlying molecular mechanism targeted by the BCB test is still unclear. To explore this question, we first confirmed that BCB-positive porcine oocytes had higher rates of meiotic maturation, better rates of cleavage and development into blastocysts, and lower death rates. Subsequent single-cell transcriptome sequencing on porcine germinal vesicle (GV)-stage oocytes identified 155 genes that were significantly differentially expressed between BCB-negative and BCB-positive oocytes. These included genes such as cdc5l, ldha, spata22, rgs2, paip1, wee1b, and hsp27, which are enriched in functionally important signaling pathways including cell cycle regulation, oocyte meiosis, spliceosome formation, and nucleotide excision repair. In BCB-positive GV oocytes that additionally had a lower frequency of DNA double-strand breaks, the CDC5L protein was significantly more abundant. cdc5l/CDC5L inhibition by short interference (si)RNA or antibody microinjection significantly impaired porcine oocyte meiotic maturation and subsequent parthenote development. Taken together, our single-oocyte sequencing data point to a potential new role for CDC5L in porcine oocyte meiosis and early embryo development, and supports further analysis of this protein in the context of the BCB test.	[Liu, Xiao-Man; Wang, Yan-Kui; Liu, Yun-Hua; Yu, Xiao-Xia; Wang, Pei-Chao; Li, Xuan; Du, Zhi-Qiang; Yang, Cai-Xia] Northeast Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Du, ZQ; Yang, CX (corresponding author), 600 Changjiang Rd, Harbin 150030, Heilongjiang, Peoples R China.	zhqdu@neau.edu.cn; caixiayang@neau.edu.cn	Yang, Cai-Xia/HGC-2198-2022		National Natural Science Foundation of China [31472098]; Northeast Agricultural University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeast Agricultural University	This work was supported by National Natural Science Foundation of China Grant 31472098 and a Start-up grant from the Northeast Agricultural University (to C. X. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Alcoba DD, 2016, ZYGOTE, V24, P83, DOI 10.1017/S0967199415000052; Alvarez GM, 2013, REPROD DOMEST ANIM, V48, P545, DOI 10.1111/rda.12123; Ashry M, 2015, MOL REPROD DEV, V82, P251, DOI 10.1002/mrd.22468; Attner MA, 2013, P NATL ACAD SCI USA, V110, P14278, DOI 10.1073/pnas.1311845110; Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Bai L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153093; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Bonnet-Garnier A, 2012, INT J DEV BIOL, V56, P877, DOI 10.1387/ijdb.120149ab; Castaneda CA, 2013, THERIOGENOLOGY, V79, P417, DOI 10.1016/j.theriogenology.2012.10.006; Chen WJ, 2016, TUMOR BIOL, V37, P4093, DOI 10.1007/s13277-015-4088-5; Coticchio G, 2015, J ASSIST REPROD GEN, V32, P1509, DOI 10.1007/s10815-015-0547-6; DESCHEPPER GG, 1987, HISTOCHEM J, V19, P467, DOI 10.1007/BF01675415; Egerszegi I, 2010, REPROD FERT DEVELOP, V22, P830, DOI 10.1071/RD09140; El Shourbagy SH, 2006, REPRODUCTION, V131, P233, DOI 10.1530/rep.1.00551; Fakruzzaman M, 2013, ANIM REPROD SCI, V142, P19, DOI 10.1016/j.anireprosci.2013.08.012; Gao YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36008; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Grupen CG, 2014, THERIOGENOLOGY, V81, P24, DOI 10.1016/j.theriogenology.2013.09.022; Gu L, 2015, CELL MOL LIFE SCI, V72, P251, DOI 10.1007/s00018-014-1739-4; Gutnisky C, 2014, REPROD FERT DEVELOP, V26, P931, DOI 10.1071/RD12397; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Hou Y, 2013, CELL, V155, P1492, DOI 10.1016/j.cell.2013.11.040; Huan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127512; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishishita S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06148; Ishizaki C, 2009, THERIOGENOLOGY, V72, P72, DOI 10.1016/j.theriogenology.2009.02.015; Janowski D, 2012, THERIOGENOLOGY, V78, P656, DOI 10.1016/j.theriogenology.2012.03.012; Jiang MX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159535; Keefe D, 2015, FERTIL STERIL, V103, P317, DOI 10.1016/j.fertnstert.2014.12.115; Kumar P, 2017, DEVELOPMENT, V144, P17, DOI 10.1242/dev.133058; LASALLE S, 2012, BIOL REPROD, V86; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158074; Liu JJ, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-47; Ma JY, 2013, CELL CYCLE, V12, P1233, DOI 10.4161/cc.24311; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Mohammadi-Sangcheshmeh A, 2014, REPROD FERT DEVELOP, V26, P441, DOI 10.1071/RD12303; Mohapatra SK, 2015, CELL REPROGRAM, V17, P141, DOI 10.1089/cell.2014.0077; Moussa M, 2015, ANIM REPROD SCI, V155, P11, DOI 10.1016/j.anireprosci.2015.01.011; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Opiela J, 2013, REPROD BIOL, V13, P177, DOI 10.1016/j.repbio.2013.07.004; Pawlak P, 2014, J REPROD DEVELOP, V60, P28, DOI 10.1262/jrd.2013-092; Reyes JM, 2015, MOL REPROD DEV, V82, P103, DOI 10.1002/mrd.22445; Rodriguez-Gonzalez E, 2002, THERIOGENOLOGY, V57, P1397, DOI 10.1016/S0093-691X(02)00645-3; Sadeesh EM, 2014, J ASSIST REPROD GEN, V31, P1541, DOI 10.1007/s10815-014-0316-y; Salimi M, 2014, CELL J, V15, P294; Salviano MB, 2016, ZYGOTE, V24, P245, DOI 10.1017/S0967199415000118; Santos ECS, 2015, ZYGOTE, V23, P352, DOI 10.1017/S0967199413000610; Sha QQ, 2017, DEVELOPMENT, V144, P452, DOI 10.1242/dev.144410; Shaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064192; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Spikings EC, 2007, BIOL REPROD, V76, P327, DOI 10.1095/biolreprod.106.054536; Su JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036181; Sun MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23555; Sun XS, 2004, MOL REPROD DEV, V69, P228, DOI 10.1002/mrd.20123; Tabandeh MR, 2012, ANIM REPROD SCI, V131, P30, DOI 10.1016/j.anireprosci.2012.02.006; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Torner H, 2008, REPRODUCTION, V135, P197, DOI 10.1530/REP-07-0348; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trombetta J.J., 2014, CURR PROTOC MOL BIOL, V107, P1; Wongsrikeao P, 2006, THERIOGENOLOGY, V66, P366, DOI 10.1016/j.theriogenology.2005.12.001; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang CX, 2012, MOL REPROD DEV, V79, P541, DOI 10.1002/mrd.22059; Yuan Y, 2017, P NATL ACAD SCI USA, V114, pE5796, DOI 10.1073/pnas.1703998114; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122	70	15	16	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1767	1780		10.1074/jbc.M117.809608	http://dx.doi.org/10.1074/jbc.M117.809608			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222335	Green Published, hybrid			2022-12-28	WOS:000424201700027
J	Zhou, M; Xue, L; Chen, YR; Li, HY; He, QF; Wang, BB; Meng, FL; Wang, M; Guan, MX				Zhou, Mi; Xue, Ling; Chen, Yaru; Li, Haiying; He, Qiufen; Wang, Bibin; Meng, Feilong; Wang, Meng; Guan, Min-Xin			A hypertension-associated mitochondrial DNA mutation introduces an m(1)G37 modification into tRNA(Met), altering its structure and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mutation; nucleotide modification; oxidative phosphorylation; oxygen consumption rates; translation	TRANSFER-RNA MODIFICATION; MATERNALLY INHERITED HYPERTENSION; PHENOTYPIC MANIFESTATION; POSTTRANSCRIPTIONAL MODIFICATIONS; 4435A-GREATER-THAN-G MUTATION; HYPERTROPHIC CARDIOMYOPATHY; MODIFICATION DEFECT; NUCLEAR MODIFIER; OXIDATIVE STRESS; LACTIC-ACIDOSIS	Defective nucleotide modifications of mitochondrial tRNAs have been associated with several human diseases, but their pathophysiology remains poorly understood. In this report, we investigated the pathogenic molecular mechanism underlying a hypertension-associated 4435AG mutation in mitochondrial tRNA(Met). The m.4435AG mutation affected a highly conserved adenosine at position 37, 3 adjacent to the tRNA's anticodon, which is important for the fidelity of codon recognition and stabilization. We hypothesized that the m.4435AG mutation introduced an m(1)G37 modification of tRNA(Met), altering its structure and function. Primer extension and methylation activity assays indeed confirmed that the m.4435AG mutation created a tRNA methyltransferase 5 (TRMT5)-catalyzed m(1)G37 modification of tRNA(Met). We found that this mutation altered the tRNA(Met) structure, indicated by an increased melting temperature and electrophoretic mobility of the mutated tRNA compared with the wildtype molecule. We demonstrated that cybrid cell lines carrying the m.4435AG mutation exhibited significantly decreased efficiency in aminoacylation and steady-state levels of tRNA(Met), as compared with those of control cybrids. The aberrant tRNA(Met) metabolism resulted in variable decreases in mitochondrial DNA (mtDNA)-encoded polypeptides in the mutant cybrids. Furthermore, we found that the m.4435AG mutation caused respiratory deficiency, markedly diminished mitochondrial ATP levels and membrane potential, and increased the production of reactive oxygen species in mutant cybrids. These results demonstrated that an aberrant m(1)G37 modification of mitochondrial tRNA(Met) affected the structure and function of its tRNA and consequently altered mitochondrial function. Our findings provide critical insights into the pathophysiology of maternally inherited hypertension, which is manifested by the deficient tRNA nucleotide modification.	[Zhou, Mi; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhou, Mi; He, Qiufen; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Xue, Ling; Chen, Yaru; Wang, Bibin] Wenzhou Med Univ, Affiliated Hosp 1, Attardi Inst Mitochondrial Biomed, Wenzhou 325035, Zhejiang, Peoples R China; [Li, Haiying] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325035, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736; He, Qiufen/0000-0002-1175-1913	National Basic Research Priorities Program of China [2014CB541704]; National Natural Science Foundation of China [81600326]; Postdoctoral Science Foundation of China [2016M591987]; Fundamental Research Funds for the Central Universities [2017QNA7026]	National Basic Research Priorities Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541704 (to M. X. G.), National Natural Science Foundation of China Grant 81600326 (to M. Z.), Postdoctoral Science Foundation of China Grant 2016M591987 (to M. Z.), and Fundamental Research Funds for the Central Universities Grant 2017QNA7026 (to M. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Addabbo F, 2009, HYPERTENSION, V53, P885, DOI 10.1161/HYPERTENSIONAHA.109.130054; Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Bjork G. R., 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus, DOI 10.1128/ECOSALPLUS]; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; BUCK M, 1982, NUCLEIC ACIDS RES, V10, P2609, DOI 10.1093/nar/10.8.2609; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Eirin A, 2015, HYPERTENSION, V65, P264, DOI 10.1161/HYPERTENSIONAHA.114.04598; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Goto-Ito S, 2008, PROTEINS, V72, P1274, DOI 10.1002/prot.22019; Goto-Ito S, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010032; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li Y, 1999, SCI CHINA SER C, V42, P185, DOI 10.1007/BF02880055; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Liu YQ, 2009, HYPERTENSION, V53, P1083, DOI 10.1161/HYPERTENSIONAHA.109.128702; Long T, 2016, J BIOL CHEM, V291, P24293, DOI 10.1074/jbc.M116.742569; Lu ZQ, 2011, EUR J HUM GENET, V19, P1181, DOI 10.1038/ejhg.2011.111; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Merante F, 1996, HUM MUTAT, V8, P216, DOI 10.1002/(SICI)1098-1004(1996)8:3<216::AID-HUMU4>3.3.CO;2-Y; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Powell CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00079; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Thorburn DR, 2004, MITOCHONDRION, V4, P363, DOI 10.1016/j.mito.2004.07.003; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Vare VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wang XJ, 2008, PHARMACOGENET GENOM, V18, P1059, DOI 10.1097/FPC.0b013e3283131661; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; YARUS M, 1986, J MOL BIOL, V192, P235, DOI 10.1016/0022-2836(86)90362-1; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794; Zhang JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05571-y; Zhang XD, 2016, TRENDS MOL MED, V22, P1025, DOI 10.1016/j.molmed.2016.10.009; Zhou M, 2017, J BIOL CHEM, V292, P13934, DOI 10.1074/jbc.M117.787028; Zhou M, 2015, RNA BIOL, V12, P900, DOI 10.1080/15476286.2015.1050576	83	45	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1425	1438		10.1074/jbc.RA117.000317	http://dx.doi.org/10.1074/jbc.RA117.000317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222331	Green Published, hybrid			2022-12-28	WOS:000423515000027
J	Kroh, HK; Chandrasekaran, R; Zhang, ZF; Rosenthal, K; Woods, R; Jin, XF; Nyborg, AC; Rainey, GJ; Warrener, P; Melnyk, RA; Spiller, BW; Lacy, DB				Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Zhang, Zhifen; Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul; Melnyk, Roman A.; Spiller, Benjamin W.; Lacy, D. Borden			A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE FORMATION; STRUCTURAL DETERMINANTS; TRANSLOCATION; MECHANISM; INFECTION; RECEPTOR; BINDING; DOMAIN; SOFTWARE; IDENTIFY	Clostridium difficile infection is the leading cause of hospital-acquired diarrhea and is mediated by the actions of two toxins, TcdA and TcdB. The toxins perturb host cell function through a multistep process of receptor binding, endocytosis, low pH-induced pore formation, and the translocation and delivery of an N-terminal glucosyltransferase domain that inactivates host GTPases. Infection studies with isogenic strains having defined toxin deletions have established TcdB as an important target for therapeutic development. Monoclonal antibodies that neutralize TcdB function have been shown to protect against C. difficile infection in animal models and reduce recurrence in humans. Here, we report the mechanism of TcdB neutralization by PA41, a humanized monoclonal antibody capable of neutralizing TcdB from a diverse array of C. difficile strains. Through a combination of structural, biochemical, and cell functional studies, involving X-ray crystallography and EM, we show that PA41 recognizes a single, highly conserved epitope on the TcdB glucosyltransferase domain and blocks productive translocation and delivery of the enzymatic cargo into the host cell. Our study reveals a unique mechanism of C. difficile toxin neutralization by a monoclonal antibody, which involves targeting a process that is conserved across the large clostridial glucosylating toxins. The PA41 antibody described here provides a valuable tool for dissecting the mechanism of toxin pore formation and translocation across the endosomal membrane.	[Kroh, Heather K.; Chandrasekaran, Ramyavardhanee; Spiller, Benjamin W.; Lacy, D. Borden] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Zhang, Zhifen; Melnyk, Roman A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Zhang, Zhifen; Melnyk, Roman A.] Hosp Sick Children, Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Rosenthal, Kim; Woods, Rob; Jin, Xiaofang; Nyborg, Andrew C.; Rainey, G. Jonah; Warrener, Paul] MedImmune LLC, Gaithersburg, MD 20878 USA; [Spiller, Benjamin W.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Lacy, D. Borden] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Rainey, G. Jonah] MabVax Therapeut Holdings Inc, San Diego, CA 92121 USA	Vanderbilt University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); AstraZeneca; Medimmune; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Lacy, DB (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, A5301 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	borden.lacy@vanderbilt.edu	Lacy, D. Borden/AFQ-2203-2022; Melnyk, Roman/GQA-9908-2022		National Institutes of Health [S10 RR026915]; Vanderbilt Center for Structural Biology; DOE Office of Science [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; Vanderbilt Structural Electron Microscopy Facility; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108778, R01AI095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Center for Structural Biology; DOE Office of Science(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; Vanderbilt Structural Electron Microscopy Facility; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Jimmy Ballard (University of Oklahoma Medical Center) for the TcdB sequences from ribotypes 027 and 078 and the B. megaterium pHis1622 expression plasmid containing TcdB holotoxin from C. difficile 027/BI/NAP1 R20291. A portion of the experiments described here used the Vanderbilt robotic crystallization facility, which was supported by National Institutes of Health Grant S10 RR026915, and the Vanderbilt Structural Electron Microscopy Facility, which is supported in part by the Vanderbilt Center for Structural Biology. This research also used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and Michigan Technology Tri-Corridor Grant 085P1000817.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anosova NG, 2015, CLIN VACCINE IMMUNOL, V22, P711, DOI 10.1128/CVI.00763-14; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; Carter GP, 2015, MBIO, V6, DOI 10.1128/mBio.00551-15; Chandrasekaran R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006070; Chen S, 2016, TOXINS, V8, pE241; Chumbler NM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.2, 10.1038/nmicrobiol.2015.2]; Chumbler NM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003072; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Diep BA, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02456-16; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Fischer A, 2007, J BIOL CHEM, V282, P29604, DOI 10.1074/jbc.M703619200; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; Gupta P, 2017, J BIOL CHEM, V292, P17290, DOI 10.1074/jbc.M117.806687; Hernandez LD, 2017, J MOL BIOL, V429, P1030, DOI 10.1016/j.jmb.2017.02.010; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Juris SJ, 2007, INFECT IMMUN, V75, P5052, DOI 10.1128/IAI.00490-07; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klingenberg O, 1996, BIOCHEM J, V313, P647, DOI 10.1042/bj3130647; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KRIVAN HC, 1986, INFECT IMMUN, V53, P573, DOI 10.1128/IAI.53.3.573-581.1986; Kroh HK, 2017, J BIOL CHEM, V292, P14401, DOI 10.1074/jbc.M117.781112; LaFrance ME, 2015, P NATL ACAD SCI USA, V112, P7073, DOI 10.1073/pnas.1500791112; Lanis JM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003523; Lanis JM, 2012, MOL MICROBIOL, V84, P66, DOI 10.1111/j.1365-2958.2012.08009.x; Legler PM, 2017, MABS-AUSTIN, V9, P43, DOI 10.1080/19420862.2016.1236882; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lo AWH, 2014, J BIOL CHEM, V289, P25374, DOI 10.1074/jbc.M114.566257; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marozsan AJ, 2012, J INFECT DIS, V206, P706, DOI 10.1093/infdis/jis416; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechaly A, 2012, J BIOL CHEM, V287, P32665, DOI 10.1074/jbc.M112.400473; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morrison C, 2015, NAT REV DRUG DISCOV, V14, P737, DOI 10.1038/nrd4770; MULLARD A, 2016, NAT REV DRUG DISCOV, V15, P811; Oganesyan V, 2014, J BIOL CHEM, V289, P29874, DOI 10.1074/jbc.M114.601328; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orth P, 2014, J BIOL CHEM, V289, P18008, DOI 10.1074/jbc.M114.560748; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; Pruitt RN, 2012, J BIOL CHEM, V287, P8013, DOI 10.1074/jbc.M111.298414; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qiu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157970; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Steele J, 2013, J INFECT DIS, V207, P323, DOI 10.1093/infdis/jis669; Tao L, 2016, NATURE, V538, P350, DOI 10.1038/nature19799; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wilcox MH, 2017, NEW ENGL J MED, V376, P305, DOI 10.1056/NEJMoa1602615; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yang ZY, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw078; Yang ZY, 2015, INFECT IMMUN, V83, P822, DOI 10.1128/IAI.02897-14; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yuan PF, 2015, CELL RES, V25, P157, DOI 10.1038/cr.2014.169; Zhang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058634; Zhang ZF, 2014, P NATL ACAD SCI USA, V111, P3721, DOI 10.1073/pnas.1400680111	74	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					941	952		10.1074/jbc.M117.813428	http://dx.doi.org/10.1074/jbc.M117.813428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180448	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000422864500015
J	Kuo, A; Lee, MY; Yang, K; Gross, RW; Sessa, WC				Kuo, Andrew; Lee, Monica Y.; Yang, Kui; Gross, Richard W.; Sessa, William C.			Caveolin-1 regulates lipid droplet metabolism in endothelial cells via autocrine prostacyclin-stimulated, cAMP-mediated lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; MASS-SPECTROMETRY; PLASMA-MEMBRANE; SHOTGUN LIPIDOMICS; PULMONARY DEFECTS; MICE; ADIPOCYTES; PROTEIN; IDENTIFICATION; ABNORMALITIES	Lipid droplets (LD) are dynamic organelles involved in intracellular lipid metabolism in almost all eukaryotic cells, and LD-associated proteins tightly regulate their dynamics. One LD coat protein is caveolin-1 (Cav-1), an essential component for caveola assembly in highly differentiated cells, including adipocytes, smooth muscle cells, and endothelial cells (EC). However, the role of Cav-1 in LD dynamics is unclear. Here we report that EC lacking Cav-1 exhibit impaired LD formation. The decreased LD formation is due to enhanced lipolysis and not caused by reduced triglyceride synthesis or fatty acid uptake. Mechanistically, the absence of Cav-1 increased cAMP/PKA signaling in EC, as indicated by elevated phosphorylation of hormone-sensitive lipase and increased lipolysis. Unexpectedly, we also observed enhanced autocrine production of prostaglandin I-2 (PGI(2), also called prostacyclin) in Cav-1KOEC, and this PGI(2) increase appeared to stimulate cAMP/PKA pathways, contributing to the enhanced lipolysis in Cav-1 KO cells. Our results reveal an unanticipated role of Cav-1 in regulating lipolysis in non-adipose tissue, indicating that Cav-1 is required for LD metabolism in EC and that it regulates cAMP-dependent lipolysis in part via the autocrine production of PGI(2).	[Kuo, Andrew; Lee, Monica Y.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06510 USA; [Lee, Monica Y.; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Kuo, Andrew] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Sch Med, Dept Med & Dev Biol, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Yang, Kui; Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Yale University; Yale University; Yale University; Washington University (WUSTL); Washington University (WUSTL)	Sessa, WC (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06510 USA.	william.sessa@yale.edu	Sessa, William C/B-6844-2011	Sessa, William C/0000-0001-5759-1938	National Institutes of Health [R01 HL64793, R01 HL61371, P01 HL1070295, R01 HL118639]; MERIT award from the American Heart Association; Leducq Fondation (MIRVAD Network); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118639, R01HL064793, R01HL061371, R01HL133178, R35HL139945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MERIT award from the American Heart Association; Leducq Fondation (MIRVAD Network); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 HL64793, R01 HL61371, and P01 HL1070295; a MERIT award from the American Heart Association and the Leducq Fondation (MIRVAD Network) (to W.C.S.), and National Institutes of Health Grant R01 HL118639 (to R.W.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Blouin CM, 2008, BIOCHEM BIOPH RES CO, V376, P331, DOI 10.1016/j.bbrc.2008.08.154; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Briand N, 2014, DIABETES, V63, P4032, DOI 10.2337/db13-1961; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chen YY, 2016, FIFTEENTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, P1; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Han XL, 2012, MASS SPECTROM REV, V31, P134, DOI 10.1002/mas.20342; Han XL, 2001, ANAL BIOCHEM, V295, P88, DOI 10.1006/abio.2001.5178; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kuo A, 2017, CIRC RES, V120, P1289, DOI 10.1161/CIRCRESAHA.116.310498; Martin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046242; Midgett C, 2011, CURR MOL MED, V11, P517, DOI 10.2174/156652411800615144; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; PALADE GE, 1953, J APPL PHYS, V24, P1424; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Pol A, 2004, MOL BIOL CELL, V15, P99, DOI 10.1091/mbc.E03-06-0368; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Razani B, 2001, J BIOL CHEM, V276, P38121; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Shiroto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087871; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang K, 2015, ANAL BIOANAL CHEM, V407, P5199, DOI 10.1007/s00216-015-8640-3; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	35	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					973	983		10.1074/jbc.RA117.000980	http://dx.doi.org/10.1074/jbc.RA117.000980			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29203526	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000422864500018
J	Goulet, DR; Orcutt, SJ; Zwolak, A; Rispens, T; Labrijn, AF; de Jong, RN; Atkins, WM; Chiu, ML				Goulet, Dennis R.; Orcutt, Steven J.; Zwolak, Adam; Rispens, Theo; Labrijn, Aran F.; de Jong, Rob N.; Atkins, William M.; Chiu, Mark L.			Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bispecific antibodies; antibody; cancer therapy; controlled Fab-arm exchange; fluorescence correlation spectroscopy (FCS); fluorescence resonance energy transfer (FRET); kinetics; reaction mechanism	BINDING; IGG4; POTENT; DOMAIN; DETERMINANTS; DISSOCIATION; GENERATION; ANTITUMOR; CHAINS	Bispecific antibodies (bsAbs) combine the antigen specificities of two distinct Abs and demonstrate therapeutic promise based on novel mechanisms of action. Among the many platforms for creating bsAbs, controlled Fab-arm exchange (cFAE) has proven useful based on minimal changes to native Ab structure and the simplicity with which bsAbs can be formed from two parental Abs. Despite a published protocol for cFAE and its widespread use in the pharmaceutical industry, the reaction mechanism has not been determined. Knowledge of the mechanism could lead to improved yields of bsAb at faster rates as well as foster adoption of process control. In this work, a combination of Forster resonance energy transfer (FRET), nonreducing SDS-PAGE, and strategic mutation of the Ab hinge region was employed to identify and characterize the individual steps of cFAE. Fluorescence correlation spectroscopy (FCS) was used to determine the affinity of parental (homodimer) and bispecific (heterodimer) interactions within the C(H)3 domain, further clarifying the thermodynamic basis for bsAb formation. The result is a clear sequence of events with rate constants that vary with experimental conditions, where dissociation of the K409R parental Ab into half-Ab controls the rate of the reaction.	[Goulet, Dennis R.; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Orcutt, Steven J.; Zwolak, Adam; Chiu, Mark L.] Janssen Res & Dev LLC, Biol Discovery, Spring House, PA 19477 USA; [Rispens, Theo] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands; [Labrijn, Aran F.; de Jong, Rob N.] Genmab, Yalelaan 60, NL-3584 CM Utrecht, Netherlands	University of Washington; University of Washington Seattle; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; University of Amsterdam; Genmab	Chiu, ML (corresponding author), 200 Great Valley Pkwy, Malvern, PA 19355 USA.	MChiu@its.jnj.com	chiu, mark/AAK-2756-2021; Goulet, Dennis/AAG-8028-2021	Goulet, Dennis/0000-0002-2949-2454; de Jong, Rob N./0000-0002-9300-6633	National Institutes of Health [T32 GM007750]; University of Washington Department of Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Department of Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant T32 GM007750 (to D. R. G.) and the University of Washington Department of Medicinal Chemistry. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Canziani GA, 2012, J MOL RECOGNIT, V25, P136, DOI 10.1002/jmr.2149; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; CREIGHTON TE, 1984, METHOD ENZYMOL, V107, P305; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Durben M, 2015, MOL THER, V23, P648, DOI 10.1038/mt.2015.2; El-Hallag IS, 2011, J CHIL CHEM SOC, V56, P837, DOI 10.4067/S0717-97072011000400003; Fan GW, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0227-0; Gramer Michael J, 2013, MAbs, V5, P962, DOI 10.4161/mabs.26233; Hanson QM, 2015, BIOCHEMISTRY-US, V54, P2931, DOI 10.1021/acs.biochem.5b00299; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Johnson S, 2010, J MOL BIOL, V399, P436, DOI 10.1016/j.jmb.2010.04.001; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kontermann RE, 2015, DRUG DISCOV TODAY, V20, P838, DOI 10.1016/j.drudis.2015.02.008; Labrijn AF, 2014, NAT PROTOC, V9, P2450, DOI 10.1038/nprot.2014.169; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lee KJ, 2016, THER CLIN RISK MANAG, V12, P1301, DOI 10.2147/TCRM.S84261; Linke R, 2010, MABS-AUSTIN, V2, P129, DOI 10.4161/mabs.2.2.11221; Liu HC, 2010, ANAL CHEM, V82, P5219, DOI 10.1021/ac100575n; Liu Z, 2015, J BIOL CHEM, V290, P7535, DOI 10.1074/jbc.M114.620260; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Moores SL, 2016, CANCER RES, V76, P3942, DOI 10.1158/0008-5472.CAN-15-2833; Nalivaiko K, 2016, MOL THER, V24, P298, DOI 10.1038/mt.2015.209; National Library of Medicine, 2016, DOS ESC STUD JNJ 611; National Library of Medicine, 2016, STUD EV SAF TOL JNJ; National Library of Medicine, 2016, DOS ESC STUD JNJ 637; Nunes JPM, 2015, CHEM COMMUN, V51, P10624, DOI 10.1039/c5cc03557k; Nunez-Prado N, 2015, DRUG DISCOV TODAY, V20, P588, DOI 10.1016/j.drudis.2015.02.013; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Rispens T, 2014, J BIOL CHEM, V289, P6098, DOI 10.1074/jbc.M113.541813; Rispens T, 2013, MOL IMMUNOL, V53, P35, DOI 10.1016/j.molimm.2012.06.012; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sahoo B, 2016, METHODS MOL BIOL, V1345, P67, DOI 10.1007/978-1-4939-2978-8_5; Schuurman J, 2016, CURR OPIN IMMUNOL, V40, pVII, DOI 10.1016/j.coi.2016.04.001; Shammas SL, 2013, J PHYS CHEM B, V117, P13346, DOI 10.1021/jp404267e; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Thakur A, 2016, EXPERT OPIN BIOL TH, V16, P675, DOI 10.1517/14712598.2016.1150996; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; Zhukovsky EA, 2016, CURR OPIN IMMUNOL, V40, P24, DOI 10.1016/j.coi.2016.02.006; ZIMMERMAN B, 1972, BIOCHEMISTRY-US, V11, P78, DOI 10.1021/bi00751a014	48	7	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					651	661		10.1074/jbc.RA117.000303	http://dx.doi.org/10.1074/jbc.RA117.000303			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29150443	hybrid, Green Published			2022-12-28	WOS:000419915400020
J	Liang, PD; Rosas-Lemus, M; Patel, D; Fang, X; Tuz, K; Juarez, O				Liang, Pingdong; Rosas-Lemus, Monica; Patel, Dhwani; Fang, Xuan; Tuz, Karina; Juarez, Oscar			Dynamic energy dependency of Chlamydia trachomatis on host cell metabolism during intracellular growth: Role of sodium-based energetics in chlamydial ATP generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP synthase; Chlamydia trachomatis; energy metabolism; host-pathogen interaction; mitochondrial metabolism; respiratory chain	NADH-QUINONE OXIDOREDUCTASE; PUMPING NADHQUINONE OXIDOREDUCTASE; UBIQUINONE-BINDING-SITE; VIBRIO-CHOLERAE; RESPIRATORY-CHAIN; ESCHERICHIA-COLI; AZITHROMYCIN RESISTANCE; DEVELOPMENTAL CYCLE; NA+-NQR; MEMBRANE	Chlamydia trachomatis is an obligate intracellular human pathogen responsible for the most prevalent sexually-transmitted infection in the world. For decades C. trachomatis has been considered an energy parasite that relies entirely on the uptake of ATP from the host cell. The genomic data suggest that C. trachomatis respiratory chain could produce a sodium gradient that may sustain the energetic demands required for its rapid multiplication. However, this mechanism awaits experimental confirmation. Moreover, the relationship of chlamydiae with the host cell, in particular its energy dependence, is not well understood. In this work, we are showing that C. trachomatis has an active respiratory metabolism that seems to be coupled to the sodium-dependent synthesis of ATP. Moreover, our results show that the inhibition of mitochondrial ATP synthesis at an early stage decreases the rate of infection and the chlamydial inclusion size. In contrast, the inhibition of the chlamydial respiratory chain at mid-stage of the infection cycle decreases the inclusion size but has no effect on infection rate. Remarkably, the addition of monensin, a Na+/H+ exchanger, completely halts the infection. Altogether, our data indicate that chlamydial development has a dynamic relationship with the mitochondrial metabolism of the host, in which the bacterium mostly depends on host ATP synthesis at an early stage, and at later stages it can sustain its own energy needs through the formation of a sodium gradient.	[Liang, Pingdong; Rosas-Lemus, Monica; Patel, Dhwani; Fang, Xuan; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA	Illinois Institute of Technology	Tuz, K; Juarez, O (corresponding author), IIT, Life Sci Bldg,3101 S Dearborn St, Chicago, IL 60616 USA.	ktuz@iit.edu; ojuarez@iit.edu	Rosas-Lemus, Monica/U-4691-2019; Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Tuz, Karina/0000-0002-1669-4612; Juarez, Oscar/0000-0002-2915-8413; Liang, Pingdong/0000-0002-8950-5755	IIT startup funds; "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico	IIT startup funds; "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico	This work was supported in part by IIT startup funds (to O. J.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by "Programa de estancias posdoctorales al extranjero" from the National Council for Science and Technology (CONACyT), Mexico.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLEN EG, 1957, J EXP MED, V105, P539, DOI 10.1084/jem.105.6.539; ALLEN EG, 1962, ANN NY ACAD SCI, V98, P229, DOI 10.1111/j.1749-6632.1962.tb30547.x; Barquera B, 2002, BIOCHEMISTRY-US, V41, P3781, DOI 10.1021/bi011873o; Barta ML, 2014, J BIOL CHEM, V289, P32214, DOI 10.1074/jbc.M114.594325; Bas S, 1998, BRIT J RHEUMATOL, V37, P1054; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Bertsova YV, 2004, FEBS LETT, V563, P207, DOI 10.1016/S0014-5793(04)00312-6; Binet R, 2007, ANTIMICROB AGENTS CH, V51, P4267, DOI 10.1128/AAC.00962-07; Binet R, 2010, ANTIMICROB AGENTS CH, V54, P1094, DOI 10.1128/AAC.01321-09; BOGACHEV AV, 1993, BIOCHIM BIOPHYS ACTA, V1142, P321, DOI 10.1016/0005-2728(93)90160-H; Byrne GI, 2010, J INFECT DIS, V201, pS126, DOI 10.1086/652398; Chowdhary Anuradha, 1998, Journal of Communicable Diseases, V30, P163; CLARK LC, 1968, ANN NY ACAD SCI, V148, P133, DOI 10.1111/j.1749-6632.1968.tb20346.x; Craigen WJ, 2008, J BIOENERG BIOMEMBR, V40, P207, DOI 10.1007/s10863-008-9146-x; de Gannes FMP, 1998, CYTOMETRY, V33, P333; Dean D, 2009, DRUG TODAY, V45, P25; Dessus-Babus S, 1998, ANTIMICROB AGENTS CH, V42, P2474, DOI 10.1128/AAC.42.10.2474; Dibrov P, 2005, BIOCHEMISTRY-MOSCOW+, V70, P150, DOI 10.1007/s10541-005-0094-3; Dibrov P, 2004, J MOL MICROB BIOTECH, V8, P1, DOI 10.1159/000082075; Dibrov P, 2017, CAN J PHYSIOL PHARM, V95, P595, DOI 10.1139/cjpp-2016-0505; Divakaruni AS, 2014, CURR PROTOC TOXICOL, V60, P1, DOI [10.1002/0471140856.tx2502s60, DOI 10.1002/0471140856.TX2502S60]; Dzioba J, 2003, J BACTERIOL, V185, P674, DOI 10.1128/JB.185.2.674-678.2003; Elwell C, 2016, NAT REV MICROBIOL, V14, P385, DOI 10.1038/nrmicro.2016.30; Engstrom P, 2015, INT J MED MICROBIOL, V305, P378, DOI 10.1016/j.ijmm.2015.02.007; ERNSTER L, 1963, J BIOL CHEM, V238, P1124; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; GHOUL M, 1989, APPL ENVIRON MICROB, V55, P1040, DOI 10.1128/AEM.55.4.1040-1043.1989; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; HACKER B, 1993, BIOCHEMISTRY-US, V32, P4403, DOI 10.1021/bi00067a033; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hammerschlag Margaret R, 2002, Semin Pediatr Infect Dis, V13, P239, DOI 10.1053/spid.2002.127201; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; HATCH TP, 1985, J BACTERIOL, V162, P938, DOI 10.1128/JB.162.3.938-942.1985; Hayashi M, 1996, FEBS LETT, V381, P174, DOI 10.1016/0014-5793(96)00114-7; Herz K, 2003, J BACTERIOL, V185, P1236, DOI 10.1128/JB.185.4.1236-1244.2003; HEYTLER PG, 1963, BIOCHEMISTRY-US, V2, P357, DOI 10.1021/bi00902a031; Iliffe-Lee ER, 1999, MOL MICROBIOL, V33, P177, DOI 10.1046/j.1365-2958.1999.01464.x; Iliffe-Lee ER, 2002, MOL MICROBIOL, V44, P819, DOI 10.1046/j.1365-2958.2002.02924.x; INABAYASHI M, 1995, BIOCHEMISTRY-US, V34, P3455, DOI 10.1021/bi00010a038; Juarez O, 2004, BBA-BIOENERGETICS, V1658, P244, DOI 10.1016/j.bbabio.2004.06.005; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2012, J BIOL CHEM, V287, P25678, DOI 10.1074/jbc.M112.366088; Juarez O, 2011, J BIOL CHEM, V286, P26383, DOI 10.1074/jbc.M111.257873; Juarez O, 2010, P NATL ACAD SCI USA, V107, P12505, DOI 10.1073/pnas.1002866107; Juarez O, 2009, BIOCHEMISTRY-US, V48, P9516, DOI 10.1021/bi900845y; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kalbacova M, 2003, CYTOM PART A, V52A, P110, DOI 10.1002/cyto.a.10031; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Malhotra M, 2013, INDIAN J MED RES, V138, P303; McClarty G, 1999, CHLAMYDIA, P69; McMillan DGG, 2011, J BIOL CHEM, V286, P39882, DOI 10.1074/jbc.M111.281675; Mehlitz A, 2017, MOL MICROBIOL, V103, P1004, DOI 10.1111/mmi.13603; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; MIYOSHI H, 1991, FEBS LETT, V292, P61, DOI 10.1016/0014-5793(91)80834-P; Morrissey I, 2002, J ANTIMICROB CHEMOTH, V49, P757, DOI 10.1093/jac/dkf031; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; MOURAD A, 1980, ANTIMICROB AGENTS CH, V18, P696, DOI 10.1128/AAC.18.5.696; Muller V, 2005, J MOL MICROB BIOTECH, V10, P167, DOI 10.1159/000091563; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; NEVEL CJV, 1977, APPL ENVIRON MICROB, V34, P251, DOI 10.1128/AEM.34.3.251-257.1977; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Omsland A, 2012, P NATL ACAD SCI USA, V109, P19781, DOI 10.1073/pnas.1212831109; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Ruppert C, 1998, J BACTERIOL, V180, P3448, DOI 10.1128/JB.180.13.3448-3452.1998; Schramm N, 1996, INFECT IMMUN, V64, P1208, DOI 10.1128/IAI.64.4.1208-1214.1996; Schwoppe C, 2002, J BACTERIOL, V184, P2108, DOI 10.1128/JB.184.8.2108-2115.2002; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Skipp PJS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149011; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; SOPER JW, 1979, J BIOL CHEM, V254, P1170; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Steuber J, 2014, BIOL CHEM, V395, P1389, DOI 10.1515/hsz-2014-0204; Strickland M, 2014, J BIOL CHEM, V289, P23723, DOI 10.1074/jbc.M114.574640; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Szaszak M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002108; Takehara K, 2009, ANAL SCI, V25, P115, DOI 10.2116/analsci.25.115; Taylor HR, 2014, LANCET, V384, P2142, DOI 10.1016/S0140-6736(13)62182-0; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; TOKUDA H, 1984, J BIOL CHEM, V259, P7785; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Tuz K, 2013, J BIOL CHEM, V288, P13676, DOI 10.1074/jbc.M112.420786; Uriarte SM, 2002, J INFECT DIS, V185, P1631, DOI 10.1086/340575; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Verkhovsky MI, 2010, BBA-BIOENERGETICS, V1797, P738, DOI 10.1016/j.bbabio.2009.12.020; Vonck RA, 2011, INFECT IMMUN, V79, P1566, DOI 10.1128/IAI.01155-10; WANG JH, 1974, ARCH BIOCHEM BIOPHYS, V162, P64, DOI 10.1016/0003-9861(74)90105-2; WHO, 2012, GLOB INC PREV SEL CU	105	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					510	522		10.1074/jbc.M117.797209	http://dx.doi.org/10.1074/jbc.M117.797209			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29123027	Green Published, hybrid			2022-12-28	WOS:000419915400008
J	Patel, AA; Durer, ZAO; van Loon, AP; Bremer, KV; Quinlan, ME				Patel, Aanand A.; Durer, Zeynep A. Oztug; van Loon, Aaron P.; Bremer, Kathryn V.; Quinlan, Margot E.			Drosophila and human FHOD family formin proteins nucleate actin filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cytoskeleton; Drosophila; formin; processivity; Fhod; Fhos; TIRF	STRESS FIBER FORMATION; HOMOLOGY 2 DOMAIN; CAPPING PROTEIN; FISSION YEAST; BARBED END; ADP-ACTIN; MOUSE FORMIN; FH1 DOMAIN; ATP-ACTIN; MIGRATION	Formins are a conserved group of proteins that nucleate and processively elongate actin filaments. Among them, the formin homology domain-containing protein (FHOD) family of formins contributes to contractility of striated muscle and cell motility in several contexts. However, the mechanisms by which they carry out these functions remain poorly understood. Mammalian FHOD proteins were reported not to accelerate actin assembly in vitro; instead, they were proposed to act as barbed end cappers or filament bundlers. Here, we show that purified Drosophila Fhod and human FHOD1 both accelerate actin assembly by nucleation. The nucleation activity of FHOD1 is restricted to cytoplasmic actin, whereas Drosophila Fhod potently nucleates both cytoplasmic and sarcomeric actin isoforms. Drosophila Fhod binds tightly to barbed ends, where it slows elongation in the absence of profilin and allows, but does not accelerate, elongation in the presence of profilin. Fhod antagonizes capping protein but dissociates from barbed ends relatively quickly. Finally, we determined that Fhod binds the sides of and bundles actin filaments. This work establishes that Fhod shares the capacity of other formins to nucleate and bundle actin filaments but is notably less effective at processively elongating barbed ends than most well studied formins.	[Patel, Aanand A.; van Loon, Aaron P.] Univ Calif Los Angeles, Mol Biol Interdept Doctoral Program, Los Angeles, CA 90095 USA; [Durer, Zeynep A. Oztug; Bremer, Kathryn V.; Quinlan, Margot E.] Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA; [Quinlan, Margot E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Durer, Zeynep A. Oztug] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Biophys, TR-34752 Istanbul, Turkey	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Acibadem University	Quinlan, ME (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles E Young Dr E, Los Angeles, CA 90095 USA.	Margot@chem.ucla.edu	durer, zeynep/G-5626-2019	Patel, Aanand/0000-0002-1509-9950; Durer, Zeynep/0000-0001-9912-510X; van Loon, Aaron/0000-0002-8597-1572	National Institutes of Health [NRSA F30 HL137263]; UCLA Medical Scientist Training Program [T32 GM008042, R01 GM096133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL137263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096133, T32GM008042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA Medical Scientist Training Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant NRSA F30 HL137263 (to A. A. P.), UCLA Medical Scientist Training Program T32 GM008042 (to A. A. P.), and R01 GM096133 (to M. E. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Haj A, 2015, EUR J CELL BIOL, V94, P101, DOI 10.1016/j.ejcb.2014.11.003; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Barko S, 2010, J BIOL CHEM, V285, P13154, DOI 10.1074/jbc.M109.093914; Bombardier JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9707; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Dwyer J, 2014, ANAT REC, V297, P1560, DOI 10.1002/ar.22984; Esslinger U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172995; Fujimoto N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148472; Gardberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074923; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grintsevich EE, 2016, NAT CELL BIOL, V18, P876, DOI 10.1038/ncb3390; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Henty-Ridilla JL, 2016, SCIENCE, V352, P1004, DOI 10.1126/science.aaf1709; Iskratsch T, 2013, DEV CELL, V27, P545, DOI 10.1016/j.devcel.2013.11.003; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Koka S, 2003, J CELL SCI, V116, P1745, DOI 10.1242/jcs.00386; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krainer EC, 2013, CYTOSKELETON, V70, P424, DOI 10.1002/cm.21113; Kucherenko MM, 2011, DEV BIOL, V352, P228, DOI 10.1016/j.ydbio.2011.01.013; Lammel U, 2014, DEVELOPMENT, V141, P1366, DOI 10.1242/dev.101352; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Monzo P, 2016, MOL BIOL CELL, V27, P1246, DOI 10.1091/mbc.E15-08-0565; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul NR, 2015, J CELL BIOL, V210, P1013, DOI 10.1083/jcb.201502040; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Roth-Johnson EA, 2014, J BIOL CHEM, V289, P4395, DOI 10.1074/jbc.M113.499921; Schonichen A, 2013, J CELL SCI, V126, P1891, DOI 10.1242/jcs.126706; Schulze N, 2014, J CELL SCI, V127, P1379, DOI 10.1242/jcs.134627; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Shwartz A, 2016, ELIFE, V5, DOI 10.7554/eLife.16540; Smith MB, 2010, CYTOSKELETON, V67, P693, DOI 10.1002/cm.20481; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zuchero J Bradley, 2007, Methods Mol Biol, V370, P213	51	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					532	540		10.1074/jbc.M117.800888	http://dx.doi.org/10.1074/jbc.M117.800888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29127202	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000419915400010
J	Honda, A; Usui, H; Sakimura, K; Igarashi, M				Honda, Atsuko; Usui, Hiroshi; Sakimura, Kenji; Igarashi, Michihiro			Rufy3 is an adapter protein for small GTPases that activates a Rac guanine nucleotide exchange factor to control neuronal polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUN DOMAIN; GROWTH; IDENTIFICATION; AXONS; GENE; SUPPRESSES; OUTGROWTH; CORTEX; FASCIN; RAFTS	RUN and FYVE domain-containing 3 (Rufy3) is an adapter protein for small GTPase proteins and is bound to activated Rap2, a Ras family protein in the developing neuron. Previously, we reported the presence of a rapid cell polarity determination mechanism involving Rufy3, which is likely required for in vivo neuronal development. However, the molecular details of this mechanism are unclear. To this end, here we produced Rufy3 knock-out (Rufy3-KO) mice to study the role of Rufy3 in more detail. Examining Rufy3-KO neurons, we found that Rufy3 is recruited via glycoprotein M6A to detergent-resistant membrane domains, which are biochemically similar to lipid rafts. We also clarified that Rufy3, as a component of a ternary complex, induces the assembly of Rap2 in the axonal growth cone, whereas in the absence of Rufy3, the accumulation of a Rac guanine nucleotide exchange factor, T-cell lymphoma invasion and metastasis 2 (Tiam2/STEF), is inhibited downstream of Rap2. We also found that Rufy3 regulates the cellular localization of Rap2 and Tiam2/STEF. Taken together, we conclude that Rufy3 is a physiological adapter for Rap2 and activates Tiam2/STEF in glycoprotein M6A-regulated neuronal polarity and axon growth.	[Honda, Atsuko; Igarashi, Michihiro] Niigata Univ, Inst Brain Res, Dept Neurochem & Mol Cell Biol, Chou Ku, Niigata 9518510, Japan; [Honda, Atsuko; Igarashi, Michihiro] Niigata Univ, Inst Brain Res, Transdisciplinary Res Program, Chou Ku, Niigata 9518510, Japan; [Usui, Hiroshi; Sakimura, Kenji] Niigata Univ, Inst Brain Res, Dept Cellular Neurobiol, Chou Ku, Niigata 9518510, Japan	Niigata University; Niigata University; Niigata University	Igarashi, M (corresponding author), Niigata Univ, Inst Brain Res, Dept Neurochem & Mol Cell Biol, Chou Ku, Niigata 9518510, Japan.; Igarashi, M (corresponding author), Niigata Univ, Inst Brain Res, Transdisciplinary Res Program, Chou Ku, Niigata 9518510, Japan.	tarokaja@med.niigata-u.ac.jp			TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas; Niigata University; Uehara Memorial Science Promoting Foundation; RIKEN BioResource Center; KAKENHI [17023019, 22240040, 24111515]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15K06770, 24700319]; Japan Society for the Promotion of Science; MEXT of Japan; Tsukada Milk Co.; Novartis Pharma Ltd.; Takeda Foundation; Grants-in-Aid for Scientific Research [16H06276, 17K19444] Funding Source: KAKEN	TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas; Niigata University; Uehara Memorial Science Promoting Foundation; RIKEN BioResource Center; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tsukada Milk Co.; Novartis Pharma Ltd.; Takeda Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas (to M. I.); project-promoting grants from Niigata University; Uehara Memorial Science Promoting Foundation (to M. I.); RIKEN BioResource Center grants for gene targeting in production of mice (to M. I.); KAKENHI Grants 17023019, 22240040, and 24111515 (to M. I.) and 15K06770 and 24700319 (to A. H.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Japan Society for the Promotion of Science; the Platform of Advanced Animal Model Support from MEXT of Japan (to M. I. and K. S.); grants from Tsukada Milk Co. and Novartis Pharma Ltd. (to A. H.); and a Takeda Foundation research grant (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Honda A, 2017, J NEUROSCI, V37, P4046, DOI 10.1523/JNEUROSCI.3319-16.2017; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Igarashi M, 2014, NEUROSCI RES, V88, P1, DOI 10.1016/j.neures.2014.07.005; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Kitagishi Y, 2013, INT J MOL SCI, V14, P6487, DOI 10.3390/ijms14036487; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Namba T, 2015, PHYSIOL REV, V95, P995, DOI 10.1152/physrev.00025.2014; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nozumi M, 2017, CELL REP, V18, P2203, DOI 10.1016/j.celrep.2017.02.008; Nozumi M, 2009, P NATL ACAD SCI USA, V106, P17211, DOI 10.1073/pnas.0904092106; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Shah B, 2016, BIOL CHEM, V397, P1055, DOI 10.1515/hsz-2016-0165; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Wei Z, 2014, J NEUROCHEM, V130, P678, DOI 10.1111/jnc.12740	28	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20936	20946		10.1074/jbc.M117.809541	http://dx.doi.org/10.1074/jbc.M117.809541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089386	Green Published, hybrid			2022-12-28	WOS:000418453400011
J	Wilkening, RV; Capodagli, GC; Khataokar, A; Tylor, KM; Neiditch, MB; Federle, MJ				Wilkening, Reid V.; Capodagli, Glenn C.; Khataokar, Atul; Tylor, Kaitlyn M.; Neiditch, Matthew B.; Federle, Michael J.			Activating mutations in quorum-sensing regulator Rgg2 and its conformational flexibility in the absence of an intermolecular disulfide bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial transcription; disulfide; pheromone; Streptococcus pyogenes (S; pyogenes); X-ray crystallography	BACILLUS-SUBTILIS; PROTEIN-STRUCTURE; VIRULENCE; RESISTANCE; EVOLUTION; SYSTEM; PLCR	Rap/Rgg/NprR/PlcR/PrgX (RRNPP) quorum-sensing systems use extracellular peptide pheromones that are detected by cytoplasmic receptors to regulate gene expression in firmicute bacteria. Rgg-type receptors are allosterically regulated through direct pheromone binding to control transcriptional activity; however, the receptor activation mechanism remains poorly understood. Previous work has identified a disulfide bond between Cys-45 residues within the homodimer interface of Rgg2 from Streptococcus dysgalactiae (Rgg2(Sd)). Here, we compared two Rgg2(Sd)(C45S) X-ray crystal structures with that of wild-type Rgg2(Sd) and found that in the absence of the intermolecular disulfide, the Rgg2(Sd) dimer interface is destabilized and Rgg2(Sd) can adopt multiple conformations. One conformation closely resembled the disulfide-locked Rgg2(Sd) secondary and tertiary structures, but another displayed more extensive rigid-body shifts as well as dramatic secondary structure changes. In parallel experiments, a genetic screen was used to identify mutations in rgg2 of Streptococcus pyogenes (rgg2(Sp)) that conferred pheromone-independent transcriptional activation of an Rgg2-stimulated promoter. Eight mutations yielding constitutive Rgg2 activity, designated Rgg2(Sp)*, were identified, and five of them clustered in or near an Rgg2 region that underwent conformational changes in one of the Rgg2(Sd)(C45S) crystal structures. The Rgg2(Sp)* mutations increased Rgg2(Sp) sensitivity to pheromone and pheromone variants while displaying decreased sensitivity to the Rgg2 antagonist cyclosporine A. We propose that Rgg2(Sp)* mutations invoke shifts in free-energy bias to favor the active state of the protein. Finally, we present evidence for an electrostatic interaction between an N-terminal Asp of the pheromone and Arg-153 within the proposed pheromone-binding pocket of Rgg2(Sp).	[Wilkening, Reid V.; Tylor, Kaitlyn M.; Federle, Michael J.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60607 USA; [Capodagli, Glenn C.; Khataokar, Atul; Neiditch, Matthew B.] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA; [Federle, Michael J.] Univ Illinois, Dept Med Chem & Pharmacognosy, Ctr Biomol Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Neiditch, MB (corresponding author), Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA.; Federle, MJ (corresponding author), Univ Illinois, Dept Med Chem & Pharmacognosy, 900 S Ashland Ave,M-C870 3152 MBRB, Chicago, IL 60607 USA.	matthew.neiditch@rutgers.edu; mfederle@uic.edu		Khataokar, Atul/0000-0001-7291-7908; Neiditch, Matthew/0000-0002-7039-4469; Tylor, Kaitlyn/0000-0002-3117-6338	National Institutes of Health [AI125452, AI091779]; Burroughs Wellcome Fund Investigators of the Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125452, R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators of the Pathogenesis of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI125452 and AI091779 and a grant from Burroughs Wellcome Fund Investigators of the Pathogenesis of Infectious Diseases. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal C, 2015, MBIO, V6, DOI 10.1128/mBio.00393-15; Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Allen RC, 2014, NAT REV MICROBIOL, V12, P300, DOI 10.1038/nrmicro3232; Asfahl KL, 2015, ISME J, V9, P1734, DOI 10.1038/ismej.2014.259; Bose B, 2011, J BACTERIOL, V193, P22, DOI 10.1128/JB.01143-10; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Cook LC, 2014, FEMS MICROBIOL REV, V38, P473, DOI 10.1111/1574-6976.12046; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; Diaz AR, 2012, J BACTERIOL, V194, P1378, DOI 10.1128/JB.06747-11; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; del Sol FG, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001511; Garcia-Contreras R, 2016, ISME J, V10, P4, DOI 10.1038/ismej.2015.84; Gerdt JP, 2014, ACS CHEM BIOL, V9, P2291, DOI 10.1021/cb5004288; Grenha R, 2013, P NATL ACAD SCI USA, V110, P1047, DOI 10.1073/pnas.1213770110; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jimenez JC, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00127; Lasarre B., 2013, MBIO, V3; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Lazazzera BA, 1997, CELL, V89, P917, DOI 10.1016/S0092-8674(00)80277-9; Le Breton Yoann, 2013, Curr Protoc Microbiol, V30, DOI 10.1002/9780471729259.mc09d03s30; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parashar V, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000589; Parashar V, 2015, P NATL ACAD SCI USA, V112, P5177, DOI 10.1073/pnas.1500357112; Parashar V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001512; Perchat S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005779; Perego M, 1996, MOL MICROBIOL, V19, P1151, DOI 10.1111/j.1365-2958.1996.tb02460.x; Shi K, 2005, P NATL ACAD SCI USA, V102, P18596, DOI 10.1073/pnas.0506163102; Swem LR, 2008, CELL, V134, P461, DOI 10.1016/j.cell.2008.06.023; Talagas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005980; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216	38	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20544	20557		10.1074/jbc.M117.801670	http://dx.doi.org/10.1074/jbc.M117.801670			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29030429	hybrid, Green Published			2022-12-28	WOS:000418267000016
J	van Hateren, A; Anderson, M; Bailey, A; Werner, JM; Skipp, P; Elliott, T				van Hateren, Andy; Anderson, Malcolm; Bailey, Alistair; Werner, Joern M.; Skipp, Paul; Elliott, Tim			Direct evidence for conformational dynamics in major histocompatibility complex class I molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; hydrogen-deuterium exchange; major histocompatibility complex (MHC); protein conformation; protein dynamic; protein folding; protein structure; structure-function; allotype; hydrogen-deuterium exchange mass spectrometry	MHC CLASS-I; PEPTIDE-LOADING COMPLEX; ANTIGEN PRESENTATION; MECHANISTIC BASIS; SELECTOR FUNCTION; ALPHA-2 DOMAIN; CUTTING EDGE; TAPASIN; TAP; HETERODIMER	Major histocompatibility complex class I molecules (MHC I) help protect jawed vertebrates by binding and presenting immunogenic peptides to cytotoxic T lymphocytes. Peptides are selected from a large diversity present in the endoplasmic reticulum. However, only a limited number of peptides complement the polymorphic MHC specificity determining pockets in a way that leads to high-affinity peptide binding and efficient antigen presentation. MHC I molecules possess an intrinsic ability to discriminate between peptides, which varies in efficiency between allotypes, but the mechanism of selection is unknown. Elucidation of the selection mechanism is likely to benefit future immune-modulatory therapies. Evidence suggests peptide selection involves transient adoption of alternative, presumably higher energy conformations than native peptide-MHC complexes. However, the instability of peptide-receptive MHC molecules has hindered characterization of such conformational plasticity. To investigate the dynamic nature of MHC, we refolded MHC proteins with peptides that can be hydrolyzed by UV light and thus released. We compared the resultant peptide-receptive MHC molecules with non-hydrolyzed peptide-loaded MHC complexes by monitoring the exchange of hydrogen for deuterium in solution. We found differences in hydrogen-deuterium exchange between peptide-loaded and peptide-receptive molecules that were negated by the addition of peptide to peptide-receptive MHC molecules. Peptide hydrolysis caused significant increases in hydrogen-deuterium exchange in sub-regions of the peptide-binding domain and smaller increases elsewhere, including in the 3 domain and the non-covalently associated (2)-microglobulin molecule, demonstrating long-range dynamic communication. Comparing two MHC allotypes revealed allotype-specific differences in hydrogen-deuterium exchange, consistent with the notion that MHC I plasticity underpins peptide selection.	[van Hateren, Andy; Bailey, Alistair; Elliott, Tim] Univ Southampton, Inst Life Sci, Fac Med, Bldg 85, Southampton SO17 1BJ, Hants, England; [van Hateren, Andy; Bailey, Alistair; Elliott, Tim] Univ Southampton, Ctr Canc Immunol, Fac Med, Bldg 85, Southampton SO17 1BJ, Hants, England; [Bailey, Alistair; Skipp, Paul] Univ Southampton, Ctr Prote Res, Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Bailey, Alistair; Skipp, Paul] Univ Southampton, Inst Life Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Werner, Joern M.] Univ Southampton, Inst Life Sci, Ctr Biol Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Werner, Joern M.] Univ Southampton, Fac Nat & Environm Sci, Bldg 85, Southampton SO17 1BJ, Hants, England; [Anderson, Malcolm] Waters Corp, Stamford Ave,Altrincham Rd, Wilmslow SK9 4AX, Cheshire, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; University of Southampton; Waters UK	Elliott, T (corresponding author), Univ Southampton, Fac Med, Ctr Canc Immunol, Southampton Univ Hosp, Tremona Rd, Southampton SO16 6YD, Hants, England.	tje@soton.ac.uk	van Hateren, Andy/GZL-0129-2022	Werner, Jorn/0000-0002-4712-1833; Elliott, Tim/0000-0003-1097-0222; Bailey, Alistair/0000-0003-0023-8679; van Hateren, Andy/0000-0002-3915-0239	Cancer Research UK Program [C7056A]; Biotechnology and Biological Sciences Research Council (BBSRC) Project [BB/M012387/1, BB/L010402/1]; Biotechnology and Biological Sciences Research Council [BB/L010402/1, BB/M012387/1] Funding Source: researchfish; Cancer Research UK [16997] Funding Source: researchfish; BBSRC [BB/L010402/1, BB/M012387/1] Funding Source: UKRI	Cancer Research UK Program(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC) Project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Cancer Research UK Program Grant C7056A (to T. E.) and Biotechnology and Biological Sciences Research Council (BBSRC) Project Grants BB/M012387/1 (to P. S.) and BB/L010402/1 (to T. E. and J. M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Bailey A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14928; Bailey A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089657; Bennett EM, 1999, J IMMUNOL, V162, P5049; Boname JM, 2005, EUR J IMMUNOL, V35, P171, DOI 10.1002/eji.200425459; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Dalchau N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002144; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fisette O, 2016, SCI REP-UK, V6, DOI 10.1038/srep19085; Fleischmann G, 2015, J IMMUNOL, V195, P4503, DOI 10.4049/jimmunol.1501515; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Garstka MA, 2015, P NATL ACAD SCI USA, V112, P1505, DOI 10.1073/pnas.1416543112; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; GREENWOOD R, 1994, J IMMUNOL, V153, P5525; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hodkinson JP, 2009, J AM SOC MASS SPECTR, V20, P278, DOI 10.1016/j.jasms.2008.10.005; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Jiang QA, 2010, TUMOR BIOL, V31, P451, DOI 10.1007/s13277-010-0054-4; KAUFMAN J, 1992, J IMMUNOL, V148, P1532; KAUFMAN J, 1995, IMMUNOL REV, V143, P63, DOI 10.1111/j.1600-065X.1995.tb00670.x; Koch M, 2007, IMMUNITY, V27, P885, DOI 10.1016/j.immuni.2007.11.007; Kurimoto E, 2013, MOL IMMUNOL, V55, P393, DOI 10.1016/j.molimm.2013.03.014; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Li SL, 1997, P NATL ACAD SCI USA, V94, P8708, DOI 10.1073/pnas.94.16.8708; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; Rizvi SM, 2014, J IMMUNOL, V192, P4967, DOI 10.4049/jimmunol.1301670; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Seliger B, 2001, TISSUE ANTIGENS, V57, P39, DOI 10.1034/j.1399-0039.2001.057001039.x; Seliger B, 2010, CANCER IMMUNOL IMMUN, V59, P529, DOI 10.1007/s00262-009-0769-5; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Simone LC, 2012, MOL IMMUNOL, V49, P628, DOI 10.1016/j.molimm.2011.11.002; Springer S, 1998, BIOCHEMISTRY-US, V37, P3001, DOI 10.1021/bi9717441; Suh WK, 1996, J EXP MED, V184, P337, DOI 10.1084/jem.184.2.337; Suh WK, 1999, J IMMUNOL, V162, P1530; Thomas C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00065; Thuring C, 2015, BRIT J CANCER, V113, P1640, DOI 10.1038/bjc.2015.387; van Hateren A, 2010, TISSUE ANTIGENS, V76, P259, DOI 10.1111/j.1399-0039.2010.01550.x; van Hateren Andy, 2017, F1000Res, V6, P158, DOI 10.12688/f1000research.10474.1; van Hateren A, 2015, MOL IMMUNOL, V68, P98, DOI 10.1016/j.molimm.2015.03.010; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Wearsch PA, 2011, P NATL ACAD SCI USA, V108, P4950, DOI 10.1073/pnas.1102524108; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zacharias M, 2004, BIOPHYS J, V87, P2203, DOI 10.1529/biophysj.104.044743	57	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20255	20269		10.1074/jbc.M117.809624	http://dx.doi.org/10.1074/jbc.M117.809624			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021251	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000417696400029
J	Muratori, C; Pakhomov, AG; Gianulis, E; Meads, J; Casciola, M; Mollica, PA; Pakhomova, ON				Muratori, Claudia; Pakhomov, Andrei G.; Gianulis, Elena; Meads, Jade; Casciola, Maura; Mollica, Peter A.; Pakhomova, Olga N.			Activation of the phospholipid scramblase TMEM16F by nanosecond pulsed electric fields (nsPEF) facilitates its diverse cytophysiological effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; chloride channel; electroporation; phosphatidylserine; plasma membrane; Anoctamin 6; TMEM16F; nanosecond pulsed electric fields (nsPEF)	CA2+-ACTIVATED CL-CHANNEL; PSEUDOPOD-LIKE BLEBS; MEMBRANE PERMEABILIZATION; INTRACELLULAR CA2+; CALCIUM-ENTRY; ANOCTAMIN 6; CELL-DEATH; PHOSPHATIDYLSERINE TRANSLOCATION; ENDOTHELIAL-CELLS; CHROMAFFIN CELLS	Nanosecond pulsed electric fields (nsPEF) are emerging as a novel modality for cell stimulation and tissue ablation. However, the downstream protein effectors responsible for nsPEF bioeffects remain to be established. Here we demonstrate that nsPEF activate TMEM16F (or Anoctamin 6), a protein functioning as a Ca2+-dependent phospholipid scramblase and Ca2+-activated chloride channel. Using confocal microscopy and patch clamp recordings, we investigated the relevance of TMEM16F activation for several bioeffects triggered by nsPEF, including phosphatidylserine (PS) externalization, nanopore-conducted currents, membrane blebbing, and cell death. In HEK 293 cells treated with a single 300-ns pulse of 25.5 kV/cm, Tmem16f expression knockdown and TMEM16F-specific inhibition decreased nsPEF-induced PS exposure by 49 and 42%, respectively. Moreover, the Tmem16f silencing significantly decreased Ca2+-dependent chloride channel currents activated in response to the nanoporation. Tmem16f expression also affected nsPEF-induced cell blebbing, with only 20% of the silenced cells developing blebs compared with 53% of the control cells. This inhibition of cellular blebbing correlated with a 25% decrease in cytosolic free Ca2+ transient at 30 s after nanoporation. Finally, in TMEM16F-overexpressing cells, a train of 120 pulses (300 ns, 20 Hz, 6 kV/cm) decreased cell survival to 34% compared with 51% in control cells (*, p < 0.01). Taken together, these results indicate that TMEM16F activation by nanoporation mediates and enhances the diverse cellular effects of nsPEF.	[Muratori, Claudia; Pakhomov, Andrei G.; Gianulis, Elena; Meads, Jade; Casciola, Maura; Pakhomova, Olga N.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA 23508 USA; [Mollica, Peter A.] Old Dominion Univ, Dept Med Diagnost & Translat Sci, Norfolk, VA 23508 USA	Old Dominion University; Old Dominion University	Muratori, C (corresponding author), 4211 Monarch Way, Norfolk, VA 23508 USA.	cmurator@odu.edu	Mollica, Peter/AAT-9553-2021	Mollica, Peter/0000-0002-0621-2819; Pakhomov, Andrei/0000-0003-3816-3860; Muratori, Claudia/0000-0002-3359-164X	Air Force Office of Scientific Research MURI grant on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems	Air Force Office of Scientific Research MURI grant on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems	This work was supported by a 2015 Air Force Office of Scientific Research MURI grant (to A. G. P.) on Nanoelectropulse-induced Electromechanical Signaling and Control of Biological Systems, administered through Old Dominion University. The authors declare that they have no conflicts of interest with the contents of this article.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; ARNOULD T, 1992, J CELL PHYSIOL, V152, P215, DOI 10.1002/jcp.1041520127; Berghofer T, 2009, BIOCHEM BIOPH RES CO, V387, P590, DOI 10.1016/j.bbrc.2009.07.072; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Carr L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41267; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Craviso GL, 2012, BIOELECTROCHEMISTRY, V87, P244, DOI 10.1016/j.bioelechem.2011.11.016; Craviso GL, 2010, CELL MOL NEUROBIOL, V30, P1259, DOI 10.1007/s10571-010-9573-1; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; GEERAERTS MD, 1991, AM J PHYSIOL, V261, pC889, DOI 10.1152/ajpcell.1991.261.5.C889; Gianulis EC, 2017, CELL MOL LIFE SCI, V74, P1741, DOI 10.1007/s00018-016-2434-4; Gowrishankar TR, 2006, BIOCHEM BIOPH RES CO, V349, P643, DOI 10.1016/j.bbrc.2006.08.097; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hu Q, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031902; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; JEWELL SA, 1982, SCIENCE, V217, P1257, DOI 10.1126/science.7112127; Jiang N, 2011, BIOELECTROMAGNETICS, V32, P148, DOI 10.1002/bem.20620; Juul CA, 2014, PFLUG ARCH EUR J PHY, V466, P1899, DOI 10.1007/s00424-013-1428-4; Kunzelmann K, 2016, CELL MOL LIFE SCI, V73, P2387, DOI 10.1007/s00018-016-2208-z; Kunzelmann K, 2014, PFLUG ARCH EUR J PHY, V466, P407, DOI 10.1007/s00424-013-1305-1; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mattheij NJA, 2016, FASEB J, V30, P727, DOI 10.1096/fj.15-280446; Munnix ICA, 2003, THROMB HAEMOSTASIS, V89, P687, DOI 10.1055/s-0037-1613576; MURATORI C, 2016, SCI REP UK, V6; Muratori C, 2017, J MEMBRANE BIOL, V250, P217, DOI 10.1007/s00232-017-9952-3; Muratori C, 2016, SCI REP-UK, V6, DOI 10.1038/srep23225; Napotnik TB, 2012, BIOELECTROMAGNETICS, V33, P257, DOI 10.1002/bem.20707; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P443, DOI 10.1002/bem.21703; Nesin V, 2012, BIOELECTROMAGNETICS, V33, P394, DOI 10.1002/bem.21696; Ousingsawat J, 2017, CELL MOL LIFE SCI, V74, P173, DOI 10.1007/s00018-016-2338-3; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pakhomov A.G., 2010, ADV ELECTROPORATION, P178; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2017, BBA-BIOMEMBRANES, V1859, P1273, DOI 10.1016/j.bbamem.2017.04.016; Pakhomov AG, 2015, BBA-BIOMEMBRANES, V1848, P958, DOI 10.1016/j.bbamem.2014.12.026; Pakhomov AG, 2014, BIOELECTROCHEMISTRY, V100, P88, DOI 10.1016/j.bioelechem.2014.01.004; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Pakhomova ON, 2014, BBA-BIOMEMBRANES, V1838, P2547, DOI 10.1016/j.bbamem.2014.06.015; Pakhomova ON, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070278; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Rassokhin MA, 2014, CELL BIOCHEM BIOPHYS, V69, P555, DOI 10.1007/s12013-014-9831-9; Rassokhin MA, 2012, J MEMBRANE BIOL, V245, P521, DOI 10.1007/s00232-012-9433-7; Ren W, 2012, BIOCHEM BIOPH RES CO, V421, P808, DOI 10.1016/j.bbrc.2012.04.094; Ren W, 2011, APOPTOSIS, V16, P382, DOI 10.1007/s10495-010-0572-y; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Scudieri P, 2015, J PHYSIOL-LONDON, V593, P3829, DOI 10.1113/JP270691; Semenov I, 2015, BIOELECTROCHEMISTRY, V105, P65, DOI 10.1016/j.bioelechem.2015.05.013; Semenov I, 2013, CELL CALCIUM, V54, P145, DOI 10.1016/j.ceca.2013.05.008; Semenov I, 2013, BBA-BIOMEMBRANES, V1828, P981, DOI 10.1016/j.bbamem.2012.11.032; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thompson GL, 2014, BIOELECTROMAGNETICS, V35, P262, DOI 10.1002/bem.21845; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Ullery JC, 2015, BIOCHEM BIOPH RES CO, V458, P411, DOI 10.1016/j.bbrc.2015.01.131; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, FEBS LETT, V572, P103, DOI 10.1016/j.febslet.2004.07.021; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Vincelette RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063122; Wang SF, 2009, BIOPHYS J, V96, P1640, DOI 10.1016/j.bpj.2008.11.011; White JA, 2004, J BIOL CHEM, V279, P22964, DOI 10.1074/jbc.M311135200; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang W, 2011, TECHNOL CANCER RES T, V10, P281, DOI 10.7785/tcrt.2012.500204; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901	81	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19381	19391		10.1074/jbc.M117.803049	http://dx.doi.org/10.1074/jbc.M117.803049			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982976	hybrid, Green Published			2022-12-28	WOS:000416226700019
J	Kim, E; Akimoto, S; Tokutsu, R; Yokono, M; Minagawa, J				Kim, Eunchul; Akimoto, Seiji; Tokutsu, Ryutaro; Yokono, Makio; Minagawa, Jun			Fluorescence lifetime analyses reveal how the high light-responsive protein LHCSR3 transforms PSII light-harvesting complexes into an energy-dissipative state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; bioenergetics; light-harvesting complex (antenna complex); photobiology; photosynthesis; photosystem II; quenching	ALGA CHLAMYDOMONAS-REINHARDTII; CORE ANTENNA PROTEIN; PHOTOSYSTEM-II; EXCITATION-ENERGY; PSBS PROTEIN; SPECTROSCOPIC PROPERTIES; THYLAKOID MEMBRANES; CONTAINING CYANOBACTERIUM; BINDING PROTEIN; EXCESS LIGHT	In green algae, light-harvesting complex stress-related 3 (LHCSR3) is responsible for the pH-dependent dissipation of absorbed light energy, a function vital for survival under high-light conditions. LHCSR3 binds the photosystem II and light-harvesting complex II (PSII-LHCII) supercomplex and transforms it into an energy-dissipative form under acidic conditions, but the molecular mechanism remains unclear. Here we show that in the green alga Chlamydomonas reinhardtii, LHCSR3 modulates the excitation energy flow and dissipates the excitation energy within the light-harvesting complexes of the PSII supercomplex. Using fluorescence decay-associated spectra analysis, we found that, when the PSII supercomplex is associated with LHCSR3 under high-light conditions, excitation energy transfer from light-harvesting complexes to chlorophyll-binding protein CP43 is selectively inhibited compared with that to CP47, preventing excess excitation energy from overloading the reaction center. By analyzing femtosecond up-conversion fluorescence kinetics, we further found that pH- and LHCSR3-dependent quenching of the PSIILHCII-LHCSR3 supercomplex is accompanied by a fluorescence emission centered at 684 nm, with a decay time constant of 18.6 ps, which is equivalent to the rise time constant of the lutein radical cation generated within a chlorophyll-lutein heterodimer. These results suggest a mechanism in which LHCSR3 transforms the PSII supercomplex into an energy-dissipative state and provide critical insight into the molecular events and characteristics in LHCSR3-dependent energy quenching.	[Kim, Eunchul; Tokutsu, Ryutaro; Minagawa, Jun] Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan; [Akimoto, Seiji] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Yokono, Makio] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Kobe University; Hokkaido University	Minagawa, J (corresponding author), Natl Inst Basic Biol, Div Environm Photobiol, Okazaki, Aichi 4448585, Japan.	minagawa@nibb.ac.jp	Tokutsu, Ryutaro/GRF-0208-2022; Kim, Eunchul/E-9565-2013; Yokono, Makio/N-8425-2015; Tokutsu, Ryutaro/V-7596-2019	Kim, Eunchul/0000-0003-3380-3953; Tokutsu, Ryutaro/0000-0003-2037-255X; Yokono, Makio/0000-0002-4813-2120; Minagawa, Jun/0000-0002-3028-3203	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H06553, JP26251033, JP16F16087]; International Research Fellowship of the JSPS; Grants-in-Aid for Scientific Research [15H05599] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); International Research Fellowship of the JSPS; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aids JP16H06553 (to J. M., R. T., S. A., and E. K.), JP26251033 (to J. M. and R. T.), and JP16F16087 (to E. K.), and a International Research Fellowship of the JSPS (to E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Akimoto S, 2015, PHOTOSYNTH RES, V125, P115, DOI 10.1007/s11120-015-0091-3; Akimoto S, 2012, BBA-BIOENERGETICS, V1817, P1483, DOI 10.1016/j.bbabio.2012.01.006; Allorent G, 2016, P NATL ACAD SCI USA, V113, P14864, DOI 10.1073/pnas.1607695114; Amarnath K, 2012, P NATL ACAD SCI USA, V109, P8405, DOI 10.1073/pnas.1205303109; Andrizhiyevskaya EG, 2005, PHOTOSYNTH RES, V84, P173, DOI 10.1007/s11120-005-0478-7; Avenson TJ, 2009, J BIOL CHEM, V284, P2830, DOI 10.1074/jbc.M807192200; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Caffarri S, 2011, BIOPHYS J, V100, P2094, DOI 10.1016/j.bpj.2011.03.049; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Cheng YC, 2008, J PHYS CHEM B, V112, P13418, DOI 10.1021/jp802730c; Connelly JP, 1997, J PHYS CHEM B, V101, P1902, DOI 10.1021/jp9619651; Correa-Galvis V, 2016, J BIOL CHEM, V291, P17478, DOI 10.1074/jbc.M116.737312; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; de Weerd FL, 2002, BIOCHEMISTRY-US, V41, P15224, DOI 10.1021/bi0261948; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; GAGNE G, 1992, PLANT MOL BIOL, V18, P429, DOI 10.1007/BF00040659; Gerotto C, 2015, PLANT PHYSIOL, V168, P1747, DOI 10.1104/pp.15.00361; Goral TK, 2012, PLANT J, V69, P289, DOI 10.1111/j.1365-313X.2011.04790.x; Groot ML, 1999, BIOPHYS J, V77, P3328, DOI 10.1016/S0006-3495(99)77164-X; Hamada F, 2015, J PHYS CHEM B, V119, P15593, DOI 10.1021/acs.jpcb.5b10073; Hamada F, 2012, BBA-BIOENERGETICS, V1817, P1992, DOI 10.1016/j.bbabio.2012.06.008; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Jarvi S, 2015, BBA-BIOENERGETICS, V1847, P900, DOI 10.1016/j.bbabio.2015.01.006; Johnson MP, 2011, J BIOL CHEM, V286, P19973, DOI 10.1074/jbc.M111.237255; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Komura M, 2006, BBA-BIOENERGETICS, V1757, P1657, DOI 10.1016/j.bbabio.2006.09.007; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Liguori N, 2016, BBA-BIOENERGETICS, V1857, P1514, DOI 10.1016/j.bbabio.2016.04.285; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Maruyama S, 2014, PLANT CELL PHYSIOL, V55, P1304, DOI 10.1093/pcp/pcu068; Mimuro M, 2007, BBA-BIOENERGETICS, V1767, P327, DOI 10.1016/j.bbabio.2007.02.012; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Miura K, 2004, PLANT PHYSIOL, V135, P1595, DOI 10.1104/pp.104.041400; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nagao R, 2014, J PHYS CHEM LETT, V5, P2983, DOI 10.1021/jz501496p; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Novoderezhkin V, 2011, PHYS CHEM CHEM PHYS, V13, P17093, DOI 10.1039/c1cp21079c; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Petroutsos D, 2011, PLANT CELL, V23, P2950, DOI 10.1105/tpc.111.087973; Pinnola A, 2016, BBA-BIOENERGETICS, V1857, P1870, DOI 10.1016/j.bbabio.2016.09.001; Raszewski G, 2008, J AM CHEM SOC, V130, P4431, DOI 10.1021/ja7099826; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Semchonok DA, 2017, BBA-BIOENERGETICS, V1858, P379, DOI 10.1016/j.bbabio.2017.02.015; Shibata Y, 2013, J AM CHEM SOC, V135, P6903, DOI 10.1021/ja312586p; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUEOKA N, 1960, P NATL ACAD SCI USA, V46, P83, DOI 10.1073/pnas.46.1.83; Tibiletti T, 2016, PLANT PHYSIOL, V171, P2717, DOI 10.1104/pp.16.00572; Tilbrook K, 2016, PLANT CELL, V28, P966, DOI 10.1105/tpc.15.00287; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tokutsu R, 2012, J BIOL CHEM, V287, P31574, DOI 10.1074/jbc.M111.331991; van Bezouwen LS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.80; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V890, P134, DOI 10.1016/0005-2728(87)90014-4; Wang LY, 2016, P NATL ACAD SCI USA, V113, P12586, DOI 10.1073/pnas.1606519113; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yokono M, 2015, BBA-BIOENERGETICS, V1847, P1274, DOI 10.1016/j.bbabio.2015.07.006; Yokono M, 2012, BBA-BIOENERGETICS, V1817, P754, DOI 10.1016/j.bbabio.2012.02.009	73	21	23	3	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18951	18960		10.1074/jbc.M117.805192	http://dx.doi.org/10.1074/jbc.M117.805192			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972177	Green Published, hybrid			2022-12-28	WOS:000415848000019
J	Kwon, SH; Oh, S; Nacke, M; Mostov, KE; Lipschutz, JH				Kwon, Sang-Ho; Oh, Sekyung; Nacke, Marisa; Mostov, Keith E.; Lipschutz, Joshua H.			Adaptor protein CD2AP and L-type lectin LMAN2 regulate exosome cargo protein trafficking through the Golgi complex (vol 291, pg 25462, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														mostov, keith/0000-0002-8123-6247				Kwon SH, 2016, J BIOL CHEM, V291, P25462, DOI 10.1074/jbc.M116.729202	1	2	3	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16523	16523		10.1074/jbc.A116.729202	http://dx.doi.org/10.1074/jbc.A116.729202			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28986432	Green Published, hybrid			2022-12-28	WOS:000412414800012
J	Morales, TGP; Ratia, K; Wang, DS; Gogos, A; Bloem, L; Driver, TG; Federle, MJ				Morales, Tiara G. Perez; Ratia, Kiira; Wang, Duo-Sheng; Gogos, Artemis; Bloem, Laura; Driver, Tom G.; Federle, Michael J.			A novel chemical inducer of Streptococcus quorum sensing acts by inhibiting the pheromone-degrading endopeptidase PepO (vol 293, pg 931, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wang, Duo-Sheng/O-9846-2018	Wang, Duo-Sheng/0000-0002-3519-2386; Gogos, Artemis/0000-0002-0555-3814	National Institutes of Health Grant [UL1TR002003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125452, R01AI091779] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Laura Bloem was inadvertently omitted as an author. The author line should appear as shown above. Dr. Bloem's affiliation is the UICentre for Drug Discovery. Accordingly, the Acknowledgments section should read as follows. We thank Dr. Reid Wilkening for preparations of S. pyogenes and S. gordonii rPepO and Drs. Jason Hickok and Gregory R. J. Thatcher of the UICentre under the UIC Center for Clinical & Translational Sciences (National Institutes of Health Grant UL1TR002003), for valuable project discussions and compound library access. Dr. Bloem provided important contributions in decisions on the best compounds to pursue for this study and in the design and evaluation of results of a kinetic bioassay (Fig. 5).	Morales TGP, 2018, J BIOL CHEM, V293, P4580, DOI [10.1074/jbc.AAC118.002674, 10.1074/jbc.M117.810994]	1	5	5	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4580	4580		10.1074/jbc.AAC118.002674	http://dx.doi.org/10.1074/jbc.AAC118.002674			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29203527	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000428204300032
J	Baughman, HER; Clouser, AF; Klevit, RE; Nath, A				Baughman, Hannah E. R.; Clouser, Amanda F.; Klevit, Rachel E.; Nath, Abhinav			HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PAIRED HELICAL FILAMENTS; ALPHA-B-CRYSTALLIN; BETA-STRUCTURE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; PLASTICITY DEFICITS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; AGGREGATION	The microtubule-associated protein tau forms insoluble, amyloid-type aggregates in various dementias, most notably Alzheimer's disease. Cellular chaperone proteins play important roles in maintaining protein solubility and preventing aggregation in the crowded cellular environment. Although tau is known to interact with numerous chaperones, it remains unclear how these chaperones function mechanistically to prevent tau aggregation and how chaperones from different classes compare in terms of mechanism. Here, we focused on the small heat shock protein HspB1 (also known as Hsp27) and the constitutive chaperone Hsc70 (also known as HspA8) and report how each chaperone interacts with tau to prevent its fibril formation. Using fluorescence and NMR spectroscopy, we show that the two chaperones inhibit tau fibril formation by distinct mechanisms. HspB1 delayed tau fibril formation by weakly interacting with early species in the aggregation process, whereas Hsc70 was highly efficient at preventing tau fibril elongation, possibly by capping the ends of tau fibrils. Both chaperones recognized aggregation-prone motifs within the microtubule-binding repeat region of tau. However, HspB1 binding remained transient in both aggregation-promoting and non-aggregating conditions, whereas Hsc70 binding was significantly tighter under aggregation-promoting conditions. These differences highlight the fact that chaperones from different families play distinct but complementary roles in the prevention of pathological protein aggregation.	[Baughman, Hannah E. R.; Nath, Abhinav] Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98195 USA; [Clouser, Amanda F.; Klevit, Rachel E.] Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Nath, A (corresponding author), Univ Washington, Dept Med Chem, Box 357610, Seattle, WA 98195 USA.; Klevit, RE (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	klevit@uw.edu; anath@uw.edu	Klevit, Rachel/AAI-7038-2021	Klevit, Rachel/0000-0002-3476-969X; Nath, Abhinav/0000-0002-2895-2973	National Institutes of Health [5T32 GM008268, 2R01EY017370]; University of Washington Royalty Research Fund; Brady Fund for Natural Products Research; NATIONAL EYE INSTITUTE [R01EY017370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); Brady Fund for Natural Products Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants 5T32 GM008268 (to H. E. R. B. and A. F. C.) and 2R01EY017370 (to R. E. K.); the University of Washington Royalty Research Fund (to A. N.); and the Brady Fund for Natural Products Research (to A. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Abisambra JF, 2010, J NEUROSCI, V30, P15374, DOI 10.1523/JNEUROSCI.3155-10.2010; Aprile FA, 2017, BIOCHEMISTRY-US, V56, P1177, DOI 10.1021/acs.biochem.6b01178; Baldwin AJ, 2012, J AM CHEM SOC, V134, P15343, DOI 10.1021/ja307874r; Barre P, 2013, PROTEIN SCI, V22, P1037, DOI 10.1002/pro.2290; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Chaari A, 2016, INT J BIOL MACROMOL, V83, P433, DOI 10.1016/j.ijbiomac.2015.10.089; Clouser AF, 2017, CELL STRESS CHAPERON, V22, P569, DOI 10.1007/s12192-017-0783-z; Cox D, 2016, J BIOL CHEM, V291, P22618, DOI 10.1074/jbc.M116.739250; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Daebel V, 2012, J AM CHEM SOC, V134, P13982, DOI 10.1021/ja305470p; Dawson HN, 2001, J CELL SCI, V114, P1179; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; Fontaine SN, 2015, HUM MOL GENET, V24, P3971, DOI 10.1093/hmg/ddv135; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; Karagoz GE, 2014, CELL, V156, P963, DOI 10.1016/j.cell.2014.01.037; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lelj-Garolla B, 2012, PROTEIN SCI, V21, P122, DOI 10.1002/pro.761; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Nakatani-Webster E, 2017, BIOPHYS J, V112, P868, DOI 10.1016/j.bpj.2017.01.011; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Patterson KR, 2011, BIOCHEMISTRY-US, V50, P10300, DOI 10.1021/bi2009147; Rajagopal P, 2015, ELIFE, V4, DOI 10.7554/eLife.07304; Rao JLUM, 2010, PLANT SIGNAL BEHAV, V5, P110, DOI 10.4161/psb.5.2.10547; Rauch JN, 2017, J MOL BIOL, V429, P128, DOI 10.1016/j.jmb.2016.11.013; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Shammas SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8025; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Smet C, 2004, CHEMBIOCHEM, V5, P1639, DOI 10.1002/cbic.200400145; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Taniguchi-Watanabe S, 2016, ACTA NEUROPATHOL, V131, P267, DOI 10.1007/s00401-015-1503-3; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Voss K, 2012, BIOCHEMISTRY-US, V51, P888, DOI 10.1021/bi2018078; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; Wszolek ZK, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-30; Xu LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076657; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024; Zwirowski S, 2017, EMBO J, V36, P783, DOI 10.15252/embj.201593378	58	54	56	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2687	2700		10.1074/jbc.M117.803411	http://dx.doi.org/10.1074/jbc.M117.803411			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29298892	Green Published, hybrid			2022-12-28	WOS:000426051900006
J	Shams, K; Kurowska-Stolarska, M; Schutte, F; Burden, AD; McKimmie, CS; Graham, GJ				Shams, Kave; Kurowska-Stolarska, Mariola; Schutte, Fabian; Burden, A. David; McKimmie, Clive S.; Graham, Gerard J.			MicroRNA-146 and cell trauma down-regulate expression of the psoriasis-associated atypical chemokine receptor ACKR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KOEBNER PHENOMENON; DECOY RECEPTOR; D6; IMMUNE; TARGETS; NOMENCLATURE; RECOGNITION; MIGRATION; INNATE	Chemokines are the principal regulators of leukocyte migration and are essential for initiation and maintenance of inflammation. Atypical chemokine receptor 2 (ACKR2) binds and scavenges proinflammatory CC-chemokines, regulates cutaneous T-cell positioning, and limits the spread of inflammation in vivo. Altered ACKR2 function has been implicated in several inflammatory disorders, including psoriasis, a common and debilitating T-cell-driven disorder characterized by thick erythematous skin plaques. ACKR2 expression is abnormal in psoriatic skin, with decreased expression correlating with recruitment of T-cells into the epidermis and increased inflammation. However, the molecular mechanisms that govern ACKR2 expression are not known. Here, we identified specific psoriasis-associated microRNAs (miRs) that bind ACKR2, inhibit its expression, and are active in primary cultures of human cutaneous cells. Using both in silico and in vitro approaches, we show that miR-146b and miR-10b directly bind the ACKR2 3'-UTR and reduce expression of ACKR2 transcripts and protein in keratinocytes and lymphatic endothelial cells, respectively. Moreover, we demonstrate that ACKR2 expression is further down-regulated upon cell trauma, an important trigger for the development of new plaques in many psoriasis patients (the Koebner phenomenon). We found that tensile cell stress leads to rapid ACKR2 down-regulation and concurrent miR-146b up-regulation. Together, we provide, for the first time, evidence for epigenetic regulation of an atypical chemokine receptor. We propose a mechanism by which cell trauma and miRs coordinately exacerbate inflammation via down-regulation of ACKR2 expression and provide a putative mechanistic explanation for the Koebner phenomenon in psoriasis.	[Shams, Kave] Univ Leeds, St James Univ Hosp, Biomed Res Ctr,Natl Inst Hlth Res, Skin Res Grp,Leeds Inst Rheumat & Musculoskeletal, Leeds LS9 7TF, W Yorkshire, England; [McKimmie, Clive S.] Univ Leeds, St James Univ Hosp, Leeds Inst Canc & Pathol, Virus Host Interact Team, Leeds LS9 7TF, W Yorkshire, England; [Shams, Kave] Chapel Allerton Hosp, Dept Dermatol, Leeds LS7 4SA, W Yorkshire, England; [Shams, Kave; Schutte, Fabian; McKimmie, Clive S.; Graham, Gerard J.] Univ Glasgow, Chemokine Res Grp, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Kurowska-Stolarska, Mariola; Burden, A. David] Univ Glasgow, Inst Infect Immun & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Burden, A. David] Dept Dermatol, Lauriston Bldg, Edinburgh EH3 9HA, Midlothian, Scotland	Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Chapel Allerton Hospital; University of Glasgow; University of Glasgow	Graham, GJ (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Chemokine Res Grp, Rm B3-27, Glasgow G12 8TA, Lanark, Scotland.	gerard.graham@glasgow.ac.uk	McKimmie, Clive/AAD-9509-2019; Kurowska-Stolarska, Mariola/AAD-1683-2019	McKimmie, Clive/0000-0002-7694-9509; Schuette, Fabian/0000-0001-5959-952X; Shams, Kave/0000-0002-8145-5351	Wellcome Trust; Medical Research Council Programme grant; Wellcome Trust Senior Investigator Award; MRC [MR/M019764/1, G0901113] Funding Source: UKRI; Medical Research Council [G0901113, MR/M019764/1] Funding Source: researchfish; Wellcome Trust [099251/Z/12/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Investigator Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a Wellcome Trust-funded Scottish Translational Medicine and Therapeutics Initiatives Fellowship award (to K. S.). Work in the laboratory of G. J. G. was supported by a Medical Research Council Programme grant and a Wellcome Trust Senior Investigator Award. The authors declare that they have no conflicts of interest with the contents of this article.	Bachelerie F, 2014, NAT IMMUNOL, V15, P207, DOI 10.1038/ni.2812; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baldwin HM, 2017, RHEUMATOLOGY, V56, P1607, DOI 10.1093/rheumatology/kex176; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Blackburn PE, 2004, BIOCHEM J, V379, P263, DOI 10.1042/BJ20031266; Borroni EM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003627; Codullo V, 2011, ANN RHEUM DIS, V70, P1115, DOI 10.1136/ard.2010.137349; Di Meglio P., 2014, PERSPECT MED, V4; Eberle Franziska C, 2016, F1000Res, V5, DOI 10.12688/f1000research.7927.1; Eulalio A, 2015, J BIOMOL SCREEN, V20, P1003, DOI 10.1177/1087057115578837; Fra AM, 2003, J IMMUNOL, V170, P2279, DOI 10.4049/jimmunol.170.5.2279; Graham GJ, 2012, IMMUNOL LETT, V145, P30, DOI 10.1016/j.imlet.2012.04.004; Graham GJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00280; Graham GJ, 2013, J PATHOL, V229, P168, DOI 10.1002/path.4123; Jens M, 2015, NAT REV GENET, V16, P113, DOI 10.1038/nrg3853; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee KM, 2014, EMBO J, V33, P2564, DOI 10.15252/embj.201488887; Lee KM, 2013, TRENDS IMMUNOL, V34, P7, DOI 10.1016/j.it.2012.08.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; McKimmie CS, 2008, J IMMUNOL, V181, P3353, DOI 10.4049/jimmunol.181.5.3353; McKimmie CS, 2013, BLOOD, V121, P3768, DOI 10.1182/blood-2012-04-425314; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Primo MN, 2012, CYTOKINE, V60, P741, DOI 10.1016/j.cyto.2012.07.031; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rot A, 2013, J IMMUNOL, V190, P6450, DOI 10.4049/jimmunol.1201429; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Shams K, 2017, J INVEST DERMATOL, V137, P85, DOI 10.1016/j.jid.2016.07.039; Singh MD, 2012, AM J PATHOL, V181, P1158, DOI 10.1016/j.ajpath.2012.06.042; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Vender R, 2015, J CUTAN MED SURG, V19, P320, DOI 10.2310/7750.2014.14109; Verma SB, 2009, CLIN EXP DERMATOL, V34, P880, DOI 10.1111/j.1365-2230.2009.03312.x; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Weiss G, 2002, J EUR ACAD DERMATOL, V16, P241, DOI 10.1046/j.1473-2165.2002.00406.x; Wilson GJ, 2017, DEVELOPMENT, V144, P74, DOI 10.1242/dev.139733; Xue XC, 2011, J IMMUNOL, V187, P5879, DOI 10.4049/jimmunol.1100535; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	38	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					3003	3012		10.1074/jbc.M117.809780	http://dx.doi.org/10.1074/jbc.M117.809780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29279330	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000426051900032
J	Ciobanasu, C; Wang, H; Henriot, V; Mathieu, C; Fente, A; Csillag, S; Vigouroux, C; Faivre, B; Le Clainche, C				Ciobanasu, Corina; Wang, Hong; Henriot, Veronique; Mathieu, Cecile; Fente, Annabelle; Csillag, Sandrine; Vigouroux, Clemence; Faivre, Bruno; Le Clainche, Christophe			Integrin-bound talin head inhibits actin filament barbed-end elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESIONS; IN-VITRO; VINCULIN-BINDING; STRUCTURAL BASIS; ACTIVATION; DOMAIN; PROTEINS; DYNAMICS; COMPLEX; FORMIN	Focal adhesions (FAs) mechanically couple the extracellular matrix to the dynamic actin cytoskeleton, via transmembrane integrins and actin-binding proteins. The molecular mechanisms by which protein machineries control force transmission along this molecular axis (i.e. modulating integrin activation and controlling actin polymerization) remain largely unknown. Talin is a major actin-binding protein that controls both the inside-out activation of integrins and actin filament anchoring and thus plays a major role in the establishment of the actin-extracellular matrix mechanical coupling. Talin contains three actin-binding domains (ABDs). The N-terminal head domain contains both the F3 integrin-activating domain and ABD1, whereas the C-terminal rod contains the actin-anchoring ABD2 and ABD3. Integrin binding is regulated by an intramolecular interaction between the N-terminal head and a C-terminal five-helix bundle (R9). Whether talin ABDs regulate actin polymerization in a constitutive or regulated manner has not been fully explored. Here, we combine kinetics assays using fluorescence spectroscopy and single actin filament observation in total internal reflection fluorescence microscopy, to examine relevant functions of the three ABDs of talin. We find that the N-terminal ABD1 blocks actin filament barbed-end elongation, whereas ABD2 and ABD3 do not show any activity. By mutating residues in ABD1, we find that this activity is mediated by a positively charged surface that is partially masked by its intramolecular interaction with R9. Our results also demonstrate that, once this intramolecular interaction is released, the integrin-bound talin head retains the ability to inhibit actin assembly.	[Ciobanasu, Corina; Wang, Hong; Henriot, Veronique; Mathieu, Cecile; Fente, Annabelle; Csillag, Sandrine; Vigouroux, Clemence; Faivre, Bruno; Le Clainche, Christophe] Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France; [Ciobanasu, Corina] Alexandru I Cuza Univ, Interdisciplinary Res Dept, Blvd Carol 1, RO-700506 Iasi, Romania	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Alexandru Ioan Cuza University	Le Clainche, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, I2BC,CEA, F-91198 Gif Sur Yvette, France.	christophe.leclainche@i2bc.paris-saclay.fr	Ciobanasu, Corina/O-4117-2014; Le Clainche, Christophe/A-4782-2015	Ciobanasu, Corina/0000-0003-1107-8738; Le Clainche, Christophe/0000-0001-5659-677X; Nguyen-Vigouroux, Clemence/0000-0002-8684-9835; WANG, Hong/0000-0002-3120-1679	Agence Nationale pour la Recherche [ANR-09-JCJC-0111 ADERACTIN, ANR-16-CE13-0007-02 PHAGOMECANO]; China Scholarship Council (CSC)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported in part by Agence Nationale pour la Recherche Grants ANR-09-JCJC-0111 ADERACTIN (to C.L.C.) and ANR-16-CE13-0007-02 PHAGOMECANO (to C.L.C.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Ph.D. fellowship from the China Scholarship Council (CSC).	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2009, METHODS MOL BIOL, V571, P401, DOI 10.1007/978-1-60761-198-1_27; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; CHUANG JZ, 1995, J CELL BIOL, V128, P1095, DOI 10.1083/jcb.128.6.1095; Ciobanasu C, 2015, NAT PROTOC, V10, P75, DOI 10.1038/nprot.2014.200; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009; Ciobanasu Corina, 2012, Int J Cell Biol, V2012, P941292, DOI 10.1155/2012/941292; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Haining AWM, 2016, FASEB J, V30, P2073, DOI 10.1096/fj.201500080R; Hemmings L, 1996, J CELL SCI, V109, P2715; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Le Clainche C, 2010, J BIOL CHEM, V285, P23418, DOI 10.1074/jbc.M110.102830; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; OHALLORAN T, 1986, METHOD ENZYMOL, V134, P69; OHALLORAN T, 1985, NATURE, V317, P449, DOI 10.1038/317449a0; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Skau CT, 2015, P NATL ACAD SCI USA, V112, pE2447, DOI 10.1073/pnas.1505035112; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	43	11	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2586	2596		10.1074/jbc.M117.808204	http://dx.doi.org/10.1074/jbc.M117.808204			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29276177	hybrid, Green Published			2022-12-28	WOS:000425308300029
J	Thibeaux, S; Siddiqi, S; Zhelyabovska, O; Moinuddin, F; Masternak, MM; Siddiqi, SA				Thibeaux, Simeon; Siddiqi, Shaila; Zhelyabovska, Olga; Moinuddin, Faisal; Masternak, Michal M.; Siddiqi, Shadab A.			Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cathepsin B (CTSB); endoplasmic reticulum (ER); Golgi; low-density lipoprotein (LDL); triglyceride; liver fatty acid binding protein (LFABP); very low-density lipoprotein (VLDL); VLDL transport vesicle (VTV); apolipoprotein B; triacylglycerol	LOW-DENSITY-LIPOPROTEIN; VLDL-TRANSPORT VESICLE; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; GROWTH-HORMONE; RAT-LIVER; INSULIN-RESISTANCE; GOLGI; SECRETION; ALPHA	Synthesis and secretion of hepatic triglycerides (TAG) associated with very-low-density lipoprotein (VLDL) play a major role in maintaining overall lipid homeostasis. This study aims to identify factors affecting synthesis and secretion of VLDL-TAG using the growth hormone-deficient Ames dwarf mouse model, which has reduced serum TAG. Proteomic analysis coupled with a bioinformatics-driven approach revealed that these mice express greater amounts of hepatic cathepsin B and lower amounts of liver fatty acid-binding protein (LFABP) than their wildtype littermates. siRNA-mediated knockdown of cathepsin B in McA-RH7777 cells resulted in a 39% increase in [H-3]TAG associated with VLDL secretion. Cathepsin B knockdown was accompanied by a 74% increase in cellular LFABP protein levels, but only when cells were exposed to 0.4 mm oleic acid (OA) complexed to BSA. The cathepsin B knockdown and 24-h treatment with OA resulted in increased CD36 expression alone and additively. Co-localization of LFABP and cathepsin B was observed in a distinct Golgi apparatus-like pattern, which required a 1-h OA treatment. Moreover, we observed co-localization of LFABP and apoB, independent of the OA treatment. Overexpression of cathepsin B resulted in decreased OA uptake and VLDL secretion. Co-expression of cathepsin B and cathepsin B-resistant mutant LFABP in McA-RH7777 cells resulted in an increased TAG secretion as compared with cells co-expressing cathepsin B and wildtype LFABP. Together, these data indicate that cathepsin B regulates VLDL secretion and free fatty acid uptake via cleavage of LFABP, which occurs in response to oleic acid exposure.	[Thibeaux, Simeon; Siddiqi, Shaila; Zhelyabovska, Olga; Moinuddin, Faisal; Masternak, Michal M.; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			NIDDK, National Institutes of Health (NIH) [R01 DK081413]; NIA, NIH [R01 AG032290]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032290] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by NIDDK, National Institutes of Health (NIH), Grant R01 DK081413 (to S. A. S.) and NIA, NIH, Grant R01 AG032290 (to M. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpegard J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003085; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Carlsson L, 2001, AM J PHYSIOL-ENDOC M, V281, pE772, DOI 10.1152/ajpendo.2001.281.4.E772; Coburn CT, 2001, J MOL NEUROSCI, V16, P117, DOI 10.1385/JMN:16:2-3:117; ELAM MB, 1992, ENDOCRINOLOGY, V131, P2717, DOI 10.1210/en.131.6.2717; ELOVSON J, 1988, J LIPID RES, V29, P1461; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; Fisher EA, 2011, J LIPID RES, V52, P1170, DOI 10.1194/jlr.M011726; Frick F, 2002, AM J PHYSIOL-ENDOC M, V283, pE1023, DOI 10.1152/ajpendo.00260.2002; Fukuo Y, 2014, HEPATOL RES, V44, P1026, DOI 10.1111/hepr.12282; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Guicciardi ME, 2001, AM J PATHOL, V159, P2045, DOI 10.1016/S0002-9440(10)63056-8; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; HONMA Y, 1994, J BIOCHEM, V116, P1025, DOI 10.1093/oxfordjournals.jbchem.a124623; Hook V, 2012, BBA-PROTEINS PROTEOM, V1824, P89, DOI 10.1016/j.bbapap.2011.08.015; Hossain T, 2014, BIOCHEM J, V459, P47, DOI 10.1042/BJ20131215; Howell KW, 2011, J SURG RES, V171, pE27, DOI 10.1016/j.jss.2011.06.033; KELLER U, 1991, HORM RES, V36, P36, DOI 10.1159/000182186; Kumar NS, 1997, AM J PHYSIOL-GASTR L, V273, pG18, DOI 10.1152/ajpgi.1997.273.1.G18; Masternak MM, 2012, PATHOBIOL AGING AGE, V2, DOI 10.3402/pba.v2i0.17293; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi Shadab A, 2015, Curr Protoc Cell Biol, V67, DOI 10.1002/0471143030.cb1121s67; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; STAHN R, 1970, J CELL BIOL, V46, P576, DOI 10.1083/jcb.46.3.576; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Swift LL, 1996, J BIOL CHEM, V271, P31491; Tiwari S, 2016, J BIOL CHEM, V291, P12514, DOI 10.1074/jbc.M115.705269; Tiwari S, 2013, J BIOL CHEM, V288, P5157, DOI 10.1074/jbc.M112.434258; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Vida M, 2013, LIVER INT, V33, P1019, DOI 10.1111/liv.12156; Wang ZH, 2006, J GERONTOL A-BIOL, V61, P323, DOI 10.1093/gerona/61.4.323; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200	45	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1910	1923		10.1074/jbc.M117.778365	http://dx.doi.org/10.1074/jbc.M117.778365			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259130	Green Published, hybrid			2022-12-28	WOS:000424948000007
J	Harner, M; Wickner, W				Harner, Max; Wickner, William			Assembly of intermediates for rapid membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane fusion; protein complex; SNARE proteins; Saccharomyces cerevisiae; membrane reconstitution	TRANS-SNARE COMPLEXES; HOMOTYPIC VACUOLE FUSION; SACCHAROMYCES-CEREVISIAE; EFFECTOR COMPLEX; TRIGGER FUSION; HOPS CATALYZES; ALPHA-SNAP; T-SNARE; DOCKING; CHAPERONES	Membrane fusion is essential for intracellular protein sorting, cell growth, hormone secretion, and neurotransmission. Rapid membrane fusion requires tethering and Sec1-Munc18 (SM) function to catalyze R-, Qa-, Qb-, and Qc-SNARE complex assembly in trans, as well as SNARE engagement by the SNARE-binding chaperone Sec17/SNAP. The hexameric vacuolar HOPS (homotypic fusion and vacuole protein sorting) complex in the yeast Saccharomyces cerevisiae tethers membranes through its affinities for the membrane Rab GTPase Ypt7. HOPS also has specific affinities for the vacuolar SNAREs and catalyzes SNARE complex assembly, but the order of their assembly into a 4-SNARE complex is unclear. We now report defined assembly intermediates on the path to membrane fusion. We found that a prefusion intermediate will assemble with HOPS and the R, Qa, and Qc SNAREs, and that this assembly undergoes rapid fusion upon addition of Qb and Sec17. HOPS-tethered membranes and all four vacuolar SNAREs formed a complex that underwent an even more dramatic burst of fusion upon Sec17p addition. These findings provide initial insights into an ordered fusion pathway consisting of the following intermediates and events: 1) Rab- and HOPS-tethered membranes, 2) a HOPS:R:Qa:Qc trans-complex, 3) a HOPS:4-SNARE trans-complex, 4) an engagement with Sec17, and 5) the rapid lipid rearrangements during fusion. In conclusion, our results indicate that the R:Qa:Qc complex forms in the context of membrane, Ypt7, HOPS, and trans-SNARE assembly and serves as a functional intermediate for rapid fusion after addition of the Qb-SNARE and Sec17 proteins.	[Harner, Max; Wickner, William] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Harner, Max] Ludwig Maximilians Univ Munchen, Biomed Ctr Munich, Inst Cardiovasc Physiol & Pathophysiol, Grosshadernerstr 9, D-82152 Planegg Martinsried, Germany	Dartmouth College; University of Munich	Wickner, W (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	Bill.Wickner@Dartmouth.edu		Harner, Max/0000-0002-5513-1046	National Institutes of Health [R35GM118037-01, 3R35GM118037-0191]; Deutsche Forschungsgemeinschaft [HA 7730/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM118037-01 and 3R35GM118037-0191 (to W. W.) and Deutsche Forschungsgemeinschaft Fellowship HA 7730/2-1 (to M. H.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; Gossing M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066304; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Ma L, 2016, CELL REP, V15, P531, DOI 10.1016/j.celrep.2016.03.050; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Orr A, 2017, MOL BIOL CELL, V28, P975, DOI 10.1091/mbc.E16-10-0743; Ostrowicz CW, 2008, AUTOPHAGY, V4, P5, DOI 10.4161/auto.5054; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seals DF, 2000, P NATL ACAD SCI USA, V97, P9402, DOI 10.1073/pnas.97.17.9402; Song HK, 2017, MOL BIOL CELL, V28, P2282, DOI 10.1091/mbc.E17-04-0218; Song HK, 2017, ELIFE, V6, DOI 10.7554/eLife.26646; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148; Zick M, 2016, MOL BIOL CELL, V27, P2590, DOI 10.1091/mbc.E16-04-0230; Zick M, 2015, P NATL ACAD SCI USA, V112, pE2290, DOI 10.1073/pnas.1506409112; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.03251; Zick M, 2014, ELIFE, V3, DOI 10.7554/eLife.01879; Zick M, 2013, MOL BIOL CELL, V24, P3746, DOI 10.1091/mbc.E13-07-0419; Zick M, 2012, MOL BIOL CELL, V23, P3429, DOI 10.1091/mbc.E12-04-0279; Zucchi PC, 2011, MOL BIOL CELL, V22, P4635, DOI 10.1091/mbc.E11-08-0680	38	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1346	1352		10.1074/jbc.RA117.000791	http://dx.doi.org/10.1074/jbc.RA117.000791			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29208657	Green Published, hybrid			2022-12-28	WOS:000423515000020
J	Lau, D; Elezagic, D; Hermes, G; Morgelin, M; Wohl, AP; Koch, M; Hartmann, U; Hollriegl, S; Wagener, R; Paulsson, M; Streichert, T; Klatt, AR				Lau, Daniela; Elezagic, Dzemal; Hermes, Gabriele; Morgelin, Matthias; Wohl, Alexander P.; Koch, Manuel; Hartmann, Ursula; Hoellriegl, Stefan; Wagener, Raimund; Paulsson, Mats; Streichert, Thomas; Klatt, Andreas R.			The cartilage-specific lectin C-type lectin domain family 3 member A (CLEC3A) enhances tissue plasminogen activator-mediated plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTROSCOPY; MATRIX PROTEIN; GROWTH-FACTOR; IN-VITRO; BINDING-PROTEIN; COILED-COIL; TETRANECTIN; EXPRESSION; MINERALIZATION	C-type lectin domain family 3 member A (CLEC3A) is a poorly characterized protein belonging to the superfamily of C-type lectins. Its closest homologue tetranectin binds to the kringle 4 domain of plasminogen and enhances its association with tissue plasminogen activator (tPA) thereby enhancing plasmin production, but whether CLEC3A contributes to plasminogen activation is unknown. Here, we recombinantly expressed murine and human full-length CLEC3As as well as truncated forms of CLEC3A in HEK-293 Epstein-Barr nuclear antigen (EBNA) cells. We analyzed the structure of recombinant CLEC3A by SDS-PAGE and immunoblot, glycan analysis, matrix-assisted laser desorption ionization time-of-flight mass spectrometry, size-exclusion chromatography, circular dichroism spectroscopy, and electron microscopy; compared the properties of the recombinant protein with those of CLEC3A extracted from cartilage; and investigated its tissue distribution and extracellular assembly by immunohistochemistry and immunofluorescence microscopy. We found that CLEC3A mainly occurs as a monomer, but also forms dimers and trimers, potentially via a coiled-coil alpha-helix. We also noted that CLEC3A can be modified with chondroitin/dermatan sulfate side chains and tends to oligomerize to form higher aggregates. We show that CLEC3A is present in resting, proliferating, and hypertrophic growth-plate cartilage and assembles into an extended extracellular network in cultures of rat chondrosarcoma cells. Further, we found that CLEC3A specifically binds to plasminogen and enhances tPA-mediated plasminogen activation. In summary, we have determined the structure, tissue distribution, and molecular function of the cartilage-specific lectin CLEC3A and show that CLEC3A binds to plasminogen and participates in tPA-mediated plasminogen activation.	[Lau, Daniela; Elezagic, Dzemal; Hermes, Gabriele; Streichert, Thomas; Klatt, Andreas R.] Univ Cologne, Inst Clin Chem, D-50924 Cologne, Germany; [Wohl, Alexander P.; Koch, Manuel; Hartmann, Ursula; Wagener, Raimund; Paulsson, Mats] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Morgelin, Matthias] Lund Univ, Div Infect Med, Dept Clin Sci Lund, Biomed Ctr BMC, SE-22100 Lund, Sweden; [Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Fac Med, D-50931 Cologne, Germany; [Wagener, Raimund; Paulsson, Mats] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Paulsson, Mats] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hoellriegl, Stefan] Dreifaltigkeits Krankenhau, D-50933 Cologne, Germany	University of Cologne; University of Cologne; Lund University; University of Cologne; University of Cologne; University of Cologne	Klatt, AR (corresponding author), Kerpener Str 62, D-50924 Cologne, Germany.	andreas.klatt@uk-koeln.de	Koch, Manuel/AAG-9914-2021	Koch, Manuel/0000-0002-2962-7814	European Community's Seventh Framework Programme Grant [602300]	European Community's Seventh Framework Programme Grant	This work was supported by European Community's Seventh Framework Programme Grant 602300 (SYBIL). The authors declare that they have no conflicts of interest with the contents of this article.	Aspberg A, 2012, J HISTOCHEM CYTOCHEM, V60, P987, DOI 10.1369/0022155412464376; CLEMMENSEN I, 1986, EUR J BIOCHEM, V156, P327, DOI 10.1111/j.1432-1033.1986.tb09586.x; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; Furst CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061407; Gebauer JM, 2016, MATRIX BIOL, V49, P106, DOI 10.1016/j.matbio.2015.07.001; HAUDENSCHILD DR, 1995, J BIOL CHEM, V270, P23150, DOI 10.1074/jbc.270.39.23150; Hiraoka A, 1997, P NATL ACAD SCI USA, V94, P7577, DOI 10.1073/pnas.94.14.7577; Holtet TL, 1997, PROTEIN SCI, V6, P1511, DOI 10.1002/pro.5560060715; IBA K, 1995, FEBS LETT, V373, P1, DOI 10.1016/0014-5793(95)00992-I; Iba K, 2009, WOUND REPAIR REGEN, V17, P108, DOI 10.1111/j.1524-475X.2008.00447.x; Jaquinod M, 1999, BIOL CHEM, V380, P1307, DOI 10.1515/BC.1999.166; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Neame PJ, 1999, BBA-GENE STRUCT EXPR, V1446, P193, DOI 10.1016/S0167-4781(99)00087-1; Nielsen BB, 1997, FEBS LETT, V412, P388, DOI 10.1016/S0014-5793(97)00664-9; Obrist P, 2004, J CLIN PATHOL, V57, P417, DOI 10.1136/jcp.2003.010058; Piecha D, 1999, J BIOL CHEM, V274, P13353, DOI 10.1074/jbc.274.19.13353; Salo J, 2008, SPINE, V33, P839, DOI 10.1097/BRS.0b013e31816b1f1d; Schnepp A, 2005, J BIOL CHEM, V280, P11274, DOI 10.1074/jbc.M414276200; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; Tsunezumi J, 2009, J CELL BIOCHEM, V106, P693, DOI 10.1002/jcb.22062; Westergaard UB, 2003, EUR J BIOCHEM, V270, P1850, DOI 10.1046/j.1432-1033.2003.03549.x; Wewer UM, 1998, DEV BIOL, V200, P247, DOI 10.1006/dbio.1998.8962; WEWER UM, 1994, J CELL BIOL, V127, P1767, DOI 10.1083/jcb.127.6.1767; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wilson R, 2016, J PROTEOME RES, V15, P1033, DOI 10.1021/acs.jproteome.5b01115; Wohl AP, 2016, J BIOL CHEM, V291, P12732, DOI 10.1074/jbc.M115.704734; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	34	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					203	214		10.1074/jbc.M117.818930	http://dx.doi.org/10.1074/jbc.M117.818930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29146595	Green Published, hybrid			2022-12-28	WOS:000419453200018
J	Matho, MH; Schlossman, A; Gilchuk, IM; Miller, G; Mikulski, Z; Hupfer, M; Wang, J; Bitra, A; Meng, XZ; Xiang, Y; Kaever, T; Doukov, T; Ley, K; Crotty, S; Peters, B; Hsieh-Wilson, LC; Crowe, JE; Zajonc, DM				Matho, Michael H.; Schlossman, Andrew; Gilchuk, Iuliia M.; Miller, Greg; Mikulski, Zbigniew; Hupfer, Matthias; Wang, Jing; Bitra, Aruna; Meng, Xiangzhi; Xiang, Yan; Kaever, Tom; Doukov, Tzanko; Ley, Klaus; Crotty, Shane; Peters, Bjoern; Hsieh-Wilson, Linda C.; Crowe, James E., Jr.; Zajonc, Dirk M.			Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; glycosaminoglycan; protein crystallization; protein structure; vaccine; viral protein; X-ray crystallography	SURFACE HEPARAN-SULFATE; CHONDROITIN SULFATE; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; SMALLPOX VACCINE; OVARIAN-CANCER; PROTEIN BINDS; A27L PROTEIN; L1 PROTEIN; EPITOPES	Vaccinia virus (VACV) envelope protein D8 is one of three glycosaminoglycan adhesion molecules and binds to the linear polysaccharide chondroitin sulfate (CS). D8 is also a target for neutralizing antibody responses that are elicited by the smallpox vaccine, which has enabled the first eradication of a human viral pathogen and is a useful model for studying antibody responses. However, to date, VACV epitopes targeted by human antibodies have not been characterized at atomic resolution. Here, we characterized the binding properties of several human anti-D8 antibodies and determined the crystal structures of three VACV-mAb variants, VACV-66, VACV-138, and VACV-304, separately bound to D8. Although all these antibodies bound D8 with high affinity and were moderately neutralizing in the presence of complement, VACV-138 and VACV-304 also fully blocked D8 binding to CS-A, the low affinity ligand for D8. VACV-138 also abrogated D8 binding to the high-affinity ligand CS-E, but we observed residual CS-E binding was observed in the presence of VACV-304. Analysis of the VACV-138- and VACV-304-binding sites along the CS-binding crevice of D8, combined with different efficiencies of blocking D8 adhesion to CS-A and CS-E allowed us to propose that D8 has a high- and low-affinity CS-binding region within its central crevice. The crevice is amenable to protein engineering to further enhance both specificity and affinity of binding to CS-E. Finally, a wild-type D8 tetramer specifically bound to structures within the developing glomeruli of the kidney, which express CS-E. We propose that through structure-based protein engineering, an improved D8 tetramer could be used as a potential diagnostic tool to detect expression of CS-E, which is a possible biomarker for ovarian cancer.	[Matho, Michael H.; Schlossman, Andrew; Hupfer, Matthias; Wang, Jing; Bitra, Aruna; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Cir, La Jolla, CA 92037 USA; [Mikulski, Zbigniew; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA; [Kaever, Tom; Crotty, Shane; Peters, Bjoern] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Gilchuk, Iuliia M.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Miller, Greg; Hsieh-Wilson, Linda C.] CALTECH, Howard Hughes Med Inst, Div Chem & Chem Engn, Pasadena, CA 91126 USA; [Meng, Xiangzhi; Xiang, Yan] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol Immunol & Mol Genet, San Antonio, TX 78229 USA; [Doukov, Tzanko] SLAC, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Crotty, Shane] Univ Calif San Diego, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; La Jolla Institute for Immunology; La Jolla Institute for Immunology; Vanderbilt University; Vanderbilt University; Vanderbilt University; California Institute of Technology; Howard Hughes Medical Institute; University of Texas System; University of Texas Health San Antonio; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org	Mikulski, Zbigniew/AAB-4447-2020; Crotty, Shane/AAC-6703-2019; Crotty, Shane/AAE-8446-2019; Crowe, James/B-5549-2009	Mikulski, Zbigniew/0000-0002-1918-9216; Crotty, Shane/0000-0002-6484-6262; Crowe, James/0000-0002-0049-1079; Doukov, Tzanko/0000-0001-8625-2572; Xiang, Yan/0000-0002-7633-1629; Zajonc, Dirk/0000-0001-7215-1981	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093627, P41GM103393] Funding Source: NIH RePORTER	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Angela Lamberth for technical assistance in preparing and staining the tissue sections for immunofluorescence microscopy. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences Grant P41GM103393.	Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Bartlett AH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001367; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Deepa SS, 2007, GLYCOBIOLOGY, V17, P631, DOI 10.1093/glycob/cwm021; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaever T, 2016, J VIROL, V90, P4334, DOI 10.1128/JVI.02878-15; Kaever T, 2014, J VIROL, V88, P11339, DOI 10.1128/JVI.01491-14; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matho MH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005148; Matho MH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004495; Matho MH, 2012, J VIROL, V86, P8050, DOI 10.1128/JVI.00836-12; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meng XZ, 2011, VIROLOGY, V409, P271, DOI 10.1016/j.virol.2010.10.019; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Salanti A, 2015, CANCER CELL, V28, P500, DOI 10.1016/j.ccell.2015.09.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sela-Culang I, 2014, STRUCTURE, V22, P646, DOI 10.1016/j.str.2014.02.003; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Su HP, 2007, VIROLOGY, V368, P331, DOI 10.1016/j.virol.2007.06.042; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; ten Dam GB, 2007, AM J PATHOL, V171, P1324, DOI 10.2353/ajpath.2007.070111; Tully SE, 2006, J AM CHEM SOC, V128, P7740, DOI 10.1021/ja061906t; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; Vallen MJE, 2014, BIOMARK MED, V8, P699, DOI [10.2217/BMM.14.6, 10.2217/bmm.14.6]; Wadstrom T, 1999, J MED MICROBIOL, V48, P223, DOI 10.1099/00222615-48-3-223; Watanabe I, 2015, GLYCOBIOLOGY, V25, P953, DOI 10.1093/glycob/cwv039; Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					390	401		10.1074/jbc.M117.814541	http://dx.doi.org/10.1074/jbc.M117.814541			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29123031	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000419453200033
J	Pelz, L; Purfurst, B; Rathjen, FG				Pelz, Laura; Purfuerst, Bettina; Rathjen, Fritz G.			The cell adhesion molecule BT-IgSF is essential for a functional blood-testis barrier and male fertility in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						blood-testis barrier; BT-IgSF (IgSF11); connexin43; IgCAM; male fertility; cell adhesion; testis; spermatogenesis; IgCAM BT-IgSF (IgSF11)	ADENOVIRUS RECEPTOR; SERTOLI-CELLS; JUNCTION PROTEIN; COMPONENT; GENE; EXPRESSION; CONNEXIN43; RAT; SPERMATOGENESIS; COXSACKIEVIRUS	The Ig-like cell adhesion molecule (IgCAM) BT-IgSF (brain- and testis-specific Ig superfamily protein) plays a major role in male fertility in mice. However, the molecular mechanism by which BT-IgSF supports fertility is unclear. Here, we found that it is localized in Sertoli cells at the blood-testis barrier (BTB) and at the apical ectoplasmic specialization. The absence of BT-IgSF in Sertoli cells in both global and conditional mouse mutants (i.e. AMHCre and Rosa26CreERT2 lines) resulted in male infertility, atrophic testes with vacuolation, azoospermia, and spermatogenesis arrest. Although transcripts of junctional proteins such as connexin43, ZO-1, occludin, and claudin11 were up-regulated in the absence of BT-IgSF, the functional integrity of the BTB was impaired, as revealed by injection of a BTB-impermeable component into the testes under in vivo conditions. Disruption of the BTB coincided with mislocalization of connexin43, which was present throughout the seminiferous epithelium and not restricted to the BTB as in wild-type tissues, suggesting impaired cell-cell communication in the BT-IgSF-KO mice. Because EM images revealed a normal BTB structure between Sertoli cells in the BT-IgSF-KO mice, we conclude that infertility in these mice is most likely caused by a functionally impaired BTB. In summary, our results indicate that BT-IgSF is expressed at the BTB and is required for male fertility by supporting the functional integrity of the BTB.	[Pelz, Laura; Rathjen, Fritz G.] Helmholtz Assoc, Dept Neurobiol, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Purfuerst, Bettina] Helmholtz Assoc, Core Facil Electron Microscopy, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rathjen, FG (corresponding author), Helmholtz Assoc, Dept Neurobiol, Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	rathjen@mdc-berlin.de			Velocigene at Regeneron Inc.; National Institutes of Health [U01HG004085, U01HG004080, U42RR024244]; CSD Consortium; KOMP Program [8500]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080, U01HG004085] Funding Source: NIH RePORTER	Velocigene at Regeneron Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSD Consortium; KOMP Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Anne Banerjee, Maria Steinecker, and Christina Schiel for technical assistance and Karola Bach for mouse breeding. We also acknowledge Dr. Karin Muller (Leibniz Institute for Zoo and Wildlife Research, Berlin, Germany) and Andreas Pelz (Charite, Berlin, Germany) for flow cytometry experiments and critical reading of the manuscript. We thank the transgenic core facility of the Max Delbruck Center for blastocyst injections and sperm rederivation. The ES cells and sperm used for this research project were generated by the trans-NIH KOMP and obtained from the KOMP Repository (www.komp.org).<SUP>3</SUP> We thank Dr. Thomas Jentsch (Max Delbruck Center and FMP, Berlin) and Dr. Florian Guillou (INRA, Paris) for providing AMHCre mice and Karina Oberheide and Corinna Goppner (both from the Max Delbruck Center) for discussion. We thank Dr. Spagnoli (Max Delbruck Center) for providing Rosa26CreERT2 mice. We acknowledge support from Velocigene at Regeneron Inc. (supported by National Institutes of Health Grant U01HG004085) and the CSD Consortium (supported by National Institutes of Health Grant U01HG004080), which funded the generation of gene-targeted ES cells for 8500 genes in the KOMP Program. Also, the archiving and distribution by the KOMP Repository at UC Davis and CHORI were supported by National Institutes of Health Grant U42RR024244.	Ahi EP, 2017, PEERJ, V5, DOI 10.7717/peerj.2843; Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; COQUELIN A, 1982, AM J PHYSIOL, V243, pE257, DOI 10.1152/ajpendo.1982.243.3.E257; Defamie N, 2003, LAB INVEST, V83, P449, DOI 10.1097/01.LAB.0000059928.82702.6D; deFeijter AW, 1996, MOL CARCINOGEN, V16, P203, DOI 10.1002/(SICI)1098-2744(199608)16:4<203::AID-MC4>3.3.CO;2-F; Duffy HS, 2002, J PHYSIOL-PARIS, V96, P243, DOI 10.1016/S0928-4257(02)00012-8; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eom DS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002899; Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165; Gerber J, 2014, HISTOL HISTOPATHOL, V29, P935, DOI 10.14670/HH-29.935; Gliki G, 2004, NATURE, V431, P320, DOI 10.1038/nature02877; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Harada H, 2005, J CELL PHYSIOL, V204, P919, DOI 10.1002/jcp.20361; Holembowski L, 2014, J CELL BIOL, V204, P1173, DOI 10.1083/jcb.201306066; Jang S, 2016, NAT NEUROSCI, V19, P84, DOI 10.1038/nn.4176; Jiang XH, 2014, ASIAN J ANDROL, V16, P572, DOI 10.4103/1008-682X.125401; Juneja SC, 1999, BIOL REPROD, V60, P1263, DOI 10.1095/biolreprod60.5.1263; Katoh M, 2003, INT J ONCOL, V23, P525; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Luangpraseuth-Prosper A, 2015, DEV BIOL, V406, P158, DOI 10.1016/j.ydbio.2015.09.002; Matthaus C, 2017, MOL CELL NEUROSCI, V81, P32, DOI 10.1016/j.mcn.2016.11.009; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Mruk Dolores D, 2012, Spermatogenesis, V2, P6; Raschperger E, 2004, J BIOL CHEM, V279, P796, DOI 10.1074/jbc.M308249200; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Silva C, 2009, MOL REPROD DEV, V76, P11, DOI 10.1002/mrd.20925; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Stoffel W, 2008, EMBO J, V27, P2281, DOI 10.1038/emboj.2008.156; Sultana T, 2014, REPRODUCTION, V147, P875, DOI 10.1530/REP-13-0653; Suzu S, 2002, BIOCHEM BIOPH RES CO, V296, P1215, DOI 10.1016/S0006-291X(02)02025-9; Sze KL, 2008, J CELL PHYSIOL, V214, P334, DOI 10.1002/jcp.21201; Wang CQF, 2007, EXP CELL RES, V313, P1373, DOI 10.1016/j.yexcr.2007.01.017; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xu JL, 2009, MOL BIOL CELL, V20, P4268, DOI 10.1091/mbc.E08-12-1236; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513	45	14	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21490	21503		10.1074/jbc.RA117.000113	http://dx.doi.org/10.1074/jbc.RA117.000113			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29123028	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-28	WOS:000419013000024
J	Bart, AG; Scott, EE				Bart, Aaron G.; Scott, Emily E.			Structural and functional effects of cytochrome b(5) interactions with human cytochrome P450 enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACULOVIRUS EXPRESSION; MICROSOMAL CYTOCHROME; 17,20-LYASE ACTIVITY; MASS-SPECTROMETRY; BINDING-SITE; HUMAN LIVER; 2E1; PURIFICATION; REDUCTASE	The small heme-containing protein cytochrome b(5) can facilitate, inhibit, or have no effect on cytochrome P450 catalysis, often in a P450-dependent and substrate-dependent manner that is not well understood. Herein, solution NMR was used to identify b(5) residues interacting with different human drug-metabolizing P450 enzymes. NMR results revealed that P450 enzymes bound to either b(5) alpha 4-5 (CYP2A6 and CYP2E1) or this region and alpha 2-3 (CYP2D6 and CYP3A4) and suggested variation in the affinity for b(5). Mutations of key b(5) residues suggest not only that different b(5) surfaces are responsible for binding different P450 enzymes, but that these different complexes are relevant to the observed effects on P450 catalysis.	[Bart, Aaron G.; Scott, Emily E.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health Grants [F37 GM076343, T32 GM008545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, T32GM008545] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants F37 GM076343 (to E.E.S.) and T32 GM008545. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Dehal SS, 1997, CANCER RES, V57, P3402; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fukami T, 2008, CHEM RES TOXICOL, V21, P720, DOI 10.1021/tx700325f; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GORSKY LD, 1986, DRUG METAB DISPOS, V14, P89; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Henderson CJ, 2015, MOL PHARMACOL, V87, P733, DOI 10.1124/mol.114.097394; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Peng HM, 2014, ARCH BIOCHEM BIOPHYS, V541, P53, DOI 10.1016/j.abb.2013.11.001; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; STRITTMATTER P, 1956, J BIOL CHEM, V221, P253; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAMBURINI PP, 1985, J BIOL CHEM, V260, P4007; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Waskell L., 2015, CYTOCHROME P450 STRU, P33, DOI [DOI 10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6_9]; Wester MR, 2002, METHOD ENZYMOL, V357, P73; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yu AM, 2001, DRUG METAB DISPOS, V29, P1362; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08392; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	45	30	30	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20818	20833		10.1074/jbc.RA117.000220	http://dx.doi.org/10.1074/jbc.RA117.000220			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079577	Green Published, hybrid			2022-12-28	WOS:000418453400002
J	Li, PT; Wang, ZF; Chu, IT; Kuan, YM; Li, MH; Huang, MC; Chiang, PC; Chang, TC; Chen, CT				Li, Pei-Tzu; Wang, Zi-Fu; Chu, I. -Te; Kuan, Yen-Min; Li, Ming-Hao; Huang, Mu-Ching; Chiang, Pei-Chi; Chang, Ta-Chau; Chen, Chin-Tin			Expression of the human telomerase reverse transcriptase gene is modulated by quadruplex formation in its first exon due to DNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER-DOT-G; G-C REPEATS; SECONDARY STRUCTURES; PROMOTER REGION; HTERT PROMOTER; HUMAN GENOME; CANCER; CTCF; NMR; DEMETHYLATION	DNA secondary structures and methylation are two well-known mechanisms that regulate gene expression. The catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), is overexpressed in similar to 90% of human cancers to maintain telomere length for cell immortalization. Binding of CCCTC-binding factor (CTCF) to the first exon of the hTERT gene can down-regulate its expression. However, DNA methylation in the first exon can prevent CTCF binding in most cancers, but the molecular mechanism is unknown. The NMR analysis showed that a stretch of guanine-rich sequence in the first exon of hTERT and located within the CTCF-binding region can form two secondary structures, a hairpin and a quadruplex. A key finding was that the methylation of cytosine at the specific CpG dinucleotides will participate in quartet formation, causing the shift of the equilibrium from the hairpin structure to the quadruplex structure. Of further importance was the finding that the quadruplex formation disrupts CTCF protein binding, which results in an increase in hTERT gene expression. Our results not only identify quadruplex formation in the first exon promoted by CpG dinucleotide methylation as a regulator of hTERT expression but also provide a possible mechanistic insight into the regulation of gene expression via secondary DNA structures.	[Li, Pei-Tzu; Kuan, Yen-Min; Huang, Mu-Ching; Chiang, Pei-Chi; Chen, Chin-Tin] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan; [Chu, I. -Te; Chang, Ta-Chau] Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan; [Wang, Zi-Fu; Chu, I. -Te; Li, Ming-Hao; Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Chen, CT (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan.; Chang, TC (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan.; Chang, TC (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan.	tcchang@po.iams.sinica.edu.tw; chintin@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012; Hsiao, Wei-Hung/B-9931-2013	Chang, Ta-Chau/0000-0001-5878-8556; Chu, I-Te/0000-0002-2235-3275; CHEN, CHIN-TIN/0000-0002-7439-8774	Academia Sinica [AS-102-TPA07]; Ministry of Science and Technology of the Republic of China [MOST-103-2113-M-001-017-MY3, MOST105-2320-B-002-056]; National Taiwan University; Academia Sinica Innovative Joint Program Grant [NTU-SINICA-105R104510]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Academia Sinica Innovative Joint Program Grant	This work was supported by Academia Sinica Grant AS-102-TPA07, Ministry of Science and Technology of the Republic of China Grants MOST-103-2113-M-001-017-MY3 (to T.C.C.) and MOST105-2320-B-002-056 (to C.T.C.), and National Taiwan University and Academia Sinica Innovative Joint Program Grant NTU-SINICA-105R104510.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bouaziz S, 1998, J MOL BIOL, V282, P637, DOI 10.1006/jmbi.1998.2031; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Choi JH, 2010, BIOCHEM BIOPH RES CO, V391, P449, DOI 10.1016/j.bbrc.2009.11.078; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gray RD, 2008, NUCLEIC ACIDS RES, V36, P4191, DOI 10.1093/nar/gkn379; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Kang HJ, 2016, J AM CHEM SOC, V138, P13673, DOI 10.1021/jacs.6b07598; Kettani A, 1998, J MOL BIOL, V282, P619, DOI 10.1006/jmbi.1998.2030; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kocman V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6831; Kuo MHJ, 2015, J AM CHEM SOC, V137, P210, DOI 10.1021/ja5089327; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Phan AT, 2002, J AM CHEM SOC, V124, P1160, DOI 10.1021/ja011977m; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rigo R, 2017, BBA-GEN SUBJECTS, V1861, P1399, DOI 10.1016/j.bbagen.2016.12.024; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang JM, 2014, J BIOL CHEM, V289, P14612, DOI 10.1074/jbc.M114.548230; Wang ZF, 2014, NUCLEIC ACIDS RES, V42, P4723, DOI 10.1093/nar/gku083	52	20	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20859	20870		10.1074/jbc.M117.808022	http://dx.doi.org/10.1074/jbc.M117.808022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084850	Green Published, hybrid			2022-12-28	WOS:000418453400005
J	Sen, S; Sanyal, S; Srivastava, DK; Dasgupta, D; Roy, S; Das, C				Sen, Sabyasachi; Sanyal, Sulagna; Srivastava, Dushyant Kumar; Dasgupta, Dipak; Roy, Siddhartha; Das, Chandrima			Transcription factor 19 interacts with histone 3 lysine 4 trimethylation and controls gluconeogenesis via the nucleosome-remodeling-deacetylase complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; gluconeogenesis; glucose metabolism; histone modification; nucleosome remodeling deacetylase (NuRD); PHD finger; transcription factor; transcription repressor; histone H3 lysine 4 trimethylation; histone deacetylation	LARGE GENE LISTS; PHD FINGER; HEPATIC GLUCONEOGENESIS; DIABETES-MELLITUS; DRUG-METABOLISM; CELL-LINES; GLUCOSE; PROTEIN; METHYLATION; INSULIN	Transcription factor 19 (TCF19) has been reported as a type 1 diabetes-associated locus involved in maintenance of pancreatic cells through a fine-tuned regulation of cell proliferation and apoptosis. TCF19 also exhibits genomic association with type 2 diabetes, although the precise molecular mechanism remains unknown. It harbors both a plant homeodomain and a forkhead-associated domain implicated in epigenetic recognition and gene regulation, a phenomenon that has remained unexplored. Here, we show that TCF19 selectively interacts with histone 3 lysine 4 trimethylation through its plant homeodomain finger. Knocking down TCF19 under high-glucose conditions affected many metabolic processes, including gluconeogenesis. We found that TCF19 overexpression represses de novo glucose production in HepG2 cells. The transcriptional repression of key genes, induced by TCF19, coincided with NuRD (nucleosome-remodeling-deacetylase) complex recruitment to the promoters of these genes. TCF19 interacted with CHD4 (chromodomain helicase DNA-binding protein 4), which is a part of the NuRD complex, in a glucose concentration-independent manner. In summary, our results show that TCF19 interacts with an active transcription mark and recruits a co-repressor complex to regulate gluconeogenic gene expression in HepG2 cells. Our study offers critical insights into the molecular mechanisms of transcriptional regulation of gluconeogenesis and into the roles of chromatin readers in metabolic homeostasis.	[Sen, Sabyasachi; Sanyal, Sulagna; Dasgupta, Dipak; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India; [Srivastava, Dushyant Kumar; Roy, Siddhartha] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Saha Institute of Nuclear Physics; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021	Das, Chandrima/0000-0002-8117-2810	Department of Atomic Energy (DAE), Government of India [12-RD-SIN-5.04-0103]	Department of Atomic Energy (DAE), Government of India(Department of Atomic Energy (DAE))	This work was supported by a research grant entitled Biomolecular Assembly, Recognition and Dynamics (BARD) (Grant 12-R&D-SIN-5.04-0103) from the Department of Atomic Energy (DAE), Government of India (to C. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2016, J BIOL CHEM, V291, P2664, DOI 10.1074/jbc.M115.679985; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; Chakrabarti S, 1998, BIOCHEM PHARMACOL, V56, P1471, DOI 10.1016/S0006-2952(98)00249-4; Chalkiadaki A, 2011, EMBO REP, V12, P985, DOI 10.1038/embor.2011.179; Cheung YH, 2011, HUM GENET, V129, P161, DOI 10.1007/s00439-010-0908-2; Donohoe DR, 2012, J CELL PHYSIOL, V227, P3169, DOI 10.1002/jcp.24054; Dreveny I, 2014, NUCLEIC ACIDS RES, V42, P822, DOI 10.1093/nar/gkt931; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Gray ST, 2005, DIABETES-METAB RES, V21, P416, DOI 10.1002/dmrr.559; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Harder MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120890; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Howe FS, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600095; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jufvas A, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-15; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kirchner H, 2013, TRENDS CELL BIOL, V23, P203, DOI 10.1016/j.tcb.2012.11.008; Krautkramer KA, 2013, AM J PHYSIOL-ENDOC M, V305, pE600, DOI 10.1152/ajpendo.00147.2013; KU DH, 1991, CELL GROWTH DIFFER, V2, P179; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; Mews P, 2014, MOL CELL BIOL, V34, P3968, DOI 10.1128/MCB.00763-14; Nair AK, 2014, DIABETOLOGIA, V57, P2334, DOI 10.1007/s00125-014-3351-4; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Pan DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066294; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Samanez CH, 2012, ARCH PHYSIOL BIOCHEM, V118, P102, DOI 10.3109/13813455.2012.683442; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Singh BK, 2013, J BIOL CHEM, V288, P30365, DOI 10.1074/jbc.M113.504845; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trape AP, 2012, MOL CANCER THER, V11, P464, DOI 10.1158/1535-7163.MCT-11-0033; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; Vidal-Puig A, 2001, NATURE, V413, P125, DOI 10.1038/35093198; Volkmar M, 2012, EMBO J, V31, P1405, DOI 10.1038/emboj.2011.503; Winkler R, 2012, DIABETES, V61, P513, DOI 10.2337/db11-0313; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	61	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20362	20378		10.1074/jbc.M117.786863	http://dx.doi.org/10.1074/jbc.M117.786863			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042441	Green Published, hybrid			2022-12-28	WOS:000418267000002
J	Lomelino, CL; Andring, JT; McKenna, R; Kilberg, MS				Lomelino, Carrie L.; Andring, Jacob T.; McKenna, Robert; Kilberg, Michael S.			Asparagine synthetase: Function, structure, and role in disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						amino acid; brain metabolism; genetic disease; inborn error of metabolism; neurological disease; protein structure; acute lymphoblastic leukemia; amino acid metabolism; asparaginase resistance; brain development	ACUTE LYMPHOBLASTIC-LEUKEMIA; PREDICTIVE BIOMARKER; ESCHERICHIA-COLI; CANCER CELLS; DEFICIENCY; MECHANISM; ENCEPHALOPATHY; PROLIFERATION; DEPRIVATION; SENSITIVITY	Asparagine synthetase (ASNS) converts aspartate and glutamine to asparagine and glutamate in an ATP-dependent reaction. ASNS is present in most, if not all, mammalian organs, but varies widely in basal expression. Human ASNS activity is highly responsive to cellular stress, primarily by increased transcription from a single gene located on chromosome 7. Elevated ASNS protein expression is associated with resistance to asparaginase therapy in childhood acute lymphoblastic leukemia. There is evidence that ASNS expression levels may also be inversely correlated with asparaginase efficacy in certain solid tumors as well. Children with mutations in the ASNS gene exhibit developmental delays, intellectual disability, microcephaly, intractable seizures, and progressive brain atrophy. Thus far, 15 unique mutations in the ASNS gene have been clinically associated with asparagine synthetase deficiency (ASD). Molecular modeling using the Escherichia coli ASNS-B structure has revealed that most of the reported ASD substitutions are located near catalytic sites or within highly conserved regions of the protein. For some ASD patients, fibroblast cell culture studies have eliminated protein and mRNA synthesis or stability as the basis for decreased proliferation.	[Lomelino, Carrie L.; Andring, Jacob T.; McKenna, Robert; Kilberg, Michael S.] Univ Florida, Coll Med, Shands Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Kilberg, MS (corresponding author), Univ Florida, Coll Med, Shands Canc Ctr, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	mkilberg@ufl.edu			NCI, National Institutes of Health [CA203565]; National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards [TL1TR001428, UL1TR001427]; NATIONAL CANCER INSTITUTE [R01CA203565] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001428, UL1TR001427] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by supported by a grant from NCI, National Institutes of Health Grant CA203565 (to M. S. K.) and by the National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards TL1TR001428 and UL1TR001427 (to C. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama T, 2014, BRAIN DEV-JPN, V36, P3, DOI 10.1016/j.braindev.2012.12.001; Alfadhel M, 2015, JIMD REP, V22, P11, DOI 10.1007/8904_2014_405; Alrifai MT, 2016, PEDIATR NEUROL, V58, P98, DOI 10.1016/j.pediatrneurol.2016.01.024; Aslanian AM, 2001, BIOCHEM J, V357, P321, DOI 10.1042/0264-6021:3570321; Aslanian AM, 2001, BIOCHEM J, V358, P59, DOI 10.1042/0264-6021:3580059; Asselin B.L., 2003, CONTEMPORARY CLIN NE, P365; Avramis VI, 2012, ANTICANCER RES, V32, P2423; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Ben-Salem S, 2015, METAB BRAIN DIS, V30, P687, DOI 10.1007/s11011-014-9618-0; BROOME JD, 1968, J EXP MED, V127, P1055, DOI 10.1084/jem.127.6.1055; Cui HY, 2007, CANCER RES, V67, P3345, DOI 10.1158/0008-5472.CAN-06-2519; Dufour E, 2012, PANCREAS, V41, P940, DOI 10.1097/MPA.0b013e318247d903; Gataullina S, 2016, NEUROPEDIATRICS, V47, P399, DOI 10.1055/s-0036-1586222; Gupta N, 2017, METAB BRAIN DIS, V32, P1889, DOI 10.1007/s11011-017-0073-6; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Lorenzi PL, 2008, MOL CANCER THER, V7, P3123, DOI 10.1158/1535-7163.MCT-08-0589; Lorenzi PL, 2006, MOL CANCER THER, V5, P2613, DOI 10.1158/1535-7163.MCT-06-0447; MILMAN HA, 1974, BIOCHEM J, V142, P27, DOI 10.1042/bj1420027; Palmer EE, 2015, MOL GENET METAB, V116, P178, DOI 10.1016/j.ymgme.2015.08.007; PATTERSON MK, 1968, J BIOL CHEM, V243, P376; Pieters R, 2011, CANCER-AM CANCER SOC, V117, P238, DOI 10.1002/cncr.25489; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; RIZZARI C, 2003, CONTEMPORARY CLIN NE, P381; Ruzzo EK, 2013, NEURON, V80, P429, DOI 10.1016/j.neuron.2013.08.013; Scholl-Burgi S, 2008, PEDIATRICS, V121, pE920, DOI 10.1542/peds.2007-1631; Seidahmed MZ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0633-0; Su N, 2008, PEDIATR BLOOD CANCER, V50, P274, DOI 10.1002/pbc.21213; Sun J, 2017, JIMD REPORTS, VOL 34, P1, DOI 10.1007/8904_2016_3; Tesson AR, 2003, ARCH BIOCHEM BIOPHYS, V413, P23, DOI 10.1016/S0003-9861(03)00118-8; Yamamoto T, 2017, BRAIN DEV-JPN, V39, P236, DOI 10.1016/j.braindev.2016.09.010; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81	36	118	120	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					19952	19958		10.1074/jbc.R117.819060	http://dx.doi.org/10.1074/jbc.R117.819060			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29084849	hybrid, Green Published			2022-12-28	WOS:000417696400001
J	Al-Saedi, F; Vaz, DP; Stones, DH; Krachler, AM				Al-Saedi, Fitua; Vaz, Diana Pereira; Stones, Daniel H.; Krachler, Anne Marie			3-Sulfogalactosyl-dependent adhesion of Escherichia coli HS multivalent adhesion molecule is attenuated by sulfatase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; intestinal epithelium; mucin; mucus; protein-lipid interaction; Multivalent Adhesion Molecule; commensal; foraging; mammalian cell entry domain	COLONIC MUCUS BARRIER; 3-DERIVED O-GLYCANS; PSEUDOMONAS-AERUGINOSA; ULCERATIVE-COLITIS; INTESTINAL-MUCOSA; IN-VIVO; MUCIN; CELLS; MICE; MICROBIOTA	Bacterial adhesion to host receptors is an early and essential step in bacterial colonization, and the nature of adhesin-receptor interactions determines bacterial localization and thus the outcome of these interactions. Here, we determined the host receptors for the multivalent adhesion molecule (MAM) from the gut commensal Escherichia coli HS (MAM(HS)), which contains an array of seven mammalian cell entry domains. The MAM(HS) adhesin interacted with a range of host receptors, through recognition of a shared 3-O-sulfogalactosyl moiety. This functional group is also found in mucin, a component of the intestinal mucus layer and thus one of the prime adherence targets for commensal E. coli. Mucin gels impeded the motility of E. coli by acting as a physical barrier, and the barrier effect was enhanced by specific interactions between mucin and MAM(HS) in a sulfation-dependent manner. Desulfation of mucin by pure sulfatase or the sulfatase-producing commensal Bacteroides thetaiotaomicron decreased binding of E. coli to mucin and increased the attachment of bacteria to the epithelial surface via interactions with surface-localized sulfated lipid and protein receptors. Together, our results demonstrate that the E. coli adhesin MAM(HS) facilitates retention of a gut commensal by attachment to mucin. They further suggest that the amount of sulfatase secreted by mucin-foraging bacteria such as B. thetaiotaomicron, inhabiting the same niche, may affect the capacity of the mucus barrier to retain commensal E. coli.	[Al-Saedi, Fitua; Vaz, Diana Pereira; Stones, Daniel H.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Vaz, Diana Pereira; Krachler, Anne Marie] Univ Texas McGovern Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Birmingham	Krachler, AM (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	anne.marie.krachler@uth.tmc.edu	Al-Saedi, Fitua/H-1690-2019; Krachler, Anne-Marie/C-8645-2014	Al-Saedi, Fitua/0000-0003-0734-8192; Krachler, Anne Marie/0000-0002-0936-0016; Stones, Daniel H./0000-0002-8981-7943; Pereira Vaz, Diana/0000-0002-8957-5913	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007916/1, BB/M021513/1]; University of Texas Science and Technology Acquisition and Retention (STAR) award; Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship; BBSRC [BB/M021513/1, BB/L007916/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M021513/1, BB/L007916/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Texas Science and Technology Acquisition and Retention (STAR) award; Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/L007916/1 and BB/M021513/1 (to A. M. K., D. P. V., and D. H. S.) and a University of Texas Science and Technology Acquisition and Retention (STAR) award (to A. M. K. and D. P. V.). A. M. K. is a co-inventor on the patent "Modulating bacterial MAM polypeptides in pathogenic disease" (U.S. Patent 9529005, issued Dec. 27, 2016).; Supported by an Iraq Ministry of Higher Education and Scientific Research Postgraduate Scholarship.	Al-Saedi F, 2016, INFECT IMMUN, V84, P1704, DOI 10.1128/IAI.00020-16; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Baron W, 2014, GLIA, V62, P927, DOI 10.1002/glia.22650; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Benjdia A, 2011, J BIOL CHEM, V286, P25973, DOI 10.1074/jbc.M111.228841; Bergstrom K, 2017, MUCOSAL IMMUNOL, V10, P91, DOI 10.1038/mi.2016.45; Chen SJ, 2014, WORLD J GASTROENTERO, V20, P9468, DOI 10.3748/wjg.v20.i28.9468; COLBURN P, 1987, BIOCHEM BIOPH RES CO, V147, P920, DOI 10.1016/S0006-291X(87)80158-4; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; Dawson PA, 2009, GUT, V58, P910, DOI 10.1136/gut.2007.147595; de Souza HL, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-21; Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043; Hawley CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081216; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Huebinger RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39341; Hummel S, 2007, J BIOL CHEM, V282, P8011, DOI 10.1074/jbc.M606029200; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263; Jansson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004487; Johansson MEV, 2014, INFLAMM BOWEL DIS, V20, P2124, DOI 10.1097/MIB.0000000000000117; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Krachler AM, 2011, J BIOL CHEM, V286, P38939, DOI 10.1074/jbc.M111.291377; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Larsson JMH, 2011, INFLAMM BOWEL DIS, V17, P2299, DOI 10.1002/ibd.21625; Laux D C, 1982, Recomb DNA Tech Bull, V5, P1; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Mahmoud RY, 2016, MOL MICROBIOL, V99, P658, DOI 10.1111/mmi.13255; Maltby R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053957; Molist A, 1997, BIOCHEM BIOPH RES CO, V238, P874, DOI 10.1006/bbrc.1997.7192; Nishiyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083703; ROBERTS DD, 1985, P NATL ACAD SCI USA, V82, P1306, DOI 10.1073/pnas.82.5.1306; Scharfman A, 2001, INFECT IMMUN, V69, P5243, DOI 10.1128/IAI.69.9.5243-5248.2001; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Takahashi T, 2012, J LIPID RES, V53, P1437, DOI 10.1194/jlr.R026682; Thomsson KA, 2000, ANAL CHEM, V72, P4543, DOI 10.1021/ac000631b; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Uchida H, 2006, BIOSCI BIOTECH BIOCH, V70, P3073, DOI 10.1271/bbb.60407; Uchida H, 2006, RES MICROBIOL, V157, P659, DOI 10.1016/j.resmic.2006.03.001; Xia BY, 2005, GLYCOBIOLOGY, V15, P747, DOI 10.1093/glycob/cwi061; Xiao SY, 2013, ADV EXP MED BIOL, V991, P27, DOI 10.1007/978-94-007-6331-9_3	48	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19792	19803		10.1074/jbc.M117.817908	http://dx.doi.org/10.1074/jbc.M117.817908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982977	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000416911300023
J	Kong, H; Chandel, NS				Kong, Hyewon; Chandel, Navdeep S.			Regulation of redox balance in cancer and T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PYRUVATE-KINASE M2; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; SUPEROXIDE ANION; ACTIVATION; ROS; ANTIOXIDANT; NRF2; MITOCHONDRIA	Reactive oxygen species (ROS) mediate redox signaling necessary for numerous cellular functions. Yet, high levels of ROS in cells and tissues can cause damage and cell death. Therefore, regulation of redox homeostasis is essential for ROS-dependent signaling that does not incur cellular damage. Cells achieve this optimal balance by coordinating ROS production and elimination. In this Minireview, we discuss the mechanisms by which proliferating cancer and T cells maintain a carefully controlled redox balance. Greater insight into such redox biology may enable precisely targeted manipulation of ROS for effective medical therapies against cancer or immunological disorders.	[Kong, Hyewon; Chandel, Navdeep S.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Chandel, NS (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	nav@northwestern.edu			National Institute of Health [5R35CA197532-02, 5P01AG049665-03, 5P01HL071643-13, T32 CA9560]; NATIONAL CANCER INSTITUTE [T32CA009560, R35CA197532] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institute of Health Grants 5R35CA197532-02, 5P01AG049665-03, and 5P01HL071643-13 (to N.S.C.). This is the second article in the Thematic Minireview Series "Redox metabolism and signaling." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Supported by National Institute of Health Pre-doctoral Training Grant T32 CA9560.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Alexander A, 2010, P NATL ACAD SCI USA, V107, P4153, DOI 10.1073/pnas.0913860107; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bar-Peled L, 2017, CELL, V171, P696, DOI 10.1016/j.cell.2017.08.051; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Brand MD, 2016, FREE RADICAL BIO MED, V100, P14, DOI 10.1016/j.freeradbiomed.2016.04.001; Brand MD, 2016, CELL METAB, V24, P582, DOI 10.1016/j.cmet.2016.08.012; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Chandel N. S., 2015, NAVIGATING METABOLIS, P37; Chandel NS, 2014, NEW ENGL J MED, V371, P177, DOI 10.1056/NEJMcibr1405701; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; CHAUDHRI G, 1986, J IMMUNOL, V137, P2646; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Cheung EC, 2016, GENE DEV, V30, P52, DOI 10.1101/gad.271130.115; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Chouchani ET, 2016, NATURE, V532, P112, DOI 10.1038/nature17399; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; D'Souza AD, 2013, MOL THER, V21, P42, DOI 10.1038/mt.2012.203; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Finkel T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002943; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Gill T, 2013, J BIOL CHEM, V288, P26246, DOI 10.1074/jbc.M113.476895; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gorlach A, 2015, REDOX BIOL, V6, P372, DOI 10.1016/j.redox.2015.08.016; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; HAMILOS DL, 1989, IMMUNOPHARMACOLOGY, V18, P223, DOI 10.1016/0162-3109(89)90020-9; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kwon J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000976; Lang PA, 2013, CELL DEATH DIFFER, V20, P649, DOI 10.1038/cdd.2012.167; Laniewski NG, 2004, J VIROL, V78, P11246, DOI 10.1128/JVI.78.20.11246-11257.2004; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Liou GY, 2016, CELL REP, V14, P2325, DOI 10.1016/j.celrep.2016.02.029; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Orr DL, 2015, NAT CHEM BIOL, V11, P834, DOI [10.1038/nchembio.1910, 10.1038/NCHEMBIO.1910]; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Previte DM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175549; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Samanta D, 2016, CANCER RES, V76, P4430, DOI 10.1158/0008-5472.CAN-16-0530; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Seth D, 2006, BIOCHEMISTRY-US, V45, P8476, DOI 10.1021/bi060157p; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Yates MS, 2009, CARCINOGENESIS, V30, P1024, DOI 10.1093/carcin/bgp100; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang BJ, 2016, IMMUNITY, V44, P568, DOI 10.1016/j.immuni.2016.01.007	99	87	87	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7499	7507		10.1074/jbc.TM117.000257	http://dx.doi.org/10.1074/jbc.TM117.000257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29282291	Green Published, hybrid			2022-12-28	WOS:000437256500003
J	Isom, DG; Page, SC; Collins, LB; Kapolka, NJ; Taghon, GJ; Dohlman, HG				Isom, Daniel G.; Page, Stephani C.; Collins, Leonard B.; Kapolka, Nicholas J.; Taghon, Geoffrey J.; Dohlman, Henrik G.			Coordinated regulation of intracellular pH by two glucose-sensing pathways in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; GTPASE-ACTIVATING PROTEIN; ENCODING ADENYLATE-CYCLASE; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; RAS PROTEINS; TRANSPORTER GENE; CYTOSOLIC PH	The yeast Saccharomyces cerevisiae employs multiple pathways to coordinate sugar availability and metabolism. Glucose and other sugars are detected by a G protein-coupled receptor, Gpr1, as well as a pair of transporter-like proteins, Rgt2 and Snf3. When glucose is limiting, however, an ATP-driven proton pump (Pma1) is inactivated, leading to a marked decrease in cytoplasmic pH. Here we determine the relative contribution of the two sugar-sensing pathways to pH regulation. Whereas cytoplasmic pH is strongly dependent on glucose abundance and is regulated by both glucose-sensing pathways, ATP is largely unaffected and therefore cannot account for the changes in Pma1 activity. These data suggest that the pH is a second messenger of the glucose-sensing pathways. We show further that different sugars differ in their ability to control cellular acidification, in the manner of inverse agonists. We conclude that the sugar-sensing pathways act via Pma1 to invoke coordinated changes in cellular pH and metabolism. More broadly, our findings support the emerging view that cellular systems have evolved the use of pH signals as a means of adapting to environmental stresses such as those caused by hypoxia, ischemia, and diabetes.	[Isom, Daniel G.; Page, Stephani C.; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Isom, Daniel G.; Kapolka, Nicholas J.; Taghon, Geoffrey J.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Collins, Leonard B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Miami; University of North Carolina; University of North Carolina Chapel Hill	Isom, DG (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave,RMSB 6078A, Miami, FL 33136 USA.; Dohlman, HG (corresponding author), Univ N Carolina, 4016 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	disom@miami.edu; hdohlman@med.unc.edu	Taghon, Geoffrey/GON-5639-2022	Dohlman, Henrik/0000-0003-2443-0729; Collins, Leonard/0000-0002-7734-9708; Kapolka, Nicholas/0000-0003-2223-8207; Taghon, Geoffrey/0000-0002-5350-5075	National Institutes of Health Grants [R35GM119518, R35GM118105, R35GM118105-S1, P30ES010126]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119518, R35GM118105] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R35GM119518 (to D. G. I.), R35GM118105 (to H. G. D.), R35GM118105-S1 (to S. P.), and P30ES010126 (to L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BEULLENS M, 1988, EUR J BIOCHEM, V172, P227, DOI 10.1111/j.1432-1033.1988.tb13877.x; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; BoyMarcotte E, 1996, MOL BIOL CELL, V7, P529, DOI 10.1091/mbc.7.4.529; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; Budovskaya YV, 2005, P NATL ACAD SCI USA, V102, P13933, DOI 10.1073/pnas.0501046102; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; CASPERSON GF, 1985, P NATL ACAD SCI USA, V82, P5060, DOI 10.1073/pnas.82.15.5060; CELENZA JL, 1984, MOL CELL BIOL, V4, P49, DOI 10.1128/MCB.4.1.49; CELENZA JL, 1984, MOL CELL BIOL, V4, P54, DOI 10.1128/MCB.4.1.54; Chandrashekarappa DG, 2013, J BIOL CHEM, V288, P89, DOI 10.1074/jbc.M112.422659; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Dechant R, 2014, MOL CELL, V55, P409, DOI 10.1016/j.molcel.2014.06.002; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; FIELD J, 1990, SCIENCE, V247, P464, DOI 10.1126/science.2405488; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gross A, 1999, BIOCHEMISTRY-US, V38, P13252, DOI 10.1021/bi9909849; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Harashima T, 2002, MOL CELL, V10, P163, DOI 10.1016/S1097-2765(02)00569-5; Heo JY, 2004, BIOCHEMISTRY-US, V43, P10102, DOI 10.1021/bi035704a; Isom DG, 2016, BIOCHEMISTRY-US, V55, P534, DOI 10.1021/acs.biochem.5b00901; Isom DG, 2015, P NATL ACAD SCI USA, V112, P5702, DOI 10.1073/pnas.1417888112; Isom DG, 2013, MOL CELL, V51, P531, DOI 10.1016/j.molcel.2013.07.012; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Jiang YF, 2017, J BIOL CHEM, V292, P12366, DOI 10.1074/jbc.C117.800896; Johnsen E, 2011, J CHROMATOGR A, V1218, P5981, DOI 10.1016/j.chroma.2011.01.066; JONES S, 1991, MOL CELL BIOL, V11, P2641, DOI 10.1128/MCB.11.5.2641; Jouandot D, 2011, J CELL BIOCHEM, V112, P3268, DOI 10.1002/jcb.23253; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2000, J EXP BIOL, V203, P81; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Kubler E, 1997, J BIOL CHEM, V272, P20321, DOI 10.1074/jbc.272.33.20321; Lafuente MJ, 2000, MOL MICROBIOL, V35, P161, DOI 10.1046/j.1365-2958.2000.01688.x; Lakshmanan J, 2003, CURR GENET, V44, P19, DOI 10.1007/s00294-003-0423-2; Lam SD, 2016, NUCLEIC ACIDS RES, V44, pD404, DOI 10.1093/nar/gkv1231; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Lorenz MC, 2000, GENETICS, V154, P609; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mosley AL, 2003, J BIOL CHEM, V278, P10322, DOI 10.1074/jbc.M212802200; MUNDER T, 1989, FEBS LETT, V242, P341, DOI 10.1016/0014-5793(89)80498-3; NAKAFUKU M, 1988, P NATL ACAD SCI USA, V85, P1374, DOI 10.1073/pnas.85.5.1374; NEIGEBORN L, 1986, MOL CELL BIOL, V6, P3569, DOI 10.1128/MCB.6.11.3569; Nicastro R, 2015, J BIOL CHEM, V290, P24715, DOI 10.1074/jbc.M115.658005; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Ozalp VC, 2010, J BIOL CHEM, V285, P37579, DOI 10.1074/jbc.M110.155119; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pan XW, 1999, MOL CELL BIOL, V19, P4874; PAPASAVVAS S, 1992, BIOCHEM BIOPH RES CO, V184, P1378, DOI 10.1016/S0006-291X(05)80035-X; Pasula S, 2007, FEBS LETT, V581, P3230, DOI 10.1016/j.febslet.2007.06.013; PERLMAN D, 1984, MOL CELL BIOL, V4, P1682, DOI 10.1128/MCB.4.9.1682; Polish JA, 2005, GENETICS, V169, P583, DOI 10.1534/genetics.104.034512; POWERS S, 1984, CELL, V36, P607, DOI 10.1016/0092-8674(84)90340-4; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Robertson LS, 2000, P NATL ACAD SCI USA, V97, P5984, DOI 10.1073/pnas.100113397; Robertson LS, 1998, P NATL ACAD SCI USA, V95, P13783, DOI 10.1073/pnas.95.23.13783; Rolland F, 2000, MOL MICROBIOL, V38, P348, DOI 10.1046/j.1365-2958.2000.02125.x; Roy A, 2013, MOL BIOL CELL, V24, P1493, DOI 10.1091/mbc.E13-01-0047; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; Shellhammer JP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006829; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; SUZUKI N, 1990, P NATL ACAD SCI USA, V87, P8711, DOI 10.1073/pnas.87.22.8711; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; TANAKA K, 1989, MOL CELL BIOL, V9, P757, DOI 10.1128/MCB.9.2.757; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Thaker TM, 2014, J BIOL CHEM, V289, P11331, DOI 10.1074/jbc.M113.539064; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; UNO I, 1985, P NATL ACAD SCI USA, V82, P7855, DOI 10.1073/pnas.82.23.7855; Versele M, 1999, EMBO J, V18, P5577, DOI 10.1093/emboj/18.20.5577; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yun CW, 1998, BIOCHEM BIOPH RES CO, V252, P29, DOI 10.1006/bbrc.1998.9600; Yun CW, 1997, BIOCHEM BIOPH RES CO, V240, P287, DOI 10.1006/bbrc.1997.7649; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	105	16	17	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2318	2329		10.1074/jbc.RA117.000422	http://dx.doi.org/10.1074/jbc.RA117.000422			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29284676	Green Published, hybrid			2022-12-28	WOS:000425308300007
J	Pollard, AM; Sourjik, V				Pollard, Abiola M.; Sourjik, Victor			Transmembrane region of bacterial chemoreceptor is capable of promoting protein clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; chemotaxis; protein self-assembly; protein-protein interaction; transmembrane domain	ACCEPTING CHEMOTAXIS PROTEINS; ESCHERICHIA-COLI; IN-VIVO; ABUNDANCE CHEMORECEPTORS; ASPARTATE RECEPTOR; MEMBRANE-PROTEINS; CROSS-LINKING; ARRAYS; ORGANIZATION; COMMUNICATION	Many membrane proteins are known to form higher-order oligomers, but the degree to which membrane regions could facilitate protein complex assembly remains largely unclear. Clusters of chemotaxis receptors are among the most prominent structures in the bacterial cell membrane, and they play important functions in processing of chemotactic signals. Although much work has been done to elucidate mechanisms of cluster formation, it almost exclusively focused on cytoplasmic interactions among receptors and other chemotaxis proteins, whereas involvement of membrane-mediated interactions was only hypothesized. Here we used imaging of constructs composed of only a fluorescent protein and the TM helices of Tar to demonstrate that interactions between the lipid bilayer and transmembrane (TM) helices of Escherichia coli chemoreceptors alone are sufficient to mediate clustering. We found that the ability to cluster depends on the sequence or length of the TM helices, implying that certain conformations of these helices facilitate clustering, whereas others do not. Notably, observed sequence specificity was apparently consistent with differences in clustering between native E. coli receptors, with the TM sequence of better-clustering high-abundance receptors being more efficient in promoting membrane-mediated complex formation. These results indicate that being more than just membrane anchors, TM helices could play an important role in the clustering and organization of membrane proteins in bacteria.	[Pollard, Abiola M.; Sourjik, Victor] Max Planck Inst Terr Microbiol, Karl von Frisch Str 16, D-35043 Marburg, Germany; [Pollard, Abiola M.; Sourjik, Victor] LOEWE Ctr Synthet Microbiol SYNMIKRO, Karl von Frisch Str 16, D-35043 Marburg, Germany	Max Planck Society	Pollard, AM; Sourjik, V (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 16, D-35043 Marburg, Germany.; Pollard, AM; Sourjik, V (corresponding author), LOEWE Ctr Synthet Microbiol SYNMIKRO, Karl von Frisch Str 16, D-35043 Marburg, Germany.	abiola.pollard@synmikro.mpi-marburg.mpg.de; victor.sourjik@synmikro.mpi-marburg.mpg.de			Deutsche Forschungsgemeinschaft [SO 568/1-1, TRR174/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grants SO 568/1-1 and TRR174/1 from the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Bondar AN, 2012, BBA-BIOMEMBRANES, V1818, P942, DOI 10.1016/j.bbamem.2011.11.035; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Briegel A, 2009, P NATL ACAD SCI USA, V106, P17181, DOI 10.1073/pnas.0905181106; CALLAHAN AM, 1985, J BACTERIOL, V161, P96, DOI 10.1128/JB.161.1.96-104.1985; Curran AR, 2003, CURR OPIN STRUC BIOL, V13, P412, DOI 10.1016/S0959-440X(03)00102-7; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; Dukhovny A, 2009, J CELL SCI, V122, P1759, DOI 10.1242/jcs.039339; Endres RG, 2009, BIOPHYS J, V96, P453, DOI 10.1016/j.bpj.2008.10.021; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; Gestwicki JE, 2002, NATURE, V415, P81, DOI 10.1038/415081a; Govindarajan S, 2012, FEMS MICROBIOL REV, V36, P1005, DOI 10.1111/j.1574-6976.2012.00348.x; Haselwandter CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003932; Jones CW, 2015, TRENDS MICROBIOL, V23, P247, DOI 10.1016/j.tim.2015.03.004; Kaiser HJ, 2011, J BIOL CHEM, V286, P40631, DOI 10.1074/jbc.M111.276444; Kentner D, 2006, MOL MICROBIOL, V61, P407, DOI 10.1111/j.1365-2958.2006.05250.x; Killian JA, 2006, CURR OPIN STRUC BIOL, V16, P473, DOI 10.1016/j.sbi.2006.06.007; Liberman L, 2004, J BACTERIOL, V186, P6643, DOI 10.1128/JB.186.19.6643-6646.2004; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Lybarger SR, 2000, P NATL ACAD SCI USA, V97, P8057, DOI 10.1073/pnas.130195397; Lybarger SR, 2005, MOL MICROBIOL, V56, P1078, DOI 10.1111/j.1365-2958.2005.04593.x; MADDOCK JR, 1993, SCIENCE, V259, P1717; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Milovanovic D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6984; Ortega DR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004723; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Piasta KN, 2014, BIOCHEMISTRY-US, V53, P5592, DOI 10.1021/bi500849p; Pinas GE, 2016, P NATL ACAD SCI USA, V113, P3335, DOI 10.1073/pnas.1600216113; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sal-Man N, 2005, J BIOL CHEM, V280, P27449, DOI 10.1074/jbc.M503095200; Sal-Man N, 2004, J MOL BIOL, V344, P855, DOI 10.1016/j.jmb.2004.09.066; Sal-Man N, 2004, BIOCHEMISTRY-US, V43, P2309, DOI 10.1021/bi0356294; Shiomi D, 2005, J BACTERIOL, V187, P7647, DOI 10.1128/JB.187.22.7647-7654.2005; SLOCUM MK, 1985, J BACTERIOL, V163, P586, DOI 10.1128/JB.163.2.586-594.1985; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Strahl H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9728; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thiem S, 2007, EMBO J, V26, P1615, DOI 10.1038/sj.emboj.7601610; Wingreen NS, 2015, ANNU REV MICROBIOL, V69, P361, DOI 10.1146/annurev-micro-091014-104313; Yang YL, 2015, MOL MICROBIOL, V96, P1272, DOI 10.1111/mmi.13006; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x	44	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2149	2158		10.1074/jbc.M117.796722	http://dx.doi.org/10.1074/jbc.M117.796722			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259129	hybrid, Green Published			2022-12-28	WOS:000424948000026
J	Xu, TJ; Chu, Q; Cui, JX; Zhao, XY				Xu, Tianjun; Chu, Qing; Cui, Junxia; Zhao, Xueyan			The inducible microRNA-203 in fish represses the inflammatory responses to Gram-negative bacteria by targeting IL-1 receptor-associated kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); translation regulation; Toll-like receptor (TLR); innate immunity; lipopolysaccharide (LPS); IRAK4; microRNA-203; negative regulation; NF-kappaB; teleost fish	KAPPA-B PATHWAY; TOLL-LIKE RECEPTORS; MIIUY CROAKER; TELEOST FISH; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTOR; MIICHTHYS-MIIUY; GENE-EXPRESSION; INNATE IMMUNE; MACROPHAGES	Innate immune responses are the first defense against pathogenic invaders. Activation and termination of these immune responses are regulated by several mechanisms. MicroRNAs (miRNAs), a group of small non-coding RNAs, have been implicated in the regulation of a spectrum of both physiological and pathological conditions, including immune responses. Although the immune regulatory miRNA networks in higher vertebrates have been well described, regulation of these responses in fish species is poorly understood. In the present study, we investigated the role of the miRNA miR-203 involved in inflammatory responses in miiuy croaker (Miichthys miiuy). We found that the Gram-negative bacterium Vibrio anguillarum and lipopolysaccharide significantly up-regulated host miR-203 expression. The increased miR-203 expression suppressed the production of inflammatory cytokines and thereby prevented mounting of a full immune response. Mechanistically, we identified and validated IL-1 receptor-associated kinase 4 (IRAK4) as a target of miR-203. We observed that miR-203 post-transcriptionally controls IRAK4 expression and thereby inhibits the activation of nuclear factor B (NF-B) signaling. In summary, our findings reveal that miR-203 in fish is a critical suppressor of innate immune responses to bacterial infection by suppressing a feedback to IRAK4-NF-B-mediated signaling.	[Xu, Tianjun; Chu, Qing] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China; [Xu, Tianjun; Cui, Junxia; Zhao, Xueyan] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan 316022, Peoples R China	Shanghai Ocean University; Zhejiang Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China.; Xu, TJ (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan 316022, Peoples R China.	tianjunxu@163.com	Xia, Cui/AAA-2699-2022		National Natural Science Foundation of China [31672682, 31370049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31672682 and 31370049. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chu Q, 2017, J IMMUNOL, V198, P3274, DOI 10.4049/jimmunol.1602064; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Chu Q, 2017, DEV COMP IMMUNOL, V67, P117, DOI 10.1016/j.dci.2016.11.004; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Frans I, 2011, J FISH DIS, V34, P643, DOI 10.1111/j.1365-2761.2011.01279.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Koziczak-Holbro M, 2007, J BIOL CHEM, V282, P13552, DOI 10.1074/jbc.M700548200; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li YK, 2013, CELL MOL IMMUNOL, V10, P65, DOI 10.1038/cmi.2012.55; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Rusinov V, 2005, NUCLEIC ACIDS RES, V33, pW696, DOI 10.1093/nar/gki364; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Siewe L, 2006, EUR J IMMUNOL, V36, P3248, DOI 10.1002/eji.200636012; Tang B, 2010, FEBS LETT, V584, P1481, DOI 10.1016/j.febslet.2010.02.063; Wang YJ, 2016, DEV COMP IMMUNOL, V63, P181, DOI 10.1016/j.dci.2016.06.004; Wang YJ, 2016, DEV COMP IMMUNOL, V62, P102, DOI 10.1016/j.dci.2016.05.001; Wang YJ, 2016, DEV COMP IMMUNOL, V61, P25, DOI 10.1016/j.dci.2016.03.005; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wei J, 2013, MOL IMMUNOL, V55, P303, DOI 10.1016/j.molimm.2013.03.004; Xiao B, 2009, J INFECT DIS, V200, P916, DOI 10.1086/605443; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902; Zhang Fengping, 2010, Weishengwu Xuebao, V50, P304; Zhang L, 2015, J IMMUNOL, V195, P5404, DOI 10.4049/jimmunol.1402933; Zhao XY, 2017, MOL IMMUNOL, V85, P123, DOI 10.1016/j.molimm.2017.02.009; Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125	45	42	43	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1386	1396		10.1074/jbc.RA117.000158	http://dx.doi.org/10.1074/jbc.RA117.000158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242191	hybrid, Green Published			2022-12-28	WOS:000423515000024
J	Darwiche, R; El Atab, O; Baroni, RM; Teixeira, PJPL; Mondego, JMC; Pereira, GAG; Schneiter, R				Darwiche, Rabih; El Atab, Ola; Baroni, Renata M.; Teixeira, Paulo J. P. L.; Mondego, Jorge M. C.; Pereira, Goncalo A. G.; Schneiter, Roger			Plant pathogenesis-related proteins of the cacao fungal pathogen Moniliophthora perniciosa differ in their lipid-binding specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; fatty acid binding protein; infection; lipid-protein interaction; sterol	WITCHES-BROOM DISEASE; SACCHAROMYCES-CEREVISIAE; CAP SUPERFAMILY; THEOBROMA-CACAO; YEAST PROTEIN; PRY1; DEFENSE; DOMAIN; MEMBER; EXPORT	Moniliophthora perniciosa is the causative agent of witches' broom disease, which devastates cacao cultures in South America. This pathogenic fungus infects meristematic tissues and derives nutrients from the plant apoplast during an unusually long-lasting biotrophic stage. To survive, the fungus produces proteins to suppress the plant immune response. Proteins of the PR-1 (pathogenesis-related 1)/CAP superfamily have been implicated in fungal virulence and immune suppression. The genome of M. perniciosa encodes 11 homologues of plant PR-1 proteins, designated MpPR-1 proteins, but their precise mode of action is poorly understood. In this study, we expressed MpPR-1 proteins in a yeast model lacking endogenous CAP proteins. We show that some members of the MpPR-1 family bind and promote secretion of sterols, whereas others bind and promote secretion of fatty acids. Lipid binding by purified MpPR-1 occurs with micromolar affinity and is saturable in vitro. Sterol binding by MpPR-1 requires the presence of a flexible loop region containing aromatic amino acids, the caveolin-binding motif. Remarkably, MpPR-1 family members that do not bind sterols can be converted to sterol binders by a single point mutation in the caveolin-binding motif. We discuss the possible implications of the lipid-binding activity of MpPR-1 family members with regard to the mode of action of these proteins during M. perniciosa infections.	[Darwiche, Rabih; El Atab, Ola; Schneiter, Roger] Univ Fribourg, Div Biochem, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Baroni, Renata M.; Mondego, Jorge M. C.] Inst Agron Campinas, BR-13083970 Campinas, SP, Brazil; [Baroni, Renata M.; Teixeira, Paulo J. P. L.; Pereira, Goncalo A. G.] Univ Estadual Campinas, Lab Genet & Expressao, BR-13083970 Campinas, SP, Brazil	University of Fribourg; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas	Schneiter, R (corresponding author), Univ Fribourg, Div Biochem, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.; Pereira, GAG (corresponding author), Univ Estadual Campinas, Lab Genet & Expressao, BR-13083970 Campinas, SP, Brazil.	goncalo@unicamp.br; roger.schneiter@unifr.ch	Teixeira, Paulo/C-1546-2013; UNICAMP, CCES -/J-7787-2015	Teixeira, Paulo/0000-0002-0776-5044; El Atab, Ola/0000-0003-3118-0828; Schneiter, Roger/0000-0002-9102-8396	Swiss National Science Foundation [31003A_153416, 31003A_173003]; Sao Paulo State Research Foundation [2009/50119-9, 2010/51884-8, 2012/07657-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sao Paulo State Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Swiss National Science Foundation Projects 31003A_153416 and 31003A_173003 (to R. S.) and Sao Paulo State Research Foundation Projects 2009/50119-9, 2010/51884-8, and 2012/07657-2. The authors declare that they have no conflicts of interest with the contents of this article.	Aime MC, 2005, MYCOLOGIA, V97, P1012, DOI 10.3852/mycologia.97.5.1012; Barau J, 2015, J EXP BOT, V66, P1325, DOI 10.1093/jxb/eru485; Baroni RM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07887-1; Barsottini MRD, 2013, MOL PLANT MICROBE IN, V26, P1281, DOI 10.1094/MPMI-05-13-0148-R; Breen S, 2017, TRENDS PLANT SCI, V22, P871, DOI 10.1016/j.tplants.2017.06.013; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Darwiche R., 2016, J STEROIDS HORM SCI, V7, P2; Darwiche R, 2017, METHODS MOL BIOL, V1645, P361, DOI 10.1007/978-1-4939-7183-1_25; Darwiche R, 2017, J BIOL CHEM, V292, P8304, DOI 10.1074/jbc.M117.781880; Darwiche R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28838; de Oliveira GAP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045620; Eberle HB, 2002, J CELL SCI, V115, P827; Gamir J, 2017, PLANT J, V89, P502, DOI 10.1111/tpj.13398; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kazan K, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006297; Kelleher A, 2014, ACTA CRYSTALLOGR D, V70, P2186, DOI 10.1107/S1399004714013315; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; Meinhardt LW, 2008, MOL PLANT PATHOL, V9, P577, DOI 10.1111/J.1364-3703.2008.00496.X; Mondego JMC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-548; Teixeira PJPL, 2014, PLANT CELL, V26, P4245, DOI 10.1105/tpc.114.130807; Prados-Rosales RC, 2012, J BIOL CHEM, V287, P21970, DOI 10.1074/jbc.M112.364034; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Teixeira PJPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045929; Teixeira PJPL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005130; Thomazella DPT, 2012, NEW PHYTOL, V194, P1025, DOI 10.1111/j.1469-8137.2012.04119.x; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Xu XQ, 2012, J BIOL CHEM, V287, P10967, DOI 10.1074/jbc.M112.340471; Zaparoli G, 2011, BIOCHEMISTRY-US, V50, P9901, DOI 10.1021/bi201253b	35	7	8	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20558	20569		10.1074/jbc.M117.811398	http://dx.doi.org/10.1074/jbc.M117.811398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042440	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000418267000017
J	Dalla Rosa, I; Zhang, HL; Khiati, S; Wu, XL; Pommier, Y				Dalla Rosa, Ilaria; Zhang, Hongliang; Khiati, Salim; Wu, Xiaolin; Pommier, Yves			Transcription profiling suggests that mitochondrial topoisomerase IB acts as a topological barrier and regulator of mitochondrial DNA transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA topoisomerase; long noncoding RNA (long ncRNA; lncRNA); mitochondria; mitochondrial DNA (mtDNA); transcription; Top1mt	MAMMALIAN MITOCHONDRIA; NUCLEOID ORGANIZATION; POLY(A) POLYMERASE; NONCODING RNAS; II-BETA; MTDNA; GENOME; POLYADENYLATION; BINDING; PROTEIN	Mitochondrial DNA (mtDNA) is essential for cell viability because it encodes subunits of the respiratory chain complexes. Mitochondrial topoisomerase IB (TOP1MT) facilitates mtDNA replication by removing DNA topological tensions produced during mtDNA transcription, but it appears to be dispensable. To test whether cells lacking TOP1MT have aberrant mtDNA transcription, we performed mitochondrial transcriptome profiling. To that end, we designed and implemented a customized tiling array, which enabled genome-wide, strand-specific, and simultaneous detection of all mitochondrial transcripts. Our technique revealed that Top1mt KO mouse cells process the mitochondrial transcripts normally but that protein-coding mitochondrial transcripts are elevated. Moreover, we found discrete long noncoding RNAs produced by H-strand transcription and encompassing the noncoding regulatory region of mtDNA in human and murine cells and tissues. Of note, these noncoding RNAs were strongly up-regulated in the absence of TOP1MT. In contrast, 7S DNA, produced by mtDNA replication, was reduced in the Top1mt KO cells. We propose that the long noncoding RNA species in the D-loop region are generated by the extension of H-strand transcripts beyond their canonical stop site and that TOP1MT acts as a topological barrier and regulator for mtDNA transcription and D-loop formation.	[Dalla Rosa, Ilaria; Zhang, Hongliang; Khiati, Salim; Pommier, Yves] NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Wu, Xiaolin] NCI, Lab Mol Technol, NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pommier, Y (corresponding author), NCI, Mol Pharmacol Lab, Dev Therapeut Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	pommier@nih.gov		Dalla Rosa, Ilaria/0000-0003-4801-2396	National Institutes of Health Intramural Research Program from the Center for Cancer Research, NCI [Z01 BC006161]; NATIONAL CANCER INSTITUTE [ZIABC006161, Z01BC006161] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from the Center for Cancer Research, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Intramural Research Program Grant Z01 BC006161 from the Center for Cancer Research, NCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akman G, 2016, P NATL ACAD SCI USA, V113, pE4276, DOI 10.1073/pnas.1600537113; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bobrowicz AJ, 2008, BIOCHEM SOC T, V36, P517, DOI 10.1042/BST0360517; Bogenhagen DF, 2012, BBA-GENE REGUL MECH, V1819, P914, DOI 10.1016/j.bbagrm.2011.11.005; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; D'Erchia AM, 2015, MITOCHONDRION, V20, P13, DOI 10.1016/j.mito.2014.10.005; Dalla Rosa I, 2014, J BIOL CHEM, V289, P18595, DOI 10.1074/jbc.M114.555367; Dietrich A, 2015, BIOCHIMIE, V117, P48, DOI 10.1016/j.biochi.2015.06.027; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094; Freyer C, 2010, NUCLEIC ACIDS RES, V38, P6577, DOI 10.1093/nar/gkq527; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khiati S, 2015, P NATL ACAD SCI USA, V112, P11282, DOI 10.1073/pnas.1511016112; Khiati S, 2014, CLIN CANCER RES, V20, P4873, DOI 10.1158/1078-0432.CCR-13-3373; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Miao ZH, 2007, CANCER RES, V67, P8752, DOI 10.1158/0008-5472.CAN-06-4554; MONTOYA J, 1981, NATURE, V290, P465, DOI 10.1038/290465a0; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rackham O, 2011, RNA, V17, P2085, DOI 10.1261/rna.029405.111; Rosa ID, 2009, NUCLEIC ACIDS RES, V37, P6414, DOI 10.1093/nar/gkp708; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; SBISA E, 1990, CURR GENET, V17, P247, DOI 10.1007/BF00312616; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Selwood SP, 2001, FEBS LETT, V494, P186, DOI 10.1016/S0014-5793(01)02345-6; Slomovic S, 2005, MOL CELL BIOL, V25, P6427, DOI 10.1128/MCB.25.15.6427-6435.2005; Sobek S, 2013, NUCLEIC ACIDS RES, V41, P9848, DOI 10.1093/nar/gkt768; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Wang JC, 2009, ANNU REV BIOCHEM, V78, P31, DOI 10.1146/annurev.biochem.78.030107.090101; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Wilson WC, 2014, HUM MOL GENET, V23, P6345, DOI 10.1093/hmg/ddu352; Zhang HL, 2004, NUCLEIC ACIDS RES, V32, P2087, DOI 10.1093/nar/gkh525; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384	44	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20162	20172		10.1074/jbc.M117.815241	http://dx.doi.org/10.1074/jbc.M117.815241			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021209	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000417696400021
J	Nagao, R; Ueoka-Nakanishi, H; Noguchi, T				Nagao, Ryo; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi			D1-Asn-298 in photosystem II is involved in a hydrogen-bond network near the redox-active tyrosine Y-Z for proton exit during water oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; Fourier transform IR (FTIR); photosynthesis; photosystem II; site-directed mutagenesis; D1-Asn298; YZ; proton trasfer; thermoluminescence; water oxidation	OXYGEN-EVOLVING COMPLEX; S-STATE CYCLE; FTIR DIFFERENCE SPECTROSCOPY; TRANSFORM INFRARED DETECTION; AMINO-ACID SUBSTITUTION; MN4CAO5 CLUSTER; D1 PROTEIN; MOLECULAR-DYNAMICS; STRUCTURAL-CHANGES; OXIDIZING COMPLEX	In photosynthetic water oxidation, two water molecules are converted into one oxygen molecule and four protons at the Mn4CaO5 cluster in photosystem II (PSII) via the S-state cycle. Efficient proton exit from the catalytic site to the lumen is essential for this process. However, the exit pathways of individual protons through the PSII proteins remain to be identified. In this study, we examined the involvement of a hydrogen-bond network near the redox-active tyrosine Y-Z in proton transfer during the S-state cycle. We focused on spectroscopic analyses of a site-directed variant of D1-Asn-298, a residue involved in a hydrogen-bond network near Y-Z. We found that the D1-N298A mutant of Synechocystis sp. PCC 6803 exhibits an O-2 evolution activity of approximate to 10% of the wild-type. D1-N298A and the wild-type D1 had very similar features of thermoluminescence glow curves and of an FTIR difference spectrum upon Y-Z oxidation, suggesting that the hydrogen-bonded structure of Y-Z and electron transfer from the Mn4CaO5 cluster to Y-Z were little affected by substitution. In the D1-N298A mutant, however, the flash-number dependence of delayed luminescence showed a monotonic increase without oscillation, and FTIR difference spectra of the S-state cycle indicated partial and significant inhibition of the S-2 S-3 and S-3 S-0 transitions, respectively. These results suggest that the D1-N298A substitution inhibits the proton transfer processes in the S-2 S-3 and S-3 S-0 transitions. This in turn indicates that the hydrogen-bond network near Y-Z can be functional as a proton transfer pathway during photosynthetic water oxidation.	[Nagao, Ryo; Ueoka-Nakanishi, Hanayo; Noguchi, Takumi] Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan	Nagoya University	Noguchi, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Mat Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.; Nagao, R (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	nagaoryo@okayama-u.ac.jp; tnoguchi@bio.phys.nagoya-u.ac.jp	Noguchi, Takumi/I-7105-2014; NAGAO, Ryo/D-4117-2012	NAGAO, Ryo/0000-0001-8212-3001; zhong xi, hua dai/0000-0001-8619-9513	Japan Society for the Promotion of Science [26840091, 17K07442, 17H03662, 17H06435]; Grants-in-Aid for Scientific Research [17K07442] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science 26840091 and 17K07442 (to R.N.) and 17H03662 and 17H06435 (to T.N.). The authors declare that they have no conflicts of interest with the contents of this article.	Amin M, 2015, J PHYS CHEM B, V119, P7366, DOI 10.1021/jp510948e; [Anonymous], 2002, PHOTOSYNTHETICA; Bao H, 2015, P NATL ACAD SCI USA, V112, pE6139, DOI 10.1073/pnas.1512008112; Berthomieu C, 1998, BIOCHEMISTRY-US, V37, P10547, DOI 10.1021/bi980788m; Capone M, 2016, J PHYS CHEM LETT, V7, P592, DOI 10.1021/acs.jpclett.5b02851; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5839, DOI 10.1021/bi00017a016; Chu HA, 2001, BBA-BIOENERGETICS, V1503, P69, DOI 10.1016/S0005-2728(00)00216-4; Chu HA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00146; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; Debus RJ, 2014, BIOCHEMISTRY-US, V53, P2941, DOI 10.1021/bi500309f; DEBUS RJ, 1992, BIOCHIM BIOPHYS ACTA, V1102, P269, DOI 10.1016/0005-2728(92)90133-M; Dilbeck PL, 2012, BIOCHEMISTRY-US, V51, P1079, DOI 10.1021/bi201659f; Diner BA, 2005, ADV PHOTO RESPIRAT, V22, P207; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORSTER V, 1985, PHOTOCHEM PHOTOBIOL, V41, P183, DOI 10.1111/j.1751-1097.1985.tb03469.x; Gabdulkhakov A, 2009, STRUCTURE, V17, P1223, DOI 10.1016/j.str.2009.07.010; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Hillier W, 2001, BIOCHEMISTRY-US, V40, P1503, DOI 10.1021/bi002436x; Ho FM, 2008, BBA-BIOENERGETICS, V1777, P140, DOI 10.1016/j.bbabio.2007.08.009; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Hundelt M, 1998, BIOCHEMISTRY-US, V37, P14450, DOI 10.1021/bi981164j; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; Ishikita H, 2006, BIOCHEMISTRY-US, V45, P2063, DOI 10.1021/bi051615h; Isobe H, 2015, J PHYS CHEM B, V119, P13922, DOI 10.1021/acs.jpcb.5b05740; JOLIOT P, 1969, PHOTOCHEM PHOTOBIOL, V10, P309, DOI 10.1111/j.1751-1097.1969.tb05696.x; Kim CJ, 2017, BIOCHEMISTRY-US, V56, P2558, DOI 10.1021/acs.biochem.6b01278; Kimura Y, 2005, BIOCHEMISTRY-US, V44, P16072, DOI 10.1021/bi051306r; Kimura Y, 2003, BIOCHEMISTRY-US, V42, P13170, DOI 10.1021/bi035420q; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Kuroda H, 2014, PLANT CELL PHYSIOL, V55, P1266, DOI 10.1093/pcp/pcu073; Li ZL, 2002, PHOTOSYNTH RES, V72, P191, DOI 10.1023/A:1016192919500; Linke K, 2014, BBA-BIOENERGETICS, V1837, P14, DOI 10.1016/j.bbabio.2013.08.003; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2011, RSC ENERGY ENVIRON S, P163; Murray JW, 2007, J STRUCT BIOL, V159, P228, DOI 10.1016/j.jsb.2007.01.016; Nagao R, 2017, J BIOL CHEM, V292, P7474, DOI 10.1074/jbc.M117.781062; Nakamura S, 2017, J AM CHEM SOC, V139, P9364, DOI 10.1021/jacs.7b04924; Nakamura S, 2016, P NATL ACAD SCI USA, V113, P12727, DOI 10.1073/pnas.1607897113; Nakamura S, 2016, BIOCHEMISTRY-US, V55, P597, DOI 10.1021/acs.biochem.5b01120; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Noguchi T, 2000, BIOCHEMISTRY-US, V39, P10943, DOI 10.1021/bi001040i; Noguchi T, 2005, ADV PHOTO RESPIRAT, V22, P367; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P6035, DOI 10.1021/bi0341612; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P15706, DOI 10.1021/bi020603i; Noguchi T, 2002, SPECTROSC-INT J, V16, P89, DOI 10.1155/2002/960232; Noguchi T, 2002, BIOCHEMISTRY-US, V41, P2322, DOI 10.1021/bi011954k; Noguchi T, 2001, BIOCHEMISTRY-US, V40, P1497, DOI 10.1021/bi0023807; NOGUCHI T, 1995, BBA-BIOENERGETICS, V1228, P189, DOI 10.1016/0005-2728(94)00171-Z; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Noguchi T, 2007, PHOTOSYNTH RES, V91, P59, DOI 10.1007/s11120-007-9137-5; Noguchi T, 2015, BBA-BIOENERGETICS, V1847, P35, DOI 10.1016/j.bbabio.2014.06.009; Noguchi T, 2013, BIOMED SPECTROSC IMA, V2, P115, DOI 10.3233/BSI-130040; Noguchi T, 2012, BIOCHEMISTRY-US, V51, P3205, DOI 10.1021/bi300294n; Ogata K, 2013, J AM CHEM SOC, V135, P15670, DOI 10.1021/ja404317d; Petrouleas V, 2005, ADV PHOTO RESPIRAT, V22, P177; Pokhrel R, 2015, BIOCHEMISTRY-US, V54, P1663, DOI 10.1021/bi501468h; Pokhrel R, 2013, BIOCHEMISTRY-US, V52, P4758, DOI 10.1021/bi301700u; Qian M, 1999, BIOCHEMISTRY-US, V38, P6070, DOI 10.1021/bi982331i; RAPPAPORT F, 1994, BBA-BIOENERGETICS, V1184, P178, DOI 10.1016/0005-2728(94)90222-4; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Renger G, 2012, BBA-BIOENERGETICS, V1817, P1164, DOI 10.1016/j.bbabio.2012.02.005; Rivalta I, 2011, BIOCHEMISTRY-US, V50, P6312, DOI 10.1021/bi200685w; Saito K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9488; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Sakamoto H, 2017, J AM CHEM SOC, V139, P2022, DOI 10.1021/jacs.6b11989; Sakashita N, 2017, BIOCHEMISTRY-US, V56, P3049, DOI 10.1021/acs.biochem.7b00220; Schlodder E, 1999, J BIOL CHEM, V274, P30387, DOI 10.1074/jbc.274.43.30387; Service RJ, 2014, BIOCHEMISTRY-US, V53, P1001, DOI 10.1021/bi401450y; Service RJ, 2011, BIOCHEMISTRY-US, V50, P63, DOI 10.1021/bi1015937; Service RJ, 2010, BIOCHEMISTRY-US, V49, P6655, DOI 10.1021/bi100730d; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; Shimada Y, 2009, BIOCHEMISTRY-US, V48, P6095, DOI 10.1021/bi900317a; Siegbahn PEM, 2012, PHYS CHEM CHEM PHYS, V14, P4849, DOI 10.1039/c2cp00034b; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Styring S, 2012, BBA-BIOENERGETICS, V1817, P76, DOI 10.1016/j.bbabio.2011.03.016; Su XD, 2017, SCIENCE, V357, P816, DOI 10.1126/science.aan0327; Suga M, 2017, NATURE, V543, P131, DOI 10.1038/nature21400; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Suzuki H, 2008, BIOCHEMISTRY-US, V47, P11024, DOI 10.1021/bi801580e; Suzuki H, 2013, BIOCHEMISTRY-US, V52, P4748, DOI 10.1021/bi301699h; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Tanaka A, 2017, J AM CHEM SOC, V139, P1718, DOI 10.1021/jacs.6b09666; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Vass I, 1996, PHOTOSYNTH RES, V48, P117, DOI 10.1007/BF00041002; Vassiliev S, 2012, BBA-BIOENERGETICS, V1817, P1671, DOI 10.1016/j.bbabio.2012.05.016; Vassiliev S, 2010, BIOCHEMISTRY-US, V49, P1873, DOI 10.1021/bi901900s; Wei XP, 2016, NATURE, V534, P69, DOI 10.1038/nature18020; Yamasato A, 2002, PLANT CELL PHYSIOL, V43, P540, DOI 10.1093/pcp/pcf066; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Young ID, 2016, NATURE, V540, P453, DOI 10.1038/nature20161	99	34	34	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20046	20057		10.1074/jbc.M117.815183	http://dx.doi.org/10.1074/jbc.M117.815183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046348	hybrid, Green Published			2022-12-28	WOS:000417696400012
J	Hershberger, KA; Abraham, DM; Martin, AS; Mao, L; Liu, J; Gu, HB; Locasale, JW; Hirschey, MD				Hershberger, Kathleen A.; Abraham, Dennis M.; Martin, Angelical S.; Mao, Lan; Liu, Juan; Gu, Hongbo; Locasale, Jason W.; Hirschey, Matthew D.			Sirtuin 5 is required for mouse survival in response to cardiac pressure overload	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiac hypertrophy; cardiac metabolism; metabolomics; proteomics; sirtuin	CAMKII ACTIVATION; IN-VIVO; PHOSPHORYLATION; HYPERTROPHY; METABOLISM; METABOLOMICS; SUCCINYLATION; MALONYLATION; DYSFUNCTION; GLYCOLYSIS	In mitochondria, the sirtuin SIRT5 is an NAD(+)-dependent protein deacylase that controls several metabolic pathways. Although a wide range of SIRT5 targets have been identified, the overall function of SIRT5 in organismal metabolic homeostasis remains unclear. Given that SIRT5 expression is highest in the heart and that sirtuins are commonly stress-response proteins, we used an established model of pressure overload-induced heart muscle hypertrophy caused by transverse aortic constriction (TAC) to determine SIRT5's role in cardiac stress responses. Remarkably, SIRT5KO mice had reduced survival upon TAC compared with wild-type mice but exhibited no mortality when undergoing a sham control operation. The increased mortality with TAC was associated with increased pathological hypertrophy and with key abnormalities in both cardiac performance and ventricular compliance. By combining high-resolution MS-based metabolomic and proteomic analyses of cardiac tissues from wild-type and SIRT5KO mice, we found several biochemical abnormalities exacerbated in the SIRT5KO mice, including apparent decreases in fatty acid oxidation and glucose oxidation as well as an overall decrease in mitochondrial NAD(+)/NADH. Together, these abnormalities suggest that SIRT5 deacylates protein substrates involved in cellular oxidative metabolism to maintain mitochondrial energy production. Overall, the functional and metabolic results presented here suggest an accelerated development of cardiac dysfunction in SIRT5KO mice in response to TAC, explaining increased mortality upon cardiac stress. Our findings reveal a key role for SIRT5 in maintaining cardiac oxidative metabolism under pressure overload to ensure survival.	[Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27701 USA; [Hershberger, Kathleen A.; Martin, Angelical S.; Liu, Juan; Locasale, Jason W.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Abraham, Dennis M.; Mao, Lan] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Abraham, Dennis M.; Mao, Lan] Duke Univ, Med Ctr, Duke Cardiovasc Physiol Core, Durham, NC 27710 USA; [Gu, Hongbo] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Div Endocrinol Metab & Nutr, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Hirschey, MD (corresponding author), Duke Mol Physiol Inst, 300 N Duke St, Durham, NC 27701 USA.	matthew.hirschey@duke.edu	Locasale, Jason W/ABE-6505-2020; Hershberger, Kathleen/AAP-2098-2020	Locasale, Jason W/0000-0002-7766-3502; Hershberger, Kathleen/0000-0002-3349-6140; Hirschey, Matthew/0000-0003-4541-5376	NIGMS, the National Institutes of Health [5T32GM007105-40]; NATIONAL CANCER INSTITUTE [R00CA168997] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL125905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018164] Funding Source: NIH RePORTER	NIGMS, the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kelsey Fisher-Wellman and also Howard Rockman and other members of the dissertation committee of K. A. H. for feedback on this work. The Duke University Pharmacological Sciences Training Program was supported by Training Grant 5T32GM007105-40 from the NIGMS, the National Institutes of Health.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Akki A, 2008, MOL CELL BIOCHEM, V311, P215, DOI 10.1007/s11010-008-9711-y; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Anderson KA, 2014, CELL, V159, DOI 10.1016/j.cell.2014.10.045; [Anonymous], 2014, SCI AM; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Chhoy P, 2016, PROTEINS CELL REGUL, V10, P105, DOI 10.1007/978-94-024-0962-8_5; Das A. M., 2011, P WORLD MED C PRAG 2, P135; Doenst T, 2013, CIRC RES, V113, P709, DOI 10.1161/CIRCRESAHA.113.300376; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engelhardt S, 1996, J AM COLL CARDIOL, V27, P146, DOI 10.1016/0735-1097(95)00425-4; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; FRITZ IB, 1961, PHYSIOL REV, V41, P52, DOI 10.1152/physrev.1961.41.1.52; Hershberger KA, 2017, NAT REV NEPHROL, V13, P213, DOI 10.1038/nrneph.2017.5; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Horton JL, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84897; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Krebs H.A., 1971, ADV ENZYME REGUL, V9, P387, DOI [10.1016/S0065-2571(71)80055-9, DOI 10.1016/S0065-2571(71)80055-9]; Lamba S, 2000, Heart Fail Rev, V5, P7; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Martin AS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93885; Nakamura Y, 2012, FEBS LETT, V586, P4076, DOI 10.1016/j.febslet.2012.10.009; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Riehle C, 2012, TRENDS CARDIOVAS MED, V22, P98, DOI 10.1016/j.tcm.2012.07.003; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sankaralingam S, 2015, PULM CIRC, V5, P15, DOI 10.1086/679608; Stokes MP, 2015, PROTEOMES, V3, DOI [10.3390/proteomes3030160, 10.3390/proteomes3030159]; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; van Oort RJ, 2010, HYPERTENSION, V55, P932, DOI 10.1161/HYPERTENSIONAHA.109.146449; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zhang WB, 2016, AGING CELL, V15, P39, DOI 10.1111/acel.12408; Zhang YX, 2017, J BIOL CHEM, V292, P10239, DOI 10.1074/jbc.M117.785022	55	50	51	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19767	19781		10.1074/jbc.M117.809897	http://dx.doi.org/10.1074/jbc.M117.809897			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972174	Green Published, hybrid			2022-12-28	WOS:000416911300021
J	Kinsella, RL; Lopez, J; Palmer, LD; Salinas, ND; Skaar, EP; Tolia, NH; Feldman, MF				Kinsella, Rachel L.; Lopez, Juvenal; Palmer, Lauren D.; Salinas, Nichole D.; Skaar, Eric P.; Tolia, Niraj H.; Feldman, Mario F.			Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence in Acinetobacter species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; bacterial toxin; chaperone; metalloprotease; type II secretion system (T2SS)	GRAM-NEGATIVE BACTERIA; STRUCTURAL INSIGHTS; BIOFILM FORMATION; BAUMANNII; SYSTEM; GLYCOSYLATION; EPIDEMIOLOGY; MEMBRANE; SURVIVAL	Acinetobacter baumannii, Acinetobacter nosocomialis, and Acinetobacter pittii are a frequent cause of multidrug-resistant, healthcare-associated infections. Our previous work demonstrated that A. nosocomialis M2 possesses a functional type II secretion system (T2SS) that is required for full virulence. Further, we identified the metallo-endopeptidase CpaA, which has been shown previously to cleave human Factor V and deregulate blood coagulation, as the most abundant type II secreted effector protein. We also demonstrated that its secretion is dependent on CpaB, a membrane-bound chaperone. In this study, we show that CpaA expression and secretion are conserved across several medically relevant Acinetobacter species. Additionally, we demonstrate that deletion of cpaA results in attenuation of A. nosocomialis M2 virulence in moth and mouse models. The virulence defects resulting from the deletion of cpaA were comparable with those observed upon abrogation of T2SS activity. The virulence defects resulting from the deletion of cpaA are comparable with those observed upon abrogation of T2SS activity. We also show that CpaA and CpaB strongly interact, forming a complex in a 1:1 ratio. Interestingly, deletion of the N-terminal transmembrane domain of CpaB results in robust secretion of CpaA and CpaB, indicating that the transmembrane domain is dispensable for CpaA secretion and likely functions to retain CpaB inside the cell. Limited proteolysis of spheroplasts revealed that the C-terminal domain of CpaB is exposed to the periplasm, suggesting that this is the site where CpaA and CpaB interact in vivo. Last, we show that CpaB does not abolish the proteolytic activity of CpaA against human Factor V. We conclude that CpaA is, to the best of our knowledge, the first characterized, bona fide virulence factor secreted by Acinetobacter species.	[Kinsella, Rachel L.; Lopez, Juvenal; Salinas, Nichole D.; Tolia, Niraj H.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA; [Kinsella, Rachel L.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Palmer, Lauren D.; Skaar, Eric P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Washington University (WUSTL); University of Alberta; Vanderbilt University	Feldman, MF (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, Campus Box 8230, St Louis, MO 63110 USA.	mariofeldman@wustl.edu	Tolia, Niraj H/D-2332-2014; Feldman, Mario/A-2637-2014	Tolia, Niraj H/0000-0002-2689-1337; Salinas, Nichole/0000-0003-4105-3718; Feldman, Mario/0000-0003-4497-0976; Lopez, Juvenal/0000-0002-3433-2412	Department of Molecular Microbiology at Washington University School of Medicine; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD); Washington University Schleshinger awards; Washington University Chancellor's graduate fellowship; National Institutes of Health [F32AI122516, T32HL094296]; National Institutes of Health Grant [R01 AI101171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101171, F32AI122516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER	Department of Molecular Microbiology at Washington University School of Medicine; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Washington University Schleshinger awards; Washington University Chancellor's graduate fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a startup fund to M. F. F. from the Department of Molecular Microbiology at Washington University School of Medicine. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarships-Doctoral Program (NSERC PGSD) and Washington University Schleshinger awards.; Supported by a Washington University Chancellor's graduate fellowship.; Funded by National Institutes of Health Grants F32AI122516 and T32HL094296.; Funded by National Institutes of Health Grant R01 AI101171.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Chusri S, 2014, ANTIMICROB AGENTS CH, V58, P4172, DOI 10.1128/AAC.02992-14; Cisneros JM, 2002, CLIN MICROBIOL INFEC, V8, P687, DOI 10.1046/j.1469-0691.2002.00487.x; Costa TRD, 2015, NAT REV MICROBIOL, V13, P343, DOI 10.1038/nrmicro3456; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; El Khattabi M, 1999, MOL GEN GENET, V261, P770; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P579, DOI 10.1111/j.1365-2958.1993.tb01718.x; Fujieda M, 2012, INFECT IMMUN, V80, P2053, DOI 10.1128/IAI.06232-11; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; KESSLER E, 1994, J BIOL CHEM, V269, P22726; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; McCoy-Simandle K, 2011, INFECT IMMUN, V79, P1984, DOI 10.1128/IAI.01077-10; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Nivaskumar M, 2014, BBA-MOL CELL RES, V1843, P1568, DOI 10.1016/j.bbamcr.2013.12.020; Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x; Park YK, 2012, INT J ANTIMICROB AG, V39, P81, DOI 10.1016/j.ijantimicag.2011.08.006; Pineau C, 2014, MOL MICROBIOL, V94, P126, DOI 10.1111/mmi.12744; Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; SCHNAITMAN CA, 1971, J BACTERIOL, V108, P553, DOI 10.1128/JB.108.1.553-563.1971; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; Weber BS, 2017, TRENDS MICROBIOL, V25, P533, DOI 10.1016/j.tim.2017.01.005; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Wendt C, 1997, J CLIN MICROBIOL, V35, P1394, DOI 10.1128/JCM.35.6.1394-1397.1997; World Health Organization, 2017, GLOBAL PRIORITY LIST, DOI DOI 10.1016/S1473-3099(09)70222-1; Yan ZF, 2017, NAT STRUCT MOL BIOL, V24, P177, DOI 10.1038/nsmb.3350	50	22	22	4	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19628	19638		10.1074/jbc.M117.808394	http://dx.doi.org/10.1074/jbc.M117.808394			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28982978	Green Published, hybrid			2022-12-28	WOS:000416911300011
J	Cook, JH; Ueno, N; Lodoen, MB				Cook, Joshua H.; Ueno, Norikiyo; Lodoen, Melissa B.			Toxoplasma gondii disrupts beta 1 integrin signaling and focal adhesion formation during monocyte hypermotility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; FLUIDIC SHEAR-STRESS; DENDRITIC CELLS; PARASITE DISSEMINATION; NANOSCALE ARCHITECTURE; INTEGRIN ACTIVATION; STRUCTURAL BASIS; IN-VIVO; MOTILITY; PYK2	The motility of blood monocytes is orchestrated by the activity of cell-surface integrins, which translate extracellular signals into cytoskeletal changes to mediate adhesion and migration. Toxoplasma gondii is an intracellular parasite that infects migratory cells and enhances their motility, but the mechanisms underlying T. gondii-induced hypermotility are incompletely understood. We investigated the molecular basis for the hypermotility of primary human peripheral blood monocytes and THP-1 cells infected with T. gondii. Compared with uninfected monocytes, T. gondii infection of monocytes reduced cell spreading and the number of activated beta 1 integrin clusters in contact with fibronectin during settling, an effect not observed in monocytes treated with lipopolysaccharide (LPS) or Escherichia coli. Furthermore, T. gondii infection disrupted the phosphorylation of focal adhesion kinase (FAK) at tyrosine 397 (Tyr397) and Tyr-925 and of the related protein proline-rich tyrosine kinase (Pyk2) at Tyr-402. The localization of paxillin, FAK, and vinculin to focal adhesions and the colocalization of these proteins with activated beta 1 integrins were also impaired in T. gondii-infected monocytes. Using time-lapse confocal microscopy of THP-1 cells expressing enhanced GFP (eGFP)-FAK during settling on fibronectin, we found that T. gondii-induced monocyte hypermotility was characterized by a reduced number of enhanced GFP-FAK-containing clusters over time compared with uninfected cells. This study demonstrates an integrin conformation-independent regulation of the beta 1 integrin adhesion pathway, providing further insight into the molecular mechanism of T. gondii-induced monocyte hypermotility.	Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lodoen, MB (corresponding author), 3238 McGaugh Hall, Irvine, CA 92617 USA.	mlodoen@uci.edu		Cook, Joshua/0000-0001-9815-6879	National Institutes of Health [R01 A1120846-02]; American Cancer Society [126688-RSG-14-202-01-MPC]; American Heart Association [13POST14580034, 15POST25550021]; UCI Undergraduate Research Opportunity Program; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR001414]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); UCI Undergraduate Research Opportunity Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01 A1120846-02 (to M. B. L), American Cancer Society Grant 126688-RSG-14-202-01-MPC (to M. B. L.), American Heart Association Postdoctoral Fellowships 13POST14580034 and 15POST25550021 (to N. U.), and UCI Undergraduate Research Opportunity Program Grants (to J. H. C.). This work was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR001414.The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Coombes JL, 2013, P NATL ACAD SCI USA, V110, pE1913, DOI 10.1073/pnas.1220272110; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Dunay IR, 2010, CURR OPIN IMMUNOL, V22, P461, DOI 10.1016/j.coi.2010.04.008; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Fuks JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003051; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Harker KS, 2013, J LEUKOCYTE BIOL, V93, P789, DOI 10.1189/jlb.1012517; Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004; ILLC D, 1995, NATURE, V377, P539; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Kanatani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139104; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Klingbeil CK, 2001, J CELL BIOL, V152, P97, DOI 10.1083/jcb.152.1.97; Lambert H, 2006, CELL MICROBIOL, V8, P1611, DOI 10.1111/j.1462-5822.2006.00735.x; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Morgado P, 2014, INFECT IMMUN, V82, P4047, DOI 10.1128/IAI.01615-14; Persat F, 2012, J LEUKOCYTE BIOL, V92, P1241, DOI 10.1189/jlb.1211600; Ruest PJ, 2000, CELL GROWTH DIFFER, V11, P41; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Su Y, 2016, P NATL ACAD SCI USA, V113, pE3872, DOI 10.1073/pnas.1605074113; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Turner CE, 2000, J CELL SCI, V113, P4139; Ueno N, 2015, IMMUNOL CELL BIOL, V93, P508, DOI 10.1038/icb.2014.106; Ueno N, 2014, CELL MICROBIOL, V16, P580, DOI 10.1111/cmi.12239; Watson JM, 2001, J BIOL CHEM, V276, P3536, DOI 10.1074/jbc.M006916200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Weidner JM, 2016, CELL MICROBIOL, V18, P1537, DOI 10.1111/cmi.12595; Weidner JM, 2013, CELL MICROBIOL, V15, P1735, DOI 10.1111/cmi.12145; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Wong BCK, 2006, CLIN CANCER RES, V12, P2512, DOI 10.1158/1078-0432.CCR-05-2572; Yano H, 2004, J CELL BIOL, V166, P283, DOI 10.1083/jcb.200312013; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050	60	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3374	3385		10.1074/jbc.M117.793281	http://dx.doi.org/10.1074/jbc.M117.793281			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29295815	Green Published, hybrid			2022-12-28	WOS:000426562800028
J	Haskamp, V; Karrie, S; Mingers, T; Barthels, S; Alberge, F; Magalon, A; Muller, K; Bill, E; Lubitz, W; Kleeberg, K; Schweyen, P; Broring, M; Jahn, M; Jahn, D				Haskamp, Vera; Karrie, Simone; Mingers, Toni; Barthels, Stefan; Alberge, Francois; Magalon, Axel; Mueller, Katrin; Bill, Eckhard; Lubitz, Wolfgang; Kleeberg, Kirstin; Schweyen, Peter; Broering, Martin; Jahn, Martina; Jahn, Dieter			The radical SAM protein HemW is a heme chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III OXIDASE HEMN; COLI NITRATE REDUCTASE; QUINOL OXIDATION SITE; IRON-SULFUR PROTEINS; ESCHERICHIA-COLI; BINDING PROTEIN; SEMIQUINONE INTERMEDIATE; PSEUDOMONAS-AERUGINOSA; BIOSYNTHESIS; BIOGENESIS	Radical S-adenosylmethionine (SAM) enzymes exist in organisms from all kingdoms of life, and all of these proteins generate an adenosyl radical via the homolytic cleavage of the S-C(5') bond of SAM. Of particular interest are radical SAM enzymes, such as heme chaperones, that insert heme into respiratory enzymes. For example, heme chaperones insert heme into target proteins but have been studied only for the formation of cytochrome c-type hemoproteins. Here, we report that a radical SAM protein, the heme chaperone HemW from bacteria, is required for the insertion of heme b into respiratory chain enzymes. As other radical SAM proteins, HemW contains three cysteines and one SAM coordinating an [4Fe-4S] cluster, and we observed one heme per subunit of HemW. We found that an intact iron-sulfur cluster was required for HemW dimerization and HemW-catalyzed heme transfer but not for stable heme binding. A bacterial two-hybrid system screen identified bacterioferritins and the heme-containing subunit NarI of the respiratory nitrate reductase NarGHI as proteins that interact with HemW. We also noted that the bacterioferritins potentially serve as heme donors for HemW. Of note, heme that was covalently bound to HemW was actively transferred to a heme-depleted, catalytically inactive nitrate reductase, restoring its nitrate-reducing enzyme activity. Finally, the human HemW orthologue radical SAM domain-containing 1 (RSAD1) stably bound heme. In conclusion, our findings indicate that the radical SAM protein family HemW/RSAD1 is a heme chaperone catalyzing the insertion of heme into hemoproteins.	[Haskamp, Vera; Karrie, Simone; Mingers, Toni; Barthels, Stefan; Mueller, Katrin; Jahn, Martina] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Kleeberg, Kirstin; Schweyen, Peter; Broering, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Inorgan & Analyt Chem, D-38106 Braunschweig, Germany; [Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Ctr Integrated Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany; [Alberge, Francois; Magalon, Axel] Aix Marseille Univ, CNRS, UMR7283, Lab Chim Bacterienne, F-13009 Marseille, France; [Bill, Eckhard; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Max Planck Society	Jahn, D (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig Ctr Integrated Syst Biol BRICS, Rebenring 56, D-38106 Braunschweig, Germany.	d.jahn@tu-bs.de	Schweyen, Peter/AAP-5374-2020	/0000-0002-1784-3640; Schweyen, Peter/0000-0003-3222-0502; Jahn, Dieter/0000-0002-4064-9205; Magalon, Axel/0000-0002-3375-738X	Deutsche Forschungsgemeinschaft [Forschergruppe FOR1220 PROTRAIN]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Forschergruppe FOR1220 PROTRAIN). The authors declare that they have no conflicts of interest with the contents of this article.	Abicht HK, 2012, BIOCHEM J, V442, P335, DOI 10.1042/BJ20111618; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Byer AS, 2015, J BIOL CHEM, V290, P3987, DOI 10.1074/jbc.R114.578161; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Fluhe E, 2012, NAT CHEM BIOL, V8, P350, DOI [10.1038/NCHEMBIO.798, 10.1038/nchembio.798]; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Frey PA, 2011, BBA-PROTEINS PROTEOM, V1814, P1548, DOI 10.1016/j.bbapap.2011.03.005; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hannappel A, 2012, BBA-BIOENERGETICS, V1817, P928, DOI 10.1016/j.bbabio.2011.09.007; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kuhner M, 2016, CHEM SCI, V7, P4633, DOI 10.1039/c6sc01140c; LaMattina JW, 2016, P NATL ACAD SCI USA, V113, P12138, DOI 10.1073/pnas.1603209113; Lanciano P, 2007, BIOCHEMISTRY-US, V46, P5323, DOI 10.1021/bi700074y; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Layer G, 2005, J BIOL CHEM, V280, P29038, DOI 10.1074/jbc.M501275200; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Magalon A, 1997, J BIOL CHEM, V272, P25652, DOI 10.1074/jbc.272.41.25652; Mehta AP, 2015, J BIOL CHEM, V290, P3980, DOI 10.1074/jbc.R114.623793; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Peters JE, 2003, J BACTERIOL, V185, P2017, DOI 10.1128/JB.185.6.2017-2021.2003; Rendon J, 2015, BBA-BIOENERGETICS, V1847, P739, DOI 10.1016/j.bbabio.2015.05.001; Rouault TA, 2015, NAT REV MOL CELL BIO, V16, P45, DOI 10.1038/nrm3909; SANYAL I, 1994, BIOCHEMISTRY-US, V33, P3625, DOI 10.1021/bi00178a020; SASARMAN S, 1968, J BACTERIOL, V96, P570; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Storbeck S, 2009, FEBS J, V276, P5973, DOI 10.1111/j.1742-4658.2009.07306.x; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Unden G., 2014, ECOSAL PLUS, V6; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; XU KP, 1992, J BACTERIOL, V174, P3953, DOI 10.1128/jb.174.12.3953-3963.1992	40	22	22	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2558	2572		10.1074/jbc.RA117.000229	http://dx.doi.org/10.1074/jbc.RA117.000229			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29282292	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000425308300027
J	Guo, H; Sun, JH; Li, X; Xiong, Y; Wang, HT; Shu, H; Zhu, RM; Liu, Q; Huang, YM; Madley, R; Wang, YL; Cui, JQ; Arvan, P; Liu, M				Guo, Huan; Sun, Jinhong; Li, Xin; Xiong, Yi; Wang, Heting; Shu, Hua; Zhu, Ruimin; Liu, Qi; Huang, Yumeng; Madley, Rachel; Wang, Yulun; Cui, Jingqiu; Arvan, Peter; Liu, Ming			Positive charge in the n-region of the signal peptide contributes to efficient post-translational translocation of small secretory preproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						positive charge; signal peptide; n-region; secretory preprotein; translocation; signal peptide; n-region; protein translocation; protein translocation; protein synthesis; protein translocation; protein domain; protein translocation; protein export; protein inport; protein processing; protein targeting	ENDOPLASMIC-RETICULUM; RECOGNITION PARTICLE; TRANSLATION ELONGATION; PROTEIN TRANSLOCATION; MEMBRANE-PROTEINS; MUTATIONS; GENE; INHIBITION; TRANSPORT; CHAPERONE	Increasing evidence indicates that many small secretory preproteins can undergo post-translational translocation across the membrane of the endoplasmic reticulum. Although the cellular machinery involved in post-translational translocation of small secretory preproteins has begun to be elucidated, the intrinsic signals contained within these small secretory preproteins that contribute to their efficient post-translational translocation remain unknown. Here, we analyzed the eukaryotic secretory proteome and discovered the small secretory preproteins tend to have a higher probability to harbor the positive charge in the n-region of the signal peptide (SP). Eliminating the positive charge of the n-region blocked post-translational translocation of newly synthesized preproteins and selectively impaired translocation efficiency of small secretory preproteins. The pathophysiological significance of the positive charge in the n-region of SP was underscored by recently identified preproinsulin SP mutations that impair translocation of preproinsulin and cause maturity onset diabetes of youth (MODY). Remarkably, we have found that slowing the polypeptide elongation rate of small secretory preproteins could alleviate the translocation defect caused by loss of the n-region positive charge of the signal peptide. Together, these data reveal not only a previously unrecognized role of the n-region's positive charge in ensuring efficient post-translational translocation of small secretory preproteins, but they also highlight the molecular contribution of defects in this process to the pathogenesis of genetic disorders such as MODY.	[Guo, Huan; Sun, Jinhong; Li, Xin; Wang, Heting; Shu, Hua; Zhu, Ruimin; Liu, Qi; Huang, Yumeng; Cui, Jingqiu; Liu, Ming] Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China; [Guo, Huan; Sun, Jinhong; Xiong, Yi; Madley, Rachel; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Wang, Yulun] Tianjin Peoples Hosp, Div Endocrinol, Tianjin 300120, Peoples R China	Tianjin Medical University; University of Michigan System; University of Michigan	Liu, M (corresponding author), Tianjin Med Univ Gen Hosp, Dept Endocrinol & Metab, 154 Anshan Rd, Tianjin 300052, Peoples R China.; Arvan, P (corresponding author), Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA.	parvan@umich.edu; mingliu@tmu.edu.cn		Liu, Ming/0000-0003-2665-4072	National Natural Science Foundation of China [81070629, 81570699, 81620108004, 81370895]; National Institutes of Health [RO1-DK088856, RO1-DK-48280, R01-DK111174]; Protein Folding Disease Initiative of the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, P30DK020572, R01DK111174, R01DK088856] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Folding Disease Initiative of the University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China Research Grants 81070629, 81570699, 81620108004, and 81370895, National Institutes of Health Grants RO1-DK088856 (to M. L.), RO1-DK-48280 (to P. A.), and R01-DK111174, and the Protein Folding Disease Initiative of the University of Michigan. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15, DOI DOI 10.1186/1471-2105-9-S12-S15; Clerico EM, 2008, BIOPOLYMERS, V90, P307, DOI 10.1002/bip.20856; Cui JQ, 2015, J BIOL CHEM, V290, P28131, DOI 10.1074/jbc.M115.692350; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; DELTOUR L, 1995, DEV BIOL, V168, P686, DOI 10.1006/dbio.1995.1114; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Fujita H, 2010, MOL BIOL CELL, V21, P2045, DOI 10.1091/mbc.E09-12-1060; GENNITY J, 1990, J BIOENERG BIOMEMBR, V22, P233, DOI 10.1007/BF00763167; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Higy M, 2004, BIOCHEMISTRY-US, V43, P12716, DOI 10.1021/bi048368m; Ikegawa S, 1997, HUM MUTAT, V9, P131, DOI 10.1002/(SICI)1098-1004(1997)9:2<131::AID-HUMU5>3.3.CO;2-U; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; KARAPLIS AC, 1995, J BIOL CHEM, V270, P1629, DOI 10.1074/jbc.270.4.1629; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2015, MOL ASPECTS MED, V42, P3, DOI 10.1016/j.mam.2014.12.001; Liu M, 2014, VITAM HORM, V95, P35, DOI 10.1016/B978-0-12-800174-5.00002-8; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; Peterson JH, 2003, J BIOL CHEM, V278, P46155, DOI 10.1074/jbc.M309082200; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Rapoport TA, 2008, FEBS J, V275, P4471, DOI 10.1111/j.1742-4658.2008.06588.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Symoens S, 2009, HUM MUTAT, V30, pE395, DOI 10.1002/humu.20887; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Zhang DW, 2012, J BIOL CHEM, V287, P7652, DOI 10.1074/jbc.M111.325001; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	46	24	25	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1899	1907		10.1074/jbc.RA117.000922	http://dx.doi.org/10.1074/jbc.RA117.000922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29229776	Green Published, hybrid			2022-12-28	WOS:000424948000005
J	Shen, L; Liu, Y; Tso, P; Wang, DQH; Davidson, WS; Woods, SC; Liu, M				Shen, Ling; Liu, Yin; Tso, Patrick; Wang, David Q. -H.; Davidson, W. Sean; Woods, Stephen C.; Liu, Min			Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; estrogen receptor; apolipoprotein; small interfering RNA (siRNA); energy metabolism; obesity	CENTRAL-NERVOUS-SYSTEM; OVARIECTOMIZED RATS; BODY-WEIGHT; FOOD-INTAKE; GENE-EXPRESSION; ENERGY-BALANCE; DIETARY-FAT; MEAL SIZE; ESTRADIOL; ALPHA	We previously found that 17-estradiol (E2) stimulates apolipoprotein A-IV (apoA-IV) gene expression in the nucleus of the solitary tract (NTS) of lean ovariectomized (OVX) rodents. Here we report that in the NTS of high-fat diet-induced obese (DIO) rats, the apoA-IV mRNA level is significantly reduced and that the estrogenic effects on apoA-IV gene expression and food intake are impaired. E2 regulates apoA-IV gene expression through its nuclear receptor (ER), which requires co-activators, such as steroid receptor coactivator-1 (SRC-1), to facilitate the transcription of targeted genes. Interestingly, SRC-1 gene expression is significantly reduced in DIO OVX rats. SRC-1 is colocalized with apoA-IV in the cells of the NTS and E2 treatment enhances the recruitment of ER and SRC-1 to the estrogen response element at the apoA-V promoter, implying the participation of SRC-1 in E2's stimulatory effect on apoA-IV gene expression. Using small hairpin RNA (shRNA), which was validated in cultured neuronal cells, we found that SRC-1 gene knockdown specifically in the NTS significantly diminished E2's anorectic action, leading to increased food intake and body weight. More importantly, the stimulatory effect of E2 on apoA-IV gene expression in the NTS was significantly attenuated in SRC-1 knockdown rats. These results collectively demonstrate the critical roles of NTS SRC-1 in mediating E2's actions on food intake and apoA-IV gene expression and suggest that reduced levels of endogenous SRC-1 and apoA-IV expression are responsible for the impaired E2's anorectic action in obese females.	[Shen, Ling; Liu, Yin; Tso, Patrick; Davidson, W. Sean; Liu, Min] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Woods, Stephen C.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45237 USA; [Wang, David Q. -H.] Albert Einstein Coll Med, Dept Med, Div Gastroenterol & Liver Dis, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Yeshiva University; Albert Einstein College of Medicine	Liu, M (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA.	lium@uc.edu		Davidson, William/0000-0003-2756-2989	National Institutes of Health [DK92779, DK95440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL140962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, P30DK078392, R01DK092779, R01DK103557, P30DK041296, R01DK095440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA025737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants DK92779 and DK95440 (to M. L. and S. C. W). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835; Asarian L, 2007, ENDOCRINOLOGY, V148, P5656, DOI 10.1210/en.2007-0341; Asarian L, 2006, PHILOS T R SOC B, V361, P1251, DOI 10.1098/rstb.2006.1860; Asarian L, 2013, AM J PHYSIOL-REG I, V305, pR1215, DOI 10.1152/ajpregu.00446.2012; Billeci AMR, 2008, CURR VASC PHARMACOL, V6, P112, DOI 10.2174/157016108783955338; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Eckel LA, 2004, PHYSIOL BEHAV, V82, P35, DOI 10.1016/j.physbeh.2004.04.023; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FUJIMOTO K, 1993, J CLIN INVEST, V91, P1830, DOI 10.1172/JCI116395; Fukuhara M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45815; Geary N, 2001, ENDOCRINOLOGY, V142, P4751, DOI 10.1210/en.142.11.4751; Geary N, 2000, APPETITE, V35, P273, DOI 10.1006/appe.2000.0362; Geary N., 2007, SEX DIFFERENCES BRAI, P253; Giraud S, 2002, J BIOL CHEM, V277, P8004, DOI 10.1074/jbc.M111486200; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jutras Brandon L, 2012, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01f01s24; Kantor B, 2011, MOL THER, V19, P547, DOI 10.1038/mt.2010.277; Kuller LH, 1997, J AM DIET ASSOC, V97, pS9, DOI 10.1016/S0002-8223(97)00724-4; Lichtenstein AH, 1998, NUTR REV, V56, pS3; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; Liu M, 2004, AM J PHYSIOL-ENDOC M, V287, pE366, DOI 10.1152/ajpendo.00448.2003; Liu M, 2001, AM J PHYSIOL-REG I, V280, pR1382, DOI 10.1152/ajpregu.2001.280.5.R1382; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; May AA, 2016, PHYSIOL BEHAV, V165, P392, DOI 10.1016/j.physbeh.2016.08.025; May AA, 2016, PHYSIOL BEHAV, V163, P312, DOI 10.1016/j.physbeh.2016.05.019; Molenda-Figueira HA, 2008, ENDOCRINOLOGY, V149, P5272, DOI 10.1210/en.2008-0048; Na SY, 1998, J BIOL CHEM, V273, P10831, DOI 10.1074/jbc.273.18.10831; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; ONATE SA, 1995, SCIENCE, V270, P1354; Paxinos G., 2004, J CHEM INF MODEL, V5th; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Santollo J, 2007, AM J PHYSIOL-REG I, V293, pR2194, DOI 10.1152/ajpregu.00385.2007; Shen L, 2008, PHYSIOL BEHAV, V95, P161, DOI 10.1016/j.physbeh.2008.05.022; Shen L, 2008, DIABETES, V57, P2092, DOI 10.2337/db08-0291; Shen L, 2007, ENDOCRINOLOGY, V148, P2681, DOI 10.1210/en.2006-1596; Shen L, 2017, ONCOTARGET, V8, P84028, DOI 10.18632/oncotarget.21062; Shen L, 2014, ENDOCRINOLOGY, V155, P3882, DOI 10.1210/en.2014-1239; Shen L, 2010, ENDOCRINOLOGY, V151, P3163, DOI 10.1210/en.2010-0203; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith SN, 2015, J PAIN, V16, P283, DOI 10.1016/j.jpain.2014.12.007; Spary EJ, 2010, J NEUROENDOCRINOL, V22, P492, DOI 10.1111/j.1365-2826.2010.01977.x; Thammacharoen S, 2008, ENDOCRINOLOGY, V149, P1609, DOI 10.1210/en.2007-0340; Woods SC, 2004, PHYSIOL BEHAV, V83, P573, DOI 10.1016/j.physbeh.2004.07.026; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Xiong Y, 2010, DIABETES, V59, P2505, DOI 10.2337/db10-0315; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Yie JM, 1999, P NATL ACAD SCI USA, V96, P13108, DOI 10.1073/pnas.96.23.13108; Zhu LR, 2013, ENDOCRINOLOGY, V154, P150, DOI 10.1210/en.2012-2007; Zhu Z, 2013, HORM BEHAV, V63, P533, DOI 10.1016/j.yhbeh.2013.01.009	53	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2091	2101		10.1074/jbc.RA117.000237	http://dx.doi.org/10.1074/jbc.RA117.000237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29263093	hybrid, Green Published			2022-12-28	WOS:000424948000021
J	Huang, WG; Wang, XY; Endo-Streeter, S; Barrett, M; Waybright, J; Wohlfeld, C; Hajicek, N; Harden, TK; Sondek, J; Zhang, QS				Huang, Weigang; Wang, Xiaoyang; Endo-Streeter, Stuart; Barrett, Matthew; Waybright, Jarod; Wohlfeld, Christian; Hajicek, Nicole; Harden, T. Kendall; Sondek, John; Zhang, Qisheng			A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phospholipase C; lipid metabolism; inositol phospholipid; G protein-coupled receptor (GPCR); receptor tyrosine kinase; fluorogenic reporter	CATALYTIC DOMAIN; CONTINUOUS ASSAY; BETA; CA2+; PHOSPHOINOSITIDES; ACTIVATION; PLC; PROTEINS; BINDING; CELLS	A diverse group of cell-surface receptors, including many G protein-coupled receptors and receptor tyrosine kinases, activate phospholipase C (PLC) isozymes to hydrolyze phosphatidylinositol 4,5-bisphosphate into the second messengers diacylglycerol and 1,4,5-inositol trisphosphate. Consequently, PLCs control various cellular processes, and their aberrant regulation contributes to many diseases, including cancer, atherosclerosis, and rheumatoid arthritis. Despite the widespread importance of PLCs in human biology and disease, it has been impossible to directly monitor the real-time activation of these enzymes at membranes. To overcome this limitation, here we describe XY-69, a fluorogenic reporter that preferentially partitions into membranes and provides a selective tool for measuring the real-time activity of PLCs as either purified enzymes or in cellular lysates. Indeed, XY-69 faithfully reported the membrane-dependent activation of PLC-3 by G(q). Therefore, XY-69 can replace radioactive phosphatidylinositol 4,5-bisphosphate used in conventional PLC assays and will enable high-throughput screens to identify both orthosteric and allosteric PLC inhibitors. In the future, cell-permeable variants of XY-69 represent promising candidates for reporting the activation of PLCs in live cells with high spatiotemporal resolution.	[Huang, Weigang; Wang, Xiaoyang; Waybright, Jarod; Wohlfeld, Christian; Zhang, Qisheng] Univ North Carolina Chapel Hill, Div Chem Biol & Med Chem, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Endo-Streeter, Stuart; Barrett, Matthew; Hajicek, Nicole; Harden, T. Kendall; Sondek, John; Zhang, Qisheng] Univ North Carolina Chapel Hill, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Sondek, John] Univ North Carolina Chapel Hill, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Sondek, John; Zhang, Qisheng] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhang, QS (corresponding author), Eshelman Sch Pharm, Div Chem Biol & Med Chem, 125 Mason Farm Rd, Chapel Hill, NC 27599 USA.	qszhang@unc.edu		Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [GM098894, GM057391, CA177993]; University of North Carolina at Chapel Hill Small Grant Program; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA177993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057391, R01GM098894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill Small Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM098894 (to J. S. and Q. Z.), GM057391 (to J. S.), and CA177993 (to Q. Z.) and by University of North Carolina at Chapel Hill Small Grant Program (to W. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartlett PJ, 2005, J BIOL CHEM, V280, P21837, DOI 10.1074/jbc.M411843200; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Ellis MV, 1998, J BIOL CHEM, V273, P11650, DOI 10.1074/jbc.273.19.11650; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Grobler JA, 1998, BIOCHEMISTRY-US, V37, P5020, DOI 10.1021/bi972952w; Harden TK, 2009, J LIPID RES, V50, pS243, DOI 10.1194/jlr.R800045-JLR200; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Jenco JM, 1997, BIOCHEM J, V327, P431; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kataoka K, 2015, NAT GENET, V47, P1304, DOI 10.1038/ng.3415; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Kleusch C, 2012, MOLECULES, V17, P1055, DOI 10.3390/molecules17011055; Kubiak RJ, 2003, J ORG CHEM, V68, P960, DOI 10.1021/jo0206418; Martins M, 2014, P NATL ACAD SCI USA, V111, P4239, DOI 10.1073/pnas.1311500111; Mentel M, 2011, ANGEW CHEM INT EDIT, V50, P3811, DOI 10.1002/anie.201007796; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Ozaki S, 2000, P NATL ACAD SCI USA, V97, P11286, DOI 10.1073/pnas.210197897; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rukavishnikov AV, 1999, BIOORG MED CHEM LETT, V9, P1133, DOI 10.1016/S0960-894X(99)00166-3; Rusten TE, 2006, NAT METHODS, V3, P251, DOI 10.1038/nmeth867; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Subramanian D, 2010, NAT CHEM BIOL, V6, P324, DOI 10.1038/nchembio.348; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Wang XY, 2012, BIOCHEMISTRY-US, V51, P5300, DOI 10.1021/bi300637h; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Zaikova TO, 2001, BIOCONJUGATE CHEM, V12, P307, DOI 10.1021/bc0001138	36	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1728	1735		10.1074/jbc.RA117.000926	http://dx.doi.org/10.1074/jbc.RA117.000926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29263090	Green Published, hybrid			2022-12-28	WOS:000424201700023
J	Buckley, C; Nelson, RJ; Mullins, LJ; Sharp, MGF; Fleming, S; Kenyon, CJ; Semprini, S; Steppan, D; Peti-Peterdi, J; Kurtz, A; Christian, H; Mullins, JJ				Buckley, Charlotte; Nelson, Robert J.; Mullins, Linda J.; Sharp, Matthew G. F.; Fleming, Stewart; Kenyon, Christopher J.; Semprini, Sabrina; Steppan, Dominik; Peti-Peterdi, Janos; Kurtz, Armin; Christian, Helen; Mullins, John J.			Phenotypic dissection of the mouse Ren1d knockout by complementation with human renin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						granulation; human renin; juxtaglomerular; macula densa; renin; renin angiotensin system; electron microscopy (EM); confocal microscopy; immunochemistry; mouse; secretion; animal model; transgenic mice	MACULA DENSA; JUXTAGLOMERULAR CELLS; EXPRESSION; RELEASE; GENES; GRANULATION; INHIBITION; SECRETION; PRORENIN; DISTINCT	Normal renin synthesis and secretion is important for the maintenance of juxtaglomerular apparatus architecture. Mice lacking a functional Ren1d gene are devoid of renal juxtaglomerular cell granules and exhibit an altered macula densa morphology. Due to the species-specificity of renin activity, transgenic mice are ideal models for experimentally investigating and manipulating expression patterns of the human renin gene in a native cellular environment without confounding renin-angiotensin system interactions. A 55-kb transgene encompassing the human renin locus was crossed onto the mouse Ren1d-null background, restoring granulation in juxtaglomerular cells. Correct processing of human renin in dense core granules was confirmed by immunogold labeling. After stimulation of the renin-angiotensin system, juxtaglomerular cells contained rhomboid protogranules with paracrystalline contents, dilated rough endoplasmic reticulum, and electron-lucent granular structures. However, complementation of Ren1d(-/-) mice with human renin was unable to rescue the abnormality seen in macula densa structure. The juxtaglomerular apparatus was still able to respond to tubuloglomerular feedback in isolated perfused juxtaglomerular apparatus preparations, although minor differences in glomerular tuft contractility and macula densa cell calcium handling were observed. This study reveals that the human renin protein is able to complement the mouse Ren1d(-/-) non-granulated defect and suggests that granulopoiesis requires a structural motif that is conserved between the mouse Ren1d and human renin proteins. It also suggests that the altered macula densa phenotype is related to the activity of the renin-1d enzyme in a local juxtaglomerular renin-angiotensin system.	[Buckley, Charlotte; Nelson, Robert J.; Mullins, Linda J.; Sharp, Matthew G. F.; Kenyon, Christopher J.; Semprini, Sabrina; Mullins, John J.] Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Fleming, Stewart] Univ Dundee, Ninewells Hosp, Sch Med, Dundee DD1 9SY, Scotland; [Steppan, Dominik; Kurtz, Armin] Univ Regensburg, Physiol Inst, D-93053 Regensburg, Germany; [Peti-Peterdi, Janos] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Peti-Peterdi, Janos] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Christian, Helen] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Nelson, Robert J.] Novimmune SA, 14 Chemin Aulx, CH-1228 Geneva, Switzerland	University of Edinburgh; University of Dundee; University of Regensburg; University of Southern California; University of Southern California; University of Oxford; NovImmune SA	Buckley, C (corresponding author), Univ Edinburgh, Univ BHF Ctr Cardiovasc Sci, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.; Mullins, JJ (corresponding author), 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	cbuckley@exseed.ed.ac.uk; J.Mullins@ed.ac.uk		Buckley, Charlotte/0000-0002-7961-4544; Christian, Helen/0000-0002-4263-5499; Mullins, Linda/0000-0002-6743-8707	British Heart Foundation Centre of Research Excellence Ph.D. studentship Award [RE/08/001/23904]; Wellcome Trust Cardiovascular Research Initiative Ph.D. studentship Award [WT052633MA]; Shared Instrument Grant from the National Institutes of Health [1 S10 OD021833]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064324] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021833] Funding Source: NIH RePORTER	British Heart Foundation Centre of Research Excellence Ph.D. studentship Award; Wellcome Trust Cardiovascular Research Initiative Ph.D. studentship Award(Wellcome Trust); Shared Instrument Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by British Heart Foundation Centre of Research Excellence 4-year Ph.D. studentship Award RE/08/001/23904 (to C. B.) and Wellcome Trust Cardiovascular Research Initiative 4-year Ph.D. studentship Award WT052633MA (to R. J. N.). This work was also supported by Shared Instrument Grant 1 S10 OD021833 from the National Institutes of Health (to J. P-P). Published abstracts from this work were presented at Experimental Biology, April 20-24, 2013, Boston, MA and the Angiotensin Gorden Conference, February 21-26, 2016, Lucca, Italy. The authors declare that they have no conflicts of interest with the contents of this article.	ABEL KJ, 1990, GENETICS, V124, P937; ABEL KJ, 1988, NUCLEIC ACIDS RES, V16, P2111, DOI 10.1093/nar/16.5.2111; Abel MH, 2013, J NEUROENDOCRINOL, V25, P863, DOI 10.1111/jne.12081; BERKA JLA, 1990, J HYPERTENS, V8, P229; BERKA JLA, 1992, CELL TISSUE RES, V268, P141, DOI 10.1007/BF00338063; Christensen TH, 2015, EXP PHYSIOL, V100, P1362, DOI 10.1113/EP085177; Clark AF, 1997, J BIOL CHEM, V272, P18185, DOI 10.1074/jbc.272.29.18185; DICKINSON DP, 1984, GENETICS, V108, P651; GOLDSTONE R, 1983, J CLIN ENDOCR METAB, V56, P264, DOI 10.1210/jcem-56-2-264; GREENBERG SG, 1993, AM J PHYSIOL, V265, pF578, DOI 10.1152/ajprenal.1993.265.4.F578; HACKENTHAL E, 1990, PHYSIOL REV, V70, P1067, DOI 10.1152/physrev.1990.70.4.1067; Huerta-Ocampo I, 2005, ENDOCRINOLOGY, V146, P5012, DOI 10.1210/en.2005-0335; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; MULLINS JJ, 1982, EMBO J, V1, P1461, DOI 10.1002/j.1460-2075.1982.tb01338.x; Mullins LJ, 2000, J BIOL CHEM, V275, P40378, DOI 10.1074/jbc.M007315200; OGAWA K, 1995, ANAT RECORD, V243, P336, DOI 10.1002/ar.1092430308; OLIVER WJ, 1966, P SOC EXP BIOL MED, V122, P923; PANTHIER JJ, 1983, EMBO J, V2, P675, DOI 10.1002/j.1460-2075.1983.tb01483.x; Peti-Peterdi J, 1999, AM J PHYSIOL-RENAL, V277, pF472, DOI 10.1152/ajprenal.1999.277.3.F472; Peti-Peterdi J, 2003, J CLIN INVEST, V112, P76, DOI 10.1172/JCI200318018; Peti-Peterdi J, 2002, AM J PHYSIOL-RENAL, V282, pF324, DOI 10.1152/ajprenal.00251.2001; Peti-Peterdi J, 2000, AM J PHYSIOL-RENAL, V278, pF452, DOI 10.1152/ajprenal.2000.278.3.F452; Peti-Peterdi J, 2006, AM J PHYSIOL-RENAL, V291, pF473, DOI 10.1152/ajprenal.00425.2005; PICCINI N, 1982, CELL, V30, P205, DOI 10.1016/0092-8674(82)90026-5; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Sharp MGF, 1996, HYPERTENSION, V28, P1126, DOI 10.1161/01.HYP.28.6.1126; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; SKOTT O, 1987, SCIENCE, V237, P1618, DOI 10.1126/science.3306925; Steppan D, 2013, KIDNEY INT, V83, P233, DOI 10.1038/ki.2012.392; TOFFELMIRE EB, 1989, J CLIN INVEST, V83, P679, DOI 10.1172/JCI113932; Yan Y, 1998, CIRC RES, V83, P1279, DOI 10.1161/01.RES.83.12.1279; Yang TX, 2000, J BIOL CHEM, V275, P37922, DOI 10.1074/jbc.M006218200	32	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1151	1162		10.1074/jbc.RA117.000160	http://dx.doi.org/10.1074/jbc.RA117.000160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29123029	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000423515000005
J	Flynn, JD; McGlinchey, RP; Walker, RL; Lee, JC				Flynn, Jessica D.; McGlinchey, Ryan P.; Walker, Robert L., III; Lee, Jennifer C.			Structural features of alpha-synuclein amyloid fibrils revealed by Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; PARKINSONS-DISEASE; SECONDARY STRUCTURE; IN-VITRO; THIOFLAVINE-T; MUTANT FORMS; A-SYNUCLEIN; AGGREGATION; MUTATION; INSIGHTS	Parkinson's disease (PD) is associated with the formation of alpha-synuclein amyloid fibrils. Elucidating the role of these beta-sheet-rich fibrils in disease progression is crucial; however, collecting detailed structural information on amyloids is inherently difficult because of their insoluble, non-crystalline, and polymorphic nature. Here, we show that Raman spectroscopy is a facile technique for characterizing structural features of alpha-synuclein fibrils. Combining Raman spectroscopy with aggregation kinetics and transmission electron microscopy, we examined the effects of pH and ionic strength as well as four PD-related mutations (A30P, E46K, G51D, and A53T) on alpha-synuclein fibrils. Raman spectral differences were observed in the amide-I, amide-III, and fingerprint regions, indicating that secondary structure and tertiary contacts are influenced by pH and to a lesser extent by NaCl. Faster aggregation times appear to facilitate unique fibril structure as determined by the highly reproducible amide-I band widths, linking aggregation propensity and fibril polymorphism. Importantly, Raman spectroscopy revealed molecular-level perturbations of fibril conformation by the PD-related mutations that are not apparent through transmission electron microscopy or limited proteolysis. The amide-III band was found to be particularly sensitive, with G51D exhibiting the most distinctive features, followed by A53T and E46K. Relating to a cellular environment, our data would suggest that fibril polymorphs can be formed in different cellular compartments and potentially result in distinct phenotypes. Our work sets a foundation toward future cellular Raman studies of amyloids.	[Flynn, Jessica D.; McGlinchey, Ryan P.; Walker, Robert L., III; Lee, Jennifer C.] NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lee, JC (corresponding author), NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	Flynn, Jessica/G-1693-2017; Lee, Jennifer/E-9658-2015	Flynn, Jessica/0000-0002-9310-4882; Lee, Jennifer/0000-0003-0506-8349	National Institutes of Health, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006236] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Carey PR, 2006, ANNU REV PHYS CHEM, V57, P527, DOI 10.1146/annurev.physchem.57.032905.104521; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Dearborn AD, 2016, J BIOL CHEM, V291, P2310, DOI 10.1074/jbc.M115.698787; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ghosh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09228; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kurouski D, 2015, ANALYST, V140, P4967, DOI 10.1039/c5an00342c; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Louros NN, 2017, J STRUCT BIOL, V199, P140, DOI 10.1016/j.jsb.2017.06.002; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; McColl LH, 2003, J AM CHEM SOC, V125, P10019, DOI 10.1021/ja021464v; McGlinchey RP, 2017, BIOCHEMISTRY-US, V56, P3881, DOI 10.1021/acs.biochem.7b00360; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Mensch C, 2017, J RAMAN SPECTROSC, V48, P910, DOI 10.1002/jrs.5149; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petrucci S, 2016, PARKINSONISM RELAT D, V22, pS16, DOI 10.1016/j.parkreldis.2015.08.015; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ranjan P, 2017, ACS CHEM NEUROSCI, V8, P2235, DOI 10.1021/acschemneuro.7b00149; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Rygula A, 2013, J RAMAN SPECTROSC, V44, P1061, DOI 10.1002/jrs.4335; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Stefanis L, 2014, COLD SPRING HARB PER, V4, P1; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105	53	54	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					767	776		10.1074/jbc.M117.812388	http://dx.doi.org/10.1074/jbc.M117.812388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191831	hybrid, Green Published			2022-12-28	WOS:000422864500002
J	Prabhala, BK; Aduri, NG; Sharma, N; Shaheen, A; Sharma, A; Iqbal, M; Hansen, PR; Brasen, C; Gajhede, M; Rahman, M; Mirza, O				Prabhala, Bala K.; Aduri, Nanda G.; Sharma, Neha; Shaheen, Aqsa; Sharma, Arpan; Iqbal, Mazhar; Hansen, Paul R.; Brasen, Christoffer; Gajhede, Michael; Rahman, Moazur; Mirza, Osman			The prototypical proton-coupled oligopeptide transporter YdgR from Escherichia coli facilitates chloramphenicol uptake into bacterial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG EFFLUX PUMPS; PEPTIDE TRANSPORTER; E. COLI; HAEMOPHILUS-INFLUENZAE; SALMONELLA-TYPHI; RESISTANCE; PROTEIN; ANTIBIOTICS; RECOGNITION; MDFA	Chloramphenicol (Cam) is a broad-spectrum antibiotic used to combat bacterial infections in humans and animals. Cam export from bacterial cells is one of the mechanisms by which pathogens resist Cam's antibacterial effects, and several different proteins are known to facilitate this process. However, to date no report exists on any specific transport protein that facilitates Cam uptake. The proton-coupled oligopeptide transporter (POT) YdgR from Escherichia coli is a prototypical member of the POT family, functioning in proton-coupled uptake of di- and tripeptides. By following bacterial growth and conducting LC-MS-based assays we show here that YdgR facilitates Cam uptake. Some YdgR variants displaying reduced peptide uptake also exhibited reduced Cam uptake, indicating that peptides and Cam bind YdgR at similar regions. Homology modeling of YdgR, Cam docking, and mutational studies suggested a binding mode that resembles that of Cam binding to the multidrug resistance transporter MdfA. To our knowledge, this is the first report of Cam uptake into bacterial cells mediated by a specific transporter protein. Our findings suggest a specific bacterial transporter for drug uptake that might be targeted to promote greater antibiotic influx to increase cytoplasmic antibiotic concentration for enhanced cytotoxicity.	[Prabhala, Bala K.; Aduri, Nanda G.; Sharma, Neha; Sharma, Arpan; Hansen, Paul R.; Brasen, Christoffer; Gajhede, Michael; Mirza, Osman] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Shaheen, Aqsa; Iqbal, Mazhar; Rahman, Moazur] NIBGE, Hlth Biotechnol Div, Faisalabad, Pakistan	University of Copenhagen; Pakistan Institute of Engineering & Applied Science	Mirza, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark.	om@sund.ku.dk	Rahman, Moazur/C-5515-2019; Iqbal, Mazhar/C-5536-2019	Rahman, Moazur/0000-0003-2892-1250; Iqbal, Mazhar/0000-0002-8675-1125; Gajhede, Michael/0000-0001-9864-2287; Aduri, Nanda Gowtham/0000-0003-4301-7446; Prabhala, Bala Krishna/0000-0002-0165-3113; Mirza, Osman Asghar/0000-0001-9435-0690; Sharma, Neha/0000-0002-8653-4921; Hansen, Paul Robert/0000-0001-9357-8001	Faculty of Health and Medical Sciences, University of Copenhagen	Faculty of Health and Medical Sciences, University of Copenhagen	This work was supported by the Faculty of Health and Medical Sciences, University of Copenhagen (to A.N.G. and P.B.K.). The authors declare that they have no conflicts of interest with the contents of this article.	ABDELSAYED S, 1987, J ANTIMICROB CHEMOTH, V19, P7, DOI 10.1093/jac/19.1.7; Aduri NG, 2015, J BIOL CHEM, V290, P29931, DOI 10.1074/jbc.M115.675603; Aygul A, 2015, MIKROBIYOL BUL, V49, P278, DOI 10.5578/mb.8964; BISSONNETTE L, 1991, J BACTERIOL, V173, P4493, DOI 10.1128/JB.173.14.4493-4502.1991; BURNS JL, 1987, J GEN MICROBIOL, V133, P1273; Chang C, 2006, DRUG METAB DISPOS, V34, P1976, DOI 10.1124/dmd.106.012351; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Ernst HA, 2009, BIOCHEM BIOPH RES CO, V389, P112, DOI 10.1016/j.bbrc.2009.08.098; Ford D, 2003, HISTOCHEM CELL BIOL, V119, P37, DOI 10.1007/s0418-002-0479-y; Franje CA, 2010, J PHARMACEUT BIOMED, V53, P869, DOI 10.1016/j.jpba.2010.06.013; GRUHZIT OM, 1949, J CLIN INVEST, V28, P943, DOI 10.1172/JCI102184; Guettou F, 2014, NAT STRUCT MOL BIOL, V21, P728, DOI 10.1038/nsmb.2860; Hanekamp JC, 2015, ENVIRON TOXICOL PHAR, V39, P213, DOI 10.1016/j.etap.2014.11.016; Harder D, 2008, FAKULTAT WISSENSCHAF, P121; Harder D, 2008, FEBS J, V275, P3290, DOI 10.1111/j.1742-4658.2008.06477.x; Heng J, 2015, CELL RES, V25, P1060, DOI 10.1038/cr.2015.94; Jensen JM, 2014, INT J BIOCHEM CELL B, V55, P311, DOI 10.1016/j.biocel.2014.09.016; Jensen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047780; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2012, INT J MOL SCI, V13, P4484, DOI 10.3390/ijms13044484; Lee SH, 2013, TOX RESEARCH, V29, P107, DOI 10.5487/TR.2013.29.2.107; Lewinson O, 2003, P NATL ACAD SCI USA, V100, P1667, DOI 10.1073/pnas.0435544100; Lewinson O, 2006, MOL MICROBIOL, V61, P277, DOI 10.1111/j.1365-2958.2006.05254.x; MORTIMER PGS, 1993, J ANTIMICROB CHEMOTH, V32, P195, DOI 10.1093/jac/32.2.195; Newstead S, 2015, BBA-GEN SUBJECTS, V1850, P488, DOI 10.1016/j.bbagen.2014.05.011; Opperman TJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00421; Paixao Laura, 2009, J Biol Eng, V3, P18, DOI 10.1186/1754-1611-3-18; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poole K, 2000, ANTIMICROB AGENTS CH, V44, P2233, DOI 10.1128/AAC.44.9.2233-2241.2000; Prabhala BK, 2017, RES MICROBIOL, V168, P443, DOI 10.1016/j.resmic.2017.01.005; Prabhala BK, 2015, INT J PEPT RES THER, V21, P1, DOI 10.1007/s10989-014-9427-7; Prabhala BK, 2014, FEBS LETT, V588, P560, DOI 10.1016/j.febslet.2014.01.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schindler BD, 2013, FUTURE MICROBIOL, V8, P491, DOI [10.2217/FMB.13.16, 10.2217/fmb.13.16]; Shaheen A, 2015, J INFECT CHEMOTHER, V21, P357, DOI 10.1016/j.jiac.2015.01.002; Srikumar R, 1997, J BIOL CHEM, V272, P13614, DOI 10.1074/jbc.272.21.13614; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; TORO CS, 1990, ANTIMICROB AGENTS CH, V34, P1715, DOI 10.1128/AAC.34.9.1715; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Xu ZL, 2015, ANTIBIOTICS-BASEL, V4, P379, DOI 10.3390/antibiotics4030379	43	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1007	1017		10.1074/jbc.M117.805960	http://dx.doi.org/10.1074/jbc.M117.805960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150447	hybrid, Green Published			2022-12-28	WOS:000422864500021
J	Bhide, GP; Zapater, JL; Colley, KJ				Bhide, Gaurang P.; Zapater, Joseph L.; Colley, Karen J.			Autopolysialylation of polysialyltransferases is required for polysialylation and polysialic acid chain elongation on select glycoprotein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neural cell adhesion molecule; neuropilin-2; polysialic acid; polysialyltransferase; synaptic cell adhesion molecule; sialic acid; sialyltransferase; glycoprotein biosynthesis; glycosylation; glycosyltransferase	CELL-ADHESION MOLECULE; SWISS-MODEL; ST8SIA IV; N-CAM; AMINO-ACIDS; SYNCAM 1; PROTEIN; NEUROPILIN-2; BIOSYNTHESIS; SEQUENCES	Polysialic acid (polySia) is a large glycan polymer that is added to some glycoproteins by two polysialyltransferases (polySTs), ST8Sia-II and ST8Sia-IV. As polySia modulates cell adhesion and signaling, immune cell function, and tumor metastasis, it is of interest to determine how the polySTs recognize their select substrates. We have recently identified residues within the ST8Sia-IV polybasic region (PBR) that are required for neural cell adhesion molecule (NCAM) recognition and subsequent polysialylation. Here, we compared the PBR sequence requirements for NCAM, neuropilin-2 (NRP-2), and synaptic cell adhesion molecule 1 (SynCAM 1) for polysialylation by their respective polySTs. We found that the polySTs use unique but overlapping sets of PBR residues for substrate recognition, that the NCAM-recognizing PBR sites in ST8Sia-II and ST8Sia-IV include homologous residues, but that the ST8Sia-II site is larger, and that fewer PBR residues are involved in NRP-2 and SynCAM 1 recognition than in NCAM recognition. Noting that the two sites for ST8Sia-IV autopolysialylation flank the PBR, we evaluated the role of PBR residues in autopolysialylation and found that the requirements for polyST autopolysialylation and substrate polysialylation overlap. These data together with the evaluation of the polyST autopolysialylation mechanism enabled us to further identify PBR residues potentially playing dual roles in substrate recognition and in polySia chain polymerization. Finally, we found that ST8Sia-IV autopolysialylation is required for NRP-2 polysialylation and that ST8Sia-II autopolysialylation promotes the polymerization of longer polySia chains on SynCAM 1, suggesting a critical role for polyST autopolysialylation in substrate selection and polySia chain elongation.	[Bhide, Gaurang P.; Zapater, Joseph L.; Colley, Karen J.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA; [Zapater, Joseph L.] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu		Bhide, Gaurang/0000-0002-6120-3747	National Institutes of Health [RO1 GM101949]; NIGMS [F31 GM096739]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM096739, R01GM101949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1 GM101949 (to K. J. C.) and NIGMS Fellowship F31 GM096739 (to J. L. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angata K, 2003, BIOCHIMIE, V85, P195, DOI 10.1016/S0300-9084(03)00051-8; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhide GP, 2017, BIOCHEMISTRY-US, V56, P1504, DOI 10.1021/acs.biochem.6b01221; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Bhide GP, 2016, J BIOL CHEM, V291, P9444, DOI 10.1074/jbc.M116.714329; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brenachot X, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00245; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Colley KJ, 2014, CRIT REV BIOCHEM MOL, V49, P498, DOI 10.3109/10409238.2014.976606; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; Foley DA, 2009, J BIOL CHEM, V284, P15505, DOI 10.1074/jbc.M809696200; Galuska CE, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6020027; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang RB, 2017, CURR TOP MED CHEM, V17, P2359, DOI 10.2174/1568026617666170414150730; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kiermaier E, 2016, SCIENCE, V351, P186, DOI 10.1126/science.aad0512; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; Rollenhagen M, 2013, J BIOL CHEM, V288, P22880, DOI 10.1074/jbc.M113.463927; Rollenhagen M, 2012, J BIOL CHEM, V287, P35170, DOI 10.1074/jbc.M112.375642; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sato C, 2013, J BIOCHEM, V154, P115, DOI 10.1093/jb/mvt057; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Thompson MG, 2013, J BIOL CHEM, V288, P7282, DOI 10.1074/jbc.M112.438374; Thompson MG, 2011, J BIOL CHEM, V286, P4525, DOI 10.1074/jbc.M110.200386; Toikka J, 1998, J BIOL CHEM, V273, P28557, DOI 10.1074/jbc.273.44.28557; Volkers G, 2015, NAT STRUCT MOL BIOL, V22, P627, DOI 10.1038/nsmb.3060; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Werneburg S, 2016, GLIA, V64, P1314, DOI 10.1002/glia.23004; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; Zhou GP, 2015, PROTEIN PEPTIDE LETT, V22, P137, DOI 10.2174/0929866521666141019192221; ZUBER C, 1992, J BIOL CHEM, V267, P9965	46	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					701	716		10.1074/jbc.RA117.000401	http://dx.doi.org/10.1074/jbc.RA117.000401			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183999	hybrid, Green Published			2022-12-28	WOS:000419915400024
J	Clerman, A; Noor, Z; Fishelevich, R; Lockatell, V; Hampton, BS; Shah, NG; Salcedo, MV; Todd, NW; Atamas, SP; Luzina, IG				Clerman, Andrew; Noor, Zahid; Fishelevich, Rita; Lockatell, Virginia; Hampton, Brian S.; Shah, Nirav G.; Salcedo, Mariah V.; Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.			The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast; nuclear translocation; proteasome; protein degradation; protein-protein interaction; interleukin-33	EPITHELIAL PROGENITOR CELLS; IMPORTIN-BETA; CYTOKINE IL-33; LUNG-DISEASE; IN-VIVO; INFLAMMATION; FAMILY; TRANSCRIPTION; EXPRESSION; CHROMATIN	Human mature IL-33 is a member of the IL-1 family and a potent regulator of immunity through its pro-T helper cell 2 activity. Its precursor form, full-length interleukin-33 (FLIL33), is an intranuclear protein in many cell types, including fibroblasts, and its intracellular levels can change in response to stimuli. However, the mechanisms controlling the nuclear localization of FLIL33 or its stability in cells are not understood. Here, we identified importin-5 (IPO5), a member of the importin family of nuclear transport proteins, as an intracellular binding partner of FLIL33. By overexpressing various FLIL33 protein segments and variants in primary human lung fibroblasts and HEK293T cells, we show that FLIL33, but not mature interleukin-33, physically interacts with IPO5 and that this interaction localizes to a cluster of charged amino acids (positions 46-56) but not to an adjacent segment (positions 61-67) in the FLIL33 N-terminal region. siRNA-mediated IPO5 knockdown in cell culture did not affect nuclear localization of FLIL33. However, the IPO5 knockdown significantly decreased the intracellular levels of overexpressed FLIL33, reversed by treatment with the 20S proteasome inhibitor bortezomib. Furthermore, FLIL33 variants deficient in IPO5 binding remained intranuclear and exhibited decreased levels, which were also restored by the bortezomib treatment. These results indicate that the interaction between FLIL33 and IPO5 is localized to a specific segment of the FLIL33 protein, is not required for nuclear localization of FLIL33, and protects FLIL33 from proteasome-dependent degradation.	[Clerman, Andrew; Noor, Zahid; Fishelevich, Rita; Lockatell, Virginia; Shah, Nirav G.; Salcedo, Mariah V.; Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.] Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Hampton, Brian S.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Hampton, Brian S.] Univ Maryland, Sch Med, Ctr Innovat Biomed Resources, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA; [Todd, Nevins W.; Atamas, Sergei P.; Luzina, Irina G.] Baltimore Vet Affairs Med Ctr, Res Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Atamas, SP (corresponding author), Univ Maryland, Sch Med, Dept Med, 10 S Pine St,MSTF 8-34, Baltimore, MD 21201 USA.	satamas@umaryland.edu	Hampton, Brian/G-8427-2015	Hampton, Brian/0000-0003-4650-2869	NHLBI, National Institutes of Health [R01HL126897]; Veterans Affairs Merit Awards [I01CX000101, I01BX002499]; Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126897] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000101, I01BX002499] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs Merit Awards(US Department of Veterans Affairs); Scleroderma Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R01HL126897 (to S. P. A.). This work was also supported by Veterans Affairs Merit Awards I01CX000101 (to I. G. L.) and I01BX002499 (to S. P. A.) and a Scleroderma Foundation award (to S. P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 2011, J IMMUNOL, V187, P1609, DOI 10.4049/jimmunol.1003080; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Baas R, 2016, J BIOL CHEM, V291, P24121, DOI 10.1074/jbc.M116.748582; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Bessa J, 2014, J AUTOIMMUN, V55, P33, DOI 10.1016/j.jaut.2014.02.012; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Chung KM, 2008, MOL CELLS, V26, P291; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De la Fuente M, 2015, CYTOKINE GROWTH F R, V26, P615, DOI 10.1016/j.cytogfr.2015.07.017; Deane R, 1997, MOL CELL BIOL, V17, P5087, DOI 10.1128/MCB.17.9.5087; Gordon ED, 2016, P NATL ACAD SCI USA, V113, P8765, DOI 10.1073/pnas.1601914113; Holtzman Michael J, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS287, DOI 10.1513/AnnalsATS.201402-056AW; Huber FM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14354; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kobayashi J, 2013, J MOL BIOL, V425, P1852, DOI 10.1016/j.jmb.2013.02.035; Kopach P., J BIOL CHEM, V289; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Luzina IG, 2015, CYTOKINE, V74, P88, DOI 10.1016/j.cyto.2014.11.008; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Luzina IG, 2012, J IMMUNOL, V189, P403, DOI 10.4049/jimmunol.1200259; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Murphy GEJ, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2009.120113; Ni YM, 2015, INT J MOL SCI, V16, P27956, DOI 10.3390/ijms161126063; Ohta S, 2016, CELL SIGNAL, V28, P1025, DOI 10.1016/j.cellsig.2016.04.013; Oshio T, 2017, J DERMATOL SCI, V85, P106, DOI 10.1016/j.jdermsci.2016.10.008; Pei C, 2014, IMMUNOLOGY, V141, P9, DOI 10.1111/imm.12174; Ross AE, 2003, MOL CELL BIOL, V23, P5308, DOI 10.1128/MCB.23.15.5308-5319.2003; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Shan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151701; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tao LQ, 2014, INT J CLIN EXP PATHO, V7, P4930; Wischnewski J, 2000, MECH DEVELOP, V95, P245, DOI 10.1016/S0925-4773(00)00337-3; Zhong YW, 2011, J BIOL CHEM, V286, P33921, DOI 10.1074/jbc.M111.272906	40	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21653	21661		10.1074/jbc.M117.807636	http://dx.doi.org/10.1074/jbc.M117.807636			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29127199	hybrid, Green Published			2022-12-28	WOS:000419013000039
J	Houliston, RS; Lemak, A; Iqbal, A; Ivanochko, D; Duan, SL; Kaustov, L; Ong, MS; Fan, LX; Senisterra, G; Brown, PJ; Wang, YX; Arrowsmith, CH				Houliston, R. Scott; Lemak, Alexander; Iqbal, Aman; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Fan, Lixin; Senisterra, Guillermo; Brown, Peter J.; Wang, Yun-Xing; Arrowsmith, Cheryl H.			Conformational dynamics of the TTD-PHD histone reader module of the UHRF1 epigenetic regulator reveals multiple histone-binding states, allosteric regulation, and druggability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; CHEMICAL PROBE; TUDOR DOMAIN; RECOGNITION; NMR; RESOLUTION; PROTEINS; MACROMOLECULES; PREDICTION; SCATTERING	UHRF1 is a key mediator of inheritance of epigenetic DNA methylation patterns during cell division and is a putative target for cancer therapy. Recent studies indicate that interdomain interactions critically influence UHRF1's chromatin-binding properties, including allosteric regulation of its histone binding. Here, using an integrative approach that combines small angle X-ray scattering, NMR spectroscopy, and molecular dynamics simulations, we characterized the dynamics of the tandem tudor domain-plant homeodomain (TTD-PHD) histone reader module, including its 20-residue interdomain linker. We found that the apo TTD-PHD module in solution comprises a dynamic ensemble of conformers, approximately half of which are compact conformations, with the linker lying in the TTD peptide-binding groove. These compact conformations are amenable to cooperative, high-affinity histone binding. In the remaining conformations, the linker position was in flux, and the reader adopted both extended and compact states. Using a small-molecule fragment screening approach, we identified a compound, 4-benzylpiperidine-1-carboximidamide, that binds to the TTD groove, competes with linker binding, and promotes open TTD-PHD conformations that are less efficient at H3K9me3 binding. Our work reveals a mechanism by which the dynamic TTD-PHD module can be allosterically targeted with small molecules to modulate its histone reader function for therapeutic or experimental purposes.	[Houliston, R. Scott; Lemak, Alexander; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Houliston, R. Scott; Lemak, Alexander; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Iqbal, Aman; Ong, Michelle S.; Senisterra, Guillermo; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Fan, Lixin] Leidos Biomed Res Inc, Small Angle Xray Scattering Core Facil, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Wang, Yun-Xing] NCI, NIH, Frederick, MD 21702 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Structural Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arrowsmith, CH (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	carrow@uhnresearch.ca		Kaustov, Lilia/0000-0002-8474-559X; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250	Princess Margaret Cancer Centre of the University Health Network; Argonne National Laboratory [DE-AC02-06CH11357]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant) [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust	Princess Margaret Cancer Centre of the University Health Network(University of Toronto); Argonne National Laboratory(United States Department of Energy (DOE)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	The operation of the Arrowsmith NMR facility is supported by the Princess Margaret Cancer Centre of the University Health Network. The shared Beamline 12-ID-B resource was allocated under Agreement PUP-24152 between the National Cancer Institute and the Argonne National Laboratory. Use of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility, was operated by the Argonne National Laboratory under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute (Grant OGI-055), Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alhosin M, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0453-5; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11197; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Goddard T.D., 2004, SPARKY 3; Harrison JS, 2016, ELIFE, V5, DOI 10.7554/eLife.17101; He YP, 2017, NAT CHEM BIOL, V13, P389, DOI 10.1038/nchembio.2306; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lallous N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027599; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Myrianthopoulos V, 2016, EUR J MED CHEM, V114, P390, DOI 10.1016/j.ejmech.2016.02.043; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rezaei-Ghaleh N, 2015, BIOINFORMATICS, V31, P1319, DOI 10.1093/bioinformatics/btu824; Rezaei-Ghaleh N, 2013, ANGEW CHEM INT EDIT, V52, P11410, DOI 10.1002/anie.201305094; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Stuckey JI, 2016, NAT CHEM BIOL, V12, P180, DOI 10.1038/nchembio.2007; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tauber M, 2015, NUCLEUS-PHILA, V6, P123, DOI 10.1080/19491034.2015.1026022; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Trotzier MA, 2004, BIOCHEM BIOPH RES CO, V319, P590, DOI 10.1016/j.bbrc.2004.05.028; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012; Yang J, 2017, ONCOGENE, V36, P4828, DOI 10.1038/onc.2017.96; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhou L, 2015, CANCER BIOL THER, V16, P1241, DOI 10.1080/15384047.2015.1056411	47	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20947	20959		10.1074/jbc.M117.799700	http://dx.doi.org/10.1074/jbc.M117.799700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074623	Green Published, hybrid			2022-12-28	WOS:000418453400012
J	Schneider, DJ; Speth, JM; Penke, LR; Wettlaufer, SH; Swanson, JA; Peters-Golden, M				Schneider, Daniel J.; Speth, Jennifer M.; Penke, Loka R.; Wettlaufer, Scott H.; Swanson, Joel A.; Peters-Golden, Marc			Mechanisms and modulation of microvesicle uptake in a model of alveolar cell communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TUMOR-DERIVED MICROVESICLES; COATED VESICLE FORMATION; CIGARETTE-SMOKE EXTRACT; EPIDERMAL-GROWTH-FACTOR; ACUTE LUNG INJURY; EXTRACELLULAR VESICLES; OXIDATIVE STRESS; EPITHELIAL-CELLS; MYOFIBROBLAST DIFFERENTIATION	Extracellular vesicles, including exosomes and shed microvesicles (MVs), can be internalized by recipient cells to modulate function. Although the mechanism by which extracellular vesicles are internalized is incompletely characterized, it is generally considered to involve endocytosis and an initial surface-binding event. Furthermore, modulation of uptake by microenvironmental factors is largely unstudied. Here, we used flow cytometry, confocal microscopy, and pharmacologic and molecular targeting to address these gaps in knowledge in a model of pulmonary alveolar cell-cell communication. Alveolar macrophage-derived MVs were fully internalized by alveolar epithelial cells in a time-, dose-, and temperature-dependent manner. Uptake was dependent on dynamin and actin polymerization. However, it was neither saturable nor dependent on clathrin or receptor binding. Internalization was enhanced by extracellular proteins but was inhibited by cigarette smoke extract via oxidative disruption of actin polymerization. We conclude that MV internalization occurs via a pathway more consistent with fluid-phase than receptor-dependent endocytosis and is subject to bidirectional modulation by relevant pathologic perturbations.	[Schneider, Daniel J.; Speth, Jennifer M.; Penke, Loka R.; Wettlaufer, Scott H.; Peters-Golden, Marc] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Swanson, Joel A.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Swanson, Joel A.; Peters-Golden, Marc] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	PENKE, LOKA RAGHU KUMAR/L-7255-2016; Swanson, Joel A/P-4362-2014	Swanson, Joel A/0000-0003-0900-8212; Schneider, Daniel/0000-0002-0344-2811; Speth, Jennifer/0000-0002-7724-6995; PENKE, LOKA RAGHU KUMAR/0000-0002-2780-7950	National Institutes of Health [R01 HL-125555, NIH RO1 HL-94311, T32 HL-774923, UL1TR000433, R01-GM 101189, R01-GM110215]; American Heart Association [15POST25280003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, R01HL125555, R01HL094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101189, R01GM110215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL-125555 and NIH RO1 HL-94311 (to M.P.-G.), T32 HL-774923 (to D.J.S. and J.M.S.), UL1TR000433(to J.M.S.), R01-GM 101189 and R01-GM110215 (to J.A.S.), and from the American Heart Association 15POST25280003 (to L.R.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Gaytan R, 2003, BIOCHEM BIOPH RES CO, V305, P510, DOI 10.1016/S0006-291X(03)00796-4; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Atay S, 2011, AM J REPROD IMMUNOL, V66, P259, DOI 10.1111/j.1600-0897.2011.00995.x; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, pL895, DOI 10.1152/ajplung.00180.2014; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Barth K, 2005, HISTOCHEM CELL BIOL, V124, P453, DOI 10.1007/s00418-005-0048-2; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Buchackert Y, 2012, J PHYSIOL-LONDON, V590, P5167, DOI 10.1113/jphysiol.2012.233403; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Cheng J, 2006, CELL BIOCHEM BIOPHYS, V45, P177, DOI 10.1385/CBB:45:2:177; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; Happonen KE, 2016, J BIOL CHEM, V291, P10586, DOI 10.1074/jbc.M115.699058; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL458, DOI 10.1152/ajplung.00237.2002; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Kosmider B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026059; LANNAN S, 1994, AM J PHYSIOL, V266, pL92, DOI 10.1152/ajplung.1994.266.1.L92; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Li XY, 1998, AM J RESP CRIT CARE, V157, P1027, DOI 10.1164/ajrccm.157.4.9605080; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; MILLER YE, 1989, EXP LUNG RES, V15, P635, DOI 10.3109/01902148909069623; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Monteil C, 1999, TOXICOLOGY, V133, P129, DOI 10.1016/S0300-483X(99)00015-3; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mougeolle A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122654; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Noda N, 2013, INT IMMUNOL, V25, P643, DOI 10.1093/intimm/dxt033; Nolte-'t Hoen ENM, 2013, J LEUKOCYTE BIOL, V93, P395, DOI 10.1189/jlb.0911480; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Oosthuyzen W, 2016, J AM SOC NEPHROL, V27, P3345, DOI 10.1681/ASN.2015050568; Palmer SE, 2015, CURR BIOL, V25, P868, DOI 10.1016/j.cub.2015.01.061; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Parry SN, 2008, KIDNEY BLOOD PRESS R, V31, P16, DOI 10.1159/000112921; Penke LRK, 2014, J BIOL CHEM, V289, P17151, DOI 10.1074/jbc.M114.558130; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schorey JS, 2016, J CLIN INVEST, V126, P1181, DOI 10.1172/JCI81132; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Sohrab S, 2009, FASEB J, V23, P3149, DOI 10.1096/fj.09-129304; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; SUNDQVIST T, 1993, ACTA PHYSIOL SCAND, V149, P127, DOI 10.1111/j.1748-1716.1993.tb09604.x; Takano M, 2012, LUNG, V190, P651, DOI 10.1007/s00408-012-9413-9; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Xu R, 2016, J CLIN INVEST, V126, P1152, DOI 10.1172/JCI81129; Yamada H, 2016, NEUROSCI LETT, V628, P179, DOI 10.1016/j.neulet.2016.06.030; Yumoto R, 2006, AM J PHYSIOL-LUNG C, V290, pL946, DOI 10.1152/ajplung.00173.2005; Yumoto R, 2012, DRUG METAB PHARMACOK, V27, P336, DOI 10.2133/dmpk.DMPK-11-RG-127; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	77	51	52	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20897	20910		10.1074/jbc.M117.792416	http://dx.doi.org/10.1074/jbc.M117.792416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29101235	Green Published, hybrid			2022-12-28	WOS:000418453400008
J	Kolobova, E; Roland, JT; Lapierre, LA; Williams, JA; Mason, TA; Goldenring, JR				Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Williams, Janice A.; Mason, Twila A.; Goldenring, James R.			The C-terminal region of A-kinase anchor protein 350 (AKAP350A) enables formation of microtubule-nucleation centers and interacts with pericentriolar proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						A-kinase anchoring protein (AKAP); centrosome; microscopy; microtubule; protein kinase A (PKA); AKAP450; AKAP9; Cdk5RAP2; Cep170; Cep68	TUBULIN RING COMPLEX; GOLGI-APPARATUS; CENTROSOME COHESION; TARGETING MOTIF; CENTRIOLE CYCLE; CELL-CYCLE; CDK5RAP2; AKAP450; CEP68; LOCALIZATION	Microtubules in animal cells assemble (nucleate) from both the centrosome and the cis-Golgi cisternae. A-kinase anchor protein 350 kDa (AKAP350A, also called AKAP450/CG-NAP/AKAP9) is a large scaffolding protein located at both the centrosome and Golgi apparatus. Previous findings have suggested that AKAP350 is important for microtubule dynamics at both locations, but how this scaffolding protein assembles microtubule nucleation machinery is unclear. Here, we found that overexpression of the C-terminal third of AKAP350A, enhanced GFP-AKAP350A(2691-3907), induces the formation of multiple microtubule-nucleation centers (MTNCs). Nevertheless, these induced MTNCs lacked true centriole proteins, such as Cep135. Mapping analysis with AKAP350A truncations demonstrated that AKAP350A contains discrete regions responsible for promoting or inhibiting the formation of multiple MTNCs. Moreover, GFP-AKAP350A(2691-3907) recruited several pericentriolar proteins to MTNCs, including -tubulin, pericentrin, Cep68, Cep170, and Cdk5RAP2. Proteomic analysis indicated that Cdk5RAP2 and Cep170 both interact with the microtubule nucleation-promoting region of AKAP350A, whereas Cep68 interacts with the distal C-terminal AKAP350A region. Yeast two-hybrid assays established a direct interaction of Cep170 with AKAP350A. Super-resolution and deconvolution microscopy analyses were performed to define the association of AKAP350A with centrosomes, and these studies disclosed that AKAP350A spans the bridge between centrioles, co-localizing with rootletin and Cep68 in the linker region. siRNA-mediated depletion of AKAP350A caused displacement of both Cep68 and Cep170 from the centrosome. These results suggest that AKAP350A acts as a scaffold for factors involved in microtubule nucleation at the centrosome and coordinates the assembly of protein complexes associating with the intercentriolar bridge.	[Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; [Mason, Twila A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Kolobova, Elena; Roland, Joseph T.; Lapierre, Lynne A.; Mason, Twila A.; Goldenring, James R.] Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, MRB 4,Rm 10435-G,2213 Garland Ave, Nashville, TN 37232 USA; [Goldenring, James R.] Nashville Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA; [Williams, Janice A.] Vanderbilt Cell Imaging Shared Resource, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Goldenring, JR (corresponding author), Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, MRB 4,Rm 10435-G,2213 Garland Ave, Nashville, TN 37232 USA.	jim.goldenring@vanderbilt.edu			National Institutes of Health [S10 OD012324, CA68485, DK20593, DK58404, HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, P60DK020593, P30DK020593, R01DK043405] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Fluorescence microscopy was performed through the use of the Vanderbilt University Cell Imaging Shared Resource, and MudPIT Proteomics was performed in the Vanderbilt Protein Mass Spectrometry Shared Resource supported by National Institutes of Health Grants S10 OD012324, CA68485, DK20593, DK58404, and HD15052. Deconvolution microscopy was performed in the Vanderbilt Digital Histology Shared Resource.	ALVEY PL, 1985, J CELL SCI, V78, P147; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Baetz NW, 2013, MOL BIOL CELL, V24, P643, DOI 10.1091/mbc.E12-09-0659; Bahe S, 2005, J CELL BIOL, V171, P27, DOI 10.1083/jcb.200504107; Barr AR, 2010, J CELL BIOL, V189, P23, DOI 10.1083/jcb.200912163; Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; Fang GL, 2014, J CELL SCI, V127, P1631, DOI 10.1242/jcs.139451; Fong KW, 2008, MOL BIOL CELL, V19, P115, DOI 10.1091/mbc.E07-04-0371; Fry AM, 2015, NAT CELL BIOL, V17, P3, DOI 10.1038/ncb3087; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL SCI, V120, P4321, DOI 10.1242/jcs.020248; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hanafusa H, 2015, NAT CELL BIOL, V17, P1024, DOI 10.1038/ncb3204; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jana SC, 2014, CURR OPIN CELL BIOL, V26, P96, DOI 10.1016/j.ceb.2013.12.001; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068523; Keryer G, 2003, MOL BIOL CELL, V14, P2436, DOI 10.1091/mbc.E02-09-0614; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087016; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Kraemer N, 2011, CELL MOL LIFE SCI, V68, P1719, DOI 10.1007/s00018-011-0635-4; KURIYAMA R, 1981, J CELL BIOL, V91, P814, DOI 10.1083/jcb.91.3.814; Larocca MC, 2006, EUR J CELL BIOL, V85, P611, DOI 10.1016/j.ejcb.2005.10.008; Larocca MC, 2004, MOL BIOL CELL, V15, P2771, DOI 10.1091/mbc.E03-10-0757; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Li S, 2012, EMBO J, V31, P552, DOI 10.1038/emboj.2011.460; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Man XH, 2015, EUR J CELL BIOL, V94, P162, DOI 10.1016/j.ejcb.2015.01.004; Mason TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027699; Mattaloni S. M., 2013, CELL LOGIST, V3, DOI DOI 10.4161/CL.26331; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Pagan JK, 2015, NAT CELL BIOL, V17, P31, DOI 10.1038/ncb3076; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Schmidt PH, 1999, J BIOL CHEM, V274, P3055, DOI 10.1074/jbc.274.5.3055; Shanks RA, 2002, J BIOL CHEM, V277, P40967, DOI 10.1074/jbc.M203307200; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Steadman BT, 2002, J BIOL CHEM, V277, P30165, DOI 10.1074/jbc.M201914200; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Takahashi M, 1999, J BIOL CHEM, V274, P17267, DOI 10.1074/jbc.274.24.17267; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tonucci FM, 2015, J CELL SCI, V128, P3277, DOI 10.1242/jcs.170878; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Witczak O, 1999, EMBO J, V18, P1858, DOI 10.1093/emboj/18.7.1858; Wu JC, 2016, DEV CELL, V39, P44, DOI 10.1016/j.devcel.2016.08.009; Zimmerman S, 2005, MOL BIOL CELL, V16, P2719, DOI 10.1091/mbc.E04-08-0676	50	8	8	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20394	20409		10.1074/jbc.M117.806018	http://dx.doi.org/10.1074/jbc.M117.806018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29054927	Green Published, hybrid			2022-12-28	WOS:000418267000004
J	Smith, KR; Rajgor, D; Hanley, JG				Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.			Differential regulation of the Rac1 GTPase-activating protein (GAP) BCR during oxygen/glucose deprivation in hippocampal and cortical neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase-activating protein (GAP); guanine nucleotide exchange factor (GEF); hippocampus; ischemia; NMDA receptor (NMDAR); BCR; cortex; OGD; Tiam1	CELL-DEATH; DENDRITIC SPINES; ISCHEMIC-STROKE; BRAIN ISCHEMIA; NMDA RECEPTOR; KINASES; PTPRT; FYN	Brain ischemia causes oxygen and glucose deprivation (OGD) in neurons, triggering a cascade of events leading to synaptic accumulation of glutamate. Excessive activation of glutamate receptors causes excitotoxicity and delayed cell death in vulnerable neurons. Following global cerebral ischemia, hippocampal CA1 pyramidal neurons are more vulnerable to injury than their cortical counterparts, but the mechanisms that underlie this difference are unclear. Signaling via Rho-family small GTPases, their upstream guanine nucleotide exchange factors, and GTPase-activating proteins (GAPs) is differentially dysregulated in response to OGD/ischemia in hippocampal and cortical neurons. Increased Rac1 activity caused by OGD/ischemia contributes to neuronal death in hippocampal neurons via diverse effects on NADPH oxidase activity and dendritic spine morphology. The Rac1 guanine nucleotide exchange factor Tiam1 mediates an OGD-induced increase in Rac1 activity in hippocampal neurons; however, the identity of an antagonistic GAP remains elusive. Here we show that the Rac1 GAP breakpoint cluster region (BCR) associates with NMDA receptors (NMDARs) along with Tiam1 and that this protein complex is more abundant in hippocampal compared with cortical neurons. Although total BCR is similar in the two neuronal types, BCR is more active in hippocampal compared with cortical neurons. OGD causes an NMDAR- and Ca2+-permeable AMPAR-dependent deactivation of BCR in hippocampal but not cortical neurons. BCR knockdown occludes OGD-induced Rac1 activation in hippocampal neurons. Furthermore, disrupting the Tiam1-NMDAR interaction with a fragment of Tiam1 blocks OGD-induced Tiam1 activation but has no effect on the deactivation of BCR. This work identifies BCR as a critical player in Rac1 regulation during OGD in hippocampal neurons.	[Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.] Univ Bristol, Ctr Synapt Plast, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England; [Smith, Katharine R.; Rajgor, Dipen; Hanley, Jonathan G.] Univ Bristol, Sch Biochem, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England; [Smith, Katharine R.] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Bristol; University of Bristol; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Smith, KR (corresponding author), Univ Bristol, Ctr Synapt Plast, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England.; Smith, KR (corresponding author), Univ Bristol, Sch Biochem, Biomedical Sci Bldg, Bristol BS8 1TD, Avon, England.; Smith, KR (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	katharine.r.smith@ucdenver.edu		Hanley, Jonathan/0000-0003-1704-4707	Marie Curie Outgoing Postdoctoral Fellowship [302281]; Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol); Biotechnology and Biological Sciences Research Council (BBSRC); MRC [MR/L011131/1] Funding Source: UKRI; Medical Research Council [MR/L011131/1] Funding Source: researchfish	Marie Curie Outgoing Postdoctoral Fellowship; Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Marie Curie Outgoing Postdoctoral Fellowship (302281) and a Wellcome Trust Institutional Strategic Support Fund Elizabeth Blackwell Institute Early Career Fellowship (University of Bristol), both awarded to K. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Biotechnology and Biological Sciences Research Council (BBSRC).	Blanco-Suarez E, 2014, J CEREBR BLOOD F MET, V34, P1898, DOI 10.1038/jcbfm.2014.158; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Brown CE, 2008, NEUROSCIENTIST, V14, P139, DOI 10.1177/1073858407309854; Dixon RM, 2009, J BIOL CHEM, V284, P14230, DOI 10.1074/jbc.M901203200; Du CP, 2012, CNS NEUROSCI THER, V18, P754, DOI 10.1111/j.1755-5949.2012.00357.x; Hou XY, 2007, NEUROSCI LETT, V420, P235, DOI 10.1016/j.neulet.2007.03.048; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Lee JR, 2015, BMB REP, V48, P249, DOI 10.5483/BMBRep.2015.48.5.037; Lim SH, 2009, EMBO J, V28, P3564, DOI 10.1038/emboj.2009.289; Nishizawa Y, 2001, LIFE SCI, V69, P369, DOI 10.1016/S0024-3205(01)01142-0; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Park AR, 2012, J CELL SCI, V125, P4518, DOI 10.1242/jcs.105502; Penzes P, 2008, TRENDS CELL BIOL, V18, P405, DOI 10.1016/j.tcb.2008.07.002; Penzes P, 2012, CYTOSKELETON, V69, P426, DOI 10.1002/cm.21015; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Rajgor D, 2017, J BIOL CHEM, V292, P9774, DOI 10.1074/jbc.M117.776302; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Terawaki S, 2010, EMBO J, V29, P236, DOI 10.1038/emboj.2009.323; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Um K, 2014, DEV CELL, V29, P701, DOI 10.1016/j.devcel.2014.05.011; Zhang QG, 2009, BRAIN RES, V1265, P138, DOI 10.1016/j.brainres.2009.01.033; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Zhu H, 2012, J NEUROCHEM, V120, P574, DOI 10.1111/j.1471-4159.2011.07550.x	25	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20173	20183		10.1074/jbc.M117.796292	http://dx.doi.org/10.1074/jbc.M117.796292			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046349	Green Published, hybrid			2022-12-28	WOS:000417696400022
J	Bitra, A; Doukov, T; Wang, J; Picarda, G; Benedict, CA; Croft, M; Zajonc, DM				Bitra, Aruna; Doukov, Tzanko; Wang, Jing; Picarda, Gaelle; Benedict, Chris A.; Croft, Michael; Zajonc, Dirk M.			Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface receptor; galectin; N-linked glycosylation; protein structure; protein-protein interaction; recombinant protein expression; site-directed mutagenesis; surface plasmon resonance (SPR); tumor necrosis factor (TNF); X-ray crystallography	TNF RECEPTOR-LIGAND; T-CELL RESPONSES; FACTOR-KAPPA-B; DEATH RECEPTORS; SUPERFAMILY; BINDING; MEMBERS; COSTIMULATION; COMPLEX; FAMILY	4-1BB (CD137) is a TNF receptor superfamily (TNFRSF) member that is thought to undergo receptor trimerization upon binding to its trimeric TNF superfamily ligand (4-1BBL) to stimulate immune responses. 4-1BB also can bind to the tandem repeat-type lectin galectin-9 (Gal-9), and signaling through mouse (m)4-1BB is reduced in galectin-9 (Gal-9)-deficient mice, suggesting a pivotal role of Gal-9 in m4-1BB activation. Here, using sulfur-SAD phasing, we determined the crystal structure of m4-1BB to 2.2- resolution. We found that similar to other TNFRSFs, m4-1BB has four cysteine-rich domains (CRDs). However, the organization of CRD1 and the orientation of CRD3 and CRD4 with respect to CRD2 in the m4-1BB structure distinctly differed from those of other TNFRSFs. Moreover, we mapped two Asn residues within CRD4 that are N-linked glycosylated and mediate m4-1BB binding to Gal-9. Kinetics studies of m4-1BB disclosed a very tight nanomolar binding affinity to m4-1BBL with an unexpectedly strong avidity effect. Both N- and C-terminal domains of Gal-9 bound m4-1BB, but with lower affinity compared with m4-1BBL. Although the TNF homology domain (THD) of human (h)4-1BBL forms non-covalent trimers, we found that m4-1BBL formed a covalent dimer via 2 cysteines absent in h4-1BBL. As multimerization and clustering is a prerequisite for TNFR intracellular signaling, and as m4-1BBL can only recruit two m4-1BB monomers, we hypothesize that m4-1BBL and Gal-9 act together to aid aggregation of m4-1BB monomers to efficiently initiate m4-1BB signaling.	[Bitra, Aruna; Wang, Jing; Picarda, Gaelle; Benedict, Chris A.; Croft, Michael; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol LJI, Div Immune Regulat, La Jolla, CA 92037 USA; [Doukov, Tzanko] Stanford Synchrotron Radiat Light Source, Menlo Pk, CA 94025 USA; [Croft, Michael] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Dept Internal Med, Fac Med & Hlth Sci, B-9000 Ghent, Belgium	University of California System; University of California San Diego; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Immune Regulat, 9420 Athena Cir, La Jolla, CA 92037 USA.	dzajonc@lji.org		Doukov, Tzanko/0000-0001-8625-2572; Zajonc, Dirk/0000-0001-7215-1981	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS Grant [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI110929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Stanford Synchrotron Lightsource (SSRL) for access to remote data collection and the SSRL beamline scientists for support. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the United States Dept. of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by National Institutes of Health, NIGMS Grant P41GM103393.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Bansal-Pakala P, 2002, J IMMUNOL, V169, P5005, DOI 10.4049/jimmunol.169.9.5005; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Chattopadhyay K, 2008, P NATL ACAD SCI USA, V105, P635, DOI 10.1073/pnas.0710529105; Chattopadhyay K, 2007, P NATL ACAD SCI USA, V104, P19452, DOI 10.1073/pnas.0709264104; Chattopadhyay K, 2009, IMMUNOL REV, V229, P356, DOI 10.1111/j.1600-065X.2009.00778.x; Compaan DM, 2006, STRUCTURE, V14, P1321, DOI 10.1016/j.str.2006.06.015; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Eldredge J, 2006, BIOCHEMISTRY-US, V45, P10117, DOI 10.1021/bi060210+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukumori T, 2004, CANCER RES, V64, P3376, DOI 10.1158/0008-5472.CAN-04-0336; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Jang IK, 1998, BIOCHEM BIOPH RES CO, V242, P613, DOI 10.1006/bbrc.1997.8016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Lang I, 2016, J BIOL CHEM, V291, P5022, DOI 10.1074/jbc.M115.683946; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Loo DT, 1997, J BIOL CHEM, V272, P6448, DOI 10.1074/jbc.272.10.6448; Madireddi S, 2014, J EXP MED, V211, P1425, DOI 10.1084/jem.20132687; Magis C, 2012, TRENDS BIOCHEM SCI, V37, P353, DOI 10.1016/j.tibs.2012.06.002; Mazurek N, 2012, CELL DEATH DIFFER, V19, P523, DOI 10.1038/cdd.2011.123; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nelson CA, 2012, STRUCTURE, V20, P1971, DOI 10.1016/j.str.2012.08.030; Nemcovicova I, 2014, ACTA CRYSTALLOGR D, V70, P851, DOI 10.1107/S1399004713033750; Nemoviova I., 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003224, DOI 10.1371/JOURNAL.PPAT.100322423555243]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; POLLOK KE, 1994, EUR J IMMUNOL, V24, P367, DOI 10.1002/eji.1830240215; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabu C, 2005, J BIOL CHEM, V280, P41472, DOI 10.1074/jbc.M506881200; Rossmann M. G., 1972, MOL REPLACEMENT METH; Ru H, 2012, ACTA CRYSTALLOGR D, V68, P521, DOI 10.1107/S0907444912004490; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith W, 2013, CELL HOST MICROBE, V13, P324, DOI 10.1016/j.chom.2013.02.003; Snell LM, 2011, IMMUNOL REV, V244, P197, DOI 10.1111/j.1600-065X.2011.01063.x; Starck L, 2005, EUR J IMMUNOL, V35, P1257, DOI 10.1002/eji.200425686; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Won EY, 2010, J BIOL CHEM, V285, P9202, DOI 10.1074/jbc.M109.084442; Wyzgol A, 2009, J IMMUNOL, V183, P1851, DOI 10.4049/jimmunol.0802597; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Yoshida H, 2010, J BIOL CHEM, V285, P36969, DOI 10.1074/jbc.M110.163402; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P641, DOI 10.1073/pnas.0711206105	59	23	24	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1317	1329		10.1074/jbc.M117.814905	http://dx.doi.org/10.1074/jbc.M117.814905			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29242193	hybrid, Green Published			2022-12-28	WOS:000423515000018
J	Lee, KH; Hwang, JA; Kim, SO; Kim, JH; Shin, SC; Kim, EE; Lee, KS; Rhee, K; Jeon, BH; Bang, JK; Cha-Molstad, H; Soung, NK; Jang, JH; Ko, SK; Lee, HG; Ahn, JS; Kwon, YT; Kim, BY				Lee, Kyung Ho; Hwang, Jeong-Ah; Kim, Sun-Ok; Kim, Jung Hee; Shin, Sang Chul; Kim, Eunice EunKyeong; Lee, Kyung S.; Rhee, Kunsoo; Jeon, Byeong Hwa; Bang, Jeong Kyu; Cha-Molstad, Hyunjoo; Soung, Nak-Kyun; Jang, Jae-Hyuk; Ko, Sung-Kyun; Lee, Hee Gu; Ahn, Jong Seog; Kwon, Yong Tae; Kim, Bo Yeon			Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; BOX DOMAIN; METASTASIS; CENTROSOME; PLASTICITY; INVASION; GROWTH; PHENIX	Elevated expression of human enhancer filamentation 1 (HEF1;also known as NEDD9 or Cas-L) is an essential stimulus for the metastatic process of various solid tumors. This process requires HEF1 localization to focal adhesions (FAs). Although the association of HEF1 with FAs is considered to play a role in cancer cell migration, the mechanism targeting HEF1 to FAs remains unclear. Moreover, up-regulation of Polo-like kinase 1 (Plk1) positively correlates with human cancer metastasis, yet how Plk1 deregulation promotes metastasis remains elusive. Here, we report that casein kinase 1 delta (CK1 delta) phosphorylates HEF1 at Ser-780 and Thr-804 and that these phosphorylation events promote a physical interaction between Plk1 and HEF1. We found that this interaction is critical for HEF1 translocation to FAs and for inducing migration of HeLa cells. Plk1-docking phosphoepitopes were mapped/ confirmed in HEF1 by various methods, including X-ray crystallography, and mutated for functional analysis in HeLa cells. In summary, our results reveal the role of a phosphorylation-dependent HEF1-Plk1 complex in HEF1 translocation to FAs to induce cell migration. Our findings provide critical mechanistic insights into the HEF1-Plk1 complex-dependent localization of HEF1 to FAs underlying the metastatic process and may therefore contribute to the development of new cancer therapies.	[Lee, Kyung Ho; Hwang, Jeong-Ah; Kim, Sun-Ok; Cha-Molstad, Hyunjoo; Soung, Nak-Kyun; Jang, Jae-Hyuk; Ko, Sung-Kyun; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, World Class Inst, 30 Yeongudanji Ro, Cheongwon 28116, Chungbuk, South Korea; [Kim, Jung Hee; Shin, Sang Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Hwarangno 14-Gil 5, Seoul 02792, South Korea; [Lee, Kyung S.] NCI, Ctr Canc Res, Lab Metab, Bethesda, MD 20892 USA; [Rhee, Kunsoo] Seoul Natl Univ, Dept Biol Sci, Seoul 08826, South Korea; [Hwang, Jeong-Ah; Jeon, Byeong Hwa] Chungnam Natl Univ, Coll Med, Dept Physiol, Res Inst Med Sci, Daejeon 35015, South Korea; [Bang, Jeong Kyu] Korea Basic Sci Inst, Div Magnet Resonance, Ochang 28119, South Korea; [Lee, Hee Gu] Korea Res Inst Biosci & Biotechnol, Genome Struct Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul 03080, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul 03080, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Science & Technology (KIST); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Chungnam National University; Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kwon, YT (corresponding author), Seoul Natl Univ, Coll Med, Prot Metab Med Res Ctr, Seoul 03080, South Korea.; Lee, KH; Kim, BY (corresponding author), KRIBB, Anticanc Agent Res Ctr, World Class Inst, 30 Yeongudanji Ro, Cheongwon 28116, Chungbuk, South Korea.	leekh@kribb.re.kr; yok5@snu.ac.kr; bykim@kribb.re.kr	Jeon, Byeong Hwa/D-4160-2012	Jeon, Byeong Hwa/0000-0002-3347-2739; Ko, Sung-Kyun/0000-0002-8202-1205	R&D Convergence Program of the National Research Council of Science and Technology (NST) of the Republic of Korea [CAP-16-03-KRIBB]; International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea [NRF-2016R1A2B3011389]; KRIBB Research Initiative Program; NATIONAL CANCER INSTITUTE [ZIABC011518] Funding Source: NIH RePORTER	R&D Convergence Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea; Basic Science Research Program of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea; KRIBB Research Initiative Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R&D Convergence Program Grant CAP-16-03-KRIBB and the International Cooperation Research Program of the National Research Council of Science and Technology (NST) of the Republic of Korea. This work was also supported by Basic Science Research Program Grant NRF-2016R1A2B3011389 of the Ministry of Science, ICT, and Future Planning (MSIP) of Korea and the KRIBB Research Initiative Program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; DeLano W.L, PYMOL MOL GRAPHICS S; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Gu ZZ, 2011, J CELL BIOL, V193, P61, DOI 10.1083/jcb.201007003; Jia JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14626; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Knecht R, 1999, CANCER RES, V59, P2794; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rizki A, 2007, CANCER RES, V67, P11106, DOI 10.1158/0008-5472.CAN-07-2348; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	41	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					847	862		10.1074/jbc.M117.802587	http://dx.doi.org/10.1074/jbc.M117.802587			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29191835	Green Published, hybrid			2022-12-28	WOS:000422864500008
J	Yamamura, H; Nishimura, K; Hagihara, Y; Suzuki, Y; Imaizumi, Y				Yamamura, Hisao; Nishimura, Kaori; Hagihara, Yumiko; Suzuki, Yoshiaki; Imaizumi, Yuji			TMEM16A and TMEM16B channel proteins generate Ca2+-activated Cl- current and regulate melatonin secretion in rat pineal glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; SMOOTH-MUSCLE-CELLS; MURINE PORTAL-VEIN; LARGE-CONDUCTANCE; CA2+ CHANNELS; K+ CHANNELS; ANOCTAMIN 1; EXPRESSION; NOREPINEPHRINE; MODULATION	Pinealocytes regulate circadian rhythm by synthesizing and secreting melatonin. These cells generate action potentials; however, the contribution of specific ion channels to melatonin secretion from pinealocytes remains unclear. In this study, the involvement and molecular identity of Ca2+-activated Cl- (Cl-Ca) channels in the regulation of melatonin secretion were examined in rat pineal glands. Treatment with the ClCa channel blockers, niflumic acid or T16A(inh)-A01, significantly reduced melatonin secretion in pineal glands. After pineal K+ currents were totally blocked under whole-cell patch clamp conditions, depolarization and subsequent repolarization induced a slowly activating outward current and a substantial inward tail current, respectively. Both of these current changes were dependent on intracellular Ca2+ concentration and inhibited by niflumic acid and T16A(inh)-A01. Quantitative real-time PCR, Western blotting, and immunocytochemical analyses revealed that TMEM16A and TMEM16B were highly expressed in pineal glands. siRNA knockdown of TMEM16A and/or TMEM16B showed that both channels contribute to Cl-Ca currents in pinealocytes. Conversely, co-expression of TMEM16A and TMEM16B channels or the expression of this tandem channel in HEK293 cells mimicked the electrophysiological characteristics of Cl-Ca currents in pinealocytes. Moreover, bimolecular fluorescence complementation, FRET, and co-immunoprecipitation experiments suggested that TMEM16A and TMEM16B can form heteromeric channels, as well as homomeric channels. In conclusion, pineal Cl-Ca channels are composed of TMEM16A and TMEM16B subunits, and these fluxes regulate melatonin secretion in pineal glands.	[Yamamura, Hisao; Nishimura, Kaori; Hagihara, Yumiko; Suzuki, Yoshiaki; Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Nagoya, Aichi 4678603, Japan	Nagoya City University	Yamamura, H (corresponding author), 3-1 Tanabedori Mizuhoku, Nagoya, Aichi 4678603, Japan.	yamamura@phar.nagoya-cu.ac.jp	Suzuki, Yoshiaki/ABH-5320-2020; Imaizumi, Yuji/AAF-6585-2020	Suzuki, Yoshiaki/0000-0002-7879-6059; 	Japan Society for the Promotion of Science [17H05537, 26293021, 25460104, 16K08278]; Grants-in-Aid for Scientific Research [16K08278] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on Innovative strate their involvement in melatonin secretion in rat pineal Areas 17H05537 (to H.Y.), Grant-in-Aid for Scientific Research (B) 26293021 (to Y.I.), and Grants-in-Aid for Scientific Research (C) 25460104 and 16K08278 (to H.Y.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Adomaviciene A, 2013, J PHYSIOL-LONDON, V591, P3487, DOI 10.1113/jphysiol.2013.251660; AGUAYO LG, 1988, J PHYSIOL-LONDON, V405, P397, DOI 10.1113/jphysiol.1988.sp017339; Bernstein K, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.018; Billig GM, 2011, NAT NEUROSCI, V14, P763, DOI 10.1038/nn.2821; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CASTELLANO A, 1989, PFLUG ARCH EUR J PHY, V413, P644, DOI 10.1007/BF00581815; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Darvish N, 1998, J NEUROPHYSIOL, V79, P2546, DOI 10.1152/jn.1998.79.5.2546; Dauner K, 2012, CELL TISSUE RES, V347, P327, DOI 10.1007/s00441-012-1324-9; Fallah G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004697; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; FRESCHI JE, 1986, BRAIN RES, V368, P366, DOI 10.1016/0006-8993(86)90583-4; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; IMAIZUMI Y, 1989, J PHYSIOL-LONDON, V411, P131, DOI 10.1113/jphysiol.1989.sp017565; Inayama M, 2015, CELL CALCIUM, V57, P337, DOI 10.1016/j.ceca.2015.02.005; Kitamura K, 2001, JPN J PHARMACOL, V85, P351, DOI 10.1254/jjp.85.351; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Lee SY, 2006, AM J PHYSIOL-CELL PH, V290, pC1060, DOI 10.1152/ajpcell.00343.2005; Letz B, 1997, J PHYSIOL-LONDON, V499, P329, DOI 10.1113/jphysiol.1997.sp021930; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maurya DK, 2014, DEV NEUROBIOL, V74, P657, DOI 10.1002/dneu.22159; Mizutani H, 2016, AM J PHYSIOL-CELL PH, V310, pC740, DOI 10.1152/ajpcell.00342.2015; Mizutani H, 2014, AM J PHYSIOL-CELL PH, V306, pC1008, DOI 10.1152/ajpcell.00014.2014; Ohshiro J, 2014, J PHARMACOL SCI, V125, P107, DOI 10.1254/jphs.14015SC; Ohshiro J, 2014, BIOCHEM BIOPH RES CO, V443, P518, DOI 10.1016/j.bbrc.2013.11.117; Ohya S, 2001, PFLUG ARCH EUR J PHY, V441, P611, DOI 10.1007/s004240000463; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Phansuwan-Pujito P, 1999, MICROSC RES TECHNIQ, V46, P281, DOI 10.1002/(SICI)1097-0029(19990815/01)46:4/5<281::AID-JEMT5>3.0.CO;2-N; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; REUSS S, 1984, EXP BRAIN RES, V55, P455; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Scudieri P, 2013, BIOCHEM J, V452, P443, DOI 10.1042/BJ20130348; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186252; Suzuki Y, 2016, J BIOL CHEM, V291, P24247, DOI 10.1074/jbc.M116.743302; Suzuki Y, 2013, J BIOL CHEM, V288, P36750, DOI 10.1074/jbc.M113.511485; Tien J, 2013, P NATL ACAD SCI USA, V110, P6352, DOI 10.1073/pnas.1303672110; Yamada H, 1998, J NEUROSCI, V18, P2056; Yamada H, 1998, J NEUROSCI, V18, P4946; Yamamura H, 2015, J PHARMACOL SCI, V128, P1, DOI 10.1016/j.jphs.2015.04.004; Yamamura H, 2012, AM J PHYSIOL-CELL PH, V302, pC1257, DOI 10.1152/ajpcell.00191.2011; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zemkova H, 2011, ENDOCRINOLOGY, V152, P3842, DOI 10.1210/en.2011-1180; Zhao L, 2016, EXP THER MED, V11, P1755, DOI 10.3892/etm.2016.3158	49	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					995	1006		10.1074/jbc.RA117.000326	http://dx.doi.org/10.1074/jbc.RA117.000326			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187602	Green Published, hybrid			2022-12-28	WOS:000422864500020
J	Morgan, MT; Nguyen, LAH; Hancock, HL; Fahrni, CJ				Morgan, M. Thomas; Nguyen, Lily Anh H.; Hancock, Haylie L.; Fahrni, Christoph J.			Glutathione limits aquacopper(I) to sub-femtomolar concentrations through cooperative assembly of a tetranuclear cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; metal homeostasis; peptides; spectroscopy; thermodynamics; phosphorescence; potentiometry	SYNTHETIC FLUORESCENT-PROBES; X-RAY-ABSORPTION; PROTEIN INTERACTIONS; COPPER(I) COMPLEXES; THIOLATE CLUSTERS; CU(I); REDOX; SPECIATION; CRYSTAL; CELL	The tripeptide glutathione (GSH) is a crucial intracellular reductant and radical scavenger, but it may also coordinate the soft Cu(I) cation and thereby yield pro-oxidant species. The GSH-Cu(I) interaction is thus a key consideration for both redox and copper homeostasis in cells. However, even after nearly four decades of investigation, the nature and stability of the GSH-Cu(I) complexes formed under biologically relevant conditions remain controversial. Here, we revealed the unexpected predominance of a tetranuclear [Cu-4(GS)(6)] cluster that is sufficiently stable to limit the effective free aquacopper(I) concentration to the sub-femtomolar regime. Combined spectrophotometric-potentiometric titrations at biologically realistic GSH/Cu(I) ratios, enabled by our recently developed Cu(I) affinity standards and corroborated by low-temperature phosphorescence studies, established cooperative assembly of [Cu-4(GS)(6)] as the dominant species over a wide pH range, from 5.5 to 7.5. Our robust model for the glutathione-Cu(I) equilibrium system sets a firm upper limit on the thermodynamic availability of intracellular copper that is 3 orders of magnitude lower than previously estimated. Taking into account their ability to catalyze the production of deleterious superoxide, the formation of Cu(I)-glutathione complexes might be avoided under normal physiological conditions. The actual intracellular Cu(I) availability may thus be regulated a further 3 orders of magnitude below the GSH/Cu(I) affinity limit, consistent with the most recent affinity determinations of Cu(I) chaperones.	[Morgan, M. Thomas; Nguyen, Lily Anh H.; Hancock, Haylie L.; Fahrni, Christoph J.] Georgia Inst Technol, Sch Chem & Biochem, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Fahrni, CJ (corresponding author), Sch Chem & Biochem, 901 Atlantic Dr, Atlanta, GA 30332 USA.; Fahrni, CJ (corresponding author), Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.	fahrni@chemistry.gatech.edu		Morgan, Michael Thomas/0000-0003-3308-1567	National Institutes of Health [GM067169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM067169. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; [Anonymous], 2004, NIST STANDARD REFERE; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BAUMGARTNER M, 1993, J SOLID STATE CHEM, V107, P63, DOI 10.1006/jssc.1993.1324; Benitez JJ, 2008, J AM CHEM SOC, V130, P2446, DOI 10.1021/ja7107867; Benitez JJ, 2011, FARADAY DISCUSS, V148, P71, DOI 10.1039/c004913a; Binstead R. A., 2001, SPECFIT GLOBAL ANAL; Brugger J, 2007, COMPUT GEOSCI-UK, V33, P248, DOI 10.1016/j.cageo.2006.06.011; Coppola S, 2000, BIOCHEM SOC T, V28, P56, DOI 10.1042/bst0280056; Corazza A, 1996, EUR J BIOCHEM, V236, P697, DOI 10.1111/j.1432-1033.1996.0697d.x; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; DANCE IG, 1978, AUST J CHEM, V31, P2195, DOI 10.1071/CH9782195; DANCE IG, 1983, POLYHEDRON, V2, P1031, DOI 10.1016/S0277-5387(00)81450-3; Fahrni CJ, 2013, CURR OPIN CHEM BIOL, V17, P656, DOI 10.1016/j.cbpa.2013.05.019; Faller P, 2010, FEBS J, V277, P2921, DOI 10.1111/j.1742-4658.2010.07717.x; Fujisawa K, 1998, INORG CHEM, V37, P168, DOI 10.1021/ic971317b; Hatori Y, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030025; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Johnson DK, 2015, DALTON T, V44, P16494, DOI 10.1039/c5dt02689j; Keller AM, 2012, J AM CHEM SOC, V134, P8934, DOI 10.1021/ja3018835; Konigsberger LC, 2015, DALTON T, V44, P20413, DOI 10.1039/c5dt02129d; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Maiti BK, 2007, EUR J INORG CHEM, P5548, DOI 10.1002/ejic.200700784; Martell A. E., 1974, CRITICAL STABILITY C; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Morgan MT, 2016, CHEM SCI, V7, P1468, DOI [10.1039/c5sc03643g, 10.1039/C5SC03643G]; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Poger D, 2008, J BIOL INORG CHEM, V13, P1239, DOI 10.1007/s00775-008-0408-1; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Pushkar Y, 2013, AGING CELL, V12, P823, DOI 10.1111/acel.12112; Roschitzki B, 2002, J BIOL INORG CHEM, V7, P611, DOI 10.1007/s00775-002-0339-1; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheller JS, 2017, METALLOMICS, V9, P447, DOI 10.1039/c7mt00041c; Shen C, 2015, METALLOMICS, V7, P56, DOI 10.1039/c4mt00288a; Speisky H, 2008, BIOORGAN MED CHEM, V16, P6568, DOI 10.1016/j.bmc.2008.05.026; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Walsh MJ, 2013, J INORG BIOCHEM, V128, P112, DOI 10.1016/j.jinorgbio.2013.07.012; Wegner SV, 2011, CHEM COMMUN, V47, P2571, DOI 10.1039/c0cc04292g; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074	49	42	41	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21558	21567		10.1074/jbc.M117.817452	http://dx.doi.org/10.1074/jbc.M117.817452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101230	Green Published, hybrid			2022-12-28	WOS:000419013000030
J	Peeler, JC; Schedin-Weiss, S; Soula, M; Kazmi, MA; Sakmar, TP				Peeler, Jennifer C.; Schedin-Weiss, Sophia; Soula, Mariluz; Kazmi, Manija A.; Sakmar, Thomas P.			Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine receptor; G protein-coupled receptor (GPCR); proteasome; protein degradation; ubiquitylation (ubiquitination)	NON-LYSINE UBIQUITINATION; ENDOPLASMIC-RETICULUM; ADRENERGIC-RECEPTOR; E3 LIGASE; PROTEIN; RESIDUES; PROTEASOME; COMPLEX; SERINE; UBIQUITYLATION	How an optimal level of human dopamine D4 receptor (hD4R) is maintained in synaptic membranes is not known. We show here that hD4R is ubiquitinated in primary neurons. We go on to show that ubiquitin is attached to hD4R through isopeptide and ester bonds. When lysine (Lys) residues of the hD4R are substituted with arginine (Arg) residues, cellular hD4R protein levels increase. A synergistic effect on hD4R levels is noted when cytoplasmic serine (Ser) and threonine (Thr) residues are mutated. Chloroquine, an inhibitor of lysosomal degradation, did not have an effect on hD4R protein levels. However, treatment with bortezomib, an inhibitor of the 20S proteasome, caused a dose-dependent increase in hD4R protein levels. The effect of bortezomib was attenuated in the receptor variants that lacked Lys or Ser/Thr residues, and the hD4R mutant that lacked 17 cytoplasmic Lys, Ser, and Thr residues was nearly insensitive to bortezomib treatment. We conclude that both isopeptide and ester bond ubiquitination regulate proteasomal degradation of hD4R.	[Peeler, Jennifer C.; Soula, Mariluz; Kazmi, Manija A.; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA; [Schedin-Weiss, Sophia; Sakmar, Thomas P.] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, S-14157 Huddinge, Sweden	Rockefeller University; Karolinska Institutet	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA.	sakmar@rockefeller.edu		Schedin Weiss, Sophia/0000-0003-2143-7052	National Science Foundation Graduate Research Fellowships Program [DGE-1325261]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083688] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowships Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Science Foundation Graduate Research Fellowships Program under Grant DGE-1325261.	Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Domingues C, 2012, CELL DEATH DIFFER, V19, P470, DOI 10.1038/cdd.2011.116; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Furth KE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00102; Gilkerson J, 2015, PLANT PHYSIOL, V168, P708, DOI 10.1104/pp.15.00402; Golnik R, 2016, J BIOL CHEM, V291, P8805, DOI 10.1074/jbc.M115.705178; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Kocsis B, 2014, BRAIN STRUCT FUNCT, V219, P2173, DOI 10.1007/s00429-013-0607-6; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Nikolaidis A, 2010, SOC COGN AFFECT NEUR, V5, P188, DOI 10.1093/scan/nsp049; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Schedin-Weiss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063962; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Skieterska K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050923; Skieterska K, 2016, CELL SIGNAL, V28, P1001, DOI 10.1016/j.cellsig.2016.05.003; Skieterska K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145654; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spooren A, 2010, CELL SIGNAL, V22, P600, DOI 10.1016/j.cellsig.2009.11.013; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063	34	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21623	21630		10.1074/jbc.M116.758961	http://dx.doi.org/10.1074/jbc.M116.758961			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101232	Green Published, hybrid			2022-12-28	WOS:000419013000036
J	Warner, MD; Azmi, IF; Kang, S; Zhao, YD; Bell, SP				Warner, Megan D.; Azmi, Ishara F.; Kang, Sukhyun; Zhao, Yanding; Bell, Stephen P.			Replication origin-flanking roadblocks reveal origin-licensing dynamics and altered sequence dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); cell cycle; DNA helicase; DNA replication; DNA-protein interaction; nucleosome; Saccharomyces cerevisiae; cdt1; helicase loading; origin of replication	DNA-REPLICATION; RECOGNITION COMPLEX; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL ELEMENTS; CMG HELICASE; BINDING-SITE; ORC; INITIATION; CHROMOSOME	In eukaryotes, DNA replication initiates from multiple origins of replication for timely genome duplication. These sites are selected by origin licensing, during which the core enzyme of the eukaryotic DNA replicative helicase, the Mcm2-7 (minichromosome maintenance) complex, is loaded at each origin. This origin licensing requires loading two Mcm2-7 helicases around origin DNA in a head-to-head orientation. Current models suggest that the origin-recognition complex (ORC) and cell-division cycle 6 (Cdc6) proteins recognize and encircle origin DNA and assemble an Mcm2-7 double-hexamer around adjacent double-stranded DNA. To test this model and assess the location of Mcm2-7 initial loading, we placed DNA-protein roadblocks at defined positions adjacent to the essential ORC-binding site within Saccharomyces cerevisiae origin DNA. Roadblocks were made either by covalent cross-linking of the HpaII methyltransferase to DNA or through binding of a transcription activator-like effector (TALE) protein. Contrary to the sites of Mcm2-7 recruitment being precisely defined, only single roadblocks that inhibited ORC-DNA binding showed helicase loading defects. We observed inhibition of helicase loading without inhibition of ORC-DNA binding only when roadblocks were placed on both sides of the origin to restrict sliding of a helicase-loading intermediate. Consistent with a sliding helicase-loading intermediate, when either one of the flanking roadblocks was eliminated, the remaining roadblock had no effect on helicase loading. Interestingly, either origin-flanking nucleosomes or roadblocks resulted in helicase loading being dependent on an additional origin sequence known to be a weaker ORC-DNA-binding site. Together, our findings support a model in which sliding helicase-loading intermediates increase the flexibility of the DNA sequence requirements for origin licensing.	[Warner, Megan D.; Azmi, Ishara F.; Kang, Sukhyun; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Dept Biol, Rm 68-630,77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhao, Yanding] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Kang, Sukhyun] Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Zhao, Yanding] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA; [Bell, Stephen P.] Howard Hughes Med Inst, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Brandeis University; Institute for Basic Science - Korea (IBS); Dartmouth College; Howard Hughes Medical Institute	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Rm 68-630,77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Kang, Sukhyun/0000-0002-7567-0231; Bell, Stephen/0000-0002-2876-610X	Koch Institute Support Grant from the NCI, National Institutes of Health [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Koch Institute Support Grant from the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Koch Institute Support Grant P30-CA14051 from the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azmi IF, 2017, ELIFE, V6, DOI 10.7554/eLife.22512; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2016, GENETICS, V203, P1027, DOI 10.1534/genetics.115.186452; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bleichert F, 2013, ELIFE, V2, DOI 10.7554/eLife.00882; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Chang F, 2008, MOL CELL BIOL, V28, P5071, DOI 10.1128/MCB.00206-08; Chang FJ, 2011, NUCLEIC ACIDS RES, V39, P6523, DOI 10.1093/nar/gkr301; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Coster G, 2017, SCIENCE, V357, P314, DOI 10.1126/science.aan0063; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Liachko I, 2013, GENOME RES, V23, P698, DOI 10.1101/gr.144659.112; Lin S, 1997, MOL CELL BIOL, V17, P5473, DOI 10.1128/MCB.17.9.5473; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1994, MOL CELL BIOL, V14, P7643, DOI 10.1128/MCB.14.11.7643; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; THEIS JF, 1994, MOL CELL BIOL, V14, P7652, DOI 10.1128/MCB.14.11.7652; Ticau S, 2017, NAT STRUCT MOL BIOL, V24, P309, DOI 10.1038/nsmb.3375; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; Tocilj A, 2017, ELIFE, V6, DOI 10.7554/eLife.20818; Wilmes GM, 2002, P NATL ACAD SCI USA, V99, P101, DOI 10.1073/pnas.012578499; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Yuan ZN, 2017, NAT STRUCT MOL BIOL, V24, P316, DOI 10.1038/nsmb.3372; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	47	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21417	21430		10.1074/jbc.M117.815639	http://dx.doi.org/10.1074/jbc.M117.815639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29074622	Green Published, hybrid			2022-12-28	WOS:000419013000018
J	Henderson, JC; Herrera, CM; Trent, MS				Henderson, Jeremy C.; Herrera, Carmen M.; Trent, M. Stephen			AlmG, responsible for polymyxin resistance in pandemic Vibrio cholerae, is a glycyltransferase distantly related to lipid A late acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIPOTEICHOIC ACID; TEICHOIC-ACID; D-ALANINE; LIPOPOLYSACCHARIDE; MUTANT; GENES; LPS; IDENTIFICATION; BIOSYNTHESIS	Cationic antimicrobial peptides (CAMPs), such as polymyxins, are used as a last-line defense in treatment of many bacterial infections. However, some bacteria have developed resistance mechanisms to survive these compounds. Current pandemic O1 Vibrio cholerae biotype El Tor is resistant to polymyxins, whereas a previous pandemic strain of the biotype Classical is polymyxin-sensitive. The almEFG operon found in El Tor V. cholerae confers >100-fold resistance to antimicrobial peptides through aminoacylation of lipopolysaccharide (LPS), expected to decrease the negatively charged surface of the V. cholerae outer membrane. This Gram-negative system bears striking resemblance to a related Gram-positive cell-wall remodeling strategy that also promotes CAMP resistance. Mutants defective in AlmEF-dependent LPS modification exhibit reduced fitness in vivo. Here, we present investigation of AlmG, the hitherto uncharacterized member of the AlmEFG pathway. Evidence for AlmG glycyl to lipid substrate transferase activity is demonstrated in vivo by heterologous expression of V. cholerae pathway enzymes in a specially engineered Escherichia coli strain. Development of a minimal keto-deoxyoctulosonate (Kdo)-lipidAdomain in E. coli was necessary to facilitate chemical structure analysis and to produce a mimetic Kdo-lipid A domain AlmG substrate to that synthesized by V. cholerae. Our biochemical studies support a uniquely nuanced pathway of Gram-negative CAMPs resistance and provide a more detailed description of an enzyme of the pharmacologically relevant lysophosphospholipid acyltransferase (LPLAT) superfamily.	[Henderson, Jeremy C.; Herrera, Carmen M.; Trent, M. Stephen] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Trent, MS (corresponding author), Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis, Athens, GA 30602 USA.	strent@uga.edu		Henderson, Jeremy/0000-0001-6509-0842	National Institute of Health [RO1 AI076322]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health Grant RO1 AI076322 (to M. S. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bilecen K, 2015, INFECT IMMUN, V83, P1199, DOI 10.1128/IAI.02700-14; Boll JM, 2015, MBIO, V6, DOI 10.1128/mBio.00478-15; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Engskog MKR, 2011, CARBOHYD RES, V346, P1241, DOI 10.1016/j.carres.2011.04.030; Ernst R, 2016, J MOL BIOL, V428, P4776, DOI 10.1016/j.jmb.2016.08.013; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; Hankins JV, 2009, J BIOL CHEM, V284, P25804, DOI 10.1074/jbc.M109.022772; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henderson JC, 2014, ACS CHEM BIOL, V9, P2382, DOI 10.1021/cb500438x; Henderson JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50623; Herrera CM, 2017, MOL MICROBIOL, V106, P582, DOI 10.1111/mmi.13835; Herrera CM, 2014, MBIO, V5, DOI 10.1128/mBio.02283-14; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu J, 2011, VIROLOGY, V417, P304, DOI 10.1016/j.virol.2011.06.005; Molinaro A, 2008, GLYCOBIOLOGY, V18, P260, DOI 10.1093/glycob/cwm140; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Oger PM, 2015, SUBCELL BIOCHEM, V72, P383, DOI 10.1007/978-94-017-9918-8_19; Pasquina LW, 2013, CURR OPIN MICROBIOL, V16, P531, DOI 10.1016/j.mib.2013.06.014; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rubin EJ, 2014, MOL MICROBIOL, V91, P887, DOI 10.1111/mmi.12501; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Wang JL, 2014, MAR DRUGS, V12, P1495, DOI 10.3390/md12031495; Yildiz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086751; Yilmaz P, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01524; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	51	23	23	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21205	21215		10.1074/jbc.RA117.000131	http://dx.doi.org/10.1074/jbc.RA117.000131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29101229	Green Published, hybrid			2022-12-28	WOS:000418453400034
J	Sunden, F; AlSadhan, I; Lyubimov, A; Doukov, T; Swan, J; Herschlag, D				Sunden, Fanny; AlSadhan, Ishraq; Lyubimov, Artem; Doukov, Tzanko; Swan, Jeffrey; Herschlag, Daniel			Differential catalytic promiscuity of the alkaline phosphatase superfamily bimetallo core reveals mechanistic features underlying enzyme evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE RESIDUES; CRYSTAL-STRUCTURE; COMPARATIVE ENZYMOLOGY; DIVERGENT EVOLUTION; PHOSPHORYL-TRANSFER; BIOLOGICAL-ACTIVITY; SULFATASE ACTIVITY; TRANSITION-STATE; PROTEIN; PHOSPHOTRIESTERASE	Members of enzyme superfamilies specialize in different reactions but often exhibit catalytic promiscuity for one another's reactions, consistent with catalytic promiscuity as an important driver in the evolution of new enzymes. Wanting to understand how catalytic promiscuity and other factors may influence evolution across a superfamily, we turned to the well-studied alkaline phosphatase (AP) superfamily, comparing three of its members, two evolutionarily distinct phosphatases and a phosphodiesterase. We mutated distinguishing active-site residues to generate enzymes that had a common Zn2+ bimetallo core but little sequence similarity and different auxiliary domains. We then tested the catalytic capabilities of these pruned enzymes with a series of substrates. A substantial rate enhancement of similar to 10(11)-fold for both phosphate mono-and diester hydrolysis by each enzyme indicated that the Zn2+ bimetallo core is an effective mono/di-esterase generalist and that the bimetallo cores were not evolutionarily tuned to prefer their cognate reactions. In contrast, our pruned enzymes were ineffective sulfatases, and this limited promiscuity may have provided a driving force for founding the distinct one-metal-ion branch that contains all known AP superfamily sulfatases. Finally, our pruned enzymes exhibited 10(7)-10(8)-fold phosphotriesterase rate enhancements, despite absence of such enzymes within the AP superfamily. We speculate that the superfamily active-site architecture involved in nucleophile positioning prevents accommodation of the additional triester substituent. Overall, we suggest that catalytic promiscuity, and the ease or difficulty of remodeling and building onto existing protein scaffolds, have greatly influenced the course of enzyme evolution. Uncovering principles and properties of enzyme function, promiscuity, and repurposing provides lessons for engineering new enzymes.	[Sunden, Fanny; AlSadhan, Ishraq; Swan, Jeffrey; Herschlag, Daniel] Stanford Univ, Beckman Ctr, Dept Biochem, Stanford, CA 94305 USA; [Lyubimov, Artem] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lyubimov, Artem] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Lyubimov, Artem] Stanford Univ, Dept Struct Biol, Stanford, CA 94305 USA; [Lyubimov, Artem] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Lyubimov, Artem] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Stanford ChEM H Chem Engn & Med Human Hlth, Stanford, CA 94305 USA; [Doukov, Tzanko] Stanford Univ, Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Macromol Crystallog Grp, Stanford, CA 94309 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Herschlag, D (corresponding author), Stanford Univ, Beckman Ctr, Dept Biochem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Stanford ChEM H Chem Engn & Med Human Hlth, Stanford, CA 94305 USA.	herschla@stanford.edu		Doukov, Tzanko/0000-0001-8625-2572	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049243, R01GM064798, R01GM049243] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, NCRR, Biomedical Technology Program, and the NIGMS. We thank Filip Yabukarski for assistance with collecting crystallographic data for PafA*. We thank Patsy Babbitt and Jonathan Lassila for helpful discussions, advice, and communication of unpublished results. We thank Daniel Mokhtari and Ariana Peck and members of the Herschlag laboratory for discussions and comments on the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Andrews LD, 2014, BIOCHEMISTRY-US, V53, P6811, DOI 10.1021/bi500765p; BABBITT PC, 1995, SCIENCE, V267, P1159, DOI 10.1126/science.7855594; Babtie A, 2010, CURR OPIN CHEM BIOL, V14, P200, DOI 10.1016/j.cbpa.2009.11.028; Babtie AC, 2009, ANGEW CHEM INT EDIT, V48, P3692, DOI 10.1002/anie.200805843; Baier F, 2016, BIOCHEMISTRY-US, V55, P6375, DOI 10.1021/acs.biochem.6b00723; Bar-Rogovsky H, 2015, PROTEIN ENG DES SEL, V28, P507, DOI 10.1093/protein/gzv038; BASAIF SA, 1989, J ORG CHEM, V54, P5483, DOI 10.1021/jo00284a019; BENKOVIC SJ, 1966, J AM CHEM SOC, V88, P5504, DOI 10.1021/ja00975a026; Berlutti F, 2001, MICROBIOL-SGM, V147, P2831, DOI 10.1099/00221287-147-10-2831; Bigley AN, 2013, BBA-PROTEINS PROTEOM, V1834, P443, DOI 10.1016/j.bbapap.2012.04.004; Bihani SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022767; Bobyr E, 2012, J MOL BIOL, V415, P102, DOI 10.1016/j.jmb.2011.10.040; Boltes I, 2001, STRUCTURE, V9, P483, DOI 10.1016/S0969-2126(01)00609-8; Bond CS, 1997, STRUCTURE, V5, P277, DOI 10.1016/S0969-2126(97)00185-8; Bricogne G., 2016, BUSTER VERSION 2 10; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chapman E, 2004, ANGEW CHEM INT EDIT, V43, P3526, DOI 10.1002/anie.200300631; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Das S, 2015, CURR OPIN GENET DEV, V35, P40, DOI 10.1016/j.gde.2015.09.005; Edwards DR, 2012, J AM CHEM SOC, V134, P525, DOI 10.1021/ja208827q; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Feder ME, 2007, J EXP BIOL, V210, P1653, DOI 10.1242/jeb.02725; Furnham N, 2016, J MOL BIOL, V428, P253, DOI 10.1016/j.jmb.2015.11.010; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; Gorelik A, 2017, J BIOL CHEM, V292, P7087, DOI 10.1074/jbc.M116.769273; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Jencks W. P., 1976, HDB BIOCH MOL BIOL; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jonas S, 2008, J MOL BIOL, V384, P120, DOI 10.1016/j.jmb.2008.08.072; Jonas S, 2009, PURE APPL CHEM, V81, P731, DOI 10.1351/PAC-CON-08-10-20; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim A, 2011, BIOCHEMISTRY-US, V50, P3481, DOI 10.1021/bi200165h; KIRBY AJ, 1967, J AM CHEM SOC, V89, P415, DOI 10.1021/ja00978a044; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Lassila JK, 2008, BIOCHEMISTRY-US, V47, P12853, DOI 10.1021/bi801488c; Le Du MH, 2002, J MOL BIOL, V316, P941, DOI 10.1006/jmbi.2001.5384; Lukatela G, 1998, BIOCHEMISTRY-US, V37, P3654, DOI 10.1021/bi9714924; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng QS, 2011, J GENET GENOMICS, V38, P63, DOI 10.1016/j.jcg.2011.01.003; Mohamed MF, 2013, BBA-PROTEINS PROTEOM, V1834, P417, DOI 10.1016/j.bbapap.2012.07.015; MURPHY JE, 1995, J MOL BIOL, V253, P604, DOI 10.1006/jmbi.1995.0576; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolic-Hughes I, 2004, J AM CHEM SOC, V126, P11814, DOI 10.1021/ja0480421; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; O'Brien PJ, 2008, BIOCHEMISTRY-US, V47, P7663, DOI 10.1021/bi800545n; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 2006, CHEM REV, V106, P720, DOI 10.1021/cr040481v; O'Brien PJ, 1998, J AM CHEM SOC, V120, P12369, DOI 10.1021/ja983390m; O'Brien PJ, 2002, BIOCHEMISTRY-US, V41, P3207, DOI 10.1021/bi012166y; O'Brien PJ, 1999, J AM CHEM SOC, V121, P11022, DOI 10.1021/ja9932582; Ohno S., 1970, EVOLUTION GENE DUPLI; Olguin LF, 2008, J AM CHEM SOC, V130, P16547, DOI 10.1021/ja8047943; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pandya C, 2014, J BIOL CHEM, V289, P30229, DOI 10.1074/jbc.R114.572990; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; RATNER H, 1984, INFECT CONT HOSP EP, V5, P237, DOI 10.1017/S0195941700060197; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Sunden F, 2016, J AM CHEM SOC, V138, P14273, DOI 10.1021/jacs.6b06186; Sunden F, 2015, ELIFE, V4, DOI 10.7554/eLife.06181; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; TULL D, 1994, BIOCHEMISTRY-US, V33, P6363, DOI 10.1021/bi00186a041; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Voordeckers K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001446; Wang J, 2005, BIOCHEMISTRY-US, V44, P8378, DOI 10.1021/bi050155p; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]; Wiersma-Koch H, 2013, BIOCHEMISTRY-US, V52, P9167, DOI 10.1021/bi4010045; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Zalatan JG, 2006, BIOCHEMISTRY-US, V45, P9788, DOI 10.1021/bi060847t; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059	86	12	13	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20960	20974		10.1074/jbc.M117.788240	http://dx.doi.org/10.1074/jbc.M117.788240			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29070681	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000418453400013
J	Yamasaki, K; Daiho, T; Danko, S; Yasuda, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Yasuda, Satoshi; Suzuki, Hiroshi			Nanodisc-based kinetic assays reveal distinct effects of phospholipid headgroups on the phosphoenzyme transition of sarcoplasmic reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; kinetics; lipid-protein interaction; membrane enzyme; phospholipid; sarcoplasmic reticulum (SR)	ADP-INSENSITIVE PHOSPHOENZYME; CALCIUM-PUMP; CA-ATPASE; CRYSTAL-STRUCTURES; TRANSMEMBRANE HELIX; CYTOPLASMIC DOMAINS; HYDROLYSIS; PROTEIN; H+; COUNTERTRANSPORT	Sarco(endo)plasmic reticulum Ca2+-ATPase catalyzes ATP-driven Ca2+ transport from the cytoplasm to the lumen and is critical for a range of cell functions, including muscle relaxation. Here, we investigated the effects of the headgroups of the 1-palmitoyl-2-oleoyl glycerophospholipids phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), and phosphatidylglycerol (PG) on sarcoplasmic reticulum (SR) Ca2+-ATPase embedded into a nanodisc, a lipid-bilayer construct harboring the specific lipid. We found that Ca2+-ATPase activity in a PC bilayer is comparable with that of SR vesicles and is suppressed in the other phospholipids, especially in PS. Ca2+ affinity at the high-affinity transport sites in PC was similar to that of SR vesicles, but 2-3-fold reduced in PE and PS. Ca2+ on- and off-rates in the non-phosphorylated ATPase were markedly reduced in PS. Rate-limiting phosphoenzyme (EP) conformational transition in 0.1 m KCl was as rapid in PC as in SR vesicles, but slowed in other phospholipids, especially in PS. Using kinetic plots of the logarithm of rate versus the square of mean activity coefficient of solutes in 0.1-1 m KCl, we noted that PC is optimal for the EP transition, but PG and especially PS had markedly unfavorable electrostatic effects, and PE exhibited a strong non-electrostatic restriction. Thus, the major SR membrane lipid PC is optimal for all steps and, unlike the other headgroups, contributes favorable electrostatics and non-electrostatic elements during the EP transition. Our analyses further revealed that the surface charge of the lipid bilayer directly modulates the transition rate.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Yasuda, Satoshi; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			JSPS KAKENHI Grant [JP15K06988, JP15H04346]; Grants-in-Aid for Scientific Research [15H04346, 17K07297] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant JP15K06988 (to K. Y.) and JSPS KAKENHI Grant JP15H04346 (to H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Bick RJ, 1998, J MEMBRANE BIOL, V164, P169, DOI 10.1007/s002329900402; CAFFREY M, 1981, BIOCHEMISTRY-US, V20, P1949, DOI 10.1021/bi00510a034; Clausen JD, 2013, EMBO J, V32, P3231, DOI 10.1038/emboj.2013.250; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41172; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Drachmann ND, 2014, FEBS J, V281, P4249, DOI 10.1111/febs.12957; Fuller N, 2003, BIOPHYS J, V85, P1667, DOI 10.1016/S0006-3495(03)74596-2; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Habeck M, 2017, P NATL ACAD SCI USA, V114, P2904, DOI 10.1073/pnas.1620799114; HARA H, 1986, J BIOL CHEM, V261, P6584; Her C, 2016, BIOPHYS J, V111, P989, DOI 10.1016/j.bpj.2016.06.041; Hunter GW, 1999, BIOCHEMISTRY-US, V38, P1356, DOI 10.1021/bi9822224; Justesen BH, 2013, J BIOL CHEM, V288, P26419, DOI 10.1074/jbc.M112.446948; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin-Molina A, 2012, BIOPHYS J, V102, P2095, DOI 10.1016/j.bpj.2012.03.009; Meissner G, 1974, Methods Enzymol, V32, P475; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Scarlata S, 1997, BIOPHYS CHEM, V67, P269, DOI 10.1016/S0301-4622(97)00053-7; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Starling AP, 1996, BIOCHEM J, V320, P309, DOI 10.1042/bj3200309; TANFORD C, 1978, SCIENCE, V200, P1012, DOI 10.1126/science.653353; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WEBER K, 1969, J BIOL CHEM, V244, P4406; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; YAMAGUCHI M, 1985, J BIOL CHEM, V260, P4896; YAMAGUCHI M, 1984, J BIOL CHEM, V259, P9526; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2013, J BIOL CHEM, V288, P20646, DOI 10.1074/jbc.M113.482711; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9; YU X, 1994, J BIOL CHEM, V269, P16656	50	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20218	20227		10.1074/jbc.M117.816702	http://dx.doi.org/10.1074/jbc.M117.816702			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29032359	Green Published, hybrid			2022-12-28	WOS:000417696400026
J	Muhlenhoff, U; Richter, N; Pines, O; Pierik, AJ; Lill, R				Muhlenhoff, Ulrich; Richter, Nadine; Pines, Ophry; Pierik, Antonio J.; Lill, Roland			Specialized function of yeast Isa1 and Isa2 proteins in the maturation of mitochondrial [4Fe-4S] proteins (vol 286, pg 41205, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Lill, Roland/0000-0002-8345-6518				Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152	1	3	3	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17979	17979		10.1074/jbc.AAC117.000255	http://dx.doi.org/10.1074/jbc.AAC117.000255			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	29079644	Green Published, hybrid			2022-12-28	WOS:000414013000034
J	Magdaong, NCM; Blankenship, RE				Magdaong, Nikki Cecil M.; Blankenship, Robert E.			Photoprotective, excited-state quenching mechanisms in diverse photosynthetic organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						photosynthesis; photosynthetic pigment; carotenoid; chlorophyll; redox regulation; antenna; non-photochemical quenching; xanthophyll cycle	ORANGE CAROTENOID PROTEIN; GREEN SULFUR BACTERIA; CANDIDATUS CHLORACIDOBACTERIUM THERMOPHILUM; EXCITATION-ENERGY REGULATION; IRON-STARVED CYANOBACTERIA; STRESS-RELATED PROTEIN; SP PCC 6803; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; CHLOROFLEXUS-AURANTIACUS	Light-harvesting complexes (LHCs) serve a dual role in photosynthesis, depending on the prevailing light conditions. In low light, they ensure photosynthetic efficiency by maximizing the light absorption cross-section and subsequent energy storage. Under excess light conditions, LHCs perform photoprotective quenching functions to prevent harmful chemical species such as triplet chlorophyll and singlet oxygen from forming and damaging the photosynthetic apparatus. In this Minireview, various photoprotective quenching mechanisms that have been identified in different photosynthetic organisms are surveyed and summarized, and implications for improving photosynthetic productivity are briefly discussed.	[Magdaong, Nikki Cecil M.; Blankenship, Robert E.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA; [Magdaong, Nikki Cecil M.; Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Magdaong, Nikki Cecil M.; Blankenship, Robert E.] Washington Univ, Photosynthet Antenna Res Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Blankenship, RE (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.; Blankenship, RE (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.; Blankenship, RE (corresponding author), Washington Univ, Photosynthet Antenna Res Ctr, St Louis, MO 63130 USA.	blankenship@wustl.edu			Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]	Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. This is the first article in the Thematic Minireview series "Green biological chemistry." The authors declare that they have no conflicts of interest with the contents of this article.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; Alboresi A, 2010, P NATL ACAD SCI USA, V107, P11128, DOI 10.1073/pnas.1002873107; Allorent G, 2013, PLANT CELL, V25, P545, DOI 10.1105/tpc.112.108274; Arellano JB, 2000, PHOTOCHEM PHOTOBIOL, V72, P669, DOI 10.1562/0031-8655(2000)072<0669:NLPSOC>2.0.CO;2; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; Ballottari M, 2016, J BIOL CHEM, V291, P7334, DOI 10.1074/jbc.M115.704601; Bandara S, 2017, P NATL ACAD SCI USA, V114, P6286, DOI 10.1073/pnas.1700956114; Berera R, 2012, J PHYS CHEM B, V116, P2568, DOI 10.1021/jp2108329; Berera R, 2010, CHEM PHYS, V373, P65, DOI 10.1016/j.chemphys.2010.01.011; Berera R, 2009, BIOPHYS J, V96, P2261, DOI 10.1016/j.bpj.2008.12.3905; Berteotti S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21339; Bhaya D, 2002, FEMS MICROBIOL LETT, V215, P209, DOI 10.1111/j.1574-6968.2002.tb11393.x; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; BLANKENSHIP RE, 2003, LIGHT HARVESTING ANT, P195; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Brooks MD, 2014, ADV PHOTOSYNTH RESP, V40, P297, DOI 10.1007/978-94-017-9032-1_13; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Buchel C, 2015, J PLANT PHYSIOL, V172, P62, DOI 10.1016/j.jplph.2014.04.018; Chen HYS, 2017, BBA-BIOENERGETICS, V1858, P249, DOI 10.1016/j.bbabio.2017.01.001; Correa-Galvis V, 2016, J BIOL CHEM, V291, P17478, DOI 10.1074/jbc.M116.737312; Correa-Galvis V, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.225, 10.1038/nplants.2015.225]; Costas AMG, 2011, J BACTERIOL, V193, P6701, DOI 10.1128/JB.06124-11; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; DemmigAdams B, 2014, NONPHOTOCHEMICAL QUE; Derks A, 2015, BBA-BIOENERGETICS, V1847, P468, DOI 10.1016/j.bbabio.2015.02.008; Dinc E, 2016, P NATL ACAD SCI USA, V113, P7673, DOI 10.1073/pnas.1605380113; Engelken J, 2012, ADV PHOTOSYNTH RESP, V33, P265, DOI 10.1007/978-94-007-1533-2_11; Fan MR, 2015, NAT STRUCT MOL BIOL, V22, P729, DOI 10.1038/nsmb.3068; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Frigaard NU, 1999, BBA-BIOENERGETICS, V1413, P108, DOI 10.1016/S0005-2728(99)00094-8; Frigaard NU, 1997, ARCH MICROBIOL, V167, P343, DOI 10.1007/s002030050453; Frigaard NU, 1998, PHOTOSYNTH RES, V58, P81, DOI 10.1023/A:1006043706652; Ghazaryan A, 2016, BBA-BIOENERGETICS, V1857, P1373, DOI 10.1016/j.bbabio.2016.04.288; Girolomoni L, 2017, J EXP BOT, V68, P628, DOI 10.1093/jxb/erw462; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Gupta S, 2015, P NATL ACAD SCI USA, V112, pE5567, DOI 10.1073/pnas.1512240112; Gwizdala M, 2016, J AM CHEM SOC, V138, P11616, DOI 10.1021/jacs.6b04811; Gwizdala M, 2011, PLANT CELL, V23, P2631, DOI 10.1105/tpc.111.086884; Harris D, 2016, P NATL ACAD SCI USA, V113, pE1655, DOI 10.1073/pnas.1523680113; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Hohmann-Marriott MF, 2007, BBA-BIOENERGETICS, V1767, P106, DOI 10.1016/j.bbabio.2006.11.011; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Kana R, 2014, PLANT PHYSIOL, V165, P1618, DOI 10.1104/pp.114.236075; Kerfeld CA, 2003, STRUCTURE, V11, P55, DOI 10.1016/S0969-2126(02)00936-X; Kim H, 2007, BIOPHYS J, V93, P192, DOI 10.1529/biophysj.106.103556; Kirilovsky D, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.180, 10.1038/nplants.2016.180]; Kirilovsky D, 2015, PHOTOSYNTH RES, V126, P3, DOI 10.1007/s11120-014-0031-7; Kirilovsky D, 2012, BBA-BIOENERGETICS, V1817, P158, DOI 10.1016/j.bbabio.2011.04.013; Knoppova J, 2014, PLANT CELL, V26, P1200, DOI 10.1105/tpc.114.123919; Komenda J, 2016, BBA-BIOENERGETICS, V1857, P288, DOI 10.1016/j.bbabio.2015.08.011; Kondo T, 2017, NAT CHEM, V9, P772, DOI [10.1038/NCHEM.2818, 10.1038/nchem.2818]; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Krupnik T, 2013, J BIOL CHEM, V288, P23529, DOI 10.1074/jbc.M113.484659; Kuzminov FI, 2012, BBA-BIOENERGETICS, V1817, P1012, DOI 10.1016/j.bbabio.2012.03.022; Lavaud J, 2014, ADV PHOTOSYNTH RESP, V40, P421, DOI 10.1007/978-94-017-9032-1_20; Lea-Smith DJ, 2014, PLANT PHYSIOL, V165, P705, DOI 10.1104/pp.114.237206; Leverenz RL, 2015, SCIENCE, V348, P1463, DOI 10.1126/science.aaa7234; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu HJ, 2016, BIOCHEMISTRY-US, V55, P1003, DOI 10.1021/acs.biochem.6b00013; Liu LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003134; Llansola-Portoles MJ, 2017, J BIOL CHEM, V292, P1396, DOI 10.1074/jbc.M116.753723; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Lu Y, 2017, BIOCHEMISTRY-US, V56, P2812, DOI 10.1021/acs.biochem.7b00202; Maksimov EG, 2014, BBA-BIOENERGETICS, V1837, P1540, DOI 10.1016/j.bbabio.2014.01.010; Maksimov EG, 2017, BIOPHYS J, V112, P46, DOI 10.1016/j.bpj.2016.11.3193; Maksimov EG, 2015, BIOPHYS J, V109, P595, DOI 10.1016/j.bpj.2015.06.052; Melo TB, 2000, SPECTROCHIM ACTA A, V56, P2001, DOI 10.1016/S1386-1425(00)00289-4; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Minagawa J, 2015, PLANT J, V82, P413, DOI 10.1111/tpj.12805; Mirkovic T., 2016, CHEM REV, V117, P249, DOI [10.1021/acs.chemrev.6b00002, DOI 10.1021/acs.chemrev.6b00002, DOI 10.1016/j.bbabio.2007.07.006]; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Niedzwiedzki DM, 2016, BBA-BIOENERGETICS, V1857, P1430, DOI 10.1016/j.bbabio.2016.04.280; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Olson JM, 2004, PHOTOSYNTH RES, V80, P181, DOI 10.1023/B:PRES.0000030428.36950.43; Orf GS, 2016, P NATL ACAD SCI USA, V113, pE4486, DOI 10.1073/pnas.1603330113; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Ort DR, 2015, P NATL ACAD SCI USA, V112, P8529, DOI 10.1073/pnas.1424031112; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Penik J., 2014, STRUCTURAL BASIS BIO, P77; Petroutsos D, 2016, NATURE, V537, P563, DOI 10.1038/nature19358; Pinnola A, 2015, J BIOL CHEM, V290, P24340, DOI 10.1074/jbc.M115.668798; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Sacharz J, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.225; Scott M, 2006, BIOCHEMISTRY-US, V45, P8952, DOI 10.1021/bi060767p; Sedoud A, 2014, PLANT CELL, V26, P1781, DOI 10.1105/tpc.114.123802; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]; Sutter M, 2013, P NATL ACAD SCI USA, V110, P10022, DOI 10.1073/pnas.1303673110; Tian LJ, 2011, J AM CHEM SOC, V133, P18304, DOI 10.1021/ja206414m; Tietz S, 2017, PLANT CELL ENVIRON, V40, P1243, DOI 10.1111/pce.12924; Tokita S, 2000, PHOTOCHEM PHOTOBIOL, V72, P345, DOI 10.1562/0031-8655(2000)072<0345:QOBFIC>2.0.CO;2; Tokutsu R, 2013, P NATL ACAD SCI USA, V110, P10016, DOI 10.1073/pnas.1222606110; Tronrud DE, 2009, PHOTOSYNTH RES, V100, P79, DOI 10.1007/s11120-009-9430-6; vanNoort PI, 1997, BIOPHYS J, V72, P316, DOI 10.1016/S0006-3495(97)78670-3; Wang Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010432; Wen JZ, 2011, BIOCHEMISTRY-US, V50, P3502, DOI 10.1021/bi200239k; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Xue HD, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1058462; Zhang H, 2014, BIOCHEMISTRY-US, V53, P13, DOI 10.1021/bi401539w; ZHOU WL, 1994, PHOTOSYNTH RES, V41, P89, DOI 10.1007/BF02184148	108	33	34	8	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 6	2018	293	14					5018	5025		10.1074/jbc.TM117.000233	http://dx.doi.org/10.1074/jbc.TM117.000233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB9QQ	29298897	Green Published, hybrid			2022-12-28	WOS:000429409300007
J	Bailey, SS; Payne, KAP; Fisher, K; Marshall, SA; Cliff, MJ; Spiess, R; Parker, DA; Rigby, SEJ; Leys, D				Bailey, Samuel S.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Cliff, Matthew J.; Spiess, Reynard; Parker, David A.; Rigby, Stephen E. J.; Leys, David			The role of conserved residues in Fdc decarboxylase in prenylated flavin mononucleotide oxidative maturation, cofactor isomerization, and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FERULIC ACID DECARBOXYLASE; BACTERIAL UBIQUINONE BIOSYNTHESIS; 1,3-DIPOLAR CYCLOADDITION; MECHANISM; SYSTEM; UBIX	The UbiD family of reversible decarboxylases act on aromatic, heteroaromatic, and unsaturated aliphatic acids and utilize a prenylated flavin mononucleotide (prFMN) as cofactor, bound adjacent to a conserved Glu-Arg-Glu/Asp ionic network in the enzyme's active site. It is proposed that UbiD activation requires oxidative maturation of the cofactor, for which two distinct isomers, prFMN(ketimine) and prFMN(iminium), have been observed. It also has been suggested that only the prFMN(iminium) form is relevant to catalysis, which requires transient cycloaddition between substrate and cofactor. Using Aspergillus niger Fdc1 as a model system, we reveal that isomerization ofprFMN(iminium) to prFMN(ketimine) is a light-dependent process that is largely independent of the Glu(277)-Arg(173)-Glu(282) network and accompanied by irreversible loss of activity. On the other hand, efficient catalysis was highly dependent on an intact Glu-Arg-Glu network, as only Glu -> Asp substitutions retain activity. Surprisingly, oxidative maturation to form the prFMN(iminium) species is severely affected only for the R173A variant. In summary, the unusual irreversible isomerization of prFMN is light-dependent and probably proceeds via high-energy intermediates but is independent of the Glu-Arg-Glu network. Our results from mutagenesis, crystallographic, spectroscopic, and kinetic experiments indicate a clear role for the Glu-Arg-Glu network in both catalysis and oxidative maturation.	[Bailey, Samuel S.; Payne, Karl A. P.; Fisher, Karl; Marshall, Stephen A.; Cliff, Matthew J.; Spiess, Reynard; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Parker, David A.] Westhollow Technol Ctr, Innovat Biodomain Shell Int Explorat & Prod, Houston, TX 77082 USA	University of Manchester	Leys, D (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Fisher, Karl/A-5956-2013	Fisher, Karl/0000-0003-3539-8939; Cliff, Matthew/0000-0002-7482-0234; Marshall, Stephen/0000-0001-7678-4989; payne, karl/0000-0002-6331-6374	BBSRC [BB/K017802/1, BB/P000622/1]; ERC [ADG_695013]; BBSRC iCASE studentship; Biotechnology and Biological Sciences Research Council [BB/K017802/1, 1482350, BB/P000622/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); BBSRC iCASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by BBSRC Grants BB/K017802/1 and BB/P000622/1, ERC Grant ADG_695013, and a BBSRC iCASE studentship (to S. S. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Clennan EL, 2005, TETRAHEDRON, V61, P6665, DOI 10.1016/j.tet.2005.04.017; Ebenau-Jehle C, 2017, ISME J, V11, P224, DOI 10.1038/ismej.2016.91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KL, 2017, J AM CHEM SOC, V139, P10972, DOI 10.1021/jacs.7b05060; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; He ZQ, 1996, J BACTERIOL, V178, P3539, DOI 10.1128/jb.178.12.3539-3543.1996; Heuts DPHM, 2009, FEBS J, V276, P3405, DOI 10.1111/j.1742-4658.2009.07053.x; Jordan F, 2013, ACS CATAL, V3, P1601, DOI 10.1021/cs400272x; KEMAL C, 1977, P NATL ACAD SCI USA, V74, P405, DOI 10.1073/pnas.74.2.405; Lan CL, 2016, J ORG CHEM, V81, P9289, DOI 10.1021/acs.joc.6b01872; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Long F, 2017, ACTA CRYSTALLOGR D, V73, P112, DOI 10.1107/S2059798317000067; Marshall SA, 2017, ARCH BIOCHEM BIOPHYS, V632, P209, DOI 10.1016/j.abb.2017.07.014; Marshall SA, 2017, J BIOL CHEM, V292, P4623, DOI 10.1074/jbc.M116.762732; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Payer SE, 2017, ANGEW CHEM INT EDIT, V56, P13893, DOI 10.1002/anie.201708091; Payne KAP, 2015, NATURE, V522, P497, DOI 10.1038/nature14560; Sorigue D, 2017, SCIENCE, V357, P903, DOI 10.1126/science.aan6349; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; White MD, 2015, NATURE, V522, P502, DOI 10.1038/nature14559; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida T, 2002, BIOSCI BIOTECH BIOCH, V66, P2388, DOI 10.1271/bbb.66.2388	23	28	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2272	2287		10.1074/jbc.RA117.000881	http://dx.doi.org/10.1074/jbc.RA117.000881			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29259125	hybrid, Green Published			2022-12-28	WOS:000425308300004
J	Huang, BS; Li, X; Tu, XM; Zhao, W; Zhu, D; Feng, Y; Si, X; Chen, JG				Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang			OTX1 regulates cell cycle progression of neural progenitors in the developing cerebral cortex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; neurogenesis; proliferation; gene expression; mouse; cerebral cortex; gliogenesis; in utero electroporation; OTX1; progenitors	CORTICAL-NEURONS; GENE-TRANSFER; BRAIN; DIFFERENTIATION; EXPRESSION; NEOCORTEX; STEM; ELECTROPORATION; NEUROGENESIS; TRANSGENES	The progenitor cells in the cerebral cortex coordinate proliferation and mitotic exit to generate the correct number of neurons and glial cells during development. However, mechanisms for regulating the mitotic cycle of cortical progenitors are not fully understood. Otx1 is one of the homeobox-containing transcription factors frequently implicated in the development of the central nervous system. Mice bearing a targeted deletion of Otx1 exhibit brain hypoplasia and a decrease in the number of cortical neurons. We hypothesized that Otx1 might be crucial to the proliferation and differentiation of cortical progenitors. Otx1 knockdown by in utero electroporation in the mouse brain reduced the proportion of the G(1) phase while increasing the S and M phases of progenitor cells. The knockdown diminished Tbr1+ neurons but increased GFAP+ astrocytes in the early postnatal cortex as revealed by lineage tracing study. Tbr2+ basal progenitors lacking Otx1 were held at the transit-amplifying stage. In contrast, overexpression of wildtype Otx1 but not an astrocytoma-related mutant Y320C inhibited proliferation of the progenitor cells in embryonic cortex. This study demonstrates that Otx1 is one of the key elements regulating cortical neurogenesis, and a loss-of-function in Otx1 may contribute to the overproduction of astrocytes in vivo.	[Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China; [Huang, Baoshan; Li, Xue; Tu, Xiaomeng; Zhao, Wei; Zhu, Dan; Feng, Yue; Si, Xiang; Chen, Jie-Guang] Wenzhou Med Univ, Zhejiang Prov Key Lab Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Chen, JG (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, State Key Lab Optometry Ophthalmol & Vis Sci, Wenzhou 325027, Zhejiang, Peoples R China.; Chen, JG (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Optometry & Ophthalmol, Wenzhou 325027, Zhejiang, Peoples R China.	jgchen@mail.eye.ac.cn			National Natural Science Foundation of China [81571096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81571096 (to J. G. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Beatty J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-16; Bellipanni G, 2010, J CELL PHYSIOL, V222, P286, DOI 10.1002/jcp.21944; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gao P, 2014, CELL, V159, P775, DOI 10.1016/j.cell.2014.10.027; Ge WP, 2016, NEUROSCIENCE, V323, P3, DOI 10.1016/j.neuroscience.2015.08.057; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Larsen KB, 2010, J HISTOCHEM CYTOCHEM, V58, P669, DOI 10.1369/jhc.2010.955757; Liu XD, 2011, EUR J HUM GENET, V19, P1264, DOI 10.1038/ejhg.2011.112; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Panto MR, 2004, EUR J NEUROSCI, V19, P2893, DOI 10.1111/j.0953-816X.2004.03326.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sato Y, 2007, DEV BIOL, V305, P616, DOI 10.1016/j.ydbio.2007.01.043; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043; Yoshida A, 2010, GENES CELLS, V15, P501, DOI 10.1111/j.1365-2443.2010.01397.x; Zhang YA, 2002, MOL CELL NEUROSCI, V19, P430, DOI 10.1006/mcne.2001.1076	32	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2137	2148		10.1074/jbc.RA117.001249	http://dx.doi.org/10.1074/jbc.RA117.001249			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29273633	Green Published, hybrid			2022-12-28	WOS:000424948000025
J	Pan, WF; Sun, K; Tang, K; Xiao, QP; Ma, CX; Yu, C; Wei, ZY				Pan, Wenfei; Sun, Kang; Tang, Kun; Xiao, Qingpin; Ma, Chenxue; Yu, Cong; Wei, Zhiyi			Structural insights into ankyrin repeat-mediated recognition of the kinesin motor protein KIF21A by KANK1, a scaffold protein in focal adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; focal adhesion; protein complex; scaffold protein; tumor suppressor gene; KANK; ankyrin repeat	CELL; GROWTH; GENE; MICROTUBULES; ASSOCIATION; APOPTOSIS; MIGRATION; MUTATION; DELETION; MATRIX	Kidney ankyrin repeat-containing proteins (KANK1/2/3/4) belong to a family of scaffold proteins, playing critical roles in cytoskeleton organization, cell polarity, and migration. Mutations in KANK proteins are implicated in cancers and genetic diseases, such as nephrotic syndrome. KANK proteins can bind various target proteins through different protein regions, including a highly conserved ankyrin repeat domain (ANKRD). However, the molecular basis for target recognition by the ANKRD remains elusive. In this study, we solved a high-resolution crystal structure of the ANKRD of KANK1 in complex with a short sequence of the motor protein kinesin family member 21A (KIF21A), revealing that the highly specific target-binding mode of the ANKRD involves combinatorial use of two interfaces. Mutations in either interface disrupted the KANK1-KIF21A interaction. Cellular immunofluorescence localization analysis indicated that binding-deficient mutations block recruitment of KIF21A to focal adhesions by KANK1. In conclusion, our structural study provides mechanistic explanations for the ANKRD-mediated recognition of KIF21A and for many disease-related mutations identified in human KANK proteins.	[Pan, Wenfei; Sun, Kang; Tang, Kun; Xiao, Qingpin; Ma, Chenxue; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Sun, Kang; Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Tang, Kun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Xiao, Qingpin] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China	Southern University of Science & Technology; Nankai University; University of Macau	Wei, ZY (corresponding author), Southern Univ Sci & Technol, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	weizy@sustc.edu.cn	Tang, Kun/GSD-3218-2022; Wei, Zhiyi/C-4315-2014; yu, cong/V-5140-2018; , 余聪/AAK-9457-2020; Wei, Zhiyi/N-9995-2019	Wei, Zhiyi/0000-0002-4446-6502; yu, cong/0000-0003-2912-6347; Wei, Zhiyi/0000-0002-4446-6502; sun, kang/0000-0003-4632-0176	Recruitment Program of Global Youth Experts of China; National Natural Science Foundation of China [31770791, 31570741, 31600612]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, ZDSYS20140509142721429]	Recruitment Program of Global Youth Experts of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission	This work was supported in part by National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.) and 31600612 (to K. T.), Natural Science Foundation of Guangdong Province Grant 2016A030312016, Science and Technology Planning Project of Guangdong Province Grant 2017B030301018, and Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 and ZDSYS20140509142721429. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Recruitment Program of Global Youth Experts of China.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Chen T, 2017, ONCOL REP, V38, P1663, DOI 10.3892/or.2017.5823; Cheng L, 2014, NEURON, V82, P334, DOI 10.1016/j.neuron.2014.02.038; Cui ZB, 2017, SCI REP-UK, V7, DOI 10.1038/srep40325; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ding M, 2003, DEVELOPMENT, V130, P5791, DOI 10.1242/dev.00791; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Guo XH, 2014, INT J ONCOL, V44, P797, DOI 10.3892/ijo.2014.2247; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Kakinuma N, 2009, BIOCHEM BIOPH RES CO, V386, P639, DOI 10.1016/j.bbrc.2009.06.109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li CC, 2011, P NATL ACAD SCI USA, V108, P19228, DOI 10.1073/pnas.1117011108; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Ramot Y, 2014, J MED GENET, V51, P388, DOI 10.1136/jmedgenet-2014-102346; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Stehbens S, 2012, J CELL BIOL, V198, P481, DOI 10.1083/jcb.201206050; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Wang CY, 2014, J APPL PHYS, V115, DOI 10.1063/1.4862798; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	34	11	11	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1944	1956		10.1074/jbc.M117.815779	http://dx.doi.org/10.1074/jbc.M117.815779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29217769	Green Published, hybrid			2022-12-28	WOS:000424948000010
J	Condon, SGF; Deena-Al Mahbuba; Armstrong, CR; Diaz-Vazquez, G; Craven, SJ; LaPointe, LM; Khadria, AS; Chadda, R; Crooks, JA; Rangarajan, N; Weibel, DB; Hoskins, AA; Robertson, JL; Cui, Q; Senes, A				Condon, Samson G. F.; Deena-Al Mahbuba; Armstrong, Claire R.; Diaz-Vazquez, Gladys; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Chadda, Rahul; Crooks, John A.; Rangarajan, Nambirajan; Weibel, Douglas B.; Hoskins, Aaron A.; Robertson, Janice L.; Cui, Qiang; Senes, Alessandro			The FtsLB subcomplex of the bacterial divisome is a tetramer with an uninterrupted FtsL helix linking the transmembrane and periplasmic regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						co-evolution; divisome; cell division; bacteria; Escherichia coli (E; coli); membrane protein; computational biology; molecular modeling; fluorescence resonance energy transfer (FRET); bioinformatics; molecular dynamics; bacterial genetics	CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; COILED-COILS; IMPROVED PREDICTION; SEPTAL RING; MOLECULAR-DYNAMICS; CONFORMER LIBRARY; CYTOKINETIC RING; TRIMERIC COMPLEX	In Escherichia coli, FtsLB plays a central role in the initiation of cell division, possibly transducing a signal that will eventually lead to the activation of peptidoglycan remodeling at the forming septum. The molecular mechanisms by which FtsLB operates in the divisome, however, are not understood. Here, we present a structural analysis of the FtsLB complex, performed with biophysical, computational, and in vivo methods, that establishes the organization of the transmembrane region and proximal coiled coil of the complex. FRET analysis in vitro is consistent with formation of a tetramer composed of two FtsL and two FtsB subunits. We predicted subunit contacts through co-evolutionary analysis and used them to compute a structural model of the complex. The transmembrane region of FtsLB is stabilized by hydrophobic packing and by a complex network of hydrogen bonds. The coiled coil domain probably terminates near the critical constriction control domain, which might correspond to a structural transition. The presence of strongly polar amino acids within the core of the tetrameric coiled coil suggests that the coil may split into two independent FtsQ-binding domains. The helix of FtsB is interrupted between the transmembrane and coiled coil regions by a flexible Gly-rich linker. Conversely, the data suggest that FtsL forms an uninterrupted helix across the two regions and that the integrity of this helix is indispensable for the function of the complex. The FtsL helix is thus a candidate for acting as a potential mechanical connection to communicate conformational changes between periplasmic, membrane, and cytoplasmic regions.	[Condon, Samson G. F.; Deena-Al Mahbuba; Armstrong, Claire R.; Diaz-Vazquez, Gladys; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Crooks, John A.; Rangarajan, Nambirajan; Weibel, Douglas B.; Hoskins, Aaron A.; Senes, Alessandro] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Condon, Samson G. F.; Deena-Al Mahbuba; Craven, Samuel J.; LaPointe, Loren M.; Khadria, Ambalika S.; Crooks, John A.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Diaz-Vazquez, Gladys] Univ Wisconsin, Biophys Grad Program, Madison, WI 53706 USA; [Cui, Qiang] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Chadda, Rahul; Robertson, Janice L.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Iowa	Senes, A (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	senes@wisc.edu	Chadda, Rahul/AAM-2085-2020; Rangarajan, Nambirajan/AAU-1349-2020	Rangarajan, Nambirajan/0000-0002-8332-2448; SENES, ALESSANDRO/0000-0002-3807-2275; Robertson, Janice/0000-0002-5499-9943; Condon, Samson/0000-0001-5072-9316	National Institutes of Health (NIH) [R01-GM099752]; National Science Foundation (NSF) [CHE-1415910]; NSF [DMS-1661900]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099752, R21GM126476, R01GM120260] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007359] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by National Institutes of Health (NIH) Grant R01-GM099752, National Science Foundation (NSF) Grant CHE-1415910 (to A. S.), and NSF Grant DMS-1661900 (to Q. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Bramkamp M, 2006, MOL MICROBIOL, V62, P580, DOI 10.1111/j.1365-2958.2006.05402.x; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown JH, 1996, PROTEINS, V26, P134; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Chen JC, 2001, MOL MICROBIOL, V42, P395, DOI 10.1046/j.1365-2958.2001.02640.x; Cho H, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.172, 10.1038/nmicrobiol.2016.172]; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Du SS, 2016, P NATL ACAD SCI USA, V113, pE5052, DOI 10.1073/pnas.1606656113; Egan AJF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00455; Emami K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.253; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; Ghigo JM, 1999, MOL MICROBIOL, V31, P725, DOI 10.1046/j.1365-2958.1999.01213.x; Glas M, 2015, J BIOL CHEM, V290, P21498, DOI 10.1074/jbc.M115.654756; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Hale CA, 1999, J BACTERIOL, V181, P167, DOI 10.1128/JB.181.1.167-176.1999; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hicks MR, 2002, J STRUCT BIOL, V137, P73, DOI 10.1006/jsbi.2002.4462; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; Kim JK, 2015, NUCLEIC ACIDS RES, V43, pW413, DOI 10.1093/nar/gkv360; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kulp DW, 2012, J COMPUT CHEM, V33, P1645, DOI 10.1002/jcc.22968; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mannik J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006638; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Meeske AJ, 2016, NATURE, V537, P634, DOI 10.1038/nature19331; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2014, J BIOL CHEM, V289, P14707, DOI 10.1074/jbc.M114.557371; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; North B, 2001, J MOL BIOL, V311, P1081, DOI 10.1006/jmbi.2001.4900; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Paintdakhi A, 2016, MOL MICROBIOL, V99, P767, DOI 10.1111/mmi.13264; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robichon C, 2008, J BACTERIOL, V190, P6048, DOI 10.1128/JB.00462-08; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schmidt NW, 2017, PROTEIN SCI, V26, P414, DOI 10.1002/pro.3095; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Subramaniam S, 2014, PROTEINS, V82, P3177, DOI 10.1002/prot.24685; Subramaniam S, 2012, PROTEINS, V80, P2218, DOI 10.1002/prot.24111; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van Saparoea HBV, 2013, J BIOL CHEM, V288, P24340, DOI 10.1074/jbc.M113.485888; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yang DC, 2011, P NATL ACAD SCI USA, V108, pE1052, DOI 10.1073/pnas.1107780108; Yang JC, 2004, MOL MICROBIOL, V52, P651, DOI 10.1111/j.1365-2958.2004.03991.x; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995	93	16	16	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1623	1641		10.1074/jbc.RA117.000426	http://dx.doi.org/10.1074/jbc.RA117.000426			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29233891	Green Published, hybrid			2022-12-28	WOS:000424201700015
J	Fiebig, T; Litschko, C; Freiberger, F; Bethe, A; Berger, M; Gerardy-Schahn, R				Fiebig, Timm; Litschko, Christa; Freiberger, Friedrich; Bethe, Andrea; Berger, Monika; Gerardy-Schahn, Rita			Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS SEROGROUP; GLYCOCONJUGATE VACCINE; CONJUGATE VACCINE; POLYSACCHARIDE; CARBOHYDRATE; POLYSIALYLTRANSFERASE; TETRASACCHARIDE; PERSPECTIVE; POLYMERASE; MECHANISM	Neisseria meningitidis serogroups A and X are among the leading causes of bacterial meningitis in the African meningitis belt. Glycoconjugate vaccines, consisting of an antigenic carrier protein coupled to the capsular polysaccharide of the bacterial pathogen, are the most effective strategy for prevention of meningococcal disease. However, the distribution of effective glycoconjugate vaccines in this region is limited by the high cost of cultivating pathogens and purification of their capsular polysaccharides. Moreover, chemical approaches to synthesize oligosaccharide antigens have proven challenging. In the current study, we present a chemoenzymatic approach for generating tailored oligosaccharide fractions ready for activation and coupling to the carrier protein. In a first step, the elongation modes of recombinant capsular polymerases from Neisseria meningitidis serogroups A (CsaB) and X (CsxA) were characterized. We observed that CsaB is a distributive enzyme, and CsxA is a processive enzyme. Sequence comparison of these two stealth family proteins revealed a C-terminal extension in CsxA, which conferred processivity because of the existence of a second product-binding site. Deletion of the C-terminal domain converted CsxA into a distributive enzyme, allowing facile control of product length by adjusting the ratio of donor to acceptor sugars. Solid-phase fixation of the engineered capsular polymerases enabled rapid production of capsular polysaccharides with high yield and purity. In summary, the tools developed here provide critical steps toward reducing the cost of conjugate vaccine production, which will increase access in regions with the greatest need. Our work also facilitates efforts to study the relationship between oligosaccharide size and antigenicity.	[Fiebig, Timm; Litschko, Christa; Freiberger, Friedrich; Bethe, Andrea; Berger, Monika; Gerardy-Schahn, Rita] Hannover Med Sch, Inst Clin Biochem, D-30625 Hannover, Germany	Hannover Medical School	Gerardy-Schahn, R (corresponding author), Hannover Med Sch, Carl Neuberg Str 1, D-30625 Hannover, Germany.	gerardy-schahn.rita@mh-hannover.de		Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	LOM from Medizinische Hochschule Hannover (Hannover Medical School)	LOM from Medizinische Hochschule Hannover (Hannover Medical School)	This work was supported by LOM (impact-oriented funding) funds to the Institute of Clinical Biochemistry from Medizinische Hochschule Hannover (Hannover Medical School). T.F., M.B., A.B., F.F., and R.G.-S. have submitted patent applications for glycoconjugate vaccines against NmA and NmX.	Adamo R, 2017, ACCOUNTS CHEM RES, V50, P1270, DOI 10.1021/acs.accounts.7b00106; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P145; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Avci FY, 2011, NAT MED, V17, P1602, DOI 10.1038/nm.2535; Barnighausen T, 2014, P NATL ACAD SCI USA, V111, P12313, DOI 10.1073/pnas.1400475111; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; Berti F, 2013, ACS CHEM BIOL, V8, P1653, DOI 10.1021/cb400423g; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; Broker M, 2009, VACCINE, V27, P5574, DOI 10.1016/j.vaccine.2009.07.036; Costantino P, 2011, EXPERT OPIN DRUG DIS, V6, P1045, DOI 10.1517/17460441.2011.609554; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; Fallarini S, 2015, ACS INFECT DIS, V1, P487, DOI 10.1021/acsinfecdis.5b00071; Fiebig T, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.17; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Forsee WT, 2006, J BIOL CHEM, V281, P6283, DOI 10.1074/jbc.M511124200; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Gao Q, 2013, ACS CHEM BIOL, V8, P2561, DOI 10.1021/cb400463u; Harale KR, 2017, ORG CHEM FRONT, V4, P2348, DOI 10.1039/c7qo00468k; Harale KR, 2015, RSC ADV, V5, P41332, DOI 10.1039/c5ra02993g; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814; Kulkarni PS, 2015, CLIN INFECT DIS, V61, pS483, DOI 10.1093/cid/civ500; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Litschko C, 2015, J BIOL CHEM, V290, P24355, DOI 10.1074/jbc.M115.678094; Maurice J, 2015, LANCET, V385, P2241, DOI 10.1016/S0140-6736(15)61050-9; May JF, 2009, P NATL ACAD SCI USA, V106, P11851, DOI 10.1073/pnas.0901407106; Micoli F, 2013, P NATL ACAD SCI USA, V110, P19077, DOI 10.1073/pnas.1314476110; Morelli L, 2014, BEILSTEIN J ORG CHEM, V10, P2367, DOI 10.3762/bjoc.10.247; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; Romanow A, 2014, J BIOL CHEM, V289, P33945, DOI 10.1074/jbc.M114.597773; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Schumann B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf5347; SEPPALA I, 1989, J IMMUNOL, V143, P1259; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Vionnet J, 2007, GLYCOBIOLOGY, V17, P735, DOI 10.1093/glycob/cwm032; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036	43	22	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					953	962		10.1074/jbc.RA117.000488	http://dx.doi.org/10.1074/jbc.RA117.000488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187601	Green Published, hybrid			2022-12-28	WOS:000422864500016
J	Ji, WB; Luo, YB; Ahmad, E; Liu, ST				Ji, Wenbin; Luo, Yibo; Ahmad, Ejaz; Liu, Song-Tao			Direct interactions of mitotic arrest deficient 1 (MAD1) domains with each other and MAD2 conformers are required for mitotic checkpoint signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						MAD1; MAD2; mitotic checkpoint; MPS1 kinase; mitosis; signal transduction; kinetochore; mitotic spindle; checkpoint control	SPINDLE ASSEMBLY CHECKPOINT; UNATTACHED KINETOCHORES; PROTEIN BUBR1; CHROMOSOME BIORIENTATION; ANAPHASE INHIBITOR; KINASE-ACTIVITY; BUDDING YEAST; CORE COMPLEX; PHOSPHORYLATION; MITOSIS	As a sensitive signaling system, the mitotic checkpoint ensures faithful chromosome segregation by delaying anaphase onset even when a single kinetochore is unattached to mitotic spindle microtubules. The key signal amplification reaction for the checkpoint is the conformational conversion of open mitotic arrest deficient 2 (O-MAD2) into closed MAD2 (C-MAD2). The reaction has been suggested to be catalyzed by an unusual catalyst, a MAD1:C-MAD2 tetramer, but how the catalysis is executed and regulated remains elusive. Here, we report that in addition to the well-characterized middle region of MAD1 containing the MAD2-interaction motif (MIM), both N- and C-terminal domains (NTD and CTD) of MAD1 also contribute to mitotic checkpoint signaling. Unlike the MIM, which stably associated only with C-MAD2, the NTD and CTD in MAD1 surprisingly bound both O- and C-MAD2, suggesting that these two domains interact with both substrates and products of the O-to-C conversion. MAD1(NTD) and MAD1(CTD) also interacted with each other and with the MPS1 protein kinase, which phosphorylated both NTD and CTD. This phosphorylation decreased the NTD:CTD interaction and also CTD's interaction with MPS1. Of note, mutating the phosphorylation sites in the MAD1(CTD), including Thr-716, compromised MAD2 binding and the checkpoint responses. We further noted that Ser-610 and Tyr-634 also contribute to the mitotic checkpoint signaling. Our results have uncovered that the MAD1(NTD) and MAD1(CTD) directly interact with each other and with MAD2 conformers and are regulated by MPS1 kinase, providing critical insights into mitotic checkpoint signaling.	[Ji, Wenbin; Luo, Yibo; Ahmad, Ejaz; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019; Ahmad, Ejaz/L-1506-2013	Ahmad, Ejaz/0000-0002-5713-6713; Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Medicine [NIH R01CA169500]; NATIONAL CANCER INSTITUTE [R01CA169500] Funding Source: NIH RePORTER	National Institutes of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Medicine Grant NIH R01CA169500 (to S.-T.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akera T, 2015, NAT CELL BIOL, V17, P1124, DOI 10.1038/ncb3219; Ballister ER, 2014, J CELL BIOL, V204, P901, DOI 10.1083/jcb.201311113; Campbell MS, 2001, J CELL SCI, V114, P953; Caron D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aah3525; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chi YH, 2008, J BIOL CHEM, V283, P35834, DOI 10.1074/jbc.M804967200; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Elowe S, 2017, CELL CYCLE, V16, P746, DOI 10.1080/15384101.2017.1302632; Faesen AC, 2017, NATURE, V542, P498, DOI 10.1038/nature21384; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Hara M, 2015, P NATL ACAD SCI USA, V112, P11252, DOI 10.1073/pnas.1512197112; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Heinrich S, 2014, EMBO REP, V15, P291, DOI 10.1002/embr.201338114; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Ji ZJ, 2017, ELIFE, V6, DOI 10.7554/eLife.22513; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; Kim S, 2010, P NATL ACAD SCI USA, V107, P19772, DOI 10.1073/pnas.1009000107; Kruse T, 2014, EMBO REP, V15, P282, DOI 10.1002/embr.201338101; Kuijt TEF, 2014, CHROMOSOMA, V123, P471, DOI 10.1007/s00412-014-0458-9; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Lischetti T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970484; Lischetti T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6563; Liu ST, 2016, AIMS MOL SCI, V3, P597, DOI 10.3934/molsci.2016.4.597; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; London N, 2014, GENE DEV, V28, P140, DOI 10.1101/gad.233700.113; Lou Y, 2004, J BIOL CHEM, V279, P20049, DOI 10.1074/jbc.M314205200; Luo XL, 2004, NAT STRUCT MOL BIOL, V11, P338, DOI 10.1038/nsmb748; Luo XL, 2000, NAT STRUCT BIOL, V7, P224; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Luo XL, 2008, STRUCTURE, V16, P1616, DOI 10.1016/j.str.2008.10.002; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Mapelli M, 2007, CURR OPIN STRUC BIOL, V17, P716, DOI 10.1016/j.sbi.2007.08.011; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Moasser MM, 1999, CANCER RES, V59, P6145; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; St-Denis N, 2016, CELL REP, V17, P2488, DOI 10.1016/j.celrep.2016.10.078; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2008, J CELL BIOL, V181, P893, DOI 10.1083/jcb.200712028; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; Wassmann K, 2003, EMBO J, V22, P797, DOI 10.1093/emboj/cdg071; Wolanin K, 2010, MOL CANCER THER, V9, P1328, DOI 10.1158/1535-7163.MCT-09-0936; Yang CY, 2014, CARCINOGENESIS, V35, P2007, DOI 10.1093/carcin/bgu087; Yang MJ, 2008, PLOS BIOL, V6, P643, DOI 10.1371/journal.pbio.0060050; Yang MJ, 2007, CELL, V131, P744, DOI 10.1016/j.cell.2007.08.048; Zhang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15822; Zhou HN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10151	69	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					484	496		10.1074/jbc.RA117.000555	http://dx.doi.org/10.1074/jbc.RA117.000555			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162720	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000419915400006
J	Khandelwal, NK; Chauhan, N; Sarkar, P; Esquivel, BD; Coccetti, P; Singh, A; Coste, AT; Gupta, M; Sanglard, D; White, TC; Chauvel, M; d'Enfert, C; Chattopadhyay, A; Gaur, NA; Mondal, AK; Prasad, R				Khandelwal, Nitesh Kumar; Chauhan, Neeraj; Sarkar, Parijat; Esquivel, Brooke D.; Coccetti, Paola; Singh, Ashutosh; Coste, Alix T.; Gupta, Meghna; Sanglard, Dominique; White, Theodore C.; Chauvel, Murielle; d'Enfert, Christophe; Chattopadhyay, Amitabha; Gaur, Naseem A.; Mondal, Alok Kumar; Prasad, Rajendra			Azole resistance in a Candida albicans mutant lacking the ABC transporter CDR6/ROA1 depends on TOR signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; membrane transport; mTOR complex (mTORC); multidrug transporter; yeast; Azole resistance; CDR6; TOR signaling	DRUG-RESISTANCE; MEMBRANE-FLUIDITY; HSP90; YEAST; PROTEINS; GROWTH; RAPAMYCIN; FAMILY; GENE; EPIDEMIOLOGY	ATP-binding cassette (ABC) transporters help export various substrates across the cell membrane and significantly contribute to drug resistance. However, a recent study reported an unusual case in which the loss of an ABC transporter in Candida albicans, orf19.4531 (previously named ROA1), increases resistance against antifungal azoles, which was attributed to an altered membrane potential in the mutant strain. To obtain further mechanistic insights into this phenomenon, here we confirmed that the plasma membrane-localized transporter (renamed CDR6/ROA1 for consistency with C. albicans nomenclature) could efflux xenobiotics such as berberine, rhodamine 123, and paraquat. Moreover, a CDR6/ROA1 null mutant, NKKY101, displayed increased susceptibility to these xenobiotics. Interestingly, fluorescence recovery after photobleaching (FRAP) results indicated that NKKY101 mutant cells exhibited increased plasma membrane rigidity, resulting in reduced azole accumulation and contributing to azole resistance. Transcriptional profiling revealed that ribosome biogenesis genes were significantly up-regulated in the NKKY101 mutant. As ribosome biogenesis is a well-known downstream phenomenon of target of rapamycin (TOR1) signaling, we suspected a link between ribosome biogenesis and TOR1 signaling in NKKY101. Therefore, we grew NKKY101 cells on rapamycin and observed TOR1 hyperactivation, which leads to Hsp90-dependent calcineurin stabilization and thereby increased azole resistance. This in vitro finding was supported by in vivo data from a mouse model of systemic infection in which NKKY101 cells led to higher fungal load after fluconazole challenge than wild-type cells. Taken together, our study uncovers a mechanism of azole resistance in C. albicans, involving increased membrane rigidity and TOR signaling.	[Khandelwal, Nitesh Kumar; Singh, Ashutosh; Gupta, Meghna; Mondal, Alok Kumar; Prasad, Rajendra] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Chauhan, Neeraj] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Sarkar, Parijat; Chattopadhyay, Amitabha] CSIR Ctr Cellular & Mol Biol, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Esquivel, Brooke D.] Univ Missouri, Sch Biol Sci Cell Biol & Biophys, Kansas City, MO 64110 USA; [Coccetti, Paola] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Coccetti, Paola] Ctr Syst Biol, SYSBIO, I-20126 Milan, Italy; [Singh, Ashutosh] Lucknow Univ, Dept Biochem, Lucknow 226024, Uttar Pradesh, India; [Sanglard, Dominique] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; [Sanglard, Dominique] Univ Hosp Ctr, Rue Bugnon 48, CH-1011 Lausanne, Switzerland; [Gupta, Meghna] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Chauvel, Murielle; d'Enfert, Christophe] INRA, Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, F-75015 Paris, France; [Gaur, Naseem A.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Prasad, Rajendra] Amity Univ Haryana, Amity Inst Integrat Sci & Hlth, Amity Educ Valley Gurgao 122413, India	Jawaharlal Nehru University, New Delhi; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Missouri System; University of Missouri Kansas City; University of Milano-Bicocca; Lucknow University; University of Lausanne; University of California System; University of California San Francisco; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Prasad, R (corresponding author), Amity Univ Haryana, Amity Inst Integrat Sci & Hlth, Amity Educ Valley Gurgao 122413, India.	rp47jnu@gmail.com	Gupta, Meghna/AGY-3073-2022; Gupta, Meghna/AAZ-4389-2021; Coccetti, Paola/Y-2365-2019; SINGH, ASHUTOSH/AAR-1283-2021; Sanglard, Dominique/K-6032-2017; Khandelwal, Nitesh Kumar/AAX-6273-2021	Gupta, Meghna/0000-0002-7432-3211; Coccetti, Paola/0000-0001-5898-5883; SINGH, ASHUTOSH/0000-0002-0995-6696; Sanglard, Dominique/0000-0002-5244-4178; Khandelwal, Nitesh Kumar/0000-0002-6319-8048; Gaur, Naseem/0000-0002-1224-8789; Coste, Alix/0000-0001-9481-9778; Sarkar, Parijat/0000-0001-9435-5600	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, BT/PR14879/BRB10/885/2010]; National Institutes of Health [R01AI124499]; DST PURSE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124499] Funding Source: NIH RePORTER	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DST PURSE grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by the Department of Biotechnology, Ministry of Science and Technology, Government of India, Grants BT/01/CEIB/10/III/02, BT/PR7392/MED/29/652/2012, and BT/PR14879/BRB10/885/2010 (to R. P.). Research in the laboratory of N. C. was supported by National Institutes of Health Grant R01AI124499. The research work in the laboratory of A. K. M. was supported by a DST PURSE grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe F, 2009, BBA-BIOMEMBRANES, V1788, P743, DOI 10.1016/j.bbamem.2008.12.002; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Clarke RJ, 1997, BBA-BIOMEMBRANES, V1323, P223, DOI 10.1016/S0005-2736(96)00188-5; Coccetti P, 2004, MOL MICROBIOL, V51, P447, DOI 10.1046/j.1365-2958.2003.03836.x; Cowen L. E., 2014, COLD SPRING HARB PER, DOI [10. 1101/cshperspect. a019752 25384768, DOI 10.1101/CSHPERSPECT.A01975225384768]; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2013, CURR OPIN MICROBIOL, V16, P377, DOI 10.1016/j.mib.2013.03.005; Croons V, 2009, J PHARMACOL EXP THER, V329, P856, DOI 10.1124/jpet.108.149948; Cruz MC, 2001, ANTIMICROB AGENTS CH, V45, P3162, DOI 10.1128/AAC.45.11.3162-3170.2001; Dawaliby R, 2016, J BIOL CHEM, V291, P3658, DOI 10.1074/jbc.M115.706523; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Dhamgaye S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-396; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Duina AA, 1998, J BIOL CHEM, V273, P18974, DOI 10.1074/jbc.273.30.18974; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0; Haldar S, 2012, BIOPHYS J, V102, P1561, DOI 10.1016/j.bpj.2012.03.004; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hawle P, 2007, EUKARYOT CELL, V6, P521, DOI 10.1128/EC.00343-06; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Imai J, 2000, MOL CELL BIOL, V20, P9262, DOI 10.1128/MCB.20.24.9262-9270.2000; Jiang LH, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fow024; Khandelwal NK, 2016, BIOCHEM J, V473, P1537, DOI 10.1042/BCJ20160024; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Kohli A, 2002, ANTIMICROB AGENTS CH, V46, P1046, DOI 10.1128/AAC.46.4.1046-1052.2002; KOPPEL DE, 1980, BIOPHYS J, V30, P187, DOI 10.1016/S0006-3495(80)85087-9; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Lamping E, 2007, EUKARYOT CELL, V6, P1150, DOI 10.1128/EC.00091-07; Leach MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003069; Lee J, 2012, MOL CELL, V45, P836, DOI 10.1016/j.molcel.2012.01.018; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lyons CN, 2000, ANTIMICROB AGENTS CH, V44, P2296, DOI 10.1128/AAC.44.9.2296-2303.2000; Mahto KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113664; Mansfield BE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001126; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollinedo F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00140; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Mukhopadhyay K, 2002, ANTIMICROB AGENTS CH, V46, P3695, DOI 10.1128/AAC.46.12.3695-3705.2002; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nicholls S, 2009, MOL MICROBIOL, V74, P844, DOI 10.1111/j.1365-2958.2009.06883.x; Pasrija R, 2008, ANTIMICROB AGENTS CH, V52, P694, DOI 10.1128/AAC.00861-07; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Prasad R, 2016, FUNGAL GENET BIOL, V93, P25, DOI 10.1016/j.fgb.2016.05.008; Prasad R, 2015, EUKARYOT CELL, V14, P1154, DOI 10.1128/EC.00137-15; Prasad T, 2006, ANTIMICROB AGENTS CH, V50, P3597, DOI 10.1128/AAC.00653-06; Pucadyil TJ, 2004, BIOCHEMISTRY-US, V43, P15852, DOI 10.1021/bi0480887; RAO SS, 1967, BIOCHEM BIOPH RES CO, V29, P696, DOI 10.1016/0006-291X(67)90273-2; Rawal MK, 2013, J BIOL CHEM, V288, P24480, DOI 10.1074/jbc.M113.488353; Rella A, 2016, PROG LIPID RES, V61, P63, DOI 10.1016/j.plipres.2015.11.003; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Sanchez-Casalongue ME, 2015, J BIOL CHEM, V290, P7221, DOI 10.1074/jbc.M114.626523; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; SANGLARD D, 1995, ANTIMICROB AGENTS CH, V39, P2378, DOI 10.1128/AAC.39.11.2378; Sanglard D, 2016, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00011; Shah AH, 2014, BIOCHEM J, V460, P223, DOI 10.1042/BJ20140010; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma P, 2005, CURR GENET, V48, P162, DOI 10.1007/s00294-005-0010-9; Shekhar-Guturja T, 2016, NAT CHEM BIOL, V12, P867, DOI [10.1038/nchembio.2165, 10.1038/NCHEMBIO.2165]; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Shukla S, 2003, EUKARYOT CELL, V2, P1361, DOI 10.1128/EC.2.6.1361-1375.2003; Smriti, 2002, YEAST, V19, P303, DOI 10.1002/yea.818; Starke-Peterkovic T, 2005, AM J PHYSIOL-REG I, V288, pR663, DOI 10.1152/ajpregu.00434.2004; Starke-Peterkovic T, 2006, BIOPHYS J, V90, P4060, DOI 10.1529/biophysj.105.074666; SWEENEY R, 1991, GENETICS, V127, P327; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tripodi F, 2010, BIOCHEM BIOPH RES CO, V398, P44, DOI 10.1016/j.bbrc.2010.06.028; Vandeputte P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026962; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	83	31	33	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					412	432		10.1074/jbc.M117.807032	http://dx.doi.org/10.1074/jbc.M117.807032			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29158264	Green Published, hybrid			2022-12-28	WOS:000419915400002
J	Mishra, S; Wu, SY; Fuller, AW; Wang, Z; Rose, KL; Schey, KL; Mchaourab, HS				Mishra, Sanjay; Wu, Shu-Yu; Fuller, Alexandra W.; Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.; Mchaourab, Hassane S.			Loss of B-crystallin function in zebrafish reveals critical roles in the development of the lens and stress resistance of the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyopathy; cataract; chaperone; small heat shock protein (sHsp); zebrafish; B-crystallin; lens development; glucocorticoid receptor signaling	ALPHA-A-CRYSTALLIN; CORTICOSTEROID-INDUCED CATARACTS; SHOCK PROTEINS; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONE; CRYOELECTRON MICROSCOPY; DILATED CARDIOMYOPATHY; SUBSTRATE-BINDING; ADULT ZEBRAFISH; DANIO-RERIO	Genetic mutations in the human small heat shock protein B-crystallin have been implicated in autosomal cataracts and skeletal myopathies, including heart muscle diseases (cardiomyopathy). Although these mutations lead to modulation of their chaperone activity in vitro, the in vivo functions of B-crystallin in the maintenance of both lens transparency and muscle integrity remain unclear. This lack of information has hindered a mechanistic understanding of these diseases. To better define the functional roles of B-crystallin, we generated loss-of-function zebrafish mutant lines by utilizing the CRISPR/Cas9 system to specifically disrupt the two B-crystallin genes, Ba and Bb. We observed lens abnormalities in the mutant lines of both genes, and the penetrance of the lens phenotype was higher in Ba than Bb mutants. This finding is in contrast with the lack of a phenotype previously reported in B-crystallin knock-out mice and suggests that the elevated chaperone activity of the two zebrafish orthologs is critical for lens development. Besides its key role in the lens, we uncovered another critical role for B-crystallin in providing stress tolerance to the heart. The B-crystallin mutants exhibited hypersusceptibility to develop pericardial edema when challenged by crowding stress or exposed to elevated cortisol stress, both of which activate glucocorticoid receptor signaling. Our work illuminates the involvement of B-crystallin in stress tolerance of the heart presumably through the proteostasis network and reinforces the critical role of the chaperone activity of B-crystallin in the maintenance of lens transparency.	[Mishra, Sanjay; Wu, Shu-Yu; Fuller, Alexandra W.; Mchaourab, Hassane S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Wang, Zhen; Rose, Kristie L.; Schey, Kevin L.] Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Mchaourab, HS (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	mchaourab@vanderbilt.edu	Mishra, Sanjay/ABF-9252-2021	Mishra, Sanjay/0000-0002-7775-9600	National Institutes of Health [R01 EY12018, P30 EY008126]; Clinical and Translational Science Award from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center [UL1 RR024975-01]; Vanderbilt University School of Medicine Cell Imaging Shared Resource; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012018, P30EY008126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center; Vanderbilt University School of Medicine Cell Imaging Shared Resource; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01 EY12018 (to H.M.), P30 EY008126 (to H.M. and K.L.S.), and the Clinical and Translational Science Award UL1 RR024975-01, from the Vanderbilt University Proteomics Facility in the Mass Spectrometry Research Center, and the Vanderbilt University School of Medicine Cell Imaging Shared Resource. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; AOYAMA A, 1993, MOL CELL BIOL, V13, P1824, DOI 10.1128/MCB.13.3.1824; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Asomugha CO, 2011, MOL VIS, V17, P2356; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benjamin IJ, 2007, AM J PHYSIOL-HEART C, V293, pH3201, DOI 10.1152/ajpheart.01363.2006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Bidinost C, 2006, INVEST OPHTH VIS SCI, V47, P1274, DOI 10.1167/iovs.05-1095; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BROCKLEBANK JT, 1982, ARCH DIS CHILD, V57, P30; Buhrdel JB, 2015, BIOCHEM BIOPH RES CO, V461, P217, DOI 10.1016/j.bbrc.2015.03.149; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Cain JT, 2017, AM J MED GENET A, V173, P1200, DOI 10.1002/ajmg.a.38162; Castorino JJ, 2011, INVEST OPHTH VIS SCI, V52, P6774, DOI 10.1167/iovs.10-6579; Chen QY, 2016, CHEMOSPHERE, V144, P1162, DOI 10.1016/j.chemosphere.2015.09.089; Cheng XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060213; COSTAGLIOLA C, 1989, BRIT J DERMATOL, V120, P472, DOI 10.1111/j.1365-2133.1989.tb04181.x; Davidson EH, 2002, DEV BIOL, V246, P162, DOI 10.1006/dbio.2002.0635; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Dickerson JE, 1997, EXP EYE RES, V65, P507, DOI 10.1006/exer.1997.0359; Djabali K, 1997, J CELL SCI, V110, P2759; DONSHIK PC, 1981, ANN OPHTHALMOL, V13, P29; Elicker KS, 2007, GENE, V403, P60, DOI 10.1016/j.gene.2007.08.003; Forrest KML, 2011, NEUROMUSCULAR DISORD, V21, P37, DOI 10.1016/j.nmd.2010.11.003; Ghosh JG, 2005, PROTEIN SCI, V14, P684, DOI 10.1110/ps.041152805; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Harding RL, 2008, EXP EYE RES, V86, P807, DOI 10.1016/j.exer.2008.02.009; Hayes JM, 2012, MOL BIOL CELL, V23, P4725, DOI 10.1091/mbc.E12-09-0672; HEAD MW, 1994, J CELL PHYSIOL, V159, P41, DOI 10.1002/jcp.1041590107; Hill EG, 2008, J PROTEOME RES, V7, P3091, DOI 10.1021/pr070520u; Hoage T, 2012, METHODS MOL BIOL, V843, P11, DOI 10.1007/978-1-61779-523-7_2; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; JAKOB U, 1993, J BIOL CHEM, V268, P1517; James ER, 2007, J OCUL PHARMACOL TH, V23, P403, DOI 10.1089/jop.2006.0067; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kinyamu HK, 2008, MOL CARCINOGEN, V47, P845, DOI 10.1002/mc.20440; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Koteiche HA, 2015, BIOCHEMISTRY-US, V54, P5949, DOI 10.1021/acs.biochem.5b00678; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Krishnamoorthy V, 2013, MOL CELL BIOCHEM, V379, P59, DOI 10.1007/s11010-013-1627-5; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leske MC, 1997, OPHTHALMOLOGY, V104, P1987, DOI 10.1016/S0161-6420(97)30043-8; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Mao L, 2006, GENE EXPR PATTERNS, V6, P127, DOI 10.1016/j.modgep.2005.07.002; Marvin M, 2008, DEV DYNAM, V237, P454, DOI 10.1002/dvdy.21414; McCarty CA, 2000, INVEST OPHTH VIS SCI, V41, P3720; Mchaourab HS, 2012, BIOCHEMISTRY-US, V51, P5105, DOI 10.1021/bi300525x; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; Mou HW, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1237-8; Muchowski PJ, 1997, J BIOL CHEM, V272, P2578; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Nahomi RB, 2013, BIOCHEMISTRY-US, V52, P8126, DOI 10.1021/bi400638s; Neppl RL, 2014, J BIOL CHEM, V289, P17240, DOI 10.1074/jbc.M114.549584; Nesan D, 2012, MOL CELL ENDOCRINOL, V363, P85, DOI 10.1016/j.mce.2012.07.010; Neu-Yilik G, 2011, RNA, V17, P843, DOI 10.1261/rna.2401811; Oakley RH, 2015, J STEROID BIOCHEM, V153, P27, DOI 10.1016/j.jsbmb.2015.03.009; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Oakley RH, 2013, P NATL ACAD SCI USA, V110, P17035, DOI 10.1073/pnas.1302546110; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; Pinz I, 2008, FASEB J, V22, P84, DOI 10.1096/fj.07-8130com; Posner M, 1999, BBA-GENE STRUCT EXPR, V1447, P271, DOI 10.1016/S0167-4781(99)00155-4; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Reddy VS, 2015, CURR MOL MED, V15, P47, DOI 10.2174/1566524015666150114112853; RENFRO L, 1992, DERMATOL CLIN, V10, P505; Rog-Zielinska EA, 2014, J MOL ENDOCRINOL, V52, pR125, DOI 10.1530/JME-13-0204; Roy SG, 2009, CELL PHYSIOL BIOCHEM, V24, P1, DOI 10.1159/000227803; Sacconi S, 2012, NEUROMUSCULAR DISORD, V22, P66, DOI 10.1016/j.nmd.2011.07.004; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Sallin P, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160012; Santhoshkumar P, 2009, BIOCHEMISTRY-US, V48, P5066, DOI 10.1021/bi900085v; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Sharma KK, 1997, BIOCHEM BIOPH RES CO, V239, P217, DOI 10.1006/bbrc.1997.7460; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Shi J, 2013, J BIOL CHEM, V288, P4819, DOI 10.1074/jbc.M112.388132; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; Shih YH, 2015, CIRC-CARDIOVASC GENE, V8, P261, DOI 10.1161/CIRCGENETICS.114.000702; Simon S, 2007, J BIOL CHEM, V282, P34276, DOI 10.1074/jbc.M703267200; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P1773; Thisse B, 2014, METHODS MOL BIOL, V1211, P53, DOI 10.1007/978-1-4939-1459-3_5; Thornell E, 2015, CELL MOL LIFE SCI, V72, P4127, DOI 10.1007/s00018-015-1996-x; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; Veenstra DL, 1999, AM J KIDNEY DIS, V33, P829, DOI 10.1016/S0272-6386(99)70414-2; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang Z, 2015, INVEST OPHTH VIS SCI, V56, P8349, DOI 10.1167/iovs.15-18273; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zou P, 2015, EXP EYE RES, V138, P104, DOI 10.1016/j.exer.2015.07.001	100	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					740	753		10.1074/jbc.M117.808634	http://dx.doi.org/10.1074/jbc.M117.808634			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162721	hybrid, Green Published			2022-12-28	WOS:000419915400027
J	Senechal, F; Habrylo, O; Hocq, L; Domon, JM; Marcelo, P; Lefebvre, V; Pelloux, J; Mercadante, D				Senechal, Fabien; Habrylo, Olivier; Hocq, Ludivine; Domon, Jean-Marc; Marcelo, Paulo; Lefebvre, Valerie; Pelloux, Jerome; Mercadante, Davide			Structural and dynamical characterization of the pH-dependence of the pectin methylesterase-pectin methylesterase inhibitor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pH regulation; protein-protein interaction; plant biochemistry; molecular dynamics; molecular modeling; plant cell wall; plant physiology	PLANT-CELL-WALL; IMAGE-ANALYSIS; ARABIDOPSIS-THALIANA; MOLECULAR-DYNAMICS; METHYL ESTERASE; PROTEIN; EXPRESSION; METHYLESTERIFICATION; INVERTASE; INSIGHTS	Pectin methylesterases (PMEs) catalyze the demethylesterification of pectin, one of the main polysaccharides in the plant cell wall, and are of critical importance in plant development. PME activity generates highly negatively charged pectin and mutates the physiochemical properties of the plant cell wall such that remodeling of the plant cell can occur. PMEs are therefore tightly regulated by proteinaceous inhibitors (PMEIs), some of which become active upon changes in cellular pH. Nevertheless, a detailed picture of how this pH-dependent inhibition of PME occurs at the molecular level is missing. Herein, using an interdisciplinary approach that included homology modeling, MD simulations, and biophysical and biochemical characterizations, we investigated the molecular basis of PME3 inhibition by PMEI7 in Arabidopsis thaliana. Our complementary approach uncovered how changes in the protonation of amino acids at the complex interface shift the network of interacting residues between intermolecular and intramolecular. These shifts ultimately regulate the stability of the PME3-PMEI7 complex and the inhibition of the PME as a function of the pH. These findings suggest a general model of how pH-dependent proteinaceous inhibitors function. Moreover, they enhance our understanding of how PMEs may be regulated by pH and provide new insights into how this regulation may control the physical properties and structure of the plant cell wall.	[Senechal, Fabien; Habrylo, Olivier; Hocq, Ludivine; Domon, Jean-Marc; Lefebvre, Valerie; Pelloux, Jerome] Univ Picardie, BIOPI Biol Plantes & Innovat EA3900, SFR Condorcet FR CNRS 3417, 33 Rue St Leu, F-80039 Amiens, France; [Marcelo, Paulo] Univ Picardie Jules Verne, Plateforme ICAP, Ctr Univ Rech Sante, F-80054 Amiens, France; [Mercadante, Davide] Heidelberg HITS, Heidelberg Inst Theoret Studies, D-16920 Heidelberg, Germany; [Mercadante, Davide] Heidelberg Univ, IWR Interdisciplinary Ctr Sci Comp, D-69120 Heidelberg, Germany	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg	Pelloux, J (corresponding author), Univ Picardie, BIOPI Biol Plantes & Innovat EA3900, SFR Condorcet FR CNRS 3417, 33 Rue St Leu, F-80039 Amiens, France.; Mercadante, D (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jerome.pelloux@u-picardie.fr; d.mercadante@bioc.uzh.ch	Sénéchal, Fabien/AAR-8411-2021	Pelloux, Jerome/0000-0002-9371-1711; Mercadante, Davide/0000-0001-6792-7706; Fabien, Senechal/0000-0002-4145-7205; Marcelo, Paulo/0000-0002-2586-8119	Agence Nationale de la Recherche [ANR-12-BSV5-0001 GALAPAGOS, ANR-14-CE34-0010-03 PECTOSIGN]; Conseil Regional de Picardie; Institut Universitaire de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Conseil Regional de Picardie(Region Hauts-de-France); Institut Universitaire de France	This work was supported by Agence Nationale de la Recherche Projects ANR-12-BSV5-0001 GALAPAGOS and ANR-14-CE34-0010-03 PECTOSIGN and by grants from the Conseil Regional de Picardie (to F. S.) and the Institut Universitaire de France (to J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	AMREIN KE, 1993, P NATL ACAD SCI USA, V90, P10285, DOI 10.1073/pnas.90.21.10285; Anderson CT, 2016, J EXP BOT, V67, P495, DOI 10.1093/jxb/erv501; Andre T., 2013, DNA DNA INTERACTION; Baldwin L, 2014, PHYTOCHEMISTRY, V104, P37, DOI 10.1016/j.phytochem.2014.04.011; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bonavita A, 2016, J AGR FOOD CHEM, V64, P5866, DOI 10.1021/acs.jafc.6b01718; Bourgault R, 2002, ANAL BIOCHEM, V300, P87, DOI 10.1006/abio.2001.5450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Degraeve P, 2003, J FOOD SCI, V68, P716, DOI 10.1111/j.1365-2621.2003.tb05738.x; Demir N, 2001, J FOOD ENG, V47, P275, DOI 10.1016/S0260-8774(00)00127-8; Di Matteo A, 2005, PLANT CELL, V17, P849, DOI 10.1105/tpc.104.028886; Fries M, 2007, EMBO J, V26, P3879, DOI 10.1038/sj.emboj.7601816; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Griesbach J., 2013, PROTEIN SMALL MOL IN; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Hamann T, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00077; Hocq L, 2017, PLANT PHYSIOL, V173, P1075, DOI 10.1104/pp.16.01790; Hothorn M, 2004, PLANT CELL, V16, P3437, DOI 10.1105/tpc.104.025684; Hothorn M, 2010, P NATL ACAD SCI USA, V107, P17427, DOI 10.1073/pnas.1004481107; Houston K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00984; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jayani RS, 2005, PROCESS BIOCHEM, V40, P2931, DOI 10.1016/j.procbio.2005.03.026; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4; Kashyap DR, 2001, BIORESOURCE TECHNOL, V77, P215, DOI 10.1016/S0960-8524(00)00118-8; Le Gall Hyacinthe, 2015, Plants-Basel, V4, P112, DOI 10.3390/plants4010112; Levesque-Tremblay G, 2015, PLANTA, V242, P791, DOI 10.1007/s00425-015-2358-5; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilling J, 2000, PLANTA, V210, P391, DOI 10.1007/PL00008147; Ren CW, 2000, PLANT PHYSIOL, V124, P231, DOI 10.1104/pp.124.1.231; Routledge KE, 2009, J MOL BIOL, V389, P776, DOI 10.1016/j.jmb.2009.04.042; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scognamiglio MA, 2003, J PROTEIN CHEM, V22, P363, DOI 10.1023/A:1025342207831; Senechal F, 2015, J BIOL CHEM, V290, P23320, DOI 10.1074/jbc.M115.639534; Senechal F, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.4161/15592324.2014.983351; Senechal F, 2014, J EXP BOT, V65, P5125, DOI 10.1093/jxb/eru272; Sexton TR, 2012, PLANT PHYSIOL, V158, P531, DOI 10.1104/pp.111.181602; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sun CL, 2016, J EXP BOT, V67, P979, DOI 10.1093/jxb/erv514; Tucker MR, 2014, CURR OPIN PLANT BIOL, V17, P137, DOI 10.1016/j.pbi.2013.11.015; Weber M, 2013, PLANT J, V76, P151, DOI 10.1111/tpj.12279; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zhao CZ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0582-6	55	7	8	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21538	21547		10.1074/jbc.RA117.000197	http://dx.doi.org/10.1074/jbc.RA117.000197			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109147	Green Published, hybrid			2022-12-28	WOS:000419013000028
J	Stranava, M; Man, P; Skalova, T; Kolenko, P; Blaha, J; Fojtikova, V; Martinek, V; Dohnalek, J; Lengalova, A; Rosulek, M; Shimizu, T; Martinkova, M				Stranava, Martin; Man, Petr; Skalova, Tereza; Kolenko, Petr; Blaha, Jan; Fojtikova, Veronika; Martinek, Vaclav; Dohnalek, Jan; Lengalova, Alzbeta; Rosulek, Michal; Shimizu, Toru; Martinkova, Marketa			Coordination and redox state-dependent structural changes of the heme-based oxygen sensor AfGcHK associated with intraprotein signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; TRANSCRIPTION ACTIVATOR COOA; COUPLED HISTIDINE KINASE; CRYSTAL-STRUCTURE; DIGUANYLATE CYCLASE; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; BRADYRHIZOBIUM-JAPONICUM; LIGAND DISCRIMINATION; RESPONSE REGULATOR	The heme-based oxygen sensor histidine kinase AfGcHK is part of a two-component signal transduction system in bacteria. O-2 binding to the Fe(II) heme complex of its N-terminal globin domain strongly stimulates autophosphorylation at His(183) in its C-terminal kinase domain. The 6-coordinate heme Fe(III)-OH- and -CN- complexes of AfGcHK are also active, but the 5-coordinate heme Fe(II) complex and the heme-free apo-form are inactive. Here, we determined the crystal structures of the isolated dimeric globin domains of the active Fe(III)-CN- and inactive 5-coordinate Fe(II) forms, revealing striking structural differences on the heme-proximal side of the globin domain. Using hydrogen/deuterium exchange coupled with mass spectrometry to characterize the conformations of the active and inactive forms of full-length AfGcHK in solution, we investigated the intramolecular signal transduction mechanisms. Major differences between the active and inactive forms were observed on the heme-proximal side (helix H5), at the dimerization interface (helices H6 and H7 and loop L7) of the globin domain and in the ATP-binding site (helices H9 and H11) of the kinase domain. Moreover, separation of the sensor and kinase domains, which deactivates catalysis, increased the solvent exposure of the globin domain-dimerization interface (helix H6) as well as the flex ibility and solvent exposure of helix H11. Together, these results suggest that structural changes at the heme-proximal side, the globin domain-dimerization interface, and the ATP-binding site are important in the signal transduction mechanism of AfGcHK. We conclude that AfGcHK functions as an ensemble of molecules sampling at least two conformational states.	[Stranava, Martin; Man, Petr; Blaha, Jan; Fojtikova, Veronika; Martinek, Vaclav; Lengalova, Alzbeta; Rosulek, Michal; Shimizu, Toru; Martinkova, Marketa] Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova Albertov 2030-8, Prague 12843 2, Czech Republic; [Man, Petr; Rosulek, Michal] Czech Acad Sci, Inst Microbiol, Vvi, Biocev, Vestec 25250, Czech Republic; [Skalova, Tereza; Kolenko, Petr; Dohnalek, Jan] Czech Acad Sci, Inst Biotechnol, Vvi, Biocev, Vestec 25250, Czech Republic; [Kolenko, Petr] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Dept Solid State Engn, Brehova 7, Prague 11519 1, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Technical University Prague	Martinkova, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova Albertov 2030-8, Prague 12843 2, Czech Republic.	marketa.martinkova@natur.cuni.cz	Man, Petr/H-2451-2014; Bláha, Jan/P-7642-2019; Martinkova, Marketa/E-3748-2012; Rosulek, Michal/L-6752-2017; Rosulek, Michal/R-8927-2019; Skalova, Tereza/G-6422-2014; Martinek, Vaclav/E-6710-2011; Lengalova, Alzbeta/G-9148-2017; Kolenko, Petr/G-5732-2014	Man, Petr/0000-0002-1485-2197; Bláha, Jan/0000-0003-4221-3162; Martinkova, Marketa/0000-0002-0865-8785; Rosulek, Michal/0000-0002-2426-7928; Rosulek, Michal/0000-0002-2426-7928; Skalova, Tereza/0000-0003-3186-2431; Martinek, Vaclav/0000-0003-3321-4526; Lengalova, Alzbeta/0000-0002-8386-9363; Kolenko, Petr/0000-0002-4619-9276; Shimizu, Toru/0000-0002-3950-5554; Dohnalek, Jan/0000-0002-8083-7980	Charles University Grant [UNCE 204025/2012]; Grant Agency of the Czech Republic [15-19883S]; Grant Agency of Charles University [362115, 704217]; Ministry of Education, Youth, and Sports of the Czech Republic of COST Action CA15126 MOBIEU [LM2015043, LTC17065]; ERDF fund Grants [CZ.02.1.01/0.0/0.0/16_013/0001776, CZ.1.05/1.1.00/02.0109]; Grant Agency of the Czech Technical University in Prague [SGS16/246/OHK4/3T/14]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	Charles University Grant; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University; Ministry of Education, Youth, and Sports of the Czech Republic of COST Action CA15126 MOBIEU; ERDF fund Grants; Grant Agency of the Czech Technical University in Prague; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	This work was supported in part by Charles University Grant UNCE 204025/2012; Grant Agency of the Czech Republic Grant 15-19883S; Grant Agency of Charles University Grants 362115 and 704217; Ministry of Education, Youth, and Sports of the Czech Republic Grant LM2015043 CIISB, Biocev Crystallization, Diffraction and LTC17065 in frame of COST Action CA15126 MOBIEU; ERDF fund Grants CZ.02.1.01/0.0/0.0/16_013/0001776 and CZ.1.05/1.1.00/02.0109; and Grant Agency of the Czech Technical University in Prague Grant SGS16/246/OHK4/3T/14. This work was also partly funded by Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions.	Abriata LA, 2017, ACCOUNTS CHEM RES, V50, P1359, DOI 10.1021/acs.accounts.6b00593; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cunningham KA, 2009, MOL MICROBIOL, V71, P659, DOI 10.1111/j.1365-2958.2008.06554.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Fojtikova V, 2015, BIOCHEMISTRY-US, V54, P5017, DOI 10.1021/acs.biochem.5b00517; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadek A, 2017, BBA-GEN SUBJECTS, V1861, P157, DOI 10.1016/j.bbagen.2016.11.016; Keedy DA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004507; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Komori H, 2007, J MOL BIOL, V367, P864, DOI 10.1016/j.jmb.2007.01.043; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249; Nakajima K, 2012, J INORG BIOCHEM, V108, P163, DOI 10.1016/j.jinorgbio.2011.09.019; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rao MX, 2017, BIOCHEMISTRY-US, V56, P1274, DOI 10.1021/acs.biochem.6b01133; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimizu T, 2015, CHEM REV, V115, P6491, DOI 10.1021/acs.chemrev.5b00018; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stranava M, 2016, PROTEINS, V84, P1375, DOI 10.1002/prot.25083; Tarnawski M, 2015, ACTA CRYSTALLOGR D, V71, P2158, DOI 10.1107/S139900471501545X; Trcka F, 2014, J BIOL CHEM, V289, P9887, DOI 10.1074/jbc.M113.526046; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Willett JW, 2017, MOL MICROBIOL, V103, P197, DOI 10.1111/mmi.13525; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	47	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20921	20935		10.1074/jbc.M117.817023	http://dx.doi.org/10.1074/jbc.M117.817023			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29092908	hybrid, Green Published			2022-12-28	WOS:000418453400010
J	Boroda, S; Takkellapati, S; Lawrence, RT; Entwisle, SW; Pearson, JM; Granade, ME; Mullins, GR; Eaton, JM; Villen, J; Harris, TE				Boroda, Salome; Takkellapati, Sankeerth; Lawrence, Robert T.; Entwisle, Samuel W.; Pearson, Jennifer M.; Granade, Mitchell E.; Mullins, Garrett R.; Eaton, James M.; Villen, Judit; Harris, Thurl E.			The phosphatidic acid-binding, polybasic domain is responsible for the differences in the phosphoregulation of lipins 1 and 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); phosphatase; phosphatidic acid; phosphatidylethanolamine; phosphorylation; di-anionic; lipin; lpin1; lpin3	SACCHAROMYCES-CEREVISIAE; BOND SWITCH; METABOLISM; PHOSPHORYLATION; PROTEINS; DISTINCT; PHOSPHOHYDROLASE; TRANSLOCATION; LOCALIZATION; ENZYMES	Lipins 1, 2, and 3 are Mg2+-dependent phosphatidic acid phosphatases and catalyze the penultimate step of triacylglycerol synthesis. We have previously investigated the biochemistry of lipins 1 and 2 and shown that di-anionic phosphatidic acid (PA) augments their activity and lipid binding and that lipin 1 activity is negatively regulated by phosphorylation. In the present study, we show that phosphorylation does not affect the catalytic activity of lipin 3 or its ability to associate with PA in vitro. The lipin proteins each contain a conserved polybasic domain (PBD) composed of nine lysine and arginine residues located between the conserved N- and C-terminal domains. In lipin 1, the PBD is the site of PA binding and sensing of the PA electrostatic charge. The specific arrangement and number of the lysines and arginines of the PBD vary among the lipins. We show that the different PBDs of lipins 1 and 3 are responsible for the presence of phosphoregulation on the former but not the latter enzyme. To do so, we generated lipin 1 that contained the PBD of lipin 3 and vice versa. The lipin 1 enzyme with the lipin 3 PBD lost its ability to be regulated by phosphorylation but remained downstream of phosphorylation by mammalian target of rapamycin. Conversely, the presence of the lipin 1 PBD in lipin 3 subjected the enzyme to negative intramolecular control by phosphorylation. These results indicate a mechanism for the observed differences in lipin phosphoregulation in vitro.	[Boroda, Salome; Takkellapati, Sankeerth; Pearson, Jennifer M.; Granade, Mitchell E.; Mullins, Garrett R.; Eaton, James M.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Lawrence, Robert T.; Entwisle, Samuel W.; Villen, Judit] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Virginia; University of Washington; University of Washington Seattle	Harris, TE (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	teh3c@virginia.edu		Granade, Mitchell/0000-0003-3134-858X; Harris, Thurl/0000-0003-1742-6043	National Institutes of Health [R01 DK101946, R35 GM119536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119536, T32GM007055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grants R01 DK101946 (to T. E. H.) and R35 GM119536 (to J. V). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Csaki LS, 2014, MOL METAB, V3, P145, DOI 10.1016/j.molmet.2013.11.008; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eaton JM, 2014, J BIOL CHEM, V289, P18055, DOI 10.1074/jbc.M114.547604; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GOMEZMUNOZ A, 1992, FEBS LETT, V301, P103, DOI 10.1016/0014-5793(92)80219-7; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hofer CT, 2010, METHODS MOL BIOL, V606, P69, DOI 10.1007/978-1-60761-447-0_6; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Reue K, 2008, FEBS LETT, V582, P90, DOI 10.1016/j.febslet.2007.11.014; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Salas-Santiago B, 2014, G3-GENES GENOM GENET, V4, P761, DOI 10.1534/g3.113.010140; Schweitzer GG, 2015, JIMD REP, V23, P113, DOI 10.1007/8904_2015_440; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; Wagner C, 2001, MOL MICROBIOL, V41, P155, DOI 10.1046/j.1365-2958.2001.02495.x; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	46	19	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20481	20493		10.1074/jbc.M117.786574	http://dx.doi.org/10.1074/jbc.M117.786574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	28982975	Green Published, hybrid			2022-12-28	WOS:000418267000012
J	Mei, M; Zhai, C; Li, XZ; Zhou, Y; Peng, WF; Ma, LX; Wang, QH; Iverson, BL; Zhang, GM; Yi, L				Mei, Meng; Zhai, Chao; Li, Xinzhi; Zhou, Yu; Peng, Wenfang; Ma, Lixin; Wang, Qinhong; Iverson, Brent L.; Zhang, Guimin; Yi, Li			Characterization of aromatic residue-controlled protein retention in the endoplasmic reticulum of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); flow cytometry; fluorescence; protein sorting; protein trafficking (Golgi); yeast; ER retention sequence; Erd2; protein ER retention; surface display	LUMINAL ER PROTEINS; DISULFIDE-ISOMERASE DEPLETION; YEAST GENE; SECRETORY PATHWAY; HDEL RECEPTOR; KDEL RECEPTOR; HOMOLOG; IDENTIFICATION; SPECIFICITY; LIBRARIES	An endoplasmic reticulum (ER) retention sequence (ERS) is a characteristic short sequence that mediates protein retention in the ER of eukaryotic cells. However, little is known about the detailed molecular mechanism involved in ERS-mediated protein ER retention. Using a new surface display-based fluorescence technique that effectively quantifies ERS-promoted protein ER retention within Saccharomyces cerevisiae cells, we performed comprehensive ERS analyses. We found that the length, type of amino acid residue, and additional residues at positions -5 and -6 of the C-terminal HDEL motif all determined the retention of ERS in the yeast ER. Moreover, the biochemical results guided by structure simulation revealed that aromatic residues (Phe-54, Trp-56, and other aromatic residues facing the ER lumen) in both the ERS (at positions -6 and -4) and its receptor, Erd2, jointly determined their interaction with each other. Our studies also revealed that this aromatic residue interaction might lead to the discriminative recognition of HDEL or KDEL as ERS in yeast or human cells, respectively. Our findings expand the understanding of ERS-mediated residence of proteins in the ER and may guide future research into protein folding, modification, and translocation affected by ER retention.	[Mei, Meng; Zhai, Chao; Li, Xinzhi; Zhou, Yu; Peng, Wenfang; Ma, Lixin; Zhang, Guimin; Yi, Li] Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Peoples R China; [Wang, Qinhong] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Iverson, Brent L.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	Hubei University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of Texas System; University of Texas Austin	Zhang, GM; Yi, L (corresponding author), Hubei Univ, Hubei Key Lab Ind Biotechnol, Hubei Collaborat Innovat Ctr Green Transformat Bi, Wuhan 430062, Peoples R China.	zhangguimin6@hotmail.com; liyi@hubu.edu.cn	Peng, Wenfang/D-1894-2014	Peng, Wenfang/0000-0001-9073-1509; Zhang, Guimin/0000-0002-7824-0077	National Natural Science Foundation of China [31540068]; Ministry of Science and Technology of China [2014AA022203C]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022203] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by Grant 31540068 from the National Natural Science Foundation of China (to L. Y.) and Grant 2014AA022203C from the Ministry of Science and Technology of China (to G. Z.). The authors declared that they have no conflicts of interest with the contents of this article.	Alanen HI, 2011, J MOL BIOL, V409, P291, DOI 10.1016/j.jmb.2011.03.070; BLUMBERG H, 1991, NATURE, V349, P627, DOI 10.1038/349627a0; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Brezski RJ, 2010, MABS-AUSTIN, V2, P212, DOI 10.4161/mabs.2.3.11780; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chung JJ, 2003, MOL CELL PROTEOMICS, V2, P173, DOI 10.1074/mcp.M300008-MCP200; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; EINERHAND AWC, 1995, MOL CELL BIOL, V15, P3405; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Friedmann E, 2002, J BIOL CHEM, V277, P35274, DOI 10.1074/jbc.M201044200; Grandier-Vazeille X, 2001, BIOCHEMISTRY-US, V40, P9758, DOI 10.1021/bi010277r; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Guerrero JL, 2016, ACS CHEM BIOL, V11, P961, DOI 10.1021/acschembio.5b01051; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; James P, 1996, GENETICS, V144, P1425; Kamimura D, 2016, INT IMMUNOL, V28, P117, DOI 10.1093/intimm/dxv059; Kamimura D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8474; LEWIS MJ, 1990, NATURE, V348, P162, DOI 10.1038/348162a0; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ohishi K, 2001, EMBO J, V20, P4088, DOI 10.1093/emboj/20.15.4088; PELHAM HRB, 1988, EMBO J, V7, P1757, DOI 10.1002/j.1460-2075.1988.tb03005.x; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Scheel AA, 1998, J BIOL CHEM, V273, P2467, DOI 10.1074/jbc.273.4.2467; SCHLENSTEDT G, 1995, J CELL BIOL, V129, P979, DOI 10.1083/jcb.129.4.979; SEMENZA JC, 1992, J MOL BIOL, V224, P1, DOI 10.1016/0022-2836(92)90571-Z; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Siggs OM, 2015, P NATL ACAD SCI USA, V112, pE5706, DOI 10.1073/pnas.1515619112; TACHIBANA C, 1992, MOL CELL BIOL, V12, P4601, DOI 10.1128/MCB.12.10.4601; Tachikawa H, 1997, BIOCHEM BIOPH RES CO, V239, P710, DOI 10.1006/bbrc.1997.7426; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yi L, 2015, METHODS MOL BIOL, V1319, P81, DOI 10.1007/978-1-4939-2748-7_5; Yi L, 2013, P NATL ACAD SCI USA, V110, P7229, DOI 10.1073/pnas.1215994110; Zhai C, 2014, ONCOGENE, V33, P484, DOI 10.1038/onc.2012.604	44	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20707	20719		10.1074/jbc.M117.812107	http://dx.doi.org/10.1074/jbc.M117.812107			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29038295	hybrid, Green Published			2022-12-28	WOS:000418267000031
J	Jiang, JY; Liu, Z; Ge, C; Chen, C; Zhao, FY; Li, H; Chen, TY; Yao, M; Li, JJ				Jiang, Jingyi; Liu, Zheng; Ge, Chao; Chen, Cong; Zhao, Fangyu; Li, Hong; Chen, Taoyang; Yao, Ming; Li, Jinjun			NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; FOXO; hepatocellular carcinoma; metastasis; tumor suppressor gene; NK3 Homeobox 1	BREAST-CANCER CELLS; PROSTATE-CANCER; TOPOISOMERASE-I; PROTEIN NKX3.1; DNA-DAMAGE; FOXO1; GENE; METASTASIS; CARCINOGENESIS; CONTRIBUTES	Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality in China, and the molecular mechanism of uncontrolled HCC progression remains to be explored. NK3 homeobox 1 (NKX3.1), an androgen-regulated prostate-specific transcription factor, suppresses tumors in prostate cancer, but its role in HCC is unknown, especially in hepatocellular carcinoma. In the present study, the differential expression analyses in HCC tissues and matched adjacent noncancerous liver tissues revealed that NKX3.1 is frequently down-regulated in human primary HCC tissues compared with matched adjacent noncancerous liver tissues. We also noted that NKX3.1 significantly inhibits proliferation and mobility of HCC cells both in vitro and in vivo. Furthermore, NKX3.1 overexpression resulted in cell cycle arrest at the G(1)/S phase via direct binding to the promoter of forkhead box O1 (FOXO1) and up-regulation of expression. Of note, FOXO1 silencing in NKX3.1-overexpressing cells reversed the inhibitory effects of NKX3.1 on HCC cell proliferation and invasion. Consistently, both FOXO1 and NKX3.1 were down-regulated in human HCC tissues, and their expression was significantly and positively correlated with each other. These results suggest that NKX3.1 functions as a tumor suppressor in HCC cells through directly up-regulating FOXO1 expression.	[Jiang, Jingyi; Liu, Zheng] Fudan Univ, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Jiang, Jingyi; Liu, Zheng; Ge, Chao; Chen, Cong; Zhao, Fangyu; Li, Hong; Yao, Ming; Li, Jinjun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong 226200, Peoples R China	Fudan University; Shanghai Jiao Tong University	Li, JJ (corresponding author), 25 Ln 2200 Xietu Rd, Shanghai 200032, Peoples R China.	jjli@shsci.org		Li, Jinjun/0000-0002-6895-3508	National Natural Science Foundation of China [81472726]; National Key Sci-Tech Special Project of China [2013ZX10002-011]; SKLORG Research Foundation [91-15-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Special Project of China; SKLORG Research Foundation	This work was supported in part by National Natural Science Foundation of China Grant 81472726, National Key Sci-Tech Special Project of China Grant 2013ZX10002-011, and SKLORG Research Foundation Grant 91-15-03. The authors declare that they have no conflicts of interest with the contents of this article.	Abate-Shen C, 2003, CANCER RES, V63, P3886; Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bhatt S, 2016, ONCOGENE, V35, P5722, DOI 10.1038/onc.2016.105; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Bowen C, 2015, CANCER RES, V75, P2686, DOI 10.1158/0008-5472.CAN-14-3387; Bowen C, 2010, CANCER RES, V70, P3089, DOI 10.1158/0008-5472.CAN-09-3138; Cai BW, 2013, CELL REP, V4, P516, DOI 10.1016/j.celrep.2013.06.039; Calvisi DF, 2009, GASTROENTEROLOGY, V137, P1816, DOI 10.1053/j.gastro.2009.08.005; Critelli RM, 2015, DIGEST DIS, V33, P635, DOI 10.1159/000438472; Debelec-Butuner B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109868; Dong TX, 2017, ONCOTARGET, V8, P1703, DOI [10.18632/oncotarget.13786, 10.18632/oncotarget.15954]; Dutta A, 2016, SCIENCE, V352, P1576, DOI 10.1126/science.aad9512; Fan CH, 2013, BIOMED PHARMACOTHER, V67, P521, DOI 10.1016/j.biopha.2013.04.014; Fendler A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080807; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jung HS, 2014, CELL SIGNAL, V26, P1456, DOI 10.1016/j.cellsig.2014.02.022; Kang J, 2015, EXP THER MED, V9, P345, DOI 10.3892/etm.2014.2123; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P2884, DOI 10.1073/pnas.042688999; Kim MJ, 2002, CANCER RES, V62, P2999; Kurimoto F, 2001, INT J MOL MED, V8, P89; Lee SY, 2013, CELL CYCLE, V12, P67, DOI 10.4161/cc.22962; Li CS, 2016, SAE INT J PASSENG CA, V9, P1, DOI 10.4271/2015-01-2846; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Markowski MC, 2008, CANCER RES, V68, P6896, DOI 10.1158/0008-5472.CAN-08-0578; Miyaguchi K, 2012, INT J ONCOL, V40, P1907, DOI 10.3892/ijo.2012.1373; Mosquera JM, 2009, CLIN CANCER RES, V15, P4706, DOI 10.1158/1078-0432.CCR-08-2927; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song LN, 2015, MOL CANCER RES, V13, P913, DOI 10.1158/1541-7786.MCR-14-0680; Song LN, 2013, BIOCHEM J, V453, P125, DOI 10.1042/BJ20130012; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tikhanovich I, 2013, J GASTROEN HEPATOL, V28, P125, DOI 10.1111/jgh.12021; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Wallis CJD, 2015, J CANCER, V6, P1295, DOI 10.7150/jca.13176; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xu D, 2013, ONCOL REP, V29, P653, DOI 10.3892/or.2012.2138; Yamaguchi F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-468; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-909; Yu F, 2014, ONCOL REP, V31, P1459, DOI 10.3892/or.2013.2957; Zeng YB, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0328-z; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954	47	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19146	19159		10.1074/jbc.M117.793760	http://dx.doi.org/10.1074/jbc.M117.793760			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972178	Green Published, hybrid			2022-12-28	WOS:000416226700002
J	Sabra, H; Brunner, M; Mandati, V; Wehrle-Haller, B; Lallemand, D; Ribba, AS; Chevalier, G; Guardiola, P; Block, MR; Bouvard, D				Sabra, Hiba; Brunner, Molly; Mandati, Vinay; Wehrle-Haller, Bernhard; Lallemand, Dominique; Ribba, Anne-Sophie; Chevalier, Genevieve; Guardiola, Philippe; Block, Marc R.; Bouvard, Daniel			1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; cell proliferation; integrin; Rac (Rac GTPase); yes-associated protein (YAP)	RECEPTOR TYROSINE KINASES; SMALL-MOLECULE INHIBITOR; SMALL GTPASE RAC1; HIPPO PATHWAY; TUMOR-SUPPRESSOR; PLASMA-MEMBRANE; P21-ACTIVATED KINASE; OSTEOBLAST FUNCTION; CELL-PROLIFERATION; MATRIX ADHESION	Cell adhesion to the extracellular matrix or to surrounding cells plays a key role in cell proliferation and differentiation and is critical for proper tissue homeostasis. An important pathway in adhesion-dependent cell proliferation is the Hippo signaling cascade, which is coregulated by the transcription factors Yes-associated protein 1 (YAP1) and transcriptional coactivator with PDZ-binding motif (TAZ). However, how cells integrate extracellular information at the molecular level to regulate YAP1's nuclear localization is still puzzling. Herein, we investigated the role of 1 integrins in regulating this process. We found that 1 integrin-dependent cell adhesion is critical for supporting cell proliferation in mesenchymal cells both in vivo and in vitro. 1 integrin-dependent cell adhesion relied on the relocation of YAP1 to the nucleus after the down-regulation of its phosphorylated state mediated by large tumor suppressor gene 1 and 2 (LATS1/2). We also found that this phenotype relies on 1 integrin-dependent local activation of the small GTPase RAC1 at the plasma membrane to control the activity of P21 (RAC1)-activated kinase (PAK) of group 1. We further report that the regulatory protein merlin (neurofibromin 2, NF2) interacts with both YAP1 and LATS1/2 via its C-terminal moiety and FERM domain, respectively. PAK1-mediated merlin phosphorylation on Ser-518 reduced merlin's interactions with both LATS1/2 and YAP1, resulting in YAP1 dephosphorylation and nuclear shuttling. Our results highlight RAC/PAK1 as major players in YAP1 regulation triggered by cell adhesion.	[Sabra, Hiba; Brunner, Molly; Ribba, Anne-Sophie; Chevalier, Genevieve; Block, Marc R.; Bouvard, Daniel] Univ Grenoble Alpes, CNRS 5309, Inst Adv Biosci, INSERM 1209, F-38042 Grenoble, France; [Mandati, Vinay] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Wehrle-Haller, Bernhard] Univ Geneva, Dept Cell Physiol & Metab, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Lallemand, Dominique] Ecole Polytech, CNRS 7654, Dept Biochem, F-91128 Palaiseau, France; [Guardiola, Philippe] Ctr Hosp Univ, F-49933 Angers, France; [Guardiola, Philippe] Univ Angers, Inst Biol Hlth Transcriptome & Epigen, Plateform, F-49933 Angers, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Scripps Research Institute; University of Geneva; Institut Polytechnique de Paris; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Bouvard, D (corresponding author), Univ Grenoble Alpes, Inst Adv Biosci, Site Sante,BP170, F-38042 Grenoble 9, France.	daniel.bouvard@univ-grenoble-alpes.fr	Mandati, Vinay/AAZ-1898-2020; Bouvard, Daniel/B-1260-2017; lallemand, dominique/O-7445-2017; Block, Marc R/M-2740-2013	Bouvard, Daniel/0000-0002-0845-6681; lallemand, dominique/0000-0002-0212-7342; Block, Marc R/0000-0003-2214-9706; Ribba, Anne-Sophie/0000-0001-5342-8455	"Ministere de la Recherche"; INCa (Institut National du Cancer); Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant	"Ministere de la Recherche"(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, FranceSpanish Government); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant	Supported by a fellowship from "Ministere de la Recherche," INCa (Institut National du Cancer), and Societe Francaise de lutte contre les cancers de l'enfant (SFCE) grant.	Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Bouvier C, 2016, ONCOTARGET, V7, P64702, DOI 10.18632/oncotarget.11876; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Choma DP, 2007, J INVEST DERMATOL, V127, P31, DOI 10.1038/sj.jid.5700505; Das S, 2015, P NATL ACAD SCI USA, V112, pE267, DOI 10.1073/pnas.1409667112; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dib K, 2003, J BIOL CHEM, V278, P24181, DOI 10.1074/jbc.M302300200; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Matsumoto S, 2014, EMBO J, V33, P702, DOI 10.1002/embj.201386942; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Reginensi A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003380; Robertson LK, 2011, J IMMUNOL, V187, P5824, DOI 10.4049/jimmunol.1003690; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sero JE, 2017, CELL SYST, V4, P84, DOI 10.1016/j.cels.2016.11.015; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Weed SA, 1998, J CELL SCI, V111, P2433; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	54	66	68	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19179	19197		10.1074/jbc.M117.808063	http://dx.doi.org/10.1074/jbc.M117.808063			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972170	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000416226700004
J	Tran, AX; Dong, CJ; Whitfield, C				Tran, An X.; Dong, Changjiang; Whitfield, Chris			Structure and functional analysis of LptC, a conserved membrane protein involved in the lipopolysaccharide export pathway in Escherichia coli (col 285, pg 33529, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Tran AX, 2010, J BIOL CHEM, V285, P33529, DOI 10.1074/jbc.M110.144709	1	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18731	18731		10.1074/jbc.AAC117.000510	http://dx.doi.org/10.1074/jbc.AAC117.000510			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	29127206	hybrid, Green Published			2022-12-28	WOS:000414958100029
J	McGee, JH; Shim, SY; Lee, SJ; Swanson, PK; Jiang, SY; Durney, MA; Verdine, GL				McGee, John H.; Shim, So Youn; Lee, Seung-Joo; Swanson, Paige K.; Jiang, Sam Y.; Durney, Michael A.; Verdine, Gregory L.			Exceptionally high-affinity Ras binders that remodel its effector domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SURFACE DISPLAY; K-RAS; CYCLIC-PEPTIDES; ACTIVATION; PROTEIN; SOS; INHIBITORS; NUCLEOTIDES; POLYPEPTIDE; MUTATIONS	The Ras proteins are aberrantly activated in a wide range of human cancers, often endowing tumors with aggressive properties and resistance to therapy. Decades of effort to develop direct Ras inhibitors for clinical use have thus far failed, largely because of a lack of adequate small-molecule-binding pockets on the Ras surface. Here, we report the discovery of Rasbinding miniproteins from a naive library and their evolution to afford versions with midpicomolar affinity to Ras. A series of biochemical experiments indicated that these miniproteins bind to the Ras effector domain as dimers, and high-resolution crystal structures revealed that these miniprotein dimers bind Ras in an unprecedented mode in which the Ras effector domain is remodeled to expose an extended pocket that connects two isolated pockets previously found to engage small-molecule ligands. We also report a Ras point mutant that stabilizes the protein in the open conformation trapped by these miniproteins. These findings provide new tools for studying Ras structure and function and present opportunities for the development of both miniprotein and small-molecule inhibitors that directly target the Ras proteins.	[McGee, John H.; Durney, Michael A.; Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [McGee, John H.; Shim, So Youn; Lee, Seung-Joo; Swanson, Paige K.; Jiang, Sam Y.; Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Shim, So Youn; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Med Sch, Cambridge, MA 02138 USA; [Shim, So Youn; Verdine, Gregory L.] FOG Pharmaceut, Cambridge, MA 02140 USA; [Lee, Seung-Joo] Warp Drive Bio, Cambridge, MA 02139 USA; [Swanson, Paige K.] Finch Therapeut, Somerville, MA 02143 USA; [Durney, Michael A.] Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Verdine, GL (corresponding author), Harvard Univ, 12 Oxford St, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu	Shim, Jae-Jin/T-5633-2019; Shim, So Youn/T-5482-2019		Lustgarten Foundation	Lustgarten Foundation	This work was supported by a grant from the Lustgarten Foundation. The research reported herein is the subject of a license option agreement between Harvard University and FOG Pharmaceuticals. G. L. V. is a major shareholder in FOG Pharmaceuticals.	Besse D, 1997, ANGEW CHEM INT EDIT, V36, P883, DOI 10.1002/anie.199708831; BLUNDELL TL, 1981, P NATL ACAD SCI-BIOL, V78, P4175, DOI 10.1073/pnas.78.7.4175; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drosten M, 2014, ONCOGENE, V33, P2857, DOI 10.1038/onc.2013.254; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Hodges AM, 2007, J AM CHEM SOC, V129, P11024, DOI 10.1021/ja074859t; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kauke MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05889-7; Levinson AM, 2017, J AM CHEM SOC, V139, P7632, DOI 10.1021/jacs.7b02988; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Muraoka S, 2012, FEBS LETT, V586, P1715, DOI 10.1016/j.febslet.2012.04.058; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Smith BA, 2008, J AM CHEM SOC, V130, P2948, DOI 10.1021/ja800074v; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Strub MP, 2003, STRUCTURE, V11, P1359, DOI 10.1016/j.str.2003.09.014; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Upadhyaya P, 2015, ANGEW CHEM INT EDIT, V54, P7602, DOI 10.1002/anie.201502763; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	46	17	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3265	3280		10.1074/jbc.M117.816348	http://dx.doi.org/10.1074/jbc.M117.816348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29282294	Green Published, hybrid			2022-12-28	WOS:000426562800020
J	McClenaghan, C; Hanson, A; Sala-Rabanal, M; Roessler, HI; Josifova, D; Grange, DK; van Haaften, G; Nichols, CG				McClenaghan, Conor; Hanson, Alex; Sala-Rabanal, Monica; Roessler, Helen I.; Josifova, Dragana; Grange, Dorothy K.; van Haaften, Gijs; Nichols, Colin G.			Cantu syndrome-associated SUR2 (ABCC9) mutations in distinct structural domains result in K-ATP channel gain-of-function by differential mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						potassium channel; ABC transporter; cardiovascular disease; electrophysiology; nucleotide	SENSITIVE POTASSIUM CHANNELS; VASCULAR SMOOTH-MUSCLE; SULFONYLUREA RECEPTOR; PHYSIOLOGICAL ROLES; HIGH-AFFINITY; NUCLEOTIDES; DOMINANT; SUBUNITS; MANIFESTATIONS; IDENTIFICATION	The complex disorder Cantu syndrome (CS) arises from gain-of-function mutations in either KCNJ8 or ABCC9, the genes encoding the Kir6.1 and SUR2 subunits of ATP-sensitive potassium (K-ATP) channels, respectively. Recent reports indicate that such mutations can increase channel activity by multiple molecular mechanisms. In this study, we determined the mechanism by which K-ATP function is altered by several substitutions in distinct structural domains of SUR2: D207E in the intracellular L0-linker and Y985S, G989E, M1060I, and R1154Q/R1154W in TMD2. We engineered substitutions at their equivalent positions in rat SUR2A (D207E, Y981S, G985E, M1056I, and R1150Q/R1150W) and investigated functional consequences using macroscopic rubidium (Rb-86(+)) efflux assays and patch-clamp electrophysiology. Our results indicate that D207E increases K-ATP channel activity by increasing intrinsic stability of the open state, whereas the cluster of Y981S/G985E/M1056I substitutions, as well as R1150Q/R1150W, augmented Mg-nucleotide activation. We also tested the responses of these channel variants to inhibition by the sulfonylurea drug glibenclamide, a potential pharmacotherapy for CS. None of the D207E, Y981S, G985E, or M1056I substitutions had a significant effect on glibenclamide sensitivity. However, Gln and Trp substitution at Arg-1150 significantly decreased glibenclamide potency. In summary, these results provide additional confirmation that mutations in CS-associated SUR2 mutations result in K-ATP gain-of-function. They help link CS genotypes to phenotypes and shed light on the underlying molecular mechanisms, including consequences for inhibitory drug sensitivity, insights that may inform the development of therapeutic approaches to manage CS.	[McClenaghan, Conor; Hanson, Alex; Sala-Rabanal, Monica; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Grange, Dorothy K.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Pediat, St Louis, MO 63110 USA; [Roessler, Helen I.; van Haaften, Gijs] Univ Med Ctr Utrecht, Dept Med Genet, Postbus 85500, NL-3508 GA Utrecht, Netherlands; [Josifova, Dragana] Guys & St Thomas NHS Trust, Dept Clin Genet, Great Maze Pond, London SE1 9RT, England	Washington University (WUSTL); Washington University (WUSTL); Utrecht University; Utrecht University Medical Center; Guy's & St Thomas' NHS Foundation Trust	Nichols, CG (corresponding author), Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	van Haaften, Gijs/G-7832-2012; Sala-Rabanal, Monica/AAU-2383-2021	van Haaften, Gijs/0000-0003-3033-0329; McClenaghan, Conor/0000-0002-0859-3854; Hanson, Alex/0000-0002-4931-0590	National Institutes of Health from NHLBI [HL140024]; E-Rare Joint Transnational Cantu Treat Program [I-2101-B26]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL140024] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); E-Rare Joint Transnational Cantu Treat Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL140024 from NHLBI (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the E-Rare Joint Transnational Cantu Treat Program Grant I-2101-B26 (to G. v. H.).	Afifi HH, 2016, PEDIATR DERMATOL, V33, pE109, DOI 10.1111/pde.12821; Ashfield R, 1999, DIABETES, V48, P1341, DOI 10.2337/diabetes.48.6.1341; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; BONEV AD, 1993, AM J PHYSIOL, V264, pC1190, DOI 10.1152/ajpcell.1993.264.5.C1190; Brownstein CA, 2013, EUR J MED GENET, V56, P678, DOI 10.1016/j.ejmg.2013.09.009; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cooper PE, 2017, J BIOL CHEM, V292, P17387, DOI 10.1074/jbc.M117.804971; Cooper PE, 2015, J GEN PHYSIOL, V146, P527, DOI 10.1085/jgp.201511495; Cooper PE, 2014, HUM MUTAT, V35, P809, DOI 10.1002/humu.22555; Ellard S, 2007, AM J HUM GENET, V81, P375, DOI 10.1086/519174; Fang K, 2006, J PHYSIOL-LONDON, V576, P379, DOI 10.1113/jphysiol.2006.112748; Flagg TP, 2010, PHYSIOL REV, V90, P799, DOI 10.1152/physrev.00027.2009; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Foster MN, 2016, PHYSIOL REV, V96, P177, DOI 10.1152/physrev.00003.2015; Grange DK, 2006, AM J MED GENET A, V140A, P1673, DOI 10.1002/ajmg.a.31348; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guerrero CRL, 2016, NEUROLOGY, V87, P270, DOI 10.1212/WNL.0000000000002861; Hambrock A, 2002, BRIT J PHARMACOL, V136, P995, DOI 10.1038/sj.bjp.0704801; Hambrock A, 2001, MOL PHARMACOL, V60, P190, DOI 10.1124/mol.60.1.190; Harakalova M, 2012, NAT GENET, V44, P793, DOI 10.1038/ng.2324; Ko Eun A., 2008, Journal of Smooth Muscle Research, V44, P65, DOI 10.1540/jsmr.44.65; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Levin MD, 2015, HEART RHYTHM, V12, P2316, DOI 10.1016/j.hrthm.2015.06.042; Li AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000365; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Matsuoka T, 2000, CIRC RES, V87, P873, DOI 10.1161/01.RES.87.10.873; NAKASHIMA M, 1995, J PHARMACOL EXP THER, V272, P379; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nichols CG, 2013, CIRC RES, V112, P1059, DOI 10.1161/CIRCRESAHA.112.300514; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Proks P, 2014, J GEN PHYSIOL, V144, P469, DOI 10.1085/jgp.201411222; Proks P, 2013, DIABETES METAB J, V37, P157, DOI 10.4093/dmj.2013.37.3.157; QUAMME GA, 1990, BIOCHEM BIOPH RES CO, V167, P1406, DOI 10.1016/0006-291X(90)90679-H; Reimann F, 2000, MOL PHARMACOL, V58, P1318, DOI 10.1124/mol.58.6.1318; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; van Bon BWM, 2012, AM J HUM GENET, V90, P1094, DOI 10.1016/j.ajhg.2012.04.014; Vedovato N, 2016, DIABETOLOGIA, V59, P1430, DOI 10.1007/s00125-016-3964-x; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	47	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2041	2052		10.1074/jbc.RA117.000351	http://dx.doi.org/10.1074/jbc.RA117.000351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29275331	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000424948000017
J	Blummel, AS; Drepper, F; Knapp, B; Eimer, E; Warscheid, B; Muller, M; Frobel, J				Bluemmel, Anne-Sophie; Drepper, Friedel; Knapp, Bettina; Eimer, Ekaterina; Warscheid, Bettina; Mueller, Matthias; Froebel, Julia			Structural features of the TatC membrane protein that determine docking and insertion of a twin-arginine signal peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); mass spectrometry (MS); membrane protein; protein cross-linking; protein export; protein targeting; Dicyclohexylcarbodiimide (DCCD; DCC); TatC; twin-arginine translocation	ESCHERICHIA-COLI; TRANSPORT-SYSTEM; PRECURSOR PROTEINS; BINDING-SITE; TRANSLOCATION SYSTEM; BACILLUS-SUBTILIS; FOLDED PROTEINS; COMPONENT; COMPLEX; SUBUNIT	Twin-arginine translocation (Tat) systems transport folded proteins across cellular membranes with the concerted action of mostly three membrane proteins: TatA, TatB, and TatC. Hetero-oligomers of TatB and TatC form circular substrate-receptor complexes with a central binding cavity for twin-arginine-containing signal peptides. After binding of the substrate, energy from an electro-chemical proton gradient is transduced into the recruitment of TatA oligomers and into the actual translocation event. We previously reported that Tat-dependent protein translocation into membrane vesicles of Escherichia coli is blocked by the compound N,N-dicyclohexylcarbodiimide (DCCD, DCC). We have now identified a highly conserved glutamate residue in the transmembrane region of E. coli TatC, which when modified by DCCD interferes with the deep insertion of a Tat signal peptide into the TatBC receptor complex. Our findings are consistent with a hydrophobic binding cavity formed by TatB and TatC inside the lipid bilayer. Moreover, we found that DCCD mediates discrete intramolecular cross-links of E. coli TatC involving both its N- and C-tails. These results confirm the close proximity of two distant sequence sections of TatC proposed to concertedly function as the primary docking site for twin-arginine signal peptides.	[Bluemmel, Anne-Sophie; Eimer, Ekaterina; Mueller, Matthias; Froebel, Julia] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Bluemmel, Anne-Sophie] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Bluemmel, Anne-Sophie; Eimer, Ekaterina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Knapp, Bettina; Warscheid, Bettina] Univ Freiburg, Fac Biol, Inst Biol 2, Biochem Funct Prote, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de		Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795	Deutsche Forschungsgemeinschaft [SFB 746, FOR 1905]; Excellence Initiative of the German Federal & State Governments [GSC-4, EXC-294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 746 and Grant FOR 1905 and the Excellence Initiative of the German Federal & State Governments (GSC-4, Spemann Graduate School, and EXC-294, BIOSS). The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; Berks BC, 2014, CURR OPIN STRUC BIOL, V27, P32, DOI 10.1016/j.sbi.2014.03.003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Chan A, 2016, EUR J CELL BIOL, V95, P585, DOI 10.1016/j.ejcb.2016.10.004; Cleon F, 2015, MOL MICROBIOL, V98, P111, DOI 10.1111/mmi.13106; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Eimer E, 2015, J BIOL CHEM, V290, P29281, DOI 10.1074/jbc.M115.696005; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HASSINEN IE, 1993, BIOCHIM BIOPHYS ACTA, V1144, P107, DOI 10.1016/0005-2728(93)90164-B; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Moser Michael, 2007, V390, P63; MULLER M, 1987, EMBO J, V6, P3855, DOI 10.1002/j.1460-2075.1987.tb02723.x; MUSSER SM, 1993, BIOPHYS J, V65, P2348, DOI 10.1016/S0006-3495(93)81309-2; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Patel R, 2014, BBA-MOL CELL RES, V1843, P1620, DOI 10.1016/j.bbamcr.2014.02.013; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Reimann L, 2017, MOL CELL PROTEOMICS, V16, P346, DOI 10.1074/mcp.M116.065425; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Simone D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078742; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	50	5	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21320	21329		10.1074/jbc.M117.812560	http://dx.doi.org/10.1074/jbc.M117.812560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089385	Green Published, hybrid			2022-12-28	WOS:000419013000009
J	Casey, AK; Moehlman, AT; Zhang, JM; Servage, KA; Kramer, H; Orth, K				Casey, Amanda K.; Moehlman, Andrew T.; Zhang, Junmei; Servage, Kelly A.; Kramer, Helmut; Orth, Kim			Fic-mediated deAMPylation is not dependent on homodimerization and rescues toxic AMPylation in flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLUTAMINE-SYNTHETASE; DROSOPHILA-MELANOGASTER; DEADENYLYLATION; ADENYLYLATION; MUTATIONS; BINDING; DOMAIN; SITE	Protein chaperones play a critical role in proteostasis. The activity of the major endoplasmic reticulum chaperone BiP (GRP78) is regulated by Fic-mediated AMPylation during resting states. By contrast, during times of stress, BiP is deAMPylated. Here, we show that excessive AMPylation by a constitutively active FicE247G mutant is lethal in Drosophila. This lethality is cell-autonomous, as directed expression of the mutant FicE247G to the fly eye does not kill the fly but rather results in a rough and reduced eye. Lethality and eye phenotypes are rescued by the deAMPylation activity of wild-type Fic. Consistent with Fic acting as a deAMPylation enzyme, its activity was both time-and concentration-dependent. Furthermore, Fic deAMPylation activity was sufficient to suppress the AMPylation activity mediated by the constitutively active FicE247G mutant in Drosophila S2 lysates. Further, we show that the dual enzymatic activity of Fic is, in part, regulated by Fic dimerization, as loss of this dimerization increases AMPylation and reduces deAMPylation of BiP.	[Casey, Amanda K.; Zhang, Junmei; Servage, Kelly A.; Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-120F, Dallas, TX 75390 USA; [Moehlman, Andrew T.; Kramer, Helmut] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Zhang, Junmei; Servage, Kelly A.; Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-120F, Dallas, TX 75390 USA.	Kim.Orth@UTSouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	National Institutes of Health (NIH) [R01 GM115188]; Welch Foundation [I-1561]; Once Upon a Time Foundation; NIH [EY010199, EY021922]; National Science Foundation [1000176311]; NATIONAL EYE INSTITUTE [R01EY021922, R01EY010199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115188] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Once Upon a Time Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) Grant R01 GM115188, Welch Foundation Grant I-1561, and Once Upon a Time... Foundation (to K. O.), NIH Grants EY010199 and EY021922 (to H. K.), and National Science Foundation Graduate Research Fellowship 1000176311 (to A. T. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON WB, 1970, BIOCHEM BIOPH RES CO, V41, P704, DOI 10.1016/0006-291X(70)90070-7; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Bunney TD, 2014, STRUCTURE, V22, P1831, DOI 10.1016/j.str.2014.10.007; Ceriani M Fernanda, 2007, Methods Mol Biol, V362, P415; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Harms A, 2016, ANNU REV MICROBIOL, V70, P341, DOI 10.1146/annurev-micro-102215-095245; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Nandi N, 2014, J CELL BIOL, V207, P253, DOI 10.1083/jcb.201404028; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Ray M, 2015, J GENET, V94, P407, DOI 10.1007/s12041-015-0535-8; Roy CR, 2015, NAT REV MICROBIOL, V13, P631, DOI 10.1038/nrmicro3520; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Truttmann MC, 2017, P NATL ACAD SCI USA, V114, pE152, DOI 10.1073/pnas.1619234114; Truttmann MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006023; Vasudevan D, 2016, METHODS MOL BIOL, V1491, P131, DOI 10.1007/978-1-4939-3581-9_11; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	28	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21193	21204		10.1074/jbc.M117.799296	http://dx.doi.org/10.1074/jbc.M117.799296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089387	hybrid, Green Published			2022-12-28	WOS:000418453400033
J	Vigneron, N; Ferrari, V; Stroobant, V; Habib, JA; Van den Eynde, BJ				Vigneron, Nathalie; Ferrari, Violette; Stroobant, Vincent; Habib, Joanna Abi; Van den Eynde, Benoit J.			Peptide splicing by the proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CLASS-I MOLECULES; CD4 T-CELLS; 20S PROTEASOME; ENDOPLASMIC-RETICULUM; STANDARD PROTEASOME; ANTIGENIC PEPTIDES; PROTEIN; AMINOPEPTIDASE; INHIBITOR; EPITOPES	The proteasome is the major protease responsible for the production of antigenic peptides recognized by CD8(+) cytolytic T cells (CTL). These peptides, generally 8-10 amino acids long, are presented at the cell surface by major histocompatibility complex (MHC) class I molecules. Originally, these peptides were believed to be solely derived from linear fragments of proteins, but this concept was challenged several years ago by the isolation of anti-tumor CTL that recognized spliced peptides, i.e. peptides composed of fragments distant in the parental protein. The splicing process was shown to occur in the proteasome through a transpeptidation reaction involving an acyl-enzyme intermediate. Here, we review the steps that led to the discovery of spliced peptides as well as the recent advances that uncover the unexpected importance of spliced peptides in the composition of the MHC class I repertoire.	[Vigneron, Nathalie; Ferrari, Violette; Stroobant, Vincent; Habib, Joanna Abi; Van den Eynde, Benoit J.] Catholic Univ Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Vigneron, Nathalie; Ferrari, Violette; Stroobant, Vincent; Habib, Joanna Abi; Van den Eynde, Benoit J.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Van den Eynde, Benoit J.] WELBIO Walloon Excellence Life Sci & Biotechnol, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; WELBIO	Van den Eynde, BJ (corresponding author), Catholic Univ Louvain, Ludwig Inst Canc Res, de Duve Inst, Ave Hippocrate 75 B1-74-03, B-1200 Brussels, Belgium.	benoit.vandeneynde@bru.licr.org		Abi Habib, Joanna/0000-0002-9920-6927; Van den Eynde, Benoit/0000-0002-4995-3270	Fonds National de la Recherche Scientifique Fellowship FRIA Grant [1.E091.14]; Fonds National de la Recherche Scientifique Fellowship TELEVIE Grant [7455115F]	Fonds National de la Recherche Scientifique Fellowship FRIA Grant(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique Fellowship TELEVIE Grant(Fonds de la Recherche Scientifique - FNRS)	Supported by Fonds National de la Recherche Scientifique Fellowship FRIA Grant 1.E091.14.; Supported by Fonds National de la Recherche Scientifique Fellowship TELEVIE Grant 7455115F.	Altrich-VanLith ML, 2006, J IMMUNOL, V177, P5440, DOI 10.4049/jimmunol.177.8.5440; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Berkers CR, 2015, J IMMUNOL, V195, P4075, DOI 10.4049/jimmunol.1402454; Berkers CR, 2015, J IMMUNOL, V195, P4085, DOI 10.4049/jimmunol.1402455; Calis JJA, 2015, IMMUNOGENETICS, V67, P85, DOI 10.1007/s00251-014-0815-0; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dalet A, 2011, P NATL ACAD SCI USA, V108, pE323, DOI 10.1073/pnas.1101892108; Dalet A, 2011, EUR J IMMUNOL, V41, P39, DOI 10.1002/eji.201040750; Dalet A, 2010, J IMMUNOL, V184, P3016, DOI 10.4049/jimmunol.0901277; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2006, CHEM BIOL, V13, P607, DOI 10.1016/j.chembiol.2006.04.005; Guillaume B, 2012, J IMMUNOL, V189, P3538, DOI 10.4049/jimmunol.1103213; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Li XH, 2014, J BIOL CHEM, V289, P17392, DOI 10.1074/jbc.M114.561183; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; MA CP, 1992, J BIOL CHEM, V267, P10515; Michaux A, 2014, J IMMUNOL, V192, P1962, DOI 10.4049/jimmunol.1302032; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; NIKAIDO T, 1990, CLIN EXP IMMUNOL, V79, P209; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tomaru U, 2009, BLOOD, V113, P5186, DOI 10.1182/blood-2008-11-187633; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vigneron N, 2015, ANAL BIOCHEM, V482, P7, DOI 10.1016/j.ab.2015.04.019; Vigneron N, 2014, BIOMOLECULES, V4, P994, DOI 10.3390/biom4040994; Vigneron N, 2011, CELL MOL LIFE SCI, V68, P1503, DOI 10.1007/s00018-011-0658-x; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Wiles TA, 2017, J AUTOIMMUN, V78, P11, DOI 10.1016/j.jaut.2016.10.007; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860	54	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21170	21179		10.1074/jbc.R117.807560	http://dx.doi.org/10.1074/jbc.R117.807560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29109146	Green Published, hybrid			2022-12-28	WOS:000418453400031
J	Carden, T; Singh, B; Mooga, V; Bajpai, P; Singh, KK				Carden, Trevor; Singh, Bhupendra; Mooga, Ved; Bajpai, Prachi; Singh, Keshav K.			Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; DNA methylation; gene expression; microRNA (miRNA); mitochondria; miR-663; retrograde signaling; OXPHOS; tumorigenesis	ADENOMATOUS-POLYPOSIS-COLI; BREAST-CANCER CELLS; RESPIRATORY-CHAIN; CROSS-TALK; H-RAS; TRANSFORMATION; DYSFUNCTION; RESISTANCE; MIGRATION; APOPTOSIS	The normal cellular function requires communication between mitochondria and the nucleus, termed mitochondria-to-nucleus retrograde signaling. Disruption of this mechanism has been implicated in the development of cancers. Many proteins are known modulators of retrograde signaling, but whether microRNAs (miRNAs) are also involved is unknown. We conducted an miRNA microarray analysis using RNA from a parental cell line, a Rho(0) line lacking mitochondrial DNA (mtDNA) and a Rho(0) line with restored mtDNA. We found that miR-663 was down-regulated in the mtDNA-depleted Rho(0) line. mtDNA restoration reversed this miRNA to parental level, suggesting that miR-663 may be epigenetically regulated by retrograde signaling. By using methylation-specific PCR and bisulfite sequencing we demonstrate that miR-663 promoter is epigenetically regulated not only by genetic but also by pharmacological disruption of oxidative phosphorylation (OXPHOS). Restoration of OXPHOS Complex I inhibitor-induced miR-663 expression by N-acetylcysteine suggested that reactive oxygen species (ROS) play a key role in epigenetic regulation of miR-663. We determined that miR-663 regulates the expression of nuclear-encoded respiratory chain subunits involved in Complexes I, II, III, and IV. miR-663 also controlled the expression of the Complexes I (NDUFAF1), II (SDHAF2), III (UQCC2), and IV (SCO1) assembly factors and was required for stability of respiratory supercomplexes. Furthermore, using luciferase assays, we found that miR-663 directly regulates UQCC2. The anti-miR-663 reduced OXPHOS complex activity and increased in vitro cellular proliferation and promoted tumor development in vivo in mice. We also found that increased miR-663 expression in breast tumors consistently correlates with increased patient survival. We provide the first evidence for miRNA controlling retrograde signaling, demonstrating its epigenetic regulation and its role in breast tumorigenesis.	[Carden, Trevor; Singh, Bhupendra; Mooga, Ved; Bajpai, Prachi; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Environm Hlth Sci, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Singh, Keshav K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Sch Med, Kaul Genet Bdg,Ste 620,720 20th St, South Birmingham, AL 35294 USA.	kksingh@uab.edu			U.S. Department of Veterans Affairs [1I0IBX001716]; National Institutes of Health [R01 CA204430]; NATIONAL CANCER INSTITUTE [R01CA204430] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001716] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U.S. Department of Veterans Affairs Grant 1I0IBX001716 and National Institutes of Health Grant R01 CA204430. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Beukers W, 2014, EUR J HUM GENET, V22, P837, DOI 10.1038/ejhg.2013.251; Bucha S, 2015, BIOCHEM BIOPH RES CO, V465, P797, DOI 10.1016/j.bbrc.2015.08.090; Challa AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155812; Chaudhuri AD, 2016, J BIOL CHEM, V291, P6483, DOI 10.1074/jbc.M115.691352; Chowdhury AR, 2017, ONCOGENE, V36, P397, DOI 10.1038/onc.2016.211; Compton S, 2011, J BIOL CHEM, V286, P20297, DOI 10.1074/jbc.M110.163063; Cruz-Bermudez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096820; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Delsite Robert, 2002, Mol Cancer, V1, P6, DOI 10.1186/1476-4598-1-6; Desouki MM, 2005, CANCER BIOL THER, V4, P1367, DOI 10.4161/cbt.4.12.2233; Dong TY, 2015, J CANCER, V6, P1222, DOI 10.7150/jca.11279; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hoenerhoff MJ, 2009, ONCOGENE, V28, P3022, DOI 10.1038/onc.2009.165; Hong Q, 2015, MICROCIRCULATION, V22, P306, DOI 10.1111/micc.12200; Hu HY, 2013, J BIOL CHEM, V288, P10973, DOI 10.1074/jbc.M112.434340; Hu WT, 2014, RNA BIOL, V11, P1189, DOI 10.4161/rna.34345; Huang Y, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.09.0082; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510; Johnston AJ, 2002, J BIOL CHEM, V277, P42197, DOI 10.1074/jbc.M205613200; Kaipparettu BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061747; Kim JS, 2014, BIOCHEM BIOPH RES CO, V446, P894, DOI 10.1016/j.bbrc.2014.03.027; Kinoshita T, 2017, J HUM GENET, V62, P67, DOI 10.1038/jhg.2016.87; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Kulawiec M, 2006, CANCER BIOL THER, V5, P967, DOI 10.4161/cbt.5.8.2880; Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89; Kulawiec M, 2009, CANCER BIOL THER, V8, P1378, DOI 10.4161/cbt.8.14.8751; Kulawiec M, 2008, CANCER BIOL THER, V7, P1732, DOI 10.4161/cbt.7.11.6729; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Li JC, 2010, PLOS GENET, V6, DOI [10.1371/journal.pgen.1000795, 10.1186/1746-4811-6-1]; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Li QZ, 2016, ONCOL REP, V35, P1125, DOI 10.3892/or.2015.4432; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu ZY, 2011, ASIAN PAC J CANCER P, V12, P2819; Miao CG, 2015, IMMUNOL LETT, V166, P45, DOI 10.1016/j.imlet.2015.05.011; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Mukherjee N, 2012, CANCER SCI, V103, P210, DOI 10.1111/j.1349-7006.2011.02131.x; Owens KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023846; Prasad CP, 2008, LIFE SCI, V83, P318, DOI 10.1016/j.lfs.2008.06.019; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Saffran HA, 2007, EMBO REP, V8, P188, DOI 10.1038/sj.embor.7400878; Sawyer C, 2003, CANCER RES, V63, P1667; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Shapovalov Y, 2011, J BIOL CHEM, V286, P22331, DOI 10.1074/jbc.M111.250092; Shi Y, 2015, CLIN CANCER RES, V21, P4004, DOI 10.1158/1078-0432.CCR-14-2807; Shi Y, 2014, CLIN CANCER RES, V20, P1803, DOI 10.1158/1078-0432.CCR-13-2284; Singh K. K., 2015, MITOCHONDRION, V24, pS6; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Singh KK, 2005, GENE, V354, P140, DOI 10.1016/j.gene.2005.03.027; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Smiraglia DJ, 2008, CANCER BIOL THER, V7, P1182, DOI 10.4161/cbt.7.8.6215; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Tao YF, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-74; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034; Tzenaki N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00040; Vartak R, 2013, PROTEIN CELL, V4, P582, DOI 10.1007/s13238-013-3032-y; Vislovukh A, 2013, BRIT J CANCER, V108, P2304, DOI 10.1038/bjc.2013.243; Waaijer MEC, 2014, BIOGERONTOLOGY, V15, P269, DOI 10.1007/s10522-014-9496-1; Wang ZH, 2016, TUMOR BIOL, V37, P7633, DOI 10.1007/s13277-015-4653-y; Xie CH, 2007, BIOCHEM BIOPH RES CO, V364, P656, DOI 10.1016/j.bbrc.2007.10.047; Xiong SB, 2014, PROTEIN CELL, V5, P737, DOI 10.1007/s13238-014-0089-1; Yang Y, 2013, FEBS J, V280, P5109, DOI 10.1111/febs.12485; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	79	39	42	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20694	20706		10.1074/jbc.M117.797001	http://dx.doi.org/10.1074/jbc.M117.797001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29066618	Green Published, hybrid			2022-12-28	WOS:000418267000030
J	Jakka, P; Namani, S; Murugan, S; Rai, N; Radhakrishnan, G				Jakka, Padmaja; Namani, Swapna; Murugan, Subathra; Rai, Nivedita; Radhakrishnan, Girish			The Brucella effector protein TcpB induces degradation of inflammatory caspases and thereby subverts non-canonical inflammasome activation in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell death; cytokine; inflammasome; lipopolysaccharide (LPS); ubiquitylation (ubiquitination); Brucella; caspase-1; caspase-4; pyroptosis	DOMAIN-CONTAINING PROTEIN; INNATE IMMUNE RECEPTORS; BACTERIAL PATHOGENS; CELL-DEATH; ABORTUS INFECTION; INTRACELLULAR LPS; MELITENSIS; RESPONSES; NEOTOMAE; PROMOTES	The inflammasome contains intracellular receptors that recognize various pathogen-associated molecular patterns and play crucial roles in innate immune responses to invading pathogens. Non-canonical inflammasome activation is mediated by caspase-4/11, which recognizes intracellular LPS and promotes pyroptosis and secretion of proinflammatory cytokines. Brucella species are infectious intracellular pathogens that replicate in professional and non-professional phagocytic cells and subvert immune responses for chronic persistence in the host. The Brucella effector protein TcpB suppresses Toll-like receptor 2 (TLR2)- and TLR4-mediated innate immune responses by targeted degradation of the Toll/interleukin-1 receptor (TIR) domain-containing adaptor protein. TcpB is a cell-permeable protein with multiple functions, and its intracellular targets other than TIR domain-containing adaptor protein remain unclear. Here, we report that TcpB induces ubiquitination and degradation of the inflammatory caspases 1, 4, and 11. Furthermore, in both mouse and human macrophages, TcpB attenuated LPS-induced non-canonical inflammasome activation and suppressed pyroptosis and secretion of IL-1 and IL-1 induced by intracellular LPS delivery. The intact TIR domain was essential for TcpB to subvert the non-canonical inflammasome activation as a TcpB(G158A) mutant failed to suppress pyroptotic cell death and inflammatory responses. Brucella-infected macrophages exhibited minimal pyroptosis but secreted IL-1, which was suppressed by TcpB. We also demonstrated that TcpB protein can efficiently attenuate Salmonella enterica serovar Typhimurium-induced pyroptosis and proinflammatory cytokine secretion in macrophages. Because TcpB suppresses both TLR4- and caspase-4/11-mediated inflammation, TcpB might be a candidate target for developing drugs against LPS-induced septicemia.	[Jakka, Padmaja; Namani, Swapna; Murugan, Subathra; Rai, Nivedita; Radhakrishnan, Girish] Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500049, Telangana, India; [Jakka, Padmaja] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Manipal Academy of Higher Education (MAHE)	Radhakrishnan, G (corresponding author), Natl Inst Anim Biotechnol, Lab Immunol & Microbial Pathogenesis, Hyderabad 500049, Telangana, India.	girish@niab.org.in		Radhakrishnan, Girish/0000-0001-9088-0029	Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India	Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India	This work was supported in part by funding from the Department of Biotechnology, Ministry of Science and Technology, Government of India, through the National Institute of Animal Biotechnology, Hyderabad, India. The authors declare that they have no conflicts of interest with the contents of this article.	Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Aziz M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.488; Baker PJ, 2015, EUR J IMMUNOL, V45, P2918, DOI 10.1002/eji.201545655; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Byndloss MX, 2016, ANNU REV ANIM BIOSCI, V4, P111, DOI 10.1146/annurev-animal-021815-111326; Cardoso PCG, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-13; Casson CN, 2015, P NATL ACAD SCI USA, V112, P6688, DOI 10.1073/pnas.1421699112; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Covert J, 2009, EXP BIOL MED, V234, P1450, DOI 10.3181/0904-RM-124; Durward M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034925; GOLDSTEIN J, 1992, INFECT IMMUN, V60, P1385, DOI 10.1128/IAI.60.4.1385-1389.1992; Gomes MTR, 2013, J IMMUNOL, V190, P3629, DOI 10.4049/jimmunol.1202817; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Knodler LA, 2014, CELL HOST MICROBE, V16, P249, DOI 10.1016/j.chom.2014.07.002; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Man SM, 2016, NAT REV IMMUNOL, V16, P7, DOI 10.1038/nri.2015.7; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martirosyan A, 2013, FUTURE MICROBIOL, V8, P147, DOI [10.2217/FMB.12.140, 10.2217/fmb.12.140]; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Oliveira SC, 2012, VET IMMUNOL IMMUNOP, V148, P129, DOI 10.1016/j.vetimm.2011.05.036; Pallett MA, 2017, MUCOSAL IMMUNOL, V10, P602, DOI 10.1038/mi.2016.77; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rosadini CV, 2015, CURR OPIN IMMUNOL, V32, P61, DOI 10.1016/j.coi.2014.12.011; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Smith JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003785; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	44	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20613	20627		10.1074/jbc.M117.815878	http://dx.doi.org/10.1074/jbc.M117.815878			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29061850	Green Published, hybrid			2022-12-28	WOS:000418267000022
J	Morey, C; Kienle, CN; Klopper, TH; Burkhardt, P; Fasshauer, D				Morey, Czuee; Kienle, C. Nickias; Klopper, Tobias H.; Burkhardt, Pawel; Fasshauer, Dirk			Evidence for a conserved inhibitory binding mode between the membrane fusion assembly factors Munc18 and syntaxin in animals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transporter type 4 (GLUT4); insulin; membrane transport; secretion; SNARE proteins; Munc18; SM protein; syntaxin	N-TERMINAL PEPTIDE; NEUROTRANSMITTER RELEASE; CLOSED-CONFORMATION; VESICLE DOCKING; SEC1 HOMOLOG; YEAST SEC1; SNARE; COMPLEX; PROTEIN; EXOCYTOSIS	The membrane fusion necessary for vesicle trafficking is driven by the assembly of heterologous SNARE proteins orchestrated by the binding of Sec1/Munc18 (SM) proteins to specific syntaxin SNARE proteins. However, the precise mode of interaction between SM proteins and SNAREs is debated, as contrasting binding modes have been found for different members of the SM protein family, including the three vertebrate Munc18 isoforms. While different binding modes could be necessary, given their roles in different secretory processes in different tissues, the structural similarity of the three isoforms makes this divergence perplexing. Although the neuronal isoform Munc18a is well-established to bind tightly to both the closed conformation and the N-peptide of syntaxin 1a, thereby inhibiting SNARE complex formation, Munc18b and -c, which have a more widespread distribution, are reported to mainly interact with the N-peptide of their partnering syntaxins and are thought to instead promote SNARE complex formation. We have reinvestigated the interaction between Munc18c and syntaxin 4 (Syx4). Using isothermal titration calorimetry, we found that Munc18c, like Munc18a, binds to both the closed conformation and the N-peptide of Syx4. Furthermore, using a novel kinetic approach, we found that Munc18c, like Munc18a, slows down SNARE complex formation through high-affinity binding to syntaxin. This strongly suggests that secretory Munc18s in general control the accessibility of the bound syntaxin, probably preparing it for SNARE complex assembly.	[Morey, Czuee; Kienle, C. Nickias; Fasshauer, Dirk] Univ Lausanne, Dept Neurosci Fondamentales, Rue Bugnon 9, CH-1005 Lausanne, Switzerland; [Klopper, Tobias H.] Whitehat Life Sci Ltd, 20 Wenlock Rd, London N1 7GU, England; [Burkhardt, Pawel] Marine Biol Assoc UK, Citadel Hill Marine Lab, Plymouth PL1 2PB, Devon, England	University of Lausanne; Marine Biological Association United Kingdom	Fasshauer, D (corresponding author), Univ Lausanne, Dept Neurosci Fondamentales, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.	Dirk.Fasshauer@unil.ch	Fasshauer, Dirk/B-1563-2013	Fasshauer, Dirk/0000-0002-1040-4282; Burkhardt, Pawel/0000-0001-9826-057X	German Science Foundation [FA 297/3-1]; Swiss National Science Foundation [31003A_160343]	German Science Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by German Science Foundation Grant FA 297/3-1 and Swiss National Science Foundation Grant 31003A_160343. The authors declare that they have no conflicts of interest with the contents of this article.	Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Aran V, 2009, BIOCHEM J, V419, P655, DOI 10.1042/BJ20082293; Archbold JK, 2014, CURR OPIN STRUC BIOL, V29, P44, DOI 10.1016/j.sbi.2014.09.003; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Barclay JW, 2012, CELL CALCIUM, V52, P289, DOI 10.1016/j.ceca.2012.03.005; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Bracher A, 2001, J MOL BIOL, V306, P7, DOI 10.1006/jmbi.2000.4347; Bracher A, 2000, STRUCTURE, V8, P685, DOI 10.1016/S0969-2126(00)00156-8; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Dawidowski D, 2016, STRUCTURE, V24, P392, DOI 10.1016/j.str.2016.01.005; Demircioglu FE, 2014, P NATL ACAD SCI USA, V111, P13828, DOI 10.1073/pnas.1408254111; Dieckmann NMG, 2015, TRAFFIC, V16, P1330, DOI 10.1111/tra.12337; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Freedman SJ, 2003, J BIOL CHEM, V278, P13462, DOI 10.1074/jbc.M210483200; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GengyoAndo K, 1996, J NEUROSCI, V16, P6695; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; Halachmi N, 1996, J NEUROCHEM, V66, P889; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; He EQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15915; Hong WJ, 2014, TRENDS CELL BIOL, V24, P35, DOI 10.1016/j.tcb.2013.09.006; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Jakhanwal S, 2017, EMBO J, V36, P1788, DOI 10.15252/embj.201696270; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; James Declan J, 2013, Front Endocrinol (Lausanne), V4, P187, DOI 10.3389/fendo.2013.00187; Jewell JL, 2008, J BIOL CHEM, V283, P21734, DOI 10.1074/jbc.M710445200; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; KATAGIRI H, 1995, J BIOL CHEM, V270, P4963, DOI 10.1074/jbc.270.10.4963; Kim K, 2012, BIOCHEM J, V446, P383, DOI 10.1042/BJ20120057; Kioumourtzoglou D, 2014, BIOCHEM SOC T, V42, P1396, DOI 10.1042/BST20140114; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; Kloepper TH, 2008, MOL BIOL EVOL, V25, P2055, DOI 10.1093/molbev/msn151; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Ma L, 2015, ELIFE, V4, DOI 10.7554/eLife.09580; Margittai M, 2003, P NATL ACAD SCI USA, V100, P15516, DOI 10.1073/pnas.2331232100; Martin-Urdiroz M, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00024; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson Mary, 2009, Biochem J, V418, pe1, DOI 10.1042/BJ20082389; Park S, 2016, MOL BIOL CELL, V27, P669, DOI 10.1091/mbc.E15-09-0638; Peng RW, 2010, BIOCHEM J, V431, P353, DOI 10.1042/BJ20100145; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Ramalingam L, 2014, TRENDS ENDOCRIN MET, V25, P601, DOI 10.1016/j.tem.2014.06.010; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rehman A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183366; Rehman A, 2014, IUCRJ, V1, P505, DOI 10.1107/S2052252514020727; Richter DJ, 2013, ANNU REV GENET, V47, P509, DOI 10.1146/annurev-genet-111212-133456; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; SALZBERG A, 1993, DEVELOPMENT, V117, P1309; Schindelman G, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-26; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shin YK, 2013, P NATL ACAD SCI USA, V110, P14116, DOI 10.1073/pnas.1313749110; Spessott WA, 2017, TRAFFIC, V18, P442, DOI 10.1111/tra.12490; Spessott WA, 2015, BLOOD, V125, P1566, DOI 10.1182/blood-2014-11-610816; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stamberger H, 2016, NEUROLOGY, V86, P954, DOI 10.1212/WNL.0000000000002457; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Varoqueaux F, 2017, ANNU REV GENET, V51, P455, DOI 10.1146/annurev-genet-120116-024648; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang S, 2017, EMBO J, V36, P816, DOI 10.15252/embj.201695775; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Wu B, 2015, J CELL SCI, V128, P2957, DOI 10.1242/jcs.156398; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhou P, 2013, EMBO J, V32, P159, DOI 10.1038/emboj.2012.307; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	103	6	6	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20449	20460		10.1074/jbc.M117.811182	http://dx.doi.org/10.1074/jbc.M117.811182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29046354	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000418267000009
J	Shao, XM; Ding, ZH; Zhao, M; Liu, K; Sun, HY; Chen, JT; Liu, XM; Zhang, YZ; Hong, Y; Li, HS; Li, HC				Shao, Ximing; Ding, Zhihao; Zhao, Ming; Liu, Ke; Sun, Haiyan; Chen, Juntao; Liu, Xianming; Zhang, Yuzhen; Hong, Yang; Li, Huashun; Li, Hongchang			Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; endocytosis; intracellular trafficking; Notch pathway; protein degradation; Delta-like 4; Numb	SPECIFY CELL FATE; ASYMMETRIC DIVISION; FAMILY PROTEINS; DROSOPHILA; ENDOCYTOSIS; SEGREGATION; RECEPTOR; SANPODO; ENDOSOMES; ISOFORMS	The biological antagonism between the signaling proteins Numb and Notch has been implicated in the regulation of many developmental processes, especially in asymmetric cell division. Mechanistic studies show that Numb inactivates Notch via endocytosis and proteasomal degradation that directly reduce Notch protein levels at the cell surface. However, some aspects of how Numb antagonizes Notch remain unclear. Here, we report a novel mechanism in which Numb acts as a Notch antagonist by controlling the intracellular destination and stability of the Notch ligand Delta-like 4 (Dll4) through a postendocytic-sorting process. We observed that Numb/Numblike knockdown increases the stability and cell-surface accumulation of Dll4. Further study indicated that Numb acts as a sorting switch to control the postendocytic trafficking of Dll4. Of note, the Numb/Numblike knockdown decreased Dll4 delivery to the lysosome, while increasing the recycling of Dll4 to the plasma membrane. Moreover, we demonstrate that this enrichment of Dll4 at the cell surface within Numb/Numblike knockdown cells could activate Notch signaling in neighboring cells. We also provide evidence that Numb negatively controls the Dll4 plasma membrane recycling through a well-documented recycling regulator protein AP1. In conclusion, our study has uncovered a molecular mechanism whereby Numb regulates the endocytic trafficking of the Notch ligand Dll4. Our findings provide a new perspective on how Numb counteracts Notch signaling and sheds additional critical insights into the antagonistic relationship between Numb and Notch signaling.	[Shao, Ximing; Ding, Zhihao; Liu, Ke; Sun, Haiyan; Chen, Juntao; Liu, Xianming; Li, Hongchang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen Key Lab Mol Biol Neural Dev,Guangdong Ke, Shenzhen 518055, Guangdong, Peoples R China; [Zhao, Ming] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646000, Sichuan, Peoples R China; [Zhang, Yuzhen] Tongji Univ, Sch Med, Shanghai East Hosp, Res Ctr Translat Med,Key Lab Arrhythmias,Minist E, Shanghai 200120, Peoples R China; [Hong, Yang] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Li, Huashun] ATCG Corp, BioBay, Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Southwest Medical University; Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, HC (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen Key Lab Mol Biol Neural Dev,Guangdong Ke, Shenzhen 518055, Guangdong, Peoples R China.; Li, HS (corresponding author), ATCG Corp, BioBay, Suzhou Ind Pk, Suzhou 215123, Jiangsu, Peoples R China.	huashunli@tongji.edu.cn; hc.li@siat.ac.cn	Shao, Ximing/GPK-0381-2022; Li, Hongchang/GQO-9662-2022; Zhao, Ming/AFY-4507-2022		Ministry of Science and Technology of the People's Republic of China [2014CB964602]; National Natural Science Foundation of China [31601174, 31671397, 81702952]; Natural Science Foundation of Guangdong Province [2016A030312006]; Shenzhen Science and Technology Program [JCYJ20160229204338907]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Program	This work was supported by Grant 2014CB964602 from the Ministry of Science and Technology of the People's Republic of China, Grants 31601174, 31671397, and 81702952 from the National Natural Science Foundation of China, Grant 2016A030312006 from Natural Science Foundation of Guangdong Province, and Grant JCYJ20160229204338907 from Shenzhen Science and Technology Program. The authors declare that they have no conflicts of interest with the contents of this article.	Babaoglan AB, 2009, DEVELOPMENT, V136, P4089, DOI 10.1242/dev.040386; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Cotton M, 2013, CURR BIOL, V23, P581, DOI 10.1016/j.cub.2013.02.020; Couturier L, 2013, CURR BIOL, V23, P588, DOI 10.1016/j.cub.2013.03.002; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Gomez MR, 1997, DEVELOPMENT, V124, P4857; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Johnson SA, 2016, MOL BIOL CELL, V27, P2857, DOI 10.1091/mbc.E15-11-0751; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lear BC, 1999, MECH DEVELOP, V88, P207, DOI 10.1016/S0925-4773(99)00190-2; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; O'Connor-Giles KM, 2003, DEV CELL, V5, P231, DOI 10.1016/S1534-5807(03)00226-0; Park SY, 2014, BIOSCIENCE REP, V34, P381, DOI 10.1042/BSR20140069; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pece S, 2011, BBA-REV CANCER, V1815, P26, DOI 10.1016/j.bbcan.2010.10.001; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shao XM, 2016, CELL RES, V26, P593, DOI 10.1038/cr.2016.34; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shergill B, 2012, DEV CELL, V22, P1313, DOI 10.1016/j.devcel.2012.04.007; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Smith CA, 2004, MOL BIOL CELL, V15, P3698, DOI 10.1091/mbc.E04-01-0026; Sorensen EB, 2008, TRAFFIC, V9, P1791, DOI 10.1111/j.1600-0854.2008.00790.x; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; Yan B, 2010, BRAIN DEV-JPN, V32, P293, DOI 10.1016/j.braindev.2009.03.008; Zhao C, 2014, DEVELOPMENT, V141, P281, DOI 10.1242/dev.093690	50	13	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20628	20643		10.1074/jbc.M117.800946	http://dx.doi.org/10.1074/jbc.M117.800946			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042443	Green Published, hybrid			2022-12-28	WOS:000418267000023
J	Takada, YK; Yu, J; Fujita, M; Saegusa, J; Wu, CY; Takada, Y				Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Saegusa, Jun; Wu, Chun-Yi; Takada, Yoshikazu			Direct binding to integrins and loss of disulfide linkage in interleukin-1 (IL-1) are involved in the agonistic action of IL-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; integrin; interleukin-1 (IL-1); mutagenesis; NF-B (NF-KB); IL-1; disulfide linkage; agonistic action	TERNARY COMPLEX-FORMATION; RECEPTOR IGF1R; DEFECTIVE MUTANT; ALPHA-V-BETA-3; ANTAGONIST; ALPHA-6-BETA-4; TUMORIGENESIS; FIBRONECTIN; ACTIVATION; CELLS	There is a strong link between integrins and interleukin-1 (IL-1), but the specifics of the role of integrins in IL-1 signaling are unclear. We describe that IL-1 specifically bound to integrins v3 and 51. The E128K mutation in the IL1R-binding site enhanced integrin binding. We studied whether direct integrin binding is involved in IL-1 signaling. We compared sequences of IL-1 and IL-1 receptor antagonist (IL1RN), which is an IL-1 homologue but has no agonistic activity. Several surface-exposed Lys residues are present in IL-1, but not in IL1RN. A disulfide linkage is present in IL1RN, but is not in IL-1 because of natural C117F mutation. Substitution of the Lys residues to Glu markedly reduced integrin binding of E128K IL-1, suggesting that the Lys residues mediate integrin binding. The Lys mutations reduced, but did not completely abrogate, agonistic action of IL-1. We studied whether the disulfide linkage plays a role in agonistic action of IL-1. Reintroduction of the disulfide linkage by the F117C mutation did not affect agonistic activity of WT IL-1, but effectively reduced the remaining agonistic activity of the Lys mutants. Also, deletion of the disulfide linkage in IL1RN by the C116F mutation did not make it agonistic. We propose that the direct binding to IL-1 to integrins is primarily important for agonistic IL-1 signaling, and that the disulfide linkage indirectly affects signaling by blocking conformational changes induced by weak integrin binding to the Lys mutants. The integrin-IL-1 interaction is a potential target for drug discovery.	[Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Saegusa, Jun; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Takada, Yoko K.; Yu, Jessica; Fujita, Masaaki; Wu, Chun-Yi; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Yu, Jessica] Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sec 2, Taipei 11529, Taiwan; [Yu, Jessica] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, 250 Wu Hsing St, Taipei 11031, Taiwan	University of California System; University of California Davis; University of California System; University of California Davis; Academia Sinica - Taiwan; Taipei Medical University	Takada, Y (corresponding author), Suite 3300,4645 Second Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu			National Institutes of Health [R33CA196445, T32 HL007013]; Kanae Foundation for the Promotion of Medical Science; Taiwan Protein Project [MOST105-0210-01-12-01, MOST106-0210-01-15-04]; NATIONAL CANCER INSTITUTE [R33CA196445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kanae Foundation for the Promotion of Medical Science; Taiwan Protein Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R33CA196445, funding from The Kanae Foundation for the Promotion of Medical Science (to M.F.), and National Institutes of Health Grant T32 HL007013 (to J.Y.). This research was supported by Taiwan Protein Project Grants MOST105-0210-01-12-01 and MOST106-0210-01-15-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; CURTIS BM, 1989, P NATL ACAD SCI USA, V86, P3045, DOI 10.1073/pnas.86.9.3045; Dangerfield JP, 2005, J LEUKOCYTE BIOL, V77, P159, DOI 10.1189/jlb.0704421; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Fujita M, 2013, J BIOL CHEM, V288, P19593, DOI 10.1074/jbc.M113.470872; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; GRUTTER MG, 1994, PROTEIN ENG, V7, P663, DOI 10.1093/protein/7.5.663; Hailey KL, 2013, J MOL BIOL, V425, P2382, DOI 10.1016/j.jmb.2013.03.016; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Kawaguchi M, 2001, BIOCHEM BIOPH RES CO, V288, P711, DOI 10.1006/bbrc.2001.5809; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Peng Q, 2005, J IMMUNOL, V174, P2258, DOI 10.4049/jimmunol.174.4.2258; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang AZ, 1997, ARTHRITIS RHEUM, V40, P1298, DOI 10.1002/art.1780400715; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273	27	10	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20067	20075		10.1074/jbc.M117.818302	http://dx.doi.org/10.1074/jbc.M117.818302			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030430	hybrid, Green Published			2022-12-28	WOS:000417696400014
J	Tian, YY; Shen, X; Wang, R; Klages-Mundt, NL; Lynn, EJ; Martin, SK; Ye, Y; Gao, M; Chen, JJ; Schlacher, K; Li, L				Tian, Yanyan; Shen, Xi; Wang, Rui; Klages-Mundt, Naeh L.; Lynn, Erica J.; Martin, Sara K.; Ye, Yin; Gao, Min; Chen, Junjie; Schlacher, Katharina; Li, Lei			Constitutive role of the Fanconi anemia D2 gene in the replication stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA repair; DNA replication; gene knock-out; genomic instability; Fanconi anemia; nucleases; replication stress	CROSS-LINK REPAIR; DNA-END-RESECTION; MONOUBIQUITINATED FANCD2; CORE-COMPLEX; HOMOLOGOUS RECOMBINATION; UBIQUITIN LIGASE; GENOME STABILITY; BINDING-PROTEIN; FORK RECOVERY; BREAK REPAIR	In response to DNA cross-linking damage, the Fanconi anemia (FA) core complex activates the FA pathway by monoubiquitinating Fanconi anemia complementation group D2 (FANCD2) for the initiation of the nucleolytic processing of the DNA cross-links and stabilization of stalled replication forks. Given that all the classic FA proteins coordinately monoubiquitinate FANCD2, it is unclear why losses of individual classic FA genes yield varying cellular sensitivities to cross-linking damage. To address this question, we generated cellular knock-out models of FA core complex components and FANCD2 and found that FANCD2-null mutants display higher levels of spontaneous chromosomal damage and hypersensitivity to replication-blocking lesions than Fanconi anemia complementation group L (FANCL)-null mutants, suggesting that FANCD2 provides a basal level of DNA protection countering endogenous lesions in the absence of monoubiquitination. FANCD2's ubiquitination-independent function is likely involved in optimized recruitment of nucleolytic activities for the processing and protection of stressed replication forks. Our results reveal that FANCD2 has a ubiquitination-independent role in countering endogenous levels of replication stress, a function that is critical for the maintenance of genomic stability.	[Tian, Yanyan; Shen, Xi; Wang, Rui; Klages-Mundt, Naeh L.; Lynn, Erica J.; Martin, Sara K.; Ye, Yin; Gao, Min; Chen, Junjie; Li, Lei] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Schlacher, Katharina] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Klages-Mundt, Naeh L.; Martin, Sara K.; Chen, Junjie; Li, Lei] Univ Texas MD Anderson Canc Ctr, Program Genet & Epigenet, Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Schlacher, Katharina] Univ Texas MD Anderson Canc Ctr, Program Canc Biol, Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Li, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Unit 1052, 6565 MD Anderson Blvd, Houston, TX 77030 USA.	leili@mdanderson.org		SCHLACHER, KATHARINA/0000-0001-7226-6391; Martin, Sara/0000-0002-7661-272X; Klages-Mundt, Naeh/0000-0001-8240-6589; /0000-0002-5592-9349	National Institutes of Health [CA179441, CA190635, CA193124-Project 3, CA157448]; Cancer Prevention and Research Institute of Texas Grant [RP150538]; Olive Stringer endowed professorship; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE [R01CA157448, P01CA193124, P30CA016672, R01CA190635, R21CA179441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Olive Stringer endowed professorship; Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA179441 and CA190635 and CA193124-Project 3 (to L. L.) and CA157448 (to J. C.), Cancer Prevention and Research Institute of Texas Grant RP150538 (to J. C. and L. L.), the Olive Stringer endowed professorship (to L. L.), and a recruitment award from the Cancer Prevention and Research Institute of Texas (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali AM, 2012, BLOOD, V119, P3285, DOI 10.1182/blood-2011-10-385963; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Collis SJ, 2006, DNA REPAIR, V5, P1398, DOI 10.1016/j.dnarep.2006.06.010; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; Feeney L, 2017, MOL CELL, V66, P610, DOI 10.1016/j.molcel.2017.04.021; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; GERMAN J, 1987, BLOOD, V69, P1637; Hira A, 2015, AM J HUM GENET, V96, P1001, DOI 10.1016/j.ajhg.2015.04.022; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Inano S, 2017, MOL CELL, V66, P622, DOI 10.1016/j.molcel.2017.04.022; Kais Z, 2016, CELL REP, V15, P2488, DOI 10.1016/j.celrep.2016.05.031; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Karanja KK, 2014, CELL CYCLE, V13, P1540, DOI 10.4161/cc.28476; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Lachaud C, 2016, SCIENCE, V351, P846, DOI 10.1126/science.aad5634; Leung JWC, 2012, P NATL ACAD SCI USA, V109, P4491, DOI 10.1073/pnas.1118720109; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Liang CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12124; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; POLL EHA, 1985, HUM GENET, V71, P206, DOI 10.1007/BF00284574; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Rickman KA, 2015, CELL REP, V12, P35, DOI 10.1016/j.celrep.2015.06.014; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Thongthip S, 2016, GENE DEV, V30, P645, DOI 10.1101/gad.276261.115; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Unno J, 2014, CELL REP, V7, P1039, DOI 10.1016/j.celrep.2014.04.005; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang AT, 2015, MOL CELL, V59, P478, DOI 10.1016/j.molcel.2015.07.009; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yan ZJ, 2012, MOL CELL, V47, P61, DOI 10.1016/j.molcel.2012.05.026; Yan ZJ, 2010, MOL CELL, V37, P865, DOI 10.1016/j.molcel.2010.01.039; Yeo JE, 2014, HUM MOL GENET, V23, P3695, DOI 10.1093/hmg/ddu078; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645	56	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20184	20195		10.1074/jbc.M117.814780	http://dx.doi.org/10.1074/jbc.M117.814780			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29021208	hybrid, Green Published			2022-12-28	WOS:000417696400023
J	McCarthy, MT; Moncayo, G; Hiron, TK; Jakobsen, NA; Valli, A; Soga, T; Adam, J; O'Callaghan, CA				McCarthy, Michael T.; Moncayo, Gerard; Hiron, Thomas K.; Jakobsen, Niels A.; Valli, Alessandro; Soga, Tomoyoshi; Adam, Julie; O'Callaghan, Christopher A.			Purine nucleotide metabolism regulates expression of the human immune ligand MICA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; NKG2D LIGANDS; NK CELLS; RECEPTOR; GLUCOSE; BLOCKADE; COSTIMULATION; CYTOTOXICITY; ACTIVATION; ENGAGEMENT	Expression of the cell-surface glycoprotein MHC class I poly-peptide-related sequence A (MICA) is induced in dangerous, abnormal, or "stressed" cells, including cancer cells, virus-infected cells, and rapidly proliferating cells. MICA is recognized by the activating immune cell receptor natural killer group 2D (NKG2D), providing a mechanism by which immune cells can identify and potentially eliminate pathological cells. Immune recognition through NKG2D is implicated in cancer, atherosclerosis, transplant rejection, and inflammatory diseases, such as rheumatoid arthritis. Despite the wide range of potential therapeutic applications of MICA manipulation, the factors that control MICA expression are unclear. Here we use metabolic interventions and metabolomic analyses to show that the transition from quiescent cellular metabolism to a "Warburg" or biosynthetic metabolic state induces MICA expression. Specifically, we show that glucose transport into the cell and active glycolytic metabolism are necessary to up-regulate MICA expression. Active purine synthesis is necessary to support this effect of glucose, and increases in purine nucleotide levels are sufficient to induce MICA expression. Metabolic induction of MICA expression directly influences NKG2D-dependent cytotoxicity by immune cells. These findings support a model of MICA regulation where by the purine metabolic activity of individual cells is reflected by cell-surface MICA expression and is the subject of surveillance by NKG2D receptor-expressing immune cells.	[McCarthy, Michael T.; Moncayo, Gerard; Hiron, Thomas K.; Jakobsen, Niels A.; Adam, Julie; O'Callaghan, Christopher A.] Univ Oxford, Nuffield Dept Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Valli, Alessandro; Adam, Julie] Nuffield Dept Med, Target Discovery Inst, Oxford OX3 7FZ, England; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Keio University	O'Callaghan, CA (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	chris.ocallaghan@ndm.ox.ac.uk		Hiron, Thomas/0000-0001-9062-8472; Adam, Julie/0000-0002-7980-7151; McCarthy, Michael/0000-0001-7148-7096; Jakobsen, Niels Asger/0000-0002-5776-5085	Medical Research Council Grants [G116/165, G0901998]; National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program; Novo Nordisk Foundation Grant [NNF15CC0018346]; Medical Research Council [G0901998, G116/165] Funding Source: researchfish; Novo Nordisk Fonden [NNF15SA0018346] Funding Source: researchfish; MRC [G0901998, G116/165] Funding Source: UKRI	Medical Research Council Grants(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program; Novo Nordisk Foundation Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grants G116/165 and G0901998, the National Institute for Health Research Oxford Comprehensive Biomedical Research Centre Program, and Novo Nordisk Foundation Grant NNF15CC0018346. The authors declare that they have no conflicts of interest with the contents of this article.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Andersson AK, 2011, ARTHRITIS RHEUM-US, V63, P2617, DOI 10.1002/art.30460; Andre P, 2004, EUR J IMMUNOL, V34, P961, DOI 10.1002/eji.200324705; Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cerboni C, 2007, BLOOD, V110, P606, DOI 10.1182/blood-2006-10-052720; Cerboni C, 2009, BLOOD, V113, P2955, DOI 10.1182/blood-2008-06-165944; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Eagle RA, 2006, HUM IMMUNOL, V67, P159, DOI 10.1016/j.humimm.2006.02.015; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freckmann Guido, 2007, J Diabetes Sci Technol, V1, P695; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hirschey MD, 2015, SEMIN CANCER BIOL, V35, pS129, DOI 10.1016/j.semcancer.2015.10.002; Ito Y, 2008, AM J PHYSIOL-GASTR L, V294, pG199, DOI 10.1152/ajpgi.00286.2007; Kim JY, 2006, EXP MOL MED, V38, P474, DOI 10.1038/emm.2006.56; Kloss M, 2008, J IMMUNOL, V181, P6711, DOI 10.4049/jimmunol.181.10.6711; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; LANDINI MP, 1984, J GEN VIROL, V65, P1229, DOI 10.1099/0022-1317-65-7-1229; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; McGilvray RW, 2009, CLIN CANCER RES, V15, P6993, DOI 10.1158/1078-0432.CCR-09-0991; Rajasekaran K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012635; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reinicke K, 2012, J CELL BIOCHEM, V113, P553, DOI 10.1002/jcb.23379; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Suarez-Alvarez B, 2009, AM J TRANSPLANT, V9, P251, DOI 10.1111/j.1600-6143.2008.02526.x; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Valli A, 2015, ONCOTARGET, V6, P1920, DOI 10.18632/oncotarget.3058; Vantourout P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007579; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yu YJ, 2011, TRENDS MICROBIOL, V19, P360, DOI 10.1016/j.tim.2011.04.002; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10	50	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3913	3924		10.1074/jbc.M117.809459	http://dx.doi.org/10.1074/jbc.M117.809459			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29279329	Green Published, hybrid			2022-12-28	WOS:000427587500006
J	Blanden, MJ; Suazo, KF; Hildebrandt, ER; Hardgrove, DS; Patel, M; Saunders, WP; Distefano, MD; Schmidt, WK; Hougland, JL				Blanden, Melanie J.; Suazo, Kiall F.; Hildebrandt, Emily R.; Hardgrove, Daniel S.; Patel, Meet; Saunders, William P.; Distefano, Mark D.; Schmidt, Walter K.; Hougland, James L.			Efficient farnesylation of an extended C-terminal C(x)(3)X sequence motif expands the scope of the prenylated proteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; CAAX MOTIF; A-FACTOR; MEMBRANE LOCALIZATION; CARBOXYL-METHYLATION; DIPHOSPHATE ANALOGS; LIPID MODIFICATIONS; FLUORESCENCE ASSAY; PROVIDE INSIGHTS	Protein prenylation is a post-translational modification that has been most commonly associated with enabling protein trafficking to and interaction with cellular membranes. In this process, an isoprenoid group is attached to a cysteine near the C terminus of a substrate protein by protein farnesyltransferase (FTase) or protein geranylgeranyltransferase type I or II (GGTase-I and GGTase-II). FTase and GGTase-I have long been proposed to specifically recognize a four-amino acid CAAX C-terminal sequence within their substrates. Surprisingly, genetic screening reveals that yeast FTase can modify sequences longer than the canonical CAAX sequence, specifically C(x)(3)X sequences with four amino acids downstream of the cysteine. Biochemical and cell-based studies using both peptide and protein substrates reveal that mammalian FTase orthologs can also prenylate C(x)(3)X sequences. As the search to identify physiologically relevant C(x)(3)X proteins begins, this new prenylation motif nearly doubles the number of proteins within the yeast and human proteomes that can be explored as potential FTase substrates. This work expands our understanding of prenylation's impact within the proteome, establishes the biologically relevant reactivity possible with this new motif, and opens new frontiers in determining the impact of non-canonically prenylated proteins on cell function.	[Blanden, Melanie J.; Hougland, James L.] Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA; [Suazo, Kiall F.; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Hildebrandt, Emily R.; Hardgrove, Daniel S.; Patel, Meet; Saunders, William P.; Schmidt, Walter K.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Syracuse University; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia	Hougland, JL (corresponding author), Syracuse Univ, Dept Chem, Syracuse, NY 13244 USA.	hougland@syr.edu		Suazo, Kiall Francis/0000-0002-0803-8332; Hougland, James/0000-0003-0444-1017; Distefano, Mark/0000-0002-2872-0259	National Institutes of Health [GM084152, GM117148]; Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship [P200A090277]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084152, R01GM117148] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM084152 (to M. D. D.) and GM117148 (to W. K. S.) and Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship P200A090277 (to M. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Quadan T, 2011, TRENDS MICROBIOL, V19, P573, DOI 10.1016/j.tim.2011.08.003; Alsina M, 2004, BLOOD, V103, P3271, DOI 10.1182/blood-2003-08-2764; Benetka W, 2006, MONATSH CHEM, V137, P1241, DOI 10.1007/s00706-006-0534-9; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Caplin BE, 1998, J BIOL CHEM, V273, P9472, DOI 10.1074/jbc.273.16.9472; CASEY PJ, 1995, SCIENCE, V268, P221, DOI 10.1126/science.7716512; CASEY PJ, 1994, CURR OPIN CELL BIOL, V6, P219, DOI 10.1016/0955-0674(94)90139-2; CASSIDY PB, 1995, METHOD ENZYMOL, V250, P30; CHAN RK, 1982, MOL CELL BIOL, V2, P11, DOI 10.1128/MCB.2.1.11; Chen P, 1997, J CELL BIOL, V136, P251, DOI 10.1083/jcb.136.2.251; Chen Z, 2000, J BIOL CHEM, V275, P41251, DOI 10.1074/jbc.M006687200; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; Cui GL, 2005, BIOCHEMISTRY-US, V44, P16513, DOI 10.1021/bi051020m; DeGraw AJ, 2010, CHEM BIOL DRUG DES, V76, P460, DOI 10.1111/j.1747-0285.2010.01037.x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; Feig LA, 2002, CURR BIOL, V12, pR259, DOI 10.1016/S0960-9822(02)00787-X; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Flynn SC, 2014, CHEMBIOCHEM, V15, P2205, DOI 10.1002/cbic.201402239; Ganesan L, 2015, J MEMBRANE BIOL, V248, P929, DOI 10.1007/s00232-015-9835-4; Gangopadhyay SA, 2014, BIOCHEMISTRY-US, V53, P434, DOI 10.1021/bi4011732; Guo Z, 2008, EMBO J, V27, P2444, DOI 10.1038/emboj.2008.164; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hartman HL, 2005, BIOCHEMISTRY-US, V44, P15314, DOI 10.1021/bi0509503; Hast MA, 2011, J BIOL CHEM, V286, P35149, DOI 10.1074/jbc.M111.250506; HEILMEYER LMG, 1992, P NATL ACAD SCI USA, V89, P9554, DOI 10.1073/pnas.89.20.9554; Hentschel A, 2016, PROTEOMICS, V16, P759, DOI 10.1002/pmic.201500353; Hildebrandt ER, 2016, ELIFE, V5, DOI 10.7554/eLife.15899; Hosokawa A, 2007, INT J PEPT RES THER, V13, P345, DOI 10.1007/s10989-007-9090-3; Hougland JL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404954; Hougland JL, 2010, J MOL BIOL, V395, P176, DOI 10.1016/j.jmb.2009.10.038; Hougland JL, 2009, BIOCHEMISTRY-US, V48, P1691, DOI 10.1021/bi801710g; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Jennings BC, 2016, BIOORG MED CHEM LETT, V26, P1333, DOI 10.1016/j.bmcl.2015.12.079; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; KHOSRAVIFAR R, 1992, J BIOL CHEM, V267, P24363; Kilpatrick EL, 2007, J BIOL CHEM, V282, P14038, DOI 10.1074/jbc.M701338200; Kim S, 2005, J BIOL CHEM, V280, P27481, DOI 10.1074/jbc.M414192200; KIMURA Y, 1995, SCIENCE, V268, P1362, DOI 10.1126/science.7761857; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Krishnankutty RK, 2009, YEAST, V26, P451, DOI 10.1002/yea.1678; Lamphear C. L., 2012, THESIS; Lane KT, 2006, J LIPID RES, V47, P681, DOI 10.1194/jlr.R600002-JLR200; Lau HY, 2017, ONCOGENE, V36, P3934, DOI 10.1038/onc.2016.508; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; London N, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002170; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Lu Z, 1998, J BIOL CHEM, V273, P5970, DOI 10.1074/jbc.273.10.5970; MARSHALL CJ, 1993, SCIENCE, V259, P1865, DOI 10.1126/science.8456312; Martin DDO, 2011, BIOCHIMIE, V93, P18, DOI 10.1016/j.biochi.2010.10.018; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2007, PLOS COMPUT BIOL, V3, P634, DOI 10.1371/journal.pcbi.0030066; MICHAELIS S, 1988, MOL CELL BIOL, V8, P1309, DOI 10.1128/MCB.8.3.1309; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Nadolski MJ, 2007, FEBS J, V274, P5202, DOI 10.1111/j.1742-4658.2007.06056.x; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Palsuledesai CC, 2016, ACS CHEM BIOL, V11, P2820, DOI 10.1021/acschembio.6b00421; PICKETT WC, 1995, ANAL BIOCHEM, V225, P60, DOI 10.1006/abio.1995.1108; Piispanen AE, 2011, EUKARYOT CELL, V10, P1473, DOI 10.1128/EC.05153-11; POMPLIANO DL, 1992, J AM CHEM SOC, V114, P7945, DOI 10.1021/ja00046a070; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rashidian M, 2013, J AM CHEM SOC, V135, P16388, DOI 10.1021/ja403813b; Rashidian M, 2012, J AM CHEM SOC, V134, P8455, DOI 10.1021/ja211308s; Rashidian M, 2010, CHEM COMMUN, V46, P8998, DOI 10.1039/c0cc03305g; Reid TS, 2004, BIOCHEMISTRY-US, V43, P6877, DOI 10.1021/bi049723b; Reid TS, 2004, J MOL BIOL, V343, P417, DOI 10.1016/j.jmb.2004.08.056; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Resh MD, 2013, CURR BIOL, V23, pR431, DOI 10.1016/j.cub.2013.04.024; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; SCHABER MD, 1990, J BIOL CHEM, V265, P14701; Schmidt WK, 2000, J BIOL CHEM, V275, P6227, DOI 10.1074/jbc.275.9.6227; Selvig K, 2013, EUKARYOT CELL, V12, P1462, DOI 10.1128/EC.00193-13; Shen F, 1996, J BIOL CHEM, V271, P3692; SIKORSKI RS, 1989, GENETICS, V122, P19; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Stirtan WG, 1997, BIOCHEMISTRY-US, V36, P4552, DOI 10.1021/bi962579c; Strickland CL, 1998, BIOCHEMISTRY-US, V37, P16601, DOI 10.1021/bi981197z; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suazo KF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38615; Subramanian T, 2012, BIOCHEMISTRY-US, V51, P8307, DOI 10.1021/bi3011362; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Turek-Etienne TC, 2003, BIOCHEMISTRY-US, V42, P3716, DOI 10.1021/bi0266838; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang YC, 2014, ACS CHEM BIOL, V9, P1726, DOI 10.1021/cb5002312; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; YOKOYAMA K, 1992, BIOCHEM SOC T, V20, P489, DOI 10.1042/bst0200489; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhang Y, 2015, BIOCONJUGATE CHEM, V26, P2542, DOI 10.1021/acs.bioconjchem.5b00553; Zhu Kuichun, 2003, Curr Opin Investig Drugs, V4, P1428; Zverina EA, 2012, CURR OPIN CHEM BIOL, V16, P544, DOI 10.1016/j.cbpa.2012.10.015	100	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2770	2785		10.1074/jbc.M117.805770	http://dx.doi.org/10.1074/jbc.M117.805770			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29282289	Green Published, hybrid			2022-12-28	WOS:000426051900013
J	Zhu, C; Ji, XY; Zhang, HT; Zhou, Q; Cao, XL; Tang, M; Si, Y; Yan, H; Li, L; Liang, TB; Feng, XH; Zhao, B				Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Li, Li; Liang, Tingbo; Feng, Xin-Hua; Zhao, Bin			Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anaphase-promoting complex; LATS2; USP9X; ubiquitination; deubiquitination; protein stability; tumor suppressor gene; signal transduction; Hippo pathway	ORGAN SIZE CONTROL; EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC DUCTAL ADENOCARCINOMA; PROTEIN-INTERACTION NETWORK; CELL-CYCLE EXIT; PROMOTES APOPTOSIS; SIGNALING PATHWAY; TEAD/TEF FAMILY; YAP ONCOPROTEIN; GROWTH-CONTROL	The Hippo pathway plays important roles in controlling organ size and in suppressing tumorigenesis through large tumor suppressor kinase 1/2 (LATS1/2)-mediated phosphorylation of YAP/TAZ transcription co-activators. The kinase activity of LATS1/2 is regulated by phosphorylation in response to extracellular signals. Moreover, LATS2 protein levels are repressed by the ubiquitin-proteasome system in conditions such as hypoxia. However, the mechanism that removes the ubiquitin modification from LATS2 and thereby stabilizes the protein is not well understood. Here, using tandem affinity purification (TAP), we found that anaphase-promoting complex/cyclosome (APC/C), a ubiquitin ligase complex, and USP9X, a deubiquitylase, specifically interact with LATS2. We also found that although APC1 co-localizes with LATS2 to intracellular vesicle structures, it does not regulate LATS2 protein levels and activity. In contrast, USP9X ablation drastically diminished LATS2 protein levels. We further demonstrated that USP9X deubiquitinates LATS2 and thus prevents LATS2 degradation by the proteasome. Furthermore, in pancreatic cancer cells, USP9X loss activated YAP and enhanced the oncogenic potential of the cells. In addition, the tumorigenesis induced by the USP9X ablation depended not only on LATS2 repression, but also on YAP/TAZ activity. We conclude that USP9X is a deubiquitylase of the Hippo pathway kinase LATS2 and that the Hippo pathway functions as a downstream signaling cascade that mediates USP9X's tumor-suppressive activity.	[Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Feng, Xin-Hua; Zhao, Bin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhu, Chu; Ji, Xinyan; Zhang, Haitao; Zhou, Qi; Cao, Xiaolei; Tang, Mei; Si, Yuan; Yan, Huan; Feng, Xin-Hua; Zhao, Bin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310058, Zhejiang, Peoples R China; [Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Canc Prevent & Intervent, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Li] Hangzhou Normal Univ, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Hangzhou Normal University	Zhao, B (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Zhao, B (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	binzhao@zju.edu.cn		, Huan/0000-0003-3370-0479	National Key R&D Program of China [2017YFA0504502]; National Natural Science Foundation of China Key Project [81730069]; Excellent Young Scholars Project [31422036]; General Project [31471316]; International Collaboration Project [31661130150]; 111 Project [B13026]; Qianjiang Scholar Plan of Hangzhou; Thousand Young Talents Plan of China; Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship; Academy of Medical Sciences (AMS) [NAF003\\1004] Funding Source: researchfish	National Key R&D Program of China; National Natural Science Foundation of China Key Project(National Natural Science Foundation of China (NSFC)); Excellent Young Scholars Project; General Project; International Collaboration Project; 111 Project(Ministry of Education, China - 111 Project); Qianjiang Scholar Plan of Hangzhou; Thousand Young Talents Plan of China; Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This work was supported by National Key R&D Program of China Grant 2017YFA0504502, National Natural Science Foundation of China Key Project Grant 81730069, Excellent Young Scholars Project Grant 31422036, General Project Grant 31471316, International Collaboration Project Grant 31661130150, 111 Project Grant B13026, the Qianjiang Scholar Plan of Hangzhou, the Thousand Young Talents Plan of China, and the Academy of Medical Sciences (United Kingdom) Newton Advanced Fellowship (to B. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Aylon Y, 2009, ONCOGENE, V28, P4469, DOI 10.1038/onc.2009.270; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bae SJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7314; Bothos J, 2005, CANCER RES, V65, P6568, DOI 10.1158/0008-5472.CAN-05-0862; Chen Q, 2015, GENE DEV, V29, P1285, DOI 10.1101/gad.264234.115; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Dai XM, 2015, CELL RES, V25, P1175, DOI 10.1038/cr.2015.101; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Guo XC, 2017, GENE DEV, V31, P247, DOI 10.1101/gad.294348.116; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Ho KC, 2011, P NATL ACAD SCI USA, V108, P4870, DOI 10.1073/pnas.1101273108; Nguyen HT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.1; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Q, 2014, DEV CELL, V31, P291, DOI 10.1016/j.devcel.2014.09.012; Li SX, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.38; Li W, 2014, CANCER CELL, V26, P48, DOI 10.1016/j.ccr.2014.05.001; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Masuda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118662; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murtaza M, 2015, CELL MOL LIFE SCI, V72, P2075, DOI 10.1007/s00018-015-1851-0; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Sackton KL, 2014, NATURE, V514, P646, DOI 10.1038/nature13660; Salah Z, 2013, CELL CYCLE, V12, P3817, DOI 10.4161/cc.26672; Salah Z, 2011, CANCER RES, V71, P2010, DOI 10.1158/0008-5472.CAN-10-3516; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Si Y, 2017, CANCER RES, V77, P4868, DOI 10.1158/0008-5472.CAN-17-0391; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Toloczko A, 2017, CANCER RES, V77, P4921, DOI 10.1158/0008-5472.CAN-16-3413; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yeung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061027; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110	64	31	32	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1178	1191		10.1074/jbc.RA117.000392	http://dx.doi.org/10.1074/jbc.RA117.000392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29183995	hybrid, Green Published			2022-12-28	WOS:000423515000007
J	Aghdassi, AA; John, DS; Sendler, M; Weiss, FU; Reinheckel, T; Mayerle, J; Lerch, MM				Aghdassi, Ali A.; John, Daniel S.; Sendler, Matthias; Weiss, F. Ulrich; Reinheckel, Thomas; Mayerle, Julia; Lerch, Markus M.			Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATIONIC TRYPSINOGEN GENE; ACINAR-CELLS; HEREDITARY PANCREATITIS; PROTEASE ACTIVATION; ASPARTIC PROTEASE; PROCATHEPSIN-B; MICE; APOPTOSIS; DEGRADATION; CANCER	Acute pancreatitis is a complex disorder involving both premature intracellular protease activation and inflammatory cell invasion. An initiating event is the intracellular activation of trypsinogen by cathepsin B (CTSB), which can be induced directly via G protein-coupled receptors on acinar cells or through inflammatory cells. Here, we studied CTSB regulation by another lysosomal hydrolase, cathepsin D (CTSD), using mice with a complete (CTSD-/-) or pancreas-specific conditional CTSD knockout (KO) (CTSD(f/f/)p48(Cre/+)). We induced acute pancreatitis by repeated caerulein injections and isolated acinar and bone marrow cells for ex vivo studies. Supramaximal caerulein stimulation induced subcellular redistribution of CTSD from the lysosomal to the zymogen-containing subcellular compartment of acinar cells and activation of CTSD, CTSB, and trypsinogen. Of note, the CTSD KO greatly reduced CTSB and trypsinogen activation in acinar cells, and CTSD directly activated CTSB but not trypsinogen in vitro. During pancreatitis in pancreas-specific CTSD(f/f/)p48(Cre/+) animals, markers of severity were reduced only at 1 h, whereas in the complete KO, this effect also included the late disease phase (8 h), indicating an important effect of extra-acinar CTSD on course of the disease. CTSD-/- leukocytes exhibited reduced cytokine release after lipopolysaccharide (LPS) stimulation, and CTSD KO also reduced caspase-3 activation and apoptosis in acinar cells stimulated with the intestinal hormone cholecystokinin. In summary, CTSD is expressed in pancreatic acinar and inflammatory cells, undergoes subcellular redistribution and activation during experimental pancreatitis, and regulates disease severity by potently activating CTSB. Its impact is only minimal and transient in the early, acinar cell-dependent phase of pancreatitis and much greater in the later, inflammatory cell-dependent phase of the disease.	[Aghdassi, Ali A.; John, Daniel S.; Sendler, Matthias; Weiss, F. Ulrich; Mayerle, Julia; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, D-17475 Greifswald, Germany; [Reinheckel, Thomas] Albert Ludwigs Univ Freiburg, Med Fac, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Mayerle, Julia] Ludwigs Maximilians Univ Munich, Dept Med 2, D-80539 Munich, Germany	Greifswald Medical School; University of Freiburg; University of Munich	Aghdassi, AA (corresponding author), Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	aghdassi@uni-greifswald.de	Mayerle, Julia/W-7907-2019; Aghdassi, Ali/X-5836-2019; Sendler, Matthias/V-9341-2017; Reinheckel, Thomas/AAL-9761-2021; Lerch, Markus M./E-2206-2016	Reinheckel, Thomas/0000-0001-9866-9105; Lerch, Markus M./0000-0002-9643-8263; Mayerle, Julia/0000-0002-3666-6459; Weiss, Frank Ulrich/0000-0003-3369-6369; Aghdassi, Ali/0000-0002-0569-7316; Sendler, Matthias/0000-0003-3554-9426; Sendler, Matthias/0000-0001-6494-4105	Deutsche Forschungsgemeinschaft [DFG AG 203/2-1]; DFG [GRK1947]; PePPP Project - European Union [ESF/14-BM-A55-0045/16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); PePPP Project - European Union	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG AG 203/2-1 (to A. A. A.) with additional support from DFG GRK1947(A3) and the PePPP Project Grant ESF/14-BM-A55-0045/16 funded by the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Aghdassi AA, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-26; Balaji KN, 2002, J EXP MED, V196, P493, DOI 10.1084/jem.20011836; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Conner G. E, 2002, HDB PROTEOLYTIC ENZY, P746; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; Fusek Martin, 2005, Biomedical Papers (Olomouc), V149, P43; GREENBAUM LM, 1959, J BIOL CHEM, V234, P2885; Haendeler J, 2005, J BIOL CHEM, V280, P42945, DOI 10.1074/jbc.M506985200; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; KAWABATA T, 1993, J BIOCHEM-TOKYO, V113, P389, DOI 10.1093/oxfordjournals.jbchem.a124056; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Keim V, 2001, AM J MED, V111, P622, DOI 10.1016/S0002-9343(01)00958-5; Kern U, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0313-5; Ketscher A, 2016, BIOCHIMIE, V122, P219, DOI 10.1016/j.biochi.2015.07.020; Ketterer S, 2017, FEBS J, V284, P1437, DOI 10.1111/febs.13980; Kirschke H, 1985, Prog Clin Biol Res, V180, P61; KOIKE H, 1982, AM J PHYSIOL, V242, pG297, DOI 10.1152/ajpgi.1982.242.4.G297; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Laurent-Matha V, 2006, J BIOCHEM, V139, P363, DOI 10.1093/jb/mvj037; Lerch MM, 1997, GASTROENTEROLOGY, V113, P1355, DOI 10.1053/gast.1997.v113.pm9322531; LERCH MM, 1993, GASTROENTEROLOGY, V104, P1768, DOI 10.1016/0016-5085(93)90658-Y; LERCH MM, 1995, J CLIN INVEST, V95, P2222, DOI 10.1172/JCI117912; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Mehanna S, 2016, BIOCHEM BIOPH RES CO, V469, P405, DOI 10.1016/j.bbrc.2015.12.002; Meister T, 2010, J PHYSIOL PHARMACOL, V61, P565; Menzel K, 2006, CLIN EXP IMMUNOL, V146, P169, DOI 10.1111/j.1365-2249.2006.03188.x; Mooren FC, 2001, FASEB J, V15, P659, DOI 10.1096/fj.00-0172com; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Polajnar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102500; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Sah RP, 2013, GASTROENTEROLOGY, V144, P1076, DOI 10.1053/j.gastro.2013.01.041; Saluja AK, 1997, GASTROENTEROLOGY, V113, P304, DOI 10.1016/S0016-5085(97)70108-2; Schaschke N, 2000, FEBS LETT, V482, P91, DOI 10.1016/S0014-5793(00)02047-0; SCHMIDT J, 1992, GASTROENTEROLOGY, V103, P1009, DOI 10.1016/0016-5085(92)90036-X; Schwaiger T, 2014, GUT, V63, P494, DOI 10.1136/gutjnl-2012-303635; Sendler M, 2016, J BIOL CHEM, V291, P14717, DOI 10.1074/jbc.M116.718999; Sendler M, 2013, GUT, V62, P430, DOI 10.1136/gutjnl-2011-300771; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; Talukdar R, 2016, GASTROENTEROLOGY, V151, P747, DOI 10.1053/j.gastro.2016.06.042; Van Acker GJD, 2002, AM J PHYSIOL-GASTR L, V283, pG794, DOI 10.1152/ajpgi.00363.2001; vanderStappen JWJ, 1996, INT J CANCER, V67, P547, DOI 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4; Wartmann T, 2010, GASTROENTEROLOGY, V138, P726, DOI 10.1053/j.gastro.2009.10.048; WATANABE O, 1984, AM J PHYSIOL, V246, pG457, DOI 10.1152/ajpgi.1984.246.4.G457; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Wu GS, 1998, ONCOGENE, V16, P2177, DOI 10.1038/sj.onc.1201755; Zaidi N, 2008, BIOCHEM BIOPH RES CO, V376, P5, DOI 10.1016/j.bbrc.2008.08.099; Zheng X, 2008, BBA-MOL CELL RES, V1783, P2294, DOI 10.1016/j.bbamcr.2008.07.027; Zhou W, 2006, NEUROSCIENCE, V143, P689, DOI 10.1016/j.neuroscience.2006.08.019	61	31	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1018	1029		10.1074/jbc.M117.814772	http://dx.doi.org/10.1074/jbc.M117.814772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29229780	Green Published, hybrid			2022-12-28	WOS:000422864500022
J	Countryman, P; Fan, YL; Gorthi, A; Pan, H; Strickland, J; Kaur, P; Wang, XC; Lin, JG; Lei, XY; White, C; You, CJ; Wirth, N; Tessmer, I; Piehler, J; Riehn, R; Bishop, AJR; Tao, YJ; Wang, H				Countryman, Preston; Fan, Yanlin; Gorthi, Aparna; Pan, Hai; Strickland, Jack; Kaur, Parminder; Wang, Xuechun; Lin, Jiangguo; Lei, Xiaoying; White, Christian; You, Changjiang; Wirth, Nicolas; Tessmer, Ingrid; Piehler, Jacob; Riehn, Robert; Bishop, Alexander J. R.; Tao, Yizhi Jane; Wang, Hong			Cohesin SA2 is a sequence-independent DNA-binding protein that recognizes DNA replication and repair intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; STRAND-BREAK REPAIR; ATOMIC-FORCE MICROSCOPY; ONE-DIMENSIONAL DIFFUSION; HOMOLOGY-DIRECTED REPAIR; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TELOMERIC DNA; QUANTUM-DOT; COMPLEX	Proper chromosome alignment and segregation during mitosis depend on cohesion between sister chromatids, mediated by the cohesin protein complex, which also plays crucial roles in diverse genome maintenance pathways. Current models attribute DNA binding by cohesin to entrapment of dsDNA by the cohesin ring subunits (SMC1, SMC3, and RAD21 in humans). However, the biophysical properties and activities of the fourth core cohesin subunit SA2 (STAG2) are largely unknown. Here, using single-molecule atomic force and fluorescence microscopy imaging as well as fluorescence anisotropy measurements, we established that SA2 binds to both dsDNA and ssDNA, albeit with a higher binding affinity for ssDNA. We observed that SA2 can switch between the 1D diffusing (search) mode on dsDNA and stable binding (recognition) mode at ssDNA gaps. Although SA2 does not specifically bind to centromeric or telomeric sequences, it does recognize DNA structures often associated with DNA replication and double-strand break repair, such as a double-stranded end, single-stranded overhang, flap, fork, and ssDNA gap. SA2 loss leads to a defect in homologous recombination-mediated DNA double-strand break repair. These results suggest that SA2 functions at intermediate DNA structures during DNA transactions in genome maintenance pathways. These findings have important implications for understanding the function of cohesin in these pathways.	[Countryman, Preston; Pan, Hai; Strickland, Jack; Kaur, Parminder; Lin, Jiangguo; White, Christian; Riehn, Robert; Wang, Hong] North Carolina State Univ, Phys Dept, Riddick Hall 421,2401 Stinson Dr, Raleigh, NC 27695 USA; [Wang, Xuechun] North Carolina State Univ, Biomed Engn Dept, Raleigh, NC 27695 USA; [Wang, Hong] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Fan, Yanlin; Lei, Xiaoying; Tao, Yizhi Jane] Rice Univ, Dept BioSci, Houston, TX 77251 USA; [Gorthi, Aparna; Bishop, Alexander J. R.] Univ Texas Hlth, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Gorthi, Aparna; Bishop, Alexander J. R.] Univ Texas Hlth, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Lin, Jiangguo] South China Univ Technol, Sch Biosci & Bioengn, Inst Biomech, Guangzhou 510006, Guangdong, Peoples R China; [Lei, Xiaoying] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China; [You, Changjiang; Piehler, Jacob] Univ Osnabruck, Div Biophys, Barbarstr 11, D-49076 Osnabruck, Germany; [Wirth, Nicolas; Tessmer, Ingrid] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Rice University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; South China University of Technology; Shandong University; University Osnabruck; University of Wurzburg	Wang, H (corresponding author), North Carolina State Univ, Phys Dept, Riddick Hall 421,2401 Stinson Dr, Raleigh, NC 27695 USA.	hong_wang@ncsu.edu	Wang, Hong/F-3164-2014; You, Changjiang/L-3901-2014; Riehn, Robert/A-7195-2011; You, Changjiang/AFK-2816-2022; Tessmer, Ingrid/O-2810-2013	Wang, Hong/0000-0003-0165-3559; You, Changjiang/0000-0002-7839-6397; Riehn, Robert/0000-0002-4408-3560; You, Changjiang/0000-0002-7839-6397; Tessmer, Ingrid/0000-0002-8353-6315; kaur, Parminder/0000-0001-9183-4315; Bishop, Alexander/0000-0002-5742-4387; Gorthi, Aparna/0000-0001-5935-4098; Pan, Hai/0000-0001-6660-9052; Wirth, Nicolas Thilo/0000-0003-0799-1321	National Institutes of Health [ES027641, R01GM107559, K22ES012264, 1R15ES019128, 1R01CA152063, NCI T32 CA 148724, P30 ES025128, R01-GM107559]; Voelcker Fund Young Investigator Award; CPRIT [RP150445]; Deutsche Forschungsgemeinschaft [Forschungszentrum FZ82]; Welch Foundation [C-1565]; NATIONAL CANCER INSTITUTE [T32CA148724, R01CA152063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES019128, P30ES025128, R21ES027641, K22ES012264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Voelcker Fund Young Investigator Award; CPRIT; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants ES027641 (to H.W.), R01GM107559 (to H.W. and R.R.), K22ES012264, 1R15ES019128, and 1R01CA152063 (to A.J.R.B.), NCI T32 CA 148724 (to A.G.), and P30 ES025128 (through a pilot project grant to H.W. by the Center for Human Health and the Environment (CHHE) at North Carolina State University); a Voelcker Fund Young Investigator Award and CPRIT Grant RP150445 (to A.J.R.B.); Deutsche Forschungsgemeinschaft Forschungszentrum FZ82 (to I.T.); and Welch Foundation Grant C-1565 (to Y.J.T.). This work was also supported by National Institutes of Health Grant R01-GM107559. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atienza JM, 2005, MOL CANCER THER, V4, P361; Balakrishnan L, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010173; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; Bisht KK, 2013, J CELL SCI, V126, P3493, DOI 10.1242/jcs.130872; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Buechner CN, 2013, J MOL RECOGNIT, V26, P605, DOI 10.1002/jmr.2311; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Carramolino L, 1997, GENE, V195, P151, DOI 10.1016/S0378-1119(97)00121-2; Carretero M, 2013, EMBO J, V32, P2938, DOI 10.1038/emboj.2013.230; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cuadrado A, 2012, CELL CYCLE, V11, P2233, DOI 10.4161/cc.20318; Fuentes-Perez ME, 2013, METHODS, V60, P113, DOI 10.1016/j.ymeth.2013.02.005; Gelot C, 2016, MOL CELL, V61, P15, DOI 10.1016/j.molcel.2015.11.002; Geng H, 2011, ANAL BIOCHEM, V413, P179, DOI 10.1016/j.ab.2011.02.017; Ghodke H, 2014, P NATL ACAD SCI USA, V111, pE1862, DOI 10.1073/pnas.1323856111; Gorman J, 2008, NAT STRUCT MOL BIOL, V15, P768, DOI 10.1038/nsmb.1441; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hara K, 2014, NAT STRUCT MOL BIOL, V21, P864, DOI 10.1038/nsmb.2880; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Hirano M, 2006, MOL CELL, V21, P175, DOI 10.1016/j.molcel.2005.11.026; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; Iakoucheva LM, 2002, BIOCHEMISTRY-US, V41, P131, DOI 10.1021/bi011041q; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kaur P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20513; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10200; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Kong XD, 2014, MOL CELL BIOL, V34, P685, DOI 10.1128/MCB.01503-13; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Lee OC, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021906; Leith JS, 2012, P NATL ACAD SCI USA, V109, P16552, DOI 10.1073/pnas.1120452109; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lin JG, 2016, NUCLEIC ACIDS RES, V44, P6363, DOI 10.1093/nar/gkw518; Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nelson SR, 2014, P NATL ACAD SCI USA, V111, pE2091, DOI 10.1073/pnas.1400386111; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Piazza I, 2014, NAT STRUCT MOL BIOL, V21, P560, DOI 10.1038/nsmb.2831; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Remeseiro S, 2012, EMBO J, V31, P2090, DOI 10.1038/emboj.2012.60; Roig MB, 2014, FEBS LETT, V588, P3692, DOI 10.1016/j.febslet.2014.08.015; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Rudra S, 2012, CELL CYCLE, V11, P2114, DOI 10.4161/cc.20547; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schar P, 2004, NUCLEIC ACIDS RES, V32, P3921, DOI 10.1093/nar/gkh716; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 2015, CURR BIOL, V25, pR108, DOI 10.1016/j.cub.2014.12.015; Skibbens RV, 2011, TRENDS GENET, V27, P499, DOI 10.1016/j.tig.2011.08.004; Skibbens RV, 2010, TRENDS CELL BIOL, V20, P507, DOI 10.1016/j.tcb.2010.06.003; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Stigler J, 2016, CELL REP, V15, P988, DOI 10.1016/j.celrep.2016.04.003; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Tittel-Elmer M, 2012, MOL CELL, V48, P98, DOI 10.1016/j.molcel.2012.07.004; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; van der Lehr P, 2017, ELIFE, V6, DOI 10.7554/eLife.26980; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wang H, 2008, NANO LETT, V8, P1631, DOI 10.1021/nl080316l; Watrin E, 2016, CURR OPIN GENET DEV, V37, P59, DOI 10.1016/j.gde.2015.12.004; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Yang Y, 2005, NUCLEIC ACIDS RES, V33, P4322, DOI 10.1093/nar/gki708; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Zabrady K, 2016, NUCLEIC ACIDS RES, V44, P1064, DOI 10.1093/nar/gkv1021; Zakari M, 2015, WIRES DEV BIOL, V4, P489, DOI 10.1002/wdev.190; Zhang NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069458; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	91	24	24	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1054	1069		10.1074/jbc.M117.806406	http://dx.doi.org/10.1074/jbc.M117.806406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29175904	Green Published, hybrid			2022-12-28	WOS:000422864500025
J	Folci, A; Steinberger, A; Lee, B; Stanika, R; Scheruebel, S; Campiglio, M; Ramprecht, C; Pelzmann, B; Hell, JW; Obermair, GJ; Heine, M; Di Biase, V				Folci, Alessandra; Steinberger, Angela; Lee, Boram; Stanika, Ruslan; Scheruebel, Susanne; Campiglio, Marta; Ramprecht, Claudia; Pelzmann, Brigitte; Hell, Johannes W.; Obermair, Gerald J.; Heine, Martin; Di Biase, Valentina			Molecular mimicking of C-terminal phosphorylation tunes the surface dynamics of Ca(V)1.2 calcium channels in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CA2+ CHANNEL; RECEPTOR; LOCALIZATION; TRAFFICKING; CAV1.2; AKAP79/150; EXPRESSION; PLASTICITY; SUBUNITS	L-type voltage-gated Ca(V)1.2 calcium channels (CaV1.2) are key regulators of neuronal excitability, synaptic plasticity, and excitation-transcription coupling. Surface-exposed Ca(V)1.2 distributes in clusters along the dendrites of hippocampal neurons. A permanent exchange between stably clustered and laterally diffusive extra-clustered channels maintains steady-state levels of Ca(V)1.2 at dendritic signaling domains. A dynamic equilibrium between anchored and diffusive receptors is a common feature among ion channels and is crucial to modulate signaling transduction. Despite the importance of this fine regulatory system, the molecular mechanisms underlying the surface dynamics of Ca(V)1.2 are completely unexplored. Here, we examined the dynamic states of Ca(V)1.2 depending on phosphorylation on Ser1700 and Ser-1928 at the channel C terminus. Phosphorylation at these sites is strongly involved in Ca(V)1.2-mediated nuclear factor of activated T cells (NFAT) signaling, long-term potentiation, and responsiveness to adrenergic stimulation. We engineered Ca(V)1.2 constructs mimicking phosphorylation at Ser-1700 and Ser-1928 and analyzed their behavior at the membrane by immunolabeling protocols, fluorescence recovery after photobleaching, and single particle tracking. We found that the phosphomimetic S1928E variant increases the mobility of Ca(V)1.2 without altering the steady-state maintenance of cluster in young neurons and favors channel stabilization later in differentiation. Instead, mimicking phosphorylation at Ser1700 promoted the diffusive state of Ca(V)1.2 irrespective of the differentiation stage. Together, these results reveal that phos-phorylation could contribute to the establishment of channel anchoring mechanisms depending on the neuronal differentiation state. Finally, our findings suggest a novel mechanism by which phosphorylation at the C terminus regulates calcium signaling by tuning the content of Ca(V)1.2 at signaling complexes.	[Folci, Alessandra; Steinberger, Angela; Scheruebel, Susanne; Ramprecht, Claudia; Pelzmann, Brigitte; Di Biase, Valentina] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria; [Lee, Boram; Hell, Johannes W.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Stanika, Ruslan; Campiglio, Marta; Obermair, Gerald J.] Med Univ Innsbruck, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Heine, Martin] Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany	Medical University of Graz; University of California System; University of California Davis; Medical University of Innsbruck; Leibniz Institut fur Neurobiologie (LIN)	Di Biase, V (corresponding author), Harrachgasse 21, A-8010 Graz, Austria.	valentina.di-biase@medunigraz.at	, Gerald/AAD-3183-2020; Di Biase, Valentina/AAE-9529-2022; Folci, Alessandra/ABF-8954-2021; Di Biase, Valentina/T-3714-2017; Di Biase, Valentina/AFE-2569-2022; Folci, Alessandra/AAB-7843-2019; Di Biase, Valentina/AFT-6986-2022; Hell, Johannes W./P-5085-2019	Di Biase, Valentina/0000-0002-3292-6516; Di Biase, Valentina/0000-0002-3292-6516; Folci, Alessandra/0000-0002-8158-118X; Di Biase, Valentina/0000-0002-3292-6516; Campiglio, Marta/0000-0002-9629-2073; Stanika, Ruslan/0000-0002-7651-3131; Hell, Johannes W/0000-0001-7960-7531; Scheruebel, Susanne/0000-0001-8887-2097	Austrian Science Fund (FWF) [P25085, P24079, F44150]; Austrian National Bank [16435]; National Institutes of Health Grants [R01NS078792, R01AG055357]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG055357] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian National Bank; National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Austrian Science Fund (FWF) Grants P25085 (to V.D.B.), P24079 and F44150 (to G.J.O.), Austrian National Bank (Anniversary Fund) Grant 16435 (to B.P.), and National Institutes of Health Grants R01NS078792 and R01AG055357 (to J.W.H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; Altier C, 2011, NAT NEUROSCI, V14, P173, DOI 10.1038/nn.2712; Altier C, 2012, CHANNELS, V6, P157, DOI 10.4161/chan.20865; Bard L, 2010, P NATL ACAD SCI USA, V107, P19561, DOI 10.1073/pnas.1002690107; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Carta M, 2013, EMBO J, V32, P496, DOI 10.1038/emboj.2012.334; Chameu P, 1999, NEUROSCIENCE, V90, P383, DOI 10.1016/S0306-4522(98)00457-6; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Di Biase V, 2011, J NEUROSCI, V31, P13682, DOI 10.1523/JNEUROSCI.2300-11.2011; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Dionisio N, 2015, BBA-MOL CELL RES, V1853, P1145, DOI 10.1016/j.bbamcr.2015.02.014; Dupuis JP, 2014, EMBO J, V33, P842, DOI 10.1002/embj.201386356; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Green EM, 2007, NEURON, V55, P615, DOI 10.1016/j.neuron.2007.07.024; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hall DD, 2013, NEURON, V78, P483, DOI 10.1016/j.neuron.2013.02.032; Hell JW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3141pe33; HELL JW, 1995, EMBO J, V14, P3036, DOI 10.1002/j.1460-2075.1995.tb07306.x; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Huang G, 2007, J BIOL CHEM, V282, P14283, DOI 10.1074/jbc.M611529200; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Kabir ZD, 2016, J PHYSIOL-LONDON, V594, P5823, DOI 10.1113/JP270673; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lyu LT, 2017, J PHARMACOL SCI, V133, P240, DOI 10.1016/j.jphs.2017.03.002; Marshall MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175257; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Mitterdorfer J, 1996, J BIOL CHEM, V271, P30330, DOI 10.1074/jbc.271.48.30330; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Nystoriak MA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf9647; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oz S, 2017, J PHYSIOL-LONDON, V595, P3181, DOI 10.1113/JP274015; Patriarchi T, 2016, EMBO J, V35, P1330, DOI 10.15252/embj.201593409; Peixoto RT, 2012, NEURON, V76, P396, DOI 10.1016/j.neuron.2012.07.006; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; Qian H, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf9659; Rao A, 1998, J NEUROSCI, V18, P1217; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Schneider R, 2015, NEURON, V86, P672, DOI 10.1016/j.neuron.2015.03.050; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Stanika R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34528; van der Kooij MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5995; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Weick JP, 2003, J NEUROSCI, V23, P3446; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654	59	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1040	1053		10.1074/jbc.M117.799585	http://dx.doi.org/10.1074/jbc.M117.799585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180451	Green Published, hybrid			2022-12-28	WOS:000422864500024
J	Bowden, CFM; Chan, ACK; Li, EJW; Arrieta, AL; Eltis, LD; Murphy, MEP				Bowden, Catherine F. M.; Chan, Anson C. K.; Li, Emily J. W.; Arrieta, Angele L.; Eltis, Lindsay D.; Murphy, Michael E. P.			Structure-function analyses reveal key features in Staphylococcus aureus IsdB-associated unfolding of the heme-binding pocket of human hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HAPTOGLOBIN; SURFACE PROTEIN; NEAT DOMAIN; IRON; RECEPTOR; DETERMINANTS; COMPLEX; SYSTEM; IDENTIFICATION; OXYHEMOGLOBIN	IsdB is a receptor on the surface of the bacterial pathogen Staphylococcus aureus that extracts heme from hemoglobin (Hb) to enable growth on Hb as a sole iron source. IsdB is critically important both for in vitro growth on Hb and in infection models and is also highly up-regulated in blood, serum, and tissue infection models, indicating a key role of this receptor in bacterial virulence. However, structural information for IsdB is limited. We present here a crystal structure of a complex between human Hb and IsdB. In this complex, the alpha subunits of Hb are refolded with the heme displaced to the interface with IsdB. We also observe that atypical residues of Hb, His58 and His89 of alpha Hb, coordinate to the heme iron, which is poised for transfer into the heme-binding pocket of IsdB. Moreover, the porphyrin ring interacts with IsdB residues Tyr440 and Tyr444. Previously, Tyr440 was observed to coordinate heme iron in an IsdB.heme complex structure. A Y440F/ Y444F IsdB variant we produced was defective in hemetransferyetformedastablecomplexwithHb(K-d = 6 +/- 2 mu M) in solution with spectroscopic features of the bis-His species observed in the crystal structure. Haptoglobin binds to a distinct site onHbto inhibit heme transfer to IsdB and growth of S. aureus, and a ternary complex of IsdB.Hb.Hp was observed. We propose a model for IsdB heme transfer from Hb that involves unfolding of Hb and heme iron ligand exchange.	[Bowden, Catherine F. M.; Chan, Anson C. K.; Li, Emily J. W.; Arrieta, Angele L.; Eltis, Lindsay D.; Murphy, Michael E. P.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Murphy, MEP (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca		Chan, Anson/0000-0001-6625-8942	Canadian Institutes of Health Research [MOP-49597]; Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship; Canada Foundation for Innovation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Canadian Institutes of Health Research Grant MOP-49597 (to M. E. P. M.) and a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship - Doctoral scholarship (to C. F. M. B.). Support for laboratory infrastructure was provided by the Canada Foundation for Innovation (to M. E. P. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allard M, 2006, MICROBES INFECT, V8, P1679, DOI 10.1016/j.micinf.2006.01.022; Andrade MA, 2002, GENOME BIOL, V3; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bowden CFM, 2014, BIOCHEMISTRY-US, V53, P2286, DOI 10.1021/bi500230f; BUNN HF, 1968, J BIOL CHEM, V243, P465; Cheng TM, 2007, CLIN BIOCHEM, V40, P1045, DOI 10.1016/j.clinbiochem.2007.04.018; Wobeto VPD, 2008, GENET MOL BIOL, V31, P602, DOI 10.1590/S1415-47572008000400002; Dickson CF, 2015, ACTA CRYSTALLOGR D, V71, P1295, DOI 10.1107/S1399004715005817; Dickson CF, 2014, J BIOL CHEM, V289, P6728, DOI 10.1074/jbc.M113.545566; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; EATON JW, 1982, SCIENCE, V215, P691, DOI 10.1126/science.7036344; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Etz H, 2002, P NATL ACAD SCI USA, V99, P6573, DOI 10.1073/pnas.092569199; Fonner BA, 2014, BIOCHEMISTRY-US, V53, P3922, DOI 10.1021/bi5005188; FRANCIS RT, 1985, INT J BIOCHEM, V17, P767, DOI 10.1016/0020-711X(85)90262-9; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; MANSOURI A, 1973, BIOCHEMISTRY-US, V12, P4946, DOI 10.1021/bi00748a020; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2013, JOVE-J VIS EXP, DOI 10.3791/50072; Pishchany G, 2014, J INFECT DIS, V209, P1764, DOI 10.1093/infdis/jit817; RACHMILEWITZ EA, 1971, J BIOL CHEM, V246, P3356; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; Saederup KL, 2016, J BIOL CHEM, V291, P23989, DOI 10.1074/jbc.M116.755934; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Waness A, 2010, J GLOB INFECT DIS, V2, P49, DOI 10.4103/0974-777X.59251; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	54	29	29	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					177	190		10.1074/jbc.M117.806562	http://dx.doi.org/10.1074/jbc.M117.806562			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29109153	Green Published, hybrid			2022-12-28	WOS:000419453200016
J	Shizu, R; Min, J; Sobhany, M; Pedersen, LC; Mutoh, S; Negishi, M				Shizu, Ryota; Min, Jungki; Sobhany, Mack; Pedersen, Lars C.; Mutoh, Shingo; Negishi, Masahiko			Interaction of the phosphorylated DNA-binding domain in nuclear receptor CAR with its ligand-binding domain regulates CAR activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; nuclear receptor; nuclear translocation; phosphorylation; protein-protein interaction; CAR; DNA-binding domain; ligand-binding domain; heterodimer; homodimer	CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; GLUCOCORTICOID-RECEPTOR; ANDROSTANE RECEPTOR; PROGESTERONE-RECEPTOR; CYP2B GENE; LIVER; DIMERIZATION; HETERODIMER; CYTOPLASM; TRANSLOCATION	The nuclear protein constitutive active/androstane receptor (CAR or NR1I3) regulates several liver functions such as drug and energy metabolism and cell growth or death, which are often involved in the development of diseases such as diabetes and hepatocellular carcinoma. CAR undergoes a conversion from inactive homodimers to active heterodimers with retinoid X receptor (RXR), and phosphorylation of the DNA-binding domain (DBD) at Thr-38 in CAR regulates this conversion. Here, we uncovered the molecular mechanism by which this phosphorylation regulates the intramolecular interaction between CAR's DBD and ligand-binding domain (LBD), enabling the homodimer-heterodimer conversion. Phosphomimetic substitution of Thr-38 with Asp increased co-immunoprecipitation of the CAR DBD with CAR LBD in Huh-7 cells. Isothermal titration calorimetry assays also revealed that recombinant CAR DBD-T38D, but not nonphosphorylated CAR DBD, bound the CAR LBD peptide. This DBD-LBD interaction masked CAR's dimer interface, preventing CAR homodimer formation. Of note, EGF signaling weakened the interaction of CAR DBD T38D with CAR LBD, converting CAR to the homodimer form. The DBD-T38D-LBD interaction also prevented CAR from forming a heterodimer with RXR. However, this interaction opened up a CAR surface, allowing interaction with protein phosphatase 2A. Thr-38 dephosphorylation then dissociated the DBD-LBD interaction, allowing CAR heterodimer formation with RXR. We conclude that the intramolecular interaction of phosphorylated DBD with the LBD enables CAR to adapt a transient monomer configuration that can be converted to either the inactive homodimer or the active heterodimer.	[Shizu, Ryota; Mutoh, Shingo; Negishi, Masahiko] NIEHS, Dept Pharmacogenet, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Min, Jungki; Pedersen, Lars C.] NIEHS, Genome Integr & Struct Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Sobhany, Mack] NIEHS, Dept Nucl Integr, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Dept Pharmacogenet, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Negishi@niehs.nih.gov	Shizu, Ryota/ACP-9957-2022; Pedersen, Lars/C-6173-2019; Negishi, Masahiko/F-7805-2019	Pedersen, Lars/0000-0002-4488-4077; Negishi, Masahiko/0000-0002-2076-8928; Shizu, Ryota/0000-0002-0465-5077; Min, Jungki/0000-0003-1860-3064	National Institutes of Health Intramural Research program [Z01ES1005-01, ZIA ES102645]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102645, ZIAES080040, ZIAES102645] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Intramural Research program Grants Z01ES1005-01 and ZIA ES102645. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; Dong BN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6944; Dong B, 2009, P NATL ACAD SCI USA, V106, P18831, DOI 10.1073/pnas.0909731106; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; Grimm SL, 2016, J MOL BIOL, V428, P3831, DOI 10.1016/j.jmb.2016.06.020; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Helsen C, 2014, MOL CELL ENDOCRINOL, V382, P97, DOI 10.1016/j.mce.2013.09.009; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Kanno Y, 2005, BBA-MOL CELL RES, V1745, P215, DOI 10.1016/j.bbamcr.2005.06.012; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Kraus WL, 1995, P NATL ACAD SCI USA, V92, P12314, DOI 10.1073/pnas.92.26.12314; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Mutoh S, 2009, J BIOL CHEM, V284, P34785, DOI 10.1074/jbc.M109.048108; Nadal M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14388; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Osabe M, 2011, J BIOL CHEM, V286, P35763, DOI 10.1074/jbc.M111.284596; Putcha BDK, 2009, J BIOL CHEM, V284, P22517, DOI 10.1074/jbc.M109.026682; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Sberna AL, 2011, J HEPATOL, V55, P154, DOI 10.1016/j.jhep.2010.10.029; Shizu R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00649-16; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Takimoto GS, 2003, J STEROID BIOCHEM, V85, P209, DOI 10.1016/S0960-0760(03)00197-3; Tetel MJ, 1997, MOL ENDOCRINOL, V11, P1114, DOI 10.1210/me.11.8.1114; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yasujima T, 2016, J PHARMACOL EXP THER, V357, P367, DOI 10.1124/jpet.116.232140; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	36	14	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					333	344		10.1074/jbc.M117.806604	http://dx.doi.org/10.1074/jbc.M117.806604			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29133527	Green Published, hybrid			2022-12-28	WOS:000419453200028
J	van IJzendoorn, DGP; Forghany, Z; Liebelt, F; Vertegaal, AC; Jochemsen, AG; Bovee, JVMG; Szuhai, K; Baker, DA				van IJzendoorn, David G. P.; Forghany, Zary; Liebelt, Frauke; Vertegaal, Alfred C.; Jochemsen, Aart G.; Bovee, Judith V. M. G.; Szuhai, Karoly; Baker, David A.			Functional analyses of a human vascular tumor FOS variant identify a novel degradation mechanism and a link to tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; c-Fos; cancer biology; protein degradation; transcription regulation; vascular biology	INDEPENDENT PROTEASOMAL DEGRADATION; C-FOS; EPITHELIOID HEMANGIOMA; PROTO-ONCOPROTEIN; DOWN-REGULATION; TEL ETV6; IN-VIVO; AP-1; IDENTIFICATION; ACTIVATION	Epithelioid hemangioma is a locally aggressive vascular neoplasm, found in bones and soft tissue, whose cause is currently unknown, but may involve oncogene activation. FOS is one of the earliest viral oncogenes to be characterized, and normal cellular FOS forms part of the activator protein 1 (AP-1) transcription factor complex, which plays a pivotal role in cell growth, differentiation, and survival as well as the DNA damage response. Despite this, a causal link between aberrant FOS function and naturally occurring tumors has not yet been established. Here, we describe a thorough molecular and biochemical analysis of a mutant FOS protein we identified in these vascular tumors. The mutant protein lacks a highly conserved helix consisting of the C-terminal four amino acids of FOS, which we show is indispensable for fast, ubiquitin-independent FOS degradation via the 20S proteasome. Our work reveals that FOS stimulates endothelial sprouting and that perturbation of normal FOS degradation could account for the abnormal vessel growth typical of epithelioid hemangioma. To the best of our knowledge, this is the first functional characterization of mutant FOS proteins found in tumors.	[van IJzendoorn, David G. P.; Bovee, Judith V. M. G.] LUMC, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Forghany, Zary; Liebelt, Frauke; Vertegaal, Alfred C.; Jochemsen, Aart G.; Szuhai, Karoly; Baker, David A.] LUMC, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	Szuhai, K; Baker, DA (corresponding author), LUMC, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands.	K.Szuhai@lumc.nl; d.baker@lumc.nl	Vertegaal, Alfred/ABG-8141-2021; Vertegaal, Alfred CO/Y-3875-2018; Szuhai, Karoly/A-1100-2008; van IJzendoorn, David/AAQ-9052-2021; van IJzendoorn, David/N-3932-2017	Vertegaal, Alfred/0000-0002-7989-0493; Vertegaal, Alfred CO/0000-0002-7989-0493; Szuhai, Karoly/0000-0002-1228-4245; Bovee, Judith/0000-0003-1155-0481; van IJzendoorn, David/0000-0002-2249-5919	Dutch Cancer Society [30861]; Netherlands Organization for Scientific Research Grant ZON-MW VICI [016.VICI.170.055]	Dutch Cancer Society(KWF Kankerbestrijding); Netherlands Organization for Scientific Research Grant ZON-MW VICI	This work was supported by the Dutch Cancer Society Grant 30861 (to D. A. B.) and Netherlands Organization for Scientific Research Grant ZON-MW VICI 016.VICI.170.055 (to J. V. M. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Acquaviva C, 2001, ONCOGENE, V20, P7563, DOI 10.1038/sj.onc.1204880; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Baker D, 2014, BIOCHEM SOC T, V42, P225, DOI 10.1042/BST20130055; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Campbell KM, 2000, BIOCHEMISTRY-US, V39, P2708, DOI 10.1021/bi9923555; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; HAAS S, 1995, CARCINOGENESIS, V16, P985, DOI 10.1093/carcin/16.5.985; Han XR, 2016, ONCOGENE, V35, P4179, DOI 10.1038/onc.2015.482; Heo SH, 2010, J CELL PHYSIOL, V224, P734, DOI 10.1002/jcp.22175; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Huang SC, 2015, AM J SURG PATHOL, V39, P1313, DOI 10.1097/PAS.0000000000000469; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; Juncker-Jensen A, 2013, CANCER RES, V73, P4196, DOI 10.1158/0008-5472.CAN-12-4495; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rosenberg AE, 2013, WHO CLASSIFICATION T, P333; Roukens MG, 2008, MOL CELL BIOL, V28, P4394, DOI 10.1128/MCB.01914-07; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Roukens MG, 2010, NAT CELL BIOL, V12, P933, DOI 10.1038/ncb2096; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; STANCOVSKI I, 1995, MOL CELL BIOL, V15, P7106; van IJzendoorn DGP, 2015, GENE CHROMOSOME CANC, V54, P565, DOI 10.1002/gcc.22269; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; WILSON T, 1988, EMBO J, V7, P4193, DOI 10.1002/j.1460-2075.1988.tb03316.x; Ye N, 2014, J MED CHEM, V57, P6930, DOI 10.1021/jm5004733	38	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21282	21290		10.1074/jbc.C117.815845	http://dx.doi.org/10.1074/jbc.C117.815845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29150442	hybrid, Green Published			2022-12-28	WOS:000419013000006
J	Furukawa, A; Kakita, K; Yamada, T; Ishizuka, M; Sakamoto, J; Hatori, N; Maeda, N; Ohsaka, F; Saitoh, T; Nomura, T; Kuroki, K; Nambu, H; Arase, H; Matsunaga, S; Anada, M; Ose, T; Hashimoto, S; Maenaka, K				Furukawa, Atsushi; Kakita, Kosuke; Yamada, Tomoki; Ishizuka, Mikihiro; Sakamoto, Jiro; Hatori, Nanao; Maeda, Naoyoshi; Ohsaka, Fumina; Saitoh, Takashi; Nomura, Takao; Kuroki, Kimiko; Nambu, Hisanori; Arase, Hisashi; Matsunaga, Shigeki; Anada, Masahiro; Ose, Toyoyuki; Hashimoto, Shunichi; Maenaka, Katsumi			Structural and thermodynamic analyses reveal critical features of glycopeptide recognition by the human PILR alpha immune cell receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 RECEPTOR; BINDING; ACTIVATION; LIGANDS; PEPTIDE; GLYCAN; CD99	Before entering host cells, herpes simplex virus-1 uses its envelope glycoprotein B to bind paired immunoglobulin-like type 2 receptor alpha (PILR alpha) on immune cells. PILR alpha belongs to the Siglec (sialic acid (SA)-binding immunoglobulin-like lectin)- like family, members of which bind SA. PILR alpha is the only Siglec member to recognize not only the sialylated O-linked sugar T antigen (sTn) but also its attached peptide region. We previously determined the crystal structure of PILR alpha complexed with the sTn-linked glycopeptide of glycoprotein B, revealing the simultaneous recognition of sTn and peptide by the receptor. However, the contribution of each glycopeptide component to PILR alpha binding was largely unclear. Here, we chemically synthesized glycopeptide derivatives and determined the thermodynamic parameters of their interaction with PILR alpha. We show that glycopeptides with different sugar units linking SA and peptides (i.e. "GlcNAc-type" and "deoxy-GlcNAc-type" glycopeptides) have lower affinity and more enthalpy-driven binding than the wild type (i.e. GalNAc-type glycopeptide). The crystal structures of PILR alpha complexed with these glycopeptides highlighted the importance of stereochemical positioning of the O4 atom of the sugar moiety. These results provide insights both for understanding the unique O-glycosylated peptide recognition by the PILR alpha and for the rational design of herpes simplex virus-1 entry inhibitors.	[Furukawa, Atsushi; Ishizuka, Mikihiro; Sakamoto, Jiro; Kuroki, Kimiko; Ose, Toyoyuki; Maenaka, Katsumi] Hokkaido Univ, Lab Biomol Sci, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Kakita, Kosuke; Hatori, Nanao; Nambu, Hisanori; Matsunaga, Shigeki; Anada, Masahiro; Hashimoto, Shunichi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Synthet & Ind Chem, Sapporo, Hokkaido 0600812, Japan; [Yamada, Tomoki; Maeda, Naoyoshi; Ohsaka, Fumina; Saitoh, Takashi; Nomura, Takao; Maenaka, Katsumi] Hokkaido Univ, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido 0600812, Japan; [Arase, Hisashi] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Arase, Hisashi] Osaka Univ, Res Inst Microbial Dis, Dept Immunochem, Suita, Osaka 5650871, Japan; [Saitoh, Takashi] Hokkaido Pharmaceut Univ, Sch Pharm, Sapporo, Hokkaido 0068590, Japan; [Nambu, Hisanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama 9300194, Japan; [Anada, Masahiro] Musashino Univ, Fac Pharm, Tokyo 2028585, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Osaka University; Osaka University; University of Toyama	Maenaka, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	maenaka@pharm.hokudai.ac.jp	Anada, Masahiro/A-3805-2012; 敦, 古川/AAI-4018-2021; Ose, Toyoyuki/AAW-7821-2020; Arase, Hisashi/C-8442-2009; Anada, Masahiro/M-5205-2019	Anada, Masahiro/0000-0002-7691-5114; Ose, Toyoyuki/0000-0002-2001-9388; Arase, Hisashi/0000-0002-1153-3166; Anada, Masahiro/0000-0002-7691-5114; Furukawa, Atsushi/0000-0003-1281-2252; maenaka, katsumi/0000-0002-5459-521X	Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers [S2701]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Japan AMED; Hokkaido University; MEXT under "Support Program for Implementation of New Equipment Sharing System"; Grants-in-Aid for Scientific Research [17H05793, 15H02545, 17K08848] Funding Source: KAKEN	Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan AMED; Hokkaido University; MEXT under "Support Program for Implementation of New Equipment Sharing System"; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by "Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers" Grant S2701 (to K. M.); the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and Development (AMED); the Platform Project for Supporting Drug Discovery and Life Science Research funded by Japan AMED and Hokkaido University; and the Global Facility Center and Pharma Science Open Unit funded by MEXT under "Support Program for Implementation of New Equipment Sharing System." The authors declare that they have no conflicts of interest with the contents of this article.	Chen SY, 2013, J AM CHEM SOC, V135, P6562, DOI 10.1021/ja400461h; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; Kakita K., 2016, THESIS; Kogure A, 2011, BIOCHEM BIOPH RES CO, V405, P428, DOI 10.1016/j.bbrc.2011.01.047; Kuroki K, 2014, P NATL ACAD SCI USA, V111, P8877, DOI 10.1073/pnas.1324105111; Kuroki K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00429; Lu Q, 2014, P NATL ACAD SCI USA, V111, P8221, DOI 10.1073/pnas.1320716111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagae M, 2014, STRUCTURE, V22, P1711, DOI 10.1016/j.str.2014.09.009; Radhakrishnan P, 2014, P NATL ACAD SCI USA, V111, pE4066, DOI 10.1073/pnas.1406619111; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Sun YL, 2012, J BIOL CHEM, V287, P15837, DOI 10.1074/jbc.M111.286633; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wang J, 2013, NAT IMMUNOL, V14, P34, DOI 10.1038/ni.2456; Zeraik AE, 2014, J BIOL CHEM, V289, P7799, DOI 10.1074/jbc.M113.525352; Zhao BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115872	21	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21128	21136		10.1074/jbc.M117.799239	http://dx.doi.org/10.1074/jbc.M117.799239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29046357	Green Published, hybrid			2022-12-28	WOS:000418453400027
J	Lange, H; Muhlenhoff, U; Denzel, M; Kispal, G; Lill, R				Lange, Heike; Muhlenhoff, Ulrich; Denzel, Martin; Kispal, Gyula; Lill, Roland			The heme synthesis defect of mutants impaired in mitochondrial iron-sulfur protein biogenesis is caused by reversible inhibition of ferrochelatase (vol 279, pg 29101, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Lill, Roland/0000-0002-8345-6518				Lange H, 2004, J BIOL CHEM, V279, P29101, DOI 10.1074/jbc.M403721200	1	0	0	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20656	20656		10.1074/jbc.AAC117.000997	http://dx.doi.org/10.1074/jbc.AAC117.000997			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29247132	Green Published, hybrid			2022-12-28	WOS:000418267000026
J	Xie, JD; Chen, SR; Pan, HL				Xie, Jing-Dun; Chen, Shao-Rui; Pan, Hui-Lin			Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate receptor; microtubule; neurophysiology; neuroscience; neurotransmitter; pain; synaptic plasticity; tubulin	ROOT GANGLIA NEURONS; SPINAL-CORD; SUBSTANTIA-GELATINOSA; CHLORIDE HOMEOSTASIS; NERVE INJURY; DORSAL-HORN; RAT; ACTIVATION; HYPERSENSITIVITY; PHARMACOLOGY	Chemotherapeutic drugs such as paclitaxel cause painful peripheral neuropathy in many cancer patients and survivors. Although NMDA receptors (NMDARs) at primary afferent terminals are known to be critically involved in chemotherapy-induced chronic pain, the upstream signaling mechanism that leads to presynaptic NMDAR activation is unclear. Group I metabotropic glutamate receptors (mGluRs) play a role in synaptic plasticity and NMDAR regulation. Here we report that the Group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG) significantly increased the frequency of miniature excitatory postsynaptic currents (EPSCs) and the amplitude of monosynaptic EPSCs evoked from the dorsal root. DHPG also reduced the paired-pulse ratio of evoked EPSCs in spinal dorsal horn neurons. These effects were blocked by the selective mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP), but not by an mGluR1 antagonist. MPEP normalized the frequency of miniature EPSCs and the amplitude of evoked EPSCs in paclitaxel-treated rats but had no effect in vehicle-treated rats. Furthermore, mGluR5 protein levels in the dorsal root ganglion and spinal cord synaptosomes were significantly higher in paclitaxel- than in vehicle-treated rats. Inhibiting protein kinase C (PKC) or blocking NMDARs abolished DHPG-induced increases in the miniature EPSC frequency of spinal dorsal horn neurons in vehicle- and paclitaxel-treated rats. Moreover, intrathecal administration of MPEP reversed pain hypersensitivity caused by paclitaxel treatment. Our findings suggest that paclitaxel-induced painful neuropathy is associated with increased presynaptic mGluR5 activity at the spinal cord level, which serves as upstream signaling for PKC-mediated tonic activation of NMDARs. mGluR5 is therefore a promising target for reducing chemotherapy-induced neuropathic pain.	[Xie, Jing-Dun; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Xie, Jing-Dun] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510060, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM120844 and NS101880 and a grant from the N. G. and Helen T. Hawkins Endowment (to H.-L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2014, J BIOL CHEM, V289, P31111, DOI 10.1074/jbc.M114.600320; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Huang H, 2007, J NEUROSCI, V27, P11560, DOI 10.1523/JNEUROSCI.2147-07.2007; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Li DP, 2014, J NEUROSCI, V34, P4309, DOI 10.1523/JNEUROSCI.4295-13.2014; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li JQ, 2010, J NEUROCHEM, V112, P162, DOI 10.1111/j.1471-4159.2009.06437.x; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; Serge A, 2003, J CELL SCI, V116, P5015, DOI 10.1242/jcs.00822; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Theiss C, 2000, CELL TISSUE RES, V299, P213, DOI 10.1007/s004419900120; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valerio A, 1997, NEUROSCI RES, V28, P49, DOI 10.1016/S0168-0102(97)01175-9; Werner CG, 2007, EUR J NEUROSCI, V25, P3597, DOI 10.1111/j.1460-9568.2007.05614.x; Xie JD, 2017, NEUROPHARMACOLOGY, V123, P477, DOI 10.1016/j.neuropharm.2017.06.027; Xie JD, 2016, J BIOL CHEM, V291, P19364, DOI 10.1074/jbc.M116.732347; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	36	29	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20644	20654		10.1074/jbc.M117.818476	http://dx.doi.org/10.1074/jbc.M117.818476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074619	hybrid, Green Published			2022-12-28	WOS:000418267000024
J	Byun, H; Park, J; Kim, SC; Ahn, JH				Byun, Hyunjong; Park, Jiyeon; Kim, Sun Chang; Ahn, Jung Hoon			A lower isoelectric point increases signal sequence-mediated secretion of recombinant proteins through a bacterial ABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; membrane transport; protein secretion; protein translocation; recombinant protein expression; isoelectric point; membrane potential	ESCHERICHIA-COLI; SWISS-MODEL; EVOLUTIONARY CONSERVATION; CHARGED RESIDUES; OUTER-MEMBRANE; TRANSLOCATION; MECHANISM; PEPTIDES; LIPASE; POLYPEPTIDE	Efficient protein production for industrial and academic purposes often involves engineering microorganisms to produce and secrete target proteins into the culture. Pseudomonas fluorescens has a TliDEF ATP-binding cassette transporter, a type I secretion system, which recognizes C-terminal LARD3 signal sequence of thermostable lipase TliA. Many proteins are secreted by TliDEF in vivo when recombined with LARD3, but there are still others that cannot be secreted by TliDEF even when LARD3 is attached. However, the factors that determine whether or not a recombinant protein can be secreted through TliDEF are still unknown. Here, we recombined LARD3 with several proteins and examined their secretion through TliDEF. We found that the proteins secreted via LARD3 are highly negatively charged with highly-acidic isoelectric points (pI) lower than 5.5. Attaching oligo-aspartate to lower the pI of negatively-charged recombinant proteins improved their secretion, and attaching oligo-arginine to negatively-charged proteins blocked their secretion by LARD3. In addition, negatively supercharged green fluorescent protein (GFP) showed improved secretion, whereas positively supercharged GFP did not secrete. These results disclosed that proteins' acidic pI and net negative charge are major factors that determine their secretion through TliDEF. Homology modeling for TliDEF revealed that TliD dimer forms evolutionarily-conserved positively-charged clusters in its pore and substrate entrance site, which also partially explains the pI dependence of the TliDEF-dependent secretions. In conclusion, lowering the isoelectric point improved LARD3-mediated protein secretion, both widening the range of protein targets for efficient production via secretion and signifying an important aspect of ABC transporter-mediated secretions.	[Byun, Hyunjong; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Park, Jiyeon; Ahn, Jung Hoon] Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, Busan 47162, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Ahn, JH (corresponding author), Korea Adv Inst Sci & Technol, Korea Sci Acad, Dept Biol & Chem, 403 Changjo Kwan,105-47 Baegyanggwanmun Ro, Busan 7162, South Korea.	hoony@kaist.ac.kr	Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Byun, Hyunjong/0000-0003-1704-5013; Ahn, Jung Hoon/0000-0002-7779-4318	Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning	Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning	This work was supported by the Intelligent Synthetic Biology Center of the Global Frontier Project; URP Program of the Korea Advanced Institute of Science and Technology; and the R&E Program of the Republic of Korea Ministry of Science, ICT and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JH, 1999, J BACTERIOL, V181, P1847, DOI 10.1128/JB.181.6.1847-1852.1999; Anthony-Cahill S. J, 2013, BIOCHEMISTRY-US, P138; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Chen R, 2012, BIOTECHNOL ADV, V30, P1102, DOI 10.1016/j.biotechadv.2011.09.013; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; DAMPER PD, 1981, ANTIMICROB AGENTS CH, V20, P803, DOI 10.1128/AAC.20.6.803; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Eom GT, 2016, PROCESS BIOCHEM, V51, P999, DOI 10.1016/j.procbio.2016.05.004; Galvez AF, 2001, CANCER RES, V61, P7473; GRAEVENITZ AV, 1971, YALE J BIOL MED, V44, P265; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harley CA, 1996, J BIOL CHEM, V271, P24625, DOI 10.1074/jbc.271.40.24625; Higgins MK, 2004, J MOL BIOL, V342, P697, DOI 10.1016/j.jmb.2004.07.088; Hink MA, 2000, J BIOL CHEM, V275, P17556, DOI 10.1074/jbc.M001348200; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Kang'ethe W, 2013, P NATL ACAD SCI USA, V110, pE4246, DOI 10.1073/pnas.1310345110; KENNEDY EP, 1982, P NATL ACAD SCI-BIOL, V79, P1092, DOI 10.1073/pnas.79.4.1092; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim D, 2006, EXP CELL RES, V312, P1277, DOI 10.1016/j.yexcr.2005.12.029; KOHARA A, 1991, J BIOL CHEM, V266, P20363; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Morgan JLW, 2017, STRUCTURE, V25, P522, DOI 10.1016/j.str.2017.01.010; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Novo D, 1999, CYTOMETRY, V35, P55, DOI 10.1002/(SICI)1097-0320(19990101)35:1<55::AID-CYTO8>3.0.CO;2-2; ODANI S, 1987, J BIOL CHEM, V262, P10502; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Park Y, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-60; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ryu J, 2015, APPL ENVIRON MICROB, V81, P1735, DOI 10.1128/AEM.03514-14; Seidman C. E, 1987, CURRENT PROTOCOLS MO, V1; SEN K, 1988, J BIOL CHEM, V263, P1182; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Son M, 2012, APPL ENVIRON MICROB, V78, P8454, DOI 10.1128/AEM.02476-12; Squires C.H., 2004, BIOPROCESS INT, V2004, P54; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wilkins MR, 1999, METH MOL B, V112, P531; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; YAMANE K, 1988, J BIOL CHEM, V263, P19690; Yang KS, 2015, ACS CATAL, V5, P5016, DOI 10.1021/cs502079g	50	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19782	19791		10.1074/jbc.M117.786749	http://dx.doi.org/10.1074/jbc.M117.786749			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972172	hybrid, Green Published			2022-12-28	WOS:000416911300022
J	Nakanishi, A; Hatano, N; Fujiwara, Y; Sha'ri, A; Takabatake, S; Akano, H; Kanayama, N; Magari, M; Nozaki, N; Tokumitsu, H				Nakanishi, Akihiro; Hatano, Naoya; Fujiwara, Yuya; Sha'ri, Arian; Takabatake, Shota; Akano, Hiroki; Kanayama, Naoki; Magari, Masaki; Nozaki, Naohito; Tokumitsu, Hiroshi			AMP-activated protein kinase-mediated feedback phosphorylation controls the Ca2+/calmodulin (CaM) dependence of Ca2+/CaM-dependent protein kinase kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); Ca2+; calmodulin-dependent protein kinase (CaMK); calmodulin (CaM); phosphorylation; protein kinase	MOLECULAR-CLONING; REGULATORY MECHANISM; ESCHERICHIA-COLI; CALMODULIN; BETA; CASCADE; CALCIUM; IV; TRANSCRIPTION; EXPRESSION	The Ca2+/calmodulin-dependent protein kinase kinase (CaMKK)/5-AMP-activated protein kinase (AMPK) phosphorylation cascade affects various Ca2+-dependent metabolic pathways and cancer growth. Unlike recombinant CaMKK that exhibits higher basal activity (autonomous activity), activation of the CaMKK/AMPK signaling pathway requires increased intracellular Ca2+ concentrations. Moreover, the Ca2+/CaM dependence of CaMKK appears to arise from multiple phosphorylation events, including autophosphorylation and activities furnished by other protein kinases. However, the effects of proximal downstream kinases on CaMKK activity have not yet been evaluated. Here, we demonstrate feedback phosphorylation of CaMKK at multiple residues by CaMKK-activated AMPK in addition to autophosphorylation in vitro, leading to reduced autonomous, but not Ca2+/CaM-activated, CaMKK activity. MS analysis and site-directed mutagenesis of AMPK phosphorylation sites in CaMKK indicated that Thr(144) phosphorylation by activated AMPK converts CaMKK into a Ca2+/CaM-dependent enzyme as shown by completely Ca2+/CaM-dependent CaMKK activity of a phosphomimetic T144E CaMKK mutant. CaMKK mutant analysis indicated that the C-terminal domain (residues 471-587), including the autoinhibitory region, plays an important role in stabilizing an inactive conformation in a Thr(144) phosphorylation-dependent manner. Furthermore, immunoblot analysis with anti-phospho-Thr(144) antibody revealed phosphorylation of Thr(144) in CaMKK in transfected COS-7 cells that was further enhanced by exogenous expression of AMPK. These results indicate that AMPK-mediated feedback phosphorylation of CaMKK regulates the CaMKK/AMPK signaling cascade and may be physiologically important for intracellular maintenance of Ca2+-dependent AMPK activation by CaMKK.	[Nakanishi, Akihiro; Fujiwara, Yuya; Sha'ri, Arian; Takabatake, Shota; Akano, Hiroki; Kanayama, Naoki; Magari, Masaki; Tokumitsu, Hiroshi] Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Okayama 7008530, Japan; [Hatano, Naoya] Kobe Univ, Integrated Ctr Mass Spectrometry, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Nozaki, Naohito] MAB Inst Inc, Iida, Nagano 3950157, Japan	Okayama University; Kobe University	Tokumitsu, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Div Med Bioengn, Kita Ku, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	tokumit@okayama-u.ac.jp	MAGARI, Masaki/B-2555-2011; Tokumitsu, Hiroshi/M-3978-2015; Kanayama, Naoki/G-1518-2010	Magari, Masaki/0000-0002-4624-0160; Tokumitsu, Hiroshi/0000-0002-2193-6794; Kanayama, Naoki/0000-0003-1778-2005	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26440056]; Grants-in-Aid for Scientific Research [15H04196] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research 26440056 (to H. T.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KA, 1998, J BIOL CHEM, V273, P31880, DOI 10.1074/jbc.273.48.31880; Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; COLBRAN RJ, 1992, NEUROCHEM INT, V21, P469, DOI 10.1016/0197-0186(92)90080-B; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; Fujiwara Y, 2016, J BIOL CHEM, V291, P13802, DOI 10.1074/jbc.M116.727867; Fujiwara Y, 2015, BIOCHEMISTRY-US, V54, P3969, DOI 10.1021/acs.biochem.5b00149; FUKUNAGA K, 1989, J BIOL CHEM, V264, P21830; Ghislat G, 2012, J BIOL CHEM, V287, P38625, DOI 10.1074/jbc.M112.365767; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Horigane S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0189-3; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Joseph JD, 2000, J BIOL CHEM, V275, P38230, DOI 10.1074/jbc.M006422200; KIMURA K, 1994, J BIOL CHEM, V269, P24523; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kitani T, 1997, J BIOCHEM-TOKYO, V122, P243; LEE JSC, 1994, J BIOL CHEM, V269, P2158; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Nakamuta S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002011; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SELBERT MA, 1995, J BIOL CHEM, V270, P17616, DOI 10.1074/jbc.270.29.17616; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tokumitsu H, 2000, J BIOL CHEM, V275, P20090, DOI 10.1074/jbc.M002193200; Tokumitsu H, 1996, J BIOL CHEM, V271, P5617, DOI 10.1074/jbc.271.10.5617; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Tokumitsu H, 2001, BIOCHEMISTRY-US, V40, P13925, DOI 10.1021/bi010863k; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tokumitsu H, 2011, BIOCHEMISTRY-US, V50, P8193, DOI 10.1021/bi201005g; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Yamauchi M, 2008, MOL ENDOCRINOL, V22, P893, DOI 10.1210/me.2007-0249	51	29	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19804	19813		10.1074/jbc.M117.805085	http://dx.doi.org/10.1074/jbc.M117.805085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974582	Green Published, hybrid			2022-12-28	WOS:000416911300024
J	Yurkovich, JT; Zielinski, DC; Yang, L; Paglia, G; Rolfsson, O; Sigurjonsson, OE; Broddrick, JT; Bordbar, A; Wichuk, K; Brynjolfsson, S; Palsson, S; Gudmundsson, S; Palsson, BO				Yurkovich, James T.; Zielinski, Daniel C.; Yang, Laurence; Paglia, Giuseppe; Rolfsson, Ottar; Sigurjonsson, Olafur E.; Broddrick, Jared T.; Bordbar, Aarash; Wichuk, Kristine; Brynjolfsson, Sigurdur; Palsson, Sirus; Gudmundsson, Sveinn; Palsson, Bernhard O.			Quantitative time-course metabolomics in human red blood cells reveal the temperature dependence of human metabolic networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computational biology; erythrocyte; metabolism; metabolomics; systems biology	OMICS TECHNOLOGIES; STORAGE; QUALITY; COEFFICIENT; RESPONSES; HEMOLYSIS; DATABASE; SCALE	The temperature dependence of biological processes has been studied at the levels of individual biochemical reactions and organism physiology (e.g. basal metabolic rates) but has not been examined at the metabolic network level. Here, we used a systems biology approach to characterize the temperature dependence of the human red blood cell (RBC) metabolic network between 4 and 37 degrees C through absolutely quantified exo- and endometabolomics data. We used an Arrhenius-type model (Q(10)) to describe how the rate of a biochemical process changes with every 10 degrees C change in temperature. Multivariate statistical analysis of the metabolomics data revealed that the same metabolic network-level trends previously reported for RBCs at 4 degrees C were conserved but accelerated with increasing temperature. We calculated a median Q(10) coefficient of 2.89 +/- 1.03, within the expected range of 2-3 for biological processes, for 48 individual metabolite concentrations. We then integrated these metabolomics measurements into a cell-scale metabolic model to study pathway usage, calculating a median Q(10) coefficient of 2.73 +/- 0.75 for 35 reaction fluxes. The relative fluxes through glycolysis and nucleotide metabolism pathways were consistent across the studied temperature range despite the non-uniform distributions of Q(10) coefficients of individual metabolites and reaction fluxes. Together, these results indicate that the rate of change of network-level responses to temperature differences in RBC metabolism is consistent between 4 and 37 degrees C. More broadly, we provide a baseline characterization of a biochemical network given no transcriptional or translational regulation that can be used to explore the temperature dependence of metabolism.	[Yurkovich, James T.; Zielinski, Daniel C.; Yang, Laurence; Broddrick, Jared T.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Palsson, Bernhard O.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Yurkovich, James T.; Palsson, Bernhard O.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Broddrick, Jared T.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Paglia, Giuseppe] EURAC Res, Inst Biomed, Viale Druso Drususallee 1, I-39100 Bolzano, Bozen, Italy; [Rolfsson, Ottar; Wichuk, Kristine; Brynjolfsson, Sigurdur; Palsson, Sirus; Palsson, Bernhard O.] Univ Iceland, Ctr Syst Biol, Sturlugata 8, IS-101 Reykjavik, Iceland; [Sigurjonsson, Olafur E.; Gudmundsson, Sveinn] Landspitali Univ Hosp, Blood Bank, Snorrabraut 60, IS-105 Reykjavik, Iceland; [Sigurjonsson, Olafur E.] Reykjavik Univ, Sch Sci & Engn, Menntavegur 1, IS-101 Reykjavik, Iceland; [Bordbar, Aarash; Palsson, Sirus] Sinopia Biosci, San Diego, CA 92101 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; European Academy of Bozen-Bolzano; University of Iceland; Landspitali National University Hospital; Reykjavik University	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA.; Palsson, BO (corresponding author), Univ Iceland, Ctr Syst Biol, Sturlugata 8, IS-101 Reykjavik, Iceland.	palsson@ucsd.edu	/AAG-5264-2021; Sigurjonsson, Olafur/T-8190-2019; Brynjolfsson, Sigurdur/AAT-4654-2020; Paglia, Giuseppe/H-2012-2018; Brynjolfsson, Sigurdur/H-4588-2012	/0000-0001-6460-6771; Sigurjonsson, Olafur/0000-0002-4968-842X; Paglia, Giuseppe/0000-0003-4724-6801; Rolfsson, Ottar/0000-0003-4258-6057; Yang, Laurence/0000-0001-6663-7643; Brynjolfsson, Sigurdur/0000-0001-9435-2258; Broddrick, Jared/0000-0003-4871-4822	European Research Council [ERC-232816]; United States Department of Energy [DE-SC0008701]; NHLBI, National Institutes of Health [R43HL123074]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL123074] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); United States Department of Energy(United States Department of Energy (DOE)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by European Research Council Grant ERC-232816; United States Department of Energy Grant DE-SC0008701 and NHLBI, National Institutes of Health Grant R43HL123074. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Belehradek J, 1930, BIOL REV BIOL P CAMB, V5, P30; Bordbar A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46249; Bordbar A, 2016, TRANSFUSION, V56, P852, DOI 10.1111/trf.13460; Bordbar A, 2015, CELL SYST, V1, P283, DOI 10.1016/j.cels.2015.10.003; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-110; BORGMANN AI, 1976, J COMP PHYSIOL, V107, P185, DOI 10.1007/BF00691225; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Burnside WR, 2014, OIKOS, V123, P1449, DOI 10.1111/oik.01199; Chaui-Berlinck JG, 2002, P ROY SOC B-BIOL SCI, V269, P15, DOI 10.1098/rspb.2001.1845; Clarke A, 2004, FUNCT ECOL, V18, P243, DOI 10.1111/j.0269-8463.2004.00841.x; Cohen E, 1896, STUDIES CHEM DYNAMIC, P130; CRIDDLE RS, 1994, PLANT CELL ENVIRON, V17, P233, DOI 10.1111/j.1365-3040.1994.tb00289.x; D'Alessandro A, 2017, TRANSFUS APHER SCI, V56, P248, DOI 10.1016/j.transci.2017.03.006; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2015, TRANSFUSION, V55, P205, DOI 10.1111/trf.12804; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hardy R. N, 1979, STUDIES BIOL; HEGARTY TW, 1973, NATURE, V243, P305, DOI 10.1038/243305a0; Hochachka P.W., 1991, Biochemistry and Molecular Biology of Fishes, V1, P313; HOGMAN CF, 1981, VOX SANG, V41, P274; KAVANAU JL, 1950, J GEN PHYSIOL, V34, P193, DOI 10.1085/jgp.34.2.193; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; LAIDLER KJ, 1984, J CHEM EDUC, V61, P494, DOI 10.1021/ed061p494; Larhlimi A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-57; Lee JS, 2017, J CLIN INVEST, V127, P100, DOI 10.1172/JCI91309; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Paglia G, 2016, BLOOD, V128, pE43, DOI 10.1182/blood-2016-06-721688; Paglia G, 2014, TRANSFUSION, V54, P2911, DOI 10.1111/trf.12710; Rapido F, 2017, J CLIN INVEST, V127, P375, DOI 10.1172/JCI90837; Roback JD, 2014, TRANSFUS MED REV, V28, P41, DOI 10.1016/j.tmrv.2014.01.003; Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851; Sierra CA, 2012, BIOGEOCHEMISTRY, V108, P1, DOI 10.1007/s10533-011-9596-9; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; SOMERO GN, 1968, BIOCHEM J, V110, P395, DOI 10.1042/bj1100395; Southwood AL, 2003, J EXP BIOL, V206, P4521, DOI 10.1242/jeb.00689; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yurkovich J. T., 2017, P 1 IEEE C CONTR TEC; Yurkovich JT, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005424	40	30	30	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19556	19564		10.1074/jbc.M117.804914	http://dx.doi.org/10.1074/jbc.M117.804914			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29030425	hybrid, Green Published			2022-12-28	WOS:000416911300002
J	Mosesso, R; Dougherty, DA				Mosesso, Richard; Dougherty, Dennis A.			A triad of residues is functionally transferrable between 5-HT3 serotonin receptors and nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; BINDING-SITE; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; AMINO-ACIDS; ANTAGONIST; 5-HT(3)A; LOOP	Cys-loop receptors are pentameric ligand-gated ion channels that facilitate communication within the nervous system. Upon neurotransmitter binding, these receptors undergo an allosteric activation mechanism connecting the binding event to the membrane-spanning channel pore, which expands to conduct ions. Some of the earliest steps in this activation mechanism are carried out by residues proximal to the binding site, the relative positioning of which may reflect functional differences among members of the Cys-loop family of receptors. Herein, we investigated key side-chain interactions near the binding site via mutagenesis and two-electrode voltage-clamp electrophysiology in serotonin-gated 5-HT3A receptors (5-HT(3A)Rs) and nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus laevis oocytes. We found that a triad of residues aligning to Thr-152, Glu-209, and Lys-211 in the 5-HT3AR can be exchanged between the homomeric 5-HT3AR and the muscle-type nAChR alpha-subunit with small functional consequences. Via triple mutant cycle analysis, we demonstrated that this triad forms an interdependent network in the muscle-type nAChR. Furthermore, nAChR-type mutations of the 5-HT3AR affect the affinity of nicotine, a competitive antagonist of 5-HT(3A)Rs, in a cooperative manner. Using mutant cycle analyses between the 5-HT3A triad, loop A residues Asn-101 and Glu-102, beta 9 residue Lys-197, and the channel gate at Thr-257, we observed that residues in this region are energetically linked to the channel gate and are particularly sensitive to mutations that introduce a net positive charge. This study expands our understanding of the differences and similarities in the activation mechanisms of Cysloop receptors.	[Mosesso, Richard; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Dept Chem & Chem Engn, Crellin 359,1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadoc@caltech.edu		Dougherty, Dennis/0000-0003-1464-2461	National Institutes of Health [NS 34407]; Training Grant NIH/NRSA [T32 GM07616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant NIH/NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS 34407 and Training Grant NIH/NRSA T32 GM07616. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Colquhoun D, 2007, TRENDS PHARMACOL SCI, V28, P608, DOI 10.1016/j.tips.2007.09.011; CROSS KML, 1995, BRIT J PHARMACOL, V114, P1636, DOI 10.1111/j.1476-5381.1995.tb14951.x; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dougherty DA, 2014, CHEMBIOCHEM, V15, P1710, DOI 10.1002/cbic.201402080; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Giastas P, 2017, BR J PHARM; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Gurley DA, 1998, NEUROSCI LETT, V247, P107, DOI 10.1016/S0304-3940(98)00306-1; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Horenstein NA, 2007, J BIOL CHEM, V282, P5899, DOI 10.1074/jbc.M609202200; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Kouvatsos N, 2016, P NATL ACAD SCI USA, V113, P9635, DOI 10.1073/pnas.1602619113; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Lynagh T, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00160; Mallipeddi PL, 2013, J MOL GRAPH MODEL, V44, P145, DOI 10.1016/j.jmgm.2013.05.010; Miles TF, 2012, ACS CHEM NEUROSCI, V3, P753, DOI 10.1021/cn3000586; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Nasiripourdori A, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-3; Price KL, 2008, BIOCHEMISTRY-US, V47, P6370, DOI 10.1021/bi800222n; Shanata JAP, 2012, METHODS MOL BIOL, V796, P97, DOI 10.1007/978-1-61779-334-9_6; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Thompson AJ, 2013, BRIT J PHARMACOL, V170, P391, DOI 10.1111/bph.12287; Thompson AJ, 2005, J BIOL CHEM, V280, P20476, DOI 10.1074/jbc.M413610200; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	37	3	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2903	2914		10.1074/jbc.M117.810432	http://dx.doi.org/10.1074/jbc.M117.810432			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29298898	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000426051900024
J	Yaparla, A; Popovic, M; Grayfer, L				Yaparla, Amulya; Popovic, Milan; Grayfer, Leon			Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; immunology; innate immunity; macrophage; Xenopus; interleukin-34; Frog virus 3; Interleukin-34; antiviral immunity; colony-stimulating factor-1	COLONY-STIMULATING FACTOR; FROG VIRUS 3; GENE REGULATORY NETWORKS; INTERFERON RESPONSE; IMMUNE-RESPONSES; LANGERHANS CELLS; FACTOR-I; RANAVIRUS; EXPRESSION; IL-34	Infections by ranaviruses such as Frog virus 3 (Fv3), are significantly contributing to worldwide amphibian population declines. Notably, amphibian macrophages (M phi s) are important to both the Fv3 infection strategies and the immune defense against this pathogen. However, the mechanisms underlying amphibian M phi Fv3 susceptibility and resistance remain unknown. M phi differentiation is mediated by signaling through the colony-stimulating factor-1 receptor (CSF-1R) which is now known to be bound not only by CSF-1, but also by the unrelated interleukin-34 (IL-34) cytokine. Pertinently, amphibian (Xenopus laevis) M phi s differentiated by CSF-1 and IL-34 are highly susceptible and resistant to Fv3, respectively. Accordingly, in the present work, we elucidate the facets of this M phi Fv3 susceptibility and resistance. Because cellular resistance to viral replication is marked by expression of antiviral restriction factors, it was intuitive to find that IL-34-M phi s possess significantly greater mRNA levels of select restriction factor genes than CSF-1-M phi s. Xenopodinae amphibians have highly expanded repertoires of antiviral interferon (IFN) cytokine gene families, and our results indicated that in comparison with the X. laevis CSF-1-M phi s, the IL-34-M phi s express substantially greater transcripts of representative IFN genes, belonging to distinct gene family clades, as well as their cognate receptor genes. Finally, we demonstrate that IL-34-M phi-conditioned supernatants confer IFN-mediated anti-Fv3 protection to the virally susceptible X. laevis kidney (A6) cell line. Together, this work underlines the differentiation pathways leading to Fv3-susceptible and -resistant amphibian M phi populations and defines the molecular mechanisms responsible for these differences.	[Yaparla, Amulya; Popovic, Milan; Grayfer, Leon] George Washington Univ, Dept Biol Sci, 800 22nd St NW,Suite 6000, Washington, DC 20052 USA	George Washington University	Grayfer, L (corresponding author), George Washington Univ, Dept Biol Sci, 800 22nd St NW,Suite 6000, Washington, DC 20052 USA.	leon_grayfer@gwu.edu			George Washington University	George Washington University	This work was supported by start-up funding from George Washington University (to L. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363; Ballana E, 2015, TRENDS MICROBIOL, V23, P680, DOI 10.1016/j.tim.2015.08.002; Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Bayley AE, 2013, DIS AQUAT ORGAN, V103, P171, DOI 10.3354/dao02574; Belosevic M, 2006, FISH SHELLFISH IMMUN, V20, P152, DOI 10.1016/j.fsi.2004.10.010; Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Droin N, 2010, J LEUKOCYTE BIOL, V87, P745, DOI 10.1189/jlb.1209780; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Dwyer AR, 2016, J LEUKOCYTE BIOL, V100, P163, DOI 10.1189/jlb.2A0815-344RR; Gan Z, 2017, DEV COMP IMMUNOL, V67, P166, DOI 10.1016/j.dci.2016.10.007; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Grayfer L, 2016, DEV COMP IMMUNOL, V58, P60, DOI 10.1016/j.dci.2015.12.008; Grayfer L, 2015, J LEUKOCYTE BIOL, V98, P641, DOI 10.1189/jlb.4AB0315-117RR; Grayfer L, 2015, J VIROL, V89, P5072, DOI 10.1128/JVI.00051-15; Grayfer L, 2014, J LEUKOCYTE BIOL, V96, P1143, DOI 10.1189/jlb.4A0614-295R; Grayfer L, 2014, J VIROL, V88, P5766, DOI 10.1128/JVI.00223-14; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; Grayfer L, 2009, FISH SHELLFISH IMMUN, V26, P406, DOI 10.1016/j.fsi.2008.12.001; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; GUILBERT LJ, 1980, J CELL BIOL, V85, P153, DOI 10.1083/jcb.85.1.153; Guillonneau C, 2017, CELL MOL LIFE SCI, V74, P2569, DOI 10.1007/s00018-017-2482-4; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Hanington PC, 2007, J BIOL CHEM, V282, P31865, DOI 10.1074/jbc.M706278200; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Landsberg JH, 2013, DIS AQUAT ORGAN, V105, P89, DOI 10.3354/dao02625; Lang FC, 2017, SCI REP-UK, V7, DOI 10.1038/srep39861; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Li DJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003880; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Morales HD, 2007, J VIROL, V81, P2240, DOI 10.1128/JVI.01104-06; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Pentland I, 2015, VIRUSES-BASEL, V7, P3574, DOI 10.3390/v7072791; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Reeve BC, 2013, ECOHEALTH, V10, P190, DOI 10.1007/s10393-013-0834-6; Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sang YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29072; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Singh H, 2014, TRENDS IMMUNOL, V35, P211, DOI 10.1016/j.it.2014.03.006; Trang K, 2017, VIRAL IMMUNOL, V30, P142, DOI 10.1089/vim.2016.0160; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Wang TH, 2008, J IMMUNOL, V181, P3310, DOI 10.4049/jimmunol.181.5.3310; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wendel ES, 2017, VIROLOGY, V503, P12, DOI 10.1016/j.virol.2017.01.001; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Yamane F, 2014, J LEUKOCYTE BIOL, V95, P19, DOI 10.1189/jlb.0613311; Yaparla A, 2016, DEV COMP IMMUNOL, V63, P136, DOI 10.1016/j.dci.2016.05.014; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	59	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1736	1744		10.1074/jbc.M117.794065	http://dx.doi.org/10.1074/jbc.M117.794065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29259133	Green Published, hybrid			2022-12-28	WOS:000424201700024
J	Sikora, AE; Wierzbicki, IH; Zielke, RA; Ryner, RF; Korotkov, KV; Buchanan, SK; Noinaj, N				Sikora, Aleksandra E.; Wierzbicki, Igor H.; Zielke, Ryszard A.; Ryner, Rachael F.; Korotkov, Konstantin V.; Buchanan, Susan K.; Noinaj, Nicholas			Structural and functional insights into the role of BamD and BamE within the beta-barrel assembly machinery in Neisseria gonorrhoeae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BAM complex; BamD; BamE; cell envelope; Neisseria gonorrhoeae	OUTER-MEMBRANE LIPOPROTEIN; CRYSTAL-STRUCTURE; CELL-ENVELOPE; ESSENTIAL COMPONENT; YAET COMPLEX; PROTEIN; BIOGENESIS; SYSTEM; DOMAIN; SMPA	The -barrel assembly machinery (BAM) is a conserved multicomponent protein complex responsible for the biogenesis of -barrel outer membrane proteins (OMPs) in Gram-negative bacteria. Given its role in the production of OMPs for survival and pathogenesis, BAM represents an attractive target for the development of therapeutic interventions, including drugs and vaccines against multidrug-resistant bacteria such as Neisseria gonorrhoeae. The first structure of BamA, the central component of BAM, was from N. gonorrhoeae, the etiological agent of the sexually transmitted disease gonorrhea. To aid in pharmaceutical targeting of BAM, we expanded our studies to BamD and BamE within BAM of this clinically relevant human pathogen. We found that the presence of BamD, but not BamE, is essential for gonococcal viability. However, BamE, but not BamD, was cell-surface-displayed under native conditions; however, in the absence of BamE, BamD indeed becomes surface-exposed. Loss of BamE altered cell envelope composition, leading to slower growth and an increase in both antibiotic susceptibility and formation of membrane vesicles containing greater amounts of vaccine antigens. Both BamD and BamE are expressed in diverse gonococcal isolates, under host-relevant conditions, and throughout different phases of growth. The solved structures of Neisseria BamD and BamE share overall folds with Escherichia coli proteins but contain differences that may be important for function. Together, these studies highlight that, although BAM is conserved across Gram-negative bacteria, structural and functional differences do exist across species, which may be leveraged in the development of species-specific therapeutics in the effort to combat multidrug resistance.	[Sikora, Aleksandra E.; Wierzbicki, Igor H.; Zielke, Ryszard A.; Ryner, Rachael F.] Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97330 USA; [Korotkov, Konstantin V.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Buchanan, Susan K.] NIDDK, NIH, Bethesda, MD 20892 USA; [Noinaj, Nicholas] Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA; [Noinaj, Nicholas] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Oregon State University; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Sikora, AE (corresponding author), Oregon State Univ, Dept Pharmaceut Sci, Coll Pharm, Corvallis, OR 97330 USA.; Noinaj, N (corresponding author), Purdue Univ, Dept Biol Sci, Markey Ctr Struct Biol, W Lafayette, IN 47907 USA.; Noinaj, N (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	aleksandra.sikora@oregonstate.edu; nnoinaj@purdue.edu	Sikora, Aleksandra E/HGD-6641-2022	Korotkov, Konstantin/0000-0002-2182-6843	NIAID, National Institutes of Health [R01-AI117235]; Intramural Research Program of the NIDDK, National Institutes of Health; Department of Biological Sciences at Purdue University; Showalter Trust Award; NIAID, National Institutes of Health Grant [1K22AI113078-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI113078, R01AI117235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the NIDDK, National Institutes of Health; Department of Biological Sciences at Purdue University; Showalter Trust Award; NIAID, National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIAID, National Institutes of Health Grant R01-AI117235. To whom correspondence may be addressed. E-mail: aleksandra.sikora@oregonstate.edu.; Supported by the Intramural Research Program of the NIDDK, National Institutes of Health.; Supported by the Department of Biological Sciences at Purdue University, a Showalter Trust Award, and NIAID, National Institutes of Health Grant 1K22AI113078-01. To whom correspondence may be addressed. E-mail: nnoinaj@purdue.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Baarda BI, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00037-17; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bergal HT, 2016, STRUCTURE, V24, P243, DOI 10.1016/j.str.2015.10.030; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CONNELL TD, 1988, MOL MICROBIOL, V2, P227, DOI 10.1111/j.1365-2958.1988.tb00024.x; Dong C, 2012, ACTA CRYSTALLOGR D, V68, P95, DOI 10.1107/S0907444911051031; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Fussenegger M, 1996, MOL MICROBIOL, V19, P1095, DOI 10.1046/j.1365-2958.1996.457984.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Jansen KB, 2015, J BIOL CHEM, V290, P2126, DOI 10.1074/jbc.M114.584524; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jongerius I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003528; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, BIOCHEMISTRY-US, V50, P1081, DOI 10.1021/bi101659u; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lewis C, 2008, MICROBIOL-SGM, V154, P979, DOI 10.1099/mic.0.2007/011999-0; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mehr IJ, 2000, GENETICS, V154, P523; MENARD R, 1993, J BACTERIOL, V175, P5899; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; O'Neil PK, 2015, BIOCHEMISTRY-US, V54, P6303, DOI 10.1021/acs.biochem.5b00852; Ochsner UA, 1999, J BACTERIOL, V181, P1099, DOI 10.1128/JB.181.4.1099-1109.1999; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BR, 2015, J BACTERIOL, V197, P1051, DOI 10.1128/JB.02329-14; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Ricci DP, 2012, BBA-BIOMEMBRANES, V1818, P1067, DOI 10.1016/j.bbamem.2011.08.020; Rigel NW, 2012, J BACTERIOL, V194, P1002, DOI 10.1128/JB.06426-11; Roier S, 2016, MICROB CELL, V3, P257, DOI 10.15698/mic2016.06.508; Rollauer SE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0023; Roman-Hernandez G, 2014, ELIFE, V3, DOI 10.7554/eLife.04234; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Ryan KR, 2010, MICROBIOL-SGM, V156, P742, DOI 10.1099/mic.0.035055-0; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Spence J. M., 2008, CURR PROTOC MICROBIO, DOI [10. 1002/9780471729259. mc04a01s8 18770539, DOI 10.1002/9780471729259.MC04A01S818770539]; Unemo M, 2015, SEX TRANSM INFECT, V91, pA111, DOI 10.1136/sextrans-2015-052270.295; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Webb CT, 2012, J MOL BIOL, V422, P545, DOI 10.1016/j.jmb.2012.05.035; Wierzbicki IH, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.432; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zielke R. A., 2014, CURR PROTOC MICROBIO, V34, DOI [10. 1002/9780471729259. mc04a03s34 25082007, DOI 10.1002/9780471729259.MC04A03S3425082007]; Zielke RA, 2016, MOL CELL PROTEOMICS, V15, P2338, DOI 10.1074/mcp.M116.058800; Zielke RA, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0453-1; Zielke RA, 2014, MOL CELL PROTEOMICS, V13, P1299, DOI 10.1074/mcp.M113.029538	77	23	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1106	1119		10.1074/jbc.RA117.000437	http://dx.doi.org/10.1074/jbc.RA117.000437			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29229778	Green Published, hybrid			2022-12-28	WOS:000423515000001
J	Welty, S; Teng, YQ; Liang, ZB; Zhao, WX; Sanders, LH; Greenamyre, JT; Rubio, ME; Thathiah, A; Kodali, R; Wetzel, R; Levine, AS; Lan, L				Welty, Starr; Teng, Yaqun; Liang, Zhuobin; Zhao, Weixing; Sanders, Laurie H.; Greenamyre, J. Timothy; Rubio, Maria Eulalia; Thathiah, Amantha; Kodali, Ravindra; Wetzel, Ronald; Levine, Arthur S.; Lan, Li			RAD52 is required for RNA-templated recombination repair in post-mitotic neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer's disease; amyloid (A); neuron; recombination; RNA; oxidative damage	DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DNA-DAMAGE; ATM GENE; NEUROGENESIS; ANTIOXIDANTS; PROTEIN; CANCER; RISK	It has been long assumed that post-mitotic neurons only utilize the error-prone non-homologous end-joining pathway to repair double-strand breaks (DSBs) associated with oxidative damage to DNA, given the inability of non-replicating neuronal DNA to utilize a sister chromatid template in the less error-prone homologous recombination (HR) repair pathway. However, we and others have found recently that active transcription triggers a replication-independent recombinational repair mechanism in G(0)/G(1) phase of the cell cycle. Here we observed that the HR repair protein RAD52 is recruited to sites of DNA DSBs in terminally differentiated, post-mitotic neurons. This recruitment is dependent on the presence of a nascent mRNA generated during active transcription, providing evidence that an RNA-templated HR repair mechanism exists in non-dividing, terminally differentiated neurons. This recruitment of RAD52 in neurons is decreased by transcription inhibition. Importantly, we found that high concentrations of amyloid , a toxic protein associated with Alzheimer's disease, inhibits the expression and DNA damage response of RAD52, potentially leading to a defect in the error-free, RNA-templated HR repair mechanism. This study shows a novel RNA-dependent repair mechanism of DSBs in post-mitotic neurons and demonstrates that defects in this pathway may contribute to neuronal genomic instability and consequent neurodegenerative phenotypes such as those seen in Alzheimer's disease.	[Welty, Starr; Teng, Yaqun; Levine, Arthur S.; Lan, Li] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA; [Welty, Starr; Teng, Yaqun; Levine, Arthur S.; Lan, Li] UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Teng, Yaqun] Tsinghua Univ, Sch Med, 1 Tsinghua Yuan, Beijing 100084, Peoples R China; [Liang, Zhuobin; Zhao, Weixing] Yale Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sanders, Laurie H.] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27710 USA; [Greenamyre, J. Timothy; Thathiah, Amantha] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Wetzel, Ronald] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15213 USA; [Rubio, Maria Eulalia] Univ Pittsburgh, Sch Med, Dept Neurobiol & Otolaryngol, Pittsburgh, PA 15261 USA; [Kodali, Ravindra] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University; Yale University; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University	Lan, L (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, 5117 Ctr Ave, Pittsburgh, PA 15213 USA.	lil64@pitt.edu	Liang, Zhuobin/ABC-1209-2020; Wetzel, Ronald/G-7453-2011	Greenamyre, J. Timothy/0000-0003-3468-7878	National Institutes of Health [GM118833, DC013048]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by National Institutes of Health Grants GM118833 (to L. L.) and DC013048 (to M. E. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Haber JE, 1999, NATURE, V398, P665, DOI 10.1038/19423; Heidenreich E, 2003, EMBO J, V22, P2274, DOI 10.1093/emboj/cdg203; Helfricht A, 2013, CELL CYCLE, V12, P3070, DOI 10.4161/cc.26033; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Keskin H, 2014, NATURE, V515, P436, DOI 10.1038/nature13682; Khanna KK, 2000, JNCI-J NATL CANCER I, V92, P795, DOI 10.1093/jnci/92.10.795; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Lan L, 2005, J CELL SCI, V118, P4153, DOI 10.1242/jcs.02544; Lan L, 2004, DNA REPAIR, V3, P135, DOI 10.1016/j.dnarep.2003.10.005; Lawson ARJ, 2011, GENOME RES, V21, P505, DOI 10.1101/gr.115782.110; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ma CJ, 2017, J BIOL CHEM, V292, P11702, DOI 10.1074/jbc.M117.794545; Mazina OM, 2017, MOL CELL, V67, P19, DOI 10.1016/j.molcel.2017.05.019; Nakanishi K, 2011, METHODS MOL BIOL, V745, P283, DOI 10.1007/978-1-61779-129-1_16; Ristic D, 2003, NUCLEIC ACIDS RES, V31, P5229, DOI 10.1093/nar/gkg729; Sanders LH, 2014, NEUROBIOL DIS, V70, P214, DOI 10.1016/j.nbd.2014.06.014; Shen XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0124-15.2016; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Suberbielle E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9897; Wei LZ, 2015, P NATL ACAD SCI USA, V112, pE3495, DOI 10.1073/pnas.1507105112; Wei LZ, 2013, J CELL SCI, V126, P4414, DOI 10.1242/jcs.128272; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201	36	51	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1353	1362		10.1074/jbc.M117.808402	http://dx.doi.org/10.1074/jbc.M117.808402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29217771	Green Published, hybrid			2022-12-28	WOS:000423515000021
J	Guo, Q; Liao, SH; Zhu, ZL; Li, Y; Li, FD; Xu, C				Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao			Structural basis for the recognition of kinesin family member 21A (KIF21A) by the ankyrin domains of KANK1 and KANK2 proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell signaling; kinesin; structural biology; X-ray crystallography; ankyrin domain	REPEAT; BINDING; GROWTH; MOTIF; TRANSDUCTION; MUTATIONS; GENE	A well-controlled microtubule organization is essential for intracellular transport, cytoskeleton maintenance, and cell development. KN motif and ankyrin repeat domain-containing protein 1 (KANK1), a member of KANK family, recruits kinesin family member 21A (KIF21A) to the cell cortex to control microtubule growth via its C-terminal ankyrin domain. However, how the KANK1 ankyrin domain recognizes KIF21A and whether other KANK proteins can also bind KIF21A remain unknown. Here, using a combination of structural, site-directed mutagenesis, and biochemical studies, we found that a stretch of approximate to 22 amino acids in KIF21A is sufficient for binding to KANK1 and its close homolog KANK2. We further solved the complex structure of the KIF21A peptide with either the KANK1 ankyrin domain or the KANK2 ankyrin domain. In each complex, KIF21A is recognized by two distinct pockets of the ankyrin domain and adopts helical conformations upon binding to the ankyrin domain. The elucidated KANK structures may advance our understanding of the role of KANK1 as a scaffolding molecule in controlling microtubule growth at the cell periphery.	[Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Guo, Qiong; Liao, Shanhui; Zhu, Zhongliang; Li, Yue; Li, Fudong; Xu, Chao] Chinese Acad Sci, Hefei Sci Ctr CAS, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Liao, SH; Xu, C (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.; Liao, SH; Xu, C (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.; Liao, SH; Xu, C (corresponding author), Chinese Acad Sci, Hefei Sci Ctr CAS, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China.	ajsod@mail.ustc.edu.cn; xuchaor@ustc.edu.cn	Liao, Shanhui/N-1628-2018; Xu, Chao/G-3885-2010	Liao, Shanhui/0000-0002-5083-667X; Xu, Chao/0000-0003-0444-7080	National Natural Science Foundation of China [31570737, 31770806, 31500601]; Thousand Young Talent program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Young Talent program	This work was supported by National Natural Science Foundation of China Grants 31570737 and 31770806 (to C. X.) and 31500601 (to S. L.) and the "Thousand Young Talent program" (to C. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akhmanova A, 2009, TRAFFIC, V10, P268, DOI 10.1111/j.1600-0854.2008.00869.x; Allison SJ, 2015, NAT REV NEPHROL, V11, P387, DOI [10.1038/nrneph.2015.86, 10.1038/nrneph.2015.79]; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gallagher D, 2015, DEV CELL, V32, P31, DOI 10.1016/j.devcel.2014.11.031; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Ihara S, 2011, NAT CELL BIOL, V13, P641, DOI 10.1038/ncb2233; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liu HY, 2016, ELIFE, V5, DOI 10.7554/eLife.12856; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nie JY, 2015, STRUCTURE, V23, P700, DOI 10.1016/j.str.2015.02.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; van der Vaart B, 2013, DEV CELL, V27, P145, DOI 10.1016/j.devcel.2013.09.010; Wang C, 2014, ELIFE, V3, DOI 10.7554/eLife.04353; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Xu C, 2016, GENE DEV, V30, P2376, DOI 10.1101/gad.288340.116; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Xu C, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002979; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	41	8	8	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					557	566		10.1074/jbc.M117.817494	http://dx.doi.org/10.1074/jbc.M117.817494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183992	hybrid, Green Published			2022-12-28	WOS:000419915400012
J	Nadanaka, S; Kinouchi, H; Kitagawa, H				Nadanaka, Satomi; Kinouchi, Hiroki; Kitagawa, Hiroshi			Chondroitin sulfate-mediated N-cadherin/-catenin signaling is associated with basal-like breast cancer cell invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-catenin (B-catenin); breast cancer; cadherin; cell invasion; chondroitin sulfate; extracellular matrix; glycobiology; glycosaminoglycan; proteoglycan; sulfotransferase	E-DISACCHARIDE EXPRESSION; BETA-CATENIN; HEPARAN-SULFATE; GENE-EXPRESSION; GROWTH-FACTOR; CLEAVAGE; BIOSYNTHESIS; MIGRATION; ADHESION; BINDING	Tumor metastasis involves cancer cell invasion across basement membranes and interstitial tissues. The initial invasion step consists of adherence of the tumor cell to the extracellular matrix (ECM), and this binding transduces a variety of signals from the ECM to the tumor cell. Accordingly, it is critical to establish the mechanisms by which extracellular cues influence the intracellular activities that regulate tumor cell invasion. Here, we found that invasion of the basal-like breast cancer cell line BT-549 is enhanced by the ECM component chondroitin sulfates (CSs). CSs interacted with and induced proteolytic cleavage of N-cadherin in the BT-549 cells, yielding a C-terminal intracellular N-cadherin fragment that formed a complex with -catenin. Of note, the cleavage of N-cadherin increased cytoplasmic and nuclear -catenin levels; induced the matrix metalloproteinase 9 (MMP9) gene, a target of -catenin nuclear signaling; and augmented the invasion potential of the cells. We also found that CS-induced N-cadherin proteolysis requires caveolae-mediated endocytosis. An inhibitor of that process, nystatin, blocked both the endocytosis and proteolytic cleavage of N-cadherin induced by CS and also suppressed BT-549 cell invasion. Knock-out of chondroitin 4-O-sulfotransferase-1 (C4ST-1), a key CS biosynthetic enzyme, suppressed activation of the N-cadherin/-catenin pathway through N-cadherin endocytosis and significantly decreased BT-549 cell invasion. These results suggest that CSs produced by C4ST-1 might be useful therapeutic targets in the management of basal-like breast cancers.	[Nadanaka, Satomi; Kinouchi, Hiroki; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [23110003];  [16H05088];  [25460080]; Grants-in-Aid for Scientific Research [17K07353] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research on Innovative Areas 23110003 (to H. K.), Scientific Research (B) 16H05088 (to H. K.), and (C) 25460080 (to S. N.), and the Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.), from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Buchanan SM, 2010, P NATL ACAD SCI USA, V107, P17774, DOI 10.1073/pnas.1013105107; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Iida J, 2015, EXP CELL RES, V330, P358, DOI 10.1016/j.yexcr.2014.11.002; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Jang C, 2011, FASEB J, V25, P4174, DOI 10.1096/fj.11-185926; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kawauchi T, 2012, INT J MOL SCI, V13, P4564, DOI 10.3390/ijms13044564; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Koike T, 2012, BIOCHEM BIOPH RES CO, V420, P523, DOI 10.1016/j.bbrc.2012.03.024; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Ma R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0425-0; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mary S, 2002, MOL BIOL CELL, V13, P285, DOI 10.1091/mbc.01-07-0337; McCusker Catherine D, 2009, Commun Integr Biol, V2, P155; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Miyata S, 2012, NAT NEUROSCI, V15, P414, DOI 10.1038/nn.3023; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2008, J BIOL CHEM, V283, P27333, DOI 10.1074/jbc.M802997200; Nadanaka S, 2016, BIOCHEM BIOPH RES CO, V480, P234, DOI 10.1016/j.bbrc.2016.10.035; Nadanaka S, 2014, J BIOL CHEM, V289, P15231, DOI 10.1074/jbc.M113.545343; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Nadanaka S, 2011, J BIOL CHEM, V286, P4199, DOI 10.1074/jbc.M110.155093; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Nishimura R, 2008, BREAST CANCER-TOKYO, V15, P303, DOI 10.1007/s12282-008-0042-3; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; PIERCEALL WE, 1995, ONCOGENE, V11, P1319; Porlan E, 2014, NAT CELL BIOL, V16, P629, DOI 10.1038/ncb2993; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Presto J, 2008, P NATL ACAD SCI USA, V105, P4751, DOI 10.1073/pnas.0705807105; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Ra HJ, 2009, J BIOL CHEM, V284, P27924, DOI 10.1074/jbc.M109.035147; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rhee J, 2007, NAT CELL BIOL, V9, P883, DOI 10.1038/ncb1614; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Sirko S, 2010, STEM CELLS, V28, P775, DOI 10.1002/stem.309; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Ueda Y, 2002, INT J CANCER, V99, P681, DOI 10.1002/ijc.10418; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Williams H, 2010, CARDIOVASC RES, V87, P137, DOI 10.1093/cvr/cvq042; Willis CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103966; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	58	39	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					444	465		10.1074/jbc.M117.814509	http://dx.doi.org/10.1074/jbc.M117.814509			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183998	Green Published, hybrid			2022-12-28	WOS:000419915400004
J	Glidden, MD; Yang, YW; Smith, NA; Phillips, NB; Carr, K; Wickramasinghe, NP; Ismail-Beigi, F; Lawrence, MC; Smith, BJ; Weiss, MA				Glidden, Michael D.; Yang, Yanwu; Smith, Nicholas A.; Phillips, Nelson B.; Carr, Kelley; Wickramasinghe, Nalinda P.; Ismail-Beigi, Faramarz; Lawrence, Michael C.; Smith, Brian J.; Weiss, Michael A.			Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PICHIA-PASTORIS; GROWTH-FACTOR-I; MOLECULAR-DYNAMICS; BACKBONE DYNAMICS; CONFORMATIONAL DISORDER; DISTANCE RESTRAINTS; CRYSTAL-STRUCTURES; MODEL-FREE; NMR; STABILITY	Domain-minimized insulin receptors (IRs) have enabled crystallographic analysis of insulin-bound "micro-receptors." In such structures, the C-terminal segment of the insulin B chain inserts between conserved IR domains, unmasking an invariant receptor-binding surface that spans both insulinAand B chains. This "open" conformation not only rationalizes the inactivity of single-chain insulin (SCI) analogs (in which the A and B chains are directly linked), but also suggests that connecting (C) domains of sufficient length will bind the IR. Here, we report the high-resolution solution structure and dynamics of such an active SCI. The hormone's closed-to-open transition is foreshadowed by segmental flexibility in the native state as probed by heteronuclear NMR spectroscopy and multiple conformer simulations of crystallographic protomers as described in the companion article. We propose a model of the SCI's IR-bound state based on molecular-dynamics simulations of a micro-receptor complex. In this model, a loop defined by the SCI's B and C domains encircles the C-terminal segment of the IR beta-subunit. This binding mode predicts a conformational transition between an ultra-stable closed state (in the free hormone) and an active open state (on receptor binding). Optimization of this switch within an ultra-stable SCI promises to circumvent insulin's complex global cold chain. The analog's biphasic activity, which serendipitously resembles current premixed formulations of soluble insulin and microcrystalline suspension, may be of particular utility in the developing world.	[Glidden, Michael D.; Yang, Yanwu; Phillips, Nelson B.; Carr, Kelley; Wickramasinghe, Nalinda P.; Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Glidden, Michael D.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Nicholas A.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Melbourne, Vic 3086, Australia; [Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; La Trobe University; Walter & Eliza Hall Institute; University of Melbourne	Weiss, MA (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	weissma@iu.edu	Smith, Brian J/F-8282-2011; Lawrence, Michael C/A-5357-2009; Wickramasinghe, Nalinda P/F-9465-2010; Smith, Nicholas A/I-7422-2016	Smith, Brian J/0000-0003-0498-1910; Smith, Nicholas A/0000-0001-8894-4249; Wickramasinghe, Nalinda P./0000-0002-8700-2775; Lawrence, Michael/0000-0003-1999-0801	National Institutes of Health [R01 DK040949, R01 DK069764]; Australian National Health and Medical Research Council [APP1058233]; Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme; National Computational Infrastructure (NCI); Australian Government; Australian Government Research Training Program Scholarship; Sanofi (Germany); Medical Scientist Training Program [5T32GM007250-38]; American Diabetes Association [7-13-IN-31, 1-08-RA-149];  [1F30DK104618-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK069764, F30DK104618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government Operational Infrastructure Support; Australian NHMRC Independent Research Institutes Infrastructure Support Scheme(National Health and Medical Research Council (NHMRC) of Australia); National Computational Infrastructure (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Government(Australian GovernmentCGIAR); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Sanofi (Germany)(Sanofi-Aventis); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work, a contribution of the Cleveland Center for Membrane and Structural Biology and CWRU Institute for the Science of Origins, was supported in part by National Institutes of Health Grants R01 DK040949 and R01 DK069764 (to M. A. W.), by Australian National Health and Medical Research Council Project Grant APP1058233 (to M. C. L.), Victorian State Government Operational Infrastructure Support, Australian NHMRC Independent Research Institutes Infrastructure Support Scheme, both to his institution, and by the National Computational Infrastructure (NCI), which is supported by the Australian Government. This work was also supported by an Australian Government Research Training Program Scholarship (to N. A. S.). M. A. W. has equity in Thermalin Diabetes, LLC (Cleveland, OH), where he serves as Chief Innovation Officer; he has also been a consultant to Merck Research Laboratories and DEKA Research & Development Corp. N. B. P. and F. I.-B. are consultants to Thermalin Diabetes, LLC. Part of M.C.L.'s research is funded by Sanofi (Germany). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Pre-doctoral Fellow of the National Institutes of Health supported by Medical Scientist Training Program 5T32GM007250-38 and Fellowship 1F30DK104618-01.; Supported in part by American Diabetes Association Grants 7-13-IN-31 and 1-08-RA-149.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Angyan AF, 2013, MOLECULES, V18, P10548, DOI 10.3390/molecules180910548; BADGER J, 1992, BIOPHYS J, V61, P816, DOI 10.1016/S0006-3495(92)81886-6; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Becker RHA, 2007, DIABETES TECHNOL THE, V9, P109, DOI 10.1089/dia.2006.0035; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Binder PM, 2011, EMBO REP, V12, P495, DOI 10.1038/embor.2011.83; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BREMS DN, 1991, J BIOL CHEM, V266, P1611; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; BURLING FT, 1994, ISRAEL J CHEM, V34, P165; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabail MZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7406; Campbell E, 2016, NAT CHEM BIOL, V12, P944, DOI [10.1038/NCHEMBIO.2175, 10.1038/nchembio.2175]; Carr K., 2017, THESIS; Charity KW, 2016, DIABETES RES CLIN PR, V112, P37, DOI 10.1016/j.diabres.2015.11.006; CISZAK E, 1995, STRUCTURE, V3, P615, DOI 10.1016/S0969-2126(01)00195-2; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COSMATOS A, 1978, J BIOL CHEM, V253, P6586; Croll TI, 2016, STRUCTURE, V24, P469, DOI 10.1016/j.str.2015.12.014; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DeFelippis MR, 2001, CRIT REV THER DRUG, V18, P201; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fushman D, 2012, METHODS MOL BIOL, V831, P485, DOI 10.1007/978-1-61779-480-3_24; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Glidden MD, 2018, J BIOL CHEM, V293, P47, DOI 10.1074/jbc.M117.808626; Goddard D., 2008, SPARKY 3; Guillausseau PJ, 2008, DIABETES METAB, V34, pS43, DOI 10.1016/S1262-3636(08)73394-9; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Heise T, 1998, DIABETES CARE, V21, P800, DOI 10.2337/diacare.21.5.800; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua Qing-Xin, 2011, Front Endocrinol (Lausanne), V2, P48, DOI 10.3389/fendo.2011.00048; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; Kalra S, 2013, J Assoc Physicians India, V61, P9; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kjeldsen T, 1999, BIOTECHNOL APPL BIOC, V29, P79; Laajoki LG, 2000, J BIOL CHEM, V275, P10009, DOI 10.1074/jbc.275.14.10009; Levin EJ, 2007, STRUCTURE, V15, P1040, DOI 10.1016/j.str.2007.06.019; Li QX, 2014, BBA-BIOMEMBRANES, V1838, P1313, DOI 10.1016/j.bbamem.2014.01.005; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; OHARA T, 1989, J BIOL CHEM, V264, P20625; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Pandyarajan V, 2016, J BIOL CHEM, V291, P12978, DOI 10.1074/jbc.M115.708347; Pandyarajan V, 2014, J BIOL CHEM, V289, P23367, DOI 10.1074/jbc.M114.588277; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sanbonmatsu KY, 2012, CURR OPIN STRUC BIOL, V22, P168, DOI 10.1016/j.sbi.2012.01.008; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Setter SM, 2000, ANN PHARMACOTHER, V34, P1423; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi LX, 2017, DIABETES THER, V8, P915, DOI 10.1007/s13300-017-0286-z; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sohma Y, 2010, J BIOL CHEM, V285, P5040, DOI 10.1074/jbc.M109.062992; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Sugiki T, 2012, METHODS MOL BIOL, V831, P19, DOI 10.1007/978-1-61779-480-3_2; TORDA AE, 1990, J MOL BIOL, V214, P223, DOI 10.1016/0022-2836(90)90157-H; TORDA AE, 1989, CHEM PHYS LETT, V157, P289, DOI 10.1016/0009-2614(89)87249-5; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vinther TN, 2013, PROTEIN SCI, V22, P296, DOI 10.1002/pro.2211; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weiss M., 2013, J HLTH SPEC, V1, P59, DOI DOI 10.4103/1658-600X.114683; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850; Yang YW, 2010, J BIOL CHEM, V285, P7847, DOI 10.1074/jbc.C109.084921; Zaykov AN, 2016, NAT REV DRUG DISCOV, V15, P425, DOI 10.1038/nrd.2015.36; Zhang Y. Z., 1995, THESIS	100	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					69	88		10.1074/jbc.M117.808667	http://dx.doi.org/10.1074/jbc.M117.808667			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29114034	Green Published, hybrid			2022-12-28	WOS:000419453200005
J	Wilson, RH; Martin-Avila, E; Conlan, C; Whitney, SM				Wilson, Robert H.; Martin-Avila, Elena; Conlan, Carly; Whitney, Spencer M.			An improved Escherichia coli screen for Rubisco identifies a protein-protein interface that can enhance CO2-fixation kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBAL FOOD; PHOTOSYNTHESIS; TOBACCO; GROWTH; CHLOROPLASTS; EXPRESSION; EFFICIENCY; ENZYME; PLANTS; CO2	An overarching goal of photosynthesis research is to identify how components of the process can be improved to benefit crop productivity, global food security, and renewable energy storage. Improving carbon fixation has mostly focused on enhancing the CO2 fixing enzyme ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). This grand challenge has mostly proved ineffective because of catalytic mechanism constraints and required chaperone complementarity that hinder Rubisco biogenesis in alternative hosts. Here we refashion Escherichia coli metabolism by expressing a phosphoribulokinase-neomycin phosphotransferase fusion protein to produce a high-fidelity, high-throughput Rubisco-directed evolution (RDE2) screen that negates false-positive selection. Successive evolution rounds using the plant-like Te-Rubisco from the cyanobacterium Thermosynechococcus elongatus BP1 identified two large subunit and six small subunit mutations that improved carboxylation rate, efficiency, and specificity. Structural analysis revealed the amino acids clustered in an unexplored subunit interface of the holoenzyme. To study its effect on plant growth, the Te-Rubisco was transformed into tobacco by chloroplast transformation. As previously seen for Synechocccus PCC6301 Rubisco, the specialized folding and assembly requirements of Te-Rubisco hinder its heterologous expression in leaf chloroplasts. Our findings suggest that the ongoing efforts to improve crop photosynthesis by integrating components of a cyanobacteria CO2-concentrating mechanism will necessitate co-introduction of the ancillary molecular components required for Rubisco biogenesis.	[Wilson, Robert H.; Martin-Avila, Elena; Conlan, Carly; Whitney, Spencer M.] Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia	Australian National University	Whitney, SM (corresponding author), Australian Natl Univ, Res Sch Biol, Acton, ACT 2601, Australia.	spencer.whitney@anu.edu.au	Wilson, Robbie/AAP-7650-2020; Whitney, Spencer M/C-9266-2009; Wilson, Robert H/C-3593-2019	Wilson, Robbie/0000-0003-4168-2805; Whitney, Spencer M/0000-0003-2954-2359; Wilson, Robert H/0000-0003-4168-2805	Australian Research Council Centre of Excellence for Translational Photosynthesis Grant [CE140100015]	Australian Research Council Centre of Excellence for Translational Photosynthesis Grant(Australian Research Council)	This work was supported by Australian Research Council Centre of Excellence for Translational Photosynthesis Grant CE140100015 (to S. M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Antonovsky N, 2017, CURR OPIN BIOTECH, V47, P83, DOI 10.1016/j.copbio.2017.06.006; Antonovsky N, 2016, CELL, V166, P115, DOI 10.1016/j.cell.2016.05.064; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Cai Z, 2014, PROTEIN CELL, V5, P552, DOI 10.1007/s13238-014-0072-x; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Greene DN, 2007, BIOCHEM J, V404, P517, DOI 10.1042/BJ20070071; Hanson MR, 2016, PLANT J, V87, P38, DOI 10.1111/tpj.13139; He ZL, 1997, PLANT PHYSIOL, V115, P1569, DOI 10.1104/pp.115.4.1569; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; KANE HJ, 1994, AUST J PLANT PHYSIOL, V21, P449, DOI 10.1071/PP9940449; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Mueller-Cajar O, 2008, BIOCHEM J, V414, P205, DOI 10.1042/BJ20080668; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Occhialini A, 2016, PLANT J, V85, P148, DOI 10.1111/tpj.13098; Ort DR, 2015, P NATL ACAD SCI USA, V112, P8529, DOI 10.1073/pnas.1424031112; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Price GD, 2014, NATURE, V513, P497, DOI 10.1038/nature13749; Sharwood RE, 2017, NEW PHYTOL, V213, P494, DOI 10.1111/nph.14351; Sharwood RE, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.186, 10.1038/nplants.2016.186]; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Tcherkez G, 2016, PLANT CELL ENVIRON, V39, P983, DOI 10.1111/pce.12629; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Whitfield JH, 2015, PROTEIN SCI, V24, P1412, DOI 10.1002/pro.2721; Whitney SM, 2003, PLANT PHYSIOL, V133, P287, DOI 10.1104/pp.103.026146; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; Whitney SM, 2015, P NATL ACAD SCI USA, V112, P3564, DOI 10.1073/pnas.1420536112; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Wilson RH., 2017, DIRECTED ENZYME EVOL, P101, DOI [10.1007/978-3-319-50413-1_4, DOI 10.1007/978-3-319-50413-1_4]; Wilson RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22284; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107	38	42	43	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					18	27		10.1074/jbc.M117.810861	http://dx.doi.org/10.1074/jbc.M117.810861			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	28986448	Green Published, hybrid			2022-12-28	WOS:000419453200002
J	Lim, KYB; Godde, NJ; Humbert, PO; Kvansakul, M				Lim, Krystle Y. B.; Goedde, Nathan J.; Humbert, Patrick O.; Kvansakul, Marc			Structural basis for the differential interaction of Scribble PDZ domains with the guanine nucleotide exchange factor -PIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell polarity; PDZ domain; X-ray crystallography; -pix; Scribble	PROMOTES MAMMARY TUMORIGENESIS; POLARITY PROTEIN SCRIB; CELL-POLARITY; LIGAND SPECIFICITY; MIGRATION; COMPLEX; CANCER; POLARIZATION; FEATURES; REVEALS	Scribble is a highly conserved protein regulator of cell polarity that has been demonstrated to function as a tumor suppressor or, conversely, as an oncogene in a context-dependent manner, and it also controls many physiological processes ranging from immunity to memory. Scribble consists of a leucine-rich repeat domain and four PDZ domains, with the latter being responsible for most of Scribble's complex formation with other proteins. Given the similarities of the Scribble PDZ domain sequences in their binding grooves, it is common for these domains to show overlapping preferences for the same ligand. Yet, Scribble PDZ domains can still exhibit unique binding profiles toward other ligands. This raises the fundamental question as to how these PDZ domains discriminate ligands and exert specificities in Scribble complex formation. To better understand how Scribble PDZ domains direct cell polarity signaling, we investigated here their interactions with the well-characterized Scribble binding partner -PIX, a guanine nucleotide exchange factor. We report the interaction profiles of all isolated Scribble PDZ domains with a -PIX peptide. We show that Scribble PDZ1 and PDZ3 are the major interactors with -PIX and reveal a distinct binding hierarchy in the interactions between the individual Scribble PDZ domains and -PIX. Furthermore, using crystal structures of PDZ1 and PDZ3 bound to -PIX, we define the structural basis for Scribble's ability to specifically engage -PIX via its PDZ domains and provide a mechanistic platform for understanding Scribble--PIX-coordinated cellular functions such as directional cell migration.	[Lim, Krystle Y. B.; Goedde, Nathan J.; Humbert, Patrick O.; Kvansakul, Marc] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Lim, Krystle Y. B.; Goedde, Nathan J.; Humbert, Patrick O.] Peter MacCallum Canc Ctr, Cell Cycle & Canc Genet Lab, Div Res, Melbourne, Vic 3002, Australia; [Humbert, Patrick O.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3002, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Humbert, Patrick O.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Humbert, Patrick O.; Kvansakul, Marc] La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia	La Trobe University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; University of Melbourne; La Trobe University	Humbert, PO; Kvansakul, M (corresponding author), La Trobe Univ, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	p.humbert@latrobe.edu.au; m.kvansakul@latrobe.edu.au	Kvansakul, Marc/AAF-2453-2019; Humbert, Patrick O/L-4264-2016	Kvansakul, Marc/0000-0003-2639-2498; Humbert, Patrick O/0000-0002-1366-6691; Godde, Nathan/0000-0002-3413-407X; Lim, Krystle/0000-0002-4008-6529	National Health and Medical Research Council Australia [APP1103871]; Senior Research Fellowship [APP1079133]; Australian Research Council Fellowship [FT130101349]; La Trobe University Scholarship	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship; Australian Research Council Fellowship(Australian Research Council); La Trobe University Scholarship	This work was supported in whole or part by the National Health and Medical Research Council Australia Project Grant APP1103871 (to M. K. and P. O. H.), Senior Research Fellowship APP1079133 (to P. O. H.), Australian Research Council Fellowship FT130101349 (to M. K.), and La Trobe University Scholarship (to K. Y. B. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Appleton BA, 2006, J BIOL CHEM, V281, P22312, DOI 10.1074/jbc.M602901200; Arnaud C, 2009, FEBS LETT, V583, P2326, DOI 10.1016/j.febslet.2009.06.034; Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Cervantes-Sandoval I, 2016, NEURON, V90, P1230, DOI 10.1016/j.neuron.2016.05.010; Dow LE, 2007, ONCOGENE, V26, P2272, DOI 10.1038/sj.onc.1210016; Elsum IA, 2014, ONCOGENE, V33, P5523, DOI 10.1038/onc.2013.498; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feigin ME, 2014, CANCER RES, V74, P3180, DOI 10.1158/0008-5472.CAN-13-3415; Godde NJ, 2014, EXP CELL RES, P1, DOI DOI 10.1371/J0URNAL.PGEN.1004323; Halaoui R, 2015, ONCOGENE, V34, P939, DOI 10.1038/onc.2014.59; Humbert PO, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P65, DOI 10.1007/978-3-319-14463-4_4; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Jarjour AA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallay LM, 2006, J CELL BIOCHEM, V99, P647, DOI 10.1002/jcb.20992; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; McCaffrey LM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009654; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Michaelis UR, 2013, CIRC RES, V112, P924, DOI 10.1161/CIRCRESAHA.112.300592; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Nola S, 2008, HUM MOL GENET, V17, P3552, DOI 10.1093/hmg/ddn248; Ohno S, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P3, DOI 10.1007/978-3-319-14463-4_1; Ono Y, 2015, CELL REP, V10, P1135, DOI 10.1016/j.celrep.2015.01.045; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Pearson HB, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0440-z; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Rautureau GJP, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.178; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Skelton NJ, 2003, J BIOL CHEM, V278, P7645, DOI 10.1074/jbc.M209751200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vacca B, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P51, DOI 10.1007/978-3-319-14463-4_3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang YN, 2006, J BIOL CHEM, V281, P22299, DOI 10.1074/jbc.M602902200; Zheng WY, 2016, NAT CELL BIOL, V18, P1244, DOI 10.1038/ncb3413	41	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20425	20436		10.1074/jbc.M117.799452	http://dx.doi.org/10.1074/jbc.M117.799452			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29061852	Green Published, hybrid			2022-12-28	WOS:000418267000007
J	Hughey, CC; James, FD; Bracy, DP; Donahue, EP; Young, JD; Viollet, B; Foretz, M; Wasserman, DH				Hughey, Curtis C.; James, Freyja D.; Bracy, Deanna P.; Donahue, E. Patrick; Young, Jamey D.; Viollet, Benoit; Foretz, Marc; Wasserman, David H.			Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						energy metabolism; fibroblast growth factor (FGF); intermediary metabolism; isotopic tracer; liver metabolism; metabolic flux analysis	SKELETAL-MUSCLE GLYCOGEN; IN-VIVO; METABOLIC-REGULATION; GLUCOSE-HOMEOSTASIS; ENERGY-METABOLISM; MUSCULAR WORK; FATTY LIVER; SHORT-TERM; INSULIN; METFORMIN	Pathologies including diabetes and conditions such as exercise place an unusual demand on liver energy metabolism, and this demand induces a state of energy discharge. Hepatic AMP-activated protein kinase (AMPK) has been proposed to inhibit anabolic processes such as gluconeogenesis in response to cellular energy stress. However, both AMPK activation and glucose release from the liver are increased during exercise. Here, we sought to test the role of hepatic AMPK in the regulation of in vivo glucose-producing and citric acid cycle-related fluxes during an acute bout of muscular work. We used H-2/C-13 metabolic flux analysis to quantify intermediary metabolism fluxes in both sedentary and treadmill-running mice. Additionally, liver-specific AMPK 1 and 2 subunit KO and WT mice were utilized. Exercise caused an increase in endogenous glucose production, glycogenolysis, and gluconeogenesis from phosphoenolpyruvate. Citric acid cycle fluxes, pyruvate cycling, anaplerosis, and cataplerosis were also elevated during this exercise. Sedentary nutrient fluxes in the postabsorptive state were comparable for the WT and KO mice. However, the increment in the endogenous rate of glucose appearance during exercise was blunted in the KO mice because of a diminished glycogenolytic flux. This lower rate of glycogenolysis was associated with lower hepatic glycogen content before the onset of exercise and prompted a reduction in arterial glucose during exercise. These results indicate that liver AMPK12 is required for maintaining glucose homeostasis during an acute bout of exercise.	[Hughey, Curtis C.; James, Freyja D.; Bracy, Deanna P.; Donahue, E. Patrick; Young, Jamey D.; Wasserman, David H.] Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA; [James, Freyja D.; Bracy, Deanna P.; Wasserman, David H.] Vanderbilt Univ, Mouse Metab Phenotyping Ctr, Nashville, TN 37232 USA; [Young, Jamey D.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37232 USA; [Viollet, Benoit; Foretz, Marc] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit; Foretz, Marc] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Wasserman, DH (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, 823 Light Hall,2215 Garland Ave, Nashville, TN 37232 USA.	david.wasserman@vanderbilt.edu	Viollet, Benoit/N-2397-2019; Young, Jamey/A-5857-2012; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032	NIDDK, National Institutes of Health [DK050277, DK054902, DK106348]; Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P30DK058404, U24DK059637, P30DK020593, U2CDK059637, R01DK106348, R01DK050277, R01DK054902, R56DK054902, R37DK050277] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Diabetes Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Grants DK050277 (to D. H. W.), DK054902 (to D. H. W.), and DK106348 (to J. D. Y.) and a Diabetes Canada Postdoctoral Fellowship (to C. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2011, ANAL CHEM, V83, P3211, DOI 10.1021/ac200012p; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; Ayala JE, 2011, JOVE-J VIS EXP, DOI 10.3791/3188; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Burgess SC, 2005, AM J PHYSIOL-ENDOC M, V289, pE53, DOI 10.1152/ajpendo.00601.2004; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Camacho RC, 2005, EXERC SPORT SCI REV, V33, P17; Carlson CL, 1999, J APPL PHYSIOL, V86, P669, DOI 10.1152/jappl.1999.86.2.669; Solaz-Fuster MC, 2008, HUM MOL GENET, V17, P667, DOI 10.1093/hmg/ddm339; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; HEMS R, 1966, BIOCHEM J, V101, P284, DOI 10.1042/bj1010284; Jiao P, 2013, MOL CELL ENDOCRINOL, V375, P157, DOI 10.1016/j.mce.2013.05.021; Kang L, 2012, J APPL PHYSIOL, V113, P1173, DOI 10.1152/japplphysiol.01344.2011; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; Lee-Young RS, 2010, AM J PHYSIOL-REG I, V298, pR1399, DOI 10.1152/ajpregu.00004.2010; Lee-Young RS, 2009, J BIOL CHEM, V284, P23925, DOI 10.1074/jbc.M109.021048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Markan KR, 2016, SEMIN CELL DEV BIOL, V53, P85, DOI 10.1016/j.semcdb.2015.09.021; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; MORGAN CR, 1965, DIABETES, V14, P669, DOI 10.2337/diab.14.10.669; Nilsson EC, 2006, J BIOL CHEM, V281, P7244, DOI 10.1074/jbc.M510461200; Otero YF, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.250; Perry RJ, 2016, J BIOL CHEM, V291, P12161, DOI 10.1074/jbc.M116.720631; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Previs SF, 2015, AM J PHYSIOL-ENDOC M, V309, pE727, DOI 10.1152/ajpendo.00216.2015; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Roach PJ, 2012, BIOCHEM J, V441, P763, DOI 10.1042/BJ20111416; ROACH PJ, 1976, J BIOL CHEM, V251, P1920; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; Salminen A, 2017, J MOL MED, V95, P123, DOI 10.1007/s00109-016-1477-1; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Scheffler T. L., 2016, PHYSL REP; SCRUTTON MC, 1974, J BIOL CHEM, V249, P7057; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shearer J, 2004, EXERC SPORT SCI REV, V32, P120, DOI 10.1097/00003677-200407000-00008; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Tanimura Y., 2016, PHYSL REP; VERHOEVEN AJM, 1995, EUR J BIOCHEM, V228, P236; Vernia S, 2009, J BIOL CHEM, V284, P8247, DOI 10.1074/jbc.M808492200; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang HM, 2008, BIOCHEM PHARMACOL, V75, P457, DOI 10.1016/j.bcp.2007.08.028; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; WASSERMAN DH, 1989, AM J PHYSIOL, V256, pE500, DOI 10.1152/ajpendo.1989.256.4.E500; WASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108, DOI 10.1152/ajpendo.1989.257.1.E108; WASSERMAN DH, 1992, AM J PHYSIOL, V263, pE345, DOI 10.1152/ajpendo.1992.263.2.E345; WASSERMAN DH, 1991, AM J PHYSIOL, V260, pE811, DOI 10.1152/ajpendo.1991.260.6.E811; Williams AS, 2017, DIABETES, V66, P325, DOI 10.2337/db16-0484; WOLFE RR, 1986, J CLIN INVEST, V77, P900, DOI 10.1172/JCI112388; WOODS HF, 1973, BIOCHEM J, V132, P55, DOI 10.1042/bj1320055; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhu SL, 2014, ACTA BIOCH BIOPH SIN, V46, P1041, DOI 10.1093/abbs/gmu097	82	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20125	20140		10.1074/jbc.M117.811547	http://dx.doi.org/10.1074/jbc.M117.811547			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038293	Green Published, hybrid			2022-12-28	WOS:000417696400019
J	Lisa, S; Domingo, B; Martinez, J; Gilch, S; Llopis, JF; Schatzl, HM; Gasset, M				Lisa, Silvia; Domingo, Beatriz; Martinez, Javier; Gilch, Sabine; Llopis, Juan F.; Schatzl, Hermann M.; Gasset, Maria			RETRACTION: Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms. (Retraction of Vol 287, Pg 36693, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Gasset, Maria/K-4339-2012	Gasset, Maria/0000-0001-6436-4055				Lisa S, 2012, J BIOL CHEM, V287, P36693, DOI 10.1074/jbc.M112.398776	1	0	0	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20045	20045		10.1074/jbc.W117.000978	http://dx.doi.org/10.1074/jbc.W117.000978			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29222196	Green Published, hybrid			2022-12-28	WOS:000417696400011
J	Knittle, AM; Helkkula, M; Johnson, MS; Sundvall, M; Elenius, K				Knittle, Anna M.; Helkkula, Maria; Johnson, Mark S.; Sundvall, Maria; Elenius, Klaus			SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; nuclear transport; posttranslational modification (PTM); protein export; receptor tyrosine kinase; small ubiquitin-like modifier (SUMO); ErbB4; HER4; regulated intramembrane proteolysis (RIP); nuclear transport; RTK; breast cancer	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; EXPORT SIGNALS; ESTROGEN-RECEPTOR; ACTIVATED STAT3; EGF RECEPTOR; IN-VIVO; PROTEIN; LOCALIZATION; EXPRESSION	Erb-B2 receptor tyrosine kinase 4 (ErbB4) is a kinase that can signal via a proteolytically released intracellular domain (ICD) in addition to classical receptor tyrosine kinase-activated signaling cascades. Previously, we have demonstrated that ErbB4 ICD is posttranslationally modified by the small ubiquitin-like modifier (SUMO) and functionally interacts with the PIAS3 SUMO E3 ligase. However, direct evidence of SUMO modification in ErbB4 signaling has remained elusive. Here, we report that the conserved lysine residue 714 in the ErbB4 ICD undergoes SUMO modification, which was reversed by sentrin-specific proteases (SENPs) 1, 2, and 5. Although ErbB4 kinase activity was not necessary for the SUMOylation, the SUMOylated ErbB4 ICD was tyrosine phosphorylated to a higher extent than unmodified ErbB4 ICD. Mutation of the SUMOylation site compromised neither ErbB4-induced phosphorylation of the canonical signaling pathway effectors Erk1/2, Akt, or STAT5 nor ErbB4 stability. In contrast, SUMOylation was required for nuclear accumulation of the ErbB4 ICD. We also found that Lys-714 was located within a leucine-rich stretch, which resembles a nuclear export signal, and could be inactivated by site-directed mutagenesis. Furthermore, SUMOylation modulated the interaction of ErbB4 with chromosomal region maintenance 1 (CRM1), the major nuclear export receptor for proteins. Finally, the SUMO acceptor lysine was functionally required for ErbB4 ICD-mediated inhibition of mammary epithelial cell differentiation in a three-dimensional cell culture model. Our findings indicate that a SUMOylation-mediated mechanism regulates nuclear localization and function of the ICD of ErbB4 receptor tyrosine kinase.	[Knittle, Anna M.; Helkkula, Maria; Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland; [Knittle, Anna M.; Helkkula, Maria; Sundvall, Maria; Elenius, Klaus] Univ Turku, MediCity Res Lab, FI-20520 Turku, Finland; [Knittle, Anna M.] Univ Turku, Turku Doctoral Programmes Biomed Sci & Mol Med, FI-20014 Turku, Finland; [Johnson, Mark S.] Abo Akad Univ, Struct Bioinformat Lab, Biochem, Fac Sci & Engn, FI-20500 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Univ Turku, Dept Radiotherapy & Oncol, FI-20014 Turku, Finland; [Sundvall, Maria; Elenius, Klaus] Turku Univ Hosp, FI-20014 Turku, Finland	University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku	Sundvall, M; Elenius, K (corresponding author), Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	maria.sundvall@utu.fi; klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827; Sundvall, Maria H/0000-0002-0494-2965	Academy of Finland; Cancer Foundation of Finland; Cancer Society of Southwest Finland; Finnish Cultural Foundation; Foundation of Abo Akademi University; Ida Montin Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Orion-Farmos Research Foundation; Sigrid Juselius Foundation; Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation; Cancer Foundation Finland sr [130077, 160067] Funding Source: researchfish	Academy of Finland(Academy of Finland); Cancer Foundation of Finland; Cancer Society of Southwest Finland; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Foundation of Abo Akademi University; Ida Montin Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Orion-Farmos Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; Turku University Foundation; Cancer Foundation Finland sr	This work was financially supported by the Academy of Finland; the Cancer Foundation of Finland; the Cancer Society of Southwest Finland; the Finnish Cultural Foundation; the Foundation of Abo Akademi University; the Ida Montin Foundation; the Joe, Pentti, and Tor Borg Memorial Fund; the Orion-Farmos Research Foundation; the Sigrid Juselius Foundation; the Turku Doctoral Programme of Biomedical Sciences; Turku University Central Hospital; and the Turku University Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bawa-Khalfe T, 2012, P NATL ACAD SCI USA, V109, P17466, DOI 10.1073/pnas.1209378109; de la Cruz-Herrera CF, 2015, ONCOGENE, V34, P1442, DOI 10.1038/onc.2014.48; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761; Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612; Engelsma D, 2004, EMBO J, V23, P3643, DOI 10.1038/sj.emboj.7600370; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gilmore-Hebert M, 2010, MOL CANCER RES, V8, P1388, DOI 10.1158/1541-7786.MCR-10-0042; Hang J, 2002, J BIOL CHEM, V277, P19961, DOI 10.1074/jbc.M201799200; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Impens F, 2014, P NATL ACAD SCI USA, V111, P12432, DOI 10.1073/pnas.1413825111; Jones FE, 2008, J MAMMARY GLAND BIOL, V13, P247, DOI 10.1007/s10911-008-9076-6; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kurppa KJ, 2016, ONCOGENE, V35, P1283, DOI 10.1038/onc.2015.185; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lamoliatte F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6409; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Linggi B, 2006, ONCOGENE, V25, P160, DOI 10.1038/sj.onc.1209003; Linggi B, 2006, J BIOL CHEM, V281, P25373, DOI 10.1074/jbc.M603998200; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; McHale K, 2008, MODERN PATHOL, V21, P565, DOI 10.1038/modpathol.2008.7; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Muraoka-Cook RS, 2009, MOL CELL BIOL, V29, P4935, DOI 10.1128/MCB.01705-08; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paatero I, 2012, J BIOL CHEM, V287, P9659, DOI 10.1074/jbc.M111.299537; Packham S, 2015, BIOCHEMISTRY-US, V54, P5157, DOI 10.1021/acs.biochem.5b00640; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Pircher TJ, 1997, MOL CELL ENDOCRINOL, V133, P169, DOI 10.1016/S0303-7207(97)00164-0; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Rytinki MM, 2009, J BIOL CHEM, V284, P26184, DOI 10.1074/jbc.M109.038943; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Santiago A, 2013, MOL BIOL CELL, V24, P2739, DOI 10.1091/mbc.E12-10-0771; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Srinivasan R, 2000, CANCER RES, V60, P1483; Sundvall M, 2007, ONCOGENE, V26, P6905, DOI 10.1038/sj.onc.1210501; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Tammsalu T, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005146; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vidal GA, 2005, J BIOL CHEM, V280, P19777, DOI 10.1074/jbc.M412457200; Wang LM, 2004, ONCOL REP, V11, P1319; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood LD, 2003, P NATL ACAD SCI USA, V100, P3257, DOI 10.1073/pnas.0637114100; Yang SF, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2063-1; Yao Q, 2011, J BIOL CHEM, V286, P27342, DOI 10.1074/jbc.M111.220848; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	73	11	12	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19890	19904		10.1074/jbc.M117.794271	http://dx.doi.org/10.1074/jbc.M117.794271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28974580	Green Published, hybrid			2022-12-28	WOS:000416911300031
J	Nilsson, I; Grove, K; Dovala, D; Uehara, T; Lapointe, G; Six, DA				Nilsson, Inga; Grove, Kerri; Dovala, Dustin; Uehara, Tsuyoshi; Lapointe, Guillaume; Six, David A.			Molecular characterization and verification of azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid incorporation into bacterial lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gel electrophoresis; gram-negative bacteria; lipopolysaccharide (LPS); mass spectrometry (MS); metabolic tracer; microscopy; outer membrane; Kdo; labeling	ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOSYNTHESIS; CONSERVATION; PURIFICATION; RESISTANCE; ENDOTOXIN; EXCISION; DIVISION; PROGRESS	3-Deoxy-d-manno-oct-2-ulosonic acid (Kdo) is an essential component of LPS in the outer leaflet of the Gram-negative bacterial outer membrane. Although labeling of Escherichia coli with the chemical reporter 8-azido-3,8-dideoxy-d-manno-oct-2-ulosonic acid (Kdo-N-3) has been reported, its incorporation into LPS has not been directly shown. We have now verified Kdo-N-3 incorporation into E. coli LPS at the molecular level. Using microscopy and PAGE analysis, we show that Kdo-N-3 is localized to the outer membrane and specifically incorporates into rough and deep-rough LPS. In an E. coli strain lacking endogenous Kdo biosynthesis, supplementation with exogenous Kdo restored full-length core-LPS, which suggests that the Kdo biosynthetic pathways might not be essential in vivo in the presence of sufficient exogenous Kdo. In contrast, exogenous Kdo-N-3 only restored a small fraction of core LPS with the majority incorporated into truncated LPS. The truncated LPS were identified as Kdo-N-3-lipid IVA and (Kdo-N-3)(2)-lipid IVA by MS analysis. The low level of Kdo-N-3 incorporation could be partly explained by a 6-fold reduction in the specificity constant of the CMP-Kdo synthetase KdsB with Kdo-N-3 compared with Kdo. These results indicate that the azido moiety in Kdo-N-3 interferes with its utilization and may limit its utility as a tracer of LPS biosynthesis and transport in E. coli. We propose that our findings will be helpful for researchers using Kdo and its chemical derivatives for investigating LPS biosynthesis, transport, and assembly in Gram-negative bacteria.	[Nilsson, Inga; Dovala, Dustin; Uehara, Tsuyoshi; Six, David A.] Novartis Inst BioMed Res, Dept Infect Dis, Emeryville, CA 94608 USA; [Grove, Kerri; Lapointe, Guillaume] Novartis Inst BioMed Res, Dept Global Discovery Chem, Emeryville, CA 94608 USA	Novartis; Novartis	Six, DA (corresponding author), Novartis Inst BioMed Res, Dept Infect Dis, Emeryville, CA 94608 USA.	david.six@novartis.com	Six, David A/D-6523-2011	Six, David A/0000-0002-9013-1711; Uehara, Tsuyoshi/0000-0001-6994-4286; Lapointe, Guillaume/0000-0002-0451-0505				BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Carroll L, 2013, ORG BIOMOL CHEM, V11, P5772, DOI 10.1039/c3ob40897c; COOK WR, 1986, J BACTERIOL, V168, P1430, DOI 10.1128/jb.168.3.1430-1438.1986; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Dumont A, 2012, ANGEW CHEM INT EDIT, V51, P3143, DOI 10.1002/anie.201108127; Dumont M, 2016, PLANT J, V85, P437, DOI 10.1111/tpj.13104; Fugier E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127700; Gu YH, 2015, STRUCTURE, V23, P496, DOI 10.1016/j.str.2015.01.001; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; Khan AU, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1012-8; Kocaoglu O, 2016, NAT CHEM BIOL, V12, P472, DOI [10.1038/NCHEMBIO.2109, 10.1038/nchembio.2109]; Lewenza S, 2006, J BACTERIOL, V188, P3516, DOI 10.1128/JB.188.10.3516-3524.2006; Li L, 2016, MOLECULES, V21, DOI 10.3390/molecules21101393; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lin CH, 1997, BIOCHEMISTRY-US, V36, P780, DOI 10.1021/bi962055c; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Mikula H, 2014, CARBOHYD CHEM, V2, P207; Moison E, 2017, ACS CHEM BIOL, V12, P928, DOI 10.1021/acschembio.7b00159; Moon K, 2013, MOL MICROBIOL, V89, P52, DOI 10.1111/mmi.12257; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ning XH, 2008, ANGEW CHEM INT EDIT, V47, P2253, DOI 10.1002/anie.200705456; Okuda S, 2016, NAT REV MICROBIOL, V14, P337, DOI 10.1038/nrmicro.2016.25; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajapaksha RMCP, 2004, APPL ENVIRON MICROB, V70, P2966, DOI 10.1128/AEM.70.5.2966-2973.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siegrist MS, 2015, FEMS MICROBIOL REV, V39, P184, DOI 10.1093/femsre/fuu012; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Smyth KM, 2013, CARBOHYD RES, V380, P70, DOI 10.1016/j.carres.2013.07.006; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Ventola C Lee, 2015, P T, V40, P344; Wang W, 2017, BIOCHEMISTRY-US, V56, P3889, DOI 10.1021/acs.biochem.7b00539; Wang Z, 2015, MAR DRUGS, V13, P3325, DOI 10.3390/md13063325; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yilmaz C, 2017, BIOCHEM PHARMACOL, V133, P43, DOI 10.1016/j.bcp.2016.10.005; Zhao JS, 2010, MOL MICROBIOL, V78, P820, DOI 10.1111/j.1365-2958.2010.07305.x; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	46	17	17	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19840	19848		10.1074/jbc.M117.814962	http://dx.doi.org/10.1074/jbc.M117.814962			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29018092	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000416911300027
J	Adebali, O; Sancar, A; Selby, CP				Adebali, Ogun; Sancar, Aziz; Selby, Christopher P.			Mfd translocase is necessary and sufficient for transcription-coupled repair in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; DNA sequencing; Escherichia coli (E; coli); genomics; nucleotide excision repair; Mfd; UvrD; lac operon; ppGpp; transcription-coupled repair	NUCLEOTIDE-EXCISION-REPAIR; STRAND-SPECIFIC REPAIR; DNA-POLYMERASE-I; LACTOSE OPERON; HELICASE-II; PROTEIN; VITRO; RESOLUTION; NUCLEASE; DOMAINS	Nucleotide excision repair in Escherichia coli is stimulated by transcription, specifically in the transcribed strand. Previously, it was shown that this transcription-coupled repair (TCR) is mediated by the Mfd translocase. Recently, it was proposed that in fact the majority of TCR in E. coli is catalyzed by a second pathway (backtracking-mediated TCR) that is dependent on the UvrD helicase and the guanosine pentaphosphate (ppGpp) alarmone/stringent response regulator. Recently, we reported that as measured by the excision repair-sequencing (XR-seq), UvrD plays no role in TCR genome-wide. Here, we tested the role of ppGpp and UvrD in TCR genome-wide and in the lacZ operon using the XR-seq method, which directly measures repair. We found that the mfd mutation abolishes TCR genome-wide and in the lacZ operon. In contrast, the relA(-)spoT(-) mutant deficient in ppGpp synthesis carries out normal TCR. We conclude that UvrD and ppGpp play no role in TCR in E. coli.	[Adebali, Ogun; Sancar, Aziz; Selby, Christopher P.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A; Selby, CP (corresponding author), 3070 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu; cselby@med.unc.edu	Adebali, Ogun/N-4159-2016	Adebali, Ogun/0000-0001-9213-4070	National Institutes of Health [GM118102, ES027255]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Ahn B, 2000, MOL CELLS, V10, P592, DOI 10.1007/s100590000017; BOCKRATH RC, 1977, MOL GEN GENET, V156, P133, DOI 10.1007/BF00283485; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Fan J, 2016, NATURE, V536, P234, DOI 10.1038/nature19080; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; HUSAIN I, 1985, P NATL ACAD SCI USA, V82, P6774, DOI 10.1073/pnas.82.20.6774; Kamarthapu V, 2016, SCIENCE, V352, P993, DOI 10.1126/science.aad6945; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; KUNALA S, 1995, J MOL BIOL, V246, P264, DOI 10.1006/jmbi.1994.0082; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Llorens-Rico V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501363; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Mellon I, 1996, P NATL ACAD SCI USA, V93, P1292, DOI 10.1073/pnas.93.3.1292; Miller JH, 1972, EXPT MOL GENETICS, P349; OLLER AR, 1992, P NATL ACAD SCI USA, V89, P11036, DOI 10.1073/pnas.89.22.11036; ORREN DK, 1992, J BIOL CHEM, V267, P780; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Selby CP, 2017, PHOTOCHEM PHOTOBIOL, V93, P280, DOI 10.1111/php.12675; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P8232, DOI 10.1073/pnas.88.18.8232; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1990, J BIOL CHEM, V265, P21330; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; Thomason MK, 2015, J BACTERIOL, V197, P18, DOI 10.1128/JB.02096-14; Vinella D, 2012, J BACTERIOL, V194, P261, DOI 10.1128/JB.06238-11; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465	38	29	29	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18386	18391		10.1074/jbc.C117.818807	http://dx.doi.org/10.1074/jbc.C117.818807			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28986449	hybrid, Green Published			2022-12-28	WOS:000414958100001
J	Robinett, NG; Peterson, RL; Culotta, VC				Robinett, Natalie G.; Peterson, Ryan L.; Culotta, Valeria C.			Eukaryotic copper-only superoxide dismutases (SODs): A new class of SOD enzymes and SOD-like protein domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; CANDIDA-ALBICANS; REACTIVE OXYGEN; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; BINDING SITES; ACTIVE-SITE; IN-VIVO	The copper-containing superoxide dismutases (SODs) represent a large family of enzymes that participate in the metabolism of reactive oxygen species by disproportionating superoxide anion radical to oxygen and hydrogen peroxide. Catalysis is driven by the redox-active copper ion, and in most cases, SODs also harbor a zinc at the active site that enhances copper catalysis and stabilizes the protein. Such bimetallic Cu, Zn-SODs are widespread, from the periplasm of bacteria to virtually every organelle in the human cell. However, a new class of copper-containing SODs has recently emerged that function without zinc. These copper-only enzymes serve as extracellular SODs in specific bacteria (i.e. Mycobacteria), throughout the fungal kingdom, and in the fungus-like oomycetes. The eukaryotic copper-only SODs are particularly unique in that they lack an electrostatic loop for substrate guidance and have an unusual open-access copper site, yet they can still react with superoxide at rates limited only by diffusion. Copper-only SOD sequences similar to those seen in fungi and oomycetes are also found in the animal kingdom, but rather than single-domain enzymes, they appear as tandem repeats in large polypeptides we refer to as CSRPs (copper-only SOD-repeat proteins). Here, we compare and contrast the Cu, Zn versus copper-only SODs and discuss the evolution of copper-only SOD protein domains in animals and fungi.	[Robinett, Natalie G.; Peterson, Ryan L.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	vculott1@jhu.edu			National Institutes of Health [GM50016]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050016, R37GM050016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM50016 (to V. C. C.). This is the fourth article in the Thematic Minireview series "Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Amorim-Vaz S, 2015, MBIO, V6, DOI 10.1128/mBio.00942-15; Antonyuk SV, 2009, J MOL BIOL, V388, P310, DOI 10.1016/j.jmb.2009.03.026; BANCI L, 1991, EUR J BIOCHEM, V196, P123, DOI 10.1111/j.1432-1033.1991.tb15794.x; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Barry AN, 2010, J BIOL INORG CHEM, V15, P47, DOI 10.1007/s00775-009-0595-4; Battistoni A, 2003, BIOCHEM SOC T, V31, P1326; Battistoni A, 1996, PROTEIN SCI, V5, P2125, DOI 10.1002/pro.5560051020; BENOV L, 1995, ARCH BIOCHEM BIOPHYS, V319, P508, DOI 10.1006/abbi.1995.1324; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Breitenbach M, 2015, BIOMOLECULES, V5, P318, DOI 10.3390/biom5020318; Broxton CN, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005295; Bruno VM, 2015, MBIO, V6, DOI 10.1128/mBio.00182-15; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CARRICO RJ, 1970, J BIOL CHEM, V245, P723; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CRAPO JD, 1992, P NATL ACAD SCI USA, V89, P10405, DOI 10.1073/pnas.89.21.10405; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Fanning S, 2012, EUKARYOT CELL, V11, P896, DOI 10.1128/EC.00103-12; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fenlon LA, 2014, CELL HOST MICROBE, V15, P7, DOI 10.1016/j.chom.2014.01.001; FISHER CL, 1994, PROTEINS, V19, P24, DOI 10.1002/prot.340190105; Fisher CL, 1997, PROTEINS, V29, P103, DOI 10.1002/(SICI)1097-0134(199709)29:1<103::AID-PROT8>3.0.CO;2-G; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; GOSCIN SA, 1972, BIOCHIM BIOPHYS ACTA, V289, P276, DOI 10.1016/0005-2744(72)90078-2; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Imlay KRC, 1996, J BACTERIOL, V178, P2564, DOI 10.1128/jb.178.9.2564-2571.1996; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Lamb AL, 1999, NAT STRUCT BIOL, V6, P724; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; LIN SJ, 1995, P NATL ACAD SCI USA, V92, P3784, DOI 10.1073/pnas.92.9.3784; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Miramon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052850; Mondola P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00594; Moris D, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.17; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Petersen SV, 2008, J BIOL CHEM, V283, P15031, DOI 10.1074/jbc.M801548200; Peterson RL, 2016, J BIOL CHEM, V291, P20911, DOI 10.1074/jbc.M116.748251; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; PUGET K, 1974, BIOCHEM BIOPH RES CO, V58, P830, DOI 10.1016/S0006-291X(74)80492-4; Qin ZY, 2006, FASEB J, V20, P334, DOI 10.1096/fj.05-4564fje; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards TA, 2011, P NATL ACAD SCI USA, V108, P15258, DOI 10.1073/pnas.1105100108; Richards TA, 2007, PLANT SIGNAL BEHAV, V2, P112, DOI 10.4161/psb.2.2.3640; Ringrose JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2424; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rossi DCP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006763; Savory F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004805; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Sheng YW, 2014, CHEM REV, V114, P3854, DOI 10.1021/cr4005296; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Strausak D, 1999, J BIOL CHEM, V274, P11170, DOI 10.1074/jbc.274.16.11170; STROMQVIST M, 1993, J CHROMATOGR-BIOMED, V621, P139, DOI 10.1016/0378-4347(93)80089-M; STROMQVIST M, 1991, J CHROMATOGR, V548, P293, DOI 10.1016/S0021-9673(01)88611-8; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tamayo D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004481; Thewes S, 2007, MOL MICROBIOL, V63, P1606, DOI 10.1111/j.1365-2958.2007.05614.x; Tsang CK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4446; Tscherner M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005218; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P4245, DOI 10.1073/pnas.76.9.4245; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; Wood LK, 2009, J BIOL CHEM, V284, P404, DOI 10.1074/jbc.M807027200; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	94	45	45	3	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4636	4643		10.1074/jbc.TM117.000182	http://dx.doi.org/10.1074/jbc.TM117.000182			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29259135	Green Published, hybrid			2022-12-28	WOS:000428848300006
J	Strang, KH; Croft, CL; Sorrentino, ZA; Chakrabarty, P; Golde, TE; Giasson, BI				Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.			Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-BINDING REGION; PAIRED HELICAL FILAMENTS; FRONTOTEMPORAL DEMENTIA; TRANSGENIC MICE; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; FTDP-17 MUTATIONS; IN-VIVO; SULFATED GLYCOSAMINOGLYCANS; NEURODEGENERATIVE-DISEASES	The accumulation of aberrantly aggregated MAPT (microtubule-associated protein Tau) defines a spectrum of tauopathies, including Alzheimer's disease. Mutations in the MAPT gene cause frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), characterized by neuronal pathological Tau inclusions in the form of neurofibrillary tangles and Pick bodies and in some cases glial Tau pathology. Increasing evidence points to the importance of prion-like seeding as a mechanism for the pathological spread in tauopathy and other neurodegenerative diseases. Herein, using a cell culture model, we examined a multitude of genetic FTDP-17 Tau variants for their ability to be seeded by exogenous Tau fibrils. Our findings revealed stark differences between FTDP-17 Tau variants in their ability to be seeded, with variants at Pro(301) and Ser(320) showing robust aggregation with seeding. Similarly, we elucidated the importance of certain Tau protein regions and unique residues, including the role of Pro(301) in inhibiting Tau aggregation. We also revealed potential barriers in cross-seeding between three-repeat and four-repeat Tau isoforms. Overall, these differences alluded to potential mechanistic differences between wildtype and FTDP-17 Tau variants, as well as different Tau isoforms, in influencing Tau aggregation. Furthermore, by combining two FTDP-17 Tau variants (either P301L or P301S with S320F), we generated aggressive models of tauopathy that do not require exogenous seeding. These models will allow for rapid screening of potential therapeutics to alleviate Tau aggregation without the need for exogenous Tau fibrils. Together, these studies provide novel insights in the molecular determinants that modulate Tau aggregation.	[Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA; [Strang, Kevin H.; Croft, Cara L.; Sorrentino, Zachary A.; Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Chakrabarty, Paramita; Golde, Todd E.; Giasson, Benoit I.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Giasson, BI (corresponding author), BMS J483 CTRND,1275 Ctr Dr, Gainesville, FL 32610 USA.	bgiasson@ufl.edu		Sorrentino, Zachary/0000-0001-8835-0432; Croft, Cara Louise/0000-0001-7969-5084	National Institutes of Health [R01NS089022]; Florida Department of Health [7AZ25]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082168, R01NS089622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG047266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01NS089022 and the Florida Department of Health Grant 7AZ25. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Ayers JI, 2018, BIOL PSYCHIAT, V83, P337, DOI 10.1016/j.biopsych.2017.04.003; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Boluda S, 2015, ACTA NEUROPATHOL, V129, P221, DOI 10.1007/s00401-014-1373-0; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Crystal AS, 2003, J NEUROCHEM, V86, P1359, DOI 10.1046/j.1471-4159.2003.01949.x; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Denk F, 2009, NEUROBIOL AGING, V30, P1, DOI 10.1016/j.neurobiolaging.2007.05.010; Deramecourt V, 2012, J ALZHEIMERS DIS, V31, P741, DOI 10.3233/JAD-2012-120160; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Elbaum-Garfinkle S, 2014, P NATL ACAD SCI USA, V111, P6311, DOI 10.1073/pnas.1315983111; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Ganguly P, 2015, J PHYS CHEM B, V119, P4582, DOI 10.1021/acs.jpcb.5b00175; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goedert M, 1999, FEBS LETT, V450, P306, DOI 10.1016/S0014-5793(99)00508-6; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Iqbal K, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.225; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2016, ACTA NEUROPATHOL, V131, P27, DOI 10.1007/s00401-015-1507-z; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Lim S, 2014, COMPUT STRUCT BIOTEC, V12, P7, DOI 10.1016/j.csbj.2014.09.011; Liu F, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-8; LOPRESTI P, 1995, P NATL ACAD SCI USA, V92, P10369, DOI 10.1073/pnas.92.22.10369; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; Miyasaka T, 2001, J NEUROPATH EXP NEUR, V60, P872, DOI 10.1093/jnen/60.9.872; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Peeraer E, 2015, NEUROBIOL DIS, V73, P83, DOI 10.1016/j.nbd.2014.08.032; Poepsel S, 2015, NAT CHEM BIOL, V11, P862, DOI [10.1038/NCHEMBIO.1931, 10.1038/nchembio.1931]; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberson ED, 2012, ANN NEUROL, V72, P837, DOI 10.1002/ana.23722; Rossi G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.008; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Smit FX, 2017, J PHYS CHEM B, V121, P3250, DOI 10.1021/acs.jpcb.6b07045; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Stancu IC, 2015, ACTA NEUROPATHOL, V129, P875, DOI 10.1007/s00401-015-1413-4; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Waxman EA, 2010, BIOCHEM BIOPH RES CO, V391, P1415, DOI 10.1016/j.bbrc.2009.12.079; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794	83	55	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2408	2421		10.1074/jbc.M117.815357	http://dx.doi.org/10.1074/jbc.M117.815357			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29259137	Green Published, hybrid			2022-12-28	WOS:000425308300015
J	Campos, WF; Dressano, K; Ceciliato, PHO; Guerrero-Abad, JC; Silva, AL; Fiori, CS; do Canto, AM; Bergonci, T; Claus, LAN; Silva-Filho, MC; Moura, DS				Campos, Wellington F.; Dressano, Keini; Ceciliato, Paulo H. O.; Guerrero-Abad, Juan Carlos; Silva, Aparecida Leonir; Fiori, Celso S.; do Canto, Amanda Morato; Bergonci, Tabata; Claus, Lucas A. N.; Silva-Filho, Marcio C.; Moura, Daniel S.			Arabidopsis thaliana rapid alkalinization factor 1-mediated root growth inhibition is dependent on calmodulin-like protein 38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); cell growth; cell signaling; development; peptide hormone; rapid alkalinization factor; root; secreted protein; secretory pathway	SUSPENSION-CULTURED CELLS; EXTRACELLULAR CALMODULIN; PEPTIDE-HORMONE; PLANT-GROWTH; POLLEN GERMINATION; BINDING-PROTEINS; HAIR DEVELOPMENT; FUSION PROTEINS; CALCIUM SENSOR; RALF PEPTIDE	Arabidopsis thaliana rapid alkalinization factor 1 (AtRALF1) is a small secreted peptide hormone that inhibits root growth by repressing cell expansion. Although it is known that AtRALF1 binds the plasma membrane receptor FERONIA and conveys its signals via phosphorylation, the AtRALF1 signaling pathway is largely unknown. Here, using a yeast two-hybrid system to search for AtRALF1-interacting proteins in Arabidopsis, we identified calmodulin-like protein 38 (CML38) as an AtRALF1-interacting partner. We also found that CML38 and AtRALF1 are both secreted proteins that physically interact in a Ca2+- and pH-dependent manner. CML38-knockout mutants generated via T-DNA insertion were insensitive to AtRALF1, and simultaneous treatment with both AtRALF1 and CML38 proteins restored sensitivity in these mutants. Hybrid plants lacking CML38 and having high accumulation of the AtRALF1 peptide did not exhibit the characteristic short-root phenotype caused by AtRALF1 overexpression. Although CML38 was essential for AtRALF1-mediated root inhibition, it appeared not to have an effect on the AtRALF1-induced alkalinization response. Moreover, acridinium-labeling of AtRALF1 indicated that the binding of AtRALF1 to intact roots is CML38-dependent. In summary, we describe a new component of the AtRALF1 response pathway. The new component is a calmodulin-like protein that binds AtRALF1, is essential for root growth inhibition, and has no role in AtRALF1 alkalinization.	[Campos, Wellington F.; Dressano, Keini; Ceciliato, Paulo H. O.; Guerrero-Abad, Juan Carlos; Silva, Aparecida Leonir; Fiori, Celso S.; do Canto, Amanda Morato; Bergonci, Tabata; Claus, Lucas A. N.; Moura, Daniel S.] Univ Sao Paulo, ESALQ, Dept Ciencias Biol, Lab Bioquim Prot, BR-13418900 Piracicaba, SP, Brazil; [Silva-Filho, Marcio C.] Univ Sao Paulo, ESALQ, Dept Genet, Lab Biol Mol Plantas, BR-13418900 Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Moura, DS (corresponding author), Univ Sao Paulo, ESALQ, Dept Ciencias Biol, Lab Bioquim Prot, BR-13418900 Piracicaba, SP, Brazil.	danielmoura@usp.br	da Silva, Aparecida Leonir/H-8398-2016; Silva, Aparecida/AAJ-9250-2020; Guerrero-Abad, Juan Carlos/I-3728-2014; Campos, Wellington/GZG-2946-2022; Silva, Aparecida/AAR-9442-2020; do Canto, Amanda Morato/A-6807-2015; Moura, Daniel S/D-6673-2012; Silva-Filho, Marcio/F-2639-2012; Bergonci, Tábata/E-3759-2014	da Silva, Aparecida Leonir/0000-0002-1887-4414; Guerrero-Abad, Juan Carlos/0000-0002-7285-9506; Silva, Aparecida/0000-0002-1887-4414; do Canto, Amanda Morato/0000-0002-3989-8351; Moura, Daniel S/0000-0003-2042-1403; Silva-Filho, Marcio/0000-0003-2129-0388; Bergonci, Tábata/0000-0001-9100-6974; Alves Neubus Claus, Lucas/0000-0001-8591-8969	FAPESP; CNPq; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by FAPESP and CNPq. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CAPES.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Bedinger PA, 2010, PLANT SIGNAL BEHAV, V5, P1342, DOI 10.4161/psb.5.11.12954; Bender KW, 2013, PLANT J, V76, P634, DOI 10.1111/tpj.12323; Bender KW, 2013, PLANT PHYSIOL, V163, P486, DOI 10.1104/pp.113.221069; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bergonci T, 2014, J EXP BOT, V65, P2219, DOI 10.1093/jxb/eru099; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; BIRO RL, 1984, PLANT PHYSIOL, V75, P382, DOI 10.1104/pp.75.2.382; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Butenko MA, 2014, PLANT CELL, V26, P1838, DOI 10.1105/tpc.113.120071; Cao J, 2012, EVOL BIOINFORM, V8, P271, DOI 10.4137/EBO.S9652; Chen J, 2016, P NATL ACAD SCI USA, V113, pE5519, DOI 10.1073/pnas.1608449113; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; Cui SJ, 2005, J BIOL CHEM, V280, P31420, DOI 10.1074/jbc.M501349200; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; do Canto AM, 2014, PLANT PHYSIOL BIOCH, V75, P45, DOI 10.1016/j.plaphy.2013.12.005; Dressano K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007053; Du CQ, 2016, P NATL ACAD SCI USA, V113, pE8326, DOI 10.1073/pnas.1609626113; Escobara NM, 2003, PLANT CELL, V15, P1507, DOI 10.1105/tpc.013284; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GRIGNON C, 1991, ANNU REV PLANT PHYS, V42, P103, DOI 10.1146/annurev.pp.42.060191.000535; Haruta M, 2008, BIOCHEMISTRY-US, V47, P6311, DOI 10.1021/bi8001488; Haruta M, 2014, SCIENCE, V343, P408, DOI 10.1126/science.1244454; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; Lokdarshi A, 2016, PLANT PHYSIOL, V170, P1046, DOI 10.1104/pp.15.01407; Ma LG, 1997, PLANTA, V202, P336, DOI 10.1007/s004250050135; Ma LG, 1999, PLANT CELL, V11, P1351, DOI 10.1105/tpc.11.7.1351; Masachis S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.43, 10.1038/nmicrobiol.2016.43]; Matos JL, 2008, FEBS LETT, V582, P3343, DOI 10.1016/j.febslet.2008.08.025; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Mingossi FB, 2010, PLANT MOL BIOL, V73, P271, DOI 10.1007/s11103-010-9613-8; Murphy E, 2014, TRENDS PLANT SCI, V19, P664, DOI 10.1016/j.tplants.2014.06.005; Osterrieder A, 2010, J EXP BOT, V61, P405, DOI 10.1093/jxb/erp315; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Scheer JM, 2005, PLANTA, V221, P667, DOI 10.1007/s00425-004-1442-z; Scholz SS, 2014, MOL PLANT, V7, P1712, DOI 10.1093/mp/ssu102; Snedden WA, 2001, NEW PHYTOL, V151, P35, DOI 10.1046/j.1469-8137.2001.00154.x; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Srivastava R, 2009, PLANT J, V59, P930, DOI 10.1111/j.1365-313X.2009.03926.x; Stegmann M, 2017, SCIENCE, V355, P287, DOI 10.1126/science.aal2541; STINEMETZ CL, 1992, PLANT GROWTH REGUL, V11, P419, DOI 10.1007/BF00130651; SUN DY, 1995, PLANT CELL PHYSIOL, V36, P133; SUN DY, 1994, PLANT SCI, V99, P1, DOI 10.1016/0168-9452(94)90114-7; Vanderbeld B, 2007, PLANT MOL BIOL, V64, P683, DOI 10.1007/s11103-007-9189-0; Wang QL, 2009, J BIOL CHEM, V284, P12000, DOI 10.1074/jbc.M808028200; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Zhao Q, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00807	66	25	26	1	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2159	2171		10.1074/jbc.M117.808881	http://dx.doi.org/10.1074/jbc.M117.808881			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29282286	hybrid, Green Published			2022-12-28	WOS:000424948000027
J	Moody, RR; Lo, MC; Meagher, JL; Lin, CC; Stevers, NO; Tinsley, SL; Jung, I; Matvekas, A; Stuckey, JA; Sun, DX				Moody, Rebecca Reed; Lo, Miao-Chia; Meagher, Jennifer L.; Lin, Chang-Ching; Stevers, Nicholas O.; Tinsley, Samantha L.; Jung, Inkyung; Matvekas, Aleksas; Stuckey, Jeanne A.; Sun, Duxin			Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; cancer stem cells; crystal structure; epigenetics; histone chaperone; protein complex; protein-protein interaction; BCL11A; RBBP4; TNBC	NEGATIVE BREAST-CANCER; FETAL-HEMOGLOBIN EXPRESSION; STEM-CELLS; REPRESSOR COMPLEX; DRUG-RESISTANCE; MAMMALIAN-CELLS; PROTEIN COMPLEX; METASTASIS; NURD; METHYLATION	The transcription factor BCL11A has recently been reported to be a driving force in triple-negative breast cancer (TNBC), contributing to the maintenance of a chemoresistant breast cancer stem cell (BCSC) population. Although BCL11A was shown to suppress -globin and p21 and to induce MDM2 expression in the hematopoietic system, its downstream targets in TNBC are still unclear. For its role in transcriptional repression, BCL11A was found to interact with several corepressor complexes; however, the mechanisms underlying these interactions remain unknown. Here, we reveal that BCL11A interacts with histone methyltransferase (PRC2) and histone deacetylase (NuRD and SIN3A) complexes through their common subunit, RBBP4/7. In fluorescence polarization assays, we show that BCL11A competes with histone H3 for binding to the negatively charged top face of RBBP4. To define that interaction, we solved the crystal structure of RBBP4 in complex with an N-terminal peptide of BCL11A (residues 2-16, BCL11A(2-16)). The crystal structure identifies novel interactions between BCL11A and the side of the -propeller of RBBP4 that are not seen with histone H3. We next show that BCL11A(2-16) pulls down RBBP4, RBBP7, and other components of PRC2, NuRD, and SIN3A from the cell lysate of the TNBC cell line SUM149. Furthermore, we demonstrate the therapeutic potential of targeting the RBBP4-BCL11A binding by showing that a BCL11A peptide can decrease aldehyde dehydrogenase-positive BCSCs and mammosphere formation capacity in SUM149. Together, our findings have uncovered a previously unidentified mechanism that BCL11A may use to recruit epigenetic complexes to regulate transcription and promote tumorigenesis.	[Moody, Rebecca Reed; Sun, Duxin] Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA; [Moody, Rebecca Reed; Lo, Miao-Chia; Lin, Chang-Ching; Stevers, Nicholas O.; Tinsley, Samantha L.; Jung, Inkyung; Matvekas, Aleksas; Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Meagher, Jennifer L.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Stuckey, Jeanne A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sun, DX (corresponding author), Univ Michigan, Chem Biol Program, Ann Arbor, MI 48109 USA.; Lo, MC; Sun, DX (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA.	miaoclo@umich.edu; duxins@umich.edu	Sun, Duxin/AAA-1774-2022	Lin, Chang-Ching/0000-0001-6659-5543; Stevers, Nicholas/0000-0003-1082-6423; Tinsley, Samantha Lauren/0000-0002-8761-5504	DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NCI, National Institutes of Health [P30CA046592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817. Research reported in this publication was supported by the NCI, National Institutes of Health under award number P30CA046592 (for flow cytometry).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balboula AZ, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.128298; Bricogne G, 2017, BUSTER VERSION 2 10; Brown R, 2014, NAT REV CANCER, V14, P747, DOI 10.1038/nrc3819; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Cetin I, 2014, ASIAN PAC J CANCER P, V15, P2427, DOI 10.7314/APJCP.2014.15.6.2427; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connarn JN, 2014, J BIOL CHEM, V289, P2908, DOI 10.1074/jbc.M113.519421; Davidovich C, 2014, NUCLEIC ACIDS RES, V42, P9236, DOI 10.1093/nar/gku540; Deng L, 2014, CANCER RES, V74, P6648, DOI 10.1158/0008-5472.CAN-13-3710; Dias C, 2016, AM J HUM GENET, V99, P253, DOI 10.1016/j.ajhg.2016.05.030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gangemi R, 2009, CURR MED CHEM, V16, P1688, DOI 10.2174/092986709788186147; Gao C, 2013, BLOOD, V121, P1413, DOI 10.1182/blood-2012-04-424275; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Jene-Sanz A, 2013, MOL CELL BIOL, V33, P3951, DOI 10.1128/MCB.00426-13; Kagara N, 2012, AM J PATHOL, V181, P257, DOI 10.1016/j.ajpath.2012.03.019; Khaled WT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6987; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Liu ST, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/172010; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Millard CJ, 2016, ELIFE, V5, DOI 10.7554/eLife.13941; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Munoz P, 2012, MOL ONCOL, V6, P620, DOI 10.1016/j.molonc.2012.10.006; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Saathoff H, 2015, BIOORGAN MED CHEM, V23, P960, DOI 10.1016/j.bmc.2015.01.023; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110	43	32	33	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2125	2136		10.1074/jbc.M117.811463	http://dx.doi.org/10.1074/jbc.M117.811463			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29263092	hybrid, Green Published			2022-12-28	WOS:000424948000024
J	Tang, JY; Bullen, NP; Ahmad, S; Whitney, JC				Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.			Diverse NADase effector families mediate interbacterial antagonism via the type VI secretion system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microbiology; bacteria; protein secretion; protein structure; protein-protein interaction; type VI secretion; interbacterial antagonism; Pseudomonas protegens; NADase effectors	COMPLETE GENOME SEQUENCE; STRUCTURE REFINEMENT; RHS PROTEINS; TOXIN; VGRG; PAAR; COLONIZATION; COMPETITION; PATHOGENS; PATHWAYS	The bacterial type VI secretion system (T6SS) mediates antagonistic cell-cell interactions between competing Gram-negative bacteria. In plant-beneficial bacteria, this pathway has been shown to suppress the growth of bacterial pathogens; however, the identification and mode of action of T6SS effector proteins that mediate this protective effect remain poorly defined. Here, we identify two previously uncharacterized effectors required for interbacterial antagonism by the plant commensal bacterium Pseudomonas protegens. Consistent with the established effector-immunity paradigm for antibacterial T6SS substrates, the toxic activities of these effectors are neutralized by adjacently encoded cognate immunity determinants. Although one of these effectors, RhsA, belongs to the family of DNase enzymes, the activity of the other was not apparent from its sequence. To determine the mechanism of toxicity of this latter effector, we determined its 1.3 crystal structure in complex with its immunity protein and found that it resembles NAD(P)(+)-degrading enzymes. In line with this structural similarity, biochemical characterization of this effector, termed Tne2 (Type VI secretion NADase effector family 2), demonstrates that it possesses potent NAD(P)(+) hydrolase activity. Tne2 is the founding member of a widespread family of interbacterial NADases predicted to transit not only the Gram-negative T6SS but also the Gram-positive type VII secretion system, a pathway recently implicated in interbacterial competition among Firmicutes. Together, this work identifies new T6SS effectors employed by a plant commensal bacterium to antagonize its competitors and broadly implicates NAD(P)(+)-hydrolyzing enzymes as substrates of interbacterial conflict pathways found in diverse bacterial phyla.	[Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.] McMaster Univ, Michael DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Tang, Jenny Y.; Bullen, Nathan P.; Ahmad, Shehryar; Whitney, John C.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Whitney, JC (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada.	jwhitney@mcmaster.ca		Ahmad, Shehryar/0000-0002-2747-5212	McMaster University; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05350]	McMaster University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by start-up funds from McMaster University and Discovery Grant RGPIN-2017-05350 from the Natural Sciences and Engineering Research Council of Canada (to J.C.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anderson MC, 2017, CELL HOST MICROBE, V21, P769, DOI 10.1016/j.chom.2017.05.004; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bernal P, 2017, ISME J, V11, P972, DOI 10.1038/ismej.2016.169; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Bosch J, 2007, ACTA CRYSTALLOGR D, V63, P179, DOI 10.1107/S0907444906045471; Cao Zhenping, 2016, Nat Microbiol, V2, P16183, DOI 10.1038/nmicrobiol.2016.183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cianfanelli FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005735; Decoin V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089411; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hecht AL, 2016, EMBO REP, V17, P1281, DOI 10.15252/embr.201642282; Ho BT, 2017, P NATL ACAD SCI USA, V114, P9427, DOI 10.1073/pnas.1711219114; JOHNSON SL, 1970, J BIOL CHEM, V245, P4519; Koskiniemi S, 2013, P NATL ACAD SCI USA, V110, P7032, DOI 10.1073/pnas.1300627110; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ma JL, 2017, ENVIRON MICROBIOL, V19, P345, DOI 10.1111/1462-2920.13621; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2016, P NATL ACAD SCI USA, V113, pE5044, DOI 10.1073/pnas.1608858113; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Sun J, 2015, NAT STRUCT MOL BIOL, V22, P672, DOI 10.1038/nsmb.3064; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vettiger A, 2016, CELL, V167, P99, DOI 10.1016/j.cell.2016.08.023; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Whitney JC, 2017, ELIFE, V6, DOI 10.7554/eLife.26938; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	50	57	58	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1504	1514		10.1074/jbc.RA117.000178	http://dx.doi.org/10.1074/jbc.RA117.000178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29237732	Green Published, hybrid			2022-12-28	WOS:000424201700002
J	Mallis, RJ; Arthanari, H; Lang, MJ; Reinherz, EL; Wagner, G				Mallis, Robert J.; Arthanari, Haribabu; Lang, Matthew J.; Reinherz, Ellis L.; Wagner, Gerhard			NMR-directed design of pre-TCR beta and pMHC molecules implies a distinct geometry for pre-TCR relative to alpha beta TCR recognition of pMHC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTORS; MHC CLASS-I; THYMIC SELECTION; THYMOCYTE DEVELOPMENT; FAB FRAGMENT; PEPTIDE; COMPLEX; PROTEINS; PREDICTION; DISCRIMINATION	The pre-T cell receptor (pre-TCR) guides early thymocytes through maturation processes within the thymus via interaction with self-ligands displayed on thymic epithelial cells. The pre-TCR is a disulfide-linked heterodimer composed of an invariant pre-TCR alpha (pT alpha) subunit and a variable beta subunit, the latter of which is incorporated into the mature TCR in subsequent developmental progression. This interaction of pre-TCR with peptide- major histocompatibility complex (pMHC) molecules has recently been shown to drive robust pre-TCR signaling and thymocyte maturation. Although the native sequences of beta are properly folded and suitable for NMR studies in isolation, a tendency to self-associate rendered binding studies with physiological ligands difficult to interpret. Consequently, to structurally define this critical interaction, we have re-engineered the extracellular regions of beta, designated as beta-c1, for prokaryotic production to be used in NMR spectroscopy. Given the large size of the full extracellular domain of class I MHC molecules such as H-K-b, we produced a truncated form termed K-b-t harboring properties favorable for NMR measurements. This system has enabled robust measurement of a pre-TCR-pMHC interaction directly analogous to that of TCR alpha beta-pMHC. Binding surface analysis identified a contact surface comparable in size to that of the TCR alpha beta-pMHC but potentially with a rather distinct binding orientation. A tilting of the pre-TCR beta when bound to the pMHC ligand recognition surface versus the upright orientation of TCR alpha beta would alter the direction of force application between pre-TCR and TCR mechanosensors, impacting signal initiation.	[Mallis, Robert J.; Arthanari, Haribabu; Wagner, Gerhard] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Arthanari, Haribabu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Reinherz, Ellis L.] Harvard Med Sch, Dana Farber Canc Inst, Lab Immunobiol, Dept Med Oncol, Boston, MA 02115 USA; [Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu		Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health [P01GM04746, R01AI37581]; National Institute of Biomedical Imaging and Bioengineering [P41-EB002026, R01AI19807, R01AI100643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R01AI100643, R01AI037581, R01AI136301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health Grants P01GM04746 and R01AI37581 and National Institute of Biomedical Imaging and Bioengineering Grant P41-EB002026 (to G.W.) and R01AI19807 (to E. L. R.) and R01AI100643 (to E. L. R. and M. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2014, R LANG ENV STAT COMP; Baker BM, 2017, TRENDS IMMUNOL, V38, P2, DOI 10.1016/j.it.2016.11.003; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng YN, 2017, P NATL ACAD SCI USA, V114, pE8204, DOI 10.1073/pnas.1703559114; Garcia KC, 2012, IMMUNITY, V36, P887, DOI 10.1016/j.immuni.2012.05.018; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; MacRaild CA, 2014, J BIOMOL NMR, V58, P155, DOI 10.1007/s10858-014-9813-7; Mallis RJ, 2016, BIOMOL NMR ASSIGN, V10, P35, DOI 10.1007/s12104-015-9632-0; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; POWELL LD, 1987, J IMMUNOL, V139, P1206; Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005	43	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					754	766		10.1074/jbc.M117.813493	http://dx.doi.org/10.1074/jbc.M117.813493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29101227	Green Published, hybrid			2022-12-28	WOS:000422864500001
J	Ushijima, T; Fujimoto, N; Matsuyama, S; Kan-o, M; Kiyonari, H; Shioi, G; Kage, Y; Yamasaki, S; Takeya, R; Sumimoto, H				Ushijima, Tomoki; Fujimoto, Noriko; Matsuyama, Sho; Kan-o, Meikun; Kiyonari, Hiroshi; Shioi, Go; Kage, Yohko; Yamasaki, Sho; Takeya, Ryu; Sumimoto, Hideki			The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DILATED CARDIOMYOPATHY; STRIATED-MUSCLE; HIGH-EFFICIENCY; THIN-FILAMENTS; MOUSE EMBRYO; PHOSPHORYLATION; HYPERTROPHY; DISEASE; KNOCKOUT; ROLES	Cardiac development and function require actin-myosin interactions in the sarcomere, a highly organized contractile structure. Sarcomere assembly mediated by formin homology 2 domain-containing 3 (Fhod3), a member of formins that directs formation of straight actin filaments, is essential for embryonic cardiogenesis. However, the role of Fhod3 in the neonatal and adult stages has remained unknown. Here, we generated floxed Fhod3 mice to bypass the embryonic lethality of an Fhod3 knockout (KO). Perinatal KO of Fhod3 in the heart caused juvenile lethality at around day 10 after birth with enlarged hearts composed of severely impaired myofibrils, indicating that Fhod3 is crucial for postnatal heart development. Tamoxifeninduced conditional KO of Fhod3 in the adult heart neither led to lethal effects nor did it affect sarcomere structure and localization of sarcomere components. However, adult Fhod3-deleted mice exhibited a slight cardiomegaly and mild impairment of cardiac function, conditions that were sustained over 1 year without compensation during aging. In addition to these agerelated changes, systemic stimulation with the alpha 1-adrenergic receptor agonist phenylephrine, which induces sustained hypertension and hypertrophy development, induced expression of fetal cardiac genes that was more pronounced in adult Fhod3deleted mice than in the control mice, suggesting that Fhod3 modulates hypertrophic changes in the adult heart. We conclude that Fhod3 plays a crucial role in both postnatal cardiac development and functional maintenance of the adult heart.	[Ushijima, Tomoki; Fujimoto, Noriko; Matsuyama, Sho; Kan-o, Meikun; Kage, Yohko; Takeya, Ryu; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Matsuyama, Sho; Kage, Yohko; Takeya, Ryu] Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan; [Kiyonari, Hiroshi] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi; Shioi, Go] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo 6500047, Japan; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka 8128582, Japan	Kyushu University; University of Miyazaki; RIKEN; RIKEN; Kyushu University	Sumimoto, H (corresponding author), Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan.; Takeya, R (corresponding author), Univ Miyazaki, Fac Med, Dept Pharmacol, Miyazaki 8891692, Japan.	takeya@med.miyazaki-u.ac.jp; hsumi@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [26460371]; SHINGAKUJUTSU [25117515]; Takeda Science Foundation; Institute of Seizon and Life Sciences; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University;  [26111009]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SHINGAKUJUTSU; Takeda Science Foundation(Takeda Science Foundation (TSF)); Institute of Seizon and Life Sciences; Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University; 	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" Grant 26111009 (to H. S.), Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 26460371 (to R. T.), SHINGAKUJUTSU Grant 25117515 (to R. T.), grants from the Takeda Science Foundation (to R. T.) and the Institute of Seizon and Life Sciences (to R. T.), and the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University (to R. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Ajima R, 2015, DEV BIOL, V408, P126, DOI 10.1016/j.ydbio.2015.10.003; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; FARIVAR RS, 1995, HYPERTENSION, V25, P809, DOI 10.1161/01.HYP.25.4.809; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Fujimoto N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148472; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gotthardt M, 2003, J BIOL CHEM, V278, P6059, DOI 10.1074/jbc.M211723200; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kan-o M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034765; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Koitabashi N, 2009, CIRC RES, V105, P12, DOI 10.1161/CIRCRESAHA.109.198416; Kooij V, 2016, CARDIOVASC RES, V110, P238, DOI 10.1093/cvr/cvw050; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; McKeown CR, 2014, DEV DYNAM, V243, P800, DOI 10.1002/dvdy.24115; Mori J, 2012, CIRC-HEART FAIL, V5, P493, DOI 10.1161/CIRCHEARTFAILURE.112.966705; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Nishii K, 2008, DEV BIOL, V322, P65, DOI 10.1016/j.ydbio.2008.07.007; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Perriard JC, 2003, TRENDS CARDIOVAS MED, V13, P30, DOI 10.1016/S1050-1738(02)00209-8; Randall TS, 2014, EUR J CELL BIOL, V93, P205, DOI 10.1016/j.ejcb.2013.11.004; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Skau CT, 2015, ANNU REV BIOPHYS, V44, P285, DOI 10.1146/annurev-biophys-060414-034308; Skwarek-Maruszewska A, 2009, J CELL SCI, V122, P2119, DOI 10.1242/jcs.046805; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takeya R, 2008, EMBO J, V27, P618, DOI 10.1038/emboj.2008.7; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Yuan BY, 2014, AM J PATHOL, V184, P1967, DOI 10.1016/j.ajpath.2014.04.007; Zhou Q, 2017, HYPERTENSION, V69, P1070, DOI 10.1161/HYPERTENSIONAHA.116.08662	47	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					148	162		10.1074/jbc.M117.813931	http://dx.doi.org/10.1074/jbc.M117.813931			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158260	Green Published, hybrid			2022-12-28	WOS:000419453200014
J	Kumar, RP; Morehouse, BR; Fofana, J; Trieu, MM; Zhou, DH; Lorenz, MO; Oprian, DD				Kumar, Ramasamy P.; Morehouse, Benjamin R.; Fofana, Josiane; Trieu, Melissa M.; Zhou, Daniel H.; Lorenz, Molly O.; Oprian, Daniel D.			Structure and monomer/dimer equilibrium for the guanylyl cyclase domain of the optogenetics protein RhoGC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; cyclic GMP (cGMP); disulfide; guanylate cyclase (guanylyl cyclase); optogenetics; rhodopsin; Blastocladiella emersonii; class III nucleotidyl cyclase	ADENYLYL-CYCLASE; CATALYTIC DOMAINS; CRYSTAL-STRUCTURE; FUSION PROTEIN; PURIFICATION; EXPRESSION; INTERFACE; MECHANISM; CGMP; TOOL	RhoGC is a fusion protein from the aquatic fungus Blastocladiella emersonii, combining a type I rhodopsin domain with a guanylyl cyclase domain. It has generated excitement as an optogenetics tool for the manipulation of cyclic nucleotide signaling pathways. To investigate the regulation of the cyclase activity, we isolated the guanylyl cyclase domain from Escherichia coli with (GCwCC(Rho)) and without (GC(Rho)) the coiled-coil linker. Both constructs were constitutively active but were monomeric as determined by size-exclusion chromatography and analytical ultracentrifugation, whereas other class III nucleotidyl cyclases are functional dimers. We also observed that crystals of GC(Rho) have only a monomer in an asymmetric unit. Dimers formed when crystals were grown in the presence of the non-cyclizable substrate analog 2,3-dideoxyguanosine-5-triphosphate, MnCl2, and tartrate, but their quaternary structure did not conform to the canonical pairing expected for class III enzymes. Moreover, the structure contained a disulfide bond formed with an active-site Cys residue required for activity. We consider it unlikely that the disulfide would form under intracellular reducing conditions, raising the possibility that this unusual dimer might have a biologically relevant role in the regulation of full-length RhoGC. Although we did not observe it with direct methods, a functional dimer was identified as the active state by following the dependence of activity on total enzyme concentration. The low affinity observed for GC(Rho) monomers is unusual for this enzyme class and suggests that dimer formation may contribute to light activation of the full-length protein.	[Kumar, Ramasamy P.; Morehouse, Benjamin R.; Fofana, Josiane; Trieu, Melissa M.; Zhou, Daniel H.; Lorenz, Molly O.; Oprian, Daniel D.] Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA	Brandeis University	Oprian, DD (corresponding author), Brandeis Univ, Dept Biochem, 415 South St, Waltham, MA 02454 USA.	oprian@brandeis.edu		Ramasamy, Prem/0000-0002-6555-8289; Morehouse, Benjamin/0000-0003-3352-5463	Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596] Funding Source: NIH RePORTER	Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research used resources of the Advanced Light Source, which is a Department of Energy Office of Science User Facility under Contract No. DE-AC02-05CH11231. We are grateful to the staff at the Advanced Light Source-Berkeley Center for Structural Biology for their assistance in X-ray data collection. We thank the Adar family and friends for continued support throughout this work. We also thank Prof. Timothy Street and Jackson Halpin for sharing their HPLC and providing technical advice. We thank Prof. Bruce Foxman for helpful discussions on crystallography.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Allerston CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057644; Avelar GM, 2014, CURR BIOL, V24, P1234, DOI 10.1016/j.cub.2014.04.009; Barathy D, 2014, IUCRJ, V1, P338, DOI 10.1107/S2052252514016741; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao SQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9046; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Lamarche LB, 2017, BIOCHEMISTRY-US, V56, P5812, DOI 10.1021/acs.biochem.7b00519; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lucas KA, 2000, PHARMACOL REV, V52, P375; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Scheib U, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0611; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Trieu MM, 2017, J BIOL CHEM, V292, P10379, DOI 10.1074/jbc.M117.789636; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yoshida K, 2017, J BIOL CHEM, V292, P7531, DOI 10.1074/jbc.M117.775569; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0	34	12	12	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21578	21589		10.1074/jbc.M117.812685	http://dx.doi.org/10.1074/jbc.M117.812685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118188	hybrid, Green Published			2022-12-28	WOS:000419013000032
J	Sood, C; Francis, AC; Desai, TM; Melikyan, GB				Sood, Chetan; Francis, Ashwanth C.; Desai, Tanay M.; Melikyan, Gregory B.			An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; FRET; retrovirus; single particle analysis; virus entry; HIV maturation; live-cell imaging; fusion pore	MEMBRANE-FUSION; PARTICLE FUSION; PORE FORMATION; LIVING CELLS; HEMIFUSION; MATURATION; VISUALIZATION; GLYCOPROTEIN; ENDOCYTOSIS; ENDOSOMES	Enveloped viruses transfer their genomes into host cells by fusing their membrane to that of the cell. To visualize single-virus fusion in living cells, researchers take advantage of the proteolytic maturation of HIV, type 1 (HIV-1), which can generate free fluorescent proteins within the viral particle. Co-labeling viruses with a content marker and a fluorescently tagged Vpr (a viral core protein) enables detection of single-virus fusions, but a major limitation of this approach is that not all viral particles incorporate both markers. Here we designed a labeling strategy based on the bifunctional mCherry-2xCL-YFP-Vpr construct, in which 2xCL denotes a tandem cleavage site for the viral protease. This bifunctional marker was efficiently cleaved during virus maturation, producing free mCherry and the core-associated YFP-Vpr. A nearly perfect colocalization of these two markers in virions and their fixed 1:1 ratio enabled automated detection of single-particle fusion in both fixed and live cells based on loss of the mCherry signal. Furthermore, a drop in FRET efficiency between YFP and mCherry because of cleavage of the bifunctional marker, which manifested as a marked shift in the normalized YFP/mCherry fluorescence ratio, reliably predicted viral protease activity in single virions. This feature could discriminate between the particles containing free mCherry, and therefore likely representing mature viruses, and immature particles whose fusion cannot be detected. In summary, our new labeling strategy offers several advantages compared with previous approaches, including increased reliability and throughput of detection of viral fusion. We anticipate that our method will have significant utility for studying viral fusion and maturation.	[Sood, Chetan; Francis, Ashwanth C.; Desai, Tanay M.; Melikyan, Gregory B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Desai, Tanay M.] Carl Zeiss Microscopy, Thornwood, NY 10594 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Carl Zeiss AG	Melikyan, GB (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.; Melikyan, GB (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.	gmeliki@emory.edu	Francis, Ashwanth Christopher/N-5730-2018	Francis, Ashwanth Christopher/0000-0002-8663-2038	National Institutes of Health [R01 GM054787, R01 AI053668]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM054787 and R01 AI053668 (to G. B. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Banerjee I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068450; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chernomordik LV, 2005, CELL, V123, P375, DOI 10.1016/j.cell.2005.10.015; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Dale BM, 2011, CELL HOST MICROBE, V10, P551, DOI 10.1016/j.chom.2011.10.015; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Desai TM, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0215-z; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Francis AC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005709; Francis AC, 2014, AIDS RES HUM RETROV, V30, P717, DOI [10.1089/aid.2013.0277, 10.1089/AID.2013.0277]; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Jha NK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001260; Jiang JY, 2006, VIROLOGY, V346, P460, DOI 10.1016/j.virol.2005.11.008; Jiang XJ, 2002, MOL BIOL CELL, V13, P1522, DOI 10.1091/mbc.01-11-0552; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Jones DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13449; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Mamede JI, 2017, P NATL ACAD SCI USA, V114, pE7169, DOI 10.1073/pnas.1706245114; Markosyan RM, 2005, MOL BIOL CELL, V16, P5502, DOI 10.1091/mbc.E05-06-0496; Matos PM, 2013, J BIOL CHEM, V288, P12416, DOI 10.1074/jbc.M113.462028; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Melikyan GB, 2005, P NATL ACAD SCI USA, V102, P8728, DOI 10.1073/pnas.0501864102; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Oum YH, 2016, J VIROL METHODS, V233, P62, DOI 10.1016/j.jviromet.2016.02.016; Padilla-Parra S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-47; Padilla-Parra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071002; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Padilla-Parra S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002694; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Santos CD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005897; Simmons JA, 2016, J VIROL, V90, P605, DOI 10.1128/JVI.01828-15; Sood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148944; Spence JS, 2016, MBIO, V7, DOI 10.1128/mBio.01857-15; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087	44	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20196	20207		10.1074/jbc.M117.818088	http://dx.doi.org/10.1074/jbc.M117.818088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29046351	hybrid, Green Published			2022-12-28	WOS:000417696400024
J	Xiong, Y; Zhang, YX; Xin, N; Yuan, Y; Zhang, Q; Gong, P; Wu, YY				Xiong, Yi; Zhang, Yixin; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying			1,25-Dihydroxyvitamin D-3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; diabetes; FOXO; osteoblast; vitamin D; forkhead transcription factor 1; PI3K; Akt pathway; high glucose; osteocalcin	TITANIUM IMPLANT OSSEOINTEGRATION; OXIDATIVE STRESS; VITAMIN-D; LENTIVIRAL VECTOR; G-PROTEIN; INSULIN; OSTEOCALCIN; MELLITUS; TYPE-1; RISK	1,25-Dihydroxyvitamin D-3 (1,25(OH)(2)D-3) is the active form of vitamin D, which is responsible for reducing the risk for diabetes mellitus (DM), decreasing insulin resistance, and improving insulin secretion. Previous studies have shown that 1,25(OH)(2)D-3 inhibited the activity of FoxO1, which has been implicated in the regulation of glucose metabolism. However, its function and mechanism of action in DM-induced energy disorders and also in bone development remains unclear. Here, using in vitro and in vivo approaches including osteoblast-specific, conditional FoxO1-knock-out mice, we demonstrate that 1,25(OH)(2)D-3 ameliorates abnormal osteoblast proliferation in DM-induced oxidative stress conditions and rescues the impaired glucose and bone metabolism through FoxO1 nuclear exclusion resulting from the activation of PI3K/Akt signaling. Using alizarin red staining, alkaline phosphatase assay, Western blot, and real-time qPCR techniques, we found that 1,25(OH)(2)D-3 promotes osteoblast differentiation and expression of osteogenic phenotypic markers (i.e. alkaline phosphatase (1), collagen 1 (COL-1), osteocalcin (OCN), and osteopontin (OPN)) in a high-glucose environment. Moreover, 1,25(OH)(2)D-3 increased both total OCN secretion and levels of uncarboxylated OCN (GluOC) by phosphorylating FoxO1 and promoting its nuclear exclusion, indicated by Western blot and cell immunofluorescence analyses. Taken together, our findings confirm that FoxO1 is a key mediator involved in glucose homeostasis and indicate that 1,25(OH)(2)D-3 improves glucose metabolism and bone development via regulation of PI3K/Akt/FoxO1/OCN pathway.	[Xiong, Yi; Zhang, Yixin; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying] Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, Chengdu 610041, Sichuan, Peoples R China; [Xiong, Yi; Xin, Na; Yuan, Ying; Zhang, Qin; Gong, Ping; Wu, Yingying] Sichuan Univ, West China Hosp Stomatol, Dept Implantol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Yixin] Sichuan Univ, West China Hosp Stomatol, Dept Prosthodont, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Gong, P; Wu, YY (corresponding author), Sichuan Univ, State Key Lab Oral Dis, Natl Clin Res Ctr Oral Dis, West China Hosp Stomatol, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.; Gong, P; Wu, YY (corresponding author), Sichuan Univ, Dept Implantol, West China Hosp Stomatol, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Sichuan, Peoples R China.	dentistgong@hotmail.com; yywdentist@163.com	XIONG, Yi/HGU-1217-2022	Xiong, Yi/0000-0002-6676-202X	National Natural Science Foundation of China [NSFC 81400543, NSFC 81571008]; Outstanding Scholars Research Funding of Sichuan University [2017SCU04A21]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Scholars Research Funding of Sichuan University	This work was supported by National Natural Science Foundation of China Grants NSFC 81400543 and NSFC 81571008 and Outstanding Scholars Research Funding of Sichuan University (2017SCU04A21). The authors declare that they have no conflicts of interest with the contents of this article.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P495, DOI 10.1007/s00198-005-0013-x; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Botolin S, 2006, J CELL BIOCHEM, V99, P411, DOI 10.1002/jcb.20842; Brotto M, 2015, BONE, V80, P109, DOI 10.1016/j.bone.2015.02.010; Brotto M, 2014, CURR OSTEOPOROS REP, V12, P135, DOI 10.1007/s11914-014-0209-0; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CANALIS E, 1993, CALCIFIED TISSUE INT, V53, pS90, DOI 10.1007/BF01673411; Carnevale V, 2004, DIABETES-METAB RES, V20, P196, DOI 10.1002/dmrr.449; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fiorellini JP, 1999, CLIN ORAL IMPLAN RES, V10, P362, DOI 10.1111/j.1600-0501.1999.tb00011.x; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058; Gerritsen M, 2000, J BIOMED MATER RES, V53, P702, DOI 10.1002/1097-4636(2000)53:6<702::AID-JBM13>3.0.CO;2-V; Ghodsi M, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0275-1; Ghosh P, 2015, ENDOCR REV, V36, P272, DOI 10.1210/er.2014-1099; Hasegawa H, 2008, INT J ORAL MAX IMPL, V23, P237; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; Iyer S, 2017, J BONE MINER RES, V32, P60, DOI 10.1002/jbmr.2934; Iyer S, 2013, J CLIN INVEST, V123, P3409, DOI 10.1172/JCI68049; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jehle Sigrid, 2014, Swiss Med Wkly, V144, pw13942, DOI 10.4414/smw.2014.13942; Kanazawa I, 2011, OSTEOPOROSIS INT, V22, P1191, DOI 10.1007/s00198-010-1310-6; Klein GL, 2014, WORLD J DIABETES, V5, P14, DOI 10.4239/wjd.v5.i1.14; Kousteni S, 2012, BONE, V50, P437, DOI 10.1016/j.bone.2011.06.034; Kousteni S, 2011, J BONE MINER RES, V26, P912, DOI 10.1002/jbmr.306; Kurra S, 2014, ENDOCRIN METAB CLIN, V43, P233, DOI 10.1016/j.ecl.2013.09.004; Lee DH, 2006, CELL BIOL TOXICOL, V22, P39, DOI 10.1007/s10565-006-0018-z; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Littorin B, 2006, DIABETOLOGIA, V49, P2847, DOI 10.1007/s00125-006-0426-x; Liu G, 1998, CALCIFIED TISSUE INT, V62, P286, DOI 10.1007/s002239900432; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Mizokami A, 2017, BIOCHEM PHARMACOL, V132, P1, DOI 10.1016/j.bcp.2017.02.001; O'Loughlin A, 2010, INT J LOW EXTR WOUND, V9, P90, DOI 10.1177/1534734610371600; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; OIKARINEN K, 1995, COMMUNITY DENT ORAL, V23, P114, DOI 10.1111/j.1600-0528.1995.tb00212.x; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Perez-Lopez FR, 2007, MATURITAS, V58, P117, DOI 10.1016/j.maturitas.2007.05.002; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; Schwartz Ann V, 2004, Curr Diab Rep, V4, P364, DOI 10.1007/s11892-004-0039-z; Schwartz AV, 2003, CALCIFIED TISSUE INT, V73, P515, DOI 10.1007/s00223-003-0023-7; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Strotmeyer Elsa S, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P429, DOI 10.1097/MED.0b013e3282f1cba3; Thomas DM, 1996, J BONE MINER RES, V11, P1312; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vestergaard P, 2009, CALCIFIED TISSUE INT, V84, P45, DOI 10.1007/s00223-008-9195-5; Wasielica-Berger J, 2007, ADV MED SCI-POLAND, V52, P222; Wei JW, 2014, DIABETES, V63, P1021, DOI 10.2337/db13-0887; Wu YY, 2013, BONE, V52, P1, DOI 10.1016/j.bone.2012.09.005; Wu YK, 2012, ZOOTAXA, P1; Xiang L, 2014, J PERIODONTAL RES, V49, P554, DOI 10.1111/jre.12135; Xiang L, 2017, BONE, V94, P135, DOI 10.1016/j.bone.2015.08.009; Yang JH, 2010, CELL BIOCHEM FUNCT, V28, P334, DOI 10.1002/cbf.1668; Zoch ML, 2016, BONE, V82, P42, DOI 10.1016/j.bone.2015.05.046	63	24	30	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20270	20280		10.1074/jbc.M117.796367	http://dx.doi.org/10.1074/jbc.M117.796367			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042442	Green Published, hybrid			2022-12-28	WOS:000417696400030
J	Bykov, VJN; Issaeva, N; Zache, N; Shilov, A; Hultcrantz, M; Bergman, J; Selivanova, G; Wiman, KG				Bykov, Vladimir J. N.; Issaeva, Natalia; Zache, Nicole; Shilov, Alexandre; Hultcrantz, Monica; Bergman, Jan; Selivanova, Galina; Wiman, Klas G.			Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs (vol 280, pg 30384, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Wiman, Klas/AAB-8399-2021	Wiman, Klas/0000-0002-7113-524X; Selivanova, Galina/0000-0002-8698-4332; Issaeva, Natalia/0000-0001-5483-6610				Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200	1	6	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19607	19607		10.1074/jbc.AAC117.000815	http://dx.doi.org/10.1074/jbc.AAC117.000815			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29196570	Green Published, hybrid			2022-12-28	WOS:000416911300007
J	Sehgal, P; Szalai, P; Olesen, C; Praetorius, HA; Nissen, P; Christensen, SB; Engedal, N; Moller, JV				Sehgal, Pankaj; Szalai, Paula; Olesen, Claus; Praetorius, Helle A.; Nissen, Poul; Christensen, Soren Brogger; Engedal, Nikolai; Moller, Jesper V.			Inhibition of the sarco/endoplasmic reticulum (ER) Ca2+-ATPase by thapsigargin analogs induces cell death via ER Ca2+ depletion and the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; calcium; endoplasmic reticulum (ER); stromal interaction molecule 1 (STIM1); unfolded protein response (UPR)	PROSTATE-SPECIFIC ANTIGEN; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; CANCER CELLS; INTRACELLULAR CALCIUM; APOPTOSIS; CALPAIN; PRODRUG; STRESS; INACTIVATION	Calcium (Ca2+) is a fundamental regulator of cell signaling and function. Thapsigargin (Tg) blocks the sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA), disrupts Ca2+ homeostasis, and causes cell death. However, the exact mechanisms whereby SERCA inhibition induces cell death are incompletely understood. Here, we report that low (0.1 m) concentrations of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively inhibit SERCA1a-mediated Ca2+ transport. We also found that, in both prostate and breast cancer cells, exposure to Tg or Tg analogs for 1 day caused extensive drainage of the ER Ca2+ stores. This Ca2+ depletion was followed by markedly reduced cell proliferation rates and morphological changes that developed over 2-4 days and culminated in cell death. Interestingly, these changes were not accompanied by bulk increases in cytosolic Ca2+ levels. Moreover, knockdown of two key store-operated Ca2+ entry (SOCE) components, Orai1 and STIM1, did not reduce Tg cytotoxicity, indicating that SOCE and Ca2+ entry are not critical for Tg-induced cell death. However, we observed a correlation between the abilities of Tg and Tg analogs to deplete ER Ca2+ stores and their detrimental effects on cell viability. Furthermore, caspase activation and cell death were associated with a sustained unfolded protein response. We conclude that ER Ca2+ drainage and sustained unfolded protein response activation are key for initiation of apoptosis at low concentrations of Tg and Tg analogs, whereas high cytosolic Ca2+ levels and SOCE are not required.	[Sehgal, Pankaj; Olesen, Claus; Praetorius, Helle A.; Moller, Jesper V.] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark; [Sehgal, Pankaj] Univ Toronto, Sunnybrook Res Inst, Biol Platform, Toronto, ON M4N 3M5, Canada; [Sehgal, Pankaj] Univ Toronto, Dept Biochem, Toronto, ON M4N 3M5, Canada; [Sehgal, Pankaj; Olesen, Claus; Nissen, Poul; Moller, Jesper V.] Danish Res Fdn, Ctr Membrane Pumps Cells & Dis Pumpkin, DK-8000 Aarhus, Denmark; [Szalai, Paula; Engedal, Nikolai] Univ Oslo, Ctr Mol Med Norway NCMM, Nord European Mol Biol Lab EMBL Partnership Mol M, POB 1137 Blindern, N-0318 Oslo, Norway; [Nissen, Poul] Danish Res Inst Translat Neurosci DANDRITE, Dept Mol Biol & Genet, Nord EMBL Partnership Mol Med, DK-8000 Aarhus, Denmark; [Christensen, Soren Brogger] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark	Aarhus University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Oslo; University of Copenhagen	Moller, JV (corresponding author), Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark.; Engedal, N (corresponding author), Univ Oslo, Ctr Mol Med Norway NCMM, Nord European Mol Biol Lab EMBL Partnership Mol M, POB 1137 Blindern, N-0318 Oslo, Norway.	k.n.engedal@ncmm.uio.no; jvm@biomed.au.dk	Engedal, Nikolai/AAJ-8951-2020; Christensen, Søren Brøgger/H-4526-2019; Lindner, Paula/S-6929-2019	Engedal, Nikolai/0000-0003-3718-3464; Christensen, Søren Brøgger/0000-0002-5773-6874; Lindner, Paula/0000-0003-0734-6429; Olesen, Claus/0000-0002-0462-1686; Praetorius, Helle/0000-0002-0970-5061; Nissen, Poul/0000-0003-0948-6628	Danish Council for Strategic Research (SPOT-Light); Danish National Research Foundation (DNRF); Canadian Institutes of Health Foundation; DNRF; Lundbeck Foundation; Karen Elise Jensen Foundation; Lundbeck Foundation [R191-2015-1512] Funding Source: researchfish	Danish Council for Strategic Research (SPOT-Light); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond); Canadian Institutes of Health Foundation(Canadian Institutes of Health Research (CIHR)); DNRF; Lundbeck Foundation(Lundbeckfonden); Karen Elise Jensen Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Council for Strategic Research (SPOT-Light) and from The Danish National Research Foundation (DNRF) to the Centre for Membrane Pumps in Cells and Disease (PUMPkin). The experiments performed at Sunnybrook Research Institute were supported by grants from the Canadian Institutes of Health Foundation (to David W. Andrews). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by DNRF and grants from The Lundbeck Foundation (to J. V. M.) and the Karen Elise Jensen Foundation (to C. O.).	Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CHRISTENSEN SB, 1982, J ORG CHEM, V47, P649; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Denmeade SR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003886; Denmeade SR, 1997, CANCER RES, V57, P4924; Denmeade SR, 2005, CANCER BIOL THER, V4, P14; Denmeade SR, 2003, J NATL CANCER I, V95, P990, DOI 10.1093/jnci/95.13.990; Dubois C, 2013, FEBS J, V280, P5430, DOI 10.1111/febs.12475; Engedal N, 2013, AUTOPHAGY, V9, P1475, DOI 10.4161/auto.25900; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Fortea MI, 2001, J BIOL CHEM, V276, P37266, DOI 10.1074/jbc.M103949200; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; Griend DJV, 2009, MOL CANCER THER, V8, P1340, DOI 10.1158/1535-7163.MCT-08-1136; Jakobsen CM, 2001, J MED CHEM, V44, P4696, DOI 10.1021/jm010985a; Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; LEVY D, 1990, J BIOL CHEM, V265, P19524; Levy O, 2016, BIOMATERIALS, V91, P140, DOI 10.1016/j.biomaterials.2016.03.023; Lotem J, 1998, P NATL ACAD SCI USA, V95, P4601, DOI 10.1073/pnas.95.8.4601; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Mahalingam D, 2016, BRIT J CANCER, V114, P986, DOI 10.1038/bjc.2016.72; Moller JV, 2016, METHODS MOL BIOL, V1377, P11, DOI 10.1007/978-1-4939-3179-8_3; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Muruganandan S, 2006, TOXICOL SCI, V94, P118, DOI 10.1093/toxsci/kfl084; Musgaard M, 2012, BIOPHYS J, V102, P268, DOI 10.1016/j.bpj.2011.12.009; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; SAGARA Y, 1992, J BIOL CHEM, V267, P1286; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Tombal B, 2000, PROSTATE, V43, P303; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; WICTOME M, 1992, FEBS LETT, V304, P109, DOI 10.1016/0014-5793(92)80599-C; Winther AML, 2010, J BIOL CHEM, V285, P28883, DOI 10.1074/jbc.M110.136242; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200	43	92	94	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19656	19673		10.1074/jbc.M117.796920	http://dx.doi.org/10.1074/jbc.M117.796920			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972171	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000416911300013
J	Kaut, A; Lange, H; Diekert, K; Kispal, G; Lill, R				Kaut, Anita; Lange, Heike; Diekert, Kerstin; Kispal, Gyula; Lill, Roland			Isa1p is a component of the mitochondrial machinery for maturation of cellular iron-sulfur proteins and requires conserved cysteine residues for function (vol 275, pg 15955, 2000)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Lill, Roland/0000-0002-8345-6518				Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 27	2017	292	43					17980	17980		10.1074/jbc.AAC117.000256	http://dx.doi.org/10.1074/jbc.AAC117.000256			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1ZL	29079645	Green Published, hybrid			2022-12-28	WOS:000414013000035
J	Hsu, SHC; Nadesan, P; Puviindran, V; Section, WBS; Kirsch, DG; Alman, BA				Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Section, William B. Stallcup; Kirsch, David G.; Alman, Benjamin A.			Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY-BASED IMMUNOTHERAPY; FACTOR-BINDING PROTEIN-3; PDGF ALPHA-RECEPTOR; FACTOR I RECEPTOR; ANTIGEN HMW-MAA; NG2 PROTEOGLYCAN; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; CELL-SURFACE; FACTORS IGFS	Sarcomas, and the mesenchymal precursor cells from which they arise, express chondroitin sulfate proteoglycan 4 (NG2/CSPG4). However, NG2/CSPG4's function and its capacity to serve as a therapeutic target in this tumor type are unknown. Here, we used cells from human tumors and a genetically engineered autochthonous mouse model of soft-tissue sarcomas (STSs) to determine NG2/CSPG4's role in STS initiation and growth. Inhibiting NG2/CSPG4 expression in established murine and human STSs decreased tumor volume by almost two-thirds and cell proliferation rate by 50%. NG2/CSPG4 antibody immunotherapy in human sarcomas established as xenografts in mice similarly decreased tumor volume, and expression of a lentivirus blocking NG2/CSPG4 expression inhibited tumor cell proliferation and increased the latency of engraftment. Gene profiling showed that Ng2/Cspg4 deletion altered the expression of genes regulating cell proliferation and apoptosis. Surprisingly, Ng2/Cspg4 deletion at the time of tumor initiation resulted in larger tumors. Gene expression profiling indicated substantial down-regulation of insulin-like growth factor binding protein (Igfbp) genes when Ng2/Cspg4 is depleted at tumor initiation, but not when Ng2/Cspg4 is depleted after tumor initiation. Such differences may have clinical significance, as therapeutic targeting of a signaling pathway such as NG2/CSPG4 may have different effects on cell behavior with tumor progression. NG2/CSPG4 depletion has divergent effects, depending on the developmental stage of sarcoma. In established tumors, IGF signaling is active, and NG2 inhibition targets cell proliferation and apoptosis.	[Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Alman, Benjamin A.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA; [Hsu, Shu-Hsuan Claire; Nadesan, Puviindran; Puviindran, Vijitha; Alman, Benjamin A.] Duke Univ, RegenerationNext Initiat, Durham, NC 27710 USA; [Kirsch, David G.] Duke Univ, Dept Radiat Oncol, Durham, NC 27710 USA; [Section, William B. Stallcup] Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA	Duke University; Duke University; Duke University; Sanford Burnham Prebys Medical Discovery Institute	Alman, BA (corresponding author), DUMC2888,200 Trent Dr,Orange Zone 5th Floor, Durham, NC 27710 USA.	ben.alman@duke.edu			NCI, National Institutes of Health [R01 CA183811]; NATIONAL CANCER INSTITUTE [R01CA183811] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health, Grant R01 CA183811. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benassi MS, 2009, J ORTHOP RES, V27, P135, DOI 10.1002/jor.20694; Borden EC, 2003, CLIN CANCER RES, V9, P1941; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Campoli MR, 2004, CRIT REV IMMUNOL, V24, P267, DOI 10.1615/CritRevImmunol.v24.i4.40; Cattaruzza S, 2013, J MOL CELL BIOL, V5, P176, DOI 10.1093/jmcb/mjt010; Cattaruzza S, 2013, ANGIOGENESIS, V16, P309, DOI 10.1007/s10456-012-9316-7; Chang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030637; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Duan CM, 1999, J BIOL CHEM, V274, P37147, DOI 10.1074/jbc.274.52.37147; Fletcher CDM, 2014, MODERN PATHOL, V27, pS98, DOI 10.1038/modpathol.2013.172; Fottner C, 1999, HORM METAB RES, V31, P203, DOI 10.1055/s-2007-978720; Grako KA, 1999, J CELL SCI, V112, P905; Granata R, 2004, FASEB J, V18, P1456, DOI 10.1096/fj.04-1618fje; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Ho L, 2009, CANCER CELL, V16, P126, DOI 10.1016/j.ccr.2009.05.013; Hollowood AD, 2000, INT J CANCER, V88, P336, DOI 10.1002/1097-0215(20001101)88:3<336::AID-IJC3>3.3.CO;2-1; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Jin QR, 2014, CARCINOGENESIS, V35, P2232, DOI 10.1093/carcin/bgu129; Joo NE, 2008, CELL DEATH DIFFER, V15, P899, DOI 10.1038/cdd.2008.22; Joo NE, 2014, DNA CELL BIOL, V33, P854, DOI 10.1089/dna.2014.2399; Joy AM, 2003, J CELL SCI, V116, P4409, DOI 10.1242/jcs.00712; KAGESHITA T, 1992, PIGM CELL RES, P132; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; King DM, 2009, CLIN ORTHOP RELAT R, V467, P2838, DOI 10.1007/s11999-009-0989-1; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lehnhardt M, 2009, LANGENBECK ARCH SURG, V394, P313, DOI 10.1007/s00423-008-0368-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Matushansky I, 2009, EXPERT REV ANTICANC, V9, P1135, DOI [10.1586/era.09.76, 10.1586/ERA.09.76]; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Mittelman A, 1995, CLIN CANCER RES, V1, P705; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nicolosi PA, 2015, THERANOSTICS, V5, P530, DOI 10.7150/thno.10824; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Petrovici Karin, 2010, Cancer Genomics & Proteomics, V7, P173; Poon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037940; Rivera Z, 2012, CLIN CANCER RES, V18, P5352, DOI 10.1158/1078-0432.CCR-12-0628; Sato S, 2016, CELL REP, V16, P917, DOI 10.1016/j.celrep.2016.06.058; Scotlandi K, 1996, CANCER RES, V56, P4570; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; VanderVen LTM, 1997, BRIT J CANCER, V75, P1631, DOI 10.1038/bjc.1997.278; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wagner S, 2008, CLIN CANCER RES, V14, P8178, DOI 10.1158/1078-0432.CCR-08-0371; Walter HJ, 1999, ENDOCRINOLOGY, V140, P520, DOI 10.1210/en.140.1.520; Wang CYY, 2012, CANCER RES, V72, P1013, DOI 10.1158/0008-5472.CAN-11-2531; Wang J. -G., 2011, FRESHW FISH, V4, P6, DOI DOI 10.1371/J0URNAL.P0NE.0023062; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Wei QX, 2015, ONCOTARGET, V6, P40283, DOI 10.18632/oncotarget.5375; Williams AC, 2000, CANCER RES, V60, P22; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; You WK, 2014, ANGIOGENESIS, V17, P61, DOI 10.1007/s10456-013-9378-1; Young NP, 2011, CANCER RES, V71, P4040, DOI 10.1158/0008-5472.CAN-10-4563; Yu L, 2011, IMMUNOL RES, V50, P294, DOI 10.1007/s12026-011-8232-z	59	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2466	2475		10.1074/jbc.M117.805051	http://dx.doi.org/10.1074/jbc.M117.805051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29196603	hybrid, Green Published			2022-12-28	WOS:000425308300019
J	Hu, ZP; Riquelme, MA; Wang, B; Bugay, V; Brenner, R; Gu, SM; Jiang, JX				Hu, Zhengping; Riquelme, Manuel A.; Wang, Bin; Bugay, Vladislav; Brenner, Robert; Gu, Sumin; Jiang, Jean X.			Cataract-associated connexin 46 mutation alters its interaction with calmodulin and function of hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; LENS DEVELOPMENT; XENOPUS-OOCYTES; PLASMA-MEMBRANE; VOLTAGE; CALCIUM; COMMUNICATION; PERMEABILITY; DEPENDENCE; BINDING	Connexin channels help maintain eye lens homeostasis and transparency. The G143R missense substitution in connexin (Cx) 46 is associated with congenital Coppock cataracts; however, the underlying molecular mechanism is largely unknown. Here, we report that compared with WT Cx46, the G143R substitution abolishes hemichannel conductance in Xenopus oocytes and in HeLa cells. Moreover, this substitution is dominant-negative and inhibits conductance of WT Cx46. CD analysis indicated that the substitution greatly reduces the alpha-helical structure of the intracellular Cx46 loop domain. Protein pull-down assays and isothermal titration calorimetry revealed that this Cx46 domain directly interacts with calmodulin (CaM) in a Ca2+-dependent fashion, an observation confirmed by immuno-fluorescent co-localization of Cx46 with CaM. Interestingly, the G143R substitution enhanced the Cx46-CaM interaction and attenuated its abolishment by Ca2+ depletion. Moreover, Cx46 increased dye influx, and the G143R substitution augmented this effect. Inhibition of Ca2+-mediated CaM activation blocked hemichannel permeability. The membrane potential plays a crucial role in Cx46 membrane permeability. We found that the activity of hemichannels is detectable under rest and hyperpolarization conditions but is eliminated with depolarization. These results suggested that the G143R substitution impairs voltage-dependent electrical conductance and alters membrane permeability mediated by Cx46 hemichannels. The latter likely is caused by the substitution-induced structural changes of the intracellular loop domain associated with the increased interaction with CaM and reduced Ca2+ sensitivity. The data suggest that the G143R-induced enhancement of the CaM-Cx46 interaction results in altered hemichannel activities and might be related to cataract formation.	[Hu, Zhengping; Riquelme, Manuel A.; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Wang, Bin; Bugay, Vladislav; Brenner, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Hu, Zhengping] Cent S Univ, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Central South University	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu		Hu, Zhengping/0000-0001-7369-1314; Brenner, Robert/0000-0002-1036-8031; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085]; Welch Foundation [AQ-1507]; National Science Foundation [1456862]; NATIONAL EYE INSTITUTE [R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY012085 (to J.X.J.), Welch Foundation Grant AQ-1507 (to J.X.J.), and National Science Foundation Grant 1456862 (to R.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bargiello TA, 2012, BBA-BIOMEMBRANES, V1818, P1807, DOI 10.1016/j.bbamem.2011.09.019; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Billaud M, 2014, PHARMACOL REV, V66, P513, DOI 10.1124/pr.112.007351; Chen YY, 2011, BIOCHEM J, V435, P711, DOI 10.1042/BJ20101726; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; EBIHARA L, 1993, J GEN PHYSIOL, V102, P59, DOI 10.1085/jgp.102.1.59; Ebihara L, 2011, INVEST OPHTH VIS SCI, V52, P882, DOI 10.1167/iovs.10-6200; Figueroa V, 2013, BBA-BIOMEMBRANES, V1828, P1169, DOI 10.1016/j.bbamem.2012.12.006; Flores CE, 2010, J NEUROSCI, V30, P9488, DOI 10.1523/JNEUROSCI.4466-09.2010; Forrester JVDA., 1996, EYE BASIC SCI PRACTI; Gong X, 2007, J MEMBRANE BIOL, V218, P9, DOI 10.1007/s00232-007-9033-0; Goodenough D.A., 1992, Seminars in Cell Biology, V3, P49; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Jiang JX, 2010, CURR MOL MED, V10, P851; Mathias RT, 2007, J MEMBRANE BIOL, V216, P1, DOI 10.1007/s00232-007-9019-y; Mathias RT, 2010, PHYSIOL REV, V90, P179, DOI 10.1152/physrev.00034.2009; Mese G, 2007, J INVEST DERMATOL, V127, P2516, DOI 10.1038/sj.jid.5700770; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PAUL DL, 1991, J CELL BIOL, V115, P1077, DOI 10.1083/jcb.115.4.1077; PERACCHIA C, 1983, PFLUG ARCH EUR J PHY, V399, P152, DOI 10.1007/BF00663912; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Pinto BI, 2016, J BIOL CHEM, V291, P15740, DOI 10.1074/jbc.M115.709402; Qu Y, 2002, P NATL ACAD SCI USA, V99, P697, DOI 10.1073/pnas.022324499; Ren Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074732; Retamal MA, 2007, J MEMBRANE BIOL, V218, P49, DOI 10.1007/s00232-007-9043-y; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; ROSE B, 1977, NATURE, V267, P625, DOI 10.1038/267625a0; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Trexler EB, 1996, P NATL ACAD SCI USA, V93, P5836, DOI 10.1073/pnas.93.12.5836; VanMarle J, 1997, EXP EYE RES, V65, P83, DOI 10.1006/exer.1997.0313; Wang N, 2013, NEUROPHARMACOLOGY, V75, P506, DOI 10.1016/j.neuropharm.2013.08.021; Zhang L, 2012, MOL VIS, V18, P2114; Zhang XR, 2005, ARCH BIOCHEM BIOPHYS, V440, P111, DOI 10.1016/j.abb.2005.06.004; Zhang YP, 2013, BIOCHEM BIOPH RES CO, V436, P424, DOI 10.1016/j.bbrc.2013.05.118; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2009, BIOPHYS J, V96, P2832, DOI 10.1016/j.bpj.2008.12.3941; Zou J, 2014, FEBS LETT, V588, P1430, DOI 10.1016/j.febslet.2014.01.003	39	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2573	2585		10.1074/jbc.RA117.001348	http://dx.doi.org/10.1074/jbc.RA117.001348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29298900	Green Published, hybrid			2022-12-28	WOS:000425308300028
J	Boulet, A; Vest, KE; Maynard, MK; Gammon, MG; Russell, AC; Mathews, AT; Cole, SE; Zhu, XY; Phillips, CB; Kwong, JQ; Dodani, SC; Leary, SC; Cobine, PA				Boulet, Aren; Vest, Katherine E.; Maynard, Margaret K.; Gammon, Micah G.; Russell, Antoinette C.; Mathews, Alexander T.; Cole, Shelbie E.; Zhu, Xinyu; Phillips, Casey B.; Kwong, Jennifer Q.; Dodani, Sheel C.; Leary, Scot C.; Cobine, Paul A.			The mammalian phosphate carrier SLC25A3 is a mitochondrial copper transporter required for cytochrome c oxidase biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; cytochrome c oxidase (complex IV); mitochondria; copper transport; membrane transport	SACCHAROMYCES-CEREVISIAE; HYPERTROPHIC CARDIOMYOPATHY; FUNCTIONAL-CHARACTERIZATION; BACTERIAL EXPRESSION; TISSUE DISTRIBUTION; BINDING PROTEIN; HUMAN MYOBLASTS; ATP SYNTHASOME; P-I; SCO2	Copper is required for the activity of cytochrome c oxidase (COX), the terminal electron-accepting complex of the mitochondrial respiratory chain. The likely source of copper used for COX biogenesis is a labile pool found in the mitochondrial matrix. In mammals, the proteins that transport copper across the inner mitochondrial membrane remain unknown. We previously reported that the mitochondrial carrier family protein Pic2 in budding yeast is a copper importer. The closest Pic2 ortholog in mammalian cells is the mitochondrial phosphate carrier SLC25A3. Here, to investigate whether SLC25A3 also transports copper, we manipulated its expression in several murine and human cell lines. SLC25A3 knockdown or deletion consistently resulted in an isolated COX deficiency in these cells, and copper addition to the culture medium suppressed these biochemical defects. Consistent with a conserved role for SLC25A3 in copper transport, its heterologous expression in yeast complemented copper-specific defects observed upon deletion of PIC2. Additionally, assays in Lactococcus lactis and in reconstituted liposomes directly demonstrated that SLC25A3 functions as a copper transporter. Taken together, these data indicate that SLC25A3 can transport copper both in vitro and in vivo.	[Boulet, Aren; Leary, Scot C.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK 7N 5E5, Canada; [Vest, Katherine E.; Maynard, Margaret K.; Gammon, Micah G.; Russell, Antoinette C.; Mathews, Alexander T.; Cole, Shelbie E.; Zhu, Xinyu; Phillips, Casey B.; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA; [Kwong, Jennifer Q.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Dodani, Sheel C.] Univ Texas Dallas, Dept Chem & Biochem, Dallas, TX 75080 USA	University of Saskatchewan; Auburn University System; Auburn University; Emory University; University of Texas System; University of Texas Dallas	Cobine, PA (corresponding author), Auburn Univ, Dept Biol Sci, 101 Rouse Life Sci, Auburn, AL 36849 USA.	paul.cobine@auburn.edu	Cobine, Paul/AAH-6619-2020; Kwong, Jennifer/L-4348-2019; Cobine, Paul A/G-3107-2011	Cobine, Paul/0000-0001-6012-0985; Cobine, Paul A/0000-0001-6012-0985; Vest, Katherine/0000-0002-3391-8649; Russell, Antoinette/0000-0003-4725-1758	National Science Foundation [MCB1158497]; National Institutes of Health [R01GM120211, R01GM079465]; Canadian Institutes of Health Research; Summer Scholar Cellular and Molecular Bioscience Program, Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, R01GM120211] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1158497] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Summer Scholar Cellular and Molecular Bioscience Program, Auburn University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB1158497 (to P. A. C.), National Institutes of Health Grants R01GM120211 (to P. A. C. and S. C. L.) and R01GM079465 (to Christopher J. Chang (University of California-Berkeley) for work performed by S. C. D.), and Canadian Institutes of Health Research (to S. C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the Summer Scholar Cellular and Molecular Bioscience Program, Auburn University.	Allen KJ, 2006, BIOMETALS, V19, P555, DOI 10.1007/s10534-005-5918-5; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Antonicka H, 2003, AM J HUM GENET, V72, P101, DOI 10.1086/345489; Baker ZN, 2017, HUM MOL GENET, V26, P4617, DOI 10.1093/hmg/ddx344; Baker ZN, 2017, METALLOMICS, V9, P1501, DOI 10.1039/c7mt00221a; Bode M, 2015, MOL BIOL CELL, V26, P2385, DOI 10.1091/mbc.E14-11-1526; Bourens M, 2014, HUM MOL GENET, V23, P2901, DOI 10.1093/hmg/ddu003; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Carr HS, 2002, J BIOL CHEM, V277, P31237, DOI 10.1074/jbc.M204854200; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Cavero S, 2003, MOL MICROBIOL, V50, P1257, DOI 10.1046/j.1365-2958.2003.03742.x; Chen C, 2004, J BIOL CHEM, V279, P31761, DOI 10.1074/jbc.M401353200; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, J BIOL CHEM, V281, P36552, DOI 10.1074/jbc.M606839200; Diaz F, 2010, BBA-MOL BASIS DIS, V1802, P100, DOI 10.1016/j.bbadis.2009.07.013; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Fiermonte G, 2003, J BIOL CHEM, V278, P32778, DOI 10.1074/jbc.M302317200; Fiermonte G, 1998, J BIOL CHEM, V273, P22782, DOI 10.1074/jbc.273.35.22782; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Hlynialuk C. J., 2015, CELL REP, V2015, pS2211; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Horvath R, 2005, J INHERIT METAB DIS, V28, P479, DOI 10.1007/s10545-005-0479-x; Jaksch M, 2000, HUM MOL GENET, V9, P795, DOI 10.1093/hmg/9.5.795; Jaksch M, 2001, HUM MOL GENET, V10, P3025, DOI 10.1093/hmg/10.26.3025; Jaksch M, 2001, NEUROLOGY, V57, P1440, DOI 10.1212/WNL.57.8.1440; Jett KA, 2018, J BIOL CHEM, V293, P4644, DOI 10.1074/jbc.R117.816132; Joost K, 2010, PEDIATR NEUROL, V42, P227, DOI 10.1016/j.pediatrneurol.2009.10.004; Kaplan JH, 2016, BIOPHYS J, V110, P7, DOI 10.1016/j.bpj.2015.11.025; Kim BE, 2010, CELL METAB, V11, P353, DOI 10.1016/j.cmet.2010.04.003; Ko YH, 2003, J BIOL CHEM, V278, P12305, DOI 10.1074/jbc.C200703200; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; Leary SC, 2007, CELL METAB, V5, P403, DOI 10.1016/j.cmet.2007.04.002; Leary SC, 2013, HUM MUTAT, V34, P1366, DOI 10.1002/humu.22385; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Leary SC, 2009, HUM MOL GENET, V18, P2230, DOI 10.1093/hmg/ddp158; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Lu YW, 2017, MOL BIOL CELL, V28, P1489, DOI 10.1091/mbc.E17-03-0195; Marobbio CMT, 2015, MOL GENET METAB, V115, P27, DOI 10.1016/j.ymgme.2015.03.003; Marobbio CMT, 2003, EMBO J, V22, P5975, DOI 10.1093/emboj/cdg574; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2011, NEUROMUSCULAR DISORD, V21, P803, DOI 10.1016/j.nmd.2011.06.005; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Morgada MN, 2015, P NATL ACAD SCI USA, V112, P11771, DOI 10.1073/pnas.1505056112; Pacheu-Grau D, 2015, CELL METAB, V21, P823, DOI 10.1016/j.cmet.2015.04.012; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2000, J BIOENERG BIOMEMBR, V32, P67, DOI 10.1023/A:1005564429242; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pyatskowit JW, 2008, COMP BIOCHEM PHYS C, V147, P316, DOI 10.1016/j.cbpc.2007.11.008; Reddi AR, 2013, CELL, V152, P224, DOI 10.1016/j.cell.2012.11.046; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Seifert EL, 2016, J BIOL CHEM, V291, P26126, DOI 10.1074/jbc.M116.744714; Smith D, 2005, J BIOL CHEM, V280, P17652, DOI 10.1074/jbc.C500061200; Stroud DA, 2015, HUM MOL GENET, V24, P5404, DOI 10.1093/hmg/ddv265; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valnot I, 2000, AM J HUM GENET, V67, P1104; Vest KE, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150223; Vest KE, 2013, J BIOL CHEM, V288, P23884, DOI 10.1074/jbc.M113.470674; West EC, 2004, EXP BIOL MED, V229, P756, DOI 10.1177/153537020422900807; Williams JR, 2016, NEUROBIOL DIS, V89, P1, DOI 10.1016/j.nbd.2016.01.020; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	64	56	56	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1887	1896		10.1074/jbc.RA117.000265	http://dx.doi.org/10.1074/jbc.RA117.000265			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29237729	hybrid, Green Published			2022-12-28	WOS:000424948000003
J	Ha, BH; Boggon, TJ				Ha, Byung Hak; Boggon, Titus J.			The crystal structure of pseudokinase PEAK1 (Sugen kinase 269) reveals an unusual catalytic cleft and a novel mode of kinase fold dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; crystal structure; dimerization; protein kinase; PTEN-induced putative kinase (PINK1)	SIGNALING NETWORK; PROTEIN; PHOSPHORYLATION; SGK269/PEAK1; RECOGNITION; MECHANISMS; COMPLEX; LIVE	The pseudokinase group encompasses some 10% of protein kinases, but pseudokinases diverge from canonical kinases in key motifs. The two members of the small new kinase family 3 (NKF3) group are considered pseudokinases. These proteins, pseudopodium-enriched atypical kinase 1 (PEAK1, Sugen kinase 269, or SgK269) and pragmin (Sugen kinase 223 or SgK223), act as scaffolds in growth factor signaling pathways, and both contain a kinase fold with degraded kinase motifs at their C termini. These kinases may harbor regions that mediate oligomerization or control other aspects of signal transduction, but a lack of structural information has precluded detailed investigations into their functional roles. In this study, we determined the X-ray crystal structure of the PEAK1 pseudokinase domain to 2.3 resolution. The structure revealed that the PEAK1 kinase-like domain contains a closed nucleotide-binding cleft that in this conformation may deleteriously affect nucleotide binding. Moreover, we found that N- and C-terminal extensions create a highly unusual all -helical split-dimerization region, termed here the split helical dimerization (SHED) region. Sequence conservation analysis suggested that this region facilitates a dimerization mode that is conserved between PEAK1 and pragmin. Finally, we observed structural similarities between the PEAK1 SHED region and the C-terminal extension of the Parkinson's disease-associated kinase PINK1. In summary, PEAK1's kinase cleft is occluded, and its newly identified SHED region may promote an unexpected dimerization mode. Similarities of PEAK1 with the active kinase PINK1 may reclassify the latter as a member of the new kinase family 3 group.	[Ha, Byung Hak; Boggon, Titus J.] Yale Univ, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA; [Boggon, Titus J.] Yale Univ, Dept Mol Biophys & Biochem, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA	Yale University; Yale University	Boggon, TJ (corresponding author), Yale Univ, Dept Pharmacol, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.; Boggon, TJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, SHM B-316A,333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu			National Institutes of Health [R01NS085078, R01GM109487, R01GM114621, R01GM102262, S10OD018007]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM114621, R01GM102262, R01GM109487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085078] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01NS085078, R01GM109487, R01GM114621, R01GM102262, and S10OD018007. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agajanian M, 2015, BIOCHEM BIOPH RES CO, V465, P606, DOI 10.1016/j.bbrc.2015.08.071; Agajanian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135748; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bristow JM, 2013, J BIOL CHEM, V288, P123, DOI 10.1074/jbc.M112.410910; Croucher DR, 2013, CANCER RES, V73, P1969, DOI 10.1158/0008-5472.CAN-12-1472; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Hamill S, 2016, MOL CELL, V62, P397, DOI 10.1016/j.molcel.2016.04.001; Hammaren HM, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150226; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Kelber JA, 2010, ONCOTARGET, V1, P219, DOI 10.18632/oncotarget.128; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2017, ELIFE, V6, DOI 10.7554/eLife.29985; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liu L, 2016, J BIOL CHEM, V291, P21571, DOI 10.1074/jbc.M116.748897; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Murphy JM, 2017, CURR OPIN STRUC BIOL, V47, P95, DOI 10.1016/j.sbi.2017.07.004; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Ohara O, 2002, DNA RES, V9, P47, DOI 10.1093/dnares/9.2.47; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01279-9; Schubert AF, 2017, NATURE, V552, P51, DOI 10.1038/nature24645; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stiegler AL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00483-x; Strnadel J, 2017, CANCER RES, V77, P1997, DOI 10.1158/0008-5472.CAN-16-2594; Tactacan CM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0412-3; Titz B, 2010, ONCOGENE, V29, P5895, DOI 10.1038/onc.2010.331; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zheng Y, 2013, NATURE, V499, P166, DOI 10.1038/nature12308	43	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1642	1650		10.1074/jbc.RA117.000751	http://dx.doi.org/10.1074/jbc.RA117.000751			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29212708	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000424201700016
J	Ma, ZX; Strickland, KT; Cherne, MD; Sehanobish, E; Rohde, KH; Self, WT; Davidson, VL				Ma, Zhongxin; Strickland, Kyle T.; Cherne, Michelle D.; Sehanobish, Esha; Rohde, Kyle H.; Self, William T.; Davidson, Victor L.			The Rv2633c protein of Mycobacterium tuberculosis is a non-heme di-iron catalase with a possible role in defenses against oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catalase; metalloenzyme; Mycobacterium tuberculosis; reactive oxygen species (ROS); enzyme kinetics; hemerythrin; non-heme iron	METHYLOCOCCUS-CAPSULATUS BATH; HEMERYTHRIN; DIVERSITY; TUNNEL; ENZYME; PH	The Rv2633c gene in Mycobacterium tuberculosis is rapidly up-regulated after macrophage infection, suggesting that Rv2633c is involved in M. tuberculosis pathogenesis. However, the activity and role of the Rv2633c protein in host colonization is unknown. Here, we analyzed the Rv2633c protein sequence, which revealed the presence of an HHE cation-binding domain common in hemerythrin-like proteins. Phylogenetic analysis indicated that Rv2633c is a member of a distinct subset of hemerythrin-like proteins exclusive to mycobacteria. The Rv2633c sequence was significantly similar to protein sequences from other pathogenic strains within that subset, suggesting that these proteins are involved in mycobacteria virulence. We expressed and purified the Rv2633c protein in Escherichia coli and found that it contains two iron atoms, but does not behave like a hemerythrin. It migrated as a dimeric protein during size-exclusion chromatography. It was not possible to reduce the protein or observe any evidence for its interaction with O-2. However, Rv2633c did exhibit catalase activity with a k(cat) of 1475 s(-1) and K-m of 10.1 +/- 1.7 mm. Cyanide and azide inhibited the catalase activity with K-i values of 3.8 m and 37.7 m, respectively. Rv2633c's activity was consistent with a role in defenses against oxidative stress generated during host immune responses after M. tuberculosis infection of macrophages. We note that Rv2633c is the first example of a non-heme di-iron catalase, and conclude that it is a member of a subset of hemerythrin-like proteins exclusive to mycobacteria, with likely roles in protection against host defenses.	[Ma, Zhongxin; Strickland, Kyle T.; Cherne, Michelle D.; Sehanobish, Esha; Rohde, Kyle H.; Self, William T.; Davidson, Victor L.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Davidson, VL (corresponding author), 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu	Self, William/A-6704-2008; Self, William/Q-4113-2019		Burnett School of Biomedical Sciences	Burnett School of Biomedical Sciences	This research was supported by Startup Funds from the Burnett School of Biomedical Sciences (to K. H. R. and V. L. D). The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch RB, 2011, MOL MICROBIOL, V80, P678, DOI 10.1111/j.1365-2958.2011.07601.x; BAERT JL, 1992, EUR J BIOCHEM, V209, P563, DOI 10.1111/j.1432-1033.1992.tb17321.x; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chen KHC, 2015, J INORG BIOCHEM, V150, P81, DOI 10.1016/j.jinorgbio.2015.04.001; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Homolka S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000988; Isaza CE, 2006, BIOCHEMISTRY-US, V45, P9023, DOI 10.1021/bi0607812; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karlsen OA, 2005, FEBS J, V272, P2428, DOI 10.1111/j.1742-4658.2005.04663.x; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li XB, 2015, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00777, 10.3389/fmicb.2014.00573, 10.3389/fmicb.2014.00800]; Makris TM, 2010, P NATL ACAD SCI USA, V107, P15391, DOI 10.1073/pnas.1007953107; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Njuma OJ, 2017, J BIOL CHEM, V292, P18408, DOI 10.1074/jbc.M117.791202; Que L, 1996, ACCOUNTS CHEM RES, V29, P190, DOI 10.1021/ar950146g; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; TAKAGI T, 1991, FEBS LETT, V285, P25, DOI 10.1016/0014-5793(91)80716-G; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Whittaker JW, 2012, ARCH BIOCHEM BIOPHYS, V525, P111, DOI 10.1016/j.abb.2011.12.008; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046	30	10	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1590	1595		10.1074/jbc.RA117.000421	http://dx.doi.org/10.1074/jbc.RA117.000421			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29242190	hybrid, Green Published			2022-12-28	WOS:000424201700012
J	Wales, JA; Chen, CY; Breci, L; Weichsel, A; Bernier, SG; Sheppeck, JE; Solinga, R; Nakai, T; Renhowe, PA; Jung, J; Montfort, WR				Wales, Jessica A.; Chen, Cheng-Yu; Breci, Linda; Weichsel, Andrzej; Bernier, Sylvie G.; Sheppeck, James E., II; Solinga, Robert; Nakai, Takashi; Renhowe, Paul A.; Jung, Joon; Montfort, William R.			Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); nitric oxide; protein-drug interaction; photoaffinity labeling; mass spectrometry (MS); nuclear magnetic resonance (NMR)	NO-INDEPENDENT STIMULATORS; IRON-HISTIDINE BOND; NITRIC-OXIDE; H-NOX; NMR-SPECTROSCOPY; CLOSTRIDIUM-BOTULINUM; SITE IDENTIFICATION; YC-1 BINDING; PROTEINS; ACTIVATION	Soluble guanylyl cyclase (sGC) is the receptor for nitric oxide and a highly sought-after therapeutic target for the management of cardiovascular diseases. New compounds that stimulate sGC show clinical promise, but where these stimulator compounds bind and how they function remains unknown. Here, using a photolyzable diazirine derivative of a novel stimulator compound, IWP-051, and MS analysis, we localized drug binding to the 1 heme domain of sGC proteins from the hawkmoth Manduca sexta and from human. Covalent attachments to the stimulator were also identified in bacterial homologs of the sGC heme domain, referred to as H-NOX domains, including those from Nostoc sp. PCC 7120, Shewanella oneidensis, Shewanella woodyi, and Clostridium botulinum, indicating that the binding site is highly conserved. The identification of photoaffinity-labeled peptides was aided by a signature MS fragmentation pattern of general applicability for unequivocal identification of covalently attached compounds. Using NMR, we also examined stimulator binding to sGC from M. sexta and bacterial H-NOX homologs. These data indicated that stimulators bind to a conserved cleft between two subdomains in the sGC heme domain. L12W/T48W substitutions within the binding pocket resulted in a 9-fold decrease in drug response, suggesting that the bulkier tryptophan residues directly block stimulator binding. The localization of stimulator binding to the sGC heme domain reported here resolves the longstanding question of where stimulators bind and provides a path forward for drug discovery.	[Wales, Jessica A.; Chen, Cheng-Yu; Breci, Linda; Weichsel, Andrzej; Montfort, William R.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Bernier, Sylvie G.; Sheppeck, James E., II; Solinga, Robert; Nakai, Takashi; Renhowe, Paul A.; Jung, Joon] Ironwood Pharmaceut, Cambridge, MA 02142 USA	University of Arizona; Ironwood Pharmaceuticals, Inc.	Montfort, WR (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	montfort@email.arizona.edu			National Institutes of Health from NIEHS [ES06694]; National Institutes of Health from NCI [CA023074]; BIO5 Institute of the University of Arizona; National Institutes of Health from the National Center for Research Resources (NCRR) [1S10 RR028868-01]; National Institutes of Health from NIGMS [P41GM103399, P41RR002301]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; U.S. Department of Agriculture; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002781, S10RR028868, S10RR008438, S10RR025062, S10RR023438, S10RR029220, P41RR002301] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, T32GM008804, R01GM117357] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BIO5 Institute of the University of Arizona; National Institutes of Health from the National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mass spectrometry and proteomics data were acquired by the Arizona Proteomics Consortium supported by National Institutes of Health Grant ES06694 from NIEHS to the Southwest Environmental Health Sciences Center (SWEHSC), National Institutes of Health Grant CA023074 from NCI to the University of Arizona Cancer Center, and the BIO5 Institute of the University of Arizona. The Thermo Fisher LTQ Orbitrap Velos mass spectrometer was provided by National Institutes of Health Grant 1S10 RR028868-01 from the National Center for Research Resources (NCRR). This study made use of the National Magnetic Resonance Facility at Madison (NMRFAM), which is supported by National Institutes of Health Grant P41GM103399 from NIGMS (old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison, the National Institutes of Health (Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220), the National Science Foundation (Grants DMB-8415048, OIA-9977486, and BIR-9214394), and the U.S. Department of Agriculture. We are particularly grateful to Dr. Marco Tonelli of NMRFAM for help with acquiring and interpreting NMR data.	Aguirre C., 2015, CURR PROTOC PROTEIN, V81, DOI [10. 1002/0471140864. ps1718s81 26237672, DOI 10.1002/0471140864.PS1718S8126237672]; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Daiber A, 2015, ANTIOXID REDOX SIGN, V23, P899, DOI 10.1089/ars.2015.6376; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dubinsky L, 2012, BIOORGAN MED CHEM, V20, P554, DOI 10.1016/j.bmc.2011.06.066; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Follmann M, 2013, ANGEW CHEM INT EDIT, V52, P9442, DOI 10.1002/anie.201302588; Friebe A, 1996, EMBO J, V15, P6863, DOI 10.1002/j.1460-2075.1996.tb01078.x; Fritz BG, 2013, BIOCHEMISTRY-US, V52, P1568, DOI 10.1021/bi301570m; Galle J, 1999, BRIT J PHARMACOL, V127, P195, DOI 10.1038/sj.bjp.0702495; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Herzik MA, 2014, P NATL ACAD SCI USA, V111, pE4156, DOI 10.1073/pnas.1416936111; Hespen CW, 2016, ACS CHEM BIOL, V11, P2337, DOI 10.1021/acschembio.6b00431; Hu XH, 2008, J BIOL CHEM, V283, P20968, DOI 10.1074/jbc.M801501200; Hu XH, 2008, J AM CHEM SOC, V130, P15748, DOI 10.1021/ja804103y; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Lahiri T, 2014, BIOCHEMISTRY-US, V53, P2126, DOI 10.1021/bi401597m; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Mota F, 2014, BIOORG MED CHEM LETT, V24, P1075, DOI 10.1016/j.bmcl.2014.01.015; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakai T, 2016, ACS MED CHEM LETT, V7, P465, DOI 10.1021/acsmedchemlett.5b00479; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Plate L, 2013, TRENDS BIOCHEM SCI, V38, P566, DOI 10.1016/j.tibs.2013.08.008; Purohit R, 2014, BIOCHEMISTRY-US, V53, P101, DOI 10.1021/bi4015133; Ramanathan S, 2011, BIOCHEMISTRY-US, V50, P7787, DOI 10.1021/bi201060c; Smith E, 2015, FUTURE MED CHEM, V7, P159, DOI [10.4155/FMC.14.152, 10.4155/fmc.14.152]; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Stone JR, 1998, CHEM BIOL, V5, P255, DOI 10.1016/S1074-5521(98)90618-4; Straub A, 2001, BIOORG MED CHEM LETT, V11, P781, DOI 10.1016/S0960-894X(01)00073-7; Verhoest PR, 2012, J MED CHEM, V55, P9045, DOI 10.1021/jm3007799; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter MB, 2011, P NATL ACAD SCI USA, V108, pE881, DOI 10.1073/pnas.1114038108; Wysocki VH, 2000, J MASS SPECTROM, V35, P1399, DOI 10.1002/1096-9888(200012)35:12<1399::AID-JMS86>3.0.CO;2-R; Ying JF, 2017, J BIOMOL NMR, V68, P101, DOI 10.1007/s10858-016-0072-7; Yoo BK, 2012, ACS CHEM BIOL, V7, P2046, DOI 10.1021/cb3003539; Yoo BK, 2012, J BIOL CHEM, V287, P6851, DOI 10.1074/jbc.M111.299297; Zhang HM, 2014, CHEM COMMUN, V50, P4891, DOI 10.1039/c4cc01528b; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	51	26	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1850	1864		10.1074/jbc.RA117.000457	http://dx.doi.org/10.1074/jbc.RA117.000457			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29222330	hybrid, Green Published			2022-12-28	WOS:000424201700033
J	Zhao, B; Xu, ST; Dong, XC; Lu, CF; Springer, TA				Zhao, Bo; Xu, Shutong; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.			Prodomain-growth factor swapping in the structure of pro-TGF-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						activin; bone morphogenetic protein (BMP); crystal structure; dimerization; transforming growth factor beta (TGF-); heterodimer; prodomain; proprotein convertase; swapping; Arg-Gly-Asp-Leu-any-any-Leu; Ile (RGDLXX(L; I)); latent TGF--binding proteins (LTBPs); glycoprotein-A repetitions predominant protein (GARP); latency-associated peptide (LAP); growth factor (GF); Protein Data Bank (PDB)	LATENT TGF-BETA; MORPHOGENETIC PROTEIN HETERODIMERS; MACROMOLECULAR STRUCTURE; MESODERM INDUCTION; BMP2/7 HETERODIMER; IN-VITRO; SECRETION; ACTIVATION; GARP; FACTOR-BETA-1	TGF- is synthesized as a proprotein that dimerizes in the endoplasmic reticulum. After processing in the Golgi to cleave the N-terminal prodomain from the C-terminal growth factor (GF) domain in each monomer, pro-TGF- is secreted and stored in latent complexes. It is unclear which prodomain and GF monomer are linked before proprotein convertase cleavage and how much conformational change occurs following cleavage. We have determined a structure of pro-TGF-1 with the proprotein convertase cleavage site mutated to mimic the structure of the TGF-1 proprotein. Structure, mutation, and model building demonstrate that the prodomain arm domain in one monomer is linked to the GF that interacts with the arm domain in the other monomer in the dimeric structure (i.e. the prodomain arm domain and GF domain in each monomer are swapped). Swapping has important implications for the mechanism of biosynthesis in the TGF- family and is relevant to the mechanism for preferential formation of heterodimers over homodimers for some members of the TGF- family. Our structure, together with two previous ones, also provides insights into which regions of the prodomain-GF complex are highly structurally conserved and which are perturbed by crystal lattice contacts.	[Zhao, Bo; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.] Childrens Hosp Boston, 3 Blackfan Circle, Boston, MA 02115 USA; [Zhao, Bo; Dong, Xianchi; Lu, Chafen; Springer, Timothy A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 3 Blackfan Circle, Boston, MA 02115 USA; [Xu, Shutong] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Xu, Shutong; Springer, Timothy A.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp Boston, 3 Blackfan Circle, Boston, MA 02115 USA.; Springer, TA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 3 Blackfan Circle, Boston, MA 02115 USA.	springer_lab@crystal.harvard.edu	Zhao, Bo/GVT-7665-2022	Zhao, Bo/0000-0002-2163-6484	National Institutes of Health [R01 AR067288]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant R01 AR067288. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Buijs JT, 2012, ONCOGENE, V31, P2164, DOI 10.1038/onc.2011.400; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dong XC, 2017, NATURE, V542, P55, DOI 10.1038/nature21035; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hinck A. P., 2016, COLD SPRING HARB PER, V8, DOI [10.1101/cshperspect.a022103, DOI 10.1101/CSHPERSPECT.A022103]; HSUEH AJW, 1987, P NATL ACAD SCI USA, V84, P5082, DOI 10.1073/pnas.84.14.5082; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Robertson IB, 2013, CYTOKINE GROWTH F R, V24, P355, DOI 10.1016/j.cytogfr.2013.06.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Wang XC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12469; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Zheng YN, 2012, TISSUE ENG PT A, V18, P621, DOI [10.1089/ten.tea.2011.0366, 10.1089/ten.TEA.2011.0366]	37	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1579	1589		10.1074/jbc.M117.809657	http://dx.doi.org/10.1074/jbc.M117.809657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29109152	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000424201700011
J	Fahrner, M; Pandey, SK; Muik, M; Traxler, L; Butorac, C; Stadlbauer, M; Zayats, V; Krizova, A; Plenk, P; Frischauf, I; Schindl, R; Gruber, HJ; Hinterdorfer, P; Ettrich, R; Romanin, C; Derler, I				Fahrner, Marc; Pandey, Saurabh K.; Muik, Martin; Traxler, Lukas; Butorac, Carmen; Stadlbauer, Michael; Zayats, Vasilina; Krizova, Adela; Plenk, Peter; Frischauf, Irene; Schindl, Rainer; Gruber, Hermann J.; Hinterdorfer, Peter; Ettrich, Rudiger; Romanin, Christoph; Derler, Isabella			Communication between N terminus and loop2 tunes Orai activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); calcium release-activated calcium channel protein 1 (ORAI1); electrophysiology; signal transduction; stromal interaction molecule 1 (STIM1)	FAST CA2+-DEPENDENT INACTIVATION; MOLECULAR-DYNAMICS SIMULATIONS; CRAC CHANNELS; TRANSMEMBRANE SEGMENT; STIM1; PORE; PROTEIN; DOMAIN; DETERMINANTS; PERMEATION	Ca2+ release-activated Ca2+ (CRAC) channels constitute the major Ca2+ entry pathway into the cell. They are fully reconstituted via intermembrane coupling of the Ca2+-selective Orai channel and the Ca2+-sensing protein STIM1. In addition to the Orai C terminus, the main coupling site for STIM1, the Orai N terminus is indispensable for Orai channel gating. Although the extended transmembrane Orai N-terminal region (Orai1 amino acids 73-91; Orai3 amino acids 48-65) is fully conserved in the Orai1 and Orai3 isoforms, Orai3 tolerates larger N-terminal truncations than Orai1 in retaining store-operated activation. In an attempt to uncover the reason for these isoform-specific structural requirements, we analyzed a series of Orai mutants and chimeras. We discovered that it was not the N termini, but the loop2 regions connecting TM2 and TM3 of Orai1 and Orai3 that featured distinct properties, which explained the different, isoform-specific behavior of Orai N-truncation mutants. Atomic force microscopy studies and MD simulations suggested that the remaining N-terminal portion in the non-functional Orai1 N-truncation mutants formed new, inhibitory interactions with the Orai1-loop2 regions, but not with Orai3-loop2. Such a loop2 swap restored activation of the N-truncation Orai1 mutants. To mimic interactions between the N terminus and loop2 in full-length Orai1 channels, we induced close proximity of the N terminus and loop2 via cysteine cross-linking, which actually caused significant inhibition of STIM1-mediated Orai currents. In aggregate, maintenance of Orai activation required not only the conserved N-terminal region but also permissive communication of the Orai N terminus and loop2 in an isoform-specific manner.	[Fahrner, Marc; Muik, Martin; Traxler, Lukas; Butorac, Carmen; Stadlbauer, Michael; Krizova, Adela; Plenk, Peter; Frischauf, Irene; Schindl, Rainer; Gruber, Hermann J.; Hinterdorfer, Peter; Romanin, Christoph; Derler, Isabella] Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria; [Pandey, Saurabh K.; Zayats, Vasilina; Ettrich, Rudiger] Acad Sci Czech Republ, Inst Microbiol, Ctr Nanobiol & Struct Biol, Nove Hrady 37333, Czech Republic; [Schindl, Rainer] Med Univ Graz, Inst Biophys, Neue Stiftingtalstr 6-4, A-8010 Graz, Austria	Johannes Kepler University Linz; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Medical University of Graz	Romanin, C; Derler, I (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	christoph.romanin@jku.at; Isabella.derler@jku.at	Schindl, Rainer/V-4205-2019; Fahrner, Marc/AAI-7927-2021; Pandey, Saurabh Kumar/H-8148-2014; Frischauf, Irene/AAG-2007-2019; Romanin, Christoph/D-5399-2009; Hoeglinger, Carmen/AAF-9364-2021; Derler, Isabella/B-7871-2019; Ettrich, Rudi H/C-1463-2011; Schindl, Rainer/E-3959-2013	Pandey, Saurabh Kumar/0000-0002-5923-5045; Frischauf, Irene/0000-0003-0661-2932; Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Ettrich, Rudi H/0000-0001-8624-7706; Fahrner, Marc/0000-0002-2689-0158; Tiffner, Adela/0000-0002-7529-4504; Hinterdorfer, Peter/0000-0003-2583-1305; Hoglinger, Carmen/0000-0002-2754-592X; Schindl, Rainer/0000-0003-0896-8887; Zayats, Vasilina/0000-0002-9355-8171	Austrian Science Fund (FWF) [P25210, P27641, P28123, P28498, P28701, P26067, P27263, W1250]; program Inter-COST [LTC17069]; European Cooperation in Science and Technology (COST) action [BM1406]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); program Inter-COST; European Cooperation in Science and Technology (COST) action(European Cooperation in Science and Technology (COST))	This work was supported in part by the Austrian Science Fund (FWF) projects P25210 and P27641 (to I. D.), P28123 (to M. F.), P28498 (to M. M.), P28701 (to R. S.), P26067 (to R. S. and C. R.), and P27263 as well as W1250 (to C. R.) and by the program Inter-COST (project LTC17069) (to R. E.). This work was also supported in part by a European Cooperation in Science and Technology (COST) action (BM1406) (to R. S., R. H. E., and C. R). The authors declare that they have no conflicts of interest with the contents of this article.	Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Bergsmann J, 2011, J BIOL CHEM, V286, P31565, DOI 10.1074/jbc.M111.227546; Bogeski I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000672; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2018, J BIOL CHEM, V293, P1259, DOI 10.1074/jbc.M117.812206; Derler I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad7808; Derler I, 2013, J BIOL CHEM, V288, P29025, DOI 10.1074/jbc.M113.501510; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Derler I, 2009, J BIOL CHEM, V284, P15903, DOI 10.1074/jbc.M808312200; Ebner A, 2007, BIOCONJUGATE CHEM, V18, P1176, DOI 10.1021/bc070030s; Endo Y, 2015, HUM MOL GENET, V24, P637, DOI 10.1093/hmg/ddu477; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Fahrner M, 2014, J BIOL CHEM, V289, P33231, DOI 10.1074/jbc.M114.610022; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frischauf I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1901; Frischauf I, 2011, J BIOL CHEM, V286, P8577, DOI 10.1074/jbc.M110.187179; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTTER JL, 1993, REV SCI INSTRUM, V64, P3342, DOI 10.1063/1.1144449; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lis A, 2010, J GEN PHYSIOL, V136, P673, DOI 10.1085/jgp.201010484; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; McNally BA, 2013, J PHYSIOL-LONDON, V591, P2833, DOI 10.1113/jphysiol.2012.250456; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; McNally BA, 2009, P NATL ACAD SCI USA, V106, P22516, DOI 10.1073/pnas.0909574106; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Nesin V, 2014, P NATL ACAD SCI USA, V111, P4197, DOI 10.1073/pnas.1312520111; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Palty R, 2015, CELL RES, V25, P963, DOI 10.1038/cr.2015.80; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rothberg BS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003971; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2011, J BIOL CHEM, V286, P35318, DOI 10.1074/jbc.M111.265884; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wildling L, 2011, BIOCONJUGATE CHEM, V22, P1239, DOI 10.1021/bc200099t; Yamashita M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14512; Yamashita M, 2011, J BIOL CHEM, V286, P9429, DOI 10.1074/jbc.M110.189035; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2011, P NATL ACAD SCI USA, V108, P17838, DOI 10.1073/pnas.1114821108; Zheng HY, 2013, J BIOL CHEM, V288, P11263, DOI 10.1074/jbc.M113.450254; Zhou YD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13725; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	70	32	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1271	1285		10.1074/jbc.M117.812693	http://dx.doi.org/10.1074/jbc.M117.812693			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29237733	Green Published, hybrid			2022-12-28	WOS:000423515000014
J	Durand, A; Bourbon, ML; Steunou, AS; Khalfaoui-Hassani, B; Legrand, C; Guitton, A; Astier, C; Ouchane, S				Durand, Anne; Bourbon, Marie-Line; Steunou, Anne-Soisig; Khalfaoui-Hassani, Bahia; Legrand, Camille; Guitton, Audrey; Astier, Chantal; Ouchane, Soufian			Biogenesis of the bacterial cbb(3) cytochrome c oxidase: Active subcomplexes support a sequential assembly model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRADYRHIZOBIUM-JAPONICUM; TERMINAL-OXIDASES; SUBUNIT; CCOQ; ADAPTATION; EXPRESSION; INSIGHTS; PATHWAY; GROWTH; GENES	The cbb(3) oxidase has a high affinity for oxygen and is required for growth of bacteria, including pathogens, in oxygen-limited environments. However, the assembly of this oxidase is poorly understood. Most cbb(3) are composed of four subunits: the catalytic CcoN subunit, the two cytochrome c subunits (CcoO and CcoP) involved in electron transfer, and the small CcoQ subunit with an unclear function. Here, we address the role of these four subunits in cbb(3) biogenesis in the purple bacterium Rubrivivax gelatinosus. Analyses of membrane proteins from different mutants revealed the presence of active CcoNQO and CcoNO sub-complexes and also showed that the CcoP subunit is not essential for their assembly. However, CcoP was required for the oxygen reduction activity in the absence of CcoQ. We also found that CcoQ is dispensable for forming an active CcoNOP subcomplex in membranes. CcoNOP exhibited oxygen reductase activity, indicating that the cofactors (hemes b and copper for CcoN and cyto-chromes c for CcoO and CcoP) were present within the subunits. Finally, we discovered the presence of a CcoNQ subcomplex and showed that CcoN is the required anchor for the assembly of the full CcoNQOP complex. On the basis of these findings, we propose a sequential assembly model in which the CcoQ subunit is required for the early maturation step: CcoQ first associates with CcoN before the CcoNQ-CcoO interaction. CcoP associates to CcoNQO subcomplex in the late maturation step, and once the CcoNQOP complex is fully formed, CcoQ is released for degradation by the FtsH protease. This model could be conserved in other bacteria, including the pathogenic bacteria lacking the assembly factor CcoH as in R. gelatinosus.	[Durand, Anne; Bourbon, Marie-Line; Steunou, Anne-Soisig; Khalfaoui-Hassani, Bahia; Legrand, Camille; Guitton, Audrey; Astier, Chantal; Ouchane, Soufian] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, Commissariat Energie Atom,CNRS, F-91198 Gif Sur Yvette, France; [Khalfaoui-Hassani, Bahia] Univ Penn, Dept Biol, 433 S Univ Ave, Philadelphia, PA 19104 USA	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Pennsylvania	Durand, A; Ouchane, S (corresponding author), CNRS, I2BC, UMR9198, F-91198 Gif Sur Yvette, France.	anne.durand@i2bc.paris-saclay.fr; soufian.ouchane@i2bc.paris-saclay.fr	OUCHANE, Soufian/HHM-5430-2022; Ouchane, Soufian/ABE-2609-2020	Ouchane, Soufian/0000-0002-8161-3866; Steunou, Anne Soisig/0000-0002-0731-0226	Agence Nationale de la Recherche [BLAN06-2_147814]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant BLAN06-2_147814. The authors declare that they have no conflicts of interest with the contents of this article.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Azzouzi A, 2013, MOL MICROBIOL, V88, P339, DOI 10.1111/mmi.12188; Buschmann S, 2010, SCIENCE, V329, P327, DOI 10.1126/science.1187303; Colburn-Clifford J, 2010, MOL PLANT MICROBE IN, V23, P1042, DOI 10.1094/MPMI-23-8-1042; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Ekici S, 2013, J BACTERIOL, V195, P261, DOI 10.1128/JB.01415-12; Ekici S, 2012, BBA-BIOENERGETICS, V1817, P898, DOI 10.1016/j.bbabio.2011.10.011; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hassani BK, 2010, J BIOL CHEM, V285, P19891, DOI 10.1074/jbc.M109.086066; Hassani BK, 2010, J BIOL CHEM, V285, P19330, DOI 10.1074/jbc.M110.116020; Hirai T, 2016, P NATL ACAD SCI USA, V113, P12815, DOI 10.1073/pnas.1613308113; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; de Bagues MPJ, 2007, INFECT IMMUN, V75, P531, DOI 10.1128/IAI.01185-06; Koch HG, 1998, J BACTERIOL, V180, P969, DOI 10.1128/JB.180.4.969-978.1998; Koch HG, 2000, J MOL BIOL, V297, P49, DOI 10.1006/jmbi.2000.3555; Kohlstaedt M, 2017, BBA-BIOENERGETICS, V1858, P231, DOI 10.1016/j.bbabio.2016.12.006; Kohlstaedt M, 2016, MBIO, V7, DOI 10.1128/mBio.01921-15; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mendz GL, 2000, ARCH MICROBIOL, V174, P1, DOI 10.1007/s002030000174; Myllykallio H, 2000, TRENDS MICROBIOL, V8, P542, DOI 10.1016/S0966-842X(00)91831-6; O'Gara JP, 1998, J BACTERIOL, V180, P4044; Oh JI, 2002, J BIOL CHEM, V277, P16220, DOI 10.1074/jbc.M200198200; Pawlik G, 2010, J BACTERIOL, V192, P6378, DOI 10.1128/JB.00988-10; Peters A, 2008, J BACTERIOL, V190, P5576, DOI 10.1128/JB.00534-08; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, BIOCHEM SOC T, V30, P653, DOI 10.1042/bst0300653; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; PREISIG O, 1993, P NATL ACAD SCI USA, V90, P3309, DOI 10.1073/pnas.90.8.3309; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; UFFEN RL, 1976, P NATL ACAD SCI USA, V73, P3298, DOI 10.1073/pnas.73.9.3298; Zufferey R, 1998, J BIOL CHEM, V273, P6452, DOI 10.1074/jbc.273.11.6452; Zufferey R, 1997, FEBS LETT, V412, P75, DOI 10.1016/S0014-5793(97)00746-1; Zufferey R, 1996, J BIOL CHEM, V271, P9114, DOI 10.1074/jbc.271.15.9114	37	3	3	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					808	818		10.1074/jbc.M117.805184	http://dx.doi.org/10.1074/jbc.M117.805184			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150446	hybrid, Green Published			2022-12-28	WOS:000422864500005
J	Montpas, N; St-Onge, G; Nama, N; Rhainds, D; Benredjem, B; Girard, M; Hickson, G; Pons, V; Heveker, N				Montpas, Nicolas; St-Onge, Genevieve; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Hickson, Gilles; Pons, Veronique; Heveker, Nikolaus			Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; DISTINCT CONFORMATIONS; CRYSTAL-STRUCTURE; AGONIST; INTERNALIZATION; ACTIVATION; GRADIENT; PATHWAYS; DYNAMICS	The atypical chemokine receptor ACKR3 contributes to chemotaxis by binding, internalizing, and degrading the chemokines CXCL11 and CXCL12 to shape and terminate chemotactic gradients during development and immune responses. Although unable to trigger G protein activation, both ligands activate G protein-independent ACKR3 responses and prompt arrestin recruitment. This offers a model to specifically study ligand-specific receptor conformations leading to G protein-independent signaling and to functional parameters such as receptor transport and chemokine degradation. We here show chemokine specificity in arrestin recruitment, by different effects of single amino acid substitutions in ACKR3 on arrestin in response to CXCL12 or CXCL11. Chemokine specificity in receptor transport was also observed, as CXCL11 induced faster receptor internalization, slower recycling, and longer intracellular sojourn of ACKR3 than CXCL12. Internalization and recycling rates of the ACKR3 R142(3.50)A substitution in response to each chemokine were similar; however, ACKR3 R1423.50A degraded only CXCL12 and not CXCL11. This suggests that ligand-specific intracellular receptor transport is required for chemokine degradation. Remarkably, the failure of ACKR3 R1423.50A to degrade CXCL11 was not caused by the lack of arrestin recruitment; rather, arrestin was entirely dispensable for scavenging of either chemokine. This suggests the involvement of another, yet unidentified, ACKR3 effector in scavenging. In summary, our study correlates ACKR3 ligand-specific conformational transitions with chemokine-dependent recep-tor transport dynamics and points toward unexpected ligand specificity in the mechanisms of chemokine degradation.	[Montpas, Nicolas; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Heveker, Nikolaus] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3T 1J4, Canada; [Montpas, Nicolas; St-Onge, Genevieve; Nama, Nassr; Rhainds, David; Benredjem, Besma; Girard, Melanie; Hickson, Gilles; Heveker, Nikolaus] Univ Montreal, St Justine Hosp, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Hickson, Gilles] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada; [Pons, Veronique] Univ Toulouse, Inst Malad Metab & Cardiovasc, UMR 1048, INSERM, F-31432 Toulouse, France	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Heveker, N (corresponding author), St Justine Hosp, Dept Biochem & Mol Med, Res Ctr, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca	Nama, Nassr/J-1578-2016	Nama, Nassr/0000-0002-0199-3599; Hickson, Gilles/0000-0001-7670-9815; PONS, Veronique/0000-0001-5821-8481	Canadian Institutes of Health Research (CIHR) [MOP123421]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP123421. The authors declare that they have no conflicts of interest with the contents of this article.	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Bachelerie F, 2015, BRIT J PHARMACOL, V172, P3945, DOI 10.1111/bph.13182; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Benredjem B, 2017, J BIOL CHEM, V292, P31, DOI 10.1074/jbc.M116.762252; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Birdsong WT, 2013, J NEUROSCI, V33, P4118, DOI 10.1523/JNEUROSCI.4187-12.2013; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Borroni EM, 2013, SCI SIGNAL, V6, pS1; Bot G, 1998, J PHARMACOL EXP THER, V284, P283; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cabana J, 2015, J BIOL CHEM, V290, P15835, DOI 10.1074/jbc.M114.627356; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Canals M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034192; Chung KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054942; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Cruz-Orengo L, 2011, J EXP MED, V208, P327, DOI 10.1084/jem.20102010; Defea K, 2008, BRIT J PHARMACOL, V153, pS298, DOI 10.1038/sj.bjp.0707508; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gravel S, 2010, J BIOL CHEM, V285, P37939, DOI 10.1074/jbc.C110.147470; Gustavsson M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14135; Hoffmann F, 2012, J BIOL CHEM, V287, P28362, DOI 10.1074/jbc.M111.335679; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Karin N, 2016, J LEUKOCYTE BIOL, V99, P857, DOI 10.1189/jlb.2MR0915-441R; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Luker KE, 2009, NEOPLASIA, V11, P1022, DOI 10.1593/neo.09724; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; McCulloch CV, 2008, J BIOL CHEM, V283, P7972, DOI 10.1074/jbc.M710128200; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Valentin-Hansen L, 2015, J BIOL CHEM, V290, P24495, DOI 10.1074/jbc.M115.641944; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Weber M, 2004, MOL BIOL CELL, V15, P2492, DOI 10.1091/mbc.E03-09-0634; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zohar Y, 2014, J CLIN INVEST, V124, P2009, DOI 10.1172/JCI71951	63	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					893	905		10.1074/jbc.M117.814947	http://dx.doi.org/10.1074/jbc.M117.814947			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29180449	hybrid, Green Published			2022-12-28	WOS:000422864500011
J	Notomi, T; Kuno, M; Hiyama, A; Nozaki, T; Ohura, K; Ezura, Y; Noda, M				Notomi, Takuya; Kuno, Miyuki; Hiyama, Akiko; Nozaki, Tadashige; Ohura, Kiyoshi; Ezura, Yoichi; Noda, Masaki			Role of lysosomal channel protein TPC2 in osteoclast differentiation and bone remodeling under normal and low-magnesium conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL; NAADP; MYOINOSITOL; SKELETAL; CALCIUM; MG2+; ACTIVATION; EXERCISE	The bone is the main storage site for Ca2+ and Mg2+ ions in the mammalian body. Although investigations into Ca2+ signaling have progressed rapidly and led to better understanding of bone biology, the Mg2+ signaling pathway and associated molecules remain to be elucidated. Here, we investigated the role of a potential Mg2+ signaling-related lysosomal molecule, two-pore channel subtype 2 (TPC2), in osteoclast differentiation and bone remodeling. Previously, we found that under normal Mg2+ conditions, TPC2 promotes osteoclastogenesis. We observed that under low-Mg2+ conditions, TPC2 inhibited, rather than promoted, the osteoclast differentiation and that the phosphatidylinositol 3,5-bisphosphate (PI(3,5) P-2) signaling pathway played a role in the TPC2 activation under low-Mg2+ conditions. Furthermore, PI(3,5) P-2 depolarized the membrane potential by increasing the intracellular Na+ levels. To investigate how membrane depolarization affects osteoclast differentiation, we generated a light-sensitive cell line and developed a system for the light-stimulated depolarization of the membrane potential. The light-induced depolarization inhibited the osteoclast differentiation. We then tested the effect of myo-inositol supplementation, which increased the PI(3,5) P-2 levels in mice fed a low-Mg2+ diet. The myo-inositol supplementation rescued the low-Mg2+ diet-induced trabecular bone loss, which was accompanied by the inhibition of osteoclastogenesis. These results indicate that low-Mg2+-induced osteoclastogenesis involves changes in the role of TPC2, which are mediated through the PI(3,5) P-2 pathway. Our findings also suggest that myo-inositol consumption might provide beneficial effects in Mg2+ deficiency-induced skeletal diseases.	[Notomi, Takuya; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, 1-5-45 Yushima, Tokyo 1138510, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program Mol Sci Tooth & Bon, Tokyo 1138510, Japan; [Notomi, Takuya; Hiyama, Akiko; Nozaki, Tadashige; Ohura, Kiyoshi] Osaka Dent Univ, Dept Pharmacol, Hirakata, Osaka 5731121, Japan; [Kuno, Miyuki] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno, Osaka 5458585, Japan; [Noda, Masaki] Yokohama City Minato Red Cross Hosp, Yokohama, Kanagawa 2318682, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka Metropolitan University	Notomi, T; Noda, M (corresponding author), Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, 1-5-45 Yushima, Tokyo 1138510, Japan.	notomi@cc.osaka-dent.ac.jp; noda.mph@mri.tmd.ac.jp	Ezura, Yoichi/L-9485-2016		Uehara Memorial Foundation; Nakatomi Foundation; Naito Foundation; Japan Society for the Promotion of Science [24119505, 25670638, 26282182, 26253085, 15K15558, 16K15655]	Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Uehara Memorial Foundation, the Nakatomi Foundation, and the Naito Foundation and by Japan Society for the Promotion of Science Grants KAKENHI 24119505, 25670638, 26282182, 26253085, 15K15558, and 16K15655. The authors declare that they have no conflicts of interest with the contents of this article.	ANGELOFF LG, 1977, ACTA PHARMACOL TOX, V40, P209; Belluci MM, 2013, J NUTR BIOCHEM, V24, P1488, DOI 10.1016/j.jnutbio.2012.12.008; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; CLEMENTS RS, 1980, AM J CLIN NUTR, V33, P1954, DOI 10.1093/ajcn/33.9.1954; Dai ZJ, 2011, J BONE MINER RES, V26, P582, DOI 10.1002/jbmr.240; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Guo JT, 2017, P NATL ACAD SCI USA, V114, P1009, DOI 10.1073/pnas.1616191114; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kubota T, 2003, BIOCHEM BIOPH RES CO, V303, P332, DOI 10.1016/S0006-291X(03)00346-2; Nieves JW, 2013, OSTEOPOROSIS INT, V24, P771, DOI 10.1007/s00198-012-2214-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Notomi T, 2001, J BONE MINER RES, V16, P166, DOI 10.1359/jbmr.2001.16.1.166; Notomi T, 2015, BONE, V81, P306, DOI 10.1016/j.bone.2015.07.031; Notomi T, 2015, J BONE MINER RES, V30, P1618, DOI 10.1002/jbmr.2507; Notomi T, 2014, BONE, V65, P42, DOI 10.1016/j.bone.2014.05.002; Notomi T, 2012, J BIOL CHEM, V287, P35057, DOI 10.1074/jbc.M111.328930; Parfitt A. M., 1980, CLIN DISORDERS FLUID, P947; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Rude RK, 2009, J AM COLL NUTR, V28, P131, DOI 10.1080/07315724.2009.10719764; Seaborn CD, 2002, BIOL TRACE ELEM RES, V89, P239, DOI 10.1385/BTER:89:3:239; Shindo Y, 2015, BBA-MOL CELL RES, V1853, P3182, DOI 10.1016/j.bbamcr.2015.08.013; Smriti AAC, 2015, P NATL ACAD SCI USA, V112, P15432, DOI 10.1073/pnas.1518253112; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yaman F, 2016, DRUG DES DEV THER, V10, P2081, DOI 10.2147/DDDT.S109271; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	34	11	11	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20998	21010		10.1074/jbc.M117.780072	http://dx.doi.org/10.1074/jbc.M117.780072			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084844	Green Published, hybrid			2022-12-28	WOS:000418453400016
J	Sundararajan, K; Goley, ED				Sundararajan, Kousik; Goley, Erin D.			The intrinsically disordered C-terminal linker of FtsZ regulates protofilament dynamics and superstructure in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; cytokinesis; cytoskeleton; electron microscopy (EM); intrinsically disordered protein; Caulobacter crescentus; FtsZ; bundling	CELL-DIVISION PROTEIN; TUBULIN-LIKE PROTEIN; Z-RING; BACTERIAL; CAULOBACTER; GTP; IDENTIFICATION; MEMBRANE; PROMOTES; SUGGESTS	The bacterial tubulin FtsZ polymerizes to form a discontinuous ring that drives bacterial cell division by directing local cell wall synthesis. FtsZ comprises a polymerizing GTPase domain, an intrinsically disordered C-terminal linker (CTL), and a C-terminal conserved peptide (CTC). FtsZ protofilaments align circumferentially in the cell, with the CTC mediating attachment to membrane-associated division proteins. The assembly of FtsZ protofilaments into dynamic clusters is critical for cell division, but the interactions between protofilaments and regulatory mechanisms that mediate cluster assembly and dynamics are unknown. Here, we describe a role for the CTL of Caulobacter crescentus FtsZ as an intrinsic regulator of lateral interactions between protofilaments in vitro. FtsZ lacking its CTL (CTL) shows a dramatically increased propensity to form long multifilament bundles compared with wild type (WT). CTL also displays a reduced GTP hydrolysis rate compared with WT, but this altered activity does not account for bundle formation, as reducing protofilament turnover in WT is not sufficient to induce bundling. Surprisingly, binding of the membrane-anchoring protein FzlC disrupts CTL bundling in a CTC-dependent manner. Moreover, the CTL affects the ability of the FtsZ curving protein FzlA to promote formation of helical bundles. We conclude that the CTL of FtsZ influences polymer structure and dynamics both through intrinsic effects on lateral interactions and turnover and by influencing extrinsic regulation of FtsZ by binding partners. Our characterization of CTL function provides a biochemical handle for understanding the relationship between FtsZ-ring structure and function in bacterial cytokinesis.	[Sundararajan, Kousik; Goley, Erin D.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Goley, ED (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 N Wolfe St,520 Wood Basic Sci Bldg, Baltimore, MD 21205 USA.	egoley1@jhmi.edu	Sundararajan, Kousik/ABF-9599-2020	Goley, Erin/0000-0002-8518-2303; Sundararajan, Kousik/0000-0002-1375-5491	National Institutes of Health [R01GM108640]; National Institutes of Health [R01GM108640]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01GM108640 (to E. D. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Buske PJ, 2015, SEMIN CELL DEV BIOL, V37, P3, DOI 10.1016/j.semcdb.2014.09.017; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Egelman EH, 1998, CURR BIOL, V8, pR288, DOI 10.1016/S0960-9822(98)70175-7; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Gardner KAJA, 2013, MOL MICROBIOL, V89, P264, DOI 10.1111/mmi.12279; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Hou S, 2012, J BIOL CHEM, V287, P23878, DOI 10.1074/jbc.M111.309492; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Meier EL, 2016, MOL MICROBIOL, V101, P265, DOI 10.1111/mmi.13388; Meier EL, 2014, CURR OPIN CELL BIOL, V26, P19, DOI 10.1016/j.ceb.2013.08.006; Milam SL, 2013, J BIOL CHEM, V288, P23675, DOI 10.1074/jbc.M113.491845; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Scheffers DJ, 2000, MOL MICROBIOL, V35, P1211, DOI 10.1046/j.1365-2958.2000.01791.x; Schumacher MA, 2017, J BIOL CHEM, V292, P3740, DOI 10.1074/jbc.M116.773192; Sundararajan K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8281; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Vaughan S, 2004, J MOL EVOL, V58, P19, DOI 10.1007/s00239-003-2523-5; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Woldemeskel SA, 2017, MOL MICROBIOL, V105, P721, DOI 10.1111/mmi.13731; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995	39	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20509	20527		10.1074/jbc.M117.809939	http://dx.doi.org/10.1074/jbc.M117.809939			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29089389	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000418267000014
J	Wang, ZL; Thinn, AMM; Zhu, JQ				Wang, Zhengli; Thinn, Aye Myat Myat; Zhu, Jieqing			A pivotal role for a conserved bulky residue at the 1-helix of the I integrin domain in ligand binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell adhesion; cell migration; integrin; leukocyte; von Willebrand factor; VWA domain	FUNCTION-ASSOCIATED ANTIGEN-1; VON-WILLEBRAND-FACTOR; STRUCTURAL BASIS; LEUKOCYTE INTEGRIN; CRYSTAL-STRUCTURE; A-DOMAIN; ALPHA-I; GLIDING MOTILITY; COLLAGEN-BINDING; LFA-1 INHIBITION	The ligand-binding I and I domains of integrin are the best-studied von Willebrand factor A domains undergoing significant conformational changes for affinity regulation. In both I and I domains, the 1- and 7-helixes work in concert to shift the metal-ion-dependent adhesion site between the resting and active states. An absolutely conserved Gly in the middle of the 1-helix of I helps maintain the resting I conformation, whereas the homologous position in the I 1-helix contains a conserved Phe. A functional role of this Phe is structurally unpredictable. Using (L2) integrin as a model, we found that the residue volume at the Phe position in the 1-helix is critical for (L2) activation because trimming the Phe by small amino acid substitutions abolished (L2) binding with soluble and immobilized intercellular cell adhesion molecule 1. Similar results were obtained for (M2) integrin. Our experimental and molecular dynamics simulation data suggested that the bulky Phe acts as a pawl that stabilizes the downward ratchet-like movement of 6-7 loop and 7-helix, required for high-affinity ligand binding. This mechanism may apply to other von Willebrand factor A domains undergoing large conformational changes. We further demonstrated that the conformational cross-talk between (L) I and (2) I could be uncoupled because the (2) extension and headpiece opening could occur independently of the I activation. Reciprocally, the I activation does not inevitably lead to the conformational changes of the (2) subunit. Such loose linkage between the I and I is attributed to the I flexibility and could accommodate the (L2)-mediated rolling adhesion of leukocytes.	[Wang, Zhengli; Thinn, Aye Myat Myat; Zhu, Jieqing] BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Thinn, Aye Myat Myat; Zhu, Jieqing] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Zhu, JQ (corresponding author), BloodCtr Wisconsin, Blood Res Inst, 8727 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Jieqing.Zhu@bcw.edu			NHLBI, National Institutes of Health [HL122985, HL131836]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131836, R56HL122985] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants HL122985 and HL131836 (to J. Zhu) from the NHLBI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Barton SJ, 2004, BIOCHEM J, V380, P401, DOI 10.1042/BJ20031973; Brondijk THC, 2012, P NATL ACAD SCI USA, V109, P5253, DOI 10.1073/pnas.1112388109; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chin YKY, 2013, J BIOL CHEM, V288, P36796, DOI 10.1074/jbc.M113.480251; Crump MP, 2004, BIOCHEMISTRY-US, V43, P2394, DOI 10.1021/bi035422a; Deuquet J, 2012, EMBO J, V31, P3, DOI 10.1038/emboj.2011.442; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphries MJ, 2004, BIOCHEM SOC T, V32, P407, DOI 10.1042/BST0320407; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Liddington RC, 2014, ADV EXP MED BIOL, V819, P111, DOI 10.1007/978-94-017-9153-3_8; Liu JF, 2015, J CELL SCI, V128, P1718, DOI 10.1242/jcs.160663; Lu CF, 1997, J IMMUNOL, V159, P268; Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Nordenfelt P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13119; Nunes AM, 2016, PROTEIN SCI, V25, P1672, DOI 10.1002/pro.2972; Potin D, 2006, J MED CHEM, V49, P6946, DOI 10.1021/jm0610806; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; ROBINSON MK, 1992, J IMMUNOL, V148, P1080; Salas A, 2004, IMMUNITY, V20, P393, DOI 10.1016/S1074-7613(04)00082-2; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Santelli E, 2004, NATURE, V430, P905, DOI 10.1038/nature02763; Sen M, 2013, J CELL BIOL, V203, P629, DOI 10.1083/jcb.201308083; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shimaoka M, 2002, P NATL ACAD SCI USA, V99, P16737, DOI 10.1073/pnas.252633099; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2000, NAT STRUCT BIOL, V7, P674, DOI 10.1038/77978; Song GJ, 2014, P NATL ACAD SCI USA, V111, P4862, DOI 10.1073/pnas.1403059111; Song GJ, 2012, P NATL ACAD SCI USA, V109, P21420, DOI 10.1073/pnas.1218581109; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 2016, P NATL ACAD SCI USA, V113, P2940, DOI 10.1073/pnas.1601379113; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Suhre MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4392; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Wattanasin S, 2005, BIOORG MED CHEM LETT, V15, P1217, DOI 10.1016/j.bmcl.2004.11.072; Weitz-Schmidt G, 2004, J BIOL CHEM, V279, P46764, DOI 10.1074/jbc.M407951200; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Zhang CM, 2013, J CELL SCI, V126, P5735, DOI 10.1242/jcs.137828; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596; Zhu JQ, 2013, J CELL BIOL, V201, P1053, DOI 10.1083/jcb.201212037	66	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20756	20768		10.1074/jbc.M117.790519	http://dx.doi.org/10.1074/jbc.M117.790519			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29079572	hybrid, Green Published			2022-12-28	WOS:000418267000035
J	Oda, K; Oda, T; Matoba, Y; Sato, M; Irie, T; Sakaguchi, T				Oda, Kosuke; Oda, Takashi; Matoba, Yasuyuki; Sato, Mamoru; Irie, Takashi; Sakaguchi, Takemasa			Structural analysis of the STAT1:STAT2 heterodimer revealed the mechanism of Sendai virus C protein-mediated blockade of type 1 interferon signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; interferon; negative-strand RNA virus; signal transduction; small-angle X-ray scattering (SAXS); surface plasmon resonance (SPR); paramyxovirus	V PROTEIN; VIRAL PATHOGENESIS; PLASMA-MEMBRANE; ACTIVATION; PARAMYXOVIRUS; BINDING; RNA; INHIBITION; SCATTERING; PARTICLES	Sendai virus (SeV), which causes respiratory diseases in rodents, possesses the C protein that blocks the signal transduction of interferon (IFN), thereby escaping from host innate immunity. We previously demonstrated by using protein crystallography that two molecules of Y3 (the C-terminal half of the C protein) can bind to the homodimer of the N-terminal domain of STAT1 (STAT1ND), elucidating the mechanism of inhibition of IFN- signal transduction. SeV C protein also blocks the signal transduction of IFN-/ by inhibiting the phosphorylation of STAT1 and STAT2, although the mechanism for the inhibition is unclear. Therefore, we sought to elucidate the mechanism of inhibition of the IFN signal transduction via STAT1 and STAT2. Small angle X-ray scattering analysis indicated that STAT1ND associates with the N-terminal domain of STAT2 (STAT2ND) with the help of a Gly-rich linker. We generated a linker-less recombinant protein possessing a STAT1ND:STAT2ND heterodimeric structure via an artificial disulfide bond. Analytical size-exclusion chromatography and surface plasmon resonance revealed that one molecule of Y3 can associate with a linker-less recombinant protein. We propose that one molecule of C protein associates with the STAT1:STAT2 heterodimer, inducing a conformational change to an antiparallel form, which is easily dephosphorylated. This suggests that association of C protein with the STAT1ND:STAT2ND heterodimer is an important factor to block the IFN-/ signal transduction.	[Oda, Kosuke; Irie, Takashi; Sakaguchi, Takemasa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima 7348551, Japan; [Matoba, Yasuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Microbiol, Hiroshima 7348551, Japan; [Oda, Takashi; Sato, Mamoru] Yokohama City Univ, Grad Sch Med Life Sci, Struct Biol Lab, Yokohama, Kanagawa 2300045, Japan	Hiroshima University; Hiroshima University; Yokohama City University	Sakaguchi, T (corresponding author), Kasumi 1-2-3,Minami Ku, Hiroshima 7348551, Japan.	tsaka@hiroshima-u.ac.jp	Sakaguchi, Takemasa/H-1488-2019; ODA, KOSUKE/ABD-2610-2021	Sakaguchi, Takemasa/0000-0002-3754-1252; 	INAMORI Foundation; GlaxoSmithKline Japan; Takeda Science Foundation; Japan Society for the Promotion of Science [15K151430, 16H051975]; Japan Agency for Medical Research and Development	INAMORI Foundation; GlaxoSmithKline Japan(GlaxoSmithKline); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the INAMORI Foundation (to K. O.), GlaxoSmithKline Japan (to K. O.), the Takeda Science Foundation (to K. O.), Japan Society for the Promotion of Science Grants 15K151430 and 16H051975 (to T. S. and K. O.), and the Japan Agency for Medical Research and Development (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Begitt A, 2014, NAT IMMUNOL, V15, P168, DOI 10.1038/ni.2794; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chichili VPR, 2013, PROTEIN SCI, V22, P153, DOI 10.1002/pro.2206; DeLano W.L, PYMOL MOL GRAPHICS S; Domoszlai T, 2014, J CELL SCI, V127, P1899, DOI 10.1242/jcs.137422; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Garcin D, 1999, J VIROL, V73, P6559, DOI 10.1128/JVI.73.8.6559-6565.1999; Glatter O., 1982, SMALL ANGLE XRAY SCA; Gotoh B, 2004, FEBS LETT, V567, P291, DOI 10.1016/j.febslet.2004.05.001; Gotoh B, 2003, J VIROL, V77, P3360, DOI 10.1128/JVI.77.6.3360-3370.2003; Gotoh B, 1999, FEBS LETT, V459, P205, DOI 10.1016/S0014-5793(99)01241-7; Gotoh G, 2003, VIROLOGY, V316, P29, DOI 10.1016/S0042-6822(03)00590-7; Ho J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000117; Huang C, 2000, J VIROL, V74, P7834, DOI 10.1128/JVI.74.17.7834-7841.2000; Irie T, 2008, VIROLOGY, V374, P495, DOI 10.1016/j.virol.2008.01.004; Irie T, 2008, VIROLOGY, V371, P108, DOI 10.1016/j.virol.2007.09.020; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Irie T, 2014, J VIROL, V88, P690, DOI 10.1128/JVI.02798-13; Irie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073740; Irie T, 2012, J VIROL, V86, P7136, DOI 10.1128/JVI.06705-11; Irie T, 2010, VIROLOGY, V405, P334, DOI 10.1016/j.virol.2010.06.031; Irie T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010719; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; KIYOTANI K, 1990, VIROLOGY, V177, P65, DOI 10.1016/0042-6822(90)90460-9; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Komatsu T, 2000, J VIROL, V74, P2477, DOI 10.1128/JVI.74.5.2477-2480.2000; Komatsu T, 2002, FEBS LETT, V511, P139, DOI 10.1016/S0014-5793(01)03301-4; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Mao X, 2005, MOL CELL, V17, P761, DOI 10.1016/j.molcel.2005.02.021; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Mertens C, 2006, GENE DEV, V20, P3372, DOI 10.1101/gad.1485406; Nagai Y, 2011, BIOLOGY OF PARAMYXOVIRUSES, P115; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Oda K, 2015, J VIROL, V89, P11487, DOI 10.1128/JVI.01887-15; Ota N, 2004, NAT IMMUNOL, V5, P208, DOI 10.1038/ni1032; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Roberts A.R.G.D.P., 2013, FIELDS VIROLOGY, V6th, P957; Saijo M, 2002, J CLIN MICROBIOL, V40, P372, DOI 10.1128/JCM.40.2.372-375.2002; Sakaguchi T, 2005, J VIROL, V79, P8933, DOI 10.1128/JVI.79.14.8933-8941.2005; Sakaguchi T, 2011, MICROBIOL IMMUNOL, V55, P760, DOI 10.1111/j.1348-0421.2011.00379.x; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; Sugahara F, 2004, VIROLOGY, V325, P1, DOI 10.1016/j.virol.2004.04.019; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wenta N, 2008, P NATL ACAD SCI USA, V105, P9238, DOI 10.1073/pnas.0802130105; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102	58	7	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19752	19766		10.1074/jbc.M117.786285	http://dx.doi.org/10.1074/jbc.M117.786285			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28978648	Green Published, hybrid			2022-12-28	WOS:000416911300020
J	Kitai, Y; Iwakami, M; Saitoh, K; Togi, S; Isayama, S; Sekine, Y; Muromoto, R; Kashiwakura, J; Yoshimura, A; Oritani, K; Matsuda, T				Kitai, Yuichi; Iwakami, Masashi; Saitoh, Kodai; Togi, Sumihito; Isayama, Serina; Sekine, Yuichi; Muromoto, Ryuta; Kashiwakura, Jun-ichi; Yoshimura, Akihiko; Oritani, Kenji; Matsuda, Tadashi			STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; prostate cancer; protein degradation; signal transduction; STAT3; c-CBL	TRANSDUCING ADAPTER PROTEIN-2; STAT3 ACTIVATION; EGF RECEPTOR; PHASE-II; CELLS; DEGRADATION; GEFITINIB; ENDOCYTOSIS; RESPONSES; KINASE	Signal-transducing adaptor family member-2 (STAP-2) is an adaptor protein that regulates various intracellular signaling pathways and promotes tumorigenesis in melanoma and breast cancer cells. However, the contribution of STAP-2 to the behavior of other types of cancer cells is unclear. Here, we show that STAP-2 promotes tumorigenesis of prostate cancer cells through up-regulation of EGF receptor (EGFR) signaling. Tumor growth of a prostate cancer cell line, DU145, was strongly decreased by STAP-2 knockdown. EGF-induced gene expression and phosphorylation of AKT, ERK, and STAT3 were significantly decreased in STAP-2-knockdown DU145 cells. Mechanistically, we found that STAP-2 interacted with EGFR and enhanced its stability by inhibiting c-CBL-mediated EGFR ubiquitination. Our results indicate that STAP-2 promotes prostate cancer progression via facilitating EGFR activation.	[Kitai, Yuichi; Iwakami, Masashi; Saitoh, Kodai; Togi, Sumihito; Isayama, Serina; Sekine, Yuichi; Muromoto, Ryuta; Kashiwakura, Jun-ichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan; [Oritani, Kenji] Int Univ Hlth & Welf, Dept Hematol, 4-3 Kouzunomori, Chiba 2868686, Japan	Hokkaido University; Keio University; International University of Health & Welfare	Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Sekine, Yuichi/S-8813-2019; Muromoto, Ryuta/E-4203-2012; Togi, Sumihito/ABH-6734-2020; Matsuda, Tadashi/A-3835-2012; Yoshimura, Akihiko/K-5515-2013	Sekine, Yuichi/0000-0002-2861-603X; Muromoto, Ryuta/0000-0002-7474-493X; Matsuda, Tadashi/0000-0002-3089-3757; Togi, Sumihito/0000-0002-3189-8111	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Canil CM, 2005, J CLIN ONCOL, V23, P455, DOI 10.1200/JCO.2005.02.129; Carrion-Salip D, 2012, INT J ONCOL, V41, P1128, DOI 10.3892/ijo.2012.1509; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Ikeda O, 2011, CANCER SCI, V102, P756, DOI 10.1111/j.1349-7006.2010.01842.x; Ikeda O, 2010, J BIOL CHEM, V285, P38093, DOI 10.1074/jbc.M110.162388; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kitai Y, 2015, J BIOL CHEM, V290, P1269, DOI 10.1074/jbc.M114.611053; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Matsuda Tadashi, 2015, World J Biol Chem, V6, P324, DOI 10.4331/wjbc.v6.i4.324; Mellinghoff IK, 2002, CANCER RES, V62, P5254; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2012, ONCOGENE, V31, P4384, DOI 10.1038/onc.2011.604; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2015, J BIOL CHEM, V290, P17462, DOI 10.1074/jbc.M115.658575; Sekine Y, 2014, J IMMUNOL, V192, P3488, DOI 10.4049/jimmunol.1300886; Sekine Y, 2012, J IMMUNOL, V188, P6194, DOI 10.4049/jimmunol.1103467; Sekine Y, 2009, BIOCHEM BIOPH RES CO, V384, P187, DOI 10.1016/j.bbrc.2009.04.109; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290	31	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19392	19399		10.1074/jbc.M117.802884	http://dx.doi.org/10.1074/jbc.M117.802884			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28986450	Green Published, hybrid			2022-12-28	WOS:000416226700020
J	Maldonado, EN; DeHart, DN; Patnaik, J; Klatt, SC; Gooz, MB; Lemasters, JJ				Maldonado, Eduardo N.; DeHart, David N.; Patnaik, Jyoti; Klatt, Sandra C.; Gooz, Monika Beck; Lemasters, John J.			ATP/ADP turnover and import of glycolytic ATP into mitochondria in cancer cells is independent of the adenine nucleotide translocator (vol 291, pg 19642, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Maldonado, Eduardo/0000-0002-5285-3027	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK083262] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA021191] Funding Source: Medline; NIDDK NIH HHS [T32 DK083262] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		EDUARDO N, 2016, J BIOL CHEM, V291, P19642, DOI DOI 10.1074/JBC.A116.734814	1	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16969	16969		10.1074/jbc.A116.734814	http://dx.doi.org/10.1074/jbc.A116.734814			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	29030537	Green Published, hybrid			2022-12-28	WOS:000413140600017
J	Nabokina, SM; Inoue, K; Subramanian, VS; Valle, JE; Yuasa, H; Said, HM				Nabokina, Svetlana M.; Inoue, Katsuhisa; Subramanian, Veedamali S.; Valle, Judith E.; Yuasa, Hiroaki; Said, Hamid M.			Molecular identification and functional characterization of the human colonic thiamine pyrophosphate transporter (vol 289, pg 4405, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction															National Institutes of Health [AA 18071]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A grant was omitted from the grant support footnote. The following information should be added: This work was supported in part by National Institutes of Health Grant AA 18071.	Nabokina SM, 2014, J BIOL CHEM, V289, P4405, DOI 10.1074/jbc.M113.528257	1	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16526	16526		10.1074/jbc.A113.528257	http://dx.doi.org/10.1074/jbc.A113.528257			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28986434	Green Published, hybrid			2022-12-28	WOS:000412414800014
J	Krotee, P; Griner, SL; Sawaya, MR; Cascio, D; Rodriguez, JA; Shi, D; Philipp, S; Murray, K; Saelices, L; Lee, J; Seidler, P; Glabe, CG; Jiang, L; Gonen, T; Eisenberg, DS				Krotee, Pascal; Griner, Sarah L.; Sawaya, Michael R.; Cascio, Duilio; Rodriguez, Jose A.; Shi, Dan; Philipp, Stephan; Murray, Kevin; Saelices, Lorena; Lee, Ji; Seidler, Paul; Glabe, Charles G.; Jiang, Lin; Gonen, Tamir; Eisenberg, David S.			Common fibrillar spines of amyloid-beta and human islet amyloid polypeptide revealed by microelectron diffraction and structure-based inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION STRUCTURE; AMYLIN GENE S20G; ALZHEIMERS-DISEASE; A-BETA; DATA-COLLECTION; MICROED DATA; AMINO-ACID; PROTEIN; AGGREGATION; TOXICITY	Amyloid-beta (A beta) and human islet amyloid polypeptide (hIAPP) aggregate to form amyloid fibrils that deposit in tissues and are associated with Alzheimer's disease (AD) and type II diabetes (T2D), respectively. Individuals with T2D have an increased risk of developing AD, and conversely, AD patients have an increased risk of developing T2D. Evidence suggests that this link between AD and T2D might originate from a structural similarity between aggregates of A beta and hIAPP. Using the cryoEM method microelectron diffraction, we determined the atomic structures of 11-residue segments from both A beta and hIAPP, termed A beta (24-34) WT and hIAPP(19-29) S20G, with 64% sequence similarity. We observed a high degree of structural similarity between their backbone atoms (0.96-angstrom root mean square deviation). Moreover, fibrils of these segments induced amyloid formation through self- and cross-seeding. Furthermore, inhibitors designed for one segment showed cross-efficacy for full-length A beta and hIAPP and reduced cytotoxicity of both proteins, although by apparently blocking different cytotoxic mechanisms. The similarity of the atomic structures of A beta (24-34) WT and hIAPP(19-29) S20G offers a molecular model for cross-seeding between A beta and hIAPP.	[Krotee, Pascal; Griner, Sarah L.; Sawaya, Michael R.; Cascio, Duilio; Rodriguez, Jose A.; Murray, Kevin; Saelices, Lorena; Lee, Ji; Seidler, Paul; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, US Dept Energy DOE Inst, Mol Biol Inst,Dept Biol Chem, Los Angeles, CA 90024 USA; [Krotee, Pascal; Griner, Sarah L.; Sawaya, Michael R.; Cascio, Duilio; Rodriguez, Jose A.; Murray, Kevin; Saelices, Lorena; Lee, Ji; Seidler, Paul; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, US Dept Energy DOE Inst, Mol Biol Inst,Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Shi, Dan; Gonen, Tamir] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Philipp, Stephan; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Biochem Dept, Fac Sci, Jeddah 22252, Saudi Arabia; [Glabe, Charles G.] King Abdulaziz Univ, King Fahd Med Res Ctr, Expt Biochem Unit, Jeddah 22252, Saudi Arabia; [Jiang, Lin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Mol Biol Inst, Los Angeles, CA 90095 USA; [Jiang, Lin] Univ Calif Los Angeles, David Geffen Sch Med, BRI, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Irvine; King Abdulaziz University; King Abdulaziz University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Eisenberg, DS (corresponding author), Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Saelices Gomez, Lorena/0000-0002-1904-2150; Sawaya, Michael/0000-0003-0874-9043	National Institutes of Health [R01 AG029430]; NATIONAL INSTITUTE ON AGING [P01AG000538, R01AG029430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 AG029430. D. S. E. is a Science Advisory Board member and equity holder in ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; Andreetto E, 2015, ANGEW CHEM INT EDIT, V54, P13095, DOI 10.1002/anie.201504973; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fonte V, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-61; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hattne J, 2015, ACTA CRYSTALLOGR A, V71, P353, DOI 10.1107/S2053273315010669; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kapurniotu A, 2001, BIOPOLYMERS, V60, P438, DOI 10.1002/1097-0282(2001)60:6<438::AID-BIP10182>3.0.CO;2-A; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee SC, 2001, CLIN ENDOCRINOL, V54, P541, DOI 10.1046/j.1365-2265.2001.01244.x; Liu SA, 2017, PROTEIN SCI, V26, P8, DOI 10.1002/pro.2989; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Lorenzo A, 1996, ANN NY ACAD SCI, V777, P89, DOI 10.1111/j.1749-6632.1996.tb34406.x; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; MILLER SM, 1995, DRUG DEVELOP RES, V35, P20, DOI 10.1002/ddr.430350105; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Morita S, 2011, J DIABETES INVEST, V2, P287, DOI 10.1111/j.2040-1124.2011.00102.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Nannenga BL, 2014, NAT METHODS, V11, P927, DOI [10.1038/nmeth.3043, 10.1038/NMETH.3043]; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Ross CD, 2009, GENETICS, V183, P929, DOI 10.1534/genetics.109.109322; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Shi D, 2016, NAT PROTOC, V11, P895, DOI 10.1038/nprot.2016.046; Shi D, 2013, ELIFE, V2, DOI 10.7554/eLife.01345; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 1996, FEBS LETT, V379, P203, DOI 10.1016/0014-5793(95)01512-4; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	69	38	39	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2888	2902		10.1074/jbc.M117.806109	http://dx.doi.org/10.1074/jbc.M117.806109			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29282295	Green Published, hybrid			2022-12-28	WOS:000426051900023
J	Delbart, F; Brams, M; Gruss, F; Noppen, S; Peigneur, S; Boland, S; Chaltin, P; Brandao-Neto, J; von Delft, F; Touw, WG; Joosten, RP; Liekens, S; Tytgat, J; Ulens, C				Delbart, Florian; Brams, Marijke; Gruss, Fabian; Noppen, Sam; Peigneur, Steve; Boland, Sandro; Chaltin, Patrick; Brandao-Neto, Jose; von Delft, Frank; Touw, Wouter G.; Joosten, Robbie P.; Liekens, Sandra; Tytgat, Jan; Ulens, Chris			An allosteric binding site of the alpha 7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; IN-VITRO; MODULATION; DOMAIN; VALIDATION; MECHANISM; IDENTIFICATION; POTENTIATION; COGNITION; INSIGHTS	Nicotinic acetylcholine receptors (nAChRs) belong to the family of pentameric ligand-gated ion channels and mediate fast excitatory transmission in the central and peripheral nervous systems. Among the different existing receptor subtypes, the homomeric alpha 7 nAChR has attracted considerable attention because of its possible implication in several neurological and psychiatric disorders, including cognitive decline associated with Alzheimer's disease or schizophrenia. Allosteric modulators of ligand-gated ion channels are of particular interest as therapeutic agents, as they modulate receptor activity without affecting normal fluctuations of synaptic neurotransmitter release. Here, we used X-ray crystallography and surface plasmon resonance spectroscopy of alpha 7-acetylcholine-binding protein (AChBP), a humanized chimera of a snail AChBP, which has 71% sequence similarity with the extracellular ligand-binding domain of the human alpha 7 nAChR, to investigate the structural determinants of allosteric modulation. We extended previous observations that an allosteric site located in the vestibule of the receptor offers an attractive target for receptor modulation. We introduced seven additional humanizing mutations in the vestibule-located binding site of AChBP to improve its suitability as a model for studying allosteric binding. Using a fragment-based screening approach, we uncovered an allosteric binding site located near the beta 8-beta 9 loop, which critically contributes to coupling ligand binding to channel opening in human alpha 7 nAChR. This work expands our understanding of the topology of allosteric binding sites in AChBP and, by extrapolation, in the human alpha 7nAChRas determined by electrophysiology measurements. Our insights pave the way for drug design strategies targeting nAChRs involved in ion channel-mediated disorders.	[Delbart, Florian; Brams, Marijke; Gruss, Fabian; Ulens, Chris] Katholieke Univ Leuven, Fac Med, Lab Struct Neurobiol, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Noppen, Sam; Liekens, Sandra] Katholieke Univ Leuven, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Rega Inst Med Res, B-3000 Leuven, Belgium; [Peigneur, Steve; Tytgat, Jan] Katholieke Univ Leuven, Lab Toxicol & Pharmacol, Fac Pharmaceut Sci, B-3000 Leuven, Belgium; [Boland, Sandro; Chaltin, Patrick] Cistim Leuven Vzw, Ctr Innovat & Stimulat Drug Discovery Leuven, B-3001 Heverlee, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Innovat & Stimulat Drug Discovery Leuven, B-3001 Heverlee, Belgium; [Chaltin, Patrick] Katholieke Univ Leuven, Ctr Drug Design & Discovery, B-3001 Heverlee, Belgium; [Brandao-Neto, Jose; von Delft, Frank] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot OX11 0QX, Oxon, England; [Touw, Wouter G.; Joosten, Robbie P.] Netherlands Canc Inst, Div Biochem, NL-1066 CX Amsterdam, Netherlands	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven; Diamond Light Source; Netherlands Cancer Institute	Ulens, C (corresponding author), Dept Cellular & Mol Med, Lab Struct Neurobiol, Herestr 49,PB601, B-3000 Leuven, Belgium.	chris.ulens@kuleuven.be	Joosten, Robbie P./I-9317-2012; Noppen, Sam/F-8681-2018	Joosten, Robbie P./0000-0002-2323-2686; Noppen, Sam/0000-0002-2831-5042; Brandao-Neto, Jose/0000-0001-6015-320X; Tytgat, Jan/0000-0003-1778-6022; von Delft, Frank/0000-0003-0378-0017; Peigneur, Steve/0000-0003-0504-5702	KU Leuven C3-project [C32/16/035]; Horizon program of the European Union; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant [665501]; research Foundation Flanders (FWO); Netherlands Organization for Scientific Research (NWO) [723.013.003]; iNEXT project [653706]	KU Leuven C3-project(KU Leuven); Horizon program of the European Union; European Union's Horizon research and innovation program under Marie Sklodowska-Curie Grant; research Foundation Flanders (FWO)(FWO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); iNEXT project	This work was supported in part by KU Leuven C3-project C32/16/035 (to C.U., S.L., and J.T.) and iNEXT project 653706 supported by the Horizon 2020 program of the European Union (to F.D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Union's Horizon 2020 research and innovation program under Marie Sklodowska-Curie Grant 665501 with the research Foundation Flanders (FWO).; Supported by Vidi Grant 723.013.003 from the Netherlands Organization for Scientific Research (NWO).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Billen B, 2012, P NATL ACAD SCI USA, V109, P9173, DOI 10.1073/pnas.1116397109; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Broad LM, 2006, J PHARMACOL EXP THER, V318, P1108, DOI 10.1124/jpet.106.104505; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chatzidaki A, 2015, BIOCHEM PHARMACOL, V97, P408, DOI 10.1016/j.bcp.2015.07.028; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Galzi JL, 1996, EMBO J, V15, P5824, DOI 10.1002/j.1460-2075.1996.tb00969.x; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Hansen SB, 2007, J MOL BIOL, V369, P895, DOI 10.1016/j.jmb.2007.03.067; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Hibbs RE, 2009, EMBO J, V28, P3040, DOI 10.1038/emboj.2009.227; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hu HD, 2017, BIOPHYS J, V112, p321A, DOI 10.1016/j.bpj.2016.11.1739; Huang X, 2017, NAT STRUCT MOL BIOL, V24, P108, DOI 10.1038/nsmb.3329; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Joosten RP, 2017, CURR OPIN STRUC BIOL, V44, P9, DOI 10.1016/j.sbi.2016.10.010; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kurtzer GM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177459; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Malysz J, 2009, J PHARMACOL EXP THER, V330, P257, DOI 10.1124/jpet.109.151886; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; Nys M, 2016, P NATL ACAD SCI USA, V113, pE6696, DOI 10.1073/pnas.1603101113; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Plested AJR, 2016, NAT STRUCT MOL BIOL, V23, P494, DOI 10.1038/nsmb.3214; Sauguet L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149795; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schiebel J, 2016, ACS CHEM BIOL, V11, P1693, DOI 10.1021/acschembio.5b01034; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; Spurny R, 2015, P NATL ACAD SCI USA, V112, pE2543, DOI 10.1073/pnas.1418289112; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Touw WG, 2016, ACTA CRYSTALLOGR D, V72, P1110, DOI 10.1107/S2059798316013036; Touw WG, 2016, J MOL BIOL, V428, P1375, DOI 10.1016/j.jmb.2016.02.002; Touw WG, 2015, ACTA CRYSTALLOGR D, V71, P1604, DOI 10.1107/S1399004715008263; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; van Beusekom B, 2018, PROTEIN SCI, V27, P798, DOI 10.1002/pro.3353; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429	62	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2534	2545		10.1074/jbc.M117.815316	http://dx.doi.org/10.1074/jbc.M117.815316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29237730	Green Published, hybrid			2022-12-28	WOS:000425308300025
J	Rabbani, S; Fiege, B; Eris, D; Silbermann, M; Jakob, RP; Navarra, G; Maier, T; Ernst, B				Rabbani, Said; Fiege, Brigitte; Eris, Deniz; Silbermann, Marleen; Jakob, Roman Peter; Navarra, Giulio; Maier, Timm; Ernst, Beat			Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial adhesion; circular dichroism (CD); isothermal titration calorimetry (ITC); nuclear magnetic resonance (NMR); surface plasmon resonance (SPR); chemical shift perturbation (CSP); fluorescence polarization (FP); full length (FL); lectin domain (LD); pilin domain (PD)	CATCH-BOND MECHANISM; ESCHERICHIA-COLI; RECEPTOR-BINDING; TYROSINE GATE; COMPETITIVE-BINDING; CIRCULAR-DICHROISM; PROTEIN COMPLEXES; NMR-SPECTROSCOPY; STRUCTURAL BASIS; CELL-ADHESION	For many biological processes such as ligand binding, enzymatic catalysis, or protein folding, allosteric regulation of protein conformation and dynamics is fundamentally important. One example is the bacterial adhesin FimH, where the C-terminal pilin domain exerts negative allosteric control over binding of the N-terminal lectin domain to mannosylated ligands on host cells. When the lectin and pilin domains are separated under shear stress, the FimH-ligand interaction switches in a so-called catch-bond mechanism from the low- to high-affinity state. So far, it has been assumed that the pilin domain is essential for the allosteric propagation within the lectin domain that would otherwise be conformationally rigid. To test this hypothesis, we generated mutants of the isolated FimH lectin domain and characterized their thermodynamic, kinetic, and structural properties using isothermal titration calorimetry, surface plasmon resonance, nuclear magnetic resonance, and X-ray techniques. Intriguingly, some of the mutants mimicked the conformational and kinetic behaviors of the full-length protein and, even in absence of the pilin domain, conducted the cross-talk between allosteric sites and the mannoside-binding pocket. Thus, these mutants represent a minimalistic allosteric system of FimH, useful for further mechanistic studies and antagonist design.	[Rabbani, Said; Fiege, Brigitte; Eris, Deniz; Silbermann, Marleen; Navarra, Giulio; Ernst, Beat] Univ Basel, Dept Pharmaceut Sci, Pharmactr, Klingelbergstr 50, CH-4056 Basel, Switzerland; [Jakob, Roman Peter; Maier, Timm] Univ Basel, Focal Area Struct Biol, Dept Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland	University of Basel; University of Basel	Ernst, B (corresponding author), Univ Basel, Dept Pharmaceut Sci, Pharmactr, Klingelbergstr 50, CH-4056 Basel, Switzerland.	beat.ernst@unibas.ch	Ernst, Beat/AAN-8420-2020; Rabbani, Said/GLT-9313-2022; Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; Baker BM, 1997, J MOL BIOL, V268, P557, DOI 10.1006/jmbi.1997.0977; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Cooper A., 2011, BIOPHYSICAL CHEM; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eris D, 2016, CHEMBIOCHEM, V17, P1012, DOI 10.1002/cbic.201600066; Fiege B, 2015, CHEMBIOCHEM, V16, P1235, DOI 10.1002/cbic.201402714; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grzymajlo K, 2010, MICROBIOL-SGM, V156, P1738, DOI 10.1099/mic.0.039206-0; Han ZF, 2012, J MED CHEM, V55, P3945, DOI 10.1021/jm300165m; Hartmann M, 2011, EUR J ORG CHEM, V2011, P3583, DOI 10.1002/ejoc.201100407; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Interlandi G, 2016, PROTEINS, V84, P990, DOI 10.1002/prot.25050; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kalas V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601944; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kisiela DI, 2013, P NATL ACAD SCI USA, V110, P19089, DOI 10.1073/pnas.1314395110; Kleeb S, 2015, J MED CHEM, V58, P2221, DOI 10.1021/jm501524q; Klein T, 2010, J MED CHEM, V53, P8627, DOI 10.1021/jm101011y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Mayer K, 2017, J MED CHEM, V60, P5646, DOI 10.1021/acs.jmedchem.7b00342; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; MURPHY KP, 1994, PROTEINS, V18, P63, DOI 10.1002/prot.340180108; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nilsson LM, 2007, MOL MICROBIOL, V65, P1158, DOI 10.1111/j.1365-2958.2007.05858.x; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; OSCARSON S, 1993, CARBOHYD RES, V247, P323, DOI 10.1016/0008-6215(93)84266-9; Pang LJ, 2012, CHEMMEDCHEM, V7, P1404, DOI 10.1002/cmdc.201200125; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Rabbani S, 2010, ANAL BIOCHEM, V407, P188, DOI 10.1016/j.ab.2010.08.007; Robinson KA, 2000, ACTA CRYSTALLOGR D, V56, P996, DOI 10.1107/S0907444900007587; Rodriguez VB, 2013, J BIOL CHEM, V288, P24128, DOI 10.1074/jbc.M113.461376; Roos G, 2013, ACS MED CHEM LETT, V4, P1085, DOI 10.1021/ml400269v; Sager CP, 2018, CHEM SCI, V9, P646, DOI 10.1039/c7sc04289b; Salmon L, 2011, BIOCHEMISTRY-US, V50, P2735, DOI 10.1021/bi200177v; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; Scharenberg M, 2014, CHEMMEDCHEM, V9, P78, DOI 10.1002/cmdc.201300349; Schilling JD, 2001, J INFECT DIS, V183, pS36, DOI 10.1086/318855; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; Sokurenko EV, 2008, CELL HOST MICROBE, V4, P314, DOI 10.1016/j.chom.2008.09.005; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Torchia DA, 2011, J MAGN RESON, V212, P1, DOI 10.1016/j.jmr.2011.07.010; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Vanwetswinkel S, 2014, J MED CHEM, V57, P1416, DOI 10.1021/jm401666c; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wellens A, 2012, BIOCHEMISTRY-US, V51, P4790, DOI 10.1021/bi300251r; Yakovenko O, 2015, P NATL ACAD SCI USA, V112, P9884, DOI 10.1073/pnas.1503160112	76	15	17	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1835	1849		10.1074/jbc.M117.802942	http://dx.doi.org/10.1074/jbc.M117.802942			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29180452	Green Published, hybrid			2022-12-28	WOS:000424201700032
J	Woolfrey, KM; O'Leary, H; Goodell, DJ; Robertson, HR; Horne, EA; Coultrap, SJ; Dell'Acqua, ML; Bayer, KU				Woolfrey, Kevin M.; O'Leary, Heather; Goodell, Dayton J.; Robertson, Holly R.; Horne, Eric A.; Coultrap, Steven J.; Dell'Acqua, Mark L.; Bayer, K. Ulrich			CaMKII regulates the depalmitoylation and synaptic removal of the scaffold protein AKAP79/150 to mediate structural long-term depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ca2+; calmodulin-dependent protein kinase II (CaMKII); calmodulin (CaM); dendritic spine; synapse; synaptic plasticity; AKAP79; 150; long-term depression (LTD)	KINASE ANCHORING PROTEIN; NMDA RECEPTOR ACTIVATION; AKAP150-ANCHORED PKA; AUTONOMOUS CAMKII; AMPA RECEPTORS; INHIBITORY AUTOPHOSPHORYLATION; PHOSPHORYLATION SITES; DENDRITIC SPINES; GLUR1 SUBUNIT; PALMITOYLATION	Both long-term potentiation (LTP) and depression (LTD) of excitatory synapse strength require the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and its autonomous activity generated by Thr-286 autophosphorylation. Additionally, LTP and LTD are correlated with dendritic spine enlargement and shrinkage that are accompanied by the synaptic accumulation or removal, respectively, of the AMPA-receptor regulatory scaffold protein A-kinase anchoring protein (AKAP) 79/150. We show here that the spine shrinkage associated with LTD indeed requires synaptic AKAP79/150 removal, which in turn requires CaMKII activity. In contrast to normal CaMKII substrates, the substrate sites within the AKAP79/150 N-terminal polybasic membrane-cytoskeletal targeting domain were phosphorylated more efficiently by autonomous compared with Ca2+/CaM-stimulated CaMKII activity. This unusual regulation was mediated by Ca2+/CaM binding to the substrate sites resulting in protection from phosphorylation in the presence of Ca2+/CaM, a mechanism that favors phosphorylation by prolonged, weak LTD stimuli versus brief, strong LTP stimuli. Phosphorylation by CaMKII inhibited AKAP79/150 association with F-actin; it also facilitated AKAP79/150 removal from spines but was not required for it. By contrast, LTD-induced spine removal of AKAP79/150 required its depalmitoylation on two Cys residues within the N-terminal targeting domain. Notably, such LTD-induced depalmitoylation was also blocked by CaMKII inhibition. These results provide a mechanism how CaMKII can indeed mediate not only LTP but also LTD through regulated substrate selection; however, in the case of AKAP79/150, indirect CaMKII effects on palmitoylation are more important than the effects of direct phosphorylation. Additionally, our results provide the first direct evidence for a function of the well-described AKAP79/150 trafficking in regulating LTD-induced spine shrinkage.	[Woolfrey, Kevin M.; O'Leary, Heather; Goodell, Dayton J.; Robertson, Holly R.; Horne, Eric A.; Coultrap, Steven J.; Dell'Acqua, Mark L.; Bayer, K. Ulrich] Univ Colorado, Dept Pharmacol, Sch Med, Mail Stop 8303,RC1-North,12800 East 19th Ave, Aurora, CO 80045 USA; [O'Leary, Heather] Univ Colorado, Sch Med, Dept Pediat, Neurol Sect, Aurora, CO 80045 USA; [Robertson, Holly R.] Duke Clin Res Inst, Durham, NC 27710 USA; [Horne, Eric A.] Lundbeck LLC, Deerfield, IL 60015 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University	Dell'Acqua, ML; Bayer, KU (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Mail Stop 8303,RC1-North,12800 East 19th Ave, Aurora, CO 80045 USA.	mark.dellacqua@ucdenver.edu; ulli.bayer@ucdenver.edu			National Institutes of Health [R01NS040701, R01NS080851, R01NS081248, T32GM007635]; University of Colorado [PCT/US08/077934]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154, R01NS040701, R01NS081248, R01NS080851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01NS040701 (to M. L. D.), R01NS080851 and R01NS081248 (to K. U. B.), and T32GM007635 (to H. O., E. A. H., and H. R. R.). The University of Colorado holds the patent rights for tatCN21, its derivatives, and its uses (PCT/US08/077934 "Compositions and methods for improved CaMKII inhibitors and uses thereof"). K. U. B. is owner of Neurexus Therapeutics, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barcomb K, 2014, FASEB J, V28, P3810, DOI 10.1096/fj.14-250407; Bayer KU, 1998, EMBO J, V17, P5598, DOI 10.1093/emboj/17.19.5598; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Brandao KE, 2012, J COMP NEUROL, V520, P81, DOI 10.1002/cne.22692; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Brooks IM, 2011, J BIOL CHEM, V286, P6697, DOI 10.1074/jbc.M110.183558; Cho E, 2016, PHARMACOL RES, V111, P133, DOI 10.1016/j.phrs.2016.06.008; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Coultrap S.J., 2012, NEUROMETHODS PROTEIN, P49; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Fernandez-Monreal M, 2012, J NEUROSCI, V32, P13200, DOI 10.1523/JNEUROSCI.0061-12.2012; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Globa AK, 2017, CURR OPIN NEUROBIOL, V45, P210, DOI 10.1016/j.conb.2017.02.016; Gomez LL, 2002, J NEUROSCI, V22, P7027; Goodell DJ, 2017, CELL REP, V19, P2231, DOI 10.1016/j.celrep.2017.05.068; Goodell DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096522; Gorny X, 2012, J NEUROCHEM, V122, P714, DOI 10.1111/j.1471-4159.2012.07828.x; Halpain S, 1998, J NEUROSCI, V18, P9835; HANSON PI, 1992, J BIOL CHEM, V267, P17216; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kay HY, 2015, J CLIN INVEST, V125, P3904, DOI 10.1172/JCI79727; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kim K, 2015, NEURON, V87, P813, DOI 10.1016/j.neuron.2015.07.023; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lemonidis K, 2015, BIOCHEM SOC T, V43, P217, DOI 10.1042/BST20140270; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Myers JB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15742; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Pi HJ, 2010, J NEUROSCI, V30, P8704, DOI 10.1523/JNEUROSCI.0133-10.2010; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Sanabria H, 2009, J BIOL CHEM, V284, P9770, DOI 10.1074/jbc.M809518200; Sanders SS, 2015, BIOCHEM SOC T, V43, P205, DOI 10.1042/BST20140242; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Seeger C, 2012, J MOL RECOGNIT, V25, P495, DOI 10.1002/jmr.2215; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang Y, 2005, J BIOL CHEM, V280, P12683, DOI 10.1074/jbc.M411494200; Woolfrey KM, 2015, J NEUROSCI, V35, P442, DOI 10.1523/JNEUROSCI.2243-14.2015; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	76	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1551	1567		10.1074/jbc.M117.813808	http://dx.doi.org/10.1074/jbc.M117.813808			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29196604	Green Published, hybrid			2022-12-28	WOS:000424201700008
J	Forsberg, Z; Bissaro, B; Gullesen, J; Dalhus, B; Vaaje-Kolstad, G; Eijsink, VGH				Forsberg, Zarah; Bissaro, Bastien; Gullesen, Jonathan; Dalhus, Bjorn; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.			Structural determinants of bacterial lytic polysaccharide monooxygenase functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulose; chitin; hydrogen peroxide; protein evolution; site-directed mutagenesis; substrate specificity; LPMO; regioselectivity	OXIDATIVE CLEAVAGE; CELLOBIOSE DEHYDROGENASE; CELLULOSE DEGRADATION; CRYSTAL-STRUCTURE; BINDING; CHITIN; OLIGOSACCHARIDES; SPECIFICITY; ACTIVATION; DISCOVERY	Bacterial lytic polysaccharide monooxygenases (LPMO10s) use redox chemistry to cleave glycosidic bonds in the two foremost recalcitrant polysaccharides found in nature, namely cellulose and chitin. Analysis of correlated mutations revealed that the substrate-binding and copper-containing surface of LPMO10s composes a network of co-evolved residues and interactions, whose roles in LPMO functionality are unclear. Here, we mutated a subset of these correlated residues in a newly characterized C1/C4-oxidizing LPMO10 from Micromonospora aurantiaca (MaLPMO10B) to the corresponding residues in strictly C1-oxidizing LPMO10s. We found that surface properties near the catalytic copper, i.e. side chains likely to be involved in substrate positioning, are major determinants of the C1:C4 ratio. Several MaLPMO10B mutants almost completely lost C4-oxidizing activity while maintaining C1-oxidizing activity. These mutants also lost chitin-oxidizing activity, which is typically observed for C1/C4-oxidizing, but not for C1-oxidizing, cellulose-active LPMO10s. Selective loss in C1-oxidizing activity was not observed. Additional mutational experiments disclosed that neither truncation of the MaLPMO10B family 2 carbohydrate-binding module nor mutations altering access to the solvent-exposed axial copper coordination site significantly change the C1:C4 ratio. Importantly, several of the mutations that altered interactions with the substrate exhibited reduced stability. This effect could be explained by productive substrate binding that protects LPMOs from oxidative self-inactivation. We discuss these stability issues in view of recent findings on LPMO catalysis, such as the involvement of H2O2. Our results show that residues on the substrate-binding surface of LPMOs have co-evolved to optimize several of the interconnected properties: substrate binding and specificity, oxidative regioselectivity, catalytic efficiency, and stability.	[Forsberg, Zarah; Bissaro, Bastien; Gullesen, Jonathan; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway; [Bissaro, Bastien] INRA, UMR792, Ingn Syst Biol & Proc, F-31400 Toulouse, France; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, N-0318 Oslo, Norway; [Dalhus, Bjorn] Rigshosp, Oslo Univ Hosp, Clin Lab Med, Dept Microbiol, N-0424 Oslo, Norway	Norwegian University of Life Sciences; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of Oslo; University of Oslo; National Hospital Norway	Forsberg, Z (corresponding author), Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, N-1432 As, Norway.	zarah.forsberg@nmbu.no	Forsberg, Zarah/AAM-2395-2020; Bissaro, Bastien/AAI-6814-2020; Dalhus, Bjørn/AAK-2895-2020; BISSARO, Bastien/AAL-7130-2021	Bissaro, Bastien/0000-0001-8354-3892; Forsberg, Zarah/0000-0002-8236-7986	Research Council of Norway [214138, 214613, 226247]; Vista Programme of the Norwegian Academy of Science and Letters Grant [6510]; European Union [267196]; French Institut National de la Recherche Agronomique (INRA); South-Eastern Norway Regional Health Authority Grant [2015095]	Research Council of Norway(Research Council of Norway); Vista Programme of the Norwegian Academy of Science and Letters Grant; European Union(European Commission); French Institut National de la Recherche Agronomique (INRA); South-Eastern Norway Regional Health Authority Grant	This work was supported by Research Council of Norway Grants 214138, 214613, and 226247 (to G. V.-K. and V. G. H. E.), by Vista Programme of the Norwegian Academy of Science and Letters Grant 6510 (to Z. F.), by European Union in the framework of the Marie-Curie FP7 COFUND People Programme (through the award of an AgreenSkills Fellowship under Grant 267196), by the French Institut National de la Recherche Agronomique (INRA) (to B. B.), and by the South-Eastern Norway Regional Health Authority Grant 2015095 (Regional Core Facility for Structural Biology) (to B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Book AJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-109; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtade G, 2016, P NATL ACAD SCI USA, V113, P5922, DOI 10.1073/pnas.1602566113; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Danneels B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178446; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Forsberg Z, 2014, P NATL ACAD SCI USA, V111, P8446, DOI 10.1073/pnas.1402771111; Forsberg Z, 2014, BIOCHEMISTRY-US, V53, P1647, DOI 10.1021/bi5000433; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0284-1; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Harris PV, 2014, CURR OPIN CHEM BIOL, V19, P162, DOI 10.1016/j.cbpa.2014.02.015; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuipers RKP, 2009, PROTEINS, V76, P608, DOI 10.1002/prot.22374; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vu VV, 2014, J AM CHEM SOC, V136, P562, DOI 10.1021/ja409384b; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2016, J CHROMATOGR A, V1445, P46, DOI 10.1016/j.chroma.2016.03.064; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	60	64	64	0	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1397	1412		10.1074/jbc.M117.817130	http://dx.doi.org/10.1074/jbc.M117.817130			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29222333	Green Published, hybrid			2022-12-28	WOS:000423515000025
J	Goins, CM; Schreidah, CM; Dajnowicz, S; Ronning, DR				Goins, Christopher M.; Schreidah, Celine M.; Dajnowicz, Steven; Ronning, Donald R.			Structural basis for lipid binding and mechanism of the Mycobacterium tuberculosis Rv3802 phospholipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; phospholipase A; hydrolase; drug discovery; phosphatidylinositol; alpha; beta-Hydrolase; Rv3802	PHOSPHATIDYLINOSITOL MANNOSIDE; INHIBITION; MEMBRANE; PROTEINS; GROWTH; GENES; MODEL; A(2)	The Mycobacterium tuberculosis rv3802c gene encodes an essential enzyme with thioesterase and phospholipase A activity. Overexpression of Rv3802 orthologs in Mycobacterium smegmatis and Corynebacterium glutamicum increases mycolate content and decreases glycerophospholipids. Although a role in modulating the lipid composition of the unique mycomembrane has been proposed, the true biological function of Rv3802 remains uncertain. In this study, we present the first M. tuberculosis Rv3802 X-ray crystal structure, solved to 1.7 resolution. On the basis of the binding of PEG molecules to Rv3802, we identified its lipid-binding site and the structural basis for phosphatidyl-based substrate binding and phospholipase A activity. We found that movement of the 8-helix affords lipid binding and is required for catalytic turnover through covalent tethering. We gained insights into the mechanism of acyl hydrolysis by observing differing arrangements of PEG and water molecules within the active site. This study provides structural insights into biological function and facilitates future structure-based drug design toward Rv3802.	[Goins, Christopher M.; Schreidah, Celine M.; Dajnowicz, Steven; Ronning, Donald R.] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft, Toledo, OH 43606 USA; [Dajnowicz, Steven] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA	University System of Ohio; University of Toledo; United States Department of Energy (DOE); Oak Ridge National Laboratory	Ronning, DR (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft, Toledo, OH 43606 USA.	Donald.Ronning@utoledo.edu	Schreidah, Celine/GSI-6761-2022	Schreidah, Celine/0000-0002-4967-5880; Ronning, Donald/0000-0003-2583-8849	National Institutes of Health [AI105084]; Office of Undergraduate Research at the University of Toledo; First Year Summer Research Experience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105084] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Undergraduate Research at the University of Toledo; First Year Summer Research Experience; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI105084. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of funding from the First Year Summer Research Experience, awarded by the Office of Undergraduate Research at the University of Toledo.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albesa-Jove D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10906; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; DeLano W. L., 2013, THE PYMOL MOLECULAR; Dennis EA, 2015, J LIPID RES, V56, P1245, DOI 10.1194/jlr.E061101; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2000, J BIOL CHEM, V275, P30092, DOI 10.1074/jbc.M004658200; Jackson M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021105; Jackson M, 2013, FUTURE MICROBIOL, V8, P855, DOI 10.2217/fmb.13.52; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Marsh D, 2003, PROTEIN SCI, V12, P2109, DOI 10.1110/ps.0396803; Meniche X, 2009, J BACTERIOL, V191, P7323, DOI 10.1128/JB.01042-09; Miltner E, 2005, INFECT IMMUN, V73, P4214, DOI 10.1128/IAI.73.7.4214-4221.2005; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Parish T, 1997, J BACTERIOL, V179, P7827, DOI 10.1128/jb.179.24.7827-7833.1997; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Ravindran MS, 2014, MOL CELL PROTEOMICS, V13, P435, DOI 10.1074/mcp.M113.029942; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; WHO U, 2016, 2016 GLOB TUB REP	39	4	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1363	1372		10.1074/jbc.RA117.000240	http://dx.doi.org/10.1074/jbc.RA117.000240			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29247008	Green Published, hybrid			2022-12-28	WOS:000423515000022
J	Merriman, C; Huang, Q; Gu, W; Yu, LP; Fu, D				Merriman, Chengfeng; Huang, Qiong; Gu, Wei; Yu, Liping; Fu, Dax			A subclass of serum anti-ZnT8 antibodies directed to the surface of live pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cells; cell surface antigen; pancreatic islet; therapeutic target; ZnT8	ZINC TRANSPORTER ZNT8; INSULIN-DEPENDENT DIABETICS; BETA-CELLS; B-CELLS; TYPE-1; AUTOANTIBODIES; AUTOANTIGEN; RISK; MICE; IDENTIFICATION	The islet-specific zinc transporter ZnT8 is a major self-antigen found in insulin granules of pancreatic -cells. Frequent insulin secretion exposes ZnT8 to the cell surface, but the humoral antigenicity of the surface-displayed ZnT8 remains unknown. Here we show that a membrane-embedded human ZnT8 antigen triggered a vigorous immune response in ZnT8 knock-out mice. Approximately 50% of serum immunoreactivities toward ZnT8 were mapped to its transmembrane domain that is accessible to extracellular ZnT8 antibody (ZnT8A). ZnT8A binding was detected on live rat insulinoma INS-1E cells, and the binding specificity was validated by a CRISPR/Cas9 mediated ZnT8 knock-out. Applying established ZnT8A assays to purified serum antibodies from patients with type 1 diabetes, we detected human ZnT8A bound to live INS-1E cells, whereas a ZnT8 knock-out specifically reduced the surface binding. Our results demonstrate that ZnT8 is a cell surface self-antigen, raising the possibility of a direct involvement in antibody-mediated -cell dysfunction and cytotoxicity.	[Merriman, Chengfeng; Huang, Qiong; Fu, Dax] Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA; [Gu, Wei] Amgen Inc, Sect Metab Disorders, Thousand Oaks, CA 91320 USA; [Yu, Liping] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	Johns Hopkins University; Johns Hopkins Medicine; Amgen; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Fu, D (corresponding author), Johns Hopkins Sch Med, Dept Physiol, 725 North Wolfe St, Baltimore, MD 21205 USA.	dfu3@jhmi.edu	Huang, Qiong/HGC-7895-2022	Huang, Qiong/0000-0002-0570-5961	National Institutes of Health [S10OD016374, S10OD016315, S10RR13777001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065137] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016374, S10OD016315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Hao Zhang from the Flow Cytometry and Immunology Core Facility at Johns Hopkins Bloomberg School of Public Health for assistance in flow cytometry data acquisition and analysis. The Zeiss confocal microscope was supported through National Institutes of Health shared instrumentation Grant S10OD016374. The MoFlo XDP cell sorter was supported through National Institutes of Health Grants S10OD016315 and S10RR13777001.	Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; Campbell-Thompson M, 2016, DIABETES, V65, P719, DOI 10.2337/db15-0779; Chujo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055595; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dang M, 2011, J IMMUNOL, V186, P6056, DOI 10.4049/jimmunol.1003815; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; DECLERCK PJ, 1995, J BIOL CHEM, V270, P8397, DOI 10.1074/jbc.270.15.8397; DOBERSEN MJ, 1982, DIABETES, V31, P459, DOI 10.2337/diabetes.31.5.459; Enee E, 2012, DIABETES, V61, P1779, DOI 10.2337/db12-0071; Gyulkhandanyan AV, 2008, J BIOL CHEM, V283, P10184, DOI 10.1074/jbc.M707005200; Hinman RM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0543-8; Huang Q, 2017, J BIOL CHEM, V292, P4034, DOI 10.1074/jbc.M116.772152; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2012, J DIABETES INVEST, V3, P202, DOI 10.1111/j.2040-1124.2012.00199.x; LERNMARK A, 1978, NEW ENGL J MED, V299, P375, DOI 10.1056/NEJM197808242990802; Li SF, 2013, VACCINE, V31, P1610, DOI 10.1016/j.vaccine.2012.12.008; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merriman C, 2016, J BIOL CHEM, V291, P26950, DOI 10.1074/jbc.M116.764605; Murgia C, 2009, NUTR METAB CARDIOVAS, V19, P431, DOI 10.1016/j.numecd.2008.09.004; Niegowska M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22266; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; PETERSON C, 1992, DIABETES RES CLIN PR, V17, P33, DOI 10.1016/0168-8227(92)90041-O; RABIN DU, 1994, J IMMUNOL, V152, P3183; Scotto M, 2012, DIABETOLOGIA, V55, P2026, DOI 10.1007/s00125-012-2543-z; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Tooley JE, 2014, CURR OPIN ENDOCRINOL, V21, P287, DOI 10.1097/MED.0000000000000076; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; VANDEWINKEL M, 1982, J CLIN INVEST, V70, P41, DOI 10.1172/JCI110601; VIVES M, 1992, DIABETES, V41, P1624, DOI 10.2337/diabetes.41.12.1624; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wan H, 2017, P NATL ACAD SCI USA, V114, P10196, DOI 10.1073/pnas.1711169114; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wenzlau JM, 2013, CURR DIABETES REP, V13, P608, DOI 10.1007/s11892-013-0405-9; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	39	13	13	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					579	587		10.1074/jbc.RA117.000195	http://dx.doi.org/10.1074/jbc.RA117.000195			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184000	hybrid, Green Published			2022-12-28	WOS:000419915400014
J	Miyazawa, M; Noguchi, K; Kujirai, M; Katayama, K; Yamagoe, S; Sugimoto, Y				Miyazawa, Masanori; Noguchi, Kohji; Kujirai, Mana; Katayama, Kazuhiro; Yamagoe, Satoshi; Sugimoto, Yoshikazu			IL-10 promoter transactivation by the viral K-RTA protein involves the host-cell transcription factors, specificity proteins 1 and 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						herpesvirus; interleukin; specificity protein 1 (Sp1); transcription; viral transcription; IL-10; SP3; transactivation	SARCOMA-ASSOCIATED HERPESVIRUS; READING FRAME 50; EFFUSION LYMPHOMA-CELLS; KAPOSIS-SARCOMA; GENE-EXPRESSION; LYTIC-CYCLE; CASTLEMAN-DISEASE; BINDING PROTEIN; ORF50 PROTEIN; DNA-BINDING	Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus-8 (HHV-8) causes a persistent infection, presenting latent and lytic replication phases during its life cycle. KSHV-related diseases are associated with deregulated expression of inflammatory cytokines, including IL-6 and IL-10, but the mechanisms underlying this dysregulation are unclear. Herein, we report a molecular mechanism for KSHV-induced IL-10 gene expression. KSHV replication and transcription activator (K-RTA) is a molecular switch for the initiation of expression of viral lytic genes, and we describe, for the first time, that K-RTA significantly activates the promoter of the human IL-10 gene. Of note, mutations involving a basic region of K-RTA reduced the association of K-RTA with the IL-10 promoter. Moreover, the host-cell transcription factors, specificity proteins (SP) 1 and 3, play a pivotal cooperative role in K-RTA-mediated transactivation of the IL-10 promoter. K-RTA can interact with SP1 and SP3 directly in vitro, and electrophoresis mobility shift assays (EMSAs) revealed co-operative interaction involving K-RTA, SP1, and SP3 in binding to the IL-10 promoter. As DNase I footprinting assays indicated that K-RTA did not affect SP3 binding to the IL-10 promoter, SP3 can function to recruit K-RTA to the IL-10 promoter. These findings indicate that K-RTA can directly contribute to IL-10 up-regulation via a functional interplay with the cellular transcription factors SP1 and SP3.	[Miyazawa, Masanori; Noguchi, Kohji; Kujirai, Mana; Katayama, Kazuhiro; Sugimoto, Yoshikazu] Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan; [Yamagoe, Satoshi] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan	Keio University; National Institute of Infectious Diseases (NIID)	Noguchi, K (corresponding author), Keio Univ, Fac Pharm, Div Chemotherapy, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	nogu-chi-kj@pha.keio.ac.jp	Katayama, Kazuhiro/AAH-2914-2019	Katayama, Kazuhiro/0000-0003-4232-7661	Japan Society for the Promotion of Science KAKENHI [S1411004, 15K14409, 26460076]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid from the Japan Society for the Promotion of Science KAKENHI S1411004, 15K14409, and 26460076. The authors declare that they have no conflicts of interest with the contents of this article.	Aoki Y, 2000, BLOOD, V96, P1599, DOI 10.1182/blood.V96.4.1599.h8001599_1599_1601; Asou H, 1998, BLOOD, V91, P2475, DOI 10.1182/blood.V91.7.2475.2475_2475_2481; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bjerke GA, 2011, MOL CELL BIOL, V31, P3723, DOI 10.1128/MCB.01456-10; Boshoff C, 1998, ADV CANCER RES, V75, P57, DOI 10.1016/S0065-230X(08)60739-3; Boshoff C, 2001, ANNU REV MED, V52, P453, DOI 10.1146/annurev.med.52.1.453; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Cannon JS, 2000, J VIROL, V74, P10187, DOI 10.1128/JVI.74.21.10187-10193.2000; Carroll KD, 2007, J VIROL, V81, P8451, DOI 10.1128/JVI.00265-07; Chang PJ, 2005, J VIROL, V79, P8750, DOI 10.1128/JVI.79.14.8750-8763.2005; Chang PJ, 2004, J VIROL, V78, P10657, DOI 10.1128/JVI.78.19.10657-10673.2004; Chang PJ, 2002, J VIROL, V76, P3168, DOI 10.1128/JVI.76.7.3168-3178.2002; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen JG, 2000, J VIROL, V74, P8623, DOI 10.1128/JVI.74.18.8623-8634.2000; Deng H, 2007, CURR TOP MICROBIOL, V312, P157; Gasperini P, 2008, J LEUKOCYTE BIOL, V84, P994, DOI 10.1189/jlb.1107777; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Guito Jonathan, 2012, Front Microbiol, V3, P30, DOI 10.3389/fmicb.2012.00030; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jackson B, 2011, J CELL SCI, V124, P1681, DOI 10.1242/jcs.077552; Jochum S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002704; Jones KD, 1999, BLOOD, V94, P2871; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mesri EA, 2010, NAT REV CANCER, V10, P707, DOI 10.1038/nrc2888; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Murray PJ, 1997, J IMMUNOL, V158, P315; Noguchi K, 2004, J BIOL CHEM, V279, P32716, DOI 10.1074/jbc.M404104200; Noguchi K, 2006, EMBO J, V25, P5372, DOI 10.1038/sj.emboj.7601396; Noguchi K, 2017, J BIOL CHEM, V292, P1910, DOI 10.1074/jbc.M116.747048; Oksenhendler E, 2000, BLOOD, V96, P2069, DOI 10.1182/blood.V96.6.2069.h8002069_2069_2073; Palmeri D, 2011, J VIROL, V85, P11901, DOI 10.1128/JVI.05479-11; Persson LM, 2010, J VIROL, V84, P1334, DOI 10.1128/JVI.01301-09; Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073; Qin ZQ, 2010, J LEUKOCYTE BIOL, V87, P25, DOI 10.1189/jlb.0409251; Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342; Roan F, 2002, VIROLOGY, V301, P293, DOI 10.1006/viro.2002.1582; Santarelli R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04241; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Song MJ, 2002, J VIROL, V76, P5000, DOI 10.1128/JVI.76.10.5000-5013.2002; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Staudt MR, 2007, CURR TOP MICROBIOL, V312, P71; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Wang SE, 2003, J VIROL, V77, P600, DOI 10.1128/JVI.77.1.600-623.2003; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wang SZE, 2004, J VIROL, V78, P4248, DOI 10.1128/JVI.78.8.4248-4267.2004; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang L, 1998, DNA CELL BIOL, V17, P735	57	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					662	676		10.1074/jbc.M117.802900	http://dx.doi.org/10.1074/jbc.M117.802900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29184003	Green Published, hybrid			2022-12-28	WOS:000419915400021
J	Nagy, N; de la Zerda, A; Kaber, G; Johnson, PY; Hu, KH; Kratochvil, MJ; Yadava, K; Zhao, WT; Cui, Y; Navarro, G; Annes, JP; Wight, TN; Heilshorn, SC; Bollyky, PL; Butte, MJ				Nagy, Nadine; de la Zerda, Adi; Kaber, Gernot; Johnson, Pamela Y.; Hu, Kenneth H.; Kratochvil, Michael J.; Yadava, Koshika; Zhao, Wenting; Cui, Yi; Navarro, Guadalupe; Annes, Justin P.; Wight, Thomas N.; Heilshorn, Sarah C.; Bollyky, Paul L.; Butte, Manish J.			Hyaluronan content governs tissue stiffness in pancreatic islet inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; autoimmune disease; diabetes; atomic force microscopy (AFM); hydrogels; tissue stiffness; extracellular matrix	MOLECULAR-WEIGHT HYALURONAN; EXTRACELLULAR-MATRIX; BINDING PROTEINS; STEM-CELLS; ACID; INHIBITION; INTEGRITY; INSULITIS; AUTOIMMUNITY; CONTRIBUTES	We have identified a novel role for hyaluronan (HA), an extracellular matrix polymer, in governing the mechanical properties of inflamed tissues. We recently reported that insulitis in type 1 diabetes of mice and humans is preceded by intraislet accumulation of HA, a highly hygroscopic polymer. Using the double transgenic DO11.10 x RIPmOVA (DORmO) mouse model of type 1 diabetes, we asked whether autoimmune insulitis was associated with changes in the stiffness of islets. To measure islet stiffness, we used atomic force microscopy (AFM) and developed a novel bed of nails-like approach that uses quartz glass nanopillars to anchor islets, solving a long-standing problem of keeping tissue-scale objects immobilized while performing AFM. We measured stiffness via AFM nanoindentation with a spherical indenter and found that insulitis made islets mechanically soft compared with controls. Conversely, treatment with 4-methylumbelliferone, a small-molecule inhibitor of HA synthesis, reduced HA accumulation, diminished swelling, and restored basal tissue stiffness. These results indicate that HA content governs the mechanical properties of islets. In hydrogels with variable HA content, we confirmed that increased HA leads to mechanically softer hydrogels, consistent with our model. In light of recent reports that the insulin production of islets is mechanosensitive, these findings open up an exciting new avenue of research into the fundamental mechanisms by which inflammation impacts local cellular responses.	[Nagy, Nadine; Kaber, Gernot; Kratochvil, Michael J.; Yadava, Koshika; Bollyky, Paul L.] Stanford Univ, Dept Med, Div Infect Dis, 279 Campus Dr,Beckman Ctr,Rm B237, Stanford, CA 94305 USA; [de la Zerda, Adi; Kratochvil, Michael J.; Zhao, Wenting; Cui, Yi; Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Hu, Kenneth H.] Stanford Univ, Stanford Biophys, Stanford, CA 94305 USA; [Navarro, Guadalupe; Annes, Justin P.] Stanford Univ, Dept Med, Div Endocrinol, Stanford, CA 94305 USA; [Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol Allergy & Rheumatol, Stanford, CA 94305 USA; [Johnson, Pamela Y.; Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA 98101 USA; [Butte, Manish J.] Univ Calif Los Angeles, Dept Pediat, Div Immunol Allergy & Rheumatol, Los Angeles, CA 90095 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Benaroya Research Institute; University of California System; University of California Los Angeles	Nagy, N (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, 279 Campus Dr,Beckman Ctr,Rm B237, Stanford, CA 94305 USA.	nnagy@stanford.edu	Butte, Manish/T-8860-2019; Cui, Yi/L-5804-2013; zhao, wenting/AAB-5269-2019; ZHAO, Wenting/M-8613-2016; Butte, Manish/AAM-8604-2020	Butte, Manish/0000-0002-4490-5595; Cui, Yi/0000-0002-6103-6352; zhao, wenting/0000-0002-6143-5185; ZHAO, Wenting/0000-0002-6143-5185; Butte, Manish/0000-0002-4490-5595; Heilshorn, Sarah/0000-0002-9801-6304; Annes, Justin/0000-0001-8431-3589	Deutsche Forschungsgemeinschaft [NA 965/2-1, KA 3441/1-1]; National Institutes of Health [R01 DK096087-01, R01 GM111808, U01 AI101984, R01 DK101530, R01 GM110482, U01 AI101990]; National Science Foundation Graduate Research Fellowship; National Science Foundation [CBET-1264833]; Stanford Diabetes Research Center; Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology; Juvenile Diabetes Research Foundation [1-SRA-2018-518-S-B, nPOD 25-2010-648, 3-PDF-2014-224-A-N]; Harrington Foundation; Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101990, U01AI101984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101530, P30DK017047, R01DK096087, P30DK116074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111808, R01GM110482] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Stanford Diabetes Research Center; Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Harrington Foundation; Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Deutsche Forschungsgemeinschaft Grants NA 965/2-1 (to N. N.) and KA 3441/1-1 (to G. K.); National Institutes of Health Grants R01 DK096087-01, R01 GM111808, and U01 AI101984 (to P. L. B.), R01 DK101530 (to J. P. A.), and R01 GM110482 (to M. J. B.); National Institutes of Health Pilot Project Grant U01 AI101990 (to T. N. W.); a National Science Foundation Graduate Research Fellowship (to A. d. l. Z.); National Science Foundation Grant CBET-1264833 (to M. J. B.); a P&F award from the Stanford Diabetes Research Center (to N. N.); a grant from the Stanford ChEM-H Interdisciplinary Postdoctoral Training Program in Quantitative Mechanobiology (to M. J. K.); Juvenile Diabetes Research Foundation Grants 1-SRA-2018-518-S-B (to P. L. B.), nPOD 25-2010-648 (to T. N. W.), and 3-PDF-2014-224-A-N (to N. N.); a Harrington Foundation grant (to P. L. B.); and a grant from the Stanford Child Health Research Institute (to M. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Assavag-Asherie N., 2015, PLOS ONE, V1; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Bogdani M, 2014, DIABETES, V63, P2727, DOI 10.2337/db13-1658; Bollyky PL, 2012, CURR DIABETES REP, V12, P471, DOI 10.1007/s11892-012-0297-0; Bollyky PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005063; Carrero JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059701; Cavallari G, 2012, CELL TRANSPLANT, V21, P2771, DOI 10.3727/096368912X637046; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Chaurasia SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037456; Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200; Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; FRASER JRE, 1981, BIOCHEM J, V200, P415, DOI 10.1042/bj2000415; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hanson L, 2015, NAT NANOTECHNOL, V10, P554, DOI [10.1038/nnano.2015.88, 10.1038/NNANO.2015.88]; Harrington S, 2017, TISSUE ENG PT A, V23, P1088, DOI [10.1089/ten.tea.2016.0477, 10.1089/ten.TEA.2016.0477]; Hesterberg, 2015, RESAMPLE RESAMPLING; Hull RL, 2015, J HISTOCHEM CYTOCHEM, V63, P592, DOI 10.1369/0022155415576542; Irving-Rodgers HF, 2008, DIABETOLOGIA, V51, P1680, DOI 10.1007/s00125-008-1085-x; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kang L, 2013, DIABETES, V62, P1888, DOI 10.2337/db12-1502; KATO Y, 1995, J RHEUMATOL, V22, P158; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Kuipers HF, 2016, P NATL ACAD SCI USA, V113, P1339, DOI 10.1073/pnas.1525086113; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32; Li YP, 2006, BIOMATERIALS, V27, P1437, DOI 10.1016/j.biomaterials.2005.08.020; Lieleg O, 2011, TRENDS CELL BIOL, V21, P543, DOI 10.1016/j.tcb.2011.06.002; Lieleg O, 2009, BIOPHYS J, V97, P1569, DOI 10.1016/j.bpj.2009.07.009; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Morgan JT, 2014, BIOTECHNIQUES, V56, P40, DOI 10.2144/000114126; Mueller AM, 2014, J BIOL CHEM, V289, P22888, DOI 10.1074/jbc.M114.559583; Nagy N, 2015, J CLIN INVEST, V125, P3928, DOI 10.1172/JCI79271; Nagy N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00123; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Nyitray CE, 2014, TISSUE ENG PT A, V20, P1888, DOI [10.1089/ten.TEA.2013.0692, 10.1089/ten.tea.2013.0692]; Rehfeldt F, 2012, INTEGR BIOL-UK, V4, P422, DOI 10.1039/c2ib00150k; Responte DJ, 2012, J R SOC INTERFACE, V9, P3564, DOI 10.1098/rsif.2012.0399; Ruppert SM, 2014, IMMUNOL RES, V58, P186, DOI 10.1007/s12026-014-8495-2; Screen HRC, 2006, ACTA BIOMATER, V2, P505, DOI 10.1016/j.actbio.2006.05.008; Serban Monica A, 2008, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1014s40; Singleton PA, 2010, AM J PHYSIOL-LUNG C, V299, pL639, DOI 10.1152/ajplung.00405.2009; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Valva P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023218; Velten F, 1999, BIOMATERIALS, V20, P2161, DOI 10.1016/S0142-9612(99)00119-2; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Wolf K, 2011, TRENDS CELL BIOL, V21, P736, DOI 10.1016/j.tcb.2011.09.006; Xie C, 2010, NANO LETT, V10, P4020, DOI 10.1021/nl101950x; Yoshioka Y, 2013, ARTHRITIS RHEUM-US, V65, P1160, DOI 10.1002/art.37861; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	54	28	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					567	578		10.1074/jbc.RA117.000148	http://dx.doi.org/10.1074/jbc.RA117.000148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29183997	hybrid, Green Published			2022-12-28	WOS:000419915400013
J	Choi, S; Neequaye, P; French, SW; Gonzalez, FJ; Gyamfi, MA				Choi, Sora; Neequaye, Prince; French, Samuel W.; Gonzalez, Frank J.; Gyamfi, Maxwell A.			Pregnane X receptor promotes ethanol-induced hepatosteatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALCOHOLIC LIVER-DISEASE; CONSTITUTIVE ANDROSTANE RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; INDUCED FATTY LIVER; EARLY GROWTH RESPONSE-1; DIET-INDUCED OBESITY; NUCLEAR RECEPTORS; ALDEHYDE DEHYDROGENASE; PXR GENE; INDUCED HEPATOTOXICITY	The pregnane X receptor (PXR, NR1I2) is a xenobiotic-sensing nuclear receptor that modulates the metabolic response to drugs and toxic agents. Both PXR activation and deficiency promote hepatic triglyceride accumulation, a hallmark feature of alcoholic liver disease. However, the molecular mechanism of PXR-mediated activation of ethanol (EtOH)-induced steatosis is unclear. Here, using male wildtype (WT) and Pxr-null mice, we examined PXR-mediated regulation of chronic EtOH-induced hepatic lipid accumulation and hepatotoxicity. EtOH ingestion for 8 weeks significantly (1.8-fold) up-regulated Pxr mRNA levels in WT mice. The EtOH exposure also increased mRNAs encoding hepatic constitutive androstane receptor (3-fold) and its target, Cyp2b10 (220-fold), in a PXR-dependent manner. Furthermore, WT mice had higher serum EtOH levels and developed hepatic steatosis characterized by micro-and macrovesicular lipid accumulation. Consistent with the development of steatosis, lipogenic gene induction was significantly increased in WT mice, including sterol regulatory element-binding protein 1c target gene fatty-acid synthase (3.0-fold), early growth response-1 (3.2-fold), and TNF alpha (3.0-fold), whereas the expression of peroxisome proliferator-activated receptor alpha target genes was suppressed. Of note, PXR deficiency suppressed these changes and steatosis. Protein levels, but not mRNAs levels, of EtOH-metabolizing enzymes, including alcohol dehydrogenase 1, aldehyde dehydrogenase 1A1, and catalase, as well as the microsomal triglyceride transfer protein, involved in regulating lipid output were higher in Pxr-null than in WT mice. These findings establish that PXR signaling contributes to ALD development and suggest that PXR antagonists may provide a new approach for ALD therapy.	[Choi, Sora; Neequaye, Prince; Gyamfi, Maxwell A.] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst, Durham, NC 27707 USA; [French, Samuel W.] Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of North Carolina; North Carolina Central University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gyamfi, MA (corresponding author), North Carolina Cent Univ, JLC Biomed Biotechnol Res Inst, Cardiometab Res Program, 700 George St, Durham, NC 27707 USA.	mgyamfi@nccu.edu			National Institutes of Health [U54 AA019765, 1U54MD012392, P20 MD000175, U01-021898]; NCI Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC005562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019765] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD000175, U54MD012392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Intramural Research Program of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants U54 AA019765, 1U54MD012392, P20 MD000175, and U01-021898 and in part by the NCI Intramural Research Program of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aleynik SI, 1998, ALCOHOL CLIN EXP RES, V22, P192, DOI 10.1097/00000374-199802000-00026; ALGAR EM, 1986, INT J BIOCHEM, V18, P49, DOI 10.1016/0020-711X(86)90007-8; Bitter A, 2015, ARCH TOXICOL, V89, P2089, DOI 10.1007/s00204-014-1348-x; Blednov YA, 2015, ALCOHOL CLIN EXP RES, V39, P136, DOI 10.1111/acer.12610; Caparros-Martin JA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0312-4; Chen XS, 2011, LAB INVEST, V91, P1136, DOI 10.1038/labinvest.2011.68; Cheng J, 2012, TOXICOL SCI, V129, P456, DOI 10.1093/toxsci/kfs211; Cheng J, 2010, J PHARMACOL EXP THER, V335, P32, DOI 10.1124/jpet.110.170225; Cheng J, 2009, DRUG METAB DISPOS, V37, P1611, DOI 10.1124/dmd.109.027565; Ciuclan L, 2010, J HEPATOL, V52, P407, DOI 10.1016/j.jhep.2009.12.003; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Cui JY, 2016, BBA-GENE REGUL MECH, V1859, P1198, DOI 10.1016/j.bbagrm.2016.04.010; Dai T, 2003, EXP MOL PATHOL, V75, P194, DOI 10.1016/S0014-4800(03)00091-1; Das BC, 2008, BIOORG MED CHEM LETT, V18, P3974, DOI 10.1016/j.bmcl.2008.06.018; Ding XS, 2005, J PHARMACOL EXP THER, V314, P120, DOI 10.1124/jpet.105.085225; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Dring MM, 2006, GASTROENTEROLOGY, V130, P341, DOI 10.1053/j.gastro.2005.12.008; Fu ZD, 2016, DRUG METAB DISPOS, V44, P842, DOI 10.1124/dmd.115.068270; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Goodwin B, 2001, MOL PHARMACOL, V60, P427; Gyamfi MA, 2008, J PHARMACOL EXP THER, V324, P443, DOI 10.1124/jpet.107.132258; Gyamfi MA, 2006, J PHARMACOL EXP THER, V319, P360, DOI 10.1124/jpet.106.108175; Gyamfi MA, 2010, EXP BIOL MED, V235, P547, DOI 10.1258/ebm.2009.009249; Gyamfi MA, 2009, TOXICOL APPL PHARM, V234, P166, DOI 10.1016/j.taap.2008.09.022; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; He P, 2006, DRUG METAB DISPOS, V34, P1198, DOI 10.1124/dmd.105.008904; Heit C, 2015, ADV EXP MED BIOL, V815, P375, DOI 10.1007/978-3-319-09614-8_22; Hoekstra M, 2009, MOL PHARMACEUT, V6, P182, DOI 10.1021/mp800131d; Imaoka S, 2004, CANCER LETT, V203, P117, DOI 10.1016/j.canlet.2003.09.009; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue K, 2009, FEBS LETT, V583, P2126, DOI 10.1016/j.febslet.2009.05.031; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; KHOGALI AM, 1974, TUBERCLE, V55, P231, DOI 10.1016/0041-3879(74)90050-6; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Koga T, 2016, J BIOL CHEM, V291, P25255, DOI 10.1074/jbc.M116.755447; Konishi T, 2003, EXP MOL PATHOL, V74, P183, DOI 10.1016/S0014-4800(03)00006-6; Kono H, 1999, AM J PHYSIOL-GASTR L, V277, pG1259, DOI 10.1152/ajpgi.1999.277.6.G1259; KOSTRUBSKY VE, 1995, ARCH BIOCHEM BIOPHYS, V322, P516, DOI 10.1006/abbi.1995.1495; Langmann T, 2004, GASTROENTEROLOGY, V127, P26, DOI 10.1053/j.gastro.2004.04.019; Lawrimore CJ, 2017, ALCOHOL CLIN EXP RES, V41, P939, DOI 10.1111/acer.13368; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; LIEBER CS, 1989, HEPATOLOGY, V10, P501, DOI 10.1002/hep.1840100417; Lim YP, 2015, ARCH TOXICOL, V89, P57, DOI 10.1007/s00204-014-1230-x; Lounis MA, 2016, BBA-MOL CELL BIOL L, V1861, P1662, DOI 10.1016/j.bbalip.2016.07.012; Ma YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038734; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Mandrekar P, 2016, HEPATOLOGY, V64, P1343, DOI 10.1002/hep.28530; Marek CJ, 2005, BIOCHEM J, V387, P601, DOI 10.1042/BJ20041598; Martinez A, 2007, INFLAMM BOWEL DIS, V13, P1484, DOI 10.1002/ibd.20252; McMullen MR, 2005, GASTROENTEROLOGY, V128, P2066, DOI 10.1053/j.gastro.2005.02.065; Mezey E, 2005, BIOCHEM BIOPH RES CO, V337, P1324, DOI 10.1016/j.bbrc.2005.10.003; Nakajima T, 2004, HEPATOLOGY, V40, P972, DOI 10.1002/hep.20399; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Nanji AA, 2004, J PHARMACOL EXP THER, V310, P417, DOI 10.1124/jpet.103.064717; Niemela O, 2000, J HEPATOL, V33, P893, DOI 10.1016/S0168-8278(00)80120-8; Pang MY, 2009, J HEPATOL, V50, P1192, DOI 10.1016/j.jhep.2009.01.021; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Planque C, 2016, ONCOTARGET, V7, P56558, DOI 10.18632/oncotarget.10646; Purohit V, 2004, ALCOHOL, V34, P3, DOI 10.1016/j.alcohol.2004.06.008; Qiao EQ, 2013, ONCOL LETT, V5, P1093, DOI 10.3892/ol.2013.1149; Shah YM, 2007, AM J PHYSIOL-GASTR L, V292, pG1114, DOI 10.1152/ajpgi.00528.2006; Shan WW, 2008, HEPATOLOGY, V47, P225, DOI 10.1002/hep.21925; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Sinz MW, 2013, DRUG METAB REV, V45, P3, DOI 10.3109/03602532.2012.743560; Sookoian S, 2010, PHARMACOGENET GENOM, V20, P1, DOI 10.1097/FPC.0b013e328333a1dd; Spruiell K, 2015, J PHARMACOL EXP THER, V354, P459, DOI 10.1124/jpet.115.224295; Spruiell K, 2014, BIOCHEM PHARMACOL, V89, P399, DOI 10.1016/j.bcp.2014.03.019; Spruiell K, 2014, J BIOL CHEM, V289, P3244, DOI 10.1074/jbc.M113.494575; Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Sugimoto T, 2002, J HEPATOL, V36, P157, DOI 10.1016/S0168-8278(01)00263-X; Sui YP, 2011, J LIPID RES, V52, P1652, DOI 10.1194/jlr.M017376; Sun MX, 2015, DRUG METAB DISPOS, V43, P335, DOI 10.1124/dmd.114.062307; Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011; Teng S, 2007, BRIT J PHARMACOL, V151, P367, DOI 10.1038/sj.bjp.0707235; Thomes PG, 2013, INT J BIOCHEM CELL B, V45, P454, DOI 10.1016/j.biocel.2012.10.002; Tomita K, 2004, GASTROENTEROLOGY, V126, P873, DOI 10.1053/j.gastro.2003.12.008; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Venkatesh M, 2011, MOL PHARMACOL, V80, P124, DOI 10.1124/mol.111.071787; Wada S, 2008, J HEPATOL, V49, P441, DOI 10.1016/j.jhep.2008.04.026; Wan YJY, 1998, GENET TEST, V2, P79, DOI 10.1089/gte.1998.2.79; Wang HB, 2003, CURR DRUG METAB, V4, P515, DOI 10.2174/1389200033489262; Wang XY, 2017, MOL MED REP, V15, P3459, DOI 10.3892/mmr.2017.6435; Wang YM, 2014, EXPERT OPIN DRUG MET, V10, P1521, DOI 10.1517/17425255.2014.963555; Warren KR, 2013, J GASTROEN HEPATOL, V28, P4, DOI 10.1111/jgh.12246; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wu WB, 2014, BIOCHEM BIOPH RES CO, V443, P68, DOI 10.1016/j.bbrc.2013.11.057; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yamazaki Y, 2007, GUT, V56, P565, DOI 10.1136/gut.2006.093260; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zakhari S, 2007, HEPATOLOGY, V46, P2032, DOI 10.1002/hep.22010; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zhao LY, 2017, BIOCHEM PHARMACOL, V142, P194, DOI 10.1016/j.bcp.2017.07.019; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	99	12	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					1	17		10.1074/jbc.M117.815217	http://dx.doi.org/10.1074/jbc.M117.815217			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29123032	Green Published, hybrid			2022-12-28	WOS:000419453200001
J	Cheng, CW; Leong, KW; Ng, YM; Kwong, YL; Tse, E				Cheng, Chi-Wai; Leong, Ka-Wai; Ng, Yiu-Ming; Kwong, Yok-Lam; Tse, Eric			The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell cycle; cyclin-dependent kinase (CDK); phosphorylation; prolyl isomerase; PIN1; immunoprecipitation; p27	HUMAN HEPATOCELLULAR-CARCINOMA; CELL-CYCLE; P27(KIP1); PROTEIN; PHOSPHORYLATION; DEGRADATION; OVEREXPRESSION; PROTEOLYSIS; ACTIVATION; COMPLEX	PIN1 is a peptidyl-prolyl isomerase that catalyzes the cis/trans isomerization of peptide bonds between proline and phosphorylated serine/threonine residues. By changing the conformation of its protein substrates, PIN1 increases the activities of key proteins that promote cell cycle progression and oncogenesis. Moreover, it has been shown that PIN1 stabilizes and increases the level of the cyclin-dependent kinase (CDK) inhibitor p27, which inhibits cell cycle progression by binding cyclin A- and cyclin E-CDK2. Notwithstanding the associated increase in the p27 level, PIN1 expression promotes rather than retards cell proliferation. To explain the paradoxical effects of PIN1 on p27 levels and cell cycle progression, we hypothesized that PIN1 relieves CDK2 inhibition by suppressing the CDK inhibitory activity of p27. Here, we confirmed that PIN1-expressing cells exhibit higher p27 levels but have increased CDK2 activities and higher proliferation rates in the S-phase compared with Pin1-null fibroblasts or PIN1-depleted hepatoma cells. Using co-immunoprecipitation and CDK kinase activity assays, we found that PIN1 binds the phosphorylated Thr(187)-Pro motif in p27 and reduces p27's interaction with cyclin A- or cyclin E-CDK2, leading to increased CDK2 kinase activity. In conclusion, our results indicate that although PIN1 increases p27 levels, it also attenuates p27's inhibitory activity on CDK2 and thereby contributes to increased G(1)-S phase transitions and cell proliferation.	[Cheng, Chi-Wai; Leong, Ka-Wai; Ng, Yiu-Ming; Kwong, Yok-Lam; Tse, Eric] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tse, E (corresponding author), Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China.	ewctse@hku.hk	Tse, Eric/ABB-4021-2020	Tse, Eric/0000-0002-8351-4722; Cheng, Timothy/0000-0002-3006-1440				Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Behrsin CD, 2007, J MOL BIOL, V365, P1143, DOI 10.1016/j.jmb.2006.10.078; Broude EV, 2007, ONCOGENE, V26, P6954, DOI 10.1038/sj.onc.1210516; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cheng CW, 2013, AM J PATHOL, V182, P765, DOI 10.1016/j.ajpath.2012.11.034; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Leong KW, 2017, ONCOTARGET, V8, P11343, DOI 10.18632/oncotarget.14526; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Mohanty AR, 2012, J BIOL CHEM, V287, P21757, DOI 10.1074/jbc.M112.346254; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pang R, 2004, ONCOGENE, V23, P4182, DOI 10.1038/sj.onc.1207493; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; Pang R, 2007, GASTROENTEROLOGY, V132, P1088, DOI 10.1053/j.gastro.2006.12.030; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Shinoda K, 2015, BRIT J CANCER, V113, P1323, DOI 10.1038/bjc.2015.272; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Tong Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.3; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Uranbileg B, 2012, J BIOL CHEM, V287, P6275, DOI 10.1074/jbc.M111.318295; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	32	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21431	21441		10.1074/jbc.M117.801373	http://dx.doi.org/10.1074/jbc.M117.801373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118189	Green Published, hybrid			2022-12-28	WOS:000419013000019
J	Jia, QQ; Liu, SN; Wen, D; Cheng, YX; Bendena, WG; Wang, J; Li, S				Jia, Qiangqiang; Liu, Suning; Wen, Di; Cheng, Yongxu; Bendena, William G.; Wang, Jian; Li, Sheng			Juvenile hormone and 20-hydroxyecdysone coordinately control the developmental timing of matrix metalloproteinase-induced fat body cell dissociation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						development; juvenile hormone (JH); matrix metalloproteinase (Mmp); signal transduction; steroid hormone; 20-hydroxyecdysone; cell dissociation; fat body	DROSOPHILA METAMORPHOSIS; KRUPPEL-HOMOLOG; INSECT METAMORPHOSIS; IN-VIVO; MELANOGASTER; LARVAL; GENE; BOMBYX; MET; BETA-FTZ-F1	Tissue remodeling is a crucial process in animal development and disease progression. Coordinately controlled by the two main insect hormones, juvenile hormone (JH) and 20-hydroxyecdysone (20E), tissues are remodeled context-specifically during insect metamorphosis. We previously discovered that two matrix metalloproteinases (Mmps) cooperatively induce fat body cell dissociation in Drosophila. However, the molecular events involved in this Mmp-mediated dissociation are unclear. Here we report that JH and 20E coordinately and precisely control the developmental timing of Mmp-induced fat body cell dissociation. We found that during the larval-prepupal transition, the anti-metamorphic factor Kr-h1 transduces JH signaling, which directly inhibited Mmp expression and activated expression of tissue inhibitor of metalloproteinases (timp) and thereby suppressed Mmp-induced fat body cell dissociation. We also noted that upon a decline in the JH titer, a prepupal peak of 20E suppresses Mmp-induced fat body cell dissociation through the 20E primary-response genes, E75 and Blimp-1, which inhibited expression of the nuclear receptor and competence factor ftz-F1. Moreover, upon a decline in the 20E titer, ftz-F1 expression was induced by the 20E early-late response gene DHR3, and then ftz-F1 directly activated Mmp expression and inhibited timp expression, causing Mmp-induced fat body cell dissociation during 6-12 h after puparium formation. In conclusion, coordinated signaling via JH and 20E finely tunes the developmental timing of Mmp-induced fat body cell dissociation. Our findings shed critical light on hormonal regulation of insect metamorphosis.	[Jia, Qiangqiang; Liu, Suning] South China Normal Univ, Guangzhou Key Lab Insect Dev Regulat & Applicat R, Inst Insect Sci & Technol, Guangzhou 510631, Guangdong, Peoples R China; [Jia, Qiangqiang; Liu, Suning] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China; [Wen, Di] Qiannan Normal Coll Nationalities, Dept Life Sci, Duyun 558000, Guizhou, Peoples R China; [Cheng, Yongxu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai 201306, Peoples R China; [Bendena, William G.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Wang, Jian] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	South China Normal University; South China Normal University; Shanghai Ocean University; Queens University - Canada; University System of Maryland; University of Maryland College Park	Wang, J (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	jianwang@umd.edu; lisheng@scnu.edu.cn	Bendena, William/N-6080-2019	Jia, Qiangqiang/0000-0003-2650-7566	National Science Foundation of China [31620103917, 31560609, 31330072, 31572325]; National Key Research and Development Program of China [2016YFD0101900]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Science Foundation of China Grants 31620103917, 31560609, 31330072, and 31572325 and National Key Research and Development Program of China Grant 2016YFD0101900 (to S. Li and D. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Akagi K, 2016, DEVELOPMENT, V143, P2410, DOI 10.1242/dev.133595; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Bond ND, 2011, DEV BIOL, V360, P286, DOI 10.1016/j.ydbio.2011.09.015; Bowler T, 2006, DEV BIOL, V299, P78, DOI 10.1016/j.ydbio.2006.07.007; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Godenschwege TA, 2000, EUR J CELL BIOL, V79, P495, DOI 10.1078/0171-9335-00072; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Huang JH, 2011, DEVELOPMENT, V138, P2283, DOI 10.1242/dev.057687; Jia QQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07535; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2017, P NATL ACAD SCI USA, V114, P1057, DOI 10.1073/pnas.1615423114; Kayukawa T, 2016, J BIOL CHEM, V291, P1751, DOI 10.1074/jbc.M115.686121; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Li K, 2016, J BIOL CHEM, V291, P18163, DOI 10.1074/jbc.M116.737072; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Luo J, 2015, SCI CHINA LIFE SCI, V58, P379, DOI 10.1007/s11427-014-4786-z; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Parvy JP, 2014, DEVELOPMENT, V141, P3955, DOI 10.1242/dev.102020; Pearson JR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005763; Pecasse F, 2000, DEV BIOL, V221, P53, DOI 10.1006/dbio.2000.9687; Qi XF, 2016, P NATL ACAD SCI USA, V113, P3803, DOI 10.1073/pnas.1523614113; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Talamillo A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003473; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Urena E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006020; Wen D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005038; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608	41	30	33	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21504	21516		10.1074/jbc.M117.818880	http://dx.doi.org/10.1074/jbc.M117.818880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29118190	hybrid, Green Published			2022-12-28	WOS:000419013000025
J	Nemec, AA; Howell, LA; Peterson, AK; Murray, MA; Tomko, RJ				Nemec, Antonia A.; Howell, Lauren A.; Peterson, Anna K.; Murray, Matthew A.; Tomko, Robert J., Jr.			Autophagic clearance of proteasomes in yeast requires the conserved sorting nexin Snx4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autophagy; proteasome; protein degradation; proteolysis; sorting nexin (SNX)	SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; RECYCLING COMPARTMENT; NITROGEN STARVATION; 26S PROTEASOMES; DEGRADATION; NUCLEAR; COMPLEXES; PROTEINS; RECEPTOR	Turnover of the 26S proteasome by autophagy is an evolutionarily conserved process that governs cellular proteolytic capacity and eliminates inactive particles. In most organisms, proteasomes are located in both the nucleus and cytoplasm. However, the specific autophagy routes for nuclear and cytoplasmic proteasomes are unclear. Here, we investigate the spatial control of autophagic proteasome turnover in budding yeast (Saccharomyces cerevisiae). We found that nitrogen starvation-induced proteasome autophagy is independent of known nucleophagy pathways but is compromised when nuclear protein export is blocked. Furthermore, via pharmacological tethering of proteasomes to chromatin or the plasma membrane, we provide evidence that nuclear proteasomes at least partially disassemble before autophagic turnover, whereas cytoplasmic proteasomes remain largely intact. A targeted screen of autophagy genes identified a requirement for the conserved sorting nexin Snx4 in the autophagic turnover of proteasomes and several other large multisubunit complexes. We demonstrate that Snx4 cooperates with sorting nexins Snx41 and Snx42 to mediate proteasome turnover and is required for the formation of cytoplasmic proteasome puncta that accumulate when autophagosome formation is blocked. Together, our results support distinct mechanistic paths in the turnover of nuclear versus cytoplasmic proteasomes and point to a critical role for Snx4 in cytoplasmic agglomeration of proteasomes en route to autophagic destruction.	[Nemec, Antonia A.; Howell, Lauren A.; Peterson, Anna K.; Murray, Matthew A.; Tomko, Robert J., Jr.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Tomko, RJ (corresponding author), 1115 W Call St, Tallahassee, FL 32306 USA.	robert.tomko@med.fsu.edu		Tomko Jr., Robert/0000-0003-2515-1078	Florida State University College of Medicine; National Institutes of Health from NIGMS [1R01GM118600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118600] Funding Source: NIH RePORTER	Florida State University College of Medicine; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by start-up funds from the Florida State University College of Medicine and National Institutes of Health Grant 1R01GM118600 from NIGMS (to R. J. T., Jr.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Bean BDM, 2017, TRAFFIC, V18, P110, DOI 10.1111/tra.12459; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Cohen-Kaplan V, 2016, P NATL ACAD SCI USA, V113, pE7490, DOI 10.1073/pnas.1615455113; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Dambacher CM, 2016, ELIFE, V5, DOI 10.7554/eLife.13027; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Elbaz-Alon Y, 2015, CELL REP, V12, P7, DOI 10.1016/j.celrep.2015.06.022; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Enenkel C, 1999, MOL BIOL REP, V26, P131, DOI 10.1023/A:1006973803960; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Guthrie C, 1991, GUIDE YEAST GENETICS; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; Hettema EH, 2003, EMBO J, V22, P548, DOI 10.1093/emboj/cdg062; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kramer MH, 2017, MOL CELL, V65, P761, DOI 10.1016/j.molcel.2016.12.024; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Le Fourn V, 2013, CELL MOL LIFE SCI, V70, P1985, DOI 10.1007/s00018-012-1236-6; Ma MX, 2017, TRAFFIC, V18, P134, DOI 10.1111/tra.12462; Marshall RS, 2016, CELL REP, V16, P1717, DOI 10.1016/j.celrep.2016.07.015; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Maruzs T, 2015, TRAFFIC, V16, P1088, DOI 10.1111/tra.12309; Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Nice DC, 2002, J BIOL CHEM, V277, P30198, DOI 10.1074/jbc.M204736200; Nilsson A, 2001, YEAST, V18, P1371, DOI 10.1002/yea.786; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Ohashi Y, 2010, MOL BIOL CELL, V21, P3998, DOI 10.1091/mbc.E10-05-0457; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rodkaer SV, 2014, FEMS YEAST RES, V14, P683, DOI 10.1111/1567-1364.12157; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Savulescu AF, 2011, MOL BIOL CELL, V22, P880, DOI 10.1091/mbc.E10-07-0595; Shpilka T, 2015, P NATL ACAD SCI USA, V112, P1434, DOI 10.1073/pnas.1409476112; Solis GP, 2013, MOL BIOL CELL, V24, P2689, DOI 10.1091/mbc.E12-12-0854; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; Thomsson E, 2003, APPL ENVIRON MICROB, V69, P3251, DOI 10.1128/AEM.69.6.3251-3257.2003; Tomko RJ, 2014, MOL CELL, V53, P433, DOI 10.1016/j.molcel.2013.12.009; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Waite KA, 2016, J BIOL CHEM, V291, P3239, DOI 10.1074/jbc.M115.699124; Wang XR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001232; Wani PS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27873; Welter E, 2015, EMBO J, V34, P131, DOI 10.15252/embj.201490621; Welter E, 2010, AUTOPHAGY, V6, P794, DOI 10.4161/auto.6.6.12348; Wileman T, 2013, ESSAYS BIOCHEM, V55, P153, DOI [10.1042/bse0550153, 10.1042/BSE0550153]; Zhao D, 2016, J CELL SCI, V129, P4289, DOI 10.1242/jcs.194373	70	41	41	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21466	21480		10.1074/jbc.M117.817999	http://dx.doi.org/10.1074/jbc.M117.817999			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29109144	Green Published, hybrid			2022-12-28	WOS:000419013000022
J	Sedy, JR; Balmert, MO; Ware, BC; Smith, W; Nemcovicova, I; Norris, PS; Miller, BR; Aivazian, D; Ware, CF				Sedy, John R.; Balmert, M. Olivia; Ware, Brian C.; Smith, Wendell; Nemcovicova, Ivana; Norris, Paula S.; Miller, Brian R.; Aivazian, Dikran; Ware, Carl F.			A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ACTIVATION; CO-STIMULATION; UL144 GENE; BTLA; EXPRESSION; CD160; POLYMORPHISMS; INNATE; CANCER; HVEM	The human cytomegalovirus opening reading frame UL144 is an ortholog of the TNF receptor superfamily member, herpesvirus entry mediator (HVEM; TNFRSF14). HVEM binds the TNF ligands, LIGHT and LTa; the immunoglobulin inhibitory receptor, B and T lymphocyte attenuator (BTLA); and the natural killer cell-activating receptor CD160. However, UL144 selectively binds BTLA, avoiding activation of inflammatory signaling initiated by CD160 in natural killer cells. BTLA and CD160 cross-compete for binding HVEM, but the structural basis for the ligand selectivity by UL144 and how it acts as an anti-inflammatory agonist remains unclear. Here, we modeled the UL144 structure and characterized its binding with BTLA. The UL144 structure was predicted to closely mimic the surface of HVEM, and we also found that both HVEM and UL144 bind a common epitope of BTLA, whether engaged in trans or in cis, that is shared with a BTLA antibody agonist. On the basis of the UL144 selectivity, we engineered a BTLA-selective HVEM protein to understand the basis for ligand selectivity and BTLA agonism to develop novel anti-inflammatory agonists. This HVEM mutein did not bind CD160 or TNF ligands but did bind BTLA with 10-fold stronger affinity than wild-type HVEM and retained potent inhibitory activity that reduced T-cell receptor, B-cell receptor, and interferon signaling in B cells. In conclusion, using a viral immune evasion strategy that shows broad immune-ablating activity, we have identified a novel anti-inflammatory BTLA-selective agonist.	[Sedy, John R.; Balmert, M. Olivia; Ware, Brian C.; Smith, Wendell; Norris, Paula S.; Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Nemcovicova, Ivana] Slovak Acad Sci, Biomed Res Ctr, SK-84505 Bratislava, Slovakia; [Miller, Brian R.; Aivazian, Dikran] Pfizer Inc, Ctr Therapeut Innovat, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Slovak Academy of Sciences; Pfizer	Sedy, JR; Ware, CF (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA.	jsedy@sbpdiscovery.org; cware@sbpdiscovery.org	Nemčovičová, Ivana/I-3477-2013; Nemčovičová, Ivana/ABA-6080-2021	Nemčovičová, Ivana/0000-0003-1733-9986; Nemčovičová, Ivana/0000-0003-1733-9986; Sedy, John/0000-0002-6428-1054	National Institutes of Health [AI048073, AI067890, CA164679, CA177322]; American Heart Association [AHA-14BGIA20380277]; National Psoriasis Foundation [NPF2015]; Slovak Research and Development Agency [APVV-14-0839]; Scientific Grant Agency of the Slovak Republic [2/0103/15]; NATIONAL CANCER INSTITUTE [R01CA164679, P01CA177322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048073, R01AI067890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Psoriasis Foundation; Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency of the Slovak Republic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI048073, AI067890, CA164679, and CA177322 (to C. F. W.), a gift from the Perkins Family Foundation (to C. F. W.), American Heart Association Grant AHA-14BGIA20380277 (to J. R. S.), National Psoriasis Foundation Grant NPF2015 (to J. R. S.), Slovak Research and Development Agency Grant APVV-14-0839 (to I. N.), the Scientific Grant Agency of the Slovak Republic Grant 2/0103/15 (to I. N.), and a research contract from Pfizer Centers for Therapeutic Innovation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albring JC, 2010, J EXP MED, V207, P2551, DOI 10.1084/jem.20102017; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bekiaris V, 2013, IMMUNITY, V39, P1082, DOI 10.1016/j.immuni.2013.10.017; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Callahan M. K., 2013, CANC IMMUNOTHERAPY, P211; Chen HP, 2015, J GEN VIROL, V96, P3613, DOI 10.1099/jgv.0.000308; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Cheung TC, 2005, P NATL ACAD SCI USA, V102, P13218, DOI 10.1073/pnas.0506172102; Cheung TC, 2009, J IMMUNOL, V183, P7286, DOI 10.4049/jimmunol.0902490; Cheung TC, 2009, P NATL ACAD SCI USA, V106, P6244, DOI 10.1073/pnas.0902115106; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Gobessi S, 2007, BLOOD, V109, P2032, DOI 10.1182/blood-2006-03-011759; Hurchla MA, 2005, J IMMUNOL, V174, P3377, DOI 10.4049/jimmunol.174.6.3377; Kobayashi Y, 2013, P NATL ACAD SCI USA, V110, P5121, DOI 10.1073/pnas.1222093110; Liu WF, 2015, MOL BIOTECHNOL, V57, P914, DOI 10.1007/s12033-015-9881-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2010, ANNU REV IMMUNOL, V28, P389, DOI 10.1146/annurev-immunol-030409-101202; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; Otsuki N, 2006, BIOCHEM BIOPH RES CO, V344, P1121, DOI 10.1016/j.bbrc.2006.03.242; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Poole E, 2013, J VIROL, V87, P4261, DOI 10.1128/JVI.03497-12; Reddehase MJ, 2002, NAT REV IMMUNOL, V2, P831, DOI 10.1038/nri932; Sedy JR, 2008, NAT REV IMMUNOL, V8, P861, DOI 10.1038/nri2434; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Sedy J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016279; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sperling AI, 1998, J IMMUNOL, V161, P6459; Tu TC, 2015, J EXP MED, V212, P415, DOI 10.1084/jem.20131601; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wu TH, 2007, IMMUNOL CELL BIOL, V85, P590, DOI 10.1038/sj.icb.7100087	39	14	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21060	21070		10.1074/jbc.M117.813295	http://dx.doi.org/10.1074/jbc.M117.813295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29061848	hybrid, Green Published			2022-12-28	WOS:000418453400021
J	Haj, M; Wijeweera, A; Rudnizky, S; Taunton, J; Pnueli, L; Melamed, P				Haj, Majd; Wijeweera, Andrea; Rudnizky, Sergei; Taunton, Jack; Pnueli, Lilach; Melamed, Philippa			Mitogen- and stress-activated protein kinase 1 is required for gonadotropin-releasing hormone-mediated activation of gonadotropin -subunit expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone modification; mitogen-activated protein kinase (MAPK); phosphorylation; pituitary gland	HISTONE H3 PHOSPHORYLATION; IMMEDIATE-EARLY GENES; RNA-POLYMERASE-II; LUTEINIZING-HORMONE; TRANSCRIPTIONAL ACTIVATION; CHROMATIN MODIFICATION; DISTINCT MECHANISMS; MSK1; ACETYLATION; PROMOTER	Pituitary gonadotropin hormones are regulated by gonadotropin-releasing hormone (GnRH) via MAPK signaling pathways that stimulate gene transcription of the common -subunit (Cga) and the hormone-specific -subunits of gonadotropin. We have reported previously that GnRH-induced activities at these genes include various histone modifications, but we did not examine histone phosphorylation. This modification adds a negative charge to residues of the histone tails that interact with the negatively charged DNA, is associated with closed chromatin during mitosis, but is increased at certain genes for transcriptional activation. Thus, the functions of this modification are unclear. We initially hypothesized that GnRH might induce phosphorylation of Ser-10 in histone 3 (H3S10p) as part of its regulation of gonadotropin gene expression, possibly involving cross-talk with H3K9 acetylation. We found that GnRH increases the levels of both modifications around the Cga gene transcriptional start site and that JNK inhibition dramatically reduces H3S10p levels. However, this modification had only a minor effect on Cga expression and no effect on H3K9ac. GnRH also increased H3S28p and H3K27ac levels and also those of activated mitogen- and stress-activated protein kinase 1 (MSK1). MSK1 inhibition dramatically reduced H3S28p levels in untreated and GnRH-treated cells and also affected H3K27ac levels. Although not affecting basal Cga expression, MSK1/2 inhibition repressed GnRH activation of Cga expression. Moreover, ChIP analysis revealed that GnRH-activated MSK1 targets the first nucleosome just downstream from the TSS. Given that the elongating RNA polymerase II (RNAPII) stalls at this well positioned nucleosome, GnRH-induced H3S28p, possibly in association with H3K27ac, would facilitate the progression of RNAPII.	[Haj, Majd; Wijeweera, Andrea; Rudnizky, Sergei; Pnueli, Lilach; Melamed, Philippa] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Technion Israel Institute of Technology; University of California System; University of California San Francisco	Melamed, P (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	philippa@tx.technion.ac.il		el haj, mohamad/0000-0001-7635-7557; Rudnizky, Sergei/0000-0002-0520-0752	Israel Science Foundation [840/12]; European Framework program Marie Curie Actions	Israel Science Foundation(Israel Science Foundation); European Framework program Marie Curie Actions	This work was supported by Israel Science Foundation Grant 840/12 (to P. M.) and the European Framework program Marie Curie Actions. The authors declare that they have no conflicts of interest with the contents of this article.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Banerjee T, 2011, MOL CELL BIOL, V31, P4858, DOI 10.1128/MCB.05631-11; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Feng J, 2008, BIOL REPROD, V79, P546, DOI 10.1095/biolreprod.108.068106; Gehani SS, 2010, MOL CELL, V39, P886, DOI 10.1016/j.molcel.2010.08.020; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; Josefowicz SZ, 2016, MOL CELL, V64, P347, DOI 10.1016/j.molcel.2016.09.026; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Klein AM, 2013, CURR OPIN CELL BIOL, V25, P272, DOI 10.1016/j.ceb.2013.01.002; Lau PNI, 2011, P NATL ACAD SCI USA, V108, P2801, DOI 10.1073/pnas.1012798108; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Melamed P, 2006, MOL CELL ENDOCRINOL, V252, P167, DOI 10.1016/j.mce.2006.03.024; Melamed P, 2008, TRENDS ENDOCRIN MET, V19, P25, DOI 10.1016/j.tem.2007.10.008; Miller RS, 2012, MOL CELL BIOL, V32, P2349, DOI 10.1128/MCB.00394-12; Mouillet JF, 2004, J BIOL CHEM, V279, P7832, DOI 10.1074/jbc.M312574200; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005; Pnueli L, 2015, P NATL ACAD SCI USA, V112, P4369, DOI 10.1073/pnas.1414841112; Pnueli L, 2011, MOL CELL BIOL, V31, P5023, DOI 10.1128/MCB.06083-11; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rossetto D, 2012, EPIGENETICS-US, V7, P1098, DOI 10.4161/epi.21975; Rudnizky S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12958; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Sawicka A, 2014, BBA-GENE REGUL MECH, V1839, P711, DOI 10.1016/j.bbagrm.2014.04.013; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Simboeck E, 2010, J BIOL CHEM, V285, P41062, DOI 10.1074/jbc.M110.184481; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tiwari VK, 2012, NAT GENET, V44, P94, DOI 10.1038/ng.1036; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wiersma M, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0103-3; Wijeweera A, 2015, BBA-GENE REGUL MECH, V1849, P328, DOI 10.1016/j.bbagrm.2015.01.001; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Xie JJ, 2005, MOL ENDOCRINOL, V19, P2624, DOI 10.1210/me.2005-0056; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yosefzon Y, 2017, P NATL ACAD SCI USA, V114, P10131, DOI 10.1073/pnas.1704393114; Zhong SP, 2001, J BIOL CHEM, V276, P33213, DOI 10.1074/jbc.M103973200; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	48	12	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20720	20731		10.1074/jbc.M117.797845	http://dx.doi.org/10.1074/jbc.M117.797845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29054929	Green Published, hybrid			2022-12-28	WOS:000418267000032
J	Jindal, GA; Goyal, Y; Humphreys, JM; Yeung, E; Tian, KJ; Patterson, VL; He, HX; Burdine, RD; Goldsmith, EJ; Shvartsman, SY				Jindal, Granton A.; Goyal, Yogesh; Humphreys, John M.; Yeung, Eyan; Tian, Kaijia; Patterson, Victoria L.; He, Haixia; Burdine, Rebecca D.; Goldsmith, Elizabeth J.; Shvartsman, Stanislav Y.			How activating mutations affect MEK1 regulation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; mitogen-activated protein kinase (MAPK); protein phosphorylation; Raf kinase; zebrafish; MEK1	MAP KINASE KINASE; PROTEIN-KINASE; DUAL PHOSPHORYLATION; RAS PATHWAY; ZEBRAFISH; INHIBITORS; GASTRULATION; RASOPATHIES; COMPLEX; CELLS	The MEK1 kinase directly phosphorylates ERK2, after the activation loop of MEK1 is itself phosphorylated by Raf. Studies over the past decade have revealed a large number of disease-related mutations in the MEK1 gene that lead to tumorigenesis and abnormal development. Several of these mutations result in MEK1 constitutive activity, but how they affect MEK1 regulation and function remains largely unknown. Here, we address these questions focusing on two pathogenic variants of the Phe-53 residue, which maps to the well-characterized negative regulatory region of MEK1. We found that these variants are phosphorylated by Raf faster than the wild-type enzyme, and this phosphorylation further increases their enzymatic activity. However, the maximal activities of fully phosphorylated wild-type and mutant enzymes are indistinguishable. On the basis of available structural information, we propose that the activating substitutions destabilize the inactive conformation of MEK1, resulting in its constitutive activity and making it more prone to Raf-mediated phosphorylation. Experiments in zebrafish revealed that the effects of activating variants on embryonic development reflect the joint control of the negative regulatory region and activating phosphorylation. Our results underscore the complexity of the effects of activating mutations on signaling systems, even at the level of a single protein.	[Jindal, Granton A.; Goyal, Yogesh; Tian, Kaijia; Shvartsman, Stanislav Y.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Jindal, Granton A.; Goyal, Yogesh; Yeung, Eyan; Patterson, Victoria L.; Burdine, Rebecca D.; Shvartsman, Stanislav Y.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Jindal, Granton A.; Goyal, Yogesh; Yeung, Eyan; Tian, Kaijia; Patterson, Victoria L.; Shvartsman, Stanislav Y.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Humphreys, John M.; He, Haixia; Goldsmith, Elizabeth J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	Princeton University; Princeton University; Princeton University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Shvartsman, SY (corresponding author), Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA.; Shvartsman, SY (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.; Shvartsman, SY (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Goldsmith, EJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	elizabeth.goldsmith@utsouthwestern.edu; stas@princeton.edu	Shvartsman, Stanislav/GPP-4025-2022; Jindal, Granton/GLU-4486-2022	Shvartsman, Stanislav/0000-0002-9152-9334; Jindal, Granton/0000-0003-2803-9831; Goyal, Yogesh/0000-0003-3502-6465	National Institutes of Health [R01 GM086537]; National Science Foundation Graduate Research Fellowship [DGE 1148900]; Welch Foundation [I1128]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM086537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM086537 (to J. M. H., H. H., E. J. G., Y. G., K. T., V. L. P., E. Y., R. D. B., and S. Y. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Graduate Research Fellowship Grant DGE 1148900.; Supported by Welch Foundation Grant I1128.	Anastasaki C, 2012, DIS MODEL MECH, V5, P546, DOI 10.1242/dmm.008672; Anastasaki C, 2009, HUM MOL GENET, V18, P2543, DOI 10.1093/hmg/ddp186; Bromberg-White JL, 2012, BRIEF FUNCT GENOMICS, V11, P300, DOI 10.1093/bfgp/els022; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Couto JA, 2017, AM J HUM GENET, V100, P546, DOI 10.1016/j.ajhg.2017.01.018; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Goyal Y, 2017, DIS MODEL MECH, V10, P923, DOI 10.1242/dmm.030163; Goyal Y, 2017, NAT GENET, V49, P465, DOI 10.1038/ng.3780; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Jindal GA, 2017, P NATL ACAD SCI USA, V114, P510, DOI 10.1073/pnas.1615651114; Jindal GA, 2015, DIS MODEL MECH, V8, P769, DOI 10.1242/dmm.020339; Johnson HE, 2017, DEV CELL, V40, P185, DOI 10.1016/j.devcel.2016.12.002; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Krens SFG, 2008, DEV BIOL, V319, P370, DOI 10.1016/j.ydbio.2008.04.032; Mansour SJ, 1996, BIOCHEMISTRY-US, V35, P15529, DOI 10.1021/bi961854s; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piala AT, 2014, BIOPHYS J, V107, P2006, DOI 10.1016/j.bpj.2014.09.024; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; RESING KA, 1995, BIOCHEMISTRY-US, V34, P2610, DOI 10.1021/bi00008a027; Runtuwene V, 2011, DIS MODEL MECH, V4, P393, DOI 10.1242/dmm.007112; Schottenfeld J, 2007, DEVELOPMENT, V134, P1605, DOI 10.1242/dev.02827; SEGER R, 1992, J BIOL CHEM, V267, P14373; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Xu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-436	32	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18814	18820		10.1074/jbc.C117.806067	http://dx.doi.org/10.1074/jbc.C117.806067			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	29018093	Green Published, hybrid			2022-12-28	WOS:000415848000007
J	Loderer, C; Jonna, VR; Crona, M; Grinberg, IR; Sahlin, M; Hofer, A; Lundin, D; Sjoberg, BM				Loderer, Christoph; Jonna, Venkateswara Rao; Crona, Mikael; Grinberg, Inna Rozman; Sahlin, Margareta; Hofer, Anders; Lundin, Daniel; Sjoeberg, Britt-Marie			A unique cysteine-rich zinc finger domain present in a majority of class II ribonucleotide reductases mediates catalytic turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metal ion-protein interaction; oligomerization; oxidation-reduction (redox); phylogenetics; ribonucleotide reductase; thioredoxin	ESCHERICHIA-COLI; SWISS-MODEL; CRYSTAL-STRUCTURE; REDUCTION; SITE; ENZYME; GLUTAREDOXIN; SPECIFICITY; EXPRESSION; MECHANISM	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to the corresponding deoxyribonucleotides, used in DNA synthesis and repair. Two different mechanisms help deliver the required electrons to the RNR active site. Formate can be used as reductant directly in the active site, or glutaredoxins or thioredoxins reduce a C-terminal cysteine pair, which then delivers the electrons to the active site. Here, we characterized a novel cysteine-rich C-terminal domain (CRD), which is present in most class II RNRs found in microbes. The NrdJd-type RNR from the bacterium Stackebrandtia nassauensis was used as a model enzyme. We show that the CRD is involved in both higher oligomeric state formation and electron transfer to the active site. The CRD-dependent formation of high oligomers, such as tetramers and hexamers, was induced by addition of dATP or dGTP, but not of dTTP or dCTP. The electron transfer was mediated by an array of six cysteine residues at the very C-terminal end, which also coordinated a zinc atom. The electron transfer can also occur between subunits, depending on the enzyme's oligomeric state. An investigation of the native reductant of the system revealed no interaction with glutaredoxins or thioredoxins, indicating that this class II RNR uses a different electron source. Our results indicate that the CRD has a crucial role in catalytic turnover and a potentially new terminal reduction mechanism and suggest that the CRD is important for the activities of many class II RNRs.	[Loderer, Christoph; Crona, Mikael; Grinberg, Inna Rozman; Sahlin, Margareta; Lundin, Daniel; Sjoeberg, Britt-Marie] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Jonna, Venkateswara Rao; Hofer, Anders] Umea Univ, Dept Med Biochem, SE-90187 Umea, Sweden; [Crona, Mikael] Swedish Orphan Biovitrum AB, SE-11276 Solna, Sweden	Stockholm University; Umea University; Swedish Orphan Biovitrum	Lundin, D; Sjoberg, BM (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.	daniel.lundin@dbb.su.se; britt-marie.sjoberg@dbb.su.se		Lundin, Daniel/0000-0002-8779-6464; Hofer, Anders/0000-0003-2890-2957	Swedish Research Council [2016-01920]; Swedish Cancer Society [CAN 2016/670]; Wenner-Gren Foundations; Carl Trygger's Foundation; Kempe Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Foundations; Carl Trygger's Foundation; Kempe Foundations	This work was supported by Swedish Research Council Grant 2016-01920 and Swedish Cancer Society Grant CAN 2016/670 and by the Wenner-Gren Foundations, Carl Trygger's Foundation, and Kempe Foundations. The authors declare that they have no conflicts of interest with the contents of this article.	ABERG A, 1989, J BIOL CHEM, V264, P12249; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; AVERETT DR, 1983, J BIOL CHEM, V258, P9831; Berardi MJ, 1999, J MOL BIOL, V292, P151, DOI 10.1006/jmbi.1999.3067; BERTINI I, 1985, J CHEM EDUC, V62, P924, DOI 10.1021/ed062p924; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BOOKER S, 1994, BIOCHEMISTRY-US, V33, P12676, DOI 10.1021/bi00208a019; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRACEY MH, 1994, BIOCHEMISTRY-US, V33, P13126, DOI 10.1021/bi00248a023; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Crona M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134293; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Domkin V, 2014, SCI REP-UK, V4, DOI 10.1038/srep05539; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Lawrence CC, 1998, CURR OPIN CHEM BIOL, V2, P650, DOI 10.1016/S1367-5931(98)80097-5; Li FH, 2015, ANGEW CHEM INT EDIT, V54, P4597, DOI 10.1002/anie.201410433; Logan DT, 2003, P NATL ACAD SCI USA, V100, P3826, DOI 10.1073/pnas.0736456100; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9752, DOI 10.1021/bi00155a031; MULLIEZ E, 1995, P NATL ACAD SCI USA, V92, P8759, DOI 10.1073/pnas.92.19.8759; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Torrents E, 2005, J BIOL CHEM, V280, P16571, DOI 10.1074/jbc.M501322200; Torrents E, 2000, J BIOL CHEM, V275, P2463, DOI 10.1074/jbc.275.4.2463; VlamisGardikas A, 1997, J BIOL CHEM, V272, P11236; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P2217, DOI 10.1073/pnas.0611095104; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					19044	19054		10.1074/jbc.M117.806331	http://dx.doi.org/10.1074/jbc.M117.806331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972190	Green Published, hybrid			2022-12-28	WOS:000415848000027
J	Na, L; Tang, YD; Wang, CH; Liu, C; Wang, XJ				Na, Lei; Tang, Yan-Dong; Wang, Cuihui; Liu, Cong; Wang, Xiaojun			Rhesus monkey TRIM5 alpha protein SPRY domain contributes to AP-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DEPENDENT CYTOKINE EXPRESSION; CELLULAR ANTIVIRAL RESPONSE; I INTERFERON INDUCTION; IMMUNODEFICIENCY-VIRUS; NONREDUNDANT ROLE; GENE DISRUPTION; LIGASE ACTIVITY; TARGETING TAB2; B30.2 DOMAIN	TRIM5 alpha is an important host restriction factor that could potently block retrovirus infection. The SPRY domain of TRIM5 alpha mediates post-entry restriction by recognition of and binding to the retroviral capsid. Human TRIM5 alpha also functions as an innate immune sensor to activate AP-1 and NF-kappa B signaling, which subsequently restrict virus replication. Previous studies have shown that the AP-1 and NF-kappa B signaling activation relies on the RING motif of TRIM5 alpha. In this study, we have demonstrated that the SPRY domain is essential for rhesus macaque TRIM5 alpha to activate AP-1 but not NF-kappa B signaling. The AP-1 activation mainly depends on all of the beta-sheet barrel on SPRY structure of TRIM5 alpha. Furthermore, the SPRY-mediated auto-ubiquitination of TRIM5 alpha is required for AP-1 activation. This study reports that rhesus macaque TRIM5 alpha mainly undergoes Lys27-linked and Met1-linked auto-polyubiquitination. Finally, we found that the TRIM5 alpha signaling function was positively correlated with its retroviral restriction activity. This study discovered an important role of the SPRY domain in immune signaling and antiviral activity and further expanded our knowledge of the antiviral mechanism of TRIM5 alpha.	[Na, Lei; Tang, Yan-Dong; Wang, Cuihui; Liu, Cong; Wang, Xiaojun] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, XJ (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang, Peoples R China.	wangxiaojun@caas.cn	Wang, Xiaojun/AAF-5687-2020; Tang, Yan-Dong/ABE-7678-2021	Tang, Yan-Dong/0000-0002-5690-2690; Wang, Xiaojun/0000-0003-4521-4099	National Natural Science Foundation of China [31602034, 31222054, 81561128010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31602034 (to L. N.) and 31222054 and 81561128010 (to X. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Arriagada G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002019; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Besse A, 2007, J BIOL CHEM, V282, P3918, DOI 10.1074/jbc.M608867200; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Dutrieux J, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0155-7; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Fletcher AJ, 2015, EMBO J, V34, P2078, DOI 10.15252/embj.201490361; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Goff SP, 2004, ANNU REV GENET, V38, P61, DOI 10.1146/annurev.genet.38.072902.094136; Gong J, 2011, ARCH VIROL, V156, P1997, DOI 10.1007/s00705-011-1097-6; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Hu MM, 2014, P NATL ACAD SCI USA, V111, P1509, DOI 10.1073/pnas.1318227111; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kar AK, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-1; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Keown JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep26837; Kim J, 2011, J VIROL, V85, P8116, DOI 10.1128/JVI.00341-11; Kuang YQ, 2015, MED MICROBIOL IMMUN, V204, P557, DOI 10.1007/s00430-015-0417-y; Lamb A, 2009, EMBO REP, V10, P1242, DOI 10.1038/embor.2009.210; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Lascano J, 2016, J VIROL, V90, P308, DOI 10.1128/JVI.02496-15; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11; Liu T, 2016, CELL REP, V16, P1988, DOI 10.1016/j.celrep.2016.07.019; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Na L, 2014, BIOCHEM BIOPH RES CO, V446, P470, DOI 10.1016/j.bbrc.2014.02.132; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Nepveu-Traversy ME, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2015.e00056; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ozato K, 2009, J IMMUNOL, V183, P7619, DOI 10.4049/jimmunol.0990103; Palicharla VR, 2015, CELL SIGNAL, V27, P2355, DOI 10.1016/j.cellsig.2015.09.001; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Qin YF, 2016, CELL RES, V26, P613, DOI 10.1038/cr.2016.27; Qiu Hui, 2013, Virologica Sinica, V28, P209, DOI 10.1007/s12250-013-3343-4; Rajsbaum R, 2014, J MOL BIOL, V426, P1265, DOI 10.1016/j.jmb.2013.12.005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Sakuma R, 2007, NAT MED, V13, P631, DOI 10.1038/nm1562; Shi M, 2008, NAT IMMUNOL, V9, P369, DOI 10.1038/ni1577; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Tareen SU, 2011, CELL HOST MICROBE, V9, P349, DOI 10.1016/j.chom.2011.05.003; Tareen SU, 2011, VIROLOGY, V409, P113, DOI 10.1016/j.virol.2010.09.018; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Uchil PD, 2013, J VIROL, V87, P257, DOI 10.1128/JVI.01804-12; Versteeg GA, 2014, CYTOKINE GROWTH F R, V25, P563, DOI 10.1016/j.cytogfr.2014.08.001; Versteeg GA, 2013, IMMUNITY, V38, P384, DOI 10.1016/j.immuni.2012.11.013; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yang Y, 2014, VIROLOGY, V448, P217, DOI 10.1016/j.virol.2013.10.012; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yudina Z, 2015, CELL REP, V12, P788, DOI 10.1016/j.celrep.2015.06.072; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492; Zhou Z, 2014, P NATL ACAD SCI USA, V111, pE245, DOI 10.1073/pnas.1316941111	71	3	5	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2661	2674		10.1074/jbc.RA117.000127	http://dx.doi.org/10.1074/jbc.RA117.000127			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29196608	hybrid, Green Published			2022-12-28	WOS:000426051900004
J	Huynh, M; Pak, C; Markovina, S; Callander, NS; Chng, KS; Wuerzberger-Davis, SM; Bakshi, DD; Kink, JA; Hematti, P; Hope, C; Asimakopoulos, F; Rui, LX; Miyamoto, S				Huynh, Mailee; Pak, Chorom; Markovina, Stephanie; Callander, Natalie S.; Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Bakshi, Debayan D.; Kink, John A.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin; Miyamoto, Shigeki			Hyaluronan and proteoglycan link protein 1 (HAPLN1) activates bortezomib-resistant NF-kappa B activity and increases drug resistance in multiple myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEDD8-ACTIVATING ENZYME-INHIBITOR; EXTRACELLULAR-MATRIX; ALPHA DEGRADATION; CELLS; PATHWAY; UBIQUITINATION; MATRIKINES; THERAPY; DOMAINS; BINDING	Nuclear factor-kappa B (NF-kappa B) is a family of transcription factors that play a key role in cell survival and proliferation in many hematological malignancies, including multiple myeloma (MM). Bortezomib, a proteasome inhibitor used in the management of MM, can inhibit both canonical and noncanonical activation of NF-kappa B in MM cells. However, we previously reported that a significant fraction of freshly isolated MM cells harbor bortezomib-resistant NF-kappa B activity. Here, we report that hyaluronan and proteoglycan link protein 1 (HAPLN1) is produced in bone marrow stromal cells from MM patients, is detected in patients' bone marrow plasma, and can activate an atypical bortezomib-resistant NF-kappa B pathway in MM cells. We found that this pathway involves bortezomib-resistant degradation of the inhibitor of NF-kappa B (I kappa B alpha), despite efficient bortezomib-mediated inhibition of proteasome activity. Moreover, HAPLN1 can also confer bortezomib-resistant survival of MM cells. We propose that HAPLN1 is a novel pathogenic factor in MM that induces an atypical NF-kappa B activation and thereby promotes bortezomib resistance in MM cells.	[Huynh, Mailee] Univ Wisconsin, Canc Biol Grad Program, Madison, WI 53705 USA; [Pak, Chorom] Univ Wisconsin, Mol & Cellular Pharmacol Grad Program, Madison, WI 53705 USA; [Markovina, Stephanie; Bakshi, Debayan D.] Univ Wisconsin, Cellular & Mol Biol Grad Program, Madison, WI 53705 USA; [Markovina, Stephanie] Univ Wisconsin, Med Sci Training Program, Madison, WI 53705 USA; [Callander, Natalie S.; Kink, John A.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA; [Callander, Natalie S.; Hematti, Peiman; Hope, Chelsea; Asimakopoulos, Fotis; Rui, Lixin; Miyamoto, Shigeki] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; [Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53705 USA; [Chng, Kenneth S.; Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI 53705 USA; [Pak, Chorom] Lynx Biosci, Madison, WI 53714 USA; [Markovina, Stephanie] Washington Univ, Sch Med, Siteman Canc Ctr, Dept Radiat Oncol, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Siteman Cancer Center; Washington University (WUSTL)	Miyamoto, S (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, 6159 Wisconsin Inst Med Res,1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu	li, rui/GSD-4367-2022; rui, li/GYR-3791-2022	De Bakshi, Debayan/0000-0002-8429-2965	National Institutes of Health (NIH) [R01 CA155192, RO1 CA077474-14S1, R21 CA194868]; Multiple Myeloma Research Foundation Senior Investigator Awards; University of Wisconsin Carbone Cancer Center Grant [P30 CA014520]; Trillium Fund; NIH [T32 CA009135, R01 CA077474-14S1, T32 GM008688, F30 AG029714-02]; University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE [R01CA155192, R01CA187299, T32CA009135, R21CA194868, R01CA077474, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008688, T32GM008692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG029714] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation Senior Investigator Awards; University of Wisconsin Carbone Cancer Center Grant; Trillium Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (NIH) Grants R01 CA155192, RO1 CA077474-14S1, and R21 CA194868 and Multiple Myeloma Research Foundation Senior Investigator Awards (to S. Miyamoto); University of Wisconsin Carbone Cancer Center Grant P30 CA014520 and the Trillium Fund (to S. Miyamoto, N. S. C., F. A., and P. H.); NIH Grant T32 CA009135 (to M. H. and C. P); NIH Grant R01 CA077474-14S1 (to M. H.); the SciMed Graduate Research Scholars Fellowship at the University of Wisconsin-Madison (to M. H.); NIH Grant T32 GM008688 (C. P.); and NIH Grant F30 AG029714-02 (to S. Markovina). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bianchi G, 2014, CA-CANCER J CLIN, V64, P422, DOI 10.3322/caac.21252; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Demchenko YN, 2010, ONCOTARGET, V1, P59, DOI 10.18632/oncotarget.109; Di Marzo L, 2016, ONCOTARGET, V7, P60698, DOI 10.18632/oncotarget.10849; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Dingli D, 2017, MAYO CLIN PROC, V92, P578, DOI 10.1016/j.mayocp.2017.01.003; Dong HJ, 2009, LEUKEMIA LYMPHOMA, V50, P974, DOI 10.1080/10428190902895780; Gilmore TD, 2007, CANCER CELL, V12, P95, DOI 10.1016/j.ccr.2007.07.010; Glavey SV, 2017, LEUKEMIA, V31, P2426, DOI 10.1038/leu.2017.102; Godbersen JC, 2014, CLIN CANCER RES, V20, P1576, DOI 10.1158/1078-0432.CCR-13-0987; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hideshima T, 2002, J BIOL CHEM, V277, P16639, DOI 10.1074/jbc.M200360200; Hideshima T, 2009, BLOOD, V114, P1046, DOI 10.1182/blood-2009-01-199604; Hooper C, 2014, J BIOL CHEM, V289, P33161, DOI 10.1074/jbc.M114.582478; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Laubach J, 2016, LEUKEMIA, V30, P1005, DOI 10.1038/leu.2015.356; Lohr JG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac7037; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Maki CG, 1996, CANCER RES, V56, P2649; Maquart F, 2005, BIOCHIMIE, V87, P353, DOI 10.1016/j.biochi.2004.10.006; Maquart FX, 2004, CRIT REV ONCOL HEMAT, V49, P199, DOI 10.1016/j.critrevonc.2003.06.007; Markovina S, 2008, MOL CANCER RES, V6, P1356, DOI 10.1158/1541-7786.MCR-08-0108; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Mishima Y, 2017, CELL REP, V19, P218, DOI 10.1016/j.celrep.2017.03.025; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Monboisse J.C., 2013, J CARCINOG MUTAGEN, V4, P148; Murray MY, 2014, BIOCHEM SOC T, V42, P804, DOI 10.1042/BST20140126; NGUYEN Q, 1993, BIOCHEM J, V295, P595, DOI 10.1042/bj2950595; Nikesitch N, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.40; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Papadas A., 2017, HDB EXP PHA IN PRESS; PERIN JP, 1987, J BIOL CHEM, V262, P13269; PERKINS SJ, 1989, J MOL BIOL, V206, P737, DOI 10.1016/0022-2836(89)90580-9; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Ricard-Blum S, 2014, EXP DERMATOL, V23, P457, DOI 10.1111/exd.12435; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200; Shumway SD, 2004, BIOCHEM J, V380, P173, DOI 10.1042/BJ20031796; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wiita AP, 2013, ELIFE, V2, DOI 10.7554/eLife.01236; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753	59	20	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2452	2465		10.1074/jbc.RA117.000667	http://dx.doi.org/10.1074/jbc.RA117.000667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29279332	Green Published, hybrid			2022-12-28	WOS:000425308300018
J	Ringel, MT; Drager, G; Bruser, T				Ringel, Michael T.; Draeger, Gerald; Brueser, Thomas			PvdO is required for the oxidation of dihydropyoverdine as the last step of fluorophore formation in Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLGLYCINE-GENERATING ENZYME; POLYACRYLAMIDE GELS; ELECTROPHORETIC TRANSFER; PYOVERDINE CHROMOPHORE; SIDEROPHORE; AERUGINOSA; PROTEINS; IDENTIFICATION; NITROCELLULOSE; BIOSYNTHESIS	Pyoverdines are important siderophores that guarantee iron supply to important pathogenic and non-pathogenic pseudomonads in host habitats. A key characteristic of all pyoverdines is the fluorescent dihydroxyquinoline group that contributes two ligands to the iron complexes. Pyoverdines are derived from the non-ribosomally synthesized peptide ferribactin, and their fluorophore is generated by periplasmic oxidation and cyclization reactions of D-tyrosine and L-diaminobutyric acid. The formation of the fluorophore is known to be driven by the periplasmic tyrosinase PvdP. Here we report that the putative periplasmic oxidoreductase PvdO of Pseudomonas fluorescens A506 is required for the final oxidation of dihydropyoverdine to pyoverdine, which completes the fluorophore. The pvdO deletion mutant accumulates dihydropyoverdine, and this phenotype is fully complemented by recombinant PvdO. The autoxidation of dihydropyoverdine at alkaline pH and the presence of high copper concentrations can mask this phenotype. Mutagenesis of conserved residues with potential catalytic function identified Glu-260 as an essential residue whose mutation abolished function without affecting stability or transport. Glu-260 of PvdO is at the exact position of the active-site cysteine in the structurally related formylglycine-generating enzyme. Evolution thus used the same protein fold for two distinct functionalities. As purified PvdO was inactive, additional factors are required for catalysis.	[Ringel, Michael T.; Brueser, Thomas] Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany; [Draeger, Gerald] Leibniz Univ Hannover, Inst Organ Chem, Schneiderberg 1 B, D-30167 Hannover, Germany	Leibniz University Hannover; Leibniz University Hannover	Bruser, T (corresponding author), Leibniz Univ Hannover, Inst Microbiol, Herrenhauser Str 2, D-30419 Hannover, Germany.	brueser@ifmb.uni-hannover.de		Bruser, Thomas/0000-0002-5889-8306	German Science Foundation (DFG) [GRK1798, BR 2285/7-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by German Science Foundation (DFG) Grant GRK1798 "Signaling at the Plant-Soil Interface" and Project BR 2285/7-1. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHTGARY AM, 1994, INORG CHEM, V33, P6391, DOI 10.1021/ic00104a059; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baysse C, 2002, FEBS LETT, V523, P23, DOI 10.1016/S0014-5793(02)02915-0; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bultreys A, 2001, APPL ENVIRON MICROB, V67, P1718, DOI 10.1128/AEM.67.4.1718-1727.2001; Buongiorno D, 2013, COORDIN CHEM REV, V257, P541, DOI 10.1016/j.ccr.2012.04.028; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cezard C, 2015, CURR MED CHEM, V22, P165, DOI 10.2174/0929867321666141011194624; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Drake EJ, 2011, ACS CHEM BIOL, V6, P1277, DOI 10.1021/cb2002973; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ellermann M, 2017, FREE RADICAL BIO MED, V105, P68, DOI 10.1016/j.freeradbiomed.2016.10.489; Finn RD, 2017, NUCLEIC ACIDS RES, V45, pD190, DOI 10.1093/nar/gkw1107; Hannauer M, 2012, FEBS LETT, V586, P96, DOI 10.1016/j.febslet.2011.12.004; Holder PG, 2015, J BIOL CHEM, V290, P15730, DOI 10.1074/jbc.M115.652669; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ize B, 2014, METHODS MOL BIOL, V1149, P185, DOI 10.1007/978-1-4939-0473-0_15; Jacques P, 2003, LETT APPL MICROBIOL, V36, P259, DOI 10.1046/j.1472-765X.2003.01304.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Meury M, 2017, ANGEW CHEM INT EDIT, V56, P8115, DOI 10.1002/anie.201702901; Nadal-Jimenez P, 2014, J BACTERIOL, V196, P2681, DOI 10.1128/JB.01376-13; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ringel MT, 2017, J BIOL CHEM, V292, P18660, DOI 10.1074/jbc.M117.812545; Ringel MT, 2016, J BIOL CHEM, V291, P23929, DOI 10.1074/jbc.M116.755611; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6446, DOI 10.1021/bi00525a025; TEINTZE M, 1981, BIOCHEMISTRY-US, V20, P6457, DOI 10.1021/bi00525a026; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Yeterian E, 2010, AMINO ACIDS, V38, P1447, DOI 10.1007/s00726-009-0358-0; Yuan ZL, 2017, BIOCHEM BIOPH RES CO, V484, P195, DOI 10.1016/j.bbrc.2016.12.181	39	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2330	2341		10.1074/jbc.RA117.000121	http://dx.doi.org/10.1074/jbc.RA117.000121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29208656	Green Published, hybrid			2022-12-28	WOS:000425308300008
J	Bon, N; Couasnay, G; Bourgine, A; Sourice, S; Beck-Cormier, S; Guicheux, J; Beck, L				Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent			Phosphate (P-i)-regulated heterodimerization of the high-affinity sodium-dependent P-i transporters PiT1/Slc20a1 and PiT2/Slc20a2 underlies extracellular P-i sensing independently of P-i uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); bone; cartilage; extracellular-signal-regulated kinase (ERK); signaling; PiT1; PiT2; membrane transporters; phosphate sensing	APE LEUKEMIA-VIRUS; INORGANIC-PHOSPHATE; GENE-EXPRESSION; CELL-SURFACE; HYPERTROPHIC CHONDROCYTES; RETROVIRAL RECEPTOR; RAF/MEK/ERK PATHWAY; INDUCED APOPTOSIS; MESSENGER-RNA; OSTEOBLAST	Extracellular phosphate (P-i) can act as a signaling molecule that directly alters gene expression and cellular physiology. The ability of cells or organisms to detect changes in extracellular P-i levels implies the existence of a P-i-sensing mechanism that signals to the body or individual cell. However, unlike in prokaryotes, yeasts, and plants, the molecular players involved in P-i sensing in mammals remain unknown. In this study, we investigated the involvement of the high-affinity, sodium-dependent P-i transporters PiT1 and PiT2 in mediating P-i signaling in skeletal cells. We found that deletion of PiT1 or PiT2 blunted the P-i-dependent ERK1/2-mediated phosphorylation and subsequent gene up-regulation of the mineralization inhibitors matrix Gla protein and osteopontin. This result suggested that both PiTs are necessary for P-i signaling. Moreover, the ERK1/2 phosphorylation could be rescued by overexpressing P-i transport-deficient PiT mutants. Using cross-linking and bioluminescence resonance energy transfer approaches, we found that PiT1 and PiT2 form high-abundance homodimers and P-i-regulated low-abundance heterodimers. Interestingly, in the absence of sodium-dependent P-i transport activity, the PiT1-PiT2 heterodimerization was still regulated by extracellular P-i levels. Of note, when two putative P-i-binding residues, Ser-128 (in PiT1) and Ser-113 (in PiT2), were substituted with alanine, the PiT1-PiT2 heterodimerization was no longer regulated by extracellular P-i. These observations suggested that P-i binding rather than P-i uptake may be the key factor in mediating P-i signaling through the PiT proteins. Taken together, these results demonstrate that P-i-regulated PiT1-PiT2 heterodimerization mediates P-i sensing independently of P-i uptake.	[Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent] INSERM, RMeS Regenerat Med & Skeleton, STEP Team Skeletal Physiopathol & Joint Regenerat, U1229, F-44042 Nantes, France; [Bon, Nina; Couasnay, Greig; Bourgine, Annabelle; Sourice, Sophie; Beck-Cormier, Sarah; Guicheux, Jerome; Beck, Laurent] Univ Nantes, RMeS, UFR Odontol, UMR S 1229, F-44042 Nantes, France; [Guicheux, Jerome] CHU Nantes, PHU OTONN 4, F-44042 Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Nantes Universite; CHU de Nantes	Beck, L (corresponding author), INSERM, Fac Chirurg Dent, RMeS, U1229, 1 Pl Alexis Ricordeau, F-44042 Nantes, France.	laurent.beck@inserm.fr	Couasnay, Greig/CAG-1588-2022; Beck-Cormier, Sarah/P-3091-2014; BECK, Laurent/P-2952-2014; guicheux, Jerome/F-7767-2013	Beck-Cormier, Sarah/0000-0001-5258-1933; BECK, Laurent/0000-0002-6730-2762; guicheux, Jerome/0000-0003-2754-3024; couasnay, greig/0000-0002-8190-7178	Region des Pays de la Loire (SENSEO); University of Nantes; Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique); Region des Pays de la Loire (BIOREGOS); INSERM; INSERM, Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique and SENSEO) [CIMATH 2]	Region des Pays de la Loire (SENSEO); University of Nantes; Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique); Region des Pays de la Loire (BIOREGOS); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); INSERM, Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique and SENSEO)	This work was supported by in part grants from INSERM, Region des Pays de la Loire (CIMATH 2, Nouvelle Equipe/Nouvelle Thematique and SENSEO). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from Region des Pays de la Loire (SENSEO) and University of Nantes.; Recipient of a fellowship from Region des Pays de la Loire (Nouvelle Equipe/Nouvelle Thematique) and University of Nantes.; Recipient of a fellowship from Region des Pays de la Loire (BIOREGOS) and INSERM.	Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200; Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bergwitz C, 2011, ADV CHRONIC KIDNEY D, V18, P132, DOI 10.1053/j.ackd.2011.01.004; BERNER YN, 1988, ANNU REV NUTR, V8, P121, DOI 10.1146/annurev.nu.08.070188.001005; Bottger P, 2005, FEBS J, V272, P3060, DOI 10.1111/j.1742-4658.2005.04720.x; Bottger P, 2004, J VIROL, V78, P9564, DOI 10.1128/JVI.78.17.9564-9567.2004; Bottger P, 2002, J BIOL CHEM, V277, P42741, DOI 10.1074/jbc.M207096200; Bottger P, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-21; Bourgine A, 2011, ARCH ORAL BIOL, V56, P977, DOI 10.1016/j.archoralbio.2011.03.001; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Chavkin NW, 2015, EXP CELL RES, V333, P39, DOI 10.1016/j.yexcr.2015.02.002; Chien ML, 1998, VIROLOGY, V240, P109, DOI 10.1006/viro.1997.8933; Chien ML, 1997, J VIROL, V71, P4564, DOI 10.1128/JVI.71.6.4564-4570.1997; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Conradas KA, 2005, MOL CELL PROTEOMICS, V4, P1284, DOI 10.1074/mcp.M500082-MCP200; ESCOUBET B, 1992, J ENDOCRINOL, V133, P301, DOI 10.1677/joe.0.1330301; Farrell KB, 2009, J BIOL CHEM, V284, P29979, DOI 10.1074/jbc.M109.022566; Forand A, 2016, CELL REP, V16, P2736, DOI 10.1016/j.celrep.2016.08.012; Forand A, 2013, BLOOD, V121, P666, DOI 10.1182/blood-2012-05-427302; Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Julien M, 2009, J BONE MINER RES, V24, P1856, DOI [10.1359/JBMR.090508, 10.1359/jbmr.090508]; Kanatan M, 2003, J CELL PHYSIOL, V196, P180, DOI 10.1002/jcp.10270; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Khoshniat S, 2011, BONE, V48, P894, DOI 10.1016/j.bone.2010.12.002; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Klahr S, 1980, Adv Cyclic Nucleotide Res, V13, P133; KNOCHEL JP, 1977, ARCH INTERN MED, V137, P203, DOI 10.1001/archinte.137.2.203; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Kumar R, 2009, CURR OPIN NEPHROL HY, V18, P281, DOI 10.1097/MNH.0b013e32832b5094; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundquist Patrik, 2002, Swed Dent J Suppl, P1; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Marshall RW, 1976, CALCIUM PHOSPHATE MA, P162; Michigami T, 2013, CONTRIB NEPHROL, V180, P14, DOI 10.1159/000346776; Miedlich SU, 2010, J BIOL CHEM, V285, P18270, DOI 10.1074/jbc.M109.098616; MILLER DG, 1994, J VIROL, V68, P8270, DOI 10.1128/JVI.68.12.8270-8276.1994; Miyamoto K, 1999, NEPHROL DIAL TRANSPL, V14, P73, DOI 10.1093/ndt/14.suppl_1.73; Mouillon JM, 2006, FEMS YEAST RES, V6, P171, DOI 10.1111/j.1567-1364.2006.00036.x; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Naviglio S, 2006, J CELL BIOCHEM, V98, P1584, DOI 10.1002/jcb.20892; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Popova Y, 2010, P NATL ACAD SCI USA, V107, P2890, DOI 10.1073/pnas.0906546107; Qi WJ, 2016, BIOCHEM SOC T, V44, P766, DOI 10.1042/BST20160026; Ravera S, 2007, AM J PHYSIOL-CELL PH, V293, pC606, DOI 10.1152/ajpcell.00064.2007; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Salaun C, 2010, J BIOL CHEM, V285, P34408, DOI 10.1074/jbc.M110.130989; Salaun C, 2004, J MOL BIOL, V340, P39, DOI 10.1016/j.jmb.2004.04.050; Salaun C, 2002, J VIROL, V76, P4304, DOI 10.1128/JVI.76.9.4304-4311.2002; Salaun C, 2001, J VIROL, V75, P5584, DOI 10.1128/JVI.75.12.5584-5592.2001; SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5; Silver J, 2003, CURR OPIN NEPHROL HY, V12, P357, DOI 10.1097/00041552-200307000-00003; Takeyama S, 2001, BIOCHEM BIOPH RES CO, V282, P798, DOI 10.1006/bbrc.2001.4652; Teixeira CC, 2001, AM J PHYSIOL-CELL PH, V281, pC833, DOI 10.1152/ajpcell.2001.281.3.C833; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; WALSER M, 1961, J CLIN INVEST, V40, P723, DOI 10.1172/JCI104306; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Yoshiko Y, 2007, MOL CELL BIOL, V27, P4465, DOI 10.1128/MCB.00104-07; Zoidis E, 2004, J ENDOCRINOL, V181, P531, DOI 10.1677/joe.0.1810531	71	55	55	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2102	2114		10.1074/jbc.M117.807339	http://dx.doi.org/10.1074/jbc.M117.807339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29233890	Green Published, hybrid			2022-12-28	WOS:000424948000022
J	Magi, S; Iwamoto, K; Yumoto, N; Hiroshima, M; Nagashima, T; Ohki, R; Garcia-Munoz, A; Volinsky, N; Von Kriegsheim, A; Sako, Y; Takahashi, K; Kimura, S; Kholodenko, BN; Okada-Hatakeyama, M				Magi, Shigeyuki; Iwamoto, Kazunari; Yumoto, Noriko; Hiroshima, Michio; Nagashima, Takeshi; Ohki, Rieko; Garcia-Munoz, Amaya; Volinsky, Natalia; Von Kriegsheim, Alexander; Sako, Yasushi; Takahashi, Koichi; Kimura, Shuhei; Kholodenko, Boris N.; Okada-Hatakeyama, Mariko			Transcriptionally inducible Pleckstrin homology-like domain, family A, member 1, attenuates ErbB receptor activity by inhibiting receptor oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; mathematical modeling; oligomerization; receptor tyrosine kinase; signal transduction	GROWTH-FACTOR RECEPTOR; BREAST-CANCER; NEGATIVE FEEDBACK; CELL-DIFFERENTIATION; EPITHELIAL-CELLS; DOWN-REGULATION; PROTEIN; KINASE; ACTIVATION; EXPRESSION	Feedback control is a key mechanism in signal transduction, intimately involved in regulating the outcome of the cellular response. Here, we report a novel mechanism by which PHLDA1, Pleckstrin homology-like domain, family A, member 1, negatively regulates ErbB receptor signaling by inhibition of receptor oligomerization. We have found that the ErbB3 ligand, heregulin, induces PHILDA1 expression in MCF-7 cells. Transcriptionally-induced PHLDA1 protein directly binds to ErbB3, whereas knockdown of PHLDA1 increases complex formation between ErbB3 and ErbB2. To provide insight into the mechanism for our time-course and single-cell experimental observations, we performed a systematic computational search of network topologies of the mathematical models based on receptor dimer-tetramer formation in the ErbB activation processes. Our results indicate that only a model in which PHLDA1 inhibits formation of both dimers and tetramer can explain the experimental data. Predictions made from this model were further validated by single-molecule imaging experiments. Our studies suggest a unique regulatory feature of PHLDA1 to inhibit the ErbB receptor oligomerization process and thereby control the activity of receptor signaling network.	[Magi, Shigeyuki; Iwamoto, Kazunari; Yumoto, Noriko; Okada-Hatakeyama, Mariko] RIKEN Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Magi, Shigeyuki; Iwamoto, Kazunari; Okada-Hatakeyama, Mariko] Osaka Univ, Inst Prot Res, Lab Cell Syst, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Iwamoto, Kazunari; Takahashi, Koichi] RIKEN Quantitat Biol Ctr QBiC, Lab Biochem Simulat, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan; [Hiroshima, Michio] RIKEN Quantitat Biol Ctr QBiC, Lab Cell Signaling Dynam, 6-2-3 Furuedai, Suita, Osaka 5650874, Japan; [Hiroshima, Michio; Sako, Yasushi] RIKEN Adv Sci Inst, Cellular Informat Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Nagashima, Takeshi] Tohoku Univ, Div Cell Proliferat, United Ctr Adv Res & Translat Med, Grad Sch Med,Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Ohki, Rieko] Natl Canc Ctr, Res Inst, Div Rare Canc Res, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan; [Garcia-Munoz, Amaya; Volinsky, Natalia; Von Kriegsheim, Alexander; Kholodenko, Boris N.] Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland; [Kholodenko, Boris N.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland; [Kholodenko, Boris N.] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Kimura, Shuhei] Tottori Univ, Grad Sch Engn, 4-101 Koyama Minami, Tottori 6808552, Japan	RIKEN; Osaka University; RIKEN; RIKEN; RIKEN; Tohoku University; National Cancer Center - Japan; University College Dublin; University College Dublin; University College Dublin; Tottori University	Okada-Hatakeyama, M (corresponding author), RIKEN Ctr Integrat Med Sci IMS, Lab Integrated Cellular Syst, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.; Okada-Hatakeyama, M (corresponding author), Osaka Univ, Inst Prot Res, Lab Cell Syst, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Syst Biol Ireland, Dublin 4, Ireland.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.; Kholodenko, BN (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland.	boris.kholodenko@ucd.ie; mokada@protein.osaka-u.ac.jp	Admin, SBI/HGB-2738-2022; von Kriegsheim, Alex/C-2371-2016	Iwamoto, Kazunari/0000-0001-9794-9420; von Kriegsheim, Alex/0000-0002-4952-8573	JSPS KAKENHI [15KT0084]; RIKEN Epigenome and Single Cell Project Grants; Cooperative Research Program of Institute for Protein Research, Osaka University [CRa-17-01]; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT SPIRE Supercomputational Life Science; European Union FP7 SynSignal [613879]; European Union H2020 SmartNanoTox [686098]; Grants-in-Aid for Scientific Research [16K21624] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); RIKEN Epigenome and Single Cell Project Grants; Cooperative Research Program of Institute for Protein Research, Osaka University; Nagase Science Technology Foundation; Astellas Foundation for Research on Metabolic Disorders; MEXT SPIRE Supercomputational Life Science; European Union FP7 SynSignal; European Union H2020 SmartNanoTox; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported in part by JSPS KAKENHI Grant 15KT0084, RIKEN Epigenome and Single Cell Project Grants, the Cooperative Research Program of Institute for Protein Research, Osaka University Grant CRa-17-01, Nagase Science Technology Foundation, and Astellas Foundation for Research on Metabolic Disorders (to M. O.-H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by MEXT SPIRE Supercomputational Life Science.; Supported by European Union FP7 SynSignal Grant 613879 and European Union H2020 SmartNanoTox Grant 686098. To whom correspondence may be addressed. E-mail: boris.kholodenko@ucd.ie.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Basseri S, 2013, DIABETES, V62, P158, DOI 10.2337/db12-0256; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Dunn EF, 2011, J VIROL, V85, P422, DOI 10.1128/JVI.01671-10; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Grossmann KS, 2009, P NATL ACAD SCI USA, V106, P16704, DOI 10.1073/pnas.0904336106; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hiroshima M, 2012, P NATL ACAD SCI USA, V109, P13984, DOI 10.1073/pnas.1200464109; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; Johnson EO, 2011, J CELL SCI, V124, P2711, DOI 10.1242/jcs.084970; Karamouzis MV, 2016, ONCOTARGET, V7, P5576, DOI 10.18632/oncotarget.6762; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kastrati I, 2015, ONCOGENE, V34, P2309, DOI 10.1038/onc.2014.180; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Kimura S., 2011, SICE J CONTROL MEASU, V4, P105, DOI DOI 10.9746/JCMSI.4.105-4889; Li GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106349; Li JN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.61; Mina M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11999; Moad AIH, 2013, CELL BIOCHEM BIOPHYS, V66, P567, DOI 10.1007/s12013-012-9504-5; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nagai MA, 2007, BREAST CANCER RES TR, V106, P49, DOI 10.1007/s10549-006-9475-6; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nagashima T, 2015, FEBS J, V282, P613, DOI 10.1111/febs.13172; Nakaoka Y, 2007, J CLIN INVEST, V117, P1771, DOI 10.1172/JCI30651; Neef R, 2002, CANCER RES, V62, P5920; Park CG, 1996, IMMUNITY, V4, P583, DOI 10.1016/S1074-7613(00)80484-7; Park ES, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.67; Pryor MM, 2015, MOL BIOL CELL, V26, P4109, DOI 10.1091/mbc.E14-06-1114; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Sithanandam G, 2005, AM J RESP CELL MOL, V33, P490, DOI 10.1165/rcmb.2005-0049OC; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steinkamp MP, 2014, MOL CELL BIOL, V34, P965, DOI 10.1128/MCB.01605-13; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033041; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Turriziani Benedetta, 2014, Biology (Basel), V3, P320, DOI 10.3390/biology3020320; Volinsky N, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140172; Wang Xiaoqi, 2018, Oncotarget, V9, P24914, DOI 10.18632/oncotarget.3674; Webb SED, 2008, BIOPHYS J, V94, P803, DOI 10.1529/biophysj.107.112623; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Zhang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041613	52	6	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2206	2218		10.1074/jbc.M117.778399	http://dx.doi.org/10.1074/jbc.M117.778399			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29233889	Green Published, hybrid			2022-12-28	WOS:000424948000031
J	Yangyuoru, PM; Bradburn, DA; Liu, ZH; Xiao, TS; Russell, R				Yangyuoru, Philip M.; Bradburn, Devin A.; Liu, Zhonghua; Xiao, Tsan Sam; Russell, Rick			The G-quadruplex (G4) resolvase DHX36 efficiently and specifically disrupts DNA G4s via a translocation-based helicase mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme mechanism; G-quadruplex; pre-steady-state kinetics; RNA folding; RNA helicase	DEAH-BOX HELICASE; TETRAMOLECULAR QUADRUPLEX; RNA TETRAPLEX; MAJOR SOURCE; HUMAN GENOME; LOOP-LENGTH; RHAU; RECOGNITION; G4-DNA; UNWINDS	Single-stranded DNA (ssDNA) and RNA regions that include at least four closely spaced runs of three or more consecutive guanosines strongly tend to fold into stable G-quadruplexes (G4s). G4s play key roles as DNA regulatory sites and as kinetic traps that can inhibit biological processes, but how G4s are regulated in cells remains largely unknown. Here, we developed a kinetic framework for G4 disruption by DEAH-box helicase 36 (DHX36), the dominant G4 resolvase in human cells. Using tetramolecular DNA and RNA G4s with four to six G-quartets, we found that DHX36-mediated disruption is highly efficient, with rates that depend on G4 length under saturating conditions (k(cat)) but not under subsaturating conditions (k(cat)/K-m). These results suggest that a step during G4 disruption limits the k(cat) value and that DHX36 binding limits k(cat)/K-m. Similar results were obtained for unimolecular DNA G4s. DHX36 activity depended on a 3 ssDNA extension and was blocked by a polyethylene glycol linker, indicating that DHX36 loads onto the extension and translocates 3-5 toward the G4. DHX36 unwound dsDNA poorly compared with G4s of comparable intrinsic lifetime. Interestingly, we observed that DHX36 has striking 3-extension sequence preferences that differ for G4 disruption and dsDNA unwinding, most likely arising from differences in the rate-limiting step for the two activities. Our results indicate that DHX36 disrupts G4s with a conventional helicase mechanism that is tuned for great efficiency and specificity for G4s. The dependence of DHX36 on the 3-extension sequence suggests that the extent of formation of genomic G4s may not track directly with G4 stability.	[Yangyuoru, Philip M.; Bradburn, Devin A.; Russell, Rick] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Yangyuoru, Philip M.; Bradburn, Devin A.; Russell, Rick] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Liu, Zhonghua; Xiao, Tsan Sam] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Case Western Reserve University	Russell, R (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Russell, R (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	rick_russell@cm.utexas.edu	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X	National Institutes of Health [GM070456]; Welch Foundation [F-1563]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM070456 (to R. R.) and Welch Foundation Grant F-1563 (to R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Biffi G, 2014, NAT CHEM, V6, P75, DOI [10.1038/NCHEM.1805, 10.1038/nchem.1805]; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Bugaut A, 2008, BIOCHEMISTRY-US, V47, P689, DOI 10.1021/bi701873c; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Chatterjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6556; Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051; CHEONG CJ, 1992, BIOCHEMISTRY-US, V31, P8406, DOI 10.1021/bi00151a003; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Deng JP, 2001, P NATL ACAD SCI USA, V98, P13665, DOI 10.1073/pnas.241374798; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gao X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.571; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Harrington C, 1997, J BIOL CHEM, V272, P24631, DOI 10.1074/jbc.272.39.24631; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Heddi B, 2015, P NATL ACAD SCI USA, V112, P9608, DOI 10.1073/pnas.1422605112; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Lai JC, 2012, BLOOD, V119, P4291, DOI 10.1182/blood-2011-08-362954; Lattmann S, 2010, NUCLEIC ACIDS RES, V38, P6219, DOI 10.1093/nar/gkq372; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Meier M, 2013, J BIOL CHEM, V288, P35014, DOI 10.1074/jbc.M113.512970; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Mullen MA, 2010, NUCLEIC ACIDS RES, V38, P8149, DOI 10.1093/nar/gkq804; Newman M, 2017, J MOL BIOL, V429, P3121, DOI 10.1016/j.jmb.2016.11.033; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Piazza A, 2015, EMBO J, V34, P1718, DOI 10.15252/embj.201490702; Prabu JR, 2015, MOL CELL, V60, P487, DOI 10.1016/j.molcel.2015.10.011; Rachwal PA, 2007, NUCLEIC ACIDS RES, V35, P4214, DOI 10.1093/nar/gkm316; Russell R, 2013, RNA BIOL, V10, P44, DOI 10.4161/rna.22210; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Smaldino PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132668; Tauchert MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21510; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; Wu CG, 2016, NUCLEIC ACIDS RES, V44, P8742, DOI 10.1093/nar/gkw574; You HJ, 2017, NUCLEIC ACIDS RES, V45, P206, DOI 10.1093/nar/gkw881	49	22	22	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1924	1932		10.1074/jbc.M117.815076	http://dx.doi.org/10.1074/jbc.M117.815076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29269411	Green Published, hybrid			2022-12-28	WOS:000424948000008
J	Bratkowski, M; Unarta, IC; Zhu, LZ; Shubbar, M; Huang, XH; Liu, X				Bratkowski, Matthew; Unarta, Ilona Christy; Zhu, Lizhe; Shubbar, Murtada; Huang, Xuhui; Liu, Xin			Structural dissection of an interaction between transcription initiation and termination factors implicated in promoter-terminator cross-talk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						general transcription factor (GTF); RNA polymerase II; transcription initiation factor; transcription regulation; transcription termination; gene looping; promoter-terminator cross-talk; TFIIB; Ssu72	RNA-POLYMERASE-II; START SITE SELECTION; GENE LOOPS; FACTOR-TFIIB; TATA BOX; CONFORMATIONAL-CHANGE; DOMAIN PHOSPHATASE; CRYSTAL-STRUCTURE; YEAST TFIIB; SSU72	Functional cross-talk between the promoter and terminator of a gene has long been noted. Promoters and terminators are juxtaposed to form gene loops in several organisms, and gene looping is thought to be involved in transcriptional regulation. The general transcription factor IIB (TFIIB) and the C-terminal domain phosphatase Ssu72, essential factors of the transcription preinitiation complex and the mRNA processing and polyadenylation complex, respectively, are important for gene loop formation. TFIIB and Ssu72 interact both genetically and physically, but the molecular basis of this interaction is not known. Here we present a crystal structure of the core domain of TFIIB in two new conformations that differ in the relative distance and orientation of the two cyclin-like domains. The observed extraordinary conformational plasticity may underlie the binding of TFIIB to multiple transcription factors and promoter DNAs that occurs in distinct stages of transcription, including initiation, reinitiation, and gene looping. We mapped the binding interface of the TFIIB-Ssu72 complex using a series of systematic, structure-guided in vitro binding and site-specific photocross-linking assays. Our results indicate that Ssu72 competes with acidic activators for TFIIB binding and that Ssu72 disrupts an intramolecular TFIIB complex known to impede transcription initiation. We also show that the TFIIB-binding site on Ssu72 overlaps with the binding site of symplekin, a component of the mRNA processing and polyadenylation complex. We propose a hand-off model in which Ssu72 mediates a conformational transition in TFIIB, accounting for the role of Ssu72 in transcription reinitiation, gene looping, and promoter-terminator cross-talk.	[Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA; [Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Bratkowski, Matthew; Shubbar, Murtada; Liu, Xin] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Unarta, Ilona Christy; Zhu, Lizhe; Huang, Xuhui] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Unarta, Ilona Christy; Zhu, Lizhe; Huang, Xuhui] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Kowloon, Hong Kong, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.; Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Basic Res Div, Dept Obstet & Gynecol, Dallas, TX 75390 USA.; Liu, X (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	xin.liu@utsouthwestern.edu	Huang, Xuhui/ABE-3207-2021; Zhu, Lizhe/K-1139-2012	Huang, Xuhui/0000-0002-7119-9358; Zhu, Lizhe/0000-0001-8252-7807	DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; Office of Science, Office of Basic Energy Sciences, of the DOE [DE-AC02-05CH11231]; DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM121662, R01GM114576] Funding Source: NIH RePORTER	DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, of the DOE(United States Department of Energy (DOE)); DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Shih-Chia Tso, Thomas Scheuermann, and Chad Brautigam for assistance with ITC experiments and Diana Tomchick and Zhe Chen for help with X-ray data collection. We thank Haydn Ball of the UT Southwestern Protein Technology Core for peptide synthesis. We thank Qiong Wu and Jose Rizo-Rey for preliminary NMR analysis. We thank Michael Carey (Department of Biological Chemistry, UCLA, Los Angeles, CA) for generously providing the VP16AD expression plasmid. We thank Peter Schultz (Scripps Research Institute) for generously providing the pEVOL-pBpA plasmid. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract DE-AC02-06CH11357. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the DOE under contract DE-AC02-05CH11231. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the DOE, Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIGMS, National Institutes of Health, Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; BAGBY S, 1995, CELL, V82, P857, DOI 10.1016/0092-8674(95)90483-2; Blau C, 2013, COMPUT PHYS COMMUN, V184, P2856, DOI 10.1016/j.cpc.2013.07.018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burley SK, 1998, CELL, V94, P551, DOI 10.1016/S0092-8674(00)81596-2; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; CHAMBERS RS, 1995, J BIOL CHEM, V270, P14962, DOI 10.1074/jbc.270.25.14962; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Cox JM, 1997, P NATL ACAD SCI USA, V94, P13475, DOI 10.1073/pnas.94.25.13475; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deng WS, 2005, GENE DEV, V19, P2418, DOI 10.1101/gad.342405; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glossop JA, 2004, NUCLEIC ACIDS RES, V32, P1829, DOI 10.1093/nar/gkh504; GONZALEZ TF, 1985, THEOR COMPUT SCI, V38, P293, DOI 10.1016/0304-3975(85)90224-5; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hawkes NA, 2000, CURR BIOL, V10, P273, DOI 10.1016/S0960-9822(00)00363-8; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ibrahim BS, 2009, P NATL ACAD SCI USA, V106, P13242, DOI 10.1073/pnas.0904309106; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kobor MS, 2000, MOL CELL BIOL, V20, P7438, DOI 10.1128/MCB.20.20.7438-7449.2000; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Mapendano CK, 2010, MOL CELL, V40, P410, DOI 10.1016/j.molcel.2010.10.012; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; O'Reilly D, 2007, GENOMICS, V90, P407, DOI 10.1016/j.ygeno.2007.04.010; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perkins KJ, 2008, MOL CELL, V29, P56, DOI 10.1016/j.molcel.2007.11.030; PINTO I, 1994, J BIOL CHEM, V269, P30569; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Proudfoot N, 2002, CURR BIOL, V12, pR855, DOI 10.1016/S0960-9822(02)01353-2; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROBERTS SGE, 1994, NATURE, V371, P717, DOI 10.1038/371717a0; ROBERTS SGE, 1995, CURR BIOL, V5, P508, DOI 10.1016/S0960-9822(95)00103-5; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Sato S, 2011, BIOCHEMISTRY-US, V50, P250, DOI 10.1021/bi1016183; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; St-Pierre B, 2005, NUCLEIC ACIDS RES, V33, P464, DOI 10.1093/nar/gki171; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tsai FTF, 2000, EMBO J, V19, P25, DOI 10.1093/emboj/19.1.25; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu WH, 1999, GENETICS, V153, P643; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479; Zhang DW, 2012, J BIOL CHEM, V287, P8541, DOI 10.1074/jbc.M111.335687; Zhang DY, 2000, NUCLEIC ACIDS RES, V28, P1913, DOI 10.1093/nar/28.9.1913	76	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 2	2018	293	5					1651	1665		10.1074/jbc.M117.811521	http://dx.doi.org/10.1074/jbc.M117.811521			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU9UD	29158257	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000424201700017
J	Gludovacz, E; Maresch, D; de Carvalho, LL; Puxbaum, V; Baier, LJ; Sutzl, L; Guedez, G; Grunwald-Gruber, C; Ulm, B; Pils, S; Ristl, R; Altmann, F; Jilma, B; Salminen, TA; Borth, N; Boehm, T				Gludovacz, Elisabeth; Maresch, Daniel; de Carvalho, Leonor Lopes; Puxbaum, Verena; Baier, Laurenz J.; Suetzl, Leander; Guedez, Gabriela; Gruenwald-Gruber, Clemens; Ulm, Barbara; Pils, Sophie; Ristl, Robin; Altmann, Friedrich; Jilma, Bernd; Salminen, Tiina A.; Borth, Nicole; Boehm, Thomas			Oligomannosidic glycans at Asn-110 are essential for secretion of human diamine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADHESION PROTEIN-1 VAP-1; N-LINKED GLYCAN; HUMAN-PREGNANCY; PLASMA; GLYCOSYLATION; HISTAMINE; PURIFICATION; ENVIRONMENT; INHIBITION; EXPRESSION	N-Glycosylation plays a fundamental role in many biological processes. Human diamine oxidase (hDAO), required for histamine catabolism, has multiple N-glycosylation sites, but their roles, for example in DAO secretion, are unclear. We recently reported that the N-glycosylation sites Asn-168, Asn-538, and Asn-745 in recombinant hDAO (rhDAO) carry complex-type glycans, whereas Asn-110 carries only mammalian-atypical oligomannosidic glycans. Here, we show that Asn-110 in native hDAO from amniotic fluid and Caco-2 cells, DAO from porcine kidneys, and rhDAO produced in two different HEK293 cell lines is also consistently occupied by oligomannosidic glycans. Glycans at Asn-168 were predominantly sialylated with bi-to tetra-antennary branches, and Asn-538 and Asn-745 had similar complex-type glycans with some tissue-and cell linespecific variations. The related copper-containing amine oxidase human vascular adhesion protein-1 also exclusively displayed high-mannose glycosylation at Asn-137. X-ray structures revealed that the residues adjacent to Asn-110 and Asn-137 form a highly conserved hydrophobic cleft interacting with the core trisaccharide. Asn-110 replacement with Gln completely abrogated rhDAOsecretion and caused retention in the endoplasmic reticulum. Mutations of Asn-168, Asn-538, and Asn-745 reduced rhDAO secretion by 13, 71, and 32%, respectively. Asn-538/ 745 double and Asn-168/538/745 triple substitutions reduced rhDAO secretion by 85 and 94%. Because of their locations in the DAO structure, Asn-538 and Asn-745 glycosylations might be important for efficient DAO dimer formation. These functional results are reflected in the high evolutionary conservation of all four glycosylation sites. Human DAO is abundant only in the gastrointestinal tract, kidney, and placenta, and glycosylation seems essential for reaching high enzyme expression levels in these tissues.	[Gludovacz, Elisabeth; Puxbaum, Verena; Baier, Laurenz J.; Borth, Nicole] Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria; [Maresch, Daniel; Gruenwald-Gruber, Clemens; Altmann, Friedrich; Boehm, Thomas] Univ Nat Resources & Life Sci, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria; [Suetzl, Leander] Univ Nat Resources & Life Sci, Dept Food Sci & Technol, Muthgasse 18, A-1190 Vienna, Austria; [Gludovacz, Elisabeth; Jilma, Bernd; Boehm, Thomas] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Clin Pharmacol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Ulm, Barbara; Pils, Sophie] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Obstet & Gynecol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Med Stat IMS, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [de Carvalho, Leonor Lopes; Guedez, Gabriela; Salminen, Tiina A.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Tykistokatu 6A, FIN-20520 Turku, Finland	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Abo Akademi University	Borth, N (corresponding author), Univ Nat Resources & Life Sci, Dept Biotechnol, Muthgasse 18, A-1190 Vienna, Austria.; Boehm, T (corresponding author), Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Dept Clin Pharmacol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	nicole.borth@boku.ac.at; thomas.boehm@meduniwien.ac.at	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021; Guédez, Gabriela/O-2180-2019	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Guédez, Gabriela/0000-0002-3711-8470; Jilma, Bernd/0000-0001-5652-7977; Gludovacz, Elisabeth/0000-0002-1837-2422; Sutzl, Leander/0000-0002-8889-2343; Ristl, Robin/0000-0002-4163-9236; Altmann, Friedrich/0000-0002-0112-7877; Grunwald-Gruber, Clemens/0000-0002-6097-8348	Academy of Finland [288534]; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Academy of Finland Grant 288534 (to T.A.S.), the National Doctoral Programme in Informational and Structural Biology (to L.L.C.), and The Sigrid Juselius Foundation (to T.A.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bartko J, 2016, ALCOHOL, V54, P51, DOI 10.1016/j.alcohol.2016.06.001; BAYLIN SB, 1975, BIOCHIM BIOPHYS ACTA, V397, P294, DOI 10.1016/0005-2744(75)90119-9; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Bligt-Linden E, 2013, J MED CHEM, V56, P9837, DOI 10.1021/jm401372d; Boehm T, 2017, CLIN BIOCHEM, V50, P444, DOI 10.1016/j.clinbiochem.2016.12.011; Caramelo JJ, 2015, FEBS LETT, V589, P3379, DOI 10.1016/j.febslet.2015.07.021; CRABBE JC, 1976, BIOCHEM J, V155, P679; DAGOSTINO L, 1986, DIGESTION, V34, P243, DOI 10.1159/000199337; DANIELE B, 1990, GASTROENTEROLOGY, V99, P1675, DOI 10.1016/0016-5085(90)90474-F; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Dumont J, 2016, CRIT REV BIOTECHNOL, V36, P1110, DOI 10.3109/07388551.2015.1084266; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elmore BO, 2002, J BIOL INORG CHEM, V7, P565, DOI 10.1007/s00775-001-0331-1; GAHL WA, 1982, BRIT J OBSTET GYNAEC, V89, P202, DOI 10.1111/j.1471-0528.1982.tb03614.x; Gludovacz E, 2016, J BIOTECHNOL, V227, P120, DOI 10.1016/j.jbiotec.2016.04.002; Green MR., 2012, MOL CLONING LAB MANU; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Imamura Y, 1997, GENOMICS, V40, P277, DOI 10.1006/geno.1996.4570; Jitsuhara Y, 2002, J BIOCHEM, V132, P803, DOI 10.1093/oxfordjournals.jbchem.a003290; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Klanert G, 2014, BIOTECHNOL J, V9, P538, DOI 10.1002/biot.201300216; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurkijarvi R, 1998, J IMMUNOL, V161, P1549; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAYMON CARL W., 1939, JOUR INVEST DERMAT, V2, P301; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Maintz L, 2008, HUM REPROD UPDATE, V14, P485, DOI 10.1093/humupd/dmn014; McGrath AP, 2010, BIOCHEMISTRY-US, V49, P8316, DOI 10.1021/bi1010915; McGrath AP, 2010, ACTA CRYSTALLOGR F, V66, P137, DOI 10.1107/S1744309109052130; McGrath AP, 2009, BIOCHEMISTRY-US, V48, P9810, DOI 10.1021/bi9014192; Meuris L, 2014, NAT BIOTECHNOL, V32, P485, DOI 10.1038/nbt.2885; Miller H, 1940, J AMER MED ASSOC, V114, P1742; Nymalm Y, 2003, ACTA CRYSTALLOGR D, V59, P1288, DOI 10.1107/S090744490300979X; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Pichler J, 2009, J BIOTECHNOL, V141, P80, DOI 10.1016/j.jbiotec.2009.03.001; Probst OC, 2006, J CELL SCI, V119, P4935, DOI 10.1242/jcs.03283; Rose DR, 2012, CURR OPIN STRUC BIOL, V22, P558, DOI 10.1016/j.sbi.2012.06.005; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 2007, PROG INFLAM RES, P237, DOI DOI 10.1007/978-3-7643-7975-9_; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; SATTLER J, 1988, AGENTS ACTIONS, V23, P361, DOI 10.1007/BF02142588; Schwelberger HG, 2007, J NEURAL TRANSM, V114, P757, DOI 10.1007/s00702-007-0684-x; Schwelberger HG, 1999, INFLAMM RES, V48, pS83; Schwelberger HG, 2013, J NEURAL TRANSM, V120, P983, DOI 10.1007/s00702-013-0983-3; SJAASTAD OV, 1967, Q J EXP PHYSIOL CMS, V52, P319, DOI 10.1113/expphysiol.1967.sp001918; Skropeta D, 2009, BIOORGAN MED CHEM, V17, P2645, DOI 10.1016/j.bmc.2009.02.037; Slominska-Wojewodzka M, 2015, MOLECULES, V20, P9816, DOI 10.3390/molecules20069816; SOUTHREN AL, 1964, AM J OBSTET GYNECOL, V89, P199; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Toyoda T, 2002, J BIOCHEM, V131, P511, DOI 10.1093/oxfordjournals.jbchem.a003128; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2016, SYMBOL NOMENCLATURE; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wang H, 2016, J PROTEOME RES, V15, P923, DOI 10.1021/acs.jproteome.5b00921; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493	71	8	9	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1070	1087		10.1074/jbc.M117.814244	http://dx.doi.org/10.1074/jbc.M117.814244			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187599	Green Published, hybrid			2022-12-28	WOS:000422864500026
J	Yang, J; Zhang, R; Jiang, X; Lv, JZ; Li, Y; Ye, HY; Liu, WJ; Wang, G; Zhang, CC; Zheng, N; Dong, M; Wang, Y; Chen, PY; Santosh, K; Jiang, Y; Liu, J				Yang, Jie; Zhang, Rui; Jiang, Xin; Lv, Jingzhang; Li, Ying; Ye, Hongyu; Liu, Wenjuan; Wang, Gang; Zhang, Cuicui; Zheng, Na; Dong, Ming; Wang, Yan; Chen, Peiya; Santosh, Kumar; Jiang, Yong; Liu, Jie			Toll-like receptor 4-induced ryanodine receptor 2 oxidation and sarcoplasmic reticulum Ca2+ leakage promote cardiac contractile dysfunction in sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; POLYMICROBIAL SEPSIS; THERAPEUTIC STRATEGY; DEFECTIVE REGULATION; FREE-RADICALS; HEART; RELEASE; FKBP12.6; CHANNELS; BINDING	Studies suggest the potential role of a sarcoplasmic reticulum (SR) Ca2+ leak in cardiac contractile dysfunction in sepsis. However, direct supporting evidence is lacking, and the mechanisms underlying this SR leak are poorly understood. Here, we investigated the changes in cardiac Ca2+ handling and contraction in LPS-treated rat cardiomyocytes and a mouse model of polymicrobial sepsis produced by cecal ligation and puncture (CLP). LPS decreased the systolic Ca2+ transient and myocyte contraction as well as SR Ca2+ content. Meanwhile, LPS increased Ca2+ spark-mediated SR Ca2+ leak. Preventing the SR leak with ryanodine receptor (RyR) blocker tetracaine restored SR load and increased myocyte contraction. Similar alterations in Ca2+ handling were observed in cardiomyocytes from CLP mice. Treatment with JTV-519, an anti-SR leak drug, restored Ca2+ handling and improved cardiac function. In the LPS-treated cardiomyocytes, mitochondrial reactive oxygen species and oxidative stress in RyR2 were increased, whereas the levels of the RyR2-associated FK506-binding protein 1B (FKBP12.6) were decreased. The Toll-like receptor 4 (TLR4)-specific inhibitor TAK-242 reduced the oxidative stress in LPS-treated cells, decreased the SR leak, and normalized Ca2+ handling and myocyte contraction. Consistently, TLR4 deletion significantly improved cardiac function and corrected abnormal Ca2+ handling in the CLP mice. This study provides evidence for the critical role of the SR Ca2+ leak in the development of septic cardiomyopathy and highlights the therapeutic potential of JTV-519 by preventing SR leak. Furthermore, it reveals that TLR4 activation-induced mitochondrial reactive oxygen species production and the resulting oxidative stress in RyR2 contribute to the SR Ca2+ leak.	[Yang, Jie; Zhang, Rui; Jiang, Yong; Liu, Jie] Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China; [Yang, Jie; Li, Ying; Liu, Wenjuan; Wang, Gang; Zhang, Cuicui; Zheng, Na; Dong, Ming; Wang, Yan; Chen, Peiya; Santosh, Kumar; Liu, Jie] Shenzhen Univ, Sch Med, Dept Pathophysiol, Shenzhen 518060, Peoples R China; [Jiang, Xin] Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 2, Dept Cardiol, Shenzhen 518000, Peoples R China; [Lv, Jingzhang] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen 518045, Peoples R China; [Ye, Hongyu] Zhongshan Peoples Hosp, Dept Cardiothorac Surg, Zhongshan 528415, Peoples R China	Southern Medical University - China; Shenzhen University; Jinan University	Liu, J (corresponding author), Shenzhen Univ, Sch Med, Dept Pathophysiol, Shenzhen 518060, Peoples R China.; Jiang, Y (corresponding author), Southern Med Univ, State Key Lab Organ Failure Res, Guangdong Prov Key Lab Prote, Guangzhou 510515, Guangdong, Peoples R China.	jiang48231@163.com; liuj@szu.edu.cn	Li, Ying/AAC-1331-2021; liu, wen/HGE-3071-2022		National Science Foundation of China [31371159, 31671179, 81401570, 31400982, 81670211, 81372030]; Basic Research Foundation of SZ [JCYJ20160308091147262]; NSFC-Guangdong Joint Foundation of China [U1601225]; Key Scientific and Technological Program of Guangzhou City [201607020016]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Foundation of SZ; NSFC-Guangdong Joint Foundation of China; Key Scientific and Technological Program of Guangzhou City	This work was supported by National Science Foundation of China Grants 31371159 and 31671179 (to J. L.), 81401570 (to J. X.), 31400982 (to W. L.), 81670211 (to G. W.), and 81372030 (to J. Y.); by Basic Research Foundation of SZ Grant JCYJ20160308091147262 (to J. L.); by NSFC-Guangdong Joint Foundation of China Grant U1601225 (to J. Y.); and by Key Scientific and Technological Program of Guangzhou City Grant 201607020016 (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Bers DM, 2005, ANN NY ACAD SCI, V1047, P86, DOI 10.1196/annals.1341.008; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Blayney LM, 2010, CARDIOVASC RES, V85, P68, DOI 10.1093/cvr/cvp273; Bode EF, 2011, J PHYSIOL-LONDON, V589, P4723, DOI 10.1113/jphysiol.2011.211052; Cimolai MC, 2015, INT J MOL SCI, V16, P17763, DOI 10.3390/ijms160817763; Cheng HP, 2002, FRONT BIOSCI, V7, pD1867, DOI 10.2741/cheng; Deng JX, 2008, FREE RADICAL BIO MED, V44, P375, DOI 10.1016/j.freeradbiomed.2007.09.023; Deng JX, 2012, J MOL CELL CARDIOL, V53, P646, DOI 10.1016/j.yjmcc.2012.08.009; Du B, 2013, CRIT CARE MED, V41, P84, DOI 10.1097/CCM.0b013e31826a4082; Duncan DJ, 2010, CELL CALCIUM, V47, P378, DOI 10.1016/j.ceca.2010.02.002; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Fauconnier J, 2011, P NATL ACAD SCI USA, V108, P13258, DOI 10.1073/pnas.1100286108; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gao M, 2015, J IMMUNOL, V195, P672, DOI 10.4049/jimmunol.1403155; Gao M, 2012, CRIT CARE MED, V40, P2390, DOI 10.1097/CCM.0b013e3182535aeb; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kong XN, 2010, J IMMUNOL, V185, P569, DOI 10.4049/jimmunol.0902315; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Kwon OS, 2016, AM J PHYSIOL-REG I, V311, pR879, DOI 10.1152/ajpregu.00253.2016; Li H, 2014, J BIOL CHEM, V289, P23075, DOI 10.1074/jbc.M114.591495; Lukyanenko V, 2001, BIOPHYS J, V81, P785, DOI 10.1016/S0006-3495(01)75741-4; Ma H, 2016, J INFECT DIS, V214, P1773, DOI 10.1093/infdis/jiw449; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; Neri M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3423450; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Okatan EN, 2013, J NUTR BIOCHEM, V24, P2110, DOI 10.1016/j.jnutbio.2013.08.002; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Raj S, 2014, J PEDIATR-US, V164, P72, DOI 10.1016/j.jpeds.2013.09.027; Reiken S, 2003, J BIOL CHEM, V278, P444, DOI 10.1074/jbc.M207028200; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Roy J, 2015, FREE RADICAL BIO MED, V86, P269, DOI 10.1016/j.freeradbiomed.2015.04.014; Sacherer M, 2012, BRIT J PHARMACOL, V167, P493, DOI 10.1111/j.1476-5381.2012.01995.x; Sepulveda M, 2017, CRIT CARE MED, V45, pE399, DOI 10.1097/CCM.0000000000002101; Terentyev D, 2008, CIRC RES, V103, P1466, DOI 10.1161/CIRCRESAHA.108.184457; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Venetucci LA, 2006, CIRC RES, V98, P1299, DOI 10.1161/01.RES.0000222000.35500.65; Wang W, 2010, AM J PHYSIOL-HEART C, V299, pH322, DOI 10.1152/ajpheart.00392.2010; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yancey DM, 2015, AM J PHYSIOL-HEART C, V308, pH651, DOI 10.1152/ajpheart.00638.2014; Yang ZK, 2005, CARDIOVASC RES, V65, P167, DOI 10.1016/j.cardiores.2004.09.008; Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131; Yano M, 2005, CIRCULATION, V112, P3633, DOI 10.1161/CIRCULATIONAHA.105.555623; Yano M, 2003, CIRCULATION, V107, P477, DOI 10.1161/01.CIR.0000044917.74408.BE; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhang CC, 2014, J MOL CELL CARDIOL, V74, P260, DOI 10.1016/j.yjmcc.2014.06.003; Zhang M, 2014, ANESTHESIOLOGY, V121, P1270, DOI 10.1097/ALN.0000000000000337; Zhang X, 2009, CARDIOVASC RES, V84, P253, DOI 10.1093/cvr/cvp212; Zhao YT, 2017, CARDIOVASC RES, V113, P332, DOI 10.1093/cvr/cvw247; Zheng J, 2010, CELL CALCIUM, V47, P449, DOI 10.1016/j.ceca.2010.03.006; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zhu XS, 2005, CRIT CARE MED, V33, P598, DOI 10.1097/01.ccm.0000152223.27176.A6	64	25	25	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					794	807		10.1074/jbc.M117.812289	http://dx.doi.org/10.1074/jbc.M117.812289			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29150444	hybrid, Green Published			2022-12-28	WOS:000422864500004
J	Zang, K; Li, FH; Ma, QJ				Zang, Kun; Li, Fuhua; Ma, Qingjun			The dUTPase of white spot syndrome virus assembles its active sites in a noncanonical manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEOXYURIDINE TRIPHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PROTEIN STRUCTURES; TRIMERIC DUTPASES; ESCHERICHIA-COLI; PYROPHOSPHATASE; MECHANISM; LIGAND; IDENTIFICATION; REFINEMENT	dUTPases are essential enzymes for maintaining genome integrity and have recently been shown to play moonlighting roles when containing extra sequences. Interestingly, the trimeric dUTPase of white spot syndrome virus (wDUT) harbors a sequence insert at the position preceding the C-terminal catalytic motifV(pre-V insert), rarely seen in other dUTPases. However, whether this extra sequence endowswDUTwith additional properties is unknown. Herein, we present the crystal structures of wDUT in both ligand-free and ligand-bound forms. We observed that the pre-V insert in wDUT forms an unusual beta-hairpin structure in the domain-swapping region and thereby facilitates a unique orientation of the adjacent C-terminal segment, positioning the catalytic motif V onto the active site of its own subunit instead of a third subunit. Consequently, wDUT employs two-subunit active sites, unlike the widely accepted paradigm that the active site of trimeric dUTPase is contributed by all three subunits. According to results from local structural comparisons, the active-site configuration ofwDUTis similar to that of known dUTPases. However, we also found that residues in the second-shell region of the active site are reconfigured in wDUT as an adaption to its unique C-terminal orientation. We also show that deletion of the pre-V insert significantly reduces wDUT's enzymatic activity and thermal stability. We hypothesize that this rare structural arrangement confers additional functionality to wDUT. In conclusion, our study expands the structural diversity in the conserved dUTPase family and illustrates how sequence insertion and amino acid substitution drive protein evolution cooperatively.	[Zang, Kun; Li, Fuhua; Ma, Qingjun] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China; [Zang, Kun; Li, Fuhua; Ma, Qingjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China; [Zang, Kun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ma, QJ (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Nanhai Rd 7, Qingdao 266071, Peoples R China.; Ma, QJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266237, Peoples R China.	qma@qdio.ac.cn			National Natural Science Foundation of China [31572660]; 1000 Talents Program of China; 100 Talents Program of the Chinese Academy of Sciences; AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant [2015ASTP]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1000 Talents Program of China; 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant	This work was supported by National Natural Science Foundation of China Grant 31572660, the 1000 Talents Program of China, the 100 Talents Program of the Chinese Academy of Sciences, and the AoShan Talents Program of Qingdao National Laboratory for Marine Science and Technology Grant 2015ASTP (to Q. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Tormo-Mas MA, 2013, MOL CELL, V49, P947, DOI 10.1016/j.molcel.2012.12.013; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Ariza ME, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00504; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; CEDERGRENZEPPEZAUER ES, 1992, NATURE, V355, P740, DOI 10.1038/355740a0; Chu RY, 1996, J BIOL CHEM, V271, P27670, DOI 10.1074/jbc.271.44.27670; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GADSDEN MH, 1993, EMBO J, V12, P4425, DOI 10.1002/j.1460-2075.1993.tb06127.x; Garcia-Nafria J, 2013, ACTA CRYSTALLOGR D, V69, P1367, DOI 10.1107/S090744491300735X; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Harkiolaki M, 2004, STRUCTURE, V12, P41, DOI 10.1016/j.str.2003.11.016; Homma K, 2009, ACTA CRYSTALLOGR F, V65, P1030, DOI 10.1107/S1744309109034459; Hormozdiari F, 2009, J COMPUT BIOL, V16, P159, DOI 10.1089/cmb.2008.03TT; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu XQ, 2005, VIRUS RES, V110, P21, DOI 10.1016/j.virusres.2005.01.003; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Madrid AS, 2012, J VIROL, V86, P8693, DOI 10.1128/JVI.00252-12; Maiques E, 2016, NUCLEIC ACIDS RES, V44, P5457, DOI 10.1093/nar/gkw317; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyahara S, 2012, J MED CHEM, V55, P5483, DOI 10.1021/jm300416h; Mol CD, 1996, STRUCTURE, V4, P1077, DOI 10.1016/S0969-2126(96)00114-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy GN, 2016, J AM CHEM SOC, V138, P15035, DOI 10.1021/jacs.6b09012; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nyiri K, 2017, BBA-GEN SUBJECTS, V1861, P3593, DOI 10.1016/j.bbagen.2016.05.024; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Pecsi I, 2011, P NATL ACAD SCI USA, V108, P14437, DOI 10.1073/pnas.1013872108; Penades JR, 2013, CURR OPIN MICROBIOL, V16, P163, DOI 10.1016/j.mib.2013.02.005; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson JA, 2008, ACCOUNTS CHEM RES, V41, P1278, DOI 10.1021/ar700259k; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Takacs E, 2010, FEBS LETT, V584, P3047, DOI 10.1016/j.febslet.2010.05.018; Tarbouriech N, 2005, STRUCTURE, V13, P1299, DOI 10.1016/j.str.2005.06.009; Tchigvintsev A, 2011, BIOCHEM J, V437, P243, DOI 10.1042/BJ20110304; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130; Varga B, 2007, FEBS LETT, V581, P4783, DOI 10.1016/j.febslet.2007.09.005; Verbruggen B, 2016, VIRUSES, V8, pE23; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Vertessy BG, 1996, BIOCHEM BIOPH RES CO, V219, P294, DOI 10.1006/bbrc.1996.0226; Vertessy BG, 1997, PROTEINS, V28, P568, DOI 10.1002/(SICI)1097-0134(199708)28:4<568::AID-PROT10>3.0.CO;2-E; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang QS, 2015, NUCL SCI TECH, V26, P12, DOI 10.13538/j.1001-8042/nst.26.010102; Williams D, 2011, BBA-MOL CELL RES, V1813, P315, DOI 10.1016/j.bbamcr.2010.11.021; Wilson PM, 2008, MOL CANCER THER, V7, P3029, DOI 10.1158/1535-7163.MCT-08-0280; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zhang R, 2017, J VIROL, V91, DOI [10.1128/JVI.01148-17, 10.1128/jvi.01148-17]	57	10	10	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					1088	1099		10.1074/jbc.M117.815266	http://dx.doi.org/10.1074/jbc.M117.815266			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29187596	Green Published, hybrid			2022-12-28	WOS:000422864500027
J	Kebouchi, M; Saul, F; Taher, R; Landier, A; Beaudeau, B; Dubrac, S; Weber, P; Haouz, A; Picardeau, M; Benaroudj, N				Kebouchi, Mounira; Saul, Frederick; Taher, Raleb; Landier, Annie; Beaudeau, Benedicte; Dubrac, Sarah; Weber, Patrick; Haouz, Ahmed; Picardeau, Mathieu; Benaroudj, Nadia			Structure and function of the Leptospira interrogans peroxide stress regulator (PerR), an atypical PerR devoid of a structural metal-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloprotein; microbiology; oxidative stress; reactive oxygen species (ROS); structural biology; transcription regulation; PerR; Leptospira; spirochetes	BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; HYDROGEN-PEROXIDE; IRON HOMEOSTASIS; FUR HOMOLOGS; OXYGEN; VIRULENCE; INSIGHTS; REGULON; RESISTANCE	Peroxide sensing is essential for bacterial survival during aerobic metabolism and host infection. Peroxide stress regulators (PerRs) are homodimeric transcriptional repressors with each monomer typically containing both structural and regulatory metal-binding sites. PerR binding to gene promoters is controlled by the presence of iron in the regulatory site, and iron-catalyzed oxidation of PerR by H2O2 leads to the dissociation of PerR from DNA. In addition to a regulatory metal, most PerRs require a structural metal for proper dimeric assembly. We present here a structural and functional characterization of the PerR from the pathogenic spirochete Leptospira interrogans, a rare example of PerR lacking a structural metal-binding site. In vivo studies showed that the leptospiral PerR belongs to the peroxide stimulon in pathogenic species and is involved in controlling resistance to peroxide. Moreover, a perR mutant had decreased fitness in other host-related stress conditions, including at 37 degrees C or in the presence of superoxide anion. In vitro, leptospiral PerR could bind to the perR promoter region in a metal-dependent manner. The crystal structure of the leptospiral PerR revealed an asymmetric homodimer, with one monomer displaying complete regulatory metal coordination in the characteristic caliper-like DNA-binding conformation and the second monomer exhibiting disrupted regulatory metal coordination in an open non-DNA-binding conformation. This structure showed that leptospiral PerR assembles into a dimer in which a metal-induced conformational switch can occur independently in the two monomers. Our study demonstrates that structural metal binding is not compulsory for PerR dimeric assembly and for regulating peroxide stress.	[Kebouchi, Mounira; Taher, Raleb; Landier, Annie; Beaudeau, Benedicte; Picardeau, Mathieu; Benaroudj, Nadia] Inst Pasteur, Unite Biol Spirochetes, F-75015 Paris, France; [Saul, Frederick; Weber, Patrick; Haouz, Ahmed] Inst Pasteur, CNRS, UMR 3528, Plate Forme Cristallog, F-75015 Paris, France; [Dubrac, Sarah] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75015 Paris, France; [Kebouchi, Mounira] Univ Lorraine, INRA, UR AFPA, PB2P, F-54518 Vandoeuvre Les Nancy, France; [Taher, Raleb] Inst Biol Struct, 71 Ave Martyrs, F-38044 Grenoble 9, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Universite de Lorraine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Picardeau, M; Benaroudj, N (corresponding author), Inst Pasteur, Unite Biol Spirochetes, F-75015 Paris, France.	mathieu.picardeau@pasteur.fr; nadia.benaroudj@pasteur.fr		Sarah, Dubrac/0000-0002-9810-5390; Benaroudj, Nadia/0000-0002-6475-0041; HAOUZ, Ahmed/0000-0003-1196-1635	Institut Pasteur; Agence National de la Recherche [ANR-08-MIE-018]	Institut Pasteur(European Commission); Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by the Institut Pasteur and Agence National de la Recherche Grant ANR-08-MIE-018. The authors declare that they have no conflicts of interest with the contents of this article.	Adler B, 2014, VET MICROBIOL, V172, P353, DOI 10.1016/j.vetmic.2014.06.015; Ahn BE, 2016, P NATL ACAD SCI USA, V113, pE23, DOI 10.1073/pnas.1522687112; Araujo AM, 2014, AM J TROP MED HYG, V90, P719, DOI 10.4269/ajtmh.13-0667; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deng ZQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8642; Derre I, 1999, MOL MICROBIOL, V31, P117, DOI 10.1046/j.1365-2958.1999.01152.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdogan HM, 2008, VET RES COMMUN, V32, P333, DOI 10.1007/s11259-008-9036-z; Eshghi A, 2012, INFECT IMMUN, V80, P3892, DOI 10.1128/IAI.00466-12; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; Fujishima K, 2013, APPL ENVIRON MICROB, V79, P1436, DOI 10.1128/AEM.03306-12; Giedroc DP, 2009, MOL MICROBIOL, V73, P1, DOI 10.1111/j.1365-2958.2009.06752.x; Gryllos I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000145; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hillmann F, 2008, MOL MICROBIOL, V68, P848, DOI 10.1111/j.1365-2958.2008.06192.x; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Lin CSH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089027; Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10; Long LH, 1999, BIOCHEM BIOPH RES CO, V262, P605, DOI 10.1006/bbrc.1999.1263; Makthal N, 2013, J BIOL CHEM, V288, P18311, DOI 10.1074/jbc.M113.456590; Marangoni A, 2006, WORLD J GASTROENTERO, V12, P3077, DOI 10.3748/wjg.v12.i19.3077; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Pappas CJ, 2015, APPL ENVIRON MICROB, V81, P3176, DOI 10.1128/AEM.00173-15; Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; ROVIN BH, 1990, KIDNEY INT, V37, P1509, DOI 10.1038/ki.1990.142; Sethu R, 2016, ACS CHEM BIOL, V11, P1438, DOI 10.1021/acschembio.5b01054; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shlyonsky V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9512807; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Wen YT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85; Zhukova A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00010	57	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					497	509		10.1074/jbc.M117.804443	http://dx.doi.org/10.1074/jbc.M117.804443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29146596	Green Published, hybrid			2022-12-28	WOS:000419915400007
J	Charley, PA; Wilusz, CJ; Wilusz, J				Charley, Phillida A.; Wilusz, Carol J.; Wilusz, Jeffrey			Identification of phlebovirus and arenavirus RNA sequences that stall and repress the exoribonuclease XRN1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBGENOMIC FLAVIVIRUS RNA; GENE-EXPRESSION; HUR PROTEIN; MOSQUITO; TRANSCRIPTION; DEGRADATION; PSEUDOKNOT; POLYADENYLATION; DEADENYLATION; INTERFERENCE	Regulated mRNA decay plays a vital role in determining both the level and quality of cellular gene expression. Viral RNAs must successfully evade this host RNA decay machinery to establish a productive infection. One way for RNA viruses to accomplish this is to target the cellular exoribonuclease XRN1, because this enzyme is accessible in the cytoplasm and plays a major role in mRNA decay. Members of the Flaviviridae use RNA structures in their 5 -or 3 -untranslated regions to stall and repress XRN1, effectively stabilizing viral RNAs while also causing significant dysregulation of host cell mRNA stability. Here, we use a series of biochemical assays to demonstrate that the 3 -terminal portion of the nucleocapsid (N) mRNA of Rift Valley fever virus, a phlebovirus of the Bunyaviridae family, also can effectively stall and repress XRN1. The region responsible for impeding XRN1 includes a G-rich portion that likely forms a G-quadruplex structure. The 3 -terminal portions of ambisense-derived transcripts of multiple arenaviruses also stalled XRN1. Therefore, we conclude thatRNAsfrom two additional families of mammalian RNA viruses stall and repress XRN1. This observation. emphasizes the importance and commonality of this viral strategy to interfere with the 5 -to-3 exoribonuclease component of the cytoplasmic RNA decay machinery	[Charley, Phillida A.; Wilusz, Carol J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Wilusz, Carol/AAC-2901-2021		National Institutes of Health [AI123136]; College of Veterinary Medicine and Biomedical Sciences College Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine and Biomedical Sciences College Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI123136 and a grant from the College of Veterinary Medicine and Biomedical Sciences College Research Council (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Akiyama BM, 2016, CURR OPIN STRUC BIOL, V36, P40, DOI 10.1016/j.sbi.2015.12.006; Alkan C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004519; Balistreri G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010024; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242; Bosco-Lauth AM, 2016, EMERG INFECT DIS, V22, P2070, DOI 10.3201/eid2212.160472; Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022; CHANG JH, 2011, MOL BIOL, V18, P270, DOI DOI 10.1038/NSMB.1984; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Charley PA, 2014, CURR OPIN VIROL, V9, P14, DOI 10.1016/j.coviro.2014.09.001; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Cheng CP, 2006, J VIROL, V80, P2631, DOI 10.1128/JVI.80.6.2631-2640.2006; Cheng E, 2012, J VIROL, V86, P10173, DOI 10.1128/JVI.05560-11; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Flobinus A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100272; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garneau NL, 2008, J VIROL, V82, P880, DOI 10.1128/JVI.01205-07; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Grande-Perez A, 2016, CURR TOP MICROBIOL, V392, P231, DOI 10.1007/82_2015_468; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hogg JR, 2016, J VIROL, V90, P7010, DOI 10.1128/JVI.00607-16; Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08; Jaag HM, 2009, VIROLOGY, V386, P344, DOI 10.1016/j.virol.2009.01.015; Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599; Linthicum KJ, 2016, ANNU REV ENTOMOL, V61, P395, DOI 10.1146/annurev-ento-010715-023819; Lopez N, 2007, VIRUS RES, V124, P237, DOI 10.1016/j.virusres.2006.10.007; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Millevoi S, 2012, WIRES RNA, V3, P495, DOI 10.1002/wrna.1113; Molleston JM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010002; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708; Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Nagarajan VK, 2013, BBA-GENE REGUL MECH, V1829, P590, DOI 10.1016/j.bbagrm.2013.03.005; OPYRCHAL M, 2005, MOL BIOL, V235, P1321, DOI DOI 10.1016/J.IBMB.2005.08.004; Pashler AL, 2016, BIOCHEM SOC T, V44, P1377, DOI 10.1042/BST20160107; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Stammler SN, 2011, RNA, V17, P1747, DOI 10.1261/rna.2816711; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Ullmer W, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120335; WILUSZ J, 1988, CELL, V52, P221, DOI 10.1016/0092-8674(88)90510-7; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07	54	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					285	295		10.1074/jbc.M117.805796	http://dx.doi.org/10.1074/jbc.M117.805796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29118186	hybrid, Green Published			2022-12-28	WOS:000419453200024
J	Skowronska, M; McDonald, M; Velichkovska, M; Leda, AR; Park, M; Toborek, M				Skowronska, Marta; McDonald, Marisa; Velichkovska, Martina; Leda, Ana Rachel; Park, Minseon; Toborek, Michal			Methamphetamine increases HIV infectivity in neural progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADULT HIPPOCAMPAL NEUROGENESIS; LASER CAPTURE MICRODISSECTION; CENTRAL-NERVOUS-SYSTEM; ANTIRETROVIRAL THERAPY; STEM-CELLS; POTENTIAL ROLE; VIRAL LOAD; NEURODEGENERATIVE DISEASES; TYPE-1 INFECTION	HIV-1 infection and methamphetamine (METH) abuse frequently occur simultaneously and may have synergistic pathological effects. Although HIV-positive/active METH users have been shown to have higher HIV viral loads and experience more severe neurological complications than non-users, the direct impact of METH on HIV infection and its link to the development of neurocognitive alternations are still poorly understood. In the present study, we hypothesized that METH impacts HIV infection of neural progenitor cells (NPCs) by a mechanism encompassingNF B/SP1-mediatedHIVLTRactivation. Mouse and human NPCs were infected with EcoHIV (modified HIV virus infectious to mice) and HIV, respectively, in the presence or absence of METH (50 or 100 M). Pretreatment with METH, but not simultaneous exposure, significantly increased HIV production in both mouse and human NPCs. To determine the mechanisms underlying these effects, cells were transfected with different variants of HIV LTR promoters and then exposed toMETH. METHtreatment induced transcriptional activity of the HIV LTR promotor, an effect that required both NF B and SP1 signaling. Pretreatment with METH also decreased neuronal differentiation of HIV-infected NPCs in both in vitro and in vivo settings. Importantly, NPC-derived daughter cells appeared to be latently infected with HIV. This study indicates that METH increases HIV infectivity of NPCs, through the NF B/SP1-dependentactivationoftheHIVLTRandwiththesubsequentalterations of NPC neurogenesis. Such events may underlie METH-exacerbated neurocognitive dysfunction in HIV-infected patients.	[Skowronska, Marta; McDonald, Marisa; Velichkovska, Martina; Leda, Ana Rachel; Park, Minseon; Toborek, Michal] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA; [Toborek, Michal] Jerzy Kukuczka Acad Phys Educ, PL-40001 Katowice, Poland	University of Miami; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Skowronska, M; Toborek, M (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, 528 Gautier Bldg,1011 NW 15th St, Miami, FL 33136 USA.	m.skowronska@miami.edu; mtoborek@med.miami.edu	Leda, Ana/AAD-9372-2021	Leda, Ana/0000-0003-0276-0487	National Institutes of Health (NIH) [DA039576, DA044579, DA027569, HL126559, MH098891, MH072567]; Miami Center for AIDS Research - NIH [P30AI073961]; NIH [NSC 2015/17/B/NZ7/02985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072567, R01MH098891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA044579, R01DA039576, R01DA027569] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Center for AIDS Research - NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) Grants DA039576, DA044579, DA027569, HL126559, MH098891, and MH072567 and by the Miami Center for AIDS Research, funded by NIH Grant P30AI073961. This work was also supported by NIH Grant NSC 2015/17/B/NZ7/02985. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Banerjee A, 2010, FREE RADICAL BIO MED, V48, P1388, DOI 10.1016/j.freeradbiomed.2010.02.023; Borgmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01143; Canto-Noges C, 2005, J MOL NEUROSCI, V27, P79, DOI 10.1385/JMN:27:1:079; Carrico AW, 2007, PSYCHOSOM MED, V69, P785, DOI 10.1097/PSY.0b013e318157b142; Chang SL, 2014, INT REV NEUROBIOL, V118, P403, DOI 10.1016/B978-0-12-801284-0.00013-0; Clarke JN, 2006, VIROLOGY, V348, P141, DOI 10.1016/j.virol.2005.12.004; Curtis MA, 2005, J CHEM NEUROANAT, V30, P55, DOI 10.1016/j.jchemneu.2005.05.001; Curtis MA, 2007, CLIN EXP PHARMACOL P, V34, P528, DOI 10.1111/j.1440-1681.2007.04609.x; Curtis MA, 2003, CELL CYCLE, V2, P428, DOI 10.4161/cc.2.5.526; Demeter K, 2004, EXP NEUROL, V188, P254, DOI 10.1016/j.expneurol.2004.04.011; Ellis RJ, 2003, J INFECT DIS, V188, P1820, DOI 10.1086/379894; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Freeman P, 2011, ARCH PEDIAT ADOL MED, V165, P736, DOI 10.1001/archpediatrics.2011.118; Gomez-Gonzalo M, 2001, J BIOL CHEM, V276, P35435, DOI 10.1074/jbc.M103020200; Hagiwara H, 2009, BRAIN RES, V1301, P189, DOI 10.1016/j.brainres.2009.09.010; Hahn YK, 2012, GLIA, V60, P1871, DOI 10.1002/glia.22403; Hahn YK, 2010, J NEUROCHEM, V114, P97, DOI 10.1111/j.1471-4159.2010.06744.x; Hauser KF, 2014, INT REV NEUROBIOL, V118, P231, DOI 10.1016/B978-0-12-801284-0.00009-9; Hildebrandt K, 1999, J NEURAL TRANSM, V106, P549, DOI 10.1007/s007020050178; Hong SZ, 2015, BRAIN BEHAV IMMUN, V45, P1, DOI 10.1016/j.bbi.2014.10.008; Jiang JJ, 2016, DRUG ALCOHOL DEPEN, V159, P246, DOI 10.1016/j.drugalcdep.2015.12.027; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; King WD, 2009, AIDS BEHAV, V13, P145, DOI 10.1007/s10461-007-9337-1; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; Le Grand JN, 2015, CELL MOL LIFE SCI, V72, P773, DOI 10.1007/s00018-014-1774-1; Leda AR, 2017, JOVE-J VIS EXP, DOI 10.3791/54804; Lee J, 2006, FASEB J, V20, P2375, DOI 10.1096/fj.06-5957fje; Lee MH, 2011, NEUROBIOL DIS, V41, P678, DOI 10.1016/j.nbd.2010.12.002; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lieberwirth C, 2016, BRAIN RES, V1644, P127, DOI 10.1016/j.brainres.2016.05.015; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Mantri CK, 2014, AM J PATHOL, V184, P92, DOI 10.1016/j.ajpath.2013.09.011; Maragos WF, 2002, J NEUROCHEM, V83, P955, DOI 10.1046/j.1471-4159.2002.01212.x; Marcondes MCG, 2010, AM J PATHOL, V177, P355, DOI 10.2353/ajpath.2010.090953; Matinella A, 2015, J NEUROL, V262, P1317, DOI 10.1007/s00415-015-7713-8; Melega WP, 2007, SYNAPSE, V61, P216, DOI 10.1002/syn.20365; MELEGA WP, 1995, J PHARMACOL EXP THER, V274, P90; Muscarella LA, 2014, J NEUROPATH EXP NEUR, V73, P50, DOI [10.1097/NEN.0000000000000026, 10.1097/NEN.0000000000000024]; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nakamura N, 2011, ARCH SEX BEHAV, V40, P793, DOI 10.1007/s10508-010-9713-1; NICOSIA N, 2009, EC COST METHAMPHETAM; Park M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34111; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rothenaigner I, 2007, AIDS, V21, P2271, DOI 10.1097/QAD.0b013e3282f12f27; Sabri F, 1999, VIROLOGY, V264, P370, DOI 10.1006/viro.1999.9998; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Salamanca SA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00445; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Soontornniyomkij V, 2016, J NEUROIMMUNE PHARM, V11, P495, DOI 10.1007/s11481-016-9699-0; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Torres-Munoz J, 2001, J NEUROPATH EXP NEUR, V60, P885, DOI 10.1093/jnen/60.9.885; Toussi SS, 2009, AIDS RES HUM RETROV, V25, P1117, DOI 10.1089/aid.2008.0282; Trillo-Pazos G, 2003, BRAIN PATHOL, V13, P144; Varela-Nallar L, 2010, BIRTH DEFECTS RES C, V90, P284, DOI 10.1002/bdrc.20193; Wang X, 2012, CURR HIV RES, V10, P407, DOI 10.2174/157016212802138797; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Winner B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021287; Wires ES, 2012, J NEUROVIROL, V18, P400, DOI 10.1007/s13365-012-0103-4; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616; Yuan CJ, 2011, PHARMACOL BIOCHEM BE, V100, P98, DOI 10.1016/j.pbb.2011.08.004; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	75	25	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					296	311		10.1074/jbc.RA117.000795	http://dx.doi.org/10.1074/jbc.RA117.000795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29158267	hybrid, Green Published			2022-12-28	WOS:000419453200025
J	Liu, F; Xu, K; Xu, ZJ; de las Rivas, M; Wang, CR; Li, X; Lu, JS; Zhou, YY; Delso, I; Merino, P; Hurtado-Guerrero, R; Zhang, Y; Wu, F				Liu, Feng; Xu, Kai; Xu, Zhijue; de las Rivas, Matilde; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Delso, Ignacio; Merino, Pedro; Hurtado-Guerrero, Ramon; Zhang, Yan; Wu, Fang			The small molecule luteolin inhibits N-acetyl--galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid precursor protein (APP); crystal structure; glycoprotein; glycosylation inhibitor; glycosyltransferase; O-glycosylation; luteolin; ppGalNAc-T	TRANSFERASE GENE FAMILY; GALNAC-TRANSFERASE; GLCNAC TRANSFERASE; UDP-GALNAC; LINKED GLYCOSYLATION; STRUCTURAL INSIGHT; ENDOTHELIAL-CELLS; SERUM-ALBUMIN; SUBSTRATE; BETA	Mucin-type O-glycosylation is the most abundant type of O-glycosylation. It is initiated by the members of the polypeptide N-acetyl--galactosaminyltransferase (ppGalNAc-T) family and closely associated with both physiological and pathological conditions, such as coronary artery disease or Alzheimer's disease. The lack of direct and selective inhibitors of ppGalNAc-Ts has largely impeded research progress in understanding the molecular events in mucin-type O-glycosylation. Here, we report that a small molecule, the plant flavonoid luteolin, selectively inhibits ppGalNAc-Ts in vitro and in cells. We found that luteolin inhibits ppGalNAc-T2 in a peptide/protein-competitive manner but not promiscuously (e.g. via aggregation-based activity). X-ray structural analysis revealed that luteolin binds to the PXP motif-binding site found in most protein substrates, which was further validated by comparing the interactions of luteolin with wild-type enzyme and with mutants using H-1 NMR-based binding experiments. Functional studies disclosed that luteolin at least partially reduced production of -amyloid protein by selectively inhibiting the activity of ppGalNAc-T isoforms. In conclusion, our study provides key structural and functional details on luteolin inhibiting ppGalNAc-T activity, opening up the way for further optimization of more potent and specific ppGalNAc-T inhibitors. Moreover, our findings may inform future investigations into site-specific O-GalNAc glycosylation and into the molecular mechanism of luteolin-mediated ppGalNAc-T inhibition.	[Liu, Feng; Xu, Kai; Xu, Zhijue; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Zhang, Yan; Wu, Fang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [Liu, Feng; Xu, Kai; Xu, Zhijue; Wang, Congrong; Li, Xing; Lu, Jishun; Zhou, Yueyang; Zhang, Yan; Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Collaborat Innovat Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China; [de las Rivas, Matilde; Merino, Pedro; Hurtado-Guerrero, Ramon] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, E-50009 Zaragoza, Spain; [Wang, Congrong] Shanghai Univ Med & Hlth Sci, Sch Basic Med Sci, 279 Zhouzhu Rd, Shanghai 201318, Peoples R China; [Delso, Ignacio] Univ Zaragoza, ISQCH, CSIC, E-50009 Zaragoza, Aragon, Spain; [Hurtado-Guerrero, Ramon] Fdn ARAID, Zaragoza 50018, Spain; [Xu, Kai] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Shanghai University of Medicine & Health Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; Shanghai Ocean University	Hurtado-Guerrero, R (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, E-50009 Zaragoza, Spain.; Zhang, Y; Wu, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	rhurtado@bifi.es; yanzhang2006@sjtu.edu.cn; fang.wu@sjtu.edu.cn	Wu, Fang/B-1945-2008; Yang, Fang/AAF-3024-2019; Delso, Ignacio/AAW-2250-2021; Merino, Pedro/K-2742-2014; de las Rivas, Matilde/AAE-4248-2021; Delso, Ignacio/F-2952-2016	Wu, Fang/0000-0002-4194-2243; Delso, Ignacio/0000-0001-8355-2289; Merino, Pedro/0000-0002-2202-3460; Delso, Ignacio/0000-0001-8355-2289; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; de las Rivas, Matilde/0000-0002-4563-6593	National Basic Research Program of China [2012CB822103, 2011CB910603]; National High Technology Research and Development Program of China [2012AA020203]; National Natural Science Foundation [31170771, 31370806, 31570796, 31270853, 81102377]; Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad [CTQ2013-44367-C2-2-P, BFU2016-75633-P]; Diputacion General de Aragon (DGA) [B89]; EU under BioStruct-X [283570, BIOSTRUCTX 5186]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020203] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad; Diputacion General de Aragon (DGA)(Gobierno de Aragon); EU under BioStruct-X; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Basic Research Program of China Grants 2012CB822103 and 2011CB910603 (to Y. Z.); National High Technology Research and Development Program of China Grant 2012AA020203 (to Y. Z.); National Natural Science Foundation Grants 31170771 (to Y. Z.), 31370806 (to Y. Z.), and 31570796 (to Y. Z.); National Basic Research Program of China Grant 2012CB822103 (to F. W.); National Natural Science Foundation Grants 31270853 and 81102377 (to F. W.); Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad, Grants CTQ2013-44367-C2-2-P and BFU2016-75633-P (to R. H.-G.); Diputacion General de Aragon (DGA) Grant B89 (to R. H.-G.); and the EU Seventh Framework Programme (2007-2013) under BioStruct-X (Grant Agreement 283570 and BIOSTRUCTX 5186) (to R. H.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal K, 2013, J AM CHEM SOC, V135, P14189, DOI 10.1021/ja405189k; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Cai WR, 2014, EUR FOOD RES TECHNOL, V238, P121, DOI 10.1007/s00217-013-2091-x; Fielding L, 2003, CURR TOP MED CHEM, V3, P39, DOI 10.2174/1568026033392705; FISCHER JJ, 1965, J AM CHEM SOC, V87, P3237, DOI 10.1021/ja01092a040; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Ghirardello M, 2016, CHEM-EUR J, V22, P7215, DOI 10.1002/chem.201600467; Glenner G G, 1984, Appl Pathol, V2, P357; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; Halim A, 2011, P NATL ACAD SCI USA, V108, P11848, DOI 10.1073/pnas.1102664108; Hang HC, 2004, CHEM BIOL, V11, P337, DOI 10.1016/j.chembiol.2004.02.023; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Kaneko MK, 2007, FEBS LETT, V581, P331, DOI 10.1016/j.febslet.2006.12.044; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kong Y, 2015, GLYCOBIOLOGY, V25, P55, DOI 10.1093/glycob/cwu089; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li X, 2012, GLYCOBIOLOGY, V22, P602, DOI 10.1093/glycob/cwr179; Lira-Navarrete E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7937; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Mjiqiza SJ, 2013, J ETHNOPHARMACOL, V149, P648, DOI 10.1016/j.jep.2013.07.019; Narwal M, 2013, J MED CHEM, V56, P3507, DOI 10.1021/jm3018783; Pan YF, 2014, BLOOD, V124, P3656, DOI 10.1182/blood-2014-04-572107; Peng C, 2010, BIOCHEM BIOPH RES CO, V402, P680, DOI 10.1016/j.bbrc.2010.10.084; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Revoredo L, 2016, GLYCOBIOLOGY, V26, P360, DOI 10.1093/glycob/cwv108; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; SARRAZIN M, 1979, MOL PHARMACOL, V15, P71; Schedin-Weiss S, 2014, FEBS J, V281, P46, DOI 10.1111/febs.12590; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Slade PG, 2012, J PROTEOME RES, V11, P6175, DOI 10.1021/pr300810f; Song L, 2017, ELIFE, V6, DOI 10.7554/eLife.24051; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; SUGIURA M, 1982, J BIOL CHEM, V257, P9501; Theoharides TC, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00225; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Wang S., 2000, STRAIT PHARM J, V12, P23; Wang Y, 2017, J MED CHEM, V60, P263, DOI 10.1021/acs.jmedchem.6b01237; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Xu YJ, 2016, J BIOL CHEM, V291, P23477, DOI 10.1074/jbc.M116.743955; Yokoyama T, 2015, J MED CHEM, V58, P7400, DOI 10.1021/acs.jmedchem.5b00893; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	54	28	29	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21304	21319		10.1074/jbc.M117.814202	http://dx.doi.org/10.1074/jbc.M117.814202			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29061849	Green Published, hybrid			2022-12-28	WOS:000419013000008
J	McNally, BA; Pendon, ZD; Trudeau, MC				McNally, Beth A.; Pendon, Zeus D.; Trudeau, Matthew C.			hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; electrophysiology; fluorescence resonance energy transfer (FRET); hERG; potassium channel; KCNH2; Long QT syndrome; hERG1a; hERG1b; human eag-related gene	LONG-QT SYNDROME; RECTIFIER K+ CURRENT; CARDIAC-ARRHYTHMIA; DOMAIN; DEACTIVATION; FAMILY; CELLS; MOUSE; EAG; SENSITIVITY	Voltage-activated human ether-a-go-go-related gene (hERG) potassium channels are critical for the repolarization of cardiac action potentials and tune-spike frequency adaptation in neurons. Two isoforms of mammalian ERG1 channel subunits, ERG1a and ERG1b, are the principal subunits that conduct the I-Kr current in the heart and are also broadly expressed in the nervous system. However, there is little direct evidence that ERG1a and ERG1b form heteromeric channels. Here, using electrophysiology, biochemistry, and fluorescence approaches, we systematically tested for direct interactions between hERG1a and hERG1b subunits. We report 1) that hERG1a dominant-negative subunits suppress hERG1b currents (and vice versa), 2) that disulfide bonds form between single cysteine residues experimentally introduced into an extracellular loop of hERG1a and hERG1b subunits and produce hERG1a-hERG1b dimers, and 3) that hERG1a and hERG1b subunits tagged with fluorescent proteins that are FRET pairs exhibit robust energy transfer at the plasma membrane. Thus, multiple lines of evidence indicated a physical interaction between hERG1a and hERG1b, consistent with them forming heteromeric channels. Moreover, co-expression of variable ratios of hERG1a and hERG1b RNA yielded channels with deactivation kinetics that reached a plateau and were different from those of hERG1b channels, consistent with a preference of hERG1b subunits for hERG1a subunits. Cross-linking studies revealed that an equal input of hERG1a and hERG1b yields more hERG1a-hERG1a or hERG1a-hERG1b dimers than hERG1b-hERG1b dimers, also suggesting that hERG1b preferentially interacts with hERG1a. We conclude that hERG1b preferentially forms heteromeric ion channels with hERG1a at the plasma membrane.	[McNally, Beth A.; Pendon, Zeus D.; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Pendon, Zeus D.] CutisPharma Inc, Wilmington, MA 01887 USA	University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu		Trudeau, Matthew/0000-0002-6971-2589	National Institutes of Health NHLBI Grant [R01 HL083121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER	National Institutes of Health NHLBI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health NHLBI Grant R01 HL083121 (to M. C. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Gerges N, 2011, BRIT J PHARMACOL, V164, P419, DOI 10.1111/j.1476-5381.2011.01378.x; Anderson CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6535; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Guasti L, 2005, J COMP NEUROL, V491, P157, DOI 10.1002/cne.20721; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jones DK, 2016, PROG BIOPHYS MOL BIO, V120, P67, DOI 10.1016/j.pbiomolbio.2016.01.002; Jones DK, 2014, P NATL ACAD SCI USA, V111, P18073, DOI 10.1073/pnas.1414945111; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Larsen AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009021; LeesMiller JP, 1997, CIRC RES, V81, P719; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Liu QN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123951; London B, 1997, CIRC RES, V81, P870; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1991, AM J PHYSIOL, V260, pH393, DOI 10.1152/ajpheart.1991.260.2.H393; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Trudeau MC, 2011, J GEN PHYSIOL, V138, P581, DOI 10.1085/jgp.201110683; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	37	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21548	21557		10.1074/jbc.M117.816488	http://dx.doi.org/10.1074/jbc.M117.816488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089383	hybrid, Green Published			2022-12-28	WOS:000419013000029
J	Shi, WG; Gao, YH; Wang, YY; Zhou, J; Wei, ZL; Ma, XN; Ma, HP; Xian, CJ; Wang, JF; Chen, KM				Shi, Wengui; Gao, Yuhai; Wang, Yuanyuan; Zhou, Jian; Wei, Zhenlong; Ma, Xiaoni; Ma, Huiping; Xian, Cory J.; Wang, Jufang; Chen, Keming			The flavonol glycoside icariin promotes bone formation in growing rats by activating the cAMP signaling pathway in primary cilia of osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; ESTROGEN-RECEPTOR-ALPHA; MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; IN-VITRO; OSTEOCLAST FORMATION; HERBA-EPIMEDII; CYCLIC-AMP; MINERALIZATION; OSTEOPOROSIS	Icariin, a prenylated flavonol glycoside isolated from the herb Epimedium, has been considered as a potential alternative therapy for osteoporosis. Previous research has shown that, unlike other flavonoids, icariin is unlikely to act via the estrogen receptor, but its exact mechanism of action is unknown. In this study, using rat calvarial osteoblast culture and rat bone growth models, we demonstrated that icariin promotes bone formation by activating the cAMP/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway requiring functional primary cilia of osteoblasts. We found that icariin increases the peak bone mass attained by young rats and promotes the maturation and mineralization of rat calvarial osteoblasts. Icariin activated cAMP/PKA/CREB signaling of the osteoblasts by increasing intracellular cAMP levels and facilitating phosphorylation of both PKA and CREB. Blocking cAMP/PKA/CREB signaling with inhibitors of the cAMP-synthesizing adenylyl cyclase (AC) and PKA inhibitors significantly inhibited the osteogenic effect of icariin in the osteoblasts. Icariin-activated cAMP/PKA/CREB signaling was localized to primary cilia, as indicated by localization of soluble AC and phosphorylated PKA. Furthermore, blocking ciliogenesis via siRNA knockdown of a cilium assembly protein, IFT88, inhibited icariin-induced PKA and CREB phosphorylation and also abolished icariin's osteogenic effect. Finally, several of these outcomes were validated in icariin-treated rats. Together, these results provide new insights into icariin function and its mechanisms of action and strengthen existing ties between cAMP-mediated signaling and osteogenesis.	[Shi, Wengui; Gao, Yuhai; Wang, Yuanyuan; Zhou, Jian; Wei, Zhenlong; Ma, Xiaoni; Chen, Keming] CPLA, Lanzhou Gen Hosp, Inst Orthopaed, Lanzhou 730050, Gansu, Peoples R China; [Ma, Huiping] CPLA, Lanzhou Gen Hosp, Dept Pharm, Lanzhou 730050, Gansu, Peoples R China; [Xian, Cory J.] Univ South Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Wang, Jufang] Chinese Acad Sci, Inst Modern Phys, Key Lab Space Radiobiol Gansu Prov, Lanzhou 730000, Gansu, Peoples R China	University of South Australia; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Chen, KM (corresponding author), CPLA, Lanzhou Gen Hosp, Inst Orthopaed, Lanzhou 730050, Gansu, Peoples R China.; Wang, JF (corresponding author), Chinese Acad Sci, Inst Modern Phys, Key Lab Space Radiobiol Gansu Prov, Lanzhou 730000, Gansu, Peoples R China.	jufangwang@impcas.ac.cn; chenkm@lut.cn	Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022; Xian, Cory/D-2646-2009; Gao, Yuhai/AHB-5767-2022; Lv, Yuanjie/AER-0767-2022	Xian, Cory/0000-0002-8467-2845; Shi, Wengui/0000-0003-1039-3576	National Natural Sciences Foundation of China [81270963, 81471090, 81770879]; International Science & Technology Cooperation Program of China [2015DFR30940]; Natural Sciences Foundation of Gansu province [1506RJZA307]; Science and Technology Research Project of Gansu Province [145RTSA012, 17JR5RA307]; National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship [1042105]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Natural Sciences Foundation of Gansu province; Science and Technology Research Project of Gansu Province; National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Natural Sciences Foundation of China Grants 81270963, 81471090, and 81770879, the International Science & Technology Cooperation Program of China Grant 2015DFR30940, Natural Sciences Foundation of Gansu province Grant 1506RJZA307, and the Science and Technology Research Project of Gansu Province Grants 145RTSA012 and 17JR5RA307. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship number 1042105.	Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chen BL, 2016, EXP THER MED, V11, P2399, DOI 10.3892/etm.2016.3177; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Chen KM, 2005, PHARMAZIE, V60, P939; Clement CA, 2009, METHOD CELL BIOL, V94, P181, DOI 10.1016/S0091-679X(08)94009-7; Garcia-Morales V., 2017, BIOCHEM PHARMACOL, V2952, P30567; Geng WD, 2009, J CELL PHYSIOL, V220, P332, DOI 10.1002/jcp.21767; HASLAM RJ, 1978, BIOCHEM J, V176, P83, DOI 10.1042/bj1760083; Hoey David A, 2012, Front Endocrinol (Lausanne), V3, P75, DOI 10.3389/fendo.2012.00075; Ichikawa S, 2009, CALCIFIED TISSUE INT, V84, P97, DOI 10.1007/s00223-008-9200-z; Indran IR, 2016, PHARMACOL THERAPEUT, V162, P188, DOI 10.1016/j.pharmthera.2016.01.015; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Labour MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35542; Liang WN, 2012, INT J MOL MED, V30, P889, DOI 10.3892/ijmm.2012.1079; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Ma HP, 2011, J CELL BIOCHEM, V112, P916, DOI 10.1002/jcb.23007; Ma XN, 2017, J ENDOCRINOL INVEST, V40, P357, DOI 10.1007/s40618-016-0568-8; Ma X. N., 2005, PLANTA MED, V60, P939; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Marion V, 2011, KIDNEY INT, V79, P1013, DOI 10.1038/ki.2010.538; Ming LG, 2013, J CELL PHYSIOL, V228, P513, DOI 10.1002/jcp.24158; Mok SK, 2010, BRIT J PHARMACOL, V159, P939, DOI 10.1111/j.1476-5381.2009.00593.x; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nian H, 2009, PHYTOMEDICINE, V16, P320, DOI 10.1016/j.phymed.2008.12.006; Park YG, 2004, INT IMMUNOPHARMACOL, V4, P779, DOI 10.1016/j.intimp.2004.03.003; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Raychowdhury MK, 2009, AM J PHYSIOL-RENAL, V296, pF87, DOI 10.1152/ajprenal.90509.2008; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schmid A, 2014, BBA-MOL BASIS DIS, V1842, P2584, DOI 10.1016/j.bbadis.2014.07.010; Shi Wen-Gui, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2704; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Wang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23827; Wang LL, 2016, CURR PHARM DESIGN, V22, P328, DOI 10.2174/1381612822666151112145907; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Xiao HH, 2014, J STEROID BIOCHEM, V143, P141, DOI 10.1016/j.jsbmb.2014.02.019; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zhai YK, 2014, BONE, V66, P189, DOI 10.1016/j.bone.2014.06.016; Zhang DW, 2016, CALCIFIED TISSUE INT, V99, P187, DOI 10.1007/s00223-016-0138-2; Zhang G, 2007, J BONE MINER RES, V22, P1072, DOI 10.1359/JBMR.070405; Zheng D, 2012, BONE, V51, P85, DOI 10.1016/j.bone.2012.04.006	52	38	42	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20883	20896		10.1074/jbc.M117.809517	http://dx.doi.org/10.1074/jbc.M117.809517			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089388	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000418453400007
J	Sengupta, I; Das, D; Singh, SP; Chakravarty, R; Das, C				Sengupta, Isha; Das, Dipanwita; Singh, Shivaram Prasad; Chakravarty, Runu; Das, Chandrima			Host transcription factor Speckled 110 kDa (Sp110), a nuclear body protein, is hijacked by hepatitis B virus protein X for viral persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; hepatitis B virus (HBV; Hep B); signal transducers and activators of transcription 1 (STAT1); small ubiquitin-like modifier (SUMO); viral protein; promyelocytic leukemia nuclear Bodies; Speckled 110 kDa (Sp110); hepatitis B virus protein x (HBx); type I interferon-response pathway	INDUCED HEPATOCELLULAR-CARCINOMA; HEPATOMA-CELL LINES; PULMONARY TUBERCULOSIS; GENE-EXPRESSION; DNA-DAMAGE; REPLICATION; INHIBITION; HBX; IDENTIFICATION; RECEPTOR	Promyelocytic leukemia nuclear bodies (PML-NB) are sub-nuclear organelles that are the hub of numerous proteins. DNA/RNA viruses often hijack the cellular factors resident in PML-NBs to promote their proliferation in host cells. Hepatitis B virus (HBV), belonging to Hepadnaviridae family, remains undetected in early infection as it does not induce the innate immune response and is known to be the cause of several hepatic diseases leading to cirrhosis and hepatocellular carcinoma. The association of PML-NB proteins and HBV is being addressed in a number of recent studies. Here, we report that the PML-NB protein Speckled 110 kDa (Sp110) is SUMO1-modified and undergoes a deSUMOylation-driven release from the PML-NB in the presence of HBV. Intriguingly, Sp110 knockdown significantly reduced viral DNA load in the culture supernatant by activation of the type I interferon-response pathway. Furthermore, we found that Sp110 differentially regulates several direct target genes of hepatitis B virus protein X (HBx), a viral co-factor. Subsequently, we identified Sp110 as a novel interactor of HBx and found this association to be essential for the exit of Sp110 from the PML-NB during HBV infection and HBx recruitment on the promoter of these genes. HBx, in turn, modulates the recruitment of its associated transcription cofactors p300/HDAC1 to these co-regulated genes, thereby altering the host gene expression program in favor of viral persistence. Thus, we report a mechanism by which HBV can evade host immune response by hijacking the PML-NB protein Sp110, and therefore, we propose it to be a novel target for antiviral therapy.	[Sengupta, Isha; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India; [Das, Dipanwita; Chakravarty, Runu] Infect Dis & Beliaghata Gen Hosp Campus, Indian Council Med Res ICMR Virus Unit, Kolkata 700010, India; [Singh, Shivaram Prasad] Kalinga Gastroenterol Fdn, Beam Diagnost Premises, Cuttack 753001, Orissa, India	Saha Institute of Nuclear Physics	Das, C (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India.	chandrima.das@saha.ac.in	Das, Chandrima/AAI-7398-2021; Singh, Shivaram Prasad/AAR-1521-2020	Singh, Shivaram Prasad/0000-0002-8197-2674; Sengupta, Isha/0000-0003-0575-3960; Das, Dipanwita/0000-0002-4804-2141; Das, Chandrima/0000-0002-8117-2810	Department of Atomic Energy, Government of India [12-RD-SIN-5.04-0103]	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was supported in part by Research Grants titled Biomolecular Assembly, Recognition, and Dynamics (BARD) Project Grant 12-R&D-SIN-5.04-0103 by the Department of Atomic Energy, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikary S, 2016, J BIOL CHEM, V291, P2664, DOI 10.1074/jbc.M115.679985; Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Bandopadhyay M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0085-6; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai Dawei, 2013, Methods Mol Biol, V1030, P151, DOI 10.1007/978-1-62703-484-5_13; Cai L, 2013, HUM GENET, V132, P265, DOI 10.1007/s00439-012-1244-5; Cai L, 2011, MED CHEM, V7, P121, DOI 10.2174/157340611794859343; Chae S, 2013, CARCINOGENESIS, V34, P1680, DOI 10.1093/carcin/bgt105; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Cheng ZK, 2016, J MED VIROL, V88, P653, DOI 10.1002/jmv.24366; Cheng ZK, 2015, VIROL SIN, V30, P261, DOI 10.1007/s12250-015-3584-5; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Choi J, 2003, BIOCHEM BIOPH RES CO, V305, P1049, DOI 10.1016/S0006-291X(03)00881-7; Chung YL, 2013, J PATHOL, V230, P377, DOI 10.1002/path.4195; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Cromlish JA, 1996, TRENDS MICROBIOL, V4, P270, DOI 10.1016/0966-842X(96)10046-9; Datta S, 2006, J MED VIROL, V78, P53, DOI 10.1002/jmv.20503; Decorsiere A, 2016, NATURE, V531, P386, DOI 10.1038/nature17170; Duprez E, 1999, J CELL SCI, V112, P381; Gearhart TL, 2010, VIROLOGY, V407, P14, DOI 10.1016/j.virol.2010.07.042; Genin P, 2003, J VIROL, V77, P7113, DOI 10.1128/JVI.77.12.7113-7119.2003; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Hu LA, 2011, J VIROL, V85, P3214, DOI 10.1128/JVI.01841-10; Hussain Z, 2009, J GEN VIROL, V90, P2272, DOI 10.1099/vir.0.010421-0; Kew MC, 2011, J GASTROEN HEPATOL, V26, P144, DOI 10.1111/j.1440-1746.2010.06546.x; Kim YH, 2005, FEBS LETT, V579, P6272, DOI 10.1016/j.febslet.2005.10.010; Kock J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037248; Kumar A, 2015, COMPUT STRUCT BIOTEC, V13, P204, DOI 10.1016/j.csbj.2015.03.001; Li N, 2012, HEPATOLOGY, V56, P803, DOI 10.1002/hep.25608; Liang L, 2011, INFECT GENET EVOL, V11, P934, DOI 10.1016/j.meegid.2011.02.017; Liu HY, 2012, J PROTEOME RES, V11, P4803, DOI 10.1021/pr2012297; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Mendy ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-23; Mhamdi M, 2007, HEPATOLOGY, V46, P95, DOI 10.1002/hep.21666; Moller A, 2003, ARCH IMMUNOL THER EX, V51, P295; Nakao K, 1999, J BIOL CHEM, V274, P28075, DOI 10.1074/jbc.274.40.28075; Nicewonger J, 2004, J VIROL, V78, P9412, DOI 10.1128/JVI.78.17.9412-9422.2004; Niu CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169648; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Olioso D, 2007, EUR J CLIN MICROBIOL, V26, P43, DOI 10.1007/s10096-006-0223-y; Pei RJ, 2014, WORLD J GASTROENTERO, V20, P11618, DOI 10.3748/wjg.v20.i33.11618; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Png E, 2012, INFECT GENET EVOL, V12, P1319, DOI 10.1016/j.meegid.2012.04.006; SELLS MA, 1988, J VIROL, V62, P2836, DOI 10.1128/JVI.62.8.2836-2844.1988; Shamay M, 2002, J BIOL CHEM, V277, P9982, DOI 10.1074/jbc.M111354200; Shona JK, 2009, VIRUS RES, V139, P14, DOI 10.1016/j.virusres.2008.09.006; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Sung WK, 2009, J BIOL CHEM, V284, P21941, DOI 10.1074/jbc.M109.014563; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; TRUANT R, 1995, J VIROL, V69, P1851, DOI 10.1128/JVI.69.3.1851-1859.1995; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Wang Q, 2014, INT J BIOL SCI, V10, P1181, DOI 10.7150/ijbs.10275; Wang T, 2012, CLIN IMMUNOL, V145, P102, DOI 10.1016/j.clim.2012.07.016; Wang WH, 2011, HEPATOLOGY, V53, P1137, DOI 10.1002/hep.24163; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Wu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22041; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316; Zhang T, 2013, J PROTEOMICS, V84, P92, DOI 10.1016/j.jprot.2013.03.028; Zhang Xiaoyong, 2013, Frontiers in Genetics, V4, P202, DOI 10.3389/fgene.2013.00202	65	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20379	20393		10.1074/jbc.M117.796839	http://dx.doi.org/10.1074/jbc.M117.796839			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29046350	hybrid, Green Published			2022-12-28	WOS:000418267000003
J	Son, S; Hwang, I; Han, SH; Shin, JS; Shin, OS; Yu, JW				Son, Seunghwan; Hwang, Inhwa; Han, Seung Hyeok; Shin, Jeon-Soo; Shin, Ok Sarah; Yu, Je-Wook			Advanced glycation end products impair NLRP3 inflammasome-mediated innate immune responses in macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycation; inflammasome; innate immunity; macrophage; NLRP3	FACTOR-KAPPA-B; ACTIVATED PROTEIN-KINASES; NLRP3-INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; INFLUENZA-VIRUS; CELL-DEATH; RECEPTOR; DISEASE; EXPRESSION; AGE	Advanced glycation end products (AGEs) are adducts formed on proteins by glycation with reducing sugars, such as glucose, and tend to form and accumulate under hyperglycemic conditions. AGE accumulation alters protein function and has been implicated in the pathogenesis of many degenerative diseases such as diabetic complications. AGEs have also been shown to promote the production of pro-inflammatory cytokines, but the roles of AGEs in inflammasome signaling have not been explored in detail. Here, we present evidence that AGEs attenuate activation of the NLRP3 inflammasome in bone marrow-derived macrophages (BMDMs) as determined by caspase-1 processing and interleukin-1 production. AGEs also dampened the assembly of the NLRP3 inflammasome, but did not affect the NLRC4 or AIM2 inflammasome activation. Moreover, our data indicated that AGE treatment inhibited Toll-like receptor (TLR)-dependent production of pro-inflammatory cytokines in BMDMs. This immunosuppressive effect of AGE was not associated with a receptor for AGEs (RAGE)-mediated signaling. Instead, AGE treatment markedly suppressed lipopolysaccharide-induced M1 polarization of macrophages. Furthermore, AGEs significantly dampened innate immune responses including NLRP3 inflammasome activation and type-I interferon production in macrophages upon influenza virus infection. These observations collectively suggest that AGEs could impair host NLRP3 inflammasome-mediated innate immune defenses against RNA virus infection leading to an increased susceptibility to infection.	[Son, Seunghwan; Hwang, Inhwa; Shin, Jeon-Soo; Yu, Je-Wook] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul 03722, South Korea; [Han, Seung Hyeok] Yonsei Univ, Dept Internal Med, Inst Kidney Dis Res, Coll Med, Seoul 03722, South Korea; [Shin, Ok Sarah] Korea Univ, Dept Biomed Sci, Coll Med, Guro Hosp, Seoul 08308, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Yu, JW (corresponding author), Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol,Coll Med, Seoul 03722, South Korea.	jewookyu@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Hwang, Inhwa/0000-0001-5235-3519; Yu, Je-Wook/0000-0001-5943-4071; Son, Seunghwan/0000-0003-2408-2613; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea from the Korean Government [2014R1A4A1008625, 2015M3A9B6073856, 2017R1A2B2007467]; Yonsei University College of Medicine Faculty Research Grant [6-2016-0090]	National Research Foundation of Korea from the Korean Government(National Research Foundation of Korea); Yonsei University College of Medicine Faculty Research Grant	This work was supported by National Research Foundation of Korea Grants 2014R1A4A1008625, 2015M3A9B6073856, and 2017R1A2B2007467 from the Korean Government and Yonsei University College of Medicine Faculty Research Grant 6-2016-0090. The authors declare that they have no conflicts of interest with the contents of this article.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Andreea SI, 2008, EXP DIABETES RES, DOI 10.1155/2008/473603; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543; Kim JA, 2016, IMMUNE NETW, V16, P286, DOI 10.4110/in.2016.16.5.286; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Liu JH, 2009, FEBS J, V276, P4598, DOI 10.1111/j.1742-4658.2009.07165.x; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; MIYATA T, 1994, J CLIN INVEST, V93, P521, DOI 10.1172/JCI117002; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Seno K, 2017, J REPROD DEVELOP, V63, P401, DOI 10.1262/jrd.2017-032; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Song Y, 2017, J CELL MOL MED, V21, P1373, DOI 10.1111/jcmm.13067; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Uribarri J, 2015, J CLIN ENDOCR METAB, V100, P1957, DOI 10.1210/jc.2014-3925; Uribarri J, 2011, DIABETES CARE, V34, P1610, DOI 10.2337/dc11-0091; Valencia JV, 2004, DIABETOLOGIA, V47, P844, DOI 10.1007/s00125-004-1392-9; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Won JH, 2015, J BIOL CHEM, V290, P27425, DOI 10.1074/jbc.M115.667063; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00333; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2016, ARCH PHARM RES, V39, P1503, DOI 10.1007/s12272-016-0827-4; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	49	39	42	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20437	20448		10.1074/jbc.M117.806307	http://dx.doi.org/10.1074/jbc.M117.806307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29051224	hybrid, Green Published			2022-12-28	WOS:000418267000008
J	Lee, S; Lee, H; Yoo, S; Kim, H				Lee, Seoeun; Lee, Hunsang; Yoo, Suji; Kim, Hyun			Molecular insights into the m-AAA protease-mediated dislocation of transmembrane helices in the mitochondrial inner membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase associated with diverse cellular activities (AAA); membrane; mitochondria; transmembrane domain; yeast; Yta10; Yta12	CHAPERONE-LIKE ACTIVITY; RHOMBOID PROTEASE; SIGNAL SEQUENCE; IN-VIVO; PROTEINS; YEAST; ATP; DEGRADATION; COMPLEX; MGM1	Protein complexes involved in respiration, ATP synthesis, and protein import reside in the mitochondrial inner membrane; thus, proper regulation of these proteins is essential for cell viability. The m-AAA protease, a conserved hetero-hexameric AAA (ATPase associated with diverse cellular activities) protease, composed of the Yta10 and Yta12 proteins, regulates mitochondrial proteostasis by mediating protein maturation and degradation. It also recognizes and mediates the dislocation of membrane-embedded substrates, including foreign transmembrane (TM) segments, but the molecular mechanism involved in these processes remains elusive. This study investigated the role of the TM domains in the m-AAA protease by systematic replacement of one TM domain at a time in yeast. Our data indicated that replacement of the Yta10 TM2 domain abolishes membrane dislocation for only a subset of substrates, whereas replacement of the Yta12 TM2 domain impairs membrane dislocation for all tested substrates, suggesting different roles of the TM domains in each m-AAA protease subunit. Furthermore, m-AAA protease-mediated membrane dislocation was impaired in the presence of a large downstream hydrophilic moiety in a membrane substrate. This finding suggested that the m-AAA protease cannot dislocate large hydrophilic domains across the membrane, indicating that the membrane dislocation probably occurs in a lipid environment. In summary, this study highlights previously underappreciated biological roles of TM domains of the m-AAA proteases in mediating the recognition and dislocation of membrane-embedded substrates.	[Lee, Seoeun; Lee, Hunsang; Yoo, Suji; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Lee, Hunsang] Donnelly Ctr, Toronto, ON M5S 3E1, Canada	Seoul National University (SNU); University of Toronto	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea.	joy@snu.ac.kr	Lee, Hunsang/ABC-5697-2020		National Research Foundation of Korea [NRF-2016R1A2B2013459]; Promising-Pioneering Researcher Program through Seoul National University	National Research Foundation of Korea(National Research Foundation of Korea); Promising-Pioneering Researcher Program through Seoul National University	The research was funded by National Research Foundation of Korea Grant NRF-2016R1A2B2013459 and a grant from the Promising-Pioneering Researcher Program through Seoul National University (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bonn F, 2011, EMBO J, V30, P2545, DOI 10.1038/emboj.2011.169; Botelho SC, 2013, J BIOL CHEM, V288, P4792, DOI 10.1074/jbc.M112.430892; Botelho SC, 2011, EMBO J, V30, P1003, DOI 10.1038/emboj.2011.29; Esser K, 2002, J MOL BIOL, V323, P835, DOI 10.1016/S0022-2836(02)01000-8; Gerdes F, 2012, BBA-MOL CELL RES, V1823, P49, DOI 10.1016/j.bbamcr.2011.09.015; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Janska H, 2013, BBA-MOL CELL RES, V1833, P381, DOI 10.1016/j.bbamcr.2012.03.016; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kim H, 2000, P NATL ACAD SCI USA, V97, P1516, DOI 10.1073/pnas.040556797; Kim HY, 2015, PROTEIN SCI, V24, P2063, DOI 10.1002/pro.2817; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; Lee S, 2011, J BIOL CHEM, V286, P4404, DOI 10.1074/jbc.M110.158741; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Leonhard K, 1999, NATURE, V398, P348, DOI 10.1038/18704; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Paetzel M, 2004, J BIOL CHEM, V279, P30781, DOI 10.1074/jbc.M401686200; Park K, 2013, J BIOL CHEM, V288, P1521, DOI 10.1074/jbc.M112.409748; Rampello AJ, 2017, J MOL BIOL, V429, P873, DOI 10.1016/j.jmb.2017.02.009; Schafer A, 2010, J MOL BIOL, V401, P182, DOI 10.1016/j.jmb.2010.06.014; Shah ZH, 2000, FEBS LETT, V478, P267, DOI 10.1016/S0014-5793(00)01859-7; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, J BIOCHEM, V146, P455, DOI 10.1093/jb/mvp122; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522	32	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20058	20066		10.1074/jbc.M117.796763	http://dx.doi.org/10.1074/jbc.M117.796763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030426	Green Published, hybrid			2022-12-28	WOS:000417696400013
J	Goji, T; Takahara, K; Negishi, M; Katoh, H				Goji, Takeo; Takahara, Kazuhiko; Negishi, Manabu; Katoh, Hironori			Cystine uptake through the cystine/glutamate antiporter xCT triggers glioblastoma cell death under glucose deprivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; cell death; glioblastoma; glucose; reactive oxygen species (ROS); cystine	OXIDATIVE STRESS; SYSTEM X(C)(-); GLUTAMINE-METABOLISM; INDUCED CYTOTOXICITY; CANCER; GLIOMA; TRANSPORTER; HOMEOSTASIS; APOPTOSIS; REDUCTASE	Oncogenic signaling in cancer cells alters glucose uptake and utilization to supply sufficient energy and biosynthetic intermediates for survival and sustained proliferation. Oncogenic signaling also prevents oxidative stress and cell death caused by increased production of reactive oxygen species. However, elevated glucose metabolism in cancer cells, especially in glioblastoma, results in the cells becoming sensitive to glucose deprivation (i.e. in high glucose dependence), which rapidly induces cell death. However, the precise mechanism of this type of cell death remains unknown. Here, we report that glucose deprivation alone does not trigger glioblastoma cell death. We found that, for cell death to occur in glucose-deprived glioblastoma cells, cystine and glutamine also need to be present in culture media. We observed that cystine uptake through the cystine/glutamate antiporter xCT under glucose deprivation rapidly induces NADPH depletion, reactive oxygen species accumulation, and cell death. We conclude that although cystine uptake is crucial for production of antioxidant glutathione in cancer cells its transport through xCT also induces oxidative stress and cell death in glucose-deprived glioblastoma cells. Combining inhibitors targeting cancer-specific glucose metabolism with cystine and glutamine treatment may offer a therapeutic approach for glioblastoma tumors exhibiting high xCT expression.	[Goji, Takeo; Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Pharmaceut Sci, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068501, Japan; [Takahara, Kazuhiko] Kyoto Univ, Dept Anim & Dev & Physiol, Sakyo Ku, Kyoto 6068501, Japan; [Negishi, Manabu; Katoh, Hironori] Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117	Ministry of Education, Science, Sports, and Culture of Japan [15K07043]; Takeda Science Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grant-in-aid for Scientific Research 15K07043 from the Ministry of Education, Science, Sports, and Culture of Japan and a grant from Takeda Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Briggs KJ, 2016, CELL, V166, P126, DOI 10.1016/j.cell.2016.05.042; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Katoh Y, 2017, MOL BIOL CELL, V28, P898, DOI 10.1091/mbc.E17-01-0051; Kim JY, 2001, BBA-BIOMEMBRANES, V1512, P335, DOI 10.1016/S0005-2736(01)00338-8; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Mandal PK, 2010, J BIOL CHEM, V285, P22244, DOI 10.1074/jbc.M110.121327; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Nabeyama A, 2010, P NATL ACAD SCI USA, V107, P6436, DOI 10.1073/pnas.0912827107; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Pader I, 2014, P NATL ACAD SCI USA, V111, P6964, DOI 10.1073/pnas.1317320111; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Polewski MD, 2016, MOL CANCER RES, V14, P1229, DOI 10.1158/1541-7786.MCR-16-0028; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Shih AY, 2006, J NEUROSCI, V26, P10514, DOI 10.1523/JNEUROSCI.3178-06.2006; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Sleire L, 2015, ONCOGENE, V34, P5951, DOI 10.1038/onc.2015.60; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Tsuchihashi K, 2016, CANCER RES, V76, P2954, DOI 10.1158/0008-5472.CAN-15-2121; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yamasaki F, 2003, CANCER CHEMOTH PHARM, V51, P271, DOI 10.1007/s00280-002-0562-z; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z	43	41	43	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19721	19732		10.1074/jbc.M117.814392	http://dx.doi.org/10.1074/jbc.M117.814392			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29038291	hybrid, Green Published			2022-12-28	WOS:000416911300017
J	Vissers, C; Ming, GL; Song, HJ				Vissers, Caroline; Ming, Guo-li; Song, Hongjun			Stem cells take the stairs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							FATE DECISIONS; NEUROGENESIS	Human embryonic stem cells progress through multiple stages in their path to neural differentiation, but the steps taken along the way are difficult to distinguish, limiting our understanding of this important process. Jing and colleagues (2) now report comprehensive analyses of transcriptome dynamics during this process that reveal five discrete stages, defined in part by highly connected transcription factor networks that link progressive stages. Surprisingly, the third stage, which appears to be critical for neural fate commitment, depends almost entirely on intracellular signaling.	[Vissers, Caroline; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Grad Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA; [Ming, Guo-li; Song, Hongjun] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Song, Hongjun] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA	Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Grad Program Biochem Cellular & Mol Biol, Baltimore, MD 21205 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.	shongjun@pennmedicine.upenn.edu		Ming, Guo-li/0000-0002-2517-6075	National Institutes of Health [R37NS047344, U19MH106434, P01NS097206, R01AG057497, R01MH105128, R35NS097370, U19AI131130, T32GM007445]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation predoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI131130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128, U19MH106434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097370, P01NS097206, R37NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG057497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Science Foundation predoctoral fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (R37NS047344, U19MH106434, P01NS097206, and R01AG057497 to H. S.; R01MH105128, R35NS097370, and U19AI131130 to G.-l. M.; and T32GM007445 to C. V.) and from The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to G-l. M.). The authors declare that they have no conflicts of interests with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a National Science Foundation predoctoral fellowship.	Huang CTL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32600; Li YY, 2017, J BIOL CHEM, V292, P19590, DOI 10.1074/jbc.M117.796383; Moris N, 2016, NAT REV GENET, V17, P693, DOI 10.1038/nrg.2016.98; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70; Yao ZZ, 2017, CELL STEM CELL, V20, P120, DOI 10.1016/j.stem.2016.09.011; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19605	19606		10.1074/jbc.H117.796383	http://dx.doi.org/10.1074/jbc.H117.796383			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29196569	Green Published, hybrid			2022-12-28	WOS:000416911300006
J	Arbez, N; Ratovitski, T; Roby, E; Chighladze, E; Stewart, JC; Ren, M; Wang, XF; Lavery, DJ; Ross, CA				Arbez, Nicolas; Ratovitski, Tamara; Roby, Elaine; Chighladze, Ekaterine; Stewart, Jacqueline C.; Ren, Mark; Wang, Xiaofang; Lavery, Daniel J.; Ross, Christopher A.			Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Huntington disease; neurodegeneration; neuron; phosphorylation; toxicity	QUANTITATIVE PROTEOMIC ANALYSIS; MITOCHONDRIAL DYNAMICS; N-17 DOMAIN; DISEASE; PHOSPHORYLATION; FRAGMENTS; CASPASE-6; PROTEIN; MICE; HD	Huntington's disease (HD) is caused in large part by a polyglutamine expansion within the huntingtin (Htt) protein. Post-translational modifications (PTMs) control and regulate many protein functions and cellular pathways, and PTMs of mutant Htt are likely important modulators of HD pathogenesis. Alterations of selected numbers of PTMs of Htt fragments have been shown to modulate Htt cellular localization and toxicity. In this study, we systematically introduced site-directed alterations in individual phosphorylation and acetylation sites in full-length Htt constructs. The effects of each of these PTM alteration constructs were tested on cell toxicity using our nuclear condensation assay and on mitochondrial viability by measuring mitochondrial potential and size. Using these functional assays in primary neurons, we identified several PTMs whose alteration can block neuronal toxicity and prevent potential loss and swelling of the mitochondria caused by mutant Htt. These PTMs included previously described sites such as serine 116 and newly found sites such as serine 2652 throughout the protein. We found that these functionally relevant sites are clustered in protease-sensitive domains throughout full-length Htt. These findings advance our understanding of the Htt PTM code and its role in HD pathogenesis. Because PTMs are catalyzed by enzymes, the toxicity-modulating Htt PTMs identified here may be promising therapeutic targets for managing HD.	[Arbez, Nicolas; Ratovitski, Tamara; Roby, Elaine; Chighladze, Ekaterine; Stewart, Jacqueline C.; Wang, Xiaofang; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ren, Mark] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Lavery, Daniel J.] CHDI Management Inc, CHDI Fdn, Princeton, NJ 08540 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cornell University	Arbez, N; Ross, CA (corresponding author), CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	narbez1@jhmi.edu; caross@jhu.edu		Ren, Mark/0000-0003-0179-3471; Lavery, Daniel J./0000-0002-4218-0527	CHDI Foundation, Inc.; National Institutes of Health [R01 NS086452]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086452] Funding Source: NIH RePORTER	CHDI Foundation, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the CHDI Foundation, Inc. and by National Institutes of Health Grant R01 NS086452. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharony I, 2015, HUM MOL GENET, V24, P2604, DOI 10.1093/hmg/ddv023; Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Aronin N, 2014, MOVEMENT DISORD, V29, P1455, DOI 10.1002/mds.26020; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Dickey AS, 2016, NAT MED, V22, P37, DOI 10.1038/nm.4003; DiGiovanni LF, 2016, HUM MOL GENET, V25, P3937, DOI 10.1093/hmg/ddw234; Dong GF, 2012, PROTEOMICS, V12, P2060, DOI 10.1002/pmic.201100380; Duan WZ, 2014, MOVEMENT DISORD, V29, P1366, DOI 10.1002/mds.25992; Duan WZ, 2003, P NATL ACAD SCI USA, V100, P2911, DOI 10.1073/pnas.0536856100; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Ehrnhoefer DE, 2009, DIS MODEL MECH, V2, P123, DOI 10.1242/dmm.002451; El-Daher MT, 2015, EMBO J, V34, P2255, DOI 10.15252/embj.201490808; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hasegawa M, 2011, J MOL NEUROSCI, V45, P480, DOI 10.1007/s12031-011-9571-x; Huang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121055; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jin J, 2016, NEUROMOL MED, V18, P581, DOI 10.1007/s12017-016-8412-z; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kratter IH, 2016, J CLIN INVEST, V126, P3585, DOI 10.1172/JCI80339; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Ratovitski T, 2017, J PROTEOME RES, V16, P2692, DOI 10.1021/acs.jproteome.6b00991; Ratovitski T, 2016, J PROTEOME RES, V15, P3266, DOI 10.1021/acs.jproteome.6b00448; Ratovitski T, 2012, CELL CYCLE, V11, P2006, DOI 10.4161/cc.20423; Ratovitski T, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.185348; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tebbenkamp ATN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050750; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Vijayvargia R, 2016, ELIFE, V5, DOI 10.7554/eLife.11184; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Watkin EE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088284; Xu Y, 2015, J NEUROCHEM, V135, P4, DOI 10.1111/jnc.13234; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702	54	32	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19238	19249		10.1074/jbc.M117.782300	http://dx.doi.org/10.1074/jbc.M117.782300			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972180	Green Published, hybrid			2022-12-28	WOS:000416226700008
J	Tsai, WC; Reineke, LC; Jain, A; Jung, SY; Lloyd, RE				Tsai, Wei-Chih; Reineke, Lucas C.; Jain, Antrix; Jung, Sung Yun; Lloyd, Richard E.			Histone arginine demethylase JMJD6 is linked to stress granule assembly through demethylation of the stress granule-nucleating protein G3BP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); protein methylation; RNA-binding protein; stress granule; stress response; demethylase	DOMAIN-CONTAINING PROTEIN; RNA-BINDING PROTEINS; CELL-FREE FORMATION; MESSENGER-RNA; TRANSLATION INITIATION; PHOSPHATIDYLSERINE RECEPTOR; EIF2-ALPHA PHOSPHORYLATION; PHASE-SEPARATION; METHYLATION; COMPLEXES	Stress granules (SG) are membrane-less organelles that are condensates of stalled translation initiation complexes and mRNAs. SG formation is a cytoprotective response to environmental stress and results from protein interactions involving regions of low amino acid complexity and poorly defined post-translational modifications of SG components. Many RNA-binding proteins are methylated, and we previously demonstrated that the potent SG-nucleating protein G3BP1 is methylated by protein arginine methyltransferase 1 and 5 (PRMT1 and PRMT5). G3BP1 methylation represses SG formation and is reversible. Here we functionally link JMJD6 (Jumonji C domain-containing protein 6) to G3BP1 demethylation. Our findings reveal that JMJD6 is a novel SG component that interacts with G3BP1 complexes, and its expression reduces G3BP1 monomethylation and asymmetric dimethylation at three Arg residues. Knockdown of JMJD6 repressed SG formation and G3BP1 demethylation, but SG formation and G3BP1 demethylation were rescued with catalytically active but not mutant JMJD6. These results suggest that JMJD6 functions directly or indirectly as an arginine demethylase of G3BP1 that promotes SG formation.	[Tsai, Wei-Chih; Reineke, Lucas C.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA; [Reineke, Lucas C.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Jain, Antrix; Jung, Sung Yun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lloyd, RE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, 1 Baylor Plaza, Houston, TX 77030 USA.	rlloyd@bcm.edu	Jain, Antrix/AEB-7319-2022	Jain, Antrix/0000-0002-2815-3645; Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health [HD007495, DK56338, CA125123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027914, R56AI050237, R01AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Mark Bedford for fruitful discussions and support. The Integrated Microscopy Core at Baylor College of Medicine with funded through National Institutes of Health Grants HD007495, DK56338, and CA125123.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen CF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06359; Courchet J, 2008, J BIOL CHEM, V283, P32131, DOI 10.1074/jbc.M802927200; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Hahn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013769; Han G, 2012, J CELL BIOCHEM, V113, P1663, DOI 10.1002/jcb.24035; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hu YJ, 2015, NUCLEIC ACIDS RES, V43, P7790, DOI 10.1093/nar/gkv645; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kunisaki Y, 2004, BLOOD, V103, P3362, DOI 10.1182/blood-2003-09-3245; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lawrence P, 2014, VIROLOGY, V452, P1, DOI 10.1016/j.virol.2013.12.040; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lloyd RE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040093; Lyons SM, 2016, NUCLEIC ACIDS RES, V44, P6949, DOI 10.1093/nar/gkw418; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Panas MD, 2016, J CELL BIOL, V215, P313, DOI 10.1083/jcb.201609081; Poulard C, 2016, ONCOTARGET, V7, P67532, DOI 10.18632/oncotarget.11376; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Rai DK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0452-8; Reineke LC, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00596-16; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Su C, 2017, BBA-MOL CELL RES, V1864, P562, DOI 10.1016/j.bbamcr.2016.12.018; Suzuki T, 2011, J MED CHEM, V54, P8236, DOI 10.1021/jm201048w; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, CHIN J POPUL RESOUR, V12, P6, DOI 10.1080/10042857.2014.886802; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Wu TF, 2015, J BIOL CHEM, V290, P20556, DOI 10.1074/jbc.M114.607713; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	75	40	40	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 17	2017	292	46					18886	18896		10.1074/jbc.M117.800706	http://dx.doi.org/10.1074/jbc.M117.800706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN2TT	28972166	Green Published, hybrid			2022-12-28	WOS:000415848000014
J	Stifter, SA; Matthews, AY; Mangan, NE; Fung, KY; Drew, A; Tate, MD; da Costa, TPS; Hampsey, D; Mayall, J; Hansbro, PM; Minambres, AG; Eid, SG; Mak, J; Scoble, J; Lovrecz, G; deWeerd, NA; Hertzog, PJ				Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; da Costa, Tatiana P. Soares; Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.; Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson; Scoble, Judy; Lovrecz, George; deWeerd, Nicole A.; Hertzog, Paul J.			Defining the distinct, intrinsic properties of the novel type I interferon, IFN epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BETA; ALPHA; MOUSE; CELLS; PURIFICATION; ACTIVATION; MATURATION; BINDING	The type I interferons (IFNs) are a family of cytokines with diverse biological activities, including antiviral, antiproliferative, and immunoregulatory functions. The discovery of the hormonally regulated, constitutively expressed IFN epsilon has suggested a function for IFNs in reproductive tract homeostasis and protection from infections, but its intrinsic activities are untested. We report here the expression, purification, and functional characterization of murine IFN epsilon (mIFN epsilon). Recombinant mIFN epsilon (rmIFN epsilon) exhibited an alpha-helical fold characteristic of type I IFNs and bound to IFN alpha/beta receptor 1 (IFNAR1) and IFNAR2, but, unusually, it had a preference for IFNAR1. Nevertheless, rmIFN epsilon induced typical type I IFN signaling activity, including STAT1 phosphorylation and activation of canonical type I IFN signaling reporters, demonstrating that it uses the JAK-STAT signaling pathway. We also found that rmIFN epsilon induces the activation of T, B, and NK cells and exhibits antiviral, antiproliferative, and antibacterial activities typical of type I IFNs, albeit with 100-1000-fold reduced potency compared with rmIFN epsilon 1 and rmIFN epsilon. Surprisingly, although the type I IFNs generally do not display cross-species activities, rmIFN epsilon exhibited high antiviral activity on human cells, suppressing HIV replication and inducing the expression of known HIV restriction factors in human lymphocytes. Our findings define the intrinsic properties of murine IFN epsilon, indicating that it distinctly interacts with IFNAR and elicits pathogen-suppressing activity with a potency enabling host defense but with limited toxicity, appropriate for a protein expressed constitutively in a sensitive mucosal site, such as the reproductive tract.	[Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; deWeerd, Nicole A.; Hertzog, Paul J.] Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia; [Stifter, Sebastian A.; Matthews, Antony Y.; Mangan, Niamh E.; Fung, Ka Yee; Drew, Alexander; Tate, Michelle D.; deWeerd, Nicole A.; Hertzog, Paul J.] Monash Univ, Sch Clin Sci Monash Hlth, Dept Mol & Translat Sci, 27-31 Wright St, Clayton, Vic 3168, Australia; [da Costa, Tatiana P. Soares] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Bundoora, Vic 3086, Australia; [Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.] Hunter Med Res Inst, Prior Res Ctr Hlth Lungs, Newcastle, NSW 2300, Australia; [Hampsey, Daniel; Mayall, Jemma; Hansbro, Phil M.] Univ Newcastle, Newcastle, NSW 2300, Australia; [Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson] Deakin Univ, Sch Med, Geelong, Vic 3220, Australia; [Minambres, Albert Garcia; Eid, Sahar G.; Mak, Johnson] CSIRO, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Mak, Johnson] Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4222, Australia; [Scoble, Judy; Lovrecz, George] CSIRO Mfg, Parkville, Vic 3052, Australia; [Stifter, Sebastian A.] Centenary Inst, Mycobacterial Lab, Camperdown, NSW 2050, Australia; [Fung, Ka Yee] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia	Hudson Institute of Medical Research; Monash University; La Trobe University; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Griffith University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney; Centenary Institute; Walter & Eliza Hall Institute	Hertzog, PJ (corresponding author), Hudson Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic 3168, Australia.	paul.hertzog@hudson.org.au	Hansbro, Phil/G-7486-2013; mak, johnson/H-4605-2014; mak, johnson/S-2457-2019; de Weerd, Nicole/X-5886-2019; Scoble, Judith A/B-4919-2016; Hertzog, Paul/I-7053-2013	Hansbro, Phil/0000-0002-4741-3035; mak, johnson/0000-0002-5229-5707; mak, johnson/0000-0002-5229-5707; de Weerd, Nicole/0000-0002-7985-189X; Scoble, Judith A/0000-0002-6652-0717; Tate, Michelle/0000-0002-0587-5514; Mangan, Niamh/0000-0003-3844-0709; lovrecz, George/0000-0001-9977-5065; Mayall, Jemma/0000-0002-0915-5020; Stifter, Sebastian/0000-0002-7825-222X; Hertzog, Paul/0000-0002-1373-8472; Soares da Costa, Tatiana P./0000-0002-6275-7485	National Health and Medical Research Council (NHMRC) [APP1070732]; NHMRC [APP1126524, APP1117527, 035733, 1123319, APP1003591, APP1059242, APP1091976]; Australian Research Council [DP110103616]; Deakin University; National Collaborative Research Infrastructure Strategy; Australian Centre for HIV and Hepatitis Virology Research Grants [2013-34, 2015-12]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Deakin University; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Centre for HIV and Hepatitis Virology Research Grants; Victorian Government's Operational Infrastructure Support Program	This work was supported by National Health and Medical Research Council (NHMRC) New Investigator Grant APP1070732 (2014 - 2016) and NHMRC Project Grant APP1126524 (to N. D. W.), NHMRC Senior Principal Research Fellowship APP1117527 and NHMRC Project Grant APP1126524 (to P. J. H.), Australian Research Council Fellowship DP110103616 (to N. E. M.), NHMRC Fellowships 035733 and 1123319 (to M. D. T.), NHMRC Grants APP1003591 and APP1059242 (to J. C. H. and P. M. H.), a Deakin University scholarship (to A. G. M.), funding from the National Collaborative Research Infrastructure Strategy (to G. L.), Australian Centre for HIV and Hepatitis Virology Research Grants 2013-34 and 2015-12 (to P. J. H., N. E. M., and J. M.), and NHMRCFellowship APP1091976 (to T. P. S. d. C.). Research at the Hudson Institute was supported by the Victorian Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Asquith KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001339; Atzeni F, 2002, CELL IMMUNOL, V220, P20, DOI 10.1016/S0008-8749(03)00002-9; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Christensen JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37111; Correcirc DH, 2009, J BIOCH, V3, P164, DOI DOI 10.1038/NPR0T.2006.204; da Costa TPS, 2016, STRUCTURE, V24, P1282, DOI 10.1016/j.str.2016.05.019; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; de Weerd NA, 2017, J BIOL CHEM, V292, P7554, DOI 10.1074/jbc.M116.773788; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Denton PW, 2011, AIDS REV, V13, P135; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Garcia-Minambres A, 2017, IMMUNOL CELL BIOL, V95, P478, DOI 10.1038/icb.2016.123; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HALLORAN PF, 1989, J IMMUNOL, V142, P4241; Hardy MP, 2004, GENOMICS, V84, P331, DOI 10.1016/j.ygeno.2004.03.003; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jaks E, 2007, J MOL BIOL, V366, P525, DOI 10.1016/j.jmb.2006.11.053; Karpusas M, 1997, P NATL ACAD SCI USA, V94, P11813, DOI 10.1073/pnas.94.22.11813; KNIGHT E, 1975, J BIOL CHEM, V250, P4139; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; MERIGAN TC, 1964, SCIENCE, V145, P811, DOI 10.1126/science.145.3634.811-a; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Mous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033934; Peng FW, 2007, PROTEIN EXPRES PURIF, V53, P356, DOI 10.1016/j.pep.2006.12.013; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Piganis RAR, 2011, J BIOL CHEM, V286, P33811, DOI 10.1074/jbc.M111.270207; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; SAMUEL CE, 1977, VIROLOGY, V77, P556, DOI 10.1016/0042-6822(77)90481-0; SENDA T, 1995, J MOL BIOL, V253, P187, DOI 10.1006/jmbi.1995.0544; Stifter SA, 2014, PROTEIN EXPRES PURIF, V94, P7, DOI 10.1016/j.pep.2013.10.019; Tasker C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88255; Nguyen-Pham TN, 2011, CELL MOL IMMUNOL, V8, P341, DOI 10.1038/cmi.2011.7; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tough DF, 2012, IMMUNOL CELL BIOL, V90, P492, DOI 10.1038/icb.2012.7; Trajanovska S, 2003, J INTERF CYTOK RES, V23, P351, DOI 10.1089/107999003322226005; Yamamoto K, 2009, J INTERF CYTOK RES, V29, P161, DOI 10.1089/jir.2008.0038; Yang LM, 2013, J INTERF CYTOK RES, V33, P760, DOI 10.1089/jir.2013.0037	42	18	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3168	3179		10.1074/jbc.M117.800755	http://dx.doi.org/10.1074/jbc.M117.800755			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29187603	Green Published, hybrid			2022-12-28	WOS:000426562800012
J	Chorba, JS; Galvan, AM; Shokat, KM				Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.			Stepwise processing analyses of the single-turnover PCSK9 protease reveal its substrate sequence specificity and link clinical genotype to lipid phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						proprotein convertase subtilisin; kexin type 9 (PCSK9); substrate specificity; serine protease; single-nucleotide polymorphism (SNP); atherosclerosis; low-density lipoprotein (LDL); high-throughput screening (HTS); protein secretion; active site	SUBTILISIN/KEXIN TYPE 9; PLASMA LDL-CHOLESTEROL; PROPROTEIN CONVERTASE; SECRETED PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; FUNCTION MUTATIONS; HEPG2 CELLS; RECEPTOR; REPORTER; VARIANTS	Proprotein convertase subtilisin/kexin type 9 (PCSK9) down-regulates the low-density lipoprotein (LDL) receptor, elevating LDL cholesterol and accelerating atherosclerotic heart disease, making it a promising cardiovascular drug target. To achieve its maximal effect on the LDL receptor, PCSK9 requires autoproteolysis. After cleavage, PCSK9 retains its prodomain in the active site as a self-inhibitor. Unlike other proprotein convertases, however, this retention is permanent, inhibiting any further protease activity for the remainder of its life cycle. Such inhibition has proven a major challenge toward a complete biochemical characterization of PCSK9's proteolytic function, which could inform therapeutic approaches against its hypercholesterolemic effects. To address this challenge, we employed a cell-based, high-throughput method using a luciferase readout to evaluate the single-turnover PCSK9 proteolytic event. We combined this method with saturation mutagenesis libraries to interrogate the sequence specificities of PCSK9 cleavage and proteolysis-independent secretion. Our results highlight several key differences in sequence identity between these two steps, complement known structural data, and suggest that PCSK9 self-proteolysis is the rate-limiting step of secretion. Additionally, we found that for missense SNPs within PCSK9, alterations in both proteolysis and secretion are common. Last, we show that some SNPs allosterically modulate PCSK9's substrate sequence specificity. Our findings indicate that PCSK9 proteolysis acts as a commonly perturbed but critical switch in controlling lipid homeostasis and provide a new hope for the development of small-molecule PCSK9 inhibitors.	[Chorba, John S.] Zuckerberg San Francisco Gen, Div Cardiol, Dept Med, San Francisco, CA 94110 USA; [Chorba, John S.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Chorba, John S.; Galvan, Adri M.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Chorba, JS (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen, Div Cardiol, Dept Med, 1001 Potrero Ave,Bldg 100 Rm 261, San Francisco, CA 94110 USA.	john.chorba@ucsf.edu			NHLBI, National Institutes of Health (NIH) [K08 HL124068, LRP HMOT1243]; NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program [UL1 TR000004]; University of California San Francisco Academic Senate; Hellman Foundation; Gilead Sciences Research Scholar Award; Pfizer ASPIRE Cardiovascular Award; Howard Hughes Medical Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL124068] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program; University of California San Francisco Academic Senate(University of California System); Hellman Foundation; Gilead Sciences Research Scholar Award; Pfizer ASPIRE Cardiovascular Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health (NIH), Grants K08 HL124068 and LRP HMOT1243; NCATS, NIH, through the University of California San Francisco Clinical and Translational Science Institute Catalyst Program (Grant UL1 TR000004); the University of California San Francisco Academic Senate; the Hellman Foundation; a Gilead Sciences Research Scholar Award; a Pfizer ASPIRE Cardiovascular Award (all to J. S. C.); and the Howard Hughes Medical Institute (to A. M. G. and K. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai X., 2016, BIOCHEM MOL BIOL J, V2, P17, DOI [10.21767/2471-8084.100026, DOI 10.21767/2471-8084.100026]; Bartok E, 2013, NAT METHODS, V10, P147, DOI [10.1038/NMETH.2327, 10.1038/nmeth.2327]; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2012, J BIOL CHEM, V287, P33745, DOI 10.1074/jbc.M112.399725; Browning JD, 2010, J LIPID RES, V51, P3359, DOI 10.1194/jlr.P009860; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cameron J, 2008, FEBS J, V275, P4121, DOI 10.1111/j.1742-4658.2008.06553.x; Cameron J, 2009, ATHEROSCLEROSIS, V203, P161, DOI 10.1016/j.atherosclerosis.2008.10.007; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; FOOTE J, 1985, J BIOL CHEM, V260, P9624; Garvie CW, 2016, PROTEIN SCI, V25, P2018, DOI 10.1002/pro.3019; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grefhorst A, 2008, J LIPID RES, V49, P1303, DOI 10.1194/jlr.M800027-JLR200; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417; Homer VM, 2008, ATHEROSCLEROSIS, V196, P659, DOI 10.1016/j.atherosclerosis.2007.07.022; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Ketteler R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r64; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leigha SEA, 2009, ATHEROSCLEROSIS, V203, P32, DOI 10.1016/j.atherosclerosis.2009.02.006; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayne J, 2011, CLIN CHEM, V57, P1415, DOI 10.1373/clinchem.2011.165191; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miyake Y, 2008, ATHEROSCLEROSIS, V196, P29, DOI 10.1016/j.atherosclerosis.2006.12.035; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Niers JM, 2011, MOL THER, V19, P1090, DOI 10.1038/mt.2011.17; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Qu L, 2014, J VIROL, V88, P10312, DOI 10.1128/JVI.01111-14; Ridker PM, 2017, NEW ENGL J MED, V376, P1527, DOI 10.1056/NEJMoa1701488; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Seidah NG, 2016, CURR OPIN LIPIDOL, V27, P274, DOI 10.1097/MOL.0000000000000295; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shelton CC, 2009, P NATL ACAD SCI USA, V106, P20228, DOI 10.1073/pnas.0910757106; Wanneh E, 2017, J CLIN LIPIDOL, V11, P55, DOI 10.1016/j.jacl.2016.09.015; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2017, NAT STRUCT MOL BIOL, V24, P611, DOI 10.1038/nsmb.3435; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	63	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1875	1886		10.1074/jbc.RA117.000754	http://dx.doi.org/10.1074/jbc.RA117.000754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259136	Green Published, hybrid			2022-12-28	WOS:000424948000002
J	Tomati, V; Pesce, E; Caci, E; Sondo, E; Scudieri, P; Marini, M; Amato, F; Castaldo, G; Ravazzolo, R; Galietta, LJV; Pedemonte, N				Tomati, Valeria; Pesce, Emanuela; Caci, Emanuela; Sondo, Elvira; Scudieri, Paolo; Marini, Monica; Amato, Felice; Castaldo, Giuseppe; Ravazzolo, Roberto; Galietta, Luis J. V.; Pedemonte, Nicoletta			High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); high-throughput screening (HTS); small interfering RNA (siRNA); interactome	CFTR CHLORIDE CHANNEL; FUSION PROTEIN; RESCUE; GENE; PROTEOSTASIS; DEGRADATION; EXPRESSION; CORRECTORS; SECRETION; PATHWAY	In cystic fibrosis, deletion of phenylalanine 508 (F508del) in the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel causes misfolding and premature degradation. One possible approach to reducing the detrimental health effects of cystic fibrosis could be the identification of proteins whose suppression rescues F508del-CFTR function in bronchial epithelial cells. However, searches for these potential targets have not yet been conducted, particularly in a relevant airway background using a functional readout. To identify proteins associated with F508del-CFTR processing, we used a high-throughput functional assay to screen an siRNA library targeting 6,650 different cellular proteins. We identified 37 proteins whose silencing significantly rescued F508del-CFTR activity, as indicated by enhanced anion transport through the plasma membrane. These proteins included FAU, UBE2I, UBA52, MLLT6, UBA2, CHD4, PLXNA1, and TRIM24, among others. We focused our attention on FAU, a poorly characterized protein with unknown function. FAU knockdown increased the plasma membrane targeting and function of F508del-CFTR, but not of wild-type CFTR. Investigation into the mechanism of action revealed a preferential physical interaction of FAU with mutant CFTR, leading to its degradation. FAU and other proteins identified in our screening may offer a therapeutically relevant panel of drug targets to correct basic defects in F508del-CFTR processing.	[Tomati, Valeria; Pesce, Emanuela; Caci, Emanuela; Sondo, Elvira; Marini, Monica; Ravazzolo, Roberto; Pedemonte, Nicoletta] Ist Giannina Gaslini, Unita Operat Complessa UOC Genet Med, I-16147 Genoa, Italy; [Scudieri, Paolo; Galietta, Luis J. V.] Telethon Inst Genet & Med, I-80078 Pozzuoli, Italy; [Amato, Felice; Castaldo, Giuseppe] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80138 Naples, Italy; [Amato, Felice; Castaldo, Giuseppe] CEINGE Adv Biotechnol Scarl, I-80145 Naples, Italy; [Ravazzolo, Roberto] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-16132 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Genoa	Pedemonte, N (corresponding author), Ist Giannina Gaslini, UOC Genet Med, Via Gerolamo Gaslini 5, I-16147 Genoa, Italy.	nicoletta.pedemonte@unige.it	Pedemonte, Nicoletta/B-3607-2010; Scudieri, Paolo/AAM-9460-2020; Galietta, Luis JV/HCG-8692-2022; Amato, Felice/AAC-6805-2022; Castaldo, Giuseppe/AAC-6782-2022; Tomati, Valeria/AAB-4543-2021; Sondo, Elvira/K-3789-2018; Pesce, Emanuela/AAB-2642-2019	Pedemonte, Nicoletta/0000-0002-5161-1720; Scudieri, Paolo/0000-0002-8112-4800; Castaldo, Giuseppe/0000-0002-4036-0874; Tomati, Valeria/0000-0003-3761-1916; Sondo, Elvira/0000-0003-0971-2082; Pesce, Emanuela/0000-0002-9070-4479	Ricerca Corrente from the Italian Ministry of Health (Linea1); Italian Cystic Fibrosis Foundation [FFC3/2009, FFC 5/2012]; Italian Ministry of Health [GR-2008-1141326]; Telethon Grant [TMLGCBX16TT]	Ricerca Corrente from the Italian Ministry of Health (Linea1); Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Italian Ministry of Health(Ministry of Health, Italy); Telethon Grant(Fondazione Telethon)	This work was supported by Ricerca Corrente from the Italian Ministry of Health (Linea1), by Italian Cystic Fibrosis Foundation Grants FFC3/2009 (with the contribution of "Anna Iacomini, Gruppo di Sostegno FFC Rita Verona, Delegazione FFC di Como") and FFC 5/2012 (with the contribution of "Danone S.p.A.") (to N. P.), by Italian Ministry of Health Grant GR-2008-1141326 (to N. P.), and by Telethon Grant TMLGCBX16TT (to L. J. V. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Almaca J, 2013, CELL, V154, P1390, DOI 10.1016/j.cell.2013.08.045; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Caci E, 2009, AM J RESP CELL MOL, V40, P211, DOI 10.1165/rcmb.2007-0456OC; Chen LH, 2011, J AM SOC NEPHROL, V22, P1076, DOI 10.1681/ASN.2010121270; Clark KL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2012.57; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gianotti A, 2013, AM J RESP CELL MOL, V49, P445, DOI 10.1165/rcmb.2012-0408OC; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; KAS K, 1992, BIOCHEM BIOPH RES CO, V187, P927, DOI 10.1016/0006-291X(92)91286-Y; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Lopes-Pacheco M, 2016, CHEMBIOCHEM, V17, P493, DOI 10.1002/cbic.201500620; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MICHIELS L, 1993, ONCOGENE, V8, P2537; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagahama M, 2009, BIOCHEM BIOPH RES CO, V382, P303, DOI 10.1016/j.bbrc.2009.03.012; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; Rehman A, 2015, NEW ENGL J MED, V373, P1783, DOI 10.1056/NEJMc1510466; Scudieri P, 2012, J PHYSIOL-LONDON, V590, P6141, DOI 10.1113/jphysiol.2012.240838; Sondo E, 2017, CURR PHARM DESIGN, V23, P176, DOI 10.2174/1381612822666161006161033; Sondo E, 2011, AM J PHYSIOL-CELL PH, V301, pC872, DOI 10.1152/ajpcell.00507.2010; Tomati V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12138; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	32	26	26	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1203	1217		10.1074/jbc.M117.816595	http://dx.doi.org/10.1074/jbc.M117.816595			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29158263	Green Published, hybrid			2022-12-28	WOS:000423515000009
J	Jadwin, JA; Curran, TG; Lafontaine, AT; White, FM; Mayer, BJ				Jadwin, Joshua A.; Curran, Timothy G.; Lafontaine, Adam T.; White, Forest M.; Mayer, Bruce J.			Src homology 2 domains enhance tyrosine phosphorylation in vivo by protecting binding sites in their target proteins from dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); growth factor receptor-bound protein 2 (GRB2); phosphorylation; phosphotyrosine; Src homology 2 domain (SH2 domain); crk	EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; SH2 DOMAINS; SIGNAL-TRANSDUCTION; ADAPTER PROTEINS; INSULIN-RECEPTOR; KINASE DOMAIN; CELL; PHOSPHOTYROSINE; GRB2	Phosphotyrosine (pTyr)-dependent signaling is critical for many cellular processes. It is highly dynamic, as signal output depends not only on phosphorylation and dephosphorylation rates but also on the rates of binding and dissociation of effectors containing phosphotyrosine-dependent binding modules such as Src homology 2 (SH2) and phosphotyrosine-binding (PTB) domains. Previous in vitro studies suggested that binding of SH2 and PTB domains can enhance protein phosphorylation by protecting the sites bound by these domains from phosphatase-mediated dephosphorylation. To test whether this occurs in vivo, we used the binding of growth factor receptor bound 2 (GRB2) to phosphorylated epidermal growth factor receptor (EGFR) as a model system. We analyzed the effects of SH2 domain overexpression on protein tyrosine phosphorylation by quantitative Western and far-Western blotting, mass spectrometry, and computational modeling. We found that SH2 overexpression results in a significant, dose-dependent increase in EGFR tyrosine phosphorylation, particularly of sites corresponding to the binding specificity of the overexpressed SH2 domain. Computational models using experimentally determined EGFR phosphorylation and dephosphorylation rates, and pTyr-EGFR and GRB2 concentrations, recapitulated the experimental findings. Surprisingly, both modeling and biochemical analyses suggested that SH2 domain overexpression does not result in a major decrease in the number of unbound phosphorylated SH2 domain-binding sites. Our results suggest that signaling via SH2 domain binding is buffered over a relatively wide range of effector concentrations and that SH2 domain proteins with overlapping binding specificities are unlikely to compete with one another for phosphosites in vivo.	[Jadwin, Joshua A.; Lafontaine, Adam T.; Mayer, Bruce J.] Univ Connecticut, Sch Med, Dept Genet & Genome Sci, Raymond & Beverly Sackler Lab Mol Med, Farmington, CT 06030 USA; [Jadwin, Joshua A.; Lafontaine, Adam T.; Mayer, Bruce J.] Univ Connecticut, Sch Med, Richard B Berlin Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; [Curran, Timothy G.; White, Forest M.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Curran, Timothy G.; White, Forest M.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Connecticut; University of Connecticut; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Mayer, BJ (corresponding author), Univ Connecticut, Sch Med, Dept Genet & Genome Sci, 263 Farmington Ave, Farmington, CT 06030 USA.	bmayer@uchc.edu		White, Forest/0000-0002-1545-1651	National Institutes of Health from the NIGMS [P41 GM103313]; NATIONAL CANCER INSTITUTE [RC1CA146843, U01CA154966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ji Yu for critical reading of this manuscript, Kazuya Machida for technical advice with biochemical experiments, Ahmed Elmokadem and Ji Yu for advice on VCell modeling and reaction kinetics, and Shobhit Jain and Gary Bader (University of Toronto, Ontario, Canada) for help and advice on comparing LOGO plots. The Virtual Cell is supported by National Institutes of Health Grant P41 GM103313 from the NIGMS.	[Anonymous], 2017, QDOAS VERSION 32 SO; Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; BATZER AG, 1995, MOL CELL BIOL, V15, P4403; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Beebe KD, 2000, BIOCHEMISTRY-US, V39, P13251, DOI 10.1021/bi0014397; BERKERS JAM, 1991, J BIOL CHEM, V266, P922; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; BIRGE RB, 1992, J BIOL CHEM, V267, P10588; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Carroll DJ, 1999, DEV BIOL, V206, P232, DOI 10.1006/dbio.1998.9145; Chook YM, 1996, J BIOL CHEM, V271, P30472, DOI 10.1074/jbc.271.48.30472; Creamer MS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-107; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Deindl S, 2009, P NATL ACAD SCI USA, V106, P20699, DOI 10.1073/pnas.0911512106; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; GERVAIS FG, 1993, MOL CELL BIOL, V13, P7112, DOI 10.1128/MCB.13.11.7112; Giubellino A, 2008, EXPERT OPIN THER TAR, V12, P1021, DOI 10.1517/14728222.12.8.1021 ; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Gupta RW, 1998, ONCOGENE, V17, P2155, DOI 10.1038/sj.onc.1202158; Hause RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044471; Hino N, 2011, J MOL BIOL, V406, P343, DOI 10.1016/j.jmb.2010.12.022; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jadwin J. A., 2017, SH2 DOMAINS METHODS, P477; Jadwin JA, 2016, ELIFE, V5, DOI 10.7554/eLife.11835; Jadwin JA, 2012, FEBS LETT, V586, P2586, DOI 10.1016/j.febslet.2012.04.019; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Jones RB, 2013, EXPERT REV PROTEOMIC, V10, P115, DOI [10.1586/epr.12.78, 10.1586/EPR.12.78]; Kaneko T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003021; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; KAVANAUGH WM, 1995, SCIENCE, V268, P1177, DOI 10.1126/science.7539155; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Kovacs E, 2015, ANNU REV BIOCHEM, V84, P739, DOI 10.1146/annurev-biochem-060614-034402; LEMMON MA, 1994, J BIOL CHEM, V269, P31653; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; MOTTO DG, 1994, J BIOL CHEM, V269, P21608; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Northrop JP, 1996, MOL CELL BIOL, V16, P2255; Novomestky F, 2012, MATRIXCALC COLLECTIO; Oh D, 2012, P NATL ACAD SCI USA, V109, P14024, DOI 10.1073/pnas.1203397109; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Pradip D, 2013, AM J CANCER RES, V3, P173; Qian DP, 1996, J EXP MED, V183, P611, DOI 10.1084/jem.183.2.611; RCore Team, 2017, R LANG ENV STAT COMP; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Rstudio Team, 2019, RSTUDIO INTEGRATED D; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Slepchenko BM, 2003, TRENDS CELL BIOL, V13, P570, DOI 10.1016/j.tcb.2003.09.002; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Teyra J, 2017, STRUCTURE, V25, P1598, DOI 10.1016/j.str.2017.07.017; Thompson CM, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0169-1; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wagih O, 2015, NAT METHODS, V12, P531, DOI 10.1038/nmeth.3396; Wagner M. J., 2013, COLD SPRING HARB PER, V5, P1; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Wilke C.O., 2017, cowplot: Streamlined plot theme and plot annotations for ``ggplot2''. R package version 0.8.0; Wills MKB, 2017, J CELL SCI, V130, P2808, DOI 10.1242/jcs.198903; Wilson TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092184; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	81	19	19	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					623	637		10.1074/jbc.M117.794412	http://dx.doi.org/10.1074/jbc.M117.794412			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29162725	Green Published, hybrid			2022-12-28	WOS:000419915400018
J	Kuusk, S; Bissaro, B; Kuusk, P; Forsberg, Z; Eijsink, VGH; Sorlie, M; Valjamae, P				Kuusk, Silja; Bissaro, Bastien; Kuusk, Piret; Forsberg, Zarah; Eijsink, Vincent G. H.; Sorlie, Morten; Valjamae, Priit			Kinetics of H2O2-driven degradation of chitin by a bacterial lytic polysaccharide monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper monooxygenase; enzyme inactivation; enzyme kinetics; hydrogen peroxide; polysaccharide; Serratia marcescens	BINDING PROTEIN CBP21; SERRATIA-MARCESCENS; OXIDATIVE-DEGRADATION; RECALCITRANT POLYSACCHARIDES; CELLOBIOSE DEHYDROGENASE; NEUROSPORA-CRASSA; CELLULOSE; ENZYMES; CLEAVAGE; OLIGOSACCHARIDES	Lytic polysaccharide monooxygenases (LPMOs) catalyze the oxidative cleavage of glycosidic bonds in recalcitrant polysaccharides, such as cellulose and chitin, and are of interest in biotechnological utilization of these abundant biomaterials. It has recently been shown that LPMOs can use H2O2, instead of O-2, as a cosubstrate. This peroxygenase-like reaction by a monocopper enzyme is unprecedented in nature and opens new avenues in chemistry and enzymology. Here, we provide the first detailed kinetic characterization of chitin degradation by the bacterial LPMO chitin-binding protein CBP21 using H2O2 as cosubstrate. The use of C-14-labeled chitin provided convenient and sensitive detection of the released soluble products, which enabled detailed kinetic measurements. The k(cat) for chitin oxidation found here (5.6 s(-1)) is more than an order of magnitude higher than previously reported (apparent) rate constants for reactions containing O-2 but no added H2O2. The k(cat)/K-m for H2O2-driven degradation of chitin was on the order of 10(6) m(-1) s(-1), indicating that LPMOs have catalytic efficiencies similar to those of peroxygenases. Of note, H2O2 also inactivated CBP21, but the second-order rate constant for inactivation was about 3 orders of magnitude lower than that for catalysis. In light of the observed CBP21 inactivation at higher H2O2 levels, we conclude that controlled generation of H(2)O(2)in situ seems most optimal for fueling LPMO-catalyzed oxidation of polysaccharides.	[Kuusk, Silja; Valjamae, Priit] Univ Tartu, Inst Mol & Cell Biol, Riia 23b-202, EE-51010 Tartu, Estonia; [Bissaro, Bastien; Forsberg, Zarah; Eijsink, Vincent G. H.; Sorlie, Morten] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-50411 Tartu, Estonia	University of Tartu; Norwegian University of Life Sciences; University of Tartu; University of Tartu Institute of Physics	Valjamae, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Bissaro, Bastien/AAI-6814-2020; Forsberg, Zarah/AAM-2395-2020; BISSARO, Bastien/AAL-7130-2021; Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493; Bissaro, Bastien/0000-0001-8354-3892; Forsberg, Zarah/0000-0002-8236-7986	Estonian Research Council [PUT1024]; Norwegian Financial Mechanism Grant [EMP171]	Estonian Research Council; Norwegian Financial Mechanism Grant	This work was supported by Estonian Research Council Grant PUT1024 and Norwegian Financial Mechanism Grant EMP171. The authors declare that they have no conflicts of interest with the contents of this article.	Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Cannella D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11134; Cornish-Bowden A, 1999, FUNDAMENTALS ENZYME; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Frommhagen M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0810-4; Frommhagen M, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0594-y; Garajova S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28276; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Hofrichter M, 2014, CURR OPIN CHEM BIOL, V19, P116, DOI 10.1016/j.cbpa.2014.01.015; Holtmann D, 2016, CHEMBIOCHEM, V17, P1391, DOI 10.1002/cbic.201600176; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Johansen KS, 2016, BIOCHEM SOC T, V44, P143, DOI 10.1042/BST20150204; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kracher D, 2016, SCIENCE, V352, P1098, DOI 10.1126/science.aaf3165; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Ladeveze S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0903-0; Loose JSM, 2016, PROTEIN SCI, V25, P2175, DOI 10.1002/pro.3043; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Martinez AT, 2016, SCIENCE, V352, P1050, DOI 10.1126/science.aaf8920; Matthews S, 2017, J BIOL CHEM, V292, P5128, DOI 10.1074/jbc.M116.762336; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; Ni Y, 2016, ANGEW CHEM INT EDIT, V55, P798, DOI 10.1002/anie.201507881; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Scott BR, 2016, BIOTECHNOL LETT, V38, P425, DOI 10.1007/s10529-015-1989-8; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Switala J, 2002, ARCH BIOCHEM BIOPHYS, V401, P145, DOI 10.1016/S0003-9861(02)00049-8; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Valderrama B, 2002, CHEM BIOL, V9, P555, DOI 10.1016/S1074-5521(02)00149-7; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Yang YL, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0470-6	39	86	88	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					523	531		10.1074/jbc.M117.817593	http://dx.doi.org/10.1074/jbc.M117.817593			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29138240	Green Published, hybrid			2022-12-28	WOS:000419915400009
J	Verma, SK; Leikina, E; Melikov, K; Gebert, C; Kram, V; Young, MF; Uygur, B; Chernomordik, LV				Verma, Santosh K.; Leikina, Evgenia; Melikov, Kamran; Gebert, Claudia; Kram, Vardit; Young, Marian F.; Uygur, Berna; Chernomordik, Leonid V.			Cell-surface phosphatidylserine regulates osteoclast precursor fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE FUSION; MEMBRANE-FUSION; ANNEXIN A1; INTERCELLULAR FUSION; DC-STAMP; EXPRESSION; PROTEIN; VIRUS; SYNCYTIN-1; ENVELOPE	Bone-resorbing multinucleated osteoclasts that play a central role in the maintenance and repair of our bones are formed from bone marrow myeloid progenitor cells by a complex differentiation process that culminates in fusion of mononuclear osteoclast precursors. In this study, we uncoupled the cell fusion step from both pre-fusion stages of osteoclastogenic differentiation and the post-fusion expansion of the nascent fusion connections. We accumulated ready-to-fuse cells in the presence of the fusion inhibitor lysophosphatidylcholine and then removed the inhibitor to study synchronized cell fusion. We found that osteoclast fusion required the dendrocyte-expressed seven transmembrane protein (DC-STAMP)-dependent non-apoptotic exposure of phosphatidylserine at the surface of fusion-committed cells. Fusion also depended on extracellular annexins, phosphatidylserine-binding proteins, which, along with annexin-binding protein S100A4, regulated fusogenic activity of syncytin 1. Thus, in contrast to fusion processes mediated by a single protein, such as epithelial cell fusion in Caenorhabditis elegans, the cell fusion step in osteoclastogenesis is controlled by phosphatidylserine-regulated activity of several proteins.	[Verma, Santosh K.; Leikina, Evgenia; Melikov, Kamran; Uygur, Berna; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Bethesda, MD 20892 USA; [Gebert, Claudia] Eunice Kennedy Shriver NICHD, Sect Genom Imprinting, Bethesda, MD 20892 USA; [Kram, Vardit; Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chernomordik, LV (corresponding author), Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov	Uygur, Berna/AAD-1043-2020; Verma, Santosh/AAQ-8952-2020	Verma, Santosh/0000-0001-6058-6494; Young, Marian F/0000-0003-0929-8854	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; NIDCR, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (to the L. V. C. laboratory), and by the NIDCR, National Institutes of Health (to the M. F. Y. laboratory). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Bjerregard B, 2014, CELL TISSUE RES, V357, P355, DOI 10.1007/s00441-014-1930-9; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Chang C, 2004, BIOL REPROD, V71, P1956, DOI 10.1095/biolreprod.104.033340; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Chen XD, 2003, CALCIFIED TISSUE INT, V72, P577, DOI 10.1007/s00223-002-1101-y; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiu YH, 2016, J CELL PHYSIOL, V231, P2402, DOI 10.1002/jcp.25389; Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113; Ciechonska M, 2014, TRENDS MICROBIOL, V22, P715, DOI 10.1016/j.tim.2014.08.005; Coudert A., 2015, 4 JOINT M EUR CALC T, P194; Curia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071995; Damazo AS, 2007, BIRTH DEFECTS RES A, V79, P524, DOI 10.1002/bdra.20368; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; DEGRELLE SA, 2017, SCI REP, V7, P4217, DOI DOI 10.1016/J.PLACENTA.2013.06.287; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; Erlandsson MC, 2013, BBA-MOL CELL RES, V1833, P2653, DOI 10.1016/j.bbamcr.2013.06.020; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frese S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132099; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hwang SY, 2011, BBA-MOL CELL RES, V1813, P979, DOI 10.1016/j.bbamcr.2010.11.002; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; Leikina E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18246; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Levaot N, 2015, BONE, V79, P21, DOI 10.1016/j.bone.2015.05.021; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Mah SJ, 2015, ARCH ORAL BIOL, V60, P1215, DOI 10.1016/j.archoralbio.2015.05.014; Markosyan RM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005373; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Moller AMJ, 2017, J CELL PHYSIOL, V232, P1396, DOI 10.1002/jcp.25633; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Myrvang HK, 2013, FEBS LETT, V587, P3210, DOI 10.1016/j.febslet.2013.08.012; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rhee I, 2013, MOL CELL BIOL, V33, P2458, DOI 10.1128/MCB.00197-13; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Suzuki J., 2013, J BIOL CHEM; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Verma SK, 2014, BIOCHEM J, V464, P293, DOI 10.1042/BJ20141233; Vignery Agnes, 2008, V475, P149, DOI 10.1007/978-1-59745-250-2_9; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Witwicka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128275; Wu Z, 2010, J IMMUNOL, V184, P3191, DOI 10.4049/jimmunol.0803609; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Youn MY, 2010, BIOSCI BIOTECH BIOCH, V74, P1956, DOI 10.1271/bbb.100280; Zaitseva E, 2017, CELL HOST MICROBE, V22, P99, DOI 10.1016/j.chom.2017.06.012	71	37	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					254	270		10.1074/jbc.M117.809681	http://dx.doi.org/10.1074/jbc.M117.809681			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29101233	Green Published, hybrid			2022-12-28	WOS:000419453200022
J	Cevik, O; Li, D; Baljinnyam, E; Manvar, D; Pimenta, EM; Waris, G; Barnes, BJ; Kaushik-Basu, N				Cevik, Ozge; Li, Dan; Baljinnyam, Erdene; Manvar, Dinesh; Pimenta, Erica M.; Waris, Gulam; Barnes, Betsy J.; Kaushik-Basu, Neerja			Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis C virus (HCV); hepatocellular carcinoma; immunosuppression; interferon regulatory factor (IRF); tumor suppressor gene; viral immunology	INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; RNA REPLICATION; BREAST-CANCER; CELL-DEATH; BECLIN 1; INDUCTION; AUTOPHAGY; EXPRESSION	Hepatitis C virus (HCV) infection is a major risk factor for the development of chronic liver disease. The disease typically progresses from chronic HCV to fibrosis, cirrhosis, hepatocellular carcinoma (HCC), and death. Chronic inflammation associated with HCV infection is implicated in cirrhosis and HCC, but the molecular players and signaling pathways contributing to these processes remain largely unknown. Interferon regulatory factor 5 (IRF5) is a molecule of interest in HCV-associated HCC because it has critical roles in virus-, Toll-like receptor (TLR)-, and IFN-induced signaling pathways. IRF5 is also a tumor suppressor, and its expression is dysregulated in several human cancers. Here, we present first evidence that IRF5 expression and signaling are modulated during HCV infection. Using HCV infection of human hepatocytes and cells with autonomously replicating HCV RNA, we found that levels of IRF5 mRNA and protein expression were down-regulated. Of note, reporter assays indicated that IRF5 re-expression inhibited HCV protein translation and RNA replication. Gene expression analysis revealed significant differences in the expression of cancer pathway mediators and autophagy proteins rather than in cytokines between IRF5- and empty vector-transfected HCV replicon cells. IRF5 re-expression induced apoptosis via loss in mitochondrial membrane potential, down-regulated autophagy, and inhibited hepatocyte cell migration/invasion. Analysis of clinical HCC specimens supports a pathologic role for IRF5 in HCV-induced HCC, as IRF5 expression was down-regulated in livers from HCV-positive versus HCV-negative HCC patients or healthy donor livers. These results identify IRF5 as an important suppressor of HCV replication and HCC pathogenesis.	[Cevik, Ozge; Li, Dan; Baljinnyam, Erdene; Manvar, Dinesh; Pimenta, Erica M.; Barnes, Betsy J.; Kaushik-Basu, Neerja] Rutgers Biomed & Hlth Sci, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Cevik, Ozge] Cumhuriyet Univ, Fac Pharm, Dept Biochem, TR-58140 Sivas, Turkey; [Li, Dan; Pimenta, Erica M.; Barnes, Betsy J.] New Jersey Med Sch Canc Ctr, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Li, Dan; Barnes, Betsy J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Waris, Gulam] Rosalind Franklin Univ Med & Sci, Chicago, IL 60064 USA; [Kaushik-Basu, Neerja] NIH, Infect Dis & Microbiol Integrated Review Grp, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cumhuriyet University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Northwell Health; Chicago Medical School; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA	Kaushik-Basu, N (corresponding author), NIH, Infect Dis & Microbiol Integrated Review Grp, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA.; Barnes, BJ (corresponding author), Feinstein Inst Med Res, 350 Community Dr,Rm 3238, Manhasset, NY 11030 USA.	bbarnes1@northwell.edu; neerja.kaushik-basu@nih.gov	Cevik, Ozge/Z-2790-2019		National Institutes of Health [CA153147, CA191903]; International Postdoctoral Research Fellowship Program by the Scientific and Technological Research Council of Turkey (TUBITAK) [2219]; NATIONAL CANCER INSTITUTE [R21CA191903, R21CA153147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Postdoctoral Research Fellowship Program by the Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA153147 (to N. K.-B.) and CA191903 (to B. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the International Postdoctoral Research Fellowship Program provided by the Scientific and Technological Research Council of Turkey (TUBITAK) 2219.	Alzaid F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88689; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Attar Bashar M, 2016, World J Gastrointest Pharmacol Ther, V7, P33, DOI 10.4292/wjgpt.v7.i1.33; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barth H, 2015, WORLD J HEPATOL, V7, P725, DOI 10.4254/wjh.v7.i5.725; Beales LP, 2003, J VIROL, V77, P6574, DOI 10.1128/JVI.77.11.6574-6579.2003; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Bishayee A, 2012, CURR CANCER DRUG TAR, V12, P1095; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brault C, 2013, VIRUSES-BASEL, V5, P954, DOI 10.3390/v5030954; Chu JS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-16; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fresquet V, 2012, BRIT J HAEMATOL, V158, P712, DOI 10.1111/j.1365-2141.2012.09226.x; Ghosh AK, 2003, VIROLOGY, V306, P51, DOI 10.1016/S0042-6822(02)00029-6; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Kemik O, 2010, BRATISL MED J, V111, P485; Kim H, 2012, J VIROL, V86, P9919, DOI 10.1128/JVI.00388-12; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Kucukguzel I, 2013, EUR J MED CHEM, V69, P931, DOI 10.1016/j.ejmech.2013.08.043; Li D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31002; Li H, 2011, AUTOPHAGY, V7, P1239, DOI 10.4161/auto.7.10.16490; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Nandakumar R, 2013, GASTROENTEROLOGY, V145, P1414, DOI 10.1053/j.gastro.2013.08.037; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Pimenta EM, 2015, IMMUNOL CELL BIOL, V93, P486, DOI 10.1038/icb.2014.110; Pimenta EM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0305-5; Rautou PE, 2011, AM J PATHOL, V178, P2708, DOI 10.1016/j.ajpath.2011.02.021; Raychoudhuri A, 2010, J VIROL, V84, P10991, DOI 10.1128/JVI.00900-10; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Vescozo T., 2014, BIOMED RES INT, V2014; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	53	28	28	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21676	21689		10.1074/jbc.M117.792721	http://dx.doi.org/10.1074/jbc.M117.792721			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29079574	Green Published, hybrid			2022-12-28	WOS:000419013000041
J	Chen, CL; Mermoud, JC; Paul, LN; Steussy, CN; Stauffacher, CV				Chen, Chun-Liang; Mermoud, James C.; Paul, Lake N.; Steussy, Calvin Nicklaus; Stauffacher, Cynthia V.			Mevalonate 5-diphosphate mediates ATP binding to the mevalonate diphosphate decarboxylase from the bacterial pathogen Enterococcus faecalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; decarboxylase; drug resistance; Enterococcus; enzyme kinetics; enzyme mechanism; isothermal titration calorimetry (ITC); mevalonate pathway	ISOTHERMAL TITRATION CALORIMETRY; SUBSTRATE-BINDING; VANCOMYCIN; RESISTANT; INHIBITION; PYROPHOSPHATE; BIOSYNTHESIS; KINASE; IDENTIFICATION; DAPTOMYCIN	The mevalonate pathway produces isopentenyl diphosphate (IPP), a building block for polyisoprenoid synthesis, and is a crucial pathway for growth of the human bacterial pathogen Enterococcus faecalis. The final enzyme in this pathway, mevalonate diphosphate decarboxylase (MDD), acts on mevalonate diphosphate (MVAPP) to produce IPP while consuming ATP. This essential enzyme has been suggested as a therapeutic target for the treatment of drug-resistant bacterial infections. Here, we report functional and structural studies on the mevalonate diphosphate decarboxylase from E. faecalis (MDDEF). The MDDEF crystal structure in complex with ATP (MDDEF-ATP) revealed that the phosphate-binding loop (amino acids 97-105) is not involved in ATP binding and that the phosphate tail of ATP in this structure is in an outward-facing position pointing away from the active site. This suggested that binding of MDDEF to MVAPP is necessary to guide ATP into a catalytically favorable position. Enzymology experiments show that the MDDEF performs a sequential ordered bi-substrate reaction with MVAPP as the first substrate, consistent with the isothermal titration calorimetry (ITC) experiments. On the basis of ITC results, we propose that this initial prerequisite binding of MVAPP enhances ATP binding. In summary, our findings reveal a substrate-induced substrate-binding event that occurs during the MDDEF-catalyzed reaction. The disengagement of the phosphate-binding loop concomitant with the alternative ATP-binding configuration may provide the structural basis for antimicrobial design against these pathogenic enterococci.	[Chen, Chun-Liang; Mermoud, James C.; Steussy, Calvin Nicklaus; Stauffacher, Cynthia V.] Purdue Univ, Dept Biol Sci, Hockmeyer Hall,Rm 327,240 South Martin Jischke Dr, W Lafayette, IN 47907 USA; [Stauffacher, Cynthia V.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, Biophys Anal Lab, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stauffacher, CV (corresponding author), Purdue Univ, Dept Biol Sci, Hockmeyer Hall,Rm 327,240 South Martin Jischke Dr, W Lafayette, IN 47907 USA.	cstauffa@purdue.edu		Chen, Chun-Liang/0000-0003-4625-4340	Purdue Center for Cancer Research; National Institutes of Health [P30 CA 023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER	Purdue Center for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Purdue Center for Cancer Research and National Institutes of Health Grant P30 CA 023168. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; Andreassi JL, 2004, BIOCHEMISTRY-US, V43, P16461, DOI 10.1021/bi048075t; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; BALLARD FJ, 1966, BIOCHEM J, V101, P70, DOI 10.1042/bj1010070; Barrett J F, 2000, Curr Opin Investig Drugs, V1, P181; Barta ML, 2012, BIOCHEMISTRY-US, V51, P5611, DOI 10.1021/bi300591x; Barta ML, 2011, J BIOL CHEM, V286, P23900, DOI 10.1074/jbc.M111.242016; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Boronat A, 2015, ADV BIOCHEM ENG BIOT, V148, P3, DOI 10.1007/10_2014_285; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Burleson BS, 2004, PHARMACOTHERAPY, V24, P1225, DOI 10.1592/phco.24.13.1225.38086; CDC, 2013, ANT RES THREATS US R; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P352; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Eyzaguirre J, 2006, ARCH BIOCHEM BIOPHYS, V454, P189, DOI 10.1016/j.abb.2006.08.002; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GULBINSKY JS, 1968, BIOCHEMISTRY-US, V7, P566, DOI 10.1021/bi00842a009; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Inokoshi J, 2016, J ANTIBIOT, V69, P798, DOI 10.1038/ja.2016.35; JABALQUINTO AM, 1989, BIOCHIM BIOPHYS ACTA, V996, P257, DOI 10.1016/0167-4838(89)90256-2; JABALQUINTO AM, 1987, BIOCHIM BIOPHYS ACTA, V916, P172, DOI 10.1016/0167-4838(87)90105-1; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Johnson AP, 2002, EUR J CLIN MICROBIOL, V21, P751, DOI 10.1007/s10096-002-0807-0; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Krepkiy D, 2004, PROTEIN SCI, V13, P1875, DOI 10.1110/ps.04725204; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Leskovac V., 2003, COMPREHENSIVE ENZYME, P171; Mermoud J., 2009, THESIS; Munoz-Price LS, 2005, CLIN INFECT DIS, V41, P565, DOI 10.1086/432121; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; Qiu YG, 2007, BIOORG MED CHEM LETT, V17, P6164, DOI 10.1016/j.bmcl.2007.09.033; RAMACHANDRAN CK, 1976, BIOCHEM BIOPH RES CO, V69, P42, DOI 10.1016/S0006-291X(76)80269-0; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; SHAMES SL, 1984, ARCH BIOCHEM BIOPHYS, V235, P359, DOI 10.1016/0003-9861(84)90209-1; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; SOLER M, 1979, INT J BIOCHEM, V10, P931, DOI 10.1016/0020-711X(79)90126-5; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundsfjord A, 2010, CLIN MICROBIOL INFEC, V16, P525, DOI 10.1111/j.1469-0691.2010.03215.x; UTTLEY AHC, 1988, LANCET, V1, P57; Vilhena C, 2012, MINI-REV MED CHEM, V12, P202, DOI 10.2174/1389557511209030202; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wilding EI, 2000, J BACTERIOL, V182, P4319, DOI 10.1128/JB.182.15.4319-4327.2000; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2016, ANTIMICROBIAL RESIST	52	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21340	21351		10.1074/jbc.M117.802223	http://dx.doi.org/10.1074/jbc.M117.802223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29025876	Green Published, hybrid			2022-12-28	WOS:000419013000011
J	Felczak, MM; Chodavarapu, S; Kaguni, JM				Felczak, Magdalena M.; Chodavarapu, Sundari; Kaguni, Jon M.			DnaC, the indispensable companion of DnaB helicase, controls the accessibility of DnaB helicase by primase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI DNAB; SINGLE-STRANDED-DNA; N-TERMINAL DOMAIN; PROTEIN-PROTEIN INTERACTIONS; REPLICATION-FORK; CHROMOSOMAL ORIGIN; HEXAMERIC HELICASE; CRYSTAL-STRUCTURE; PRIMER SYNTHESIS; SALMONELLA-TYPHIMURIUM	Former studies relying on hydrogen/deuterium exchange analysis suggest that DnaC bound to DnaB alters the conformation of the N-terminal domain (NTD) of DnaB to impair the ability of this DNA helicase to interact with primase. Supporting this idea, the work described herein based on biosensor experiments and enzyme-linked immunosorbent assays shows that the DnaB-DnaC complex binds poorly to primase in comparison with DnaB alone. Using a structural model of DnaB complexed with the C-terminal domain of primase, we found that Ile-85 is located at the interface in the NTD of DnaB that contacts primase. An alanine substitution for Ile-85 specifically interfered with this interaction and impeded DnaB function in DNA replication, but not its activity as a DNA helicase or its ability to bind to ssDNA. By comparison, substitutions of Asn for Ile-136 (I136N) and Thr for Ile-142 (I142T) in a subdomain previously named the helical hairpin in the NTD of DnaB altered the conformation of the helical hairpin and/or compromised its pair-wise arrangement with the companion subdomain in each brace of protomers of the DnaB hexamer. In contrast with the I85A mutant, the latter were defective in DNA replication due to impaired binding to both ssDNA and primase. In view of these findings, we propose that DnaC controls the ability of DnaB to interact with primase by modifying the conformation of the NTD of DnaB.	[Felczak, Magdalena M.; Chodavarapu, Sundari; Kaguni, Jon M.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Kaguni, JM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	kaguni@msu.edu	chodavarapu, sundari/Q-3272-2019; chodavarapu, sundari/Q-3279-2019		National Institutes of Health Grant [R01 GM090063]; United States Department of Agriculture National Institute of Food and Agriculture Hatch project [MICL02370]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090063] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture National Institute of Food and Agriculture Hatch project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM090063 and by United States Department of Agriculture National Institute of Food and Agriculture Hatch project MICL02370. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersen PA, 2000, MOL MICROBIOL, V36, P1327, DOI 10.1046/j.1365-2958.2000.01945.x; ARAI K, 1979, P NATL ACAD SCI USA, V76, P4308, DOI 10.1073/pnas.76.9.4308; ARAI K, 1981, J BIOL CHEM, V256, P5253; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BAKER TA, 1986, CELL, V45, P53, DOI 10.1016/0092-8674(86)90537-4; Barcena M, 2001, EMBO J, V20, P1462, DOI 10.1093/emboj/20.6.1462; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; Biswas SB, 2006, BIOCHEMISTRY-US, V45, P11505, DOI 10.1021/bi060118d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Chang P, 2000, J BIOL CHEM, V275, P26187, DOI 10.1074/jbc.M001800200; Chintakayala K, 2008, MOL MICROBIOL, V68, P360, DOI 10.1111/j.1365-2958.2008.06155.x; Chodavarapu S, 2016, NUCLEIC ACIDS RES, V44, P210, DOI 10.1093/nar/gkv961; Chodavarapu S, 2013, NUCLEIC ACIDS RES, V41, P10254, DOI 10.1093/nar/gkt774; Corn JE, 2008, NAT STRUCT MOL BIOL, V15, P163, DOI 10.1038/nsmb.1373; Corn JE, 2006, NUCLEIC ACIDS RES, V34, P4082, DOI 10.1093/nar/gkl363; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Felczak MM, 2016, J BIOL CHEM, V291, P4803, DOI 10.1074/jbc.M115.708586; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Henderson TA, 2001, MOL GENET GENOMICS, V265, P941; HWANG DS, 1988, J BIOL CHEM, V263, P10633; Itsathitphaisarn O, 2012, CELL, V151, P267, DOI 10.1016/j.cell.2012.09.014; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Kaguni JM, 2011, CURR OPIN CHEM BIOL, V15, P606, DOI 10.1016/j.cbpa.2011.07.016; Kaplan DL, 2000, J MOL BIOL, V301, P285, DOI 10.1006/jmbi.2000.3965; Kashav T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007515; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; KOBORI JA, 1982, J BIOL CHEM, V257, P13770; Kurth I, 2013, TRENDS BIOCHEM SCI, V38, P195, DOI 10.1016/j.tibs.2012.10.003; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Leipe DD, 2000, GENOME RES, V10, P5; Lewis JS, 2016, ENZYMES, V39, P31, DOI 10.1016/bs.enz.2016.04.001; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; MARSZALEK J, 1992, J BIOL CHEM, V267, P19334; MASAI H, 1990, J BIOL CHEM, V265, P15134; MAURER R, 1988, J BACTERIOL, V170, P3682, DOI 10.1128/jb.170.8.3682-3688.1988; McHenry CS, 2011, CURR OPIN CHEM BIOL, V15, P587, DOI 10.1016/j.cbpa.2011.07.018; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Oakley AJ, 2005, J BIOL CHEM, V280, P11495, DOI 10.1074/jbc.M412645200; Ozaki S, 2012, NUCLEIC ACIDS RES, V40, P1648, DOI 10.1093/nar/gkr832; Rehman SAA, 2013, J BACTERIOL, V195, P2826, DOI 10.1128/JB.00091-13; San Martin C, 1998, STRUCTURE, V6, P501; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2005, STRUCTURE, V13, P839, DOI 10.1016/j.str.2005.04.006; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Stordal L, 1996, J BACTERIOL, V178, P4620, DOI 10.1128/jb.178.15.4620-4627.1996; Strycharska MS, 2013, MOL CELL, V52, P844, DOI 10.1016/j.molcel.2013.11.016; Su XC, 2006, FEBS J, V273, P4997, DOI 10.1111/j.1742-4658.2006.05495.x; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Syson K, 2005, STRUCTURE, V13, P609, DOI 10.1016/j.str.2005.01.022; TAL M, 1985, J BIOL CHEM, V260, P9976; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; Tougu K, 1996, J BIOL CHEM, V271, P21391, DOI 10.1074/jbc.271.35.21391; TOUGU K, 1994, J BIOL CHEM, V269, P4675; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P4907, DOI 10.1073/pnas.79.16.4907; WONG A, 1988, J BACTERIOL, V170, P2668, DOI 10.1128/jb.170.6.2668-2675.1988; WU CA, 1992, J BIOL CHEM, V267, P4030; Yang SX, 2002, J MOL BIOL, V321, P839, DOI 10.1016/S0022-2836(02)00711-8; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	80	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20871	20882		10.1074/jbc.M117.807644	http://dx.doi.org/10.1074/jbc.M117.807644			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29070678	Green Published, hybrid			2022-12-28	WOS:000418453400006
J	Zoghbi, ME; Mok, L; Swartz, DJ; Singh, A; Fendley, GA; Urbatsch, IL; Altenberg, GA				Zoghbi, Maria E.; Mok, Leo; Swartz, Douglas J.; Singh, Anukriti; Fendley, Gregory A.; Urbatsch, Ina L.; Altenberg, Guillermo A.			Substrate-induced conformational changes in the nucleotide-binding domains of lipid bilayer-associated P-glycoprotein during ATP hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; fluorescence resonance energy transfer (FRET); membrane; membrane bilayer; multidrug transporter; spectroscopy; LRET; luminescence resonance energy transfer; nanodisc	ABC TRANSPORTER MSBA; LUMINESCENCE ENERGY-TRANSFER; MULTIDRUG TRANSPORTER; CATALYTIC CYCLE; ALTERNATING ACCESS; DRUG-BINDING; ELECTRON-MICROSCOPY; MUTANT PROTEINS; MOLECULAR-BASIS; EFFLUX PUMP	P-glycoprotein (Pgp) is an efflux pump important in multidrug resistance of cancer cells and in determining drug pharmacokinetics. Pgp is a prototype ATP-binding cassette transporter with two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP. Conformational changes at the NBDs (the Pgp engines) lead to changes across Pgp transmembrane domains that result in substrate translocation. According to current alternating access models (substrate-binding pocket accessible only to one side of the membrane at a time), binding of ATP promotes NBD dimerization, resulting in external accessibility of the drug-binding site (outward-facing, closed NBD conformation), and ATP hydrolysis leads to dissociation of the NBDs with the subsequent return of the accessibility of the binding site to the cytoplasmic side (inward-facing, open NBD conformation). However, previous work has not investigated these events under near-physiological conditions in a lipid bilayer and in the presence of transport substrate. Here, we used luminescence resonance energy transfer (LRET) to measure the distances between the two Pgp NBDs. Pgp was labeled with LRET probes, reconstituted in lipid nanodiscs, and the distance between the NBDs was measured at 37 degrees C. In the presence of verapamil, a substrate that activates ATP hydrolysis, the NBDs of Pgp reconstituted in nanodiscs were never far apart during the hydrolysis cycle, and we never observed the NBD-NBD distances of tens of that have previously been reported. However, we found two main conformations that coexist in a dynamic equilibrium under all conditions studied. Our observations highlight the importance of performing studies of efflux pumps under near-physiological conditions, in a lipid bilayer, at 37 degrees C, and during substrate-stimulated hydrolysis.	[Zoghbi, Maria E.; Fendley, Gregory A.; Altenberg, Guillermo A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA; [Mok, Leo; Swartz, Douglas J.; Singh, Anukriti; Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA; [Urbatsch, Ina L.; Altenberg, Guillermo A.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA; [Zoghbi, Maria E.; Fendley, Gregory A.] Univ Calif Merced, Sch Nat Sci, 4225 N Hosp Rd, Atwater, CA 95301 USA; [Mok, Leo] Amgen Inc, Mail Stop ASF1-2101A,1120 Vet Blvd, San Francisco, CA 94080 USA; [Swartz, Douglas J.] Lubbock Christian Univ, Dept Nat Sci, Lubbock, TX 79407 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of California System; University of California Merced; Amgen	Altenberg, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, 3601 4th St, Lubbock, TX 79430 USA.; Urbatsch, IL (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	ina.urbatsch@ttuhsc.edu; g.altenberg@ttuhsc.edu		Zoghbi, Maria/0000-0002-4206-4673	Cancer Prevention and Research Institute of Texas [RP101073]; National Institute of Health [RGM102928, R01GM118594]; South Plains Foundation from Lubbock, TX; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102928, R01GM118594] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Plains Foundation from Lubbock, TX; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Cancer Prevention and Research Institute of Texas Grant RP101073, National Institute of Health Grants RGM102928 and R01GM118594, and the South Plains Foundation from Lubbock, TX. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Bai JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022577; BEAUDET L, 1995, J BIOL CHEM, V270, P17159, DOI 10.1074/jbc.270.29.17159; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Brachmann CB, 1998, YEAST, V14, P115; Bretscher LE, 2008, ANAL BIOCHEM, V382, P129, DOI 10.1016/j.ab.2008.08.001; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Fiori MC, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140089; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Fribourg PF, 2014, J MOL BIOL, V426, P2059, DOI 10.1016/j.jmb.2014.03.002; George AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059854; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; JAMES DR, 1986, CHEM PHYS LETT, V126, P7, DOI 10.1016/0009-2614(86)85107-7; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Lee SC, 2017, ADV DRUG DELIVER REV, V116, P100, DOI 10.1016/j.addr.2017.07.020; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Loo TW, 2016, BIOCHEM BIOPH RES CO, V472, P379, DOI 10.1016/j.bbrc.2016.02.124; Loo TW, 2014, J BIOL CHEM, V289, P8484, DOI 10.1074/jbc.M114.552075; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pan LR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07880; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shukla S, 2017, J BIOL CHEM, V292, P7066, DOI 10.1074/jbc.M116.771634; SIEMIARCZUK A, 1990, J PHYS CHEM-US, V94, P1661, DOI 10.1021/j100367a080; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Stindt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020562; Swartz DJ, 2014, BIOSCIENCE REP, V34, P297, DOI 10.1042/BSR20140062; Szewczyk P, 2015, ACTA CRYSTALLOGR D, V71, P732, DOI 10.1107/S1399004715000978; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Urbatsch IL, 2000, J BIOL CHEM, V275, P25031, DOI 10.1074/jbc.M003962200; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; van Wonderen JH, 2014, FEBS J, V281, P2190, DOI 10.1111/febs.12773; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Wang GC, 1997, BIOCHEM J, V328, P897, DOI 10.1042/bj3280897; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Zoghbi ME, 2016, J BIOL CHEM, V291, P4453, DOI 10.1074/jbc.M115.698498; Zoghbi ME, 2014, BIOCHEM BIOPH RES CO, V443, P97, DOI 10.1016/j.bbrc.2013.11.050; Zoghbi ME, 2013, J BIOL CHEM, V288, P34259, DOI 10.1074/jbc.M113.500371; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	85	39	39	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20412	20424		10.1074/jbc.M117.814186	http://dx.doi.org/10.1074/jbc.M117.814186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29018094	hybrid, Green Published			2022-12-28	WOS:000418267000006
J	Okamoto, A; Hosoda, N; Tanaka, A; Newnam, GP; Chernoff, YO; Hoshino, S				Okamoto, Atsushi; Hosoda, Nao; Tanaka, Anri; Newnam, Gary P.; Chernoff, Yury O.; Hoshino, Shin-ichi			Proteolysis suppresses spontaneous prion generation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; prion; translation; translation control; translation regulation; translation release factor	TERMINATION FACTOR ERF3; DE-NOVO APPEARANCE; SACCHAROMYCES-CEREVISIAE; RELEASE FACTOR; SUP35 GENE; ACTIN CYTOSKELETON; PROTEASE-B; PSI PRION; INHERITANCE; MECHANISM	Prions are infectious proteins that cause fatal neurodegenerative disorders including Creutzfeldt-Jakob and bovine spongiform encephalopathy (mad cow) diseases. The yeast [PSI+] prion is formed by the translation-termination factor Sup35, is the best-studied prion, and provides a useful model system for studying such diseases. However, despite recent progress in the understanding of prion diseases, the cellular defense mechanism against prions has not been elucidated. Here, we report that proteolytic cleavage of Sup35 suppresses spontaneous de novo generation of the [PSI+] prion. We found that during yeast growth in glucose media, a maximum of 40% of Sup35 is cleaved at its N-terminal prion domain. This cleavage requires the vacuolar proteases PrA-PrB. Cleavage occurs in a manner dependent on translation but independently of autophagy between the glutamine/asparagine-rich (Q/N-rich) stretch critical for prion formation and the oligopeptide-repeat region required for prion maintenance, resulting in the removal of the Q/N-rich stretch from the Sup35 N terminus. The complete inhibition of Sup35 cleavage, by knocking out either PrA (pep4) or PrB (prb1), increased the rate of de novo formation of [PSI+] prion up to approximate to 5-fold, whereas the activation of Sup35 cleavage, by overproducing PrB, inhibited [PSI+] formation. On the other hand, activation of the PrB pathway neither cleaved the amyloid conformers of Sup35 in [PSI+] strains nor eliminated preexisting [PSI+]. These findings point to a mechanism antagonizing prion generation in yeast. Our results underscore the usefulness of the yeast [PSI+] prion as a model system to investigate defense mechanisms against prion diseases and other amyloidoses.	[Okamoto, Atsushi; Hosoda, Nao; Tanaka, Anri; Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan; [Newnam, Gary P.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Nagoya City University; University System of Georgia; Georgia Institute of Technology; Saint Petersburg State University	Hoshino, S (corresponding author), 3-1 Tanabe Dori,Mizuho Ku, Nagoya, Aichi 4678603, Japan.	hoshino@phar.nagoya-cu.ac.jp	Chernoff, Yury O/J-2833-2014	Hoshino, Shinichi/0000-0001-6135-7896	Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development; Takeda Science Foundation; National Science Foundation [MCB-1516872]; Russian Science Foundation [14-50-00069]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Takeda Science Foundation(Takeda Science Foundation (TSF)); National Science Foundation(National Science Foundation (NSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported in part by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (to S. H.), the Program on the Innovative Development and the Application of New Drugs for Hepatitis B from the Japan Agency for Medical Research and Development (to S. H), a Grant-in-Aid for Research to Nagoya City University (to S. H.), the Takeda Science Foundation (to S. H), Grant MCB-1516872 from the National Science Foundation (to Y. O. C.), and Grant 14-50-00069 from the Russian Science Foundation (to Y. O. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bailleul PA, 1999, GENETICS, V153, P81; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Borchsenius AS, 2001, EMBO J, V20, P6683, DOI 10.1093/emboj/20.23.6683; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; DOEL SM, 1994, GENETICS, V137, P659; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; GASSET M, 1992, P NATL ACAD SCI USA, V89, P10940, DOI 10.1073/pnas.89.22.10940; Geissen M, 2007, VACCINE, V25, P5631, DOI 10.1016/j.vaccine.2007.02.041; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Hashimoto Y, 2012, APOPTOSIS, V17, P1287, DOI 10.1007/s10495-012-0765-7; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Jones EW, 2002, METHOD ENZYMOL, V351, P127; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lancaster AK, 2010, GENETICS, V184, P393, DOI 10.1534/genetics.109.110213; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; MECHLER B, 1987, EMBO J, V6, P2157, DOI 10.1002/j.1460-2075.1987.tb02483.x; MOEHLE CM, 1990, GENETICS, V124, P39; MOEHLE CM, 1987, MOL CELL BIOL, V7, P4390, DOI 10.1128/MCB.7.12.4390; MOEHLE CM, 1987, GENETICS, V115, P255; NEBES VL, 1991, J BIOL CHEM, V266, P22851; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Orij R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r80; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Solforosi L, 2007, J BIOL CHEM, V282, P7465, DOI 10.1074/jbc.M610051200; TERAVANESYAN MD, 1994, GENETICS, V137, P671; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; TUITE MF, 1981, GENETICS, V98, P691; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Turnbaugh JA, 2012, J NEUROSCI, V32, P8817, DOI 10.1523/JNEUROSCI.1103-12.2012; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 2012, J BIOL CHEM, V287, P14432, DOI 10.1074/jbc.X112.355636; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xue Y., 2014, PLOS ONE, V9, P1; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182	49	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20113	20124		10.1074/jbc.M117.811323	http://dx.doi.org/10.1074/jbc.M117.811323			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038292	Green Published, hybrid			2022-12-28	WOS:000417696400018
J	Li, Z; Li, XY; Nai, SS; Geng, QZ; Liao, J; Xu, XZ; Li, J				Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing			Checkpoint kinase 1-induced phosphorylation of O-linked -N-acetylglucosamine transferase regulates the intermediate filament network during cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cytokinesis; mitosis; O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc); O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); protein phosphorylation; vimentin	VIMENTIN PHOSPHORYLATION; CROSS-TALK; GLCNACYLATION; CANCER; SEGREGATION; ACTIVATION; ANEUPLOIDY; INVASION; PATHWAY; GLCNAC	Checkpoint kinase 1 (Chk1) is a kinase instrumental for orchestrating DNA replication, DNA damage checkpoints, the spindle assembly checkpoint, and cytokinesis. Despite Chk1's pivotal role in multiple cellular processes, many of its substrates remain elusive. Here, we identified O-linked -N-acetylglucosamine (O-GlcNAc)-transferase (OGT) as one of Chk1's substrates. We found that Chk1 interacts with and phosphorylates OGT at Ser-20, which not only stabilizes OGT, but also is required for cytokinesis. Phospho-specific antibodies of OGT-pSer-20 exhibited specific signals at the midbody of the cell, consistent with midbody localization of OGT as reported previously. Moreover, phospho-deficient OGT (S20A) cells attenuated cellular O-GlcNAcylation levels and also reduced phosphorylation of Ser-71 in the cytoskeletal protein vimentin, a modification critical for severing vimentin filament during cytokinesis. Consequently, elongated vimentin bridges were observed in cells depleted of OGT via an siOGT-based approach. Lastly, expression of plasmids resistant to siOGT efficiently rescued the vimentin bridge phenotype, but the OGT-S20A rescue plasmids did not. Our results suggest a Chk1-OGT-vimentin pathway that regulates the intermediate filament network during cytokinesis.	[Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China; [Li, Zhe; Li, Xueyan; Nai, Shanshan; Geng, Qizhi; Liao, Ji; Xu, Xingzhi; Li, Jing] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China; [Xu, Xingzhi] Shenzhen Univ, Guangdong Key Lab Genome Stabil & Dis Prevent, Sch Med, Shenzhen 518060, Guangdong, Peoples R China	Capital Normal University; Capital Normal University; Shenzhen University	Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing 100048, Peoples R China.; Xu, XZ; Li, J (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China.; Xu, XZ (corresponding author), Shenzhen Univ, Guangdong Key Lab Genome Stabil & Dis Prevent, Sch Med, Shenzhen 518060, Guangdong, Peoples R China.	xingzhi.xu@szu.edu.cn; jing_li@mail.cnu.edu.cn	Xu, Xingzhi/E-8158-2012; Li, Jing/C-2031-2013	Xu, Xingzhi/0000-0002-4459-2082; Li, Jing/0000-0002-3977-1641; July, June/0000-0003-1239-3879	Beijing Nova Program Interdisciplinary Cooperation Project [Z161100004916042]; Capital Normal University (CNU) Interdisciplinary Project; National Natural Science Foundation of China (NSFC) [31461143012, 31530016]; 973 projects [2013CB911002, 2015CB910601]; Shenzhen Science and Technology Innovation Commission [JCYJ20170412113009742]; NSFC [31271446]	Beijing Nova Program Interdisciplinary Cooperation Project; Capital Normal University (CNU) Interdisciplinary Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 projects(National Basic Research Program of China); Shenzhen Science and Technology Innovation Commission; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Nova Program Interdisciplinary Cooperation Project Grant Z161100004916042 and Capital Normal University (CNU) Interdisciplinary Project (to J. Li). This work was also supported by National Natural Science Foundation of China (NSFC) funds 31461143012 and 31530016, by the 973 projects 2013CB911002 and 2015CB910601 (X. X.), the Shenzhen Science and Technology Innovation Commission JCYJ20170412113009742 (X. X.), and by NSFC fund 31271446 (J. Liao). The authors declare that they have no conflicts of interest with the contents of this article.	Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Chen Q, 2013, NATURE, V493, P561, DOI 10.1038/nature11742; D'Avino PP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015834; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim DH, 2011, BMB REP, V44, P415, DOI 10.5483/BMBRep.2011.44.6.415; Lima VV, 2011, CARDIOVASC RES, V89, P614, DOI 10.1093/cvr/cvq338; Lowery J, 2015, J BIOL CHEM, V290, P17145, DOI 10.1074/jbc.R115.640359; Mackay DR, 2015, MOL BIOL CELL, V26, P2217, DOI 10.1091/mbc.E14-11-1563; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; Niu YC, 2017, MOL MED REP, V15, P2083, DOI 10.3892/mmr.2017.6244; Pan TL, 2012, J PROTEOMICS, V75, P4676, DOI 10.1016/j.jprot.2012.02.017; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Shi AM, 2016, EUR REV MED PHARMACO, V20, P2603; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Tanaka H, 2015, J BIOL CHEM, V290, P12984, DOI 10.1074/jbc.M114.633891; Tian JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16722; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Whipple RA, 2008, CANCER RES, V68, P5678, DOI 10.1158/0008-5472.CAN-07-6589; Xu QR, 2014, NUCLEIC ACIDS RES, V42, P5594, DOI 10.1093/nar/gku236; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang Y, 2015, MOL CELL, V58, P47, DOI 10.1016/j.molcel.2015.01.038; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339	31	21	22	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19548	19555		10.1074/jbc.M117.811646	http://dx.doi.org/10.1074/jbc.M117.811646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29021254	hybrid, Green Published			2022-12-28	WOS:000416911300001
J	Soysa, HSM; Schulte, A; Suginta, W				Soysa, H. Sasimali M.; Schulte, Albert; Suginta, Wipa			Functional analysis of an unusual porin-like channel that imports chitin for alternative carbon metabolism in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; SUGAR TRANSLOCATION; CHITOOLIGOSACCHARIDE-BINDING; MALTOPORIN CHANNELS; CURRENT NOISE; PROTEIN; TRANSPORT; CHITOPORIN; MOLECULES; PATHWAY	Escherichia coli have the genetic potential to use chitin as a carbon source in the absence of glucose, importing it via the chitin-uptake channel EcChiP for processing by the glucosamine catabolic pathway. The chip gene is usually not expressed when E. coli are grown on glucose-enriched nutrients, providing a general regulatory mechanism for the pathway. EcChiP is unusual in that it is homologous to porins and monomeric instead of trimeric, the typical form of sugar-specific channels, making it unclear how this channel operates. We recently reported that EcChiP could form a stable channel in lipid membranes and that the channel is specific for chitooligosaccharides. This report describes the biophysical nature of sugar-channel interactions and the kinetics of sugar association and dissociation. Titrating EcChiP with chitohexaose resulted in protein fluorescence enhancement in a concentration-dependent manner, yielding a binding constant of 2.9 x 10(5) m(-1), consistent with the value of 2.5 x 10(5) m(-1) obtained from isothermal titration microcalorimetry. Analysis of the integrated heat change suggested that the binding process was endothermic and driven by entropy. Single-channel recordings confirmed the voltage dependence of the penetration of chitohexaose molecules into and their release from EcChiP. Once inside the pore, the sugar release rate (k(off)) from the affinity site increased with elevated voltage, regardless of the side of sugar addition. Our findings revealed distinct thermodynamic and kinetic features of the activity of sugar-specific EcChiP and advance our knowledge of the physiological possibility of chitin utilization by non-chitinolytic bacteria.	[Soysa, H. Sasimali M.; Suginta, Wipa] Suranaree Univ Technol, Biochem Electrochem Res Unit, Inst Sci, Nakhon Ratchasima 30000, Thailand; [Suginta, Wipa] Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand; [Schulte, Albert] Vidyasirimedhi Inst Sci & Technol, Sch Biomol Sci & Engn, Rayong 21210, Thailand	Suranaree University of Technology; Suranaree University of Technology; Vidyasirimedhi Institute of Science & Technology	Suginta, W (corresponding author), Suranaree Univ Technol, Ctr Excellence Adv Funct Mat, Nakhon Ratchasima 30000, Thailand.	wipa@sut.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University (NRU) project of Thailand; Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant; Deutscher Akademischer Austausch Dienst; Thailand Research Fund; Suranaree University of Technology through Basic Research Grant [BRG578001]; Suranaree University of Technology Grant [SUT1-102-60-36-13]	Suranaree University of Technology; Office of the Higher Education Commission under the National Research University (NRU) project of Thailand; Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Thailand Research Fund(Thailand Research Fund (TRF)); Suranaree University of Technology through Basic Research Grant; Suranaree University of Technology Grant	This work was supported by Suranaree University of Technology and the Office of the Higher Education Commission under the National Research University (NRU) project of Thailand. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Suranaree University of Technology through a Suranaree University of Technology-One Research One Grant (SUT-OROG) grant and the Deutscher Akademischer Austausch Dienst.; Supported by the Thailand Research Fund and Suranaree University of Technology through Basic Research Grant BRG578001 and Suranaree University of Technology Grant SUT1-102-60-36-13. To whom correspondence should be addressed. E-mail: wipa@sut.ac.th.	Abraham T, 2005, BIOCHEMISTRY-US, V44, P11279, DOI 10.1021/bi050898a; Anbazhagan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025993; Andersen C, 1998, J MEMBRANE BIOL, V164, P263, DOI 10.1007/s002329900411; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Bajaj H, 2017, ACS NANO, V11, P5465, DOI 10.1021/acsnano.6b08613; Bezrukov SM, 2000, FEBS LETT, V476, P224, DOI 10.1016/S0014-5793(00)01753-1; Bhamidimarri SP, 2016, BIOPHYS J, V110, P600, DOI 10.1016/j.bpj.2015.12.027; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Eftink MR, 1997, METHOD ENZYMOL, V278, P221; Figueroa-Bossi N, 2009, GENE DEV, V23, P2004, DOI 10.1101/gad.541609; Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37; Francetic O, 2000, MOL MICROBIOL, V35, P1506, DOI 10.1046/j.1365-2958.2000.01817.x; Francetic O, 2000, EMBO J, V19, P6697, DOI 10.1093/emboj/19.24.6697; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Hilty C, 2001, PHYS REV LETT, V86, P5624, DOI 10.1103/PhysRevLett.86.5624; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; PERI KG, 1990, BIOCHEM CELL BIOL, V68, P123, DOI 10.1139/o90-017; Piguet F, 2014, J PHYS CHEM LETT, V5, P4362, DOI 10.1021/jz502360c; Plumbridge J, 2014, MOL MICROBIOL, V92, P648, DOI 10.1111/mmi.12573; Ranok A, 2015, J BIOL CHEM, V290, P2617, DOI 10.1074/jbc.M114.588905; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schimpl M, 2012, BIOCHEM J, V446, P149, DOI 10.1042/BJ20120377; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schwarz G, 2003, BIOPHYS J, V84, P2990, DOI 10.1016/S0006-3495(03)70025-3; Singh PR, 2012, ACS NANO, V6, P10699, DOI 10.1021/nn303900y; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Soysa HSM, 2016, J BIOL CHEM, V291, P13622, DOI 10.1074/jbc.M116.728881; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Suginta W, 2016, BBA-BIOMEMBRANES, V1858, P3032, DOI 10.1016/j.bbamem.2016.09.007; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Takanao S, 2014, BIOSCI BIOTECH BIOCH, V78, P524, DOI 10.1080/09168451.2014.882755; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Van Gelder P, 2002, J BACTERIOL, V184, P2994, DOI 10.1128/JB.184.11.2994-2999.2002; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Verma SC, 2012, J BACTERIOL, V194, P4959, DOI 10.1128/JB.00533-12; Vogel J, 2006, CURR OPIN MICROBIOL, V9, P605, DOI 10.1016/j.mib.2006.10.006; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200	43	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19328	19337		10.1074/jbc.M117.812321	http://dx.doi.org/10.1074/jbc.M117.812321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28972167	Green Published, hybrid			2022-12-28	WOS:000416226700015
J	Bartholomew, B				Bartholomew, Blaine			Proteasomes beyond proteolysis: Roles in heterochromatin maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ELIMINATION	In addition to its proteolytic roles, the 26S proteasome is involved in regulating transcription and in promoting sites of active chromatin. In this report, Seo et al. provide evidence that the non-proteolytic 19S subunit of the 26S proteasome also regulates the spreading of inactive chromatin referred to as heterochromatin, suggesting further non-canonical roles of the proteasome in gene expression.	[Bartholomew, Blaine] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bartholomew, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA.	bbartholomew@mdanderson.org						Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Martienssen R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019323; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sadeghi L, 2015, EMBO REP, V16, P1673, DOI 10.15252/embr.201541214; Seo HD, 2017, J BIOL CHEM, V292, P17144, DOI 10.1074/jbc.M117.790824; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Wang JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06179; Wang JY, 2013, GENE DEV, V27, P1886, DOI 10.1101/gad.221010.113; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	10	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17156	17157		10.1074/jbc.H117.790824	http://dx.doi.org/10.1074/jbc.H117.790824			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	29030538	hybrid, Green Published			2022-12-28	WOS:000413140600034
J	Ackerman, CM; Chang, CJ				Ackerman, Cheri M.; Chang, Christopher J.			Copper signaling in the brain and beyond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SYNTHETIC FLUORESCENT-PROBES; LONG-TERM POTENTIATION; SUPEROXIDE DISMUTASES; BREAST-CANCER; HIGH-RISK; IN-VIVO; METAL; CELLS; LIVER; TRAFFICKING	Transition metals have been recognized and studied primarily in the context of their essential roles as structural and metabolic cofactors for biomolecules that compose living systems. More recently, an emerging paradigm of transition-metal signaling, where dynamic changes in transitional metal pools can modulate protein function, cell fate, and organism health and disease, has broadened our view of the potential contributions of these essential nutrients in biology. Using copper as a canonical example of transition-metal signaling, we highlight key experiments where direct measurement and/or visualization of dynamic copper pools, in combination with biochemical, physiological, and behavioral studies, have deciphered sources, targets, and physiological effects of copper signals.	[Ackerman, Cheri M.; Chang, Christopher J.] Univ Calif Berkeley, Dept Chem, 532A Latimer Hall, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Chang, Christopher J.] Lawrence Berkeley Natl Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Chang, Christopher J.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Howard Hughes Medical Institute	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, 532A Latimer Hall, Berkeley, CA 94720 USA.	chrischang@berkeley.edu			National Institutes of Health [R01 GM079465]; Fannie and John Hertz Foundation; National Institutes of Health Chemical Biology Interface Training Grant [T32 GM066698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079465, T32GM066698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fannie and John Hertz Foundation; National Institutes of Health Chemical Biology Interface Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM079465. This is the third article in the Thematic Minireview series "Metals in Biology 2018: Copper homeostasis and utilization in redox enzymes." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Fannie and John Hertz Foundation Fellowship and National Institutes of Health Chemical Biology Interface Training Grant T32 GM066698.	Acevedo KM, 2014, J BIOL CHEM, V289, P11007, DOI 10.1074/jbc.M113.538710; Acevedo KM, 2011, J BIOL CHEM, V286, P8252, DOI 10.1074/jbc.M110.128512; Ackerman CM, 2017, ANAL CHEM, V89, P22, DOI 10.1021/acs.analchem.6b04631; Acuna-Castillo C, 2000, J NEUROCHEM, V74, P1529, DOI 10.1046/j.1471-4159.2000.0741529.x; Aigner E, 2010, AM J GASTROENTEROL, V105, P1978, DOI 10.1038/ajg.2010.170; Alvarez HM, 2010, SCIENCE, V327, P331, DOI 10.1126/science.1179907; ANDERSON BI, 1951, AUST J SCI RES SER B, V4, P275; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Brady DC, 2014, NATURE, V509, P492, DOI 10.1038/nature13180; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Burkhead J. L., 2013, ROLE COPPER MODIFIER; Canton J, 2014, J LEUKOCYTE BIOL, V96, P729, DOI 10.1189/jlb.1MR0114-021R; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Castelli L, 2003, J MEMBRANE BIOL, V195, P121, DOI 10.1007/s00232-003-0614-2; Cater MA, 2013, ACS CHEM BIOL, V8, P1621, DOI 10.1021/cb400198p; Chan N, 2017, CLIN CANCER RES, V23, P666, DOI 10.1158/1078-0432.CCR-16-1326; Chang CJ, 2017, ACCOUNTS CHEM RES, V50, P535, DOI 10.1021/acs.accounts.6b00531; Chang CJ, 2015, NAT CHEM BIOL, V11, P744, DOI 10.1038/nchembio.1913; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; CRABTREE RH, 1978, J INORG NUCL CHEM, V40, P1453, DOI 10.1016/0022-1902(78)80071-2; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; D'Ambrosi N, 2015, NEUROCHEM INT, V90, P36, DOI 10.1016/j.neuint.2015.07.006; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denoyer D, 2016, ONCOTARGET, V7, P37064, DOI 10.18632/oncotarget.9245; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Dodani SC, 2014, P NATL ACAD SCI USA, V111, P16280, DOI 10.1073/pnas.1409796111; Dodani SC, 2011, P NATL ACAD SCI USA, V108, P5980, DOI 10.1073/pnas.1009932108; Doreulee N, 1997, HIPPOCAMPUS, V7, P666, DOI 10.1002/(SICI)1098-1063(1997)7:6<666::AID-HIPO8>3.3.CO;2-6; Duan XF, 2012, P NATL ACAD SCI USA, V109, P3492, DOI 10.1073/pnas.1111297109; Ermilova IP, 2005, NEUROSCI LETT, V379, P42, DOI 10.1016/j.neulet.2004.12.045; Fahrni CJ, 2013, CURR OPIN CHEM BIOL, V17, P656, DOI 10.1016/j.cbpa.2013.05.019; Festa RA, 2014, CHEM BIOL, V21, P977, DOI 10.1016/j.chembiol.2014.06.009; Field LS, 2002, J BIOENERG BIOMEMBR, V34, P373, DOI 10.1023/A:1021202119942; Fouani L, 2017, PHARMACOL RES, V115, P275, DOI 10.1016/j.phrs.2016.12.001; Gaier ED, 2014, J NEUROPHYSIOL, V111, P1927, DOI 10.1152/jn.00631.2013; Gaier ED, 2013, J NEUROSCI RES, V91, P2, DOI 10.1002/jnr.23143; Gleason JE, 2014, P NATL ACAD SCI USA, V111, P5866, DOI 10.1073/pnas.1400137111; Goldschmith A, 2005, BRAIN RES, V1056, P176, DOI 10.1016/j.brainres.2005.07.030; Grubman A, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.11; Hamza I, 2002, J BIOENERG BIOMEMBR, V34, P381, DOI 10.1023/A:1021254104012; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hatori Y, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030025; Heffern MC, 2016, P NATL ACAD SCI USA, V113, P14219, DOI 10.1073/pnas.1613628113; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Horning MS, 2001, J NEUROPHYSIOL, V86, P1652, DOI 10.1152/jn.2001.86.4.1652; Huster D, 2007, J BIOL CHEM, V282, P8343, DOI 10.1074/jbc.M607496200; Irene G, 2016, DIAGN MICR INFEC DIS, V85, P205, DOI 10.1016/j.diagmicrobio.2016.02.015; Jain S, 2013, ANN ONCOL, V24, P1491, DOI 10.1093/annonc/mds654; Johnson MDL, 2015, INFECT IMMUN, V83, P1684, DOI 10.1128/IAI.03015-14; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Kretzschmar HA, 2000, ARCH VIROL, P239; Krishnamoorthy L, 2016, NAT CHEM BIOL, V12, P586, DOI [10.1038/NCHEMBIO.2098, 10.1038/nchembio.2098]; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Ladomersky E, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00351-17; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Leiva J, 2009, BRAIN RES, V1256, P69, DOI 10.1016/j.brainres.2008.12.041; Li CX, 2015, P NATL ACAD SCI USA, V112, pE5336, DOI 10.1073/pnas.1513447112; Liggi M, 2013, CLIN RES HEPATOL GAS, V37, P36, DOI 10.1016/j.clinre.2012.03.038; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Lutsenko S, 2014, ANN NY ACAD SCI, V1315, P56, DOI 10.1111/nyas.12420; Marchetti C, 2014, BRAIN RES, V1542, P20, DOI 10.1016/j.brainres.2013.10.029; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Maureira C, 2015, EUR J NEUROSCI, V42, P3066, DOI 10.1111/ejn.13104; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; McGee TP, 2013, J NEUROSCI, V33, P13431, DOI 10.1523/JNEUROSCI.1908-13.2013; Morrell A, 2017, IUBMB LIFE, V69, P263, DOI 10.1002/iub.1613; Muchenditsi A, 2017, AM J PHYSIOL-GASTR L, V313, pG39, DOI 10.1152/ajpgi.00312.2016; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Opazo CM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00143; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Punthambaker S, 2014, NEUROPHARMACOLOGY, V77, P167, DOI 10.1016/j.neuropharm.2013.09.001; Raja MR, 2013, METALLOMICS, V5, P363, DOI 10.1039/c3mt20220h; Raza MH, 2017, J CANCER RES CLIN, V143, P1789, DOI 10.1007/s00432-017-2464-9; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Safi R, 2014, CANCER RES, V74, P5819, DOI 10.1158/0008-5472.CAN-13-3527; Santo CE, 2011, APPL ENVIRON MICROB, V77, P794, DOI 10.1128/AEM.01599-10; Santos EM, 2010, ENVIRON SCI TECHNOL, V44, P820, DOI 10.1021/es902558k; Schlief ML, 2006, P NATL ACAD SCI USA, V103, P14919, DOI 10.1073/pnas.0605390103; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Sharonova IN, 1998, EUR J NEUROSCI, V10, P522, DOI 10.1046/j.1460-9568.1998.00057.x; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; Shi XS, 2014, MBIO, V5, DOI 10.1128/mBio.00876-13; Trombley PQ, 1996, J NEUROPHYSIOL, V76, P2536, DOI 10.1152/jn.1996.76.4.2536; Turski ML, 2012, MOL CELL BIOL, V32, P1284, DOI 10.1128/MCB.05722-11; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Weiser T, 1996, BRAIN RES, V742, P211, DOI 10.1016/S0006-8993(96)01009-8; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Xiao GR, 2013, P NATL ACAD SCI USA, V110, P14995, DOI 10.1073/pnas.1308535110; Yamada Y, 2014, NEUROSCIENCE, V256, P252, DOI 10.1016/j.neuroscience.2013.10.033; Yruela I, 2013, METALLOMICS, V5, P1090, DOI 10.1039/c3mt00086a	98	76	78	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4628	4635		10.1074/jbc.R117.000176	http://dx.doi.org/10.1074/jbc.R117.000176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29084848	Green Published, hybrid			2022-12-28	WOS:000428848300005
J	Segawa, K; Kurata, S; Nagata, S				Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu			The CDC50A extracellular domain is required for forming a functional complex with and chaperoning phospholipid flippases to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; chaperone; membrane protein; mutagenesis; phospholipid; ATP11C; CDC50A; error-prone PCR; flippase	NA,K-ATPASE BETA-SUBUNIT; P-TYPE ATPASES; PHOSPHATIDYLSERINE; PROTEINS; GLYCOSYLATION; MUTAGENESIS; EXPRESSION; ASYMMETRY; P4-ATPASE; RESIDUES	Flippases are enzymes that translocate phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) from the outer to the inner leaflet in the lipid bilayer of the plasma membrane, leading to the asymmetric distribution of aminophospholipids in the membrane. One mammalian phospholipid flippase at the plasma membrane is ATP11C, a type IV P-type ATPase (P4-ATPase) that forms a heterocomplex with the transmembrane protein CDC50A. However, the structural features in CDC50A that support the function of ATP11C and other P4-ATPases have not been characterized. Here, using error-prone PCR-mediated mutagenesis of human CDC50A cDNA followed by functional screening and deep sequencing, we identified 14 amino acid residues that affect ATP11C's flippase activity. These residues were all located in CDC50A's extracellular domain and were evolutionarily well-conserved. Most of the mutations decreased CDC50A's ability to chaperone ATP11C and other P4-ATPases to their destinations. The CDC50A mutants failed to form a stable complex with ATP11C and could not induce ATP11C's PtdSer-dependent ATPase activity. Notably, one mutant variant could form a stable complex with ATP11C and transfer ATP11C to the plasma membrane, yet the ATP11C complexed with this CDC50A variant had very weak or little PtdSer- or PtdEtn-dependent ATPase activity. These results indicated that the extracellular domain of CDC50A has important roles both in CDC50A's ability to chaperone ATP11C to the plasma membrane and in inducing ATP11C's ATP hydrolysis-coupled flippase activity.	[Segawa, Katsumori; Kurata, Sachiko; Nagata, Shigekazu] Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan	Osaka University	Nagata, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka 5650871, Japan.	snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Japan Society for the Promotion of Science [16H01360, 17H05506, 15H05785]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [JPMJCR14M4]; Grants-in-Aid for Scientific Research [15K08266] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas 16H01360 and 17H05506 from the Japan Society for the Promotion of Science (to K. S.), Grant-in-Aid for Specially Promoted Research 15H05785 from the Japan Society for the Promotion of Science (to S. N.), and Grant-in-Aid JPMJCR14M4 from Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (to S. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arashiki N, 2016, HAEMATOLOGICA, V101, P559, DOI 10.3324/haematol.2016.142273; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Borgese N, 2016, J CELL SCI, V129, P1537, DOI 10.1242/jcs.183335; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; Costa SR, 2016, BIOCHEM J, V473, P1605, DOI 10.1042/BCJ20160207; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fowler DM, 2014, NAT PROTOC, V9, P2267, DOI 10.1038/nprot.2014.153; Garcia-Sanchez S, 2014, BIOCHEM J, V459, P83, DOI 10.1042/BJ20131318; HAMRICK M, 1993, J BIOL CHEM, V268, P24367; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; RENAUD KJ, 1991, J BIOL CHEM, V266, P20491; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shin H, 2015, INT J MOL SCI, V16, P23094, DOI 10.3390/ijms160923094; Stanley P., 2011, COLD SPRING HARB PER, V3; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Takahashi Y, 2011, J BIOCHEM, V149, P423, DOI 10.1093/jb/mvq155; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vestergaard AL, 2015, FEBS LETT, V589, P3908, DOI 10.1016/j.febslet.2015.11.031; Yabas M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146774; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09506-5	45	27	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2172	2182		10.1074/jbc.RA117.000289	http://dx.doi.org/10.1074/jbc.RA117.000289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29276178	Green Published, hybrid			2022-12-28	WOS:000424948000028
J	Seok, SH; Ma, ZX; Feltenberger, JB; Chen, HB; Chen, H; Scarlett, C; Lin, ZQ; Satyshur, KA; Cortopassi, M; Jefcoate, CR; Ge, Y; Tang, WP; Bradfield, CA; Xing, YN				Seok, Seung-Hyeon; Ma, Zhi-Xiong; Feltenberger, John B.; Chen, Hongbo; Chen, Hui; Scarlett, Cameron; Lin, Ziqing; Satyshur, Kenneth A.; Cortopassi, Marissa; Jefcoate, Colin R.; Ge, Ying; Tang, Weiping; Bradfield, Christopher A.; Xing, Yongna			Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aryl hydrocarbon receptor (AhR) (AHR); structure-function; dioxin; ligand-binding protein; chemical biology; Ah receptor; dioxin; kynurenine; pro-ligand; structural determinants	TRYPTOPHAN-METABOLISM; HIGH-AFFINITY; LIGAND; RECOGNITION; EXPRESSION; PATHWAY; DISEASE	Cellular metabolites act as important signaling cues, but are subject to complex unknown chemistry. Kynurenine is a tryptophan metabolite that plays a crucial role in cancer and the immune system. Despite its atypical, non-ligand-like, highly polar structure, kynurenine activates the aryl hydrocarbon receptor (AHR), a PER, ARNT, SIM (PAS) family transcription factor that responds to diverse environmental and cellular ligands. The activity of kynurenine is increased 100-1000-fold by incubation or long-term storage and relies on the hydrophobic ligand-binding pocket of AHR, with identical structural signatures for AHR induction before and after activation. We purified trace-active derivatives of kynurenine and identified two novel, closely related condensation products, named trace-extended aromatic condensation products (TEACOPs), which are active at low picomolar levels. The synthesized compound for one of the predicted structures matched the purified compound in both chemical structure and AHR pharmacology. Our study provides evidence that kynurenine acts as an AHR pro-ligand, which requires novel chemical conversions to act as a receptor agonist.	[Seok, Seung-Hyeon; Chen, Hongbo; Chen, Hui; Satyshur, Kenneth A.; Cortopassi, Marissa; Bradfield, Christopher A.; Xing, Yongna] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, McArdle Lab Canc Res, Madison, WI 53705 USA; [Ma, Zhi-Xiong; Feltenberger, John B.; Tang, Weiping] Univ Wisconsin, Sch Pharm, Med Chem Ctr, Madison, WI 53705 USA; [Scarlett, Cameron] Univ Wisconsin, Sch Pharm, Analyt Instrumentat Ctr, Mass Spectrometry Facil, Madison, WI 53705 USA; [Chen, Hongbo; Xing, Yongna] Univ Wisconsin, Biophys Grad Program, Madison, WI 53706 USA; [Lin, Ziqing; Ge, Ying] Univ Wisconsin, Human Prote Program, Madison, WI 53705 USA; [Jefcoate, Colin R.; Bradfield, Christopher A.; Xing, Yongna] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Xing, YN (corresponding author), McArdle Lab Canc Res, 1111 Highland Ave, Madison, WI 53705 USA.	xing@oncology.wisc.edu		Chen, Hongbo/0000-0001-8005-5658; Satyshur, Kenneth/0000-0001-9371-2493	National Institutes of Health [R01 GM096060, R35028377, P30CA014520, UL1TR000427]; McArdle New Direction Fund; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R35ES028377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McArdle New Direction Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 GM096060 (to Y. X.), R35028377 (to C. A. B.), P30CA014520, and UL1TR000427, as well as the McArdle New Direction Fund. All authors have intellectual property associated with this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bergander L, 2004, CHEM-BIOL INTERACT, V149, P151, DOI 10.1016/j.cbi.2004.08.005; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bohar Z, 2015, INT J MOL SCI, V16, P9772, DOI 10.3390/ijms16059772; BROWN KS, 1967, TETRAHEDRON LETT, P1721; CHANG CY, 1993, PHARMACOGENETICS, V3, P312, DOI 10.1097/00008571-199312000-00005; Changsirivathanathamrong D, 2011, CRIT CARE MED, V39, P2678, DOI 10.1097/CCM.0b013e31822827f2; DOLWICK KM, 1993, P NATL ACAD SCI USA, V90, P8566, DOI 10.1073/pnas.90.18.8566; EMA M, 1994, J BIOL CHEM, V269, P27337; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; HELFERICH WG, 1991, MOL PHARMACOL, V40, P674; Hubbard TD, 2015, DRUG METAB DISPOS, V43, P1522, DOI 10.1124/dmd.115.064246; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Jasiewicz M, 2016, HEART, V102, P230, DOI 10.1136/heartjnl-2015-308581; Korashy HM, 2006, DRUG METAB REV, V38, P411, DOI 10.1080/03602530600632063; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; LEKLEM JE, 1971, AM J CLIN NUTR, V24, P659; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Oxenkrug GF, 2010, ANN NY ACAD SCI, V1199, P1, DOI 10.1111/j.1749-6632.2009.05356.x; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; POLAND A, 1994, MOL PHARMACOL, V46, P915; POLAND A, 1991, MOL PHARMACOL, V39, P20; Polyzos KA, 2015, HAMOSTASEOLOGIE, V35, P128, DOI 10.5482/HAMO-14-10-0052; Procopio M, 2002, EUR J BIOCHEM, V269, P13, DOI 10.1046/j.0014-2956.2002.02619.x; RANNUG A, 1987, J BIOL CHEM, V262, P15422; Rannug U, 1995, CHEM BIOL, V2, P841, DOI 10.1016/1074-5521(95)90090-X; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; RUDZITE V, 1991, ADV EXP MED BIOL, V294, P663; Savouret JF, 2003, NUTR METAB CARDIOVAS, V13, P104, DOI 10.1016/S0939-4753(03)80026-1; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; TOKUYAMA T, 1967, J AM CHEM SOC, V89, P1017, DOI 10.1021/ja00980a046; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Xing YN, 2012, TOXICOL SCI, V129, P86, DOI 10.1093/toxsci/kfs194; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zelentsova EA, 2013, PHOTOCH PHOTOBIO SCI, V12, P546, DOI 10.1039/c2pp25357g	47	68	70	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					1994	2005		10.1074/jbc.RA117.000631	http://dx.doi.org/10.1074/jbc.RA117.000631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29279331	hybrid, Green Published			2022-12-28	WOS:000424948000013
J	Peixoto, AS; Geyer, RR; Iqbal, A; Truzzi, DR; Soares Moretti, AI; Laurindo, FRM; Augusto, O				Peixoto, Albert Souza; Ryan Geyer, R.; Iqbal, Asif; Truzzi, Daniela R.; Soares Moretti, Ana I.; Laurindo, Francisco R. M.; Augusto, Ohara			Peroxynitrite preferentially oxidizes the dithiol redox motifs of protein-disulfide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme inactivation; hydrogen peroxide; kinetics; protein aggregation; protein disulfide isomerase; peroxynitrite; protein nitration; thiol oxidation	AMYOTROPHIC-LATERAL-SCLEROSIS; CARBONATE RADICAL-ANION; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; SUPEROXIDE-DISMUTASE; PEROXIDASE-ACTIVITY; TYROSINE NITRATION; HYDROGEN-PEROXIDE; OXIDATION; GLUTATHIONE	Protein-disulfide isomerase (PDI) is a ubiquitous dithiol-disulfide oxidoreductase that performs an array of cellular functions, such as cellular signaling and responses to cell-damaging events. PDI can become dysfunctional by post-translational modifications, including those promoted by biological oxidants, and its dysfunction has been associated with several diseases in which oxidative stress plays a role. Because the kinetics and products of the reaction of these oxidants with PDI remain incompletely characterized, we investigated the reaction of PDI with the biological oxidant peroxynitrite. First, by determining the rate constant of the oxidation of PDI's redox-active Cys residues (Cys(53) and Cys(397)) by hydrogen peroxide (k = 17.3 +/- 1.3 m(-1) s(-1) at pH 7.4 and 25 degrees C), we established that the measured decay of the intrinsic PDI fluorescence is appropriate for kinetic studies. The reaction of these PDI residues with peroxynitrite was considerably faster (k = (6.9 +/- 0.2) x 10(4) m(-1) s(-1)), and both Cys residues were kinetically indistinguishable. Limited proteolysis, kinetic simulations, and MS analyses confirmed that peroxynitrite preferentially oxidizes the redox-active Cys residues of PDI to the corresponding sulfenic acids, which reacted with the resolving thiols at the active sites to produce disulfides (i.e. Cys(53)-Cys(56) and Cys(397)-Cys(400)). A fraction of peroxynitrite, however, decayed to radicals that hydroxylated and nitrated other active-site residues (Trp(52), Trp(396), and Tyr(393)). Excess peroxynitrite promoted further PDI oxidation, nitration, inactivation, and covalent oligomerization. We conclude that these PDI modifications may contribute to the pathogenic mechanism of several diseases associated with dysfunctional PDI.	[Peixoto, Albert Souza; Ryan Geyer, R.; Iqbal, Asif; Truzzi, Daniela R.; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, Ave Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil; [Soares Moretti, Ana I.; Laurindo, Francisco R. M.] Univ Sao Paulo, Heart Inst InCor, Sch Med, Vasc Biol Lab, BR-05403000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Augusto, O (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Ave Lineu Prestes 748, BR-05508000 Sao Paulo, Brazil.	oaugusto@iq.usp.br	Augusto, Ohara/D-3839-2012; Peixoto, Álbert Souza/E-4532-2018; moretti, ana IS/J-9064-2012; Truzzi, Daniela R/B-2540-2014	Augusto, Ohara/0000-0002-7220-4286; Peixoto, Álbert Souza/0000-0002-7234-7252; moretti, ana IS/0000-0003-3402-5778; Truzzi, Daniela R/0000-0003-4421-9621	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57721-3, 2013/07937-8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) [573530/2008-4]; Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant [2011.1.9352.1.8]; Conselho Nacional de Desenvolvimento Cientifico Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant; Conselho Nacional de Desenvolvimento Cientifico Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2008/57721-3 and 2013/07937-8, Conselho Nacional de Desenvolvimento Cientifico Tecnologico (CNPq) Grant 573530/2008-4, and Pro-Reitoria de Pesquisa da Universidade de Sao Paulo (PRPUSP) Grant 2011.1.9352.1.8. The authors are members of Nucleo de Apoio a Pesquisa (NAP) Redoxoma (PRPUSP) and the Research, Innovation and Dissemination Center (RIDC) Redoxoma (FAPESP). The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of scholarships from Conselho Nacional de Desenvolvimento Cientifico Tecnologico.; Recipients of scholarships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Annibal A, 2016, J CHROMATOGR B, V1019, P147, DOI 10.1016/j.jchromb.2015.12.022; Araujo TLS, 2017, REDOX BIOL, V12, P1004, DOI 10.1016/j.redox.2017.04.034; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; Carbone DL, 2005, CHEM RES TOXICOL, V18, P1324, DOI 10.1021/tx050078z; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Davies MJ, 2016, BIOCHEM J, V473, P805, DOI 10.1042/BJ20151227; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; de Menezes SL, 2001, J BIOL CHEM, V276, P39879, DOI 10.1074/jbc.M104012200; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; Dost B, 2012, J COMPUT BIOL, V19, P337, DOI 10.1089/cmb.2009.0267; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Flaumenhaft R, 2016, BLOOD, V128, P893, DOI 10.1182/blood-2016-04-636456; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Genaro-Mattos TC, 2015, BIOCHEMISTRY-US, V54, P2841, DOI 10.1021/bi501409d; Gonzalez-Perilli L, 2017, BBA-GEN SUBJECTS, V1861, P1131, DOI 10.1016/j.bbagen.2017.02.013; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hudson DA, 2015, FREE RADICAL BIO MED, V80, P171, DOI 10.1016/j.freeradbiomed.2014.07.037; Hugo M, 2009, BIOCHEMISTRY-US, V48, P9416, DOI 10.1021/bi901221s; Iqbal A, 2014, ARCH BIOCHEM BIOPHYS, V557, P72, DOI 10.1016/j.abb.2014.06.013; Kaetzel RS, 2004, ARCH BIOCHEM BIOPHYS, V423, P136, DOI 10.1016/j.abb.2003.10.016; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P1815, DOI 10.1089/ars.2007.1624; Karala AR, 2009, ANTIOXID REDOX SIGN, V11, P963, DOI 10.1089/ARS.2008.2326; Karimi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38572; Khan MMG, 2011, ONCOL RES, V19, P445, DOI 10.3727/096504011X13123323849717; Kim HT, 2000, ANTIOXID REDOX SIGN, V2, P485, DOI 10.1089/15230860050192260; Kozarova A, 2007, J AM SOC MASS SPECTR, V18, P260, DOI 10.1016/j.jasms.2006.09.023; Lappi AK, 2011, J MOL BIOL, V409, P238, DOI 10.1016/j.jmb.2011.03.024; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Marshall A, 2013, BIOCHEM BIOPH RES CO, V430, P231, DOI 10.1016/j.bbrc.2012.10.142; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P1046, DOI 10.1016/j.freeradbiomed.2010.06.018; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parakh S, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00030; Pescatore LA, 2012, J BIOL CHEM, V287, P29290, DOI 10.1074/jbc.M112.394551; Rabek JP, 2003, BIOCHEM BIOPH RES CO, V305, P566, DOI 10.1016/S0006-291X(03)00826-X; RADI R, 1991, J BIOL CHEM, V266, P4244; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Saaranen MJ, 2010, ANTIOXID REDOX SIGN, V12, P15, DOI 10.1089/ars.2009.2674; Santos CXC, 2000, ARCH BIOCHEM BIOPHYS, V377, P146, DOI 10.1006/abbi.2000.1751; Schwaller M, 2003, J BIOL CHEM, V278, P7154, DOI 10.1074/jbc.M211036200; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Moretti AIS, 2017, ARCH BIOCHEM BIOPHYS, V617, P106, DOI 10.1016/j.abb.2016.11.007; Tanaka LY, 2017, FREE RADICAL BIO MED, V109, P11, DOI 10.1016/j.freeradbiomed.2017.01.025; Tavender TJ, 2008, BIOCHEM J, V411, P191, DOI 10.1042/BJ20071428; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Trujillo M, 2002, ARCH BIOCHEM BIOPHYS, V397, P91, DOI 10.1006/abbi.2001.2619; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Uppu RM, 1996, ANAL BIOCHEM, V236, P242, DOI 10.1006/abio.1996.0162; Vattemi G, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002964; Walker AK, 2010, BRAIN, V133, P105, DOI 10.1093/brain/awp267; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	70	13	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 26	2018	293	4					1450	1465		10.1074/jbc.M117.807016	http://dx.doi.org/10.1074/jbc.M117.807016			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FU0AY	29191937	hybrid, Green Published			2022-12-28	WOS:000423515000029
J	Fuchs, ACD; Maldoner, L; Hipp, K; Hartmann, MD; Martin, J				Fuchs, Adrian C. D.; Maldoner, Lorena; Hipp, Katharina; Hartmann, Marcus D.; Martin, Joerg			Structural characterization of the bacterial proteasome homolog BPH reveals a tetradecameric double-ring complex with unique inner cavity properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; OXIDATIVE STRESS; HEAT-SHOCK; OXIDIZED PROTEINS; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DEGRADATION; ACTIVATION; SEQUENCE	Eukaryotic and archaeal proteasomes are paradigms for self-compartmentalizing proteases. To a large extent, their function requires interplay with hexameric ATPases associated with diverse cellular activities(AAA+) that act as substrate unfoldases. Bacteria have various types of self-compartmentalizing proteases; in addition to the proteasome itself, these include the proteasome homolog HslV, which functions together with the AAA+ HslU; the ClpP protease with its partner AAA+ ClpX; and Anbu, a recently characterized ancestral proteasome variant. Previous bioinformatic analysis has revealed a novel bacterial member of the proteasome family Betaproteobacteria proteasome homolog (BPH). Using cluster analysis, we here affirmed that BPH evolutionarily descends from HslV. Crystal structures of the Thiobacillus denitrificans and Cupriavidus metallidurans BPHs disclosed a homo-oligomeric double-ring architecture in which the active sites face the interior of the cylinder. Using small-angle X-ray scattering (SAXS) and electron microscopy averaging, we found that BPH forms tetra-decamers in solution, unlike the dodecamers seen in HslV. Although the highly acidic inner surface of BPH was in striking contrast to the cavity characteristics of the proteasome and HslV, a classical proteasomal reaction mechanism could be inferred from the covalent binding of the proteasome-specific inhibitor epoxomicin to BPH. A ligand-bound structure implied that the elongated BPH inner pore loop may be involved in substrate recognition. The apparent lack of a partner unfoldase and other unique features, such as Ser replacing Thr as the catalytic residue in certain BPH subfamilies, suggest a proteolytic function for BPH distinct from those of known bacterial self-compartmentalizing proteases.	[Fuchs, Adrian C. D.; Maldoner, Lorena; Hartmann, Marcus D.; Martin, Joerg] Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany; [Hipp, Katharina] Max Planck Inst Dev Biol, Electron Microscopy Facil, Spemannstr 35, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Hartmann, MD; Martin, J (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Spemannstr 35, D-72076 Tubingen, Germany.	marcus.hartmann@tuebingen.mpg.de; joerg.martin@tuebingen.mpg.de	Hartmann, Marcus/L-8759-2019	Hartmann, Marcus/0000-0001-6937-5677	European Community's Seventh Framework Programme under BioStruct-X [283570]; Max Planck Society	European Community's Seventh Framework Programme under BioStruct-X; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant Agreement 283570). This work was further supported by institutional funds from the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Barthelme D, 2012, SCIENCE, V337, P843, DOI 10.1126/science.1224352; Beller HR, 2006, J BACTERIOL, V188, P1473, DOI 10.1128/JB.188.4.1473-1488.2006; Ben-Nissan G, 2014, BIOMOLECULES, V4, P862, DOI 10.3390/biom4030862; Campbell MG, 2015, ELIFE, V4, DOI 10.7554/eLife.06380; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Biasio A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7439; De Mot R, 2007, TRENDS MICROBIOL, V15, P335, DOI 10.1016/j.tim.2007.06.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouzan D, 2012, J BIOL CHEM, V287, P39254, DOI 10.1074/jbc.M112.386458; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fuchs ACD, 2017, STRUCTURE, V25, P834, DOI 10.1016/j.str.2017.04.005; Gersch M, 2016, ACS CHEM BIOL, V11, P389, DOI 10.1021/acschembio.5b00757; Groll M, 1999, P NATL ACAD SCI USA, V96, P10976, DOI 10.1073/pnas.96.20.10976; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Huber EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10900; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Janssen PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010433; Jastrab JB, 2015, ANNU REV MICROBIOL, V69, P109, DOI 10.1146/annurev-micro-091014-104201; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Knight WE, 2016, P NATL ACAD SCI USA, V113, pE7116, DOI 10.1073/pnas.1607728113; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Ramachandran R, 2002, P NATL ACAD SCI USA, V99, P7396, DOI 10.1073/pnas.102188799; Raynes R, 2016, MOL ASPECTS MED, V50, P41, DOI 10.1016/j.mam.2016.05.001; Rho SH, 2008, PROTEINS, V71, P1020, DOI 10.1002/prot.21758; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valas RE, 2008, J MOL EVOL, V66, P494, DOI 10.1007/s00239-008-9075-7; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; YAMADA S, 1995, J BIOCHEM, V117, P1162, DOI 10.1093/oxfordjournals.jbchem.a124839; Yoo SJ, 1997, FEBS LETT, V412, P57, DOI 10.1016/S0014-5793(97)00742-4; Yoo SJ, 1996, J BIOL CHEM, V271, P14035, DOI 10.1074/jbc.271.24.14035; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9	53	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					920	930		10.1074/jbc.M117.815258	http://dx.doi.org/10.1074/jbc.M117.815258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29183996	hybrid, Green Published			2022-12-28	WOS:000422864500013
J	Toth, AD; Prokop, S; Gyombolai, P; Varnai, P; Balla, A; Gurevich, VV; Hunyady, L; Turu, G				Toth, Andras D.; Prokop, Susanne; Gyombolai, Pal; Varnai, Peter; Balla, Andras; Gurevich, Vsevolod V.; Hunyady, Laszlo; Turu, Gabor			Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by beta-arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ANGIOTENSIN-II RECEPTOR; AGONIST-INDUCED INTERNALIZATION; AT(1) ANGIOTENSIN; BETA(2)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; BINDING; TRAFFICKING	beta-Arrestins are key regulators and signal transducers of G protein-coupled receptors (GPCRs). The interaction between receptors and beta-arrestins is generally believed to require both receptor activity and phosphorylation by GPCR kinases. In this study, we investigated whether beta-arrestins are able to bind second messenger kinase-phosphorylated, but inactive receptors as well. Because heterologous phosphorylation is a common phenomenon among GPCRs, this mode of beta-arrestin activation may represent a novel mechanism of signal transduction and receptor cross-talk. Here we demonstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, G(q/11)-coupled GPCR, or epidermal growth factor receptor stimulation promotes beta-arrestin2 recruitment to unliganded AT1 angiotensin receptor (AT1R). We found that this interaction depends on the stability lock, a structure responsible for the sustained binding between GPCRs and beta-arrestins, formed by phosphorylated serine-threonine clusters in the receptor's C terminus and two conserved phosphate-binding lysines in the beta-arrestin2 N-domain. Using improved FlAsH-based serine-threonine clusters beta-arrestin2 conformational biosensors, we also show that the stability lock not only stabilizes the receptor-beta-arrestin interaction, but also governs the structural rearrangements within beta-arrestins. Furthermore, we found that beta-arrestin2 binds to PKC-phosphorylated AT1R in a distinct active conformation, which triggers MAPK recruitment and receptor internalization. Our results provide new insights into the activation of beta- arrestins and reveal their novel role in receptor cross-talk.	[Toth, Andras D.; Prokop, Susanne; Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Semmelweis Univ, Fac Med, Dept Physiol, H-1094 Budapest, Hungary; [Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Hungarian Acad Sci, MTA SE Lab Mol Physiol, H-1094 Budapest, Hungary; [Gyombolai, Pal; Varnai, Peter; Balla, Andras; Hunyady, Laszlo; Turu, Gabor] Semmelweis Univ, H-1094 Budapest, Hungary; [Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Vanderbilt University	Hunyady, L (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, POB 2, H-1428 Budapest, Hungary.	hunyady.laszlo@med.semmelweis-univ.hu	Gurevich, Vsevolod/A-3236-2008; Tóth, András Dávid/O-5757-2019	Gurevich, Vsevolod/0000-0002-3950-5351; Tóth, András Dávid/0000-0003-2746-9370; Gyombolai, Pal/0000-0001-7117-6351; Balla, Andras/0000-0002-6450-2793; Turu, Gabor/0000-0002-4421-3812	Hungarian National Research, Development and Innovation Fund [NKFI NK100883, K116954, NVKP_16-1-2016-0039]; Ministry of Human Capacities [UNKP-17-3-III-SE-23]; National Institutes of Health [R35 GM122491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109955, R35GM122491] Funding Source: NIH RePORTER	Hungarian National Research, Development and Innovation Fund; Ministry of Human Capacities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Hungarian National Research, Development and Innovation Fund Grants NKFI NK100883, K116954, and NVKP_16-1-2016-0039 (to L.H.), the UNKP-17-3-III-SE-23 New National Excellence Program of the Ministry of Human Capacities (to A.D.T.), and National Institutes of Health Grant R35 GM122491 (to V.V.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfonzo-Mendez MA, 2017, MOL PHARMACOL, V91, P296, DOI 10.1124/mol.116.106583; Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Balla A, 2012, J BIOL CHEM, V287, P9090, DOI 10.1074/jbc.M111.293944; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Castillo-Badillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121165; CHUANG TT, 1995, J BIOL CHEM, V270, P18660, DOI 10.1074/jbc.270.31.18660; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; De A, 2007, CANCER RES, V67, P7175, DOI 10.1158/0008-5472.CAN-06-4623; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Gaborik Z, 2004, TRENDS ENDOCRIN MET, V15, P286, DOI 10.1016/j.tem.2004.06.009; Gaborik Z, 2001, MOL PHARMACOL, V59, P239, DOI 10.1124/mol.59.2.239; Garcia-Caballero A, 2001, MOL PHARMACOL, V59, P576, DOI 10.1124/mol.59.3.576; Gimenez LE, 2014, CELL SIGNAL, V26, P1523, DOI 10.1016/j.cellsig.2014.03.019; Gimenez LE, 2012, J BIOL CHEM, V287, P9028, DOI 10.1074/jbc.M111.311803; Gulyas G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125601; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; Gyombolai P, 2013, MOL CELL ENDOCRINOL, V372, P116, DOI 10.1016/j.mce.2013.03.013; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hoffmann C, 2010, NAT PROTOC, V5, P1666, DOI 10.1038/nprot.2010.129; HUNYADY L, 1994, J BIOL CHEM, V269, P31378; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Hunyady L, 2000, REGUL PEPTIDES, V91, P29, DOI 10.1016/S0167-0115(00)00137-3; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kelly E, 2008, BRIT J PHARMACOL, V153, pS379, DOI 10.1038/sj.bjp.0707604; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kocan M, 2008, J BIOMOL SCREEN, V13, P888, DOI 10.1177/1087057108324032; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Kumari P, 2017, MOL BIOL CELL, V28, P1003, DOI 10.1091/mbc.E16-12-0818; Kumari P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13416; Le MT, 2002, J BIOL CHEM, V277, P23107, DOI 10.1074/jbc.C200201200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V279, pC1978, DOI 10.1152/ajpcell.2000.279.6.C1978; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oppermann M, 1996, J BIOL CHEM, V271, P13266, DOI 10.1074/jbc.271.22.13266; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paradis JS, 2015, P NATL ACAD SCI USA, V112, pE5160, DOI 10.1073/pnas.1508836112; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Qian HW, 1999, BIOCHEM J, V343, P637, DOI 10.1042/0264-6021:3430637; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Smith RD, 1998, MOL PHARMACOL, V54, P935, DOI 10.1124/mol.54.6.935; Szakadati G, 2015, MOL PHARMACOL, V87, P972, DOI 10.1124/mol.114.097030; Szalai B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109503; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Toth AD, 2017, MOL CELL ENDOCRINOL, V442, P113, DOI 10.1016/j.mce.2016.11.027; Toth DJ, 2012, J CELL SCI, V125, P2185, DOI 10.1242/jcs.097279; Turu G, 2009, J BIOL CHEM, V284, P16914, DOI 10.1074/jbc.M109.003681; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Yang F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9202; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Zhan XZ, 2014, CELL SIGNAL, V26, P766, DOI 10.1016/j.cellsig.2014.01.001; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang M, 1996, HYPERTENSION, V27, P269, DOI 10.1161/01.HYP.27.2.269; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zhuo Y, 2014, J BIOL CHEM, V289, P20991, DOI 10.1074/jbc.M114.560680; Zindel D, 2015, MOL PHARMACOL, V87, P349, DOI 10.1124/mol.114.095422	77	30	30	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					876	892		10.1074/jbc.M117.813139	http://dx.doi.org/10.1074/jbc.M117.813139			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29146594	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000422864500010
J	Gonzalez, E; Johnson, KM; Pallan, PS; Phan, TTN; Zhang, W; Lei, L; Wawrzak, Z; Yoshimoto, FK; Egli, M; Guengerich, FP				Gonzalez, Eric; Johnson, Kevin M.; Pallan, Pradeep S.; Phan, Thanh T. N.; Zhang, Wei; Lei, Li; Wawrzak, Zdzislaw; Yoshimoto, Francis K.; Egli, Martin; Guengerich, F. Peter			Inherent steroid 17,20-lyase activity in defunct cytochrome P450 17A enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomimetic models	C-13 NMR-SPECTRA; ANDROGEN FORMATION; ADRENAL-CORTEX; SIDE-CHAIN; P450C17; BIOSYNTHESIS; PROGESTERONE; CYP17; HYDROXYLATION; B(5)	Cytochrome P450 (P450) 17A1 catalyzes the oxidations of progesterone and pregnenolone and is the major source of androgens. The enzyme catalyzes both 17-hydroxylation and a subsequent 17,20-lyase reaction, and several mechanisms have been proposed for the latter step. Zebrafish P450 17A2 catalyzes only the 17-hydroxylations. We previously reported high similarity of the crystal structures of zebrafish P450 17A1 and 17A2 and human P450 17A1. Five residues near the heme, which differed, were changed. We also crystallized this five-residue zebrafish P450 17A1 mutant, and the active site still resembled the structure in the other proteins, with some important differences. These P450 17A1 and 17A2 mutants had catalytic profiles more similar to each other than did the wildtype proteins. Docking with these structures can explain several minor products, which require multiple enzyme conformations. The 17-hydroperoxy (OOH) derivatives of the steroids were used as oxygen surrogates. Human P450 17A1 and zebrafish P450s 17A1 and P450 17A2 readily converted these to the lyase products in the absence of other proteins or cofactors (with catalytically competent kinetics) plus hydroxylated 17-hydroxysteroids. The 17-OOH results indicate that a Compound I (FeO3+) intermediate is capable of formation and can be used to rationalize the products. We conclude that zebrafish P450 17A2 is capable of lyase activity with the 17-OOH steroids because it can achieve an appropriate conformation for lyase catalysis in this system that is precluded in the conventional reaction.	[Gonzalez, Eric; Johnson, Kevin M.; Pallan, Pradeep S.; Phan, Thanh T. N.; Zhang, Wei; Lei, Li; Egli, Martin; Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA; [Wawrzak, Zdzislaw] Argonne Natl Lab, Adv Photon Source, Life Sci Collaborat Access Team, Sect 21, Argonne, IL 60439 USA; [Yoshimoto, Francis K.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Johnson, Kevin M.] Genentech Inc, Dept Drug Metab & Pharmacokinet, 1 DNA Way, San Francisco, CA 94080 USA; [Zhang, Wei] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, 189 Songling Rd, Qingdao 266000, Shandong, Peoples R China	Vanderbilt University; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas at San Antonio (UTSA); Roche Holding; Genentech; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Yoshimoto, Francis/0000-0002-2308-2999; Zhang, Wei/0000-0001-9459-680X	National Institutes of Health [R01 GM118122, R01 GM103937, T32 ES007028]; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118122, R25GM062459, R01GM103937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM118122 (to F. P. G.), R01 GM103937 (to M. E. and F. P. G.), and T32 ES007028 (to E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attard G, 2012, J CLIN ENDOCR METAB, V97, P507, DOI 10.1210/jc.2011-2189; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BAILEY EJ, 1962, J CHEM SOC, P1578, DOI 10.1039/jr9620001578; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BETANCOR C, 1988, J CHEM SOC CHEM COMM, P947, DOI 10.1039/c39880000947; Bonomo S, 2017, J CHEM INF MODEL, V57, P1123, DOI 10.1021/acs.jcim.6b00759; Bonomo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29468; Brock BJ, 1999, BIOCHEMISTRY-US, V38, P1598, DOI 10.1021/bi9821059; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estrada DF, 2016, J BIOL CHEM, V291, P3990, DOI 10.1074/jbc.M115.677294; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FALARDEAU P, 1974, J LABELLED COMPD, V10, P239, DOI 10.1002/jlcr.2590100208; FISCHER RT, 1991, J BIOL CHEM, V266, P6124; GARDNER JN, 1968, J ORG CHEM, V33, P3294, DOI 10.1021/jo01272a055; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gilep AA, 2011, BBA-PROTEINS PROTEOM, V1814, P200, DOI 10.1016/j.bbapap.2010.06.021; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Gregory M, 2013, ANGEW CHEM INT EDIT, V52, P5342, DOI 10.1002/anie.201300760; Gregory MC, 2013, J AM CHEM SOC, V135, P16245, DOI 10.1021/ja4086403; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2016, TRENDS PHARMACOL SCI, V37, P625, DOI 10.1016/j.tips.2016.05.006; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; KADLUBAR FF, 1973, BIOCHEM BIOPH RES CO, V54, P1255, DOI 10.1016/0006-291X(73)91122-4; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; KOBAYASHI Y, 1993, BIOL PHARM BULL, V16, P1175; KOPECKY KR, 1969, CAN J CHEMISTRY, V47, P709, DOI 10.1139/v69-114; Korde SS, 1999, MAGN RESON CHEM, V37, P594, DOI 10.1002/(SICI)1097-458X(199908)37:8<594::AID-MRC484>3.0.CO;2-J; Lei L., 2016, CURR PROTOC PROTEIN, V84, DOI [10.1002/0471140864.ps2916s84, DOI 10.1002/0471140864.PS2916S8427038268]; MAK AY, 1992, J AM CHEM SOC, V114, P8309, DOI 10.1021/ja00047a063; Mak PJ, 2015, P NATL ACAD SCI USA, V112, P15856, DOI 10.1073/pnas.1519376113; MANSUY D, 1982, TETRAHEDRON LETT, V23, P2781, DOI 10.1016/S0040-4039(00)87457-2; Mapes S, 1999, J CLIN ENDOCR METAB, V84, P3382, DOI 10.1210/jc.84.9.3382; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER SL, 1991, J CHEM SOC CHEM COMM, P157, DOI 10.1039/c39910000157; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Njar VCO, 1999, CURR PHARM DESIGN, V5, P163; Njar VCO, 2015, J MED CHEM, V58, P2077, DOI 10.1021/jm501239f; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Pallan PS, 2015, J BIOL CHEM, V290, P3248, DOI 10.1074/jbc.M114.627265; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; RICHARDS.WH, 1974, J AM CHEM SOC, V96, P6652, DOI 10.1021/ja00828a018; Suzuki T, 2000, CLIN ENDOCRINOL, V53, P739, DOI 10.1046/j.1365-2265.2000.01144.x; SWERN D, 1969, ANAL CHEM, V41, P412, DOI 10.1021/ac60272a038; SWINNEY DC, 1994, BIOCHEMISTRY-US, V33, P2185, DOI 10.1021/bi00174a027; SZENDI Z, 1995, STEROIDS, V60, P442, DOI 10.1016/0039-128X(94)00047-G; TAN L, 1975, HORM RES, V6, P213, DOI 10.1159/000178695; TAN L, 1975, BIOCHEM BIOPH RES CO, V65, P1320, DOI 10.1016/S0006-291X(75)80374-3; TAN L, 1972, BIOCHIM BIOPHYS ACTA, V260, P731, DOI 10.1016/0005-2760(72)90022-7; Turcu AF, 2015, J CLIN ENDOCR METAB, V100, P2283, DOI 10.1210/jc.2015-1023; Van Den Akker ELT, 2002, J CLIN ENDOCR METAB, V87, P5714, DOI 10.1210/jc.2001-011880; Wang CX, 2017, J BIOL CHEM, V292, P10767, DOI 10.1074/jbc.M117.792465; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; Yoshimoto FK, 2015, J STEROID BIOCHEM, V151, P52, DOI 10.1016/j.jsbmb.2014.11.026; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	70	20	20	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 12	2018	293	2					541	556		10.1074/jbc.RA117.000504	http://dx.doi.org/10.1074/jbc.RA117.000504			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS6NZ	29212707	Green Published, hybrid			2022-12-28	WOS:000419915400011
J	Bidwell, PA; Haghighi, K; Kranias, EG				Bidwell, Philip A.; Haghighi, Kobra; Kranias, Evangelia G.			The antiapoptotic protein HAX-1 mediates half of phospholamban's inhibitory activity on calcium cycling and contractility in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium ATPase; calcium transport; heart; cardiac muscle; cardiomyocyte; cardiovascular; contractility; HAX-1; phospholamban; SERCA2a	CARDIAC CONTRACTILITY; SARCOPLASMIC-RETICULUM; MUSCLE; SARCOLIPIN; REGULATOR; SURVIVAL; ABLATION; PEPTIDE; GENE; CA2+	The antiapoptotic protein HAX-1 (HS-associated protein X-1) localizes to sarcoplasmic reticulum (SR) in the heart and interacts with the small membrane protein phospholamban (PLN), inhibiting the cardiac sarco/endoplasmic reticulum calcium ATPase 2a (SERCA2a) in the regulation of overall calcium handling and heart muscle contractility. However, because global HAX-1 deletion causes early lethality, how much endogenous HAX-1 contributes to PLN's inhibitory activity on calcium cycling is unknown. We therefore generated a cardiac-specific and inducible knock-out mouse model. HAX-1 ablation in the adult heart significantly increased contractile parameters and calcium kinetics, associated with increased SR calcium load. These changes occurred without any changes in the protein expression of SERCA2a, PLN, and ryanodine receptor or in the PLN phosphorylation status. The enhanced calcium cycling in the HAX-1-depleted heart was mediated through increases in the calcium affinity of SERCA2a and reduced PLN-SERCA2a binding. Comparison of the HAX-1 deletion-induced stimulatory effects with those elicited by PLN ablation indicated that HAX-1 mediates approximate to 50% of the PLN-associated inhibitory effects in the heart. Stimulation with the inotropic and lusitropic agent isoproterenol eliminated the differences among wild-type, HAX-1-deficient, and PLN-deficient hearts, and maximally stimulated contractile and calcium kinetic parameters were similar among these three groups. Furthermore, PLN overexpression in the HAX-1-null cardiomyocytes did not elicit any inhibitory effects, indicating that HAX-1 may limit PLN activity. These findings suggest that HAX-1 is a major mediator of PLN's inhibitory activity and a critical gatekeeper of SR calcium cycling and contractility in the heart.	[Bidwell, Philip A.; Haghighi, Kobra; Kranias, Evangelia G.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45267 USA; [Kranias, Evangelia G.] Acad Athens, Ctr Basic Res, Dept Mol Biol, Biomed Res Fdn, Athens 11527, Greece	University of Cincinnati; Academy of Athens	Kranias, EG (corresponding author), Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45267 USA.; Kranias, EG (corresponding author), Acad Athens, Ctr Basic Res, Dept Mol Biol, Biomed Res Fdn, Athens 11527, Greece.	Litsa.Kranias@uc.edu		Bidwell, Philip/0000-0001-5045-4535	National Institutes of Health [HL-26057, HL-64018, HL-125204]; American Heart Association [13POST13860006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL026057, R01HL026057, R01HL064018, T32HL125204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL-26057 and HL-64018 (to E. G. K.) and HL-125204 (to P. A. B.) and American Heart Association Postdoctoral Fellowship 13POST13860006 (to P. A. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Bidwell PA, 2016, METHODS MOL BIOL, V1377, P161, DOI 10.1007/978-1-4939-3179-8_16; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Brittsan AG, 2000, J BIOL CHEM, V275, P12129, DOI 10.1074/jbc.275.16.12129; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Haghighi K, 2014, J MOL CELL CARDIOL, V77, P160, DOI 10.1016/j.yjmcc.2014.10.005; Kadambi VJ, 1996, J CLIN INVEST, V97, P533, DOI 10.1172/JCI118446; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lam CK, 2015, P NATL ACAD SCI USA, V112, pE6466, DOI 10.1073/pnas.1508760112; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mueller B, 2004, BIOCHEMISTRY-US, V43, P8754, DOI 10.1021/bi049732k; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Slack JP, 2001, J MOL CELL CARDIOL, V33, P1031, DOI 10.1006/jmcc.2001.1370; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Traaseth NJ, 2008, BIOCHEMISTRY-US, V47, P3, DOI 10.1021/bi701668v; Vafiadaki E, 2007, J MOL BIOL, V367, P65, DOI 10.1016/j.jmb.2006.10.057; WAWRZYNOW A, 1992, ARCH BIOCHEM BIOPHYS, V298, P620, DOI 10.1016/0003-9861(92)90457-8; Wolska BM, 1996, AM J PHYSIOL-CELL PH, V271, pC391, DOI 10.1152/ajpcell.1996.271.1.C391; Zhao W, 2009, P NATL ACAD SCI USA, V106, P20776, DOI 10.1073/pnas.0906998106; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	24	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					359	367		10.1074/jbc.RA117.000128	http://dx.doi.org/10.1074/jbc.RA117.000128			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29150445	Green Published, hybrid			2022-12-28	WOS:000419453200030
J	Baruah, J; Hitzman, R; Zhang, JE; Chaudhuri, S; Mastej, V; Wary, KK				Baruah, Jugajyoti; Hitzman, Ryan; Zhang, Jane; Chaudhuri, Suhnrita; Mastej, Victoria; Wary, Kishore K.			The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; angiogenesis; endothelial cell; glycogen synthase kinase 3 (GSK-3); myocardial infarction; Wnt signaling	TIDEGLUSIB; CARDIOPROTECTION; EXPRESSION; INJURY; CELLS; MODULATION; STRATEGIES; PROTECTION; GSK-3-BETA; ISCHEMIA	A key feature of acute myocardial infarction (AMI) is an alteration in cardiac architecture. Signaling events that result in the inhibition of glycogen synthase kinase-3 (GSK-3) represent an adaptive response that might limit the extent of adverse remodeling in the aftermath of AMI. Here, we report that an allosteric inhibitor of GSK-3, 4-benzyl-2-(naphthalene-1-yl)-1,2,4-thiadiazolidine-3,5-dione (NP12), lessens the magnitude of adverse myocardial remodeling and promotes angiogenesis. Male and female mice 8-10 weeks old were grouped (six animals in each group) into sham surgery (sham group), left anterior descending (LAD) ligation of the coronary artery followed by intramyocardial PBS injections (control group), and LAD ligation followed by NP12 administration (NP12 group). After 7 and 14 days, the extents of fibrosis and integrity of blood vessels were determined. Intramyocardial administration of NP12 increased phosphorylation of GSK-3, reduced fibrosis, and restored diastolic function in the mice that had experienced an AMI. Morphometric analyses revealed increased CD31(+) and Ki67(+) vascular structures and decreased apoptosis in these mice. NP12 administration mediated proliferation of reparative cells in the AMI hearts. In a time-course analysis, Wnt3a and NP12 stabilized -catenin and increased expression of both Nanog and VEGFR2. Moreover, NP12 increased the expression of -catenin and Nanog in myocardium from AMI mice. Finally, loss- and gain-of-function experiments indicated that the NP12-mediated benefit is, in part, Nanog-specific. These findings indicate that NP12 reduces fibrosis, reestablishes coronary blood flow, and improves ventricular function following an AMI. We conclude that NP12 might be useful for limiting ventricular remodeling after an AMI.	[Baruah, Jugajyoti; Hitzman, Ryan; Zhang, Jane; Chaudhuri, Suhnrita; Mastej, Victoria; Wary, Kishore K.] Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Rm E403, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Wary, KK (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Rm E403, Chicago, IL 60612 USA.	kkwary@uic.edu	Baruah, Jugajyoti/AAJ-7545-2020		National Institutes of Health [HL079356]; American Heart Association [GRNT25710129, GRNT33700162]; University of Illinois at Chicago Center for Clinical and Translation Science Award [UL1RR029879]; American Heart Association Pre-doctoral Fellowships (Mid-West affiliate) [15PRE22760004]; CCTS-PECTs [1UL1TR002003]; Fulbright-Nehru Fellowship Program [2038/FNPDR/2015]; CCTS-PECTs Grant [1UL1TR002003]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079356, T32HL007829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Illinois at Chicago Center for Clinical and Translation Science Award; American Heart Association Pre-doctoral Fellowships (Mid-West affiliate); CCTS-PECTs; Fulbright-Nehru Fellowship Program; CCTS-PECTs Grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the National Institutes of Health Grant HL079356, American Heart Association Grants GRNT25710129 and GRNT33700162, and by University of Illinois at Chicago Center for Clinical and Translation Science Award UL1RR029879 (to K. K. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains supplemental Figs. S1-S13.; Supported by American Heart Association Pre-doctoral Fellowships (Mid-West affiliate) 15PRE22760004 and CCTS-PECTs 1UL1TR002003.; Supported by the Fulbright-Nehru Fellowship Program (2038/FNPDR/2015).; Supported by CCTS-PECTs Grant 1UL1TR002003.	Anderson JL, 2017, NEW ENGL J MED, V376, P2053, DOI 10.1056/NEJMra1606915; Bonaventura A, 2016, EUR J CLIN INVEST, V46, P590, DOI 10.1111/eci.12633; Cambier L, 2017, EMBO MOL MED, V9, P337, DOI 10.15252/emmm.201606924; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; Deb A, 2014, CARDIOVASC RES, V102, P214, DOI 10.1093/cvr/cvu054; del Ser T, 2013, J ALZHEIMERS DIS, V33, P205, DOI 10.3233/JAD-2012-120805; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Fan D, 2015, CIRC-HEART FAIL, V8, P970, DOI 10.1161/CIRCHEARTFAILURE.114.002029; Gaffin RD, 2011, J MOL CELL CARDIOL, V51, P812, DOI 10.1016/j.yjmcc.2011.07.026; Hausenloy DJ, 2017, CARDIOVASC RES, V113, P564, DOI 10.1093/cvr/cvx049; Hoglinger GU, 2014, MOVEMENT DISORD, V29, P479, DOI 10.1002/mds.25815; Humtsoe JO, 2010, MOL CELL BIOL, V30, P1593, DOI 10.1128/MCB.00038-09; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kohler EE, 2014, STEM CELLS, V32, P1538, DOI 10.1002/stem.1658; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Kornowski R, 2000, CIRCULATION, V101, P454, DOI 10.1161/01.CIR.101.4.454; Lal H, 2015, CIRC RES, V116, P138, DOI 10.1161/CIRCRESAHA.116.303613; Lal H, 2012, CIRCULATION, V125, P65, DOI 10.1161/CIRCULATIONAHA.111.050666; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Marijianowski MMH, 1997, J AM COLL CARDIOL, V30, P76, DOI 10.1016/S0735-1097(97)00100-9; Miura T, 2010, CARDIOVASC DRUG THER, V24, P255, DOI 10.1007/s10557-010-6234-z; Pagel PS, 2006, ANESTH ANALG, V102, P1348, DOI 10.1213/01.ane.0000202379.61338.37; Patel P, 2017, CURR TOP DEV BIOL, V123, P277, DOI 10.1016/bs.ctdb.2016.11.011; Preda MB, 2010, COMPARATIVE MED, V60, P443; Scofield SLC, 2016, JOVE-J VIS EXP, DOI 10.3791/54814; Terashima Y, 2010, J MOL CELL CARDIOL, V49, P762, DOI 10.1016/j.yjmcc.2010.08.001; Thygesen K, 2012, NAT REV CARDIOL, V9, P620, DOI 10.1038/nrcardio.2012.122; Tolosa E, 2014, MOVEMENT DISORD, V29, P470, DOI 10.1002/mds.25824; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wary KK, 2009, STEM CELLS, V27, P3112, DOI 10.1002/stem.241; Woulfe KC, 2010, CIRC RES, V106, P1635, DOI 10.1161/CIRCRESAHA.109.211482; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang RL, 2016, J CLIN INVEST, V126, P4654, DOI 10.1172/JCI90425; Zhao JL, 2013, CIRCULATION, V128, pS121, DOI 10.1161/CIRCULATIONAHA.112.000045	40	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20785	20798		10.1074/jbc.M117.814376	http://dx.doi.org/10.1074/jbc.M117.814376			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29070680	hybrid, Green Published			2022-12-28	WOS:000418267000037
J	Iida, K; Teng, JF; Cho, T; Yoshikawa-Kimura, S; Iida, H				Iida, Kazuko; Teng, Jinfeng; Cho, Toshihiko; Yoshikawa-Kimura, Sato; Iida, Hidetoshi			Post-translational processing and membrane translocation of the yeast regulatory Mid1 subunit of the Cch1/VGCC/NALCN cation channel family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; calcium transport; membrane protein; membrane transport; N-linked glycosylation; protein translocation; Saccharomyces cerevisiae; signal peptidase; yeast	GATED CALCIUM-CHANNEL; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; ALPHA(2)DELTA SUBUNITS; PROTEIN TRANSLOCATION; NEURONAL EXCITABILITY; SIGNAL PEPTIDES; COMPONENT MID1; LEAK CHANNELS	Saccharomyces cerevisiae Mid1 is composed of 548 amino acids and a regulatory subunit of Cch1, a member of the eukaryotic pore-forming, four-domain cation channel family. The amino acid sequence and voltage insensitivity of Cch1 are more similar to those of Na+ leak channel non-selective (NALCN) than to the (1) subunit of voltage-gated Ca2+ channels (VGCCs). Despite a lack in overall primary sequence similarity, Mid1 resembles in some aspects VGCC (2)/ regulatory subunits and NALCN-associated proteins. Unlike animal (2)/ subunits, Mid1 and NALCN-associated proteins are essential for the function of the pore-forming subunit. We herein investigated the processing and membrane translocation of Mid1. Mid1 was found to have a 20-amino-acid-long N-terminal signal peptide and appeared to be entirely localized extracellularly. A signal peptide-deleted Mid1 protein, Mid1N23, was N-glycosylated and retained Ca2+ influx activity through Cch1. Moreover, an N-terminal truncation analysis revealed that even truncated Mid1 lacking 209 N-terminal amino acid residues was N-glycosylated and maintained Ca2+ influx activity. A 219-amino-acid-truncated Mid1 protein lost this activity but was still N-glycosylated. In the sec71 and sec72 single mutants defective in the post-translational protein transport into the endoplasmic reticulum (ER), Mid1N23 could not mediate Ca2+ influx and did not undergo N-glycosylation, whereas wild-type Mid1 exhibited normal Ca2+ influx activity and N-glycosylation in these mutants. Therefore, the signal peptide-lacking Mid1N23 protein may be translocated to the ER exclusively through the post-translational protein translocation, which typically requires an N-terminal signal peptide. Mid1 may provide a tool for studying mechanisms of protein translocation into the ER.	[Iida, Kazuko] Tokyo Metropolitan Inst Med Sci, Lab Biomembrane, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan; [Teng, Jinfeng; Cho, Toshihiko; Yoshikawa-Kimura, Sato; Iida, Hidetoshi] Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Gakugei University	Iida, H (corresponding author), Tokyo Gakugei Univ, Dept Biol, 4-1-1 Nukui Kita Machi, Koganei, Tokyo 1848501, Japan.	iida@u-gakugei.ac.jp	Iida, Hidetoshi/AAO-5506-2020		Japan Society for the Promotion of Science [B 26291026]; Grants-in-Aid for Scientific Research [26291026] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research B 26291026 (to H. I.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Barclay J, 2001, J NEUROSCI, V21, P6095, DOI 10.1523/JNEUROSCI.21-16-06095.2001; Brodbeck J, 2002, J BIOL CHEM, V277, P7684, DOI 10.1074/jbc.M109404200; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cho T, 2017, GENES CELLS, V22, P94, DOI 10.1111/gtc.12458; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESHAIES RJ, 1987, J CELL BIOL, V105, P633, DOI 10.1083/jcb.105.2.633; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Frank K, 2008, BIOINFORMATICS, V24, P2172, DOI 10.1093/bioinformatics/btn422; Ghezzi A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00015; GREEN N, 1992, J CELL BIOL, V116, P597, DOI 10.1083/jcb.116.3.597; Hiller K, 2004, NUCLEIC ACIDS RES, V32, pW375, DOI 10.1093/nar/gkh378; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Iida K, 2004, FEBS LETT, V576, P291, DOI 10.1016/j.febslet.2004.09.021; Iida K, 2007, J BIOL CHEM, V282, P25659, DOI 10.1074/jbc.M703757200; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kamano S, 2015, J BIOL CHEM, V290, P30901, DOI 10.1074/jbc.M115.692574; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liebeskind BJ, 2012, MOL BIOL EVOL, V29, P3613, DOI 10.1093/molbev/mss182; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Mandon EC, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013342; Martin DC, 2011, J BIOL CHEM, V286, P10744, DOI 10.1074/jbc.M110.177451; Maruoka T, 2002, J BIOL CHEM, V277, P11645, DOI 10.1074/jbc.M111603200; Nacken V, 1996, GENE, V175, P253, DOI 10.1016/0378-1119(96)00171-0; Ozeki-Miyawaki C, 2005, EXP CELL RES, V311, P84, DOI 10.1016/j.yexcr.2005.08.014; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; ROTHBLATT JA, 1989, J CELL BIOL, V109, P2641, DOI 10.1083/jcb.109.6.2641; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook J., 2001, MOL CLONING LAB MANU; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Sengstag C, 2000, METHOD ENZYMOL, V327, P175, DOI 10.1016/S0076-6879(00)27275-3; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tada T, 2003, J BIOL CHEM, V278, P9647, DOI 10.1074/jbc.M206993200; Teng J, 2013, MICROBIOL-SGM, V159, P970, DOI 10.1099/mic.0.064030-0; Teng JF, 2008, MICROBIOL-SGM, V154, P3775, DOI 10.1099/mic.0.2008/021089-0; Wakamori M, 1999, J PHYSIOL-LONDON, V517, P659, DOI 10.1111/j.1469-7793.1999.0659s.x; Xie L, 2013, NEURON, V77, P1069, DOI 10.1016/j.neuron.2013.01.018; Yoshimura H, 2004, EXP CELL RES, V293, P185, DOI 10.1016/j.yexcr.2003.09.020; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	50	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20570	20582		10.1074/jbc.M117.810283	http://dx.doi.org/10.1074/jbc.M117.810283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29042437	Green Published, hybrid			2022-12-28	WOS:000418267000018
J	Chen, FF; Zhang, CX; Wu, HN; Ma, Y; Luo, XM; Gong, XQ; Jiang, F; Gui, YT; Zhang, H; Lu, F				Chen, Fangfang; Zhang, Chunxiao; Wu, Haonan; Ma, Yue; Luo, Xiaomin; Gong, Xinqi; Jiang, Fan; Gui, Yaoting; Zhang, Hui; Lu, Fei			The E3 ubiquitin ligase SCFFBXL14 complex stimulates neuronal differentiation by targeting the Notch signaling factor HES1 for proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; neurodifferentiation; proteolysis; small interfering RNA (siRNA); ubiquitylation (ubiquitination); FBXL14; HES1 oscillation; SCF ubiquitin ligase	F-BOX PROTEINS; SOMITE SEGMENTATION CLOCK; NEGATIVE FEEDBACK LOOP; EMBRYONIC STEM-CELLS; CIRCADIAN CLOCK; GENE HES1; ULTRADIAN OSCILLATIONS; PRESOMITIC MESODERM; NEURAL PROGENITORS; EXPRESSION	Molecular oscillators are important cellular regulators of, for example, circadian clocks, oscillations of immune regulators, and short-period (ultradian) rhythms during embryonic development. The Notch signaling factor HES1 (hairy and enhancer of split 1) is a well-known repressor of proneural genes, and HES1 ultradian oscillation is essential for keeping cells in an efficiently proliferating progenitor state. HES1 oscillation is driven by both transcriptional self-repression and ubiquitin-dependent proteolysis. However, the E3 ubiquitin ligase targeting HES1 for proteolysis remains unclear. Based on siRNA-mediated gene silencing screening, co-immunoprecipitation, and ubiquitination assays, we discovered that the E3 ubiquitin ligase SCFFBXL14 complex regulates HES1 ubiquitination and proteolysis. siRNA-mediated knockdown of the Cullin-RING E3 ubiquitin ligases RBX1 or CUL1 increased HES1 protein levels, prolonged its half-life, and dampened its oscillation. FBXL14, an F-box protein for SCF ubiquitin ligase, associates with HES1. FBXL14 silencing stabilized HES1, whereas FBXL14 overexpression decreased HES1 protein levels. Of note, the SCFFBXL14 complex promoted the ubiquitination of HES1 in vivo, and a conserved WRPW motif in HES1 was essential for HES1 binding to FBXL14 and for ubiquitin-dependent HES1 degradation. HES1 knockdown promoted neuronal differentiation, but FBXL14 silencing inhibited neuronal differentiation induced by HES1 ablation in mES and F9 cells. Our results suggest that SCFFBXL14 promotes neuronal differentiation by targeting HES1 for ubiquitin-dependent proteolysis and that the C-terminal WRPW motif in HES1 is required for this process.	[Chen, Fangfang; Zhang, Chunxiao; Wu, Haonan; Ma, Yue; Jiang, Fan; Lu, Fei] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Guangdong, Peoples R China; [Chen, Fangfang; Luo, Xiaomin; Gui, Yaoting] Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China; [Zhang, Chunxiao; Zhang, Hui] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA; [Gong, Xinqi] Renmin Univ China, Inst Math Sci, Beijing 100872, Peoples R China	Peking University; University Town of Shenzhen; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Renmin University of China	Gui, YT (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518036, Peoples R China.; Zhang, H (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy,SEB 4138, Las Vegas, NV 89154 USA.; Lu, F (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Rm 407,Bldg F,2199 Lishui Rd, Shenzhen 518055, Peoples R China.	guiyaoting2007@aliyun.com; hui.zhang@unlv.edu; lufei@pkusz.edu.cn	zhang, chunxiao/AAH-3229-2019; Luo, Xiao-min/A-3359-2011; gui, yaoting/GLT-3684-2022	Luo, Xiao-min/0000-0002-2334-6544; Zhang, Chunxiao/0000-0001-5543-4509; Chen, Fangfang/0000-0001-9097-5036	Natural Science Foundation of Guangdong Province [2014A030313779]; Shenzhen Science, Technology and Innovation Commission [JCYJ20160527100529884]; National Institutes of Health [R15GM116087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM116087] Funding Source: NIH RePORTER	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science, Technology and Innovation Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Natural Science Foundation of Guangdong Province Grant 2014A030313779), Shenzhen Science, Technology and Innovation Commission Grant JCYJ20160527100529884, and National Institutes of Health Grant R15GM116087. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmoity AT, 2011, EUR J MED GENET, V54, P198, DOI 10.1016/j.ejmg.2010.11.010; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bessho Y, 2003, CURR OPIN GENET DEV, V13, P379, DOI 10.1016/S0959-437X(03)00083-2; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Fang XG, 2017, J EXP MED, V214, P245, DOI 10.1084/jem.20151673; Gong XQ, 2010, PROTEINS, V78, P3150, DOI 10.1002/prot.22831; Gong XQ, 2010, SCI CHINA LIFE SCI, V53, P1152, DOI 10.1007/s11427-010-4050-0; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kang SA, 2005, BIOCHEM BIOPH RES CO, V332, P33, DOI 10.1016/j.bbrc.2005.04.089; Kitagawa K, 2016, CURR CANCER DRUG TAR, V16, P119, DOI 10.2174/1568009616666151112122231; Kobayashi T, 2015, FEBS J, V282, P2475, DOI 10.1111/febs.13290; Kobayashi T, 2011, GENES-BASEL, V2, P219, DOI 10.3390/genes2010219; Kobayashi T, 2009, GENE DEV, V23, P1870, DOI 10.1101/gad.1823109; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Li S., 2016, J FLUORESC, V2016, P1, DOI DOI 10.1109/PERC0M.2016; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shimojo H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00078; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sun Y, 2003, CANCER BIOL THER, V2, P623; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; Ventre S, 2015, J MOL BIOL, V427, P1887, DOI 10.1016/j.jmb.2015.03.007; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zheng HP, 2012, CELL RES, V22, P936, DOI 10.1038/cr.2012.37; Zhou CY, 2015, J PHYS CHEM B, V119, P1035, DOI 10.1021/jp5064676	54	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20100	20112		10.1074/jbc.M117.815001	http://dx.doi.org/10.1074/jbc.M117.815001			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29070679	hybrid, Green Published			2022-12-28	WOS:000417696400017
J	Wang, T; Cook, I; Leyh, TS				Wang, Ting; Cook, Ian; Leyh, Thomas S.			The NSAID allosteric site of human cytosolic sulfotransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; kinetics; nuclear magnetic resonance (NMR); structural model; sulfotransferase; NSAID; acetylsalicylic; mefenamic; spin label	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTEIN-LIGAND DOCKING; HUMAN-LIVER; ESTROGEN SULFOTRANSFERASE; CARDIOVASCULAR-DISEASE; MOLECULAR-DYNAMICS; PRIMARY PREVENTION; PROSTATE-CANCER; MEFENAMIC-ACID; BINDING-SITES	Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly prescribed drugs worldwidemore than 111 million prescriptions were written in the United States in 2014. NSAIDs allosterically inhibit cytosolic sulfotransferases (SULTs) with high specificity and therapeutically relevant affinities. This study focuses on the interactions of SULT1A1 and mefenamic acid (MEF)a potent, highly specific NSAID inhibitor of 1A1. Here, the first structure of an NSAID allosteric sitethe MEF-binding site of SULT1A1is determined using spin-label triangulation NMR. The structure is confirmed by site-directed mutagenesis and provides a molecular framework for understanding NSAID binding and isoform specificity. The mechanism of NSAID inhibition is explored using molecular dynamics and equilibrium and pre-steady-state ligand-binding studies. MEF inhibits SULT1A1 turnover through an indirect (helix-mediated) stabilization of the closed form of the active-site cap of the enzyme, which traps the nucleotide and slows its release. Using the NSAID-binding site structure of SULT1A1 as a comparative model, it appears that 11 of the 13 human SULT isoforms harbor an NSAID-binding site. We hypothesize that these sites evolved to enable SULT isoforms to respond to metabolites that lie within their metabolic domains. Finally, the NSAID-binding site structure offers a template for developing isozyme-specific allosteric inhibitors that can be used to regulate specific areas of sulfuryl-transfer metabolism.	[Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	tom.leyh@einstein.yu.edu			National Institutes of Health [GM121849, GM106158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121849, R01GM106158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016305] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants GM121849 and GM106158. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKSOY IA, 1994, BIOCHEM BIOPH RES CO, V200, P1621, DOI 10.1006/bbrc.1994.1637; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Baron JA, 2000, ANNU REV MED, V51, P511, DOI 10.1146/annurev.med.51.1.511; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Campbell CL, 2007, JAMA-J AM MED ASSOC, V297, P2018, DOI 10.1001/jama.297.18.2018; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DUFFEL MW, 1981, J BIOL CHEM, V256, P1123; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; FALANY CN, 1989, BIOCHEM J, V260, P641, DOI 10.1042/bj2600641; Fuster V, 2011, CIRCULATION, V123, P768, DOI 10.1161/CIRCULATIONAHA.110.963843; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497; Glatt H, 2000, CHEM-BIOL INTERACT, V129, P141, DOI 10.1016/S0009-2797(00)00202-7; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Gurpinar E, 2014, CLIN CANCER RES, V20, P1104, DOI 10.1158/1078-0432.CCR-13-1573; Haas J, 2013, DATABASE-OXFORD, V2013, DOI DOI 10.1093/DATABASE/BAT031; Huang WT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003909; John M, 2006, J AM CHEM SOC, V128, P12910, DOI 10.1021/ja063584z; King RS, 2006, CURR DRUG METAB, V7, P745, DOI 10.2174/138920006778520615; LEVY G, 1971, J PHARM SCI, V60, P215, DOI 10.1002/jps.2600600212; Leyh TS, 2013, DRUG METAB REV, V45, P423, DOI 10.3109/03602532.2013.835625; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mora S, 2016, JAMA INTERN MED, V176, P1195, DOI 10.1001/jamainternmed.2016.2648; Nowell S, 2004, CANCER EPIDEM BIOMAR, V13, P270, DOI 10.1158/1055-9965.EPI-03-0047; Patrignani P, 2016, J AM COLL CARDIOL, V68, P967, DOI 10.1016/j.jacc.2016.05.083; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Richman IB, 2017, MED CLIN N AM, V101, P713, DOI 10.1016/j.mcna.2017.03.004; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Smith CJ, 2017, CANCER EPIDEM BIOMAR, V26, P845, DOI 10.1158/1055-9965.EPI-16-1027; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Strauch KA, 2011, AAOHN J, V59, P525, DOI 10.3928/08910162-20111123-01; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Teubner W, 2007, BIOCHEM J, V404, P207, DOI 10.1042/BJ20061431; THOMAS BH, 1972, CLIN PHARMACOL THER, V13, P906; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Venkataraman H, 2014, CHEM RES TOXICOL, V27, P2071, DOI 10.1021/tx500288b; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Verdonk ML, 2004, J CHEM INF COMP SCI, V44, P793, DOI 10.1021/ci034289q; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vietri M, 2000, EUR J CLIN PHARMACOL, V56, P81, DOI 10.1007/s002280050725; Vietri M, 2002, XENOBIOTICA, V32, P587, DOI 10.1080/00498250210131581; Walczak K, 2017, POSTEP HIG MED DOSW, V71, P149; Wang LQ, 2005, J STEROID BIOCHEM, V96, P367, DOI 10.1016/j.jsbmb.2005.05.002; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2016, DRUG METAB DISPOS, V44, P481, DOI 10.1124/dmd.115.068205; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; WHITEHOUSE LW, 1977, J PHARM SCI, V66, P1399, DOI 10.1002/jps.2600661012; WHITEHOUSE LW, 1975, J PHARM SCI, V64, P819, DOI 10.1002/jps.2600640519; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; Zhou YJ, 2014, PHARMACOEPIDEM DR S, V23, P43, DOI 10.1002/pds.3463	65	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20305	20312		10.1074/jbc.M117.817387	http://dx.doi.org/10.1074/jbc.M117.817387			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29038294	Green Published, hybrid			2022-12-28	WOS:000417696400033
J	Stockli, J; Fisher-Wellman, KH; Chaudhuri, R; Zeng, XY; Fazakerley, DJ; Meoli, CC; Thomas, KC; Hoffman, NJ; Mangiafico, SP; Xirouchaki, CE; Yang, CH; Ilkayeva, O; Wong, K; Cooney, GJ; Andrikopoulos, S; Muoio, DM; James, DE				Stockli, Jacqueline; Fisher-Wellman, Kelsey H.; Chaudhuri, Rima; Zeng, Xiao-Yi; Fazakerley, Daniel J.; Meoli, Christopher C.; Thomas, Kristen C.; Hoffman, Nolan J.; Mangiafico, Salvatore P.; Xirouchaki, Chrysovalantou E.; Yang, Chieh-Hsin; Ilkayeva, Olga; Wong, Kari; Cooney, Gregory J.; Andrikopoulos, Sofianos; Muoio, Deborah M.; James, David E.			Metabolomic analysis of insulin resistance across different mouse strains and diets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; glucose metabolism; insulin resistance; metabolomics; skeletal muscle metabolism; genetic diversity; metabolite signature; strain differences	GENE-NUTRIENT INTERACTIONS; FATTY-ACID OXIDATION; ENERGY-EXPENDITURE; MEDIUM-CHAIN; OBESITY; MUSCLE; MICE; POLYMORPHISM; SENSITIVITY; ELOVL3	Insulin resistance is a major risk factor for many diseases. However, its underlying mechanism remains unclear in part because it is triggered by a complex relationship between multiple factors, including genes and the environment. Here, we used metabolomics combined with computational methods to identify factors that classified insulin resistance across individual mice derived from three different mouse strains fed two different diets. Three inbred ILSXISS strains were fed high-fat or chow diets and subjected to metabolic phenotyping and metabolomics analysis of skeletal muscle. There was significant metabolic heterogeneity between strains, diets, and individual animals. Distinct metabolites were changed with insulin resistance, diet, and between strains. Computational analysis revealed 113 metabolites that were correlated with metabolic phenotypes. Using these 113 metabolites, combined with machine learning to segregate mice based on insulin sensitivity, we identified C22:1-CoA, C2-carnitine, and C16-ceramide as the best classifiers. Strikingly, when these three metabolites were combined into one signature, they classified mice based on insulin sensitivity more accurately than each metabolite on its own or other published metabolic signatures. Furthermore, C22:1-CoA was 2.3-fold higher in insulin-resistant mice and correlated significantly with insulin resistance. We have identified a metabolomic signature composed of three functionally unrelated metabolites that accurately predicts whole-body insulin sensitivity across three mouse strains. These data indicate the power of simultaneous analysis of individual, genetic, and environmental variance in mice for identifying novel factors that accurately predict metabolic phenotypes like whole-body insulin sensitivity.	[Stockli, Jacqueline; Chaudhuri, Rima; Zeng, Xiao-Yi; Fazakerley, Daniel J.; Thomas, Kristen C.; Hoffman, Nolan J.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Fisher-Wellman, Kelsey H.; Meoli, Christopher C.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Fisher-Wellman, Kelsey H.; Ilkayeva, Olga; Wong, Kari; Muoio, Deborah M.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27708 USA; [Mangiafico, Salvatore P.; Xirouchaki, Chrysovalantou E.; Yang, Chieh-Hsin; Andrikopoulos, Sofianos] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Cooney, Gregory J.; James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hoffman, Nolan J.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Exercise & Nutr, Melbourne, Vic 3000, Australia	University of Sydney; Garvan Institute of Medical Research; Duke University; University of Melbourne; University of Sydney; Australian Catholic University	James, DE (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney Med Sch, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au	Fisher-Wellman, Kelsey/O-8209-2019; Fazakerley, Daniel/J-2652-2019; Stoeckli, Jacqueline/D-7053-2016; Stoeckli, Jacqueline/Z-4443-2019; Muoio, Debbie Marie/E-1147-2012	Fisher-Wellman, Kelsey/0000-0002-0300-829X; Fazakerley, Daniel/0000-0001-8241-2903; Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; Muoio, Deborah/0000-0003-3760-9277; Cooke, Kristen/0000-0002-3534-1660; Xirouchaki, Chrysovalantou Eleni/0000-0002-8153-8958; Hoffman, Nolan/0000-0001-5168-7082; James, David/0000-0001-5946-5257; Yang, Chieh-Hsin (Jessie)/0000-0003-4360-670X	National Health and Medical Research Council (NHMRC) [GNT1061122, GNT1086851, GNT1086850]; National Institutes of Health [2R01DK089312, 2P01-DK058398]; National Institutes of Health F32 Fellowship [1F32DK105665-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089312, P01DK058398] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health F32 Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Health and Medical Research Council (NHMRC) Project Grants GNT1061122, GNT1086851, and GNT1086850 (to D. E. J.) and National Institutes of Health Grants 2R01DK089312 and 2P01-DK058398 (to D. M. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or NHMRC.; Supported by National Institutes of Health F32 Fellowship 1F32DK105665-01A1.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Bennett B, 2006, J PHARMACOL EXP THER, V319, P299, DOI 10.1124/jpet.106.103572; Bergman BC, 2016, DIABETOLOGIA, V59, P785, DOI 10.1007/s00125-015-3850-y; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BREMER J, 1982, J LIPID RES, V23, P243; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Chaudhuri R, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.10; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; CHRISTIANSEN RZ, 1977, BIOCHIM BIOPHYS ACTA, V487, P28, DOI 10.1016/0005-2760(77)90041-8; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Imamura M, 2011, ENDOCR J, V58, P723, DOI 10.1507/endocrj.EJ11-0113; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kasumov T, 2015, OBESITY, V23, P1414, DOI 10.1002/oby.21117; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kuhn M., 2019, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Kusunoki Masataka, 2007, J Med Invest, V54, P243, DOI 10.2152/jmi.54.243; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Li QL, 2015, J BIOL CHEM, V290, P8121, DOI 10.1074/jbc.M114.631549; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Magkos F, 2013, DIABETES, V62, P2757, DOI 10.2337/db13-0185; Magnes C, 2005, ANAL CHEM, V77, P2889, DOI 10.1021/ac048314i; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Palmer ND, 2015, J CLIN ENDOCR METAB, V100, pE463, DOI 10.1210/jc.2014-2357; Parks BW, 2015, CELL METAB, V21, P334, DOI 10.1016/j.cmet.2015.01.002; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; Phillips CM, 2011, ATHEROSCLEROSIS, V214, P408, DOI 10.1016/j.atherosclerosis.2010.10.029; Phillips CM, 2010, J LIPID RES, V51, P3500, DOI 10.1194/jlr.M008474; Phillips CM, 2010, J LIPID RES, V51, P1793, DOI 10.1194/jlr.M003046; R Development Core Team, 2009, R LANG ENV STAT COMP; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; REUBSAET FAG, 1989, LIPIDS, V24, P945, DOI 10.1007/BF02544539; Robitaille J, 2007, INT J OBESITY, V31, P411, DOI 10.1038/sj.ijo.0803450; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scacchi R, 2007, NUTR METAB CARDIOVAS, V17, P632, DOI 10.1016/j.numecd.2006.12.007; Seiler SE, 2014, J LIPID RES, V55, P635, DOI 10.1194/jlr.M043448; Shen J, 2008, J LIPID RES, V49, P1839, DOI 10.1194/jlr.P700033-JLR200; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Thalacker-Mercer AE, 2014, DIABETES, V63, P791, DOI 10.2337/db13-0396; Torgo L., 2010, DATA MINING R LEARNI; Tucci S, 2015, FEBS J, V282, P4242, DOI 10.1111/febs.13418; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Tvrdik P, 1997, J BIOL CHEM, V272, P31738, DOI 10.1074/jbc.272.50.31738; Wang XS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10464; Weindruch R, 1996, TOXICOL PATHOL, V24, P742, DOI 10.1177/019262339602400618; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298	71	24	26	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19135	19145		10.1074/jbc.M117.818351	http://dx.doi.org/10.1074/jbc.M117.818351			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28982973	hybrid, Green Published			2022-12-28	WOS:000416226700001
J	Njuma, OJ; Davis, I; Ndontsa, EN; Krewall, JR; Liu, AM; Goodwin, DC				Njuma, Olive J.; Davis, Ian; Ndontsa, Elizabeth N.; Krewall, Jessica R.; Liu, Aimin; Goodwin, Douglas C.			Mutual synergy between catalase and peroxidase activities of the bifunctional enzyme KatG is facilitated by electron hole-hopping within the enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electron paramagnetic resonance (EPR); electron transfer; enzyme inactivation; free radicals; heme; hydrogen peroxide; tryptophan	CYTOCHROME-C PEROXIDASE; MYCOBACTERIUM-TUBERCULOSIS KATG; SITE-DIRECTED MUTAGENESIS; TRP CROSS-LINK; BURKHOLDERIA-PSEUDOMALLEI; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ISONIAZID RESISTANCE; DELETION MUTAGENESIS	KatG is a bifunctional, heme-dependent enzyme in the front-line defense of numerous bacterial and fungal pathogens against H2O2-induced oxidative damage from host immune responses. Contrary to the expectation that catalase and peroxidase activities should be mutually antagonistic, peroxidatic electron donors (PxEDs) enhance KatG catalase activity. Here, we establish the mechanism of synergistic cooperation between these activities. We show that at low pH values KatG can fully convert H2O2 to O-2 and H2O only if a PxED is present in the reaction mixture. Stopped-flow spectroscopy results indicated rapid initial rates of H2O2 disproportionation slowing concomitantly with the accumulation of ferryl-like heme states. These states very slowly returned to resting (i.e. ferric) enzyme, indicating that they represented catalase-inactive intermediates. We also show that an active-site tryptophan, Trp-321, participates in off-pathway electron transfer. A W321F variant in which the proximal tryptophan was replaced with a non-oxidizable phenylalanine exhibited higher catalase activity and less accumulation of off-pathway heme intermediates. Finally, rapid freeze-quench EPR experiments indicated that both WT and W321F KatG produce the same methionine-tyrosine-tryptophan (MYW) cofactor radical intermediate at the earliest reaction time points and that Trp-321 is the preferred site of off-catalase protein oxidation in the native enzyme. Of note, PxEDs did not affect the formation of the MYW cofactor radical but could reduce non-productive protein-based radical species that accumulate during reaction with H2O2. Our results suggest that catalase-inactive intermediates accumulate because of off-mechanism oxidation, primarily of Trp-321, and PxEDs stimulate KatG catalase activity by preventing the accumulation of inactive intermediates.	[Njuma, Olive J.; Ndontsa, Elizabeth N.; Krewall, Jessica R.; Goodwin, Douglas C.] Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg, Auburn, AL 36849 USA; [Davis, Ian; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Davis, Ian] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Njuma, Olive J.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Ndontsa, Elizabeth N.] Aduro Biotech Inc, 740 Heinz Ave, Berkeley, CA 94710 USA	Auburn University System; Auburn University; University of Texas System; University of Texas at San Antonio (UTSA); University System of Georgia; Georgia State University; Vanderbilt University	Goodwin, DC (corresponding author), Auburn Univ, Dept Chem & Biochem, 179 Chem Bldg, Auburn, AL 36849 USA.	goodwdc@auburn.edu	Liu, Aimin/C-1572-2017	Liu, Aimin/0000-0002-4182-8176; Goodwin, Douglas/0000-0002-7869-7704; Davis, Ian/0000-0002-1566-4972	National Science Foundation [MCB 1616059, MCB 0641614]; National Institutes of Health Grant [GM108988]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108988] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grants MCB 1616059 and MCB 0641614 from the National Science Foundation (to D. C. G.) and National Institutes of Health Grant GM108988 (to A. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Cade CE, 2010, PROTEIN SCI, V19, P458, DOI 10.1002/pro.324; Carpena X, 2006, BIOCHEMISTRY-US, V45, P5171, DOI 10.1021/bi060017f; Carpena X, 2005, EMBO REP, V6, P1156, DOI 10.1038/sj.embor.7400550; Carpena X, 2003, J MOL BIOL, V327, P475, DOI 10.1016/S0022-2836(03)00122-0; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; Colin J, 2009, J AM CHEM SOC, V131, P8557, DOI 10.1021/ja901402v; DeLano W. L., 2013, MACPYMOL MOL GRAPHIC; Donald LJ, 2003, J BIOL CHEM, V278, P35687, DOI 10.1074/jbc.M304053200; Dunford H. B., 1999, HEME PEROXIDASES, P58; Falk J. E., 1964, PORPHYRINS METALLOPO, P804; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Fita I, 2015, HEME PEROXIDASES, P133; Gasselhuber B., 2015, HEME PEROXIDASES, P156; Gasselhuber B, 2016, BIOCHEMISTRY-US, V55, P3528, DOI 10.1021/acs.biochem.6b00436; Ghiladi RA, 2005, BIOCHEMISTRY-US, V44, P15093, DOI 10.1021/bi051463q; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; Ghiladi RA, 2005, J BIOL CHEM, V280, P22651, DOI 10.1074/jbc.M502486200; GOODWIN DC, 1995, ANAL BIOCHEM, V231, P333, DOI 10.1006/abio.1995.0059; Goodwin DC, 2003, ARCH BIOCHEM BIOPHYS, V417, P18, DOI 10.1016/S0003-9861(03)00321-7; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hillar A, 2000, BIOCHEMISTRY-US, V39, P5868, DOI 10.1021/bi0000059; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Ivancich A, 2001, J AM CHEM SOC, V123, P5050, DOI 10.1021/ja0036514; Ivancich A, 2013, BIOCHEMISTRY-US, V52, P7271, DOI 10.1021/bi400963j; Jakopitsch C, 2005, J BIOL CHEM, V280, P42411, DOI 10.1074/jbc.M508009200; Jakopitsch C, 2003, FEBS LETT, V552, P135, DOI 10.1016/S0014-5793(03)00901-3; Jakopitsch C, 2004, J BIOL CHEM, V279, P46082, DOI 10.1074/jbc.M408399200; Jakopitsch C, 2003, J BIOL CHEM, V278, P20185, DOI 10.1074/jbc.M211625200; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Jakopitsch C, 2006, J INORG BIOCHEM, V100, P1091, DOI 10.1016/j.jinorgbio.2006.02.009; Kathiresan M, 2017, CHEM SCI, V8, P1152, DOI 10.1039/c6sc03125k; Kruft BI, 2015, J PHYS CHEM A, V119, P6850, DOI 10.1021/jp511358p; Kudalkar SN, 2015, BIOCHEMISTRY-US, V54, P1648, DOI 10.1021/bi501221a; Kudalkar SN, 2012, J INORG BIOCHEM, V116, P106, DOI 10.1016/j.jinorgbio.2012.08.002; Liu A, 1998, BIOCHEMISTRY-US, V37, P16369, DOI 10.1021/bi981471p; Loewen PC, 2014, J AM CHEM SOC, V136, P7249, DOI 10.1021/ja502794e; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moore RL, 2008, BBA-PROTEINS PROTEOM, V1784, P900, DOI 10.1016/j.bbapap.2008.03.008; Moore S., 2016, ROUND THE HORN SITE; Ndontsa EN, 2012, ARCH BIOCHEM BIOPHYS, V525, P215, DOI 10.1016/j.abb.2012.06.003; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Njuma OJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P27, DOI 10.1016/j.abb.2013.11.007; Passardi F, 2007, GENE, V397, P101, DOI 10.1016/j.gene.2007.04.016; PATTERSON WR, 1995, BIOCHEMISTRY-US, V34, P4331, DOI 10.1021/bi00013a023; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P11377, DOI 10.1021/bi800952b; Regelsberger G, 2001, BIOCHEM SOC T, V29, P99; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; SCOTT SL, 1993, J PHYS CHEM-US, V97, P6710, DOI 10.1021/j100127a022; Singh R, 2008, ARCH BIOCHEM BIOPHYS, V471, P207, DOI 10.1016/j.abb.2007.12.008; Singh R, 2007, J AM CHEM SOC, V129, P15954, DOI 10.1021/ja075108u; SIVARAJA M, 1989, SCIENCE, V245, P738, DOI 10.1126/science.2549632; Suarez J, 2009, J BIOL CHEM, V284, P7017, DOI 10.1074/jbc.M808106200; Suarez J, 2009, J BIOL CHEM, V284, P16146, DOI 10.1074/jbc.M109.005546; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Uhlich GA, 2012, MICROBIOL-SGM, V158, P2225, DOI 10.1099/mic.0.059535-0; Uhlich GA, 2009, MICROBIOL-SGM, V155, P3589, DOI 10.1099/mic.0.031435-0; Varnado CL, 2004, PROTEIN EXPRES PURIF, V35, P76, DOI 10.1016/j.pep.2003.12.001; Vidossich P, 2007, J AM CHEM SOC, V129, P13436, DOI 10.1021/ja072245i; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; Wiseman B, 2010, J BIOL CHEM, V285, P26662, DOI 10.1074/jbc.M110.139428; Wiseman B, 2009, J BIOL INORG CHEM, V14, P801, DOI 10.1007/s00775-009-0493-9; Yamada Y, 2002, NAT STRUCT BIOL, V9, P691, DOI 10.1038/nsb834; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Yu SW, 2003, J BIOL CHEM, V278, P44121, DOI 10.1074/jbc.M304757200; Yukl ET, 2013, BIOCHEMISTRY-US, V52, P9447, DOI 10.1021/bi401441h; Zamocky M, 2001, FEBS LETT, V492, P177, DOI 10.1016/S0014-5793(01)02237-2; Zamocky M, 2010, BIOCATALYSIS BASED ON HEME PEROXIDASES, P7, DOI 10.1007/978-3-642-12627-7_2; Zamocky M, 2010, ARCH BIOCHEM BIOPHYS, V500, P45, DOI 10.1016/j.abb.2010.03.024; Zhang Y, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P115; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2004, J BIOL CHEM, V279, P7606, DOI 10.1074/jbc.M311884200; Zhao XB, 2012, J BIOL CHEM, V287, P37057, DOI 10.1074/jbc.M112.401208; Zhao XB, 2010, J AM CHEM SOC, V132, P8268, DOI 10.1021/ja103311e; Zhao XB, 2009, J BIOL CHEM, V284, P7030, DOI 10.1074/jbc.M808107200	78	10	10	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 10	2017	292	45					18408	18421		10.1074/jbc.M117.791202	http://dx.doi.org/10.1074/jbc.M117.791202			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM4CG	28972181	Green Published, hybrid			2022-12-28	WOS:000414958100003
J	Pannunzio, NR; Watanabe, G; Lieber, MR				Pannunzio, Nicholas R.; Watanabe, Go; Lieber, Michael R.			Nonhomologous DNA end-joining for repair of DNA double-strand breaks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA repair; nucleic acid enzymology; protein structure; DNA endonuclease; DNA-dependent serine; threonine protein kinase (DNA-PK); double-stranded DNA breaks; NHEJ	DEPENDENT PROTEIN-KINASE; XRCC4-DNA LIGASE-IV; BIOCHEMICALLY DEFINED SYSTEM; V(D)J RECOMBINATION; POLYNUCLEOTIDE KINASE; ENDONUCLEASE ACTIVITY; CRYSTAL-STRUCTURE; ARTEMIS NUCLEASE; SACCHAROMYCES-CEREVISIAE; SYNTHETIC LETHALITY	Nonhomologous DNA end-joining (NHEJ) is the predominant double-strand break (DSB) repair pathway throughout the cell cycle and accounts for nearly all DSB repair outside of the S and G(2) phases. NHEJ relies on Ku to thread onto DNA termini and thereby improve the affinity of the NHEJ enzymatic components consisting of polymerases (Pol and Pol ), a nuclease (the Artemis<bold>DNA</bold>-PKcs complex), and a ligase (XLF<bold>XRCC</bold>4<bold>Lig</bold>4 complex). Each of the enzymatic components is distinctive for its versatility in acting on diverse incompatible DNA end configurations coupled with a flexibility in loading order, resulting in many possible junctional outcomes from one DSB. DNA ends can either be directly ligated or, if the ends are incompatible, processed until a ligatable configuration is achieved that is often stabilized by up to 4 bp of terminal microhomology. Processing of DNA ends results in nucleotide loss or addition, explaining why DSBs repaired by NHEJ are rarely restored to their original DNA sequence. Thus, NHEJ is a single pathway with multiple enzymes at its disposal to repair DSBs, resulting in a diversity of repair outcomes.	[Lieber, Michael R.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol,Dept Biol Sci,Sect M, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA.	lieber@usc.edu		Pannunzio, Nick/0000-0002-8290-8236; Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA100504, R01CA196671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants (to M. R. L.). This is the second article in the Thematic Minireview series "DNA double-strand break repair and pathway choice." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Anand R, 2016, MOL CELL, V64, P940, DOI 10.1016/j.molcel.2016.10.017; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Andres SN, 2012, NUCLEIC ACIDS RES, V40, P1868, DOI 10.1093/nar/gks022; Arnoult N, 2017, NATURE, V549, P548, DOI 10.1038/nature24023; Balmus G, 2016, GENE DEV, V30, P2152, DOI 10.1101/gad.290510.116; Bebenek K, 2014, BIOCHEMISTRY-US, V53, P2781, DOI 10.1021/bi4017236; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bhargava R, 2016, TRENDS GENET, V32, P566, DOI 10.1016/j.tig.2016.06.007; BLOMMERS MJJ, 1989, BIOCHEMISTRY-US, V28, P7491, DOI 10.1021/bi00444a049; Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chang HHY, 2016, J BIOL CHEM, V291, P24377, DOI 10.1074/jbc.M116.752329; Chang HHY, 2016, NUCLEIC ACIDS RES, V44, P4991, DOI 10.1093/nar/gkw456; Chang HHY, 2015, J BIOL CHEM, V290, P24036, DOI 10.1074/jbc.M115.680900; Chen BZ, 2007, CHEM RES TOXICOL, V20, P1701, DOI 10.1021/tx700164y; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Dai Y, 2003, P NATL ACAD SCI USA, V100, P2462, DOI 10.1073/pnas.0437964100; Daley JM, 2008, DNA REPAIR, V7, P67, DOI 10.1016/j.dnarep.2007.07.018; Daley JM, 2017, CELL REP, V21, P324, DOI 10.1016/j.celrep.2017.09.048; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Daley JM, 2005, MOL CELL BIOL, V25, P896, DOI 10.1128/MCB.25.3.896-906.2005; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Eustermann S, 2010, NAT STRUCT MOL BIOL, V17, P241, DOI 10.1038/nsmb.1747; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Gerodimos CA, 2017, J BIOL CHEM, V292, P13914, DOI 10.1074/jbc.M117.798850; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Grawunder U, 1998, J BIOL CHEM, V273, P24708, DOI 10.1074/jbc.273.38.24708; Grawunder U, 1998, CURR BIOL, V8, P873, DOI 10.1016/S0960-9822(07)00349-1; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; HENNER WD, 1983, J BIOL CHEM, V258, P711; HENNER WD, 1983, J BIOL CHEM, V258, P5198; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Kumar V, 2016, P NATL ACAD SCI USA, V113, P10619, DOI 10.1073/pnas.1611882113; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lescale C, 2016, CELL REP, V16, P2967, DOI 10.1016/j.celrep.2016.08.069; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Li SC, 2011, J BIOL CHEM, V286, P36368, DOI 10.1074/jbc.M111.287797; Lieber MR, 2006, IMMUNITY, V25, P7, DOI 10.1016/j.immuni.2006.07.007; Lieber MR, 2016, NAT REV CANCER, V16, P387, DOI 10.1038/nrc.2016.40; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lisby M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016535; Liu MS, 2016, J AM CHEM SOC, V138, P2389, DOI 10.1021/jacs.5b13368; Liu XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13816; Lu H, 2008, MOL CELL, V31, P485, DOI 10.1016/j.molcel.2008.05.029; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; Malu S, 2012, J EXP MED, V209, P955, DOI 10.1084/jem.20111437; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; Mehrotra PV, 2011, MOL CELL, V41, P46, DOI 10.1016/j.molcel.2010.12.008; Menon V, 2017, DNA REPAIR, V58, P29, DOI 10.1016/j.dnarep.2017.08.003; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; MIMORI T, 1986, J BIOL CHEM, V261, P375; Moon AF, 2007, NAT STRUCT MOL BIOL, V14, P45, DOI 10.1038/nsmb1180; Moon AF, 2014, NAT STRUCT MOL BIOL, V21, P253, DOI 10.1038/nsmb.2766; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Nick McElhinny S.A., 2003, MOL CELL BIOL, V23, P2309, DOI [DOI 10.1128/MCB.23.7.2309-2315.2003, 10.1128/MCB.23.7.2309-2315.2003]; Niewolik D, 2017, J BIOL CHEM, V292, P3351, DOI 10.1074/jbc.M116.770461; Ochi T, 2015, SCIENCE, V347, P185, DOI 10.1126/science.1261971; Ochi T, 2014, DNA REPAIR, V17, P98, DOI 10.1016/j.dnarep.2014.02.010; Ochi T, 2013, STRUCTURE, V21, P672, DOI 10.1016/j.str.2013.02.014; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Povirk LF, 2007, J BIOL CHEM, V282, P3547, DOI 10.1074/jbc.M607745200; Povirk Lawrence F, 2012, ISRN Mol Biol, V2012, DOI 10.5402/2012/345805; Pryor JM, 2015, P NATL ACAD SCI USA, V112, pE4537, DOI 10.1073/pnas.1505805112; Reid DA, 2017, NUCLEIC ACIDS RES, V45, P1872, DOI 10.1093/nar/gkw1221; Reid DA, 2015, P NATL ACAD SCI USA, V112, pE2575, DOI 10.1073/pnas.1420115112; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roy S, 2015, MOL CELL BIOL, V35, P3017, DOI 10.1128/MCB.01503-14; Saito S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16112; Saito S, 2016, J HUM GENET, V61, P679, DOI 10.1038/jhg.2016.46; Schimmel J, 2017, EMBO J, V36, P3634, DOI 10.15252/embj.201796948; Sibanda BL, 2017, SCIENCE, V355, P520, DOI 10.1126/science.aak9654; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Sinden Richard R., 1992, Current Opinion in Biotechnology, V3, P612, DOI 10.1016/0958-1669(92)90005-4; Slavoff SA, 2014, J BIOL CHEM, V289, P10950, DOI 10.1074/jbc.C113.533968; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Symington LS, 2016, CRIT REV BIOCHEM MOL, V51, P195, DOI 10.3109/10409238.2016.1172552; Tadi SK, 2016, CELL REP, V17, P541, DOI 10.1016/j.celrep.2016.09.026; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Watanabe G, 2017, CELL RES, V27, P1304, DOI 10.1038/cr.2017.119; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Westmoreland JW, 2010, DNA REPAIR, V9, P617, DOI 10.1016/j.dnarep.2010.02.008; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xing MT, 2017, DNA REPAIR, V57, P133, DOI 10.1016/j.dnarep.2017.07.008; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233; Yannone SM, 2008, NUCLEIC ACIDS RES, V36, P3354, DOI 10.1093/nar/gkn205; Yin XT, 2017, CELL RES, V27, P1341, DOI 10.1038/cr.2017.110; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	122	258	261	14	99	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10512	10523		10.1074/jbc.TM117.000374	http://dx.doi.org/10.1074/jbc.TM117.000374			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29247009	Green Published, hybrid			2022-12-28	WOS:000437828400012
J	Falcon, B; Noad, J; McMahon, H; Randow, F; Goedert, M				Falcon, Benjamin; Noad, Jessica; McMahon, Harvey; Randow, Felix; Goedert, Michel			Galectin-8-mediated selective autophagy protects against seeded tau aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P301S TAU; ENDOCYTIC PATHWAY; HUMAN TAUOPATHIES; ALPHA-SYNUCLEIN; MOUSE-BRAIN; IN-VITRO; NEURODEGENERATION; FILAMENTS; PROPAGATION; NEURONS	Assembled tau can transfer between cells and seed the aggregation of soluble tau. This process is thought to underlie the amplification and propagation of tau inclusions throughout the brain in neurodegenerative diseases, including Alzheimer's disease. An understanding of the mechanisms involved may provide strategies for limiting assembled tau propagation. Here, we sought to determine how assembled tau seeds gain access to the cytosol and whether this access triggers cellular defenses. We show that tau assemblies enter cells through clathrin-independent endocytosis and escape from damaged endomembranes into the cytosol, where they seed the aggregation of soluble tau. We also found that the danger receptor galectin-8 detects damaged endomembranes and activates autophagy through recruitment of the cargo receptor nuclear dot protein 52 (NDP52). Inhibition of galectin-8- and NDP52-dependent autophagy increased seeded tau aggregation, indicating that autophagy triggered by damaged endomembranes during the entry of assembled tau seeds protects against tau aggregation, in a manner similar to cellular defenses against cytosol-dwelling microorganisms. A second autophagy cargo receptor, p62, then targeted seeded tau aggregates. Our results reveal that by monitoring endomembrane integrity, cells reduce entry of tau seeds into the cytosol and thereby prevent seeded aggregation. The mechanisms described here may help inform the development of therapies aimed at inhibiting the propagation of protein assemblies in neurodegenerative diseases.	[Falcon, Benjamin; Noad, Jessica; McMahon, Harvey; Randow, Felix; Goedert, Michel] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Randow, Felix] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England; [Goedert, Michel] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge	Goedert, M (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Goedert, M (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 0QQ, England.	mg@mrc-lmb.cam.ac.uk		Ryskeldi-Falcon, Benjamin/0000-0002-8176-2618	UK Medical Research Council [MC_U105184291, MC_U105170648, MC_U105178795]; Wellcome Trust [WT104752MA]; EU Joint Programme-Neurodegenerative Disease Research Grant; Medical Research Council [MC_EX_MR/N027892/1, MC_U105184291, MC_U105170648] Funding Source: researchfish; Wellcome Trust [104752/Z/14/Z] Funding Source: researchfish; MRC [MC_EX_MR/N027892/1, MC_U105184291, MC_U105170648, MC_U105178795] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU Joint Programme-Neurodegenerative Disease Research Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by UK Medical Research Council Grants MC_U105184291 (to M. G.), MC_U105170648 (to F. R.), and MC_U105178795 (to H. M. M.); Wellcome Trust Grant WT104752MA (to F. R.); and EU Joint Programme-Neurodegenerative Disease Research Grant (to M. G. and B. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen B, 2002, J NEUROSCI, V22, P9340; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Flach K, 2012, J BIOL CHEM, V287, P43223, DOI 10.1074/jbc.M112.396176; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Freeman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062143; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gal J, 2009, J NEUROCHEM, V111, P1062, DOI 10.1111/j.1471-4159.2009.06388.x; Ghetti B, 2015, NEUROPATH APPL NEURO, V41, P24, DOI 10.1111/nan.12213; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; MORISHIMAKAWASHIMA M, 1993, NEURON, V10, P1151, DOI 10.1016/0896-6273(93)90063-W; Ozcelik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062459; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Scott IS, 2007, ACTA NEUROPATHOL, V113, P417, DOI 10.1007/s00401-006-0165-6; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Usenovic M, 2015, J NEUROSCI, V35, P14234, DOI 10.1523/JNEUROSCI.1523-15.2015; Verheyen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146127; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xu Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0100-9; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	49	63	64	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2438	2451		10.1074/jbc.M117.809293	http://dx.doi.org/10.1074/jbc.M117.809293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29282296	hybrid, Green Published			2022-12-28	WOS:000425308300017
J	Ebert, K; Ewers, M; Bisha, I; Sander, S; Rasputniac, T; Daniel, H; Antes, I; Witt, H				Ebert, Karolin; Ewers, Maren; Bisha, Ina; Sander, Simone; Rasputniac, Tanja; Daniel, Hannelore; Antes, Iris; Witt, Heiko			Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucose transport; fructose; protein chimera; molecular dynamics; membrane protein; GLUT5; GLUT7; transporter	FORCE-FIELD; PROTEIN; GLUT2; EFFICIENT; DOMAINS; SERVER	Intestinal fructose uptake is mainly mediated by glucose transporter 5 (GLUT5/SLC2A5). Its closest relative, GLUT7, is also expressed in the intestine but does not transport fructose. For rat Glut5, a change of glutamine to glutamic acid at codon 166 (p.Q166E) has been reported to alter the substrate-binding specificity by shifting Glut5-mediated transport from fructose to glucose. Using chimeric proteins of GLUT5 and GLUT7, here we identified amino acid residues of GLUT5 that define its substrate specificity. The proteins were expressed in NIH-3T3 fibroblasts, and their activities were determined by fructose radiotracer flux. We divided the human GLUT5 sequence into 26 fragments and then replaced each fragment with the corresponding region in GLUT7. All fragments that yielded reduced fructose uptake were analyzed further by assessing the role of individual amino acid residues. Various positions in the first extracellular loop, in the fifth, seventh, eighth, ninth, and tenth transmembrane domains (TMDs), and in the regions between the ninth and tenth TMDs and tenth and 11th TMDs were identified as being important for proper fructose uptake. Although the p.Q167E change did not render the human protein into a glucose transporter, molecular dynamics simulations revealed a drastic change in the dynamics and a movement of the intracellular loop connecting the sixth and seventh TMDs, which covers the exit of the ligand. Finally, we generated a GLUT7-GLUT5 chimera consisting of the N-terminal part of GLUT7 and the C-terminal part of GLUT5. Although this chimera was inactive, we demonstrate fructose transport after introduction of four amino acids derived from GLUT5.	[Ebert, Karolin; Ewers, Maren; Sander, Simone; Rasputniac, Tanja; Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum Ernahrungsmed, Klinikum Rechts Isar MRI, Pediat Nutr Med, D-85354 Freising Weihenstephan, Germany; [Bisha, Ina; Antes, Iris] Tech Univ Munich, Dept Biosci, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany; [Bisha, Ina; Antes, Iris] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany; [Daniel, Hannelore] Tech Univ Munich, Nutr Physiol, D-85354 Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Antes, I (corresponding author), Tech Univ Munich, Dept Biosci, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany.; Antes, I (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Emil Erlenmeyer Forum 8 Geb 4264, D-85354 Freising Weihenstephan, Germany.; Witt, H (corresponding author), Tech Univ Munich, Padiatr Ernahrungsmed, Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.	antes@tum.de; heiko.witt@tum.de		Ewers, Maren/0000-0002-9029-2240; Ebert, Karolin/0000-0002-6657-0191; Sander, Simone/0000-0001-8255-7096	TUM University Foundation; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [GRK 1482, SFB1035/A10]	TUM University Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants GRK 1482 (to H. W.) and SFB1035/A10 (to I. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the TUM University Foundation and the Alexander von Humboldt Foundation.	Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bisha I, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1004017; Buchs AE, 1998, ENDOCRINOLOGY, V139, P827, DOI 10.1210/en.139.3.827; BURANT CF, 1992, J BIOL CHEM, V267, P14523; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; Clemencon B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108852; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ebert K, 2017, J MEMBRANE BIOL, V250, P171, DOI 10.1007/s00232-016-9945-7; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; INUKAI K, 1995, ENDOCRINOLOGY, V136, P4850, DOI 10.1210/en.136.11.4850; Jojart B, 2007, J COMPUT CHEM, V28, P2051, DOI 10.1002/jcc.20748; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Napolitano LMR, 2015, P NATL ACAD SCI USA, V112, pE3619, DOI 10.1073/pnas.1503334112; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Patel C, 2015, FASEB J, V29, P4046, DOI 10.1096/fj.15-272195; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wilder-Smith CH, 2014, UNITED EUR GASTROENT, V2, P14, DOI 10.1177/2050640613505279; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu L, 1998, ENDOCRINOLOGY, V139, P4205, DOI 10.1210/en.139.10.4205	25	6	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 9	2018	293	6					2115	2124		10.1074/jbc.RA117.001442	http://dx.doi.org/10.1074/jbc.RA117.001442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV9YR	29259131	Green Published, hybrid			2022-12-28	WOS:000424948000023
J	Figiel, M; Krepl, M; Park, S; Poznanski, J; Skowronek, K; Golab, A; Ha, T; Sponer, J; Nowotny, M				Figiel, Malgorzata; Krepl, Miroslav; Park, Sangwoo; Poznanski, Jaroslaw; Skowronek, Krzysztof; Golab, Agnieszka; Ha, Taekjip; Sponer, Jiri; Nowotny, Marcin			Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRAND DNA-SYNTHESIS; RETROVIRAL RNASES-H; RNA/DNA HYBRID; TYPE-1; CLEAVAGE; SEQUENCE; SPECIFICITY; INITIATION; TEMPLATE	HIV-1 reverse transcriptase (RT) possesses both DNA polymerase activity and RNase H activity that act in concert to convert single-stranded RNA of the viral genome to double-stranded DNA that is then integrated into the DNA of the infected cell. Reverse transcriptase-catalyzed reverse transcription critically relies on the proper generation of a polypurine tract (PPT) primer. However, the mechanism of PPT primer generation and the features of the PPT sequence that are critical for its recognition by HIV-1 RT remain unclear. Here, we used a chemical cross-linking method together with molecular dynamics simulations and single-molecule assays to study the mechanism of PPT primer generation. We found that the PPT was specifically and properly recognized within covalently tethered HIV-1 RT-nucleic acid complexes. These findings indicated that recognition of the PPT occurs within a stable catalytic complex after its formation. We found that this unique recognition is based on two complementary elements that rely on the PPT sequence: RNase H sequence preference and incompatibility of the poly(rA/dT) tract of the PPT with the nucleic acid conformation that is required for RNase H cleavage. The latter results from rigidity of the poly(rA/dT) tract and leads to base-pair slip-page of this sequence upon deformation into a catalytically relevant geometry. In summary, our results reveal an unexpected mechanism of PPT primer generation based on specific dynamic properties of the poly(rA/dT) segment and help advance our understanding of the mechanisms in viral RNA reverse transcription.	[Figiel, Malgorzata; Golab, Agnieszka; Nowotny, Marcin] Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland; [Skowronek, Krzysztof] Int Inst Mol & Cell Biol, Biophys Core Facil, PL-02109 Warsaw, Poland; [Krepl, Miroslav; Sponer, Jiri] Czech Acad Sci, Inst Biophys, Brno 61265, Czech Republic; [Krepl, Miroslav; Sponer, Jiri] Palacky Univ, Fac Sci, Dept Phys Chem, Reg Ctr Adv Technol & Mat, Olomouc 77146, Czech Republic; [Park, Sangwoo; Ha, Taekjip] Johns Hopkins Univ, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21205 USA; [Ha, Taekjip] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Poznanski, Jaroslaw] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Ha, Taekjip] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Palacky University Olomouc; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Howard Hughes Medical Institute	Nowotny, M (corresponding author), Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland.	mnowotny@iimcb.gov.pl	Sponer, Jiri/D-9467-2012; Figiel, Małgorzata/ABF-9197-2020; Ha, Taekjip/B-9506-2009; Poznanski, Jaroslaw/F-7705-2014; Skowronek, Krzysztof/G-2855-2010; Krepl, Miroslav/F-3868-2019	Ha, Taekjip/0000-0003-2195-6258; Poznanski, Jaroslaw/0000-0003-2684-1775; Skowronek, Krzysztof/0000-0001-9973-7085; Nowotny, Marcin/0000-0001-8632-0977; Krepl, Miroslav/0000-0002-9833-4281; Sponer, Jiri/0000-0001-6558-6186; Figiel, Malgorzata/0000-0002-2211-0425	Polish National Science Center [N N301 439738]; International Early Career Scientist grant from the Howard Hughes Medical Institute; Foundation for Polish Science "Ideas for Poland" award; Czech Science Foundation [P305/12/G034]; Ministry of Education, Youth and Sports of the Czech Republic Project [LO1305]; Praemium Academiae; National Institutes of Health [GM065367]; United States National Science Foundation [PHY 1430124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367] Funding Source: NIH RePORTER; Division Of Physics [1430124] Funding Source: National Science Foundation	Polish National Science Center; International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for Polish Science "Ideas for Poland" award; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic Project; Praemium Academiae(Czech Academy of Sciences); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was initially supported by a grant from the Polish National Science Center (Contract N N301 439738); later by an International Early Career Scientist grant from the Howard Hughes Medical Institute (both to M. N.); and by a Foundation for Polish Science "Ideas for Poland" award (to M. N.), Czech Science Foundation Grant P305/12/G034 (to J. S. and M. K.), Ministry of Education, Youth and Sports of the Czech Republic Project LO1305 (to J. S.), Praemium Academiae (to J. S.), and National Institutes of Health Grant GM065367 and United States National Science Foundation Grant PHY 1430124 (to S. P. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Coppel Y, 1997, BIOCHEMISTRY-US, V36, P4817, DOI 10.1021/bi962677y; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; Dash C, 2004, J BIOL CHEM, V279, P37095, DOI 10.1074/jbc.M403306200; Dash C, 2004, NUCLEIC ACIDS RES, V32, P1539, DOI 10.1093/nar/gkh307; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Figiel M, 2017, NUCLEIC ACIDS RES, V45, P3341, DOI 10.1093/nar/gkx004; FUENTES GM, 1995, J BIOL CHEM, V270, P28169, DOI 10.1074/jbc.270.47.28169; GOLJER I, 1995, J BIOL CHEM, V270, P22980, DOI 10.1074/jbc.270.39.22980; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; Han GW, 1997, J MOL BIOL, V269, P811, DOI 10.1006/jmbi.1997.1085; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Huang HF, 2000, CHEM BIOL, V7, P355, DOI 10.1016/S1074-5521(00)00113-7; HUBER HE, 1990, J BIOL CHEM, V265, P10565; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kvaratskhelia M, 2002, J BIOL CHEM, V277, P16689, DOI 10.1074/jbc.M109914200; Lapkouski M, 2013, NAT STRUCT MOL BIOL, V20, P230, DOI 10.1038/nsmb.2485; Le Grice SFJ, 2014, NUCLEIC ACIDS MOL BI, V30, P189, DOI 10.1007/978-3-642-39796-7_8; Li A, 2016, J BIOL CHEM, V291, P26566, DOI 10.1074/jbc.M116.753160; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; MARQUET R, 1995, BIOCHIMIE, V77, P113, DOI 10.1016/0300-9084(96)88114-4; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Palaniappan C, 1998, J BIOL CHEM, V273, P3808, DOI 10.1074/jbc.273.7.3808; Powell MD, 1996, J VIROL, V70, P5288, DOI 10.1128/JVI.70.8.5288-5296.1996; PULLEN KA, 1993, J BIOL CHEM, V268, P6221; PULLEN KA, 1990, J VIROL, V64, P6274, DOI 10.1128/JVI.64.12.6274-6277.1990; Rausch JW, 2007, NUCLEIC ACIDS RES, V35, P256, DOI 10.1093/nar/gkl909; Rausch JW, 2004, INT J BIOCHEM CELL B, V36, P1752, DOI 10.1016/j.biocel.2004.02.016; Rausch JW, 2003, P NATL ACAD SCI USA, V100, P11279, DOI 10.1073/pnas.1932546100; Sarafianos SG, 2001, EMBO J, V20, P1449, DOI 10.1093/emboj/20.6.1449; Schultz SJ, 2008, VIRUS RES, V134, P86, DOI 10.1016/j.virusres.2007.12.007; Schultz SJ, 2010, J MOL BIOL, V397, P161, DOI 10.1016/j.jmb.2010.01.059; Schultz SJ, 2009, J BIOL CHEM, V284, P32225, DOI 10.1074/jbc.M109.043158; Schultz SJ, 2006, J BIOL CHEM, V281, P1943, DOI 10.1074/jbc.M510504200; Schultz SJ, 2004, J MOL BIOL, V344, P635, DOI 10.1016/j.jmb.2004.09.081; Telesnitsky A., 1997, P121; Vafabakhsh R, 2012, SCIENCE, V337, P1097, DOI 10.1126/science.1224139; Yi-Brunozzi HY, 2005, J BIOL CHEM, V280, P20154, DOI 10.1074/jbc.M411228200; Yi-Brunozzi HY, 2008, CHEM BIOL, V15, P254, DOI 10.1016/j.chembiol.2008.01.012; Zhan XY, 1997, J BIOL CHEM, V272, P22023, DOI 10.1074/jbc.272.35.22023	41	13	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					191	202		10.1074/jbc.M117.798256	http://dx.doi.org/10.1074/jbc.M117.798256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29122886	Green Published, hybrid			2022-12-28	WOS:000419453200017
J	Kelley, RA; Al-Ubaidi, MR; Sinha, T; Genc, AM; Makia, MS; Ikelle, L; Naash, MI				Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Sinha, Tirthankar; Genc, Ayse M.; Makia, Mustafa S.; Ikelle, Larissa; Naash, Muna I.			Ablation of the riboflavin-binding protein retbindin reduces flavin levels and leads to progressive and dose-dependent degeneration of rods and cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; EPITHELIUM-DERIVED FACTOR; FATTY ACYL DERIVATIVES; MACULAR DEGENERATION; OXYGEN-CONSUMPTION; OUTER RETINA; COENZYME-A; IDENTIFICATION; DEHYDROGENASE; METABOLISM	The interface between the neural retina and the retinal pigment epithelium (RPE) is critical for several processes, including visual pigment regeneration and retinal attachment to the RPE. One of its most important functions is the exchange of metabolites between the photoreceptors and RPE because photoreceptor cells have very high energy demands, largely satisfied by oxidative metabolism. The riboflavin (RF) cofactors, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), are two key cofactors involved in oxidative metabolism. We have previously shown that retbindin is a photoreceptor-specific RF-binding protein exclusively expressed in the rods and present in the interphotoreceptor matrix at the interface between the RPE and photoreceptor outer segments. Here, we show that retbindin ablation in mice causes a retinal phenotype characterized by time- and dose-dependent declines in rod and cone photoreceptor functions as early as 120 days of age. Whereas minor retinal ultrastructural defects were observed at all ages examined, a significant decline occurred in photoreceptor nuclei at 240 days of age (similar to 36.8% rods and similar to 19.9% cones). Interestingly, significant reductions in FAD and FMN levels were observed before the onset of degeneration (similar to 46.1% FAD and similar to 45% FMN). These findings suggest that the reduced levels of these flavins result in the disruption of intracellular mechanisms, leading to photoreceptor cell death. Altogether, our results suggest that retbindin is a key player in the acquisition and retention of flavins in the neural retina, warranting future investigation into retbindin's role in photoreceptor cell death in models of retinal degenerative disorders.	[Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Sinha, Tirthankar; Genc, Ayse M.; Makia, Mustafa S.; Ikelle, Larissa; Naash, Muna I.] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd,SERC 2011, Houston, TX 77204 USA; [Kelley, Ryan A.] Univ Colorado, Anschutz Med Ctr, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA	University of Houston System; University of Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd,SERC 2011, Houston, TX 77204 USA.	malubaid@central.uh.edu; mnaash@central.uh.edu	Sinha/A-5725-2013	Sinha/0000-0002-7138-0907	NEI, National Institutes of Health [R01EY026499, R01-EY10609]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY026499, R01EY010609] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health, Grants R01EY026499 and R01-EY10609 (to M. I. N. and M. R. A.) and the Foundation Fighting Blindness (to M. R. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029; Ban Y, 2000, DEV BRAIN RES, V121, P89; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; BATEY DW, 1991, INVEST OPHTH VIS SCI, V32, P1981; BATEY DW, 1992, EXP EYE RES, V54, P605, DOI 10.1016/0014-4835(92)90139-J; BATEY DW, 1990, ANAL BIOCHEM, V188, P164, DOI 10.1016/0003-2697(90)90546-L; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Bridges CC, 2002, CURR EYE RES, V24, P129, DOI 10.1076/ceyr.24.2.129.8167; Byun JY, 2006, MOL VIS, V12, P949; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; ECKHERT CD, 1993, EXPERIENTIA, V49, P1084, DOI 10.1007/BF01929917; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUTTERMAN S, 1959, J BIOL CHEM, V234, P723; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Huvaere K, 2010, J PHYS CHEM B, V114, P5583, DOI 10.1021/jp9121744; Kansara V, 2005, J OCUL PHARMACOL TH, V21, P275, DOI 10.1089/jop.2005.21.275; Kelley RA, 2015, J BIOL CHEM, V290, P5041, DOI 10.1074/jbc.M114.624189; Kim HJ, 2013, BBA-BIOENERGETICS, V1827, P627, DOI 10.1016/j.bbabio.2013.01.012; Kozhevnikova OS, 2013, CELL CYCLE, V12, P1745, DOI 10.4161/cc.24825; Kruse HD, 1940, PUBLIC HEALTH REP, V55, P157, DOI 10.2307/4583161; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lin JM, 2008, AM J OPHTHALMOL, V145, P716, DOI 10.1016/j.ajo.2007.11.006; Machalinska Anna, 2012, Klin Oczna, V114, P115; Murray AR, 2015, HUM MOL GENET, V24, P2709, DOI 10.1093/hmg/ddv031; Said HM, 2005, J PHYSIOL-LONDON, V566, P369, DOI 10.1113/jphysiol.2005.085811; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; Tomitsuka E, 2003, J BIOCHEM, V134, P191, DOI 10.1093/jb/mvg144; Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	42	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21023	21034		10.1074/jbc.M117.785105	http://dx.doi.org/10.1074/jbc.M117.785105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079576	hybrid, Green Published			2022-12-28	WOS:000418453400018
J	Ito, S; Ogawa, K; Takeuchi, K; Takagi, M; Yoshida, M; Hirokawa, T; Hirayama, S; Shin-ya, K; Shimada, I; Doi, T; Goshima, N; Natsume, T; Nagata, K				Ito, Shinya; Ogawa, Koji; Takeuchi, Koh; Takagi, Motoki; Yoshida, Masahito; Hirokawa, Takatsugu; Hirayama, Shoshiro; Shin-ya, Kazuo; Shimada, Ichio; Doi, Takayuki; Goshima, Naoki; Natsume, Tohru; Nagata, Kazuhiro			A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; drug screening; endoplasmic reticulum (ER); fibrosis; heat-shock protein (HSP); molecular chaperone; protein-protein interaction; HSP47; serpinH1	STRESS-PROTEIN HSP47; PROLYL 4-HYDROXYLASE INHIBITOR; A-COUPLED LIPOSOMES; HEAT-SHOCK-PROTEIN; RAT-LIVER FIBROSIS; ENDOPLASMIC-RETICULUM; TRIPLE-HELIX; I COLLAGEN; CELLS; PROCOLLAGEN	Fibrosis can disrupt tissue structure and integrity and impair organ function. Fibrosis is characterized by abnormal collagen accumulation in the extracellular matrix. Pharmacological inhibition of collagen secretion therefore represents a promising strategy for the management of fibrotic disorders, such as liver and lung fibrosis. Hsp47 is an endoplasmic reticulum (ER)-resident collagen-specific molecular chaperone essential for correct folding of procollagen in the ER. Genetic deletion of Hsp47 or inhibition of its interaction with procollagen interferes with procollagen triple helix production, which vastly reduces procollagen secretion from fibroblasts. Thus, Hsp47 could be a potential and promising target for the management of fibrosis. In this study, we screened small-molecule compounds that inhibit the interaction of Hsp47 with collagen from chemical libraries using surface plasmon resonance (BIAcore), and we found a molecule AK778 and its cleavage product Col003 competitively inhibited the interaction and caused the inhibition of collagen secretion by destabilizing the collagen triple helix. Structural information obtained with NMR analysis revealed that Col003 competitively binds to the collagen-binding site on Hsp47. We propose that these structural insights could provide a basis for designing more effective therapeutic drugs for managing fibrosis.	[Ito, Shinya; Nagata, Kazuhiro] Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan; [Ito, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068507, Japan; [Ogawa, Koji; Takeuchi, Koh; Hirokawa, Takatsugu; Shin-ya, Kazuo; Goshima, Naoki; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Takagi, Motoki] JBIC, Tokyo 1350064, Japan; [Yoshida, Masahito; Doi, Takayuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Hirayama, Shoshiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Prot Metab, Tokyo 1130033, Japan; [Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Tokyo 1130033, Japan; [Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan; [Nagata, Kazuhiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kyoto 6038555, Japan	Kyoto Sangyo University; Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); Tohoku University; University of Tokyo; University of Tokyo; Kyoto Sangyo University; Japan Science & Technology Agency (JST)	Nagata, K (corresponding author), Kyoto Sangyo Univ, Inst Prot Dynam, Kyoto 6038555, Japan.; Natsume, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan.; Nagata, K (corresponding author), Kyoto Sangyo Univ, Fac Life Sci, Dept Mol Biosci, Kyoto 6038555, Japan.; Nagata, K (corresponding author), Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Kyoto 6038555, Japan.	t-natsume@aist.go.jp; nagata@cc.kyoto-su.ac.jp	Takagi, Motoki/Q-7390-2019; Shin-ya, Kazuo/L-9613-2018; Yoshida, Masahito/K-6636-2019; Doi, Takayuki/U-1009-2019; 直樹, 五島/M-8363-2018; Takeuchi, Koh/B-4971-2010; Natsume, Tohru/M-7627-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Yoshida, Masahito/0000-0002-0252-7637; Takeuchi, Koh/0000-0002-6227-4627; Natsume, Tohru/0000-0002-1510-2582	Japan Society for the Promotion of Science [24227009, 11J05697]; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ACT-MS from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17H06097] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; ACT-MS from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research (S) 24227009 from the Japan Society for the Promotion of Science (to K. N.), by Japan Society for the Promotion of Science Fellowship 11J05697 (to S. I.), and in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan and the ACT-MS from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Bickel M, 1998, HEPATOLOGY, V28, P404, DOI 10.1002/hep.510280217; Boudko SP, 2012, INT J BIOCHEM CELL B, V44, P21, DOI 10.1016/j.biocel.2011.09.009; Bourhis JM, 2012, NAT STRUCT MOL BIOL, V19, P1031, DOI 10.1038/nsmb.2389; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Goddard T. D., 2014, SPARKY 3; Higashi K, 2011, J BIOL CHEM, V286, P4485, DOI 10.1074/jbc.M110.151936; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Honzawa Y, 2014, GUT, V63, P1902, DOI 10.1136/gutjnl-2013-305632; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Ito S, 2017, SEMIN CELL DEV BIOL, V62, P142, DOI 10.1016/j.semcdb.2016.11.005; Kawasaki K, 2015, J BIOL CHEM, V290, P3639, DOI 10.1074/jbc.M114.592139; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; LAMANDE SR, 1995, J BIOL CHEM, V270, P8642, DOI 10.1074/jbc.270.15.8642; Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAGATA K, 1986, J CELL BIOL, V103, P223, DOI 10.1083/jcb.103.1.223; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Nordin H, 2005, ANAL BIOCHEM, V340, P359, DOI 10.1016/j.ab.2005.02.027; Ono T, 2012, J BIOL CHEM, V287, P6810, DOI 10.1074/jbc.M111.280248; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Sakaida I, 1996, HEPATOLOGY, V23, P755, DOI 10.1002/hep.510230416; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sunamoto M, 1998, LAB INVEST, V78, P967; Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807	34	36	36	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20076	20085		10.1074/jbc.M117.815936	http://dx.doi.org/10.1074/jbc.M117.815936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29025875	Green Published, hybrid			2022-12-28	WOS:000417696400015
J	Kirschner, KM; Sciesielski, LK; Krueger, K; Scholz, H				Kirschner, Karin M.; Sciesielski, Lina K.; Krueger, Katharina; Scholz, Holger			Wilms tumor protein-dependent transcription of VEGF receptor 2 and hypoxia regulate expression of the testis-promoting gene Sox9 in murine embryonic gonads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChiP); development; gene regulation; gene silencing; gene transcription; hypoxia; immunohistochemistry; ovary; testis; transcription factor	ENDOTHELIAL GROWTH-FACTOR; MESONEPHRIC CELL-MIGRATION; SEX DETERMINATION; KIDNEY DEVELOPMENT; FRASIER-SYNDROME; VASCULAR DEVELOPMENT; GRANULOSA-CELLS; MAMMALIAN GONAD; CORD FORMATION; WT1	Wilms tumor protein 1 (WT1) has been implicated in the control of several genes in sexual development, but its function in gonad formation is still unclear. Here, we report that WT1 stimulates expression of Kdr, the gene encoding VEGF receptor 2, in murine embryonic gonads. We found that WT1 and KDR are co-expressed in Sertoli cells of the testes and somatic cells of embryonic ovaries. Vivo-morpholino-mediated WT1 knockdown decreased Kdr transcripts in cultured embryonic gonads at multiple developmental stages. Furthermore, WT1 bound to the Kdr promoter in the chromatin of embryonic testes and ovaries. Forced expression of the WT1(-KTS) isoform, which functions as a transcription factor, increased KDR mRNA levels, whereas the WT1(+KTS) isoform, which acts presumably on the post-transcriptional level, did not. ChIP indicated that WT1(-KTS), but not WT1(+KTS), binds to the KDR promoter. Treatment with the KDR tyrosine kinase inhibitor SU1498 or the KDR ligand VEGFA revealed that KDR signaling represses the testis-promoting gene Sox9 in embryonic XX gonads. WT1 knockdown abrogated the stimulatory effect of SU1498-mediated KDR inhibition on Sox9 expression. Exposure to 1% O-2 to mimic the low-oxygen conditions in the embryo increased Vegfa expression but did not affect Sox9 mRNA levels in gonadal explants. However, incubation in 1% O-2 in the presence of SU1498 significantly reduced Sox9 transcripts in cultured testes and increased Sox9 levels in ovaries. These findings demonstrate that both the local oxygen environment and WT1, which enhances KDR expression, contribute to sex-specific Sox9 expression in developing murine gonads.	[Kirschner, Karin M.; Krueger, Katharina; Scholz, Holger] Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany; [Sciesielski, Lina K.] Charite, Klin Neonatol, Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de	Sciesielski, Lina/G-3716-2017	Sciesielski, Lina/0000-0003-3458-0309; Kirschner, Karin/0000-0003-0226-8636	Deutsche Forschungsgemeinschaft [Scho634/8-1]; Else Kroner-Fresenius-Stiftung [2014_A23]; Verein fur fruhgeborene Kinder an der Charite e.V.; Focus Area "DynAge" at the Free University Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Verein fur fruhgeborene Kinder an der Charite e.V.; Focus Area "DynAge" at the Free University Berlin	This work was supported by Deutsche Forschungsgemeinschaft Grant Scho634/8-1 and grants from the Else Kroner-Fresenius-Stiftung (Grant 2014_A23), the "Verein fur fruhgeborene Kinder an der Charite e.V.", and the Focus Area "DynAge" at the Free University Berlin. The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bott RC, 2006, BIOL REPROD, V75, P56, DOI 10.1095/biolreprod.105.047225; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Brill C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43000; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chen M, 2017, DEVELOPMENT, V144, P44, DOI 10.1242/dev.144105; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clement TM, 2011, BIOL REPROD, V85, P277, DOI 10.1095/biolreprod.110.090282; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao F, 2014, HUM MOL GENET, V23, P333, DOI 10.1093/hmg/ddt423; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HACKER A, 1995, DEVELOPMENT, V121, P1603; Hammes A, 2001, CELL, V106, P319, DOI 10.1016/S0092-8674(01)00453-6; Hanson J, 2007, FRONT BIOSCI-LANDMRK, V12, P2279, DOI 10.2741/2230; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Jacobi CLJ, 2013, J BIOL CHEM, V288, P18811, DOI 10.1074/jbc.M113.464644; Kikuchi H, 1998, J MED GENET, V35, P45, DOI 10.1136/jmg.35.1.45; Kirschner KM, 2014, J BIOL CHEM, V289, P24452, DOI 10.1074/jbc.M114.564336; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Klattig J, 2007, SEX DEV, V1, P238, DOI 10.1159/000104774; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; Kobayashi A, 2005, ANN NY ACAD SCI, V1061, P9, DOI 10.1196/annals.1336.003; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; McCarty G, 2011, J BIOL CHEM, V286, P43634, DOI 10.1074/jbc.M111.310128; Meschia G, 2011, CLIN CHEST MED, V32, P15, DOI 10.1016/j.ccm.2010.11.007; Morrison AA, 2006, BIOCHEM CELL BIOL, V84, P789, DOI 10.1139/O06-065; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; PELLETIER J, 1991, GENE DEV, V5, P1345, DOI 10.1101/gad.5.8.1345; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Quinn A, 2012, SEMIN REPROD MED, V30, P351, DOI 10.1055/s-0032-1324718; RICCARDI VM, 1978, PEDIATRICS, V61, P604; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Romereim SM, 2016, RESULTS PROBL CELL D, V58, P67, DOI 10.1007/978-3-319-31973-5_4; Rudigier LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176296; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Tilmann C, 1999, DEVELOPMENT, V126, P2883; Toska E, 2014, BIOCHEM J, V461, P15, DOI 10.1042/BJ20131587; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102	53	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20281	20291		10.1074/jbc.M117.816751	http://dx.doi.org/10.1074/jbc.M117.816751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29042436	Green Published, hybrid			2022-12-28	WOS:000417696400031
J	Manthei, KA; Ahn, J; Glukhova, A; Yuan, WM; Larkin, C; Manett, TD; Chang, L; Shayman, JA; Axley, MJ; Schwendeman, A; Tesmer, JJG				Manthei, Kelly A.; Ahn, Joomi; Glukhova, Alisa; Yuan, Wenmin; Larkin, Christopher; Manett, Taylor D.; Chang, Louise; Shayman, James A.; Axley, Milton J.; Schwendeman, Anna; Tesmer, John J. G.			A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyltransferase; apolipoprotein; cholesterol; conformational change; crystallography; high-density lipoprotein (HDL); inhibitor; structural biology; HDX MS; lecithin	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; FISH-EYE DISEASE; HIGH-DENSITY-LIPOPROTEIN; CRYSTAL-STRUCTURE; OPEN CONFORMATION; LCAT DEFICIENCY; INTERFACIAL ACTIVATION; CARDIOVASCULAR-DISEASE; TERMINAL TRUNCATION; VITRO EXPRESSION	Lecithin:cholesterol acyltransferase (LCAT) plays a key role in reverse cholesterol transport by transferring an acyl group from phosphatidylcholine to cholesterol, promoting the maturation of high-density lipoproteins (HDL) from discoidal to spherical particles. LCAT is activated through an unknown mechanism by apolipoprotein A-I (apoA-I) and other mimetic peptides that form a belt around HDL. Here, we report the crystal structure of LCAT with an extended lid that blocks access to the active site, consistent with an inactive conformation. Residues Thr-123 and Phe-382 in the catalytic domain form a latch-like interaction with hydrophobic residues in the lid. Because these residues are mutated in genetic disease, lid displacement was hypothesized to be an important feature of apoA-I activation. Functional studies of site-directed mutants revealed that loss of latch interactions or the entire lid enhanced activity against soluble ester substrates, and hydrogen-deuterium exchange (HDX) mass spectrometry revealed that the LCAT lid is extremely dynamic in solution. Upon addition of a covalent inhibitor that mimics one of the reaction intermediates, there is an overall decrease in HDX in the lid and adjacent regions of the protein, consistent with ordering. These data suggest a model wherein the active site of LCAT is shielded from soluble substrates by a dynamic lid until it interacts with HDL to allow transesterification to proceed.	[Manthei, Kelly A.; Glukhova, Alisa; Manett, Taylor D.; Chang, Louise; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Manthei, Kelly A.; Glukhova, Alisa; Manett, Taylor D.; Chang, Louise; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol & Biol Chem, Ann Arbor, MI 48109 USA; [Ahn, Joomi; Larkin, Christopher; Axley, Milton J.] MedImmune, Gaithersburg, MD 20878 USA; [Yuan, Wenmin; Schwendeman, Anna] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Yuan, Wenmin; Schwendeman, Anna] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Shayman, James A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Glukhova, Alisa] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci Biol, Parkville, Vic 3052, Australia; [Glukhova, Alisa] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; AstraZeneca; Medimmune; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Monash University; Monash University	Tesmer, JJG (corresponding author), Purdue Univ, Dept Biol Sci, 240 S Martin Jischke Dr, W Lafayette, IN 47907 USA.	jtesmer@purdue.edu		Manett, Taylor/0000-0001-6315-2712; Yuan, Wenmin/0000-0002-0250-4072; Chang, Louise/0000-0001-5501-4774; Glukhova, Alisa/0000-0003-4146-965X; Manthei, Kelly/0000-0003-3874-8228; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL071818, HL122416, AR056991]; F32 Ruth L. Kirschstein NRSA [F32HL131288]; American Heart Association [15POST24870001, 16POST27760002, 13SDG17230049]; University of Michigan Chemical Biology; Veterans Affairs Merit Review Award [1I01BX002021]; MedImmune; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL122416, F32HL131288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056991] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F32 Ruth L. Kirschstein NRSA; American Heart Association(American Heart Association); University of Michigan Chemical Biology; Veterans Affairs Merit Review Award(US Department of Veterans Affairs); MedImmune(AstraZenecaMedimmune); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants HL071818 and HL122416 (to J. J. G. T.) and AR056991 (to J. A. S.), F32 Ruth L. Kirschstein NRSA F32HL131288 (to K. A. M.), American Heart Association Postdoctoral Fellowships 15POST24870001 (to K. A. M.) and 16POST27760002 (to W. Y.), American Heart Association Scientist Development Grant 13SDG17230049 (to A. S.), University of Michigan Chemical Biology Postdoctoral Fellowship (to A. G.), Veterans Affairs Merit Review Award 1I01BX002021 (to J. A. S.), and MedImmune. J. A., C. L., and M. J. A. declare that they are employees of MedImmune, the global biologics R&D arm of AstraZeneca, and own stock/stock options in AstraZeneca. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adimoolam S, 1998, J BIOL CHEM, V273, P32561, DOI 10.1074/jbc.273.49.32561; Ahn J, 2012, ANAL CHEM, V84, P7256, DOI 10.1021/ac301749h; Ahsan L., 2014, HDL HDB BIOL FUNCTIO, P159, DOI DOI 10.1016/B978-0-12-407867-3.00007-X; BOLIN DJ, 1994, J BIOL CHEM, V269, P7429; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Calabresi L, 2012, ATHEROSCLEROSIS, V222, P299, DOI 10.1016/j.atherosclerosis.2011.11.034; Charlton-Menys V, 2007, NEPHROL DIAL TRANSPL, V22, P2379, DOI 10.1093/ndt/gfm311; CHEN CH, 1982, BIOCHEM BIOPH RES CO, V107, P1091, DOI 10.1016/0006-291X(82)90633-7; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christiaens B, 2000, BBA-MOL CELL BIOL L, V1486, P321, DOI 10.1016/S1388-1981(00)00075-5; DASSEUX JL, 1999, Patent No. 6004925; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Francone OL, 1996, J LIPID RES, V37, P1609; FROHLICH J, 1987, ACTA MED SCAND, V221, P291; FUNKE H, 1991, P NATL ACAD SCI USA, V88, P4855, DOI 10.1073/pnas.88.11.4855; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; GLOMSET JA, 1968, J LIPID RES, V9, P155; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; GOTODA T, 1991, LANCET, V338, P778, DOI 10.1016/0140-6736(91)90665-C; Gu XD, 2016, J BIOL CHEM, V291, P6386, DOI 10.1074/jbc.M115.696088; Gunawardane RN, 2016, J BIOL CHEM, V291, P2799, DOI 10.1074/jbc.M115.672790; Hill J. S., 1994, THESIS; Hiraoka M, 2005, J LIPID RES, V46, P2441, DOI 10.1194/jlr.M500248-JLR200; Homan R, 2013, ANAL BIOCHEM, V441, P80, DOI 10.1016/j.ab.2013.06.018; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iacob RE, 2014, J AM SOC MASS SPECTR, V25, P2093, DOI 10.1007/s13361-014-0973-1; Iacob RE, 2013, J PHARM SCI-US, V102, P4315, DOI 10.1002/jps.23754; Jin LH, 1999, BIOCHEMISTRY-US, V38, P15659, DOI 10.1021/bi9916729; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARMIN O, 1993, J LIPID RES, V34, P81; Kim KK, 1997, STRUCTURE, V5, P173, DOI 10.1016/S0969-2126(97)00177-9; KLEIN HG, 1995, J BIOL CHEM, V270, P9443, DOI 10.1074/jbc.270.16.9443; Kuivenhoven JA, 1995, J CLIN INVEST, V96, P2783, DOI 10.1172/JCI118348; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lang DA, 1998, EUR J BIOCHEM, V254, P333, DOI 10.1046/j.1432-1327.1998.2540333.x; Lee YP, 1997, BBA-LIPID LIPID MET, V1344, P250, DOI 10.1016/S0005-2760(96)00149-X; Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x; Li D., 2015, APOLIPOPROTEIN MIMET, P29, DOI [DOI 10.1007/978-3-319-17350-4_3, 10.1007/978-3-319-17350]; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miettinen HE, 1998, ARTERIOSCL THROM VAS, V18, P591, DOI 10.1161/01.ATV.18.4.591; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nanjee MN, 2003, ATHEROSCLEROSIS, V170, P105, DOI 10.1016/S0021-9150(03)00241-7; Nardini M, 2000, J BIOL CHEM, V275, P31219, DOI 10.1074/jbc.M003903200; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; Peelman F, 1999, J LIPID RES, V40, P59; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piper DE, 2015, J LIPID RES, V56, P1711, DOI 10.1194/jlr.M059873; Pisciotta L, 2005, ATHEROSCLEROSIS, V182, P153, DOI 10.1016/j.atherosclerosis.2005.01.048; QU SJ, 1995, J LIPID RES, V36, P967; Reshetnyak Y, 2006, J BIOMOL STRUCT DYN, V24, P75, DOI 10.1080/07391102.2006.10507101; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Sorci-Thomas MG, 2009, CLIN LIPIDOL, V4, P113, DOI 10.2217/17584299.4.1.113; Vanloo B, 2000, J LIPID RES, V41, P752; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Vickaryous NK, 2003, BBA-PROTEINS PROTEOM, V1646, P164, DOI 10.1016/S1570-9639(03)00005-0; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao Y, 2005, BIOCHEMISTRY-US, V44, P1013, DOI 10.1021/bi0481489	67	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 8	2017	292	49					20313	20327		10.1074/jbc.M117.802736	http://dx.doi.org/10.1074/jbc.M117.802736			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP5XN	29030428	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000417696400034
J	Park, Y; Han, GS; Carman, GM				Park, Yeonhee; Han, Gil-Soo; Carman, George M.			A conserved tryptophan within the WRDPLVDID domain of yeast Pah1 phosphatidate phosphatase is required for its in vivo function in lipid metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diacylglycerol; glycerophospholipid; phosphatase; phosphatidic acid; triacylglycerol; yeast	SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; MEMBRANE BIOGENESIS; MEDIATED REGULATION; ORTHOLOGUE PAH1P; PROTEIN; PHOSPHORYLATION; GENE; PHO85P-PHO80P; ENZYME	PAH1-encoded phosphatidate phosphatase, which catalyzes the dephosphorylation of phosphatidate to produce diacylglycerol at the endoplasmic reticulum membrane, plays a major role in controlling the utilization of phosphatidate for the synthesis of triacylglycerol or membrane phospholipids. The conserved N-LIP and haloacid dehalogenase-like domains of Pah1 are required for phosphatidate phosphatase activity and the in vivo function of the enzyme. Its non-conserved regions, which are located between the conserved domains and at the C terminus, contain sites for phosphorylation by multiple protein kinases. Truncation analyses of the non-conserved regions showed that they are not essential for the catalytic activity of Pah1 and its physiological functions (e.g. triacylglycerol synthesis). This analysis also revealed that the C-terminal region contains a previously unrecognized WRDPLVDID domain (residues 637-645) that is conserved in yeast, mice, and humans. The deletion of this domain had no effect on the catalytic activity of Pah1 but caused the loss of its in vivo function. Site-specific mutational analyses of the conserved residues within WRDPLVDID indicated that Trp-637 plays a crucial role in Pah1 function. This work also demonstrated that the catalytic activity of Pah1 is required but is not sufficient for its in vivo functions.	Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health from the United States Public Health Service [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fernandez-Murray JP, 2016, J LIPID RES, V57, P1789, DOI 10.1194/jlr.R070920; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lussier M, 1997, GENETICS, V147, P435; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sherr GL, 2017, BIOCHEM BIOPH RES CO, V491, P693, DOI 10.1016/j.bbrc.2017.07.127; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Siniossoglou S, 2009, TRAFFIC, V10, P1181, DOI 10.1111/j.1600-0854.2009.00923.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	67	10	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19580	19589		10.1074/jbc.M117.819375	http://dx.doi.org/10.1074/jbc.M117.819375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29066621	hybrid, Green Published			2022-12-28	WOS:000416911300004
J	Rotwein, P				Rotwein, Peter			Large-scale analysis of variation in the insulin-like growth factor family in humans reveals rare disease links and common polymorphisms (vol 292, pg 9252, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Rotwein, Peter/0000-0002-9505-1817	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042748] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK042748] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Rotwein P, 2017, J BIOL CHEM, V292, P9252, DOI 10.1074/jbc.M117.783639	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19608	19608		10.1074/jbc.AAC117.000854	http://dx.doi.org/10.1074/jbc.AAC117.000854			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	29196571	Green Published, hybrid			2022-12-28	WOS:000416911300008
J	Xu, JJ; Zhang, JH; Zhuo, JM; Li, Y; Tian, YQ; Tan, HR				Xu, Jingjing; Zhang, Jihui; Zhuo, Jiming; Li, Yue; Tian, Yuqing; Tan, Huarong			Activation and mechanism of a cryptic oviedomycin gene cluster via the disruption of a global regulatory gene, adpA, in Streptomyces ansochromogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; metabolism; natural product biosynthesis; polyketide; transcriptional coactivator; AdpA; Streptomyces ansochromogenes; cryptic gene clusters; global regulators; oviedomycin	A-FACTOR; ANTIBIOTIC BIOSYNTHESIS; COELICOLOR A3(2); TRANSCRIPTIONAL REGULATORS; HETEROLOGOUS EXPRESSION; NIKKOMYCIN BIOSYNTHESIS; SECONDARY METABOLITES; MOLECULAR REGULATION; POLYKETIDE SYNTHASE; END-PRODUCT	Genome sequencing analysis has revealed at least 35 clusters of likely biosynthetic genes for secondary metabolites in Streptomyces ansochromogenes. Disruption of adpA encoding a global regulator (AdpA) resulted in the failure of nikkomycin production, whereas other antibacterial activities against Staphylococcus aureus, Bacillus cereus, and Bacillus subtilis were observed with the fermentation broth of adpA but not with that of the wild-type strain. Transcriptional analysis showed that a cryptic gene cluster (pks7), which shows high identity with an oviedomycin biosynthetic gene cluster (ovm), was activated in adpA. The corresponding product of pks7 was characterized as oviedomycin by MS and NMR spectroscopy. To understand the molecular mechanism of ovm activation, the roles of six regulatory genes situated in the ovm cluster were investigated. Among them, proteins encoded by co-transcribed genes ovmZ and ovmW are positive regulators of ovm. AdpA directly represses the transcription of ovmZ and ovmW. Co-overexpression of ovmZ and ovmW can relieve the repression of AdpA on ovm transcription and effectively activate oviedomycin biosynthesis. The promoter of ovmOI-ovmH is identified as the direct target of OvmZ and OvmW. This is the first report that AdpA can simultaneously activate nikkomycin biosynthesis but repress oviedomycin biosynthesis in one strain. Our findings provide an effective strategy that is able to activate cryptic secondary metabolite gene clusters by genetic manipulation of global regulatory genes.	[Xu, Jingjing; Zhang, Jihui; Zhuo, Jiming; Li, Yue; Tian, Yuqing; Tan, Huarong] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Xu, Jingjing; Zhuo, Jiming; Tian, Yuqing; Tan, Huarong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Tian, YQ; Tan, HR (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing 100101, Peoples R China.	tianyq@im.ac.cn; tanhr@im.ac.cn	xu, jing/GRR-8698-2022		Ministry of Science and Technology of China [2015CB150600, 2013CB734001]; National Natural Science Foundation of China [31370097, 31571281]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China Grants 2015CB150600 and 2013CB734001 and National Natural Science Foundation of China Grants 31370097 and 31571281. The authors declare that they have no conflicts of interest with the contents of this article.	Akanuma G, 2009, MOL MICROBIOL, V73, P898, DOI 10.1111/j.1365-2958.2009.06814.x; Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Bate N, 2006, MOL MICROBIOL, V62, P148, DOI 10.1111/j.1365-2958.2006.05338.x; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Du D, 2013, APPL MICROBIOL BIOT, V97, P6383, DOI 10.1007/s00253-013-4836-7; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez-Escribano JP, 2011, MICROB BIOTECHNOL, V4, P207, DOI 10.1111/j.1751-7915.2010.00219.x; Guo F, 2015, METAB ENG, V28, P134, DOI 10.1016/j.ymben.2014.12.006; Guyet A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-81; Heine D, 2014, J NAT PROD, V77, P1083, DOI 10.1021/np400915p; Higashi T, 2007, J BACTERIOL, V189, P3515, DOI 10.1128/JB.00055-07; Ichinose K, 2003, MICROBIOL-SGM, V149, P1633, DOI 10.1099/mic.0.26310-0; Kalan L, 2013, CHEM BIOL, V20, P1214, DOI 10.1016/j.chembiol.2013.09.006; Kato J, 2002, J BACTERIOL, V184, P6016, DOI 10.1128/JB.184.21.6016-6025.2002; Kealey C, 2017, BIOTECHNOL LETT, V39, P805, DOI 10.1007/s10529-017-2311-8; Kharel MK, 2012, NAT PROD REP, V29, P264, DOI 10.1039/c1np00068c; Kieser T., 2000, PRACTICAL STREPTOMYC, P406; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Li Y, 2017, SCI CHINA LIFE SCI, V60, P935, DOI 10.1007/s11427-017-9115-x; Li Y, 2016, J BIOL CHEM, V291, P5406, DOI 10.1074/jbc.M115.695874; Liu G, 2013, MICROBIOL MOL BIOL R, V77, P112, DOI 10.1128/MMBR.00054-12; Lombo F, 2004, CHEMBIOCHEM, V5, P1181, DOI 10.1002/cbic.200400073; Lombo F, 2009, CHEMBIOCHEM, V10, P296, DOI 10.1002/cbic.200800425; Lu C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0359-5; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Mendez C, 2002, J NAT PROD, V65, P779, DOI 10.1021/np010555n; Metsa-Ketela M, 2004, J ANTIBIOT, V57, P502, DOI 10.7164/antibiotics.57.502; Myronovskyi M, 2011, APPL ENVIRON MICROB, V77, P5370, DOI 10.1128/AEM.00434-11; Nazari B, 2013, APPL ENVIRON MICROB, V79, P707, DOI 10.1128/AEM.02217-12; Niu GQ, 2016, FEMS MICROBIOL REV, V40, P554, DOI 10.1093/femsre/fuw012; Novakova R, 2002, GENE, V297, P197, DOI 10.1016/S0378-1119(02)00889-2; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Olano C, 2014, MICROB BIOTECHNOL, V7, P242, DOI 10.1111/1751-7915.12116; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pan YY, 2009, MOL MICROBIOL, V72, P710, DOI 10.1111/j.1365-2958.2009.06681.x; Pullan ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-175; Sambrook J., 2001, MOL CLONING LAB MANU; Sherwood EJ, 2013, P NATL ACAD SCI USA, V110, pE2500, DOI 10.1073/pnas.1305392110; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Tobes R, 2002, NUCLEIC ACIDS RES, V30, P318, DOI 10.1093/nar/30.1.318; van Wezel GP, 2009, METHOD ENZYMOL, V458, P117, DOI 10.1016/S0076-6879(09)04805-8; Wang LQ, 2009, P NATL ACAD SCI USA, V106, P8617, DOI 10.1073/pnas.0900592106; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Xu GM, 2010, J BIOL CHEM, V285, P27440, DOI 10.1074/jbc.M110.143081; Yamazaki H, 2004, MOL MICROBIOL, V53, P555, DOI 10.1111/j.1365-2958.2004.04153.x; Yamazaki H, 2000, J BACTERIOL, V182, P4596, DOI 10.1128/JB.182.16.4596-4605.2000; Yamazaki H, 2003, J BACTERIOL, V185, P1273, DOI 10.1128/JB.185.4.1273-1283.2003; Zeng HM, 2002, CURR MICROBIOL, V45, P175, DOI 10.1007/s00284-001-0115-4; Zhong XY, 2013, SCI CHINA LIFE SCI, V56, P609, DOI 10.1007/s11427-013-4506-0; Zhou ZX, 2015, CHEMBIOCHEM, V16, P496, DOI 10.1002/cbic.201402577; Zou ZZ, 2014, MOL MICROBIOL, V94, P490, DOI 10.1111/mmi.12752	54	45	46	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 1	2017	292	48					19708	19720		10.1074/jbc.M117.809145	http://dx.doi.org/10.1074/jbc.M117.809145			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FO5OZ	28972184	hybrid, Green Published			2022-12-28	WOS:000416911300016
J	Bookwalter, CS; Tay, CL; McCrorie, R; Previs, MJ; Lu, HL; Krementsova, EB; Fagnant, PM; Baum, J; Trybus, KM				Bookwalter, Carol S.; Tay, Chwen L.; McCrorie, Rama; Previs, Michael J.; Lu, Hailong; Krementsova, Elena B.; Fagnant, Patricia M.; Baum, Jake; Trybus, Kathleen M.			Reconstitution of the core of the malaria parasite glideosome with recombinant Plasmodium class XIV myosin A and Plasmodium actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; chaperone; malaria; myosin; parasite; Plasmodium falciparum; myosin XIV; glideosome; malaria; myosin light chain; MTIP; UCS family chaperone	SKELETAL-MUSCLE MYOSIN; LIGHT-CHAIN; ESCHERICHIA-COLI; CELL INVASION; COMPLEX; MOTILITY; MOTOR; CHAPERONE; PHOSPHORYLATION; REQUIRES	Motility of the apicomplexan malaria parasite Plasmodium falciparum is enabled by a multiprotein glideosome complex, whose core is the class XIV myosin motor, PfMyoA, and a divergent Plasmodium actin (PfAct1). Parasite motility is necessary for host-cell invasion and virulence, but studying its molecular basis has been hampered by unavailability of sufficient amounts of PfMyoA. Here, we expressed milligram quantities of functional full-length PfMyoA with the baculovirus/Sf9 cell expression system, which required a UCS (UNC-45/CRO1/She4p) family myosin chaperone from Plasmodium spp. In addition to the known light chain myosin tail interacting protein (MTIP), we identified an essential light chain (PfELC) that co-purified with PfMyoA isolated from parasite lysates. The speed at which PfMyoA moved actin was fastest with both light chains bound, consistent with the light chain-binding domain acting as a lever arm to amplify nucleotide-dependent motions in the motor domain. Surprisingly, PfELC binding to the heavy chain required that MTIP also be bound to the heavy chain, unlike MTIP that bound the heavy chain independently of PfELC. Neither the presence of calcium nor deletion of the MTIP N-terminal extension changed the speed of actin movement. Of note, PfMyoA moved filaments formed from Sf9 cell-expressed PfAct1 at the same speed as skeletal muscle actin. Duty ratio estimates suggested that as few as nine motors can power actin movement at maximal speed, a feature that may be necessitated by the dynamic nature of Plasmodium actin filaments in the parasite. In summary, we have reconstituted the essential core of the glideosome, enabling drug targeting of both of its core components to inhibit parasite invasion.	[Bookwalter, Carol S.; Previs, Michael J.; Lu, Hailong; Krementsova, Elena B.; Fagnant, Patricia M.; Trybus, Kathleen M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Tay, Chwen L.; McCrorie, Rama; Baum, Jake] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Tay, Chwen L.] NHSBT, Bristol BS34 7QH, Avon, England	University of Vermont; Imperial College London	Trybus, KM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Hlth Sci Res Facil 132, Burlington, VT 05405 USA.	kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009	Baum, Jake/0000-0002-0275-352X	National Institutes of Health [AI117476, AI132378, HL124041]; Wellcome Trust Investigator Award [100993/Z/13/Z]; Human Frontier Science Organization Young Investigator Program [RGY0066/2016]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL124041, K99HL124041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI117476, R01AI132378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Investigator Award(Wellcome Trust); Human Frontier Science Organization Young Investigator Program(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI117476 and AI132378 (to K. M. T.) and HL124041 (to M. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Wellcome Trust Investigator Award 100993/Z/13/Z and Human Frontier Science Organization Young Investigator Program Award RGY0066/2016.	Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; Bird JE, 2014, P NATL ACAD SCI USA, V111, P12390, DOI 10.1073/pnas.1409459111; Bookwalter CS, 2014, J BIOL CHEM, V289, P30832, DOI 10.1074/jbc.M114.572453; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Bosch J, 2007, J MOL BIOL, V372, P77, DOI 10.1016/j.jmb.2007.06.016; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; De La Cruz EM, 2004, CURR OPIN CELL BIOL, V16, P61, DOI 10.1016/j.ceb.2003.11.011; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Frenal K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15710; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; Herm-Gotz A, 2002, EMBO J, V21, P2149, DOI 10.1093/emboj/21.9.2149; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; Koldewey P, 2017, J BIOL CHEM, V292, P12010, DOI 10.1074/jbc.R117.796862; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LI SJ, 1993, J BACTERIOL, V175, P332, DOI 10.1128/JB.175.2.332-340.1993; LOWEY S, 1993, J BIOL CHEM, V268, P20414; Lu H, 2015, P NATL ACAD SCI USA, V112, pE4168, DOI 10.1073/pnas.1507587112; Nebl T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002222; Olshina MA, 2016, FASEB J, V30, P405, DOI 10.1096/fj.15-276618; Periz J, 2017, ELIFE, V6, DOI [10.7554/eLife.24119, 10.7554/elife.24119]; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Previs MJ, 2008, ANAL CHEM, V80, P5864, DOI 10.1021/ac800337v; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Tardieux I, 2016, J CELL BIOL, V214, P507, DOI 10.1083/jcb.201605100; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Vahokoski J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004091; Warshaw DM, 2000, J BIOL CHEM, V275, P37167, DOI 10.1074/jbc.M006438200; Warshaw DM, 2004, J MUSCLE RES CELL M, V25, P467, DOI 10.1007/s10974-004-1767-z; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Williams MJ, 2015, MBIO, V6, DOI 10.1128/mBio.00845-15; World Health Organization, 2016, 2014 WORLD MAL REP; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]	43	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19290	19303		10.1074/jbc.M117.813972	http://dx.doi.org/10.1074/jbc.M117.813972			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28978649	Green Published, hybrid			2022-12-28	WOS:000416226700012
J	Chu, YD; Tu, T; Penttinen, L; Xue, XL; Wang, XY; Yi, ZL; Gong, L; Rouvinen, J; Luo, HY; Hakulinen, N; Yao, B; Su, XY				Chu, Yindi; Tu, Tao; Penttinen, Leena; Xue, Xianli; Wang, Xiaoyu; Yi, Zhuolin; Gong, Li; Rouvinen, Juha; Luo, Huiying; Hakulinen, Nina; Yao, Bin; Su, Xiaoyun			Insights into the roles of non-catalytic residues in the active site of a GH10 xylanase with activity on cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; crystal structure; glycoside hydrolase; molecular docking; mutagenesis; bifunctional; biofuels; GH10; xylanase	BACTERIUM CALDICELLULOSIRUPTOR-BESCII; HYDROLASE FAMILY 10; ANAEROCELLUM-THERMOPHILUM; SACCHAROMYCES-CEREVISIAE; MOLECULAR-DYNAMICS; CATALYTIC DOMAINS; ESCHERICHIA-COLI; PLANT BIOMASS; FORCE-FIELD; DSM 6725	Bifunctional glycoside hydrolases have potential for cost-savings in enzymatic decomposition of plant cell wall polysaccharides for biofuels and bio-based chemicals. The N-terminal GH10 domain of a bifunctional multimodular enzyme CbXyn10C/Cel48B from Caldicellulosiruptor bescii is an enzyme able to degrade xylan and cellulose simultaneously. However, the molecular mechanism underlying its substrate promiscuity has not been elucidated. Herein, we discovered that the binding cleft of CbXyn10C would have at least six sugar-binding subsites by using isothermal titration calorimetry analysis of the inactive E140Q/E248Q mutant with xylo- and cello-oligosaccharides. This was confirmed by determining the catalytic efficiency of the wild-type enzyme on these oligosaccharides. The free form and complex structures of CbXyn10C with xylose- or glucose-configured oligosaccharide ligands were further obtained by crystallographic analysis and molecular modeling and docking. CbXyn10C was found to have a typical (/)(8)-TIM barrel fold and salad-bowl shape of GH10 enzymes. In complex structures with xylo-oligosaccharides, seven sugar-binding subsites were found, and many residues responsible for substrate interactions were identified. Site-directed mutagenesis indicated that 6 and 10 amino acid residues were key residues for xylan and cellulose hydrolysis, respectively. The most important residues are centered on subsites -2 and -1 near the cleavage site, whereas residues playing moderate roles could be located at more distal regions of the binding cleft. Manipulating the residues interacting with substrates in the distal regions directly or indirectly improved the activity of CbXyn10C on xylan and cellulose. Most of the key residues for cellulase activity are conserved across GH10 xylanases. Revisiting randomly selected GH10 enzymes revealed unreported cellulase activity, indicating that the dual function may be a more common phenomenon than has been expected.	[Chu, Yindi; Tu, Tao; Xue, Xianli; Wang, Xiaoyu; Gong, Li; Luo, Huiying; Yao, Bin; Su, Xiaoyun] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Penttinen, Leena; Rouvinen, Juha; Hakulinen, Nina] Univ Eastern Finland, Dept Chem, Joensuu Campus, FIN-80101 Joensuu, Finland; [Yi, Zhuolin] Chinese Acad Sci, Chengdu Inst Biol, Chengdu 610041, Sichuan, Peoples R China; [Gong, Li] Zhejiang Univ, Coll Anim Sci, Key Lab Mol Anim Nutr & Feed Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; University of Eastern Finland; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Zhejiang University	Hakulinen, N (corresponding author), Univ Eastern Finland, POB 111,Yliopistokatu 7, FIN-80101 Joensuu, Finland.; Yao, B; Su, XY (corresponding author), Feed Res Inst, 12 S Zhongguancun St, Beijing 100081, Peoples R China.	nina.hakulinen@uef.fi; binyao@caas.cn; suxiaoyun@caas.cn		Hakulinen, Nina/0000-0003-4471-7188; Penttinen, Leena/0000-0002-7847-1676; Rouvinen, Juha/0000-0003-1843-5718	National Natural Science Foundation of China [31672458]; National Key Research and Development Program of China [2016YFD0501409-02]; China Modern Agriculture Research System [CARS-42]; Elite Youth Program of Chinese Academy of Agricultural Sciences; Academy of Finland [287241, 292705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; China Modern Agriculture Research System; Elite Youth Program of Chinese Academy of Agricultural Sciences; Academy of Finland(Academy of Finland)	This work was supported by National Natural Science Foundation of China Grant 31672458, National Key Research and Development Program of China Grant 2016YFD0501409-02, China Modern Agriculture Research System Grant CARS-42, and the Elite Youth Program of Chinese Academy of Agricultural Sciences. The work at University of Eastern Finland was conducted with financial support from the Academy of Finland (grant decisions 287241 and 292705). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SR, 2000, J BIOL CHEM, V275, P23027, DOI 10.1074/jbc.M000128200; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Groot J, 2017, BIOTECHNOL BIOENG, V114, P885, DOI 10.1002/bit.26217; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Hong SY, 2006, BIOTECHNOL LETT, V28, P1857, DOI 10.1007/s10529-006-9166-8; Ichinose H, 2012, PROCESS BIOCHEM, V47, P358, DOI 10.1016/j.procbio.2011.06.002; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kataeva I, 2013, ENERG ENVIRON SCI, V6, P2186, DOI 10.1039/c3ee40932e; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Lochner A, 2011, APPL ENVIRON MICROB, V77, P4042, DOI 10.1128/AEM.02811-10; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Nakazawa H, 2008, APPL MICROBIOL BIOT, V81, P681, DOI 10.1007/s00253-008-1667-z; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Sun HH, 2016, ANGEW CHEM INT EDIT, V55, P14275, DOI 10.1002/anie.201606722; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Xue XL, 2015, APPL ENVIRON MICROB, V81, P3823, DOI 10.1128/AEM.00432-15; Yang SJ, 2010, INT J SYST EVOL MICR, V60, P2011, DOI 10.1099/ijs.0.017731-0; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Ye LB, 2012, APPL ENVIRON MICROB, V78, P7048, DOI 10.1128/AEM.02009-12; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Zhao L, 2013, PROCESS BIOCHEM, V48, P1879, DOI 10.1016/j.procbio.2013.08.020; Zhou JP, 2009, APPL MICROBIOL BIOT, V85, P323, DOI 10.1007/s00253-009-2081-x; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zverlov V, 1998, MICROBIOL-SGM, V144, P457, DOI 10.1099/00221287-144-2-457	41	26	27	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19315	19327		10.1074/jbc.M117.807768	http://dx.doi.org/10.1074/jbc.M117.807768			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974575	Green Published, hybrid			2022-12-28	WOS:000416226700014
J	Rasouli, S; Abdolvahabi, A; Croom, CM; Plewman, DL; Shi, YH; Ayers, JI; Shaw, BF				Rasouli, Sanaz; Abdolvahabi, Alireza; Croom, Corbin M.; Plewman, Devon L.; Shi, Yunhua; Ayers, Jacob I.; Shaw, Bryan F.			Lysine acylation in superoxide dismutase-1 electrostatically inhibits formation of fibrils with prion-like seeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); fibril; oligomer; protein aggregation; lysine acetylation; motor neuron disease; succinylation	AMYOTROPHIC-LATERAL-SCLEROSIS; PROTEIN CHARGE LADDERS; WILD-TYPE SOD1; CAPILLARY-ELECTROPHORESIS; TRANSGENIC MICE; ALPHA-SYNUCLEIN; SPORADIC ALS; LINKED SOD1; NET CHARGE; AGGREGATION	The acylation of lysine residues in superoxide dismutase-1 (SOD1) has been previously shown to decrease its rate of nucleation and elongation into amyloid-like fibrils linked to amyotrophic lateral sclerosis. The chemical mechanism underlying this effect is unclear, i.e. hydrophobic/steric effects versus electrostatic effects. Moreover, the degree to which the acylation might alter the prion-like seeding of SOD1 in vivo has not been addressed. Here, we acylated a fraction of lysine residues in SOD1 with groups of variable hydrophobicity, charge, and conformational entropy. The effect of each acyl group on the rate of SOD1 fibril nucleation and elongation were quantified in vitro with thioflavin-T (ThT) fluorescence, and we performed 594 iterate aggregation assays to obtain statistically significant rates. The effect of the lysine acylation on the prion-like seeding of SOD1 was assayed in spinal cord extracts of transgenic mice expressing a G85R SOD1-yellow fluorescent protein construct. Acyl groups with >2 carboxylic acids diminished self-assembly into ThT-positive fibrils and instead promoted the self-assembly of ThT-negative fibrils and amorphous complexes. The addition of ThT-negative, acylated SOD1 fibrils to organotypic spinal cord failed to produce the SOD1 inclusion pathology that typically results from the addition of ThT-positive SOD1 fibrils. These results suggest that chemically increasing the net negative surface charge of SOD1 via acylation can block the prion-like propagation of oligomeric SOD1 in spinal cord.	[Rasouli, Sanaz; Abdolvahabi, Alireza; Croom, Corbin M.; Plewman, Devon L.; Shi, Yunhua; Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76706 USA; [Rasouli, Sanaz] Baylor Univ, Inst Biomed Studies, Waco, TX 76706 USA; [Ayers, Jacob I.] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA	Baylor University; Baylor University; State University System of Florida; University of Florida	Shaw, BF (corresponding author), Baylor Univ, Dept Chem & Biochem, Waco, TX 76706 USA.	bryan_shaw@baylor.edu	Ayers, Jacob/AAQ-7158-2021	Ayers, Jacob/0000-0003-4544-2366	National Science Foundation [CHE 1352122]; Welch Foundation [AA-1854]; NINDS, National Institutes of Health [1R01NA092788-01]; Division Of Chemistry [1352122] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE 1352122 (to B. F. S.), Welch Foundation Grant AA-1854 (to B. F. S.), and NINDS, National Institutes of Health Grant 1R01NA092788-01 (to J. I. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdolvahabi A, 2017, ACS CHEM NEUROSCI, V8, P1378, DOI 10.1021/acschemneuro.7b00029; Abdolvahabi A, 2016, ACS CHEM NEUROSCI, V7, P799, DOI 10.1021/acschemneuro.6b00048; Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Alfonso LF, 2009, MOL MED REP, V2, P533, DOI 10.3892/mmr_00000132; Antinone SE, 2013, J BIOL CHEM, V288, P21606, DOI 10.1074/jbc.M113.487231; Ayers JI, 2016, ACTA NEUROPATHOL, V132, P827, DOI 10.1007/s00401-016-1623-4; Ayyadevara S., 2017, ANTIOXID RE IN PRESS; Banks CJ, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00354-17; Bateman LA, 2013, J AM CHEM SOC, V135, P14568, DOI 10.1021/ja408322b; Carbeck JD, 1998, ACCOUNTS CHEM RES, V31, P343, DOI 10.1021/ar970255q; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Cohen TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6845; Cook C, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt259; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Felder CE, 2007, NUCLEIC ACIDS RES, V35, pW512, DOI 10.1093/nar/gkm307; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Frutiger K, 2008, AMYOTROPH LATERAL SC, V9, P184, DOI 10.1080/17482960801984358; Fukada K, 2001, EUR J NEUROSCI, V14, P2032, DOI 10.1046/j.0953-816x.2001.01828.x; Furukawa Y, 2016, J BIOL CHEM, V291, P4144, DOI 10.1074/jbc.M115.683763; Gitlin I, 2003, J PHYS CHEM B, V107, P1466, DOI 10.1021/jp027066w; Gitlin I, 2006, ANGEW CHEM INT EDIT, V45, P3022, DOI 10.1002/anie.200502530; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Iyer A, 2016, J BIOL CHEM, V291, P21110, DOI 10.1074/jbc.M116.726612; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Kundu B, 1999, PROTEINS, V37, P321, DOI 10.1002/(SICI)1097-0134(19991115)37:3<321::AID-PROT1>3.0.CO;2-L; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; de Lavor MSL, 2015, INT J CLIN EXP PATHO, V8, P9941; Menon MK, 2000, ANAL CHEM, V72, P5714, DOI 10.1021/ac000752b; Mompean M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002447; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Profit AA, 2017, BIOCONJUGATE CHEM, V28, P666, DOI 10.1021/acs.bioconjchem.6b00732; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rich JT, 2010, OTOLARYNG HEAD NECK, V143, P331, DOI 10.1016/j.otohns.2010.05.007; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rotunno MS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00253; Sangwan S, 2017, P NATL ACAD SCI USA, V114, P8770, DOI 10.1073/pnas.1705091114; Schmitt ND, 2017, J MASS SPECTROM, V52, P480, DOI 10.1002/jms.3953; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Shaw BF, 2010, J AM CHEM SOC, V132, P17411, DOI 10.1021/ja9067035; Shi YH, 2015, ACS CHEM NEUROSCI, V6, P1696, DOI 10.1021/acschemneuro.5b00146; Shi Y, 2014, PROTEIN SCI, V23, P1417, DOI 10.1002/pro.2526; Shi YH, 2013, J MOL BIOL, V425, P4388, DOI 10.1016/j.jmb.2013.07.018; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; Tanaka M, 2015, NAT CHEM BIOL, V11, P373, DOI 10.1038/nchembio.1818; Tatham MH, 2017, MOL CELL PROTEOMICS, V16, P310, DOI 10.1074/mcp.O116.065219; Taylor JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep24656; Walker JM, 2009, SPRINGER PROTOC HAND, P11, DOI 10.1007/978-1-59745-198-7_3; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Xu GL, 2015, HUM MOL GENET, V24, P1019, DOI 10.1093/hmg/ddu517; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	58	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 24	2017	292	47					19366	19380		10.1074/jbc.M117.805283	http://dx.doi.org/10.1074/jbc.M117.805283			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FN7VK	28974578	Green Published, hybrid			2022-12-28	WOS:000416226700018
